PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Borths, MR; Stevens, NJ				Borths, Matthew R.; Stevens, Nancy J.			The first hyaenodont from the late Oligocene Nsungwe Formation of Tanzania: Paleoecological insights into the Paleogene-Neogene carnivore transition	PLOS ONE			English	Article							TOOTH ERUPTION SEQUENCE; CREODONT MAMMALIA; EVOLUTION; FOSSIL; DIVERSIFICATION; DIVERSITY; RADIATION; AFRICA; ORIGIN	Throughout the Paleogene, most terrestrial carnivore niches in Afro-Arabia were occupied by Hyaenodonta, an extinct lineage of placental mammals. By the end of the Miocene, terrestrial carnivore niches had shifted to members of Carnivora, a clade with Eurasian origins. The transition from a hyaenodont-carnivore fauna to a carnivoran-carnivore fauna coincides with other ecological changes in Afro-Arabia as tectonic conditions in the African Rift System altered climatic conditions and facilitated faunal exchange with Eurasia. Fossil bearing deposits in the Nsungwe Formation in southwestern Tanzania are precisely dated to similar to 25.2 Ma (late Oligocene), preserving a late Paleogene Afro-Arabian fauna on the brink of environmental transition, including the earliest fossil evidence of the split between Old World monkeys and apes. Here we describe a new hyaenodont from the Nsungwe Formation, Pakakali rukwaensis gen. et sp. nov., a bobcat-sized taxon known from a portion of the maxilla that preserves a deciduous third premolar and alveoli of dP(4) and M-1. The crown of dP(3) bears an elongate parastyle and metastyle and a small, blade-like metacone. Based on alveolar morphology, the two more distal teeth successively increased in size and had relatively large protocones. Using a hyaenodont character-taxon matrix that includes deciduous dental characters, Bayesian phylogenetic methods resolve Pakakali within the clade Hyainailouroidea. A Bayesian biogeographic analysis of phylogenetic results resolve the Pakakali clade as Afro-Arabian in origin, demonstrating that this small carnivorous mammal was part of an endemic Afro-Arabian lineage that persisted into the Miocene. Notably, Pakakali is in the size range of carnivoran forms that arrived and began to diversify in the region by the early Miocene. The description of Pakakali is important for exploring hyaenodont ontogeny and potential influences of Afro-Arabian tectonic events upon mammalian evolution, providing a deep time perspective on the stability of terrestrial carnivore niches through time.	[Borths, Matthew R.; Stevens, Nancy J.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Borths, Matthew R.; Stevens, Nancy J.] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Stevens, NJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.; Stevens, NJ (corresponding author), Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA.	stevensn@ohio.edu	Stevens, Nancy J/E-6928-2013		National Science Foundation of the United States [DBI-1612062, EAR 0617561, EAR/IF 0933619, BCS 1127164, BCS-1313679, EAR-1349825, BCS-1638796]; Belgian Science Policy Office [BR/121/A3/PALEURAFRICA]; National Geographic Society Committee for Research Exploration; LSB Leakey Foundation; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; Div Of Biological Infrastructure [1612062] Funding Source: National Science Foundation	National Science Foundation of the United States(National Science Foundation (NSF)); Belgian Science Policy Office(Belgian Federal Science Policy Office); National Geographic Society Committee for Research Exploration(National Geographic Society); LSB Leakey Foundation; Ohio University Research Council; Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for this study was provided by: the National Science Foundation of the United States <https://www.nsf.gov/> (DBI-1612062 to MRB; EAR 0617561 to NJS; EAR/IF 0933619 to NJS; BCS 1127164 to NJS; BCS-1313679 to NJS; EAR-1349825 to NJS; BCS-1638796 to NJS), the Belgian Science Policy Office <http://www.belspo.be/belspo/fedra/proj.asp?vertical bar=en&COD=BR/121/A3/PALEURAFRICA> to NJS as (Project BR/121/A3/PALEURAFRICA), the National Geographic Society Committee for Research Exploration <http://www.nationalgeographic.com/explorers/grants-programs/cre/> to NJS, the LSB Leakey Foundation <https://leakeyfoundation.org/> to NJS, the Ohio University Research Council <https://www.ohio.edu/standingcommittees/committee.cfm?customel_datapageid_1748687=1749816> to NJS, Ohio University Heritage College of Osteopathic Medicine Research and Scholarly Affairs Committee <https://www.ohio.edu/medicine/about/offices/research-and-grants/faculty-resources/rsac.cfm> to NJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders U, 2011, PALAEONTOL Z, V85, P321, DOI 10.1007/s12542-011-0098-9; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Barry J.C., 1988, Journal of Vertebrate Paleontology, V8, P25; BARRY JC, 1980, J PALEONTOL, V54, P1128; Bastl K, 2014, PALAEONTOL Z, V88, P481, DOI 10.1007/s12542-013-0207-z; Bastl K, 2014, PALAEONTOGR ABT A, V303, P61; Bastl K, 2011, J VERTEBR PALEONTOL, V31, P181, DOI 10.1080/02724634.2011.540052; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Blackburn DC, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.907174; Borths MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173527; Borths MR, 2016, PEERJ, V4, DOI 10.7717/peerj.2639; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Close RA, 2015, CURR BIOL, V25, P2137, DOI 10.1016/j.cub.2015.06.047; Collard M., 2015, P ROYAL SOC B, V282; De Muizon C, 1997, LETHAIA, V30, P353; Egi N, 2007, J PALEONTOL, V81, P770, DOI 10.1666/pleo0022-3360(2007)081[0770:SSOAPA]2.0.CO;2; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Friscia AR, 2007, J ZOOL, V272, P82, DOI 10.1111/j.1469-7998.2006.00246.x; Friscia Anthony R., 2010, P311; Gaina C, 2013, TECTONOPHYSICS, V604, P4, DOI 10.1016/j.tecto.2013.05.037; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gheerbrant E, 2006, GEOL MAG, V143, P475, DOI 10.1017/S0016756806002032; Gorscak E, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1047; Grohe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049054; Halliday TJD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3026; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Holroyd P. A., 2010, CENOZOIC MAMMALS AFR, P851; Holroyd Patricia A., 1999, Paleobios, V19, P1; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Lee MSY, 2014, SYST BIOL, V63, P442, DOI 10.1093/sysbio/syt110; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Lewis Margaret E., 2010, P543; Lihoreau Fabrice, 2007, P89; Lund EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154403; Maddison W.P., 2016, MESQUITE MODULAR SYS; McCartney JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090415; Mellett J.S., 1977, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V1, P1; Miles AEW, 1990, COLYERS VARIATIONS D; Morales J., 2003, Geological Survey of Namibia Memoir, V19, P177; Morales J., 2008, MEMOIR GEOLOGICAL SU, V20, P291; Morlo M, 1999, GEOBIOS-LYON, V32, P297, DOI 10.1016/S0016-6995(99)80043-6; Morlo M, 2007, J VERTEBR PALEONTOL, V27, P145, DOI 10.1671/0272-4634(2007)27[145:CACFWM]2.0.CO;2; Nowak R. M., 2005, WALKERS CARNIVORES W; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Owen R., 1837, ENCY ANATOMY PHYSL, V4, P864; Painter LE, 2015, ECOLOGY, V96, P252, DOI 10.1890/14-0712.1; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; Prevosti FJ, 2013, J MAMM EVOL, V20, P3, DOI 10.1007/s10914-011-9175-9; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Rana RS, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.965308; Rao M, 2001, SCIENCE, V294, P1923; Rasmussen DT, 2009, PALAEONTOGR ABT A, V288, P1; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Rolland J, 2015, GLOBAL ECOL BIOGEOGR, V24, P1059, DOI 10.1111/geb.12354; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSE KD, 2006, BEGINNING AGE MAMMAL; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Savage R. J. G., 1965, Bulletin of the British Museum (Natural History) Geology, V10, P239; Schlosser M., 1911, Beitreage zur Palaeontologie u Geologie Oesterreich-Ungarns u des Orients Wien u Leipzig, V24; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrago CG, 2013, J EVOLUTION BIOL, V26, P2438, DOI 10.1111/jeb.12237; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Seiffert ER, 2010, ACTA PALAEONTOL POL, V55, P599, DOI 10.4202/app.2010.0023; Sen S, 2013, GEOBIOS-LYON, V46, P159, DOI 10.1016/j.geobios.2012.10.012; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Sige A B, 1990, PALAEONTOGR ABT A, pA214; Simons E.L., 1974, Annals of the Geological Survey of Egypt, V4, P157; SLAUGHTER BH, 1974, J MAMMAL, V55, P115, DOI 10.2307/1379261; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; Sole A F, 2015, PLOS ONE, V10; Sole F, 2016, PALAEONTOL ELECTRON, V19; Sole F, 2014, J SYST PALAEONTOL, V12, P303, DOI 10.1080/14772019.2013.795196; Sole F, 2009, ZOOL J LINN SOC-LOND, V156, P827, DOI 10.1111/j.1096-3642.2008.00501.x; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Stevens NJ, 2013, NATURE, V497, P611, DOI 10.1038/nature12161; Stevens WN, 2016, RUKWA RIFT BASIN TAN, V36; Ungar PS., 2010, MAMMAL TEETH; Van Valen L., 1967, Bulletin of the American Museum of Natural History, V135, P217; van Valkenburgh B., 1990, P181; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Winkler A.J., 2010, CENOZOIC MAMMALS AFR, P263; Wood HM, 2013, SYST BIOL, V62, P264, DOI 10.1093/sysbio/sys092; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zack SP, 2012, J MAMMAL, V93, P808, DOI 10.1644/11-MAMM-A-245.1	89	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185301	10.1371/journal.pone.0185301	http://dx.doi.org/10.1371/journal.pone.0185301			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020030	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400025
J	Lauridsen, MM; Mikkelsen, S; Svensson, T; Holm, J; Kluver, C; Gram, J; Vilstrup, H; de Muckadell, OBS				Lauridsen, M. M.; Mikkelsen, S.; Svensson, T.; Holm, J.; Kluver, C.; Gram, J.; Vilstrup, H.; de Muckadell, O. B. Schaffalitzky			The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study	PLOS ONE			English	Article							INTELLIGENCE; LACTULOSE; CIRRHOSIS; LIVER	Background Minimal hepatic encephalopathy (MHE) is clinically undetectable and the diagnosis requires psychometric tests. However, a lack of clarity exists as to whether the tests are in fact able to detect changes in cognition. Aim To examine if the continuous reaction time test (CRT) can detect changes in cognition with anti-HE intervention in patients with cirrhosis and without clinically manifest hepatic encephalopathy (HE). Methods Firstly, we conducted a reproducibility analysis and secondly measured change in CRT induced by anti-HE treatment in a randomized controlled pilot study: We stratified 44 patients with liver cirrhosis and without clinically manifest HE according to a normal (n = 22) or abnormal (n = 22) CRT. Each stratum was then block randomized to receive multimodal anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) or triple placebos for 3 months in a double-blinded fashion. The CRT is a simple PC-based test and the test result, the CRT index (normal threshold > 1.9), describes the patient's stability of alertness during the 10-minute test. Our study outcome was the change in CRT index in each group at study exit. The portosystemic encephalopathy (PSE) test, a paper-and-pencil test battery (normal threshold above -5), was used as a comparator test according to international guidelines. Results The patients with an abnormal CRT index who were randomized to receive the active intervention normalized or improved their CRT index (mean change 0.92 +/- 0.29, p = 0.01). Additionally, their PSE improved (change 3.85 +/- 1.83, p = 0.03). There was no such effect in any of the other study groups. Conclusion In this cohort of patients with liver cirrhosis and no manifest HE, the CRT identified a group in whom cognition improved with intensive anti-HE intervention. This finding infers that the CRT can detect a response to treatment and might help in selecting patients for treatment.	[Lauridsen, M. M.; Mikkelsen, S.; Svensson, T.; Holm, J.] Hosp South West Jutland, Dept Gastroenterol, Esbjerg, Denmark; [Kluver, C.; de Muckadell, O. B. Schaffalitzky] Odense Univ Hosp, Dept Gastrointestinal Dis, Sdr Blvd 29, Odense C, Denmark; [Gram, J.] Hosp South West Jutland, Dept Endocrinol, Esbjerg, Denmark; [Vilstrup, H.] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Aarhus, Denmark	University of Southern Denmark; Odense University Hospital; Aarhus University	Lauridsen, MM (corresponding author), Hosp South West Jutland, Dept Gastroenterol, Esbjerg, Denmark.	mette.enok.munk.lauridsen@rsyd.dk	Lauridsen, Mette Munk/AAX-6491-2020	Lauridsen, Mette Munk/0000-0003-0586-8549; Mikkelsen, Stine Ulrik/0000-0003-2104-9201; Gram, Jeppe/0000-0003-2584-1132	Danish funds; Hospital of South West Jutland Odense University Hospital Free Research Fund; University of Southern Denmark PhD, Scholarship; Esbjergfonden; Karola Jorgensens Fond	Danish funds; Hospital of South West Jutland Odense University Hospital Free Research Fund; University of Southern Denmark PhD, Scholarship; Esbjergfonden; Karola Jorgensens Fond	MM Lauridsen and the research project were funded by the following public Danish funds: The research fund at The Hospital of South West Jutland Odense University Hospital Free Research Fund, http://www.ouh.dk/wm379847; University of Southern Denmark PhD, Scholarship, http://www.sdu.dk/forskning/phd/phd_skoler/phdskolensundhedsvidenskab; Esbjergfonden, Karola Jorgensens Fond.	BANKHEAD I, 1982, J MENT DEFIC RES, V26, P73; DERenzi E., 1965, CORTEX, V1, P410, DOI DOI 10.1016/S0010-9452(65)80003-X; ELSASS P, 1985, LIVER, V5, P29; Gluud LL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001939.pub2; Gluud LL, 2015, EASL INT LIV C 2015, P175; Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262; Hulley SB, 2015, DELINEANDO PESQUISA, V4; Kimer N, 2014, ALIMENT PHARM THER, V40, P123, DOI 10.1111/apt.12803; LALLY M, 1977, AM J MENT DEF, V82, P273; Lauridsen MM, 2015, METAB BRAIN DIS, V30, P1187, DOI 10.1007/s11011-015-9688-7; Lauridsen MM, 2012, METAB BRAIN DIS, V27, P559, DOI 10.1007/s11011-012-9318-6; Lauridsen MM, 2011, METAB BRAIN DIS, V26, P135, DOI 10.1007/s11011-011-9242-1; Lauridsen MM, 2013, METAB BRAIN DIS; Lauridsen MM, 2015, J HEPATOL; Li YY, 2004, WORLD J GASTROENTERO, V10, P2397; Maldonado-Garza Hector Jesus, 2011, Ann Hepatol, V10 Suppl 2, pS40; Mittal VV, 2011, EUR J GASTROEN HEPAT, V23, P725, DOI 10.1097/MEG.0b013e32834696f5; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Schomerus H, 1998, METAB BRAIN DIS, V13, P361, DOI 10.1023/A:1020645110880; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sidhu SS, 2011, AM J GASTROENTEROL, V106, P307, DOI 10.1038/ajg.2010.455; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Weissenborn K., 2012, METAB BRAIN DIS	23	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185412	10.1371/journal.pone.0185412	http://dx.doi.org/10.1371/journal.pone.0185412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020023	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400031
J	Jasinska-Konior, K; Pochylczuk, K; Czajka, E; Michalik, M; Romanowska-Dixon, B; Swakon, J; Urbanska, K; Elas, M				Jasinska-Konior, Katarzyna; Pochylczuk, Katarzyna; Czajka, Elibieta; Michalik, Marta; Romanowska-Dixon, Boiena; Swakon, Jan; Urbanska, Krystyna; Elas, Martyna			Proton beam irradiation inhibits the migration of melanoma cells	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; UVEAL MELANOMA; SURVIVAL; RADIOTHERAPY; PROGRESSION; EXPRESSION; FIBROBLASTS; APOPTOSIS; SYSTEM; DAMAGE	Purpose In recent years experimental data have indicated that low-energy proton beam radiation might induce a difference in cellular migration in comparison to photons. We therefore set out to compare the effect of proton beam irradiation and X-rays on the survival and long-term migratory properties of two cell lines: uveal melanoma Mel270 and skin melanoma BLM. Materials and methods Cells treated with either proton beam or X-rays were analyzed for their survival using clonogenic assay and MTT test. Long-term migratory properties were assessed with time-lapse monitoring of individual cell movements, wound test and transpore migration, while the expression of the related proteins was measured with western blot. Results Exposure to proton beam and X-rays led to similar survival but the quality of the cell colonies was markedly different. More paraclones with a low proliferative activity and fewer highly-proliferative holoclones were found after proton beam irradiation in comparison to X-rays. At 20 or 40 days post-irradiation, migratory capacity was decreased more by proton beam than by X-rays. The beta-1-integrin level was decreased in Mel270 cells after both types of radiation, while vimentin, a marker of EMT, was increased in BLM cells only. Conclusions We conclude that proton beam irradiation induced long-term inhibition of cellular motility, as well as changes in the level of beta-1 integrin and vimentin. If confirmed, the change in the quality, but not in the number of colonies after proton beam irradiation might favor tumor growth inhibition after fractionated proton therapy.	[Jasinska-Konior, Katarzyna; Pochylczuk, Katarzyna; Czajka, Elibieta; Urbanska, Krystyna; Elas, Martyna] Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland; [Michalik, Marta] Fac Biochem Biophys & Biotechnol, Dept Cell Biol, Krakow, Poland; [Romanowska-Dixon, Boiena] Jagiellonian Univ, Med Coll, Dept Ophthalmol & Ophthalm Oncol, Krakow, Poland; [Swakon, Jan] PAS, Inst Nucl Phys, Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences	Elas, M (corresponding author), Fac Biochem Biophys & Biotechnol, Dept Biophys, Krakow, Poland.	martyna.elas@uj.edu.pl	Swakoń, Jan/M-5808-2018; Elas, Martyna/E-3584-2017	Swakoń, Jan/0000-0001-9262-7326; Elas, Martyna/0000-0001-6296-2844; Jasinska-Konior, Katarzyna/0000-0003-3795-1590; Urbanska, Krystyna/0000-0001-9643-4740	National Science Centre, Cracow, Poland [2012/07/B/NZ4/01657]; Ministry of Science and Higher Education	National Science Centre, Cracow, Poland(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This project was supported by grant 2012/07/B/NZ4/01657 from National Science Centre, Cracow, Poland (https://www.ncn.gov.pl/?languag=en). Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy L, 2008, PROSTATE, V68, P530, DOI 10.1002/pros.20702; Antoccia A, 2009, J RADIAT RES, V50, P457, DOI 10.1269/jrr.09008; Aypar U, 2011, MUTAT RES-FUND MOL M, V707, P24, DOI 10.1016/j.mrfmmm.2010.12.003; Beaver CM, 2014, CLONOGENICITY HOLOCL, V9; Boberek M, 2014, ROM REP PHYS, V66, P5; Burotto M, 2014, MAPK PATHWAY ACROSS, DOI [10.1002/cncr.28864, DOI 10.1002/CNCR.28864]; Chang PY, 2007, RADIAT ENVIRON BIOPH, V46, P187, DOI 10.1007/s00411-006-0087-7; Chaudhary P, 2016, INT J RAD ONCOL BIOL, V95; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Chen PW, 1997, CLIN EXP METASTAS, V15, P509, DOI 10.1023/A:1018479011340; Damato B, 2010, BRIT J CANCER, V103, P285, DOI 10.1038/sj.bjc.6605765; Dasu A, 2013, MED PHYS, V40, DOI 10.1118/1.4769417; Dendale R, 2006, INT J RADIAT ONCOL, V65, P780, DOI 10.1016/j.ijrobp.2006.01.020; Dhillon AS, 2007, MAP KINASE SIGNALLIN, P3279; Dogrusoz M, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20212; Durante M, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/9/096702; Egger E, 2001, INT J RADIAT ONCOL, V51, P138, DOI 10.1016/S0360-3016(01)01560-7; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Frese MC, 2011, INT J RAD ONCOL BIOL; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Galanty A, 2008, CELL MOL BIOL LETT, V13, P585, DOI 10.2478/s11658-008-0013-x; Gerelchuluun A, 2011, INT J RADIAT BIOL, V87, P57, DOI 10.3109/09553002.2010.518201; Girdhani S, 2013, RADIAT RES, V179, P257, DOI 10.1667/RR2839.1; Green LM, 2001, RADIAT RES, V155, P32, DOI 10.1667/0033-7587(2001)155[0032:ROTFCT]2.0.CO;2; Grosse N, 2014, INT J RADIAT ONCOL, V88, P175, DOI 10.1016/j.ijrobp.2013.09.041; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; IAEA, 2000, IAEA TECHN REP SER, V398, P1; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Kawamoto A, 2012, ONCOL REP, V27, P51, DOI 10.3892/or.2011.1485; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Komiya Yuko, 2008, Organogenesis, V4, P68; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lane AM, 2015, JAMA OPHTHALMOL, V133, P792, DOI 10.1001/jamaophthalmol.2015.0887; Li FZ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00031; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Madeja Z, 2001, BIOCHEM CELL BIOL, V79, P425, DOI 10.1139/bcb-79-4-425; McNamara AL, 2015, PHYS MED BIOL, V60, P8399, DOI 10.1088/0031-9155/60/21/8399; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Ogata T, 2005, CANCER RES, V65, P113; Paganetti H, 2002, INT J RADIAT ONCOL, V53, P407, DOI 10.1016/S0360-3016(02)02754-2; Paganetti H, 2013, SEMIN RADIAT ONCOL, V23, P77, DOI 10.1016/j.semradonc.2012.11.002; Petrovic I, 2006, INT J RADIAT BIOL, V82, P251, DOI 10.1080/09553000600669859; Petrovic I, 2010, INT J RADIAT BIOL, V86, P742, DOI 10.3109/09553002.2010.481322; Rietschel P, 2005, J CLIN ONCOL, V23, P8076, DOI 10.1200/JCO.2005.02.6534; Sage E., 2016, FREE RADIC BIOL MED; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Todorovic D, 2008, J MICROSC-OXFORD, V232, P517, DOI 10.1111/j.1365-2818.2008.02151.x; Tommasino F, 2015, CANCERS, V7, P353, DOI 10.3390/cancers7010353; Underwood T, 2016, INT J RADIAT ONCOL, V95, P56, DOI 10.1016/j.ijrobp.2015.10.006; VANMUIJEN GNP, 1989, ANTICANCER RES, V9, P879; Wedenberg M, 2013, MODEL RELATIVE BIOL; Zheng Q, 2015, HUM EXP TOXICOL, P4	53	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186002	10.1371/journal.pone.0186002	http://dx.doi.org/10.1371/journal.pone.0186002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016654	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400047
J	Suzuki, Y; Tsutsumi, K; Miyamoto, T; Yamamura, H; Imaizumi, Y				Suzuki, Yoshiaki; Tsutsumi, Kanako; Miyamoto, Tatsuya; Yamamura, Hisao; Imaizumi, Yuji			Heterodimerization of two pore domain K+ channel TASK1 and TALK2 in living heterologous expression systems	PLOS ONE			English	Article							2-PORE DOMAIN; POTASSIUM CHANNELS; FUNCTIONAL-CHARACTERISTICS; ENDOPLASMIC-RETICULUM; DISULFIDE-BRIDGE; CALCIUM-ENTRY; SUBUNITS; CONDUCTANCE; PH; ANESTHETICS	Two-pore-domain K+ (K-2P) channels sense a wide variety of stimuli such as mechanical stress, inhalational anesthetics, and changes in extracellular pH or temperature. The K-2P channel activity forms a background K+ current and, thereby, contributes to resting membrane potentials. Six subfamilies including fifteen subtypes of K-2P channels have been identified. Each K-2P channel molecule with two pores consists of a homodimer of each subtype. In addition, a few heterodimers mainly within the same subfamilies have been found recently. In the present study, the possibility of heterodimerization between TASK1 (TWIK-Related Acid-Sensitive K+ channel) and TALK2 (TWIK-Related Alkaline pH-Activated K+ channel) was examined. These channels belong to separate subfamilies and show extremely different channel properties. Surprisingly, single molecular imaging analyses in this study using a total internal reflection microscope suggested the heterodimerization of TASK1 and TALK2 in a pancreatic cell line, QGP-1. This heterodimer was also detected using a bimolecular fluorescence complementation assay in a HEK293 heterologous expression system. Fluorescence resonance energy transfer analyses showed that the affinity between TASK1 and TALK2 appeared to be close to those of homodimers. Whole-cell patch-clamp recordings revealed that TASK1 currents in HEK293 cells were significantly attenuated by co-expression of a dominant-negative form of TALK2 in comparison with that of wild-type TALK2. The sensitivities of TASK1-TALK2 tandem constructs to extracellular pH and halothane were characterized as a unique hybrid of TASK1 and TALK2. These results suggested that heterodimerization of TASK1 and TALK2 provides cells with the ability to make multiple responses to a variety of physiological and pharmacological stimuli.	[Suzuki, Yoshiaki; Tsutsumi, Kanako; Miyamoto, Tatsuya; Yamamura, Hisao; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan	Nagoya City University	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Suzuki, Yoshiaki/ABH-5320-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; Imaizumi, Yuji/0000-0001-9431-688X	JSPS KAKENHI [16H06215, 16K15127, 16K08278, 17H05537, 26293021, 16K15128]; Takeda Science Foundation; Salt Science Research Foundation [1637]; Nakatomi Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [16K08278] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Nakatomi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI [https://www.jsps.go.jp/english/] Grant Numbers, 16H06215 and 16K15127 to Y.S., 16K08278 and 17H05537 to H.Y. 26293021 and 16K15128 to Y.I. This work was also supported by a Grant-in-Aid from Takeda Science Foundation [http://www.takeda-sci.or.jp/] (to Y.S.), Salt Science Research Foundation [Grant 1637, http://www.saltscience.or.jp/english.html] (to Y.S.), the Nakatomi Foundation [http://www.nakatomi.or.jp/en/index.html] (to Y.S.) and The Uehara Memorial Foundation [http://www.ueharazadan.or.jp/] (to Y. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmole I, 2001, PFLUG ARCH EUR J PHY, V442, P828, DOI 10.1007/s004240100620; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Dadi PK, 2015, MOL ENDOCRINOL, V29, P777, DOI 10.1210/me.2014-1321; Dadi PK, 2014, ENDOCRINOLOGY, V155, P3757, DOI 10.1210/en.2013-2051; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Goldstein M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19492; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kiyoshi H, 2006, AM J PHYSIOL-HEART C, V291, pH2723, DOI 10.1152/ajpheart.00894.2005; Leithner K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157453; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Marionneau C, 2008, CIRC RES, V102, P1406, DOI 10.1161/CIRCRESAHA.107.170050; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Renigunta V, 2014, MOL BIOL CELL, V25, P1877, DOI [10.1091/mbc.E13-0592, 10.1091/mbc.E13-10-0592]; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Suzuki Y, 2016, J BIOL CHEM, V291, P24247, DOI 10.1074/jbc.M116.743302; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Wilke BU, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6540; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	35	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186252	10.1371/journal.pone.0186252	http://dx.doi.org/10.1371/journal.pone.0186252			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016681	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400064
J	Kanno, T; Yasutake, K; Tanaka, K; Hadano, S; Ikeda, JE				Kanno, Takuya; Yasutake, Kaori; Tanaka, Kazunori; Hadano, Shinji; Ikeda, Joh-E			A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection	PLOS ONE			English	Article							PROTEIN-SYNTHESIS SYSTEM; OXIDATIVE STRESS; BRAIN; PEPTIDE; PROGRESSION; EXPRESSION; CLEARANCE; SUBSTRATE; MODEL	Therapeutic agents to the central nervous system (CNS) need to be efficiently delivered to the target site of action at appropriate therapeutic levels. However, a limited number of effective drugs for the treatment of neurological diseases has been developed thus far. Further, the pharmacological mechanisms by which such therapeutic agents can protect neurons from cell death have not been fully understood. We have previously reported the novel small-molecule compound, 2-[mesityl(methyl)amino]-N-[4-(pyridin-2-yl)-1H-imidazol-2-yl] acetamide trihydrochloride (WN1316), as a unique neuroprotectant against oxidative injury and a highly promising remedy for the treatment of amyotrophic lateral sclerosis (ALS). One of the remarkable characteristics of WN1316 is that its efficacious doses in ALS mouse models are much less than those against oxidative injury in cultured human neuronal cells. It is also noted that the WN1316 cytoprotective activity observed in cultured cells is totally dependent upon the addition of fetal bovine serum in culture medium. These findings led us to postulate some serum factors being tightly linked to the WN1316 efficacy. In this study, we sieved through fetal bovine serum proteins and identified two N-linked glycoproteins, alpha-2-HS-glycoprotein (AHSG) and hemopexin (HPX), requisites to exert the WN1316 cytoprotective activity against oxidative injury in neuronal cells in vitro. Notably, the removal of glycan chains from these molecules did not affect the WN1316 cytoprotective activity. Thus, two glycoproteins, AHSG and HPX, represent a pivotal glycoprotein of the cytoprotective activity for WN1316, showing a concrete evidence for the novel glycan-independent function of serum glycoproteins in neuroprotective drug efficacy.	[Kanno, Takuya; Yasutake, Kaori; Tanaka, Kazunori; Ikeda, Joh-E] Neugen Pharma Inc, NGP Biomed Res Inst, Meguro Ku, Tokyo, Japan; [Hadano, Shinji] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan; [Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Ikeda, Joh-E] Kitasato Univ, Fac Med, Dept Mol Neurol, Sagamihara, Kanagawa, Japan; [Ikeda, Joh-E] Univ Ottawa, Fac Med, Dept Pediat, Childrens Hosp Eastern Ontario,Apoptosis Res Ctr, Ottawa, ON, Canada	Tokai University; Tokai University; Kitasato University; University of Ottawa; Children's Hospital of Eastern Ontario	Ikeda, JE (corresponding author), Neugen Pharma Inc, NGP Biomed Res Inst, Meguro Ku, Tokyo, Japan.; Ikeda, JE (corresponding author), Kitasato Univ, Fac Med, Dept Mol Neurol, Sagamihara, Kanagawa, Japan.; Ikeda, JE (corresponding author), Univ Ottawa, Fac Med, Dept Pediat, Childrens Hosp Eastern Ontario,Apoptosis Res Ctr, Ottawa, ON, Canada.	joh-e@mgcheo.med.uottawa.ca	Hadano, Shinji/ABA-5052-2021	Hadano, Shinji/0000-0002-4997-3968	Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST); Neugen Pharma	Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Neugen Pharma	This work was supported by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST) (JEI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TK, KY and KT were employees of Neugen Pharma at the time this research was performed. JEI owns stocks or shares in Neugen Pharma. Neugen Pharma provided financial support in the form of salaries for authors (TK, KY and KT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in study design (JEI), data collection (TK, KY and KT) and analysis section (TK, KT and JEI).	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Benchenane K, 2005, STROKE, V36, P1059, DOI 10.1161/01.STR.0000163050.39122.4f; Brylka L, 2013, CALCIFIED TISSUE INT, V93, P355, DOI 10.1007/s00223-012-9690-6; CAYATTE AJ, 1990, J BIOL CHEM, V265, P5883; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Endo Y, 2006, CURR OPIN BIOTECH, V17, P373, DOI 10.1016/j.copbio.2006.06.009; Goustin AS, 2013, CELL SIGNAL, V25, P981, DOI 10.1016/j.cellsig.2012.12.011; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kanno T, 2012, FREE RADICAL BIO MED, V53, P2028, DOI 10.1016/j.freeradbiomed.2012.09.010; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; KUMBLA L, 1989, FASEB J, V3, P2075, DOI 10.1096/fasebj.3.9.2472993; KUMBLA L, 1991, FASEB J, V5, P2971, DOI 10.1096/fasebj.5.14.1721594; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; PU XP, 1994, BBA-PROTEIN STRUCT M, V1208, P338, DOI 10.1016/0167-4838(94)90122-8; Rushworth JV, 2013, J BIOL CHEM, V288, P8935, DOI 10.1074/jbc.M112.400358; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Tanaka K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087728, 10.1371/journal.pone.0096410]; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tozawa Y, 2007, J BIOL CHEM, V282, P35536, DOI 10.1074/jbc.M703820200; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186227	10.1371/journal.pone.0186227	http://dx.doi.org/10.1371/journal.pone.0186227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016670	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800047
J	Li, ZW; Yuan, X; Cui, XR; Liu, X; Wang, LQ; Zhang, WS; Lu, QH; Zhu, H				Li, Zhongwei; Yuan, Xiang; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua; Zhu, Hu			Optimal experimental conditions for Welan gum production by support vector regression and adaptive genetic algorithm	PLOS ONE			English	Article							NEURAL P SYSTEMS; MACHINE CLASSIFIERS; PREDICTION; IDENTIFICATION; VALIDATION	Welan gum is a kind of novel microbial polysaccharide, which is widely produced during the process of microbial growth and metabolism in different external conditions. Welan gum can be used as the thickener, suspending agent, emulsifier, stabilizer, lubricant, film-forming agent and adhesive usage in agriculture. In recent years, finding optimal experimental conditions to maximize the production is paid growing attentions. In this work, a hybrid computational method is proposed to optimize experimental conditions for producing Welan gum with data collected from experiments records. Support Vector Regression (SVR) is used to model the relationship between Welan gum production and experimental conditions, and then adaptive Genetic Algorithm (AGA, for short) is applied to search optimized experimental conditions. As results, a mathematic model of predicting production of Welan gum from experimental conditions is obtained, which achieves accuracy rate 88.36%. As well, a class of optimized experimental conditions is predicted for producing Welan gum 31.65g/L. Comparing the best result in chemical experiment 30.63g/L, the predicted production improves it by 3.3%. The results provide potential optimal experimental conditions to improve the production of Welan gum.	[Li, Zhongwei; Yuan, Xiang; Cui, Xuerong; Liu, Xin; Wang, Leiquan; Zhang, Weishan; Lu, Qinghua] China Univ Petr, Coll Comp & Commun Engn, Qingdao 266580, Shandong, Peoples R China; [Zhu, Hu] Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China	China University of Petroleum; Fujian Normal University	Zhu, H (corresponding author), Fujian Normal Univ, Coll Chem & Mat, Fuzhou 350007, Fujian, Peoples R China.	zhuhu@fjnu.edu.cn	zhu, hu/GQQ-8365-2022	Wang, Leiquan/0000-0003-4314-0030	863 program [2015AA020925]; National Natural Science Foundation of China [61402187, 61502535, 61572522, 61572523, 61672033, 61672248]; Key Research and Development Program of Shandong Province [2017GGX10147]; China Postdoctoral Science Foundation [2016M592267]; PetroChina Innovation Foundation [2016D-5007-0305]; Fundamental Research Funds for the Central Universities [R1607005A]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R03AA020925] Funding Source: NIH RePORTER	863 program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); PetroChina Innovation Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by 863 program (2015AA020925), National Natural Science Foundation of China (61402187, 61502535, 61572522, 61572523, 61672033 and 61672248), Key Research and Development Program of Shandong Province (No. 2017GGX10147), China Postdoctoral Science Foundation funded project (2016M592267), PetroChina Innovation Foundation (2016D-5007-0305), and Fundamental Research Funds for the Central Universities (R1607005A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1999, NEURAL NETWORKS, V12, P783, DOI 10.1016/S0893-6080(99)00032-5; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Burges CJC, 1999, ADVANCES IN KERNEL METHODS, P89; Cai SX, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/904267; Chen B, 2017, NEUROCOMPUTING; Chen W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40242; Fu ZJ, 2017, IEEE T INF FOREN SEC, V12, P1874, DOI 10.1109/TIFS.2017.2692728; Goldber D. E., 1988, Machine Learning, V3, P95, DOI 10.1023/A:1022602019183; Li H, 2011, PROCESS BIOCHEM, V46, P1172, DOI 10.1016/j.procbio.2011.02.007; [李会 Li Hui], 2009, [食品与发酵工业, Food and Fermentation Industries], V35, P1; Li Z, 2016, BIOMED RES INT, V2016; Liang J, 2016, FOOD RES DEV, V37, P104; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu Q, 2016, SECUR COMMUN NETW, V9, P4002, DOI 10.1002/sec.1582; Liu X, 2012, DISCRETE DYN NAT SOC, V2012, P132; Liu X., 2017, DISCRETE DYNAMICS NA, V2017; Liu XY, 2007, ADV ENG SOFTW, V38, P668, DOI 10.1016/j.advengsoft.2006.10.009; Liu XY, 2017, NEURAL PROCESS LETT, V46, P171, DOI 10.1007/s11063-016-9577-z; Long K, 2014, CHEM ENG, V8; Ma TH, 2015, COMPUTING, V97, P1165, DOI 10.1007/s00607-015-0453-x; Ouyang S., 2003, COMPUTER ENG APPL; Scholkopf B., 1999, ADV KERNEL METHODS S; Shen J, 2017, IEEE T INF FOREN SEC, V12, P2402, DOI 10.1109/TIFS.2017.2705620; Shevade SK, 2000, IEEE T NEURAL NETWOR, V11, P1188, DOI 10.1109/72.870050; Song T, 2014, NEURAL COMPUTING APP, V24; Song T, 2016, IEEE T NANOBIOSCI, V15, P666, DOI 10.1109/TNB.2016.2598879; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Vapnik V., 2013, NATURE STAT LEARNING; Vapnik V. N., 1998, STAT LEARNING THEORY, V1; Wang R, 2015, IEEE T CYBERNETICS, V45, P1262, DOI 10.1109/TCYB.2014.2348012; Wang X, 2017, ROM J INF SCI TECH, V20, P32; Wang XS, 2014, CURR BIOINFORM, V9, P140, DOI 10.2174/1574893608999140109115649; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Wang X, 2014, J COMPUT BIOL, V21, P320, DOI 10.1089/cmb.2013.0054; Wei G, 2014, J SYST ENG ELECTRON, V25, P115, DOI 10.1109/JSEE.2014.00013; Wu TF, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S021972001650013X; Wu Y, 2014, MATH PROBLEMS ENG, V2014; Wu YF, 2011, J EXP THEOR ARTIF IN, V23, P63, DOI 10.1080/0952813X.2010.506288; Xia ZH, 2016, IEEE T INF FOREN SEC, V11, P2594, DOI 10.1109/TIFS.2016.2590944; Xia ZH, 2016, IEEE T PARALL DISTR, V27, P340, DOI 10.1109/TPDS.2015.2401003; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BBA-GEN SUBJECTS, V1860, P2735, DOI 10.1016/j.bbagen.2016.03.016; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zhang L, 2017, IEEE T CYBERNETICS, V47, P2703, DOI 10.1109/TCYB.2017.2711038; Zhang X, PATTERN RECOMMENDATI; Zhang X, 2016, IEEE T EVOLUTIONARY; Zhang X.G., 2000, ACTA AUTOM SIN, V26, P32; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhao YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162882	55	4	4	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185942	10.1371/journal.pone.0185942	http://dx.doi.org/10.1371/journal.pone.0185942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016652	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800027
J	Khanal, MK; Dhungana, RR; Bhandari, P; Gurung, Y; Paudel, KN				Khanal, Mahesh Kumar; Dhungana, Raja Ram; Bhandari, Pratiksha; Gurung, Yadav; Paudel, K. N.			Prevalence, associated factors, awareness, treatment, and control of hypertension: Findings from a cross sectional study conducted as a part of a community based intervention trial in Surkhet, Mid-western region of Nepal	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK-FACTOR; ALCOHOL-CONSUMPTION; GLOBAL BURDEN; POPULATION; COUNTRIES; SMOKING; DISEASE; SODIUM; WOMEN	Background Hypertension is one of the leading public health problems globally. About half of the deaths from cardiovascular diseases were attributed to hypertension in 2008. Reduction of blood pressure to normal range is one of the major challenges in preventing complications and future burden of cardiovascular diseases. Therefore, this study aims to determine prevalence, awareness, treatment and control of hypertension and its associated factors in Nepal. Methods This was a community based cross-sectional study conducted as a part of a community based intervention trial in Birendranagar Municipality of Surkhet district located at the Midwestern region of Nepal. We enrolled 1159 subjects aged 30 years and above. Out of 12 wards (administrative unit), four wards were selected randomly. Three hundred participants were recruited from each selected ward. Trained enumerator collected socio-demographic, anthropometric, and clinical data using standard STEPS questionnaires. Results Out of all participants, women were 71% and mean age was 47 +/- 12.6 years. The overall prevalence of hypertension was 38.9% (95% CI: 36 +/- 41.7) while age and sex adjusted prevalence was 40.6%. The hypertension was present in 48.1% (95% CI: 45.2 +/- 50.9) of men and 35.2% (95% CI: 32.4 +/- 37.9)] of women. Male gender (OR = 1.49), older age (OR = 1.04 per year), Dalit caste (OR = 1.71), past history of cigarettes smoking (OR = 2.78), current alcohol consumption (OR = 1.75), and raised body mass index (OR = 1.17 per unit) were identified as significant factors associated with hypertension. Of total hypertensive respondents, 53.4% (95% CI: 48.7-58) were aware, 29% (95% CI: 24.8-33.1) were receiving treatment for high blood pressure, and 8.2% (95% CI: 5.6-10.7) had controlled blood pressure. The awareness, treatment, and control status were worse in younger participants. Conclusions The study revealed high prevalence with low awareness, treatment, and control of hypertension in Nepal. Gender, age, ethnicity, smoking, drinking alcohol, and body mass index were associated with hypertension. Immediate public health and individual measures are warranted to reduce future burden of cardiovascular diseases.	[Khanal, Mahesh Kumar] Bheri Zonal Ayurveda Hosp, Minist Hlth, Surkhet, Nepal; [Dhungana, Raja Ram] Nepal Publ Hlth Fdn, Kathmandu, Nepal; [Bhandari, Pratiksha; Paudel, K. N.] Mid Western Reg Hosp, Minist Hlth, Surkhet, Nepal; [Gurung, Yadav] Populat Serv Int Nepal, Lalitpur, Nepal		Khanal, MK (corresponding author), Bheri Zonal Ayurveda Hosp, Minist Hlth, Surkhet, Nepal.	drmkkhanal@gmail.com	Dhungana, Raja Ram/B-3673-2016	Dhungana, Raja Ram/0000-0002-9610-6306; Gurung, Yadav/0000-0002-0397-0489; Khanal, Dr. Mahesh Kumar/0000-0001-5324-2802	Nepal Family Development Foundation, Kathmandu, Nepal	Nepal Family Development Foundation, Kathmandu, Nepal	The study was supported by a fund from Nepal Family Development Foundation, Kathmandu, Nepal. YG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WHO FOR TECHN M PAR; Aryal KN S, 2014, NONCOMMUNICABLE DIS; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Beilin LJ, 2006, HYPERTENSION, V47, P1035, DOI 10.1161/01.HYP.0000218586.21932.3c; Bowman TS, 2007, J AM COLL CARDIOL, V50, P2085, DOI 10.1016/j.jacc.2007.08.017; CBC, 2014, POPULATION MONOGRAPH; CBS. , 2014, NAT POP HOUS CENS 20; Central Bureau of Statistics and World Bank, 2012, POV NEP 2010 11; Chataut J, 2015, Kathmandu Univ Med J (KUMJ), V13, P346; Chataut J, 2011, Kathmandu Univ Med J (KUMJ), V9, P13; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cooper R, 1984, J Hypertens, V2, P361; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Dhungana RR, 2016, INT J HYPERTENS, V2016, P1, DOI 10.1155/2016/1656938; Dhungana RR, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-92; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Janus ED, 2008, INTERN MED J, V38, P879, DOI 10.1111/j.1445-5994.2007.01583.x; Kannel WB, 1996, CLIN CHIM ACTA, V246, P59; KAPLAN NM, 1995, LANCET, V345, P1588, DOI 10.1016/S0140-6736(95)90110-8; Karmacharya BM, 2017, HEART ASIA, V9, P1, DOI 10.1136/heartasia-2016-010766; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Klungel OH, 1997, J HYPERTENS, V15, P591, DOI 10.1097/00004872-199715060-00004; Kowalski K, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-148; Law MR, 2009, BMJ, V338; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Manandhar K, 2012, Kathmandu Univ Med J (KUMJ), V10, P35; McLean RM, 2014, NUTRIENTS, V6, P4651, DOI 10.3390/nu6114651; Meshram II, 2012, J POSTGRAD MED, V58, P255, DOI 10.4103/0022-3859.105444; NELSON L, 1986, LANCET, V2, P473, DOI 10.1016/S0140-6736(86)90354-5; Neupane D, 2017, AM J HYPERTENS; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; Roerecke M, LANCET PUBLIC HLTH, V2, pe108; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sankoh O, 2014, GLOBAL HLTH ACTION, V7; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sharma Deewakar, 2006, Indian Heart J, V58, P34; Sharma SK, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/821971; WEBER MA, 1989, AM J CARDIOL, V63, pH25; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, GLOB BRIEF HYP; WHO, 1997, PREV MAN GLOB EP OB; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2008, WAIST CIRCUMFERENCE; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	48	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185806	10.1371/journal.pone.0185806	http://dx.doi.org/10.1371/journal.pone.0185806			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982159	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300069
J	Perrotti, PP; Aterido, A; Fernandez-Nebro, A; Canete, JD; Ferrandiz, C; Tomero, J; Gisbert, JP; Domenech, E; Fernandez-Gutierrez, B; Gomollon, F; Garcia-Planella, E; Fernandez, E; Sanmarti, R; Gratacos, J; Martinez-Taboada, VM; Rodriguez-Rodriguez, L; Palau, N; Tortosa, R; Corbeto, ML; Lasanta, ML; Marsal, S; Julia, A				Perrotti, Pedro P.; Aterido, Adria; Fernandez-Nebro, Antonio; Canete, Juan D.; Ferrandiz, Carlos; Tomero, Jesus; Gisbert, Javier P.; Domenech, Eugeni; Fernandez-Gutierrez, Benjamin; Gomollon, Fernando; Garcia-Planella, Esther; Fernandez, Emilia; Sanmarti, Raimon; Gratacos, Jordi; Manuel Martinez-Taboada, Victor; Rodriguez-Rodriguez, Luis; Palau, Nuria; Tortosa, Raul; Corbeto, Mireia L.; Lasanta, Maria L.; Marsal, Sara; Julia, Antonio		IMID Consortium	Genetic variation associated with cardiovascular risk in autoimmune diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; IMMUNE-SYSTEM; LOCUS; SUSCEPTIBILITY; METAANALYSIS; MECHANISMS; PATHWAYS	Autoimmune diseases have a higher prevalence of cardiovascular events compared to the general population. The objective of this study was to investigate the genetic basis of cardiovascular disease (CVD) risk in autoimmunity. We analyzed genome-wide genotyping data from 6,485 patients from six autoimmune diseases that are associated with a high socioeconomic impact. First, for each disease, we tested the association of established CVD risk loci. Second, we analyzed the association of autoimmune disease susceptibility loci with CVD. Finally, to identify genetic patterns associated with CVD risk, we applied the cross-phenotype meta-analysis approach (CPMA) on the genome-wide data. A total of 17 established CVD risk loci were significantly associated with CVD in the autoimmune patient cohorts. From these, four loci were found to have significantly different genetic effects across autoimmune diseases. Six autoimmune susceptibility loci were also found to be associated with CVD risk. Genome-wide CPMA analysis identified 10 genetic clusters strongly associated with CVD risk across all autoimmune diseases. Two of these clusters are highly enriched in pathways previously associated with autoimmune disease etiology (TNF alpha and IFN gamma cytokine pathways). The results of this study support the presence of specific genetic variation associated with the increase of CVD risk observed in autoimmunity.	[Perrotti, Pedro P.; Aterido, Adria; Palau, Nuria; Tortosa, Raul; Corbeto, Mireia L.; Lasanta, Maria L.; Marsal, Sara; Julia, Antonio] Vail dHebron Res Inst, Rheumatol Res Grp, Barcelona, Spain; [Perrotti, Pedro P.] Univ Barcelona, Dept Med, Barcelona, Spain; [Aterido, Adria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Fernandez-Nebro, Antonio] Univ Malaga, Hosp Reg Univ Malaga, Inst Invest Biomed IBIMA, UGC Reumatol, Malaga, Spain; [Canete, Juan D.; Fernandez, Emilia; Sanmarti, Raimon] Hosp Clin Barcelona, Barcelona, Spain; [Canete, Juan D.; Fernandez, Emilia; Sanmarti, Raimon] IDIBAPS, Barcelona, Spain; [Ferrandiz, Carlos; Tomero, Jesus; Domenech, Eugeni] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Tomero, Jesus] Hosp Univ Guadalajara, Guadalajara, Spain; [Gisbert, Javier P.; Domenech, Eugeni] CIBERehd, Madrid, Spain; [Gisbert, Javier P.] Hosp Univ Princesa, Madrid, Spain; [Gisbert, Javier P.] IIS IP, Madrid, Spain; [Fernandez-Gutierrez, Benjamin; Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, IDISSC, Madrid, Spain; [Gomollon, Fernando] Hosp Clin Univ, Zaragoza, Spain; [Garcia-Planella, Esther] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Gratacos, Jordi] Hosp Parc Tauli, Sabadell, Spain; [Manuel Martinez-Taboada, Victor] Hosp Univ Marques de Valdecilla, Santander, Spain	University of Barcelona; Pompeu Fabra University; Universidad de Malaga; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital de La Princesa; Hospital Clinico San Carlos; Universidad de la Laguna; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Marques de Valdecilla (HUMV)	Marsal, S; Julia, A (corresponding author), Vail dHebron Res Inst, Rheumatol Res Grp, Barcelona, Spain.	sara.marsal@vhir.org; toni.julia@vhir.org	gratacos, jordi/AHC-4573-2022; Fernandez-Nebro, Antonio/K-7628-2012; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; Gisbert, Javier P/ABB-7531-2021; Cañete, Juan D/AAV-8910-2021; Gisbert, Javier P/GRY-2719-2022; Sanmarti, Raimon/M-4434-2017	Fernandez-Nebro, Antonio/0000-0002-2962-9844; Gisbert, Javier P/0000-0003-2090-3445; Cañete, Juan D/0000-0003-2606-0573; Julia Cano, Antonio/0000-0001-6064-3620; Sanmarti, Raimon/0000-0002-8864-3806; marsal, sara/0000-0001-5515-3854; Gratacos, Jordi/0000-0003-4007-4103	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]; "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR) [00587]	Spanish Ministry of Economy and Competitiveness(Spanish Government); "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR)	This study was funded by the Spanish Ministry of Economy and Competitiveness (grant numbers: PSE-010000-2006-6 and IPT-010000-2010-36) and by the "Agenda de Gestio d'Ajuts Universitaris i de Recerca" (AGAUR, Generalitat de Catalunya, FI-DGR 2016, grant number: 00587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aterido A, 2016, J INVEST DERMATOL, V136, P593, DOI 10.1016/j.jid.2015.11.026; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bowes J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7046; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cutolo M, 2005, LUPUS, V14, P675, DOI 10.1191/0961203305lu2198oa; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; El-Gabalawy H, 2010, J RHEUMATOL, V37, P2, DOI 10.3899/jrheum.091461; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Jacobsson LTH, 2005, J RHEUMATOL, V32, P1213; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Julia A, 2016, ARTHRITIS RHEUMATOL, V68, P1384, DOI 10.1002/art.39591; Julia A, 2015, ANN RHEUM DIS, V74, P1875, DOI 10.1136/annrheumdis-2014-207190; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Julia A, 2013, GUT, V62, P1440, DOI 10.1136/gutjnl-2012-302865; Kahlenberg JM, 2013, ANNU REV MED, V64, P249, DOI 10.1146/annurev-med-060911-090007; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kochi Y, 2016, INT IMMUNOL, V28, P155, DOI 10.1093/intimm/dxw002; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Lara-Pezzi E, 2012, DIS MODEL MECH, V5, P434, DOI 10.1242/dmm.009787; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Mankad R, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0497-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marson A, 2015, J CLIN INVEST, V125, P2234, DOI 10.1172/JCI78086; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Matsukura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139262; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X	45	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185889	10.1371/journal.pone.0185889	http://dx.doi.org/10.1371/journal.pone.0185889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982122	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300081
J	Barends, E; Villanueva, J; Rousseau, DM; Briner, RB; Jepsen, DM; Houghton, E; ten Have, S				Barends, Eric; Villanueva, Josh; Rousseau, Denise M.; Briner, Rob B.; Jepsen, Denise M.; Houghton, Edward; ten Have, Steven			Managerial attitudes and perceived barriers regarding evidence-based practice: An international survey	PLOS ONE			English	Article							HR PROFESSIONALS BELIEFS; PLANNED BEHAVIOR; PRACTICE GAP; MANAGEMENT; METAANALYSIS; SCIENCE; PRACTITIONERS; PERCEPTIONS; KNOWLEDGE; PREDICT	Evidence-based practice (EBP) in management is still in its infancy. Several studies suggest that managers in businesses and other organizations do not consult the scientific evidence when making decisions. To facilitate its uptake, we need to better understand practitioner attitudes and perceived barriers related to EBP. In medicine and nursing, an abundance of research exists on this subject, although such studies are rare in management. To address this gap, we surveyed 2,789 management practitioners in Belgium, the Netherlands, the United States, the United Kingdom and Australia. Our findings indicate that most managers we studied have positive attitudes towards EBP. However, lack of time and a limited understanding of scientific research are perceived as major barriers to the uptake and implementation of EBP in management. Studies in other professions where EBP is far more established also report similar barriers. We discuss the implications of our findings for practice, education and research, providing suggestions to enhance use of EBP in management practice.	[Barends, Eric] Ctr Evidence Based Management CEBMa, Amsterdam, Netherlands; [Villanueva, Josh] Claremont Grad Univ, Claremont, CA USA; [Rousseau, Denise M.] Carnegie Mellon Univ, Heinz Coll, Pittsburgh, PA 15213 USA; [Briner, Rob B.] Queen Mary Univ London, Sch Business & Management, London, England; [Jepsen, Denise M.] Macquarie Univ, Fac Business & Econ, N Ryde, NSW, Australia; [Houghton, Edward] CIPD, Human Capital & Metr, London, England; [ten Have, Steven] Vrije Univ Amsterdam, Amsterdam, Netherlands	Claremont Colleges; Claremont Graduate School; Carnegie Mellon University; University of London; Queen Mary University London; Macquarie University; Vrije Universiteit Amsterdam	Barends, E (corresponding author), Ctr Evidence Based Management CEBMa, Amsterdam, Netherlands.	e.barends@cebma.org	Jepsen, Denise/L-8524-2019; Have, Steven ten/AAH-9838-2020; Jepsen, Denise/E-8575-2011	Have, Steven ten/0000-0002-7903-0071; Jepsen, Denise/0000-0002-7106-8972				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Barends E., 2014, EVIDENCE BASED MANAG; Barends EGR, 2014, ACAD MANAG LEARN EDU, V13, P476, DOI 10.5465/amle.2014.0136; Briner R.B., 2012, HDB EVIDENCE BASED M, P112, DOI DOI 10.1093/OXFORDHB/9780199763986.013.0007; Briner RB, 2014, SKILLS FDN EVIDENCE, V13; Charlier SD, 2011, ACAD MANAG LEARN EDU, V10, P222, DOI 10.5465/AMLE.2011.62798931; Cyert RM, 1997, ORGAN DYN, V25, P45, DOI 10.1016/S0090-2616(97)90036-X; Daly J., 2005, EVIDENCE BASED MED S; Digest of Education Statistics, 2015, DIG ED STAT; DUNNETTE MD, 1968, ACAD MANAGE J, V11, P177, DOI 10.2307/255255; Empson L, 2013, J MANAGE INQUIRY, V22, P229, DOI 10.1177/1056492612446068; Estabrooks CA, 2003, J ADV NURS, V43, P506, DOI 10.1046/j.1365-2648.2003.02748.x; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Flores M, 2000, PEDIATRICS, V105; Frasure J, 2008, J ADV NURS, V61, P5, DOI 10.1111/j.1365-2648.2007.04525.x; Funk S G, 1991, Appl Nurs Res, V4, P39; Gabriel H, 2006, MARK INTELL PLAN, V24, P505, DOI 10.1108/02634500610682890; GANNON MJ, 1971, BUS HORIZONS, V14, P49, DOI 10.1016/0007-6813(71)90040-1; Garman AN, 2011, J BUS PSYCHOL, V26, P129, DOI 10.1007/s10869-011-9224-7; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; GOPINATH C, 1995, J MANAGE STUD, V32, P575, DOI 10.1111/j.1467-6486.1995.tb00789.x; Harkness JA, 2003, CROSS CULTURAL SURVE, P19; Hemsley-Brown JV, 2004, OXFORD REV ED, V29; Hodgkinson GP, 2006, J OCCUP ORGAN PSYCH, V79, P173, DOI 10.1348/096317906X104013; Howells J, 1998, IND ACAD LINKS UK; Jordan DJ, 1999, J LEISURE RES, V31, P166, DOI 10.1080/00222216.1999.11949856; Kahneman D., 2011, THINKING FAST SLOW; Kajermo KN, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-32; KIM MS, 1993, J COMMUN, V43, P101, DOI 10.1111/j.1460-2466.1993.tb01251.x; Kraft P, 2005, BRIT J SOC PSYCHOL, V44, P479, DOI 10.1348/014466604X17533; KRAUS SJ, 1995, PERS SOC PSYCHOL B, V21, P58, DOI 10.1177/0146167295211007; Lantos GP, 1994, J PROD BRAND MANAG, V3, P15; Lizarondo L, 2011, J MULTIDISCIPLINARY, V4; MCARTHUR DS, 1980, INTERFACES, V10, P110, DOI 10.1287/inte.10.1.110; McColl A, 1998, BRIT MED J, V316, P361, DOI 10.1136/bmj.316.7128.361; McKenzie C.J., 2002, EUR J MARKETING, V36, P1196; Milner M, 2006, J EVAL CLIN PRACT, V12, P639, DOI 10.1111/j.1365-2753.2006.00632.x; Mintzberg H., 1990, HARVARD BUSINESS REV; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Offermann LR, 2001, ACAD MANAGE J, V44, P376, DOI 10.2307/3069462; Patelarou AE, 2013, J COMMUN HEALTH NURS, V30, P230, DOI 10.1080/07370016.2013.838501; Ratnatunga J., 2012, J APPL MANAGEMENT AC; Rousseau DM, 2007, ACAD MANAGE J, V50, P1037; Rousseau DM, 2008, ACAD MANAG ANN, V2, P475, DOI 10.1080/19416520802211651; Rubin DB, 2004, MULTIPLE IMPUTATION; Rynes S. L., 2012, OXFORD HDB EVIDENCE; Rynes SL, 2002, HUM RESOURCE MANAGE, V41, P149, DOI 10.1002/hrm.10029; Rynes SL, 2002, 7 COMMON MISCONCEPTI; Sanders K, 2008, INT J HUM RESOUR MAN, V19, P1976, DOI 10.1080/09585190802324304; Shaneyfelt T, 2006, JAMA-J AM MED ASSOC, V296, P1116, DOI 10.1001/jama.296.9.1116; Solomons NM, 2011, J NURS MANAGE, V19, P109, DOI 10.1111/j.1365-2834.2010.01144.x; Squires JE, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-1, 10.1186/1748-5908-6-21]; Tenhiala A, 2016, HUM RESOUR MANAGE-US, V55, P179, DOI 10.1002/hrm.21656; TETLOCK PE, 1985, SOC PSYCHOL QUART, V48, P227, DOI 10.2307/3033683; TRAHAN EA, 1995, Q REV ECON FINANC, V35, P73, DOI 10.1016/1062-9769(95)90063-2; Ubbink DT, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001881; Van Dijk N, 2010, WHAT ARE BARRIERS RE, V85; Villanueva J., 2011, THESIS; Wallace DS, 2005, REV GEN PSYCHOL, V9, P214, DOI 10.1037/1089-2680.9.3.214; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	61	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184594	10.1371/journal.pone.0184594	http://dx.doi.org/10.1371/journal.pone.0184594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI6UJ	28972977	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900005
J	Gnan, S; Marsh, T; Kover, PX				Gnan, Sebastian; Marsh, Tom; Kover, Paula X.			Inflorescence photosynthetic contribution to fitness releases Arabidopsis thaliana plants from trade-off constraints on early flowering	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; CLIMATE-CHANGE; GROWTH; TIME; SELECTION; REPRODUCTION; PHENOLOGY; SHAPE; SIZE; ADAPTATION	Leaves are thought to be the primary carbon source for reproduction in plants, so a positive relationship between vegetative size and reproductive output is expected, establishing a trade-off between time to reproduction and reproductive output. A common response to higher temperatures due to climate changes is the induction of earlier transition into reproduction. Thus, in annual plants, earlier transition into flowering can potentially constrain plant size and reduce seed production. However, trade-offs between early reproduction and fitness are not always observed, suggesting mechanisms to escape the constraints of early flowering do exist. Here, we test whether inflorescence photosynthesis contribution to the reproductive output of Arabidopsis thaliana can offset the cost of early reproduction. We followed the development, growth rate and fitness of 15 accessions, and removed all rosette leaves at flowering (prior to the completion of inflorescence development or any fruit production) in half of the plants to determine the ability of inflorescences to maintain fitness in the absence of leaves. Although leaf removal significantly reduced fruit number, seed weight and plant height, even the most severely impacted accessions maintained 35% of their fitness with the inflorescence as the sole photosynthetic organ; and some accessions experienced no reduction in fitness. Differences between accessions in their ability to maintain fitness after leaf removal is best explained by earlier flowering time and the ability to maintain as many or more branches after leaf removal as in the control treatment. Although earlier flowering does constrain plant vegetative size, we found that inflorescence photosynthesis can significantly contribute to seed production, explaining why early flowering plants can maintain high fitness despite a reduction in vegetative size. Thus, plants can be released from the usually assumed trade-offs associated with earlier reproduction, and selection on inflorescence traits can mediate the impact of climate change on phenology.	[Gnan, Sebastian; Marsh, Tom; Kover, Paula X.] Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Claverton Down, Bath, Avon, England	University of Bath	Kover, PX (corresponding author), Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Claverton Down, Bath, Avon, England.	p.x.kover@bath.ac.uk						Akiyama R, 2012, PLOS ONE, V7; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Anwar MR, 2015, AGR SYST, V132, P133, DOI 10.1016/j.agsy.2014.09.010; Araujo R, 2015, J PHYCOL, V51, P808, DOI 10.1111/jpy.12321; Aschan G, 2003, FLORA, V198, P81, DOI 10.1078/0367-2530-00080; Austen EJ, 2015, EVOLUTION, V69, P2018, DOI 10.1111/evo.12709; Banta JA, 2012, ECOL LETT, V15, P769, DOI 10.1111/j.1461-0248.2012.01796.x; BAZZAZ FA, 1979, NATURE, V279, P554, DOI 10.1038/279554a0; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; CLAUSS MJ, 1994, J ECOL, V82, P447, DOI 10.2307/2261254; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Earley EJ, 2009, AM J BOT, V96, P786, DOI 10.3732/ajb.0800149; Franco M, 1996, PHILOS T R SOC B, V351, P1341, DOI 10.1098/rstb.1996.0117; GALEN C, 1993, EVOLUTION, V47, P1073, DOI 10.1111/j.1558-5646.1993.tb02136.x; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gauslaa Y, 2006, BASIC APPL ECOL, V7, P455, DOI 10.1016/j.baae.2005.12.007; Haro RJ, 2015, FIELD CROP RES, V174, P12, DOI 10.1016/j.fcr.2015.01.005; Haselhorst MSH, 2011, MOL ECOL, V20, P4042, DOI 10.1111/j.1365-294X.2011.05227.x; Johansson J, 2013, GLOBAL CHANGE BIOL, V19, P197, DOI 10.1111/gcb.12006; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kover PX, 2009, NEW PHYTOL, V183, P816, DOI 10.1111/j.1469-8137.2009.02943.x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; Laporte MM, 1996, OECOLOGIA, V106, P63, DOI 10.1007/BF00334408; Leonardos ED, 2014, ENVIRON EXP BOT, V107, P84, DOI 10.1016/j.envexpbot.2014.05.007; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Neytcheva MS, 2008, OIKOS, V117, P1298, DOI 10.1111/j.0030-1299.2008.16695.x; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Reekie Edward G., 2005, P185; Remington DL, 2013, GENETICS, V195, P1087, DOI 10.1534/genetics.113.151803; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Roff DA, 2000, J EVOLUTION BIOL, V13, P434, DOI 10.1046/j.1420-9101.2000.00186.x; SILVERTOWN J, 1989, TRENDS ECOL EVOL, V4, P24, DOI 10.1016/0169-5347(89)90013-X; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stinchcombe JR, 2010, EVOLUTION, V64, P2887, DOI 10.1111/j.1558-5646.2010.01060.x; Thiele J, 2009, BASIC APPL ECOL, V10, P340, DOI 10.1016/j.baae.2008.04.002; Tucker C, 2010, OECOLOGIA, V164, P1005, DOI 10.1007/s00442-010-1738-6; Vermeulen PJ, 2015, NEW PHYTOL, V205, P429, DOI 10.1111/nph.12984; WATSON MA, 1984, ANNU REV ECOL SYST, V15, P233, DOI 10.1146/annurev.es.15.110184.001313; Weigel D, 2012, PLANT PHYSL; Weinig C, 2003, EVOLUTION, V57, P1270, DOI 10.1111/j.0014-3820.2003.tb00335.x; Weis AE, 2014, EVOL ECOL, V28, P885, DOI 10.1007/s10682-014-9719-6; Zeeman SC, 2002, PLANT PHYSIOL, V129, P516, DOI 10.1104/pp.003756; Zhang X, 2012, G3-GENES GENOM GENET, V2, P29, DOI 10.1534/g3.111.001487	46	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185835	10.1371/journal.pone.0185835	http://dx.doi.org/10.1371/journal.pone.0185835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973036	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900058
J	Stuart, RM; Kerr, CC; Haghparast-Bidgoli, H; Estill, J; Grobicki, L; Baranczuk, Z; Prieto, L; Montanez, V; Reporter, L; Gray, RT; Skordis-Worrall, J; Keiser, O; Cheikhll, N; Boonto, K; Osornprasop, S; Lavadenz, F; Benedikt, CJ; Martin-Hughes, R; Hussain, SA; Kelly, SL; Kedziora, J; Wilson, DP				Stuart, Robyn M.; Kerr, Cliff C.; Haghparast-Bidgoli, Hassan; Estill, Janne; Grobicki, Laura; Baranczuk, Zofia; Prieto, Lorena; Montanez, Vilma; Reporter, Lyanoosh; Gray, Richard T.; Skordis-Worrall, Jolene; Keiser, Olivia; Cheikhll, Nejma; Boonto, Krittayawan; Osornprasop, Sutayut; Lavadenz, Fernando; Benedikt, Clemens J.; Martin-Hughes, Rowan; Hussain, S. Azfar; Kelly, Sherrie L.; Kedziora, J.; Wilson, David P.			Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics	PLOS ONE			English	Article							PREVENTION; RISK; INTERVENTIONS; PROGRAMS; SCALE	Background Prioritizing investments across health interventions is complicated by the nonlinear relationship between intervention coverage and epidemiological outcomes. It can be difficult for countries to know which interventions to prioritize for greatest epidemiological impact, particularly when budgets are uncertain. Methods We examined four case studies of HIV epidemics in diverse settings, each with different characteristics. These case studies were based on public data available for Belarus, Peru, Togo, and Myanmar. The Optima HIV model and software package was used to estimate the optimal distribution of resources across interventions associated with a range of budget envelopes. We constructed "investment staircases", a useful tool for understanding investment priorities. These were used to estimate the best attainable cost-effectiveness of the response at each investment level. Findings We find that when budgets are very limited, the optimal HIV response consists of a smaller number of 'core' interventions. As budgets increase, those core interventions should first be scaled up, and then new interventions introduced. We estimate that the cost-effectiveness of HIV programming decreases as investment levels increase, but that the overall cost-effectiveness remains below GDP per capita. Significance It is important for HIV programming to respond effectively to the overall level of funding availability. The analytic tools presented here can help to guide program planners understand the most cost-effective HIV responses and plan for an uncertain future.	[Stuart, Robyn M.; Kerr, Cliff C.; Reporter, Lyanoosh; Martin-Hughes, Rowan; Hussain, S. Azfar; Kelly, Sherrie L.; Kedziora, J.; Wilson, David P.] Burnet Inst, Melbourne, Vic, Australia; [Stuart, Robyn M.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [Haghparast-Bidgoli, Hassan] UCL, Inst Global Hlth, London, England; [Estill, Janne; Baranczuk, Zofia; Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Estill, Janne; Baranczuk, Zofia; Keiser, Olivia] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland; [Baranczuk, Zofia] Univ Zurich, Inst Math, Zurich, Switzerland; [Prieto, Lorena; Montanez, Vilma] Univ Pacifico, Lima, Peru; [Gray, Richard T.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Cheikhll, Nejma; Osornprasop, Sutayut; Lavadenz, Fernando; Benedikt, Clemens J.] World Bank Grp, Washington, DC USA; [Boonto, Krittayawan] UNAIDS Myanmar, Yangon, Myanmar	Burnet Institute; University of Copenhagen; University of Sydney; University of London; University College London; University of Bern; University of Geneva; University of Bern; University of Zurich; Universidad del Pacifico Peru; University of New South Wales Sydney; Kirby Institute; The World Bank	Stuart, RM (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Stuart, RM (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	robyn@optimamodel.com	Bidgoli, Hassan Haghparast/C-1601-2018; Prieto, Ana Lorena/AAD-6328-2021	Bidgoli, Hassan Haghparast/0000-0001-6365-2944; Prieto, Ana Lorena/0000-0002-6134-0987; Gray, Richard/0000-0002-2885-0483; Kedziora, David/0000-0002-0673-182X; Skordis, Jolene/0000-0002-8633-0208	Australian National Health and Medical Research Council; World Bank; World Bank's allocative efficiency program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Bank(The World Bank India); World Bank's allocative efficiency program	Funding for this study was provided by the Australian National Health and Medical Research Council (https.//www.nhmrc.gov.au/) and the World Bank (http://www.worldbank.org/).; The authors are grateful for the collaborative efforts of the teams who worked on the allocative efficiency studies conducted in Myanmar, Peru, Togo, and Belarus as part of the country-led studies funded by the World Bank's allocative efficiency program for country planning. Those activities were conducted separately to this research project but discussions in the country planning activities were valuable in highlighting distinct principles of relevance to other settings globally which created some motivation for this research study. We value the leadership of our country partners in ongoing relationships and Optima modeling activities to guide HIV response planning and decision making in each country. We also acknowledge Emiko Masaki, Marelize Gorgens and David Wilson (World Bank), who provided useful guidance on this study.	Alistar SS, 2012, MED DECIS MAKING, V32, P105, DOI 10.1177/0272989X10391808; [Anonymous], 2017, GDP PER CAP CURR US; [Anonymous], 2017, UNIT COST REPOSITORY; [Anonymous], 2017, AIDSINFO; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Brandeau ML, 2009, HEALTH CARE MANAG SC, V12, P27, DOI 10.1007/s10729-008-9074-7; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Henry J, 2016, FINANCING RESPONSE H; Howard AA, 2016, GLOBAL HLTH ACTION, P9; Kelly SL, 2017, POTENTIAL GLOBAL GAI; Kerr CC, 2017, OPTIMIZATION ADAPTIV; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kumaranayake L, 2008, AIDS, V22, pS23, DOI 10.1097/01.aids.0000327620.47103.1d; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; Ministry of Health P, 2014, PLAN ESTR MULT PREV; Myanmar Ministry of Health NAP, 2015, HIV SENT SER SURV SU; Programme National de Lutte contre le Sida et les IST, 2011, PROGRAMME NATL LUTTE; Pham QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133171; Resch S, 2015, LANCET GLOB HEALTH, V3, pE52, DOI 10.1016/S2214-109X(14)70342-0; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; Scott N, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2019-1; Soto RJ, 2007, JAIDS-J ACQ IMM DEF, V46, P101; Stuart RM, 2017, SHOULD HIV RESOURCES; The Optima Consortium for Decision Science, 2017, OPT HIV US GUID, VVI; The World Bank, 2017, OPT INV TOG HIV RESP; The World Bank, 2017, IMPR ALL TECHN EFF M; The World Bank, 2017, ALL HIV FUND EFF MYA; Togo Ministry of Health, 2014, MSM BBS SURV 2015; Togo Ministry of Health, 2014, FSW BBS SURV 2015; UNAIDS, 2010, COMB HIV PREV TAIL C; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vassall A, 2014, LANCET GLOB HEALTH, V2, pE531, DOI 10.1016/S2214-109X(14)70277-3; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; World Bank, 2015, OPT INV BEL NAT HIV; World Bank, 2017, OPT INV RESP HIV PER; Youngkong S, 2009, TROP MED INT HEALTH, V14, P930, DOI 10.1111/j.1365-3156.2009.02311.x	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185077	10.1371/journal.pone.0185077	http://dx.doi.org/10.1371/journal.pone.0185077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972975	Green Published, gold			2022-12-27	WOS:000412131900011
J	Aukes, K; Forsman, C; Brady, NJ; Astleford, K; Blixt, N; Sachdev, D; Jensen, ED; Mansky, KC; Schwertfeger, KL				Aukes, Kelly; Forsman, Cynthia; Brady, Nicholas J.; Astleford, Kristina; Blixt, Nicholas; Sachdev, Deepali; Jensen, Eric D.; Mansky, Kim C.; Schwertfeger, Kathryn L.			Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions	PLOS ONE			English	Article							KAPPA-B PATHWAYS; BONE-RESORPTION; TARGETING FGFR; MAP KINASE; DIFFERENTIATION; SURVIVAL; OSTEOBLAST; CHONDROCYTE; ACTIVATION; REGULATOR	Fibroblast growth factors (FGFs) and their receptors (FGFRs) have been implicated in promoting breast cancer growth and progression. While the autocrine effects of FGFR activation in tumor cells have been extensively studied, little is known about the effects of tumor cell-derived FGFs on cells in the microenvironment. Because FGF signaling has been implicated in the regulation of bone formation and osteoclast differentiation, we hypothesized that tumor cell-derived FGFs are capable of modulating osteoclast function and contributing to growth of metastatic lesions in the bone. Initial studies examining FGFR expression during osteoclast differentiation revealed increased expression of FGFR1 in osteoclasts during differentiation. Therefore, studies were performed to determine whether tumor cell-derived FGFs are capable of promoting osteoclast differentiation and activity. Using both non-transformed and transformed cell lines, we demonstrate that breast cancer cells express a number of FGF ligands that are known to activate FGFR1. Furthermore our results demonstrate that inhibition of FGFR activity using the clinically relevant inhibitor BGJ398 leads to reduced osteoclast differentiation and activity in vitro. Treatment of mice injected with tumor cells into the femurs with BGJ398 leads to reduced osteoclast activity and bone destruction. Together, these studies demonstrate that tumor cell-derived FGFs enhance osteoclast function and contribute to the formation of metastatic lesions in breast cancer.	[Aukes, Kelly; Forsman, Cynthia; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Brady, Nicholas J.] Univ Minnesota, Microbiol Canc Biol & Immunol Grad Program, Minneapolis, MN USA; [Astleford, Kristina; Mansky, Kim C.] Univ Minnesota, Sch Dent, Dev & Surg Sci, Minneapolis, MN 55455 USA; [Blixt, Nicholas] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Sachdev, Deepali; Mansky, Kim C.; Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Sachdev, Deepali] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Jensen, Eric D.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Schwertfeger, Kathryn L.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schwertfeger, KL (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Mansky, KC (corresponding author), Univ Minnesota, Sch Dent, Dev & Surg Sci, Minneapolis, MN 55455 USA.; Mansky, KC; Schwertfeger, KL (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Schwertfeger, KL (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN USA.	kmansky@umn.edu; schwe251@umn.edu	Brady, Nicholas/AAB-2888-2019	Brady, Nicholas/0000-0002-2928-0232; Mansky, Kim/0000-0002-2826-5030	National Institute of Arthritis and Musculoskeletal and Skin Diseases [5T32AR050938]; University of Minnesota Academic Health Center; National Cancer Institute [R01CA132827, R01CA215052]; NATIONAL CANCER INSTITUTE [R01CA132827, R01CA215052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Minnesota Academic Health Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this work was provided by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (5T32AR050938), the University of Minnesota Academic Health Center and the National Cancer Institute including R01CA132827 and R01CA215052 to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2014, BREAST CANC FACTS FI; Andre F, 2013, CLIN CANCER RES, V19, P3693, DOI 10.1158/1078-0432.CCR-13-0190; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Bosetti M, 2010, J CELL PHYSIOL, V225, P466, DOI 10.1002/jcp.22225; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Broege A, 2013, J BIOL CHEM, V288, P37230, DOI 10.1074/jbc.M113.496950; Cenni E, 2007, ANTICANCER RES, V27, P315; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; Du X, 2012, J CELL PHYSL, V227, P3731, DOI DOI 10.1002/JCP.24083; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Linares GR, 2012, J BONE MINER RES, V27, P1553, DOI 10.1002/jbmr.1600; Lu XM, 2009, BIOCHEM BIOPH RES CO, V390, P494, DOI 10.1016/j.bbrc.2009.09.123; Matsumoto T, 2013, J BONE MINER RES, V28, P1191, DOI 10.1002/jbmr.1844; Mellis DJ, 2011, J ENDOCRINOL, V211, P131, DOI 10.1530/JOE-11-0212; Meng X, 2016, ONCOGENE, V35, P2370, DOI 10.1038/onc.2015.297; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Thudium CS, 2014, CALCIFIED TISSUE INT, V95, P83, DOI 10.1007/s00223-014-9865-4; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Yoon WJ, 2014, J BIOL CHEM, V289, P8828, DOI 10.1074/jbc.M113.516237	43	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185736	10.1371/journal.pone.0185736	http://dx.doi.org/10.1371/journal.pone.0185736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968431	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600040
J	Chen, YC; Hwang-Gu, SL; Ni, HC; Liang, SHY; Lin, HY; Lin, CF; Tseng, YH; Gau, SSF				Chen, Yu-Chi; Hwang-Gu, Shoou-Lian; Ni, Hsing-Chang; Liang, Sophie Hsin-Yi; Lin, Hsiang-Yuan; Lin, Chiao-Fan; Tseng, Yu-Han; Gau, Susan Shur-Fen			Relationship between parenting stress and informant discrepancies on symptoms of ADHD/ODD and internalizing behaviors in preschool children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; VERSION-IV SCALE; CHILDHOOD PSYCHOPATHOLOGY; PSYCHOMETRIC PROPERTIES; TEACHER RATINGS; CHINESE VERSION; FIT INDEX; AGREEMENT; MOTHERS	Parent and teacher ratings of child behaviors are often discrepant, and these discrepancies may be correlated with parenting stress. The present study explored whether various parenting stress factors are associated with discrepancies between parent and teacher ratings of attention-deficit/hyperactivity disorder and oppositional defiant disorder (ODD) as well as internalizing symptoms in preschool children. We recruited 299 Taiwanese preschool children (aged 4-6 years) from the community or via clinical referrals. A structural equation modeling was used to analyze the relationships among three factors derived from the Parenting Stress Index-Short Form and informant discrepancies on symptoms of inattention, hyperactivity/impulsivity, ODD, and internalizing behaviors. Scores reported by parents were higher for each of the symptoms examined than those reported by teachers, and the degree of agreement between informants ranged from low to moderate. The parental distress factor of parenting stress was associated only with parent ratings, whereas other factors of parenting stress D parent-child dysfunctional interaction and parents' stress resulted from their child's temperament D were correlated with both parent and teacher ratings. Only parental distress factor predicted informant discrepancies for all behavioral symptoms assessed. Our findings suggest that parental distress should be considered when parent rating scores show significant discrepancies from that of teacher rating scores.	[Chen, Yu-Chi; Hwang-Gu, Shoou-Lian] Chang Gung Univ, Coll Med, Grad Inst Behav Sci, Div Clin Psychol, Taoyuan, Taiwan; [Hwang-Gu, Shoou-Lian; Ni, Hsing-Chang; Liang, Sophie Hsin-Yi; Lin, Chiao-Fan] Chang Gung Mem Hosp Linkou, Dept Child Psychiat, Taoyuan, Taiwan; [Lin, Hsiang-Yuan; Gau, Susan Shur-Fen] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan; [Tseng, Yu-Han] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; Soochow University; National Taiwan University; National Taiwan University	Gau, SSF (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei, Taiwan.; Gau, SSF (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.	gaushufe@ntu.edu.tw	Lin, Hsiang-Yuan/H-3546-2019; Chen, Yu-Chi/J-4287-2015; GAU, SUSAN SHUR-FEN/P-4726-2017	Lin, Hsiang-Yuan/0000-0001-9519-209X; Chen, Yu-Chi/0000-0001-9167-6417; GAU, SUSAN SHUR-FEN/0000-0002-2718-8221	Ministry of Science and Technology [MOST 103-2410-H-182-003-MY3]; Chang Gung University, Taiwan [NMRPD1D0131-5]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung University, Taiwan	This study was supported by grants from the Ministry of Science and Technology (MOST 103-2410-H-182-003-MY3), and Chang Gung University (NMRPD1D0131-5), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Ministry of Science and Technology (MOST 103-2410-H-182-003-MY3), and Chang Gung University (NMRPD1D0131-5), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to express all our thanks to all the parents and teachers for their participation and to all the anonymous reviewers for their valuable comments.	Abidin RR., 1995, PSYCHOL ASSESSMENT R; Abidin RR., 1983, PARENTING STRESS IND; Achenbach TM, 2011, J CLIN CHILD ADOLESC, V40, P80, DOI 10.1080/15374416.2011.533416; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2000, DIAGN STAT MAN TEXT; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; Berg-Nielsen TS, 2012, CHILD PSYCHIAT HUM D, V43, P393, DOI 10.1007/s10578-011-0271-0; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Byrne JM, 1998, CHILD NEUROPSYCHOL, V4, P49, DOI 10.1076/chin.4.1.49.3193; Carlson GA, 2011, J CHILD ADOL PSYCHOP, V21, P385, DOI 10.1089/cap.2011.2159; Carmines E.G., 1981, SOCIAL MEASUREMENT, DOI DOI 10.1207/S15327965PLI0404_1; Chiang HL, 2016, J CHILD PSYCHOL PSYC, V57, P103, DOI 10.1111/jcpp.12450; Ciarrochi J, 2008, J CHILD PSYCHOL PSYC, V49, P1279, DOI 10.1111/j.1469-7610.2008.01950.x; Collishaw S, 2009, J CHILD PSYCHOL PSYC, V50, P571, DOI 10.1111/j.1469-7610.2008.02026.x; Costa NM, 2006, J PSYCHOPATHOL BEHAV, V28, P113, DOI 10.1007/s10862-006-7489-3; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; De Los Reyes A, 2004, PSYCHOL ASSESSMENT, V16, P330, DOI 10.1037/1040-3590.16.3.330; De Los Reyes A, 2015, PSYCHOL BULL, V141, P858, DOI 10.1037/a0038498; De Los Reyes A, 2011, J CLIN CHILD ADOLESC, V40, P36, DOI 10.1080/15374416.2011.533402; DeaterDeckard K, 1996, J FAM PSYCHOL, V10, P45, DOI 10.1037/0893-3200.10.1.45; DuPaul GJ, 2001, J AM ACAD CHILD PSY, V40, P508, DOI 10.1097/00004583-200105000-00009; Eisenberg N, 2000, J PERS SOC PSYCHOL, V78, P136, DOI 10.1037//0022-3514.66.4.776; Gau SSF, 2008, INT J METH PSYCH RES, V17, P35, DOI 10.1002/mpr.237; Gau SSF, 2010, AUST NZ J PSYCHIAT, V44, P135, DOI 10.3109/00048670903282733; Gau SSF, 2009, J PEDIATR PSYCHOL, V34, P850, DOI 10.1093/jpepsy/jsn133; Gerdes AC, 2013, J ATTEN DISORD, V16, P147; Grietens H, 2004, J PSYCHOPATHOL BEHAV, V26, P137, DOI 10.1023/B:JOBA.0000013661.14995.59; Gross D, 2004, RES NURS HEALTH, V27, P413, DOI 10.1002/nur.20040; Hoffenaar PJ, 2002, J CHILD PSYCHOL PSYC, V43, P375, DOI 10.1111/1469-7610.00028; HOLM S, 1979, SCAND J STAT, V6, P65; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jen W, 1995, THESIS; Johnston C, 2001, CLIN CHILD FAM PSYCH, V4, P183, DOI 10.1023/A:1017592030434; Joormann J, 1997, PERS INDIV DIFFER, V23, P827, DOI 10.1016/S0191-8869(97)00075-5; Joreskog KG, 2005, LISREL 8 7 WINDOWS; Konold TR, 2007, J PSYCHOEDUC ASSESS, V25, P222, DOI 10.1177/0734282906297784; Langberg JM, 2010, J EMOT BEHAV DISORD, V18, P41, DOI 10.1177/1063426608330792; Lavigne JV, 2015, CHILD PSYCHIAT HUM D, V46, P308, DOI 10.1007/s10578-014-0472-4; Lavigne J, 2009, J CLIN CHILD ADOLESC, V38, P315, DOI 10.1080/15374410902851382; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Liu JH, 2011, J ABNORM CHILD PSYCH, V39, P251, DOI 10.1007/s10802-010-9452-8; Morgan J., 2002, CHILD FAMILY SOCIAL, V7, P219, DOI [10.1046/j.1365-2206.2002.00242.x, DOI 10.1046/J.1365-2206.2002.00242.X]; Muller JM, 2011, EUR CHILD ADOLES PSY, V20, P241, DOI 10.1007/s00787-011-0168-2; Murray DW, 2007, J CHILD ADOL PSYCHOP, V17, P605, DOI 10.1089/cap.2007.0060; Najman JM, 2000, J AM ACAD CHILD PSY, V39, P592, DOI 10.1097/00004583-200005000-00013; Pelham WE, 1998, J CLIN CHILD PSYCHOL, V27, P190, DOI 10.1207/s15374424jccp2702_6; Re AM, 2009, J ATTEN DISORD, V12, P532, DOI 10.1177/1087054708323001; Reitman D, 2002, J CLIN CHILD ADOLESC, V31, P384, DOI 10.1207/S15374424JCCP3103_10; Rescorla LA, 2014, J CLIN CHILD ADOLESC, V43, P627, DOI 10.1080/15374416.2014.900719; Rescorla LA, 2012, J EMOT BEHAV DISORD, V20, P68, DOI 10.1177/1063426611434158; Rettew DC, 2011, J CHILD ADOL PSYCHOP, V21, P389, DOI 10.1089/cap.2010.0153; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Rogers M.A., 2009, SCH MENTAL HLTH, V1, P89, DOI [DOI 10.1007/S12310-009-9010-0, 10.1007/s12310-009-9010-0]; Schumacker, 2001, NEW DEV TECHNIQUES S, P269, DOI DOI 10.4324/9781410601858; Shang CY, 2013, PSYCHOL MED, V43, P1093, DOI 10.1017/S0033291712001869; Sivo SA, 2006, J EXP EDUC, V74, P267, DOI 10.3200/JEXE.74.3.267-288; SOLIS ML, 1991, J CLIN CHILD PSYCHOL, V20, P372, DOI 10.1207/s15374424jccp2004_5; Solish A, 2008, RES AUTISM SPECT DIS, V2, P728, DOI 10.1016/j.rasd.2008.03.001; Soma Yukio, 2009, Environmental Health and Preventive Medicine, V14, P150, DOI 10.1007/s12199-008-0075-4; Stormont M, 1999, PSYCHOL SCHOOLS, V36, P109, DOI 10.1002/(SICI)1520-6807(199903)36:2<109::AID-PITS3>3.0.CO;2-H; Strickland J, 2012, J ABNORM CHILD PSYCH, V40, P933, DOI 10.1007/s10802-012-9622-y; Theule J, 2013, J EMOT BEHAV DISORD, V21, P3, DOI 10.1177/1063426610387433; Theule J, 2011, J CHILD FAM STUD, V20, P640, DOI 10.1007/s10826-010-9439-7; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; van der Oord S, 2006, BEHAV RES THER, V44, P1585, DOI 10.1016/j.brat.2005.11.011; Vitiello B, 2007, J CHILD ADOL PSYCHOP, V17, P593, DOI 10.1089/cap.2007.0058; Wilens TE, 2002, J DEV BEHAV PEDIATR, V23, pS31, DOI 10.1097/00004703-200202001-00006; Wu YT, 2012, RES DEV DISABIL, V33, P866, DOI 10.1016/j.ridd.2011.11.018	73	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0183467	10.1371/journal.pone.0183467	http://dx.doi.org/10.1371/journal.pone.0183467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016602	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400003
J	Magin, RS; Deng, SB; Zhang, HB; Cooperman, B; Marmorstein, R				Magin, Robert S.; Deng, Sunbin; Zhang, Haibo; Cooperman, Barry; Marmorstein, Ronen			Probing the interaction between NatA and the ribosome for co-translational protein acetylation	PLOS ONE			English	Article							N-TERMINAL ACETYLATION; SIGNAL RECOGNITION PARTICLE; ALPHA-ACETYLTRANSFERASE; MOLECULAR-BASIS; TRIGGER FACTOR; CRYSTAL-STRUCTURE; NASCENT PEPTIDES; COMPLEX REVEALS; GTPASE ARL3P; APOPTOSIS	N-terminal acetylation is among the most abundant protein modifications in eukaryotic cells. Over the last decade, significant progress has been made in elucidating the function of N-terminal acetylation for a number of diverse systems, involved in a wide variety of biological processes. The enzymes responsible for the modification are the N-terminal acetyltransferases (NATs). The NATs are a highly conserved group of enzymes in eukaryotes, which are responsible for acetylating over 80% of the soluble proteome in human cells. Importantly, many of these NATs act co-translationally; they interact with the ribosome near the exit tunnel and acetylate the nascent protein chain as it is being translated. While the structures of many of the NATs have been determined, the molecular basis for the interaction with ribosome is not known. Here, using purified ribosomes and NatA, a very well-studied NAT, we show that NatA forms a stable complex with the ribosome in the absence of other stabilizing factors and through two conserved regions; primarily through an N-terminal domain and an internal basic helix. These regions may orient the active site of the NatA to face the peptide emerging from the exit tunnel. This work provides a framework for understanding how NatA and potentially other NATs interact with the ribosome for co-translational protein acetylation and sets the foundation for future studies to decouple N-terminal acetyltransferase activity from ribosome association.	[Magin, Robert S.; Deng, Sunbin; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Magin, Robert S.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Biophys, Philadelphia, PA 19104 USA; [Deng, Sunbin; Zhang, Haibo; Cooperman, Barry; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Zhang, Haibo] Spark Therapeut, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Marmorstein, R (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Marmorstein, R (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	marmor@upenn.edu	Deng, Sunbin/AAG-6551-2021	Deng, Sunbin/0000-0001-7798-4317; Magin, Robert/0000-0002-8480-8511; Marmorstein, Ronen/0000-0003-4373-4752	National Institutes of Health [R35GM118090, T32 GM071339]; DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania [NIH P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118090, T32GM071339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R35GM118090 to R.M and T32 GM071339 to R.S.M. We also acknowledge the support of the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health grants R35GM118090 to R.M and T32 GM071339 to R.S.M. We acknowledge the support of the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (NIH P30 CA016520). We thank Glen Liszczak for guidance in ribosome purification and assay development.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Aksnes H, 2017, J BIOL CHEM, V292, P6821, DOI 10.1074/jbc.M116.770362; Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Aksnes H, 2015, CELL REP, V10, P1362, DOI 10.1016/j.celrep.2015.01.053; Arnesen T, 2006, ONCOGENE, V25, P4350, DOI 10.1038/sj.onc.1209469; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Chen D, 2014, PLOS GENET; Dikiy I, 2014, J BIOL CHEM; Ferrandez-Ayela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080697; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599; Giglione C, 2015, BIOCHIMIE, V114, P134, DOI 10.1016/j.biochi.2014.11.008; Helbig AO, 2010, MOL CELL PROTEOMICS, V9, P928, DOI 10.1074/mcp.M900463-MCP200; Hong HY, 2017, STRUCTURE, V25, P641, DOI 10.1016/j.str.2017.03.003; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kalvik TV, 2013, ONCOGENE, V32, P269, DOI 10.1038/onc.2012.82; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Liszczak G, 2011, J BIOL CHEM, V286, P37002, DOI 10.1074/jbc.M111.282863; Magin RS, 2015, STRUCTURE, V23, P332, DOI 10.1016/j.str.2014.10.025; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Myklebust LM, 2015, ONCOTARGET, V6, P34041, DOI 10.18632/oncotarget.5867; Neubauer JL, 2012, THESIS; Pavlou D, 2016, APOPTOSIS, V21, P298, DOI 10.1007/s10495-015-1207-0; PESTANA A, 1974, NATURE, V247, P200, DOI 10.1038/247200a0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; Ree R, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150168; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Schiza V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003805; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Stove SI, 2016, STRUCTURE, V24, P1044, DOI 10.1016/j.str.2016.04.020; STROUS GJA, 1974, BIOCHEM BIOPH RES CO, V58, P876, DOI 10.1016/S0006-291X(74)80498-5; STROUS GJAM, 1973, EUR J BIOCHEM, V38, P79, DOI 10.1111/j.1432-1033.1973.tb03036.x; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Wang Y, 2010, DEV DYNAMICS; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Weyer FA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15726; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Yang DX, 2013, NAT STRUCT MOL BIOL, V20, P1116, DOI 10.1038/nsmb.2637; Zhang Z., 2010, EMBO J	58	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186278	10.1371/journal.pone.0186278	http://dx.doi.org/10.1371/journal.pone.0186278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016658	gold, Green Submitted, Green Published			2022-12-27	WOS:000412627400065
J	Jaramillo, CM; de la Hoz, F; Porras, A; di Filippo, D; Choconta-Piraquive, LA; Payares, E; Montes, N; Navas, MC				Mario Jaramillo, Carlos; de la Hoz, Fernando; Porras, Alexandra; di Filippo, Diana; Angela Choconta-Piraquive, Luz; Payares, Edra; Montes, Neyla; Navas, Maria-Cristina			Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia	PLOS ONE			English	Article							GENOTYPE-F; GENETIC DIVERSITY; SURFACE-PROTEIN; HIGH-PREVALENCE; VARIANTS; VACCINE; REGION; MUTANT; INFECTION; POPULATION	Background Hepatitis B Virus (HBV) infection is a worldwide public health problem. In the 1980's a highly effective and safe vaccine against HBV was developed, although breakthrough infection still occasionally occurs because of the emergence of escape mutants. The aim of this study was to identify HBV genotypes and escape mutants in children and their mothers in Amerindian communities of the Amazonas State, Southern Colombia. Methods Blood specimens collected from children and mothers belonging to 37 Amerindian communities in Amazonas state, were screened for HBsAg and anti-HBc using ELISA. The partial region containing the S ORF was amplified by nested PCR, and amplicons were sequenced. The phylogenetic analysis was performed using the MEGA 5.05 software. Results Forty-six children (46/1275, 3.6%) and one hundred and seventy-seven mothers (177/572, 30.9%) were tested positive for the anti-HBc serological marker. Among them, 190 samples were tested for viral genome detection; 8.3% (2/31) serum samples obtained from children and 3.1% (5/159) from mothers were positive for the ORF S PCR. The predominant HBV genotype in the study population was F, subgenotype F1b; in addition, subgenotype F1a and genotype A were also characterized. Two HBV escape mutants were identified, G145R, reported worldwide, and W156*; this stop codon was identified in a child with occult HBV infection. Other mutations were found, L109R and G130E, located in critical positions of the HBsAg sequence. Conclusions This study aimed to characterize the HBV genotype F, subgenotypes F1b and F1a, and genotype A in Amerindian communities and for the first time escape mutants in Colombia. Further investigations are necessary to elucidate the frequency and the epidemiological impact of the escape mutants in the country.	[Mario Jaramillo, Carlos; di Filippo, Diana; Navas, Maria-Cristina] Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia; [de la Hoz, Fernando; Porras, Alexandra; Angela Choconta-Piraquive, Luz] Univ Nacl Colombia, Grp Epidemiol & Evaluac Salud Publ, Bogota, Colombia; [Payares, Edra] Lab Dept Salud Publ Amazonas, Leticia, Colombia; [Montes, Neyla] Alcaldia Puerto Narino, Coordinac Salud Publ, Puerto Narino, Colombia	Universidad de Antioquia; Universidad Nacional de Colombia	Navas, MC (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Gastrohepatol, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022	Porras-Ramirez, Alexandra/0000-0002-0800-1388; Navas, Maria Cristina/0000-0003-2610-9306	Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion); Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [110151929040]	Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion); Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was funded by Universidad de Antioquia (Proyecto de Sostenibilidad, Vicerrectoria de Investigacion) and by Departamento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 110151929040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 1981, BIORNEDICA REV I NAC, V1, P182; de la Fuente RA, 2011, WORLD J GASTROENTERO, V17, P1543, DOI [10.3748/wjg.v17.i12.1543, 10.3748/wjg.v17.i12. 1543]; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Alvarado-Mora MV, 2013, ANTIVIR THER, V18, P459, DOI 10.3851/IMP2599; Alvarado-Mora MV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-244; Alvarado-Mora MV, 2011, INFECT GENET EVOL, V11, P1462, DOI 10.1016/j.meegid.2011.05.020; Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Choconta-Piraquive LA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1542-z; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Campos Rodolfo H, 2005, J Clin Virol, V34 Suppl 2, pS8, DOI 10.1016/S1386-6532(05)80028-9; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chang MH, 2006, J CLIN VIROL, V36, pS45, DOI 10.1016/S1386-6532(06)80008-9; Chen CY, 2010, VACCINE, V28, P5605, DOI 10.1016/j.vaccine.2010.06.029; Cortes-Mancera Fabian, 2011, Hepat Res Treat, V2011, P363205, DOI 10.1155/2011/363205; Cuestas ML, 2012, J VIRAL HEPATITIS, V19, P754, DOI 10.1111/j.1365-2893.2012.01614.x; Cuestas ML, 2010, ANTIVIR RES, V87, P74, DOI 10.1016/j.antiviral.2010.04.005; David Rios P., 2015, REV COLOMB GASTROENT, V30, P11; de la Hoz F, 2005, TROP MED INT HEALTH, V10, P322, DOI 10.1111/j.1365-3156.2005.01399.x; De la Hoz F., 1992, BIOMEDICA, V12, P5; de la Hoz F, 2008, INT J INFECT DIS, V12, P183, DOI 10.1016/j.ijid.2007.06.010; Devesa M, 2008, J MED VIROL, V80, P20, DOI 10.1002/jmv.21024; Devesa M, 2004, J MED VIROL, V72, P377, DOI 10.1002/jmv.20015; Devesa M, 2007, VIRUS RES, V127, P177, DOI 10.1016/j.virusres.2007.01.004; Villa DD, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0402-5; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; Hsu HY, 2010, J INFECT DIS, V201, P1192, DOI 10.1086/651378; Hsu HY, 2004, GUT, V53, P1499, DOI 10.1136/gut.2003.034223; Kitab B, 2011, J INFECTION, V63, P66, DOI 10.1016/j.jinf.2011.05.007; Lai MW, 2008, ANTIVIR THER, V13, P875; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lledo JL, 2011, WORLD J GASTROENTERO, V17, P1563, DOI [10.3748/wjg.v17.i12. 1563, 10.3748/wjg.v17.i12.1563]; Martinez M, 1991, BIOMEDICA, V11, P43; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Michel ML, 2010, PATHOL BIOL, V58, P288, DOI 10.1016/j.patbio.2010.01.006; Nakano T, 2001, J GEN VIROL, V82, P359, DOI 10.1099/0022-1317-82-2-359; Pawlotsky JM, 2005, J CLIN VIROL, V34, pS125, DOI 10.1016/S1386-6532(05)80021-6; Quintero A, 2001, J MED VIROL, V64, P356, DOI 10.1002/jmv.1058; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Ríos-Ocampo Alfredo, 2013, Acta Med Colomb, V38, P143; Sa-nguanmoo P, 2012, J MED VIROL, V84, P1177, DOI 10.1002/jmv.23260; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Salud INd, 2013, INF COMP EV HEP NIV; Salud INd, 2008, INF COMP EV HEP NIV; Salud INd, 2015, INF EP EV INF FIN HE; Salud INd, 2012, INF COMP EV HEP NIV; Salud INd, 2014, INF EP EV INF FIN HE; Salud INd, 2011, INF COMP EV HEP NIV; Salud INd, 2010, INF COMP EV HEP NIV; Somi Mohammad Hossein, 2012, ISRN Gastroenterol, V2012, P960413, DOI 10.5402/2012/960413; Szomor KN, 2008, ARCH VIROL, V153, P1885, DOI 10.1007/s00705-008-0206-7; Thuy LTT, 2005, J MED VIROL, V76, P161, DOI 10.1002/jmv.20337; Venegas M, 2011, J MED VIROL, V83, P1530, DOI 10.1002/jmv.22129; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Yamani LN, 2015, J CLIN MICROBIOL, V53, P3165, DOI 10.1128/JCM.00602-15; Zarante IO AO, 2000, I COLOMBIA GEOGRAFIA, V1, P475; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	61	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0181643	10.1371/journal.pone.0181643	http://dx.doi.org/10.1371/journal.pone.0181643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016603	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400001
J	Ohno, M; Nishida, A; Sugitani, Y; Nishino, K; Inatomi, O; Sugimoto, M; Kawahara, M; Andoh, A				Ohno, Masashi; Nishida, Atsushi; Sugitani, Yoshihiko; Nishino, Kyohei; Inatomi, Osamu; Sugimoto, Mitsushige; Kawahara, Masahiro; Andoh, Akira			Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; ULCERATIVE-COLITIS; CONTROLLED-TRIAL; CLINICAL-TRIALS; HUMAN FECES; BIOAVAILABILITY; CANCER; MICE	Background and Aims Curcumin is a hydrophobic polyphenol derived from turmeric, a traditional Indian spice. Curcumin exhibits various biological functions, but its clinical application is limited due to its poor absorbability after oral administration. A newly developed nanoparticle curcumin shows improved absorbability in vivo. In this study, we examined the effects of nanoparticle curcumin (named Theracurmin) on experimental colitis in mice. Methods BALB/c mice were fed with 3% dextran sulfate sodium (DSS) in water. Mucosal cytokine expression and lymphocyte subpopulation were analyzed by real-time PCR and flow cytometry, respectively. The profile of the gut microbiota was analyzed by real-time PCR. Results Treatment with nanoparticle curcumin significantly attenuated body weight loss, disease activity index, histological colitis score and significantly improved mucosal permeability. Immunoblot analysis showed that NF-kappa B activation in colonic epithelial cells was significantly suppressed by treatment with nanoparticle curcumin. Mucosal mRNA expression of inflammatory mediators was significantly suppressed by treatment with nanoparticle curcumin. Treatment with nanoparticle curcumin increased the abundance of butyrate-producing bacteria and fecal butyrate level. This was accompanied by increased expansion of CD4(+) Foxp3(+) regulatory T cells and CD103(+) CD8 alpha(-) regulatory dendritic cells in the colonic mucosa. Conclusions Treatment with nanoparticle curcumin suppressed the development of DSS-induced colitis potentially via modulation of gut microbial structure. These responses were associated with induction of mucosal immune cells with regulatory properties. Nanoparticle curcumin is one of the promising candidates as a therapeutic option for the treatment of IBD.	[Ohno, Masashi; Nishida, Atsushi; Sugitani, Yoshihiko; Nishino, Kyohei; Inatomi, Osamu; Sugimoto, Mitsushige; Kawahara, Masahiro; Andoh, Akira] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan	Shiga University of Medical Science	Nishida, A (corresponding author), Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan.	atsuda@belle.shiga-med.ac.jp	Andoh, Akira/AAB-9303-2022	Inatomi, Osamu/0000-0002-5837-6575; Kawahara, Masahiro/0000-0002-2721-7571	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K08967, 15K19322]; Ministry of Health, Labor and Welfare of Japan [067]; Japan Agency for Medical Research and Development, AMED [15AeK0109047h0002]; Smoking Research Foundation [1848]; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [067]; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED [15AeK0109047h0002]; Grants-in-Aid for Scientific Research [16K09846, 15K08948] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation; Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (15K08967, 15K19322), a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan (067), a grant from the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED (15AeK0109047h0002), and a grant from the Smoking Research Foundation (1848).; This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; https://www.jsps.go.jp/english/e-grants/index.html, 15K08967 to A.A and 15K19322 to A.N., the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan http://www.nanbyou.or.jp/english/index.htm, 067 to A.A., the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED http://www.amed.go.jp/en/program/list/01/05/016.html, 15AeK0109047h0002 to A.A., and the Smoking Research Foundation; http://www.srf.or.jp/english/index.html, 1848 to A.A.	Ali T, 2012, DIGESTION, V85, P249, DOI 10.1159/000336720; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Berberat PO, 2005, INFLAMM BOWEL DIS, V11, P350, DOI 10.1097/01.MIB.0000164017.06538.8a; Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001; Espin JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033; Cheifetz AS, 2016, GASTROENTEROLOGY; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Huang Y.-L., 2015, NAT COMMUN, V6; Kanai M, 2014, WORLD J GASTROENTERO, V20, P9384, DOI 10.3748/wjg.v20.i28.9384; Kunnumakkara A. B., 2016, BRIT J PHARM; Lang A, 2015, CLIN GASTROENTEROL H, V13, P1444, DOI 10.1016/j.cgh.2015.02.019; Langhorst J, 2015, J CROHNS COLITIS, V9, P86, DOI 10.1093/ecco-jcc/jju007; Law IKM, 2015, GUT, V64, P1095, DOI 10.1136/gutjnl-2014-307329; Milano F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00137; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Narushima S, 2014, GUT MICROBES, V5, P333, DOI 10.4161/gmic.28572; Nishida A, 2012, GASTROENTEROLOGY, V142, P865, DOI 10.1053/j.gastro.2011.12.036; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Sheehan D, 2015, J GASTROENTEROL, V50, P495, DOI 10.1007/s00535-015-1064-1; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strojny B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164637; Sun M, 2016, J GASTROENTEROL; Sunagawa Y, 2012, BIOL PHARM BULL, V35, P139, DOI 10.1248/bpb.35.139; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yoshikawa K, 2017, J GASTROENTEROL, V52, P61, DOI 10.1007/s00535-016-1205-1	38	98	102	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185999	10.1371/journal.pone.0185999	http://dx.doi.org/10.1371/journal.pone.0185999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985227	Green Submitted, Green Published, gold			2022-12-27	WOS:000412493000013
J	Castillo, DS; Serantes, DAR; Melli, LJ; Ciocchini, AE; Ugalde, JE; Comerci, DJ; Cassola, A				Castillo, Daniela S.; Rey Serantes, Diego A.; Melli, Luciano J.; Ciocchini, Andres E.; Ugalde, Juan E.; Comerci, Diego J.; Cassola, Alejandro			A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; N-LINKED GLYCOSYLATION; TERM-FOLLOW-UP; BRUCELLA-ABORTUS; FLOW-CYTOMETRY; CAMPYLOBACTER-JEJUNI; BOVINE BRUCELLOSIS; RAPID DETECTION; GROUND-BEEF; LYMPH-NODE	Shiga toxin-producing Escherichia coli (STEC) is the major etiologic agent of hemolytic-uremic syndrome (HUS). The high rate of HUS emphasizes the urgency for the implementation of primary prevention strategies to reduce its public health impact. Argentina shows the highest rate of HUS worldwide, being E. coli O157 the predominant STEC-associated HUS serogroup (>70%), followed by E. coli O145 (>9%). To specifically detect these serogroups we aimed at developing highly specific monoclonal antibodies (mAbs) against the O-polysaccharide (O-PS) section of the lipopolysaccharide (LPS) of the dominant STEC-associated HUS serogroups in Argentina. The development of hybridomas secreting mAbs against O157 or O145 was carried out through a combined immunization strategy, involving adjuvated-bacterial immunizations followed by immunizations with recombinant O-PS-protein conjugates. We selected hybridoma clones that specifically recognized the engineered O-PS-protein conjugates of O157 or O145 serogroups. Indirect ELISA of heat-killed bacteria showed specific binding to O157 or O145 serogroups, respectively, while no cross-reactivity with other epidemiological important STEC strains, Brucella abortus, Salmonella group N or Yersinia enterocolitica O9 was observed. Western blot analysis showed specific recognition of the sought O-PS section of the LPS by all mAbs. Finally, the ability of the developed mAbs to bind the surface of whole bacteria cells was confirmed by flow cytometry, confocal microscopy and agglutination assays, indicating that these mAbs present an exceptional degree of specificity and relative affinity in the detection and identification of E. coli O157 and O145 serogroups. These mAbs may be of significant value for clinical diagnosis and food quality control applications. Thus, engineered O-PS specific moieties contained in the recombinant glycoconjugates used for combined immunization and hybridoma selection are an invaluable resource for the development of highly specific mAbs.	[Castillo, Daniela S.; Rey Serantes, Diego A.; Melli, Luciano J.; Ciocchini, Andres E.; Ugalde, Juan E.; Comerci, Diego J.; Cassola, Alejandro] Univ Nacl San Martin UNSAM, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol,Inst Tecnol Chascomus IIB I, San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Cassola, A (corresponding author), Univ Nacl San Martin UNSAM, CONICET, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol,Inst Tecnol Chascomus IIB I, San Martin, Buenos Aires, Argentina.	acassola@iibintech.com.ar		Cassola, Alejandro/0000-0001-7366-5327; Comerci, Diego J./0000-0003-1949-4226	FITS Salud Diarreas Bacterianas Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC) [0002/2011]; PICT Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica [1707]	FITS Salud Diarreas Bacterianas Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC); PICT Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica	This work was supported by FITS Salud Diarreas Bacterianas 0002/2011 Fondo Nacional Sectorial -Agencia Nacional de Promocion Cientifica y Tecnologica (AEC JEU DJC); PICT 2013-1707 Fondo para la Investigacion Cientifica y Tecnologica - Agencia Nacional de Promocion Cientifica y Tecnologica (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rivero MA, 2010, J MED MICROBIOL, V59, P345, DOI 10.1099/jmm.0.015560-0; Baker M, 2015, NATURE, V521, P274, DOI 10.1038/521274a; Basalp A, 2003, HYBRIDOMA HYBRIDOM, V22, P329, DOI 10.1089/153685903322538863; BITZAN M, 1991, J PEDIATR-US, V119, P380, DOI 10.1016/S0022-3476(05)82049-9; Bitzan M, 2009, KIDNEY INT, V75, pS62, DOI 10.1038/ki.2008.624; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; BUNDLE DR, 1984, INFECT IMMUN, V46, P389, DOI 10.1128/IAI.46.2.389-393.1984; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; CAROFF M, 1984, EUR J BIOCHEM, V139, P195, DOI 10.1111/j.1432-1033.1984.tb07994.x; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; Chinen I, 2001, J FOOD PROTECT, V64, P1346, DOI 10.4315/0362-028X-64.9.1346; Ciocchini AE, 2014, VET MICROBIOL, V172, P455, DOI 10.1016/j.vetmic.2014.04.014; Ciocchini AE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002048; Cobenas CJ, 2007, PEDIATR NEPHROL, V22, P1343, DOI 10.1007/s00467-007-0522-2; CORBEL MJ, 1984, DEV BIOLOGICALS, V56, P341; Cortina ME, 2016, J CLIN MICROBIOL, V54, P1448, DOI 10.1128/JCM.00151-16; Exeni RA, 2001, ARCH LATINOAMERICANO, P35; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Feng L, 2005, J BACTERIOL, V187, P758, DOI 10.1128/JB.187.2.758-764.2005; FENG P, 1995, EMERG INFECT DIS, V1, P47, DOI 10.3201/eid0102.950202; GIANANTONIO CA, 1964, J PEDIATR-US, V64, P478, DOI 10.1016/S0022-3476(64)80337-1; Goding J.W., 1996, MONOCLONAL ANTIBODIE; Gomez D., 2002, Revista Argentina de Microbiologia, V34, P66; GREATOREX JS, 1994, J CLIN MICROBIOL, V32, P1172, DOI 10.1128/JCM.32.5.1172-1178.1994; Guttikonda S, 2007, J IMMUNOL METHODS, V327, P1, DOI 10.1016/j.jim.2007.06.010; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hegde NV, 2012, J CLIN MICROBIOL, V50, P2137, DOI 10.1128/JCM.00137-12; Iwashkiw JA, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-13; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Johnson RP, 2014, APPL ENVIRON MICROB, V80, P2166, DOI 10.1128/AEM.03391-13; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Keir LS, 2015, HEMATOL ONCOL CLIN N, V29, P525, DOI 10.1016/j.hoc.2015.01.007; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lopez EL, 2000, INFECT DIS CLIN N AM, V14, P41, DOI 10.1016/S0891-5520(05)70217-8; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Melli LJ, 2015, J CLIN MICROBIOL, V53, P528, DOI 10.1128/JCM.02262-14; MIRZA IH, 1987, J IMMUNOL METHODS, V105, P235, DOI 10.1016/0022-1759(87)90271-7; Navarro A, 2007, J MED MICROBIOL, V56, P1447, DOI 10.1099/jmm.0.47201-0; NIELSEN KH, 1995, VET IMMUNOL IMMUNOP, V46, P285, DOI 10.1016/0165-2427(94)05361-U; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Oteiza JM, 2006, FOOD MICROBIOL, V23, P283, DOI 10.1016/j.fm.2005.04.003; PADHYE NV, 1991, J CLIN MICROBIOL, V29, P99, DOI 10.1128/JCM.29.1.99-103.1991; Palermo MS, 2009, EXPERT REV ANTI-INFE, V7, P697, DOI [10.1586/eri.09.49, 10.1586/ERI.09.49]; Patra KP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002926; PERRY MB, 1986, BIOCHEM CELL BIOL, V64, P21, DOI 10.1139/o86-004; PERRY MB, 1986, CARBOHYD RES, V156, P107, DOI 10.1016/S0008-6215(00)90103-4; Raybourne RB, 2001, CURRENT PROTOCOLS CY; Reilly A, 1998, B WORLD HEALTH ORGAN, V76, P245; Repetto HA, 2005, KIDNEY INT, V68, pS102, DOI 10.1111/j.1523-1755.2005.09717.x; Rivas M, 2006, FOODBORNE PATHOG DIS, V3, P88, DOI 10.1089/fpd.2006.3.88; Rivas M, 2003, EMERG INFECT DIS, V9, P1184; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; SHIMADA T, 1992, CURR MICROBIOL, V25, P215, DOI 10.1007/BF01570721; Spizzirri FD, 1997, PEDIATR NEPHROL, V11, P156, DOI 10.1007/s004670050248; STUART FA, 1982, VET REC, V110, P202, DOI 10.1136/vr.110.9.202-a; Szijarto V, 2014, CLIN VACCINE IMMUNOL, V21, P930, DOI 10.1128/CVI.00685-13; Tanaka Y, 2000, J APPL MICROBIOL, V88, P228, DOI 10.1046/j.1365-2672.2000.00960.x; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Westerman RB, 1997, J CLIN MICROBIOL, V35, P679, DOI 10.1128/JCM.35.3.679-684.1997; Yamaguchi N, 2003, CYTOM PART A, V54A, P27, DOI 10.1002/cyto.a.10045	64	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0182452	10.1371/journal.pone.0182452	http://dx.doi.org/10.1371/journal.pone.0182452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981517	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300002
J	Coloigner, J; Kim, Y; Bush, A; Choi, S; Balderrama, MC; Coates, TD; O'Neil, SH; Lepore, N; Wood, JC				Coloigner, Julie; Kim, Yeun; Bush, Adam; Choi, Soyoung; Balderrama, Melissa C.; Coates, Thomas D.; O'Neil, Sharon H.; Lepore, Natasha; Wood, John C.			Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia	PLOS ONE			English	Article							SILENT CEREBRAL INFARCTS; WHITE-MATTER LESIONS; CELL-DISEASE; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; BLOOD-FLOW; CHILDREN; BOLD; PERFUSION; MRI	Sickle cell disease (SCD) is a chronic blood disorder that is often associated with acute and chronic cerebrovascular complications, including strokes and impaired cognition. Using functional resting state magnetic resonance images, we performed whole-brain analysis of the amplitude of low frequency fluctuations (ALFF), to detect areas of spontaneous blood oxygenation level dependent signal across brain regions. We compared the ALFF of 20 SCD patients to that observed in 19 healthy, age and ethnicity-matched, control subjects. Significant differences were found in several brain regions, including the insula, precuneus, anterior cingulate cortex and medial superior frontal gyrus. To identify the ALFF differences resulting from anemia alone, we also compared the ALFF of SCD patients to that observed in 12 patients having comparable hemoglobin levels but lacking sickle hemoglobin. Increased ALFF in the orbitofrontal cortex and the anterior and posterior cingulate cortex and decreased ALFF in the frontal pole, cerebellum and medial superior frontal gyrus persisted after accounting for the effect of anemia. The presence of white matter hyperintensities was associated with depressed frontal and medial superior frontal gyri activity in the SCD subjects. Decreased ALFF in the frontal lobe was correlated with decreased verbal fluency and cognitive flexibility. These findings may lead to a better understanding of the pathophysiology of SCD.	[Coloigner, Julie; Kim, Yeun; Lepore, Natasha] Childrens Hosp, Div Radiol, CIBORG Lab, Los Angeles, CA 90027 USA; [Bush, Adam] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA USA; [Choi, Soyoung] Univ Southern Calif, Neurosci Grad Program, Los Angeles, CA USA; [Balderrama, Melissa C.; Coates, Thomas D.] Childrens Hosp, Div Hematol Oncol & Blood & Marrow Transplantat, Los Angeles, CA 90027 USA; [Balderrama, Melissa C.; Coates, Thomas D.; O'Neil, Sharon H.; Wood, John C.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA USA; [O'Neil, Sharon H.] Childrens Hosp, Div Neurol, Los Angeles, CA 90027 USA; [O'Neil, Sharon H.] Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA; [Wood, John C.] Childrens Hosp, Div Cardiol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; Children's Hospital Los Angeles	Coloigner, J (corresponding author), Childrens Hosp, Div Radiol, CIBORG Lab, Los Angeles, CA 90027 USA.	julie.coloigner@gmail.com	Coloigner, Julie/ABB-8849-2021; Coates, Thomas/AAN-3556-2020	Coates, Thomas/0000-0001-9878-6029; Coloigner, Julie/0000-0001-7774-8015; Choi, So Young/0000-0001-7165-4691	National Heart Lung and Blood Institute [U01 HL117718]; Clinical Translational Science Institute at Children's Hospital Los Angeles [UL1 TR001855-02]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Clinical Translational Science Institute at Children's Hospital Los Angeles	This work was supported by the National Heart Lung and Blood Institute U01 HL117718 and the Clinical Translational Science Institute at Children's Hospital Los Angeles (UL1 TR001855-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Heart Lung and Blood Institute U01 HL117718 and the Clinical Translational Science Institute at Children's Hospital Los Angeles (UL1 TR001855-02).	Balci A, 2012, AM J ROENTGENOL, V198, P1167, DOI 10.2214/AJR.11.7404; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernaudin F, 2015, BLOOD, V125, P1653, DOI 10.1182/blood-2014-09-599852; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borzage MT, 2016, PREDICTOR CEREBRAL B; Brousseau DC, 2010, AM J HEMATOL, V85, P77, DOI 10.1002/ajh.21570; Brown GG, 2003, J CEREBR BLOOD F MET, V23, P829, DOI 10.1097/01.WCB.0000071887.63724.B2; BROWN RT, 1993, J LEARN DISABIL-US, V26, P33, DOI 10.1177/002221949302600104; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Bush AM, 2016, AM J HEMATOL, V91, P912, DOI 10.1002/ajh.24441; Cha J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/907464; Chalacheva P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12463; Chen R, 2015, AM J NEURORADIOL, V36, P403, DOI 10.3174/ajnr.A4101; Choi S, 2017, NEUROIMAGE CLIN; Choi S-Y, 2015, DIFFUSE T1 HRI WHITE; Colombatti R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157090; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; DeBaun MR, 2011, HEMATOL-AM SOC HEMAT, P427, DOI 10.1182/asheducation-2011.1.427; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; DeBaun MR, 2012, BLOOD, V119, P3684, DOI 10.1182/blood-2011-05-349621; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, MANUAL CALIFORNIA VE; FOWLER MG, 1988, J DEV BEHAV PEDIATR, V9, P213; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Helton KJ, 2009, PEDIATR BLOOD CANCER, V52, P85, DOI 10.1002/pbc.21745; HEROLD S, 1986, STROKE, V17, P692, DOI 10.1161/01.STR.17.4.692; Inamo J, 2009, AM J HEMATOL, V84, P311, DOI 10.1002/ajh.21377; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kassim AA, 2016, BLOOD, V127, P2038, DOI 10.1182/blood-2016-01-694562; Kawadler JM, 2016, DEV MED CHILD NEUROL; KIM SG, 1994, NMR BIOMED, V7, P69, DOI 10.1002/nbm.1940070111; Kirk GR, 2009, CEREB CORTEX, V19, P1549, DOI 10.1093/cercor/bhn193; Kong X, 2014, HEAD MOTION CHILDREN; Kosinski PD, 2016, BRIT J HAEMATOLOGY; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CH, 2015, BEHAV BRAIN RES, V281, P339, DOI 10.1016/j.bbr.2014.11.047; Liu YJ, 2007, AM J NEURORADIOL, V28, P1009, DOI 10.3174/ajnr.A0535; Ma XF, 2015, CLIN NEUROPHYSIOL, V126, P1190, DOI 10.1016/j.clinph.2014.10.004; Mennes M, 2011, NEUROIMAGE, V54, P2950, DOI 10.1016/j.neuroimage.2010.10.046; Mestre JCR, 1997, CLIN AUTON RES, V7, P121, DOI 10.1007/BF02308838; Meyers JM, 1995, REY COMPLEX XFIGURE; Moser FG, 1996, AM J NEURORADIOL, V17, P965; Musallam KM, 2012, THROMB RES, V130, P695, DOI 10.1016/j.thromres.2012.07.013; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Nelson MD, 2000, PEDIATR RADIOL, V30, P705, DOI 10.1007/s002470000290; Noll RB, 2001, J PEDIATR PSYCHOL, V26, P69, DOI 10.1093/jpepsy/26.2.69; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Postma IR, 2016, J CLIN EXP NEUROPSYC, V38, P585, DOI 10.1080/13803395.2016.1143453; Prohovnik I, 2009, J CEREBR BLOOD F MET, V29, P803, DOI 10.1038/jcbfm.2009.6; Qi RF, 2012, RADIOLOGY, V264, P187, DOI 10.1148/radiol.12111429; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ren WC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/129180; Reynolds CR., 2004, BEHAV ASSESSMENT SYS; RODGERS GP, 1990, AM J PHYSIOL, V258, pH113, DOI 10.1152/ajpheart.1990.258.1.H113; RODGERS GP, 1984, NEW ENGL J MED, V311, P1534, DOI 10.1056/NEJM198412133112403; Sangkatumvong S, 2010, 32 ANN INT C ENG MED; Sangkatumvong S, 2008, 30 ANN INT C ENG MED; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steen RG, 2005, J CHILD NEUROL, V20, P102, DOI 10.1177/08830738050200020301; Steen RG, 2005, AM J NEURORADIOL, V26, P455; Taher AT, 2010, J THROMB HAEMOST, V8, P54, DOI 10.1111/j.1538-7836.2009.03651.x; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Tsai YH, 2014, PLOS ONE, V9; van der Land V, 2016, BRIT J HAEMATOL, V172, P274, DOI 10.1111/bjh.13819; Vigneau-Roy N, 2014, HUM BRAIN MAPP, V35, P1906, DOI 10.1002/hbm.22301; Wang LJ, 2014, J INT MED RES, V42, P966, DOI 10.1177/0300060514533524; Wang W, 2001, J PEDIATR-US, V139, P391, DOI 10.1067/mpd.2001.116935; WASSERMAN AL, 1991, AM J PEDIAT HEMATOL, V13, P14; Wechsler D., 1999, ADM SCORING MANUAL; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2003, WISC 4 WECHSLER INTE, V4th ed.; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yang Z, 2014, FRONTIERS NEUROSCIEN, V8; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou P, 2011, BRAIN IMAGING BEHAV, V5, P295, DOI 10.1007/s11682-011-9133-4; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	91	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184860	10.1371/journal.pone.0184860	http://dx.doi.org/10.1371/journal.pone.0184860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981541	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300022
J	Cui, H; Wang, CL; Qin, TF; Xu, FF; Tang, YC; Gao, Y; Zhao, KJ				Cui, Hua; Wang, Chunlian; Qin, Tengfei; Xu, Feifei; Tang, Yongchao; Gao, Ying; Zhao, Kaijun			Promoter variants of Xa23 alleles affect bacterial blight resistance and evolutionary pattern	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; DISEASE-RESISTANCE; XANTHOMONAS-ORYZAE; ARABIDOPSIS-THALIANA; GENETIC-VARIATION; TAL-EFFECTOR; NATURAL VARIATION; DNA POLYMORPHISM; PLANT-PATHOGENS; WILD RELATIVES	Bacterial blight, caused by Xanthomonas oryzae pv. oryzae (Xoo), is the most important bacterial disease in rice (Oryza sativa L.). Our previous studies have revealed that the bacterial blight resistance gene Xa23 from wild rice O. rufipogon Griff. confers the broadest-spectrum resistance against all the naturally occurring Xoo races. As a novel executor R gene, Xa23 is transcriptionally activated by the bacterial avirulence (Avr) protein AvrXa23 via binding to a 28-bp DNA element (EBEAvrXa23) in the promoter region. So far, the evolutionary mechanism of Xa23 remains to be illustrated. Here, a rice germplasm collection of 97 accessions, including 29 rice cultivars (indica and japonica) and 68 wild relatives, was used to analyze the evolution, phylogeographic relationship and association of Xa23 alleles with bacterial blight resistance. All the similar to 473 bp DNA fragments consisting of promoter and coding regions of Xa23 alleles in the germplasm accessions were PCR-amplified and sequenced, and nine single nucleotide polymorphisms (SNPs) were detected in the promoter regions (similar to 131 bp sequence upstream from the start codon ATG) of Xa23/xa23 alleles while only two SNPs were found in the coding regions. The SNPs in the promoter regions formed 5 haplotypes (Pro-A, B, C, D, E) which showed no significant difference in geographic distribution among these 97 rice accessions. However, haplotype association analysis indicated that Pro-A is the most favored haplotype for bacterial blight resistance. Moreover, SNP changes among the 5 haplotypes mostly located in the EBE/ebe regions (EBEAvrXa23 and corresponding ebes located in promoters of xa23 alleles), confirming that the EBE region is the key factor to confer bacterial blight resistance by altering gene expression. Polymorphism analysis and neutral test implied that Xa23 had undergone a bottleneck effect, and selection process of Xa23 was not detected in cultivated rice. In addition, the Xa23 coding region was found highly conserved in the Oryza genus but absent in other plant species by searching the plant database, suggesting that Xa23 originated along with the diversification of the Oryza genus from the grass family during evolution. This research offers a potential for flexible use of novel Xa23 alleles in rice breeding programs and provide a model for evolution analysis of other executor R genes.	[Cui, Hua; Wang, Chunlian; Qin, Tengfei; Xu, Feifei; Tang, Yongchao; Gao, Ying; Zhao, Kaijun] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, KJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	zhaokaijun@caas.cn			Major Science and Technology Project [2014ZX0801001B, 2016ZX08001002-009]; Chinese Academy of Agricultural Sciences	Major Science and Technology Project; Chinese Academy of Agricultural Sciences	This work was supported by grants from the Major Science and Technology Project to Create New Crop Cultivars using Gene Transfer Technology (2014ZX0801001B, 2016ZX08001002-009) and the Innovation Program of Chinese Academy of Agricultural Sciences.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bimolata W, 2013, PLANTA, V238, P293, DOI 10.1007/s00425-013-1891-3; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Ding J, 2007, MOL GENET GENOMICS, V277, P619, DOI 10.1007/s00438-007-0213-5; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellur RK, 2016, PLANT SCI, V242, P330, DOI 10.1016/j.plantsci.2015.08.020; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; FU YX, 1993, GENETICS, V133, P693; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Hall T., 2011, GERF B BIOSCI, V2, P60; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hofberger JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-966; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451; Huang B, 2012, EUPHYTICA, V187, P449, DOI 10.1007/s10681-012-0758-1; Hummel AW, 2012, NEW PHYTOL, V195, P883, DOI 10.1111/j.1469-8137.2012.04216.x; Jia YL, 2003, PHYTOPATHOLOGY, V93, P1452, DOI 10.1094/PHYTO.2003.93.11.1452; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; May R.M., 1983, P186; McDowell JM, 2003, TRENDS BIOTECHNOL, V21, P178, DOI 10.1016/S0167-7799(03)00053-2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noir S, 2001, MOL GENET GENOMICS, V265, P654, DOI 10.1007/s004380100459; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, P NATL ACAD SCI USA, V106, P20526, DOI 10.1073/pnas.0908812106; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Rose LE, 2004, GENETICS, V166, P1517, DOI 10.1534/genetics.166.3.1517; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Small RL, 2000, GENETICS, V155, P1913; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; TAJIMA F, 1989, GENETICS, V123, P585; Tian Dacheng, UNBALANCED GENE COPY; Tian DS, 2014, PLANT CELL, V26, P497, DOI 10.1105/tpc.113.119255; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Wang CL, 2014, MOL PLANT PATHOL, V15, P333, DOI 10.1111/mpp.12092; Wang CL, 2015, MOL PLANT, V8, P290, DOI 10.1016/j.molp.2014.10.010; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu LF, 2008, PLANT PHYSIOL, V148, P1497, DOI 10.1104/pp.108.123356; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2008, THEOR APPL GENET, V116, P165, DOI 10.1007/s00122-007-0656-4; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; YOSHIMURA A, 1983, PHYTOPATHOLOGY, V73, P1409, DOI 10.1094/Phyto-73-1409; Yu JY, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-3, 10.1186/1471-2199-15-20]; Zhang Q., 2001, RICE GENET NEWSL, V18, P71; Zhang XP, 2013, CROP J, V1, P143, DOI 10.1016/j.cj.2013.07.009; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z; Zhou YL, 2009, MOL BREEDING, V23, P279, DOI 10.1007/s11032-008-9232-0; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	57	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185925	10.1371/journal.pone.0185925	http://dx.doi.org/10.1371/journal.pone.0185925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982185	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300089
J	Holm, MB; Bastani, NE; Holme, AM; Zucknick, M; Jansson, T; Refsum, H; Morkrid, L; Blomhoff, R; Henriksen, T; Michelsen, TM				Holm, Maia Blomhoff; Bastani, Nasser Ezzatkhah; Holme, Ane Moe; Zucknick, Manuela; Jansson, Thomas; Refsum, Helga; Morkrid, Lars; Blomhoff, Rune; Henriksen, Tore; Michelsen, Trond Melbye			Uptake and release of amino acids in the fetal-placental unit in human pregnancies	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; HUMAN-FETUS; TRANSPORT; PLASMA; LEUCINE; METABOLISM; GLYCINE; APPROPRIATE; NUTRITION; MOTHER	Objectives The current concepts of human fetal-placental amino acid exchange and metabolism are mainly based on animal-, in vitro-and ex vivo models. We aimed to determine and assess the paired relationships between concentrations and arteriovenous differences of 19 amino acids on the maternal and fetal sides of the human placenta in a large study sample. Methods This cross-sectional in vivo study included 179 healthy women with uncomplicated term pregnancies. During planned cesarean section, we sampled blood from incoming and outgoing vessels on the maternal (radial artery and uterine vein) and fetal (umbilical vein and artery) sides of the placenta. Amino acid concentrations were measured by liquid chromatography-tandem mass spectrometry. We calculated paired arteriovenous differences and performed Wilcoxon signed-rank tests and Spearman's correlations. Results In the umbilical circulation, we observed a positive venoarterial difference (fetal uptake) for 14 amino acids and a negative venoarterial difference (fetal release) for glutamic acid (p<0.001). In the maternal circulation, we observed a positive arteriovenous difference (uteroplacental uptake) for leucine (p = 0.005), isoleucine (p = 0.01), glutamic acid (p<0.001) and arginine (p = 0.04) and a negative arteriovenous difference (uteroplacental release) for tyrosine (p = 0.002), glycine (p = 0.01) and glutamine (p = 0.02). The concentrations in the maternal artery and umbilical vein were correlated for all amino acids except tryptophan, but we observed no correlations between the uteroplacental uptake and the fetal uptake or the umbilical vein concentration. Two amino acids showed a correlation between the maternal artery concentration and the fetal uptake. Conclusions Our human in vivo study expands the current insight into fetal-placental amino acid exchange, and discloses some differences from what has been previously described in animals. Our findings are consistent with the concept that the fetal supply of amino acids in the human is the result of a dynamic interplay between fetal and placental amino acid metabolism and interconversions.	[Holm, Maia Blomhoff; Holme, Ane Moe; Henriksen, Tore; Michelsen, Trond Melbye] Oslo Univ Hosp, Dept Obstet, Div Obstet & Gynecol, Oslo, Norway; [Holm, Maia Blomhoff; Holme, Ane Moe; Henriksen, Tore] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bastani, Nasser Ezzatkhah; Refsum, Helga; Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Zucknick, Manuela] Univ Oslo, Inst Basic Med Sci, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Jansson, Thomas] Univ Colorado, Dept OB GYN, Div Reprod Sci, Anschutz Med Campus, Aurora, CO USA; [Morkrid, Lars] Oslo Univ Hosp, Dept Med Biochem, Analyt Unit Metab Dis, Oslo, Norway; [Blomhoff, Rune] Oslo Univ Hosp, Dept Clin Serv, Div Canc Med, Oslo, Norway; [Michelsen, Trond Melbye] Oslo Univ Hosp, Norwegian Advisory Unit Womens Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Oslo; University of Oslo; University of Oslo	Holm, MB (corresponding author), Oslo Univ Hosp, Dept Obstet, Div Obstet & Gynecol, Oslo, Norway.; Holm, MB (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	maia.blomhoff.holm@outlook.com	Refsum, Helga/A-4073-2010	Zucknick, Manuela/0000-0003-1317-7422	South-Eastern Norway Regional Health Authority [2016066, 2013043]; Department of Obstetrics, Oslo University Hospital, Oslo, Norway; Throne Holst Foundation; Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; Department of Obstetrics, Oslo University Hospital, Oslo, Norway; Throne Holst Foundation; Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	MBH received a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2016066 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by Department of Obstetrics, Oslo University Hospital, Oslo, Norway (http://www.oslo-universitetssykehus.no/omoss_/avdelinger_/fodeavdelingen_). NEB was supported by grants from the Throne Holst Foundation (http://www.throneholst.org/). AMH received a PhD grant from South-Eastern Norway Regional Health Authority, grant number 2013043 (http://www.helse-sorost.no/omoss_/english_/) and was partly funded by the Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). TMM was funded by the Norwegian National Advisory Unit on Womens Health, Oslo University Hospital, Oslo, Norway (http://ous-research.no/nrcwh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterman MA, 2011, AMINO ACID ANAL METH; Barker DJP, 2013, CLIN OBSTET GYNECOL, V56, P511, DOI 10.1097/GRF.0b013e31829cb9ca; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Battaglia FC, 2001, PLACENTA, V22, P145, DOI 10.1053/plac.2000.0612; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CETIN I, 1995, PEDIATR RES, V37, P571, DOI 10.1203/00006450-199505000-00002; CETIN I, 1988, AM J OBSTET GYNECOL, V158, P120, DOI 10.1016/0002-9378(88)90792-2; Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011; Cetin I, 2003, EUR J OBSTET GYN R B, V110, pS50, DOI 10.1016/S0301-2115(03)00172-6; Cetin I, 1996, AM J OBSTET GYNECOL, V174, P1575, DOI 10.1016/S0002-9378(96)70609-9; CETIN I, 1991, BIOL NEONATE, V60, P83; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Chung M, 1998, AM J PHYSIOL-ENDOC M, V274, pE13, DOI 10.1152/ajpendo.1998.274.1.E13; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Day PEL, 2013, PLACENTA, V34, P1223, DOI 10.1016/j.placenta.2013.10.003; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1219, DOI 10.1016/0002-9378(89)90670-4; Elshorbagy AK, 2010, NUTRITION, V26, P1201, DOI 10.1016/j.nut.2009.09.017; Galan HL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.054; Geddie G, 1996, PLACENTA, V17, P619, DOI 10.1016/S0143-4004(96)80080-4; Grillo MA, 2008, AMINO ACIDS, V34, P517, DOI 10.1007/s00726-007-0006-5; HAYASHI S, 1978, BIOL NEONATE, V34, P11; Holme AM, 2017, JOVE-J VIS EXP, DOI 10.3791/55847; Holme AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117084; HOLZMAN I R, 1979, Journal of Developmental Physiology (Eynsham), V1, P137; Jozwik M, 1999, AM J OBSTET GYNECOL, V180, P447, DOI 10.1016/S0002-9378(99)70230-9; Jozwik M, 2004, AM J PHYSIOL-ENDOC M, V286, pE376, DOI 10.1152/ajpendo.00428.2003; Lager S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/179827; Paolini CL, 2001, J CLIN ENDOCR METAB, V86, P5427, DOI 10.1210/jc.86.11.5427; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Prenton M A, 1969, J Obstet Gynaecol Br Commonw, V76, P404; Regnault TRH, 2002, ENDOCRINE, V19, P23, DOI 10.1385/ENDO:19:1:23; Ronzoni S, 1999, AM J OBSTET GYNECOL, V181, P477, DOI 10.1016/S0002-9378(99)70581-8; Schaefer A, PLACENTA, V14, P103; SOLTESZ G, 1985, PEDIATR RES, V19, P91, DOI 10.1203/00006450-198501000-00024; STEINGRIMSDOTTIR T, 1993, EUR J OBSTET GYN R B, V50, P197, DOI 10.1016/0028-2243(93)90201-M; Tsuchiya H, 2009, ARCH DIS CHILD-FETAL, V94, pF155, DOI 10.1136/adc.2008.147256; van den Akker CHP, 2011, PEDIATR RES, V70, P566, DOI 10.1203/PDR.0b013e31823214d1; VELAZQUEZ A, 1976, BIOL NEONATE, V29, P28	39	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185760	10.1371/journal.pone.0185760	http://dx.doi.org/10.1371/journal.pone.0185760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982184	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300067
J	Jonczyk, J; Malawska, B; Bajda, M				Jonczyk, Jakub; Malawska, Barbara; Bajda, Marek			Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 2ND EXTRACELLULAR LOOP; H-3 RECEPTOR; LIGAND-BINDING; ACTIVATION; DOCKING; POTENT; MUTAGENESIS; RECOGNITION; ANTAGONISTS	The crucial role of G-protein coupled receptors and the significant achievements associated with a better understanding of the spatial structure of known receptors in this family encouraged us to undertake a study on the histamine H3 receptor, whose crystal structure is still unresolved. The latest literature data and availability of different software enabled us to build homology models of higher accuracy than previously published ones. The new models are expected to be closer to crystal structures; and therefore, they are much more helpful in the design of potential ligands. In this article, we describe the generation of homology models with the use of diverse tools and a hybrid assessment. Our study incorporates a hybrid assessment connecting knowledge-based scoring algorithms with a two-step ligand-based docking procedure. Knowledge-based scoring employs probability theory for global energy minimum determination based on information about native amino acid conformation from a dataset of experimentally determined protein structures. For a two-step docking procedure two programs were applied: GOLD was used in the first step and Glide in the second. Hybrid approaches offer advantages by combining various theoretical methods in one modeling algorithm. The biggest advantage of hybrid methods is their intrinsic ability to self-update and self-refine when additional structural data are acquired. Moreover, the diversity of computational methods and structural data used in hybrid approaches for structure prediction limit inaccuracies resulting from theoretical approximations or fuzziness of experimental data. The results of docking to the new H3 receptor model allowed us to analyze ligand-receptor interactions for reference compounds.	[Jonczyk, Jakub; Malawska, Barbara; Bajda, Marek] Jagiellonian Univ, Med Coll, Fac Pharm, Dept Physicochem Drug Anal, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Bajda, M (corresponding author), Jagiellonian Univ, Med Coll, Fac Pharm, Dept Physicochem Drug Anal, Krakow, Poland.	marek.bajda@uj.edu.pl	Jonczyk, Jakub/AAN-1701-2020; Bajda, Marek/L-5585-2015	Jonczyk, Jakub/0000-0002-9731-908X; Bajda, Marek/0000-0001-6032-0354	National Science Center in Poland [UMO-2014/15/N/NZ7/02965]	National Science Center in Poland(National Science Centre, Poland)	A research grant no. UMO-2014/15/N/NZ7/02965 for PhD students was obtained from the National Science Center in Poland (www.ncn.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PYMOL; [Anonymous], 2016, MAESTR; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; ARRANG JM, 1987, NATURE, V327, P117, DOI 10.1038/327117a0; Axe FU, 2006, J MOL GRAPH MODEL, V24, P456, DOI 10.1016/j.jmgm.2005.10.005; Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benkert P, QMEAN SERVER; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bitner RS, 2011, NEUROPHARMACOLOGY, V60, P460, DOI 10.1016/j.neuropharm.2010.10.026; Bongers G, 2007, J NEUROCHEM, V103, P248, DOI 10.1111/j.1471-4159.2007.04752.x; Bongers G, 2007, BIOCHEM PHARMACOL, V73, P1195, DOI 10.1016/j.bcp.2007.01.008; Brunskole I, 2011, N-S ARCH PHARMACOL, V384, P301, DOI 10.1007/s00210-011-0673-3; BURGAUD JL, 1993, BRIT J PHARMACOL, V109, P960, DOI 10.1111/j.1476-5381.1993.tb13714.x; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; Deane CM, 2012, PLOS ONE, V7; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; Esbenshade TA, 2004, BIOCHEM PHARMACOL, V68, P933, DOI 10.1016/j.bcp.2004.05.048; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Galici R, 2011, PSYCHOPHARMACOLOGY, V214, P829, DOI 10.1007/s00213-010-2092-4; Gatica EA, 2012, J CHEM INF MODEL, V52, P1, DOI 10.1021/ci200412p; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; Gondard E, 2013, NEUROPSYCHOPHARMACOL, V38, P1015, DOI 10.1038/npp.2012.266; Gonzalez-Dominguez J, 2016, BIOINFORMATICS, V32, P3826, DOI 10.1093/bioinformatics/btw558; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Grove RA, 2014, CURR ALZHEIMER RES, V11, P47, DOI 10.2174/1567205010666131212110148; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hancock Arthur A, 2003, Curr Opin Investig Drugs, V4, P1190; Harusawa S, 2013, BIOORG MED CHEM LETT, V23, P6415, DOI 10.1016/j.bmcl.2013.09.052; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Huang YJP, 2014, PROTEINS, V82, P43, DOI 10.1002/prot.24488; Istyastono EP, 2011, J MED CHEM, V54, P8136, DOI 10.1021/jm201042n; Jacobsen ML., 2003, 32 ANN M EUR HIST RE; Jongejan A, 2005, ARCH PHARM, V338, P248, DOI 10.1002/ardp.200400998; Kim SK, 2011, J CHEM INF MODEL, V51, P3262, DOI 10.1021/ci200435b; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kollb-Sielecka M, 2017, SLEEP MED, V33, P125, DOI 10.1016/j.sleep.2017.01.002; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Latacz D., BIOORG MED CHEM; Latek D, 2016, J CHEM INF MODEL, V56, P630, DOI 10.1021/acs.jcim.5b00451; Lazewska D, 2014, EXPERT OPIN THER PAT, V24, P89, DOI 10.1517/13543776.2014.848197; Levoin N, 2008, ARCH PHARM, V341, P610, DOI 10.1002/ardp.200800042; Levoin N, 2013, BIOORGAN MED CHEM, V21, P4526, DOI 10.1016/j.bmc.2013.05.035; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lovenberg TW, 1999, MOL PHARMACOL, V55, P1101, DOI 10.1124/mol.55.6.1101; Modi V, 2016, PROTEINS, V84, P200, DOI 10.1002/prot.25049; MORALESFIGUEROA GE, 2014, AM CHEM SOC, V5, P637, DOI DOI 10.1021/CN500001M; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Morrey C, 2008, J PHARMACOL EXP THER, V326, P871, DOI 10.1124/jpet.108.137919; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Nakamura T, 2014, BRIT J PHARMACOL, V171, P171, DOI 10.1111/bph.12429; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Passani MB, 2000, NEUROSCI BIOBEHAV R, V24, P107, DOI 10.1016/S0149-7634(99)00053-6; Passani MB, 2004, TRENDS PHARMACOL SCI, V25, P618, DOI 10.1016/j.tips.2004.10.003; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Rai BK, 2010, PROTEINS, V78, P457, DOI 10.1002/prot.22571; Rang H., 2011, RANG DALES PHARM; Ratnala VRP, 2007, J AM CHEM SOC, V129, P867, DOI 10.1021/ja0652262; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Sander K, 2008, BIOL PHARM BULL, V31, P2163, DOI 10.1248/bpb.31.2163; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schultes S, 2013, MEDCHEMCOMM, V4, P193, DOI 10.1039/c2md20212c; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Trenite DKN, 2013, EPILEPSY BEHAV, V28, P66, DOI 10.1016/j.yebeh.2013.03.018; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; Uveges AJ, 2002, J PHARMACOL EXP THER, V301, P451, DOI 10.1124/jpet.301.2.451; VANDERGOOT H, 1992, EUR J MED CHEM, V27, P511, DOI 10.1016/0223-5234(92)90185-4; Venkatakrishnan AJ, 2016, NATURE, V536, P484, DOI 10.1038/nature19107; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wifling D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117185; Xiang Z., 2007, COMPUTATIONAL METHOD, P319; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang R, 2002, PHARMACOLOGY, V66, P128, DOI 10.1159/000063794; Yao BB, 2003, NEUROPHARMACOLOGY, V44, P773, DOI 10.1016/S0028-3908(03)00056-X; Zamponi GW, 2013, BBA-BIOMEMBRANES, V1828, P1629, DOI 10.1016/j.bbamem.2012.10.004	85	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186108	10.1371/journal.pone.0186108	http://dx.doi.org/10.1371/journal.pone.0186108			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982153	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300125
J	Pineda, C; Aguilera-Tejero, E; Morales, MC; Belinchon-Lorenzo, S; Gomez-Nieto, LC; Garcia, P; Martinez-Moreno, JM; Rodriguez-Ortiz, ME; Lopez, I				Pineda, Carmen; Aguilera-Tejero, Escolastico; Morales, Maria C.; Belinchon-Lorenzo, Silvia; Gomez-Nieto, Luis C.; Garcia, Pablo; Martinez-Moreno, Julio M.; Rodriguez-Ortiz, Maria E.; Lopez, Ignacio			Treatment of canine leishmaniasis with marbofloxacin in dogs with renal disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PARASITOLOGICAL FOLLOW-UP; TIME PCR ASSAY; VISCERAL LEISHMANIASIS; MEGLUMINE ANTIMONIATE; SYSTEMIC HYPERTENSION; CYSTATIN C; INFANTUM; ALLOPURINOL; PROTEINURIA	Treatment of canine leishmaniasis (CanL) represents a challenge. Due to the high prevalence of renal disease associated to CanL, it is important to find an effective drug that does not damage the kidneys. Marbofloxacin has been shown to be effective and well tolerated in non-azotemic dogs with leishmaniasis. To evaluate the safety and efficacy of marbofloxacin in dogs with leishmaniasis and decreased renal function, 28 dogs suffering from leishmaniasis and chronic kidney disease (CKD) were treated with oral marbofloxacin at 2 mg/Kg/day for 28 days. During treatment dogs were assessed by performing weekly physical exams, measuring blood pressure and evaluating blood and urine parameters. Lymph node aspirations were also obtained at days 0 and 28. The global clinical score decreased significantly, from 6.2 +/- 3.4 to 4.7 +/- 3.1 (p = 0.0001), after treatment. Marbofloxacin also decreased parasitic load in 72% of the dogs. No significant differences in plasma creatinine, urine specific gravity, urinary concentrations of cystatin C, ferritin and urinary protein loss were detected during treatment. A transient but significant decrease in blood pressure was detected up to day 14 (from 180.1 +/- 36.6 to 166.0 +/- 32.7 mmHg; p = 0.016). Moreover, dogs showed a significant increase in plasma albumin concentration (from 15.0 +/- 5.2 to 16.6 +/- 3.9 g/L; p = 0.014) and a significant decrease in globulin concentration (from 59.0 +/- 18.1 to 54.1 +/- 18.0 g/L; p = 0.005). The results demonstrate that, in addition to being effective for treatment of CanL, marbofloxacin is a very safe drug in dogs with CKD and leishmaniasis.	[Pineda, Carmen; Aguilera-Tejero, Escolastico; Morales, Maria C.; Garcia, Pablo; Lopez, Ignacio] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain; [Pineda, Carmen; Aguilera-Tejero, Escolastico; Martinez-Moreno, Julio M.; Lopez, Ignacio] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Belinchon-Lorenzo, Silvia; Gomez-Nieto, Luis C.] Univ Extremadura, Parasitol Unit, LeishmanCeres Lab, Caceres, Spain; [Rodriguez-Ortiz, Maria E.] Fdn Jimenez Diaz, Inst Invest Sanitaria, Nephrol Lab, Madrid, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Extremadura; Fundacion Jimenez Diaz	Lopez, I (corresponding author), Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain.; Lopez, I (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.	ignacio.lopez@uco.es	Belinchón-Lorenzo, Silvia/AAS-2719-2021; Martínez, Julio Manuel/AAA-6724-2020; Pineda, Carmen/AAF-4385-2020	Belinchón-Lorenzo, Silvia/0000-0003-2248-853X; Martínez, Julio Manuel/0000-0002-1945-5078; Lopez Villalba, Ignacio/0000-0002-4936-6121; Pineda Martos, Carmen Maria/0000-0002-3664-8699	Vetoquinol, Spain; Vetoquinol (Spain)	Vetoquinol, Spain; Vetoquinol (Spain)	This study was funded by Vetoquinol, Spain. Marbofloxacin was also supplied by Vetoquinol, Spain. Although the study was funded by Vetoquinol (Spain) and marbofloxacin was also supplied by them, the funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Bianciardi P, 2009, TOXICOL PATHOL, V37, P770, DOI 10.1177/0192623309344088; Braga ET, 2015, REV BRAS PARASITOL V, V24, P45, DOI 10.1590/S1984-29612015007; Carcelen J, 2009, VACCINE, V27, P5964, DOI 10.1016/j.vaccine.2009.07.069; Clementi A, 2011, CLIN KIDNEY J, V4, P147, DOI 10.1093/ndtplus/sfr008; Cortadellas O, 2003, J VET INTERN MED, V17, P808, DOI 10.1892/0891-6640(2003)017&lt;0808:IALEOA&gt;2.3.CO;2; Cortadellas O, 2006, J VET INTERN MED, V20, P941, DOI 10.1892/0891-6640(2006)20[941:SHIDWL]2.0.CO;2; Costa FAL, 2003, VET PATHOL, V40, P677, DOI 10.1354/vp.40-6-677; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; Finco DR, 2004, J VET INTERN MED, V18, P289, DOI 10.1892/0891-6640(2004)18&lt;289:AOSHWR&gt;2.0.CO;2; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Garcia-Martinez JD, 2015, RES VET SCI, V99, P204, DOI 10.1016/j.rvsc.2015.01.002; Goldstein RE, 2013, J VET INTERN MED, V27, pS60, DOI 10.1111/jvim.12232; Grauer GF, 2005, J SMALL ANIM PRACT, V46, P469, DOI 10.1111/j.1748-5827.2005.tb00275.x; Ikeda-Garcia FA, 2007, VET PARASITOL, V143, P254, DOI 10.1016/j.vetpar.2006.08.019; KarginKiral F, 2004, REV MED VET, V155, P226; Koutinas AF, 2001, VET PARASITOL, V98, P247, DOI 10.1016/S0304-4017(01)00399-5; Manna L, 2004, VET PARASITOL, V125, P251, DOI 10.1016/j.vetpar.2004.07.019; Manna L, 2008, VET J, V177, P279, DOI 10.1016/j.tvjl.2007.04.013; Manna L, 2009, VET J, V182, P441, DOI 10.1016/j.tvjl.2008.08.009; Manna L, 2009, RES VET SCI, V87, P76, DOI 10.1016/j.rvsc.2008.12.009; Mateo M, 2009, PARASITOL RES, V105, P155, DOI 10.1007/s00436-009-1375-3; Mettler M, 2005, BERL MUNCH TIERARZTL, V118, P37; Miro G, 2009, VET DERMATOL, V20, P397, DOI 10.1111/j.1365-3164.2009.00824.x; Mitchell HC, 1997, AM J KIDNEY DIS, V29, P897, DOI 10.1016/S0272-6386(97)90464-9; Monti P, 2012, J SMALL ANIM PRACT, V53, P254, DOI 10.1111/j.1748-5827.2012.01198.x; Pennisi MG, 2005, VET REC, V156, P346, DOI 10.1136/vr.156.11.346; Petanides TA, 2008, J VET INTERN MED, V22, P866, DOI 10.1111/j.1939-1676.2008.0129.x; Pierantozzi M, 2013, J AM ANIM HOSP ASSOC, V49, P231, DOI 10.5326/JAAHA-MS-5840; Plevraki K, 2006, J VET INTERN MED, V20, P228, DOI 10.1892/0891-6640(2006)20[228:EOATOT]2.0.CO;2; Poot J, 2005, VET PARASITOL, V130, P41, DOI 10.1016/j.vetpar.2005.03.002; Quinnell RJ, 2003, VET IMMUNOL IMMUNOP, V91, P161, DOI 10.1016/S0165-2427(02)00311-2; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Rodrigues M. L. O., 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P33, DOI 10.1590/S0036-46651999000100007; Rougier S, 2008, VET PARASITOL, V153, P244, DOI 10.1016/j.vetpar.2008.01.041; Rougier S, 2012, VET PARASITOL, V186, P245, DOI 10.1016/j.vetpar.2011.11.016; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sasaki A, 2014, J COMP PATHOL, V151, P264, DOI 10.1016/j.jcpa.2014.06.001; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1519-0; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Vouldoukis I, 2006, VET PARASITOL, V135, P137, DOI 10.1016/j.vetpar.2005.09.003; Wehner A, 2008, VET REC, V162, P141, DOI 10.1136/vr.162.5.141; Woerly V, 2009, PARASITOL RES, V105, P463, DOI 10.1007/s00436-009-1404-2	44	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185981	10.1371/journal.pone.0185981	http://dx.doi.org/10.1371/journal.pone.0185981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982165	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300101
J	Sun, RY; Tian, J; Zhang, J; Wang, LP; Guo, J; Liu, YN				Sun, Ruiying; Tian, Jie; Zhang, Jun; Wang, Liping; Guo, Jing; Liu, Yani			Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; DISEASE; PLAQUES; MICROBUBBLES; INHIBITION; MECHANISMS; SELECTIN; LESIONS; VCAM-1	Purpose The upregulation of vascular cell adhesion molecule-1 (VCAM-1) on vascular endothelium plays a great role in the progression of atherosclerosis (AS). In this study, ultrasound molecular imaging was performed to monitor the inflammation injuries in the onset and progression of atherosclerosis with microbubbles targeted to VCAM-1. Methods Mice deficient for the apolipoprotein E (ApoE(-/-)mice) with high-cholesterol diet were studied as an age-dependent model of atherosclerosis. At 8, 16, 24, and 32 weeks of age, contrast enhanced ultrasound (CEU) molecular imaging of proximal ascending aorta was performed with microbubbles targeted to VCAM-1. Plaque size, monocytes infiltration and the expression of VCAM-1 in the proximal ascending aorta were assessed by histology and western blot analysis, separately. Results In ApoE(-/-) mice, molecular imaging for VCAM-1 detected selective signal enhancement (P<0.01 versus non-targeted microbubbles) at all ages of ApoE(-/-) mice. Moreover, signals from targeted microbubbles increased from 8wks to 32wks age (P<0.05 for trend) in ApoE(-/-) mice, indicating the upregulation of VCAM-1 with the progression of atherosclerosis. Consistent with CEU imaging results, both western blot analysis and immunohistochemistry revealed the expression of VCAM-1 and monocytes infiltration were age-dependent in ApoE(-/-) mice. Conclusions CEU molecular imaging can be used to noninvasively detect the VCAM-1 expression on the endothelium in the progression of atherosclerosis. By investigating specific molecular biomarkers, it could help to monitor the inflammation and the progression of AS, which may in some extent contribute to the prediction of vulnerable plaque.	[Sun, Ruiying; Tian, Jie; Zhang, Jun; Wang, Liping; Guo, Jing; Liu, Yani] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Liu, YN (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China.	yani.liu@aliyun.com		Liu, Yani/0000-0001-5706-0811	National Science Foundation of China [81371581, 81101053]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	YNL is supported by a grant (81371581, 81101053) from the National Science Foundation of China (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Boekholdt SM, 2008, CIRCULATION, V118, P1120, DOI 10.1161/CIRCULATIONAHA.108.795195; Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m; Brunetti ND, 2014, ATHEROSCLEROSIS, V236, P456, DOI 10.1016/j.atherosclerosis.2014.07.037; Davidson BP, 2014, J AM SOC ECHOCARDIOG, V27, P786, DOI 10.1016/j.echo.2014.03.013; Deshpande N, 2012, RADIOLOGY, V262, P172, DOI 10.1148/radiol.11110323; Huo YQ, 2000, CIRC RES, V87, P153, DOI 10.1161/01.RES.87.2.153; Joseph P, 2017, EUR J NUCL MED MOL I, V44, P141, DOI 10.1007/s00259-016-3524-0; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Liu YN, 2013, CIRC-CARDIOVASC IMAG, V6, P74, DOI 10.1161/CIRCIMAGING.112.975193; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Silvola JMU, 2016, SCI REP-UK, V6, DOI 10.1038/srep35089; Singh P, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004195; Soeki T, 2016, INT HEART J, V57, P134, DOI 10.1536/ihj.15-346; Steinl DC, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004720; Veseli B. Emini, 2017, EUR J PHARM; Wu ZJ, 2013, CIRC-CARDIOVASC IMAG, V6, P974, DOI 10.1161/CIRCIMAGING.113.000805; Zhang MD, 2015, CARDIOVASC THER, V33, P118, DOI 10.1111/1755-5922.12119	23	9	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186155	10.1371/journal.pone.0186155	http://dx.doi.org/10.1371/journal.pone.0186155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982198	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300130
J	Huang, XW; Zhang, YL; Meng, L; Abbott, D; Qian, M; Wong, KKL; Zheng, RQ; Zheng, HR; Niu, LL				Huang, Xiaowei; Zhang, Yanling; Meng, Long; Abbott, Derek; Qian, Ming; Wong, Kelvin K. L.; Zheng, Rongqing; Zheng, Hairong; Niu, Lili			Evaluation of carotid plaque echogenicity based on the integral of the cumulative probability distribution using gray-scale ultrasound images	PLOS ONE			English	Article							B-MODE IMAGES; CARDIOVASCULAR EVENTS; CORONARY EVENTS; ISCHEMIC-STROKE; HIGH-RISK; ECHOLUCENT; TEXTURE; CLASSIFICATION; PREDICTION; STENOSIS	Objective Carotid plaque echogenicity is associated with the risk of cardiovascular events. Gray-scale median (GSM) of the ultrasound image of carotid plaques has been widely used as an objective method for evaluation of plaque echogenicity in patients with atherosclerosis. We proposed a computer-aided method to evaluate plaque echogenicity and compared its efficiency with GSM. Methods One hundred and twenty-five carotid plaques (43 echo-rich, 35 intermediate, 47 echolucent) were collected from 72 patients in this study. The cumulative probability distribution curves were obtained based on statistics of the pixels in the gray-level images of plaques. The area under the cumulative probability distribution curve (AUCPDC) was calculated as its integral value to evaluate plaque echogenicity. Results The classification accuracy for three types of plaques is 78.4% (kappa value, kappa = 0.673), when the AUCPDC is used for classifier training, whereas GSM is 64.8% (kappa = 0.460). The receiver operating characteristic curves were produced to test the effectiveness of AUCPDC and GSM for the identification of echolucent plaques. The area under the curve (AUC) was 0.817 when AUCPDC was used for training the classifier, which is higher than that achieved using GSM (AUC = 0.746). Compared with GSM, the AUCPDC showed a borderline association with coronary heart disease (Spearman r = 0.234, p = 0.050). Conclusions Our experimental results suggest that AUCPDC analysis is a promising method for evaluation of plaque echogenicity and predicting cardiovascular events in patients with plaques.	[Huang, Xiaowei; Meng, Long; Qian, Ming; Zheng, Hairong; Niu, Lili] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China; [Huang, Xiaowei] Univ Chinese Acad Sci, Shenzhen Coll Adv Technol, Shenzhen, Peoples R China; [Zhang, Yanling; Zheng, Rongqing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasound, Guangzhou, Guangdong, Peoples R China; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; University of Adelaide; University of Adelaide; University of Sydney; Western Sydney University	Niu, LL (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	ll.niu@siat.ac.cn	Abbott, Derek/E-8352-2011; Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105; 	National Key R&D Program of China [2016YFC0104700]; National Science Foundation Grants (NSFC) [11574341, 11674347, 81527901, 11325420, 11574342]; Shenzhen Basic Science Research [JCYJ20160429190550139, JCYJ20160429184552717]; Natural Science Foundation of Guangdong Province [2016TQ03X716, 2016TQ03R472]	National Key R&D Program of China; National Science Foundation Grants (NSFC); Shenzhen Basic Science Research; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	The work was supported by National Key R&D Program of China (2016YFC0104700), National Science Foundation Grants (NSFC Grant Nos. 11574341, 11674347, 81527901,11325420, 11574342), Shenzhen Basic Science Research (JCYJ20160429190550139, JCYJ20160429184552717), and Natural Science Foundation of Guangdong Province (2016TQ03X716, 2016TQ03R472). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2012, ULTRASOUND MED BIOL, V38, P899, DOI 10.1016/j.ultrasmedbio.2012.01.015; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Doonan RJ, 2013, EUR J VASC ENDOVASC, V46, P299, DOI 10.1016/j.ejvs.2013.05.024; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; European Carotid Plaque Study Group, 2011, Eur J Vasc Endovasc Surg, V42 Suppl 1, pS32, DOI 10.1016/j.ejvs.2011.06.022; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; GEROULAKOS G, 1993, BRIT J SURG, V80, P1274, DOI 10.1002/bjs.1800801016; Giede-Jeppe A, 2016, STROKE, V47, P1239, DOI 10.1161/STROKEAHA.116.013003; Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Gronholdt MLM, 1997, EUR J VASC ENDOVASC, V14, P439, DOI 10.1016/S1078-5884(97)80121-9; Heider P, 2010, EUR J VASC ENDOVASC, V39, P668, DOI 10.1016/j.ejvs.2010.03.012; Hirano M, 2010, ATHEROSCLEROSIS, V211, P451, DOI 10.1016/j.atherosclerosis.2010.03.003; Honda O, 2004, J AM COLL CARDIOL, V43, P1177, DOI 10.1016/j.jacc.2003.09.063; Huang XW, 2016, J ULTRAS MED, V35, P2253, DOI 10.7863/ultra.15.09002; Irie Y, 2013, ATHEROSCLEROSIS, V230, P399, DOI 10.1016/j.atherosclerosis.2013.08.015; Mathiesen EB, 2001, CIRCULATION, V103, P2171; Mayor I, 2003, ULTRASOUND MED BIOL, V29, P961, DOI 10.1016/S0301-5629(03)00905-0; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nakamura T, 2013, INT J CARDIOL, V167, P555, DOI 10.1016/j.ijcard.2012.01.064; Nordestgaard BG, 2003, CURR OPIN LIPIDOL, V14, P505, DOI 10.1097/00041433-200310000-00012; Prahl U, 2010, ULTRASOUND MED BIOL, V36, P218, DOI 10.1016/j.ultrasmedbio.2009.10.002; Reiter M, 2008, RADIOLOGY, V248, P1050, DOI 10.1148/radiol.2483071817; Roy J, 2016, EUR J VASC ENDOVASC, V51, P622, DOI 10.1016/j.ejvs.2016.01.002; Ruiz-Ares G, 2014, ULTRASOUND MED BIOL, V40, P1958, DOI 10.1016/j.ultrasmedbio.2014.04.015; Sabetai MM, 2000, STROKE, V31, P2189, DOI 10.1161/01.STR.31.9.2189; Salem MK, 2014, EUR J VASC ENDOVASC, V48, P118, DOI 10.1016/j.ejvs.2014.05.015; Shankar PM, 2003, ULTRASOUND MED BIOL, V29, P1305, DOI 10.1016/S0301-5629(03)00983-9; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	33	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185261	10.1371/journal.pone.0185261	http://dx.doi.org/10.1371/journal.pone.0185261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977008	Green Published, gold			2022-12-27	WOS:000412163100019
J	Sprokholt, JK; Heineke, MH; Kaptein, TM; van Hamme, JL; Geijtenbeek, TBH				Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.			DCs facilitate B cell responses against microbial DNA via DC-SIGN	PLOS ONE			English	Article							DENDRITIC CELLS; EXTRACELLULAR DNA; LECTIN RECEPTORS; MANNOSE RECEPTOR; IDENTIFICATION; RESISTANCE; LANGERIN; BIOFILMS; IMMUNITY; ANTIGEN	Microbial DNA is highly immunostimulatory and is sensed by endosomal pattern recognition receptors after release from internalized microbes. It is unclear how extracellular DNA released from dead microbes is delivered to endosomal PRRs to induce immune responses. Here we have investigated the ability of DCs to bind and internalize extracellular E.coli DNA as well as synthetic DNA. DCs internalized E.coli and synthetic DNA, which was dependent on the C-type lectin receptor DC-SIGN. Notably, endosomal uptake of DNA by DCs enhanced TLR9-dependent responses of B cells against DNA. Hence, we have identified DC-SIGN as a cell surface receptor for DNA that facilitates immune responses directed against DNA.	[Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Sprokholt, Joris K.; Heineke, Marieke H.; Kaptein, Tanja M.; van Hamme, John L.; Geijtenbeek, Teunis B. H.] Amsterdam Infect & Immun Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Geijtenbeek, TBH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.; Geijtenbeek, TBH (corresponding author), Amsterdam Infect & Immun Inst, Amsterdam, Netherlands.	t.b.geijtenbeek@amc.uva.nl		Sprokholt, Joris/0000-0001-8104-0028	Netherlands Organization for Scientific Research; TBHG [NGI 40-41009-98-8057, NWOVICI918.10.619, 670424]; European Research Council	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); TBHG; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Netherlands Organization for Scientific Research (http://www.nwo.nl/) TBHG, grants NGI 40-41009-98-8057 and NWOVICI918.10.619 and the European Research Council (https://erc.europa.eu/) TBHG, Advanced grant 670424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ana M. A, 2009, J IMMUNOL, V76, P211; Bode C, 2012, CPG DNA VACCINE ADJU, V10, P499; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2016, NAT REV IMMUNOL, V16, P433, DOI 10.1038/nri.2016.55; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kerkmann M, 2005, J BIOL CHEM, V280, P8086, DOI 10.1074/jbc.M410868200; Kostakioti M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010306; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lahoud MH, 2012, DEC 205 IS CELL SURF, DOI [10.1073/pnas.1208796109/-/DCSupplemental, DOI 10.1073/PNAS.1208796109/-/DCSUPPLEMENTAL]; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Moseman AP, 2013, J IMMUNOL, V191, P5615, DOI 10.4049/jimmunol.1301438; Ohba Y., 2005, NATURE, V2, P1; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; Verthelyi D, 2003, J IMMUNOL, V170, P4717, DOI 10.4049/jimmunol.170.9.4717; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wykes M, 1998, J IMMUNOL, V161, P1313	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185580	10.1371/journal.pone.0185580	http://dx.doi.org/10.1371/journal.pone.0185580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976999	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100031
J	Cicalese, L; Curcuru, G; Montalbano, M; Shirafkan, A; Georgiadis, J; Rastellini, C				Cicalese, Luca; Curcuru, Giuseppe; Montalbano, Mauro; Shirafkan, Ali; Georgiadis, Jeremias; Rastellini, Cristiana			Hazardous air pollutants and primary liver cancer in Texas	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HEPATOCELLULAR-CARCINOMA; UNLEADED GASOLINE; B6C3F1 MICE; RATS; 2,2,4-TRIMETHYLPENTANE; FORMALDEHYDE; MORTALITY; CARCINOGENICITY; IDENTIFICATION	The incidence of hepatocellular carcinoma (HCC), the most common primary liver cancer, is increasing in the US and tripled during the past two decades. The reasons for such phenomenon remain poorly understood. Texas is among continental states with the highest incidence of liver cancer with an annual increment of 5.7%. Established risk factors for HCC include Hepatitis B and C (HBV, HCV) viral infection, alcohol, tobacco and suspected risk factors include obesity and diabetes. While distribution of these risk factors in the state of Texas is similar to the national data and homogeneous, the incidence of HCC in this state is exceptionally higher than the national average and appears to be dishomogeneous in various areas of the state suggesting that other non-recognized risk factors might play a role. No population-based studies are currently available investigating the effect of exposure to Hazardous Air Pollutants (HAPs) as a contributing risk factor for liver cancer. Incidence rate of liver cancer in Texas by counties for the time period between 2002 and 2012 was obtained from the Texas Cancer Registry (TCR). Through Principal Component Analysis (PCA) a subgroup of pollutants, explaining almost all the dataset variability, were identified and used to cluster Texas counties. The analysis generated 4 clusters showing liver cancer rate either higher or lower than national average in association with either high or low levels of HAPs emission in the environment. The study shows that the selected relevant HAPs, 10 among 253 analyzed, produce a significant correlation (P = 0.01-0.05) and some of these have been previously identified as carcinogens. An association between the increased production and consequent exposure to these HAPs and a higher presence of liver cancer in certain counties is suggested. This study provides a new insight on this complex multifactorial disease suggesting that environmental substances might play a role in the etiology of this cancer.	[Cicalese, Luca; Montalbano, Mauro; Shirafkan, Ali; Georgiadis, Jeremias; Rastellini, Cristiana] Univ Texas Med Branch, Dept Surg, Texas Transplant Ctr, Galveston, TX 77555 USA; [Curcuru, Giuseppe] Univ Palermo, Dept Chem Management Informat & Mech Engn, Palermo, Italy; [Curcuru, Giuseppe] Ist EuroMediterraneo Sci & Tecnol IE MEST, Palermo, Italy; [Montalbano, Mauro] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Palermo; University of Texas System; University of Texas Medical Branch Galveston	Cicalese, L (corresponding author), Univ Texas Med Branch, Dept Surg, Texas Transplant Ctr, Galveston, TX 77555 USA.	lucicale@utmb.edu	Montalbano, Mauro/AAA-6833-2021	Montalbano, Mauro/0000-0002-0456-452X	Department of Surgery of University of Texas Medical Branch; Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo	Department of Surgery of University of Texas Medical Branch; Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo	The study was supported by departmental funds, in particular by the Department of Surgery of University of Texas Medical Branch and Department of Chemical, Management, Informatics and Mechanical Engineering, University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; ATSDR, 2000, TOX PROF TOL; BESTERVELT LL, 1995, P NATL ACAD SCI USA, V92, P3764, DOI 10.1073/pnas.92.9.3764; Bird MG, 1997, J APPL TOXICOL, V17, pS45, DOI 10.1002/(SICI)1099-1263(199705)17:1+<S45::AID-JAT410>3.3.CO;2-B; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention Division of Nutrition, PHYS ACTIVITY OBESIT; Chan PC, 1998, TOXICOL LETT, V99, P23, DOI 10.1016/S0378-4274(98)00133-7; Cogliano VJ, 2005, ENVIRON HEALTH PERSP, V113, P1205, DOI 10.1289/ehp.7542; Davila JA, 2004, GASTROENTEROLOGY, V127, P1372, DOI 10.1053/j.gastro.2004.07.020; ENGSTROM KM, 1984, SCAND J WORK ENV HEA, V10, P83, DOI 10.5271/sjweh.2354; Esposti Davide Degli, 2012, HEPATOCELLULAR CARCI; Everitt Brian S., WILEY SERIES PROBABI; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; FOWLIE AJ, 1987, J APPL TOXICOL, V7, P335, DOI 10.1002/jat.2550070508; Guyton KZ, 2009, MUTAT RES-REV MUTAT, V681, P230, DOI 10.1016/j.mrrev.2008.10.001; Hair J. F., 2006, HDB RES SCI ED, P125; Huff J, 2007, INT J OCCUP ENV HEAL, V13, P213, DOI 10.1179/oeh.2007.13.2.213; Im H, 2006, J PROTEOME RES, V5, P1354, DOI 10.1021/pr050437b; International Agency for Research on Cancer, 2012, PERS HAB IND COMB, V100; Jung KH, 2013, TOXICOL LETT, V216, P1, DOI 10.1016/j.toxlet.2012.11.001; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; LOCK EA, 1987, XENOBIOTICA, V17, P513, DOI 10.3109/00498258709043958; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; LOURY DJ, 1986, TOXICOL APPL PHARM, V85, P11, DOI 10.1016/0041-008X(86)90383-2; Lu K, 2008, CHEM RES TOXICOL, V21, P1586, DOI 10.1021/tx8000576; MALTONI C, 1989, ENVIRON HEALTH PERSP, V82, P109, DOI 10.2307/3430768; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Mennear JH, 1997, RISK ANAL, V17, P673, DOI 10.1111/j.1539-6924.1997.tb01274.x; National Toxicology Program (NTP), 2011, CHEM ASS SIT SPEC TU; Persson EC, 2013, CANCER EPIDEM BIOMAR, V22, P415, DOI 10.1158/1055-9965.EPI-12-1169; Porru S, 2001, INT J CANCER, P94; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Robin LA, 2011, APPARENT CAPITA ALCO; Song MK, 2012, TOXICOL LETT, V212, P18, DOI 10.1016/j.toxlet.2012.04.013; STANDEVEN AM, 1994, J TOXICOL ENV HEALTH, V43, P213, DOI 10.1080/15287399409531916; U.S. Department of Health and Human Services, 1993, HAZ SUBST DAT BANK H; U. S. Environmenal Protection Agency, 1999, NAT CTR ENV ASS OFF; U. S. Environmental Protection Agency, 2005, NAT CTR ENV ASS OFF; U. S. Environmental Protection Agency, 1987, N HEX HLTH ADV; United States Environmental Protection Agency (IRIS-US EPA), 1999, INT RISK INF SYST IR; US Cancer statistics Working Group, 2014, INC MORT WEB BAS REP; Yalamanchili Kanthi, 2005, Proc (Bayl Univ Med Cent), V18, P3	42	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185610	10.1371/journal.pone.0185610	http://dx.doi.org/10.1371/journal.pone.0185610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016628	gold, Green Submitted, Green Published			2022-12-27	WOS:000412627400025
J	Dai, YC; Wang, SC; Hague, MM; Lin, WH; Lin, LC; Chen, CH; Liu, YW				Dai, Yuan-Chang; Wang, Shou-Chieh; Hague, Mohammad Mezbahul; Lin, Wei-Han; Lin, Lei-Chen; Chen, Ching-Hsein; Liu, Yi-Wen			The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice	PLOS ONE			English	Article							URINARY-BLADDER CARCINOGENESIS; S-TRANSFERASE M1; DRINKING-WATER; DIMETHYLARSINIC ACID; LUNG-CANCER; CIGARETTE-SMOKING; POOLED ANALYSIS; ORAL-EXPOSURE; DAMAGE; METHYLATION	The bladder is an important organ for the storage of excreted water and metabolites. If metabolites with carcinogenic characteristics are present in urine, the urothelial lining of the bladder could be damaged and genetically altered. In this study, we analyzed the interaction of arsenic and N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) on mouse bladder carcinogenesis. Our previous study found that arsenic affects BBN-altered urothelial enzymatic activity, protein expression, DNA oxidation and global DNA CpG methylation levels. In this study, two mouse models were used. First, after administering a co-treatment of BBN and arsenic for 20 weeks, BBN alone led to a urothelial carcinoma formation of 20%, and arsenic promoted a BBN-induced urothelial carcinoma formation of 10%. The protein expression of GSTM1, GSTO1, NQO1, and p21 did not change by arsenic along with the BBN co-treatment, but the Sp1 expression increased. In the second mouse model, BBN was a pretreatment promoter; arsenic dose-dependently deteriorated BBN-promoted dysplasia by 10% and 40% at 10 ppm and 100 ppm, respectively. Conversely, BBN pretreatment also accelerated arsenic-induced dysplasia by 30%. The urothelial carcinogenic effect reversed after ceasing BBN for a period of 20 weeks. In summary, three conclusions were drawn from this study. The first is the mutual promotion of arsenic and BBN in bladder carcinogenesis. Second, arsenic dosages without bladder carcinogenicity (10 ppm) or with slight carcinogenicity (100 ppm) promote BBN-induced mice bladder cancer progression. Finally, the dysplastic urothelium had reverted to near-normal morphology after ceasing BBN intake for 20 weeks, providing a good suggestion for people who want to quit smoking.	[Dai, Yuan-Chang; Hague, Mohammad Mezbahul; Lin, Wei-Han; Chen, Ching-Hsein; Liu, Yi-Wen] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Dai, Yuan-Chang] Chiayi Christian Hosp, Dept Pathol, Chiayi, Taiwan; [Wang, Shou-Chieh] Kuang Tien Gen Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan; [Wang, Shou-Chieh] Natl Chiayi Univ, Coll Life Sci, Dept Food Sci, Chiayi, Taiwan; [Lin, Lei-Chen] Natl Chiayi Univ, Coll Agr, Dept Forestry & Nat Resources, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital; National Chiayi University; National Chiayi University	Liu, YW (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	ywlss@mail.ncyu.edu.tw		Liu, Yi-Wen/0000-0002-4715-3800	Ministry of Science and Technology Republic of China, Taiwan [MOST1042320-6-415-001-MY3]	Ministry of Science and Technology Republic of China, Taiwan	This work is supported by grants from the Ministry of Science and Technology MOST1042320-6-415-001-MY3 of the Republic of China, Taiwan.; This work is supported by grants from the Ministry of Science and Technology MOST104-2320-B-415-001-MY3 of the Republic of China, Taiwan.	Ameer SS, 2017, TOXICOL APPL PHARM, V321, P57, DOI 10.1016/j.taap.2017.02.019; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; Bustaffa E, 2014, ARCH TOXICOL, V88, P1043, DOI 10.1007/s00204-014-1233-7; Chiou HY, 2001, AM J EPIDEMIOL, V153, P411, DOI 10.1093/aje/153.5.411; Chuang JJ, 2014, TOXICOL APPL PHARM, V279, P322, DOI 10.1016/j.taap.2014.06.018; Cohen SM, 2007, TOXICOL APPL PHARM, V222, P258, DOI 10.1016/j.taap.2006.10.010; Cui X, 2006, TOXICOL SCI, V91, P372, DOI 10.1093/toxsci/kfj159; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Kinoshita A, 2007, CANCER SCI, V98, P803, DOI 10.1111/j.1349-7006.2007.00475.x; Lee CH, 2013, J INVEST DERMATOL, V133, P1890, DOI 10.1038/jid.2013.55; Lin PY, 2012, TOXICOL APPL PHARM, V259, P27, DOI 10.1016/j.taap.2011.11.016; Mandal P, 2017, N-S ARCH PHARMACOL, V390, P443, DOI 10.1007/s00210-017-1351-x; Michaud DS, 2006, AM J CLIN NUTR, V84, P1177, DOI 10.1093/ajcn/84.5.1177; Mitacek EJ, 1999, CARCINOGENESIS, V20, P133, DOI 10.1093/carcin/20.1.133; Ng JC, 2003, CHEMOSPHERE, V52, P1353, DOI 10.1016/S0045-6535(03)00470-3; Oliveira P. A., 2006, Experimental Oncology, V28, P2; Oliveira PA, 2005, J EXP CLIN CANC RES, V24, P609; Phookphan P, 2017, TOXICOL APPL PHARM, V316, P36, DOI 10.1016/j.taap.2016.12.015; Reuter VE., 2016, WHO CLASSIFICATION T; Salim EI, 2003, CARCINOGENESIS, V24, P335, DOI 10.1093/carcin/24.2.335; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Shen J, 2003, CARCINOGENESIS, V24, P1827, DOI 10.1093/carcin/bgg143; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; Steinmaus C, 2003, AM J EPIDEMIOL, V158, P1193, DOI 10.1093/aje/kwg281; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Tang FQ, 2006, MOL CARCINOGEN, V45, P861, DOI 10.1002/MC.20245; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Tyagi A, 2007, MOL CANCER THER, V6, P3248, DOI 10.1158/1535-7163.MCT-07-2006; Wang SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159102; Wanibuchi H, 1996, CARCINOGENESIS, V17, P2435, DOI 10.1093/carcin/17.11.2435; Wanibuchi H, 2004, TOXICOL APPL PHARM, V198, P366, DOI 10.1016/j.taap.2003.10.032; Wauson EM, 2002, TOXICOL SCI, V65, P211, DOI 10.1093/toxsci/65.2.211; Wu CC, 2012, J UROLOGY, V188, P1701, DOI 10.1016/j.juro.2012.07.025; Yamanaka K, 2001, BIOCHEM BIOPH RES CO, V287, P66, DOI 10.1006/bbrc.2001.5551; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186214	10.1371/journal.pone.0186214	http://dx.doi.org/10.1371/journal.pone.0186214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016672	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400061
J	Neves, FM; Viana, RL; Pie, MR				Neves, Felipe Marcel; Viana, Ricardo Luiz; Pie, Marcio Roberto			Recurrence analysis of ant activity patterns	PLOS ONE			English	Article							TIME-SERIES; PHEIDOLE-PALLIDULA; LOCOMOTOR-ACTIVITY; MOVEMENT ACTIVITY; FOOD RECRUITMENT; ANIMAL BEHAVIOR; EVOLUTION; HYMENOPTERA; PLOTS; SYNCHRONIZATION	In this study, we used recurrence quantification analysis (RQA) and recurrence plots (RPs) to compare the movement activity of individual workers of three ant species, as well as a gregarious beetle species. RQA and RPs quantify the number and duration of recurrences of a dynamical system, including a detailed quantification of signals that could be stochastic, deterministic, or both. First, we found substantial differences between the activity dynamics of beetles and ants, with the results suggesting that the beetles have quasi-periodic dynamics and the ants do not. Second, workers from different ant species varied with respect to their dynamics, presenting degrees of predictability as well as stochastic signals. Finally, differences were found among minor and major caste of the same (dimorphic) ant species. Our results underscore the potential of RQA and RPs in the analysis of complex behavioral patterns, as well as in general inferences on animal behavior and other biological phenomena.	[Neves, Felipe Marcel; Pie, Marcio Roberto] Univ Fed Parana, Dept Zool, Curitiba, Parana, Brazil; [Viana, Ricardo Luiz] Univ Fed Parana, Dept Fis, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana	Neves, FM (corresponding author), Univ Fed Parana, Dept Zool, Curitiba, Parana, Brazil.	fmarcelneves@gmail.com	Neves, Felipe Marcel/L-1382-2019; Viana, Ricardo Luiz/AAK-7722-2021; Neves, Felipe/G-4492-2013	Neves, Felipe Marcel/0000-0002-1586-6929; Viana, Ricardo Luiz/0000-0001-7298-9370; Neves, Felipe/0000-0002-1586-6929	CNPq/MCT [571334/2008-3];  [141355/2012-3]	CNPq/MCT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	CNPq/MCT (http://cnpq.br/) provided support for this study through research fellowships to MRP (571334/2008-3), as well as a graduate fellowship to FMN (141355/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; [Anonymous], 1992, ECOL SOCIOBIOL, V31, P181; Bender JA, 2011, J EXP BIOL, V214, P2057, DOI 10.1242/jeb.056481; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Boi S, 1999, P ROY SOC B-BIOL SCI, V266, P371, DOI 10.1098/rspb.1999.0647; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brodin T, 2009, BEHAV ECOL, V20, P30, DOI 10.1093/beheco/arn111; Chapman BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059437; Christensen K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0985; COLE BJ, 1991, P ROY SOC B-BIOL SCI, V244, P253, DOI 10.1098/rspb.1991.0079; COLE BJ, 1995, ANIM BEHAV, V50, P1317, DOI 10.1016/0003-3472(95)80047-6; COLE BJ, 1991, J INSECT BEHAV, V4, P129, DOI 10.1007/BF01054607; COTTON R. T., 1927, ANN ENT SOC AMER, V20, P81, DOI 10.1093/aesa/20.1.81; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; DENEUBOURG JL, 1986, PHYSICA D, V22, P176, DOI 10.1016/0167-2789(86)90239-3; DETRAIN C, 1991, J INSECT BEHAV, V4, P157, DOI 10.1007/BF01054609; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; Dinno A., DUNN TEST DUNNS TEST; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; FONDACARO JD, 1970, ANN ENTOMOL SOC AM, V63, P952, DOI 10.1093/aesa/63.4.952; Giraud T, 2000, MOL ECOL, V9, P1835, DOI 10.1046/j.1365-294x.2000.01085.x; GORDON DM, 1992, J THEOR BIOL, V156, P293, DOI 10.1016/S0022-5193(05)80677-0; Grimaldi D, 2000, P NATL ACAD SCI USA, V97, P13678, DOI 10.1073/pnas.240452097; Guimaraes ZO, 2008, PHYS LETT A, V372, P1088, DOI 10.1016/j.physleta.2007.07.088; Holldobler B., 1990, pi; Holyst JA, 2001, EUR PHYS J B, V20, P531, DOI 10.1007/PL00011109; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Korb J, 2004, NATURWISSENSCHAFTEN, V91, P291, DOI 10.1007/s00114-004-0529-5; Koto A, 2015, BEHAV ECOL SOCIOBIOL, V69, P583, DOI 10.1007/s00265-014-1869-6; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lattke JE, 1990, ACTA TERROMORIA, V2, P1; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lommelen E, 2006, J CHEM ECOL, V32, P2023, DOI 10.1007/s10886-006-9126-8; Lone SR, 2011, CHRONOBIOL INT, V28, P862, DOI 10.3109/07420528.2011.622676; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marwan N, 2005, PHYS LETT A, V336, P349, DOI 10.1016/j.physleta.2004.12.056; Marwan N, 2003, CLIM DYNAM, V21, P317, DOI 10.1007/s00382-003-0335-3; Marwan N, 2002, NONLINEAR PROC GEOPH, V9, P325, DOI 10.5194/npg-9-325-2002; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0624; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; MATLAB, 2010, MATLAB STAT TOOLB RE; Miramontes O., 1992, THESIS; Neves FM, 2012, AIP CONF PROC, V1479, P658, DOI 10.1063/1.4756220; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Oster GF, CASTE ECOLOGY SOCIAL; Pie MR, 2007, J ZOOL, V271, P99, DOI 10.1111/j.1469-7998.2006.00239.x; R Development Core Team, 2015, R LANG ENV STAT COMP; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; SOLE RV, 1993, J THEOR BIOL, V161, P343, DOI 10.1006/jtbi.1993.1060; Sweeney K, 2013, BEHAV ECOL, V24, P1205, DOI 10.1093/beheco/art052; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Webber CL, 2009, PHYS LETT A, V373, P3753, DOI 10.1016/j.physleta.2009.08.052; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WILD A., 2007, ENTOMOLOGY, V126, P1; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1985, SCIENCE, V228, P1489, DOI 10.1126/science.228.4707.1489; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M	62	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185968	10.1371/journal.pone.0185968	http://dx.doi.org/10.1371/journal.pone.0185968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016648	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800032
J	Shang, XL; Chen, JW; Chen, SY				Shang, Xiliang; Chen, Jiwu; Chen, Shiyi			A meta-analysis comparing tenotomy and tenodesis for treating rotator cuff tears combined with long head of the biceps tendon lesions	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; ARTHROSCOPIC TENOTOMY; CLINICAL-OUTCOMES; REPAIR; ANTERIOR; BRACHII; TENDINOPATHY; DEBRIDEMENT; MANAGEMENT	Purpose The purpose of this meta-analysis was to assess whether there were differences in the outcomes between tenotomy and tenodesis in treating LHBT lesions combined with rotator cuff repairs. Methods Using Medline, Embase, and Cochrane, we searched for articles comparing tenotomy and tenodesis combined with rotator cuff repair which were published before April 2016 with the terms "biceps", "tenotomy", "tenodesis", and "rotator cuff". The controlled clinical studies that met the inclusion and exclusion criteria were assessed for quality of methodology by utilizing the Coleman score. Results On the basis of the inclusion and exclusion criteria, ten articles (903 patients) were included in this meta-analysis. The Coleman score ranged between 40 and 89 in the included studies. The results showed that the incidence of the popeye sign (OR, 2.777, P = 0.000) were higher in tenotomy group compared with tenodesis group when concomitant rotator cuff repair. Statistically significant difference in favor of tenodesis was observed for Constant score (SMD, -0.230, P = 0.025). As for the arm cramping pain, patient satisfaction, VAS score, ASES score and UCLA increased score, the strength and the range of motion, there were no significant differences between tenodesis and tenotomy of the LHBT, corresponding to the currently available results in the literature. Conclusions Based on this meta-analysis, both tenotomy and tenodesis are effective in pain relief and function improvement in patients with repairable rotator cuff tears. No significant differences in post-operative functional outcome between tenotomy and tenodesis for the treatment of LHBT lesions were observed except for a lower Constant score and higher risk of Popeye deformity in tenotomy.	[Shang, Xiliang; Chen, Jiwu; Chen, Shiyi] Fudan Univ, Huashan Hosp, Dept Sports Med, Shanghai, Peoples R China	Fudan University	Chen, SY (corresponding author), Fudan Univ, Huashan Hosp, Dept Sports Med, Shanghai, Peoples R China.	Chensy136@163.com		Chen, Shiyi/0000-0001-9190-3122; Chen, Jiwu/0000-0003-2940-8985	National Natural Science Foundation of China [81301578]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81301578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the National Natural Science Foundation of China (No. 81301578).	Ahlden M, 2013, AM J SPORT MED, V41, P2484, DOI 10.1177/0363546513497926; Ahmad CS, 2007, ARTHROSCOPY, V23, P537, DOI 10.1016/j.arthro.2006.12.030; Ahmad CS, 2003, ORTHOP CLIN N AM, V34, P499, DOI 10.1016/S0030-5898(03)00093-2; Barber F Alan, 2008, Instr Course Lect, V57, P527; Barber FA, 2001, ARTHROSCOPY, V17, P636, DOI 10.1053/jars.2001.24852; Biz Carlo, 2012, Muscles Ligaments Tendons J, V2, P133; Boileau P, 2007, J BONE JOINT SURG AM, V89A, P747, DOI 10.2106/JBJS.E.01097; Checchia SL, 2005, J SHOULDER ELB SURG, V14, P138, DOI 10.1016/j.jse.2004.07.013; Cho NS, 2014, AM J SPORT MED, V42, P1161, DOI 10.1177/0363546514523719; Coleman BD, 2000, SCAND J MED SCI SPOR, V10, P2, DOI 10.1034/j.1600-0838.2000.010001002.x; De Carli A, 2012, KNEE SURG SPORT TR A, V20, P2553, DOI 10.1007/s00167-012-1918-5; Delle Rose Giacomo, 2012, Musculoskelet Surg, V96 Suppl 1, pS47, DOI 10.1007/s12306-012-0189-0; Elser F, 2011, ARTHROSCOPY, V27, P581, DOI 10.1016/j.arthro.2010.10.014; Franceschi F, 2008, AM J SPORT MED, V36, P247, DOI 10.1177/0363546507308194; Frost A, 2009, AM J SPORT MED, V37, P828, DOI 10.1177/0363546508322179; Ge HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121286; Gill TJ, 2001, J SHOULDER ELB SURG, V10, P247, DOI 10.1067/mse.2001.114259; Gurnani N, 2016, KNEE SURG SPORT TR A, V24, P3765, DOI 10.1007/s00167-015-3640-6; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hsu AR, 2011, J SHOULDER ELB SURG, V20, P326, DOI 10.1016/j.jse.2010.08.019; Ikemoto Roberto Yukio, 2012, Rev. bras. ortop., V47, P736, DOI [10.1016/S2255-4971(15)30031-8, 10.1590/S0102-36162012000600011]; Kang HJ, 2015, KNEE SURG SPORT TR A, V23, P2244, DOI 10.1007/s00167-014-3021-6; Kelly AM, 2005, AM J SPORT MED, V33, P208, DOI 10.1177/0363546504269555; Klepps S, 2002, ARTHROSCOPY, V18, P1040, DOI 10.1053/jars.2002.36467; Klinger HM, 2005, ACTA CHIR BELG, V105, P297, DOI 10.1080/00015458.2005.11679720; Koh KH, 2010, AM J SPORT MED, V38, P1584, DOI 10.1177/0363546510364053; Kukkonen J, 2013, ISRN ORTHOP, V2013, P840965; Leroux T, 2015, SPORTS HEALTH, V7, P303, DOI 10.1177/1941738114539627; Maynou C, 2005, REV CHIR ORTHOP, V91, P300, DOI 10.1016/S0035-1040(05)84327-2; Meraner D, 2016, ARCH ORTHOP TRAUM SU, V136, P101, DOI 10.1007/s00402-015-2343-2; Nassos Jonathan T, 2009, Am J Orthop (Belle Mead NJ), V38, P279; Nho SJ, 2007, J BONE JOINT SURG AM, V89A, P127, DOI 10.2106/JBJS.G.00583; Nho SJ, 2010, J AM ACAD ORTHOP SUR, V18, P645, DOI 10.5435/00124635-201011000-00002; Oh JH, 2016, ARTHROSCOPY, V32, P958, DOI 10.1016/j.arthro.2015.11.036; Patzer T, 2011, ARTHROSCOPY, V27, P611, DOI 10.1016/j.arthro.2011.01.005; Scheibel M, 2011, AM J SPORT MED, V39, P1046, DOI 10.1177/0363546510390777; Senturk I, 2011, ACTA ORTHOP TRAUMATO, V45, P41, DOI 10.3944/AOTT.2011.2308; Slenker NR, 2012, ARTHROSCOPY, V28, P576, DOI 10.1016/j.arthro.2011.10.017; Song EK, 2013, AM J SPORT MED, V41, P2340, DOI 10.1177/0363546513498998; Su WR, 2010, ARTHROSCOPY, V26, P578, DOI 10.1016/j.arthro.2009.09.007; Walch G, 2005, J SHOULDER ELB SURG, V14, P238, DOI 10.1016/j.jse.2004.07.008; Wolf RS, 2005, ARTHROSCOPY, V21, P182, DOI 10.1016/j.arthro.2004.10.014; Xu Y, 2014, KNEE SURG SPORT TR A, V22, P308, DOI 10.1007/s00167-013-2398-y; Zhang Q, 2015, KNEE SURG SPORT TR A, V23, P464, DOI 10.1007/s00167-013-2587-8	44	44	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185788	10.1371/journal.pone.0185788	http://dx.doi.org/10.1371/journal.pone.0185788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016616	gold, Green Submitted, Green Published			2022-12-27	WOS:000412601800023
J	Inomata, T; Mashaghi, A; Hong, JX; Nakao, T; Dana, R				Inomata, Takenori; Mashaghi, Alireza; Hong, Jiaxu; Nakao, Takeshi; Dana, Reza			Scaling and maintenance of corneal thickness during aging	PLOS ONE			English	Article							DRY EYE DISEASE; ULTRASOUND PACHYMETRY; BODY-SIZE; ORGAN SIZE; PREVALENCE; ANATOMY; PROFILE; MICE	Corneal thickness is tightly regulated by its boundary endothelial and epithelial layers. The regulated set-point of corneal thickness likely shows inter-individual variations, changes by age, and response to stress. Using anterior segment-optical coherence tomography, we measure murine central corneal thickness and report on body size scaling of murine central corneal thickness during aging. For aged-matched mice, we find that corneal thickness depends on sex and strain. To shed mechanistic insights into these anatomical changes, we measure epithelial layer integrity and endothelial cell density during the life span of the mice using corneal fluorescein staining and in vivo confocal microscopy, respectively and compare their trends with that of the corneal thickness. Cornea thickness increases initially (1 month: 114.7 +/- 3.0 mu m, 6 months: 126.3 +/- 1.6 mu m), reaches a maximum (9 months: 129.3 +/- 4.4 mu m) and then reduces (12 months: 127 +/- 2.9 mu m, 13 months: 119.5 +/- 7.6 mu m, 14 months: 110.6 +/- 10.6 mu m), while the body size (weight) increases with age. We find that endothelial cell density reduces from 2 months old to 8 months old as the mice age and epithelial layer accumulates damages within this time frame. Finally, we compare murine corneal thickness with those of several other mammals including humans and show that corneal thickness has an allometric scaling with body size. Our results have relevance for organ size regulation, translational pharmacology, and veterinary medicine.	[Inomata, Takenori; Mashaghi, Alireza; Hong, Jiaxu; Nakao, Takeshi; Dana, Reza] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA; [Inomata, Takenori] Juntendo Univ, Fac Med, Dept Ophthalmol, Tokyo, Japan; [Mashaghi, Alireza] Leiden Univ, Fac Math & Nat Sci, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Juntendo University; Leiden University; Leiden University - Excl LUMC	Dana, R (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Schepens Eye Res Inst, Boston, MA 02115 USA.	Reza_Dana@meei.harvard.edu	Inomata, Takenori/L-8210-2019; Mashaghi, Alireza/Q-8218-2017	Inomata, Takenori/0000-0003-3435-1055; Mashaghi, Alireza/0000-0002-2157-1211	National Institutes of Health [EY20889, EY12963]; NATIONAL EYE INSTITUTE [R01EY012963, R01EY020889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health grant EY20889 (RD) and National Institutes of Health grant EY12963 (RD).	Alario AF, 2014, VET OPHTHALMOL, V17, P207, DOI 10.1111/vop.12074; Bapodra P, 2010, J ZOO WILDLIFE MED, V41, P409, DOI 10.1638/2009-0018.1; Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Chen SH, 2012, ACTA OPHTHALMOL, V90, P449, DOI 10.1111/j.1755-3768.2010.01947.x; Chen Y, 2014, MUCOSAL IMMUNOL, V7, P38, DOI 10.1038/mi.2013.20; Chou TH, 2011, INVEST OPHTH VIS SCI, V52, P3604, DOI 10.1167/iovs.10-6340; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Das A, 2015, J ANIM PHYSIOL AN N, V99, P367, DOI 10.1111/jpn.12200; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Detweiler KB, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.19; Doughty MJ, 1995, CAN J ZOOL, V73, P2159, DOI 10.1139/z95-253; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Faber C, 2008, SCAND J LAB ANIM SCI, V35, P39; GILGER BC, 1993, AM J VET RES, V54, P228; Giuseppe Longo MM, 2014, SCALING SCALE SYMMET, P23; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Han SB, 2013, INVEST OPHTH VIS SCI, V54, P6179, DOI 10.1167/iovs.13-12089; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; HYKIN PG, 1992, CORNEA, V11, P334, DOI 10.1097/00003226-199207000-00012; Launer KJ, 1996, AGE AGEING, V25, P300, DOI 10.1093/ageing/25.4.300; Lemp Michael A., 1995, CLAO Journal, V21, P221; Leung DYL, 2006, CLIN EXP OPHTHALMOL, V34, P751, DOI 10.1111/j.1442-9071.2006.01343.x; Li LY, 2006, J R SOC INTERFACE, V3, P303, DOI 10.1098/rsif.2005.0085; Lively GD, 2010, INVEST OPHTH VIS SCI, V51, P160, DOI 10.1167/iovs.09-3429; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P240; Puk O, 2013, MAMM GENOME, V24, P295, DOI 10.1007/s00335-013-9470-2; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Shingleton AW., 2010, NAT ED KNOWL, V3, P2; Siemann E, 1996, NATURE, V380, P704, DOI 10.1038/380704a0; Song Ha Tae, 2007, Korean J Ophthalmol, V21, P163, DOI 10.3341/kjo.2007.21.3.163; Song J, 2003, INVEST OPHTH VIS SCI, V44, P548, DOI 10.1167/iovs.02-0592; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stevens CF, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0123-7; Ueno Y, 2015, OPHTHALMOLOGY, V122, P1072, DOI 10.1016/j.ophtha.2015.01.021; Vaughan D, 2004, VAUGHAN ASBURYS GEN, pv; Wang XG, 2013, VET OPHTHALMOL, V16, P130, DOI 10.1111/j.1463-5224.2012.01041.x; West GB, 2003, NATURE, V421, P713, DOI 10.1038/421713a; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	41	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185694	10.1371/journal.pone.0185694	http://dx.doi.org/10.1371/journal.pone.0185694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985226	Green Published, gold, Green Submitted			2022-12-27	WOS:000412493000009
J	Bordas-Le Floch, V; Le Mignon, M; Bussieres, L; Jain, K; Martelet, A; Baron-Bodo, V; Nony, E; Mascarell, L; Moingeon, P				Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bussieres, Laetitia; Jain, Karine; Martelet, Armelle; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe			A combined transcriptome and proteome analysis extends the allergome of house dust mite Dermatophagoides species	PLOS ONE			English	Article							GRASS-POLLEN; IDENTIFICATION; PTERONYSSINUS; RECONSTRUCTION; EXTRACTS; RHINITIS; GENOME; ASTHMA	Background House dust mites (HDMs) such as Dermatophagoides farinae and D. pteronyssinus represent major causes of perennial allergy. HDM proteomes are currently poorly characterized, with information mostly restricted to allergens. As of today, 33 distinct allergen groups have been identified for these 2 mite species, with groups 1 and 2 established as major allergens. Given the multiplicity of IgE-reactive mite proteins, potential additional allergens have likely been overlooked. Objective To perform a comprehensive characterization of the transcriptomes, proteomes and allergomes of D. farinae and D. pteronyssinus in order to identify novel allergens. Methods Transcriptomes were analyzed by RNA sequencing and de novo assembly. Comprehensive mass spectrometry-based analyses proteomes were combined with two-dimensional IgE reactivity profiling. Results Transcripts from D. farinae and D. pteronyssinus were assembled, translated into protein sequences and used to populate derived sequence databases in order to inform immunoproteomic analyses. A total of 527 and 157 proteins were identified by bottom-up MS analyses in aqueous extracts from purified HDM bodies and fecal pellets, respectively. Based on high sequence similarities (>71% identity), we also identified 2 partial and 11 complete putative sequences of currently undisclosed D. pteronyssinus counterparts of D. farinae registered allergens. Immunoprofiling on 2D-gels revealed the presence of unknown 23 kDa IgE reactive proteins in both species. Following expression of non-glycosylated recombinant forms of these molecules, we confirm that these new allergens react with serum IgEs from 42% (8/19) of HDM-allergic individuals. Conclusions Using combined transcriptome and immunoproteome approaches, we provide a comprehensive characterization of D. farinae and D. pteronyssinus allergomes. We expanded the known allergen repertoire for D. pteronyssinus and identified two novel HDM allergens, now officially referred by the International Union of Immunological Societies (IUIS) Nomenclature Subcommittee as Der f 36 and Der p 36.	[Bordas-Le Floch, Veronique; Le Mignon, Maxime; Bussieres, Laetitia; Jain, Karine; Martelet, Armelle; Baron-Bodo, Veronique; Nony, Emmanuel; Mascarell, Laurent; Moingeon, Philippe] Stallergenes Greer, Antony, France	Stallergenes Greer	Bordas-Le Floch, V (corresponding author), Stallergenes Greer, Antony, France.	veronique.bordas@stallergenesgreer.com		Martelet, Armelle/0000-0002-2348-4648; Nony, Emmanuel/0000-0003-1820-8881	Stallergenes Greer	Stallergenes Greer	This study was supported by Stallergenes Greer which provided support in the form of salaries for authors [VBLF, MLM, LB, KJ, AM, VBB, EN, LM, PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific funding was received for this work. The specific roles of these authors are articulated in the 'author contributions' section.	An S, 2013, MOL CELL PROTEOMICS, V12, P1818, DOI 10.1074/mcp.M112.027136; Angus Aaron Chen, 2004, Am J Pharmacogenomics, V4, P357, DOI 10.2165/00129785-200404060-00003; Batard T, 2016, ALLERGY, V71, P220, DOI 10.1111/all.12796; Batard T, 2006, INT ARCH ALLERGY IMM, V140, P295, DOI 10.1159/000093707; Bessot J C, 2011, Eur Ann Allergy Clin Immunol, V43, P141; Bi XZ, 2004, MOL CELL PROTEOMICS, V3, pS203; Bordas-Le Floch V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136258; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Campbell BC, 2015, J ALLERGY CLIN IMMUN, V135, P133, DOI 10.1016/j.jaci.2014.06.034; Carnes J, 2017, ANN ALLERG ASTHMA IM, V118, P249, DOI 10.1016/j.anai.2016.08.018; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Choopong J, 2016, J PROTEOME RES, V15, P422, DOI 10.1021/acs.jproteome.5b00663; Cui Y, 2016, ALLERGY, V71, P1635, DOI 10.1111/all.12999; ElRamlawy KG, 2016, J BIOL CHEM, V291, P21607, DOI 10.1074/jbc.M116.728006; Erban T, 2014, EXP APPL ACAROL, V65, P73; Evans VC, 2012, NAT METHODS, V9, P1207, DOI [10.1038/nmeth.2227, 10.1038/NMETH.2227]; Fernandez-Caldas E, 2006, CURR ALLERGY ASTHM R, V6, P413, DOI 10.1007/s11882-996-0015-6; Fernandez-Caldas Enrique, 2008, Clin Allergy Immunol, V21, P161; Fujimura T, 2017, ALLERGY; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Moingeon P, 2014, EXPERT REV VACCINES, V13, P1463, DOI 10.1586/14760584.2014.948861; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mueller GA, 2016, CLIN EXP ALLERGY, V46, P365, DOI 10.1111/cea.12680; Pittner G, 2004, CLIN EXP ALLERGY, V34, P597, DOI 10.1111/j.1365-2222.2004.1930.x; Pomes A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0622-9; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Resch Y, 2015, J ALLERGY CLIN IMMUN, V136, P1083, DOI 10.1016/j.jaci.2015.03.024; Rider SD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1198-2; Schulten V, 2013, P NATL ACAD SCI USA, V110, P3459, DOI 10.1073/pnas.1300512110; Spiric J, 2017, CLIN EXP ALLERGY, V47, P604, DOI 10.1111/cea.12931; Thomas WR, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0649-y; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; Trombone APF, 2002, CLIN EXP ALLERGY, V32, P1323, DOI 10.1046/j.1365-2745.2002.01455.x; Weghofer M, 2008, EUR J CLIN INVEST, V38, P959, DOI 10.1111/j.1365-2362.2008.02048.x; Weghofer M, 2005, CLIN EXP ALLERGY, V35, P1384, DOI 10.1111/j.1365-2222.2005.02345.x; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288	41	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185830	10.1371/journal.pone.0185830	http://dx.doi.org/10.1371/journal.pone.0185830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982170	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300073
J	Engelen, T; Watson, R; Pavani, F; de Gelder, B				Engelen, Tahnee; Watson, Rebecca; Pavani, Francesco; de Gelder, Beatrice			Affective vocalizations influence body ownership as measured in the rubber hand illusion	PLOS ONE			English	Article							EMOTION; EXCITABILITY; STIMULI; CAPTURE; THREAT; TOUCH	Emotional signals, like threatening sounds, automatically ready the perceiver to prepare an appropriate defense behavior. Conjecturing that this would manifest itself in extending the safety zone around the body we used the rubber hand illusion (RHI) to test this prediction. The RHI is a perceptual illusion in which body ownership is manipulated by synchronously stroking a rubber hand and real hand occluded from view. Many factors, both internal and external, have been shown to influence the strength of the illusion, yet the effect of emotion perception on body ownership remains unexplored. We predicted that listening to affective vocalizations would influence how strongly participants experience the RHI. In the first experiment four groups were tested that listened either to affective sounds (angry or happy vocalizations), non-vocal sounds or no sound while undergoing synchronous or asynchronous stroking of the real and rubber hand. In a second experiment three groups were tested comparing angry or neutral vocalizations and no sound condition. There was a significantly larger drift towards the rubber hand in the emotion versus the no emotion conditions. We interpret these results in the framework that the spatial increase in the RHI indicates that under threat the body has the capacity to extend its safety zone.	[Engelen, Tahnee; Watson, Rebecca; de Gelder, Beatrice] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Pavani, Francesco] Univ Trento, Dept Psychol & Cognit Sci, Trento, Italy	Maastricht University; University of Trento	de Gelder, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	b.degelder@maastrichtuniversity.nl	Engelen, Tahnée/Q-3615-2019	Engelen, Tahnée/0000-0001-9285-8968	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant [295673]; Teaching Staff Mobility fellowship - LPP/Erasmus program [2013-1-IT2-ERA02-53126]	European Research Council under the European Union's Seventh Framework Programme (FP7)/ERC Grant(European Research Council (ERC)); Teaching Staff Mobility fellowship - LPP/Erasmus program	TE, RW and BdG are supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 295673. FP was supported by a Teaching Staff Mobility fellowship funded by the LPP/Erasmus program (2013-1-IT2-ERA02-53126).	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Banissy MJ, 2010, J NEUROSCI, V30, P13552, DOI 10.1523/JNEUROSCI.0786-10.2010; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Borgomaneri S, 2015, CORTEX, V65, P232, DOI 10.1016/j.cortex.2015.01.014; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Vignemont F, 2017, SUBJECTS MATTER BODI; Engelen T, 2015, CORTEX, V73, P195, DOI 10.1016/j.cortex.2015.08.013; Flogel M, 2016, PSYCHOL RES-PSYCH FO, V80, P298, DOI 10.1007/s00426-015-0650-4; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; IJsselsteijn WA, 2006, PRESENCE-TELEOP VIRT, V15, P455, DOI 10.1162/pres.15.4.455; in 't Veld EMJH, 2014, SOC NEUROSCI-UK, V9, P249, DOI 10.1080/17470919.2014.890668; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; Komeilipoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063060; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Roelofs K, 2010, PSYCHOL SCI, V21, P1575, DOI 10.1177/0956797610384746; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006	31	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186009	10.1371/journal.pone.0186009	http://dx.doi.org/10.1371/journal.pone.0186009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982176	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300106
J	Iamartino, D; Nicolazzi, EL; Van Tassell, CP; Reecy, JM; Fritz-Waters, ER; Koltes, JE; Biffani, S; Sonstegard, TS; Schroeder, SG; Ajmone-Marsan, P; Negrini, R; Pasquariello, R; Ramelli, P; Coletta, A; Garcia, JF; Ali, A; Ramunno, L; Cosenza, G; de Oliveira, DAA; Drummond, MG; Bastianetto, E; Davassi, A; Pirani, A; Brew, F; Williams, JL				Iamartino, Daniela; Nicolazzi, Ezequiel L.; Van Tassell, Curtis P.; Reecy, James M.; Fritz-Waters, Eric R.; Koltes, James E.; Biffani, Stefano; Sonstegard, Tad S.; Schroeder, Steven G.; Ajmone-Marsan, Paolo; Negrini, Riccardo; Pasquariello, Rolando; Ramelli, Paola; Coletta, Angelo; Garcia, Jose F.; Ali, Ahmad; Ramunno, Luigi; Cosenza, Gianfranco; de Oliveira, Denise A. A.; Drummond, Marcela G.; Bastianetto, Eduardo; Davassi, Alessandro; Pirani, Ali; Brew, Fiona; Williams, John L.			Design and validation of a 90K SNP genotyping assay for the water buffalo (Bubalus bubalis)	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; PREDICTION; LOCI	Background The availability of the bovine genome sequence and SNP panels has improved various genomic analyses, from exploring genetic diversity to aiding genetic selection. However, few of the SNP on the bovine chips are polymorphic in buffalo, therefore a panel of single nucleotide DNA markers exclusive for buffalo was necessary for molecular genetic analyses and to develop genomic selection approaches for water buffalo. The creation of a 90K SNP panel for river buffalo and testing in a genome wide association study for milk production is described here. Methods The genomes of 73 buffaloes of 4 different breeds were sequenced and aligned against the bovine genome, which facilitated the identification of 22 million of sequence variants among the buffalo genomes. Based on frequencies of variants within and among buffalo breeds, and their distribution across the genome, inferred from the bovine genome sequence, 90,000 putative single nucleotide polymorphisms were selected to create an Axiom (R) Buffalo Genotyping Array 90K. Results This 90K "SNP-Chip" was tested in several river buffalo populations and found to have similar to 70% high quality and polymorphic SNPs. Of the 90K SNPs about 24K were also found to be polymorphic in swamp buffalo. The SNP chip was used to investigate the structure of buffalo populations, and could distinguish buffalo from different farms. A Genome Wide Association Study identified genomic regions on 5 chromosomes putatively involved in milk production. Conclusion The 90K buffalo SNP chip described here is suitable for the analysis of the genomes of river buffalo breeds, and could be used for genetic diversity studies and potentially as a starting point for genome-assisted selection programmes. This SNP Chip could also be used to analyse swamp buffalo, but many loci are not informative and creation of a revised SNP set specific for swamp buffalo would be advised.	[Iamartino, Daniela; Negrini, Riccardo] AIA LGS, Cremona, Italy; [Iamartino, Daniela; Biffani, Stefano; Pasquariello, Rolando; Ramelli, Paola] Fdn Parco Tecnol Padano, Lodi, Italy; [Nicolazzi, Ezequiel L.] Parco Tecnol Padano, Bioinformat Core, Lodi, Italy; [Van Tassell, Curtis P.; Sonstegard, Tad S.; Schroeder, Steven G.] USDA ARS, Anim Genom & Improvement Lab, BARC, Beltsville, MD USA; [Reecy, James M.; Fritz-Waters, Eric R.; Koltes, James E.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Negrini, Riccardo] Univ Cattolica S Cuore, Inst Zootech, Piacenza, Italy; [Coletta, Angelo] ANASB, Centurano Caserta, Italy; [Garcia, Jose F.] Univ Estadual Paulista, UNESP, Campus Aracatuba, Sao Paulo, Brazil; [Ali, Ahmad] COMSATS Inst Informat Technol, Sahiwal, Pakistan; [Ramunno, Luigi; Cosenza, Gianfranco] Univ Napoli Federico II, Fac Agr, Dipartimento Sci Zootecn & Ispez Alimenti, Portici, NA, Italy; [de Oliveira, Denise A. A.; Drummond, Marcela G.; Bastianetto, Eduardo] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Davassi, Alessandro; Pirani, Ali; Brew, Fiona] Affymetrix UK Ltd, High Wycombe, Bucks, England; [Williams, John L.] Univ Adelaide, Sch Anim & Vet Sci, Davies Res Ctr, Roseworthy, SA, Australia; [Koltes, James E.] Univ Arkansas, Dept Anim Sci, Fayetteville, AR 72701 USA; [Sonstegard, Tad S.] Recombinetics Inc, St Paul, MN USA; [Nicolazzi, Ezequiel L.] Council Dairy Cattle Breeding, 4201 Northview Dr One Town Ctr, Bowie, MD USA	United States Department of Agriculture (USDA); Iowa State University; Catholic University of the Sacred Heart; Universidade Estadual Paulista; COMSATS University Islamabad (CUI); University of Naples Federico II; Universidade Federal de Minas Gerais; University of Adelaide; University of Arkansas System; University of Arkansas Fayetteville	Iamartino, D (corresponding author), AIA LGS, Cremona, Italy.; Iamartino, D (corresponding author), Fdn Parco Tecnol Padano, Lodi, Italy.	iamartino.d@aia.it	Pasquariello, Rolando/M-2347-2019; Van Tassell, Curtis P./O-4247-2019; Pasquariello, Rolando/O-3998-2018; Biffani, Stefano/X-8264-2019	Pasquariello, Rolando/0000-0003-3191-7009; Van Tassell, Curtis P./0000-0002-8416-2087; Pasquariello, Rolando/0000-0003-3191-7009; Biffani, Stefano/0000-0001-5559-3630; NEGRINI, Riccardo/0000-0002-8735-0286	International-cooperation ASTIL BuffaloSNP project Italy-Brazil [16978, AGR0-09]; MIUR (Italian Ministry for Instruction, University and Research) project GenHome: Technological Resort for the advancement of animal genomic research	International-cooperation ASTIL BuffaloSNP project Italy-Brazil; MIUR (Italian Ministry for Instruction, University and Research) project GenHome: Technological Resort for the advancement of animal genomic research(Ministry of Education, Universities and Research (MIUR))	This study has been funded by the International-cooperation ASTIL BuffaloSNP project Italy-Brazil (Award Number: ID 16978 and Ref. N. AGR0-09, Regione Lombardia, Italy) and by the MIUR (Italian Ministry for Instruction, University and Research) project GenHome: Technological Resort for the advancement of animal genomic research. There was no additional external funding received for this study.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barker JSF, 1997, ANIM GENET, V28, P103, DOI 10.1111/j.1365-2052.1997.00085.x; Bernardes O, 2007, ITALIAN J ANIMA 1 S2, V6; Borghese A, 2011, 9 ENC BRAS BUB SANT; Borghese A, 2014, BUFFALO LIVESTOCK WO; Borghese A., 2005, REU TECHNICAL SERIES, V67, P1; Breuer, 2013, NUCLEIC ACIDS RES, V41, pD1; Brew F, 2014, 22 PAG PLANT AN C SA; Cruz L.C., 2009, WARTAZOA 2009, V19; Cruz LC, 2007, ITALIAN J ANIMA 1 S2, V6; Dhorne-Pollet S, 2012, ANIM GENET, V43, P199, DOI 10.1111/j.1365-2052.2011.02237.x; Eggen A, 2012, ANIMAL FRONTIERS, V2; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Goddard ME, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0569; Green MR, 2012, MOL CLONING LAB MANU, V1; IANNUZZI L, 1987, HEREDITAS, V106, P73, DOI 10.1111/j.1601-5223.1987.tb00238.x; Kolbehdari D., 2009, J ANIM BREED GENET; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luan T, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0064-6; Maltecca C, 2014, P 10 WORLD C GEN APP; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nicolazzi EL, 2014, BIOINFORMATICS, V30, P3118, DOI 10.1093/bioinformatics/btu486; Prothero DR, 2002, HORNS TUSKS FLIPPERS, P87; Scherf B.D., 2015, 2 FAO COMM GEN RES F; SHACKLETON D., 2003, GRZIMEKS ANIMAL LIFE, V16, P11; Sullivan P. G., 2009, INTERBULL B, V40, P157; Tanaka K, 1996, BIOCHEM GENET, V34, P443, DOI 10.1007/BF00570125; Tantia MS, 2011, INDIAN J ANIM SCI, V81, P465; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VanRaden PM, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-7; Yang B, 2007, ITALIAN J ANIMA 1 S2, V6; Yindee M, 2010, ANIM GENET, V41, P433, DOI 10.1111/j.1365-2052.2010.02020.x; Zimin A, 2013, BIOINFORMATICS	36	46	47	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185220	10.1371/journal.pone.0185220	http://dx.doi.org/10.1371/journal.pone.0185220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981529	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300029
J	Ingerslev, AK; Mutt, SJ; Laerke, HN; Hedemann, MS; Theil, PK; Nielsen, KL; Jorgensen, H; Herzig, KH; Knudsen, KEB				Ingerslev, Anne Krog; Mutt, Shivaprakash Jagalur; Laerke, Helle Nygaard; Hedemann, Mette Skou; Theil, Peter Kappel; Nielsen, Kirstine Lykke; Jorgensen, Henry; Herzig, Karl-Heinz; Knudsen, Knud Erik Bach			Postprandial PYY increase by resistant starch supplementation is independent of net portal appearance of short-chain fatty acids in pigs	PLOS ONE			English	Article							WHOLE-WHEAT GRAIN; PEPTIDE-YY; SMALL-INTESTINE; NEURAL REGULATION; RYE INGREDIENTS; DIETARY FIBER; GUT HORMONES; RELEASE; GLUCOSE; FERMENTATION	Increased dietary fiber (DF) fermentation and short-chain fatty acid (SCFA) production may stimulate peptide tyrosine-tyrosine (PYY) secretion. In this study, the effects of hindgut SCFA production on postprandial PYY plasma levels were assessed using different experimental diets in a porto-arterial catheterized pig model. The pigs were fed experimental diets varying in source and levels of DF for one week in 3x3 Latin square designs. The DF sources were whole-wheat grain, wheat aleurone, rye aleurone-rich flour, rye flakes, and resistant starch. Postprandial blood samples were collected from the catheters and analyzed for PYY levels and net portal appearance (NPA) of PYY was correlated to NPA of SCFA. No significant effects of diets on NPA of PYY were observed (P > 0.05), however, resistant starch supplementation increased postprandial NPA of PYY levels by 37 to 54% compared with rye-based and Western-style control diets (P = 0.19). This increase was caused by higher mesenteric artery and portal vein PYY plasma levels (P < 0.001) and was independent of SCFA absorption (P > 0.05). The PYY levels were higher in response to the second daily meal compared with the first daily meal (P < 0.001), but similar among diets (P > 0.10). In conclusion, the increased postprandial PYY responses in pigs fed with different levels and sources of DF are not caused by an increased SCFA absorption and suggest that other mechanisms such as neural reflexes and possibly an increased flow of digesta in the small intestine may be involved. The content of DF and SCFA production did not affect PYY levels.	[Ingerslev, Anne Krog; Laerke, Helle Nygaard; Hedemann, Mette Skou; Theil, Peter Kappel; Nielsen, Kirstine Lykke; Jorgensen, Henry; Knudsen, Knud Erik Bach] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Mutt, Shivaprakash Jagalur; Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Res Unit Biomed, Oulu, Finland; [Mutt, Shivaprakash Jagalur; Herzig, Karl-Heinz] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Poznan, Poland; [Herzig, Karl-Heinz] Med Res Ctr, Oulu, Finland; [Herzig, Karl-Heinz] Univ Hosp, Oulu, Finland; [Nielsen, Kirstine Lykke] Aarhus Univ, Dept Forens Med, Forens Chem, Aarhus N, Denmark	Aarhus University; University of Oulu; University of Oulu; Poznan University of Medical Sciences; Aarhus University	Knudsen, KEB (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	KnudErik.Bach.Knudsen@anis.au.dk	Nielsen, Kirstine/ABE-4989-2020; Mutt, Shivaprakash Jagalur/AAC-9768-2019; Lærke, Helle Nygaard/D-9882-2011	Nielsen, Kirstine/0000-0002-5955-6156; Mutt, Shivaprakash Jagalur/0000-0001-8285-551X; Lærke, Helle Nygaard/0000-0002-0303-0745; Hedemann, Mette Skou/0000-0002-1164-4405; Ingerslev, Anne Krog/0000-0001-5151-9548	Danish Strategic Research Council [10-093526]; European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN [FOOD-CT-2005-514008]	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN	The present research projects were financially supported by The Danish Strategic Research Council, project "Concepts for enhanced butyrate production to improve colonic health and insulin sensitivity ButColns" (Project No. 10-093526), and by the European Commission in the Communities Sixth Framework Programme, Project HEALTHGRAIN (FOOD-CT-2005-514008) to KEBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam CL, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-36; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; BECKH K, 1992, REGUL PEPTIDES, V37, P205, DOI 10.1016/0167-0115(92)90615-2; Boey D, 2007, PEPTIDES, V28, P390, DOI 10.1016/j.peptides.2006.07.031; Brouns F, 2002, TRENDS FOOD SCI TECH, V13, P251, DOI 10.1016/S0924-2244(02)00131-0; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cho HJ, 2015, CELL TISSUE RES, V359, P693, DOI 10.1007/s00441-014-2033-3; Cuche G, 2000, AM J PHYSIOL-GASTR L, V279, pG925, DOI 10.1152/ajpgi.2000.279.5.G925; da Silva CS, 2014, ANIMAL, V8, P1402, DOI 10.1017/S1751731114001116; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Gemen R, 2011, NUTR REV, V69, P22, DOI 10.1111/j.1753-4887.2010.00357.x; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hooda S, 2010, J NUTR, V140, P1564, DOI 10.3945/jn.110.122721; Ingerslev AK, 2014, BRIT J NUTR, V111, P1564, DOI 10.1017/S0007114513004066; Juvonen KR, 2011, NUTR METAB CARDIOVAS, V21, P748, DOI 10.1016/j.numecd.2010.02.002; Juvonen KR, 2009, J NUTR, V139, P461, DOI 10.3945/jn.108.099945; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Karhunen LJ, 2008, REGUL PEPTIDES, V149, P70, DOI 10.1016/j.regpep.2007.10.008; Karhunen LJ, 2010, J NUTR, V140, P737, DOI 10.3945/jn.109.115436; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Keenan MJ, 2012, J NUTRIGENET NUTRIGE, V5, P26, DOI 10.1159/000335319; Le Gall M, 2009, BRIT J NUTR, V102, P1590, DOI 10.1017/S0007114509990924; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nielsen TS, 2014, BRIT J NUTR, V112, P1837, DOI 10.1017/S000711451400302X; Nielsen TS, 2015, J AGR FOOD CHEM; Nilsson AC, 2015, BR J NUTR, P1; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Regmi PR, 2011, J NUTR, V141, P398, DOI 10.3945/jn.110.132449; Reimer RA, 2012, J PROTEOME RES, V11, P4065, DOI 10.1021/pr300487s; RERAT AA, 1984, BRIT J NUTR, V51, P517, DOI 10.1079/BJN19840057; Sandberg JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151985; SHEIKH SP, 1989, REGUL PEPTIDES, V26, P253, DOI 10.1016/0167-0115(89)90193-6; Slavin J, 2007, NUTR BULL, V32, P32, DOI 10.1111/j.1467-3010.2007.00603.x; Smith CE, 2011, NUTR RES REV, V24, P118, DOI 10.1017/S0954422411000023; Svendsen B, 2015, ENDOCRINOLOGY, V156, P847, DOI 10.1210/en.2014-1710; Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715; van der Wielen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107531; Voortman T, 2012, J AGR FOOD CHEM, V60, P9035, DOI 10.1021/jf2045697; Wewer Albrechtsen Nicolai J, 2016, BMC Res Notes, V9, P60, DOI 10.1186/s13104-016-1872-2; ZHANG T, 1993, REGUL PEPTIDES, V48, P321, DOI 10.1016/0167-0115(93)90160-A; Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008	48	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185927	10.1371/journal.pone.0185927	http://dx.doi.org/10.1371/journal.pone.0185927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982156	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300090
J	Jia, LQ; Tu, TY; Huai, QQ; Sun, JW; Chen, SS; Li, X; Shi, ZP; Ding, J				Jia, Luqiang; Tu, Tingyong; Huai, Qiangqiang; Sun, Jiaowen; Chen, Shanshan; Li, Xin; Shi, Zhongping; Ding, Jian			Enhancing monellin production by Pichia pastoris at low cell induction concentration via effectively regulating methanol metabolism patterns and energy utilization efficiency	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; PORCINE INTERFERON; SWEET; DEHYDROGENASE; FERMENTATION; PURIFICATION; PROMOTER; STRATEGY	In heterologous protein productions by P. pastoris, methanol induction is generally initiated when cell concentration reaches very high density. The alternative strategy by initiating methanol induction at lower cells concentration was also reported to be effective in easing DO control, reducing toxic by-metabolites accumulation and increasing targeted proteins titers. However, the methanol/energy regulation mechanisms are seldom reported. We theoretically analyzed the methanol/energy metabolisms in protein expression process with the strategies of initiating induction at higher or lower cells concentrations, using monellin production as a prototype. When initiating induction at lower cells concentration and controlling induction temperature at 30 degrees C, monellin concentration reached the highest levels of 2.62 similar to 2.71 g/L, which was 2.5 similar to 4.9 fold of those obtained with the strategy of initiating induction at higher cells concentration. With the desired induction strategy, 1) carbon metabolism ratio directing into the precursors synthesis route for monellin production reached the highest level of 65%, carbon metabolism ratios towards to precursors synthesis and ATP regeneration routes were regulated at relatively balanced levels; 2) monellin synthesis was completely cell growth associated, with the largest associated coefficient and higher specific growth rate; 3) theoretical NADH (energy) utilization efficiency. was the highest, and. stayed high levels (>= 0.8) during most period (89%) within induction phase to supply sufficient energy in supporting monellin synthesis.	[Jia, Luqiang; Tu, Tingyong; Huai, Qiangqiang; Sun, Jiaowen; Chen, Shanshan; Shi, Zhongping; Ding, Jian] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Li, Xin] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China	Jiangnan University; Wuhan Polytechnic University	Shi, ZP; Ding, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	zpshi@jiangnan.edu.cn; dingjian@jiangnan.edu.cn	Shi, Zhongping/K-9884-2019	Jia, Luqiang/0000-0001-5738-2423	Natural Science Foundation of China [21606106]; Natural Science Foundation of Jiangsu Province [BK20150127, BK20160162]; 111 Project of China [111-2-06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by Natural Science Foundation of China (#21606106), Natural Science Foundation of Jiangsu Province (#BK20150127, #BK20160162) and the 111 Project (#111-2-06) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the financial supports by Natural Science Foundation of China (#21606106), Natural Science Foundation of Jiangsu Province (#BK20150127, #BK20160162) and the 111 Project (#111-2-06) of China.	Celik E, 2010, BIOTECHNOL BIOENG, V105, P317, DOI 10.1002/bit.22543; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Charoenrat T, 2005, BIOPROC BIOSYST ENG, V27, P399, DOI 10.1007/s00449-005-0005-4; Chen ZJ, 2007, APPL MICROBIOL BIOT, V73, P1377, DOI 10.1007/s00253-006-0609-x; Ding J, 2014, J CHEM TECHNOL BIOT, V89, P1948, DOI 10.1002/jctb.4281; Ding J, 2014, CHEM IND CHEM ENG Q, V20, P29, DOI 10.2298/CICEQ120704097D; Gao MJ, 2011, KOREAN J CHEM ENG, V28, P1412, DOI 10.1007/s11814-010-0527-6; Gunes H, 2016, J CHEM TECHNOL BIOT, V91, P664, DOI 10.1002/jctb.4619; Guo YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089264; Hong F, 2002, BIOTECHNOL BIOENG, V79, P438, DOI 10.1002/bit.10297; Jahic M, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-6; Jia DX, 2013, BIOPROC BIOSYST ENG, V36, P1095, DOI 10.1007/s00449-012-0863-5; Jin H, 2011, APPL BIOCHEM BIOTECH, V165, P559, DOI 10.1007/s12010-011-9275-2; Jin H, 2010, BIOCHEM ENG J, V52, P91, DOI 10.1016/j.bej.2010.07.009; Jin S, 1995, J FERMENT BIOENG, V80, P541, DOI 10.1016/0922-338X(96)87729-4; Jungo C, 2007, J BIOTECHNOL, V131, P57, DOI 10.1016/j.jbiotec.2007.05.019; Lee CY, 2003, PROCESS BIOCHEM, V38, P1147, DOI 10.1016/S0032-9592(02)00280-7; Leone S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0299-0; Liu J, 2014, J SCI FOOD AGR, V95, P2646; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Masuda T, 2006, J BIOSCI BIOENG, V102, P375, DOI 10.1263/jbb.102.375; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; SCHUTTE H, 1976, EUR J BIOCHEM, V62, P151, DOI 10.1111/j.1432-1033.1976.tb10108.x; SUYE S, 1990, AGR BIOL CHEM TOKYO, V54, P1297, DOI 10.1080/00021369.1990.10870130; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; Wang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120458; Wang HL, 2012, BIORESOURCE TECHNOL, V124, P338, DOI 10.1016/j.biortech.2012.08.027; Xu AC, 2011, CHINA BREWING, V2, P117	29	6	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184602	10.1371/journal.pone.0184602	http://dx.doi.org/10.1371/journal.pone.0184602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981536	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300015
J	Li, XY; Zhu, LJ; Su, YY; Fang, SK				Li, Xinyuan; Zhu, Lijun; Su, Yingying; Fang, Shaokuan			Short-term efficacy and tolerability of venlafaxine extended release in adults with generalized anxiety disorder without depression: A meta-analysis	PLOS ONE			English	Article							POOLED ANALYSIS; DOUBLE-BLIND; SOMATIC SYMPTOMS; DSM-IV; PLACEBO; XR; OUTPATIENTS; DULOXETINE; SAFETY; IMPROVEMENT	Background Although efficacy of venlafaxine extended release (XR) for generalized anxiety disorder (GAD) has been reported in previous analyses in 2002 and 2004, the sample size was rather small and estimate of safety or tolerability was not clear. The present analysis had the advantage of large sample size and provided evidence for tolerability. Methods Literature databases were searched, including Pubmed, Embase, Cochrane Central Register of Controlled Trials, Web of science and clinical trials. 10 eligible articles were finally selected and data was extracted and logged into the Review Manager 5.3 by two independent authors. The risk of bias was evaluated by the Cochrane Collaboration's Risk of Bias Tool and the stability of the results was assessed by sensitivity analysis. The publication bias was assessed by funnel plot and Egger's/Begg's test using Stata Version 12.0 software. Results In the current meta-analysis, 10 articles (14 studies) satisfying the inclusion criteria were analyzed. As efficacy outcomes, our findings indicated venlafaxine XR was significantly more effective than placebo according to mean change of the Hamilton Rating Scale for Anxiety total scores [mean difference = 3.31, 95% confidence interval(CI) 1.44-5.18, P = 0.0005], response [odds ratio(OR) = 1.83, 95% CI 1.58-2.12, P< 0.00001], and remission (OR = 2.55, 95% CI 1.36-4.78, P = 0.003). In terms of tolerability, the most frequently reported treatment-emergent adverse events were nausea, dry mouth, dizziness, insomnia, somnolence, and headache. In addition, discontinuation due to all-cause (OR = 1.17, 95% CI 0.92-1.49, P = 0.19) was not significantly different between the two groups, whereas discontinuation due to adverse events was statistically higher in the venlafaxine XR group compared with the placebo treatment (OR = 2.80, 95% CI 2.21-3.54, P< 0.00001) and discontinuation due to inefficacy was lower in venlafaxine than placebo treatment (OR = 0.26, 95% CI 0.17-0.40, P< 0.00001). There was no significant publication bias and sensitivity analysis showed that our analysis exhibited high stability. Conclusion We concluded that venlafaxine XR (75-225 mg/day) is an effective and well-tolerated pharmacological treatment option for adult patients with GAD.	[Li, Xinyuan; Fang, Shaokuan] Jilin Univ, Teaching Hosp 1, Neurosci Ctr, Dept Neurol, Changchun, Jilin, Peoples R China; [Zhu, Lijun] Jilin Univ, China Japan Union Hosp, Changchun, Jilin, Peoples R China; [Su, Yingying] Jilin Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Fang, SK (corresponding author), Jilin Univ, Teaching Hosp 1, Neurosci Ctr, Dept Neurol, Changchun, Jilin, Peoples R China.	fang20063536@sina.com			National Natural Science Foundation of China [81471216, 81671186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No 81471216, No 81671186).	Allgulander C, 2008, J PSYCHOPHARMACOL, V22, P417, DOI 10.1177/0269881108091588; Ballenger JC, 1999, J CLIN PSYCHIAT, V60, P29; Bose A, 2008, DEPRESS ANXIETY, V25, P854, DOI 10.1002/da.20355; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cuijpers P, 2014, CLIN PSYCHOL REV, V34, P130, DOI 10.1016/j.cpr.2014.01.002; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P528, DOI 10.4088/JCP.v60n0805; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Furukawa TA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010919; Hackett D, 2003, EUR PSYCHIAT, V18, P182, DOI 10.1016/S0924-9338(03)00046-4; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hartford J, 2007, INT CLIN PSYCHOPHARM, V22, P167, DOI 10.1097/YIC.0b013e32807fb1b2; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kasper S, 2009, INT CLIN PSYCHOPHARM, V24, P87, DOI 10.1097/YIC.0b013e32831d7980; Katz IR, 2002, J AM GERIATR SOC, V50, P18, DOI 10.1046/j.1532-5415.2002.50003.x; Mavranezouli I, 2013, PHARMACOECONOMICS, V31, P317, DOI 10.1007/s40273-013-0031-z; Meoni P, 2004, DEPRESS ANXIETY, V19, P127, DOI 10.1002/da.10141; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montgomery SA, 2006, J CLIN PSYCHIAT, V67, P771, DOI 10.4088/JCP.v67n0511; Newman MG, 2013, ANNU REV CLIN PSYCHO, V9, P275, DOI 10.1146/annurev-clinpsy-050212-185544; Nicolini H, 2009, PSYCHOL MED, V39, P267, DOI 10.1017/S0033291708003401; Nimatoudis I, 2004, INT CLIN PSYCHOPHARM, V19, P331, DOI 10.1097/00004850-200411000-00003; Okuyama Y, 2016, NEUROPSYCH DIS TREAT, V12, P3221, DOI 10.2147/NDT.S125367; Pae CU, 2015, J PSYCHIATR RES, V64, P88, DOI 10.1016/j.jpsychires.2015.02.017; Pollack MH, 2003, J CLIN PSYCHOPHARM, V23, P250, DOI 10.1097/00004714-200306000-00006; Rickels K, 2000, AM J PSYCHIAT, V157, P968, DOI 10.1176/appi.ajp.157.6.968; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stahl SM, 2007, CNS SPECTRUMS, V12, P703, DOI 10.1017/S1092852900021544; Wang FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166833; Zhang YB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175708; Zhu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176068; Zou C, 2013, NEUROPSYCH DIS TREAT, V9, P1661, DOI 10.2147/NDT.S38899	31	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185865	10.1371/journal.pone.0185865	http://dx.doi.org/10.1371/journal.pone.0185865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982121	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300077
J	Mouthier, TMB; Kilic, B; Vervoort, P; Gruppen, H; Kabel, MA				Mouthier, Thibaut M. B.; Kilic, Baris; Vervoort, Pieter; Gruppen, Harry; Kabel, Mirjam A.			Potential of a gypsum-free composting process of wheat straw for mushroom production	PLOS ONE			English	Article							AQUEOUS-AMMONIA; ENZYMATIC-HYDROLYSIS; AGARICUS-BISPORUS; PRETREATMENT; LIGNIN; FERMENTATION; CONVERSION; PYROLYSIS; GROWTH; SUGARS	Wheat straw based composting generates a selective substrate for mushroom production. The first phase of this process requires 5 days, and a reduction in time is wished. Here, we aim at understanding the effect of gypsum on the duration of the first phase and the mechanism behind it. Hereto, the regular process with gypsum addition and the same process without gypsum were studied during a 5-day period. The compost quality was evaluated based on compost lignin composition analysed by py-GC/MS and its degradability by a commercial (hemi-) cellulolytic enzyme cocktail. The composting phase lead to the decrease of the pyrolysis products 4-vinylphenol and 4-vinylguaiacol that can be associated with p-coumarates and ferulates linking xylan and lignin. In the regular compost, the enzymatic conversion reached 32 and 39% for cellulose, and 23 and 32% for xylan after 3 and 5 days, respectively. In absence of gypsum similar values were reached after 2 and 4 days, respectively. Thus, our data show that in absence of gypsum the desired compost quality was reached 20% earlier compared to the control process.	[Mouthier, Thibaut M. B.; Kilic, Baris; Gruppen, Harry; Kabel, Mirjam A.] Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands; [Vervoort, Pieter] CNC Grondstoffen BV, Milsbeek, Netherlands	Wageningen University & Research	Kabel, MA (corresponding author), Wageningen Univ & Res, Lab Food Chem, Wageningen, Netherlands.	mirjam.kabel@wur.nl	Kabel, Mirjam/M-1051-2016	Kabel, Mirjam/0000-0002-2787-7852	Netherlands Organisation for Scientific Research (NWO) [05324104]; Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work described in this manuscript was performed at the Laboratory of Food Chemistry, Wageningen University, The Netherlands. TM, BK, GH and MK were financially supported by the Netherlands Organisation for Scientific Research (NWO) (grant number 05324104), C4C Holding BV (the Netherlands), Royal DSM and CNC holding, and DSM (The Netherlands). PV (C4C) helped in sample collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by The Netherlands Organisation for Scientific Research (NWO), Royal DSM and CNC holding.	Camarero S, 2001, J ANAL APPL PYROL, P58; Collins SRA, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0121-y; de Wild PJ, 2012, J ANAL APPL PYROL, V93, P95, DOI 10.1016/j.jaap.2011.10.002; del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; ENGLYST HN, 1984, ANALYST, V109, P937, DOI 10.1039/an9840900937; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Gerrits J. P. G., 1988, NUTR COMPOST CULTIVA, P206; Huyen TLN, 2010, BIORESOURCE TECHNOL, V101, P8224, DOI 10.1016/j.biortech.2010.05.087; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538, DOI 10.1128/AEM.60.5.1538-1546.1994; JONES D. B., 1931, U.S. Dept. Agric., Circular; Jurak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138909; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kim TH, 2005, APPL BIOCHEM BIOTECH, V121, P1119; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; KORMELINK FJM, 1993, CARBOHYD RES, V249, P355, DOI 10.1016/0008-6215(93)84100-K; Li XA, 2011, BIORESOURCE TECHNOL, V102, P4779, DOI 10.1016/j.biortech.2011.01.008; Liu ZG, 2013, BIORESOURCE TECHNOL, V135, P23, DOI 10.1016/j.biortech.2012.10.133; Maheshwari R, 2000, MICROBIOL MOL BIOL R, V64, P461, DOI 10.1128/MMBR.64.3.461-488.2000; Martinez AT, 2001, J ANAL APPL PYROL, V58, P401, DOI 10.1016/S0165-2370(00)00116-9; Martinez PM, 2016, BIORESOURCE TECHNOL, V216, P44, DOI 10.1016/j.biortech.2016.05.040; MILLER FC, 1991, AUST J EXP AGR, V31, P415, DOI 10.1071/EA9910415; Moretti MMS, 2012, BRAZ J MICROBIOL, V43, P1062, DOI [10.1590/S1517-83822012000300032, 10.1590/S1517-838220120003000032]; Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270; Prasad S, 2007, RESOUR CONSERV RECY, V50, P1, DOI 10.1016/j.resconrec.2006.05.007; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Remond C, 2010, BIORESOURCE TECHNOL, V101, P6712, DOI 10.1016/j.biortech.2010.03.115; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; Talebnia F, 2010, BIORESOURCE TECHNOL, V101, P4744, DOI 10.1016/j.biortech.2009.11.080; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; Yang Q, 2010, J ANAL APPL PYROL, V87, P65, DOI 10.1016/j.jaap.2009.10.006; Yang Z, 2014, BIORESOURCE TECHNOL, V173, P198, DOI 10.1016/j.biortech.2014.09.109	32	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185901	10.1371/journal.pone.0185901	http://dx.doi.org/10.1371/journal.pone.0185901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982119	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300082
J	Romaszko, E; Marzec-Wroblewska, U; Badura, A; Bucinski, A				Romaszko, Ewa; Marzec-Wroblewska, Urszula; Badura, Anna; Bucinski, Adam			Does consumption of red grapefruit juice alter naringenin concentrations in milk produced by breastfeeding mothers?	PLOS ONE			English	Article							ORANGE JUICE; FOOD SOURCES; FLAVANONES; HESPERETIN; HUMANS; BIOAVAILABILITY; FLAVONOLS; EXCRETION; EXPOSURE	The content of certain ingredients of human milk, such as flavonoids, depend on the types and amounts of plant products consumed and may vary from woman to woman. The aim of the study was to determine to what extent consumption of an average amount of grapefruit juice (250 ml) affected naringenin content in human milk. A total of 14 breastfeeding mothers were included in the study. The subjects remained on a diet with restricted intake of naringenin for a total of five days except on the third day, when they drank a single serving of 250 ml of grapefruit juice. A considerable subject-to-subject variability in naringenin content was observed in both initial and subsequent determinations. Baseline concentration values, which may reflect naringenin content in the milk produced by the breastfeeding mother who eat an everyday (unmodified) diet, ranged from 420.86 nmol/l to 1568.89 nmol/l, with a mean of 823.24 nmol/l. Switching to the modified diet resulted in a decrease in naringenin concentrations to the mean value of 673.89 nmol/l measured 48 hours after the switch. The highest mean values were observed four and 12 hours after consumption of the juice, equalling l908.25 nmol/l (SD +/- 676.84 nmol/l) and 868.96 nmol/l (SD +/- 665.54 nmol/l), respectively. Naringenin is commonly found in human milk in quantities expressed in nmol/l, and its concentrations vary from woman to woman. Consumption of 250 ml of red grapefruit juice by breastfeeding mothers does not significantly alter naringenin concentrations in their milk.	[Romaszko, Ewa] Univ Warmia & Mazury, Family Med Unit, Olsztyn, Poland; [Marzec-Wroblewska, Urszula; Badura, Anna; Bucinski, Adam] Nicolaus Copernicus Univ Torun, Collegium Med Bydgoszcz, Fac Farmacy, Chair & Dept Biopharm, Bydgoszcz, Poland	University of Warmia & Mazury; Nicolaus Copernicus University	Bucinski, A (corresponding author), Nicolaus Copernicus Univ Torun, Collegium Med Bydgoszcz, Fac Farmacy, Chair & Dept Biopharm, Bydgoszcz, Poland.	kizbiofarmacji@cm.umk.pl	Marzec-Wróblewska, Urszula/D-4724-2014; Badura, Anna/G-9306-2014	Marzec-Wróblewska, Urszula/0000-0002-4189-6451; Badura, Anna/0000-0002-6560-8231; Bucinski, Adam/0000-0002-0558-9139	University of Warmia and Mazury in Olsztyn, Poland	University of Warmia and Mazury in Olsztyn, Poland	This study was financially supported by University of Warmia and Mazury in Olsztyn, Poland (purchase of reagents only). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603; ALLEN JC, 1991, AM J CLIN NUTR, V54, P69, DOI 10.1093/ajcn/54.1.69; Bolca S, 2010, MOL NUTR FOOD RES, V54, pS284, DOI 10.1002/mnfr.200900519; Bolca S, 2010, AM J CLIN NUTR, V91, P976, DOI 10.3945/ajcn.2009.28854; Bredsdorff L, 2010, BRIT J NUTR, V103, P1602, DOI 10.1017/S0007114509993679; Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244; DALY SEJ, 1993, EXP PHYSIOL, V78, P209, DOI 10.1113/expphysiol.1993.sp003681; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Franke AA, 1996, CLIN CHEM, V42, P955; Franke AA, 1998, AM J CLIN NUTR, V68, p1466S, DOI 10.1093/ajcn/68.6.1466S; Fujioka K, 2006, J MED FOOD, V9, P49, DOI 10.1089/jmf.2006.9.49; Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189; Justesen U, 1998, J CHROMATOGR A, V799, P101, DOI 10.1016/S0021-9673(97)01061-3; Kanaze FI, 2007, EUR J CLIN NUTR, V61, P472, DOI 10.1038/sj.ejcn.1602543; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061420; Lorber M, 2002, ENVIRON HEALTH PERSP, V110, pA325, DOI 10.1289/ehp.021100325; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; Lu WJ, 2011, CHIRALITY, V23, P891, DOI 10.1002/chir.21005; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mullen W, 2007, J AGR FOOD CHEM, V55, P3148, DOI 10.1021/jf062970x; Nielsen ILF, 2006, J NUTR, V136, P404, DOI 10.1093/jn/136.2.404; Perrin MT, 2016, MATERN CHILD NUTR; Romaszko E, 2014, MOL NUTR FOOD RES, V58, P221, DOI 10.1002/mnfr.201200773; Rowe H, 2013, PEDIATR CLIN N AM, V60, P275, DOI 10.1016/j.pcl.2012.10.009; Shirasaka Y, 2013, J PHARM SCI-US, V102, P280, DOI [10.1002/jps.23653, 10.1002/jps.23357]; Song BJ, 2013, NUTRITION, V29, P195, DOI 10.1016/j.nut.2012.07.015; Zamora-Ros R, 2011, BRIT J NUTR, V106, P1915, DOI 10.1017/S000711451100239X	28	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185954	10.1371/journal.pone.0185954	http://dx.doi.org/10.1371/journal.pone.0185954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982188	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300096
J	Tiwari, P; Kutum, R; Sethi, T; Shrivastava, A; Girase, B; Aggarwal, S; Patil, R; Agarwal, D; Gautam, P; Agrawal, A; Dash, D; Ghosh, S; Juvekar, S; Mukerji, M; Prasher, B				Tiwari, Pradeep; Kutum, Rintu; Sethi, Tavpritesh; Shrivastava, Ankita; Girase, Bhushan; Aggarwal, Shilpi; Patil, Rutuja; Agarwal, Dhiraj; Gautam, Pramod; Agrawal, Anurag; Dash, Debasis; Ghosh, Saurabh; Juvekar, Sanjay; Mukerji, Mitali; Prasher, Bhavana			Recapitulation of Ayurveda constitution types by machine learning of phenotypic traits	PLOS ONE			English	Article							REGRESSION; REGULARIZATION; SELECTION; MEDICINE; MODELS; AREA	In Ayurveda system of medicine individuals are classified into seven constitution types, "Prakriti", for assessing disease susceptibility and drug responsiveness. Prakriti evaluation involves clinical examination including questions about physiological and behavioural traits. A need was felt to develop models for accurately predicting Prakriti classes that have been shown to exhibit molecular differences. The present study was carried out on data of phenotypic attributes in 147 healthy individuals of three extreme Prakriti types, from a genetically homogeneous population of Western India. Unsupervised and supervised machine learning approaches were used to infer inherent structure of the data, and for feature selection and building classification models for Prakriti respectively. These models were validated in a North Indian population. Unsupervised clustering led to emergence of three natural clusters corresponding to three extreme Prakriti classes. The supervised modelling approaches could classify individuals, with distinct Prakriti types, in the training and validation sets. This study is the first to demonstrate that Prakriti types are distinct verifiable clusters within a multidimensional space of multiple interrelated phenotypic traits. It also provides a computational framework for predicting Prakriti classes from phenotypic attributes. This approach may be useful in precision medicine for stratification of endophenotypes in healthy and diseased populations.	[Tiwari, Pradeep; Sethi, Tavpritesh; Aggarwal, Shilpi; Gautam, Pramod; Agrawal, Anurag; Mukerji, Mitali; Prasher, Bhavana] CSIR, Genom & Mol Med, Inst Genom & Integrat Biol, New Delhi, India; [Tiwari, Pradeep; Kutum, Rintu; Mukerji, Mitali; Prasher, Bhavana] CSIR, TRISUTRA Translat Res & Innovat Sci Ayurgen, Ayurgen Unit, Inst Genom & Integrat Biol, New Delhi, India; [Tiwari, Pradeep; Kutum, Rintu; Agrawal, Anurag; Dash, Debasis; Mukerji, Mitali; Prasher, Bhavana] CSIR, Acad Sci & Innovat Res AcSIR, IGIB, Delhi, India; [Kutum, Rintu; Dash, Debasis] CSIR, GN Ramachandran Knowledge Ctr Genome Informat, Inst Genom & Integrat Biol, New Delhi, India; [Shrivastava, Ankita; Girase, Bhushan; Patil, Rutuja; Agarwal, Dhiraj; Juvekar, Sanjay] KEM Hosp Res Ctr, Vadu Rural Hlth Program, Pune, Maharashtra, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Sethi, Tavpritesh] Indraprastha Inst Informat Technol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Indraprastha Institute of Information Technology Delhi	Mukerji, M; Prasher, B (corresponding author), CSIR, Genom & Mol Med, Inst Genom & Integrat Biol, New Delhi, India.; Mukerji, M; Prasher, B (corresponding author), CSIR, TRISUTRA Translat Res & Innovat Sci Ayurgen, Ayurgen Unit, Inst Genom & Integrat Biol, New Delhi, India.; Mukerji, M; Prasher, B (corresponding author), CSIR, Acad Sci & Innovat Res AcSIR, IGIB, Delhi, India.; Juvekar, S (corresponding author), KEM Hosp Res Ctr, Vadu Rural Hlth Program, Pune, Maharashtra, India.	sanjay.juvekar@gmail.com; mitali@igib.res.in; Bhavana.p@igib.res.in	Agrawal, Anurag/GZL-5821-2022; Patil, Rutuja/O-9996-2018; Tiwari, Dr. Pradeep/V-8314-2018; Dash, Debasis/F-3137-2012	Patil, Rutuja/0000-0001-6390-4363; Mukerji, Mitali/0000-0003-0697-5055; Agrawal, Anurag/0000-0002-0340-5252; Sethi, Tavpritesh/0000-0002-4776-7941; Tiwari, Dr. Pradeep/0000-0003-0387-9236; Girase, Bhushan/0000-0001-7105-3730; Kutum, Rintu/0000-0001-8667-6199; Dash, Debasis/0000-0002-5647-3785	CSIR [MLP901]; DBT-BINC fellowship; Council of Scientific & Industrial Research [MLP901]	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT-BINC fellowship; Council of Scientific & Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	Funding from CSIR (MLP901) and DBT-BINC fellowship to PT are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge all field staffs and study population from KEMHRC-VADU. Authors also acknowledge Binuja Varma, Amruta Vasudevan for help in genotyping experiments and Ankita Narang in genotype analysis. Indian Genome Variation Consortium (IGVC) is also acknowledged for genotype data for diverse Indian population. Project funding MLP901 from Council of Scientific & Industrial Research (http://www.csir.res.in and DBT-BINC fellowship to PT are acknowledged. CSIR-IGIB is acknowledged for infrastructure support including the data centre.	Aggarwal S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0542-9; Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Brahmachari SK, 2005, HUM GENET, V118, P1, DOI 10.1007/s00439-005-0009-9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Dance A, 2016, NATURE, V537, pS52, DOI 10.1038/537S52a; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Flores M, 2013, PERS MED, V10, P565, DOI 10.2217/pme.13.57; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Govindaraj P, 2015, SCI REP-UK, V5, DOI 10.1038/srep15786; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hastie T., 2009, UNSUPERVISED LEARNIN, P485; Hood L, 2011, NAT REV CLIN ONCOL, V8, P184, DOI 10.1038/nrclinonc.2010.227; Hornik M, 2012, R PACKAGE VERSION 1; Juyal RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045752; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prasher B, 2016, J ETHNOPHARMACOL; Prasher B, 2016, J GENET, V95, P209, DOI 10.1007/s12041-015-0607-9; Prasher B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-48; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2021, R LANGUAGE ENV STAT; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Rotti H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0506-0; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sethi TP, 2011, ACS CHEM BIOL, V6, P875, DOI 10.1021/cb2003016; Sharma P, 1999, SUSRUTA SAMHITA ENGL; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; SLINKER BK, 1985, AM J PHYSIOL, V249, pR1, DOI 10.1152/ajpregu.1985.249.1.R1; Tian Q, 2012, J INTERN MED, V271, P111, DOI 10.1111/j.1365-2796.2011.02498.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van der Laan MJ, 2003, J STAT COMPUT SIM, V73, P575, DOI 10.1080/0094965031000136012; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185380	10.1371/journal.pone.0185380	http://dx.doi.org/10.1371/journal.pone.0185380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981546	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300037
J	Tyler, AD; Randell, E; Baikie, M; Antonation, K; Janella, D; Christianson, S; Tyrrell, GJ; Graham, M; Van Domselaar, G; Sharma, MK				Tyler, Andrea D.; Randell, Elaine; Baikie, Maureen; Antonation, Kym; Janella, Debra; Christianson, Sara; Tyrrell, Gregory J.; Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.			Application of whole genome sequence analysis to the study of Mycobacterium tuberculosis in Nunavut, Canada	PLOS ONE			English	Article							MIRU-VNTRPLUS; INFECTION; MICE; TOOL; VISUALIZATION; TRANSMISSION; POLYMORPHISM; ALGORITHMS; RESISTANCE; DISCOVERY	Canada has one of the lowest rates of tuberculosis (TB) in the world, however, among certain sub-populations, disease incidence rates approach those observed in sub-Saharan Africa, and other high incidence regions. In this study, we applied mycobacterial interspersed repetitive unit (MIRU) variable number of tandem repeat (VNTR) and whole genome sequencing (WGS) to the analysis of Mycobacterium tuberculosis isolates obtained from Northern communities in the territory of Nunavut. WGS was carried out using the Illumina MiSeq, with identified variants used to infer phylogenetic relationships and annotated to infer functional implications. Additionally, the sequencing data from these isolates were augmented with publically available WGS to evaluate data from the Nunavut outbreak in the broader Canadian context. In this study, isolates could be classified into four major clusters by MIRU-VNTR analysis. These could be further resolved into sub-clusters using WGS. No evidence for antimicrobial resistance, either genetic or phenotypic, was observed in this cohort. Among most subjects with multiple samples, reactivation/incomplete treatment likely contributed to recurrence. However, isolates from two subjects appeared more likely to have occurred via reinfection, based on the large number of genomic single nucleotide variants detected. Finally, although quite distinct from previously reported Canadian MTB strains, isolates obtained from Nunavut clustered most closely with a cohort of samples originating in the Nunavik region of Northern Quebec. This study demonstrates the benefit of using WGS for discriminatory analysis of MTB in Canada, especially in high incidence regions. It further emphasizes the importance of focusing epidemiological intervention efforts on interrupting transmission chains of endemic TB throughout Northern communities, rather than relying on strategies applied in regions where the majority of TB cases result from importation of foreign strains.	[Tyler, Andrea D.; Antonation, Kym; Janella, Debra; Christianson, Sara; Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Randell, Elaine; Baikie, Maureen] Govt Nunavut, Iqaluit, NU, Canada; [Tyrrell, Gregory J.] Univ Alberta, Div Diagnost & Appl Microbiol, Edmonton, AB, Canada; [Tyrrell, Gregory J.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Tyrrell, Gregory J.] Prov Lab Publ Hlth Microbiol, Edmonton, AB, Canada; [Graham, Morag; Van Domselaar, Gary; Sharma, Meenu K.] Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Van Domselaar, Gary] Univ Manitoba, Dept Comp Sci, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Alberta; University of Alberta; University of Manitoba; University of Manitoba	Sharma, MK (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.; Sharma, MK (corresponding author), Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.	meenu.sharma@canada.ca	Sharma, Meenu/GWM-5030-2022; Tyrrell, Gregory/ABA-7203-2021; Sharma, Meenu/AAE-2536-2022	Sharma, Meenu/0000-0002-6020-9995	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada; Public Health Agency of Canada	This study was funded through an intramural grant to Meenu K Sharma from the Canadian federal Genomics Research and Development Initiative (GRDI) from the Government of Canada and the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Al-Hajoj SAM, 2010, J CLIN MICROBIOL, V48, P3813, DOI 10.1128/JCM.00556-10; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Bjorn-Mortensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33180; Blackwood KS, 2004, J CLIN MICROBIOL, V42, P5001, DOI 10.1128/JCM.42.11.5001-5006.2004; Bradley P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10063; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; de Beer JL, 2014, J CLIN MICROBIOL, V52, P1338, DOI 10.1128/JCM.03436-13; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garrison E, 2012, HAPLOTYPE BASED VARI; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatherell HA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0566-x; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Lee RS, 2015, P NATL ACAD SCI USA, V112, P13609, DOI 10.1073/pnas.1507071112; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lillebaek T, 2016, INT J MED MICROBIOL, V306, P580, DOI 10.1016/j.ijmm.2016.05.017; MacDonald N, 2011, CAN MED ASSOC J, V183, P741, DOI 10.1503/cmaj.110160; Caceres SM, 2011, PEPTIDES, V32, P1, DOI 10.1016/j.peptides.2010.09.017; Mehaffy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112928; Minion J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053466; Niemann S, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0022-2016; Orr P, 2013, CAN MED ASSOC J, V185, P287, DOI 10.1503/cmaj.121536; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Pepperell CS, 2011, P NATL ACAD SCI USA, V108, P6526, DOI 10.1073/pnas.1016708108; Petkau A, 2016, 092940 BIRXIV; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Revell LJ, 2012, EVOLUTION, V66, P2697, DOI 10.1111/j.1558-5646.2012.01645.x; Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P1677, DOI 10.1128/AAC.41.8.1677; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stucki D, 2016, J CLIN MICROBIOL, V54, P1862, DOI 10.1128/JCM.00126-16; Tischler AD, 2013, INFECT IMMUN, V81, P317, DOI 10.1128/IAI.01136-12; Tuite AR, 2013, INT J TUBERC LUNG D, V17, P1322, DOI 10.5588/ijtld.13.0145; Tyler AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148676; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Walker TM, 2016, CLIN MICROBIOL INFEC; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2016, TB EL LOW INC COUNTR; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	58	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185656	10.1371/journal.pone.0185656	http://dx.doi.org/10.1371/journal.pone.0185656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982116	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300053
J	Hardell, L; Carlberg, M				Hardell, Lennart; Carlberg, Michael			Mobile phones, cordless phones and rates of brain tumors in different age groups in the Swedish National Inpatient Register and the Swedish Cancer Register during 1998-2015	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GLIOMA; ASTROCYTOMA; IMPACT; CT	We used the Swedish Inpatient Register (IPR) to analyze rates of brain tumors of unknown type (D43) during 1998-2015. Average Annual Percentage Change (AAPC) per 100,000 increased with +2.06%, 95% confidence interval (CI) + 1.27, +2.86% in both genders combined. A joinpoint was found in 2007 with Annual Percentage Change (APC) 1998-2007 of +0.16%, 95% CI-0.94, +1.28%,and 2007-2015 of +4.24%, 95% CI +2.87, +5.63%. Highest AAPC was found in the age group 20-39 years. In the Swedish Cancer Register the age-standardized incidence rate per 100,000 increased for brain tumors, ICD-code 193.0, during 1998-2015 with AAPC in men +0.49%, 95% CI +0.05, +0.94%, and in women +0.33%, 95% CI-0.29, +0.45%. The cases with brain tumor of unknown type lack morphological examination. Brain tumor diagnosis was based on cytology/histopathology in 83% for men and in 87% for women in 1980. This frequency increased to 90% in men and 88% in women in 2015. During the same time period CT and MRI imaging techniques were introduced and morphology is not always necessary for diagnosis. If all brain tumors based on clinical diagnosis with CT or MRI had been reported to the Cancer Register the frequency of diagnoses based on cytology/histology would have decreased in the register. The results indicate underreporting of brain tumor cases to the Cancer Register. The real incidence would be higher. Thus, incidence trends based on the Cancer Register should be used with caution. Use of wireless phones should be considered in relation to the change of incidence rates.	[Hardell, Lennart; Carlberg, Michael] Orebro Univ, Fac Med & Hlth, Dept Oncol, Orebro, Sweden	Orebro University	Hardell, L (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Oncol, Orebro, Sweden.	lennart.hardell@regionorebrolar.se			Mr Brian Stein; Cancer-och Allergifonden; Cancerhjalpen; Pandora-Foundation for Independent Research, Berlin, Germany	Mr Brian Stein; Cancer-och Allergifonden; Cancerhjalpen; Pandora-Foundation for Independent Research, Berlin, Germany	The study was supported by grants from Mr Brian Stein, Cancer-och Allergifonden, Cancerhjalpen, and Pandora-Foundation for Independent Research, Berlin, Germany to LH.	ALAVI JB, 1988, CANCER, V62, P1074, DOI 10.1002/1097-0142(19880915)62:6<1074::AID-CNCR2820620609>3.0.CO;2-H; AMUNDSEN P, 1978, ACTA NEUROCHIR, V41, P177, DOI 10.1007/BF01809148; [Anonymous], 2013, IARC MON EV CARC R 2; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; BRISMAR J, 1978, NEURORADIOLOGY, V16, P506, DOI 10.1007/BF00395347; BYDDER GM, 1982, NEURORADIOLOGY, V23, P231, DOI 10.1007/BF00339389; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Carlberg M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9218486; Carlberg M, 2014, INT J ENV RES PUB HE, V11, P10790, DOI 10.3390/ijerph111010790; Constant P, 1977, Comput Tomogr, V1, P87, DOI 10.1016/0363-8235(77)90027-8; de Vocht F, 2016, ENVIRON INT, V97, P100, DOI 10.1016/j.envint.2016.10.019; Deltour I, 2012, EPIDEMIOLOGY, V23, P301, DOI 10.1097/EDE.0b013e3182448295; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; DOYLE FH, 1981, LANCET, V2, P53; ERICSON K, 1985, J COMPUT ASSIST TOMO, V9, P683, DOI 10.1097/00004728-198507010-00005; Gandhi OP, 2012, ELECTROMAGN BIOL MED, V31, P34, DOI 10.3109/15368378.2011.622827; Gaudino S, 2017, CHILD NERV SYST, V33, P35, DOI 10.1007/s00381-016-3262-4; Hardell L, 2015, INT J ENV RES PUB HE, V12, P3793, DOI 10.3390/ijerph120403793; Hardell Lennart, 2015, Pathophysiology, V22, P1, DOI 10.1016/j.pathophys.2014.10.001; Hardell L, 2013, INT J ONCOL, V43, P1036, DOI 10.3892/ijo.2013.2025; JAMIESON D, 1988, RADIOL CLIN N AM, V26, P1075; KETONEN L, 1978, ACTA NEUROL SCAND, V57, P153; Kilander C, 2014, ACTA ONCOL, V53, P822, DOI 10.3109/0284186X.2013.857429; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Laakmann E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101615; Little MP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1147; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Nilsson M, 2014, ACTA ONCOL, V53, P414, DOI 10.3109/0284186X.2013.819115; Song PJ, 2016, J BIOL REG HOMEOS AG, V30, P833; Yamamoto Y L, 1984, Neurosurg Rev, V7, P233, DOI 10.1007/BF01892905; Yang M, 2017, PLOS ONE, V4, P12; Yano H, 2017, NEUROL MED-CHIR, V57, P312, DOI 10.2176/nmc.ra.2016-0312	32	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185461	10.1371/journal.pone.0185461	http://dx.doi.org/10.1371/journal.pone.0185461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976991	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100023
J	Torino, C; Pizzini, P; Cutrupi, S; Tripepi, R; Tripepi, G; Mallamaci, F; Zoccali, C				Torino, Claudia; Pizzini, Patrizia; Cutrupi, Sebastiano; Tripepi, Rocco; Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine			Vitamin D and methylarginines in chronic kidney disease (CKD)	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; NITRIC-OXIDE SYNTHASE; ENDOTHELIAL DYSFUNCTION; ESSENTIAL-HYPERTENSION; HEMODIALYSIS-PATIENTS; PLASMA-CONCENTRATION; RANDOMIZED-TRIAL; RENAL-DISEASE; PARICALCITOL; THERAPY	Background Vitamin D associates with the plasma concentration of the endogenous inhibitor of the nitric oxide system asymmetric dimethyl arginine (ADMA) and cross-sectional studies in CKD patients treated with the vitamin D receptor activator paricalcitol show that plasma ADMA is substantially less than in those not receiving this drug. Methods In the frame of a randomized, double-blind, placebo controlled trial, the Paracalcitol and ENdothelial fuNction in chronic kidneY disease (PENNY), we investigated whether vitamin D receptor activation by paricalcitol (2 mu g/day x 12 weeks) affects the plasma concentration of ADMA and symmetric dimethyl arginine (SDMA) in 88 patients with stage 3 to 4 CKD. Results Paricalcitol produced the expected small rise in serum calcium and phosphate and a marked PTH suppression. However, ADMA [Paricalcitol: baseline 0.75 mu Mol/L (95%CI: 0.70-0.81), 12 week 0.72 mu Mol/L (95%CI: 0.66-0.78); Placebo: baseline 0.75 mu Mol/L (95%CI: 0.70-0.90) 12 weeks 0.70 mu Mol/L (95%CI: 0.66-0.74)] and SDMA [Paricalcitol: baseline 0.91 mu Mol/L (95%CI: 0.82-1.00), 12 week 0.94 mu Mol/L (95%CI: 0.82-0.1.06); Placebo: baseline 0.91 mu Mol/L (95%CI: 0.82-1.06) 12 weeks 0.99 mu Mol/L (95%CI: 0.88-1.10)] remained unchanged during the trial and 2 weeks after stopping these treatments. Conclusions Paricalcitol does not modify plasma ADMA and SDMA in patients with stage 3-4 CKD. The apparent beneficial effects of paricalcitol on ADMA registered in cross-sectional studies is likely attributable to confounding by indication rather than to a true effect of this drug on ADMA metabolism.	[Zoccali, Carmine] CNR IFC, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, Reggio Di Calabria, Italy; CNR IFC, Nephrol & Renal Transplantat Unit, Reggio Di Calabria, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Zoccali, C (corresponding author), CNR IFC, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, Reggio Di Calabria, Italy.	carmine.zoccali@tin.it	Torino, Claudia/AAF-3693-2019	Torino, Claudia/0000-0002-4967-0916; Zoccali, Carmine/0000-0002-6616-1996	AbbVie	AbbVie(AbbVie)	Our institution received funding by AbbVie for the PENNY study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekera AT, 2016, DIABETES METAB, V42, P378, DOI 10.1016/j.diabet.2016.05.002; Asagami T, 2002, METABOLISM, V51, P843, DOI 10.1053/meta.2002.33349; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; Bednarek-Skublewska A, 2010, POL ARCH MED WEWN, V120, P167, DOI 10.20452/pamw.917; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Burnett-Bowie SAM, 2012, CLIN J AM SOC NEPHRO, V7, P624, DOI 10.2215/CJN.10030911; Choi HR, 2017, MATURITAS, V102, P13, DOI 10.1016/j.maturitas.2017.05.002; de Mutsert R, 2009, KIDNEY INT, V75, P677, DOI 10.1038/ki.2008.645; Delles C, 2002, KIDNEY INT, V61, P1462, DOI 10.1046/j.1523-1755.2002.00260.x; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; Hermenegildo C, 2002, J CLIN ENDOCR METAB, V87, P5636, DOI 10.1210/jc.2002-020905; Holden DP, 2003, CIRCULATION, V108, P1575, DOI 10.1161/01.CIR.0000091083.61609.DF; Ito A, 2001, JPN CIRC J, V65, P775, DOI 10.1253/jcj.65.775; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lu R, 2002, COMPARATIVE MED, V52, P224; Lundwall K, 2015, AM J NEPHROL, V42, P265, DOI 10.1159/000441364; Maas R, 2002, VASC MED, V7, P213, DOI 10.1191/1358863x02vm429ra; Miller JE, 2012, PHARMACOEPIDEM DR S, V21, P1232, DOI 10.1002/pds.3349; Mullender M, 2004, MED BIOL ENG COMPUT, V42, P14, DOI 10.1007/BF02351006; Napoli R, 2001, CIRCULATION, V104, P3076, DOI 10.1161/hc5001.100621; Ngo DT, 2010, AM J MED, V123, P335, DOI 10.1016/j.amjmed.2009.09.024; Oliva-Damaso E, 2017, KIDNEY INT REP, V2, P165, DOI 10.1016/j.ekir.2016.10.002; Post MS, 2003, J CLIN ENDOCR METAB, V88, P4221, DOI 10.1210/jc.2003-030584; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Schulze F, 2004, CLIN CHEM LAB MED, V42, P1377, DOI 10.1515/CCLM.2004.257; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Selley ML, 2003, NEUROBIOL AGING, V24, P903, DOI 10.1016/S0197-4580(03)00007-1; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; Tripepi G, 2017, NEPHROL DIAL TRANSPL, V32, P19, DOI 10.1093/ndt/gfw439; Tripepi G, 2010, NEPHRON CLIN PRACT, V115, pC94, DOI 10.1159/000312871; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Xiao ZS, 2001, KIDNEY INT, V60, P1699, DOI 10.1046/j.1523-1755.2001.00011.x; Yilmaz MI, 2006, AM J KIDNEY DIS, V47, P42, DOI 10.1053/j.ajkd.2005.09.029; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2002, KIDNEY INT, V62, P339, DOI 10.1046/j.1523-1755.2002.00437.x; Zoccali C, 2014, HYPERTENSION	38	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185449	10.1371/journal.pone.0185449	http://dx.doi.org/10.1371/journal.pone.0185449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976989	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100022
J	Virtanen, M; Singh-Manoux, A; Batty, GD; Ebmeier, KP; Jokela, M; Harmer, CJ; Kivimaki, M				Virtanen, Marianna; Singh-Manoux, Archana; Batty, G. David; Ebmeier, Klaus P.; Jokela, Markus; Harmer, Catherine J.; Kivimaki, Mika			The level of cognitive function and recognition of emotions in older adults	PLOS ONE			English	Article							FACIAL AFFECT RECOGNITION; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; SOCIAL COGNITION; NEURODEGENERATIVE DISORDERS; PSYCHIATRIC-DISORDER; IMPAIRMENT; DEMENTIA; SCHIZOPHRENIA; HUNTINGTONS	Background The association between cognitive decline and the ability to recognise emotions in interpersonal communication is not well understood. We aimed to investigate the association between cognitive function and the ability to recognise emotions in other people's facial expressions across the full continuum of cognitive capacity. Methods Cross-sectional analysis of 4039 participants (3016 men, 1023 women aged 59 to 82 years) in the Whitehall II study. Cognitive function was assessed using a 30-item Mini-Mental State Examination (MMSE), further classified into 8 groups: 30, 29, 28, 27, 26, 25, 24, and < 24 (possible dementia) MMSE points. The Facial Expression Recognition Task (FERT) was used to examine recognition of anger, fear, disgust, sadness, and happiness. Results The multivariable adjusted difference in the percentage of accurate recognition between the highest and lowest MMSE group was 14.9 (95% CI, 11.1-18.7) for anger, 15.5 (11.9-19.2) for fear, 18.5 (15.2-21.8) for disgust, 11.6 (7.3-16.0) for sadness, and 6.3 (3.1-9.4) for happiness. However, recognition of several emotions was reduced already after 1 to 2-point reduction in MMSE and with further points down in MMSE, the recognition worsened at an accelerated rate. Conclusions The ability to recognize emotion in facial expressions is affected at an early stage of cognitive impairment and might decline at an accelerated rate with the deterioration of cognitive function. Accurate recognition of happiness seems to be less affected by a severe decline in cognitive performance than recognition of negatively valued emotions.	[Virtanen, Marianna] Finnish Inst Occupat Hlth, Helsinki, Finland; [Singh-Manoux, Archana; Batty, G. David; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Singh-Manoux, Archana] INSERM, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Batty, G. David] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Ebmeier, Klaus P.; Harmer, Catherine J.] Univ Oxford, Dept Psychiat, Warneford Hosp, Oxford, England; [Jokela, Markus] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Kivimaki, Mika] Univ Helsinki, Fac Med, Clinicum, Helsinki, Finland	Finnish Institute of Occupational Health; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Edinburgh; University of Oxford; University of Helsinki; University of Helsinki	Virtanen, M (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	marianna.virtanen@ttl.fi	Ebmeier, Klaus Peter/B-4789-2008; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018; Singh-Manoux, Archana/F-6804-2013; Jokela, Markus/A-4669-2009	Ebmeier, Klaus Peter/0000-0002-5190-7038; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Singh-Manoux, Archana/0000-0002-1244-5037; Jokela, Markus/0000-0003-0117-0012; Harmer, Catherine/0000-0002-1609-8335	Academy of Finland [258598]; National Institute of Aging, National Institutes of Health (NIH), US [R01AG013196, R01AG034454]; UK Medical Research Council, Lifelong Health and Wellbeing Initiative and Whitehall II [G1001354]; English National Institute of Health Research Oxford Biomedical Research Centre; UK Medical Research Council [K013351]; National Institutes of Health [R01AG034454, R01HL036310]; NordForsk; Nordic Programme on Health and Welfare; Economic and Social Research Council; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1, G1001354] Funding Source: researchfish; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G1001354, MR/K013351/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); National Institute of Aging, National Institutes of Health (NIH), US; UK Medical Research Council, Lifelong Health and Wellbeing Initiative and Whitehall II(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); English National Institute of Health Research Oxford Biomedical Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NordForsk; Nordic Programme on Health and Welfare; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M. Virtanen is supported by Academy of Finland (258598) (http://www.aka.fi/en/). A SinghManoux by the National Institute of Aging, National Institutes of Health (NIH), US (R01AG013196 and R01AG034454) (https://www.nih.gov/). K.P. Ebmeier is supported by the UK Medical Research Council as part of the Lifelong Health and Wellbeing Initiative and Whitehall II (G1001354) (https://www.mrc.ac.uk/) and by the English National Institute of Health Research Oxford Biomedical Research Centre (https://oxfordbrc. nihr.ac.uk/). C. Harmer reports grants from J&J, grants from UCB, personal fees from Lundbeck, Seriver, P1vital, other from Oxford Psychologists Ltd, outside the submitted work. M. Kivimaki is supported by the UK Medical Research Council (K013351) (https://www.mrc.ac.uk/), the National Institutes of Health (R01AG034454, R01HL036310) (https://www.nih.gov/), NordForsk, the Nordic Programme on Health and Welfare (https://www.nordforsk.org/en) and has a professorial fellowship from the Economic and Social Research Council (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129812; Blazer DG, 2015, JAMA-J AM MED ASSOC, V313, P2121, DOI 10.1001/jama.2015.4380; Bryson G, 1997, PSYCHIAT RES, V71, P105, DOI 10.1016/S0165-1781(97)00050-4; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; Ekman P., 1976, PICTURES FACIAL AFFE; Elamin M, 2012, J NEUROL NEUROSUR PS, V83, P1071, DOI 10.1136/jnnp-2012-302817; FEINBERG TE, 1986, ARCH GEN PSYCHIAT, V43, P276; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujie S, 2008, DEMENT GERIATR COGN, V26, P432, DOI 10.1159/000165381; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Grainger SA, 2017, J GERONTOL B-PSYCHOL, V72, P622, DOI 10.1093/geronb/gbv100; Grau-Olivares M, 2009, EXPERT REV NEUROTHER, V9, P1201, DOI [10.1586/ern.09.73, 10.1586/ERN.09.73]; Harmer CJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0407; Harmer CJ, 2009, AM J PSYCHIAT, V166, P1178, DOI 10.1176/appi.ajp.2009.09020149; Henry JD, 2012, J INT NEUROPSYCH SOC, V18, P866, DOI 10.1017/S1355617712000665; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Horning SM, 2012, AGING NEUROPSYCHOL C, V19, P657, DOI 10.1080/13825585.2011.645011; Joshi A, 2014, DEMENT GERIATR COGN, V38, P79, DOI 10.1159/000357838; Klein-Koerkamp Y, 2012, J ALZHEIMERS DIS, V32, P109, DOI 10.3233/JAD-2012-120553; Kordsachia CC, 2017, NEUROSCI BIOBEHAV R, V73, P276, DOI 10.1016/j.neubiorev.2016.11.020; Kumfor F, 2014, J NEUROL NEUROSUR PS, V85, P1076, DOI 10.1136/jnnp-2013-307098; Lee SB, 2014, PSYCHIAT INVEST, V11, P105, DOI 10.4306/pi.2014.11.2.105; Leppanen JM, 2009, NAT REV NEUROSCI, V10, P37, DOI 10.1038/nrn2554; LEWIS G, 1988, PSYCHOL MED, V18, P737, DOI 10.1017/S0033291700008448; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; O'Donnell M, 2012, EUR HEART J, V33, P1777, DOI 10.1093/eurheartj/ehs053; Peretti CS, 2008, PSYCHOTHER PSYCHOSOM, V77, P139, DOI 10.1159/000116607; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Rajan KB, 2012, J GERONTOL A-BIOL, V67, P1419, DOI 10.1093/gerona/gls098; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Scholl BJ, 1999, MIND LANG, V14, P131, DOI 10.1111/1468-0017.00106; Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665; Spector A, 2015, BRIT J PSYCHIAT, V206, P509, DOI 10.1192/bjp.bp.113.140087; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Szanto K, 2012, AM J GERIAT PSYCHIAT, V20, P257, DOI 10.1097/JGP.0b013e31820eea0c; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Varjassyova A, 2013, J ALZHEIMERS DIS, V33, P273, DOI 10.3233/JAD-2012-120148; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Woodford HJ, 2007, QJM-INT J MED, V100, P469, DOI 10.1093/qjmed/hcm051; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	44	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185513	10.1371/journal.pone.0185513	http://dx.doi.org/10.1371/journal.pone.0185513			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977015	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100025
J	Rawal, LB; Biswas, TI; Khandker, NN; Saha, SR; Chowdhury, MMB; Khan, ANS; Chowdhury, EH; Renzaho, A				Rawal, Lal B.; Biswas, Tuh In; Khandker, Nusrat Nausheen; Saha, Shekhar Ranjan; Chowdhury, Mohammed Mahiul Bidet; Khan, Abdullah Nurus Salem; Chowdhury, Enamul Hasib; Renzaho, Andre			Non-communicable disease (NCD) risk factors and diabetes among adults living in slum areas of Dhaka, Bangladesh	PLOS ONE			English	Article							HEALTH	Background Despite one-third of the urban population in Bangladesh living in urban slums and at increased risk of non-communicable diseases (NCDs), little is known about the NCD risk profile of this at-risk population. The aim of the study was to identify the prevalence of the NCD risk factors and the association of NCD risk factors with socio-demographic factors among the adults of urban slums in Dhaka, Bangladesh. Method A cross-sectional study was conducted among adult slum dwellers (aged 25 and above) residing in three purposively selected urban slums of Dhaka for at least six months preceding the survey. The risk factors assessed were-currently smoking, fruit and vegetable intake, physical activity, hypertension and body mass index (BMI). Information on selfreported diabetes was also taken. A total of 507 participants (252 females; 49.7%) were interviewed and their physical measures were taken using the WHO NCD STEPS instrument. Result The overall prevalence of NCD risk factors was: 36.0% (95% CI: 31.82-40.41) for smoking; 95.60% (95% CI: 93.60-97.40) for insufficient fruit and vegetable intake; 15.30% (95% CI: 12.12-18.71) for low physical activity; 13.70% (95% CI: 10.71-16.92) for hypertension; 22.70% (95% CI: 19.31-26.02) for overweight or obesity; and 5.00% (95%: 3.20-7.00) for self-reported diabetes. In the logistic regression model, the clustering of three or more NCD risk factors was positively associated with younger age groups (p = 0.02), no formal education (p < 0.001) and primary education level (p = 0.01), but did not differ by sex of the participants, monthly income and occupation. Conclusion All NCD risk factors are markedly high among the urban slum adults. These findings are important to support the formulation and implementation of NCD-related polices and plan of actions that recognize urban slum populations in Bangladesh as a priority sub-population.	[Rawal, Lal B.; Biswas, Tuh In; Khan, Abdullah Nurus Salem] Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sharani, Dhaka, Bangladesh; [Rawal, Lal B.; Khandker, Nusrat Nausheen; Saha, Shekhar Ranjan; Chowdhury, Mohammed Mahiul Bidet; Chowdhury, Enamul Hasib] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Biswas, Tuh In] Univ Queensland, Long Pocket Precinct, Indooroopilly, Qld, Australia; [Renzaho, Andre] Western Sydney Univ, Locked Bag 1797, Penrith, NSW, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Queensland; Western Sydney University	Rawal, LB (corresponding author), Int Ctr Diarrhoeal Dis Res, 68 Shaheed Tajuddin Ahmed Sharani, Dhaka, Bangladesh.; Rawal, LB (corresponding author), BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	drlalrawal@gmail.com	Khan, Abdullah Nurus Salam/J-1661-2018; Renzaho, Andre M.N./AAH-7679-2021	Khan, Abdullah Nurus Salam/0000-0002-8694-4349; Biswas, Tuhin/0000-0002-7837-0306; Rawal, Lal/0000-0003-1106-0108; RENZAHO, ANDRE/0000-0002-6844-0833	Australian Research Council [FT110100345]	Australian Research Council(Australian Research Council)	AR is supported by an Australian Research Council Future Fellowship FT110100345. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2009, GLOBAL HEALTH ACTION, V2, P68, DOI 10.3402/gha.v2i0.1986; Akter S, 2014, B WORLD HEALTH ORGAN, V92, P204, DOI 10.2471/BLT.13.128371; Alam Dewan S, 2016, BMC Obes, V3, P19, DOI 10.1186/s40608-016-0099-z; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Burkart K, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-32; Burkart K, 2011, ENVIRON POLLUT, V159, P2035, DOI 10.1016/j.envpol.2011.02.005; Cancer IAfRo, 2007, REV RISK ATT QUITT S; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; ElSaharty S, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9920-0; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Federation I, 2013, INT DIAB FED IDF DIA; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Goli S, 2011, CITIES, V28, P461, DOI 10.1016/j.cities.2011.05.006; Hahn EJ, 2010, AM J PREV MED, V39, pS66, DOI 10.1016/j.amepre.2010.08.013; Heilig G.K., 2014, WORLD URBANIZATION P; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Ministry of Health Myanmar World Health Organization, 2014, WORLD DIAB FDN REP N; Mirelman AJ, 2016, RELATIONSHIP NONCOMM; National Institute of Population Research and Training (NIPORT), 2014, MEASRE EV ICDDRB BAN; Organization. GWH. WHO, 2014, STEPS MAN; Razzaque A, 2011, ASIA-PAC J PUBLIC HE, V23, P183, DOI 10.1177/1010539510392743; Scollo M, 2008, TOBACCO AUSTR FACTS, P49; Streatfield PK, 2008, J HEALTH POPUL NUTR, V26, P261; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, NONC DIS RISK FACT S; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2011, GLOB STAT REP ALC HL; World Health Organization, 2015, STEPWISE APPR NONC D; World Health Organization, 2013, STEPS MAN; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization (WHO), 2015, PHYS ACTIVITY; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, P1	38	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184967	10.1371/journal.pone.0184967	http://dx.doi.org/10.1371/journal.pone.0184967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972972	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900009
J	Vedula, EM; Alonso, JL; Arnaout, MA; Charest, JL				Vedula, Else M.; Alonso, Jose Luis; Arnaout, M. Amin; Charest, Joseph L.			A microfluidic renal proximal tubule with active reabsorptive function	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; IN-VITRO; BASEMENT-MEMBRANES; GLUCOSE-UPTAKE; SCHWANN-CELLS; SHEAR-STRESS; COCULTURE; MODEL; DIFFERENTIATION	In the kidney, the renal proximal tubule (PT) reabsorbs solutes into the peritubular capillaries through active transport. Here, we replicate this reabsorptive function in vitro by engineering a microfluidic PT. The microfluidic PT architecture comprises a porous membrane with user-defined submicron surface topography separating two microchannels representing a PT filtrate lumen and a peritubular capillary lumen. Human PT epithelial cells and microvascular endothelial cells in respective microchannels created a PT-like reabsorptive barrier. Co-culturing epithelial and endothelial cells in the microfluidic architecture enhanced viability, metabolic activity, and compactness of the epithelial layer. The resulting tissue expressed tight junctions, kidney-specific morphology, and polarized expression of kidney markers. The microfluidic PT actively performed sodium-coupled glucose transport, which could be modulated by administration of a sodium-transport inhibiting drug. The microfluidic PT reproduces human physiology at the cellular and tissue levels, and measurable tissue function which can quantify kidney pharmaceutical efficacy and toxicity.	[Vedula, Else M.; Charest, Joseph L.] Draper, Biomed Microsyst Grp, Cambridge, MA 02139 USA; [Alonso, Jose Luis; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Nephrol Div, Charlestown, MA 02129 USA; [Alonso, Jose Luis; Arnaout, M. Amin] Harvard Med Sch, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Charest, JL (corresponding author), Draper, Biomed Microsyst Grp, Cambridge, MA 02139 USA.; Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Dept Med, Nephrol Div, Charlestown, MA 02129 USA.; Arnaout, MA (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.	aarnaout1@mgh.harvard.edu; jcharest@draper.com		Charest, Joseph/0000-0002-9062-2473	National Cancer Institute [R33 CA174550]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK048549, R01 DK088327]; Charles Stark Draper Laboratory: Draper Research and Development Grant; Charles Stark Draper Laboratory: University Research and Development Grant	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Charles Stark Draper Laboratory: Draper Research and Development Grant; Charles Stark Draper Laboratory: University Research and Development Grant	This work was supported by National Cancer Institute, Award: R33 CA174550, Recipient/PI: Joseph Leo Charest, Ph.D.; National Institute of Diabetes and Digestive and Kidney Diseases, Award: R01 DK048549, Recipient/PI: M. Amin Arnaout, M.D.; National Institute of Diabetes and Digestive and Kidney Diseases, Award: R01 DK088327, Recipient/PI: M. Amin Arnaout, M.D.; Charles Stark Draper Laboratory, Award: Draper Research and Development Grant, Recipient/PI: Joseph Leo Charest, Ph.D.; and Charles Stark Draper Laboratory, Award: University Research and Development Grant, Recipient/PI: M. Amin Arnaout, M.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2012, STRUCTURE FUNCTION K, P716; Aydin S, 2008, AM J PHYSIOL-CELL PH, V294, pC543, DOI 10.1152/ajpcell.00307.2007; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Blattmann A, 2008, BIOMATERIALS, V29, P2749, DOI 10.1016/j.biomaterials.2008.03.019; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Chang HC, 2013, MOL BIOSYST, V9, P2010, DOI 10.1039/c3mb70060g; Charest JL, 2005, J VAC SCI TECHNOL B, V23, P3011, DOI 10.1116/1.2127951; Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022; Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011; Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020; Chen ZJ, 2009, J NEURO-ONCOL, V92, P121, DOI 10.1007/s11060-008-9742-y; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Duan Y, 2010, P NATL ACAD SCI USA, V107, P21860, DOI 10.1073/pnas.1015751107; Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j; Frohlich EM, 2012, INTEGR BIOL-UK, V4, P75, DOI 10.1039/c1ib00096a; Frohlich EM, 2013, MICROFLUIDIC CELL CU, P279; HIRONAKA K, 1993, KIDNEY INT, V43, P334, DOI 10.1038/ki.1993.51; Huang HC, 2013, TISSUE ENG PT A, V19, P2024, DOI [10.1089/ten.tea.2012.0605, 10.1089/ten.TEA.2012.0605]; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Jang KJ, 2013, INTEGR BIOL; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2011, INTEGR BIOL-UK, V3, P134, DOI 10.1039/c0ib00018c; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Kanwal A, 2012, ANAL BIOCHEM, V429, P70, DOI 10.1016/j.ab.2012.07.003; Kelly EJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt378; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Kriz W, 2008, THE KIDNEY, P479; Kumar R, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-27; Li Q, 2013, ARCH MED RES, V44, P504, DOI 10.1016/j.arcmed.2013.09.009; Li XJ, 2009, ARCH BIOL SCI, V61, P703, DOI 10.2298/ABS0904703L; Linas SL, 1999, KIDNEY INT, V55, P1251, DOI 10.1046/j.1523-1755.1999.00360.x; Luyts K, 2015, TOXICOL IN VITRO, V29, P234, DOI 10.1016/j.tiv.2014.10.024; Maunsbach AB, 2011, HDB PHYSL, P41, DOI [10.1002/cphy.cp080102, DOI 10.1002/CPHY.CP080102]; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Prozialeck WC, 2006, TOXICOL IN VITRO, V20, P942, DOI 10.1016/j.tiv.2005.11.006; Saito K, 2006, WORLD J GASTROENTERO, V12, P6818, DOI 10.3748/wjg.v12.i42.6818; Slater SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020802; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Weber EJ, 2016, KIDNEY INT, V90, P627, DOI 10.1016/j.kint.2016.06.011; Weinberg JM, 2009, J AM SOC NEPHROL, V20, P1164, DOI 10.1681/ASN.2009040419; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Yuan Q, 2008, ARCH MED SCI, V4, P242; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang B, 2012, J HUAZHONG U SCI-MED, V32, P173, DOI 10.1007/s11596-012-0031-9; Zhang Y, 2010, CELL MOL BIOL LETT, V15, P517, DOI 10.2478/s11658-010-0026-0	49	43	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184330	10.1371/journal.pone.0184330	http://dx.doi.org/10.1371/journal.pone.0184330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020011	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400010
J	Yan, YT; Yu, LD; Castro, L; Dixon, D				Yan, Yitang; Yu, Linda; Castro, Lysandra; Dixon, Darlene			ER alpha 36, a variant of estrogen receptor a, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells	PLOS ONE			English	Article							ADIPOSE-TISSUE; BREAST-CANCER; EXPRESSION; ALPHA; RECEPTOR-ALPHA-36; COLOCALIZATION; MICROSCOPY; INDUCTION; KINASES; BETA	ER alpha 36 is a naturally occurring, membrane-associated, isoform of estrogen receptor a. The expression of ER alpha 36 is due to alternative splicing and different promoter usage. ER alpha 36 is a dominant-negative effector of ERa66-mediated transactivational activities and has the potential to trigger membrane-initiated mitogenic, nongenomic, estrogen signaling; however, the subcellular localization of ER alpha 36 remains controversial. To determine the cellular localization of ER alpha 36 in estrogen-responsive human uterine smooth muscle (ht-UtSMC) and leiomyoma (fibroid; ht-UtLM) cells, we conducted systematic confocal microscopy and subcellular fractionation analysis using ER alpha 36 antibodies. With Image J colocalizaton analysis plugin, confocal images were analyzed to obtain a Pearson's Correlation Coefficient (PCC) to quantify signal colocalization of ER alpha 36 with mitochondrial, endoplasmic reticulum, and cytoskeletal components in both cell lines. When cells were double-stained with an ER alpha 36 antibody and a mitochondrial-specific dye, MitoTracker, the PCC for the two channel signals were both greater than 0.75, indicating strong correlation between ER alpha 36 and mitochondrial signals in the two cell lines. A blocking peptide competition assay confirmed that the mitochondria-associated ER alpha 36 signal detected by confocal analysis was specific for ER alpha 36. In contrast, confocal images double-stained with an ER alpha 36 antibody and endoplasmic reticulum or cytoskeletal markers, had PCCs that were all less than 0.4, indicating no or very weak signal correlation. Fractionation studies showed that ER alpha 36 existed predominantly in membrane fractions, with minimal or undetected amounts in the cytosol, nuclear, chromatin, and cytoskeletal fractions. With isolated mitochondrial preparations, we confirmed that a known mitochondrial protein, prohibitin, was present in mitochondria, and by co-immunoprecipitation analysis that ER alpha 36 was associated with prohibitin in ht-UtLM cells. The distinctive colocalization pattern of ER alpha 36 with mitochondria in ht-UtSMC and ht-UtLM cells, and the association of ER alpha 36 with a mitochondrial-specific protein suggest that ER alpha 36 is localized primarily in mitochondria and may play a pivotal role in non-genomic signaling and mitochondrial functions.	[Yan, Yitang; Yu, Linda; Castro, Lysandra; Dixon, Darlene] NIEHS, Mol Pathogenesis Grp, NTPL, Natl Toxicol Program,NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Dixon, D (corresponding author), NIEHS, Mol Pathogenesis Grp, NTPL, Natl Toxicol Program,NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	dixon@niehs.nih.gov			National Toxicology Program (NTP) of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021196] Funding Source: NIH RePORTER	National Toxicology Program (NTP) of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS); Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the National Toxicology Program (NTP) and the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Chakraborty P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058291, 10.1371/journal.pone.0068543]; Chen JQ, 2007, BBA-MOL CELL RES, V1773, P1732, DOI 10.1016/j.bbamcr.2007.05.008; Chigira T, 2015, BIOCHEM BIOPH RES CO, V463, P726, DOI 10.1016/j.bbrc.2015.06.002; Choi M, 2015, MOL CELL BIOCHEM, V407, P181, DOI 10.1007/s11010-015-2468-1; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Hebert-Chatelain E, 2013, INT J BIOCHEM CELL B, V45, P90, DOI 10.1016/j.biocel.2012.08.014; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ivanova MM, 2010, AM J RESP CELL MOL, V42, P320, DOI 10.1165/rcmb.2009-0059OC; Li GL, 2013, MOL ONCOL, V7, P611, DOI 10.1016/j.molonc.2013.02.001; Lin SL, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-102; Pelekanou V, 2012, STEROIDS, V77, P928, DOI 10.1016/j.steroids.2011.12.016; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Sekeris C E, 1990, In Vivo, V4, P317; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Soltysik K, 2015, EUR J CELL BIOL, V94, P611, DOI 10.1016/j.ejcb.2015.10.001; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Tong JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015408; Velickovic K, 2014, J CLIN ENDOCR METAB, V99, P151, DOI 10.1210/jc.2013-2017; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; Zhang J, 2012, STEROIDS, V77, P666, DOI 10.1016/j.steroids.2012.02.013; Zinchuk, 2008, CURR PROTOC CELL BIO, V39	29	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186078	10.1371/journal.pone.0186078	http://dx.doi.org/10.1371/journal.pone.0186078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020039	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400066
J	Beard, JD; Engel, LS; Richardson, DB; Gammon, MD; Baird, C; Umbach, DM; Allen, KD; Stanwyck, CL; Keller, J; Sandler, DP; Schmidt, S; Kamel, F				Beard, John D.; Engel, Lawrence S.; Richardson, David B.; Gammon, Marilie D.; Baird, Coleen; Umbach, David M.; Allen, Kelli D.; Stanwyck, Catherine L.; Keller, Jean; Sandler, Dale P.; Schmidt, Silke; Kamel, Freya			Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival	PLOS ONE			English	Article							GULF-WAR VETERANS; MARGINAL STRUCTURAL MODELS; MULTIPLE COMPARISONS; MILLENNIUM COHORT; EPIDEMIOLOGIC DATA; NATIONAL REGISTRY; OCCUPATIONAL-EXPOSURE; ANTHRAX VACCINATION; TRAUMATIC EVENTS; HEALTH SURVEY	Background Military veterans may have higher rates of amyotrophic lateral sclerosis (ALS) mortality than non-veterans. Few studies, with sparse exposure information and mixed results, have studied relationships between military-related factors and ALS survival. We evaluated associations between military-related factors and ALS survival among U.S. military veteran cases. Methods We followed 616 medical record-confirmed cases from enrollment (2005-2010) in the Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis study until death or July 25, 2013, whichever came first. We ascertained vital status information from several sources within the Department of Veterans Affairs. We obtained information regarding military service, deployments, and 39 related exposures via standardized telephone interviews. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) and 95% confidence intervals. We adjusted for potential confounding and missing covariate data biases via inverse probability weights. We also used inverse probability weights to adjust for potential selection bias among a case group that included a disproportionate number of long-term survivors at enrollment. Results We observed 446 deaths during 24,267 person-months of follow-up (median follow-up: 28 months). Survival was shorter for cases who served before 1950, were deployed to World War II, or mixed and applied burning agents, with HRs between 1.58 and 2.57. Longer survival was associated with exposure to: paint, solvents, or petrochemical substances; local food not provided by the Armed Forces; or burning agents or Agent Orange in the field with HRs between 0.56 and 0.73. Conclusions Although most military-related factors were not associated with survival, associations we observed with shorter survival are potentially important because of the large number of military veterans.	[Beard, John D.; Engel, Lawrence S.; Richardson, David B.; Gammon, Marilie D.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Beard, John D.; Sandler, Dale P.; Kamel, Freya] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Baird, Coleen] US Army Publ Hlth Command, Environm Med Program, Aberdeen Proving Ground, MD USA; [Umbach, David M.] NIEHS, Biostat & Computat Biol Branch, Res Triangle Pk, NC USA; [Allen, Kelli D.; Stanwyck, Catherine L.] Durham VA Med Ctr, Durham, NC USA; [Allen, Kelli D.] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC USA; [Allen, Kelli D.] Univ North Carolina Chapel Hill, Thurston Arthrit Res Ctr, Chapel Hill, NC USA; [Stanwyck, Catherine L.; Schmidt, Silke] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Keller, Jean] Westat Corp, Durham, NC USA; [Beard, John D.] Brigham Young Univ, Coll Life Sci, Dept Hlth Sci, Provo, UT 84602 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Westat; Brigham Young University	Kamel, F (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	kemel@niehs.nih.gov	Engel, Larry/HCH-8527-2022	Beard, John/0000-0002-7156-0887	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS) [Z01 ES049005]; NIEHS [R01 ES13244, T32ES007018]; ALS Association [ALSA 1230]; Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health [T420H00867302]; U.S. Department of Veterans Affairs (CSP) [500A]; Westat, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049004, ZIAES103126, P30ES010126, ZIAES049028] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ALS Association; Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); U.S. Department of Veterans Affairs (CSP)(US Department of Veterans Affairs); Westat, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS; Z01 ES049005) (https://www.niehs.nih.gov/), grants from the NIEHS (R01 ES13244) and the ALS Association (ALSA 1230) (http://www.alsa.org/), and training grants from the NIEHS (T32ES007018) and the Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health (T420H00867302) (http://www.cdc.gov/niosh/). The National Registry of Veterans with ALS was supported by the U.S. Department of Veterans Affairs (CSP #500A) (http://www.va.gov/). JK is employed by Westat, Inc., a commercial company. Westat, Inc., provided support in the form of salary for an author [JK], but, along with the other funders, did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author [JK] is articulated in the "Author Contributions" section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen KD, 2008, NEUROEPIDEMIOLOGY, V30, P180, DOI 10.1159/000126910; Allison P. D., 2010, SURVIVAL ANAL USING, VSecond; Arnold N, 2006, 2 VIREC; Beard J. L, 2015, THESIS; Beard JD, 2016, ENVIRON INT, V91, P104, DOI 10.1016/j.envint.2016.02.014; Beard JD, 2015, EPIDEMIOL REV, V37, P55, DOI 10.1093/epirev/mxu001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bramsen I, 2001, J TRAUMA STRESS, V14, P733, DOI 10.1023/A:1013090005246; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Brooks BR, 2003, AMYOTRAPH LATERAL S1, V4, P114; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Coffman CJ, 2005, NEUROEPIDEMIOLOGY, V24, P141, DOI 10.1159/000083297; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Doebbeling BN, 2002, J CLIN EPIDEMIOL, V55, P477, DOI 10.1016/S0895-4356(01)00517-0; Goldberg M, 2011, ENVIRON RES, V111, P1007, DOI 10.1016/j.envres.2011.08.010; Gordon PH, 2010, J NEUROL, V257, P1713, DOI 10.1007/s00415-010-5609-1; Gordon PH, 2009, ARCH NEUROL-CHICAGO, V66, P758, DOI 10.1001/archneurol.2009.1; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; Greenland S, 2008, INT J EPIDEMIOL, V37, P430, DOI 10.1093/ije/dyn064; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; JANES GR, 1991, J CLIN PSYCHOL, V47, P80, DOI 10.1002/1097-4679(199101)47:1<80::AID-JCLP2270470112>3.0.CO;2-9; Kasarskis EJ, 2009, AMYOTROPH LATERAL SC, V10, P35, DOI 10.1080/17482960802351029; Kasarskis EJ, 2004, AMYOTROPH LATERAL SC, V5, P129, DOI 10.1080/17434470410019915; Lash, 2008, MODERN EPIDEMIOLOGY, P345; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; LeardMann CA, 2007, HUM VACCINES, V3, P245, DOI 10.4161/hv.4589; Mahan CM, 2004, ANN EPIDEMIOL, V14, P81, DOI 10.1016/S1047-2797(03)00124-8; Mandrioli J, 2006, AMYOTROPH LATERAL SC, V7, P211, DOI 10.1080/17482960600947648; Miller RG, 2000, NEUROLOGY, V54, P53, DOI 10.1212/WNL.54.1.53; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; National Center for Health Statistics Center for Disease Control and Prevention, 2013, NAT DEATH IND HOM; OBrien KM, 2014, AM J EPIDEMIOL, V179, P382, DOI 10.1093/aje/kwt258; Pastula DM, 2009, AMYOTROPH LATERAL SC, V10, P332, DOI 10.3109/17482960802320545; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Savitz DA, 1998, AM J EPIDEMIOL, V147, P813, DOI 10.1093/oxfordjournals.aje.a009532; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schmidt S, 2008, NEUROEPIDEMIOLOGY, V30, P191, DOI 10.1159/000126911; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Smith B, 2007, ANN EPIDEMIOL, V17, P976, DOI 10.1016/j.annepidem.2007.07.102; Smith B, 2007, AM J PREV MED, V32, P347, DOI 10.1016/j.amepre.2006.12.015; Smith TC, 2007, INT J ENVIRON HEAL R, V17, P271, DOI 10.1080/09603120701372243; Smith TC, 2009, J OCCUP ENVIRON MED, V51, P1193, DOI 10.1097/JOM.0b013e3181b73146; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575; Thompson JR, 1998, AM J EPIDEMIOL, V147, P801, DOI 10.1093/oxfordjournals.aje.a009530; Vergara X, 2013, J OCCUP ENVIRON MED, V55, P135, DOI 10.1097/JOM.0b013e31827f37f8; Witte JS, 1998, EPIDEMIOLOGY, V9, P563, DOI 10.1097/00001648-199809000-00016; World Health Organization, 1977, INT STAT CLASS DIS R	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185751	10.1371/journal.pone.0185751	http://dx.doi.org/10.1371/journal.pone.0185751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016608	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400029
J	Collings, SL; Lefevre, C; Johnson, ME; Evans, D; Hack, G; Stynes, G; Maguire, A				Collings, Shuk-Li; Lefevre, Cinira; Johnson, Michelle E.; Evans, David; Hack, Guido; Stynes, Gillian; Maguire, Andrew			Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany	PLOS ONE			English	Article							WARFARIN DISCONTINUATION; DABIGATRAN; APIXABAN; RISK; RIVAROXABAN; ADHERENCE; STROKE	This study examined characteristics and treatment persistence among patients prescribed oral anticoagulants (OACs) for stroke prevention in non-valvular atrial fibrillation (NVAF). We identified 15,244 patients (51.8% male, 72.7% aged >= 70) with NVAF and no prior OAC therapy who were prescribed apixaban (n = 1,303), rivaroxaban (n = 5,742), dabigatran (n = 1,622) or vitamin-K antagonists (VKAs, n = 6,577) between 1-Dec-2012 and 31-Oct-2014 in German primary care (IMS (R) Disease Analyzer). We compared OAC persistence using Cox regression over patients' entire follow-up and using a data-driven time-partitioned approach (before/after 100 days) to handle non-proportional hazards. History of stroke risk factors (stroke/transient ischaemic attack [TIA] 15.2%; thromboembolism 14.1%; hypertension 84.3%) and high bleeding risk (HAS-BLED score >= 3 68.4%) was common. Apixaban-prescribed patients had more frequent history of stroke/TIA (19.7%) and high bleeding risk (72.6%) than other OACs. 12-month persistence rates were: VKA 57.5% (95% confidence interval (CI) 56.0-59.0%), rivaroxaban 56.6% (54.9-58.2%), dabigatran 50.1% (47.2- 53.1%), apixaban 62.9% (58.8-67.0%). Over entire follow-up, compared to VKA, non-persistence was similar with apixaban (adjusted hazard ratio 1.08, 95% CI 0.95-1.24) but higher with rivaroxaban (1.21, 1.14-1.29) and dabigatran (1.53, 1.40-1.68). Using post-hoc time-partitioned approach: in first 100 days, non-persistence was higher with apixaban (1.37, 1.17-1.59), rivaroxaban (1.41, 1.30-1.53) and dabigatran (1.91, 1.70-2.14) compared to VKA. Compared to apixaban, rivaroxaban non-persistence was similar (1.03, 0.89- 1.20), dabigatran was higher (1.39, 1.17-1.66). After 100 days, apixaban non-persistence was lower than VKA (0.66, 0.52-0.85); rivaroxaban (0.97, 0.87-1.07) and dabigatran (1.10, 0.95-1.28) were similar to VKA. Furthermore, rivaroxaban (1.46, 1.13-1.88) and dabigatran (1.67, 1.26-2.19) non-persistence was higher than apixaban. This study describes real-world observations on OAC use, particularly early apixaban use following approval for NVAF, in Germany. We identified potential differential OAC prescribing and higher persistence with apixaban than other OACs after 100 days' treatment. Larger studies are needed with longer follow-up to establish long-term patterns.	[Collings, Shuk-Li; Johnson, Michelle E.; Maguire, Andrew] OXON Epidemiol, London, England; [Lefevre, Cinira; Evans, David] Bristol Myers Squibb, Ctr Observat Res & Data Sci, Paris, France; [Hack, Guido] Bristol Myers Squibb, Med Dept, Munich, Germany; [Stynes, Gillian] Bristol Myers Squibb, Worldwide Hlth Econ & Outcomes Res, London, England	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Collings, SL (corresponding author), OXON Epidemiol, London, England.	shuk-li.collings@oxonepi.com			Bristol-Myers Squibb, Paris, France; Pfizer; Bristol-Myers Squibb	Bristol-Myers Squibb, Paris, France(Bristol-Myers Squibb); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb, Paris, France (www.bmsfrance.fr) and Pfizer (www.pfizer.com). CL, DE, GH and GS were employed by Bristol-Myers Squibb at the time of the study and contributed to the study design, interpretation of results and manuscript. MJ, SC and AM were employed by OXON Epidemiology Ltd, which has received funding from Bristol-Myers Squibb to develop this study.	[Anonymous], XAR 15MG FILM COAT T; [Anonymous], PRAD 110MG HARD CAPS; [Anonymous], EL 2 5 MG FILM COAT; Bancroft T, 2016, CLIN THER, V38, P545, DOI 10.1016/j.clinthera.2016.01.008; Becher H, 2009, INT J CLIN PHARM TH, V47, P617; Beyer-Westendorf J, 2016, EUROPACE, V18, P1150, DOI 10.1093/europace/euv421; Brown Joshua D, 2016, J Manag Care Spec Pharm, V22, P1319; Camm AJ, 2015, EUROPACE, V17, P1007, DOI 10.1093/europace/euv068; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Coleman CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157769; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; DeWilde S, 2006, HEART, V92, P1064, DOI 10.1136/hrt.2005.069492; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hohnloser SH, 2016, EUR HEART J, V37, P513; Hylek EM, 2014, J AM COLL CARDIOL, V63, P2141, DOI 10.1016/j.jacc.2014.02.549; Johnson ME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011471; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Lefevre C, 2016, J AM COLL CARDIOL, V67, P769, DOI 10.1016/S0735-1097(16)30770-7; Lip GYH, 2016, INT J CLIN PRACT, V70, P752, DOI 10.1111/ijcp.12863; Miller CS, 2012, AM J CARDIOL, V110, P453, DOI 10.1016/j.amjcard.2012.03.049; National Institute for Health and Clinical Excellence, 2014, ATR FIBR MAN; O'Brien EC, 2014, AM HEART J, V168, P487, DOI 10.1016/j.ahj.2014.07.002; Olesen JB, 2015, EUROPACE, V17, P187, DOI DOI 10.1093/EUR0PACE/; Pan XY, 2014, J AM COLL CARDIOL, V63, pA415, DOI 10.1016/S0735-1097(14)60415-0; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piccini JP, 2014, EUR HEART J, V35, P250, DOI 10.1093/eurheartj/eht483; Rubboli A, 2015, CURR MED RES OPIN, V31, P1845, DOI 10.1185/03007995.2015.1086993; Savelieva I, 2014, CLIN CARDIOL, V37, P32, DOI 10.1002/clc.22204; Simonin L, 2017, CLIN REV ALLERG IMMU, V53, P14, DOI 10.1007/s12016-016-8568-1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yao X, 2016, J AM HEART ASS, V5; Zalesak M, 2013, CIRC-CARDIOVASC QUAL, V6, P567, DOI 10.1161/CIRCOUTCOMES.113.000192	36	23	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185642	10.1371/journal.pone.0185642	http://dx.doi.org/10.1371/journal.pone.0185642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016695	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400026
J	Macario, P; Pichorim, M; Doherty, PF; Toledo-Lima, GS; Oliveira, TM; Camara, TPF; Melo, SM; Silveira, JLS; Araujo, JC; Franca, LF				Macario, Phoeve; Pichorim, Mauro; Doherty, Paul F., Jr.; Toledo-Lima, Guilherme S.; Oliveira-Junior, Tonny M.; Camara, Thanyria P. F.; Melo, Shirley Macjane; Silveira, Joao Lucas S.; Araujo, Juliana C.; Franca, Leonardo F.			Apparent survival and cost of reproduction for White-lined Tanager (Tachyphonus rufus, Thraupidae) in the northern Atlantic Rainforest, Brazil	PLOS ONE			English	Article							AFRICAN SYLVIA WARBLERS; LIFE-HISTORY EVOLUTION; NEW-WORLD POPULATIONS; NEOTROPICAL BIRDS; CLUTCH-SIZE; DEMOGRAPHIC PARAMETERS; JUVENILE SURVIVAL; MODEL SELECTION; HABITAT USE; PATTERNS	Understanding latitudinal variation in avian life-history traits has been a focus of many demographic studies around the world. However, we still know little about annual or intra-annual demographic variation within tropical regions or about how factors such as breeding season and precipitation influence demographic rates. In this study, we estimated intra-annual apparent survival of the White-lined Tanager (Tachyphonus rufus) using capture-markrecapture data from northeastern Brazil. We tested whether survival varied seasonally (breeding vs. non-breeding), with rainfall, by age and residence status in our study area. Intra-annual apparent survival was correlated with the reproductive cycle, being lower during the breeding (0.65 +/- 0.16 SE) vs. the non-breeding season (0.97 +/- 0.05 SE). The annual apparent survival (similar to 0.6) was relatively low for a tropical species. In both years, we observed highest abundance in spring (November, 3.1-3.7 birds/ha) and lowest abundance in autumn-winter periods (May-August, 1.1-1.4 bird/ha). The low survival during the breeding season probably reflects the trade-off between survival and reproduction and the cost of reproduction. Our findings represent an advance in the understanding of the demography of tropical birds because we did not find a predicted high annual apparent survival, and we elucidated some aspects of intra-annual variation in survival. Further exploration of latitudinal variation in demographic traits, especially in diverse, but poorly known habitats is needed to fully vet and develop life history theories.	[Macario, Phoeve; Toledo-Lima, Guilherme S.] Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil; [Macario, Phoeve; Pichorim, Mauro; Toledo-Lima, Guilherme S.; Oliveira-Junior, Tonny M.; Camara, Thanyria P. F.; Melo, Shirley Macjane; Silveira, Joao Lucas S.; Araujo, Juliana C.] Univ Fed Rio Grande do Norte, Lab Ornitol, Dept Bot & Zool, Natal, RN, Brazil; [Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Oliveira-Junior, Tonny M.] Univ Fed Rio Grande do Norte, Programa Posgrad Ciencias Biol, Natal, RN, Brazil; [Franca, Leonardo F.] Univ Fed Rural Semi Arido, Lab Ecol Populacaes Anim, Mossoro, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Colorado State University; Universidade Federal do Rio Grande do Norte; Universidade Federal Rural do Semi-Arido (UFERSA)	Macario, P (corresponding author), Univ Fed Rio Grande do Norte, Programa Posgrad Ecol, Natal, RN, Brazil.; Macario, P (corresponding author), Univ Fed Rio Grande do Norte, Lab Ornitol, Dept Bot & Zool, Natal, RN, Brazil.	phoevemacario@gmail.com	Pichorim, Mauro/H-2224-2014	Pichorim, Mauro/0000-0002-9340-9010	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [474945/2010-3, 248588/2013-3]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	The long-term field study was financially supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq processes 474945/2010-3, 248588/2013-3), http://cnpq.br/, and the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES), http://www.capes.gov.br/, granted scholarships to GSTL, PM, and TMO Jr.	Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Anderson KE, 2012, AUK, V129, P307, DOI 10.1525/auk.2012.11164; [Anonymous], 1982, ESTIMATION ANIMAL AB; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Blake JG, 2002, AUK, V119, P132, DOI 10.1642/0004-8038(2002)119[0132:MPISGA]2.0.CO;2; Blake JG, 2008, BIOTROPICA, V40, P485, DOI 10.1111/j.1744-7429.2007.00395.x; Blake JA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003343; Blomberg EJ, 2014, ECOL EVOL, V4, P4488, DOI 10.1002/ece3.1139; Blomberg EJ, 2013, J AVIAN BIOL, V44, P149, DOI 10.1111/j.1600-048X.2012.00013.x; Boano Giovanni, 2004, Avocetta, V28, P77; Both C, 2000, J AVIAN BIOL, V31, P412, DOI 10.1034/j.1600-048X.2000.310317.x; Brawn JD, 1999, P INT ORN C, V22, P297; BRYANT DM, 1979, J ANIM ECOL, V48, P655, DOI 10.2307/4185; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Silva João Vitor Campos e, 2012, Acta Amaz., V42, P73, DOI 10.1590/S0044-59672012000100009; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; COLLAR N., 2005, HDB BIRDS WORLD, V10, P514; Conn PB, 2005, ECOLOGY, V86, P2536, DOI 10.1890/04-1799; DIJKSTRA C, 1990, J ANIM ECOL, V59, P269, DOI 10.2307/5172; Faaborg J, 1995, AUK, V112, P503, DOI 10.2307/4088741; FAABORG J, 1984, WILSON BULL, V96, P575; Fleming T.H., 1992, P355; FOGDEN MPL, 1972, IBIS, V114, P307, DOI 10.1111/j.1474-919X.1972.tb00831.x; Franca LF, 2010, J FIELD ORNITHOL, V81, P227, DOI 10.1111/j.1557-9263.2010.00279.x; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Hernandez-Matias A, 2011, IBIS, V153, P846, DOI 10.1111/j.1474-919X.2011.01158.x; Hilty S.L, 2011, HDB BIRDS WORLD, V16, P46; Hoef JMV, 2012, AM STAT, V66, P124, DOI 10.1080/00031305.2012.687494; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Johnston JP, 1997, AM NAT, V150, P771, DOI 10.1086/286093; Jullien M, 2000, ECOLOGY, V81, P3416, DOI 10.1890/0012-9658(2000)081[3416:TSVOFI]2.0.CO;2; KARR JR, 1990, AM NAT, V136, P277, DOI 10.1086/285098; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kostecke RM, 2008, CONDOR, V110, P251, DOI 10.1525/cond.2008.8459; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Lack D., 1954, P343; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lack D., 1966, POPULATION STUDIES B; LOERY G, 1987, ECOLOGY, V68, P1038, DOI 10.2307/1938375; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Marengo JA, 2013, J CLIMATE, V26, P9137, DOI 10.1175/JCLI-D-12-00642.1; MARTIN K, 1995, AM ZOOL, V35, P340; MARTIN TE, 1986, WILSON BULL, V98, P38; Martin TE, 1996, J AVIAN BIOL, V27, P263, DOI 10.2307/3677257; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Merila J, 1997, J ANIM ECOL, V66, P452, DOI 10.2307/5940; Newton I., 1998, POPULATION LIMITATIO; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; Nimer E., 1972, REV BRAS GEOGR, V34, P3; Oberg M, 2015, ECOL EVOL, V5, P345, DOI 10.1002/ece3.1345; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Parker TH, 2006, BIOTROPICA, V38, P764, DOI 10.1111/j.1744-7429.2006.00210.x; Pearce-Higgins JW, 2007, CONDOR, V109, P167, DOI 10.1650/0010-5422(2007)109[167:SOBM]2.0.CO;2; Pichorim M, 2010, ANN ZOOL FENN, V47, P123, DOI 10.5735/086.047.0205; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; RICKLEFS RE, 1977, CONDOR, V79, P376, DOI 10.2307/1368016; RICKLEFS RE, 1980, AUK, V97, P38; Ricklefs RE, 2005, ECOLOGY, V86, P2541, DOI 10.1890/05-0066; Ricklefs RE, 2000, CONDOR, V102, P3, DOI 10.1650/0010-5422(2000)102[0003:LSAMTE]2.0.CO;2; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ricklefs RE, 2007, ECOLOGY, V88, P1408, DOI 10.1890/06-1035; Ricklefs RE, 2011, J ORNITHOL, V152, P481, DOI 10.1007/s10336-010-0614-9; RIDGELY RS, 1989, BIRDS S AM; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rodrigues RR, 2014, GEOPHYS RES LETT, V41, P1012, DOI 10.1002/2013GL058703; Ruiz-Gutierrez V, 2008, ECOL APPL, V18, P838, DOI 10.1890/07-1090.1; Ruiz-Gutierrez V, 2012, AUK, V129, P500, DOI 10.1525/auk.2012.11171; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Sandercock BK, 2000, ECOLOGY, V81, P1351, DOI 10.2307/177213; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Sankamethawee W, 2011, ECOL RES, V26, P429, DOI 10.1007/s11284-011-0802-y; Schaefer HC, 2006, IBIS, V148, P411, DOI 10.1111/j.1474-919X.2006.00544.x; Schaefer HC, 2004, IBIS, V146, P427, DOI 10.1111/j.1474-919X.2004.00276.x; Sharp PJ, 1996, ANIM REPROD SCI, V42, P505, DOI 10.1016/0378-4320(96)01556-4; Sick H, 2001, ORNITOLOGIA BRASILEI; SIMONS LS, 1990, ECOLOGY, V71, P869, DOI 10.2307/1937358; Skutch A. F., 1949, Auk, V66, P1; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; SNOW DW, 1974, CONDOR, V76, P262, DOI 10.2307/1366339; Snow DW, 1962, TRINIDAD ZOOLOGICA, V47, P65; Stanley TR, 2005, WILDLIFE SOC B, V33, P782, DOI 10.2193/0091-7648(2005)33[782:SRAPFT]2.0.CO;2; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stutchbury BJM, 2001, BEHAV ECOL SOCIOBIOL; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Thomson DL, 1997, J ANIM ECOL, V66, P414, DOI 10.2307/5986; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Ward DH, 2004, CONDOR, V106, P263, DOI 10.1650/7387; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	99	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185890	10.1371/journal.pone.0185890	http://dx.doi.org/10.1371/journal.pone.0185890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016633	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400034
J	Pan, J; Li, K; Huang, W; Zhang, XQ				Pan, Jin; Li, Kai; Huang, Wei; Zhang, Xiaoqing			MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling	PLOS ONE			English	Article							PROMOTES; GROWTH; MICRORNAS; METASTASIS; ACTIVATION; MECHANISMS; PATHWAY; ROLES	Abnormal proliferation of vascular smooth muscle cells (VSMCs) contributes to the development of cardiovascular diseases. Studies have shown the great impact of microRNAs (miRNAs) on the cell proliferation of VSMCs. This study examined the effects of miR-137 on the cell proliferation and migration of VSMCs and also explored the underlying molecular mechanisms. The mRNA and protein expression levels were determined by qRT-PCR and western blot assays, respectively. The CCK-8 assay, wound healing assay and transwell migration assay were performed to measure cell proliferation and migration of VSMCs. The miR-137-targeted 3'untranslated region of insulin-like growth factor-binding protein-5 (IGFBP-5) was confirmed by luciferase reporter assay. Platelet-derived growth factor-bb (PDGF-bb) treatment enhanced cell proliferation and suppressed the expression of miR-137 in VSMCs. The gain-of-function and loss-of-function assays showed that overexpression of miR-137 suppressed the cell proliferation and migration, and also inhibited the expression of matrix genes of VSMCs; down-regulation of miR-137 had the opposite effects on VSMCs. Bioinformatics analysis and luciferase report assay results showed that IGFBP-5 was a direct target of miR-137, and miR-137 overexpression suppressed the IGFBP-5 expression and down-regulation of miR-137 increased the IGFBP-5 expression in VSMCs. PDGF-bb treatment also increased the IGFBP-5 mRNA expression. In addition, enforced expression of IGFBP-5 reversed the inhibitory effects of miR-137 on cell proliferation and migration of VSMCs. More importantly, overexpression of miR-137 also suppressed the activity of mTOR/STAT3 signaling in VSMCs. Taken together, the results suggest that miR-137 may suppress cell proliferation and migration of VSMCs via targeting IGFBP-5 and modulating mTOR/STAT3 signaling pathway.	[Pan, Jin; Huang, Wei; Zhang, Xiaoqing] Xian Med Univ, Clin Med Coll, Xian, Shaanxi, Peoples R China; [Li, Kai] Xian Med Univ, Affiliated Hosp 1, Dept Cardiol, Xian, Shaanxi, Peoples R China	Xi'an Medical University; Xi'an Medical University	Pan, J (corresponding author), Xian Med Univ, Clin Med Coll, Xian, Shaanxi, Peoples R China.	pannjin@126.com			Shaanxi Science and Technology Department [2012KRM64]	Shaanxi Science and Technology Department	This project was supported by Soft Science Project of Shaanxi Science and Technology Department (www.sninfogov.cn/), 2012KRM64 to JP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bach LA, 2015, BEST PRACT RES CL EN, V29, P713, DOI 10.1016/j.beem.2015.06.002; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bi R, 2016, BIOMED PHARMACOTHER, V84, P1711, DOI 10.1016/j.biopha.2016.10.081; Bian DH, 2017, AM J TRANSL RES, V9, P1509; Cheng Y, 2014, FEBS LETT, V588, P3274, DOI 10.1016/j.febslet.2014.07.012; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; DU YT, 2016, J INT SOC ONCODEVELO, V37, P13557; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Fan XM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5135781; Gao Y, 2016, CLIN CHIM ACTA, V460, P164, DOI 10.1016/j.cca.2016.06.044; Guo X, 2016, SCI REP-UK, V6, DOI 10.1038/srep35302; Gurha P, 2016, CURR OPIN CARDIOL, V31, P249, DOI 10.1097/HCO.0000000000000280; Huang YC, 2016, ONCOTARGET, V7, P76852, DOI 10.18632/oncotarget.12719; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim S, 2013, BMB REP, V46, P550, DOI 10.5483/BMBRep.2013.46.11.057; Li K, 2017, YONSEI MED J, V58, P234, DOI 10.3349/ymj.2017.58.1.234; Li P, 2014, ARTERIOSCL THROM VAS, V34, P2001, DOI 10.1161/ATVBAHA.113.303145; Li TJ, 2015, INT J CLIN EXP PATHO, V8, P10375; Li XD, 2017, BRIT J CANCER, V116, P66, DOI 10.1038/bjc.2016.379; Li YM, 2014, AM J TRANSL RES, V6, P507; Liu LL, 2014, ONCOTARGET, V5, P5113, DOI 10.18632/oncotarget.2089; Matsuoka T, 2014, CANCERS, V6, P1441, DOI 10.3390/cancers6031441; Millette E, 2006, TRENDS CARDIOVAS MED, V16, P25, DOI 10.1016/j.tcm.2005.11.003; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Porter KE, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0647-9; Pu X, 2014, ASIAN PAC J TROP MED, V7, P368, DOI 10.1016/S1995-7645(14)60057-2; Sun J, 2015, J NEURO-ONCOL, V122, P481, DOI 10.1007/s11060-015-1753-x; Wang HR, 2015, INT J CLIN EXP PATHO, V8, P12901; Wang P, 2016, CELL PROLIFERAT, V49, P484, DOI 10.1111/cpr.12265; Welten SMJ, 2016, CARDIOVASC RES, V110, P6, DOI 10.1093/cvr/cvw039; Wu DC, 2016, ONCOTARGET, V7, P38052, DOI 10.18632/oncotarget.9343; Xie BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141512; Xu QJ, 2004, CIRC RES, V94, pE46, DOI 10.1161/01.RES.0000124761.62846.DF; Yang F, 2016, AM J TRANSL RES, V8, P506; Yu M, 2017, INT J ONCOL, V50, P975, DOI 10.3892/ijo.2017.3852; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	39	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186245	10.1371/journal.pone.0186245	http://dx.doi.org/10.1371/journal.pone.0186245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016699	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400062
J	van Heuckelum, M; van den Ende, CHM; Houterman, AEJ; Heemskerk, CPM; van Dulmen, S; van den Bemt, BJF				van Heuckelum, Milou; van den Ende, Cornelia H. M.; Houterman, Anne E. J.; Heemskerk, Charlotte P. M.; van Dulmen, Sandra; van den Bemt, Bart J. F.			The effect of electronic monitoring feedback on medication adherence and clinical outcomes: A systematic review	PLOS ONE			English	Review							IMPROVE ADHERENCE; QUALITY; GUIDELINES; INTERVENTION; TRIAL; TRANSPLANTATION; THERAPY; IMPACT	Objective This study aims to assess the efficacy of Electronic Monitoring Feedback (EMF) as an intervention to improve medication adherence (i.e. dose-or full adherence) and clinical outcomes in adult patients. Methods A systematic search was performed in Medline, EMBASE, PsycINFO and Web of Science and reported according to the PRISMA guidelines. Randomised controlled trials (RCTs) comparing EMF with usual care were identified to systematically summarise the evidence for use of EMF in improving medication adherence and clinical outcomes. The GRADE approach was used to assess the quality of the body of evidence. Results Of 9,993 initially-identified studies, ten studies (four of high-quality and six of low-quality) were included. The sample size of the studies included varied from 18 to 205 patients. Four of the six studies (66.7%) reported a significant positive effect of EMF on mean dose adherence levels, whereas a significant positive effect of EMF on mean full adherence levels was found in all of the included studies (100%, five out of five of the studies included). A significant positive effect of EMF on clinical outcomes was reported in one of the seven studies included. The overall effect of EMF on mean dose-and full adherence was positive and the overall effect of EMF on clinical outcomes was inconclusive. Conclusion Considering the positive effect of EMF on medication adherence, EMF might be a promising intervention to enhance medication adherence. However, the effect of EMF on clinical outcomes was inconclusive. Prior to implementing EMF in clinical practice, future research with high-quality studies (e.g. adequate sample sizes, follow-up periods and no interfering co-interventions) is required to examine the (long-term) efficacy of EMF.	[van Heuckelum, Milou; van den Ende, Cornelia H. M.; van den Bemt, Bart J. F.] Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands; [van Heuckelum, Milou; van den Ende, Cornelia H. M.; van den Bemt, Bart J. F.] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands; [van den Ende, Cornelia H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands; [Houterman, Anne E. J.; van den Bemt, Bart J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands; [Heemskerk, Charlotte P. M.] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [van Dulmen, Sandra] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [van Dulmen, Sandra] Buskerud & Vestfold Univ Coll, Fac Hlth Sci, Drammen, Norway; [van Dulmen, Sandra] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands	Sint Maartens Clinic; Sint Maartens Clinic; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Netherlands Institute for Health Services Research; University College of Southeast Norway; Radboud University Nijmegen	van Heuckelum, M (corresponding author), Sint Maartenskliniek, Dept Rheumatol, Nijmegen, Netherlands.; van Heuckelum, M (corresponding author), Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands.	M.vanheuckelum@maartenskliniek.nl	van den Ende, Cornelia/ABG-7626-2020; Van den Bemt, Bart/Q-2740-2015; van den Ende, Cornelia/G-9559-2011; van Dulmen, A.M./L-4287-2015	Van den Bemt, Bart/0000-0002-8560-9514; van den Ende, Cornelia/0000-0002-4352-2824; van Dulmen, A.M./0000-0002-1651-7544; van Heuckelum, Milou/0000-0001-7179-4475				Apter AJ, 2011, J ALLERGY CLIN IMMUN, V128, P516, DOI 10.1016/j.jaci.2011.05.010; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Behner P, 2012, UNLEASHING POTENTIAL; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Brath H, 2013, BRIT J CLIN PHARMACO, V76, P47, DOI 10.1111/bcp.12184; Capgemini Consulting, 2011, PAT ADH NEXT FRONT P; de Bruin M, 2010, HEALTH PSYCHOL, V29, P421, DOI 10.1037/a0020335; De Geest S, 2006, CLIN TRANSPLANT, V20, P359, DOI 10.1111/j.1399-0012.2006.00493.x; Demonceau J, 2013, DRUGS, V73, P545, DOI 10.1007/s40265-013-0041-3; Dobbels F, 2017, J HEART LUNG TRANSPL, V36, P499, DOI 10.1016/j.healun.2017.01.007; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Interian A, 2013, DEPRESS ANXIETY, V30, P688, DOI 10.1002/da.22052; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mooney ME, 2007, ADDICT BEHAV, V32, P875, DOI 10.1016/j.addbeh.2006.06.022; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Ogna VF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/104892; Onyirimba F, 2003, ANN ALLERG ASTHMA IM, V90, P411, DOI 10.1016/S1081-1206(10)61825-X; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; SabatU E., 2003, ADHERENCE LONG TERM; Sabin LL, 2010, AIDS BEHAV, V14, P580, DOI 10.1007/s10461-009-9615-1; Santschi V, 2008, EUR J INTERN MED, V19, P427, DOI 10.1016/j.ejim.2007.12.007; Schmitz JM, 2005, J BEHAV MED, V28, P139, DOI 10.1007/s10865-005-3663-4; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7647; van den Bemt BJF, 2012, EXPERT REV CLIN IMMU, V8, P337, DOI [10.1586/ECI.12.23, 10.1586/eci.12.23]; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wu AW, 2006, AIDS PATIENT CARE ST, V20, P773, DOI 10.1089/apc.2006.20.773; Wu JR, 2012, J CARD FAIL, V18, P1, DOI 10.1016/j.cardfail.2011.09.006	29	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185453	10.1371/journal.pone.0185453	http://dx.doi.org/10.1371/journal.pone.0185453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991903	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800017
J	Li, SS; Hu, ADN; Wang, W; Ding, XY; Lu, L				Li, Songshan; Hu, Andina; Wang, Wei; Ding, Xiaoyan; Lu, Lin			Combinatorial treatment with topical NSAIDs and anti-VEGF for age-related macular degeneration, a meta-analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; KETOROLAC EYEDROPS; BROMFENAC; RANIBIZUMAB; THERAPY	Inflammation is a key pathogenic factor in age-related macular degeneration (AMD). However, the clinical importance of combining anti-VEGF agents and topical NSAIDs to reduce inflammation remains unclear. In this study, we systematically reviewed clinical trials comparing combined treatment versus anti-VEGF alone in AMD patients. We quantified treatment effects via meta-analysis. The pooled weighted mean difference (WMD, -0.91, 95% CI: -1.39 to -0.42, P = 0.0003) demonstrates that combined treatment may reduce required anti-VEGF injection number, probably by means of decreasing central retina thickness (CRT) (WMD = -22.9, 95% CI: -41.20 to -4.59, P = 0.01). The best corrected visual acuity (BCVA) did not change significantly between these two groups (WMD = -0.01, 95% CI: -0.23 to 0.20, P = 0.90). Topical NSAIDs slightly increased the incidence of foreign body sensation (Odds Ratio [OR] = 2.63, 95% Cl: 1.06 to 6.52, P = 0.76). Combining topical NSAIDs and anti-VEGF agents may provide a new strategy for AMD treatment.	[Li, Songshan; Hu, Andina; Wang, Wei; Ding, Xiaoyan; Lu, Lin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Retina Div, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Ding, XY; Lu, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Retina Div, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	dingxy75@gmail.com; lulin888@126.com						Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Baklayan GA, 2008, J OCUL PHARMACOL TH, V24, P392, DOI 10.1089/jop.2007.0082; Chen E, 2010, CLIN OPHTHALMOL, V4, P1249, DOI 10.2147/OPTH.S14092; Flaxel C, 2012, RETINA-J RET VIT DIS, V32, P417, DOI 10.1097/IAE.0b013e318229b0af; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gillies MC, 2004, ARCH OPHTHALMOL-CHIC, V122, P336, DOI 10.1001/archopht.122.3.336; Gomi F, 2012, RETINA-J RET VIT DIS, V32, P1804, DOI 10.1097/IAE.0b013e31825be87f; Russo A, 2013, BRIT J OPHTHALMOL, V97, P1273, DOI 10.1136/bjophthalmol-2013-303417; Semeraro F, 2015, RETINA-J RET VIT DIS, V35, P1547, DOI 10.1097/IAE.0000000000000525; Wang Y, 2011, EYE, V25, P127, DOI 10.1038/eye.2010.196; Warren KA, 2010, RETINA-J RET VIT DIS, V30, P260, DOI 10.1097/IAE.0b013e3181b8628e; Waterbury LD, 2006, CURR MED RES OPIN, V22, P1133, DOI 10.1185/030079906X112471; Wygledowska-Promienska D, 2015, MED SCI MONITOR, V21, P3906, DOI 10.12659/MSM.895977; Wygledowska-Promienska D, 2014, MED SCI MONITOR, V20, P1168, DOI 10.12659/MSM.890671; Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101; Zweifel SA, 2009, RETINA-J RET VIT DIS, V29, P1527, DOI 10.1097/IAE.0b013e3181b32f4c	16	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0184998	10.1371/journal.pone.0184998	http://dx.doi.org/10.1371/journal.pone.0184998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985220	Green Published, gold, Green Submitted			2022-12-27	WOS:000412493000003
J	Inghels, M; Niangoran, S; Minga, A; Yoboue, JM; Dohoun, L; Yao, A; Eholie, S; Anglaret, X; Danel, C				Inghels, Maxime; Niangoran, Serge; Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo; Eholie, Serge; Anglaret, Xavier; Danel, Christine			Missed opportunities for HIV testing among newly diagnosed HIV-infected adults in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE SETTINGS; AFRICA	Background HIV testing is crucial for starting ART earlier in HIV-infected people. We describe Missed Opportunities (MO) for HIV testing among adults newly diagnosed with HIV in Abidjan, Cote d'Ivoire. Methods Between april, 2nd 2013 and april 1st 2014, a cross-sectional study was conducted among all adults newly diagnosed (< 1year) for HIV at the Blood Donors Medical Center of Abidjan with face to face questionnaire. An MO for HIV testing was defined as a medical consultation for a clinical indicator (e.g. symptoms, hospitalization, and pregnancy) or a non-clinical indicator (e.g. high-risk sexual behavior, HIV-infected partner) potentially related to an HIV infection but did not lead to HIV test proposal by a health care professional. Results Of the 341 patients who attended the center suring this period, 273 (157 women and 116 men) were included in this analysis. 130 (47.6%) reported at least one medical consultation for an indicator relevant for a test proposal between 1 month and five years prior to their diagnosis. Among them, 92 (77.3%) experienced at least one MO for testing. The 273 included patients reported a total of 216 indicators; 146 (67.6%) were reported without test proposal and thus were MO. Hospitalization, extreme lose of weight, chronic or repeat fever and herpes zoster were the indicators with the largest number of MO. While 66 (24.2%) patients experienced non-clinical indicators relevant to risk of HIV infection, only 11 (4.0%) mentioned it to a health professional. Conclusion MO for HIV testing are frequent, even in situations for which testing is clearly recommended. Better train healthcare professionals and creating new opportunities of testing inside and, outside of medical settings are crucial to improve HIV control.	[Inghels, Maxime] Paris Descartes Inst Rech & Dev IRD, UMR 196, Ctr Populat & Dev CEPED, Paris, France; [Niangoran, Serge; Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo; Eholie, Serge; Anglaret, Xavier; Danel, Christine] CHU Treichville, Programme PAC CI ANRS Res Site, Abidjan, Cote Ivoire; [Minga, Albert; Yoboue, Jean Michel; Dohoun, Lambert; Yao, Abo] CNTS, Ctr Med Suivi Donneurs Sang, CMSDS, Abidjan, Cote Ivoire; [Eholie, Serge] Treichville Hosp, Dept Infect Dis, Abidjan, Cote Ivoire; [Anglaret, Xavier; Danel, Christine] Bordeaux Univ, Ctr Inserm 1219, Bordeaux, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm)	Inghels, M (corresponding author), Paris Descartes Inst Rech & Dev IRD, UMR 196, Ctr Populat & Dev CEPED, Paris, France.	maxime.inghels@gmail.com	Inghels, Maxime/AAY-1967-2020; Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019; Eholie, Serge/T-6008-2019	Inghels, Maxime/0000-0002-9340-2054; NIANGORAN, Serge/0000-0003-1747-1995; Anglaret, Xavier/0000-0003-3319-8423	France Recherche Nord AMP; Sud Sida-hiv Hepatites; SIDACTION	France Recherche Nord AMP; Sud Sida-hiv Hepatites; SIDACTION	The study was funded by the France Recherche Nord & Sud Sida-hiv Hepatites (http:// www.anrs.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Alvine Gomene, Benjamin Osher and Justine Althea Scott for the translation and editing of the manuscript. We also thank SIDACTION for the financial support to Maxime Inghels.	Burns FM, 2008, AIDS, V22, P115, DOI 10.1097/QAD.0b013e3282f1d4b6; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Duffus WA, 2012, J WOMENS HEALTH, V21, P170, DOI 10.1089/jwh.2010.2655; Ekouevi DK, 2010, TROP MED INT HEALTH, V15, P34, DOI 10.1111/j.1365-3156.2010.02505.x; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Klein D, 2003, JAIDS-J ACQ IMM DEF, V32, P143, DOI 10.1097/00126334-200302010-00005; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manga NM, 2009, MED MALADIES INFECT, V39, P95, DOI 10.1016/j.medmal.2008.09.021; Ministere de la Sante A et de la Lutte contre le Sida [Co A te d'Ivoire] & Institut National de la Statistique (INS) MEASURE DHS, 2013, ENQ DEM SANT IND MUL; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2013, RAPP EP MOND SID 201; van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dyl037; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wohlgemut J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-72; World Health Organization, 2015, GUID START ANT THER; World Health Organization, WORLD HLTH STAT 2015	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185117	10.1371/journal.pone.0185117	http://dx.doi.org/10.1371/journal.pone.0185117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977006	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100016
J	Lombardi, MS; Gillieron, C; Berkelaar, M; Gabay, C				Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem			Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR ACTIVATOR; PROTEIN-KINASE; BONE-RESORPTION; C-FOS; DIFFERENTIATION; EXPRESSION; PATHWAYS; LIGAND; TLR	Osteoclasts are large multinucleated cells responsible for bone resorption. Excessive inflammatory activation of osteoclasts leads to bony erosions, which are the hallmark of several diseases such as rheumatoid arthritis (RA). Salt-inducible kinases (SIK) constitute a subfamily of kinases comprising three members (SIK1,-2, and -3). Inhibition of SIK kinase activity induces an anti-inflammatory phenotype in macrophages. Since osteoclasts originate from precursors of macrophage origin, we hypothesized a role of SIK in osteoclastogenesis. We analyzed SIK1,-2 and -3 expression and function in osteoclast differentiation using the mouse macrophage cell line RAW264.7 and bone marrow-derived macrophages (BMM). We show that all three SIK are expressed in fully differentiated osteoclasts and that in BMM-derived osteoclasts there is an increased expression of SIK1 and SIK3 proteins. Interestingly, the pan-SIK inhibitor HG-9-91-01 significantly inhibited osteoclastogenesis by dose dependently reducing osteoclast differentiation markers (i. e. CathepsinK, MMP-9 and TRAP) and bone resorbing activity. Analysis of the signaling pathways activated by RANKL in RAW cells showed that SIK inhibitors did not affect RANKL-induced ERK1/2, JNK, p38 or NF-.B activation, but induced a significant downregulation in c-Fos and NFATc1 protein levels, the two main transcription factors involved in the regulation of osteoclast-specific genes. Moreover, SIK inhibition partially increased the proteasome-mediated degradation of c-Fos. SIK2 and SIK3 knockout RAW cells were generated by the CRISPR/Cas9 approach. SIK2 KO and, to a lesser extent, SIK3 KO recapitulated the effect of SIK small molecule inhibitor, thus confirming the specificity of the effect of SIK inhibition on the reduction of osteoclastogenesis. Overall, our results support the notion that the SIK signaling pathway plays a significant role among the check-points controlling osteoclastogenesis. SIK kinase inhibitors could thus represent a potential novel therapy to prevent bone erosions.	[Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland; [Lombardi, Maria Stella; Gillieron, Corine; Berkelaar, Majoska; Gabay, Cem] Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland; [Lombardi, Maria Stella] GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland	University of Geneva; University of Geneva	Lombardi, MS; Gabay, C (corresponding author), Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland.; Lombardi, MS; Gabay, C (corresponding author), Univ Geneva, Dept Pathol & Immunol, Sch Med, Geneva, Switzerland.; Lombardi, MS (corresponding author), GSK Consumer Healthcare, Dept Preclin Dev, Nyon, Switzerland.	maria-stella.x.lombardi@gsk.com; cem.gabay@houge.ch			Rheumasearch Foundation; Institute of Arthritis Research (iAR); Swiss National Science Foundation (SNF) [310030_172674]	Rheumasearch Foundation; Institute of Arthritis Research (iAR); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	This work was supported by the Rheumasearch Foundation (grant to M.S. Lombardi) and by the Institute of Arthritis Research (iAR) and the Swiss National Science Foundation (SNF grant number 310030_172674) to C. Gabay.	Adamopoulos IE, 2015, NAT REV RHEUMATOL, V11, P189, DOI 10.1038/nrrheum.2014.198; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bagnis Claude, 2009, V515, P151, DOI 10.1007/978-1-59745-559-6_10; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; BURGER EH, 1982, J EXP MED, V156, P1604, DOI 10.1084/jem.156.6.1604; Clark K, 2014, BIOCHEM SOC T, V42, P11, DOI 10.1042/BST20130124; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Darling NJ, 2017, BIOCHEM J, V474, P521, DOI 10.1042/BCJ20160646; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Han KY, 2007, BIOCHEM PHARMACOL, V74, P911, DOI 10.1016/j.bcp.2007.06.044; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lombardi MS, 2016, J LEUKOCYTE BIOL, V99, P711, DOI 10.1189/jlb.2A0715-307R; Lubberts E, 2002, ARTHRITIS RHEUM, V46, P3055, DOI 10.1002/art.10607; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Ozanne J, 2015, BIOCHEM J, V465, P271, DOI 10.1042/BJ20141165; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan TCA, 2004, HISTOL HISTOPATHOL, V19, P1325, DOI 10.14670/HH-19.1325; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200	36	16	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185426	10.1371/journal.pone.0185426	http://dx.doi.org/10.1371/journal.pone.0185426			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973003	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900017
J	Racca, V; Castiglioni, P; Panzarino, C; Oliva, F; Perna, E; Ferratini, M				Racca, Vittorio; Castiglioni, Paolo; Panzarino, Claudia; Oliva, Fabrizio; Perna, Enrico; Ferratini, Maurizio			End-stage heart failure: Two surgical approaches with different rehabilitative outcomes	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; INTERNATIONAL SOCIETY; TRANSPLANTATION; INDEX	Background A rising number of patients are surgically treated for heart failure at the more advanced stage, thanks to the increasing use of left ventricular assist device (LVAD) as a reliable alternative to heart transplantation (HTx). However, it is still unknown whether differences exist between the two surgical approaches in the efficacy of rehabilitation programmes. Therefore, aim of this study was to evaluate whether functional capacity and rehabilitative outcomes differ between HTx and implantation of LVAD. Methods and results We enrolled 51 patients with HTx and 46 with LVAD upon admission to our rehabilitationunit. We evaluated six-minute walking test (6MWT), resting oxygen saturation (SaO(2)) and nutritional assessment before and after a standardised cardiovascular rehabilitation programme. HTx and LVAD groups differed in age, anthropometric variables, gender distribution. Upon enrolment, 6MWT distance was similar in the two groups, whereas malnutrition was less frequent and the waist circumference/height ratio (WHtR) was greater in LVAD patients. SaO(2) was greater in HTx patients. Rehabilitation improved SaO(2), 6MWT distance and nutritional status. The difference in malnutrition disappeared, but WHtR remained higher in the LVAD and SaO(2) higher in the HTx patients; the 6MWT distance improved more in the HTx patients. Multivariate linear regression analysis confirmed that the type of intervention was independent predictor of 6MWT distance after rehabilitation. Conclusions HTx patients improve more rapidly and perform better after rehabilitation, suggesting the need for more tailored rehabilitation training for LVAD patients.	[Racca, Vittorio; Panzarino, Claudia; Ferratini, Maurizio] Fdn Don C Gnocchi, Santa Maria Nascente Inst IRCCS, Cardiol Rehabil Ctr, Milan, Italy; [Castiglioni, Paolo] Fdn Don C Gnocchi, Santa Maria Nascente Inst IRCCS, Biomed Technol Dept, Milan, Italy; [Oliva, Fabrizio; Perna, Enrico] Osped Niguarda Ca Granda, De Gasperis Cardio Ctr, Milan, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Fondazione Don Carlo Gnocchi Onlus; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Racca, V (corresponding author), Fdn Don C Gnocchi, Santa Maria Nascente Inst IRCCS, Cardiol Rehabil Ctr, Milan, Italy.	vracca@dongnocchi.it	Racca, Vittorio/AAK-1889-2020; Racca, Vittorio/F-3374-2013; Castiglioni, Paolo/F-8721-2018	Racca, Vittorio/0000-0002-4465-3789; Racca, Vittorio/0000-0002-4465-3789; Castiglioni, Paolo/0000-0002-8775-2605; Panzarino, Claudia/0000-0002-0296-989X	Italian Ministry of Health; Don Gnocchi Foundation	Italian Ministry of Health(Ministry of Health, Italy); Don Gnocchi Foundation	This study was supported by the Italian Ministry of Health and the Don Gnocchi Foundation (Ricerca Corrente 2014-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo OL, 2015, J HEART LUNG TRANSPL, V34, P1385, DOI 10.1016/j.healun.2015.05.027; Ammirati E, 2014, EUR J INTERN MED, V25, P422, DOI 10.1016/j.ejim.2014.02.006; [Anonymous], 2017, POL 6 ALL HEARTS HEA, P62; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Cowger J, 2013, J AM COLL CARDIOL, V61, P313, DOI 10.1016/j.jacc.2012.09.055; Dunlay SM, 2014, J HEART LUNG TRANSPL, V33, P359, DOI 10.1016/j.healun.2013.12.014; Feldman D, 2013, J HEART LUNG TRANSPL, V32, P157, DOI 10.1016/j.healun.2012.09.013; Frigerio M, 1997, J HEART LUNG TRANSPL, V16, P1087; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Kirklin JK, 2015, J HEART LUNG TRANSPL, V34, P1495, DOI 10.1016/j.healun.2015.10.003; Malnutrition Advisory Group, 2011, MALN UN SCREEN TOOL; Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023; Musci M, 2008, ANN THORAC SURG, V86, P1236, DOI 10.1016/j.athoracsur.2008.05.044; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Schumer EM, 2016, EUR HEART J, V37, P3434, DOI 10.1093/eurheartj/ehv590; Stevenson LW, 2009, J HEART LUNG TRANSPL, V28, P535, DOI 10.1016/j.healun.2009.02.015; Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Tevik K, 2015, CLIN NUTR, V34, P257, DOI 10.1016/j.clnu.2014.03.014	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185717	10.1371/journal.pone.0185717	http://dx.doi.org/10.1371/journal.pone.0185717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972991	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900041
J	Sesti-Costa, R; Francozo, MCS; Silva, GK; Proenca-Modena, JL; Silva, JS				Sesti-Costa, Renata; Santiago Francozo, Marcela Cristina; Silva, Grace Kelly; Proenca-Modena, Jose Luiz; Silva, Joao Santana			TLR3 is required for survival following Coxsackievirus B3 infection by driving T lymphocyte activation and polarization: The role of dendritic cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; B3-INDUCED MYOCARDITIS; SIGNALING PATHWAYS; VIRAL MYOCARDITIS; INTERFERON-GAMMA; CUTTING EDGE; TH17 CELLS; RECOGNITION; MACROPHAGE; IMMUNITY	Type B coxsackievirus (CVB) is a common cause of acute and chronic myocarditis, meningitis and pancreatitis, often leading to heart failure and pancreatic deficiency. The polarization of CD4(+) T lymphocytes and their cytokine milieu are key factors in the outcome of CVB-induced diseases. Thus, sensing the virus and driving the adaptive immune response are essential for the establishment of a protective immune response. TLR3 is a crucial virus recognition receptor that confers the host with resistance to CVB infection. In the current study, we found that TLR3 expression in dendritic cells plays a role in their activation upon CVB3 infection in vitro, as TLR3-deficient dendritic cells up-regulate CD80 and CD86 to a less degree than WT cells. Instead, they up-regulated the inhibitory molecule PD-L1 and secreted considerably lower levels of TNF-alpha and IL-10 and a higher level of IL-23. T lymphocyte proliferation in co-culture with CVB3-infected dendritic cells was increased by TLR3-expressing DCs and other cells. Furthermore, in the absence of TLR3, the T lymphocyte response was shifted toward a Th17 profile, which was previously reported to be deleterious for the host. TLR3-deficient mice were very susceptible to CVB3 infection, with increased pancreatic injury and extensive inflammatory infiltrate in the heart that was associated with uncontrolled viral replication. Adoptive transfer of TLR3(+) dendritic cells slightly improved the survival of TLR-deficient mice following CVB3 infection. Therefore, our findings highlight the importance of TLR3 signaling in DCs and in other cells to induce activation and polarization of the CD4(+) T lymphocyte response toward a Th1 profile and consequently for a better outcome of CVB3 infection. These data provide new insight into the immune-mediated mechanisms by which CVBs are recognized and cleared in order to prevent the development of myocarditis and pancreatitis and may contribute to the design of therapies for enteroviral infections.	[Sesti-Costa, Renata; Santiago Francozo, Marcela Cristina; Silva, Grace Kelly; Silva, Joao Santana] Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Santiago Francozo, Marcela Cristina] Ctr Expt & Clin Infect Res GmbH, TWINCORE, Inst Infect Immunol, Hannover, Germany; [Proenca-Modena, Jose Luiz] Univ Campinas UNICAMP, Dept Genet Evolut & Bioagents, Inst Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Helmholtz Association; Helmholtz-Center for Infection Research; Universidade de Sao Paulo; Universidade Estadual de Campinas	Silva, JS (corresponding author), Univ Sao Paulo, Dept Biochem & Immunol, Sch Med Ribeirao Preto, Ribeirao Preto, SP, Brazil.	jsdsilva@fmrp.usp.br	Sesti-Costa, Renata/H-9115-2012; Silva, Joao/A-4484-2008; Proenca-Modena, Jose Luiz/C-8231-2014	Sesti-Costa, Renata/0000-0002-7098-2850; Silva, Joao/0000-0002-3410-3927; Proenca-Modena, Jose Luiz/0000-0002-4996-3153	Sao Paulo Research Foundation (FAPESP) [2012/20786-6, 2013/08216-2]; University of Sao Paulo NAP-DIN [11.1.21625.01.0]; CNPq [445271/2014-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo NAP-DIN; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research leading to these results received funding from the Sao Paulo Research Foundation (FAPESP) under grants agreements no. 2012/20786-6 and no. 2013/08216-2 (Center for Research in Inflammatory Disease), and from the University of Sao Paulo NAP-DIN under grant agreement no. 11.1.21625.01.0, http://www.fapesp.br/en/. This study was also funded by CNPq, process number 445271/2014-0. http://www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Cristiane M. Milanezi and Wander C. R. da Silva for technical support. The research leading to these results received funding from the Sao Paulo Research Foundation (FAPESP) under grants agreements no 2012/20786-6 and no. 2013/08216-2 (Center for Research in Inflammatory Disease), from the University of Sao Paulo NAP-DIN under grant agreement no. 11.1.21625.01.0. http://www.fapesp.br/en/. This study was also funded by CNPq, process number 445271/2014-0. http://www.cnpq.br.	Abston ED, 2013, AM J PHYSIOL-REG I, V304, pR267, DOI 10.1152/ajpregu.00516.2011; Abston ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/129486; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Chen P, 2009, INT IMMUNOPHARMACOL, V9, P1304, DOI 10.1016/j.intimp.2009.07.014; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Fairweather D, 2005, J IMMUNOL, V174, P261, DOI 10.4049/jimmunol.174.1.261; Fairweather D, 2004, AM J PATHOL, V165, P1883, DOI 10.1016/S0002-9440(10)63241-5; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Frisancho-Kiss S, 2009, BRAIN BEHAV IMMUN, V23, P649, DOI 10.1016/j.bbi.2008.12.002; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Gauntt C, 2003, FRONT BIOSCI-LANDMRK, V8, pE23, DOI 10.2741/928; Gorbea C, 2010, J BIOL CHEM, V285, P23206, DOI 10.1074/jbc.M109.047464; Gupta S, 2008, NAT CLIN PRACT CARD, V5, P693, DOI 10.1038/ncpcardio1331; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Huber S, 2004, VIRAL IMMUNOL, V17, P358, DOI 10.1089/vim.2004.17.358; Huber SA, 2005, J VIROL, V79, P2659, DOI 10.1128/JVI.79.5.2659-2665.2005; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Kandolf R, 1999, VIRUS RES, V62, P149, DOI 10.1016/S0168-1702(99)00041-6; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kaya Z, 2002, J IMMUNOL, V168, P1552, DOI 10.4049/jimmunol.168.4.1552; Kemball CC, 2012, VIROLOGY, V429, P74, DOI 10.1016/j.virol.2012.04.005; Kemball CC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000618; Klingel K, 2003, AM J PATHOL, V162, P1709, DOI 10.1016/S0002-9440(10)64305-2; KLINGEL K, 1992, P NATL ACAD SCI USA, V89, P314, DOI 10.1073/pnas.89.1.314; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee HK, 2007, SEMIN IMMUNOL, V19, P48, DOI 10.1016/j.smim.2006.12.001; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004937; Leonard EG, 2004, PEDIATR INFECT DIS J, V23, P665, DOI 10.1097/01.inf.0000132280.36984.a9; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; McCall KD, 2015, ENDOCRINOLOGY, V156, P453, DOI 10.1210/en.2013-2006; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oshiumi H, 2011, J IMMUNOL, V187, P5320, DOI 10.4049/jimmunol.1101503; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; Proietto AI, 2004, IMMUNOBIOLOGY, V209, P163, DOI 10.1016/j.imbio.2004.03.002; Rahnefeld A, 2011, EUR J IMMUNOL, V41, P2774, DOI 10.1002/eji.201041039; Riad A, 2011, J IMMUNOL, V186, P2561, DOI 10.4049/jimmunol.1002029; Richer MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004127; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sesti-Costa R, 2013, J IMMUNOL, V191, P283, DOI 10.4049/jimmunol.1202806; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Szeles L, 2015, J IMMUNOL, V195, P1025, DOI 10.4049/jimmunol.1402033; Tracy S, 2000, J MED VIROL, V62, P70, DOI 10.1002/1096-9071(200009)62:1<70::AID-JMV11>3.0.CO;2-R; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Weinzierl AO, 2008, J VIROL, V82, P8149, DOI 10.1128/JVI.00047-08; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xie YQ, 2011, VIROLOGY, V421, P78, DOI 10.1016/j.virol.2011.09.006; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yanagawa B, 2004, J INFECT DIS, V189, P1431, DOI 10.1086/382598; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z	61	12	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185819	10.1371/journal.pone.0185819	http://dx.doi.org/10.1371/journal.pone.0185819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973047	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900057
J	Xie, FY; Hosany, S; Zhong, S; Jiang, Y; Zhang, F; Lin, LL; Wang, XB; Gao, SM; Hui, XQ				Xie, FeiYan; Hosany, Sumayyah; Zhong, Shen; Jiang, Yang; Zhang, Fen; Lin, LiLi; Wang, XiaoBo; Gao, ShenMeng; Hui, XiaoQu			MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1	PLOS ONE			English	Article							MULTI-CHEMORESISTANCE; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; LUNG-CANCER; MIR-193A-3P; EXPRESSION; APOPTOSIS; PROMOTES; GROWTH	In many cancers, microRNA-193a (miR-193a) is a suppressor miRNA, but its underlying anti-oncogenic activity in breast cancer is not known. In this study, we found decreased miR-193a (specifically, miR-193a-5p) expression not only in breast cancer cell lines but also in breast cancer tissues as compared with the adjacent non-tumor tissues. Ectopic miR-193a overexpression inhibited the proliferation, colony formation, migration, and invasion of MDA-MB-231 and BT549 cells. miR-193a reduced Wilms' tumor 1 (WT1) expression and repressed luciferase reporter activity by binding WT1 coding region sequences; mutation of the predicted miR-193a binding site abolished this effect. miR-193a and WT1 expression were significantly inversely correlated in breast cancer tissues. Importantly, the anti-cancer activity induced by miR-193a was partially reversed by WT1 overexpression, indicating an important role for WT1 in such activity related to miR-193a. Our results reveal that miR-193a-WT1 interaction plays an important role in breast cancer metastasis, and suggest that restoring miR-193a expression is a therapeutic strategy in breast cancer.	[Xie, FeiYan; Hosany, Sumayyah; Zhong, Shen; Jiang, Yang; Zhang, Fen; Lin, LiLi; Wang, XiaoBo] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Gao, ShenMeng] Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Zhejiang, Peoples R China; [Hui, XiaoQu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Gao, SM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Zhejiang, Peoples R China.; Hui, XQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China.	gaoshenmeng77@126.com; drhxj@126.com	Lin, Lili/AHC-1654-2022	Lin, Lili/0000-0002-8694-7486	Natural Science Foundation of China [81572580, 81672087]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China [grant numbers: 81572580 to Xiaoqu Hu and 81672087 to Shen Meng Gao]. The Natural Science Foundation of China can be accessed on the following URL www.nsfc.gov.cn and all the relevant information can be verified. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Deng H, 2015, BBA-MOL BASIS DIS, V1852, P520, DOI 10.1016/j.bbadis.2014.12.014; Deng H, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-234; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fisher JN, 2015, ONCOTARGET, V6, P13176, DOI 10.18632/oncotarget.3759; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Leivonen SK, 2014, MOL ONCOL, V8, P93, DOI 10.1016/j.molonc.2013.10.001; Li Y, 2015, ONCOTARGET, V6, P10195, DOI 10.18632/oncotarget.3555; Liang HW, 2015, J BIOL CHEM, V290, P926, DOI 10.1074/jbc.M114.621409; Lindstedt I, 2014, IN VIVO, V28, P675; Liu LQ, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711951; LV L, 2014, CELL DEATH DIS, V5; Lv L, 2015, CANCER LETT, V357, P105, DOI 10.1016/j.canlet.2014.11.002; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Qi XW, 2012, ONCOL REP, V28, P1231, DOI 10.3892/or.2012.1906; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Tsai KW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28176; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Wang JL, 2013, CELL PHYSIOL BIOCHEM, V32, P1707, DOI 10.1159/000356605; Wang W, 2015, J ZHEJIANG UNIV-SC B, V16, P18, DOI 10.1631/jzus.B1400184; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Williams M, 2015, ONCOTARGET, V6, P23480, DOI 10.18632/oncotarget.4346; Yang Y, 2013, ONCOGENE, V32, P3432, DOI 10.1038/onc.2012.360; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	34	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185565	10.1371/journal.pone.0185565	http://dx.doi.org/10.1371/journal.pone.0185565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016617	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400023
J	Horiuchi, K; Ishihara, M; Imanaka, K				Horiuchi, Kentaro; Ishihara, Masami; Imanaka, Kuniyasu			The essential role of optical flow in the peripheral visual field for stable quiet standing: Evidence from the use of a head-mounted display	PLOS ONE			English	Article							POSTURAL RESPONSES; VISION; LOCOMOTION; STANCE	It has long been thought that vision is the most essential factor in maintaining stable quiet standing compared to other sources (i.e., vestibular and somatosensory inputs) of information. Specifically, several vision studies on postural control have shown evidence for the importance of the visual system, particularly peripheral vision rather than central vision, and optical flow. Nevertheless, to date, no study has manipulated both visual field and optical flow concurrently. In the present study, we experimentally manipulated both the visual field (the central and peripheral visual fields) and the occurrence of optical flow during quiet standing, examining the effects of the visual field and optical flow on postural sway measured in terms of the center of pressure (CoP). Stationary random dot stimuli were presented exclusively in either the central or peripheral visual field, while the occurrence of optical flow was manipulated using a desktop (DTD) or a head-mounted (HMD) display. The optical flow that occurred while using the DTD was a function of the postural sway during quiet standing, while for the HMD, no optical flow occurred even when the body/head swayed during quiet standing. Our results show that the extent of postural sway (e.g., CoP area) was smaller when visual stimuli were presented in the peripheral visual field than that in the central visual field; this was the case while using the DTD alone, with no effects of the peripheral vision on the extent of postural sway while using the HMD. It is therefore suggested that the optical flow occurring in the peripheral visual field is essential for stable quiet standing.	[Horiuchi, Kentaro; Imanaka, Kuniyasu] Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan; [Horiuchi, Kentaro; Ishihara, Masami] Tokyo Metropolitan Univ, Dept Human Sci, Tokyo, Japan	Tokyo Metropolitan University; Tokyo Metropolitan University	Imanaka, K (corresponding author), Tokyo Metropolitan Univ, Dept Hlth Promot Sci, Tokyo, Japan.	imanaka@tmu.ac.jp			Japan Society for the Promotion of Science [25242060]; Grants-in-Aid for Scientific Research [17H00875] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (A), #25242060, awarded to KI by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; Berencsi A, 2005, HUM MOVEMENT SCI, V24, P689, DOI 10.1016/j.humov.2005.10.014; BRANDT T, 1973, EXP BRAIN RES, V16, P476, DOI 10.1007/BF00234474; Charles C, 2002, J VESTIBUL RES-EQUIL, V12, P135; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; Cunningham DW, 2006, P IEEE VIRT REAL ANN, P111, DOI 10.1109/VR.2006.14; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DIJKSTRA TMH, 1992, HUM MOVEMENT SCI, V11, P195, DOI 10.1016/0167-9457(92)90060-O; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Gibson J.J., 1966, SENSES CONSIDERED PE; Gibson J.J., 1966, SENSES CONSIDERED PE; HUFSCHMIDT A, 1980, ARCH PSYCHIAT NERVEN, V228, P135, DOI 10.1007/BF00365601; Kapteyn T S, 1983, Agressologie, V24, P321; Kawakita T, 2000, JPN J PHYSIOL, V50, P315, DOI 10.2170/jjphysiol.50.315; KELLY DH, 1984, J OPT SOC AM A, V1, P107, DOI 10.1364/JOSAA.1.000107; Kelly JW, 2008, PERCEPT PSYCHOPHYS, V70, P158, DOI 10.3758/PP.70.1.158; Kiyota Y, 2011, DISABIL REHABIL, V33, P2567, DOI 10.3109/09638288.2011.579226; Knaut LA, 2009, ARCH PHYS MED REHAB, V90, P793, DOI 10.1016/j.apmr.2008.10.030; LEE DN, 1974, PERCEPT PSYCHOPHYS, V15, P529, DOI 10.3758/BF03199297; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; MAKI BE, 1990, J AM GERIATR SOC, V38, P1, DOI 10.1111/j.1532-5415.1990.tb01588.x; Munafo J, 2017, EXP BRAIN RES, V235, P889, DOI 10.1007/s00221-016-4846-7; Nougier V, 1997, GAIT POSTURE, V5, P34, DOI 10.1016/S0966-6362(96)01071-5; Nougier V, 1998, J EXP CHILD PSYCHOL, V68, P202, DOI 10.1006/jecp.1997.2427; Osaka N., 1994, NEW SENSATION PERCEP, P923; Osterberg G, 1935, Acta Ophthalmol., V13, P11; Oullier O, 2002, HUM MOVEMENT SCI, V21, P147, DOI 10.1016/S0167-9457(02)00093-3; Park Du-Jin, 2016, J Phys Ther Sci, V28, P1769, DOI 10.1589/jpts.28.1769; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Piponnier JC, 2009, J VISION, V9, DOI 10.1167/9.1.13; PREVIC FH, 1995, J VESTIBUL RES-EQUIL, V5, P399, DOI 10.1016/0957-4271(95)00019-C; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Robert MT, 2016, GAIT POSTURE, V48, P261, DOI 10.1016/j.gaitpost.2016.06.010; Schmidt R.A., 2011, HUMAN KINETICS; STOFFREGEN TA, 1987, PERCEPTION, V16, P113, DOI 10.1068/p160113; Stoffregen TA, 2004, PRESENCE-TELEOP VIRT, V13, P601, DOI 10.1162/1054746042545274; STOFFREGEN TA, 1985, J EXP PSYCHOL HUMAN, V11, P554, DOI 10.1037/0096-1523.11.5.554; Streepey JW, 2007, GAIT POSTURE, V25, P49, DOI 10.1016/j.gaitpost.2005.12.013; Warren WH, 1996, J EXP PSYCHOL HUMAN, V22, P818, DOI 10.1037/0096-1523.22.4.818; WARREN WH, 1991, BIOL CYBERN, V65, P311, DOI 10.1007/BF00216964	43	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184552	10.1371/journal.pone.0184552	http://dx.doi.org/10.1371/journal.pone.0184552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991916	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800007
J	Pokharia, AK; Agnihotri, R; Sharma, S; Bajpai, S; Nath, J; Kumaran, RN; Negi, BC				Pokharia, Anil K.; Agnihotri, Rajesh; Sharma, Shalini; Bajpai, Sunil; Nath, Jitendra; Kumaran, R. N.; Negi, Bipin Chandra			Altered cropping pattern and cultural continuation with declined prosperity following abrupt and extreme arid event at similar to 4,200 yrs BP: Evidence from an Indus archaeological site Khirsara, Gujarat, western India	PLOS ONE			English	Article							NORTHWEST INDIA; CLIMATE-CHANGE; HARAPPAN SITE; LATE HOLOCENE; THAR DESERT; LAKE; COLLAPSE; MONSOON; PRECIPITATION; CIVILIZATION	Archaeological sites hold important clues to complex climate-human relationships of the past. Human settlements in the peripheral zone of Indus culture (Gujarat, western India) are of considerable importance in the assessment of past monsoon-human-subsistence-culture relationships and their survival thresholds against climatic stress exerted by abrupt changes. During the mature phase of Harappan culture between similar to 4,600-3,900yrsBP, the similar to 4,100 +/- 100yrsBP time slice is widely recognized as one of the major, abrupt arid-events imprinted innumerous well-dated palaeo records. However, the veracity of this dry event has not been established from any archaeological site representing the Indus (Harappan) culture, and issues concerning timing, changes in subsistence pattern, and the likely causes of eventual abandonment (collapse) continue to be debated. Here we show a significant change in crop-pattern (from barley-wheat based agriculture to 'drought-resistant' millet-based crops) at similar to 4,200 yrs BP, based on abundant macrobotanical remains and C isotopes of soil organic matter (delta C-13(SOM)) in an archaeological site at Khirsara, in the Gujarat state of western India. The crop-change appears to be intentional and was likely used as an adaptation measure in response to deteriorated monsoonal conditions. The ceramic and architectural remains of the site indicate that habitation survived and continued after the similar to 4,200yrsBP dry climatic phase, but with declined economic prosperity. Switching to millet-based crops initially helped inhabitants to avoid immediate collapse due to climatic stresses, but continued aridity and altered cropping pattern led to a decline in prosperity levels of inhabitants and eventual abandonment of the site at the end of the mature Harappan phase.	[Pokharia, Anil K.; Agnihotri, Rajesh; Sharma, Shalini; Bajpai, Sunil] Birbal Sahni Inst Palaeosci, Lucknow, Uttar Pradesh, India; [Nath, Jitendra; Kumaran, R. N.; Negi, Bipin Chandra] Archaeol Survey India, Vadodara, Gujarat, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP)	Agnihotri, R (corresponding author), Birbal Sahni Inst Palaeosci, Lucknow, Uttar Pradesh, India.	rajesh.agnihotri@bsip.res.in		Agnihotri, Rajesh/0000-0003-2069-0734; Pokharia, Anil/0000-0003-1453-0646	Birbal Sahni Institute of Palaeoscience Lucknow (autonomous unit of Department of Science and Technology, Government of India); Archaeological Survey of India Vadodara Circle Gujarat India; Birbal Sahni Institute of Palaeoscience Lucknow (autonomous unit of Department of Science and Technology, Government of India); Archaeological Survey of India Vadodara Circle Gujarat India	Birbal Sahni Institute of Palaeoscience Lucknow (autonomous unit of Department of Science and Technology, Government of India); Archaeological Survey of India Vadodara Circle Gujarat India; Birbal Sahni Institute of Palaeoscience Lucknow (autonomous unit of Department of Science and Technology, Government of India); Archaeological Survey of India Vadodara Circle Gujarat India	The work was mainly carried out with in-house funding of Birbal Sahni Institute of Palaeoscience Lucknow (autonomous unit of Department of Science and Technology, Government of India) and Archaeological Survey of India Vadodara Circle Gujarat India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkelhammer M, 2012, GEOPHYS MONOGR SER, V198, P75, DOI 10.1029/2012GM001207; Bisht R.S., 1997, FACETS INDIAN CIVILI, P107; Biswas SK, 1983, PETROLEUM ASIA J, V6, P111; Bronk RC., 2010, OXCAL PROGRAM V 4 1; Champion H. G., 1968, REVISED SURVEY FORES, P404; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; Dixit Y, 2014, GEOLOGY, V42, P339, DOI 10.1130/G35236.1; Drysdale R, 2006, GEOLOGY, V34, P101, DOI 10.1130/G22103.1; Enzel Y, 1999, SCIENCE, V284, P125, DOI 10.1126/science.284.5411.125; Farooqui A, 2013, J ARCHAEOL SCI, V40, P2631, DOI 10.1016/j.jas.2013.02.005; Goyal P, 2013, RADIOCARBON, V55, P141; IAR, 1983, IND ARCH 1980 81 REV, P14; IAR, 1973, IND ARCH 1969 70 REV, P7; IAR, 1994, IND ARCH 1989 90 REV, P20; Joshi JP, 1990, EXCAVATIONS SURKOTAD; Kaushalya R, 2014, INT ARCH PHOTOGRAMM, V40-8, P39, DOI 10.5194/isprsarchives-XL-8-39-2014; Ma MM, 2016, QUATERNARY SCI REV, V145, P57, DOI 10.1016/j.quascirev.2016.05.041; Marshall MH, 2011, GLOBAL PLANET CHANGE, V78, P147, DOI 10.1016/j.gloplacha.2011.06.004; Martin A.C., 1961, SEED IDENTIFICATION; MERH SS, 1993, CURR SCI INDIA, V64, P823; Musil AF, 1973, IDENTIFICATION CROP; Nath J., 2012, PURATATTVA, V42, P122; Oldham T., 1893, MEMOIR GEOLOGICAL SU, V19; Petrie CA, 2017, CURR ANTHROPOL, V58, P1, DOI 10.1086/690112; Pokharia AK, 2014, J ARCHAEOL SCI, V42, P442, DOI 10.1016/j.jas.2013.11.029; Pokharia AK, 2011, CURR SCI INDIA, V100, P1833; Ponton C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050722; Possehl GL, 1989, HARAPPAN CIVILIZATIO; Prasad S, 2014, EARTH PLANET SC LETT, V391, P171, DOI 10.1016/j.epsl.2014.01.043; Prasad V, 2007, HOLOCENE, V17, P889, DOI 10.1177/0959683607082403; Rajaguru S.N., 2008, OCCASIONAL PAPER, P1; Rao S. R., 1963, ANCIENT INDIA, V18-19, P5; Rao SR, 1979, LOTHAL HARAPPAN PORT, VII; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rissman P.C., 1990, HARAPPAN CIVILIZATIO; Roxy MK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8423; Ruan J, 2016, CLIM PAST, V12, P1, DOI 10.5194/cp-12-1-2016; Saraswat KS., 2002, PRAGDHARA, V12, P153; Saraswat KS., 2003, PRAGDHARA, V13, P105; Sarkar A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26555; Shinde VS, 1992, EXCAVATIONS PADRI 19, VXVII, P79; Sonawane V. H., 2003, MAN ENV, V28, P21; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; SWAIN AM, 1983, QUATERNARY RES, V19, P1, DOI 10.1016/0033-5894(83)90024-8; Sychanthavong SPH, 1935, P S QU EP 1984, P109; Vats MS, 1935, ANN REPORTS ARCHAEOL, P348; Wang G, 2008, BIOGEOSCIENCES, V5, P1325, DOI 10.5194/bg-5-1325-2008; WASSON RJ, 1984, PALAEOGEOGR PALAEOCL, V46, P345, DOI 10.1016/0031-0182(84)90006-3; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995	49	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185684	10.1371/journal.pone.0185684	http://dx.doi.org/10.1371/journal.pone.0185684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FJ1QR	28985232	Green Published, gold, Green Submitted			2022-12-27	WOS:000412493000008
J	Gordiienko, I; Shlapatska, L; Kholodniuk, V; Sklyarenko, L; Gluzman, DF; Clark, EA; Sidorenko, SP				Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sklyarenko, Lilia; Gluzman, Daniel F.; Clark, Edward A.; Sidorenko, Svetlana P.			The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES; INOSITOL PHOSPHATASE; SURFACE PHENOTYPE; PLASMA-CELLS; T-CELL; SLAM; ACTIVATION; ANTIGENS; CLL	Cell surface expression of CD150 and CD180 receptors in chronic lymphocytic leukemia (CLL) associates with mutational IGHV status and favourable prognosis. Here we show a direct correlation between cell surface expression and colocalization of these receptors on CLL B cells. In the absence of CD150 and CD180 on the cell surface both receptors were expressed in the cytoplasm. The CD150 receptor was colocalized with markers of the endoplasmic reticulum, the Golgi apparatus and early endosomes. In contrast, CD180 was detected preferentially in early endosomes. Analysis of CD150 isoforms differential expression revealed that regardless of CD150 cell surface expression the mCD150 isoform with two ITSM signaling motifs was a predominant CD150 isoform in CLL B cells. The majority of CLL cases had significantly elevated expression level of the soluble sCD150, moreover CLL B cells secrete this isoform. CD150 or CD180 crosslinking on CLL B cells alone led to activation of Akt, mTORC1, ERK1/2, p38MAPK and JNK1/2 networks. Both CD150 and CD180 target the translation machinery through mTOR independent as well as mTOR dependent pathways. Moreover, both these receptors transmit pro-survival signals via Akt-mediated inhibition of GSK3 beta and FOXO1/FOXO3a. Unexpectedly, coligation CD150 and CD180 receptors on CLL B cells led to mutual inhibition of the Akt and MAPK pathways. While CD150 and CD180 coligation resulted in reduced phosphorylation of Akt, ERK1/2, c-Jun, RSK, p70S6K, S6RP, and 4E-BP; it led to complete blocking of mTOR and p38MAPK phosphorylation. At the same time coligation of CD150 and CD40 receptors did not result in Akt and MAPK inhibition. This suggests that combination of signals via CD150 and CD180 leads to blocking of pro-survival pathways that may be a restraining factor for neoplastic CLL B cells propagation in more than 50% of CLL cases where these receptors are coexpressed.	[Gordiienko, Inna; Shlapatska, Larysa; Kholodniuk, Valeriia; Sidorenko, Svetlana P.] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Mol & Cellular Pathobiol, Kiev, Ukraine; [Sklyarenko, Lilia; Gluzman, Daniel F.] Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Oncohematol, Kiev, Ukraine; [Clark, Edward A.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; National Academy of Sciences Ukraine; Kavetsky Institute of Experimental Pathology, Oncology & Radiobiology of NASU; University of Washington; University of Washington Seattle	Sidorenko, SP (corresponding author), Natl Acad Sci Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Dept Mol & Cellular Pathobiol, Kiev, Ukraine.	svitasyd@yahoo.com		Sidorenko, Svetlana/0000-0001-8281-8006; Gordiienko, Inna/0000-0003-3759-6138; Gluzman, Daniel/0000-0001-8335-6827; Shcherbina, Valeriia/0000-0001-6077-4786	National Academy of Sciences of Ukraine [01150002970, 01160007817]; National Institutes of Health [AI52203]	National Academy of Sciences of Ukraine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by grants from National Academy of Sciences of Ukraine 01150002970 and 01160007817 (SPS) http://www.nas.gov.ua/EN/Pages/default.aspx, National Institutes of Health grant AI52203 (EAC), https://www.niaid.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bologna C, 2016, J CLIN INVEST, V126, P181, DOI 10.1172/JCI83013; Chaplin JW, 2013, J EXP MED, V210, P2135, DOI 10.1084/jem.20130188; Chaplin JW, 2011, J IMMUNOL, V187, P4199, DOI 10.4049/jimmunol.1100198; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; De Salort J, 2011, IMMUNOL LETT, V134, P129, DOI 10.1016/j.imlet.2010.09.021; Fabbri G, 2016, NAT REV CANCER, V16, P145, DOI 10.1038/nrc.2016.8; Fanoni D, 2011, IMMUNOL LETT, V134, P157, DOI 10.1016/j.imlet.2010.09.022; Goncalves-Carneiro D, 2017, J VIROL, V91, DOI 10.1128/JVI.02255-16; Gordiienko I. M., 2016, Experimental Oncology, V38, P101; Guarini A, 2008, BLOOD, V112, P782, DOI 10.1182/blood-2007-12-127688; Guieze R, 2015, BLOOD, V126, P445, DOI 10.1182/blood-2015-02-585042; Huang PY, 2014, LEUKEMIA LYMPHOMA, V55, P2085, DOI 10.3109/10428194.2013.867486; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Mavaddat N, 2000, J BIOL CHEM, V275, P28100; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mikhalap SV, 2004, BLOOD, V104, P4063, DOI 10.1182/blood-2004-04-1273; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; Muccio VE, 2016, CYTOM PART B-CLIN CY, V90, P81, DOI 10.1002/cyto.b.21279; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Packham G, 2014, HAEMATOLOGICA, V99, P1138, DOI 10.3324/haematol.2013.098384; Porakishvili N, 2005, BRIT J HAEMATOL, V131, P313, DOI 10.1111/j.1365-2141.2005.05775.x; Porakishvili N, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00265; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Rodriguez-Bayona B, 2011, IMMUNOL LETT, V134, P122, DOI 10.1016/j.imlet.2010.09.015; Romanets-Korbut O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118302; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schultz TE, 2017, J LEUKOCYTE BIOL, V101, P183, DOI 10.1189/jlb.2VMR1215-582R; Schweighofer CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028277; Shlapatska L. M., 2014, Experimental Oncology, V36, P2; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SIDORENKO SP, 1992, NEOPLASMA, V39, P3; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Sintes J, 2011, IMMUNOL CELL BIOL, V89, P161, DOI 10.1038/icb.2010.145; Somani AK, 2001, J BIOL CHEM, V276, P1938, DOI 10.1074/jbc.M006820200; ten Hacken E, 2016, J IMMUNOL, V197, P2522, DOI 10.4049/jimmunol.1600915; Wiestner A, 2015, HAEMATOLOGICA, V100, P1495, DOI 10.3324/haematol.2014.119123; Woyach JA, 2015, BLOOD, V126, P471, DOI 10.1182/blood-2015-03-585075; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003; Yurchenko M., 2011, Experimental Oncology, V33, P9; Yurchenko MY, 2010, IMMUNOL CELL BIOL, V88, P565, DOI 10.1038/icb.2010.14; Yurchenko OV, 2003, EXP ONCOL, V25, P186; Zhang SP, 2014, ANNU REV PATHOL-MECH, V9, P103, DOI 10.1146/annurev-pathol-020712-163955; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zucchetto A, 2011, IMMUNOL LETT, V134, P137, DOI 10.1016/j.imlet.2010.09.017	51	8	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185940	10.1371/journal.pone.0185940	http://dx.doi.org/10.1371/journal.pone.0185940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982149	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300093
J	Khan, S; Simpson, J; Lynch, JC; Turay, D; Mirshahidi, S; Gonda, A; Sanchez, TW; Casiano, CA; Wall, NR				Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Mirshahidi, Saied; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.			Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients	PLOS ONE			English	Article							AFRICAN-AMERICAN; HEALTH DISPARITIES; UP-REGULATION; EXOSOMES; SURVIVIN; PROGNOSIS; PATHWAY	African-American men with prostate cancer typically develop more aggressive tumors than men from other racial/ethnic groups, resulting in a disproportionately high mortality from this malignancy. This study evaluated differences in the expression of inhibitors of apoptosis proteins (IAPs), a known family of oncoproteins, in blood-derived exosomal vesicles (EV) between African-American and European-American men with prostate cancer. The Exo-Quick (TM) method was used to isolate EV from both plasma and sera of African-American (n = 41) and European-American (n = 31) men with prostate cancer, as well as from controls with no cancer diagnosis (n = 10). EV preparations were quantified by acetylcholinesterase activity assays, and assessed for their IAP content by Western blotting and densitometric analysis. Circulating levels of the IAP Survivin were evaluated by ELISA. We detected a significant increase in the levels of circulating Survivin in prostate cancer patients compared to controls (P<0.01), with the highest levels in African-American patients (P<0.01). African-American patients with prostate cancer also contained significantly higher amounts of EVs in their plasma (P<0.01) and sera (P<0.05) than European-American patients. In addition, EVs from African-American patients with prostate cancer contained significantly higher amounts of the IAPs Survivin (P<0.05), XIAP (P<0.001), and cIAP-2 (P<0.01) than EVs from European-American patients. There was no significant correlation between expression of IAPs and clinicopathological parameters in the two patient groups. Increased expression of IAPs in EVs from African-American patients with prostate cancer may influence tumor aggressiveness and contribute to the mortality disparity observed in this patient population. EVs could serve as reservoirs of novel biomarkers and therapeutic targets that may have clinical utility in reducing prostate cancer health disparities.	[Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Khan, Salma; Simpson, Jennifer; Lynch, James C.; Turay, David; Mirshahidi, Saied; Gonda, Amber; Sanchez, Tino W.; Casiano, Carlos A.; Wall, Nathan R.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Sch Med, Canc Ctr, Loma Linda, CA USA; [Mirshahidi, Saied] Loma Linda Univ, Sch Med, Biospecimen Lab, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Wall, NR (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA.; Wall, NR (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA.	nwall@llu.edu	Wall, Nathan R./H-7368-2015	Wall, Nathan R./0000-0002-3235-4386; Sanchez, Tino/0000-0002-2901-2211	National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities [P20MD0016321, P20MD006988]; Loma Linda University School of Medicine; Center for Health Disparities and Molecular Medicine	National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities; Loma Linda University School of Medicine; Center for Health Disparities and Molecular Medicine	Research reported in this publication was supported by the National Institutes of Health (NIH)-National Institute of Minority Health and Health Disparities under award numbers P20MD0016321 and P20MD006988. The authors thank Loma Linda University School of Medicine and the Center for Health Disparities and Molecular Medicine for supporting this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Basu A, 2011, PROSTATE, V71, P755, DOI 10.1002/pros.21292; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Chaudhary AK, 2016, BRIT J CANCER, V114, P1090, DOI 10.1038/bjc.2016.88; Chornokur G, 2011, PROSTATE, V71, P985, DOI 10.1002/pros.21314; Clayton A, 2004, FASEB J, V18, P977, DOI 10.1096/fj.03-1094fje; Danilewicz M, 2015, POL J PATHOL, V66, P44, DOI 10.5114/PJP.2015.51152; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Farrell J, 2013, INT J MOL SCI, V14, P15510, DOI 10.3390/ijms140815510; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Grasso L, 2015, ANAL BIOANAL CHEM, V407, P5425, DOI 10.1007/s00216-015-8711-5; Guo L, 2015, CRIT REV ONCOL HEMAT, V95, P346, DOI 10.1016/j.critrevonc.2015.04.002; Hardiman G, 2016, PHARMACOGENOMICS, V17, P1129, DOI 10.2217/pgs-2016-0025; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2015, BIOL-TARGETS THER, V9, P57, DOI 10.2147/BTT.S83864; Khan S, 2015, HISTOL HISTOPATHOL, V30, P43, DOI 10.14670/HH-30.43; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Martin DN, 2013, CURR OPIN ONCOL, V25, P235, DOI 10.1097/CCO.0b013e32835eb5d1; McGinley KF, 2016, NAT REV UROL, V13, P99, DOI 10.1038/nrurol.2015.298; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Minciacchi V. R., 2017, PROSTATE CANC PROSTA; Myers JS, 2016, J CANCER, V7, P1452, DOI 10.7150/jca.15860; Powell IJ, 2014, CANCER EPIDEM BIOMAR, V23, P1505, DOI 10.1158/1055-9965.EPI-13-1328; Powell IJ, 2013, MOL ENDOCRINOL, V27, P879, DOI 10.1210/me.2013-1039; Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015; Rodriguez-Berriguete G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-18; Saleem M, 2013, CHEM BIOL DRUG DES, V82, P243, DOI 10.1111/cbdd.12176; Savina A, 2002, J CELL SCI, V115, P2505; Schlette EJ, 2004, J CLIN ONCOL, V22, P1682, DOI 10.1200/JCO.2004.10.172; Seisen T, 2016, CANCER TREAT REV, V48, P25, DOI 10.1016/j.ctrv.2016.06.005; Shi R, 2015, ONCOTARGET, V6, P26971, DOI 10.18632/oncotarget.4699; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh N, 2015, DRUG DISCOV TODAY, V20, P578, DOI 10.1016/j.drudis.2014.11.013; Turay D, 2016, CANCER INVEST, V34, P1, DOI 10.3109/07357907.2015.1081921; Turner DP, 2015, CANCER RES, V75, P1925, DOI 10.1158/0008-5472.CAN-15-0169; Urbanelli Lorena, 2015, Recent Pat CNS Drug Discov, V10, P10; Valenzuela MMA, 2015, CANCER MICROENVIRON, V8, P65, DOI 10.1007/s12307-015-0167-9; Xiao M, 2015, ASD; Yamamoto Tetsuhisa, 2001, Medical Electron Microscopy, V34, P207, DOI 10.1007/s007950100017; Yu SR, 2015, ONCOTARGET, V6, P37151, DOI 10.18632/oncotarget.6022; Zhang L, 2016, CANCER RES, V76, P6290, DOI 10.1158/0008-5472.CAN-16-0087	44	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183122	10.1371/journal.pone.0183122	http://dx.doi.org/10.1371/journal.pone.0183122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981528	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300003
J	Wang, XH; Zheng, YC; Gan, L; Wang, X; Sang, XT; Kong, XF; Zhao, J				Wang, Xuehu; Zheng, Yongchang; Gan, Lan; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng; Zhao, Jie			Liver segmentation from CT images using a sparse priori statistical shape model (SP-SSM)	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; CLASSIFICATION; ALGORITHM	This study proposes a new liver segmentation method based on a sparse a priori statistical shape model (SP-SSM). First, mark points are selected in the liver a priori model and the original image. Then, the a priori shape and its mark points are used to obtain a dictionary for the liver boundary information. Second, the sparse coefficient is calculated based on the correspondence between mark points in the original image and those in the a priori model, and then the sparse statistical model is established by combining the sparse coefficients and the dictionary. Finally, the intensity energy and boundary energy models are built based on the intensity information and the specific boundary information of the original image. Then, the sparse matching constraint model is established based on the sparse coding theory. These models jointly drive the iterative deformation of the sparse statistical model to approximate and accurately extract the liver boundaries. This method can solve the problems of deformation model initialization and a priori method accuracy using the sparse dictionary. The SP-SSM can achieve a mean overlap error of 4.8% and a mean volume difference of 1.8%, whereas the average symmetric surface distance and the root mean square symmetric surface distance can reach 0.8 mm and 1.4 mm, respectively.	[Wang, Xuehu; Zhao, Jie] Hebei Univ, Sch Elect & Informat Engn, Baoding, Peoples R China; [Wang, Xuehu; Zhao, Jie] Key Lab Digital Med Engn Hebei Prov, Baoding, Peoples R China; [Zheng, Yongchang; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China; [Zheng, Yongchang; Wang, Xuan; Sang, Xinting; Kong, Xiangfeng] Peking Union Med Coll, Beijing, Peoples R China; [Gan, Lan] East China Jiaotong Univ, Sch Informat Engn, Nanchang, Jiangxi, Peoples R China	Hebei University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; East China Jiaotong University	Zheng, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing, Peoples R China.; Zheng, YC (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wangxuehu_tougao@163.com			Natural Science Foundation of China [61401308, 61572063]; Natural Science Foundation of Hebei Province [F2016201142, F2016201187]; Natural Social Foundation of Hebei Province [HB15TQ015]; Science research project of Hebei Province [QN2016085, ZC2016040]; Science and technology support project of Hebei Province [15210409]; Natural Science Foundation of Hebei University [2014303]; Hebei university improve comprehensive strength special funds in the Midwest	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Natural Social Foundation of Hebei Province; Science research project of Hebei Province; Science and technology support project of Hebei Province; Natural Science Foundation of Hebei University(Natural Science Foundation of Hebei Province); Hebei university improve comprehensive strength special funds in the Midwest	This work was supported in part by Natural Science Foundation of China under grant 61401308 and 61572063, Natural Science Foundation of Hebei Province under grant F2016201142 and F2016201187, Natural Social Foundation of Hebei Province under grant HB15TQ015, Science research project of Hebei Province under grant QN2016085 and ZC2016040, Science and technology support project of Hebei Province under grant 15210409, Natural Science Foundation of Hebei University under grant 2014303; Hebei university improve comprehensive strength special funds in the Midwest.	Afzali M, 2016, COMPUT BIOL MED, V73, P56, DOI 10.1016/j.compbiomed.2016.03.022; Al-Shaikhli SDS, 2016, BIOMED ENG-BIOMED TE, V61, P413, DOI 10.1515/bmt-2015-0071; Anas Emran Mohammad Abu, 2016, IEEE Trans Med Imaging, V35, P1789, DOI 10.1109/TMI.2016.2529500; Aslan MS, 2014, IET COMPUT VIS, V8, P182, DOI 10.1049/iet-cvi.2012.0226; Aslan MS, 2013, I S BIOMED IMAGING, P840; Cao SY, 2012, IEEE ENG MED BIO, P4942, DOI 10.1109/EMBC.2012.6347101; Faghih DV, 2016, APPL BIONICS BIOMECH, V2016; Farag AA, 2006, IEEE T IMAGE PROCESS, V15, P952, DOI 10.1109/TIP.2005.863949; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Guo YR, 2014, MED PHYS, V41, DOI 10.1118/1.4884224; Haddad AE, 2015, INT C IEEE ENG MED B; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Hiwatashi A, 2016, J NEURORADIOLOGY, V43, P266, DOI 10.1016/j.neurad.2016.01.147; Kato T, 2015, NEURAL NETWORKS, V66, P64, DOI 10.1016/j.neunet.2015.02.009; Khormuji MK, 2016, MED BIOL ENG COMPUT, V54, P869, DOI 10.1007/s11517-015-1382-8; Liao S, 2012, LECT NOTES COMPUT SC, V7512, P385, DOI 10.1007/978-3-642-33454-2_48; Liu HB, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0221-y; Nawano S, 2016, INT J COMPUTER ASSIS, V12, P1; Oliveira DAB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-30; Palomba D, 2012, MOLECULES, V17, P14937, DOI 10.3390/molecules171214937; Pontier DB, 2009, CURR BIOL, V19, P1384, DOI 10.1016/j.cub.2009.06.045; Ptucha R, 2014, IEEE T IMAGE PROCESS, V23, P1737, DOI 10.1109/TIP.2014.2303648; Rikxoort EMV, 2007, AUTOMATIC SEGMENTATI; Saddi Kinda A, 2007, GLOBAL TO LOCAL SHAP; Seghers D, 2007, LANDMARK BASED LIVER; Soliman A, 2017, IEEE T MED IMAGING, VPP, P1; Tong T, 2013, NEUROIMAGE, V76, P11, DOI 10.1016/j.neuroimage.2013.02.069; Wang XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118064; Ying C, 2008, DISCUSSION EVALUATIO	29	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185249	10.1371/journal.pone.0185249	http://dx.doi.org/10.1371/journal.pone.0185249			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981530	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300030
J	Bonyah, E; Khan, MA; Okosun, KO; Islam, S				Bonyah, Ebenezer; Khan, Muhammad Altaf; Okosun, K. O.; Islam, Saeed			A theoretical model for Zika virus transmission	PLOS ONE			English	Article							BRUCELLOSIS MODEL; INFECTION; DYNAMICS; OUTBREAK	In this paper, we present and analyze an SEIR Zika epidemic model. Firstly, we investigate the model with constant controls. The steady states of the model is found to be locally and globally asymptotically stable. Thereafter, we incorporate time dependent controls into the model in order to investigate the optimal effects of bednets, treatments of infective and spray of insecticides on the disease spread. Furthermore, we used Pontryagin's Maximum Principle to determine the necessary conditions for effective control of the disease. Also, the numerical results were presented.	[Bonyah, Ebenezer] Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana; [Khan, Muhammad Altaf] City Univ Sci & Informat Technol, Dept Math, Peshawar 25000, KP, Pakistan; [Bonyah, Ebenezer; Okosun, K. O.] Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa; [Islam, Saeed] Univ Mardan, Dept Math Abdul Wali Khan, KP, Pakistan	Vaal University of Technology (VUT)	Bonyah, E (corresponding author), Kumasi Tech Univ, Dept Math & Stat, Kumasi, Ghana.; Bonyah, E (corresponding author), Vaal Univ Technol, Dept Math, Vanderbijlpark, South Africa.	ebbonya@yahoo.com	Saeed, Islam/AAD-6067-2020; Khan, Muhammad Altaf/K-2201-2013; Bonyah, Ebenezer/ABE-2160-2020	Saeed, Islam/0000-0001-5263-4871; Khan, Muhammad Altaf/0000-0002-4483-7879; 				Allenl LJS, 2007, INTRO MATH BIOL; [Anonymous], 2015, ADV STUD BIOL; Birkhoff G., 1982, ORDINARY DIFFERENTIA; Bonyah E, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/576039; Castillo-Chavez C, 2004, MATH BIOSCI ENG, V1, P361, DOI 10.3934/mbe.2004.1.361; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Fleming W.H., 2012, DETERMINISTIC STOCHA; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070; Gui HL, 2017, PLOS ONE, V12; Guo H, P AM MATH SOC, V136, P2793; Javidi M, 2014, WOR J MOD SIMUL, V10, P163; Khan M.A., 2015, IJAMM, V2, P1; KHAN MM, 2017, SCI REP UK, V7; LaSalle J.P., 1976, SOC IND APPL MATH; Lee Eva K, 2016, AMIA Annu Symp Proc, V2016, P743; Li L, 2016, J BIOL SYST, V24, P519, DOI 10.1142/S0218339016500261; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Mingai L., 2016, J INTELL FUZZY SYST, P1; Mojumder MS, B WHO IN PRESS; Musso D, 2014, CLIN MICR INFECT, V20, P59; Musso D, 2014, EURO SURVEILL, V19; Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017; Okosun KO, 2014, MATH BIOSCI, V258, P19, DOI 10.1016/j.mbs.2014.09.008; Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008; Peng M, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/842614; Piqueira JRC, 2008, COMPUT SECUR, V27, P355, DOI 10.1016/j.cose.2008.07.006; Pontryagin LS, 1962, MATH THEORY OPTIMAL; Shi XY, 2011, TURK J MATH, V35, P649, DOI 10.3906/mat-1006-333; Simpson D, 1964, T ROY SOC TROP MED H, V58, P33; Sun GQ, 2016, TRANSMISSION DYNAMIC; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wan H, 2013, J APPL MATH, V2013, P1; Xing Y, 2017, APPL MATH COMPUT, V309, P192, DOI 10.1016/j.amc.2017.04.007; Yu P, 2016, J BIOL DYNAM, V10, P263, DOI 10.1080/17513758.2016.1166270; Zhang Jinhong, 2014, ScientificWorldJournal, V2014, P910421, DOI 10.1155/2014/910421	39	51	51	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185540	10.1371/journal.pone.0185540	http://dx.doi.org/10.1371/journal.pone.0185540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977007	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100026
J	Guo, MX; Li, SP; Tian, S; Wang, B; Zhao, XS				Guo, Mingxin; Li, Shipeng; Tian, Shan; Wang, Bei; Zhao, Xusheng			Transcriptome analysis of genes involved in defense against alkaline stress in roots of wild jujube (Ziziphus acidojujuba)	PLOS ONE			English	Article							CALMODULIN-LIKE PROTEIN; MEMBRANE H+-ATPASE; REACTIVE OXYGEN; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; SALT-STRESS; ENHANCED TOLERANCE; EXPRESSION; KINASE; OVEREXPRESSION	Wild jujube (Ziziphus acidojujuba Mill.) is highly tolerant to alkaline, saline and drought stress; however, no studies have performed transcriptome profiling to study the response of wild jujube to these and other abiotic stresses. In this study, we examined the tolerance of wild jujube to NaHCO3-NaOH solution and analyzed gene expression profiles in response to alkaline stress. Physiological experiments revealed that H2O2 content in leaves increased significantly and root activity decreased quickly during alkaline of pH 9.5 treatment. For transcriptome analysis, wild jujube plants grown hydroponically were treated with NaHCO3NaOH solution for 0, 1, and 12 h and six transcriptomes from roots were built. In total, 32,758 genes were generated, and 3,604 differentially expressed genes (DEGs) were identified. After 1 h, 853 genes showed significantly different expression between control and treated plants; after 12 h, expression of 2,856 genes was significantly different. The expression pattern of nine genes was validated by quantitative real-time PCR. After gene annotation and gene ontology enrichment analysis, the genes encoding transcriptional factors, serine/threonine-protein kinases, heat shock proteins, cysteine-like kinases, calmodulin-like proteins, and reactive oxygen species (ROS) scavengers were found to be closely involved in alkaline stress response. These results will provide useful insights for elucidating the mechanisms underlying alkaline tolerance in wild jujube.	[Guo, Mingxin; Li, Shipeng; Tian, Shan; Wang, Bei; Zhao, Xusheng] Luoyang Normal Univ, Coll Life Sci, Luoyang, Henan, Peoples R China	Luoyang Normal University	Zhao, XS (corresponding author), Luoyang Normal Univ, Coll Life Sci, Luoyang, Henan, Peoples R China.	15736750861@163.com		Guo, Mingxin/0000-0002-7764-1194; Li, Shipeng/0000-0003-0975-3351	Key Science and Technology Program of Henan Province [162102110160, 152102110098]; Key Scientific Research Project for Higher Education of Henan Province [168220003]; Natural Science Foundation of Henan Province [162300410198]	Key Science and Technology Program of Henan Province; Key Scientific Research Project for Higher Education of Henan Province; Natural Science Foundation of Henan Province	This work was supported by the Key Science and Technology Program of Henan Province (Grant No. 162102110160 to MG, No. 152102110098 to XZ), Key Scientific Research Project for Higher Education of Henan Province (Grant No. 168220003 to MG) and Natural Science Foundation of Henan Province (Grant No. 162300410198 to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2007, PLANT J, V50, P488, DOI 10.1111/j.1365-313X.2007.03064.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Chen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141888; [陈雄伟 Chen Xiongwei], 2013, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V33, P20; Chinchilla D, 2003, PLANT MOL BIOL, V51, P555, DOI 10.1023/A:1022337221225; Coelho SM, 2002, PLANT CELL, V14, P2369, DOI 10.1105/tpc.003285; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diedhiou CJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-49; Fuglsang AT, 2007, PLANT CELL, V19, P1617, DOI 10.1105/tpc.105.035626; Gao DJ, 2004, PLANT PHYSIOL, V134, P898, DOI 10.1104/pp.103.032508; Ge Y, 2011, FUNCT INTEGR GENOMIC, V11, P369, DOI 10.1007/s10142-010-0191-2; Gechev TS, 2005, IUBMB LIFE, V57, P181, DOI 10.1080/15216540500090793; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Guo M., 2014, EVID-BASED COMPL ALT, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0112515; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jiang CH, 2009, PLANT CELL ENVIRON, V32, P1046, DOI 10.1111/j.1365-3040.2009.01987.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knipfer T, 2011, J EXP BOT, V62, P4115, DOI 10.1093/jxb/err075; Li G., 2006, CHINA FRUITS, V2, P58; Lindemose S, 2013, INT J MOL SCI, V14, P5842, DOI 10.3390/ijms14035842; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu K, 2016, J EXP BOT, V67, P5009, DOI 10.1093/jxb/erw266; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Masand S, 2016, MOL BIOL REP, V43, P53, DOI 10.1007/s11033-015-3938-y; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Qing DJ, 2009, PLANT CELL PHYSIOL, V50, P889, DOI 10.1093/pcp/pcp038; Reddy ASN, 2001, PLANT SCI, V160, P381, DOI 10.1016/S0168-9452(00)00386-1; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudrabhatla P, 2002, PLANT PHYSIOL, V130, P380, DOI 10.1104/pp.005173; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Scholz SS, 2014, MOL PLANT, V7, P1712, DOI 10.1093/mp/ssu102; Sedaghatmehr M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12439; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Vranova E, 2002, P NATL ACAD SCI USA, V99, P10870, DOI 10.1073/pnas.152337999; Wang C, 2014, PLANT MOL BIOL, V84, P145, DOI 10.1007/s11103-013-0124-2; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Xu DH, 2011, BREEDING SCI, V61, P559, DOI 10.1270/jsbbs.61.559; Yang CW, 2009, PHOTOSYNTHETICA, V47, P79, DOI 10.1007/s11099-009-0013-8; Yang YQ, 2010, PLANT CELL, V22, P1313, DOI 10.1105/tpc.109.069609; Zhang X, 2013, J INTEGR PLANT BIOL, V55, P262, DOI 10.1111/jipb.12013; Zhang XX, 2006, J EXP BOT, V57, P193, DOI 10.1093/jxb/erj025	62	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185732	10.1371/journal.pone.0185732	http://dx.doi.org/10.1371/journal.pone.0185732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976994	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100040
J	Yang, JH; Zhang, XW; Zhang, WW; Sun, JY; Xie, YW; Zhang, YM; Burton, GA; Yu, HX				Yang, Jianghua; Zhang, Xiaowei; Zhang, Wanwan; Sun, Jingying; Xie, Yuwei; Zhang, Yimin; Burton, G. Allen; Yu, Hongxia			Indigenous species barcode database improves the identification of zooplankton	PLOS ONE			English	Article							OPEN SOFTWARE; GENE FLOW; DNA; DIVERSITY; SPECIATION; ROTIFERA; COLONIZATION; SEQUENCES; PATTERNS; ECOLOGY	Incompleteness and inaccuracy of DNA barcode databases is considered an important hindrance to the use of metabarcoding in biodiversity analysis of zooplankton at the specieslevel. Species barcoding by Sanger sequencing is inefficient for organisms with small body sizes, such as zooplankton. Here mitochondrial cytochrome c oxidase I (COI) fragment barcodes from 910 freshwater zooplankton specimens (87 morphospecies) were recovered by a high-throughput sequencing platform, Ion Torrent PGM. Intraspecific divergence of most zooplanktons was < 5%, except Branchionus leydign (Rotifer, 14.3%), Trichocerca elongate (Rotifer, 11.5%), Lecane bulla (Rotifer, 15.9%), Synchaeta oblonga (Rotifer, 5.95%) and Schmackeria forbesi (Copepod, 6.5%). Metabarcoding data of 28 environmental samples from Lake Tai were annotated by both an indigenous database and NCBI Genbank database. The indigenous database improved the taxonomic assignment of metabarcoding of zooplankton. Most zooplankton (81%) with barcode sequences in the indigenous database were identified by metabarcoding monitoring. Furthermore, the frequency and distribution of zooplankton were also consistent between metabarcoding and morphology identification. Overall, the indigenous database improved the taxonomic assignment of zooplankton.	[Yang, Jianghua; Zhang, Xiaowei; Zhang, Wanwan; Sun, Jingying; Xie, Yuwei; Yu, Hongxia] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Zhang, Yimin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Burton, G. Allen] Univ Michigan, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA	Nanjing University; University of Michigan System; University of Michigan	Zhang, XW (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	howard50003250@yahoo.com	Zhang, Xiaowei/I-2259-2012; Xie, Yuwei/CAI-7227-2022	Zhang, Xiaowei/0000-0001-8974-9963; Xie, Yuwei/0000-0001-5652-6413	Science Foundation of Jiangsu Province [BK20130015]; China Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07506-003, 2012ZX07101-007]; Fundamental Research Funds for the Central Universities; Collaborative Innovation Center for Regional Environmental Quality	Science Foundation of Jiangsu Province; China Major Science and Technology Program for Water Pollution Control and Treatment; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Collaborative Innovation Center for Regional Environmental Quality	For support, we thank Science Foundation of Jiangsu Province (BK20130015) and China Major Science and Technology Program for Water Pollution Control and Treatment (Grant #2012ZX07506-003 and 2012ZX07101-007). X.Z. was supported by the Fundamental Research Funds for the Central Universities. The research was also supported by the Collaborative Innovation Center for Regional Environmental Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For support, we thank Science Foundation of Jiangsu Province (BK20130015) and China Major Science and Technology Program for Water Pollution Control and Treatment (Grant #2012ZX07506-003 and 2012ZX07101-007). X.Z. was supported by the Fundamental Research Funds for the Central Universities. The research was also supported by the Collaborative Innovation Center for Regional Environmental Quality.	Blancobercial L, 2014, DNA BARCODING MARINE, V6, pS122; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Bucklin A, 2016, J PLANKTON RES, V38, P393, DOI 10.1093/plankt/fbw023; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiang Sieh-chih, 1979, FAUNA SINICA CRUSTAC; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Cox AJ, 2001, MOL ECOL, V10, P371, DOI 10.1046/j.1365-294x.2001.01188.x; Cristescu ME, 2012, MOL ECOL, V21, P1411, DOI 10.1111/j.1365-294X.2011.05465.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Esling P, 2015, NUCLEIC ACIDS RES, V43, P2513, DOI 10.1093/nar/gkv107; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Frolov S, 2013, HARMFUL ALGAE, V21-22, P1, DOI 10.1016/j.hal.2012.11.001; Garcia-Morales AE, 2013, MOL ECOL RESOUR, V13, P1097, DOI 10.1111/1755-0998.12080; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2002, J EVOLUTION BIOL, V15, P158, DOI 10.1046/j.1420-9101.2002.00368.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; Leray M, 2012, CORAL REEFS, V31, P383, DOI 10.1007/s00338-011-0845-0; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lindeque PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081327; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Papakostas S, 2016, SYST BIOL, V65, P508, DOI 10.1093/sysbio/syw016; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Segers H, 2008, BIODIVERS CONSERV, V17, P303, DOI 10.1007/s10531-007-9262-7; Segers H, 2008, HYDROBIOLOGIA, V595, P49, DOI 10.1007/s10750-007-9003-7; Shen Chia-jui, 1979, FAUNA SINICA CRUSTAC; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Steinberg DK, 2008, LIMNOL OCEANOGR, V53, P1327, DOI 10.4319/lo.2008.53.4.1327; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Sun CS, 2015, AQUAT BIOL, V24, P9, DOI 10.3354/ab00629; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Wallace RL, 2002, INTEGR COMP BIOL, V42, P660, DOI 10.1093/icb/42.3.660; Wares JP, 2001, EVOLUTION, V55, P2455; Wiwatanaratanabutr I, 2016, J INVERTEBR PATHOL, V141, P18, DOI 10.1016/j.jip.2016.10.003; Wiwatanaratanabutr I, 2013, J INVERTEBR PATHOL, V114, P341, DOI 10.1016/j.jip.2013.04.014; Xiang XL, 2011, MOL PHYLOGENET EVOL, V59, P386, DOI 10.1016/j.ympev.2011.02.011; Zannatul Ferdous, 2009, American Journal of Applied Sciences, V6, P1815, DOI 10.3844/ajassp.2009.1815.1819	53	15	19	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185697	10.1371/journal.pone.0185697	http://dx.doi.org/10.1371/journal.pone.0185697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977035	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100038
J	Bilinski, A; Birru, E; Peckarsky, M; Herce, M; Kalanga, N; Neumann, C; Bronson, G; Po-Chedley, S; Kachimanga, C; McBain, R; Keck, J				Bilinski, Alyssa; Birru, Ermyas; Peckarsky, Matthew; Herce, Michael; Kalanga, Noel; Neumann, Christian; Bronson, Gay; Po-Chedley, Stephen; Kachimanga, Chembe; McBain, Ryan; Keck, James			Distance to care, enrollment and loss to follow-up of HIV patients during decentralization of antiretroviral therapy in Neno District, Malawi: A retrospective cohort study	PLOS ONE			English	Article							SCALE-UP	HIV/AIDS remains the second most common cause of death in low and middle-income countries (LMICs), and only 34% of eligible patients in Africa received antiretroviral therapy (ART) in 2013. This study investigated the impact of ART decentralization on patient enrollment and retention in rural Malawi. We reviewed electronic medical records of patients registered in the Neno District ART program from August 1, 2006, when ART first became available, through December 31, 2013. We used GPS data to calculate patient-level distance to care, and examined number of annual ART visits and one-year lost to follow-up (LTFU) in HIV care. The number of ART patients in Neno increased from 48 to 3,949 over the decentralization period. Mean travel distance decreased from 7.3 km when ART was only available at the district hospital to 4.7 km when ART was decentralized to 12 primary health facilities. For patients who transferred from centralized care to nearer health facilities, mean travel distance decreased from 9.5 km to 4.7 km. Following a transfer, the proportion of patients achieving the clinic's recommended >= 4 annual visits increased from 89% to 99%. In Cox proportional hazards regression, patients living >= 8 km from a health facility had a greater hazard of being LTFU compared to patients < 8 km from a facility (adjusted HR: 1.7; 95% CI: 1.5-1.9). ART decentralization in Neno District was associated with increased ART enrollment, decreased travel distance, and increased retention in care. Increasing access to ART by reducing travel distance is one strategy to achieve the ART coverage and viral suppression objectives of the 90-90-90 UNAIDS targets in rural impoverished areas.	[Bilinski, Alyssa; Birru, Ermyas; Peckarsky, Matthew; Herce, Michael; Kalanga, Noel; Neumann, Christian; Bronson, Gay; Po-Chedley, Stephen; Kachimanga, Chembe; McBain, Ryan; Keck, James] Malawi & Partners In Hlth, Abwenzi Pa Za Umoyo, Boston, MA 02199 USA; [Bilinski, Alyssa] Harvard Grad Sch Arts & Sci, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Herce, Michael] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bilinski, A (corresponding author), Malawi & Partners In Hlth, Abwenzi Pa Za Umoyo, Boston, MA 02199 USA.; Bilinski, A (corresponding author), Harvard Grad Sch Arts & Sci, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA.	abilinski@g.harvard.edu	Po-Chedley, Stephen/O-3450-2019; kachimanga, chiyembekezo/W-9967-2019; Po-Chedley, Stephen/E-9706-2013	kachimanga, chiyembekezo/0000-0003-3507-9591; Po-Chedley, Stephen/0000-0002-0390-238X; Keck, James/0000-0001-7193-065X	Partners In Health/Abwenzi Pa Za Umoyo; National Institutes of Health [1K01TW010272-01]; Agency for Healthcare Research and Quality [T32HS000055]	Partners In Health/Abwenzi Pa Za Umoyo; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Partners In Health/Abwenzi Pa Za Umoyo (http://www.pih.org/) supported the work through routine salary/program expenses (all authors). This work was funded in part by National Institutes of Health (https://grants.nil.gov/grants/oer.htm) grant 1K01TW010272-01 (MH). This project was also supported by grant number T32HS000055 from the Agency for Healthcare Research and Quality (https://www.ahrq.gov/funding/index.html) (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 1 ED MAL GUID CLIN M; [Anonymous], 2013, GLOB REP UNAIDS REP; [Anonymous], 2013, INT HIV PROGR REP OC; [Anonymous], 2013, ACC ANT THER AFR STA; Bastard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049091; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boyer S, 2010, AIDS; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V; Carlucci JG, 2008, J ACQ IMMUN DEF SYND, V47, P615; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Franke MF, 2013, CLIN INFECT DIS, V56, P1319, DOI 10.1093/cid/cis1193; Herce ME, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19929; Houben RMGJ, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-49; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; *MIN HLTH, 2006, TREATM AIDS GUID US; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Neno District Executive Committee, 2013, NEN DISTR SOC PROF 2; Suthar AB, 2014, AIDS, V28, pS175, DOI 10.1097/QAD.0000000000000259; Therneau T, 2016, SURVIV VIGNETTES; UNAIDS, 2014, CAM DEV SUBN EST HIV, P19; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; WHO, 2013, GLOB UPD HIV TREATM; Wilson DP, 2005, PLOS MED, V2, P132, DOI 10.1371/journal.pmed.0020050; World Health Organization, 2014, GLOB HLTH OBS GHO HI	28	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185699	10.1371/journal.pone.0185699	http://dx.doi.org/10.1371/journal.pone.0185699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973035	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900037
J	Xu, Q; Yuan, XY; Gu, TT; Li, Y; Dai, WC; Shen, XK; Song, YD; Zhang, Y; Zhao, WM; Chang, GB; Chen, GH				Xu, Qi; Yuan, Xiaoya; Gu, Tiantian; Li, Yang; Dai, Wangcheng; Shen, Xiaokun; Song, Yadong; Zhang, Yang; Zhao, Wenming; Chang, Guobin; Chen, Guohong			Comparative characterization of bacterial communities in geese fed all-grass or high-grain diets	PLOS ONE			English	Article							GUT MICROBIOTA; FERMENTATION; EVOLUTION; SEQUENCES	Background Gut microbial composition is dependent on diet. Geese are herbivores and can digest crude fibre, but the relationship between composition of the microbiota and a fibre-rich diet in geese is not well understood. Results Here, caecal and faecal samples were collected simultaneously from all-grass-fed geese and high-grain-fed geese and the hypervariable V3-V4 regions of the bacterial 16S rRNA gene were sequenced. The results was identified that high-grass-fed geese possessed significantly higher alpha diversity both in caecum and faeces compared with that in allgrain- fed geese. In addition, the composition of dominant bacterium occurred remarkable shifting due to different diet patterns, Firmicutes were more abundant in all-grass-fed geese, whereas Bacteroidetes were abundant in high-grain-fed geese. Fusobacteria and Deferribacteres were obviously present in high-grain-fed geese and few in all-grass-fed geese. Most importantly, some specific microorgnisms such as Ruminococcaceae, Lachnospiraceae and Bacteroidaceae which may associated with cellulose-degrading that were characterized to show distinctly diverse between the two diet patterns. PICRUSt analysis revealed the metabolic pathways such as carbohydrate and amino acid metabolism were overrepresented in all-grass-fed geese. Conclusions In conclusion, Firmicutes and Bacteroidetes were identified abundantly when the geese was fed with all-grass feed and high-grain feed, respectively. And Ruminococcaceae, Lachnospiraceae and Bacteroidaceae were recognized as main cellulose-degrading bacteria in the geese. The functional profiles of gut microbiota revealed the dominant microbiota communities were involved mainly in the carbohydrate metabolism in all-grass-fed geese.	[Xu, Qi; Yuan, Xiaoya; Gu, Tiantian; Li, Yang; Song, Yadong; Zhang, Yang; Zhao, Wenming; Chang, Guobin; Chen, Guohong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China; [Dai, Wangcheng; Shen, Xiaokun] Waterfowl Inst Zhenjiang City, Dantu, Peoples R China	Yangzhou University	Chen, GH (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China.	ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022		ear-marked fund for Modern Agro-industry Technology Research System [CARS-42-3]; National Key Technology R&D Program of China [2015BAD03B00]; Priority Academic Program Development of Jiangsu Higher Educational Institutions [2011-137]	ear-marked fund for Modern Agro-industry Technology Research System; National Key Technology R&D Program of China(National Key Technology R&D Program); Priority Academic Program Development of Jiangsu Higher Educational Institutions	This work received financial support from the ear-marked fund for Modern Agro-industry Technology Research System (CARS-42-3), the National Key Technology R&D Program of China (2015BAD03B00), and the Priority Academic Program Development of Jiangsu Higher Educational Institutions (2011-137).	Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen G, 2013, GOOSE PRODUCTION CHI; Daly K, 2012, BRIT J NUTR, V107, P989, DOI 10.1017/S0007114511003825; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dennis KL, 2013, CANCER RES, V73, P5905, DOI 10.1158/0008-5472.CAN-13-1511; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Durant D., 2003, Wildfowl, V54, P7; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6; Guilloteau P, 2010, J DAIRY SCI, V93, P5842, DOI 10.3168/jds.2009-2751; He LW, 2015, POULTRY SCI, V94, P2464, DOI 10.3382/ps/pev237; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liu B., 2012, MOL DIVERSITY MICROO, P2; Liu JH, 2014, BRIT J NUTR, V112, P416, DOI 10.1017/S0007114514000993; Lou YJ, 2010, S AFRICAN J ANIMAL S, V40, P535; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Matsui H, 2010, ANAEROBE, V16, P83, DOI 10.1016/j.anaerobe.2009.07.005; MATTOCKS J G, 1971, Wildfowl, V22, P107; Mazzoni M, 2008, J NUTR, V138, P1426, DOI 10.1093/jn/138.8.1426; Muegge BD, 2008, NATURE REV MICROBIOL, V6, P776; Niu Q, 2015, SCI REPORTS, P5; Perumbakkam S, 2011, ANTON LEEUW INT J G, V99, P231, DOI 10.1007/s10482-010-9481-x; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; RCore Team, 2020, R LANG ENV STAT COMP; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Stanley D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0388-6; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Toyoda A, 2009, APPL ENVIRON MICROB, V75, P1667, DOI 10.1128/AEM.01838-08; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040727, 10.1371/journal.pone.0030440]; Xue ZS, 2015, MBIO, V6, DOI 10.1128/mBio.00022-15; Zeng B, 2015, SCI REPORTS, P5; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117441; Zhou HZ, 2015, CURR MICROBIOL, V71, P693, DOI 10.1007/s00284-015-0904-9	46	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185590	10.1371/journal.pone.0185590	http://dx.doi.org/10.1371/journal.pone.0185590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972993	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900029
J	Junikka, J; Molleman, L; van den Berg, P; Weissing, FJ; Puurtinen, M				Junikka, Jaakko; Molleman, Lucas; van den Berg, Pieter; Weissing, Franz J.; Puurtinen, Mikael			Assortment, but not knowledge of assortment, affects cooperation and individual success in human groups	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; VOLUNTARY COOPERATION; INDIRECT RECIPROCITY; EVOLUTION; ALTRUISM; PREFERENCES; BELIEFS; OTHERS; GAME	The success or failure of human collective action often depends on the cooperation tendencies of individuals in groups, and on the information that individuals have about each other's cooperativeness. However, it is unclear whether these two factors have an interactive effect on cooperation dynamics. Using a decision-making experiment, we confirm that groups comprising individuals with higher cooperation tendencies cooperate at a higher level than groups comprising individuals with low cooperation tendencies. Moreover, assorting individuals with similar cooperation tendency together affected behaviour so that the most cooperative individuals tended to cooperate more and the least cooperative individuals cooperated less, compared to their behaviour in randomly formed groups. In line with predictions of evolutionary models of cooperation, there was a strong positive association between individuals' cooperation tendency and success when groups were formed assortatively, whereas such association did not exist when groups were formed randomly. Surprisingly, information about group members' cooperativeness in assorted groups had no effect on cooperation levels. We discuss potential explanations for why information about cooperativeness of others may be disregarded in certain circumstances.	[Junikka, Jaakko; Puurtinen, Mikael] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Junikka, Jaakko; Puurtinen, Mikael] Univ Jyvaskyla, Ctr Excellence Biol Interact, Jyvaskyla, Finland; [Molleman, Lucas] Univ Nottingham, Sch Econ, Ctr Decis Res & Expt Econ, Univ Pk, Nottingham, England; [Molleman, Lucas] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [Molleman, Lucas; van den Berg, Pieter; Weissing, Franz J.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Groningen, Netherlands; [van den Berg, Pieter] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Leuven, Belgium; [Weissing, Franz J.] Netherlands Inst Adv Study Humanities & Social Sc, Amsterdam, Netherlands	University of Jyvaskyla; University of Jyvaskyla; University of Nottingham; Max Planck Society; University of Groningen; KU Leuven	Junikka, J (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.; Junikka, J (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, Jyvaskyla, Finland.	jaakkoj.junikka@jyu.fi	Puurtinen, Mikael/P-1549-2014	Puurtinen, Mikael/0000-0003-3340-2762; van den Berg, Pieter/0000-0001-7886-9345	Koneen Saatio [31-233]; Ubbo Emmius scholarship of the University of Groningen; European Research Council Grant Project COOPERATION [ERC-Adg 295707]; Graduate Programme of the Netherlands Organisation for Scientific Research [022.003.49]; Academy of Finland [258386]	Koneen Saatio; Ubbo Emmius scholarship of the University of Groningen; European Research Council Grant Project COOPERATION; Graduate Programme of the Netherlands Organisation for Scientific Research; Academy of Finland(Academy of Finland)	The research reported in this article was supported by the Koneen Saatio (http://www.koneensaatio.fi/en/) (Grant number 31-233) to JJJ, Ubbo Emmius scholarship of the University of Groningen (http://www.rug.nl/alumni/steun-de-rug/ubbo-emmius-fonds/projecten-activiteiten/beurzen-en-prijzen?lang=en) and European Research Council Grant Project COOPERATION (https://erc.europa.eu/) (ERC-Adg 295707) to LM, the Graduate Programme of the Netherlands Organisation for Scientific Research (https://www.nwo.nl/en/research-and-results/programmes/graduate+research+opportunities+worldwide+grow) (NWO, grant 022.003.49) to PVDB and Academy of Finland (http://www.aka.fi/en) (grant 258386) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Balliet D, 2009, GROUP PROCESS INTERG, V12, P533, DOI 10.1177/1368430209105040; Bird RB, 2015, EVOL HUM BEHAV, V36, P389, DOI 10.1016/j.evolhumbehav.2015.02.003; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Burlando RM, 2005, EXP ECON, V8, P35, DOI 10.1007/s10683-005-0436-4; Croson R., 2008, HDB EXPT EC RESULTS, P776, DOI DOI 10.1016/S1574-0722(07)00082-0; Croson RTA, 2007, THEORIES COMMITMENT; de Oliveira ACM, 2014, EXP EC; ESHEL I, 1982, P NATL ACAD SCI-BIOL, V79, P1331, DOI 10.1073/pnas.79.4.1331; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Gachter S, 2004, J ECON BEHAV ORGAN, V55, P505, DOI 10.1016/j.jebo.2003.11.006; Gachter S, 2011, J MATH SOCIOL, V35, P26, DOI 10.1080/0022250X.2010.532260; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gallo E, 2015, P NATL ACAD SCI USA, V112, P3647, DOI 10.1073/pnas.1415883112; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; Irlenbusch B, 2013, J ECON BEHAV ORGAN, V93, P321, DOI 10.1016/j.jebo.2013.03.023; KELLEY HH, 1970, J PERS SOC PSYCHOL, V16, P66, DOI 10.1037/h0029849; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Molleman L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3044; MULLEN B, 1985, J EXP SOC PSYCHOL, V21, P262, DOI 10.1016/0022-1031(85)90020-4; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Ockenfels A, 1999, J PUBLIC ECON, V71, P275, DOI 10.1016/S0047-2727(98)00072-3; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Price ME, 2005, EVOL HUM BEHAV, V26, P279, DOI 10.1016/j.evolhumbehav.2004.08.009; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Swakman V, 2015, EVOL HUM BEHAV, P1; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van den Berg P, 2015, P NATL ACAD SCI USA, V112, P2912, DOI 10.1073/pnas.1417203112; van der Veer P, 2015, HANDBOOK OF RELIGION AND THE ASIAN CITY: ASPIRATION AND URBANIZATION IN THE TWENTY-FIRST CENTURY, P1; Volk S, 2012, J ECON BEHAV ORGAN, V81, P664, DOI 10.1016/j.jebo.2011.10.006; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Yamagishi T, 2008, RATION SOC, V20, P5, DOI 10.1177/1043463107085442; Yamagishi T, 2013, ORGAN BEHAV HUM DEC, V120, P260, DOI 10.1016/j.obhdp.2012.06.002; Zahavi A, 1999, HANDICAP PRINCIPLE, P1	42	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185859	10.1371/journal.pone.0185859	http://dx.doi.org/10.1371/journal.pone.0185859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968451	Green Published, gold			2022-12-27	WOS:000412029600061
J	Carrasco, JM; Garcia, M; Navas, A; Olza, I; Gomez-Baceiredo, B; Pujol, F; Garralda, E; Centeno, C				Miguel Carrasco, Jose; Garcia, Miriam; Navas, Alejandro; Olza, Ines; Gomez-Baceiredo, Beatriz; Pujol, Francesc; Garralda, Eduardo; Centeno, Carlos			What does the media say about palliative care? A descriptive study of news coverage in written media in Spain	PLOS ONE			English	Article							COMMUNICATION; PERSPECTIVE; COUNTRIES; BARRIERS; EUROPE	Introduction The goal of palliative care (PC) is to improve the quality of life of terminal stage patients and their families. The subject frequently appears in the mass-media and this helps create a socially accepted identity. The aim of this study is to describe and analyse PC related news items appeared in the Spanish written media. Methodology A descriptive cross-sectional study was designed. Considering diffusion, scope and the range in editorial policy criteria, four printed newspapers (PN) were selected, together with four exclusively digital media sources (DM). Through Mynews, a newspaper content depository, and the search tool for each DM website, articles published between 2009 and 2014 which included the terms "palliative care" and "palliative medicine" were sought. A questionnaire was created to characterise each article identified and a descriptive analysis was undertaken. Results A total of 627 articles were identified, of which 359 (57%) were published in PN (42% in the printed editions -PE- 16% in their online editions -OE-) and 268 (43%) in DM. In general, they appeared mainly in sections concerning Health (23%), Culture and Society (18%) and General/Home News (15%). In PE, just 2% were found in the Health section and nearly 70% in Culture and Society and General/Home News. Most of the articles were informative in nature and contained socio-political messages (90%). Statements by PC professionals were found in 35% of the articles and by politicians in 32%. The most frequent content was related to facing end of life (74%) and patient quality of life (70%). Conclusions The Spanish written media reflects the socio-political interest aroused by PC. Nevertheless, messages circulating about PC do not describe professional practice, or the contribution of the same for patients. Content more in line with the clinical practice might help contribute to the development of this new area of medicine.	[Miguel Carrasco, Jose; Garralda, Eduardo; Centeno, Carlos] Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain; [Miguel Carrasco, Jose; Garralda, Eduardo; Centeno, Carlos] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Garcia, Miriam] Errea Comunicac, Pamplona, Spain; [Navas, Alejandro] Univ Navarra, Sch Commun, Publ Commun Dept, Pamplona, Spain; [Olza, Ines] Univ Navarra, Inst Culture & Soc, GRADUN, Pamplona, Spain; [Gomez-Baceiredo, Beatriz] Univ Navarra, Sch Commun, Journalism Projects Dept, Pamplona, Spain; [Pujol, Francesc] Univ Navarra, Sch Econ & Business Adm, Dept Econ, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra	Carrasco, JM (corresponding author), Univ Navarra, Inst Culture & Soc, ATLANTES Res Program, Pamplona, Spain.; Carrasco, JM (corresponding author), Navarra Inst Hlth Res IdiSNA, Pamplona, Spain.	jmcarrascog@unay.es	Centeno, Carlos/H-3430-2013; Gomez, Beatriz/AAF-1391-2021; Pujol, Francesc/Z-4767-2019; Carrasco, Jose Miguel/I-3482-2015	Centeno, Carlos/0000-0003-3395-7039; Gomez, Beatriz/0000-0001-5332-0698; Pujol, Francesc/0000-0002-0368-0529; Carrasco, Jose Miguel/0000-0002-3847-8312	Institute for Culture and Society (ICS) of the University Navarra	Institute for Culture and Society (ICS) of the University Navarra	Support for this work was received from the Institute for Culture and Society (ICS) of the University Navarra. One of the authors [MG] is employed by a commercial company [Errea Comunicacion], but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguiar F, 2013, ADV APPL SOCIOLOGY, V3, P124; Akintola O, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0051-6; Akiyama M, 2016, SUPPORT CARE CANCER, V24, P347, DOI 10.1007/s00520-015-2788-4; [Anonymous], 2011, ASOCIACION INVESTIGA; Centeno C, 2015, PALLIATIVE MED, P31; Conde F, 2009, ANALISIS SOCIOLOGICO; Daw JR, 2013, HEALTH POLICY, V110, P67, DOI 10.1016/j.healthpol.2013.01.006; De Leon E, 2014, J MED INTERNET RES, V16, P119, DOI 10.2196/jmir.2837; Duran M.A., 2004, REV ESP INVESTIG SOC, V106, P9; Gempeler F. E., 2015, REV COLOMB ANESTESIO, V43, P142; Habermas J, 1981, HIST CRITICA OPINION; Husemann S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1742-1; Khaw KT, 1999, BRIT MED J, V319, P1350, DOI 10.1136/bmj.319.7221.1350; Lynch T, 2010, PALLIATIVE MED, V24, P812, DOI 10.1177/0269216310368578; Lynch T, 2009, J PAIN SYMPTOM MANAG, V37, P305, DOI 10.1016/j.jpainsymman.2008.03.011; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; McIlfatrick S, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-34; Muszbek K, 2007, J PAIN SYMPTOM MANAG, V33, P605, DOI 10.1016/j.jpainsymman.2007.02.027; Naugle DA, 2014, J HEALTH COMMUN, V19, P190, DOI 10.1080/10810730.2014.918217; Norton SA, 2013, RES NURS HEALTH, V36, P582, DOI 10.1002/nur.21563; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4846; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Pastrana T, 2015, J PALLIAT MED, V18, P429, DOI 10.1089/jpm.2014.0120; Rodriguez Diaz R, 2004, OBSERVATORIO EUROPEO; StataCorp, 2011, STAT STAT SOFTW REL; Taiwo R., 2007, PERSPECTIVES MEDIA D; Van den Berg R, 2011, EUR J GEN PRACT, V17, P14, DOI 10.3109/13814788.2010.549224; Vega T, 2011, GAC SANIT, V25, P205, DOI 10.1016/j.gaceta.2011.02.005; World Health Organization, 2013, EUR HLTH REP 2012 CH; World Health Organization-WHO, 2014, DEF PALL CAR; World Palliative Care Alliance World Health Organization, 2014, GLOBAL ATLAS PALLIAT; Wurz A, 2013, J HEALTH COMMUN, V18, P1566, DOI 10.1080/10810730.2013.840698; 2013, WORLD HLTH REP 2013, P1	34	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184806	10.1371/journal.pone.0184806	http://dx.doi.org/10.1371/journal.pone.0184806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968433	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600010
J	Purse, BV; Masante, D; Golding, N; Pigott, D; Day, JC; Ibanez-Bernal, S; Kolb, M; Jones, L				Purse, Bethan V.; Masante, Dario; Golding, Nicholas; Pigott, David; Day, John C.; Ibanez-Bernal, Sergio; Kolb, Melanie; Jones, Laurence			How will climate change pathways and mitigation options alter incidence of vector-borne diseases? A framework for leishmaniasis in South and Meso-America	PLOS ONE			English	Article							LAND-USE CHANGE; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; POTENTIAL DISTRIBUTION; DIPTERA PSYCHODIDAE; RISK-FACTORS; SCENARIOS; DISTRIBUTIONS; BIODIVERSITY; TEMPERATURE	The enormous global burden of vector-borne diseases disproportionately affects poor people in tropical, developing countries. Changes in vector-borne disease impacts are often linked to human modification of ecosystems as well as climate change. For tropical ecosystems, the health impacts of future environmental and developmental policy depend on how vector-borne disease risks trade off against other ecosystem services across heterogeneous landscapes. By linking future socio-economic and climate change pathways to dynamic land use models, this study is amongst the first to analyse and project impacts of both land use and climate change on continental-scale patterns in vector-borne diseases. Models were developed for cutaneous and visceral leishmaniasis in the Americas D ecologically complex sand fly borne infections linked to tropical forests and diverse wild and domestic mammal hosts. Both diseases were hypothesised to increase with available interface habitat between forest and agricultural or domestic habitats and with mammal biodiversity. However, landscape edge metrics were not important as predictors of leishmaniasis. Models including mammal richness were similar in accuracy and predicted disease extent to models containing only climate and land use predictors. Overall, climatic factors explained 80% and land use factors only 20% of the variance in past disease patterns. Both diseases, but especially cutaneous leishmaniasis, were associated with low seasonality in temperature and precipitation. Since such seasonality increases under future climate change, particularly under strong climate forcing, both diseases were predicted to contract in geographical extent to 2050, with cutaneous leishmaniasis contracting by between 35% and 50%. Whilst visceral leishmaniasis contracted slightly more under strong than weak management for carbon, biodiversity and ecosystem services, future cutaneous leishmaniasis extent was relatively insensitive to future alternative socio-economic pathways. Models parameterised at narrower geographical scales may be more sensitive to land use pattern and project more substantial changes in disease extent under future alternative socio-economic pathways.	[Purse, Bethan V.; Day, John C.] NERC Ctr Ecol & Hydrol, Crowmarsh Gifford, Oxon, England; [Masante, Dario; Jones, Laurence] Environm Ctr Wales, NERC Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales; [Golding, Nicholas] Univ Melbourne, Sch Biosci, Melbourne, Vic, Australia; [Pigott, David] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA USA; [Ibanez-Bernal, Sergio] AC INECOL Red Ambiente & Sustentabilidad, Inst Ecol, Xalapa, Veracruz, Mexico; [Kolb, Melanie] Univ Nacl Autonoma Mexico, Inst Geog, Mexico City, DF, Mexico	UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); University of Melbourne; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Purse, BV (corresponding author), NERC Ctr Ecol & Hydrol, Crowmarsh Gifford, Oxon, England.	beth@ceh.ac.uk	Day, John/D-2595-2010; Purse, Bethan V/I-6640-2012; Jones, Laurence/A-3900-2011	Day, John/0000-0002-5483-4487; Purse, Bethan V/0000-0001-5140-2710; Jones, Laurence/0000-0002-4379-9006; Golding, Nick/0000-0001-8916-5570	European Union Seventh Framework Programme [283093]; Natural Environment Research Council (NERC) [NEC05100]; NERC [ceh020006] Funding Source: UKRI; Natural Environment Research Council [ceh020006] Funding Source: researchfish	European Union Seventh Framework Programme(European Commission); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 283093 - The Role Of Biodiversity In climate change mitigatioN (ROBIN). BVP received additional support from the Natural Environment Research Council (NERC) Natural Capital allocation to CEH (Natural Hazards HARM project NEC05100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 283093-The Role Of Biodiversity In climate change mitigatioN (ROBIN). BVP received additional support from the Natural Environment Research Council (NERC) Natural Capital allocation to CEH (Natural Hazards HARM project NEC05100).	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Alexander B, 2009, T ROY SOC TROP MED H, V103, P1263, DOI 10.1016/j.trstmh.2009.04.018; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2016, DISMO SPECIES DISTRI; [Anonymous], 2014, GLOB BRIEF VECT BORN; Assessment ME, 2005, EC HUM WELL BEING SY; Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Campbell-Lendrum D., 2005, ECOSYST HUM WELL BEI, P353; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; *CTR INT EARTH SCI, 2005, GRID POP WORLD VERS; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; de Almeida PS, 2013, MEM I OSWALDO CRUZ, V108, P992, DOI 10.1590/0074-0276130331; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Donalisio MR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/642910; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Pinheiro MPG, 2013, J VECTOR ECOL, V38, P307, DOI 10.1111/j.1948-7134.2013.12045.x; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gonzalez-Salazar C, 2012, ZOONOSES PUBLIC HLTH, V59, P179, DOI 10.1111/j.1863-2378.2012.01479.x; Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001; Hartemink N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020817; Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250; Hlavacova J, 2013, J MED ENTOMOL, V50, P955, DOI 10.1603/ME13053; Howe C, 2014, GLOBAL ENVIRON CHANG, V28, P263, DOI 10.1016/j.gloenvcha.2014.07.005; IPCC, 2007, CLIMATE CHANGE 2007; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jones L., 2013, SCENARIOS USE ROBIN; Karagiannis-Voules DA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002213; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430; Moo-Llanes D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002421; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006; O'Neill, 2011, M WORKSH NAT US NEW; Pan American Health Organization, 2016, LEISHM EP REP AM; Pigott DM, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.36; Pigott DM, 2014, GLOBAL DISTRIBUTION; Purse BV, 2015, BIOL J LINN SOC, V115, P664, DOI 10.1111/bij.12567; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Quintana M, 2013, MED VET ENTOMOL, V27, P39, DOI 10.1111/j.1365-2915.2012.01033.x; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Ridgeway G., 2006, GEN BOOSTED REGRESSI; Rogers DJ, 2006, ADV PARASIT, V62, P1, DOI 10.1016/S0065-308X(05)62001-5; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Stephens CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005725; Stolar J, 2015, DIVERS DISTRIB, V21, P595, DOI 10.1111/ddi.12279; Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x; Valderrama-Ardila C, 2010, AM J TROP MED HYG, V82, P243, DOI 10.4269/ajtmh.2010.09-0218; van Eupen M, D221 EC ROBIN; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; Vanwambeke SO, 2016, EXP APPL ACAROL, V68, P375, DOI 10.1007/s10493-015-0007-0; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; WHO, 2008, CLIM CHANG HLTH RES; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1; World Health Organization, 2008, The global burden of disease: 2004 update; Zeimes CB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-370; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	69	27	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183583	10.1371/journal.pone.0183583	http://dx.doi.org/10.1371/journal.pone.0183583			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020041	Green Published, Green Accepted, gold			2022-12-27	WOS:000412754400005
J	Watanabe, LP; Riddle, NC				Watanabe, Louis Patrick; Riddle, Nicole C.			Characterization of the Rotating Exercise Quantification System (REQS), a novel Drosophila exercise quantification apparatus	PLOS ONE			English	Article							WEIGHT-LOSS; RESISTANCE EXERCISE; INSULIN SENSITIVITY; ENDURANCE EXERCISE; PHYSICAL-EXERCISE; GENETIC-VARIATION; AEROBIC EXERCISE; MELANOGASTER; DISEASE; LIFE	Obesity is a disease that has reached epidemic proportions in the United States and has prompted international legislation in an attempt to curtail its prevalence. Despite the fact that one of the most prescribed treatment options for obesity is exercise, the genetic mechanisms underlying exercise response in individuals are still largely unknown. The fruit fly Drosophila melanogaster is a promising new model for studying exercise genetics. Currently, the lack of an accurate method to quantify the amount of exercise performed by the animals is limiting the utility of the Drosophila model for exercise genetics research. To address this limitation, we developed the Rotational Exercise Quantification System (REQS), a novel apparatus that is able to simultaneously induce exercise in flies while recording their activity levels. Thus, the REQS provides a method to standardize Drosophila exercise and ensure that all animals irrespective of genotype and sex experience the same level of exercise. Here, we provide a basic characterization of the REQS, validate its measurements using video-tracking technology, illustrate its potential use by presenting a comparison of two different exercise regimes, and demonstrate that it can be used to detect genotype-dependent variation in activity levels.	[Watanabe, Louis Patrick; Riddle, Nicole C.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Riddle, NC (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	riddlenc@uab.edu		Riddle, Nicole/0000-0003-1827-9145	National Institute Of Diabetes And Digestive And Kidney Diseases [P30DK056336]; Nutrition and Obesity Research Center at the University of Alabama at Birmingham; Nutrition Obesity Research Center (NORC)	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Nutrition and Obesity Research Center at the University of Alabama at Birmingham; Nutrition Obesity Research Center (NORC)	The project described was supported by Award Number P30DK056336 from the National Institute Of Diabetes And Digestive And Kidney Diseases, https://www.niddk.nih.gov/ (pilot grant from the Nutrition and Obesity Research Center at the University of Alabama at Birmingham to NCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Diabetes And Digestive And Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the assistance that was provided to us by the Biostatistics, Epidemiology, and Research Design (BERD) group with the Center for Clinical and Translational Science (CCTS) for advice on the statistical analyses. We are indebted to the UAB Research Machine Shop for their help in the development and maintenance of the REQS, as well as the Nutrition Obesity Research Center (NORC) for their funding support (Pilot and Feasibility grant to NCR). We would also like to thank the members of the Riddle lab for helpful discussions and support, as well as several anonymous reviewers for their suggestions. For help with fly husbandry specifically, we thank Michael Azar, Anthony Foster, Makayla Nixon, Cameron Gordon, and Lexus Wiley.	Ades PA, 2015, PREV MED, V80, P50, DOI 10.1016/j.ypmed.2015.03.014; Andersen G, 2015, AM J PHYSIOL-REG I, V308, pR123, DOI 10.1152/ajpregu.00321.2014; Balducci S, 2014, DIABETES-METAB RES, V30, P13, DOI 10.1002/dmrr.2514; Blazek AD, 2016, OSTEOARTHR CARTILAGE, V24, P1210, DOI 10.1016/j.joca.2016.02.004; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bouchard C, 2015, PROG CARDIOVASC DIS, V57, P337, DOI 10.1016/j.pcad.2014.08.005; Breit M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004454; Brocklebank LA, 2015, PREV MED, V76, P92, DOI 10.1016/j.ypmed.2015.04.013; Buresh R, 2014, J SPORT MED PHYS FIT, V54, P373; Cao WH, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0880-8; Chen YW, 2014, ANN MED, V46, P439, DOI 10.3109/07853890.2014.927713; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Coen PM, 2015, DIABETES, V64, P3737, DOI 10.2337/db15-0809; Coletta DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160327; Cordero Y, 2015, MED SCI SPORT EXER, V47, P1328, DOI 10.1249/MSS.0000000000000547; Denham J, 2015, EPIGENOMICS-UK, V7, P717, DOI 10.2217/epi.15.29; Drenowatz C, 2015, J SCI MED SPORT, V18, P632, DOI 10.1016/j.jsams.2014.09.009; Fock KM, 2013, J GASTROEN HEPATOL, V28, P59, DOI 10.1111/jgh.12407; Glynn EL, 2015, DIABETOLOGIA, V58, P2324, DOI 10.1007/s00125-015-3705-6; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Guo R, 2015, HEPATOB PANCREAT DIS, V14, P139, DOI 10.1016/S1499-3872(15)60355-1; Habibi Ehsanollah, 2014, J Educ Health Promot, V3, P55, DOI 10.4103/2277-9531.134751; Hammar M, 2013, BEST PRACT RES CL OB, V27, P741, DOI 10.1016/j.bpobgyn.2013.01.004; Hoffmann K, 2016, J ALZHEIMERS DIS, V50, P443, DOI 10.3233/JAD-150817; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Imayama I, 2013, J PHYS ACT HEALTH, V10, P676, DOI 10.1123/jpah.10.5.676; Ishimoto Hiroshi, 2012, Front Neurol, V3, P24, DOI 10.3389/fneur.2012.00024; Jennings BH, 2011, MATER TODAY, V14, P190, DOI 10.1016/S1369-7021(11)70113-4; Karoly HC, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/540563; Keating SE, 2015, EXPERT REV GASTROENT, V9, P1247, DOI 10.1586/17474124.2015.1075392; Khazaeli AA, 2007, MECH AGEING DEV, V128, P486, DOI 10.1016/j.mad.2007.06.005; Kim HJ, 2015, EXP GERONTOL, V70, P11, DOI 10.1016/j.exger.2015.07.006; Laughlin MH, 2015, J APPL PHYSIOL, V119, P583, DOI 10.1152/japplphysiol.00316.2015; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Lin XC, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002014; Lovell D, 2011, INT J SPORTS MED, V32, P271, DOI 10.1055/s-0030-1269844; Low KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049536; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3; Portugal EMM, 2013, NEUROPSYCHOBIOLOGY, V68, P1, DOI 10.1159/000350946; Mendez S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164706; Naldi L, 2014, BRIT J DERMATOL, V170, P634, DOI 10.1111/bjd.12735; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Parmenter BJ, 2015, VASC MED, V20, P30, DOI 10.1177/1358863X14559092; Pedersen L, 2015, CANCER J, V21, P111, DOI 10.1097/PPO.0000000000000096; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; R Core Team, 2013, R LANG ENV STAT COMP; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Ro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101107; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rynders CA, 2014, PHYSICIAN SPORTSMED, V42, P7, DOI 10.3810/psm.2014.02.2042; Shete AN, 2014, J CLIN DIAGN RES, V8, pBC1, DOI 10.7860/JCDR/2014/10896.5329; Shiraev T, 2012, AUST FAM PHYSICIAN, V41, P960; Stephens NA, 2015, J CLIN ENDOCR METAB, V100, P43, DOI 10.1210/jc.2014-2545; Sujkowski A, 2015, AGING-US, V7, P535, DOI 10.18632/aging.100789; Svetec N, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0316-2; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tonevitsky Alexander G., 2013, BMC Physiology, V13, P9, DOI 10.1186/1472-6793-13-9; Ugur B, 2016, DIS MODEL MECH, V9, P235, DOI 10.1242/dmm.023762; Upala S, 2015, INT J OBESITY, V39, P1197, DOI 10.1038/ijo.2015.64; Van Huffel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113667; Voet NBM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub4; Ward B. W., 2013, EARLY RELEASE SELECT; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; WOMACK CJ, 1995, J APPL PHYSIOL, V79, P838, DOI 10.1152/jappl.1995.79.3.838; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699; Zheng L, 2016, BIOGERONTOLOGY, P1; Zimmerman JE, 2012, SLEEP, V35, P545, DOI 10.5665/sleep.1744	71	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185090	10.1371/journal.pone.0185090	http://dx.doi.org/10.1371/journal.pone.0185090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016615	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400013
J	Fleury, MJ; Grenier, G; Bamvita, JM; Farand, L				Fleury, Marie-Josee; Grenier, Guy; Bamvita, Jean-Marie; Farand, Lambert			Relations between mental health team characteristics and work role performance	PLOS ONE			English	Article							CARE TEAMS; SERVICES; REFORM; MODEL	Effective mental health care requires a high performing, interprofessional team. Among 79 mental health teams in Quebec (Canada), this exploratory study aims to 1) determine the association between work role performance and a wide range of variables related to team effectiveness according to the literature, and to 2) using structural equation modelling, assess the covariance between each of these variables as well as the correlation with other exogenous variables. Work role performance was measured with an adapted version of a work role questionnaire. Various independent variables including team manager characteristics, user characteristics, team profiles, clinical activities, organizational culture, network integration strategies and frequency/satisfaction of interactions with other teams or services were analyzed under the structural equation model. The later provided a good fit with the data. Frequent use of standardized procedures and evaluation tools (e.g. screening and assessment tools for mental health disorders) and team manager seniority exerted the most direct effect on work role performance. While network integration strategies had little effect on work role performance, there was a high covariance between this variable and those directly affecting work role performance among mental health teams. The results suggest that the mental healthcare system should apply standardized procedures and evaluation tools and, to a lesser extent, clinical approaches to improve work role performance in mental health teams. Overall, a more systematic implementation of network integration strategies may contribute to improved work role performance in mental health care.	[Fleury, Marie-Josee] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Fleury, Marie-Josee; Grenier, Guy; Bamvita, Jean-Marie] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada; [Farand, Lambert] Univ Montreal, Dept Hlth Adm, Policy & Evaluat Sch Publ Hlth, Montreal, PQ, Canada	McGill University; Universite de Montreal	Fleury, MJ (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Fleury, MJ (corresponding author), Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada.	flemar@douglas.mcgill.ca		Fleury, Marie-Josee/0000-0002-4743-8611	Fonds de la recherche en sante du Quebec [22367]; AstraZeneca	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); AstraZeneca(AstraZeneca)	This study was funded by the Fonds de la recherche en sante du Quebec (grant number 22367): http://www.frqs.gouv.qc.ca./ and the Prends soin de toi Program from AstraZeneca. MJF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; [Anonymous], 2000, INT J MANAG REV, DOI [DOI 10.1111/1468-2370.00046, 10.1111/1468-2370.00046]; [Anonymous], INDICATEURS PERTINEN; Australian Government Department of Health, 2021, PROV HLTH CAR REM CO; Beck J, 2020, COGNITIVE BEHAV THER, V3rd; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bilsker D, 2012, CAN J PSYCHIAT, V57, P203, DOI 10.1177/070674371205700402; Blackmore G, 2012, HEALTH CARE MANAG, V31, P195, DOI 10.1097/HCM.0b013e3182619d48; Bollen KA, 1989, STRUCTURAL EQUATIONS; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Buljac-Samardzic M, 2010, HEALTH POLICY, V94, P183, DOI 10.1016/j.healthpol.2009.09.015; Cameron K.S, 2006, DIAGNOSING CHANGING; Chan D, 1998, J APPL PSYCHOL, V83, P234, DOI 10.1037/0021-9010.83.2.234; Chiocchio F, 2011, PROJ MANAG J, V42, P78, DOI 10.1002/pmj.20268; de Stampa M, 2010, INT J INTEGR CARE, V10; Department of Health, 2011, NO HLTH MENT HLTH CR; Druss BG, 2006, GEN HOSP PSYCHIAT, V28, P145, DOI 10.1016/j.genhosppsych.2005.10.006; Fleury MJ, 2006, HEALTH SERV MANAG RE, V19, P153, DOI 10.1258/095148406777888080; Fleury MJ, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2457; Franx Gerdien, 2009, Int J Integr Care, V9, pe84; Frese M, 2001, RES ORGAN BEHAV, P23; Gerowitz M B, 1996, Health Serv Manage Res, V9, P69; Goodman M, 2010, J PSYCHIATR PRACT, V16, P155, DOI 10.1097/01.pra.0000375711.47337.27; Griffin MA, 2007, ACAD MANAGE J, V50, P327, DOI 10.5465/AMJ.2007.24634438; Grumbach K, 2004, JAMA-J AM MED ASSOC, V291, P1246, DOI 10.1001/jama.291.10.1246; Hanrahan Nancy P, 2010, Policy Polit Nurs Pract, V11, P235, DOI 10.1177/1527154410390381; Heritage B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092879; Holmesland AL, 2010, INT J INTEGR CARE, V10; Huynh C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0974-7; Jacob B, 2014, SANTE MENT QUE, V39, P209, DOI 10.7202/1025915ar; Janse B, INT J INTEGR CARE, V12, pe184; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Kilpatrick K, 2011, HEALTH CARE MANAG, V30, P215, DOI 10.1097/HCM.0b013e318225e03a; Kisely S, 2014, SANTE MENT QUE, V39, P195, DOI 10.7202/1025914ar; Kodner Dennis L, 2009, Healthc Q, V13 Spec No, P6; Kozlowski S.W.J., 2003, HDB PSYCHOL IND ORG, P333, DOI [10.1002/9781118133880.hop212017, DOI 10.1002/0471264385.WEI1214]; Lemieux-Charles L, 2006, MED CARE RES REV, V63, P263, DOI 10.1177/1077558706287003; Liljegren A, 2013, INT J INTEGR CARE, V13; Lyon AR, 2015, ADM POLICY MENT HLTH, V42, P47, DOI 10.1007/s10488-014-0543-7; MacAdam M, 2011, INT J INTEGR CARE, V11; Maslin-Prothero SE, 2010, INT J INTEGR CARE, V10; Mathieu J, 2008, J MANAGE, V34, P410, DOI 10.1177/0149206308316061; McEwan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169604; Miller J L, 2000, Healthc Leadersh Manag Rep, V8, P5; Miller WR, 1996, ADDICT BEHAV, V21, P835, DOI 10.1016/0306-4603(96)00044-5; Ministry of Social Affairs and Health, 2010, PLAN MENT HLTH SUBST; Mowbray CT, 2003, AM J EVAL, V24, P315, DOI 10.1177/109821400302400303; MSSS, PLAN ACT SANT MENT 2; Nicaise P, 2014, HEALTH POLICY, V115, P120, DOI 10.1016/j.healthpol.2014.02.007; Peters AH, 2010, INT J INTEGR CARE, V10; Quaschning K, 2013, PATIENT EDUC COUNS, V91, P167, DOI 10.1016/j.pec.2012.12.007; Rapp CA, 1992, STRENGTHS PERSPECTIV, P45; Sampalli T, 2012, PATIENT PREFER ADHER, V6, P757, DOI 10.2147/PPA.S35201; Sansone RA, 2011, GEN HOSP PSYCHIAT, V33, P343, DOI 10.1016/j.genhosppsych.2011.04.006; Scammon DL, 2014, J AM BOARD FAM MED, V27, P219, DOI 10.3122/jabfm.2014.02.120338; Scott Tim, 2003, J Health Serv Res Policy, V8, P105, DOI 10.1258/135581903321466085; Seekles W, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-171; Suter Esther, 2009, Healthc Q, V13 Spec No, P16; Valentijn Pim P, 2013, Int J Integr Care, V13, pe010; van der Feltz-Cornelis Christina M, 2011, Int J Integr Care, V11 Spec Ed, pe015; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; Ye Chenglin, 2012, Int J Integr Care, V12, pe137	63	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185451	10.1371/journal.pone.0185451	http://dx.doi.org/10.1371/journal.pone.0185451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991923	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800016
J	Nam, KW; Kwon, HM; Lim, JS; Han, MK; Nam, H; Lee, YS				Nam, Ki-Woong; Kwon, Hyung-Min; Lim, Jae-Sung; Han, Moon-Ku; Nam, Hyunwoo; Lee, Yong-Seok			The presence and severity of cerebral small vessel disease increases the frequency of stroke in a cohort of patients with large artery occlusive disease	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; WHITE-MATTER LESIONS; RISK-FACTORS; RECURRENT STROKE; ROTTERDAM SCAN; LEUKOARAIOSIS; MICROBLEEDS; INFARCTS; HEALTH; TRIAL	Background Cerebral small vessel disease (SVD) commonly coexists with large artery atherosclerosis (LAA). Aim We evaluate the effect of SVD on stroke recurrence in patients for ischemic stroke with LAA. Methods We consecutively collected first-ever ischemic stroke patients who were classified as LAA mechanism between Jan 2010 and Dec 2013. Univariate and multivariate Cox analyses were performed to evaluate the association between the 2-year recurrence and demographic, clinical, and radiological factors. To evaluate the impact of SVD and its components on recurrent stroke, we used the Kaplan-Meier analysis. SVD was defined as the presence of severe white matter hyperintensity (WMH) or old lacunar infarction (OLI) or cerebral microbleeds (CMB). We also compared frequency and burden of SVD among recurrent stroke groups with different mechanisms. Results Among a total of 956 participants, 92 patients had recurrent events. Recurrence group showed a higher frequency of severe WMH, OLI, asymptomatic territorial infarction, and severe stenosis on the relevant vessel in multivariate analysis. The impact of SVD and its components on recurrent stroke was significant in any ischemic recurrent stroke, and the presence of SVD was continuously important in stroke recurrence regardless of its mechanism, including recurrent LAA stroke, recurrent small vessel occlusion stroke, and even recurrent cardioembolic stroke. Additionally, the recurrence rate increased in doseresponse manner with the increased number of SVD components. Conclusions Cerebral SVD is associated with recurrent stroke in patients with LAA. Additionally, it may affect any mechanisms of recurrent stroke and even with a dose response manner.	[Nam, Ki-Woong; Kwon, Hyung-Min; Lim, Jae-Sung; Nam, Hyunwoo; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Nam, Ki-Woong; Kwon, Hyung-Min; Nam, Hyunwoo; Lee, Yong-Seok] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea; [Lim, Jae-Sung] Hallym Univ, Dept Neurol, Sacred Heart Hosp, Anyang, South Korea; [Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Hallym University; Seoul National University (SNU)	Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.; Kwon, HM (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Neurol, Seoul, South Korea.	hmkwon@snu.ac.kr	Lim, Jae-Sung/D-5555-2012	Lim, Jae-Sung/0000-0001-6157-2908; Kwon, Hyung-Min/0000-0002-6101-7127				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2014, HLTH NIO; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Bernick C, 2001, NEUROLOGY, V57, P1222, DOI 10.1212/WNL.57.7.1222; Chutinet A, 2012, AM J NEURORADIOL, V33, P1591, DOI 10.3174/ajnr.A3015; Fazekas F, 2002, CEREBROVASC DIS, V13, P31, DOI 10.1159/000049147; Fu JH, 2005, J NEUROL NEUROSUR PS, V76, P793, DOI 10.1136/jnnp.2003.032771; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Helenius J, 2016, STROKE, V47, P24, DOI 10.1161/STROKEAHA.115.011771; HIER DB, 1991, STROKE, V22, P155, DOI 10.1161/01.STR.22.2.155; Inzitari D, 2003, STROKE, V34, P2067, DOI 10.1161/01.STR.0000080934.68280.82; Kato H, 2002, STROKE, V33; Kim GM, 2014, STROKE, V45, P479, DOI 10.1161/STROKEAHA.113.003004; Kwon HM, 2016, JAMA NEUROL, V73, P36, DOI 10.1001/jamaneurol.2015.3145; Lee SJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-31; Lim JS, 2015, JAMA NEUROL, V72, P301, DOI 10.1001/jamaneurol.2014.3958; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Weimar C, 2009, STROKE, V40, P350, DOI 10.1161/STROKEAHA.108.521419	23	16	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184944	10.1371/journal.pone.0184944	http://dx.doi.org/10.1371/journal.pone.0184944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991905	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800010
J	Tan, SK; Leung, WK; Tang, ATH; Zwahlen, RA				Tan, Su Keng; Leung, Wai Keung; Tang, Alexander Tin Hong; Zwahlen, Roger A.			Effects of mandibular setback with or without maxillary advancement osteotomies on pharyngeal airways: An overview of systematic reviews	PLOS ONE			English	Review							OBSTRUCTIVE SLEEP-APNEA; CLASS-III MALOCCLUSION; ORTHOGNATHIC SURGERY; BIMAXILLARY SURGERY; 3-DIMENSIONAL CHANGES; HEAD POSTURE; HYOID BONE; SPACE; IMPACT; TOMOGRAPHY	Background Mandibular setback osteotomies potentially lead to narrowing of the pharyngeal airways, subsequently resulting in post-surgical obstructive sleep apnea (OSA). Objective To summarize current evidence from systematic reviews that has evaluated pharyngeal airway changes after mandibular setback with or without concomitant upper jaw osteotomies. Methodology PubMed, EMBASE, Web of Science, and Cochrane Library databases were searched with no restriction of language or date. Systematic reviews studying changes in pharyngeal airway dimensions and respiratory parameters after mandibular setback with or without concomitant upper jaw osteotomies have been identified, screened for eligibility, included and analyzed in this study. Results Six systematic reviews have been included. While isolated mandibular setback osteotomies result in reduced oropharyngeal airway dimensions, the reduction is lesser in cases with concomitant upper jaw osteotomies. Only scarce evidence exists currently to what happens to naso-and hypo-pharyngeal airways. There is no evidence for post-surgical OSA, even though some studies reported reduced respiratory parameters after single-jaw mandibular setback with or without concomitant upper jaw osteotomies. Conclusion Although mandibular setback osteotomies reduce pharyngeal airway dimensions, evidence confirming post-surgical OSA was not found. Nevertheless, potential post-surgical OSA should be taken into serious consideration during the treatment planning of particular orthognathic cases. As moderate evidence exists that double-jaw surgeries lead to less compromised post-surgical pharyngeal airways, they should be considered as the method of choice especially in cases with severe dentoskeletal Class III deformity.	[Tan, Su Keng] Univ Teknol MARA, Ctr Oral & Maxillofacial Surg Studies, Fac Dent, Jalan Hosp, Sungai Buloh Campus, Selangor Darul Ehsan, Malaysia; [Tan, Su Keng; Zwahlen, Roger A.] Univ Hong Kong, Discipline Oral & Maxillofacial Surg, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Leung, Wai Keung] Univ Hong Kong, Prince Philip Dent Hosp, Discipline Periodontol, Fac Dent, Sai Ying Pun, Hong Kong, Peoples R China; [Tang, Alexander Tin Hong] 503 Tak Shing House, Hong Kong, Hong Kong, Peoples R China	Universiti Teknologi MARA; University of Hong Kong; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Discipline Oral & Maxillofacial Surg, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	zwahlen@hku.hk	Keng, Tan Su/AAK-3018-2020; LEUNG, Wai Keung/B-2159-2009	LEUNG, Wai Keung/0000-0003-1979-910X; Tan, Su Keng/0000-0002-4346-3027; ZWAHLEN, Roger Arthur/0000-0003-4666-7567	General Research Fund through the Research Grants Council of Hong Kong SAR [HKU 17121915]	General Research Fund through the Research Grants Council of Hong Kong SAR	This review was supported by the General Research Fund through the Research Grants Council of Hong Kong SAR (project number: HKU 17121915). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. The first author is partly funded by this grant to support her PhD study.	Abdelrahman TEF, 2011, J CRANIOFAC SURG, V22, P1598, DOI 10.1097/SCS.0b013e31822e5fc2; Al-Moraissi EA, 2015, INT J ORAL MAX SURG, V44, P1110, DOI 10.1016/j.ijom.2015.05.006; [Anonymous], INT J SURG; [Anonymous], 2011, INT J ORAL MAX SURG, DOI DOI 10.1016/J.IJOM.2011.07.1054; [Anonymous], 2008, ASIAN J ORAL MAXILLO, DOI DOI 10.1016/S0915-6992(08)80002-7; [Anonymous], EUROPEAN ARCH OTO RH; [Anonymous], 2003, STOMATOLOGIJA; Aydemir H, 2012, ANGLE ORTHOD, V82, P993, DOI 10.2319/091911-597.1; Becker LA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001726.pub4; Borba AM, 2016, INT J ORAL MAX SURG, V45, P472, DOI 10.1016/j.ijom.2015.10.008; Chen FS, 2007, AM J ORTHOD DENTOFAC, V131, P372, DOI 10.1016/j.ajodo.2005.06.028; Christovam IO, 2016, INT J ORAL MAX SURG, V45, P460, DOI 10.1016/j.ijom.2015.10.018; Deeks J J, 2003, Health Technol Assess, V7, piii; Degerliyurt K, 2009, INT J ORAL MAX SURG, V38, P647, DOI 10.1016/j.ijom.2009.01.010; Degerliyurt K, 2008, ORAL SURG ORAL MED O, V105, P495, DOI 10.1016/j.tripleo.2007.11.012; Demetriades N, 2010, J ORAL MAXIL SURG, V68, P2431, DOI 10.1016/j.joms.2010.02.033; Canellas JVD, 2016, SLEEP BREATH, V20, P387, DOI 10.1007/s11325-015-1274-z; Fernandez-Ferrer L, 2015, J CRANIO MAXILL SURG, V43, P248, DOI 10.1016/j.jcms.2014.11.017; Foltan R, 2011, INT J ORAL MAX SURG, V40, P146, DOI 10.1016/j.ijom.2010.10.006; Gokce SM, 2012, INT J ORAL MAX SURG, V41, P820, DOI 10.1016/j.ijom.2012.01.003; Guijarro-Martinez R, 2011, INT J ORAL MAX SURG, V40, P1227, DOI 10.1016/j.ijom.2011.06.017; GUILLEMINAULT C, 1985, CHEST, V88, P776, DOI 10.1378/chest.88.5.776; Gurani Sirwan Fernandez, 2016, J Oral Maxillofac Res, V7, pe1, DOI 10.5037/jomr.2016.7101; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; He JL, 2017, INT J SURG, V38, P31, DOI 10.1016/j.ijsu.2016.12.033; [何金龙 He Jinlong], 2016, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University .Medical Science], V36, P1467; Hochban W, 1996, INT J ORAL MAX SURG, V25, P333, DOI 10.1016/S0901-5027(06)80024-X; Hong JS, 2011, J ORAL MAXIL SURG, V69, pE401, DOI 10.1016/j.joms.2011.02.011; Huang Chiung Shing, 2014, Biomed J, V37, P184, DOI 10.4103/2319-4170.126863; Hwang S, 2010, ANGLE ORTHOD, V80, P302, DOI 10.2319/040209-188.1; Indriksone Iveta, 2014, Stomatologija, V16, P109; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Jakobsone G, 2010, ORAL SURG ORAL MED O, V110, P234, DOI 10.1016/j.tripleo.2010.03.026; Kim MA, 2014, J CRANIO MAXILL SURG, V42, P531, DOI 10.1016/j.jcms.2013.07.022; Kim MA, 2013, ANGLE ORTHOD, V83, P623, DOI 10.2319/083112-700.1; Kim NR, 2010, KOREAN J ORTHOD, V40, P145, DOI 10.4041/kjod.2010.40.3.145; Kobayashi T, 2013, BRIT J ORAL MAX SURG, V51, P312, DOI 10.1016/j.bjoms.2012.07.004; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lye KW, 2008, ANN ACAD MED SINGAP, V37, P677; Mattos CT, 2011, INT J ORAL MAX SURG, V40, P1347, DOI 10.1016/j.ijom.2011.06.020; Moher David, 2009, Open Med, V3, pe123; Nakagawa F, 1998, Int J Adult Orthodon Orthognath Surg, V13, P299; Park JW, 2010, AM J ORTHOD DENTOFAC, V138, P292, DOI 10.1016/j.ajodo.2009.10.036; RILEY RW, 1987, J ORAL MAXIL SURG, V45, P450, DOI 10.1016/0278-2391(87)90016-4; Samman Nabil, 2002, Int J Adult Orthodon Orthognath Surg, V17, P180; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Uesugi T, 2014, INT J ORAL MAX SURG, V43, P1082, DOI 10.1016/j.ijom.2014.06.010; Wang Hong-wei, 2012, Zhonghua Kou Qiang Yi Xue Za Zhi, V47, P221, DOI 10.3760/cma.j.issn.1002-0098.2012.04.007; Wang Hongwei, 2012, Hua Xi Kou Qiang Yi Xue Za Zhi, V30, P650; Welch V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001333; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141	53	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185951	10.1371/journal.pone.0185951	http://dx.doi.org/10.1371/journal.pone.0185951			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016682	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800028
J	Fleckenstein, J; Simon, P; Konig, M; Vogt, L; Banzer, W				Fleckenstein, Johannes; Simon, Perikles; Koenig, Matthias; Vogt, Lutz; Banzer, Winfried			The pain threshold of high-threshold mechanosensitive receptors subsequent to maximal eccentric exercise is a potential marker in the prediction of DOMS associated impairment	PLOS ONE			English	Article							ONSET MUSCLE SORENESS; HUMAN SKELETAL-MUSCLE; LENGTHENING CONTRACTIONS; MECHANICAL HYPERALGESIA; INJURY; DAMAGE; FIBERS; RAT; BRADYKININ; PRESSURE	Background Delayed-onset muscle soreness (DOMS) refers to dull pain and discomfort in people after participating in exercise, sport or recreational physical activities. The aim of this study was to detect underlying mechanical thresholds in an experimental model of DOMS. Methods Randomised study to detect mechanical pain thresholds in a randomised order following experimentally induced DOMS of the non-dominant arm in healthy participants. Main outcome was the detection of the pressure pain threshold (PPT), secondary thresholds included mechanical detection (MDT) and pain thresholds (MPT), pain intensity, pain perceptions and the maximum isometric voluntary force (MIVF). Results Twenty volunteers (9 female and 11 male, age 25.2 +/- 3.2 years, weight 70.5 +/- 10.8 kg, height 177.4 +/- 9.4 cm) participated in the study. DOMS reduced the PPT (at baseline 5.9 +/- 0.4 kg/cm(2)) by a maximum of 1.5 +/- 1.4 kg/cm(2) (-24%) at 48 hours (p < 0.001). This correlated with the decrease in MIVF (r = -0.48, p = 0.033). Whereas subjective pain was an indicator of the early 48 hours, the PPT was still present after 72 hours (r = 0.48, p = 0.036). Other mechanical thresholds altered significantly due to DOMS, but did show no clinically or physiologically remarkable changes. Conclusions Functional impairment following DOMS seems related to the increased excitability of high-threshold mechanosensitive nociceptors. The PPT was the most valid mechanical threshold to quantify the extent of dysfunction. Thus PPT rather than pain intensity should be considered a possible marker indicating the athletes potential risk of injury	[Fleckenstein, Johannes; Koenig, Matthias; Vogt, Lutz; Banzer, Winfried] Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany; [Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med, Mainz, Germany; [Koenig, Matthias] London South Bank Univ, Sch Appl Sci, Sport & Exercise Sci Res Ctr, London, England; [Koenig, Matthias] German Sport Univ Cologne, Inst Movement & Sport Gerontol, Sportpark Mungersdorf 6, Cologne, Germany	Goethe University Frankfurt; Johannes Gutenberg University of Mainz; London South Bank University; German Sport University Cologne	Fleckenstein, J (corresponding author), Goethe Univ Frankfurt, Inst Sports Sci, Dept Sports Med, Frankfurt, Germany.	johannes.fleckenstein@sport.uni-frankfurt.de	Simon, Perikles D/B-2293-2013; Fleckenstein, Johannes/AAL-1315-2021	Simon, Perikles D/0000-0002-7996-4034; Konig, Matthias/0000-0001-9785-3058; Fleckenstein, Johannes/0000-0003-3442-0380	Vereinigung von Freunden; Forderern der Goethe-Universitat	Vereinigung von Freunden; Forderern der Goethe-Universitat	This study was funded in part by a grant by the Vereinigung von Freunden and Forderern der Goethe-Universitat [Association of friends and sponsors of the Goethe-University Frankfurt] awarded to JF assuring independent research and publication of the data.	ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Basbaum A. I, 2000, PRINCIPLES NEURAL SC, P472; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; CHAN AW, 1992, J NEUROL NEUROSUR PS, V55, P56, DOI 10.1136/jnnp.55.1.56; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Close GL, 2005, COMP BIOCHEM PHYS A, V142, P257, DOI 10.1016/j.cbpa.2005.08.005; Dannecker EA, 2014, SPORTS MED, V44, P921, DOI 10.1007/s40279-014-0172-z; Dannecker EA, 2011, CLIN J PAIN, V27, P42, DOI 10.1097/AJP.0b013e3181f04818; DIEHL B, 1993, EXP BRAIN RES, V92, P431; Dostrovsky JO, 2013, WALL MELZACKS TXB PA, P182; DOTSON RM, 1993, MUSCLE NERVE, V16, P1049, DOI 10.1002/mus.880161008; DUBNER R, 1989, J NEUROPHYSIOL, V62, P450, DOI 10.1152/jn.1989.62.2.450; DUNCAN CJ, 1987, J CELL SCI, V87, P183; Fernandez-Carnero J, 2010, MED SCI SPORT EXER, V42, P922, DOI 10.1249/MSS.0b013e3181c29eab; Fleckenstein J, 2016, CLIN J SPORT MED, V26, P471, DOI 10.1097/JSM.0000000000000259; FRIDEN J, 1984, CELL TISSUE RES, V236, P365; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Fujii Y, 2008, PAIN, V140, P292, DOI 10.1016/j.pain.2008.08.013; Gibson W, 2009, EXP BRAIN RES, V194, P299, DOI 10.1007/s00221-008-1699-8; Gosselin LE, 2002, MUSCLE NERVE, V25, P822, DOI 10.1002/mus.10112; Graven-Nielsen T, 2004, EXP BRAIN RES, V159, P273, DOI 10.1007/s00221-004-1937-7; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Hoheisel U, 2005, PAIN, V114, P168, DOI 10.1016/j.pain.2004.12.020; Hu J, 2006, PAIN, V120, P3, DOI 10.1016/j.pain.2005.11.002; Hubscher M, 2008, J ALTERN COMPLEM MED, V14, P1011, DOI 10.1089/acm.2008.0173; Hunter KD, 1997, J APPL PHYSIOL, V82, P278, DOI 10.1152/jappl.1997.82.1.278; JENSEN K, 1990, PEPTIDES, V11, P1127, DOI 10.1016/0196-9781(90)90141-Q; Lewis PB, 2012, CLIN SPORT MED, V31, P255, DOI 10.1016/j.csm.2011.09.009; Lieber Richard L, 2002, J Am Acad Orthop Surg, V10, P67; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; LIEBER RL, 1988, ACTA PHYSIOL SCAND, V133, P587, DOI 10.1111/j.1748-1716.1988.tb08446.x; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; MACINTYRE DL, 1995, SPORTS MED, V20, P24, DOI 10.2165/00007256-199520010-00003; Maffulli N, 2015, TRANSL MED UNISA, V12, P14; Mann MK, 2006, J OROFAC PAIN, V20, P325; McMahon S.B., 2008, WALL MELZACKS TXB PA, P49; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MENSE S, 1977, J PHYSIOLOGY PARIS, V73, P233; Mense S, 2013, WALL MELZACKS TXB PA, P620; MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010; Nagi SS, 2013, J PAIN, V14, P538, DOI 10.1016/j.jpain.2013.01.009; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nosaka K, 2001, MED SCI SPORT EXER, V33, P22; Ota H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065751; Park G, 2011, ANN REHABIL MED-ARM, V35, P412, DOI 10.5535/arm.2011.35.3.412; Patel TJ, 2004, J APPL PHYSIOL, V97, P1803, DOI 10.1152/japplphysiol.00505.2003; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Queme F, 2013, J PAIN, V14, P1425, DOI 10.1016/j.jpain.2013.07.010; Ra SG, 2013, ADV EXP MED BIOL, V776, P179, DOI 10.1007/978-1-4614-6093-0_18; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; SCHMIDT R, 1995, J NEUROSCI, V15, P333; Taguchi T, 2005, J NEUROPHYSIOL, V94, P2822, DOI 10.1152/jn.00470.2005; Taguchi T, 2008, PAIN, V138, P119, DOI 10.1016/j.pain.2007.11.015; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0	64	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185463	10.1371/journal.pone.0185463	http://dx.doi.org/10.1371/journal.pone.0185463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985238	gold, Green Published, Green Submitted			2022-12-27	WOS:000412493000005
J	Shen, AL; Moran, SM; Glover, EA; Teixeira, LB; Bradfield, CA				Shen, Anna L.; Moran, Susan M.; Glover, Edward A.; Teixeira, Leandro B.; Bradfield, Christopher A.			Retinal pathology in the PPCD1 mouse	PLOS ONE			English	Article							POLYMORPHOUS CORNEAL-DYSTROPHY; IRIDOCORNEAL ENDOTHELIAL SYNDROME; DBA/2J MICE; IRIS ATROPHY; GLAUCOMA; MUTATIONS; DETACHMENT; MODEL; NEURODEGENERATION; METAPLASIA	Retinal phenotypes of the PPCD1 mouse, a mouse model of posterior polymorphous corneal dystrophy, have been characterized. PPCD1 mice on the DBA/2J background (D2. Ppcd1) have previously been reported to develop an enlarged anterior chamber due to epithelialization and proliferation of the corneal endothelium and subsequent blockage of the iridocorneal angle. Results presented here show that D2. Ppcd1 mice develop increased intraocular pressure (IOP), with measurements at three months of age revealing significant increases in IOP. Significant retinal ganglion cell layer cell loss is observed at five months of age. D2. Ppcd1 animals also exhibit marked degeneration of the outer nuclear layer in association with hyperplasia of the retinal pigment epithelium. Evidence of retinal detachment is present as early as three weeks of age. By 3.5 months of age, focal areas of outer nuclear layer loss are observed. Although the Gpnmb(R150X) mutation leads to increased IOP and glaucoma in DBA/2J mice, development of anterior segment and retinal defects in D2. Ppcd1 animals does not depend upon presence of the Gpnmb(R150X) mutation.	[Shen, Anna L.; Moran, Susan M.; Glover, Edward A.; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA; [Shen, Anna L.; Teixeira, Leandro B.; Bradfield, Christopher A.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA; [Teixeira, Leandro B.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Bradfield, Christopher A.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA.; Shen, AL; Bradfield, CA (corresponding author), Univ Wisconsin, McPherson Eye Res Inst, Madison, WI 53706 USA.; Bradfield, CA (corresponding author), Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA.	alshen@wisc.edu; bradfield@oncology.wisc.edu	Teixeira, Leandro B C/H-9272-2015; Teixeira, Leandro/AAU-6094-2021	Teixeira, Leandro B C/0000-0001-9960-678X; Teixeira, Leandro/0000-0001-9960-678X	NIH from the National Eye Institute, National Institutes of Health (NIH) [EY021376]; Core Grant for Vision Research - National Eye Institute, NIH, to the University of Wisconsin Madison [P30 EY016665]; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	NIH from the National Eye Institute, National Institutes of Health (NIH); Core Grant for Vision Research - National Eye Institute, NIH, to the University of Wisconsin Madison; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH Grant EY021376 from the National Eye Institute, National Institutes of Health (NIH) (nei.nih.gov) to CAB. We gratefully acknowledge support for this study from Nate and Kate Mahr to CAB. Portions of this study utilized shared resources supported by the Core Grant for Vision Research funded by the National Eye Institute, NIH, to the University of Wisconsin Madison (P30 EY016665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2013, JAMA OPHTHALMOL, V131, P1583, DOI 10.1001/jamaophthalmol.2013.5036; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Blake JA, 2017, NUCL ACIDS RES, V45; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chung DD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169215; Ciralsky Jessica, 2007, Semin Ophthalmol, V22, P241, DOI 10.1080/08820530701745157; Davidson AE, 2016, AM J HUM GENET, V98, P75, DOI 10.1016/j.ajhg.2015.11.018; Del Turco C, 2015, EUR J OPHTHALMOL, V25, P177, DOI 10.5301/ejo.5000526; Fernaandez-Saanchez L, 2014, INVEST OPHTH VIS SCI, V55, P6059, DOI 10.1167/iovs.14-14421; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hidayat AA, 2006, CORNEA, V25, P956, DOI 10.1097/01.ico.0000228786.84581.ee; HIRST LW, 1995, INVEST OPHTH VIS SCI, V36, P820; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Khan AK, 2015, EXP EYE RES, V130, P29, DOI 10.1016/j.exer.2014.11.007; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Le DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158467; Li Y, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-19; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; Liskova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045495; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157577; Shen AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012213; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Teixeira LBC, 2014, MOL VIS, V20, P376; Wang YX, 2015, J GLAUCOMA, V24, pe16, DOI 10.1097/IJG.0000000000000102; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241	37	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185094	10.1371/journal.pone.0185094	http://dx.doi.org/10.1371/journal.pone.0185094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981549	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300027
J	Mulbry, W; Selmer, K; Lansing, S				Mulbry, Walter; Selmer, Kaitlyn; Lansing, Stephanie			Effect of liquid surface area on hydrogen sulfide oxidation during micro-aeration in dairy manure digesters	PLOS ONE			English	Article							REMOVAL; TEMPERATURE	Although there are a variety of commercially available biological and chemical treatments for removal of hydrogen sulfide (H2S) from biogas, managing biogas H2S remains a significant challenge for agricultural digesters where labor and operational funds are very limited compared to municipal and industrial digesters. The objectives of this study were to evaluate headspace aeration for reducing H2S levels in low cost plug flow digesters and to characterize the relationship between the liquid surface area and H2S oxidation rates. Experiments with replicate field scale plug flow digesters showed that H2S levels decreased from 3500 ppmv to < 100 ppmv when headspace oxygen levels were 0.5 to 1%. Methane production was not affected by aeration rates that resulted in headspace oxygen levels of up to 1%. Pilot scale experiments using 65 to 104 L desulfurization units showed that H2S oxidation rates increased with increases in liquid surface area. These results support the hypothesis that H2S oxidation rates are limited, in part, by the surface area available for oxygen transfer, and can be increased by growth of biofilms containing H2S oxidizing bacteria. Maximum removal rates corresponded to 40 to 100 g S m(-2) d(-1) of liquid surface area at biogas retention times of 30 to 40 min.	[Mulbry, Walter; Selmer, Kaitlyn] ARS, USDA, Beltsville, MD 20705 USA; [Lansing, Stephanie] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA	United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park	Mulbry, W (corresponding author), ARS, USDA, Beltsville, MD 20705 USA.	walter.mulbry@ars.usda.gov			USDA Agricultural Research Service	USDA Agricultural Research Service(United States Department of Agriculture (USDA))	This work was funded by the USDA Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA, 2005, STAND METH EXAM WAT; Arikan OA, 2015, WASTE MANAGE, V43, P108, DOI 10.1016/j.wasman.2015.06.005; Horejs J, 2017, ANAEROBE, V46, P41; Krayzelova L, 2015, REV ENVIRON SCI BIO, V14, P703, DOI 10.1007/s11157-015-9386-2; Lansing SA, 2015, T ASABE, V58, P441; Munoz R, 2015, REV ENVIRON SCI BIO, V14, P727, DOI 10.1007/s11157-015-9379-1; Nghiem LD, 2014, BIORESOURCE TECHNOL, V173, P443, DOI 10.1016/j.biortech.2014.09.052; R Core Team, 2014, R LANG ENV STAT COMP; Ramos I, 2013, BIORESOURCE TECHNOL, V142, P633, DOI 10.1016/j.biortech.2013.05.084; SAFLEY LM, 1994, BIORESOURCE TECHNOL, V47, P165, DOI 10.1016/0960-8524(94)90116-3; van der Zee FP, 2007, BIORESOURCE TECHNOL, V98, P518, DOI 10.1016/j.biortech.2006.02.011; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Wilkie AC, 2005, DAIRY MANURE MANAGEM, P63	13	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185738	10.1371/journal.pone.0185738	http://dx.doi.org/10.1371/journal.pone.0185738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976998	Green Submitted, gold, Green Published			2022-12-27	WOS:000412163100041
J	Tempesta, C; Hijazi, A; Moussian, B; Roch, F				Tempesta, Camille; Hijazi, Assia; Moussian, Bernard; Roch, Fernando			Boudin trafficking reveals the dynamic internalisation of specific septate junction components in Drosophila	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TUBE-SIZE CONTROL; OCCLUDING JUNCTIONS; TRACHEAL MORPHOGENESIS; LIPOPROTEIN PARTICLES; TAGGED PROTEINS; NERVOUS-SYSTEM; NA+/K+ ATPASE; ORGANIZATION; MEMBER	The maintenance of paracellular barriers in invertebrate epithelia depends on the integrity of specific cell adhesion structures known as septate junctions (SJ). Multiple studies in Drosophila have revealed that these junctions have a stereotyped architecture resulting from the association in the lateral membrane of a large number of components. However, little is known about the dynamic organisation adopted by these multi-protein complexes in living tissues. We have used live imaging techniques to show that the Ly6 protein Boudin is a component of these adhesion junctions and can diffuse systemically to associate with the SJ of distant cells. We also observe that this protein and the claudin Kune-kune are endocytosed in epidermal cells during embryogenesis. Our data reveal that the SJ contain a set of components exhibiting a high membrane turnover, a feature that could contribute in a tissuespecific manner to the morphogenetic plasticity of these adhesion structures.	[Tempesta, Camille; Roch, Fernando] Univ Toulouse, CBI, CBD, CNRS,UPS, Toulouse, France; [Hijazi, Assia] Lebanese Univ, Fac Sci 1&5, Doctorate Sch Sci & Technol PRASE, Campus Rafic Hariri, Hadath Beirut, Lebanon; [Moussian, Bernard] Univ Tubingen, Interfac Inst Cell Biol, Sect Anim Genet, Tubingen, Germany	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Lebanese University; Eberhard Karls University of Tubingen	Roch, F (corresponding author), Univ Toulouse, CBI, CBD, CNRS,UPS, Toulouse, France.	fernando.roch@univ-tlse3.fr			Agence Nationale de la Recherche (France) [ANR-13-ISV7-0001-01]; research grant of the Lebanese University	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); research grant of the Lebanese University	CT and FR were supported by the Agence Nationale de la Recherche (France) ANR-13-ISV7-0001-01. AH was funded by a research grant of the Lebanese University.	Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Couturier L, 2014, J CELL BIOL, V207, P351, DOI 10.1083/jcb.201407071; Faivre-Sarrailh C, 2004, DEVELOPMENT, V131, P4931, DOI 10.1242/dev.01372; FRISTROM DK, 1982, J CELL BIOL, V94, P77, DOI 10.1083/jcb.94.1.77; Fujihara Y, 2016, J LIPID RES, V57, P538, DOI 10.1194/jlr.R063032; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Haecker A, 2008, DEVELOPMENT, V135, P1745, DOI 10.1242/dev.020891; Hijazi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017763; Hijazi A, 2009, DEVELOPMENT, V136, P2199, DOI 10.1242/dev.033845; Izumi Y, 2014, SEMIN CELL DEV BIOL, V36, P186, DOI 10.1016/j.semcdb.2014.09.009; Jaspers MHJ, 2012, J BIOL CHEM, V287, P36756, DOI 10.1074/jbc.M112.399410; Jonusaite S, 2016, J COMP PHYSIOL B, V186, P17, DOI 10.1007/s00360-015-0937-1; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2009, NATURE, V459, P1141, DOI 10.1038/nature08067; Laval M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-38; Lye CM, 2014, DEVELOPMENT, V141, P4006, DOI 10.1242/dev.111310; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; McGough IJ, 2016, DEVELOPMENT, V143, P2482, DOI 10.1242/dev.126516; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moussian B., 2010, DROSOPHILA INF SERV, V93, P215; Nelson KS, 2010, GENETICS, V185, P831, DOI 10.1534/genetics.110.114959; Nilton A, 2010, DEVELOPMENT, V137, P2427, DOI 10.1242/dev.052605; Oshima K, 2011, J CELL SCI, V124, P2861, DOI 10.1242/jcs.087700; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Schimmelpfeng K, 2006, MECH DEVELOP, V123, P487, DOI 10.1016/j.mod.2006.03.004; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Syed MH, 2011, J NEUROSCI, V31, P7876, DOI 10.1523/JNEUROSCI.0766-11.2011; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; THUMMEL CS, 1991, DROSOPHILA INFORM NE, V2; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; WOOD RL, 1959, J BIOPHYS BIOCHEM CY, V6, P343, DOI 10.1083/jcb.6.3.343; Wu VM, 2007, DEVELOPMENT, V134, P999, DOI 10.1242/dev.02785; Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134; Zihni C, 2016, NAT REV MOL CELL BIO, V17, P564, DOI 10.1038/nrm.2016.80	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185897	10.1371/journal.pone.0185897	http://dx.doi.org/10.1371/journal.pone.0185897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977027	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100052
J	Yu, EA; John, SH; Tablante, EC; King, CA; Kenneth, J; Russell, DG; Mehta, S				Yu, Elaine A.; John, Serene H.; Tablante, Elizabeth C.; King, Christine A.; Kenneth, John; Russell, David G.; Mehta, Saurabh			Host transcriptional responses following ex vivo re-challenge with Mycobacterium tuberculosis vary with disease status	PLOS ONE			English	Article							INTERFERON-GAMMA; BIOMARKERS; EXPRESSION; IDENTIFY; RELAPSE; CHEMOKINES; RESISTANCE; DEFENSE; BIOLOGY; RISK	The identification of immune correlates that are predictive of disease outcome for tuberculosis remains an ongoing challenge. To address this issue, we evaluated gene expression profiles from peripheral blood mononuclear cells following ex vivo challenge with Mycobacterium tuberculosis, among participants with active TB disease (ATBD, n = 10), latent TB infection (LTBI, n = 10), and previous active TB disease (after successful treatment; PTBD, n = 10), relative to controls (n = 10). Differential gene expression profiles were assessed by suppression-subtractive hybridization, dot blot, real-time polymerase chain reaction, and the comparative cycle threshold methods. Comparing ATBD to control samples, greater fold-increases of gene expression were observed for a number of chemotactic factors (CXCL1, CXCL3, IL8, MCP1, MIP1 alpha). ATBD was also associated with higher IL1B gene expression, relative to controls. Among LTBI samples, gene expression of several chemotactic factors (CXCL2, CXCL3, IL8) was similarly elevated, compared to individuals with PTBD. Our results demonstrated that samples from participants with ATBD and LTBI have distinct gene expression profiles in response to ex vivo M. tuberculosis infection. These findings indicate the value in further characterizing the peripheral responses to M. tuberculosis challenge as a route to defining immune correlates of disease status or outcome.	[Yu, Elaine A.; Tablante, Elizabeth C.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [John, Serene H.; Kenneth, John] St Johns Res Inst, Div Infect Dis, Bangalore, Karnataka, India; [King, Christine A.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Mehta, Saurabh] Cornell Univ, Inst Nutr Sci Global Hlth & Technol, Ithaca, NY 14853 USA	Cornell University; St. John's National Academy of Health Sciences; St. John's Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; Cornell University	Mehta, S (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.; Mehta, S (corresponding author), Cornell Univ, Inst Nutr Sci Global Hlth & Technol, Ithaca, NY 14853 USA.	smehta@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019; Mehta, Saurabh/L-8490-2017	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Mehta, Saurabh/0000-0003-3788-0665; Yu, Elaine A./0000-0003-2433-9562	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [T32-DK007158]; Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University; National Institutes of Health (National Institute of Allergy and Infectious Diseases) [AI118582]	National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University; National Institutes of Health (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases; T32-DK007158 award); the Mario Einaudi Center for International Studies (South Asia Program), Human Ecology Alumni Association, Graduate School, Division of Nutritional Sciences at Cornell University (for E.A.Y. research and travel support). D.G.R. is supported by National Institutes of Health (National Institute of Allergy and Infectious Diseases; AI118582 award). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, or the National Institutes of Health.	Achkar JM, 2015, EBIOMEDICINE, V2, P1160, DOI 10.1016/j.ebiom.2015.07.039; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cliff JM, 2016, J INFECT DIS, V213, P485, DOI 10.1093/infdis/jiv447; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Doherty TM, 2009, CLIN CHEST MED, V30, P783, DOI 10.1016/j.ccm.2009.08.008; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fritzsch FSO, 2012, ANNU REV CHEM BIOMOL, V3, P129, DOI 10.1146/annurev-chembioeng-062011-081056; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Jacobsen M, 2008, BIOL CHEM, V389, P487, DOI 10.1515/BC.2008.053; Kaufmann SHE, 2011, LANCET INFECT DIS, V11, P633, DOI 10.1016/S1473-3099(11)70146-3; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Monin L, 2014, SEMIN IMMUNOL, V26, P552, DOI 10.1016/j.smim.2014.09.004; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P223, DOI 10.1128/CVI.00381-09; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization (WHO), 2008, ANT DRUG RES WORLD 4	41	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185640	10.1371/journal.pone.0185640	http://dx.doi.org/10.1371/journal.pone.0185640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977039	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100036
J	Chang, YS; Chen, PL; Hung, JH; Chen, HY; Laim, CC; Ou, CY; Chang, CM; Wang, CK; Cheng, HC; Tseng, SH				Chang, Yi-Sheng; Chen, Po-Lin; Hung, Jia-Horung; Chen, Hsiao-Yen; Laim, Chun-Chieh; Ou, Chun-Yen; Chang, Chia-Ming; Wang, Chien-Kuo; Cheng, Hon-Chun; Tseng, Sung-Huei			Orbital complications of paranasal sinusitis in Taiwan, 1988 through 2015: Acute ophthalmological manifestations, diagnosis, and management	PLOS ONE			English	Article							SUBPERIOSTEAL ABSCESS; NONSURGICAL MANAGEMENT; CHRONIC RHINOSINUSITIS; TOMOGRAPHY; CELLULITIS; CHILDREN	Purpose Paranasal sinusitis is widespread and can lead to orbital complications, blindness, and death. However, the correlation between ophthalmological findings and disease staging remains unclear. This study aimed to investigate the staging, acute ophthalmological manifestations, diagnosis, management, and outcomes of orbital complications of paranasal sinusitis during a 27-year period. Methods We retrospectively reviewed the medical records of all patients with orbital complications of paranasal sinusitis hospitalized at the National Cheng Kung University Hospital, a medical center in Taiwan during 1988-2015. Sex, age, symptoms, history, ophthalmological findings, laboratory and imaging findings, treatments, and outcomes were analyzed by staging. Results Eighty-three patients aged 9 days to 80 years had stage I (preseptal cellulitis, n = 39 patients), II (postseptal orbital cellulitis, n = 8), III (subperiosteal abscess, n = 16), IV (orbital abscess, n = 8), or V (intracranial involvement, n = 12) complications. Peak incidences occurred in patients aged 0-19 and 60-69 years. Chronic sinusitis and diabetes mellitus were common preexisting diseases. Extraocular movement limitation and proptosis predicted postseptal (stage II or more) involvement. The likelihood of elevated intraocular pressure increased with stage. Reduced visual acuity and presence of relative afferent pupillary defect indicated consideration of magnetic resonance imaging to investigate possible intracranial extension. Ipsilateral maxillary (81.7%) and ethmoidal (75.6%) sinuses were the most common sources of infection, and the most frequently implicated pathogens were coagulase-negative Staphylococcus spp. (25.3%) and Staphylococcus aureus (20.5%). All patients received intravenous antimicrobial therapy (multi-drug therapy in 88.0%), and 55.4% underwent surgery, most commonly endoscopic sinus surgery. One (1.2%) diabetic man with stage V complications died of fungal sinusitis with intracranial invasion. Five (6.0%) patients, all stage V, lost vision despite intensive treatment. The average length of hospital stay was 13.8 days (range 2-72 days), and significantly longer stays were associated with stages II-V as compared to stage I. Conclusions Orbital infection originating from paranasal sinusitis can cause vision loss and death due to intracranial extension. Acute ophthalmological findings predict staging and prognosis. Cooperative consultation between ophthalmologists, otorhinolaryngologists, and neurologists is essential. Urgent diagnostic studies and aggressive antimicrobial therapy are indicated, and surgery should be considered.	[Chang, Yi-Sheng; Tseng, Sung-Huei] Natl Cheng Kung Univ, Dept Ophthalmol, Coll Med, Tainan, Taiwan; [Chang, Yi-Sheng; Chen, Po-Lin; Hung, Jia-Horung; Chen, Hsiao-Yen; Laim, Chun-Chieh; Cheng, Hon-Chun; Tseng, Sung-Huei] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Ophthalmol, Coll Med, Tainan, Taiwan; [Chen, Po-Lin] Kaohsiung Med Univ, Dept Med, Coll Med, Kaohsiung, Taiwan; [Hung, Jia-Horung; Laim, Chun-Chieh] Natl Cheng Kung Univ, Inst Clin Med, Coll Med, Tainan, Taiwan; [Ou, Chun-Yen] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Otorhinolaryngol, Coll Med, Tainan, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Geriatr & Gerontol, Coll Med,Dept Internal Med, Tainan, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Infect Dis, Coll Med,Dept Internal Med, Tainan, Taiwan; [Chang, Chia-Ming] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Ctr Infect Control, Tainan, Taiwan; [Wang, Chien-Kuo] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Radiol, Coll Med, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chang, YS; Tseng, SH (corresponding author), Natl Cheng Kung Univ, Dept Ophthalmol, Coll Med, Tainan, Taiwan.; Chang, YS; Tseng, SH (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Ophthalmol, Coll Med, Tainan, Taiwan.	willis@mail.ncku.edu.tw; shtseng1@gmail.com	Wang, Chien-Kuo/V-8911-2019; Wang, Chien-Kuo/A-7196-2009	Wang, Chien-Kuo/0000-0001-8887-2935				ARJMAND EM, 1993, OTOLARYNG HEAD NECK, V109, P886, DOI 10.1177/019459989310900518; Bailey BJ., 1993, HEAD NECK SURG OTOLA, P754; Batra PS., 2015, PRACTICAL MED SURG M, V1st; Chaiyasate S, 2015, INT J OTOLARYNGOL, V2015; CHANDLER JR, 1970, LARYNGOSCOPE, V80, P1414, DOI 10.1288/00005537-197009000-00007; Dankbaar JW, 2015, INSIGHTS IMAGING, V6, P509, DOI 10.1007/s13244-015-0424-y; Ferguson MP, 1999, AUST NZ J OPHTHALMOL, V27, P375; Garcia GH, 2000, OPHTHALMOLOGY, V107, P1454, DOI 10.1016/S0161-6420(00)00242-6; Gupta S, 2013, INDIAN J OTOLARYNGOL, V65, pS431, DOI 10.1007/s12070-013-0646-6; Harris G J, 1993, Trans Am Ophthalmol Soc, V91, P441; HARRIS GJ, 1983, ARCH OPHTHALMOL-CHIC, V101, P751; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Howe L, 2004, CLIN OTOLARYNGOL, V29, P725, DOI 10.1111/j.1365-2273.2004.00889.x; Kinis V, 2013, J CRANIOFAC SURG, V24, P1706, DOI 10.1097/SCS.0b013e3182a210c6; Mortimore S, 1997, J LARYNGOL OTOL, V111, P719, DOI 10.1017/S0022215100138459; PATT BS, 1991, OTOLARYNG HEAD NECK, V104, P789, DOI 10.1177/019459989110400604; Pena MT, 2013, JAMA OTOLARYNGOL, V139, P223, DOI 10.1001/jamaoto.2013.1703; Root RK, 1999, CLIN INFECT DIS PRAC; RUBIN SE, 1989, BRIT J OPHTHALMOL, V73, P576, DOI 10.1136/bjo.73.7.576; RUBINSTEIN JB, 1982, HEAD NECK SURG, V5, P15, DOI 10.1002/hed.2890050105; Sharma S, 2014, JAMA OTOLARYNGOL, V140, P1070, DOI 10.1001/jamaoto.2014.2326; Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577; Sobol SE, 2002, J OTOLARYNGOL, V31, P131, DOI 10.2310/7070.2002.10979; SOULIERE CR, 1990, INT J PEDIATR OTORHI, V19, P109, DOI 10.1016/0165-5876(90)90216-E; STAMMBERGER H, 1986, OTOLARYNG HEAD NECK, V94, P147, DOI 10.1177/019459988609400203; Younis RT, 2002, LARYNGOSCOPE, V112, P224, DOI 10.1097/00005537-200202000-00005	26	24	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184477	10.1371/journal.pone.0184477	http://dx.doi.org/10.1371/journal.pone.0184477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972988	Green Submitted, gold, Green Published			2022-12-27	WOS:000412131900004
J	Choi, YJ; Lee, DH; Han, KD; Kim, HS; Yoon, H; Shin, CM; Park, YS; Kim, N				Choi, Yoon Jin; Lee, Dong Ho; Han, Kyung-Do; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung			The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea	PLOS ONE			English	Article							MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; RISK; METAANALYSIS; CONSUMPTION; MORTALITY; TOBACCO; ADENOCARCINOMA; ALDH2	Background Epidemiologic findings of low-volume alcohol consumption in relation to gastrointestinal cancers including gastric cancer are inconsistent. Methods The association between alcohol intake and esophageal, gastric and colorectal cancer risk was examined in a population-based prospective cohort of 23,323,730 adults in Korea who had undergone a biennial evaluation provided by the National Health Insurance Corporation between the years 2009 and 2012. After median 5.4 years of follow-up, 9,171 esophageal, 135,382 gastric and 154,970 colorectal cancer cases were identified. Cox regression models were used to estimate hazard ratios (HR) and corresponding 95% confidence intervals (95% CI). Results Light drinking as well as moderate to heavy alcohol consumption significantly increased the risks of the three gastrointestinal cancers (HR 1.51; 95% CI, 1.43 -1.60; HR 1.08; 95% CI, 1.06 -1.09; HR 1.12; 95% CI, 1.11 -1.14) compared with non-drinkers after adjusting for age, sex, smoking, exercise, income, body mass index, and diabetes. The synergistically increased cancer risk between excessive amount of alcohol consumption and currently smoking or underweight individuals was observed only in the esophageal cancers. Conclusions Light drinking including even one alcoholic drink a day is associated with increased risks of esophageal, gastric and colorectal cancer.	[Choi, Yoon Jin; Lee, Dong Ho; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Dept Internal Med, Seongnam, Gyeonggi Do, South Korea; [Choi, Yoon Jin; Lee, Dong Ho; Kim, Hyun Soo; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Dong Ho; Park, Young Soo; Kim, Nayoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea	Lee, DH (corresponding author), Dept Internal Med, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Lee, DH (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	dhljohn@yahoo.com	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Shin, Cheol Min/0000-0003-2265-9845; Kim, Nayoung/0000-0002-9397-0406; Choi, Yoon Jin/0000-0002-1922-9388	Ministry of Science, ICT and Future Planning (MSIP) [2011-0030001]	Ministry of Science, ICT and Future Planning (MSIP)(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by No. 2011-0030001 from http://english.msip.go.kr/english/main/main.do, Ministry of Science, ICT and Future Planning (MSIP) to DHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Castellsague X, 1999, INT J CANCER, V82, P657, DOI 10.1002/(SICI)1097-0215(19990827)82:5&lt;657::AID-IJC7&gt;3.0.CO;2-C; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; Freedman ND, 2007, AM J EPIDEMIOL, V165, P1424, DOI 10.1093/aje/kwm051; Freedman ND, 2011, GUT, V60, P1029, DOI 10.1136/gut.2010.233866; Friedenreich CM, 2013, CANCER CAUSE CONTROL, V24, P1995, DOI 10.1007/s10552-013-0275-0; Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S; GOEDDE HW, 1992, HUM GENET, V88, P344; Hashibe M, 2007, INT J CANCER, V120, P1518, DOI 10.1002/ijc.22507; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; International Agency for Research on Cancer, 1998, REEV SOM ORG CHEM HY; Kontou N, 2012, DIS COLON RECTUM, V55, P703, DOI 10.1097/DCR.0b013e31824e612a; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Lindblad M, 2005, CANCER CAUSE CONTROL, V16, P285, DOI 10.1007/s10552-004-3485-7; Ma S-H, 2015, BRIT J CANC; Naimi TS, 2017, ADDICTION, V112, P207, DOI 10.1111/add.13451; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Organization WH, 1988, IARC MONOGRAPHS EVAL; Pandeya N, 2009, GASTROENTEROLOGY, V136, P1215, DOI 10.1053/j.gastro.2008.12.052; Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474; Peng Q, 2016, ONCOL LETT, V11, P3231, DOI 10.3892/ol.2016.4401; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Razzak AA, 2011, CANCER PREV RES, V4, P2035, DOI 10.1158/1940-6207.CAPR-11-0276; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Shin CM, 2011, EUR J GASTROEN HEPAT, V23, P411, DOI 10.1097/MEG.0b013e328343b7f5; Son Ju Ik, 2001, Korean Journal of Internal Medicine, V16, P250; Steevens J, 2010, GUT, V59, P39, DOI 10.1136/gut.2009.191080; Tramacere I, 2011, ANN ONCOL; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; Varela-Rey M, 2013, ALCOHOL RES-CURR REV, V35, P25; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30329; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383	40	49	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185778	10.1371/journal.pone.0185778	http://dx.doi.org/10.1371/journal.pone.0185778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973012	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900048
J	Aoun, M; Koubar, SH; Antoun, L; Tamim, H; Makki, M; Chelala, D				Aoun, Mabel; Koubar, Sahar H.; Antoun, Leony; Tamim, Hani; Makki, Maha; Chelala, Dania			Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; DIALYSIS OUTCOMES; PRIMARY PREVENTION; PRACTICE PATTERNS; RISK; ANTIPLATELET; STROKE; CLOPIDOGREL; MORTALITY	There is so far no international consensus concerning the prescription of antithrombotic agents in hemodialysis patients. It is not clear yet why they cause more bleeding in some patients and are beneficial in others. We therefore tried to find out what triggers bleeding in this population. This is an observational before-and-after study that included all patients undergoing hemodialysis in our center between 2005 and 2015. We divided the study into two phases: phase one (125 patients) where aspirin was used without restrictions and phase two (110 patients) where aspirin was avoided in severe hypertension and primary prevention. We aimed to assess the differential occurrence of intracerebral hemorrhage between the two phases and the cardiovascular mortality of patients whether on aspirin or not. Bleeding events occurred in 12.8% of patients in phase one and 13.6% in phase two (p = 0.85). Seven out of 125 patients (6%) in phase one experienced intracerebral hemorrhage and none in phase two. Intracerebral hemorrhage was significantly increased in those with the combination of aspirin and severe hypertension (p = 0.003). Aspirin and acenocoumadin were significantly associated with total bleeding (OR = 3.81 and 4.85 with p = 0.005 and 0.001 respectively). Cardiovascular mortality did not differ between phase one and two whether patients were on aspirin or not (p = 0.45 and 0.31 respectively). Minimizing aspirin use in hemodialysis patients with severe hypertension reduced intracerebral bleeding without a significant difference in cardiovascular mortality.	[Aoun, Mabel] St George Hosp, Dept Nephrol, Ajaltoun, Lebanon; [Aoun, Mabel; Chelala, Dania] St Joseph Univ, Dept Nephrol, Beirut, Lebanon; [Koubar, Sahar H.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Nephrol, Beirut, Lebanon; [Antoun, Leony] Holy Spirit Univ, Dept Internal Med, Kaslik, Lebanon; [Tamim, Hani; Makki, Maha] Amer Univ Beirut, Biostat Unit, Clin Res Inst, Med Ctr, Beirut, Lebanon	American University of Beirut; American University of Beirut	Aoun, M (corresponding author), St George Hosp, Dept Nephrol, Ajaltoun, Lebanon.; Aoun, M (corresponding author), St Joseph Univ, Dept Nephrol, Beirut, Lebanon.	aounmabel@yahoo.fr	Aoun, Mabel/ADU-1246-2022					Bagai A, 2016, CIRCULATION, V133, P2094, DOI 10.1161/CIRCULATIONAHA.115.021158; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Brandenburg VM, 2017, NEPHROL DIAL TRANSPL, V32, P126, DOI 10.1093/ndt/gfv438; Chan KE, 2009, J AM SOC NEPHROL, V20, P872, DOI 10.1681/ASN.2008080824; Chen CY, 2014, INT J STROKE, V9, P580, DOI 10.1111/ijs.12254; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Ethier J, 2007, AM J KIDNEY DIS, V50, P602, DOI 10.1053/j.ajkd.2007.07.007; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hiremath S, 2009, CLIN J AM SOC NEPHRO, V4, P1347, DOI 10.2215/CJN.00810209; Holden RM, 2008, CLIN J AM SOC NEPHRO, V3, P105, DOI 10.2215/CJN.01810407; Htun P, 2011, J AM SOC NEPHROL, V22, P627, DOI 10.1681/ASN.2010020220; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kaufman JS, 2003, J AM SOC NEPHROL, V14, P2313, DOI 10.1097/01.ASN.0000081661.10246.33; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Liu J, 2016, HEMODIAL INT, V20, P548, DOI 10.1111/hdi.12409; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Matthys F, 2014, EUR J PREV CARDIOL, V21, P354, DOI 10.1177/2047487312472077; Miller LM, 2006, CAN J CARDIOL, V22, P755, DOI 10.1016/S0828-282X(06)70291-4; Perry HM, 2000, JAMA-J AM MED ASSOC, V284, P465, DOI 10.1001/jama.284.4.465; Robinson BM, 2012, KIDNEY INT, V82, P570, DOI 10.1038/ki.2012.136; Sakamoto N, 2014, WORLD NEUROSURG, V81, P538, DOI 10.1016/j.wneu.2013.10.033; Saran R, 2002, AM J KIDNEY DIS, V40, P1255, DOI 10.1053/ajkd.2002.36895; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sood MM, 2013, KIDNEY INT, V84, P600, DOI 10.1038/ki.2013.170; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; Wasse H, 2003, KIDNEY INT, V64, P1455, DOI 10.1046/j.1523-1755.2003.00225.x; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185847	10.1371/journal.pone.0185847	http://dx.doi.org/10.1371/journal.pone.0185847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968454	gold, Green Submitted, Green Published			2022-12-27	WOS:000412029600059
J	Chang, SK; Liu, HI; Fukuda, H; Maunder, MN				Chang, Shui-Kai; Liu, Hung-I; Fukuda, Hiromu; Maunder, Mark N.			Data reconstruction can improve abundance index estimation: An example using Taiwanese longline data for Pacific bluefin tuna	PLOS ONE			English	Article							VESSEL MONITORING SYSTEMS; UNIT-EFFORT DATA; THUNNUS-ORIENTALIS; STANDARDIZING CATCH; FISHING EFFORT; VMS DATA; FISHERY; AREA; PREDICTION; WESTERN	Catch-per-unit-effort (CPUE) is often the main piece of information used in fisheries stock assessment; however, the catch and effort data that are traditionally compiled from commercial logbooks can be incomplete or unreliable due to many reasons. Pacific bluefin tuna (PBF) is a seasonal target species in the Taiwanese longline fishery. Since 2010, detailed catch information for each PBF has been made available through a catch documentation scheme. However, previously, only market landing data with a low coverage of logbooks were available. Therefore, several nontraditional procedures were performed to reconstruct catch and effort data from many alternative data sources not directly obtained from fishers for 2001-2015: (1) Estimating the catch number from the landing weight for 2001-2003, for which the catch number information was incomplete, based on Monte Carlo simulation; (2) deriving fishing days for 2007-2009 from voyage data recorder data, based on a newly developed algorithm; and (3) deriving fishing days for 2001-2006 from vessel trip information, based on linear relationships between fishing and at-sea days. Subsequently, generalized linear mixed models were developed with the delta-lognormal assumption for standardizing the CPUE calculated from the reconstructed data, and three-stage model evaluation was performed using (1) Akaike and Bayesian information criteria to determine the most favorable variable composition of standardization models, (2) overall R-2 via cross-validation to compare fitting performance between area-separated and area-combined standardizations, and (3) system-based testing to explore the consistency of the standardized CPUEs with auxiliary data in the PBF stock assessment model. The last stage of evaluation revealed high consistency among the data, thus demonstrating improvements in data reconstruction for estimating the abundance index, and consequently the stock assessment.	[Chang, Shui-Kai] Natl Sun Yat Sen Univ, Inst Marine Affairs, Kaohsiung, Taiwan; [Liu, Hung-I] Overseas Fisheries Dev Council Republ China, Taipei, Taiwan; [Fukuda, Hiromu] Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Shizuoka, Japan; [Maunder, Mark N.] Interamer Trop Tuna Commiss, La Jolla, CA USA	National Sun Yat Sen University; Japan Fisheries Research & Education Agency (FRA)	Chang, SK (corresponding author), Natl Sun Yat Sen Univ, Inst Marine Affairs, Kaohsiung, Taiwan.	skchang@faculty.nsysu.edu.tw	Chang, Shui-Kai/B-5038-2010	Chang, Shui-Kai/0000-0003-2929-1510	Fisheries Agency of Taiwan [104AS-11.1.2-FA-F1, 105AS-11.1.2-FA-F1, 106AS-10.1.2-FA-F1]	Fisheries Agency of Taiwan	SKC acknowledges funding supports of the Fisheries Agency of Taiwan under Project Number: 104AS-11.1.2-FA-F1, 105AS-11.1.2-FA-F1 and 106AS-10.1.2-FA-F1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2014, JAPAN INFORM PAPERS, P26; BAYLIFF W H, 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P3; Bayliff WM, 1994, FAO FISHERIES TECHNI, V336, P244; Bez N, 2011, CAN J FISH AQUAT SCI, V68, P1998, DOI 10.1139/F2011-114; Bordalo-Machado P, 2006, REV FISH SCI, V14, P369, DOI 10.1080/10641260600893766; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Brodziak J, 2013, CAN J FISH AQUAT SCI, V70, P1723, DOI 10.1139/cjfas-2013-0111; Campbell RA, 2015, FISH RES, V161, P109, DOI 10.1016/j.fishres.2014.07.004; Chang SK, 2016, MAR POLICY, V74, P99, DOI 10.1016/j.marpol.2016.09.017; Chang SK, 2014, CAN J FISH AQUAT SCI, V71, P1363, DOI 10.1139/cjfas-2013-0552; Chang SK, 2014, MAR POLICY, V43, P338, DOI 10.1016/j.marpol.2013.07.003; Chang SK, 2011, FISH RES, V107, P210, DOI 10.1016/j.fishres.2010.11.004; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Conners ME, 2009, SAMPLING ESTIMATION; Efron B, 2004, J AM STAT ASSOC, V99, P619, DOI 10.1198/016214504000000692; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fujioka K., 2015, BIOL ECOLOGY BLUEFIN, P101, DOI [10.1201/b18714, DOI 10.1201/B18714]; Fukuda S, 2011, ECOL MODEL, V222, P1401, DOI 10.1016/j.ecolmodel.2011.01.023; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; HILBORN R, 1992; Hinton M. G., 2004, ICCAT COL VOL SCI PA, V56, P169; ISC, 2014, 14 M INT SCI COMM TU, P121; ISC, 2016, 16 M INT SCI COMM TU; Itoh T, 2006, FISHERIES SCI, V72, P53, DOI 10.1111/j.1444-2906.2006.01116.x; Itoh T, 2003, FISH B-NOAA, V101, P514; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Kutner M., 2005, APPL LINEAR STAT MOD; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; LO NCH, 1992, CAN J FISH AQUAT SCI, V49, P2515, DOI 10.1139/f92-278; Lourenco S, 2006, FISH RES, V78, P89, DOI 10.1016/j.fishres.2005.12.007; Lynch PD, 2012, FISH RES, V125, P27, DOI 10.1016/j.fishres.2012.02.005; Marrs SJ, 2002, FISH RES, V58, P109, DOI 10.1016/S0165-7836(01)00362-9; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Maunder MN, 2014, 5 IATTC SCI ADVISORY; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Moran D, 2011, AQUAT BIOL, V11, P229, DOI 10.3354/ab00314; Mullowney DR, 2009, FISH RES, V100, P248, DOI 10.1016/j.fishres.2009.08.006; Ohta I., 2015, BIOL ECOLOGY BLUEFIN, P123; Palmer MC, 2009, N AM J FISH MANAGE, V29, P928, DOI 10.1577/M08-135.1; Piner K., 2012, SELECTION ASYMPTOTIC; Poos JJ, 2007, CAN J FISH AQUAT SCI, V64, P304, DOI 10.1139/F06-177; Rodriguez-Marin E, 2003, ICES J MAR SCI, V60, P1216, DOI 10.1016/S1054-3139(03)00139-5; Rossiter T, 2003, MAR POLICY, V27, P281, DOI 10.1016/S0308-597X(03)00006-X; Russell BM, 2011, HDB MARKOV CHAIN MON; Sakai O, 2016, JAPANESE COASTAL LON; SAS (Statistical Analysis Systems) Institute Inc, 2013, SAS US GUID; Shiao JC, 2017, ICES J MAR SCI, V74, P204, DOI 10.1093/icesjms/fsw142; Shimose T., 2015, BIOL ECOLOGY BLUEFIN, P47; Smith PJ, 2001, NEW ZEAL J MAR FRESH, V35, P843, DOI 10.1080/00288330.2001.9517046; Sokal R.R., 2012, BIOMETRY; Su NJ, 2008, FISH RES, V90, P235, DOI 10.1016/j.fishres.2007.10.024; Suzuki N, 2014, BULL FISH RES AGENCY, P87; Tanaka Y, 2007, FISHERIES SCI, V73, P534, DOI 10.1111/j.1444-2906.2007.01365.x; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Tseng HS, 2010, MAR POLICY, V34, P1156, DOI 10.1016/j.marpol.2010.03.015; UCLA. FAQ, 2016, FAQ WHY AR R2 F SO L; Walter JF, 2014, N AM J FISH MANAGE, V34, P1095, DOI 10.1080/02755947.2014.932865; Wang H-Y, 2014, N PAC OC PAC BLUEF T; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Yu Q, 2014, NEUROCOMPUTING, V129, P153, DOI 10.1016/j.neucom.2013.08.041; Zhang YL, 2015, J ECONOMETRICS, V187, P95, DOI 10.1016/j.jeconom.2015.02.006	65	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185784	10.1371/journal.pone.0185784	http://dx.doi.org/10.1371/journal.pone.0185784			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968434	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600048
J	Caputi, TL; Leas, E; Dredze, M; Cohen, JE; Ayers, JW				Caputi, Theodore L.; Leas, Eric; Dredze, Mark; Cohen, Joanna E.; Ayers, John W.			They're heating up: Internet search query trends reveal significant public interest in heat-not-burn tobacco products	PLOS ONE			English	Article							ELECTRONIC CIGARETTES; SURVEILLANCE; SMOKE; RISE	Heat-not-burn tobacco products, battery powered devices that heat leaf tobacco to approximately 500 degrees Fahrenheit to produce an inhalable aerosol, are being introduced in markets around the world. Japan, where manufacturers have marketed several heat-not-burn brands since 2014, has been the focal national test market, with the intention of developing global marketing strategies. We used Google search query data to estimate, for the first time, the scale and growth potential of heat-not-burn tobacco products. Average monthly searches for heat-not-burn products rose 1,426% (95% CI: 746,3574) between their first (2015) and second (2016) complete years on the market and an additional 100% (95% CI: 60, 173) between the products second (2016) and third years on the market (Jan-Sep 2017). There are now between 5.9 and 7.5 million heat-not-burn related Google searches in Japan each month based on September 2017 estimates. Moreover, forecasts relying on the historical trends suggest heat-not-burn searches will increase an additional 32% (95% CI: -4 to 79) during 2018, compared to current estimates for 2017 (Jan-Sep), with continued growth thereafter expected. Contrasting heat-not-burn's rise in Japan to electronic cigarettes' rise in the United States we find searches for heat-not-burn eclipsed electronic cigarette searches during April 2016. Moreover, the change in average monthly queries for heat-not-burn in Japan between 2015 and 2017 was 399 (95% CI: 184, 1490) times larger than the change in average monthly queries for electronic cigarettes in the Unites States over the same time period, increasing by 2,956% (95% CI: 1729, 7304) compared to only 7% (95% CI: 3,13). Our findings are a clarion call for tobacco control leaders to ready themselves as heat-not-burn tobacco products will likely garner substantial interest as they are introduced into new markets. Public health practitioners should expand heat-not-burn tobacco product surveillance, adjust existing tobacco control strategies to account for heat-not-burn tobacco products, and preemptively study the health risks/benefits, popular perceptions, and health messaging around heat-not-burn tobacco products.	[Caputi, Theodore L.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Caputi, Theodore L.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Caputi, Theodore L.] Univ Florida, Coll Med, Drug Policy Inst, Gainesville, FL USA; [Leas, Eric] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Palo Alto, CA 94304 USA; [Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Cohen, Joanna E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Global Tobacco Control, Baltimore, MD USA; [Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	University of Pennsylvania; University College Cork; State University System of Florida; University of Florida; Stanford University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; California State University System; San Diego State University	Ayers, JW (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	ayers.john.w@gmail.com	Caputi, Theodore/P-8697-2019; Caputi, Theodore/ADP-8818-2022	Caputi, Theodore/0000-0003-3498-9032; Caputi, Theodore/0000-0003-3498-9032; Dredze, Mark/0000-0002-0422-2474	Joseph Wharton Scholars program; Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health; Bloomberg Initiative to Reduce Tobacco Use; George J. Mitchell scholarship program	Joseph Wharton Scholars program; Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health; Bloomberg Initiative to Reduce Tobacco Use; George J. Mitchell scholarship program	This work was supported by the Joseph Wharton Scholars program (https://www.wharton.upenn.edu/) and the Institute for Global Tobacco Control at the Johns Hopkins Bloomberg School of Public Health, with funding from the The Bloomberg Initiative to Reduce Tobacco Use (https.//www.bloomberg.org/program/publichealth/tobacco-control/#problem) to TC and the George J. Mitchell scholarship program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funder.	Auer R, 2017, JAMA INTERN MED, V177, P1050, DOI 10.1001/jamainternmed.2017.1419; Ayers JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170702; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, AM J PREV MED, V50, pE173, DOI 10.1016/j.amepre.2015.12.008; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2014, NICOTINE TOB RES, V16, P576, DOI 10.1093/ntr/ntt186; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2014, PREV MED, V58, P81, DOI 10.1016/j.ypmed.2013.11.007; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Caputi TL, 2016, TOBACCO CONTROL; Caputi TL, 2017, NICOTINE TOBACCO RES; Cavazos-Rehg PA, 2015, TOB CONTROL, V24, P249, DOI 10.1136/tobaccocontrol-2013-051276; Delnevo CD, 2017, AM J EPIDEMIOL, P1; Du L, BLOOMBERG POLITICS; Farsalinos KE, 2017, NICOTINE TOB RES; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hyndman RJ, 2008, AUTOMATIC TIME SERIE; Katz MH, 2017, JAMA INTERN MED, V177, P1052, DOI 10.1001/jamainternmed.2017.1425; Levy DT, 2017, ADDICTION, V112, P8, DOI 10.1111/add.13394; Lopez AA, 2016, DRUG ALCOHOL DEPEN, V169, P33, DOI 10.1016/j.drugalcdep.2016.10.005; Philip Morris International, MOD RISK TOB PROD MR; Philip Morris International, WHAT AR RED RISK PRO; Philip Morris International, TOB MEETS TECHN; Protano C, 2016, Ann Ig, V28, P109, DOI 10.7416/ai.2016.2089; Soneji S, 2016, JAMA PEDIATR, V170, P511, DOI 10.1001/jamapediatrics.2015.4501; Tabuchi T, 2016, ADDICTION, V111, P706, DOI 10.1111/add.13231; Yui M, JAPAN TIMES	27	51	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185735	10.1371/journal.pone.0185735	http://dx.doi.org/10.1371/journal.pone.0185735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020019	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400042
J	Lee, BH; Seo, S; Kim, MH; Kim, Y; Jo, S; Choi, MK; Lee, H; Choi, JB; Kim, MK				Lee, Byung Ho; Seo, Sangjae; Kim, Min Hyeok; Kim, Youngjin; Jo, Soojin; Choi, Moon-ki; Lee, Hoomin; Choi, Jae Boong; Kim, Moon Ki			Normal mode-guided transition pathway generation in proteins	PLOS ONE			English	Article							CONFORMATIONAL TRANSITIONS; MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; NETWORK MODEL; MOTIONS; SIMULATIONS; PREDICTION; SCATTERING; DIFFUSION; MACHINES	The biological function of proteins is closely related to its structural motion. For instance, structurally misfolded proteins do not function properly. Although we are able to experimentally obtain structural information on proteins, it is still challenging to capture their dynamics, such as transition processes. Therefore, we need a simulation method to predict the transition pathways of a protein in order to understand and study large functional deformations. Here, we present a new simulation method called normal mode-guided elastic network interpolation (NGENI) that performs normal modes analysis iteratively to predict transition pathways of proteins. To be more specific, NGENI obtains displacement vectors that determine intermediate structures by interpolating the distance between two end-point conformations, similar to a morphing method called elastic network interpolation. However, the displacement vector is regarded as a linear combination of the normal mode vectors of each intermediate structure, in order to enhance the physical sense of the proposed pathways. As a result, we can generate more reasonable transition pathways geometrically and thermodynamically. By using not only all normal modes, but also in part using only the lowest normal modes, NGENI can still generate reasonable pathways for large deformations in proteins. This study shows that global protein transitions are dominated by collective motion, which means that a few lowest normal modes play an important role in this process. NGENI has considerable merit in terms of computational cost because it is possible to generate transition pathways by partial degrees of freedom, while conventional methods are not capable of this.	[Lee, Byung Ho; Kim, Youngjin; Jo, Soojin; Choi, Moon-ki; Lee, Hoomin; Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea; [Seo, Sangjae] Nagoya Univ, Dept Mat Chem, Nagoya, Aichi, Japan; [Kim, Min Hyeok] Korea Inst Adv Study, Sch Computat Sci, Seoul, South Korea; [Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon, South Korea	Sungkyunkwan University (SKKU); Nagoya University; Korea Institute for Advanced Study (KIAS); Sungkyunkwan University (SKKU)	Kim, MK (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea.; Kim, MK (corresponding author), Sungkyunkwan Univ, SKKU Adv Inst Nanotechnol SAINT, Suwon, South Korea.	mkkim@me.skku.ac.kr		Jo, Soojin/0000-0002-5100-316X; Seo, Sangjae/0000-0002-3555-6223	Pioneer Research Center Program [2012-0009579]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2015R1D1A1A01057280]	Pioneer Research Center Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Pioneer Research Center Program (2012-0009579 to Moon Ki Kim) and the Basic Science Research Program (2015R1D1A1A01057280 to Moon Ki Kim) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology. None of the authors has any conflicts of interest with respect to the material contained in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acbas G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4076; Adcock SA, 2006, CHEM REV, V106, P1589, DOI 10.1021/cr040426m; Athanasios CA, 2001, CONT MATH, V280, P193; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bray JK, 2011, BIOPHYS J, V101, P2966, DOI 10.1016/j.bpj.2011.10.054; BROWN KG, 1972, P NATL ACAD SCI USA, V69, P1467, DOI 10.1073/pnas.69.6.1467; Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Eitoku T, 2006, BIOPHYS J, V91, P3797, DOI 10.1529/biophysj.106.092882; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; He LL, 2011, ANAL CHEM, V83, P1510, DOI 10.1021/ac1032353; Kim MH, 2015, J STRUCT BIOL, V190, P338, DOI 10.1016/j.jsb.2015.04.007; Kim MK, 2005, BIOPHYS J, V89, P43, DOI 10.1529/biophysj.104.044347; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kruger DM, 2012, NUCLEIC ACIDS RES, V40, pW310, DOI 10.1093/nar/gks478; Leckband D, 2010, ANNU REV CHEM BIOMOL, V1, P365, DOI 10.1146/annurev-chembioeng-073009-100931; Lee J, 2009, IEEE T MICROW THEORY, V12, P3219; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; LEVITT M, 1983, J MOL BIOL, V168, P595, DOI 10.1016/S0022-2836(83)80304-0; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Nada T, 2003, BIOPHYS J, V85, P1876, DOI 10.1016/S0006-3495(03)74615-3; Pfreundschuh M, 2014, NANO LETT, V14, P2957, DOI 10.1021/nl5012905; Lopez-Blanco JR, 2014, NUCLEIC ACIDS RES, V42, pW271, DOI 10.1093/nar/gku339; SARKAR HK, 1984, BIOCHEMISTRY-US, V23, P1882, DOI 10.1021/bi00303a046; Seo S, 2014, J MOL GRAPH MODEL, V47, P25, DOI 10.1016/j.jmgm.2013.10.009; Seo S, 2012, NUCLEIC ACIDS RES, V40, pW531, DOI 10.1093/nar/gks525; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Tekpinar M, 2010, PROTEINS, V78, P2469, DOI 10.1002/prot.22755; TERAZIMA M, 1993, J CHEM PHYS, V98, P6257, DOI 10.1063/1.464819; Turton DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4999; Uyar A, 2014, BIOPHYS J, V106, P2656, DOI 10.1016/j.bpj.2014.05.017; Yang L, 2007, BIOPHYS J, V93, P920, DOI 10.1529/biophysj.106.095927; Zheng WJ, 2007, PROTEINS, V69, P43, DOI 10.1002/prot.21465	45	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185658	10.1371/journal.pone.0185658	http://dx.doi.org/10.1371/journal.pone.0185658			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020017	Green Submitted, gold, Green Published			2022-12-27	WOS:000412754400039
J	Mas, S; Gasso, P; Morer, A; Calvo, A; Bargallo, N; Lafuente, A; Lazaro, L				Mas, Sergi; Gasso, Patricia; Morer, Astrid; Calvo, Anna; Bargallo, Nuria; Lafuente, Amalia; Lazaro, Luisa			Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity (vol 11, e0153846, 2016)	PLOS ONE			English	Correction													mas, sergi/AAD-1996-2019; Bargallo, Nuria/G-6854-2016; Morer, Astrid/J-5113-2017	Bargallo, Nuria/0000-0001-6284-5402; Mas, Sergi/0000-0003-3336-6298; Morer, Astrid/0000-0001-8109-7008	Spanish Ministry of Health, Instituto de Salud Carlos III [PI13/00812]	Spanish Ministry of Health, Instituto de Salud Carlos III(Instituto de Salud Carlos IIISpanish Government)	This research was funded in part by the Spanish Ministry of Health, Instituto de Salud Carlos III (Grant Number PI13/00812).	Mas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153846	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186572	10.1371/journal.pone.0186572	http://dx.doi.org/10.1371/journal.pone.0186572			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020038	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400107
J	Pucelik, B; Paczynski, R; Dubin, G; Pereira, MM; Arnaut, LG; Dabrowski, JM				Pucelik, Barbara; Paczynski, Robert; Dubin, Grzegorz; Pereira, Mariette M.; Arnaut, Luis G.; Dabrowski, Janusz M.			Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; PHOTOPHYSICAL PROPERTIES; CATIONIC BACTERIOCHLORINS; SINGLET-OXYGEN; CENTRAL METAL; IN-VITRO; INACTIVATION; BLOCK; METALLOPORPHYRINS; PHOTOINACTIVATION	The impact of substituents on the photochemical and biological properties of tetraphenylporphyrin-based photosensitizers for photodynamic therapy of cancer (PDT) as well as photodynamic inactivation of microorganisms (PDI) was examined. Spectroscopic and physicochemical properties were related with therapeutic efficacy in PDT of cancer and PDI of microbial cells in vitro. Less polar halogenated, sulfonamide porphyrins were most readily taken up by cells compared to hydrophilic and anionic porphyrins. The uptake and PDT of a hydrophilic porphyrin was significantly enhanced with incorporation in polymeric micelles (Pluronic L121). Photodynamic inactivation studies were performed against Gram-positive (S. aureus, E. faecalis), Gram-negative bacteria (E. coli, P. aeruginosa, S. marcescens) and fungal yeast (C. albicans). We observed a 6 logs reduction of S. aureus after irradiation (10 J/cm(2)) in the presence of 20 mu M of hydrophilic porphyrin, but this was not improved with incorporation in Pluronic L121. A 2-3 logs reduction was obtained for E. coli using similar doses, and a decrease of 3-4 logs was achieved for C. albicans. Rational substitution of tetraphenylporphyrins improves their photodynamic properties and informs on strategies to obtain photosensitizers for efficient PDT and PDI. However, the design of the photosensitizers must be accompanied by the development of tailored drug formulations.	[Pucelik, Barbara; Dabrowski, Janusz M.] Jagiellonian Univ, Fac Chem, Gronostajowa 2, Krakow, Poland; [Paczynski, Robert; Dubin, Grzegorz] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Paczynski, Robert; Dubin, Grzegorz] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Pereira, Mariette M.; Arnaut, Luis G.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Jagiellonian University; Jagiellonian University; Jagiellonian University; Universidade de Coimbra	Dabrowski, JM (corresponding author), Jagiellonian Univ, Fac Chem, Gronostajowa 2, Krakow, Poland.	jdabrows@chemia.uj.edu.pl	Pereira, Mariette/N-2648-2013; Pucelik, Barbara/HII-5213-2022; Dabrowski, Janusz M./E-7250-2015; Dubin, Grzegorz/J-8168-2014; Arnaut, Luis/Q-4135-2016	Pereira, Mariette/0000-0003-4958-7677; Pucelik, Barbara/0000-0002-0235-6532; Dabrowski, Janusz M./0000-0002-8791-7035; Dubin, Grzegorz/0000-0002-5535-5760; Arnaut, Luis/0000-0002-3223-4819	National Science Center (NCN), Poland within the Sonata Bis grant [0085/IP3/2015/73]	National Science Center (NCN), Poland within the Sonata Bis grant	This work was funded by National Science Center (NCN), Poland within the Sonata Bis grant no 0085/IP3/2015/73 given to JMD.	Arnaut LG, 2014, CHEM-EUR J, V20, P5346, DOI 10.1002/chem.201304202; Azenha EG, 2002, CHEM PHYS, V280, P177, DOI 10.1016/S0301-0104(02)00485-8; Aziz MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150295; Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307; Cassidy CM, 2009, J PHOTOCH PHOTOBIO B, V95, P71, DOI 10.1016/j.jphotobiol.2009.01.005; Chin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097894; Dabrowski JM, 2016, COORDIN CHEM REV, V325, P67, DOI 10.1016/j.ccr.2016.06.007; Dabrowski JM, 2015, PHOTOCH PHOTOBIO SCI, V14, P1765, DOI 10.1039/c5pp00132c; Dabrowski JM, 2015, J COORD CHEM, V68, P3116, DOI 10.1080/00958972.2015.1073723; Dabrowski JM, 2017, ADV INORGANIC CHEM; De Boni L, 2015, CHEM PHYS LETT, V633, P146, DOI 10.1016/j.cplett.2015.05.040; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Foley JW, 2006, J MED CHEM, V49, P5291, DOI 10.1021/JM060153i; Gibbs JH, 2015, J PHOTOCH PHOTOBIO B, V145, P35, DOI 10.1016/j.jphotobiol.2015.02.006; Goncalves PJ, 2006, J PHOTOCH PHOTOBIO A, V181, P378, DOI 10.1016/j.jphotochem.2005.12.023; Goncalves PJ, 2005, CHEM PHYS LETT, V407, P236, DOI 10.1016/j.cplett.2005.03.100; GONSALVES AMAR, 1991, J HETEROCYCLIC CHEM, V28, P635, DOI 10.1002/jhet.5570280317; Grinholc M, 2015, APPL MICROBIOL BIOT, V99, P4031, DOI 10.1007/s00253-015-6539-8; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Hamblin MR, 2001, CANCER RES, V61, P7155; Huang LY, 2014, J PHOTOCH PHOTOBIO B, V141, P119, DOI 10.1016/j.jphotobiol.2014.09.016; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Huang YY, 2012, CHEMMEDCHEM, V7, P2155, DOI 10.1002/cmdc.201200351; Johnstone RAW, 1996, HETEROCYCLES, V43, P1423; KESSEL D, 1987, PHOTOCHEM PHOTOBIOL, V45, P787, DOI 10.1111/j.1751-1097.1987.tb07883.x; Maisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111792; Mamone L, 2016, J PHOTOCH PHOTOBIO B, V161, P222, DOI 10.1016/j.jphotobiol.2016.05.026; McCoy CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108500; Merchat M, 1996, J PHOTOCH PHOTOBIO B, V32, P153, DOI 10.1016/1011-1344(95)07147-4; Monteiro CJP, 2008, TETRAHEDRON, V64, P5132, DOI 10.1016/j.tet.2008.03.055; Mroz P, 2009, CANCER LETT, V282, P63, DOI 10.1016/j.canlet.2009.02.054; Murov S. L., 1993, HDB PHOTOCHEMISTRY; Pereira MM, 2010, TETRAHEDRON, V66, P9545, DOI 10.1016/j.tet.2010.09.106; Pitto-Barry A, 2014, POLYM CHEM-UK, V5, P3291, DOI 10.1039/c4py00039k; Prates RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054387; Price M, 2009, PHOTOCHEM PHOTOBIOL, V85, P1177, DOI 10.1111/j.1751-1097.2009.00555.x; Pucelik B, 2016, EUR J MED CHEM, V124, P284, DOI 10.1016/j.ejmech.2016.08.035; Pucelik B, 2016, ACS APPL MATER INTER, V8, P22039, DOI 10.1021/acsami.6b07031; Rae M, 2006, J PHYS CHEM B, V110, P12809, DOI 10.1021/jp061010a; Regiel-Futyra A, 2017, COORDINATION CHEM RE; Rinco O, 2009, J PHOTOCH PHOTOBIO A, V208, P91, DOI 10.1016/j.jphotochem.2009.08.009; Ruzie C, 2008, J ORG CHEM, V73, P5806, DOI 10.1021/jo800736c; Schastak S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011674; Shen SS, 2015, VACCINE, V33, P4341, DOI 10.1016/j.vaccine.2015.04.051; Silva EFF, 2010, CHEM-EUR J, V16, P9273, DOI 10.1002/chem.201000111; Silva M, 2014, CHEM COMMUN, V50, P6571, DOI 10.1039/c4cc01100g; Soares HT, 2016, CHEMBIOCHEM, V17, P836, DOI 10.1002/cbic.201500573; Taraszkiewicz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129301; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P1402, DOI 10.1128/AAC.50.4.1402-1410.2006; Tim M, 2015, J PHOTOCH PHOTOBIO B, V150, P2, DOI 10.1016/j.jphotobiol.2015.05.010; Topal SZ, 2014, DALTON T, V43, P6897, DOI 10.1039/c3dt53410c; Vilsinski BH, 2015, PHOTOCHEM PHOTOBIOL, V91, P518, DOI 10.1111/php.12421; Yao L, 2013, J CHEM, V2013, P10; Yuan Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176529; Zhang QZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174627; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	57	42	42	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185984	10.1371/journal.pone.0185984	http://dx.doi.org/10.1371/journal.pone.0185984			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016698	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400045
J	Westercamp, N; Mehta, SD; Jaoko, W; Okeyo, TA; Bailey, RC				Westercamp, Nelli; Mehta, Supriya D.; Jaoko, Walter; Okeyo, Timothy A.; Bailey, Robert C.			Penile coital injuries in men decline after circumcision: Results from a prospective study of recently circumcised and uncircumcised men in western Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; RANDOMIZED CONTROLLED-TRIAL; MEDICAL MALE CIRCUMCISION; ADULT MALE CIRCUMCISION; GENITAL ULCER DISEASE; HIV-INFECTION; RISK-FACTORS; FORESKIN; TRANSMISSION; METAANALYSIS	Background Penile coital injuries are one of the suggested mechanisms behind the increased risk of HIV among uncircumcised men. We evaluated the prevalence and correlates of self-reported penile coital injuries in a longitudinal community-based cohort of young (18-24 years old), newly circumcised and uncircumcised men in Western Kenya. Methods Self-reported penile coital injuries were assessed at baseline, 6, 12, 18 and 24 months of follow-up, and were defined as scratches, cuts or abrasions during sex, penile soreness during sex, and skin of the penis bleeding during sex. Associations between penile coital injuries, circumcision, sexual satisfaction, and other covariates were estimated with mixed effect models. Results Between November 2008 and April 2010 3,186 participants were enrolled (1,588 into circumcision group and 1,598 as age-matched controls). Among 2,106 (66%) participants sexually active at baseline, 53% reported any penile injury, including 44% scratches, cuts or abrasions; 32% penile pain/soreness; and 22% penile bleeding. In multivariable modeling, risk was lower for circumcised men than uncircumcised men for scratches, cuts and abrasions (aOR = 0.39; 95% CI 0.34-0.44); penile pain/soreness (aOR = 0.58; 95% CI 0.51-0.65), penile bleeding (aOR = 0.53; 95% CI 0.46-0.62), and any penile coital injuries (aOR = 0.47; 95% CI 0.42-0.53). Other significant risk factors included increasing age, history of STIs and genital sores, and multiple sex partners, while condom use was protective. Coital injuries were significantly associated with lower levels of sexual satisfaction in longitudinal analyses (scratches, cuts or abrasions: aOR = 0.87, 95% CI: 0.76-0.98; penile pain/soreness: aOR = 0.82, 95% CI: 0.72-0.93; and penile bleeding: aOR = 0.65, 95% CI: 0.55-0.76). Conclusions Self-reported penile coital injuries were common and decreased significantly following circumcision. Improving sexual experience through the removal of a potential source of sexual discomfort may resonate with many men targeted for circumcision services. The role of penile coital injuries in sexual satisfaction, HIV, HSV-2, and as a motivator for seeking circumcision services should be explored further.	[Westercamp, Nelli; Mehta, Supriya D.; Bailey, Robert C.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Jaoko, Walter] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Okeyo, Timothy A.] Nyanza Reprod Hlth Soc, Kisumu, Kenya	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi	Westercamp, N (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	kapooosha@gmail.com	Jaoko, Walter/AAN-5048-2020	Jaoko, Walter/0000-0002-7134-6581; Westercamp, Nelli/0000-0003-0136-9750	Bill and Melinda Gates Foundation [FHI360]; EngenderHealth; University of Illinois at Chicago; Nyanza Reproductive Health Society [47394]; Chicago Developmental Center for AIDS Research; NIH [P30 AI 082151]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EngenderHealth; University of Illinois at Chicago; Nyanza Reproductive Health Society; Chicago Developmental Center for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this study was provided by a grant to FHI360 from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) to support the Male Circumcision Consortium, a partnership between FHI360, EngenderHealth, and University of Illinois at Chicago working closely with the Nyanza Reproductive Health Society (grant #47394, RCB). Robert C. Bailey (RCB) received support from the Chicago Developmental Center for AIDS Research, an NIH (www.nih.gov) funded program (P30 AI 082151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2011, AM J REPROD IMMUNOL, V65, P220, DOI 10.1111/j.1600-0897.2010.00941.x; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Boily MC, 2008, SEX TRANSM INFECT, V84, pII28, DOI 10.1136/sti.2008.030346; Brito MO, 2017, J SEX MED, V14, P526, DOI 10.1016/j.jsxm.2017.01.020; CAMERON DW, 1989, LANCET, V2, P403; Cary, 2008, SAS SOFTW VERS 9 1; Desai K, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-19; Dinh MH, 2011, AM J REPROD IMMUNOL, V65, P279, DOI 10.1111/j.1600-0897.2010.00934.x; Fahrbach KM, 2010, MUCOSAL IMMUNOL, V3, P410, DOI 10.1038/mi.2010.18; FIGUEROA JP, 1994, J ACQ IMMUN DEF SYND, V7, P310; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Ganor Y, 2010, MUCOSAL IMMUNOL, V3, P506, DOI 10.1038/mi.2010.32; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kigozi G, 2009, AIDS, V23, P2209, DOI 10.1097/QAD.0b013e328330eda8; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Layer EH, 2012, AIDS CARE; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mehta SD, 2013, AIDS; Mehta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038991; Mehta SD, 2012, AIDS, V26, P1141, DOI 10.1097/QAD.0b013e328352d116; Mehta SD, 2010, J UROLOGY, V184, P203, DOI 10.1016/j.juro.2010.03.015; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mensch BS, 2003, DEMOGRAPHY, V40, P247, DOI 10.1353/dem.2003.0017; Morris BJ, 2012, AIDS CARE, V24, P1565, DOI 10.1080/09540121.2012.661836; Nordstrom MPC, 2017, J SEX MED, V14, P601, DOI 10.1016/j.jsxm.2017.02.014; OFARRELL N, 1993, GENITOURIN MED, V69, P297; Phillips AE, 2010, INT J EPIDEMIOL, V39, P1541, DOI 10.1093/ije/dyq114; Porter WM, 2001, INT J STD AIDS, V12, P216, DOI 10.1258/0956462011922922; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; SIMONSEN JN, 1988, NEW ENGL J MED, V319, P274, DOI 10.1056/NEJM198808043190504; STONE KM, 1986, JAMA-J AM MED ASSOC, V255, P1763, DOI 10.1001/jama.255.13.1763; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Vu LT, 2012, ASIA PACIFIC J PUBLI; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Westercamp N, 2012, KEN INT AIDS C WASH; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4; World Health Organization, 2007, MAL CIRC GLOB TRENDS; Zhou ZC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002100	47	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185917	10.1371/journal.pone.0185917	http://dx.doi.org/10.1371/journal.pone.0185917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016638	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400037
J	Seidl, R; Moser, C; Blumer, Y				Seidl, Roman; Moser, Corinne; Blumer, Yann			Navigating behavioral energy sufficiency. Results from a survey in Swiss cities on potential behavior change	PLOS ONE			English	Article							SUSTAINABLE LIFE-STYLES; ENVIRONMENTAL ATTITUDES; CLIMATE-CHANGE; MODEL; INTERVENTION; PSYCHOLOGY; EFFICIENCY; VALUES; GREEN	Many countries have some kind of energy-system transformation either planned or ongoing for various reasons, such as to curb carbon emissions or to compensate for the phasing out of nuclear energy. One important component of these transformations is the overall reduction in energy demand. It is generally acknowledged that the domestic sector represents a large share of total energy consumption in many countries. Increased energy efficiency is one factor that reduces energy demand, but behavioral approaches (known as "sufficiency") and their respective interventions also play important roles. In this paper, we address citizens' heterogeneity regarding both their current behaviors and their willingness to realize their sufficiency potentials-that is, to reduce their energy consumption through behavioral change. We collaborated with three Swiss cities for this study. A survey conducted in the three cities yielded thematic sets of energy-consumption behavior that various groups of participants rated differently. Using this data, we identified four groups of participants with different patterns of both current behaviors and sufficiency potentials. The paper discusses intervention types and addresses citizens' heterogeneity and behaviors from a city-based perspective.	[Seidl, Roman] Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland; [Moser, Corinne] ZHAW Sch Engn, Inst Sustainable Dev, Winterthur, Switzerland; [Blumer, Yann] Ctr Innovat & Entrepreneurship, ZHAW Sch Management & Law, Winterthur, Switzerland	ETH Zurich	Seidl, R (corresponding author), Swiss Fed Inst Technol, D USYS Transdisciplinar Lab, Zurich, Switzerland.	roman.seidl@usys.ethz.ch	Blumer, Yann/I-3346-2018	Blumer, Yann/0000-0003-0224-4538; Moser, Corinne/0000-0001-8071-3681; Seidl, Roman/0000-0002-6658-8789	Swiss National Science Foundation (SNSF) [153769]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was funded by the Swiss National Science Foundation (SNSF), http.//p3.snf.ch/project-153769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Aldenderfer MS, 1999, CLUSTER ANAL; Anable J, 2005, TRANSPORT POLICY, V12, P65, DOI 10.1016/j.tranpol.2004.11.004; [Anonymous], 2015, PERMANENT RESIDENT P; [Anonymous], AD PAR AGR 2015; [Anonymous], 2016, INTEGRATION INDIKATO; [Anonymous], 2016, AVERAGE AGE PERMANEN; Bamberg S, 2013, J ENVIRON PSYCHOL, V34, P151, DOI 10.1016/j.jenvp.2013.01.002; Barr S, 2001, ENVIRON PLANN A, V33, P2025, DOI 10.1068/a33225; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Barr S, 2006, GEOFORUM, V37, P906, DOI 10.1016/j.geoforum.2006.05.002; Batel S, 2013, ENERG POLICY, V58, P1, DOI 10.1016/j.enpol.2013.03.018; Brehm J.W., 1966, THEORY PSYCHOL REACT; Breukers Sylvia, 2013, HDB SUSTAINABLE ENG, P773, DOI DOI 10.1007/978-1-4020-8939-8; Bull R, 2015, ENERGY RES SOC SCI, V8, P32, DOI 10.1016/j.erss.2015.04.006; Cheyne C, 2016, ENERGY RES SOC SCI, V18, P139, DOI 10.1016/j.erss.2016.04.012; Cialdini R. B., 2002, Cornell Hotel and Restaurant Administration Quarterly, V43, P40, DOI 10.1016/S0010-8804(02)80030-1; Daamen DDL, 2001, ENVIRON BEHAV, V33, P229, DOI 10.1177/00139160121972963; Diekmann A, 2003, RATION SOC, V15, P441, DOI 10.1177/1043463103154002; Dietz T, 2013, DAEDALUS-US, V142, P78, DOI 10.1162/DAED_a_00186; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; European Energy Award, 2017, EUR EN AW GOLD MUN 2; Eurostat, CONS EN 2017; Frick V, ENERGY EFFI IN PRESS; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Geller ES, 2015, APPL BEHAV SCI ENV S, P307; Goldman T, 2006, TECHNOL SOC, V28, P261, DOI 10.1016/j.techsoc.2005.10.007; Gollwitzer P. M., 1990, HDB MOTIVATION COGNI, V2, P53; Harris J, 2008, ENERG EFFIC, V1, P175, DOI 10.1007/s12053-008-9011-0; Heinrichs H, 2013, GAIA, V22, P228, DOI 10.14512/gaia.22.4.5; Hinchliffe S, 1996, GLOBAL ENVIRON CHANG, V6, P53, DOI 10.1016/0959-3780(95)00113-1; Holtz T, 2015, SUFFIZIENZ ENERGIEBE; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Klockner CA, 2015, PSYCHOLOGY OF PRO-ENVIRONMENTAL COMMUNICATION: BEYOND STANDARD INFORMATION STRATEGIES, P146; Lilliestam J, 2016, ENERGY RES SOC SCI, V17, P20, DOI 10.1016/j.erss.2016.03.011; Macias T, 2014, ENVIRON BEHAV; MILLIGAN GW, 1988, J CLASSIF, V5, P181, DOI 10.1007/BF01897163; Mont O, 2014, J CLEAN PROD, V63, P24, DOI 10.1016/j.jclepro.2013.09.007; Moomaw W, 2011, RENEWABLE ENERGY SOURCES AND CLIMATE CHANGE MITIGATION: SPECIAL REPORT OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P161; Moser C, 2015, P ECEEE SUMM STUD 20; Moser C, 2016, 2016 INT EN POL PROG; Moser C, 2015, FRONT ENERGY RES, DOI 10.3389/fenrg.2015.00040; Nassen J, 2009, ENERG EFFIC, V2, P221, DOI 10.1007/s12053-009-9046-x; Notter DA, 2013, ENVIRON SCI TECHNOL, V47, P4014, DOI 10.1021/es3037548; Ohnmacht T, 2017, ENERGY RES SOC SCI, V26, P40, DOI 10.1016/j.erss.2017.01.017; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Otto S, 2014, EUR PSYCHOL, V19, P96, DOI 10.1027/1016-9040/a000182; Parag Y, 2014, ENERGY RES SOC SCI, V3, P102, DOI 10.1016/j.erss.2014.07.011; Poortinga W, 2003, J ECON PSYCHOL, V24, P49, DOI 10.1016/S0167-4870(02)00154-X; Rose G, 2007, TRANSPORT RES A-POL, V41, P351, DOI 10.1016/j.tra.2006.10.001; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2011, CONSERV BIOL, V25, P1080, DOI 10.1111/j.1523-1739.2011.01766.x; Schwartz SH, 2004, J RES PERS, V38, P230, DOI 10.1016/S0092-6566(03)00069-2; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Sutterlin B, 2011, ENERG POLICY, V39, P8137, DOI 10.1016/j.enpol.2011.10.008; Sutterlin B, 2012, SEGMENTATION CHARACT; Swiss Federal Council, 2013, BOTSCH ZUM ERST MASS; Swiss Federal Council, 2014, ORD HUM RES EXC CLIN; Swiss Federal Office of Energy, 2014, SCHWEIZ GES 2014; Swiss Federal Office of Energy, 2014, SCHWEIZ GES 2014; Tiefenbeck V, 2013, ENERG POLICY, V57, P160, DOI 10.1016/j.enpol.2013.01.021; Tobler C, 2012, J ENVIRON PSYCHOL, V32, P197, DOI 10.1016/j.jenvp.2012.02.001; Trancik JE, 2014, NATURE, V507, P300, DOI 10.1038/507300a; van Zomeren M, 2008, PSYCHOL BULL, V134, P504, DOI 10.1037/0033-2909.134.4.504; Verplanken B, 2016, J ENVIRON PSYCHOL, V45, P127, DOI 10.1016/j.jenvp.2015.11.008; WHITE LT, 1984, EVALUATION REV, V8, P167, DOI 10.1177/0193841X8400800202; Wolsink M, 2012, RENEW SUST ENERG REV, V16, P822, DOI 10.1016/j.rser.2011.09.006	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185963	10.1371/journal.pone.0185963	http://dx.doi.org/10.1371/journal.pone.0185963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016642	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800031
J	Goin, DE; Rudolph, KE; Ahern, J				Goin, Dana E.; Rudolph, Kara E.; Ahern, Jennifer			Impact of drought on crime in California: A synthetic control approach	PLOS ONE			English	Article							LEVEL UCR DATA; CLIMATE-CHANGE; VIOLENT CONFLICT; AMBIENT-TEMPERATURE; POLICE CALLS; WEATHER; RATES; SERVICE; DALLAS; HEAT	Climate and weather have been linked to criminal activity. The connection between climatological conditions and crime is of growing importance as we seek to understand the societal implications of climate change. This study describes the mechanisms theorized to link annual variations in climate to crime in California and examines the effect of drought on statewide crime rates from 2011-2015. California has suffered severe drought since 2011, resulting in intensely dry winters and several of the hottest days on record. It is likely that the drought increased economic stress and shifted routine activities of the population, potentially increasing the likelihood of crime. We used a synthetic control method to estimate the impact of California's drought on both property and violent crimes. We found a significant increase in property crimes during the drought, but no effect on violent crimes. This result was robust to several sensitivity analyses, including a negative control.	[Goin, Dana E.; Rudolph, Kara E.; Ahern, Jennifer] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Goin, DE (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	degoin@berkeley.edu		Ahern, Jennifer/0000-0002-3853-9760	National Institutes of Health [DP2 HD080350]; University of California, Berkeley Committee on Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD080350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Berkeley Committee on Research(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health Director's New Innovator Award Program DP2 HD080350. JA received the grant, https://commonfund.nih.gov/newinnovator/ index. KER was a Post-Doctoral Scholar of the Robert Wood Johnson Health and Society Scholars Program, http://www.healthandsocietyscholars. org/. The University of California, Berkeley Committee on Research provided JA initial funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of th emanuscript.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Anderson CA, 2001, CURR DIR PSYCHOL SCI, V10, P33, DOI 10.1111/1467-8721.00109; ANDERSON CA, 1984, J PERS SOC PSYCHOL, V46, P91, DOI 10.1037/0022-3514.46.1.91; ANDERSON CA, 1987, J PERS SOC PSYCHOL, V52, P1161, DOI 10.1037/0022-3514.52.6.1161; [Anonymous], 2014, AM COMMUNITY SURVEY; [Anonymous], CAL WAT US; [Anonymous], CLIM AT A GLANC; Barnett J, 2007, POLIT GEOGR, V26, P639, DOI 10.1016/j.polgeo.2007.03.003; Barnett-Ryan C., 2016, WILEY HDB PSYCHOL VI, P5; Bertrand M, 2002, 8841 NBER; Bliss L, HIST DROUGHT MEETS C; Boxall Bettina, 2015, LOS ANGELES TIMES; Brown EG, 2015, EXECUTIVE ORDER B 29; Brunsdon C, 2009, ENVIRON PLANN B, V36, P906, DOI 10.1068/b32133; Bureau of Economic Analysis, 2014, EC IND STAT; Bureau of Labor Statistics, 2014, OCC EMPL STAT; Butke P, 2010, WEATHER CLIM SOC, V2, P127, DOI 10.1175/2010WCAS1043.1; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; COHEN LE, 1979, AM SOCIOL REV, V44, P588, DOI 10.2307/2094589; COHN EG, 1993, J ENVIRON PSYCHOL, V13, P71, DOI 10.1016/S0272-4944(05)80216-6; Cohn EG, 2000, J ENV PSYCHOL, V20; COTTON JL, 1986, J APPL SOC PSYCHOL, V16, P786, DOI 10.1111/j.1559-1816.1986.tb01168.x; Department of Agricultural and Resource Economics UD, 2015, EC DROUGHT CAL FOOD, V18; Feinstein Laura., 2017, DROUGHT EQUITY CALIF; Field C.B., 2012, MANAGING RISKS EXTRE; FIELD S, 1992, BRIT J CRIMINOL, V32, P340, DOI 10.1093/oxfordjournals.bjc.a048222; Gillis J, 2015, NY TIMES; Gould ED, 2002, REV ECON STAT, V84, P45, DOI 10.1162/003465302317331919; HARRIES KD, 1988, J APPL SOC PSYCHOL, V18, P129, DOI 10.1111/j.1559-1816.1988.tb00010.x; Horrocks J., 2011, NZ EC PAPERS, V45, P231, DOI DOI 10.1080/00779954.2011.572544; Howard B.C., 2014, CALIFORNIA DROUGHT S; Howitt R.E., EC ANAL 2015 DROUGHT; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kreif Noemi, 2015, HLTH EC; Lab SP, 1988, JUSTICE Q, V5, P281; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Lovett I., 2015, NY TIMES; Maltz MD, 2003, J QUANT CRIMINOL, V19, P199, DOI 10.1023/A:1023006321454; Maltz MD, 2002, J QUANT CRIMINOL, V18, P297, DOI 10.1023/A:1016060020848; Mares D, 2013, J URBAN HEALTH, V90, P768, DOI 10.1007/s11524-013-9791-1; Mares D, 2013, CRIME LAW SOCIAL CH, V59, P185, DOI 10.1007/s10611-013-9411-8; Nagourney A., 2015, NY TIMES; NOAA, CLIM RANK; Office of Governor Edmund G. Brown Jr, 2014, GOV BROWN DECL DROUG; Press A, 2015, WALL STREET J; Ranson M, 2014, J ENVIRON ECON MANAG, V67, P274, DOI 10.1016/j.jeem.2013.11.008; Reuveny R, 2007, POLIT GEOGR, V26, P656, DOI 10.1016/j.polgeo.2007.05.001; Richtel Matt, 2015, NY TIMES; Rotton J, 2000, J PERS SOC PSYCHOL, V78, P1074, DOI 10.1037//0022-3514.78.6.1074; Rudolph KE, 2015, AM J PUBLIC HEALTH, V105, pE49, DOI 10.2105/AJPH.2015.302703; Salehyan I, 2014, POLIT GEOGR, V43, P1, DOI 10.1016/j.polgeo.2014.10.004; Scheffran J, 2012, SCIENCE, V336, P869, DOI 10.1126/science.1221339; Simister J, 2005, STRESS HEALTH, V21, P3, DOI 10.1002/smi.1029; Sorg ET, 2011, J CRIM JUST, V39, P463, DOI 10.1016/j.jcrimjus.2011.08.004; Substance Abuse and Mental Health Services Administration, 2014, NAT SURV DRUG US HLT; U.S. Energy Information Administration, 2014, STAT EN DAT SYST SED; United States Census Bureau, 2014, POPULATION ESTIMATES	60	9	9	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185629	10.1371/journal.pone.0185629	http://dx.doi.org/10.1371/journal.pone.0185629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977002	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100034
J	Lewis, B; Lough, JM; Nash, MC; Diaz-Pulido, G				Lewis, Bonnie; Lough, Janice M.; Nash, Merinda C.; Diaz-Pulido, Guillermo			Presence of skeletal banding in a reef-building tropical crustose coralline alga	PLOS ONE			English	Article							OCEAN ACIDIFICATION; GROWTH-RATES; RED ALGAE; RHODOPHYTA; SEA; DOLOMITE; RECONSTRUCTION; LUMINESCENCE; RHODOLITHS; MICROPROBE	The presence of banding in the skeleton of coralline algae has been reported in many species, primarily from temperate and polar regions. Similar to tree rings, skeletal banding can provide information on growth rate, age, and longevity; as well as records of past environmental conditions and the coralline alga's growth responses to such changes. The aim of this study was to explore the presence and characterise the nature of banding in the tropical coralline alga Porolithon onkodes, an abundant and key reef-building species on the Great Barrier Reef (GBR) Australia, and the Indo-Pacific in general. To achieve this we employed various methods including X-ray diffraction (XRD) to determine seasonal mol% magnesium (Mg), mineralogy mapping to investigate changes in dominant mineral phases, scanning electron microscopy-electron dispersive spectroscopy (SEM-EDS), and micro-computed tomography (micro-CT) scanning to examine changes in cell size and density banding, and UV light to examine reproductive (conceptacle) banding. Seasonal variation in the Mg content of the skeleton did occur and followed previously recorded variations with the highest mol% MgCO3 in summer and lowest in winter, confirming the positive relationship between seawater temperature and mol% MgCO3. Rows of conceptacles viewed under UV light provided easily distinguishable bands that could be used to measure vertical growth rate (1.4 mm year(-1)) and age of the organism. Micro-CT scanning showed obvious banding patterns in relation to skeletal density, and mineralogical mapping revealed patterns of banding created by changes in Mg content. Thus, we present new evidence for seasonal banding patterns in the tropical coralline alga P. onkodes. This banding in the P. onkodes skeleton can provide valuable information into the present and past life history of this important reef-building species, and is essential to assess and predict the response of these organisms to future climate and environmental changes.	[Lewis, Bonnie; Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan, Qld, Australia; [Lewis, Bonnie; Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Nathan, Qld, Australia; [Lough, Janice M.; Diaz-Pulido, Guillermo] ARC Ctr Excellence Coral Reef Studies, Douglas, Qld, Australia; [Lough, Janice M.] Australian Inst Marine Sci, Townsville, Qld, Australia; [Nash, Merinda C.] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT, Australia	Griffith University; Griffith University; Australian Institute of Marine Science; Australian National University	Lewis, B (corresponding author), Griffith Univ, Griffith Sch Environm, Nathan, Qld, Australia.; Lewis, B (corresponding author), Griffith Univ, Australian Rivers Inst Coast & Estuaries, Nathan, Qld, Australia.	bonnie.lewis@griffithuni.edu.au	Diaz-Pulido, Guillermo/B-3648-2013; Lough, Janice M/L-1682-2013	Lough, Janice M/0000-0002-3789-1009; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Lewis, Bonnie/0000-0002-0624-3359	Great Barrier Reef Foundation; Australian Research Council [DP 120101778]	Great Barrier Reef Foundation; Australian Research Council(Australian Research Council)	This research was funded by the Great Barrier Reef Foundation (https:/www/barrier.reef.org/) and the Australian Research Council (DP 120101778) grants awarded to GDP.	Adey W, 2013, ADEY BIOL PHYSL ECOL; Adey W, 2015, PALAIOS, V30, P281, DOI 10.2110/palo.2014.075; ADEY WH, 1978, PHYCOLOGIA, V17, P361, DOI 10.2216/i0031-8884-17-4-361.1; Agegian C. R., 1981, P 4 INT COR REEF S M, V2, P419; AIMS, 2016, REEF MON HERS ISL LO; ALEXANDERSSON T, 1974, J SEDIMENT PETROL, V44, P7; ANDRAKE W, 1980, J PHYCOL, V16, P620, DOI 10.1111/j.1529-8817.1980.tb03081.x; [Anonymous], 2011, QUATERNARY AUSTRALAS; Barnes DJ, 2003, J EXP MAR BIOL ECOL, V295, P91, DOI 10.1016/S0022-0981(03)00274-0; Blake C, 2003, PHYCOLOGIA, V42, P606, DOI 10.2216/i0031-8884-42-6-606.1; Burdett H, 2011, PALAEOGEOGR PALAEOCL, V302, P65, DOI 10.1016/j.palaeo.2010.07.027; Caswell, 2000, MATRIX POPULATION MO; CHAVE KE, 1965, SCIENCE, V147, P621, DOI 10.1126/science.147.3658.621; CHIHARA M, 1974, J PHYCOL, V10, P266, DOI 10.1111/j.1529-8817.1974.tb02712.x; Darrenougue N, 2014, QUATERNARY SCI REV, V93, P34, DOI 10.1016/j.quascirev.2014.03.005; Darrenougue N, 2013, MAR ECOL PROG SER, V474, P105, DOI 10.3354/meps10085; Dean AJ, 2015, CORAL REEFS, V34, P581, DOI 10.1007/s00338-015-1263-5; Diaz-Pulido G, 2007, CLIMATE CHANGE GREAT; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; EDYVEAN RGJ, 1984, BOT MAR, V27, P391, DOI 10.1515/botm.1984.27.9.391; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; Frantz BR, 2000, LIMNOL OCEANOGR, V45, P1773, DOI 10.4319/lo.2000.45.8.1773; FREIWALD A, 1994, SEDIMENTOLOGY, V41, P963, DOI 10.1111/j.1365-3091.1994.tb01435.x; Gamboa G, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006262; Halfar J, 2008, GEOLOGY, V36, P463, DOI 10.1130/G24635A.1; Halfar J, 2011, PALAEOGEOGR PALAEOCL, V302, P71, DOI 10.1016/j.palaeo.2010.04.009; Halfar J, 2000, J GEOPHYS RES-OCEANS, V105, P22107, DOI 10.1029/1999JC000128; Halfar J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028811; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harvey A.S., 2005, CORALLINE ALGAE CENT; Hetzinger S, 2009, PALAIOS, V24, P406, DOI 10.2110/palo.2008.p08-116r; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kamenos NA, 2008, GEOCHIM COSMOCHIM AC, V72, P771, DOI 10.1016/j.gca.2007.11.019; Kamenos NA, 2009, GEOCHIM COSMOCHIM AC, V73, P1901, DOI 10.1016/j.gca.2009.01.010; Kamenos NA, 2017, COAST RES LIBR, V15, P27, DOI 10.1007/978-3-319-29315-8_2; Kamenos NA, 2010, J PHYCOL, V46, P331, DOI 10.1111/j.1529-8817.2009.00780.x; Krayesky-Self S, 2016, J PHYCOLOGY; Lewis B, 2017, MAR ECOL PROG SER, V568, P73, DOI 10.3354/meps12074; Lewis B, 2017, J EXP MAR BIOL ECOL, V490, P64, DOI 10.1016/j.jembe.2017.02.004; Littler M.M., 1984, PROGR PHYCOLOGICAL R, V3, P323; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Lough JM, 2015, CORAL REEFS, V34, P739, DOI 10.1007/s00338-015-1297-8; Lough JM, 2011, CORAL REEFS, V30, P169, DOI 10.1007/s00338-010-0688-0; Lough JM, 2011, EARTH-SCI REV, V108, P170, DOI 10.1016/j.earscirev.2011.07.001; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; MOBERLY R, 1970, SEDIMENTOLOGY, V14, P113, DOI 10.1111/j.1365-3091.1970.tb00185.x; MOBERLY R, 1968, SEDIMENTOLOGY, V11, P61, DOI 10.1111/j.1365-3091.1968.tb00841.x; Nash MC, 2015, BIOGEOSCIENCES, V12, P5247, DOI 10.5194/bg-12-5247-2015; Nash MC, 2013, NAT CLIM CHANGE, V3, P268, DOI 10.1038/NCLIMATE1760; Nash MC, 2011, BIOGEOSCIENCES, V8, P3331, DOI 10.5194/bg-8-3331-2011; Nash MC, 2013, J SEDIMENT RES, V83, P1085, DOI 10.2110/jsr.2013.67; NORO T, 1983, Bulletin of the Faculty of Fisheries Hokkaido University, V34, P1; Ordonez A, 2014, BIOL BULL-US, V226, P255, DOI 10.1086/BBLv226n3p255; Ragazzola F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20572; Ringeltaube P, 2000, BOT MAR, V43, P431, DOI 10.1515/BOT.2000.045; Rivera MG, 2004, CIENC MAR, V30, P235, DOI 10.7773/cm.v30i12.104; Schafer P, 2011, PALAIOS, V26, P420, DOI 10.2110/palo.2010.p10-138r; Sletten HR, 2017, PALAEOGEOGR PALAEOCL, V465, P264, DOI 10.1016/j.palaeo.2016.10.038; Steneck R, CRUSTOSE CORALLINE A; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Steneck RS, 1997, P 8 INT COR REEF S J; Torrano-Silva BN, 2015, MICRON, V72, P34, DOI 10.1016/j.micron.2015.02.004	63	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185124	10.1371/journal.pone.0185124	http://dx.doi.org/10.1371/journal.pone.0185124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976988	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000412163100017
J	Lee, S; Harwood, M; Girouard, D; Meyers, MJ; Campbell, MA; Beamer, G; Tzipori, S				Lee, Sangun; Harwood, Melanie; Girouard, Don; Meyers, Marvin J.; Campbell, Mary A.; Beamer, Gillian; Tzipori, Saul			The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis	PLOS ONE			English	Article							PARVUM; CHILDREN; PAROMOMYCIN; INFECTION; DIARRHEA; COMMUNITY; RIFABUTIN; DISEASE; CULTURE; BOVINE	Recent reports highlighting the global significance of cryptosporidiosis among children, have renewed efforts to develop control measures. We have optimized the gnotobiotic piglet model of acute diarrhea to evaluate azithromycin (AZR), nitazoxanide (NTZ), or treatment with both against Cryptosporidium hominis, the species responsible for most human cases. Piglets, animals reproducibly clinically susceptible to C. hominis, when inoculated with 10(6) oocysts, developed acute diarrhea with oocyst excretion in feces within 3 days. Ten day-treatment with recommended doses for children, commencing at onset of diarrhea, showed that treatment with AZR or NTZ relieved symptoms early in the treatment compared with untreated animals. Piglets treated with AZR exhibited no reduction of oocyst excretion whereas treatment with NTZ significantly reduced oocyst shedding early, increasing however after 5 days. While treatment with AZR+NTZ led to considerable symptomatic improvement, it had a modest effect on reducing mucosal injury, and did not completely eliminate oocyst excretion. Doubling the dose of AZR and/or NTZ did not improve the clinical outcome, confirming clinical observations that NTZ is only partially effective in reducing duration of diarrhea in children. This investigation confirms the gnotobiotic piglet as a useful tool for drug evaluation for the treatment of cryptosporidiosis in children.	[Lee, Sangun; Harwood, Melanie; Girouard, Don; Beamer, Gillian; Tzipori, Saul] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA; [Meyers, Marvin J.; Campbell, Mary A.] St Louis Univ, Sch Med, Ctr World Hlth & Med, St Louis, MO USA	Tufts University; Saint Louis University	Tzipori, S (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA.	saul.tzipori@tufts.edu		Meyers, Marvin/0000-0001-5484-619X; Girouard Jr., Donald/0000-0001-9935-0470	Bill & Melinda Gates Foundation [OPP1132800]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, OPP1132800 (www.gatesfoundation.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2007, BRIT J CLIN PHARMACO, V63, P387, DOI 10.1111/j.1365-2125.2007.02873.x; Abubakar I, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004932.pub2; Akiyoshi DE, 2002, INFECT IMMUN, V70, P5670, DOI 10.1128/IAI.70.10.5670-5675.2002; Allam Amal F., 2002, Journal of the Egyptian Society of Parasitology, V32, P969; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Baker DR, 1997, ADV EXP MED BIOL, V412, P53; Blanshard C, 1997, INT J STD AIDS, V8, P124, DOI 10.1258/0956462971919543; Bowers M, 1998, BETA, P30; Chappell CL, 2006, AM J TROP MED HYG, V75, P851, DOI 10.4269/ajtmh.2006.75.851; Cooper CA, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-5; Engelking L. R, 2015, TXB VET PHYSL CHEM; Fielder SE, 2016, MERCK VET MANUAL, P11; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Gargala G, 2000, J ANTIMICROB CHEMOTH, V46, P57, DOI 10.1093/jac/46.1.57; Giacometti A, 2000, J ANTIMICROB CHEMOTH, V45, P453, DOI 10.1093/jac/45.4.453; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P885, DOI 10.1007/s100960050424; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Holmberg SD, 1998, JAMA-J AM MED ASSOC, V279, P384, DOI 10.1001/jama.279.5.384; Hong DK, 2007, PEDIATR TRANSPLANT, V11, P94, DOI 10.1111/j.1399-3046.2006.00593.x; Ifeonu OO, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw137; Jackson P., 2002, CLIN EXAMINATION FAR, V1rd; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; Kadappu K K, 2002, J Postgrad Med, V48, P179; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Mead JR, 2014, HUM VACC IMMUNOTHER, V10, P1505, DOI 10.4161/hv.28485; Molbak K, 1997, AM J CLIN NUTR, V65, P149, DOI 10.1093/ajcn/65.1.149; Morada M, 2016, INT J PARASITOL, V46, P21, DOI 10.1016/j.ijpara.2015.07.006; Nasir A, 2013, J PARASITOL, V99, P715, DOI 10.1645/12-42.1; Ollivett TL, 2009, J DAIRY SCI, V92, P1643, DOI 10.3168/jds.2008-1474; Pozio E, 2004, APMIS, V112, P309, DOI 10.1111/j.1600-0463.2004.apm11204-0513.x; REHG JE, 1991, J INFECT DIS, V163, P1293, DOI 10.1093/infdis/163.6.1293; Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005; Saif LJ, 1996, ARCH VIROL, P153; Schnyder M, 2009, VET PARASITOL, V160, P149, DOI 10.1016/j.vetpar.2008.10.094; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Theodos CM, 1998, ANTIMICROB AGENTS CH, V42, P1959, DOI 10.1128/AAC.42.8.1959; Tumwine JK, 2003, AM J TROP MED HYG, V68, P710, DOI 10.4269/ajtmh.2003.68.710; TZIPORI S, 1994, CLIN DIAGN LAB IMMUN, V1, P450, DOI 10.1128/CDLI.1.4.450-463.1994; VARGAS SL, 1993, J PEDIATR-US, V123, P154, DOI 10.1016/S0022-3476(05)81562-8; Viel H, 2007, PARASITOL RES, V102, P163, DOI 10.1007/s00436-007-0744-z; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yeom Su-Cheong, 2012, Lab Anim Res, V28, P245, DOI 10.5625/lar.2012.28.4.245	43	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185906	10.1371/journal.pone.0185906	http://dx.doi.org/10.1371/journal.pone.0185906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973041	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900065
J	Theron, A; Roth, RL; Hoppe, H; Parkinson, C; van der Westhuyzen, CW; Stoychev, S; Wiid, I; Pietersen, RD; Baker, B; Kenyon, CP				Theron, A.; Roth, R. L.; Hoppe, H.; Parkinson, C.; van der Westhuyzen, C. W.; Stoychev, S.; Wiid, I.; Pietersen, R. D.; Baker, B.; Kenyon, C. P.			Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; KLEBSIELLA-AEROGENES; SALMONELLA-TYPHIMURIUM; ENZYME; GROWTH; AVIUM; GENE; PURIFICATION; EXPRESSION	Glutamine synthetase is a ubiquitous central enzyme in nitrogen metabolism that is controlled by up to four regulatory mechanisms, including adenylylation of some or all of the twelve subunits by adenylyl transferase. It is considered a potential therapeutic target for the treatment of tuberculosis, being essential for the growth of Mycobacterium tuberculosis, and is found extracellularly only in the pathogenic Mycobacterium strains. Human glutamine synthetase is not regulated by the adenylylation mechanism, so the adenylylated form of bacterial glutamine synthetase is of particular interest. Previously published reports show that, when M. tuberculosis glutamine synthetase is expressed in Escherichia coli, the E. coli adenylyl transferase does not optimally adenylylate the M. tuberculosis glutamine synthetase. Here, we demonstrate the production of soluble adenylylated M. tuberulosis glutamine synthetase in E. coli by the co-expression of M. tuberculosis glutamine synthetase and M. tuberculosis adenylyl transferase. The differential inhibition of adenylylated M. tuberulosis glutamine synthetase and deadenylylated M. tuberulosis glutamine synthetase by ATP based scaffold inhibitors are reported. Compounds selected on the basis of their enzyme inhibition were also shown to inhibit M. tuberculosis in the BACTEC 460TB T assay as well as the intracellular inhibition of M. tuberculosis in a mouse bone-marrow derived macrophage assay.	[Theron, A.; Roth, R. L.; Hoppe, H.; van der Westhuyzen, C. W.; Stoychev, S.; Kenyon, C. P.] CSIR Biosci, Pretoria, South Africa; [Parkinson, C.] Charles Sturt Univ, Sch Biomed Sci, Orange, NSW, Australia; [Wiid, I.; Pietersen, R. D.; Baker, B.; Kenyon, C. P.] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Hoppe, H.] Rhodes Univ, Dept Biochem Microbiol & Biotechnol, Grahamstown, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; Charles Sturt University; National Research Foundation - South Africa; Stellenbosch University; Rhodes University	Kenyon, CP (corresponding author), CSIR Biosci, Pretoria, South Africa.; Kenyon, CP (corresponding author), Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa.	kenyon@sun.ac.za	Baker, Bienyameen/F-9150-2015; Theron, Anjo/Q-5565-2018	Baker, Bienyameen/0000-0002-2158-6763; Theron, Anjo/0000-0002-0497-4473; Pietersen, Ray-Dean/0000-0002-3794-8503; Kenyon, Colin/0000-0003-1590-7230; Parkinson, Christopher/0000-0003-4547-7091; van der Westhuyzen, Chris/0000-0002-2873-6234; Stoychev, Stoyan/0000-0001-7504-4313; Roth, Robyn/0000-0002-6486-7549	Innovation Fund [T80051]	Innovation Fund	This work forms part of a project (T80051) funded by The Innovation Fund, which is managed by the National Research Foundation (NRF) in South Africa.	BACKMAN K, 1981, P NATL ACAD SCI-BIOL, V78, P3743, DOI 10.1073/pnas.78.6.3743; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; BLOOM FR, 1977, J BACTERIOL, V130, P983, DOI 10.1128/JB.130.3.983-990.1977; BROWN JR, 1994, J MOL EVOL, V38, P566; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Couturier C, 2015, BIOORG MED CHEM LETT, V25, P1455, DOI 10.1016/j.bmcl.2015.02.035; DECHASTELLIER C, 1995, EUR J CELL BIOL, V68, P167; FOOR F, 1975, P NATL ACAD SCI USA, V72, P4844, DOI 10.1073/pnas.72.12.4844; GAILLARDIN CM, 1978, J BACTERIOL, V133, P1329, DOI 10.1128/JB.133.3.1329-1338.1978; George G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021007; Ginsburg A, 1973, ENZYMES GLUTAMINE ME, P9; Gising J, 2012, J MED CHEM, V55, P2894, DOI 10.1021/jm201212h; Harth G, 1997, J BIOL CHEM, V272, P22728, DOI 10.1074/jbc.272.36.22728; Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425; Harth G, 2003, INFECT IMMUN, V71, P456, DOI 10.1128/IAI.71.1.456-464.2003; Held D, 2003, INNOVATIONS, V18, P406; HIRSCHFIELD GR, 1990, J BACTERIOL, V172, P1005, DOI 10.1128/jb.172.2.1005-1013.1990; HOLZER H, 1968, P NATL ACAD SCI USA, V60, P721, DOI 10.1073/pnas.60.2.721; JANSSEN KA, 1977, J BACTERIOL, V129, P993, DOI 10.1128/JB.129.2.993-1000.1977; Johnson R, 2010, INT J TUBERC LUNG D, V14, P119; Kenyon CP, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-36; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Kosikowska P, 2016, J ENZYM INHIB MED CH, V31, P931, DOI 10.3109/14756366.2015.1070846; KUMADA Y, 1993, P NATL ACAD SCI USA, V90, P3009, DOI 10.1073/pnas.90.7.3009; KUSTU SG, 1975, J BACTERIOL, V122, P1006, DOI 10.1128/JB.122.3.1006-1016.1975; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerlund O, 2007, COMB CHEM HIGH T SCR, V10, P783, DOI 10.2174/138620707783018478; Leisching G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153079; LUDDEN PW, 1978, BIOCHEM J, V175, P251, DOI 10.1042/bj1750251; MECKE D, 1966, BIOCHEM BIOPH RES CO, V24, P452, DOI 10.1016/0006-291X(66)90182-3; Mehta R, 2004, J BIOL CHEM, V279, P22477, DOI 10.1074/jbc.M401652200; Mowbray SL, 2014, MOLECULES, V19, P13161, DOI 10.3390/molecules190913161; Nilsson MT, 2009, J MOL BIOL, V393, P504, DOI 10.1016/j.jmb.2009.08.028; Odell LR, 2009, BIOORG MED CHEM LETT, V19, P4790, DOI 10.1016/j.bmcl.2009.06.045; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Reitzer L.J., 1987, E COLI SALMONELLA CE, P302; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SHAPIRO BM, 1968, J BIOL CHEM, V243, P3769; SHAPIRO BM, 1970, ANNU REV MICROBIOL, V24, P501, DOI 10.1146/annurev.mi.24.100170.002441; SHAPIRO BM, 1968, BIOCHEMISTRY-US, V7, P2153, DOI 10.1021/bi00846a018; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; SIDDIQI SH, 1993, J CLIN MICROBIOL, V31, P2332, DOI 10.1128/JCM.31.9.2332-2338.1993; Singh J, 2004, BIOCHEM BIOPH RES CO, V317, P634, DOI 10.1016/j.bbrc.2004.03.094; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; TYLER B, 1978, ANNU REV BIOCHEM, V47, P1127, DOI 10.1146/annurev.bi.47.070178.005403; WIETZERBIN J, 1975, BIOCHEM BIOPH RES CO, V62, P246, DOI 10.1016/S0006-291X(75)80130-6; WOLHEUTER RM, 1973, ENZYMES GLUTAMINE ME, P45; WOOLFOLK CA, 1966, ARCH BIOCHEM BIOPHYS, V116, P177, DOI 10.1016/0003-9861(66)90026-9	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185068	10.1371/journal.pone.0185068	http://dx.doi.org/10.1371/journal.pone.0185068			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972974	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900010
J	Whiteley, L; Haug, M; Klein, K; Willmann, M; Bohn, E; Chiantia, S; Schwarz, S				Whiteley, Liam; Haug, Maria; Klein, Kristina; Willmann, Matthias; Bohn, Erwin; Chiantia, Salvatore; Schwarz, Sandra			Cholesterol and host cell surface proteins contribute to cell-cell fusion induced by the Burkholderia type VI secretion system 5	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTRACELLULAR LIFE-CYCLE; MEMBRANE CURVATURE; LIPID RAFTS; PSEUDOMALLEI; PATHOGENESIS; RECEPTORS; INFECTION; IDENTIFICATION; MECHANISM	Following escape into the cytoplasm of host cells, Burkholderia pseudomallei and the related species Burkholderia thailandensis employ the type VI secretion system 5 ( T6SS-5) to induce plasma membrane fusion with an adjacent host cell. This process leads to the formation of multinucleated giant cells and facilitates bacterial access to an uninfected host cell in a direct manner. Despite its importance in virulence, the mechanism of the T6SS-5 and the role of host cell factors in cell-cell fusion remain elusive. To date, the T6SS-5 is the only system of bacterial origin known to induce host-cell fusion. To gain insight into the nature of T6SS-5-stimulated membrane fusion, we investigated the contribution of cholesterol and proteins exposed on the host cell surface, which were shown to be critically involved in virus-mediated giant cell formation. In particular, we analyzed the effect of host cell surface protein and cholesterol depletion on the formation of multinucleated giant cells induced by B. thailandensis. Acute protease treatment of RAW264.7 macrophages during infection with B. thailandensis followed by agarose overlay assays revealed a strong reduction in the number of cell-cell fusions compared with EDTA treated cells. Similarly, proteolytic treatment of specifically infected donor cells or uninfected recipient cells significantly decreased multinucleated giant cell formation. Furthermore, modulating host cell cholesterol content by acute cholesterol depletion from cellular membranes by methyl-beta-cyclodextrin treatment or exogenous addition of cholesterol impaired the ability of B. thailandensis to induce cell-cell fusions. The requirement of physiological cholesterol levels suggests that the membrane organization or mechanical properties of the lipid bilayer influence the fusion process. Altogether, our data suggest that membrane fusion induced by B. pseudomallei and B. thailandensis involves a complex interplay between the T6SS-5 and the host cell.	[Whiteley, Liam; Haug, Maria; Klein, Kristina; Willmann, Matthias; Bohn, Erwin; Schwarz, Sandra] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany; [Chiantia, Salvatore] Potsdam Univ, Dept Biochem, Potsdam, Germany	Eberhard Karls University of Tubingen; University of Potsdam	Schwarz, S (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Tubingen, Germany.	sandra.schwarz@med.uni-tuebingen.de	Chiantia, Salvatore/U-6363-2019	Chiantia, Salvatore/0000-0003-0791-967X	German Research Foundation (DFG) [SCHWS 1517/2-1]; German Excellence Initiative [ZUK63]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative	This work was supported by the German Research Foundation (DFG;http://www.dfg.de/) SCHWS 1517/2-1 to SS, and the German Excellence Initiative (http://www.dfg.de/en/ research_funding/programmes/excellenceinitiative/) ZUK63 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar S, 2006, J VIROL, V80, P2815, DOI 10.1128/JVI.80.6.2815-2822.2006; BLANK H, 1951, JAMA-J AM MED ASSOC, V146, P1410, DOI 10.1001/jama.1951.63670150005012b; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Compton AA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006099; Corcoran JA, 2006, J BIOL CHEM, V281, P31778, DOI 10.1074/jbc.M602566200; Currie BJ, 2015, SEMIN RESP CRIT CARE, V36, P111, DOI 10.1055/s-0034-1398389; Domanska MK, 2013, BIOPHYS J, V105, P1383, DOI 10.1016/j.bpj.2013.08.003; Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Harley VS, 1998, MICROBIOS, V94, P35; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Imhoff H, 2007, J VIROL, V81, P4158, DOI 10.1128/JVI.02647-06; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kondo Y, 2009, CLIN EXP IMMUNOL, V158, P84, DOI 10.1111/j.1365-2249.2009.03990.x; Koseoglu S, 2011, ANAL BIOANAL CHEM, V400, P2963, DOI 10.1007/s00216-011-5002-7; Lai AL, 2012, J MOL BIOL, V418, P3, DOI 10.1016/j.jmb.2012.02.010; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; LIFSON J, 1986, J EXP MED, V164, P2101, DOI 10.1084/jem.164.6.2101; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Matsuyama S, 2002, J VIROL, V76, P11819, DOI 10.1128/JVI.76.23.11819-11826.2002; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; Morizono K, 2011, CURR OPIN VIROL, V1, P13, DOI 10.1016/j.coviro.2011.05.001; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; SalasBenito JS, 1997, J VIROL, V71, P7246, DOI 10.1128/JVI.71.10.7246-7252.1997; Schwarz S, 2014, INFECT IMMUN, V82, P1445, DOI 10.1128/IAI.01368-13; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Viswanathan G, 2015, CHEM PHYS LIPIDS, V189, P19, DOI 10.1016/j.chemphyslip.2015.05.006; Whiteley L, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00468-17, 10.1128/iai.00468-17]; Wong J, 2015, CELL HOST MICROBE, V18, P38, DOI 10.1016/j.chom.2015.06.002	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185715	10.1371/journal.pone.0185715	http://dx.doi.org/10.1371/journal.pone.0185715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973030	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900040
J	Kurian, SM; Ferreri, K; Wang, CH; Todorov, I; Al-Abdullah, IH; Rawson, J; Mullen, Y; Salomon, DR; Kandeel, F				Kurian, Sunil M.; Ferreri, Kevin; Wang, Chia-Hao; Todorov, Ivan; Al-Abdullah, Ismail H.; Rawson, Jeffrey; Mullen, Yoko; Salomon, Daniel R.; Kandeel, Fouad			Gene expression signature predicts human islet integrity and transplant functionality in diabetic mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; APOPTOSIS-INDUCING LIGAND; ENDOCRINE PANCREAS; OXYGEN-CONSUMPTION; GRAFT FUNCTION; TISSUE FACTOR; DIFFERENTIATION; MELLITUS; RECEPTOR; PATHWAY	There is growing evidence that transplantation of cadaveric human islets is an effective therapy for type 1 diabetes. However, gauging the suitability of islet samples for clinical use remains a challenge. We hypothesized that islet quality is reflected in the expression of specific genes. Therefore, gene expression in 59 human islet preparations was analyzed and correlated with diabetes reversal after transplantation in diabetic mice. Analysis yielded 262 differentially expressed probesets, which together predict islet quality with 83% accuracy. Pathway analysis revealed that failing islet preparations activated inflammatory pathways, while functional islets showed increased regeneration pathway gene expression. Gene expression associated with apoptosis and oxygen consumption showed little overlap with each other or with the 262 probeset classifier, indicating that the three tests are measuring different aspects of islet cell biology. A subset of 36 probesets surpassed the predictive accuracy of the entire set for reversal of diabetes, and was further reduced by logistic regression to sets of 14 and 5 without losing accuracy. These genes were further validated with an independent cohort of 16 samples. We believe this limited number of gene classifiers in combination with other tests may provide complementary verification of islet quality prior to their clinical use.	[Kurian, Sunil M.; Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Ferreri, Kevin; Wang, Chia-Hao; Todorov, Ivan; Al-Abdullah, Ismail H.; Rawson, Jeffrey; Mullen, Yoko; Kandeel, Fouad] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Translat Res & Cellular Therapeut, 1500 E Duarte Rd, Duarte, CA 91010 USA	Scripps Research Institute; City of Hope	Kandeel, F (corresponding author), City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Translat Res & Cellular Therapeut, 1500 E Duarte Rd, Duarte, CA 91010 USA.	fkandeel@coh.org	Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263	National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center [U42RR016607]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016607] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this work is from the National Institute of Diabetes and Digestive and Kidney Diseases, Southern California Islet Cell Resources (SC-ICR) Center, grant U42RR016607.	Ahn YB, 2007, DIABETOLOGIA, V50, P334, DOI 10.1007/s00125-006-0536-5; Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnefond A, 2013, DIABETES METAB, V39, P276, DOI 10.1016/j.diabet.2013.02.007; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Cheung SSC, 2005, PANCREAS, V30, P105, DOI 10.1097/01.mpa.0000148515.77497.4b; Cras-Meneur C, 2009, GENE DEV, V23, P2088, DOI 10.1101/gad.1800209; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Eizirik DL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002552; Ejarque M, 2013, J BIOL CHEM, V288, P11705, DOI 10.1074/jbc.M112.388173; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fiorina P, 2003, DIABETES CARE, V26, P1129, DOI 10.2337/diacare.26.4.1129; Fiorina P, 2003, J AM SOC NEPHROL, V14, P2150, DOI 10.1097/01.ASN.0000077339.20759.A3; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Firestein GS, 1999, ARTHRITIS RHEUM-US, V42, P609, DOI 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I; Frumento D, 2017, J ENDOCRINOL INVEST, V40, P803, DOI 10.1007/s40618-017-0641-y; Gaber AO, 2004, TRANSPL P, V36, P1108, DOI 10.1016/j.transproceed.2004.04.055; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Grieco FA, 2011, DIABETES-METAB RES, V27, P755, DOI 10.1002/dmrr.1247; Hanson MS, 2010, TRANSPLANTATION, V89, P1178, DOI 10.1097/TP.0b013e3181d54bce; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jamiolkowski Ryan M., 2012, Yale Journal of Biology and Medicine, V85, P37; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kissler HJ, 2010, CLIN TRANSPLANT, V24, P236, DOI 10.1111/j.1399-0012.2009.01052.x; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Loweth AC, 1998, DIABETES, V47, P727, DOI 10.2337/diabetes.47.5.727; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Melzi R, 2004, TRANSPLANTATION, V78, P1564, DOI 10.1097/01.TP.0000144184.20085.41; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nakayama S, 2008, DIABETOLOGIA, V51, P1883, DOI 10.1007/s00125-008-1080-2; Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ou D, 2002, DIABETOLOGIA, V45, P1678, DOI 10.1007/s00125-002-0926-2; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Piemonti L, 2013, DIABETES, V62, P1656, DOI 10.2337/db12-1258; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rush BT, 2004, TRANSPLANTATION, V77, P1147, DOI 10.1097/01.TP.0000116769.94299.F4; Russell MA, 2013, ISLETS, V5, P95, DOI 10.4161/isl.24249; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shibasaki S, 2010, ENDOCR J, V57, P211, DOI 10.1507/endocrj.K09E-291; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sussel L, 1998, DEVELOPMENT, V125, P2213; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Todorov I, 2010, TRANSPLANTATION, V90, P836, DOI 10.1097/TP.0b013e3181f1db5d; Westermark GT, 2003, UPSALA J MED SCI, V108, P193, DOI 10.3109/2000-1967-113; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhang T, 2010, ENDOCRINOLOGY, V151, P2030, DOI 10.1210/en.2009-1224	68	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185331	10.1371/journal.pone.0185331	http://dx.doi.org/10.1371/journal.pone.0185331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968432	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600019
J	Stokes, A; Berry, KM; Mchiza, Z; Parker, WA; Labadarios, D; Chola, L; Hongoro, C; Zuma, K; Brennan, AT; Rockers, PC; Rosen, S				Stokes, Andrew; Berry, Kaitlyn M.; Mchiza, Zandile; Parker, Whadi-ah; Labadarios, Demetre; Chola, Lumbwe; Hongoro, Charles; Zuma, Khangelani; Brennan, Alana T.; Rockers, Peter C.; Rosen, Sydney			Prevalence and unmet need for diabetes care across the care continuum in a national sample of South African adults: Evidence from the SANHANES-1, 2011-2012	PLOS ONE			English	Article							THERAPY; CASCADE	South Africa faces an epidemic of chronic non-communicable diseases (NCDs), yet national surveillance is limited due to the lack of recent data. We used data from the first comprehensive national survey on NCDs-the South African National Health and Nutrition Examination Survey (SANHANES-1 (2011-2012))-to evaluate the prevalence of and health system response to diabetes through a diabetes care cascade. We defined diabetes as a Hemoglobin A1c equal to or above 6.5% or currently on treatment for diabetes. We constructed a diabetes care cascade by categorizing the population with diabetes into those who were unscreened, screened but undiagnosed, diagnosed but untreated, treated but uncontrolled, and treated and controlled. We then used multivariable logistic regression models to explore factors associated with diagnosed and undiagnosed diabetes. The age-standardized prevalence of diabetes in South Africans aged 15+ was 10.1%. Prevalence rates were higher among the non-white population and among women. Among individuals with diabetes, a total of 45.4% were unscreened, 14.7% were screened but undiagnosed, 2.3% were diagnosed but untreated, 18.1% were treated but uncontrolled, and 19.4% were treated and controlled, suggesting that 80.6% of the diabetic population had unmet need for care. The diabetes care cascade revealed significant losses from lack of screening, between screening and diagnosis, and between treatment and control. These results point to significant unmet need for diabetes care in South Africa. Additionally, this analysis provides a benchmark for evaluating efforts to manage the rising burden of diabetes in South Africa.	[Stokes, Andrew; Berry, Kaitlyn M.; Brennan, Alana T.; Rockers, Peter C.; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Mchiza, Zandile; Parker, Whadi-ah; Labadarios, Demetre; Chola, Lumbwe; Hongoro, Charles; Zuma, Khangelani] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Cape Town, South Africa; [Brennan, Alana T.; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa	Boston University; Human Sciences Research Council-South Africa; University of Witwatersrand	Stokes, A (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.	acstokes@bu.edu	Chola, Lumbwe/AFX-3377-2022	Parker, Whadi-ah/0000-0001-8308-8447; Berry, Kaitlyn/0000-0002-2928-6773; Hongoro, Charles/0000-0002-9715-4940; Rosen, Sydney/0000-0002-6560-2964; Brennan, Alana/0000-0002-7746-0668; Zuma, Khangelani/0000-0003-4492-5083; Chola, Lumbwe/0000-0001-6488-2813; Stokes, Andrew/0000-0002-8502-3636				Ali MK, 2014, ANN INTERN MED, V161, P681, DOI 10.7326/M14-0019; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; [Anonymous], 2000, NON TRADITIONAL REF; Booysen BL, 2015, S AFRICAN FAM PRACT, P57; Bradshaw D, 2007, JEMDSA, V12, P65, DOI 10.1080/22201009.2007.10872159; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Clouse K, 2013, J ACQ IMMUN DEF SYND, V62, P22, DOI DOI 10.1097/QAI.0B013E318273AC48.PATIENT; Department of Health; Republic of South Africa, 2013, STRAT PLAN PREV CONT; Fox MP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002268; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gardner EM, 2014, LANCET INFECT DIS, V14, P5, DOI 10.1016/S1473-3099(13)70272-X; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation, 2015, IDF DIABETES ATLAS; International Diabetes Federation, 2011, IDF DIABETES ATLAS, DOI [10.1007/978-90-481-3271-3, DOI 10.1007/978-90-481-3271-3]; International Diabetes Federation, 2012, DIAB AT A GLANC, DOI [10.1080/03071845709419205, DOI 10.1080/03071845709419205]; Isaacs A, 2015, S AFRICAN FAM PRACT, P6190; Labadarios D, 2014, SAMJ S AFR MED J, V104, P675, DOI [10.7196/SAMJ.8842, 10.7196/samj.8842]; Matsebula V, 2016, SOCIOECONOMIC CORREL; McLaren Z, 2013, DISTANCE BARRIER HLT; Mendenhall E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2615-3; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Moodley L, 2007, S AFRICAN FAM PRACT, P49; Peer N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043336; Perlman DC, 2017, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00296; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rowe KA, 2005, INT J TUBERC LUNG D, V9, P263; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shisana O, 2014, S AFRICAN NATL HLTH; Shisana O, 2014, S AFRICAN NATL HLTH; Statistics South Africa, 2014, PRETORIA, V3, P1; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	33	38	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0184264	10.1371/journal.pone.0184264	http://dx.doi.org/10.1371/journal.pone.0184264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968435	gold, Green Submitted, Green Published			2022-12-27	WOS:000412029600006
J	Bragulat, MR; Eustaquio, A; Cabanes, FJ				Bragulat, M. Rosa; Eustaquio, Alba; Cabanes, F. Javier			Study on the presence of ochratoxin a in cultures of ochratoxigenic and nonochratoxigenic strains of Aspergillus carbonarius	PLOS ONE			English	Article							TEMPERATURE; GROWTH; GRAPES; FUNGI	Ochratoxin A (OTA) is a potent nephrotoxin and carcinogen which is found in a wide variety of common foods and beverages and it is produced by several species of Aspergillus and Penicillium. Ochratoxin a (OT alpha), a major metabolite of OTA, has also been reported to occur in cultures of OTA-producing species. However there is some controversial about the participation of OT alpha in the biosynthesis of OTA, mainly because its biosynthesis pathway has not yet been completely characterized. Aspergillus carbonarius is the main responsible source of ochratoxin A (OTA) in food commodities such as wine, grapes or dried vine fruits from main viticultural regions worldwide. However, little is known about the presence of OT alpha in isolates of A. carbonarius. In this study we evaluated the effects of temperature and incubation time on OT alpha production by both OTA and non-OTA-producing strains of A. carbonarius. OTA and OT alpha were detected on the basis of HPLC fluorometric response compared with that of their standards and confirmed by HPLC-MS in selected samples. The non-OTA-producing strains did produce neither OTA nor OT alpha at any of the conditions tested. The OTA-producing strains studied were able to produce both OTA and OT alpha in most of the conditions tested. In general, higher amounts of OTA than OT alpha were produced, but a positive correlation in the production of these two metabolites was detected. The lack of production of both OTA and OT alpha in the non-OTA-producing strains could be caused by the presence of silent genes or by mutations in functional or regulatory genes involved in OTA production.	[Bragulat, M. Rosa; Cabanes, F. Javier] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Spain; [Eustaquio, Alba] Univ Autonoma Barcelona, Chem Anal Serv, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Cabanes, FJ (corresponding author), Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Spain.	javier.cabanes@uab.es	Cabanes, F. Javier/B-8255-2009; Bragulat, M. Rosa/L-1910-2014	Cabanes, F. Javier/0000-0002-2244-5778; Bragulat, M. Rosa/0000-0003-1853-1777	Ministerio de Economia y Competitividad of the Spanish Government [AGL2014-52516-R]	Ministerio de Economia y Competitividad of the Spanish Government(Spanish Government)	This research was supported by the Ministerio de Economia y Competitividad of the Spanish Government (AGL2014-52516-R). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2014, FOOD MICROBIOL, V44, P243, DOI 10.1016/j.fm.2014.06.014; Astoreca AL, 2010, TOXINS, V2, P2593, DOI 10.3390/toxins2112593; Bragulat MR, 2001, INT J FOOD MICROBIOL, V71, P139, DOI 10.1016/S0168-1605(01)00581-5; Cabanes FJ, 2013, FOOD MICROBIOL, V36, P135, DOI 10.1016/j.fm.2013.05.004; Copetti MV, 2014, INT J FOOD MICROBIOL, V178, P13, DOI 10.1016/j.ijfoodmicro.2014.02.023; Crespo-Sernpere A, 2010, INT J FOOD MICROBIOL, V142, P170, DOI 10.1016/j.ijfoodmicro.2010.06.019; Esteban A, 2004, RES MICROBIOL, V155, P861, DOI 10.1016/j.resmic.2004.07.002; Farber P, 2001, Mycotoxin Res, V17 Suppl 2, P150, DOI 10.1007/BF03036425; Ferrara M, 2016, APPL ENVIRON MICROB, V78, P8208; Frisvad JC, 2004, STUD MYCOL, V59, P31; Gallo A, 2012, APPL ENVIRON MICROB, V78, P8208, DOI 10.1128/AEM.02508-12; Garcia-Cela E, 2014, INT J FOOD MICROBIOL, V173, P89, DOI 10.1016/j.ijfoodmicro.2013.12.012; Harris JP, 2001, PHYTOCHEMISTRY, V58, P709, DOI 10.1016/S0031-9422(01)00316-8; Cabanes FJ, 2008, ASPERGILLUS IN THE GENOMIC ERA, P57; Cabanes FJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09086; Cabanes FJ, 2010, TOXINS, V2, P1111, DOI 10.3390/toxins2051111; Mitchell D, 2004, J APPL MICROBIOL, V97, P439, DOI 10.1111/j.1365-2672.2004.02321.x; Noonim P, 2008, INT J FOOD MICROBIOL, V128, P197, DOI 10.1016/j.ijfoodmicro.2008.08.005; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; VANDERME.KJ, 1965, NATURE, V205, P1112, DOI 10.1038/2051112a0; Varga J, 2010, TOXINS, V2, P1718, DOI 10.3390/toxins2071718; Vettorazzi A, 2014, FOOD CHEM TOXICOL, V72, P273, DOI 10.1016/j.fct.2014.07.020	22	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185986	10.1371/journal.pone.0185986	http://dx.doi.org/10.1371/journal.pone.0185986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016677	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400046
J	Rosenberg, M; Ranapurwala, SI; Townes, A; Bengtson, AM				Rosenberg, Molly; Ranapurwala, Shabbar I.; Townes, Ashley; Bengtson, Angela M.			Do black lives matter in public health research and training?	PLOS ONE			English	Article							LIFE EXPECTANCY GAP; STRUCTURAL RACISM; UNITED-STATES; GUN VIOLENCE; TRENDS; DEATH	Objective To examine whether investments made in public health research align with the health burdens experienced by white and black Americans. Methods In this cross-sectional study of all deaths in the United States in 2015, we compared the distribution of potential years of life lost (PYLL) across 39 causes of death by race and identified key differences. We examined the relationship between cause-of-death-specific PYLL and key indicators of public health investment (federal funding and number of publications) by race using linear spline models. We also compared the number of courses available at the top schools of public health relevant to the top causes of death contributor to PYLL for black and white Americans. Results Homicide was the number one contributor to PYLL among black Americans, while ischemic heart disease was the number one contributor to PYLL among white Americans. Firearm-related violence accounted for 88% of black PYLL attributed to homicide and 71% of white PYLL attributed to homicide. Despite the high burden of PYLL, homicide research was the focus of few federal grants or publications. In comparison, ischemic heart disease garnered 341 grants and 594 publications. The number of public health courses available relevant to homicide (n = 9) was similar to those relevant to ischemic heart disease (n = 10). Conclusions Black Americans are disproportionately affected by homicide, compared to white Americans. For both black and white Americans, the majority of PYLL due to homicide are firearm-related. Yet, homicide research is dramatically underrepresented in public health research investments in terms of grant funding and publications, despite available public health training opportunities. If left unchecked, the observed disproportionate distribution of investments in public health resources threatens to perpetuate a system that disadvantages black Americans.	[Rosenberg, Molly] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Ranapurwala, Shabbar I.; Bengtson, Angela M.] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Townes, Ashley] Indiana Univ, Sch Publ Hlth, Dept Appl Hlth Sci, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Indiana University System; Indiana University Bloomington	Rosenberg, M (corresponding author), Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.	rosenmol@indiana.edu		Bengtson, Angela/0000-0003-1305-8132; Rosenberg, Molly/0000-0001-6679-6791				American Public Health Association, 2017, WHAT IS PUBL HLTH 20; [Anonymous], 2017, US NEWS WORLD REPORT; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Brownson RC, 2009, ANNU REV PUBL HEALTH, V30, P175, DOI 10.1146/annurev.publhealth.031308.100134; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; Centers for Disease Control and Prevention (CDC), 1999, MMWR-MORBID MORTAL W, V48, P369; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, MORT MULT CAUS FIL 2; Crosby AE, 2013, MMWR-MORBID MORTAL W, V62, P179; Garcia JJL, 2015, AM J PUBLIC HEALTH, V105, pE27, DOI 10.2105/AJPH.2015.302706; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Grosse SD, 2009, MED CARE, V47, pS94, DOI 10.1097/MLR.0b013e31819c9571; Hardeman RR, 2016, NEW ENGL J MED, V375, P2113, DOI 10.1056/NEJMp1609535; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; Harper S, 2014, HEALTH AFFAIR, V33, P1375, DOI 10.1377/hlthaff.2013.1273; National Center for Helath Statistics, 2012, STATUS TURTLES QATAR; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Rubin R, 2016, JAMA-J AM MED ASSOC, V315, P1689, DOI 10.1001/jama.2016.1707; Stark DE, 2017, JAMA-J AM MED ASSOC, V317, P84, DOI 10.1001/jama.2016.16215; U.S. Census Bureau, 2015, QUICKF US 2015; United States Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2017, HLTH PEOPL 2020; US Department of Health and Human Services, 2017, NIH RES PORT ONL REP; US Department of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics, 2009, ICD10 US DEP HLTH HU	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185957	10.1371/journal.pone.0185957	http://dx.doi.org/10.1371/journal.pone.0185957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016639	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400043
J	Dinse, GE; Parks, CG; Weinberg, CR; Meier, HCS; Co, CA; Chan, EKL; Miller, FW				Dinse, Gregg E.; Parks, Christine G.; Weinberg, Clarice R.; Meier, Helen C. S.; Co, Carol A.; Chan, Edward K. L.; Miller, Frederick W.			Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004)	PLOS ONE			English	Article							GENERAL-POPULATION; AUTOANTIBODIES; CANCER; AUTOIMMUNITY; RISK; PREVALENCE; DISEASE; BREAST; SERUM	Objective Recent studies suggest antinuclear antibodies (ANA) may be related to mortality risk, but evidence is sparse and inconclusive. Thus, we investigated ANA associations with all-cause and cause-specific mortality in U.S. adults. Methods Our sample included 3357 adults (ages >= 20 years) from the 1999-2004 National Health and Nutrition Examination Survey with ANA measurements (1: 80 dilution) and mortality data through 2011 (median follow-up: 9.4 years). We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) via weighted Cox regression to assess ANA associations with mortality from all causes, cardiovascular disease (CVD), and cancer. Models adjusted for age, sex, race/ethnicity, education, and obesity. Analyses examined mortality in the full sample and in subgroups based on self-reported histories of CVD and cancer, both overall and stratified by sex and age at enrollment. Results Overall, ANA were not strongly associated with death from all causes (HR: 1.13; CI: 0.79, 1.60), from CVD (HR: 1.60; CI: 0.80, 3.20), or from cancer (HR: 1.58; CI: 0.75, 3.33), though all three HR estimates exceeded 1. In the subgroup with a history of cancer, ANA were associated with elevated all-cause mortality in men (HR: 2.28; CI: 1.01, 5.14) and in participants who enrolled at age >= 75 years (HR: 1.99; CI: 1.04, 3.80). Conclusion These findings suggest that ANA are not strongly associated with mortality in the general population. Longitudinal studies with repeated assessments are needed to understand the temporal relationship between ANA, aging-associated diseases, and mortality.	[Dinse, Gregg E.; Co, Carol A.] Social & Sci Syst, Durham, NC USA; [Parks, Christine G.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Weinberg, Clarice R.] NIEHS, Biostat & Computat Biol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Meier, Helen C. S.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA; [Chan, Edward K. L.] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA; [Miller, Frederick W.] NIEHS, Clin Res Branch, NIH, Bethesda, MD 20892 USA	Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin System; University of Wisconsin Milwaukee; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Miller, FW (corresponding author), NIEHS, Clin Res Branch, NIH, Bethesda, MD 20892 USA.	millerf@mail.nih.gov	Chan, Edward K. L./B-5671-2009; Miller, Frederick/D-2431-2019	Chan, Edward K. L./0000-0003-3938-9503; Miller, Frederick/0000-0003-2831-9593; Weinberg, Clarice/0000-0002-7713-8556; Meier, Helen/0000-0003-4400-0216	NIH, National Institute of Environmental Health Sciences [ES101074, GS-23F-9806H]; Social & Scientific Systems; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101074] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Social & Scientific Systems; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (project ES101074) and contract GS-23F-9806H to Social & Scientific Systems. Two authors (GED, CAC) were employed by Social & Scientific Systems; this company provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Cardonick E, 2014, INT J WOMENS HEALTH, V6, P935, DOI 10.2147/IJWH.S52381; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Chan EKL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00412; COX DR, 1972, J R STAT SOC B, V34, P187; Cox DR., 1970, ANAL BINARY DATA; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300; Franks AL, 2012, ANTICANCER RES, V32, P1119; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Harrell FE, 2001, REGRESSION MODELING; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Heegaard NHH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030997; Hollingsworth Peter N., 1996, P74, DOI 10.1016/B978-044482383-0/50013-3; Hurme M, 2007, MECH AGEING DEV, V128, P407, DOI 10.1016/j.mad.2007.03.001; Ishikawa M, 2008, CLIN EXP NEPHROL, V12, P200, DOI 10.1007/s10157-008-0030-0; Lewandowski LB, 2016, CURR OPIN RHEUMATOL, V28, P460, DOI 10.1097/BOR.0000000000000307; Li QZ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3271; Liang KP, 2009, J RHEUMATOL, V36, P2462, DOI 10.3899/jrheum.090188; Litwin Christine M, 2016, J Immunoassay Immunochem, V37, P439, DOI 10.1080/15321819.2016.1174136; Liu L, 2016, INT J PUBLIC HEALTH, V61, P751, DOI 10.1007/s00038-016-0858-0; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Majka DS, 2014, RHEUM DIS CLIN N AM, V40, P659, DOI 10.1016/j.rdc.2014.07.006; Meier HC, 2016, CANC EPIDEMIOL BIOMA; Miller FW, 2011, ADV EXP MED BIOL, V711, P61; Nakano H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081678; O'Sullivan M, 2016, BEST PRACT RES CL RH, V30, P81, DOI 10.1016/j.berh.2016.03.003; Parks CG, 2014, CANCER EPIDEM BIOMAR, V23, P2492, DOI 10.1158/1055-9965.EPI-14-0429; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Rubin RL, 2015, EXPERT OPIN DRUG SAF, V14, P361, DOI 10.1517/14740338.2015.995089; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Selmi C, 2016, AUTOIMMUN REV, V15, P162, DOI 10.1016/j.autrev.2015.10.007; Shah AA, 2015, ARTHRITIS RHEUMATOL, V67, P317, DOI 10.1002/art.38928; Singh RP, 2012, AUTOIMMUN REV, V11, P664, DOI 10.1016/j.autrev.2011.11.017; Solow EB, 2015, J AM COLL CARDIOL, V65, P2669, DOI 10.1016/j.jacc.2015.03.578; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tan EM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3557; Teague H, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0557-y; Wang Y, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-16; WASSERMAN J, 1975, CLIN EXP IMMUNOL, V19, P417; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096; XAVIER RM, 1995, MECH AGEING DEV, V78, P145, DOI 10.1016/0047-6374(94)01532-Q; YADIN O, 1989, CLIN EXP IMMUNOL, V75, P402; Yang Y, 2012, EXP GERONTOL, V47, P695, DOI 10.1016/j.exger.2012.06.009	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185977	10.1371/journal.pone.0185977	http://dx.doi.org/10.1371/journal.pone.0185977			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016697	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800034
J	Hebestreit, JM; May, A				Hebestreit, Julia M.; May, Arne			Topiramate modulates trigeminal pain processing in thalamo-cortical networks in humans after single dose administration	PLOS ONE			English	Article							MIGRAINE PATIENTS; CONTROLLED-TRIAL; DOUBLE-BLIND; EFFICACY; PLACEBO; FMRI; CONNECTIVITY; LAMOTRIGINE; DISABILITY; MECHANISM	Migraine is the sixth most common cause of disability in the world. Preventive migraine treatment is used to reduce frequency, severity and duration of attacks and therefore lightens the burden on the patients' quality of life and reduces disability. Topiramate is one of the preventive migraine treatments of proven efficacy. The mechanism of action underlying the preventive effect of topiramate in migraine remains largely unknown. Using functional magnetic resonance imaging ( fMRI) we examined the central effects of a single dose of topiramate (100mg) on trigeminal pain in humans, compared to placebo (mannitol). In this prospective, within subject, randomized, placebo-controlled and double-blind study, 23 healthy participants received a standardized nociceptive trigeminal stimulation and control stimuli whilst being in the scanner. No differences in the subjective intensity ratings of the painful stimuli were observed between topiramate and placebo sessions. In contrast, topiramate significantly decreased the activity in the thalamus and other pain processing areas. Additionally, topiramate increased functional coupling between the thalamus and several brain regions such as the bilateral precuneus, posterior cingulate cortex and secondary somatosensory cortex. These data suggest that topiramate exhibits modulating effects on nociceptive processing in thalamo-cortical networks during trigeminal pain and that the preventive effect of topiramate on frequent migraine is probably mediated by an effect on thalamo-cortical networks.	[Hebestreit, Julia M.; May, Arne] Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	May, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Dept Syst Neurosci, Hamburg, Germany.	a.may@uke.de		May, Arne/0000-0002-3499-1506	German Research Foundation [1862/12-1, SFB936/A5]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation, 1862/12-1 and SFB936/A5 to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou AP, 2011, CEPHALALGIA, V31, P1343, DOI 10.1177/0333102411418259; Andreou AP, 2010, NEUROBIOL DIS, V37, P314, DOI 10.1016/j.nbd.2009.10.007; Blum D, 2006, NEUROLOGY, V67, P400, DOI 10.1212/01.wnl.0000232737.72555.06; Brandes JL, 2004, JAMA-J AM MED ASSOC, V291, P965, DOI 10.1001/jama.291.8.965; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Contin M, 2001, J CHROMATOGR B, V761, P133, DOI 10.1016/S0378-4347(01)00302-4; Coppola G, 2005, BRAIN, V128, P98, DOI 10.1093/brain/awh334; Coppola G, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-76; D'Amico D, 2003, NEUROL SCI, V24, pS97; Edwards KR, 2003, CNS SPECTRUMS, V8, P428, DOI 10.1017/S1092852900018733; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Hoffmann J, 2014, EXPERT REV CLIN PHAR, V7, P191, DOI 10.1586/17512433.2014.885835; Kececi H, 2009, J CLIN NEUROSCI, V16, P1588, DOI 10.1016/j.jocn.2009.03.025; Koban L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049784; Kroger IL, 2015, NEUROLOGY, V84, P2124, DOI 10.1212/WNL.0000000000001610; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Meador KJ, 2005, NEUROLOGY, V64, P2108, DOI 10.1212/01.WNL.0000165994.46777.BE; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Schneiderman JH, 1998, CAN J NEUROL SCI, V25, pS3, DOI 10.1017/S031716710003482X; Schulte LH, 2016, BRAIN, V139, P1987, DOI 10.1093/brain/aww097; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; Silberstein SD, 2007, HEADACHE, V47, P170, DOI 10.1111/j.1526-4610.2006.00684.x; Stankewitz A, 2010, CEPHALALGIA, V30, P475, DOI 10.1111/j.1468-2982.2009.01968.x; Steiner TJ, 2013, CEPHALALGIA, V33, P289, DOI 10.1177/0333102412473843; Storer RJ, 2013, CEPHALALGIA, V33, P291, DOI 10.1177/0333102412472069; Sun J, 2015, ALIMENT PHARM THER, V42, P845, DOI 10.1111/apt.13334; Szaflarski JP, 2012, EPILEPSY BEHAV, V24, P74, DOI 10.1016/j.yebeh.2012.02.022; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wandschneider B, 2017, NEUROLOGY, V88, P1165, DOI 10.1212/WNL.0000000000003736; Yasuda CL, 2013, EPILEPSY RES, V105, P250, DOI 10.1016/j.eplepsyres.2012.12.007; Yuan K, 2013, J PAIN, V14, P836, DOI 10.1016/j.jpain.2013.02.010	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184406	10.1371/journal.pone.0184406	http://dx.doi.org/10.1371/journal.pone.0184406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991914	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800006
J	Malmstrom, CM; Butterfield, HS; Planck, L; Long, CW; Eviner, VT				Malmstrom, Carolyn M.; Butterfield, H. Scott; Planck, Laura; Long, Christopher W.; Eviner, Valerie T.			Novel fine-scale aerial mapping approach quantifies grassland weed cover dynamics and response to management	PLOS ONE			English	Article							TAENIATHERUM-CAPUT-MEDUSAE; INVASIVE PLANTS; RANGELAND; DISPERSAL; DIVERSITY; PATTERNS; CHEATGRASS; AGREEMENT; PHENOLOGY; COMMUNITY	Invasive weeds threaten the biodiversity and forage productivity of grasslands worldwide. However, management of these weeds is constrained by the practical difficulty of detecting small-scale infestations across large landscapes and by limits in understanding of landscape- scale invasion dynamics, including mechanisms that enable patches to expand, contract, or remain stable. While high-end hyperspectral remote sensing systems can effectively map vegetation cover, these systems are currently too costly and limited in availability for most land managers. We demonstrate application of a more accessible and cost-effective remote sensing approach, based on simple aerial imagery, for quantifying weed cover dynamics over time. In California annual grasslands, the target communities of interest include invasive weedy grasses (Aegilops triuncialis and Elymus caput-medusae) and desirable forage grass species (primarily Avena spp. and Bromus spp.). Detecting invasion of annual grasses into an annual-dominated community is particularly challenging, but we were able to consistently characterize these two communities based on their phenological differences in peak growth and senescence using maximum likelihood supervised classification of imagery acquired twice per year (in mid-and end-of season). This approach permitted us to map weed-dominated cover at a 1-m scale (correctly detecting 93% of weed patches across the landscape) and to evaluate weed cover change over time. We found that weed cover was more pervasive and persistent in management units that had no significant grazing for several years than in those that were grazed, whereas forage cover was more abundant and stable in the grazed units. This application demonstrates the power of this method for assessing fine-scale vegetation transitions across heterogeneous landscapes. It thus provides means for small-scale early detection of invasive species and for testing fundamental questions about landscape dynamics.	[Malmstrom, Carolyn M.; Planck, Laura; Long, Christopher W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Malmstrom, Carolyn M.] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Malmstrom, Carolyn M.] Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Butterfield, H. Scott] Nature Conservancy, San Francisco, CA USA; [Eviner, Valerie T.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Planck, Laura] Quantum Spatial Inc, Portland, OR USA	Michigan State University; Michigan State University; Michigan State University; Nature Conservancy; University of California System; University of California Davis	Malmstrom, CM (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Malmstrom, CM (corresponding author), Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA.; Malmstrom, CM (corresponding author), Michigan State Univ, Grad Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	carolynm@msu.edu		Eviner, Valerie/0000-0001-5530-9417	United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant [2006-55320-17247]; Michigan State University AgBioResearch; United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project [CA-D-PLS-7641-H]; CalFed Bay-Delta Authority Grant [2001-H2110-1-N31]	United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant; Michigan State University AgBioResearch; United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project; CalFed Bay-Delta Authority Grant	This project was supported by the United States Department of Agriculture National Institute of Food and Agriculture National Research Initiative Controlling Weedy and Invasive Plants Program Grant #2006-55320-17247, https://www.nifa.usda.gov/(CMM, VTE); Michigan State University AgBioResearch, http://agbioresearch.msu.edu/ (CMM); and by the United States Department of Food and Agriculture National Institute of Food and Agriculture, Agricultural Experiment Station Project CA-D-PLS-7641-H, https://www.nifa.usda.gov (VTE). It built on work previously funded by the CalFed Bay-Delta Authority Grant 2001-H2110-1-N31, http://calwater.ca.gov/calfed/oversight/CBDA/(CMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Arianoutsou M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079174; BARTOLOME JW, 1980, J RANGE MANAGE, V33, P4, DOI 10.2307/3898219; Belnap J, 2012, RANGELAND ECOL MANAG, V65, P569, DOI 10.2111/REM-D-11-00157.1; Bestelmeyer BT, 2011, J APPL ECOL, V48, P746, DOI 10.1111/j.1365-2664.2011.01982.x; BOVEY R W, 1987, Reviews of Weed Science, V3, P57; BOVEY RODNEY W., 1961, WEEDS, V9, P307, DOI 10.2307/4040420; Bradley BA, 2005, REMOTE SENS ENVIRON, V94, P204, DOI 10.1016/j.rse.2004.08.016; Bradley BA, 2014, BIOL INVASIONS, V16, P1411, DOI 10.1007/s10530-013-0578-9; Butterfield HS, 2009, INT J REMOTE SENS, V30, P3133, DOI 10.1080/01431160802558774; Butterfield HS, 2006, RANGELAND ECOL MANAG, V59, P541, DOI 10.2111/05-184R1.1; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chuong J, 2016, RANGELAND ECOL MANAG, V69, P52, DOI 10.1016/j.rama.2015.10.009; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Collins SL, 2015, AM NAT, V185, pE30, DOI 10.1086/679315; Congalton R. G., 2009, MATER CHARACT, DOI DOI 10.1016/J.MATCHAR.2009.07.002; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Daubenmire R., 1968, Advances in Ecological Research, V5, P209, DOI 10.1016/S0065-2504(08)60226-3; Davies K.W., 2008, RANGELANDS, V30, P13; Davies KW, 2007, WEED SCI, V55, P178, DOI 10.1614/WS-06-161; Davies KW, 2011, OECOLOGIA, V167, P481, DOI 10.1007/s00442-011-1992-2; Davy JS, 2015, CALIF AGR, V69, P230, DOI 10.3733/ca.v069n04p230; Decarolis F, 2014, CENT ISS CONT ECON T, P1, DOI 10.1007/s11119-013-9304-y; Denison R.F., 1996, CALIF AGR, V50, P9; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; DITOMASO JM, 2010, RANGELANDS, V32, P43, DOI DOI 10.2111/RANGELANDS-D-09-00007.1; DiTomaso JM, 2008, INVAS PLANT SCI MANA, V1, P241, DOI 10.1614/IPSM-07-031.1; Drenovsky RE, 2007, BIOL INVASIONS, V9, P107, DOI 10.1007/s10530-006-0007-4; Duncan C., 2005, INVASIVE PLANTS RANG; Duncan CA, 2004, WEED TECHNOL, V18, P1411, DOI 10.1614/0890-037X(2004)018[1411:ATEEAS]2.0.CO;2; Eviner VT, 2016, ECOSYSTEMS OF CALIFORNIA, P449; EVINER VT, 2010, RANGELANDS, V32, P21, DOI DOI 10.2111/RANGELANDS-D-09-00005.1; GAMON JA, 1993, REMOTE SENS ENVIRON, V44, P239, DOI 10.1016/0034-4257(93)90019-T; GEORGE MR, 1992, J RANGE MANAGE, V45, P436, DOI 10.2307/4002898; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Herold M, 2002, ENVIRON PLANN A, V34, P1443, DOI 10.1068/a3496; Homburger H, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0053-6; Huang C, 2009, INT J REMOTE SENS, V30, P897, DOI 10.1080/01431160802395243; Huang CY, 2009, SENSORS-BASEL, V9, P4869, DOI 10.3390/s90604869; James JJ, 2015, RANGELAND ECOL MANAG, V68, P215, DOI 10.1016/j.rama.2015.03.006; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Julia R, 2007, J ENVIRON MANAGE, V85, P876, DOI 10.1016/j.jenvman.2006.10.024; Laliberte AS, 2011, REMOTE SENS-BASEL, V3, P2529, DOI 10.3390/rs3112529; Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Macon D. K., 2016, Rangelands, V38, P222; Malmstrom CM, 2009, RESTOR ECOL, V17, P526, DOI 10.1111/j.1526-100X.2008.00411.x; Malmstrom CM, 2004, 01N31 CALFED EC REST; Mariotte P, 2017, APPL VEG SCI, V20, P28, DOI 10.1111/avsc.12291; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Nafus AM, 2017, INVAS PLANT SCI MANA, V7, P210; Ndzeidze SK, 2011, DETECTING MEDUSAHEAD; Nelson P.R., 2005, ANAL MEANS GRAPHICAL; O'Neill RV, 1988, LANDSCAPE ECOL, V1, P153, DOI 10.1007/BF00162741; Parece T, 2014, REMOTE SENSING ANAL; Perovic D, 2015, J APPL ECOL, V52, P505, DOI 10.1111/1365-2664.12394; Peters A., 1996, Rangelands, V18, P8; Peterson EB, 2005, INT J REMOTE SENS, V26, P2491, DOI 10.1080/01431160500127815; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Plieninger T, 2012, ENVIRON MANAGE, V50, P427, DOI 10.1007/s00267-012-9900-z; Porensky LM, 2016, J APPL ECOL, V53, P1013, DOI 10.1111/1365-2664.12630; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Sandel B, 2012, J VEG SCI, V23, P906, DOI 10.1111/j.1654-1103.2012.01406.x; Santos MJ, 2016, ECOL APPL, V26, P1733, DOI 10.1890/15-0615; Sawalhah MN, 2014, RANGELAND ECOL MANAG, V67, P710, DOI 10.2111/REM-D-14-00047.1; Seabloom EW, 2005, ECOL MONOGR, V75, P199, DOI 10.1890/03-0841; Sheley R, 2010, RANGELAND ECOL MANAG, V63, P605, DOI 10.2111/REM-D-09-00187.1; Sheley R., 2011, CONSERVATION BENEFIT, P291; Singh N, 2009, INT J REMOTE SENS, V30, P3441, DOI 10.1080/01431160802562222; Stromberg MR., 2007, CALIFORNIA GRASSLAND, P254; Tamouridou AA, 2017, INT J REMOTE SENS, V38, P2246, DOI 10.1080/01431161.2016.1252475; Teillet PM, 1997, REMOTE SENS ENVIRON, V61, P139, DOI 10.1016/S0034-4257(96)00248-9; Thomason MJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169328; TORELL PAUL J., 1961, WEEDS, V9, P124, DOI 10.2307/4040395; Trimble Navigation Limited, 2009, TRIMBL MAPP GIS PROD; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172	81	4	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0181665	10.1371/journal.pone.0181665	http://dx.doi.org/10.1371/journal.pone.0181665			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016604	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800003
J	Brieno-Enriquez, MA; Moak, SL; Holloway, JK; Cohen, PE				Brieno-Enriquez, Miguel A.; Moak, Stefannie L.; Holloway, J. Kim; Cohen, Paula E.			NIMA-related kinase 1 (NEK1) regulates meiosis I spindle assembly by altering the balance between alpha-Adducin and Myosin X	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CALMODULIN-BINDING DOMAIN; SEXUAL-DIMORPHISM; CHROMOSOME SEGREGATION; MICROTUBULE-BINDING; MAMMALIAN MEIOSIS; PROTEIN-KINASE; GERM-CELLS; CENTROSOME; PHOSPHORYLATION	NIMA-related kinase 1 (NEK1) is a serine/threonine and tyrosine kinase that is highly expressed in mammalian germ cells. Mutations in Nek1 induce anemia, polycystic kidney and infertility. In this study we evaluated the role of NEK1 in meiotic spindle formation in both male and female gametes. Our results show that the lack of NEK1 provokes an abnormal organization of the meiosis I spindle characterized by elongated and/or multipolar spindles, and abnormal chromosome congression. The aberrant spindle structure is concomitant with the disruption in localization and protein levels of myosin X (MYO10) and alpha-adducin (ADD1), both of which are implicated in the regulation of spindle formation during mitosis. Interaction of ADD1 with MYO10 is dependent on phosphorylation, whereby phosphorylation of ADD1 enables its binding to MYO10 on mitotic spindles. Reduction in ADD1 protein in NEK1 mutant mice is associated with hyperphosphorylation of ADD1, thereby preventing the interaction with MYO10 during meiotic spindle formation. Our results reveal a novel regulatory role for NEK1 in the regulation of spindle architecture and function during meiosis.	[Brieno-Enriquez, Miguel A.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; Cornell Univ, Ctr Reprod Genom, Ithaca, NY USA	Cornell University; Cornell University	Brieno-Enriquez, MA (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	mab587@cornell.edu		Brieno-Enriquez, Miguel Angel/0000-0002-8806-0918; Holloway, Courtney Jean/0000-0003-3661-1957	Empire State Stem Cell Fund through New York State Department of Health [C30293GG]; National Institute of Child Health and Human Development (NICHD) [5R00HD065870]; National Institute of General Medical Sciences (NIGMS); March of Dimes [1R01GM097263, MOD2006-844]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD090289, K99HD090289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097263] Funding Source: NIH RePORTER	Empire State Stem Cell Fund through New York State Department of Health; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.A.B-E is supported by a Postdoctoral fellowship by the Empire State Stem Cell Fund through New York State Department of Health Contract # C30293GG. This project is funded by grants from the National Institute of Child Health and Human Development (NICHD) to J.K.H (5R00HD065870), and from National Institute of General Medical Sciences (NIGMS) and March of Dimes to P.E.C. (1R01GM097263, MOD2006-844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi KM, 2008, MOL BIOL CELL, V19, P536, DOI 10.1091/mbc.E07-08-0818; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Brieno-Enriquez MA, 2016, CELL REP, V17, P977, DOI 10.1016/j.celrep.2016.09.059; Chan PC, 2014, J CELL BIOL, V204, P19, DOI 10.1083/jcb.201306083; Chen YM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-5; Duro E, 2015, GENE DEV, V29, P109, DOI 10.1101/gad.255554.114; Franco T, 2016, BIOCH J; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gorbsky GJ, 2015, FEBS J, V282, P2458, DOI 10.1111/febs.13166; Gray S, 2016, ANNU REV GENET, V50, P175, DOI 10.1146/annurev-genet-120215-035111; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hayashi T, 2000, BIOL REPROD, V62, P1722, DOI 10.1095/biolreprod62.6.1722; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hilton LK, 2009, BIOCHEM BIOPH RES CO, V389, P52, DOI 10.1016/j.bbrc.2009.08.086; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Holloway K, 2011, GENES-BASEL, V2, P260, DOI 10.3390/genes2010260; Janaswami PM, 1997, GENOMICS, V40, P101, DOI 10.1006/geno.1996.4567; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Kwon MJ, 2015, DEV CELL, V34, P323, DOI 10.1016/j.devcel.2015.06.013; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; MCKIM KS, 1995, SCIENCE, V270, P1595, DOI 10.1126/science.270.5242.1595; Meirelles Gabriela Vaz, 2014, World J Biol Chem, V5, P141, DOI 10.4331/wjbc.v5.i2.141; Morelli MA, 2005, REPRODUCTION, V130, P761, DOI 10.1530/rep.1.00865; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; Ohkura H., 2015, COLD SPRING HARB PER, V7, P7; Page J, 1998, CHROMOSOME RES, V6, P639, DOI 10.1023/A:1009209628300; Patil M, 2013, CELL CYCLE, V12, P2608, DOI 10.4161/cc.25624; Sandquist JC, 2016, CYTOSKELETON, V73, P351, DOI 10.1002/cm.21311; SCARAMUZZINO DA, 1993, P NATL ACAD SCI USA, V90, P3398, DOI 10.1073/pnas.90.8.3398; Sdelci S, 2012, CURR BIOL, V22, P1516, DOI 10.1016/j.cub.2012.06.027; Sun Xianfei, 2013, Methods Mol Biol, V957, P1, DOI 10.1007/978-1-62703-191-2_1; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062	41	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185780	10.1371/journal.pone.0185780	http://dx.doi.org/10.1371/journal.pone.0185780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982183	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300068
J	Cros, MJ; Aubertot, JN; Peyrard, N; Sabbadin, R				Cros, Marie-Josee; Aubertot, Jean-Noel; Peyrard, Nathalie; Sabbadin, Regis			GMDPtoolbox: A Matlab library for designing spatial management policies. Application to the long-term collective management of an airborne disease	PLOS ONE			English	Article							PHOMA STEM CANKER; OILSEED RAPE; RESISTANCE MANAGEMENT; BIODIVERSITY	Designing management policies in ecology and agroecology is complex. Several components must be managed together while they strongly interact spatially. Decision choices must be made under uncertainty on the results of the actions and on the system dynamics. Furthermore, the objectives pursued when managing ecological systems or agroecosystems are usually long term objectives, such as biodiversity conservation or sustainable crop production. The framework of Graph-Based Markov Decision Processes (GMDP) is well adapted to the qualitative modeling of such problems of sequential decision under uncertainty. Spatial interactions are easily modeled and integrated control policies (combining several action levers) can be designed through optimization. The provided policies are adaptive, meaning that management actions are decided at each time step (for instance yearly) and the chosen actions depend on the current system state. This framework has already been successfully applied to forest management and invasive species management. However, up to now, no "easy-to-use" implementation of this framework was available. We present GMDPtoolbox, a Matlab toolbox which can be used both for the design of new management policies and for comparing policies by simulation. We provide an illustration of the use of the toolbox on a realistic crop disease management problem: the design of long term management policy of blackleg of canola using an optimal combination of three possible cultural levers. This example shows how GMDPtoolbox can be used as a tool to support expert thinking.	[Cros, Marie-Josee; Peyrard, Nathalie; Sabbadin, Regis] INRA, MIAT UR 875, Toulouse, France; [Aubertot, Jean-Noel] INRA INPT, AGIR UMR 1248, Toulouse, France	INRAE; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Cros, MJ (corresponding author), INRA, MIAT UR 875, Toulouse, France.	Marie-Josee.Cros@inra.fr			European Union [265865- PURE]; ANR project AGROBIOSE [ANR-13-AGRO-0001]	European Union(European Commission); ANR project AGROBIOSE(French National Research Agency (ANR))	This work has been partly supported by the European Union Seventh Framework Program (FP7/2007-2013) under the grant agreement n265865- PURE (https://ec.europa.eu/research/fp7). This study was also funded by the ANR project AGROBIOSE (ANR-13-AGRO-0001) (http://www.agence-nationale-recherche.fr/?Projet=ANR-13-AGRO-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, NEURO DYNAMIC PROGRA; Attoumani-Ronceux A, 2012, NOTICE CALCULATEUR S; Aubertot JN, 2006, EUR J PLANT PATHOL, V114, P91, DOI 10.1007/s10658-005-3628-z; Aubertot JN, 2004, CROP PROT, V23, P635, DOI 10.1016/j.cropro.2003.11.015; Chapron G, 2014, ECOGRAPHY, V37, P916; Cheng Q., 2013, P INT C NEUR INF PRO, P2976; Choisy M, 2007, P EUR C COMPL SYST E; Coble HD, 2016, WEED SCI, V64, P661, DOI 10.1614/WS-D-15-00032.1; Cordwell S., MARKOV DECISION PROC; De Farias DP, 2003, OPER RES, V51, P850, DOI 10.1287/opre.51.6.850.24925; Duru M, 2015, AGRON SUSTAIN DEV, V35, P1259, DOI 10.1007/s13593-015-0306-1; Fackler P., MDPSOLVE SOFTWARE DY; Forsell N, 2011, ANN OPER RES, V190, P57, DOI 10.1007/s10479-009-0522-7; Guestrin C, 2002, ADV NEUR IN, V14, P1523; Hoey J, 1999, P INT C UNC ART INT; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Kee-Eung Kim, 2002, PRICAI 2002: Trends in Artificial Intelligence. 7th Pacific Rim International Conference on Artificial Intelligence. Proceedings (Lecture Notes in Artificial Intelligence Vol.2417), P80; Lescourret F, 2015, CURR OPIN ENV SUST, V14, P68, DOI 10.1016/j.cosust.2015.04.001; Lo-Pelzer E, 2010, FIELD CROP RES, V118, P73, DOI 10.1016/j.fcr.2010.04.007; Marcroft SJ, 2004, AUST J EXP AGR, V44, P601, DOI 10.1071/EA03087; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Murphy K., MARKOV DECISION PROC; Murphy KP., 2002, DYNAMIC BAYESIAN NET; Nicol S, 2015, P 27 INT C CONS BIOL; Peyrard N, 2007, P AM PHYT SOC SOC NE; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Puech T, 2015, ACTUALISATION BASE D; Puterman ML., 2014, MARKOV DECISION PROC; Radoszycki J, 2015, P INT C PRINC PRACT; Sabbadin R, 2012, INT J APPROX REASON, V53, P66, DOI 10.1016/j.ijar.2011.09.007; Schneider O, 2006, SOIL TILL RES, V85, P115, DOI 10.1016/j.still.2004.12.007; Sigaud O., 2010, MARKOV DECISION PROC; Souchere V, 2010, ENVIRON MODELL SOFTW, V25, P1359, DOI 10.1016/j.envsoft.2009.03.002; Sridhar V, 2014, CURR SCI INDIA, V107, P1640; St-Aubin R, 2000, P C NEUR INF PROC SY, P1089; Thind, 2012, PLANT PATHOL, V61, P820, DOI [10.1111/j.1365, DOI 10.1111/J.1365-3059.2012.02623.X]; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	38	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186014	10.1371/journal.pone.0186014	http://dx.doi.org/10.1371/journal.pone.0186014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982151	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300107
J	Shrestha, CL; Assani, KD; Rinehardt, H; Albastroiu, F; Zhang, SZ; Shell, R; Amer, AO; Schlesinger, LS; Kopp, BT				Shrestha, Chandra L.; Assani, Kaivon D.; Rinehardt, Hannah; Albastroiu, Florentina; Zhang, Shuzhong; Shell, Richard; Amer, Amal O.; Schlesinger, Larry S.; Kopp, Benjamin T.			Cysteamine-mediated clearance of antibiotic-resistant pathogens in human cystic fibrosis macrophages	PLOS ONE			English	Article							BURKHOLDERIA-CENOCEPACIA; LUNG INFLAMMATION; AUTOPHAGY; CFTR; MACHINERY; INFECTION; MUTATION; IMMUNITY; STRAINS; RESCUE	Members of the Burkholderia cepacia complex are virulent, multi-drug resistant pathogens that survive and replicate intracellularly in patients with cystic fibrosis (CF). We have discovered that B. cenocepacia cannot be cleared from CF macrophages due to defective autophagy, causing continued systemic inflammation and infection. Defective autophagy in CF is mediated through constitutive reactive oxygen species (ROS) activation of transglutaminase-2 (TG2), which causes the sequestration (accumulation) of essential autophagy initiating proteins. Cysteamine is a TG2 inhibitor and proteostasis regulator with the potential to restore autophagy. Therefore, we sought to examine the impact of cysteamine on CF macrophage autophagy and bacterial killing. Human peripheral blood monocyte-derived macrophages (MDMs) and alveolar macrophages were isolated from CF and non-CF donors. Macrophages were infected with clinical isolates of relevant CF pathogens. Cysteamine caused direct bacterial growth killing of live B. cenocepacia, B. multivorans, P. aeruginosa and MRSA in the absence of cells. Additionally, B. cenocepacia, B. multivorans, and P. aeruginosa invasion were significantly decreased in CF MDMs treated with cysteamine. Finally, cysteamine decreased TG2, p62, and beclin-1 accumulation in CF, leading to increased Burkholderia uptake into autophagosomes, increased macrophage CFTR expression, and decreased ROS and IL-1 beta production. Cysteamine has direct anti-bacterial growth killing and improves human CF macrophage autophagy resulting in increased macrophage-mediated bacterial clearance, decreased inflammation, and reduced constitutive ROS production. Thus, cysteamine may be an effective adjunct to antibiotic regimens in CF.	[Shrestha, Chandra L.; Assani, Kaivon D.; Rinehardt, Hannah; Albastroiu, Florentina; Zhang, Shuzhong; Kopp, Benjamin T.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Shell, Richard; Kopp, Benjamin T.] Nationwide Childrens Hosp, Sect Pediat Pulmonol, Columbus, OH 43205 USA; [Amer, Amal O.; Schlesinger, Larry S.; Kopp, Benjamin T.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Amer, Amal O.] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Schlesinger, Larry S.] Texas Biomed Res Inst, San Antonio, TX USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Texas Biomedical Research Institute	Kopp, BT (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.; Kopp, BT (corresponding author), Nationwide Childrens Hosp, Sect Pediat Pulmonol, Columbus, OH 43205 USA.; Kopp, BT (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	Benjamin.Kopp@NationwideChildrens.org		kopp, Benjamin/0000-0002-2021-7990; Rinehardt, Hannah/0000-0003-2571-0239	NIH NIAID [1K08AI108792-01A1]; CTSA [UL1TR001070]; NIH [P30 DK089507]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124121, K08AI108792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by NIH NIAID 1K08AI108792-01A1 (BTK) and CTSA UL1TR001070 (The Ohio State University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thank you to Richard Montione from the Campus Microscopy and Imaging Facility at OSU for assistance with EM images. The authors thank Dr. Mark Wewers for kindly donating the IL-1 beta antibody, Dr. Miguel Valvano for kindly donating the B. cenocepacia strains, and Dr. Michael Bailey for kindly donating the enteric bacterial strains. The authors thank Dr. Jane Burns at the CF Isolate Core at Seattle Children's Research Institute for provision of the B. multivorans strain (Seattle CF Isolate Core supported by NIH P30 DK089507). Thank you to Amy Mackos for assistance in handling of enteric bacterial strains.	Abdulrahman BA, 2013, J BIOL CHEM, V288, P2049, DOI 10.1074/jbc.M112.411728; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Al-Khodor S, 2014, CELL MICROBIOL, V16, P378, DOI 10.1111/cmi.12223; Assani K, 2017, J IMMUNOL; Assani K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096681; Mestre MB, 2012, AUTOPHAGY, V8, P1865, DOI 10.4161/auto.22161; Bruscia EM, 2016, J INNATE IMMUN, V8, P550, DOI 10.1159/000446825; Charrier C, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0189-2; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Devereux G, 2016, CLIN DRUG INVEST, V36, P605, DOI 10.1007/s40261-016-0405-z; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Elmonem MA, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0426-y; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ferrari E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.476; Fraser-Pitt D, 2016, ANTIMICROB AGENTS CH; Gustave JE, 2013, J CYST FIBROS, V12, P384, DOI 10.1016/j.jcf.2012.10.011; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Junkins RD, 2014, AUTOPHAGY, V10, P538, DOI 10.4161/auto.27750; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Kopp BT, 2012, BIOCHEM BIOPH RES CO, V424, P221, DOI 10.1016/j.bbrc.2012.06.066; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Langman CB, 2012, CLIN J AM SOC NEPHRO, V7, P1112, DOI 10.2215/CJN.12321211; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mihai MM, 2015, CURR TOP MED CHEM, V15, P1552; O'Keeffe KM, 2015, INFECT IMMUN, V83, P3445, DOI 10.1128/IAI.00358-15; Park JM, 2013, NUTR RES, V33, P677, DOI 10.1016/j.nutres.2013.05.019; Ralhan A, 2016, J INNATE IMMUN, V8, P531, DOI 10.1159/000446840; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Tazi MF, 2016, AUTOPHAGY, V12, P2026, DOI 10.1080/15548627.2016.1217370; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Vij N, 2017, EXPERT OPIN DRUG DEL, V14, P483, DOI 10.1080/17425247.2016.1223040	36	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186169	10.1371/journal.pone.0186169	http://dx.doi.org/10.1371/journal.pone.0186169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982193	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300131
J	Healy, ME; Hill, D; Berwick, M; Edgar, H; Gross, J; Hunley, K				Healy, Meghan E.; Hill, Deirdre; Berwick, Marianne; Edgar, Heather; Gross, Jessica; Hunley, Keith			Social-group identity and population substructure in admixed populations in New Mexico and Latin America	PLOS ONE			English	Article							HISPANICS; ADMIXTURE; GENETICS; VALLEY	We examined the relationship between continental-level genetic ancestry and racial and ethnic identity in an admixed population in New Mexico with the goal of increasing our understanding of how racial and ethnic identity influence genetic substructure in admixed populations. Our sample consists of 98 New Mexicans who self-identified as Hispanic or Latino (NM-HL) and who further categorized themselves by race and ethnic subgroup membership. The genetic data consist of 270 newly-published autosomal microsatellites from the NM-HL sample and previously published data from 57 globally distributed populations, including 13 admixed samples from Central and South America. For these data, we 1) summarized the major axes of genetic variation using principal component analyses, 2) performed tests of Hardy Weinberg equilibrium, 3) compared empirical genetic ancestry distributions to those predicted under a model of admixture that lacked substructure, 4) tested the hypotheses that individuals in each sample had 100%, 0%, and the sample-mean percentage of African, European, and Native American ancestry. We found that most NM-HL identify themselves and their parents as belonging to one of two groups, conforming to a region-specific narrative that distinguishes recent immigrants from Mexico from individuals whose families have resided in New Mexico for generations and who emphasize their Spanish heritage. The "Spanish" group had significantly lower Native American ancestry and higher European ancestry than the "Mexican" group. Positive FIS values, PCA plots, and heterogeneous ancestry distributions suggest that most Central and South America admixed samples also contain substructure, and that this substructure may be related to variation in social identity. Genetic substructure appears to be common in admixed populations in the Americas and may confound attempts to identify disease-causing genes and to understand the social causes of variation in health outcomes and social inequality.	[Healy, Meghan E.; Edgar, Heather; Gross, Jessica; Hunley, Keith] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Hill, Deirdre; Berwick, Marianne] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Hunley, K (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	khunley@unm.edu		Gross, Jessica/0000-0002-5221-8218; Hunley, Keith/0000-0003-0987-8277	University of New Mexico; National Science Foundation [0962825]	University of New Mexico; National Science Foundation(National Science Foundation (NSF))	This research was funded by grants from the University of New Mexico and the National Science Foundation (BCS #0962825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by grants from the University of New Mexico and the National Science Foundation (BCS #0962825).	[Anonymous], 2014, R LANG ENV STAT COMP; Anton-Culver H, 2004, PUBLIC HEALTH GENOM, V6, P171; Basu A, 2008, HUM GENET, V124, P207, DOI 10.1007/s00439-008-0541-5; Birkby WH, 2008, J FORENSIC SCI, V53, P29, DOI 10.1111/j.1556-4029.2007.00611.x; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; Brooks James F., 2002, CAPTIVES COUSINS SLA; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Chavez Fray Angelico, 1992, ORIGINS NEW MEXICO F; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Escamilla MA, 1996, AM J MED GENET, V67, P244, DOI 10.1002/(SICI)1096-8628(19960531)67:3<244::AID-AJMG2>3.3.CO;2-8; GONZALES PB, 1993, J SOUTHWEST, V35, P158; Huckell B., 2014, ARCHAEOLOGY GREAT BA, P17; Hunley K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161018; Institute of Medicine, 2009, RAC ETHN LANG DAT ST; Instituto Brasileiro de Geografia e Estat o A stica, 2008, ETHN RAC CHAR POP ST; Klimentidis YC, 2009, AM J PHYS ANTHROPOL, V138, P375, DOI 10.1002/ajpa.20945; Lisabeth LD, 2011, ANN HUM GENET, V75, P508, DOI 10.1111/j.1469-1809.2011.00657.x; Mersha TB, 2015, FRONT GENET, P6; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nieto-Phillips JM, 2008, LANGUAGE BLOOD MAKIN; Office of Management and Budget, 1997, FED REGISTER, V62, P58782; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Petruccelli J., 2001, SELETIVIDADE COR ESC, V23, P5; Pritchard JK, 2000, GENETICS, V155, P945; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shriner D., 2013, CURR PROTOC HUM GENE; Siegel J, 1979, P23 US DEP COMM BUR; Suarez-Orozco M. M., 2008, LATINOS REMAKING AM; TJARKS A, 1978, AMERICAS, V35, P45, DOI 10.2307/980925; Verdu P, 2011, GENETICS, V189, P1413, DOI 10.1534/genetics.111.132787; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wang ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013336; Wilson CM, 1981, NEW MEXICO PLAZA ARC; Young BN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094303	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185503	10.1371/journal.pone.0185503	http://dx.doi.org/10.1371/journal.pone.0185503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FI7FU	28977000	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100024
J	Osipowicz, G; Witas, H; Lisowska-Gaczorek, A; Reitsema, L; Szostek, K; Ploszaj, T; Kuriga, J; Makowiecki, D; Jedrychowska-Danska, K; Cienkosz-Stepanczak, B				Osipowicz, Grzegorz; Witas, Henryk; Lisowska-Gaczorek, Aleksandra; Reitsema, Laurie; Szostek, Krzysztof; Ploszaj, Tomasz; Kuriga, Justyna; Makowiecki, Daniel; Jedrychowska-Danska, Krystyna; Cienkosz-Stepanczak, Beata			Origin of the ornamented baton perce from the Golebiewo site 47 as a trigger of discussion on long-distance exchange among Early Mesolithic communities of Central Poland and Northern Europe	PLOS ONE			English	Article							REINDEER RANGIFER-TARANDUS; ISOTOPE RATIOS; OXYGEN ISOTOPES; BONE-COLLAGEN; STABLE-ISOTOPES; FAUNAL CHANGE; COLONIZATION; SCANDINAVIA; ENVIRONMENT; DEGLACIATION	This article describes evidence for contact and exchange among Mesolithic communities in Poland and Scandinavia, based on the interdisciplinary analysis of an ornamented baton perce A from Golebiewo site 47 (Central Poland). Typological and chronological-cultural analyses show the artefact to be most likely produced in the North European Plain, during the Boreal period. Carbon-14 dating confirms the antiquity of the artefact. Ancient DNA analysis shows the artefact to be of Rangifer tarandus antler. Following this species designation, a dispersion analysis of Early-Holocene reindeer remains in Europe was conducted, showing this species to exist only in northern Scandinavia and north-western Russia in this period. Therefore, the baton from Golebiewo constitutes the youngest reindeer remains in the European Plain and south-western Scandinavia known to date. An attempt was made to determine the biogeographic region from which the antler used to produce the artefact originates from. To this end, comprehensive delta(18) O, delta C-13 and delta N-15 isotope analyses were performed. North Karelia and South Lapland were determined as the most probable regions in terms of isotopic data, results which correspond to the known distribution range of Rangifer tarandus at this time. In light of these finds, the likelihood of contact between Scandinavia and Central Europe in Early Holocene is evaluated. The baton perce A from Golebiewo is likely key evidence for long-distance exchange during the Boreal period.	[Osipowicz, Grzegorz; Kuriga, Justyna; Makowiecki, Daniel] Nicolaus Copernicus Univ, Inst Archaeol, Torun, Kuyavian Pomera, Poland; [Witas, Henryk; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna] Med Univ Lodz, Dept Mol Biol, Lodz, Lodz Voivodeshi, Poland; [Lisowska-Gaczorek, Aleksandra; Szostek, Krzysztof; Cienkosz-Stepanczak, Beata] Jagiellonian Univ, Inst Zool, Krakow, Lesser Poland V, Poland; [Reitsema, Laurie] Univ Georgia, Bioarcheol & Biochem Lab, Athens, GA 30602 USA	Nicolaus Copernicus University; Medical University Lodz; Jagiellonian University; University System of Georgia; University of Georgia	Osipowicz, G (corresponding author), Nicolaus Copernicus Univ, Inst Archaeol, Torun, Kuyavian Pomera, Poland.	grezegor@umk.pl	Osipowicz, Grzegorz/O-5013-2015; Makowiecki, Daniel/AAA-9506-2021; Ploszaj, Tomasz/S-9849-2016	Osipowicz, Grzegorz/0000-0002-4393-655X; Makowiecki, Daniel/0000-0002-1821-4627; Szostek, Krzysztof/0000-0001-7815-928X; Reitsema, Laurie/0000-0003-1127-3496; Ploszaj, Tomasz/0000-0002-9503-278X; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010	National Science Center (NCN) in Cracow (Poland) [N 2013/08/M/HS3/00379, 2016/23/B/HS3/00689]	National Science Center (NCN) in Cracow (Poland)	The work was funded by the scientific projects from the National Science Center (NCN) in Cracow (Poland) no. N 2013/08/M/HS3/00379 and 2016/23/B/HS3/00689.; We would like to thank Wojciech Sosnowski and Ma o gorzata Kurzynska for passing on the artefact for analysis, all participants of the discussion that held at Research Gate, in connection to the presentation of the preliminary results of the study and Mikael A. Manninen for making available the map used at article. The work was funded by the scientific projects from the National Science Center (NCN) in Cracow (Poland) no. N 2013/08/M/HS3/00379 and 2016/23/B/HS3/00689.	Aaris-Sorensen K, 2007, J ARCHAEOL SCI, V34, P914, DOI 10.1016/j.jas.2006.09.014; Allain J., 1985, GALLIA PR HIST, V28, P37; Baales M, 2002, ARCHAEOMETRY S1, V44, P30; Bergman I, 2004, J WORLD PREHIST, V18, P155, DOI 10.1007/s10963-004-2880-z; Bergsvik KA, 2015, EUR J ARCHAEOL, V18, P190, DOI 10.1179/1461957114Y.0000000073; Bjornstad G, 2012, J ARCHAEOL SCI, V39, P102, DOI 10.1016/j.jas.2011.09.006; Bokiniec AZ, 1987, NEOLIT POCZATKI EPOK, p[11, 223]; Bondestam K, 1994, THESIS, V234, P161; Britton K, 2009, J ARCHAEOL SCI, V36, P1163, DOI 10.1016/j.jas.2009.01.003; Chaix L., 2003, 6 INT C MES EUR STOC, P645; Chaix L., 2009, 7 INT C MES EUR BELF, P190; Clark JGD, 1936, MESOLITHIC SETTLEMEN; Coard R, 1999, HOLOCENE, V9, P372, DOI 10.1191/095968399672435429; Costamagno S, 2016, QUATERN INT, V414, P34, DOI 10.1016/j.quaint.2015.11.103; Cyrek Krzysztof, 2000, Folia Quaternaria, V71, P5; Darling WG, 2004, QUATERNARY SCI REV, V23, P743, DOI 10.1016/j.quascirev.2003.06.016; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; DENIRO MJ, 1985, J ARCHAEOL SCI, V12, P1, DOI 10.1016/0305-4403(85)90011-1; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; Drucker D, 2011, DERNIERS RENNES DORD, P22; Drucker D, 2000, PALEO, V12, P127; Drucker DG, 2011, QUATERN INT, V245, P218, DOI 10.1016/j.quaint.2011.05.007; Drucker DG, 2009, MEMOIRE SOC PREHISTO, P73; Drucker DG, 2015, QUATERN INT, V359, P304, DOI 10.1016/j.quaint.2014.11.028; Dupras TL, 2001, J ARCHAEOL SCI, V28, P1199, DOI 10.1006/jasc.2001.0640; Foss M. E., 1952, MAT ISSLEDOVANIYA AR, pEastern; Galinski T, 2002, SPOLECZENSTWA MEZOLI; Gizejewski Z, 2004, POLAND EUR J WILDLIF, V50, P2017; Gramsch B., 1979, VEROFFENTLICHUNGEN P, V12, P39; Gron O, 2003, ANTIQUITY, V77, P685, DOI 10.1017/S0003598X00061640; Gron O, 1995, BAR INT SERIES, V616; Gurina NN, 1956, OLENEOSTROVSKI MOGIL; Hartz S., 2010, QUARTAR, V57, P155, DOI DOI 10.7485/QU57_08; Henton E, 2010, ARCHAEOMETRY, V52, P429, DOI 10.1111/j.1475-4754.2009.00492.x; Hoogewerff J, 2001, J ARCHAEOL SCI, V28, P983, DOI 10.1006/jasc.2001.0659; IAEA, 2006, GLOB NETW IS PREC GN; Jacobi RM, 2009, QUATERNARY SCI REV, V28, P1895, DOI 10.1016/j.quascirev.2009.03.006; Kabaciriski J., 2009, POLAND QUARTAR, V56, P119; Kabaciriski J, 2011, ELKS EARLY STONE AGE, V86, P151; Kankaanpaa J., 2011, MONOGRAPH ARCHAEOLOG, P43; Kind CJ, 2003, THESIS; Kleppe JI, 2014, BAR INT SERIES, V2599, P121; Knudson KJ, 2009, AM J PHYS ANTHROPOL, V138, P473, DOI 10.1002/ajpa.20965; Kobusiewicz M., 1975, ARCHAEOLOGIA POLONA, V16, P7; Kortelainen NM, 2004, J HYDROL, V285, P143, DOI 10.1016/j.jhydrol.2003.08.014; Kozlowski SK, 1972, PRADZIEJE ZIEM POLSK; Kriiska A., 2016, COMP PERSPECTIVES CO, P19; Kriiska A., 1999, ENV CULTURAL HIST E, V57, P157; Kukawka S., 1997, RUBIEZY SRODKOWOEURO; Kunkel O., 1936, MONATSBLATTER GESELL, V50, P47; lacumin P, 2002, EARTH PLANET SC LETT, V201, P213; lacumin P, 2000, PALAEOGEOGR PALAEOCL, V163, P33; LARSSON L, 1990, J WORLD PREHIST, V4, P257, DOI 10.1007/BF00974882; LINDGREN C., 2007, ROAD STUDIES L LARSS, P161; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lorenc Michal, 2006, Acta Zoologica Cracoviensia, V49A, P41, DOI 10.3409/000000006783995508; Loze I., 1973, MESOLITHIC EUROPE, P381; Malinowski B., 1961, ARGONAUTS W PACIFIC; Mannermaa K., 2016, MESOLITHIC MISCELLAN, V2, P19; Manninen M. A., 2011, MESOLITHIC INTERFACE, P143; Marciniak M., 1993, MESOLITHIC MISCELLAN, V14, P7; Mauss M., 2001, IDEM SOCIOLOGIA ANTR, P165; Moller P, 2013, HOLOCENE, V23, P104, DOI 10.1177/0959683612455546; Mowat F., 1973, TUNDRA SELECTIONS GR; Musil R., 2003, NEANDERTHALS MODERN, P167; O'Neil J.R., 1994, ISR J EARTH SCI, V43, P203; Olofsson A., 2003, ARCHAEOLOGY ENV; Oshibkina S. V., 1983, MEZOLIT BASSEYNA SUK; Osipowicz G., 2015, 9 INT C MES EUR MESO; Osipowicz G., 2010, NARZEDZIA KRZEMIENNE; Osipowicz G., 2014, WIAD ARCHEOL 65, P149; OSIPOWICZ G., 2015, PRZEGLAD ARCHEOLOGIC, V63, P59; Osipowicz G, 2017, SPOLECZNOSCI MEZOLIT; Osipowicz G., 2013, PRZEGLAD ARCHEOLOGIC, V61, P145; Osipowicz G, 2014, J LITHIC STUD, V1, P213, DOI 10.2218/jls.v1i1.774; Passe T, 2010, P SEM SEA LEV DISPL, P47; Peltier A, 1992, FICHES TYPOLOGIQUES, P7; Pesonen P., 1996, HELSINKI PAPERS ARCH, V9, P9; Piel-Desruisseaux JL, 2007, OUTILS PREHISTORIQUE; Piskorska T, 2014, QUATERN INT, p[359, 157]; Plaza DK, 2013, PRACE ARCHEOLOGICZNE, V66, P159; Plonka T., 2003, PORTABLE ART MESOLIT; Pokutta DA, 2013, POPULATION DYNAMICS; Pozzi E., 2004, MAGDALENIENS ART CIV; PRICE TD, 1990, ANTIQUITY, V64, P849, DOI 10.1017/S0003598X00078960; Prowse TL, 2007, AM J PHYS ANTHROPOL, V132, P510, DOI 10.1002/ajpa.20541; Rankama T, 2001, BOREAS, V30, P131; Rankama T., 2011, QUARTAR, V58, P183; Rankama T, 2008, ANTIQUITY, V82, P884, DOI 10.1017/S0003598X00097659; Reitsema LJ, 2013, J ARCHAEOL SCI, V40, P3636, DOI 10.1016/j.jas.2013.04.015; Riede F., 2014, OXFORD HDB ARCHAEOLO, P556; Ringsjoholm Sjostrom A., 1997, SWEDEN LUND ARCHAEOL, V3, P5; Roed KH, 2011, QUATERN INT, V238, P83, DOI 10.1016/j.quaint.2010.07.031; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sawicki L., 1921, WIADOMO 101 ARCHEOLO, V6, P47; Schurr MR, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P95, DOI 10.1016/B978-012372510-3.50007-1; Shaw B, 2010, J ARCHAEOL SCI, V37, P605, DOI 10.1016/j.jas.2009.10.025; Sommer RS, 2014, J BIOGEOGR, V41, P298, DOI 10.1111/jbi.12193; Sommer RS, 2011, GLOBAL CHANGE BIOL, V17, P2049, DOI 10.1111/j.1365-2486.2011.02388.x; Sorensen M, 2013, NOR ARCHAEOL REV, V46, P19, DOI 10.1080/00293652.2013.770416; Stevens RE, 2009, J HUM EVOL, V57, P131, DOI 10.1016/j.jhevol.2009.01.011; Subetto DA, 2002, BOREAS, V31, P1, DOI 10.1080/03009480210647; Sulgostowska Z, 1984, WIADOMOSCI ARCHEOLOG, V49, P191; Tallavaara M., 2014, BAR INT SERIES, V2599, P161; Terberger T., 2000, BODENDENKMALPFLEGE M, V48, P7; Ukkonen P, 2006, BOREAS, V35, P222, DOI 10.1080/03009480600578065; Volokitin A. V., 2004, ARCHAEOLOGY ETHNOLOG, P2; Volokitin AV, 2015, 4 NO ARCH C P OCT 19, P8; Volokitin AV, 2016, URO RAN, V4, P155; Volokitin AV, 2013, URO RAN, V8, P13; White C, 2004, J ARCHAEOL SCI, V31, P233, DOI 10.1016/j.jas.2003.08.007; White CD, 2004, J ANTHROPOL ARCHAEOL, V23, P385, DOI 10.1016/j.jaa.2004.08.002; White CD, 1998, J ARCHAEOL SCI, V25, P643, DOI 10.1006/jasc.1997.0259; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Wygal BT, 2014, J WORLD PREHIST, V27, P111, DOI 10.1007/s10963-014-9075-z; Zagorska I., 2007, ROAD STUDIES L LARSS, V26, P193; Zhilin M.G, 2001, KOSTYANAYA IND MEZOL	118	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184560	10.1371/journal.pone.0184560	http://dx.doi.org/10.1371/journal.pone.0184560			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977014	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100006
J	Carnwath, G; Nelson, C				Carnwath, Gunnar; Nelson, Cara			Effects of biotic and abiotic factors on resistance versus resilience of Douglas fir to drought	PLOS ONE			English	Article							RING GROWTH-RESPONSES; TREE MORTALITY; CLIMATE-CHANGE; FOREST GROWTH; NORTHERN ARIZONA; RADIAL GROWTH; MIXED-CONIFER; STAND; VARIABILITY; TEMPERATURE	Significant increases in tree mortality due to drought-induced physiological stress have been documented worldwide. This trend is likely to continue with increased frequency and severity of extreme drought events in the future. Therefore, understanding the factors that influence variability in drought responses among trees will be critical to predicting ecosystem responses to climate change and developing effective management actions. In this study, we used hierarchical mixed-effects models to analyze drought responses of Pseudotsuga menziesii in 20 unmanaged forests stands across a broad range of environmental conditions in northeastern Washington, USA. We aimed to 1) identify the biotic and abiotic attributes most closely associated with the responses of individual trees to drought and 2) quantify the variability in drought responses at different spatial scales. We found that growth rates and competition for resources significantly affected resistance to a severe drought event in 2001: slow-growing trees and trees growing in subordinate canopy positions and/or with more neighbors suffered greater declines in radial growth during the drought event. In contrast, the ability of a tree to return to normal growth when climatic conditions improved (resilience) was unaffected by competition or relative growth rates. Drought responses were significantly influenced by tree age: older trees were more resistant but less resilient than younger trees. Finally, we found differences between resistance and resilience in spatial scale: a significant proportion (approximately 50%) of the variability in drought resistance across the study area was at broad spatial scales (i.e. among different forest types), most likely due to differences in the total amount of precipitation received at different elevations; in contrast, variation in resilience was overwhelmingly (82%) at the level of individual trees within stands and there was no difference in drought resilience among forest types. Our results suggest that for Pseudotsuga menziesii resistance and resilience to drought are driven by different factors and vary at different spatial scales.	[Carnwath, Gunnar; Nelson, Cara] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Carnwath, Gunnar] US Forest Serv, Custer Gallatin Natl Forest, Bozeman, MT 59715 USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Carnwath, G (corresponding author), Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.; Carnwath, G (corresponding author), US Forest Serv, Custer Gallatin Natl Forest, Bozeman, MT 59715 USA.	gcarnwath@fs.fed.us	Nelson, Cara/AAC-2493-2020	Nelson, Cara/0000-0001-7508-0859	USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program); Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant [EPS-1101342]	USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program); Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant	This work was supported by McIntire-Stennis appropriations to the University of Montana, USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program), and the Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant EPS-1101342. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the USDA Forest Service Region 6 Area Ecology Program and Colville National Forest, especially M. Borysewicz, for logistical support; M. Yager, J. Bohlert, K. Bednarczyk, P. Stothart, T. Anfinson, and B. Maddox for data collection and core processing; and E. Sutherland, S. Running, J. Goodburn, and A. Sala for help with study design and manuscript review. This material is based on work supported by McIntire-Stennis appropriations to the University of Montana, USDA Forest Service (Region 6 Area Ecology Program and Student Career Experience Program), and the Montana Institute on Ecosystems by the National Science Foundation EPSCoR program grant EPS-1101342. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Montana Institute on Ecosystems or the National Science Foundation.	Adams HD, 2005, J BIOGEOGR, V32, P1629, DOI 10.1111/j.1365-2699.2005.01292.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; APPLEQUIST M. B., 1958, JOUR FOREST, V56, P141; Aussenac G, 2000, ANN FOR SCI, V57, P287; Battles JJ, 2008, CLIMATIC CHANGE, V87, pS193, DOI 10.1007/s10584-007-9358-9; Benito D, 2008, TREES-STRUCT FUNCT, V22, P363; BIGING GS, 1992, FOREST SCI, V38, P695; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brooker RW, 2006, NEW PHYTOL, V171, P271, DOI 10.1111/j.1469-8137.2006.01752.x; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Linares JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P485, DOI 10.1111/j.1466-8238.2009.00465.x; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Carnwath GC, 2016, J ECOL, V104, P1421, DOI 10.1111/1365-2745.12604; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Case MJ, 2005, CAN J FOREST RES, V35, P2743, DOI 10.1139/X05-191; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Crookston NL, 2010, FOREST ECOL MANAG, V260, P1198, DOI 10.1016/j.foreco.2010.07.013; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; DeClerck FAJ, 2006, ECOLOGY, V87, P2787, DOI 10.1890/0012-9658(2006)87[2787:SRASSI]2.0.CO;2; DEKORT I, 1993, CAN J FOREST RES, V23, P1480, DOI 10.1139/x93-185; Dobbertin M, 2005, EUR J FOREST RES, V124, P319, DOI 10.1007/s10342-005-0085-3; Domec JC, 2003, PLANT CELL ENVIRON, V26, P471, DOI 10.1046/j.1365-3040.2003.00978.x; Eis S., 1974, Canadian Journal of Forest Research, V4, P28, DOI 10.1139/x74-005; Fekedulegn D, 2003, FOREST ECOL MANAG, V177, P409, DOI 10.1016/S0378-1127(02)00446-2; Floyd ML, 2009, ECOL APPL, V19, P1223, DOI 10.1890/08-1265.1; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Fritts H. C., 1976, TREE RINGS CLIMATE; Galiano L, 2011, NEW PHYTOL, V190, P750, DOI 10.1111/j.1469-8137.2010.03628.x; Ganey JL, 2011, FOREST ECOL MANAG, V261, P162, DOI 10.1016/j.foreco.2010.09.048; Gazol A, 2016, J ECOL, V104, P1063, DOI 10.1111/1365-2745.12575; Gimeno TE, 2008, TREE PHYSL; Gitlin AR, 2006, CONSERV BIOL, V20, P1477, DOI 10.1111/j.1523-1739.2006.00424.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holman ML, 2006, CAN J FOREST RES, V36, P92, DOI 10.1139/X05-225; Holmes R.L., 1986, TREE RING CHRONOLOGI, P41; IPCC, 2007, CLIM CHANG 2007 IPCC; Klos RJ, 2009, ECOL APPL, V19, P699, DOI 10.1890/08-0330.1; Koepke DF, 2010, OECOLOGIA, V163, P1079, DOI 10.1007/s00442-010-1671-8; Kramer P. G., 1983, PLANT SOIL WATER REL; Larsson L.A., 2003, CDENDRO CYBIS DENDRO; Larsson L-A, 2003, COORECORDER IMAGE CO; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Lloret F, 2011, OIKOS, V120, P1909, DOI 10.1111/j.1600-0706.2011.19372.x; Ma ZH, 2012, P NATL ACAD SCI USA, V109, P2423, DOI 10.1073/pnas.1111576109; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Manion PD, 1981, TREE DIS CONCEPT ENG; Martinez-Meier A, 2008, FOREST ECOL MANAG, V256, P837, DOI 10.1016/j.foreco.2008.05.041; Martinez-Vilalta J, 2012, OECOLOGIA, V168, P877, DOI 10.1007/s00442-011-2132-8; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Merlin M, 2015, FOREST ECOL MANAG, V339, P22, DOI 10.1016/j.foreco.2014.11.032; MONSERUD RA, 1984, FOREST SCI, V30, P943; Monserud RA, 1979, RELATIONS INSIDE OUT; Moreno-Gutierrez C, 2012, PLANT CELL ENVIRON, V35, P1026, DOI 10.1111/j.1365-3040.2011.02469.x; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Oberhuber W, 2000, PLANT ECOL, V146, P231; Ogle K, 2000, ECOLOGY, V81, P3237, DOI 10.1890/0012-9658(2000)081[3237:TRVIPP]2.0.CO;2; Orwig DA, 1997, TREES-STRUCT FUNCT, V11, P474, DOI 10.1007/s004680050110; Orwin KH, 2004, SOIL BIOL BIOCHEM, V36, P1907, DOI 10.1016/j.soilbio.2004.04.036; Peterson DW, 2001, ECOLOGY, V82, P3330, DOI 10.1890/0012-9658(2001)082[3330:MHGRTC]2.0.CO;2; PHIPPS R L, 1982, Tree-Ring Bulletin, V42, P11; Pichler P, 2003, FOREST ECOL MANAG, P688; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Pretzsch H, 2013, PLANT BIOLOGY, V15, P483, DOI 10.1111/j.1438-8677.2012.00670.x; Rich PM, 2008, ECOLOGY, V89, P342, DOI 10.1890/06-2137.1; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Stokes M.A., 1968, INTRO TREE RING DATI; Stout DL, 2003, TREE PHYSIOL, V23, P43, DOI 10.1093/treephys/23.1.43; SZEICZ JM, 1994, CAN J FOREST RES, V24, P120, DOI 10.1139/x94-017; Tardif J, 1997, CAN J FOREST RES, V27, P108, DOI 10.1139/cjfr-27-1-108; Tilman D., 1982, Monographs in Population Biology, pi; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; vandenBrakel JA, 1996, FOREST SCI, V42, P206; VILLALBA R, 1994, ECOLOGY, V75, P1450, DOI 10.2307/1937468; VOSE JM, 1994, FOREST ECOL MANAG, V64, P25, DOI 10.1016/0378-1127(94)90124-4; WHITE TL, 1987, FOREST SCI, V33, P283; Williams C., 1995, FORESTED PLANT ASS C; Zang C, 2014, GLOBAL CHANGE BIOL, V20, P3767, DOI 10.1111/gcb.12637; Zhang YX, 2010, FOREST ECOL MANAG, V260, P1076, DOI 10.1016/j.foreco.2010.06.034; Zimmermann M.H., 1984, XYLEM STRUCTURE ASCE, V26, P165	85	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185604	10.1371/journal.pone.0185604	http://dx.doi.org/10.1371/journal.pone.0185604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973008	gold, Green Submitted, Green Published			2022-12-27	WOS:000412131900031
J	Hofmann, S; Everaars, J; Schweiger, O; Frenzel, M; Bannehr, L; Cord, AF				Hofmann, Sylvia; Everaars, Jeroen; Schweiger, Oliver; Frenzel, Mark; Bannehr, Lutz; Cord, Anna F.			Modelling patterns of pollinator species richness and diversity using satellite image texture	PLOS ONE			English	Article							FLOWER-VISITING BEES; AGRICULTURAL LANDSCAPES; ENVIRONMENTAL HETEROGENEITY; BIRD COMMUNITIES; BIODIVERSITY; VEGETATION; CONFIGURATION; PRODUCTIVITY; ASSEMBLAGES; RESOLUTION	Assessing species richness and diversity on the basis of standardised field sampling effort represents a cost-and time-consuming method. Satellite remote sensing (RS) can help overcome these limitations because it facilitates the collection of larger amounts of spatial data using cost-effective techniques. RS information is hence increasingly analysed to model biodiversity across space and time. Here, we focus on image texture measures as a proxy for spatial habitat heterogeneity, which has been recognized as an important determinant of species distributions and diversity. Using bee monitoring data of four years (2010-2013) from six 4 x 4 km field sites across Central Germany and a multimodel inference approach we test the ability of texture features derived from Landsat-TM imagery to model local pollinator biodiversity. Textures were shown to reflect patterns of bee diversity and species richness to some extent, with the first-order entropy texture and terrain roughness being the most relevant indicators. However, the texture measurements accounted for only 3-5% of up to 60% of the variability that was explained by our final models, although the results are largely consistent across different species groups (bumble bees, solitary bees). While our findings provide indications in support of the applicability of satellite imagery textures for modeling patterns of bee biodiversity, they are inconsistent with the high predictive power of texture metrics reported in previous studies for avian biodiversity. We assume that our texture data captured mainly heterogeneity resulting from landscape configuration, which might be functionally less important for wild bees than compositional diversity of plant communities. Our study also highlights the substantial variability among taxa in the applicability of texture metrics for modelling biodiversity.	[Hofmann, Sylvia] Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Everaars, Jeroen] German Ctr Integrat Biodivers Res Halle Jena Leip, Leipzig, Germany; [Everaars, Jeroen; Schweiger, Oliver; Frenzel, Mark] Helmholtz Ctr Environm Res, Dept Community Ecol, Halle Sa, Germany; [Bannehr, Lutz] Inst Geoinformat & Surveying, Facil Management & Geoinformat, Dept Architecture, Dessau, Germany; [Cord, Anna F.] Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Hofmann, S (corresponding author), Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	sylvia.hofmann@ufz.de	Cord, Anna/AAE-8327-2022; Everaars, Jeroen/AAR-6131-2021; Everaars, Jeroen/AGP-5653-2022; Hofmann, Sylvia/AAO-4802-2021; Frenzel, Mark/ABB-9845-2021; Schweiger, Oliver/B-4909-2008; Frenzel, Mark/D-4778-2015	Everaars, Jeroen/0000-0001-8569-7377; Everaars, Jeroen/0000-0001-8569-7377; Schweiger, Oliver/0000-0001-8779-2335; Hofmann, Dr. S./0000-0003-0621-9049; Frenzel, Mark/0000-0003-1068-2394; Cord, Anna F./0000-0003-3183-8482	Helmholtz long-range strategic research funding (POF III)	Helmholtz long-range strategic research funding (POF III)	This work was supported by the Helmholtz long-range strategic research funding (POF III). However, the authors received no specific funding for this work.	Gallardo-Cruz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030506; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; [Anonymous], 2021, LANG ENV STAT COMP; Anys H., 1994, P 1 INT AIRB REM SEN, V3; Arellano G, 2017, GLOBAL ECOL BIOGEOGR, V26, P191, DOI 10.1111/geb.12531; BAKER WL, 1992, LANDSCAPE ECOL, V7, P291, DOI 10.1007/BF00131258; Baldi G, 2008, ECOL SOC, V13; Barton K., 2016, MUMIN MULTIMODEL INF; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Beyer HL, 2012, GEOSPATIAL MODELLING; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bjornstad ON, 2016, NCF SPATIAL NONPARAM; Blaszczynski JS, 1997, PHOTOGRAMM ENG REM S, V63, P183; Boscolo D, 2017, PERSPECT ECOL CONSER, V15, P18, DOI 10.1016/j.pecon.2017.03.002; Breitbach N, 2012, OECOLOGIA, V168, P425, DOI 10.1007/s00442-011-2090-1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chapman RN, 2004, AGR ECOSYST ENVIRON, V104, P577, DOI 10.1016/j.agee.2004.01.026; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; Culbert PD, 2009, IEEE J-STARS, V2, P299, DOI 10.1109/JSTARS.2009.2021959; do Carmo FF, 2016, J VEG SCI, V27, P50, DOI 10.1111/jvs.12342; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Duro D. C., 2007, PROGR PHYS GEOGRAPHY, V31, P1; Duro DC, 2014, REMOTE SENS ENVIRON, V144, P214, DOI 10.1016/j.rse.2014.01.001; Evans J.S., ARCGIS TOOLBOX SURFA; Fox J, 2016, PACKAGECAR, DOI DOI 10.1177/0049124105277200; Frenzel M, 2016, ECOL INDIC, V65, P113, DOI 10.1016/j.ecolind.2015.11.020; Garibaldi L., 2011, ECOSYSTEM SERVICES A, P119; Hall-Beyer M., 2016, GLCM TUTORIAL HOME P; Hall-Beyer M., 2007, GLCM TUTORIAL HOME P; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Henry PY, 2008, BIODIVERS CONSERV, V17, P3357, DOI 10.1007/s10531-008-9417-1; Herkul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055624; Holzschuh A, 2007, J APPL ECOL, V44, P41, DOI 10.1111/j.1365-2664.2006.01259.x; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Hsieh TC, 2016, INT SYMP WIREL; Jayapal R, 2009, FOREST ECOL MANAG, V257, P2287, DOI 10.1016/j.foreco.2009.03.010; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuemmerle T, 2009, J LAND USE SCI, V4, P85, DOI 10.1080/17474230802648786; Lau MK, 2015, DIVERSITYSAMPLER FUN; Lee PY, 2005, J BIOGEOGR, V32, P1139, DOI 10.1111/j.1365-2699.2005.01254.x; Hernandez-Stefanoni JL, 2012, INT J APPL EARTH OBS, V19, P359, DOI 10.1016/j.jag.2012.04.002; Luoto M, 2004, ECOL APPL, V14, P1946, DOI 10.1890/02-5176; MAC ARTHUR ROBERT H., 1967; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Marini L, 2011, J BIOGEOGR, V38, P78, DOI 10.1111/j.1365-2699.2010.02376.x; Masek J.G., 2012, LEDAPS LANDSAT CALIB; MCGARIGAL K, 1995, PNW351 USDA FOR SERV; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Papanikolaou AD, 2017, J APPL ECOL, V54, P527, DOI 10.1111/1365-2664.12763; PATEL D, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL III, P92, DOI 10.1109/ICPR.1992.201935; Pinheiro J., 2016, NLME LINEAR NONLINEA; Riedinger V, 2015, ECOLOGY, V96, P1351, DOI 10.1890/14-1124.1; Riley S. J., 1999, INTERMOUNTAIN J SCI, V5, P1; Ripley R, 2016, MASS SUPPORT FUNCTIO; Rocchini D, 2010, MEASURING SPATIAL DI; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Rocchini D, 2016, REMOTE SENS ECOL CON, V2, P25, DOI 10.1002/rse2.9; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rocchini D, 2010, J ENVIRON MONITOR, V12, P825, DOI 10.1039/b921835a; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; St-Louis V, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0197; St-Louis V, 2006, REMOTE SENS ENVIRON, V105, P299, DOI 10.1016/j.rse.2006.07.003; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; Steckel J, 2014, BIOL CONSERV, V172, P56, DOI 10.1016/j.biocon.2014.02.015; Torne-Noguera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097255; Tuanmu MN, 2015, GLOBAL ECOL BIOGEOGR, V24, P1329, DOI 10.1111/geb.12365; Vierling KT, 2011, ECOL APPL, V21, P577, DOI 10.1890/09-2155.1; Wallis CIB, 2017, ECOL INDIC; Warner T, 2011, GEOGR COMPASS, V5, P781, DOI 10.1111/j.1749-8198.2011.00451.x; Wood EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063211; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Wrbka T, 2004, LAND USE POLICY, V21, P289, DOI 10.1016/j.landusepol.2003.10.012; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	81	11	12	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185591	10.1371/journal.pone.0185591	http://dx.doi.org/10.1371/journal.pone.0185591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973006	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900030
J	Knapp, J; Damy, S; Brillaud, J; Tissot, JD; Navion, J; Melior, R; Afonsol, E; Hormaz, V; Gottstein, B; Umhang, G; Casulli, A; Dadeau, F; Millon, L; Raoul, F				Knapp, Jenny; Damy, Sylvie; Brillaud, Jonathan; Tissot, Jean-Daniel; Navion, Jeremy; Melior, Raphael; Afonsol, Eve; Hormaz, Vanessa; Gottstein, Bruno; Umhang, Gerald; Casulli, Adriano; Dadeau, Frederic; Millon, Laurence; Raoul, Francis			EWET: Data collection and interface for the genetic analysis of Echinococcus multilocularis based on EmsB microsatellite	PLOS ONE			English	Article							GENUS ECHINOCOCCUS; CESTODA TAENIIDAE; TAPEWORM; LOCI; INVESTIGATE; DIVERSITY; ESTONIA; AREA	Evolution and dispersion history on Earth of organisms can best be studied through biological markers in molecular epidemiological studies. The biological diversity of the cestode Echinococcus multilocularis was investigated in different cladistic approaches. First the morphological aspects were explored in connection with its ecology. More recently, molecular aspects were investigated to better understand the nature of the variations observed among isolates. The study of the tandemly repeated multilocus microsatellite EmsB allowed us to attain a high genetic diversity level where other classic markers have failed. Since 2006, EmsB data have been collected on specimens from various endemic foci of the parasite in Europe (in historic and newly endemic areas), Asia (China, Japan and Kyrgyzstan), and North America (Canada and Alaska). Biological data on the isolates and metadata were also recorded (e.g. host, geographical location, EmsB analysis, citation in the literature). In order to make available the data set of 1,166 isolates from classic and aberrant domestic and wild animal hosts (larval lesions and adult worms) and from human origin, an open web access interface, developed in PHP, and connected to a PostgreSQL database, was developed in the EmsB Website for the Echinococcus Typing (EWET) project. It allows researchers to access data collection, perform genetic analyses online (e.g. defining the genetic distance between their own samples and the samples in the database), consult distribution maps of EmsB profiles, and record and share their new EmsB genotyping data. In order to standardize the EmsB analyses performed in the different laboratories throughout the world, a calibrator was developed. The final aim of this project was to gather and arrange available data to permit to better understand the dispersion and transmission patterns of the parasite among definitive and intermediate hosts, in order to organize control strategies on the ground.	[Knapp, Jenny; Damy, Sylvie; Brillaud, Jonathan; Tissot, Jean-Daniel; Navion, Jeremy; Afonsol, Eve; Millon, Laurence; Raoul, Francis] Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France; [Melior, Raphael] Observ Besancon, UMS OSU THETA Bourgogne Franche Comte 3245, Besancon, France; [Gottstein, Bruno] Inst Parasitol Bern, Bern, Switzerland; [Hormaz, Vanessa; Umhang, Gerald] Anses Nancy Lab Rabies & Wildlife, Wildlife Surveillance & Ecoepidemiol Unit, Natl Reference Lab Echinococcus Spp, Technopole Agr & Vet, Malzeville, France; [Casulli, Adriano] Ist Super Sanita, WHO Collaborating Ctr Epidemiol Detect & Control, Rome, Italy; [Casulli, Adriano] Ist Super Sanita, European Reference Lab Parasites, Rome, Italy; [Dadeau, Frederic] Univ Bourgogne Franche Comte, FEMTO ST Inst, CNRS, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM)	Knapp, J (corresponding author), Univ Bourgogne Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, Besancon, France.	jenny.knapp@univ-comte.fr	Raoul, Francis/H-7706-2012; UMHANG, Gérald/K-6513-2019; Afonso, Eve/L-1286-2013; CASULLI, ADRIANO/O-2278-2015; Millon, laurence/AAK-5980-2020	Raoul, Francis/0000-0001-9566-9599; UMHANG, Gérald/0000-0001-6944-7474; Afonso, Eve/0000-0001-5836-9909; CASULLI, ADRIANO/0000-0001-9183-7591; Damy, Sylvie/0000-0002-1524-0862	Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project [2013C-09405]; Centre National de Reference des Echinococcoses	Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project; Centre National de Reference des Echinococcoses	The Conseil Regional de Franche-Comte by the OREAS (Observatoire des Relations Ecosystemes - anthropisation- sante) project (Grant No: 2013C-09405) and the Centre National de Reference des Echinococcoses have permitted to develop the website (student allowances).	Archak S, 2007, NUCLEIC ACIDS RES, V35, pD36, DOI 10.1093/nar/gkl778; Bart JM, 2006, INFECT GENET EVOL, V6, P390, DOI 10.1016/j.meegid.2006.01.006; Bhattacharjee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094088; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005477; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Casulli A, 2010, VET PARASITOL, V174, P241, DOI 10.1016/j.vetpar.2010.08.023; Casulli A, 2009, INT J PARASITOL, V39, P837, DOI 10.1016/j.ijpara.2008.12.001; Charbonnier A, 2014, PARASITE, V21, DOI 10.1051/parasite/2014075; Eckert J., 2001, WHO OIE MANUAL ECHIN; Haag KL, 1997, PARASITOLOGY, V115, P521, DOI 10.1017/S0031182097001649; Hahn M, 2001, ELECTROPHORESIS, V22, P2691, DOI 10.1002/1522-2683(200108)22:13<2691::AID-ELPS2691>3.0.CO;2-S; Jenkins DJ, 2005, INT J PARASITOL, V35, P1205, DOI 10.1016/j.ijpara.2005.07.014; Knapp J, 2008, INFECT GENET EVOL, V8, P367, DOI 10.1016/j.meegid.2008.02.010; Knapp J, 2007, J CLIN MICROBIOL, V45, P2943, DOI 10.1128/JCM.02107-06; Knapp J, 2012, INFECT GENET EVOL, V12, P1270, DOI 10.1016/j.meegid.2012.03.008; Knapp J, 2011, MOL PHYLOGENET EVOL, V61, P628, DOI 10.1016/j.ympev.2011.07.022; Knapp J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000452; Kobayashi Y, 2008, THEOR POPUL BIOL, V74, P84, DOI 10.1016/j.tpb.2008.05.001; Laurimaa L, 2015, VET PARASITOL, V212, P200, DOI 10.1016/j.vetpar.2015.06.004; Laurimaa L, 2015, EMERG INFECT DIS, V21, P163, DOI 10.3201/eid2101.140136; Lavikainen A, 2008, PARASITOLOGY, V135, P1457, DOI 10.1017/S003118200800499X; Maillard S, 2009, J CLIN MICROBIOL, V47, P3608, DOI 10.1128/JCM.00938-09; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Nakao M, 2003, INFECT GENET EVOL, V3, P159, DOI 10.1016/S1567-1348(03)00070-4; Nakao M, 2009, PARASITOL INT, V58, P384, DOI 10.1016/j.parint.2009.07.010; Roussel S, 2011, INT J MED MICROBIOL, V301, P150, DOI 10.1016/j.ijmm.2010.07.002; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tardieu H, 2000, METHODE MERISE PRINC; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Umhang G, 2014, INFECT GENET EVOL, V22, P142, DOI 10.1016/j.meegid.2014.01.018; Valot B, 2015, INFECT GENET EVOL, V32, P338, DOI 10.1016/j.meegid.2015.03.040	35	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0183849	10.1371/journal.pone.0183849	http://dx.doi.org/10.1371/journal.pone.0183849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972978	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900003
J	Pillai, N; Dusheiko, M; Burnand, B; Pittet, V				Pillai, Nadia; Dusheiko, Mark; Burnand, Bernard; Pittet, Valerie			A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease	PLOS ONE			English	Review							ACTIVE ULCERATIVE-COLITIS; SEVERE CROHNS-DISEASE; UTILITY ANALYSIS; MAINTENANCE TREATMENT; COMBINATION THERAPY; ECONOMIC-EVALUATION; ORAL MESALAZINE; STANDARD CARE; TOP-DOWN; INFLIXIMAB	Background Inflammatory bowel disease (IBD) is a chronic disease placing a large health and economic burden on health systems worldwide. The treatment landscape is complex with multiple strategies to induce and maintain remission while avoiding long-term complications. The extent to which rising treatment costs, due to expensive biologic agents, are offset by improved outcomes and fewer hospitalisations and surgeries needs to be evaluated. This systematic review aimed to assess the cost-effectiveness of treatment strategies for IBD. Materials and methods A systematic literature search was performed in March 2017 to identify economic evaluations of pharmacological and surgical interventions, for adults diagnosed with Crohn's disease (CD) or ulcerative colitis (UC). Costs and incremental cost-effectiveness ratios (ICERs) were adjusted to reflect 2015 purchasing power parity (PPP). Risk of bias assessments and a narrative synthesis of individual study findings are presented. Results Forty-nine articles were included; 24 on CD and 25 on UC. Infliximab and adalimumab induction and maintenance treatments were cost-effective compared to standard care in patients with moderate or severe CD; however, in patients with conventional-drug refractory CD, fistulising CD and for maintenance of surgically-induced remission ICERs were above acceptable cost-effectiveness thresholds. In mild UC, induction of remission using high dose mesalazine was dominant compared to standard dose. In UC refractory to conventional treatments, infliximab and adalimumab induction and maintenance treatment were not cost-effective compared to standard care; however, ICERs for treatment with vedolizumab and surgery were favourable. Conclusions We found that, in general, while biologic agents helped improve outcomes, they incurred high costs and therefore were not cost-effective, particularly for use as maintenance therapy. The cost-effectiveness of biologic agents may improve as market prices fall and with the introduction of biosimilars. Future research should identify optimal treatment strategies reflecting routine clinical practice, incorporate indirect costs and evaluate lifetime costs and benefits.	[Pillai, Nadia; Dusheiko, Mark; Burnand, Bernard; Pittet, Valerie] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Dusheiko, Mark] Univ York, Ctr Hlth Econ, York, N Yorkshire, England; [Dusheiko, Mark] Univ Lausanne, Fac Business & Econ HEC, Lausanne, Switzerland; [Burnand, Bernard] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Cochrane Switzerland, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of York - UK; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pillai, N (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	nadia.pillai@chuv.ch		Pillai, Nadia/0000-0003-2076-9100; Pittet, Valerie/0000-0003-2208-966X	Swiss National Science Foundation (SNSF) [33CS30-148422]; Institute of Social and Preventive Medicine (IUMSP) PhD Fellowship	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Institute of Social and Preventive Medicine (IUMSP) PhD Fellowship	This study was supported by the Swiss National Science Foundation (SNSF) grant No 33CS30-148422 (Swiss IBD cohort study). NP is supported by the Institute of Social and Preventive Medicine (IUMSP) PhD Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot A, 2015, THER ADV GASTROENTER, V8, P66, DOI 10.1177/1756283X14558193; Ananthakrishnan AN, 2012, DIGEST DIS SCI, P1; Ananthakrishnan AN, 2011, AM J GASTROENTEROL, V106, P2009, DOI 10.1038/ajg.2011.237; Anderson R, 2010, HEALTH ECON, V19, P350, DOI 10.1002/hec.1486; Archer R, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20390; Arseneau KO, 2001, GASTROENTEROLOGY, V120, P1640, DOI 10.1053/gast.2001.24884; Bakhshai Justin, 2010, J Med Econ, V13, P63, DOI 10.3111/13696990903543424; Beilman CL, 2016, CAN J GASTROENTEROL, V2016; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Blackhouse G, 2012, J CROHNS COLITIS, V6, P77, DOI 10.1016/j.crohns.2011.07.007; Bodger K, 2009, ALIMENT PHARM THER, V30, P265, DOI 10.1111/j.1365-2036.2009.04033.x; Bodger K, 2011, PHARMACOECONOMICS, V29, P387, DOI 10.2165/11584820-000000000-00000; Brereton Nic, 2010, J Med Econ, V13, P148, DOI 10.3111/13696990903562861; Buckland A, 2008, ALIMENT PHARM THER, V28, P1287, DOI 10.1111/j.1365-2036.2008.03856.x; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Chaudhary Mohammad A, 2013, Biol Ther, V3, P45; Clark W, 2003, HLTH TECHNOLOGY ASSE, V7; Claxton K, 2015, HEALTH ECON, V24, P1, DOI 10.1002/hec.3130; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Connolly MP, 2012, NETH J MED, V70, P272; Connolly MP, 2014, J CROHNS COLITIS, V8, P357, DOI 10.1016/j.crohns.2013.09.015; Connolly MP, 2009, J CROHNS COLITIS, V3, P168, DOI 10.1016/j.crohns.2009.02.005; Connolly MP, 2009, J CROHNS COLITIS, V3, P32, DOI 10.1016/j.crohns.2008.10.004; Danese S, 2017, NAT REV GASTRO HEPAT, V14, P22, DOI 10.1038/nrgastro.2016.155; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Doherty GA, 2012, INFLAMM BOWEL DIS, V18, P1608, DOI 10.1002/ibd.21904; Dretzke J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15060; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; Erim DO, 2015, J CROHNS COLITIS, V9, P669, DOI 10.1093/ecco-jcc/jjv090; Essat M, 2014, VEDOLIZUMAB TREATMEN; Goldman D, 2012, EC VALUE MED INNOVAT; Gregor JC, 1997, INFLAMM BOWEL DIS, V3, P265, DOI 10.1002/ibd.3780030405; Hanauer SB, 2005, NAT CLIN PRACT GASTR, V2, P493, DOI 10.1038/ncpgasthep0318; Hanauer SB, 1996, NEW ENGL J MED, V334, P841, DOI 10.1056/NEJM199603283341307; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Huoponen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145087; Jaisson-Hot I, 2004, INT J TECHNOL ASSESS, V20, P274, DOI 10.1017/S0266462304001084; Jorgensen KK, 2017, LANCET, V389, P2304, DOI 10.1016/S0140-6736(17)30068-5; Kaplan GG, 2007, ALIMENT PHARM THER, V26, P1509, DOI 10.1111/j.1365-2036.2007.03548.x; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Knies S, 2009, PHARMACOECONOMICS, V27, P767, DOI 10.2165/11314120-000000000-00000; Lindsay J, 2008, ALIMENT PHARM THER, V28, P76, DOI 10.1111/j.1365-2036.2008.03709.x; Loftus EV, 2009, EUR J GASTROEN HEPAT, V21, P1302, DOI 10.1097/MEG.0b013e32832a8d71; M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731; Marchetti M, 2013, EUR J HEALTH ECON, V14, P853, DOI 10.1007/s10198-012-0430-7; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Marshall J, 2002, INFLIXIMAB TREATMENT; Moher D, 2009, PLOS MED, V6, P1, DOI DOI 10.1371/; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moss AC, 2015, GASTROENTEROL REP, V3, P63, DOI 10.1093/gastro/gou087; NICE, 2021, GUIDE METHODS TECHNO; Odes S, 2014, CLINICOECONOMIC OUTC, V6, P431, DOI 10.2147/CEOR.S39212; OECD, 2017, PURCH POW PAR PPP IN; OECD, 2017, INFL CPI IND, DOI 10. 1787/eee82e6e-en; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Panaccione Remo, 2010, Therap Adv Gastroenterol, V3, P179, DOI 10.1177/1756283X09357579; Panes J, 2007, DIGEST LIVER DIS, V39, P617, DOI 10.1016/j.dld.2007.03.007; Park KT, 2012, ANN SURG, V256, P117, DOI 10.1097/SLA.0b013e3182445321; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Poole CD, 2010, J CROHNS COLITIS, V4, P275, DOI 10.1016/j.crohns.2009.11.010; Prenzler A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-157; Priest VL, 2006, PHARMACOECONOMICS, V24, P767, DOI 10.2165/00019053-200624080-00004; Punekar YS, 2010, EUR J HEALTH ECON, V11, P67, DOI 10.1007/s10198-009-0199-5; Rafia R, 2016, PHARMACOECONOMICS, V34, P1241, DOI 10.1007/s40273-016-0436-6; Ramsey S, 2005, VALUE HEALTH, V8, P521, DOI 10.1111/j.1524-4733.2005.00045.x; Saini SD, 2012, CLIN GASTROENTEROL H, V10, P1143, DOI 10.1016/j.cgh.2012.05.003; Saito S, 2013, J CROHNS COLITIS, V7, P167, DOI 10.1016/j.crohns.2012.04.007; Schneider Yecheskel, 2016, Gastroenterol Hepatol (N Y), V12, P617; Stawowczyk E, 2016, EUR J CLIN PHARMACOL, V72, P1319, DOI 10.1007/s00228-016-2103-4; Stawowczyk E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160444; Stawowczyk E, 2016, PHARMACOTHERAPY, V36, P472, DOI 10.1002/phar.1742; Stone CD, 2012, DIGEST DIS SCI, V57, P3042, DOI 10.1007/s10620-012-2417-8; Taleban S, 2016, DIGEST DIS SCI, V61, P550, DOI 10.1007/s10620-015-3886-3; Tang DH, 2013, INFLAMM BOWEL DIS, V19, P2673, DOI 10.1097/MIB.0b013e3182916046; Tang DH, 2012, PHARMACOTHERAPY, V32, P515, DOI 10.1002/j.1875-9114.2011.01053.x; Tappenden P, 2016, PHARMACOECONOMICS, V34, P1023, DOI 10.1007/s40273-016-0409-9; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Trallori G, 1997, PHARMACOECONOMICS, V11, P444, DOI 10.2165/00019053-199711050-00006; Tsai HH, 2016, EXPERT REV PHARM OUT, P1; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2; University of York Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Wilson MR, 2017, EUR J HLTH EC; Woehl A, 2007, VALUE HEALTH, V10, pA355, DOI 10.1016/S1098-3015(10)65262-X; Xie Feng, 2009, Cost Eff Resour Alloc, V7, P20, DOI 10.1186/1478-7547-7-20; Yen EF, 2008, AM J GASTROENTEROL, V103, P3094, DOI 10.1111/j.1572-0241.2008.02130.x; Yokomizo L, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000093; Yu AP, 2009, PHARMACOECONOMICS, V27, P609, DOI 10.2165/11312710-000000000-00000	90	63	64	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185500	10.1371/journal.pone.0185500	http://dx.doi.org/10.1371/journal.pone.0185500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973005	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900021
J	Wu, LC; Li, MN; Tian, L; Wang, SX; Wu, LJ; Ku, LX; Zhang, J; Song, XH; Liu, HP; Chen, YH				Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Zhang, Jun; Song, Xiaoheng; Liu, Haiping; Chen, Yanhui			Global transcriptome analysis of the maize (Zea mays L.) inbred line 08LF during leaf senescence initiated by pollination-prevention	PLOS ONE			English	Article							ABSCISIC-ACID; JASMONIC ACID; GENE-EXPRESSION; ARABIDOPSIS; DEFENSE; STRESS; IDENTIFICATION; REVEALS; BIOSYNTHESIS; CONVERGENCE	In maize (Zea mays), leaf senescence acts as a nutrient recycling process involved in proteins, lipids, and nucleic acids degradation and transport to the developing sink. However, the molecular mechanisms of pre-maturation associated with pollination-prevention remain unclear in maize. To explore global gene expression changes during the onset and progression of senescence in maize, the inbred line 08LF, with severe early senescence caused by pollination prevention, was selected. Phenotypic observation showed that the onset of leaf senescence of 08LF plants occurred approximately 14 days after silking (DAS) by pollination prevention. Transcriptional profiling analysis of the leaf at six developmental stages during induced senescence revealed that a total of 5,432 differentially expressed genes (DEGs) were identified, including 2314 up-regulated genes and 1925 down-regulated genes. Functional annotation showed that the up-regulated genes were mainly enriched in multi-organism process and nitrogen compound transport, whereas down-regulated genes were involved in photosynthesis. Expression patterns and pathway enrichment analyses of early-senescence related genes indicated that these DEGs are involved in complex regulatory networks, especially in the jasmonic acid pathway. In addition, transcription factors from several families were detected, particularly the CO-like, NAC, ERF, GRAS, WRKY and ZF-HD families, suggesting that these transcription factors might play important roles in driving leaf senescence in maize as a result of pollination-prevention.	[Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Song, Xiaoheng; Chen, Yanhui] Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Henan, Peoples R China; [Wu, Liancheng; Li, Mingna; Tian, Lei; Wang, Shunxi; Wu, Liuji; Ku, Lixia; Song, Xiaoheng; Chen, Yanhui] Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Zhang, Jun] Henan Acad Agr Sci, Inst 3Cereal, Henan Prov Key Lab Maize Biol, Zhengzhou, Henan, Peoples R China; [Liu, Haiping] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Henan Agricultural University; Henan Agricultural University; Henan Academy of Agricultural Sciences; Michigan Technological University	Chen, YH (corresponding author), Henan Agr Univ, Coll Agron, Synerget Innovat Ctr Henan Grain Crops, Zhengzhou, Henan, Peoples R China.; Chen, YH (corresponding author), Henan Agr Univ, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	chy9953@163.com		Tian, Lei/0000-0001-5374-0641	national key research and development program of China [2016YFD0101205-3]; Major Science and Technology Projects of Henan Province, China [161100110500]; Basic and Frontier Project of Henan Province, China [142300413218]	national key research and development program of China; Major Science and Technology Projects of Henan Province, China; Basic and Frontier Project of Henan Province, China	This work was supported by the national key research and development program of China (2016YFD0101205-3), the Major Science and Technology Projects of Henan Province, China (No.161100110500), and the Basic and Frontier Project of Henan Province, China (No.142300413218).	ALLISON JCS, 1970, PLANT PHYSIOL, V46, P435, DOI 10.1104/pp.46.3.435; Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Berberich T, 1999, MOL GEN GENET, V262, P534, DOI 10.1007/s004380051115; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; CEPPI D, 1987, PLANT PHYSIOL, V85, P720, DOI 10.1104/pp.85.3.720; Christ B, 2014, J PLANT GROWTH REGUL, V33, P4, DOI 10.1007/s00344-013-9392-y; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Desclos M, 2009, PROTEOMICS, V9, P3580, DOI 10.1002/pmic.200800984; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gao XQ, 2008, MOL PLANT MICROBE IN, V21, P98, DOI 10.1094/MPMI-21-1-0098; Gaudet P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000431; Gnanasekaran T, 2016, J EXP BOT, V67, P2495, DOI 10.1093/jxb/erw067; Goetz S, 2012, PLANT PHYSIOL, V158, P1715, DOI 10.1104/pp.111.192658; Greenboim-Wainberg Y, 2005, PLANT CELL, V17, P92, DOI 10.1105/tpc.104.028472; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Guo YF, 2012, PLANT CELL ENVIRON, V35, P644, DOI 10.1111/j.1365-3040.2011.02442.x; Hao da C, 2011, PLOS ONE, V6; He P, 2005, J EXP BOT, V56, P1117, DOI 10.1093/jxb/eri103; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Huang CK, 2015, PLANT MOL BIOL, V88, P269, DOI 10.1007/s11103-015-0321-2; Jiang YJ, 2014, PLANT CELL, V26, P230, DOI 10.1105/tpc.113.117838; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Khan AL, 2013, WORLD J MICROB BIOT, V29, P2133, DOI 10.1007/s11274-013-1378-1; Kong XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069847; Koyama T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00650; Ku LX, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0930-1; Lee HN, 2015, BIOCHEM BIOPH RES CO, V463, P24, DOI 10.1016/j.bbrc.2015.05.010; Lee SH, 2015, J INTEGR PLANT BIOL, V57, P562, DOI 10.1111/jipb.12276; LEOPOLD AC, 1961, SCIENCE, V134, P1727, DOI 10.1126/science.134.3492.1727; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li ZH, 2014, NUCLEIC ACIDS RES, V42, pD1200, DOI 10.1093/nar/gkt1061; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Liang CZ, 2014, P NATL ACAD SCI USA, V111, P10013, DOI 10.1073/pnas.1321568111; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lin M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0433-5; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaughlin JE, 2004, ANN BOT-LONDON, V94, P675, DOI 10.1093/aob/mch193; Meguro M, 2011, PLANT CELL, V23, P3442, DOI 10.1105/tpc.111.089714; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Nooden LD, 1988, PHENOMENA SENESCENCE, P1; Okada K, 1998, PLANT CELL PHYSIOL, V39, P394, DOI 10.1093/oxfordjournals.pcp.a029382; OuYang FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127896; Palmer NA, 2015, FUNCT INTEGR GENOMIC, V15, P1, DOI 10.1007/s10142-014-0393-0; PARTHIER B, 1990, J PLANT GROWTH REGUL, V9, P57, DOI 10.1007/BF02041942; Reinbothe C, 2009, FEBS J, V276, P4666, DOI 10.1111/j.1742-4658.2009.07193.x; Ren GD, 2010, J INTEGR PLANT BIOL, V52, P496, DOI 10.1111/j.1744-7909.2010.00945.x; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarwat M, 2013, BIOTECHNOL ADV, V31, P1153, DOI 10.1016/j.biotechadv.2013.02.003; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; Seltmann MA, 2010, PLANT PHYSIOL, V152, P1940, DOI 10.1104/pp.110.153114; Shan XY, 2011, PLANT PHYSIOL, V155, P751, DOI 10.1104/pp.110.166595; Song Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29843; Song YW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00181; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thomson WW, 1987, ULTRASTRUCTURE SENES; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; UEDA J, 1980, PLANT PHYSIOL, V66, P246, DOI 10.1104/pp.66.2.246; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; Wang Y, 2012, J EXP BOT, V63, P5887, DOI 10.1093/jxb/ers238; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei SS, 2015, PLANT SCI, V233, P72, DOI 10.1016/j.plantsci.2015.01.002; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Woo HR, 2016, PLANT PHYSIOL, V171, P452, DOI 10.1104/pp.15.01929; Wu L., 2016, ACM T INTEL SYST TEC, V7, DOI DOI 10.18632/0NC0TARGET.8489; Wu XY, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0755-y; Wu XY, 2016, PLANT MOL BIOL, V92, P555, DOI 10.1007/s11103-016-0532-1; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Xie Y, 2014, DEVELOPMENT, V141, P4772, DOI 10.1242/dev.117689; Yan YX, 2012, PLANT CELL, V24, P1420, DOI 10.1105/tpc.111.094151; Yoshida S, 2003, CURR OPIN PLANT BIOL, V6, P79, DOI 10.1016/S1369526602000092; Young TE, 2004, PLANT J, V38, P910, DOI 10.1111/j.1365-313X.2004.02093.x; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115617	94	7	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185838	10.1371/journal.pone.0185838	http://dx.doi.org/10.1371/journal.pone.0185838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973044	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900060
J	Haskell, CA; Beauchamp, DA; Bollens, SM				Haskell, Craig A.; Beauchamp, David A.; Bollens, Stephen M.			Linking functional response and bioenergetics to estimate juvenile salmon growth in a reservoir food web	PLOS ONE			English	Article							CHINOOK SALMON; LOWER COLUMBIA; ONCORHYNCHUS-TSHAWYTSCHA; SOCKEYE-SALMON; AMERICAN SHAD; ZOOPLANKTON; SIZE; TEMPERATURE; FISH; CONSUMPTION	Juvenile salmon (Oncorhynchus spp.) use of reservoir food webs is understudied. We examined the feeding behavior of subyearling Chinook salmon (O. tshawytscha) and its relation to growth by estimating the functional response of juvenile salmon to changes in the density of Daphnia, an important component of reservoir food webs. We then estimated salmon growth across a broad range of water temperatures and daily rations of two primary prey, Daphnia and juvenile American shad (Alosa sapidissima) using a bioenergetics model. Laboratory feeding experiments yielded a Type-II functional response curve: C = 29.858 P *(4.271 + P)(-1) indicating that salmon consumption (C) of Daphnia was not affected until Daphnia densities (P) were < 30 . L-1. Past field studies documented Daphnia densities in lower Columbia River reservoirs of < 3 . L-1 in July but as high as 40 . L-1 in August. Bioenergetics modeling indicated that subyearlings could not achieve positive growth above 22 degrees C regardless of prey type or consumption rate. When feeding on Daphnia, subyearlings could not achieve positive growth above 20 degrees C (water temperatures they commonly encounter in the lower Columbia River during summer). At 16-18 degrees C, subyearlings had to consume about 27,000 Daphnia . day(-1) to achieve positive growth. However, when feeding on juvenile American shad, subyearlings had to consume 20 shad . day(-1) at 16-18 degrees C, or at least 25 shad . day(-1) at 20 degrees C to achieve positive growth. Using empirical consumption rates and water temperatures from summer 2013, subyearlings exhibited negative growth during July (-0.23 to -0.29 g . d(-1)) and August (-0.05 to -0.07 g . d(-1)). By switching prey from Daphnia to juvenile shad which have a higher energy density, subyearlings can partially compensate for the effects of higher water temperatures they experience in the lower Columbia River during summer. However, achieving positive growth as piscivores requires subyearlings to feed at higher consumption rates than they exhibited empirically. While our results indicate compromised growth in reservoir habitats, the long-term repercussions to salmon populations in the Columbia River Basin are unknown.	[Haskell, Craig A.] US Geol Survey, Western Fisheries Res Ctr, Cook, WA 98605 USA; [Beauchamp, David A.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Bollens, Stephen M.] Washington State Univ, Sch Environm, Vancouver, WA USA; [Bollens, Stephen M.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Washington State University; Washington State University	Haskell, CA (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Cook, WA 98605 USA.	chaskell@usgs.gov		Haskell, Craig/0000-0002-3604-1758	National Science Foundation GK-12 Grant; U.S. Geological Survey through the YES (Youth and Education in Science)	National Science Foundation GK-12 Grant(National Science Foundation (NSF)); U.S. Geological Survey through the YES (Youth and Education in Science)	This work was supported by a National Science Foundation GK-12 Grant to Stephen Bollens and administered as a fellowship to Craig Haskell by Washington State University. The U.S. Geological Survey provided funds through the YES (Youth and Education in Science).	Adams JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144095; Alexander ME, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0946; BARTELL SM, 1986, CAN J FISH AQUAT SCI, V43, P160, DOI 10.1139/f86-018; Beauchamp DA, 2009, AM FISHERIES SOC S, P19; Bollens SM, 2012, AQUAT INVASIONS, V7, P101, DOI 10.3391/ai.2012.7.1.011; Brachvogel R, 2013, MAR BIOL, V160, P465, DOI 10.1007/s00227-012-2104-5; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; BRETT JR, 1971, J FISH RES BOARD CAN, V28, P409, DOI 10.1139/f71-053; BRODEUR RD, 1992, CAN J FISH AQUAT SCI, V49, P1670, DOI 10.1139/f92-186; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burnham B K, 2002, MODEL SELECTION INFE; Chipps SR, 2008, T AM FISH SOC, V137, P298, DOI 10.1577/T05-236.1; Claiborne AM, 2014, MAR ECOL PROG SER, V515, P187, DOI 10.3354/meps10963; Connor WP, 2012, T AM FISH SOC, V141, P1207, DOI 10.1080/00028487.2012.685121; Coutant C. C., 2006, RETURN RIVER RESTORI, P249; CRADDOCK DR, 1976, T AM FISH SOC, V105, P72, DOI 10.1577/1548-8659(1976)105<72:OAUOZB>2.0.CO;2; CULVER DA, 1985, CAN J FISH AQUAT SCI, V42, P1380, DOI 10.1139/f85-173; Cummins KW, 1971, INT ASS THEOR APPL L, V18; DART (Data access in real time), 2016, DART DAT ACC REAL TI; DAUBLE DD, 1989, FISH B-NOAA, V87, P775; Dick JTA, 2013, BIOL INVASIONS, V15, P837, DOI 10.1007/s10530-012-0332-8; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Duffy EJ, 2010, T AM FISH SOC, V139, P803, DOI 10.1577/T08-244.1; EGGERS DM, 1979, J FISH RES BOARD CAN, V36, P1018, DOI 10.1139/f79-141; Emerson JE, 2015, AQUAT INVASIONS, V10, P25, DOI 10.3391/ai.2015.10.1.03; Gadomski DM, 1998, ENVIRON BIOL FISH, V51, P353, DOI 10.1023/A:1007485015830; Galbreath GC, 2000, MANUAL FISHERIES SUR; Gilbreath LG, 2000, LIMNOLOGICAL INVESTI, P140; Gosselain V, 1998, FRESHWATER BIOL, V39, P9, DOI 10.1046/j.1365-2427.1998.00258.x; Guo Z, 2016, ECOL FRESHW FISH; Hanson P. C., 1997, WISCUT97001 U WISC S; Hartman KJ, 2007, BIOENERGETICS ANAL I, P515; Haskell CA, 2017, ECOL FRESHW FISH, P1; Haskell CA, 2006, RIVER RES APPL, V22, P739, DOI 10.1002/rra.927; Haskell CA, 2006, NORTHWEST SCI, V80, P47; Haskell CA, 2017, T AM FISH SOC, V146, P291, DOI 10.1080/00028487.2016.1264997; Haskell CA, 2013, T AM FISH SOC, V142, P606, DOI 10.1080/00028487.2012.728164; Huntington C, 1996, FISHERIES, V21, P6, DOI 10.1577/1548-8446(1996)021&lt;0006:ASOHNS&gt;2.0.CO;2; Huusko A, 2011, FUNCT ECOL, V25, P628, DOI 10.1111/j.1365-2435.2010.01808.x; Koski ML, 2002, CAN J FISH AQUAT SCI, V59, P707, DOI 10.1139/F02-045; LUECKE C, 1993, T AM FISH SOC, V122, P386, DOI 10.1577/1548-8659(1993)122<0386:NETEDO>2.3.CO;2; Madenjian CP, 2004, CAN J FISH AQUAT SCI, V61, P627, DOI [10.1139/f04-033, 10.1139/F04-033]; Mains EM, 1956, DISTRIBUTION SIZE TI; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Marine KR, 2004, N AM J FISH MANAGE, V24, P198, DOI 10.1577/M02-142; McConnaha WE, 2006, RETURN RIVER RESTORI, P1; Moss JH, 2007, J FISH BIOL, V70, P610, DOI 10.1111/j.1095-8649.2007.01340.x; Moss JH, 2009, DEEP-SEA RES PT II, V56, P2553, DOI 10.1016/j.dsr2.2009.03.005; MUIR W D, 1988, Regulated Rivers Research and Management, V2, P1, DOI 10.1002/rrr.3450020102; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; NMFS (National Marine Fisheries Service), 1992, FED REGISTER, V57, P14653; PACE ML, 1992, CAN J FISH AQUAT SCI, V49, P1060, DOI 10.1139/f92-117; Plumb JM, 2015, T AM FISH SOC, V144, P323, DOI 10.1080/00028487.2014.986336; PTAGIS (Pit Tag Information System), 2016, COL BAS PIT TAG INF; Quinn T. P., 2004, BEHAV ECOLOGY PACIFI; REAL LA, 1979, ECOLOGY, V60, P481, DOI 10.2307/1936067; RONDORF DW, 1990, T AM FISH SOC, V119, P16, DOI 10.1577/1548-8659(1990)119&lt;0016:FEOSCS&gt;2.3.CO;2; Schindler DE, 2005, ECOLOGY, V86, P198, DOI 10.1890/03-0408; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; STEWART DJ, 1991, CAN J FISH AQUAT SCI, V48, P909, DOI 10.1139/f91-107; Stockwell JD, 1999, T AM FISH SOC, V128, P169, DOI 10.1577/1548-8659(1999)128&lt;0169:KFADIT&gt;2.0.CO;2; Thompson JN, 2016, J FISH BIOL, V89, P1720, DOI 10.1111/jfb.13078; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Trudel M, 2005, N AM J FISH MANAGE, V25, P374, DOI 10.1577/M04-018.1; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353	65	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185933	10.1371/journal.pone.0185933	http://dx.doi.org/10.1371/journal.pone.0185933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020032	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400053
J	Dardmeh, F; Alipour, H; Gazerani, P; van der Horst, G; Brandsborg, E; Nielsen, HI				Dardmeh, Fereshteh; Alipour, Hiva; Gazerani, Parisa; van der Horst, Gerhard; Brandsborg, Erik; Nielsen, Hans Ingolf			Lactobacillus rhamnosus PB01 (DSM 14870) supplementation affects markers of sperm kinematic parameters in a diet-induced obesity mice model	PLOS ONE			English	Article							BODY-MASS INDEX; HIGH-FAT DIET; DECREASED ANDROGEN LEVELS; SEMEN QUALITY; OXIDATIVE STRESS; REPRODUCTIVE HORMONES; LINOLEIC-ACID; C57BL/6 MICE; IN-VITRO; MEN	Probiotics have been proposed as alternatives to pharmacological products in several medical conditions including the modulation of obesity, which is frequently associated with poor semen quality. However, effects of probiotics on male fertility have been less investigated. This study assessed the effect of Lactobacillus rhamnosus PB01 (DSM-14870) on sperm kinematic parameters in Normal-weight (NW) and diet-induced obese (DIO) models. NW and DIO C57BL/6NTac mice were divided into two subgroups with or without a single daily dose (1x10(9)CFU) of L. rhamnosus for four weeks. Sperm motility and kinematics together with blood lipid profiles and reproductive hormone levels were assessed using the sperm class analyzer system. Probiotic supplementation increased serum testosterone, LH and FSH levels in both NW and DIO groups resulting in significantly (P<0.05) higher velocity (VSL, VCL and VAP) and percentages of progressively motile sperm and significantly lower percentages of immotile sperm. Other kinematic parameters (Lin, STR, ALH and BCF) were also increased in both probiotic supplemented DIO and NW groups at the 10% level of significance. Probiotic supplemented DIO mice demonstrated significantly higher percentages of progressively motile sperm versus DIO controls. This study demonstrated the potential of L. rhamnosus PB01 as a regulatory agent with positive effects on weight loss and reproductive-hormones, significantly improving sperm motility and kinematic parameters in male DIO models.	[Dardmeh, Fereshteh; Alipour, Hiva; Gazerani, Parisa; Nielsen, Hans Ingolf] Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Biomed Grp, Aalborg, Denmark; [Dardmeh, Fereshteh; Gazerani, Parisa] Aalborg Univ, SMI, Dept Hlth Sci & Technol, Fac Med, Aalborg, Denmark; [van der Horst, Gerhard] Univ Western Cape, Dept Med Biosci, Bellville, South Africa; [Brandsborg, Erik] Bifodan AS, Hundested, Denmark	Aalborg University; Aalborg University; University of the Western Cape	Dardmeh, F (corresponding author), Aalborg Univ, Fac Med, Dept Hlth Sci & Technol, Biomed Grp, Aalborg, Denmark.; Dardmeh, F (corresponding author), Aalborg Univ, SMI, Dept Hlth Sci & Technol, Fac Med, Aalborg, Denmark.	Feda@hst.aau.dk	Gazerani, Parisa/D-1540-2009; Van+der+Horst, Gerhard/AAB-7489-2020; Alipour, Hiva/D-1106-2010	Gazerani, Parisa/0000-0003-0109-3600; Alipour, Hiva/0000-0002-8500-4208; Dardmeh, Fereshteh/0000-0002-2034-0147	"Department of Health Science and Technology", Aalborg University, Aalborg, Denmark; Ferring pharmaceuticals; Department of Health Science and Technology (Aalborg University, Denmark)	"Department of Health Science and Technology", Aalborg University, Aalborg, Denmark; Ferring pharmaceuticals(Ferring Pharmaceuticals); Department of Health Science and Technology (Aalborg University, Denmark)	This study was supported by internal funding from the "Department of Health Science and Technology", Aalborg University, Aalborg, Denmark. The sperm class analyzer (SCA) computer aided sperm analysis (CASA) system was provided by a fund from Ferring pharmaceuticals to Aalborg University Hospital (H.I.N). Bifodan A/S provided the probiotic supplements used in this study. EB is employed at the Research and Development department of Bifodan A/S. EB provided scientific input on the preparation and use of the probiotics but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders ("Ferring pharmaceuticals" and "Bifodan A/S") provided support only in the form of the mentioned materials and instruments used in the study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank the Department of Health Science and Technology (Aalborg University, Denmark) for their research grant supporting this study, Bifodan A/S for providing the Probiotic supplements, the Staff at the animal facility of Aalborg University Hospital and Dr. Afshin Samani for his excellent guidance in statistical analysis.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Amann RP, 2004, J ANDROL, V25, P317; Amann RP, 2014, THERIOGENOLOGY, V81, P5, DOI 10.1016/j.theriogenology.2013.09.004; Angelakis E, 2013, LANCET INFECT DIS, V13, P889, DOI 10.1016/S1473-3099(13)70179-8; Ariagno JI, 2016, ASIAN J ANDROL; Arora T, 2013, NUTRITION, V29, P591, DOI 10.1016/j.nut.2012.07.017; Bakos HW, 2011, FERTIL STERIL, V95, P1700, DOI 10.1016/j.fertnstert.2010.11.044; Bieniek JM, 2016, FERTIL STERIL, V106, P1070, DOI 10.1016/j.fertnstert.2016.06.041; BROOKS DE, 1983, AUST J BIOL SCI, V36, P205, DOI 10.1071/BI9830205; Chen XL, 2013, ANIMAL, V7, P287, DOI 10.1017/S1751731112001528; Dardmeh F, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/5080438; Duty SM, 2004, J ANDROL, V25, P293; Fan YN, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005533; Fejes I, 2006, ARCH ANDROLOGY, V52, P97, DOI 10.1080/01485010500315479; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Fernandez CDB, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-32; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Gong T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140889; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Henderson NA, 2005, BIOL REPROD, V72, P436, DOI 10.1095/biolreprod.104.033548; Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Ibrahim HAM, 2012, BIOL TRACE ELEM RES, V147, P251, DOI 10.1007/s12011-011-9308-2; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Jungheim ES, 2012, OBSTET GYN CLIN N AM, V39, P479, DOI 10.1016/j.ogc.2012.09.002; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054617; Kim M, 2013, BIOMOL THER, V21, P476, DOI 10.4062/biomolther.2013.063; Kondo S, 2010, BIOSCI BIOTECH BIOCH, V74, P1656, DOI 10.1271/bbb.100267; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ljiljak D, 2012, ADVANCES IN EMBRYO TRANSFER, P65; Magnusdottir EV, 2005, HUM REPROD, V20, P208, DOI 10.1093/humrep/deh569; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Maretti C, 2017, ANDROLOGY-US, V5, P439, DOI 10.1111/andr.12336; Martinez AIP, 2004, ANIM REPROD SCI, V82-3, P209, DOI 10.1016/j.anireprosci.2004.04.024; Mortimer ST, 2015, ASIAN J ANDROL, V17, P545, DOI 10.4103/1008-682X.154312; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Ooi LG, 2010, INT J MOL SCI, V11, P2499, DOI 10.3390/ijms11062499; ORGEBINCRIST MC, 1973, NATURE, V245, P328, DOI 10.1038/245328a0; Oyeyipo I. P., 2015, Asian Pacific Journal of Reproduction, V4, P236; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Palmer NO, 2012, AM J PHYSIOL-ENDOC M, V5005, P768; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Pavlovich CP, 2001, J UROLOGY, V165, P837, DOI 10.1016/S0022-5347(05)66540-8; Pinto-Fochi ME, 2016, REPRODUCTION, V152, P795, DOI 10.1530/REP-16-0072; Poutahidis T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084877; Purohit Ashok, 1999, Indian Journal of Experimental Biology, V37, P396; Qin DD, 2007, ASIAN J ANDROL, V9, P827, DOI 10.1111/j.1745-7262.2007.00268.x; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Schettgen T, 2002, J CHROMATOGR B, V778, P121, DOI 10.1016/S0378-4347(01)00452-2; Sekhavat L, 2010, AGING MALE, V13, P155, DOI 10.3109/13685530903536643; Shalaby MA, 2004, PHARMACOL RES, V50, P137, DOI 10.1016/j.phrs.2003.10.013; Sousa R, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-5; Su HM, 2016, J ZHEJIANG UNIV-SC B, V17, P437, DOI 10.1631/jzus.B1600074; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Suresh S, 2010, INT J ANDROL, V33, P22, DOI 10.1111/j.1365-2605.2008.00949.x; Takemura N, 2010, EXP BIOL MED, V235, P849, DOI 10.1258/ebm.2010.009377; Toocheck C, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.132068; van der Horst G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-351; Vermeulen A, 1996, ANN MED, V28, P13, DOI 10.3109/07853899608999068; Walker William H, 2011, Spermatogenesis, V1, P116; Williams LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106159; Winters SJ, 2006, J ANDROL, V27, P560, DOI 10.2164/jandrol.05193	72	40	40	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185964	10.1371/journal.pone.0185964	http://dx.doi.org/10.1371/journal.pone.0185964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016685	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400044
J	Dong, LY; Liu, SF; Xu, P; Deng, W; Li, XD; Tharreau, D; Li, J; Zhou, JW; Wang, Q; Tao, DY; Yang, QZ				Dong, Liying; Liu, Shufang; Xu, Peng; Deng, Wei; Li, Xundong; Tharreau, Didier; Li, Jing; Zhou, Jiawu; Wang, Qun; Tao, Dayun; Yang, Qinzhong			Fine mapping of Pi57(t) conferring broad spectrum resistance against Magnaporthe oryzae in introgression line IL-E1454 derived from Oryza longistaminata	PLOS ONE			English	Article							RICE BLAST RESISTANCE; RECESSIVE GENE; RECOMBINATION FREQUENCY; IDENTIFICATION; CULTIVAR; GRISEA; INDICA; DNA	Wild species of the genus Oryza are excellent gene pools for improvement of agronomic traits of Asian cultivated rice. The blast resistance gene Pi57(t) in the introgression line IL-E1454 derived from Oryza longistaminata was previously mapped on rice chromosome 12. Inoculation with 322 Magnaporthe oryzae isolates collected from 6 countries indicated that Pi57(t) conferred broad spectrum resistance against M. oryzae. Two mapping populations consisting of 29070 and 10375 F-2 plants derived from the crosses of resistant donor IL-E1454 with susceptible parents RD23 and Lijiangxintuanheigu respectively, were used for fine mapping of Pi57(t) locus. Based on genotyping and phenotyping results of recombinants screened from the two crosses, Pi57(t) was finally mapped to a 51.7-kb region flanked by two molecular markers (STS57-320 and STS57-372) on the short arm and close to the centromere of chromosome 12. Six candidate resistance genes were predicted in the target region according to the reference sequence of Nipponbare. These results could facilitate both marker-assisted selection for disease-resistant breeding and gene cloning.	[Dong, Liying; Liu, Shufang; Li, Xundong; Wang, Qun; Yang, Qinzhong] Yunnan Acad Agr Sci, Agr Environm & Resources Inst, Kunming, Yunnan, Peoples R China; [Xu, Peng; Deng, Wei; Li, Jing; Zhou, Jiawu; Tao, Dayun] Yunnan Acad Agr Sci, Food Crops Inst, Kunming, Yunnan, Peoples R China; [Xu, Peng] Xishuangbanna Trop Bot Garden, Key Lab Trop Plant Resources & Sustainable Use, Kunming, Yunnan, Peoples R China; [Tharreau, Didier] UMR BGPI, Ctr Cooperat Int Rech Agron Dev, Montpellier, France	Yunnan Academy of Agricultural Sciences; Yunnan Academy of Agricultural Sciences; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; CIRAD	Yang, QZ (corresponding author), Yunnan Acad Agr Sci, Agr Environm & Resources Inst, Kunming, Yunnan, Peoples R China.; Tao, DY (corresponding author), Yunnan Acad Agr Sci, Food Crops Inst, Kunming, Yunnan, Peoples R China.	taody12@aliyun.com; qzhyang@163.com	Tharreau, Didier/AAI-8632-2020; Li, xundong/GOH-1297-2022; Zhou, Jiawu/AAJ-1963-2021; Tao, Dayun/AAI-8321-2020; Tharreau, Didier/ABH-1048-2021	Tharreau, Didier/0000-0003-3961-6120; Tao, Dayun/0000-0002-8884-1589	National Natural Science Foundation of China [31360462, 31560493]; Yunnan Provincial Science and Technology Department [20141A009]; Special Fund for Agro-Scientific Research in the Public Interest [201303129]; Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department; Special Fund for Agro-Scientific Research in the Public Interest; Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China	This research was supported by grants from National Natural Science Foundation of China (31360462, 31560493) to Qinzhong Yang, Yunnan Provincial Science and Technology Department (20141A009) to Qinzhong Yang, the Special Fund for Agro-Scientific Research in the Public Interest (201303129), Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr. Khay S, Dr. Douangboupha B, Dr. Somrith A and Dr. Chung NH for the provision of blast isolates. This research was supported by grants from National Natural Science Foundation of China (31360462, 31560493), Yunnan Provincial Science and Technology Department (20141A009), the Special Fund for Agro-Scientific Research in the Public Interest (201303129), Scientific Observing and Experimental Station of Crops Pests in Kunming, Ministry of Agriculture, China.	Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deng YW, 2017, SCIENCE, V355, P962, DOI 10.1126/science.aai8898; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Farkhari M, 2011, PLANT BREEDING, V130, P533, DOI 10.1111/j.1439-0523.2011.01866.x; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; He XY, 2012, SCI CHINA LIFE SCI, V55, P141, DOI 10.1007/s11427-012-4282-2; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jia YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043066; Koide Y, 2013, MOL BREEDING, V32, P241, DOI 10.1007/s11032-013-9865-5; Kumar P, 2010, MOL BREEDING, V25, P217, DOI 10.1007/s11032-009-9320-9; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lei CL, 2013, CROP J, V1, P2, DOI 10.1016/j.cj.2013.07.007; Li W, 2008, MOL BREEDING, V22, P141, DOI 10.1007/s11032-008-9163-9; Liang ZJ, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0120-7; Liao JJ, 2016, ELIFE, V5, DOI [10.7554/eLife.19377, 10.7554/elife.19377]; Liu XQ, 2007, MOL GENET GENOMICS, V278, P403, DOI 10.1007/s00438-007-0258-5; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; OU SH, 1985, COMMONWEALTH MYCOLOG, P109; Raboin LM, 2012, PLANT PATHOL, V61, P1103, DOI 10.1111/j.1365-3059.2012.02602.x; Sallaud C, 2003, THEOR APPL GENET, V106, P794, DOI 10.1007/s00122-002-1088-9; Sester M, 2014, PLANT PATHOL, V63, P373, DOI 10.1111/ppa.12099; SILUE D, 1992, PHYTOPATHOLOGY, V82, P577, DOI 10.1094/Phyto-82-577; Su J, 2015, THEOR APPL GENET, V128, P2213, DOI 10.1007/s00122-015-2579-9; Wang R, 2016, MATH PROBLEMS ENG, V2016, P1, DOI DOI 10.1016/J.NEUR0SCIENCE.2016.08.051; Wu JZ, 2003, PLANT J, V36, P720, DOI 10.1046/j.1365-313X.2003.01903.x; Xu P, 2015, EUPHYTICA, V205, P95, DOI 10.1007/s10681-015-1402-7; Yang QZ, 2009, THEOR APPL GENET, V118, P1027, DOI 10.1007/s00122-008-0959-0; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeigler R. S., 1994, RICE BLAST DIS, P16; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	37	13	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186201	10.1371/journal.pone.0186201	http://dx.doi.org/10.1371/journal.pone.0186201			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016662	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400059
J	Eloot, S; Van Biesen, W; Roels, S; Delrue, W; Schepers, E; Dhondt, A; Vanholder, R; Glorieux, G				Eloot, Sunny; Van Biesen, Wim; Roels, Sanne; Delrue, Willem; Schepers, Eva; Dhondt, Annemieke; Vanholder, Raymond; Glorieux, Griet			Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; P-CRESOL; ASYMMETRICAL DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; SYNBIOTIC TREATMENT; RENAL-FAILURE; MORTALITY; SOLUTES; TRIAL	Background and aim Numerous outcome studies and interventional trials in hemodialysis (HD) patients are based on uremic toxin concentrations determined at one single or a limited number of time points. The reliability of these studies however entirely depends on how representative these cross-sectional concentrations are. We therefore investigated the variability of predialysis concentrations of uremic toxins over time. Methods Prospectively collected predialysis serum samples of the midweek session of week 0, 1, 2, 3, 4, 8, 12, and 16 were analyzed for a panel of uremic toxins in stable chronic HD patients (N = 18) while maintaining dialyzer type and dialysis mode during the study period. Results Concentrations of the analyzed uremic toxins varied substantially between individuals, but also within stable HD patients (intra-patient variability). For urea, creatinine, beta-2-micro-globulin, and some protein-bound uremic toxins, Intra-class Correlation Coefficient (ICC) was higher than 0.7. However, for phosphorus, uric acid, symmetric and asymmetric dimethylarginine, and the protein-bound toxins hippuric acid and indoxyl sulfate, ICC values were below 0.7, implying a concentration variability within the individual patient even exceeding 65% of the observed inter-patient variability. Conclusion Intra-patient variability may affect the interpretation of the association between a single concentration of certain uremic toxins and outcomes. When performing future outcome and interventional studies with uremic toxins other than described here, one should quantify their intra-patient variability and take into account that for solutes with a large intra-patient variability associations could be missed.	[Eloot, Sunny; Van Biesen, Wim; Delrue, Willem; Schepers, Eva; Dhondt, Annemieke; Vanholder, Raymond; Glorieux, Griet] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium; [Roels, Sanne] Univ Ghent, Dept Data Anal, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	Eloot, S (corresponding author), Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium.	sunny.eloot@ugent.be			Belgian Fund for Research Flanders (FWO Vlaanderen) [G0A4614N]	Belgian Fund for Research Flanders (FWO Vlaanderen)	This study was financially supported by the Belgian Fund for Research Flanders (FWO Vlaanderen, project number G0A4614N).	Bammens B, 2006, KIDNEY INT, V69, P1081, DOI 10.1038/sj.ki.5000115; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Crespo-Salgado J, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0195-9; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Deltombe O, 2017, ANAL METHODS-UK, V9, P1935, DOI 10.1039/c7ay00054e; Dou L, 2015, J AM SOC NEPHROL, V26, P876, DOI 10.1681/ASN.2013121283; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; FLEISS JL, 1986, CONTROL CLIN TRIALS, V7, P267, DOI 10.1016/0197-2456(86)90034-6; Guida B, 2014, NUTR METAB CARDIOVAS, V24, P1043, DOI 10.1016/j.numecd.2014.04.007; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Liabeuf S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067168; Liabeuf S, 2012, KIDNEY INT, V82, P1297, DOI 10.1038/ki.2012.301; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; Lu TM, 2011, CLIN J AM SOC NEPHRO, V6, P1566, DOI 10.2215/CJN.08490910; Meert N, 2012, NEPHROL DIAL TRANSPL, V27, P2388, DOI 10.1093/ndt/gfr672; Meert N, 2010, ARTIF ORGANS, V34, P580, DOI 10.1111/j.1525-1594.2010.01005.x; Meert N, 2009, J NEPHROL, V22, P352; Nakabayashi I, 2011, NEPHROL DIAL TRANSPL, V26, P1094, DOI 10.1093/ndt/gfq624; Nakazato Y, 2015, CLIN EXP NEPHROL, V19, P1165, DOI 10.1007/s10157-015-1108-0; Nazzal L, 2017, NEPHROL DIAL TRANSPL; Poesen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140820; Raj DSC, 2000, NEPHROL DIAL TRANSPL, V15, P58, DOI 10.1093/ndt/15.1.58; Rossi M, 2016, CLIN J AM SOC NEPHRO, V11, P223, DOI 10.2215/CJN.05240515; Santoro A, 2008, AM J KIDNEY DIS, V52, P507, DOI 10.1053/j.ajkd.2008.05.011; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Yilmaz MI, 2008, J AM SOC NEPHROL, V19, P388, DOI 10.1681/ASN.2007040461; Zewinger S, 2017, EUR HEART J, V38, P1597, DOI 10.1093/eurheartj/ehx118; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	34	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186010	10.1371/journal.pone.0186010	http://dx.doi.org/10.1371/journal.pone.0186010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016645	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400048
J	Park, HJ; Park, YM; Kim, JH; Lee, HS; Kim, HJ; Ahn, CM; Byun, MK				Park, Hye Jung; Park, Yoo Mi; Kim, Jie-Hyun; Lee, Hye Sun; Kim, Hyung Jung; Ahn, Chul Min; Byun, Min Kwang			Effectiveness of proton pump inhibitor in unexplained chronic cough	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; CLINICAL-PRACTICE GUIDELINES; DOUBLE-BLIND; PRIMARY-CARE; MANAGEMENT; OMEPRAZOLE; DIAGNOSIS; SYMPTOMS; ASTHMA; PATHOGENESIS	Background Current guidelines recommend that patients with unexplained chronic cough undergo empirical proton pump inhibitor (PPI) treatment, but scientific evidence for this treatment is lacking. We investigated the effectiveness and appropriate dose of PPI therapy in chronic cough. Methods We included 27 patients with unexplained chronic cough after excluding subjects with positive response to postnasal drip medication. Subjects were randomized to a placebo, standard, and high dose of PPI groups with blinding. The drug or placebo was administered orally for 8 weeks, and the Leicester Cough Questionnaire (LCQ) score and visual analogue scale (VAS) scores were collected. Results The LCQ score in the PPI group significantly improved from 0 weeks (11.4 +/- 1.4) to 4 weeks (14.8 +/- 1.4) and to 8 weeks (17.1 +/- 1.4), whereas that in the placebo group did not improve from 0 weeks (13.7 +/- 1.1) to 8 weeks (11.8 +/- 1.4); the difference between the 2 groups was significant (P < 0.001). In subgroup analysis according to reflux, significant improvements in the LCQ score were observed in the PPI group regardless of reflux (P < 0.001 in the reflux group and P < 0.001 in the no reflux group, respectively; P = 0.188 between the 2 groups). In addition, improvements in LCQ and VAS scores between the standard- and high-dose PPI groups were not significantly different; however, adverse reactions were induced by only the high dose (16.7%). Conclusions The results of this pilot study support the empirical use of the standard dose of PPI for 8 weeks in patients suffering from unexplained chronic cough regardless of whether reflux is present.	[Park, Hye Jung; Park, Yoo Mi; Kim, Jie-Hyun; Kim, Hyung Jung; Ahn, Chul Min; Byun, Min Kwang] Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Byun, MK (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea.	littmann@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019; Lee, Hye Sun/J-2154-2015	Kim, Jie-Hyun/0000-0002-9198-3326; Byun, Min Kwang/0000-0003-1525-1745; Park, Hye Jung/0000-0002-1862-1003; Park, YooMi/0000-0002-3642-7300; Lee, Hye Sun/0000-0001-6328-6948	Hanmi Pharmaceutical Co., Ltd.	Hanmi Pharmaceutical Co., Ltd.	Hanmi Pharmaceutical Co., Ltd., provided investigational drugs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Chang AB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004823.pub3; Charbel S, 2005, AM J GASTROENTEROL, V100, P283, DOI 10.1111/j.1572-0241.2005.41210.x; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; Dellon ES, 2013, AM J GASTROENTEROL, V108, P679, DOI 10.1038/ajg.2013.71; ENRIGHT PL, 1994, CHEST, V106, P827, DOI 10.1378/chest.106.3.827; Faruqi S, 2011, RESPIROLOGY, V16, P1150, DOI 10.1111/j.1440-1843.2011.02014.x; Fock KM, 2008, J GASTROEN HEPATOL, V23, P8, DOI 10.1111/j.1440-1746.2007.05249.x; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Gibson P, 2016, CHEST, V149, P27, DOI 10.1378/chest.15-1496; Harding SM, 1999, J ALLERGY CLIN IMMUN, V104, P251, DOI 10.1016/S0091-6749(99)70360-X; ING AJ, 1994, AM J RESP CRIT CARE, V149, P160, DOI 10.1164/ajrccm.149.1.8111576; IRWIN RS, 1993, CHEST, V104, P1511, DOI 10.1378/chest.104.5.1511; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Irwin RS, 2002, PULM PHARMACOL THER, V15, P261, DOI 10.1006/pupt.2002.0348; Iwakiri K, 2016, J GASTROENTEROL, V51, P751, DOI 10.1007/s00535-016-1227-8; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; Jones R, 2009, ALIMENT PHARM THER, V30, P1030, DOI 10.1111/j.1365-2036.2009.04142.x; Jung HS, 2013, J NEUROGASTROENTEROL, V19, P338, DOI 10.5056/jnm.2013.19.3.338; Kiljander TO, 2000, EUR RESPIR J, V16, P633, DOI 10.1034/j.1399-3003.2000.16d11.x; Kiljander TO, 1999, CHEST, V116, P1257, DOI 10.1378/chest.116.5.1257; Kiljander TO, 2003, AM J MED, V115, p65S, DOI 10.1016/S0002-9343(03)00196-7; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Noordzij JP, 2001, LARYNGOSCOPE, V111, P2147, DOI 10.1097/00005537-200112000-00013; Ours TM, 1999, AM J GASTROENTEROL, V94, P3131, DOI 10.1111/j.1572-0241.1999.01504.x; Park HJ, 2014, ALLERGY ASTHMA IMMUN, V6, P222, DOI 10.4168/aair.2014.6.3.222; Pavord ID, 2008, LANCET, V371, P1375, DOI 10.1016/S0140-6736(08)60596-6; Polley L, 2008, CHEST, V134, P295, DOI 10.1378/chest.07-0141; Pratter MR, 2006, CHEST, V129, p222S, DOI 10.1378/chest.129.1_suppl.222S; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Shaheen NJ, 2011, ALIMENT PHARM THER, V33, P225, DOI 10.1111/j.1365-2036.2010.04511.x; Sharma VK, 2001, ALIMENT PHARM THERAP, V15, P227, DOI 10.1046/j.1365-2036.2001.00904.x; Woodwell David A, 2004, Adv Data, P1	37	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185397	10.1371/journal.pone.0185397	http://dx.doi.org/10.1371/journal.pone.0185397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016626	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400016
J	Schriever, VA; Han, PF; Weise, S; Hosel, F; Pellegrino, R; Hummel, T				Schriever, Valentin Alexander; Han, Pengfei; Weise, Stefanie; Hoesel, Franziska; Pellegrino, Robert; Hummel, Thomas			Time frequency analysis of olfactory induced EEG-power change	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS CONCENTRATION; TRIGEMINAL STIMULI; IDENTIFICATION; VOLUME	Objectives The objective of the present study was to investigate the usefulness of time-frequency analysis (TFA) of olfactory-induced EEG change with a low-cost, portable olfactometer in the clinical investigation of smell function. Materials & methods A total of 78 volunteers participated. The study was composed of three parts where olfactory stimuli were presented using a custom-built olfactometer. Part I was designed to optimize the stimulus as well as the recording conditions. In part II EEG-power changes after olfactory/trigeminal stimulation were compared between healthy participants and patients with olfactory impairment. In Part III the test-retest reliability of the method was evaluated in healthy subjects. Results Part I indicated that the most effective paradigm for stimulus presentation was cued stimulus, with an interstimulus interval of 18-20s at a stimulus duration of 1000ms with each stimulus quality presented 60 times in blocks of 20 stimuli each. In Part II we found that central processing of olfactory stimuli analyzed by TFA differed significantly between healthy controls and patients even when controlling for age. It was possible to reliably distinguish patients with olfactory impairment from healthy individuals at a high degree of accuracy (healthy controls vs anosmic patients: sensitivity 75%; specificity 89%). In addition we could show a good test-retest reliability of TFA of chemosensory induced EEG-power changes in Part III. Conclusions Central processing of olfactory stimuli analyzed by TFA reliably distinguishes patients with olfactory impairment from healthy individuals at a high degree of accuracy. Importantly this can be achieved with a simple olfactometer.	[Schriever, Valentin Alexander; Han, Pengfei; Weise, Stefanie; Hoesel, Franziska; Pellegrino, Robert; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Schriever, Valentin Alexander] Tech Univ Dresden, Abt Neuropadiat Med Fak Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hummel, T (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	Thomas.hummel@uniklinikum-dresden.de	Pellegrino, Robert/L-1719-2019	Han, Pengfei/0000-0001-8266-6655	Dr. Robert Pfleger Stiftung; German Research Foundation; TU Dresden	Dr. Robert Pfleger Stiftung; German Research Foundation(German Research Foundation (DFG)); TU Dresden(European Commission)	This study was supported by the Dr. Robert Pfleger Stiftung to VAS and TH, the German Research Foundation, and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Dr. Robert Pfleger Stiftung to VAS and TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Boesveldt S, 2007, CLIN NEUROPHYSIOL, V118, P690, DOI 10.1016/j.clinph.2006.11.004; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; EVANS WJ, 1993, CHEM SENSES, V18, P751, DOI 10.1093/chemse/18.6.751; Frasnelli J, 2011, CHEM SENSES, V36, P405, DOI 10.1093/chemse/bjr001; Frasnelli J, 2003, J CLIN NEUROPHYSIOL, V20, P80, DOI 10.1097/00004691-200302000-00011; Geisler MW, 2000, INT J PSYCHOPHYSIOL, V37, P309, DOI 10.1016/S0167-8760(00)00111-2; Huart C, 2013, RHINOLOGY, V51, P210, DOI [10.4193/Rhin13.007, 10.4193/Rhino13.007]; Huart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033221; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOBAL G, 1978, EEG-EMG-Z ELEK ELEKT, V9, P135; LIVERMORE A, 1992, ELECTROEN CLIN NEURO, V83, P201, DOI 10.1016/0013-4694(92)90145-8; Lotsch J, 2006, BEHAV BRAIN RES, V170, P78, DOI 10.1016/j.bbr.2006.02.013; Lorig TS, 2000, INT J PSYCHOPHYSIOL, V36, P91, DOI 10.1016/S0167-8760(99)00104-X; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; Morgan CD, 1999, PSYCHOPHYSIOLOGY, V36, P281, DOI 10.1017/S0048577299980265; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Stuck BA, 2006, CLIN NEUROPHYSIOL, V117, P1367, DOI 10.1016/j.clinph.2006.03.004; Welge-Lussen A, 2003, J CLIN NEUROPHYSIOL, V20, P135, DOI 10.1097/00004691-200304000-00008	19	19	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185596	10.1371/journal.pone.0185596	http://dx.doi.org/10.1371/journal.pone.0185596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016623	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400024
J	Kushanov, FN; Buriev, ZT; Shermatov, SE; Turaev, OS; Norov, TM; Pepper, AE; Saha, S; Ulloa, M; Yu, JZ; Jenkins, JN; Abdukarimov, A; Abdurakhmonov, IY				Kushanov, Fakhriddin N.; Buriev, Zabardast T.; Shermatov, Shukhrat E.; Turaev, Ozod S.; Norov, Tokhir M.; Pepper, Alan E.; Saha, Sukumar; Ulloa, Mauricio; Yu, John Z.; Jenkins, Johnie N.; Abdukarimov, Abdusattor; Abdurakhmonov, Ibrokhim Y.			QTL mapping for flowering-time and photoperiod insensitivity of cotton Gossypium darwinii Watt	PLOS ONE			English	Article							PROTEIN-KINASE CK2; QUANTITATIVE TRAIT LOCUS; HIRSUTUM L. GERMPLASM; FIBER QUALITY TRAITS; 1ST FRUITING BRANCH; UPLAND COTTON; LINKAGE DISEQUILIBRIUM; MOLECULAR DIVERSITY; BARBADENSE L.; GENETIC-MAP	Most wild and semi-wild species of the genus Gossypium are exhibit photoperiod-sensitive flowering. The wild germplasm cotton is a valuable source of genes for genetic improvement of modern cotton cultivars. A bi-parental cotton population segregating for photoperiodic flowering was developed by crossing a photoperiod insensitive irradiation mutant line with its pre-mutagenesis photoperiodic wild-type G. darwinii Watt genotype. Individuals from the F-2 and F-3 generations were grown with their parental lines and F-1 hybrid progeny in the long day and short night summer condition (natural day-length) of Uzbekistan to evaluate photoperiod sensitivity, i.e., flowering-time during the seasons 2008-2009. Through genotyping the individuals of this bi-parental population segregating for flowering-time, linkage maps were constructed using 212 simple-sequence repeat (SSR) and three cleaved amplified polymorphic sequence (CAPS) markers. Six QTLs directly associated with flowering-time and photoperiodic flowering were discovered in the F-2 population, whereas eight QTLs were identified in the F-3 population. Two QTLs controlling photoperiodic flowering and duration of flowering were common in both populations. In silico annotations of the flanking DNA sequences of mapped SSRs from sequenced cotton (G. hirsutum L.) genome database has identified several potential 'candidate' genes that are known to be associated with regulation of flowering characteristics of plants. The outcome of this research will expand our understanding of the genetic and molecular mechanisms of photoperiodic flowering. Identified markers should be useful for marker-assisted selection in cotton breeding to improve early flowering characteristics.	[Kushanov, Fakhriddin N.; Buriev, Zabardast T.; Shermatov, Shukhrat E.; Turaev, Ozod S.; Norov, Tokhir M.; Abdukarimov, Abdusattor; Abdurakhmonov, Ibrokhim Y.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Lab Struct & Funct Genom, Tashkent, Uzbekistan; [Pepper, Alan E.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Saha, Sukumar; Jenkins, Johnie N.] USDA ARS, Crop Sci Res Lab, Starkville, MS USA; [Ulloa, Mauricio] USDA ARS, Plant Stress & Germplasm Dev Res, Lubbock, TX USA; [Yu, John Z.] USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX USA	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Abdurakhmonov, IY (corresponding author), Acad Sci Uzbek, Ctr Genom & Bioinformat, Lab Struct & Funct Genom, Tashkent, Uzbekistan.	genomics@uzsci.net	Norov, Tokhir/AAA-9428-2021; Buriev, Zabardast/AAE-2579-2021; Shermatov, Shukhrat/H-1186-2015; Kushanov, Fakhriddin/C-9483-2018; To'rayev, Ozod/ABE-4791-2021; Turaev, Ozod/AAA-5527-2022; Abdurakhmonov, Ibrokhim Y./F-5588-2015; Kushanov, Fakhriddin/N-9968-2019	Shermatov, Shukhrat/0000-0002-1864-8126; Kushanov, Fakhriddin/0000-0001-8446-8118; Turaev, Ozod/0000-0002-6379-312X; Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Buriev, Zabardast/0000-0001-7737-9168	Academy of Sciences of Uzbekistan; Science and Technology Agency [FA-F5-T030, FA-A6-T081, FA-A6-T085, YF5-FA-T-005]; FNK; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF) [P121/P121B, P120/P120A]; Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	Academy of Sciences of Uzbekistan; Science and Technology Agency; FNK; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF); Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	This work was supported by the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan Currently renamed as Science and Technology Agency) have provided basic science research grant No. FA-F5-T030 to IYA, and several applied research grants No.FA-A6-T081, FA-A6-T085 and YF5-FA-T-005 to IYA and FNK and the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) have provided international cooperative grants P121/P121B, and P120/P120A to IYA, AEP, SS, JZY, and JNJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan for basic science (FA-F5-T030), and several applied (FA-A6-T081, FA-A6-T085 and YF5-FA-T-005) research grants. We greatly acknowledge the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) for international cooperative grants P121/P121B, and P120/P120A, which were devoted to study cotton flowering and genetic mapping of agronomic traits. We thank the Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan for capacity funding of the Center of Genomics and Bioinformatics, Uzbekistan. We greatly acknowledge the Uzbek and US partner laboratories for the assistance with molecular mapping experiments described in this work. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. The US Department of Agriculture is equal an opportunity provider and employer.	Abdurakhmonov IY, 2007, EUPHYTICA, V156, P141, DOI 10.1007/s10681-007-9361-2; Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov IY, 2007, J HERED, V98, P258, DOI 10.1093/jhered/esm007; Abdurakhmonov IY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4062; Abdurakhmonov IY, 2012, GENETIC DIVERSITY IN PLANTS, P313; Abdurakhmonov IY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-119; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Abdurakhmonov IY, 2016, PLANT SCI, V7, P202, DOI DOI 10.3389/FPLS.2016.00202; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Casal JJ, 2000, PHOTOCHEM PHOTOBIOL, V71, P1, DOI 10.1562/0031-8655(2000)071&lt;0001:PCPPII&gt;2.0.CO;2; Chen HD, 2015, GENE, V574, P273, DOI 10.1016/j.gene.2015.08.022; Chen Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078254, 10.1371/journal.pone.0080879, 10.1371/journal.pone.0080419]; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fankhauser C, 1997, ANNU REV CELL DEV BI, V13, P203, DOI 10.1146/annurev.cellbio.13.1.203; Garner WW, 1923, J AGRIC RES, V23, P0871; Godoy AS, 1999, EUPHYTICA, V105, P155, DOI 10.1023/A:1003490016166; Guo YF, 2008, EUPHYTICA, V163, P113, DOI 10.1007/s10681-007-9613-1; Guo YF, 2009, EUPHYTICA, V166, P317, DOI 10.1007/s10681-008-9809-z; Gutierrrez OA, 2010, THEOR APPL GENET, V121, P1323, DOI 10.1007/s00122-010-1391-9; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Jia YH, 2014, J INTEGR AGR, V13, P1845, DOI 10.1016/S2095-3119(13)60668-1; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kushanov FN, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0448-4; Lai D, 2011, PLOS ONE, V6, P1; Li CQ, 2013, BREEDING SCI, V63, P154, DOI 10.1270/jsbbs.63.154; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Muhammad Iqbal, 2013, World Applied Sciences Journal, V21, P1062; Mulekar JJ, 2014, J EXP BOT, V65, P2883, DOI 10.1093/jxb/ert401; Mulekar JJ, 2012, PLANT J, V69, P343, DOI 10.1111/j.1365-313X.2011.04794.x; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Olsten MEK, 2005, MOL CELL BIOCHEM, V274, P115, DOI 10.1007/s11010-005-3072-6; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Saeed M, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue3-fulltext-3; SAID JI, 2015, COMP METAANALYSIS QT, V290, P1003, DOI DOI 10.1007/S00438-014-0963-9; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2011, CROP SCI, V51, P2005, DOI 10.2135/cropsci2010.11.0653; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; SINGH M, 1993, THEOR APPL GENET, V86, P437, DOI 10.1007/BF00838558; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Ulloa M, 2006, J COTTON SCI, V10, P114; Van Ooijen JW, 2001, PLANT RES INT; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang CCN, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-15; Wang S., WINDOWS QTL CARTOGRA; Wang WS, 2016, PLANT CELL REP, V35, P1071, DOI 10.1007/s00299-016-1939-5; Weebadde CK, 2008, PLANT BREEDING, V127, P94, DOI 10.1111/j.1439-0523.2007.01430.x; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1990, BIOCHEM SYST ECOL, V18, P517, DOI 10.1016/0305-1978(90)90123-W; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu YX, 2007, PLANT SYST EVOL, V268, P199, DOI 10.1007/s00606-007-0565-7; Yu JZ, 2014, MOL GENET GENOMICS, V289, P1347, DOI 10.1007/s00438-014-0930-5; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu X., 2010, ARABIDOPSIS BOOK, pe0135; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhu LL, 2014, CROP SCI, V54, P2492, DOI 10.2135/cropsci2014.03.0258	68	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186240	10.1371/journal.pone.0186240	http://dx.doi.org/10.1371/journal.pone.0186240			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016665	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800048
J	List, R; Postolka, B; Schutz, P; Hitz, M; Schwilch, P; Gerber, H; Ferguson, SJ; Taylor, WR				List, Renate; Postolka, Barbara; Schutz, Pascal; Hitz, Marco; Schwilch, Peter; Gerber, Hans; Ferguson, Stephen J.; Taylor, William R.			A moving fluoroscope to capture tibiofemoral kinematics during complete cycles of free level and downhill walking as well as stair descent	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; IN-VIVO KINEMATICS; TREADMILL WALKING; GAIT ANALYSIS; 3-DIMENSIONAL KINEMATICS; REPLACEMENT KINEMATICS; JOINT KINEMATICS; IMAGES; SINGLE; FORCE	Videofluoroscopy has been shown to provide essential information in the evaluation of the functionality of total knee arthroplasties. However, due to the limitation in the field of view, most systems can only assess knee kinematics during highly restricted movements. To avoid the limitations of a static image intensifier, a moving fluoroscope has been presented as a standalone system that allows tracking of the knee during multiple complete cycles of level- and downhill-walking, as well as stair descent, in combination with the synchronous assessment of ground reaction forces and whole body skin marker measurements. Here, we assess the ability of the system to keep the knee in the field of view of the image intensifier. By measuring ten total knee arthroplasty subjects, we demonstrate that it is possible to maintain the knee to within 1.8 +/- 1.4 cm vertically and 4.0 +/- 2.6 cm horizontally of the centre of the intensifier throughout full cycles of activities of daily living. Since control of the system is based on real-time feedback of a wire sensor, the system is not dependent on repeatable gait patterns, but is rather able to capture pathological motion patterns with low inter-trial repeatability.	[List, Renate; Postolka, Barbara; Schutz, Pascal; Hitz, Marco; Schwilch, Peter; Gerber, Hans; Ferguson, Stephen J.; Taylor, William R.] ETH, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	List, R (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.	rlist@ethz.ch	Taylor, William R./F-8692-2010; Postolka, Barbara/P-9290-2019; Schütz, Pascal/E-4745-2014; Ferguson, Stephen J./A-4118-2012; List, Renate/D-3884-2011	Taylor, William R./0000-0003-4060-4098; Postolka, Barbara/0000-0002-1996-1501; Schütz, Pascal/0000-0003-1711-7881; Ferguson, Stephen J./0000-0003-0650-5889; List, Renate/0000-0003-3292-1915	RMS foundation (Bettlach, Switzerland); Philips Medical Systems (Switzerland); Medacta International SA (Castel San Pietro, Switzerland); Commission for Technology and Innovation (Bern, Switzerland)	RMS foundation (Bettlach, Switzerland); Philips Medical Systems (Switzerland); Medacta International SA (Castel San Pietro, Switzerland); Commission for Technology and Innovation (Bern, Switzerland)	The development was financially supported by RMS foundation (Bettlach, Switzerland), Philips Medical Systems (Switzerland), Medacta International SA (Castel San Pietro, Switzerland) and the Commission for Technology and Innovation (Bern, Switzerland).	Akbarshahi M, 2010, J BIOMECH, V43, P1292, DOI 10.1016/j.jbiomech.2010.01.002; Alton F, 1998, CLIN BIOMECH, V13, P434, DOI 10.1016/S0268-0033(98)00012-6; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328, DOI 10.2106/00004623-198264090-00008; Banks S, 2006, J BIOMECHANICS S1, V39, pS446, DOI [10.1016/S0021-9290(06)84824-4, DOI 10.1016/S0021-9290(06)84824-4]; Banks SA, 2005, KNEE SURG SPORT TR A, V13, P551, DOI 10.1007/s00167-004-0565-x; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Burckhardt K, 2005, IEEE T MED IMAGING, V24, P676, DOI 10.1109/TMI.2005.846849; Cappozzo A, 2005, GAIT POSTURE, V21, P186, DOI 10.1016/j.gaitpost.2004.01.010; Catani F, 2009, J ORTHOP RES, V27, P1569, DOI 10.1002/jor.20941; De K, 2013, PROCEDIA ENGINEER, V64, P149, DOI 10.1016/j.proeng.2013.09.086; Dennis A D, 1999, Acta Chir Orthop Traumatol Cech, V66, P323; deQuervain IAK, 1997, J ARTHROPLASTY, V12, P168, DOI 10.1016/S0883-5403(97)90063-2; Fantozzi S, 2003, GAIT POSTURE, V17, P225, DOI 10.1016/S0966-6362(02)00096-6; Foresti M, 2008, 8 INT S COMP METH BI; Foresti M., 2009, THESIS; Foresti M, 2006, J BIOMECH, V39, pS109; Gander W., 1997, SOLVING PROBLEMS SCI, V3, P339; Guan S, 2016, IEEE T MED IMAGING, V35, P326, DOI 10.1109/TMI.2015.2473168; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; Kramers de Quervain I.A., 2008, SCHWEIZERISCHE Z SPO, V56, P35; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leardini A, 2006, CLIN BIOMECH, V21, P870, DOI 10.1016/j.clinbiomech.2006.03.007; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Li GA, 2004, J BIOMECH ENG-T ASME, V126, P314, DOI 10.1115/1.1691448; List R, 2012, FOOT ANKLE INT, V33, P883, DOI 10.3113/FAI.2012.0883; Liu F, 2006, J BIOMECH, V39, pS213, DOI 10.1016/S0021-9290(06)83779-6; Mahfouz MR, 2003, IEEE T MED IMAGING, V22, P1561, DOI 10.1109/TMI.2003.820027; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Moro-oka T, 2007, KNEE SURG SPORT TR A, V15, P93, DOI 10.1007/s00167-006-0134-6; Schutz P, 2016, 14 S 3 D AN HUM MOV; Sharma A, 2008, J BIOMECH, V41, P642, DOI 10.1016/j.jbiomech.2007.09.027; Stacoff A, 2005, GAIT POSTURE, V21, P24, DOI 10.1016/j.gaitpost.2003.11.003; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; Stoquart G, 2008, NEUROPHYSIOL CLIN, V38, P105, DOI 10.1016/j.neucli.2008.02.002; STRATHY GM, 1983, J BIOMECH, V16, P517, DOI 10.1016/0021-9290(83)90066-0; Van de Velde SK, 2010, ACTA ORTHOP BELG, V76, P107; Warabi T, 2005, NEUROSCI RES, V53, P343, DOI 10.1016/j.neures.2005.08.005; Wass E, 2005, GAIT POSTURE, V21, P72, DOI 10.1016/j.gaitpost.2004.01.003; Watt JR, 2010, CLIN BIOMECH, V25, P444, DOI 10.1016/j.clinbiomech.2009.09.002; Weese J, 1997, IEEE T INF TECHNOL B, P1; Yamokoski JD, 2011, GAIT POSTURE, V34, P508, DOI 10.1016/j.gaitpost.2011.07.002; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379; Zhu ZL, 2012, COMPUT METHOD BIOMEC, V15, P1245, DOI 10.1080/10255842.2011.597387; Zihlmann MS, 2006, GAIT POSTURE, V24, P475, DOI 10.1016/j.gaitpost.2005.12.012; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310	47	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185952	10.1371/journal.pone.0185952	http://dx.doi.org/10.1371/journal.pone.0185952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016647	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800029
J	Rice, JP; Seifert, M; Moser, KS; Rodwell, TC				Rice, Jason P.; Seifert, Marva; Moser, Kathleen S.; Rodwell, Timothy C.			Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RAPID DETECTION; UNITED-STATES; SMEAR MICROSCOPY; DRUG-RESISTANCE; IMPLEMENTATION; MUTATIONS; ACCURACY; STRAINS; SAMPLES	Performance of the Xpert MTB/RIF assay, designed to simultaneously detect Mycobacterium tuberculosis complex (MTBC) and rifampin (RIF) resistance, has been well documented in low-resource settings with high TB-incidence. However, few studies have assessed its accuracy in low TB incidence settings. We evaluated the performance of Xpert MTB/RIF using clinical sputum specimens routinely collected from suspect pulmonary TB patients over a 4-year time period in San Diego County, California. Xpert MTB/RIF results were compared to acid-fast bacilli (AFB) smear microscopy, mycobacterial culture, and phenotypic drug susceptibility testing (DST). Of 751 sputum specimens, 134 (17.8%) were MTBC culture-positive and 2 (1.5%) were multidrug-resistant (MDR). For the detection of MTBC, Xpert MTB/RIF sensitivity was 89.6% (97.7% and 74.5% in smear-positive and -negative sputa, respectively) and specificity was 97.2%; while AFB smear sensitivity and specificity were 64.9% and 77.8%, respectively. Xpert MTB/RIF detected 35 of 47 smear-negative culture-positive specimens, and excluded 124 of 137 smear-positive culture-negative specimens. Xpert MTB/RIF also correctly excluded 99.2% (121/122) of nontuberculous mycobacteria (NTM) specimens, including all 33 NTM false-positives by smear microscopy. For the detection of RIF resistance, Xpert MTB/RIF sensitivity and specificity were 100% and 98.3%, respectively. Our findings demonstrate that Xpert MTB/RIF is able to accurately detect MTBC and RIF resistance in routinely collected respiratory specimens in a low TB-incidence setting, with comparable performance to that achieved in high-incidence settings; and suggest that under these conditions the assay has particular utility in detecting smear-negative TB cases, excluding smear-positive patients without MTBC disease, and differentiating MTBC from NTM.	[Rice, Jason P.] Univ Calif San Diego, Div Prevent Med, San Diego, CA 92103 USA; [Seifert, Marva; Rodwell, Timothy C.] Univ Calif San Diego, Div Pulm Crit Care & Sleep Med, San Diego, CA 92103 USA; [Moser, Kathleen S.] Cty San Diego Hlth & Human Serv Agcy, TB Control & Refugee Hlth Program, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rice, JP (corresponding author), Univ Calif San Diego, Div Prevent Med, San Diego, CA 92103 USA.	ricejp78@gmail.com		Seifert, Marva/0000-0002-7554-6396	National Institutes of Health [T32-HL098062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL134632, T32HL098062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MS is supported by the National Institutes of Health [T32-HL098062]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P7; [Anonymous], 2013, FDA PERM MARK 1 US T; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bowles EC, 2011, INT J TUBERC LUNG D, V15, P988, DOI 10.5588/ijtld.10.0574; Centers for Disease Control and Prevention (CDC), 2008, REP EXP CONS RAP MOL; Centers for Disease Control and Prevention (CDC), 2008, REP EXP CONS US NUCL; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; County of San Diego Tuberculosis Control Program, 2014, TUB CONTR PROGR 2013; County of San Diego Tuberculosis Control Program, 2016, COMP NAT STAT COUNT; Deggim V, 2013, J CLIN MICROBIOL, V51, P2396, DOI 10.1128/JCM.00151-13; Dickinson Becton, 2015, BACTEC MGIT 960 SIRE; Dickinson Becton, 2009, BACTEC MGIT 960 PZA; Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; GLI, 2014, MYC LAB MAN; Global Laboratory Initiative (GLI), 2015, GUID PROV TECHN SUPP; Guerra RL, 2007, CHEST, V132, P946, DOI 10.1378/chest.06-2959; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Iademarco MF, 2013, MMWR-MORBID MORTAL W, V62, P821; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13; Lin SYG, 2014, CLIN LAB MED, V34, P297, DOI 10.1016/j.cll.2014.02.005; LoBue PA, 2005, INT J TUBERC LUNG D, V9, P501; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; McAlister AJ, 2015, J CLIN MICROBIOL, V53, P1752, DOI 10.1128/JCM.03433-14; McShane PJ, 2015, CHEST, V148, P1517, DOI 10.1378/chest.15-0458; Miller MB, 2011, J CLIN MICROBIOL, V49, P3458, DOI 10.1128/JCM.05212-11; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; US Food and Drug Administration (FDA), 2013, 510 K DEC SUMM DE NO; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; WHO, 2011, AUT REAL TIM NUCL AC; Williamson DA, 2012, DIAGN MICR INFEC DIS, V74, P207, DOI 10.1016/j.diagmicrobio.2012.06.013; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2014, WHOHTMTB20141; World Health Organization (WHO), 2015, WHOHTMTB201511 WHOHTMTB201511; World Health Organization (WHO), 2014, FRAM TUB EL LOW INC; World Health Organization-WHO, 2015, STOP TB PARTN GLOB P; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; 2012, GLOB TUB REP 2013, P1	55	29	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186139	10.1371/journal.pone.0186139	http://dx.doi.org/10.1371/journal.pone.0186139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016684	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800041
J	Zhu, QY; Pan, XT; Sun, YB; Wang, ZB; Liu, FG; Li, AQ; Zhao, ZH; Wang, YL; Li, K; Mi, LY				Zhu, Qingyun; Pan, Xinting; Sun, Yunbo; Wang, Zhengbin; Liu, Fuguo; Li, Aiqin; Zhao, Zhihui; Wang, Yunlong; Li, Kun; Mi, Liangyu			Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DELIVERY; MDA-7/IL-24; ANGIOGENESIS; MORTALITY; VEGF	Objectives Pancreatic cancer is one of the most common malignancies of the digestive system, and remains a clinical challenge. This study aimed to assess the effects of bovine serum albumin (BSA) nanoparticles carrying the hMDA-7 gene (BSA-NP-hMDA-7) in the treatment of pancreatic cancer. Methods BSA-NP-hMDA-7 was generated by nanotechnology and gene recombination technology. A total of 5 BXPC-3 or PANC-1 pancreatic cancer cell groups were examined, including Control, BSA-NPs, Empty vector, hMDA-7 plasmid, and hMDA-7 BSA-NPs groups, respectively. Proliferation and apoptosis of cultured cells were assessed by the MTT method and flow-cytometry, respectively. In addition, pancreatic cancer models were established with both cell lines in nude mice, and the expression profiles of hMDA-7 and VEGF in cancer tissues were measured by Western blot and immunohistochemistry. Results BSA-NP-hMDA-7 nanoparticles were successfully generated, and significantly inhibited the proliferation of BXPC-3 and PANC-1 cells; in addition, apoptosis rates were higher in both cell lines after treatment with BSA-NP-hMDA-7 (P < 0.05). Nude mouse xenograft studies indicated that treatment with BSA-NP-hMDA-7 nanoparticles resulted in decreased tumor size. Moreover, the hMDA-7 protein was found in tumor tissues after hMDA-7 gene transfection, while BSA-NP-hMDA-7 significantly suppressed VEGF expression in tumor tissues. Similar results were obtained for both BXPC-3 and PANC-1 xenograft models. Conclusion BSA nanoparticles carrying the hMDA-7 gene effectively transfected BXPC-3 and PANC-1 pancreatic cancer cells, causing reduced cell proliferation and enhanced apoptosis in vitro. In mouse xenografts, BSA-NP-hMDA-7 treatment decreased tumor size and reduced VEGF expression. These findings indicated that BSA-NP-hMDA-7 might exert anticancer effects via VEGF suppression.	[Zhu, Qingyun; Pan, Xinting; Sun, Yunbo; Wang, Zhengbin; Liu, Fuguo; Li, Aiqin; Li, Kun] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China; [Zhao, Zhihui; Wang, Yunlong] Qingdao Univ, Nano New Mat Key Labs, Qingdao, Peoples R China; [Mi, Liangyu] Qingdao Univ, Affiliated Hosp, Dept ICU, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Pan, XT (corresponding author), Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China.	0536pxt@163.com						Abu Lila AS, 2010, PHARM RES-DORDR, V27, P1171, DOI 10.1007/s11095-010-0110-1; Azab B, 2012, J CELL PHYSIOL, V227, P2145, DOI 10.1002/jcp.22947; Berruti A, 2011, NEW ENGL J MED, V364, P1871, DOI 10.1056/NEJMc1102746; Cabral H, 2013, P NATL ACAD SCI USA, V110, P11397, DOI 10.1073/pnas.1301348110; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chitkara D, 2014, DRUG DELIV TRANSL RE, V4, P439, DOI 10.1007/s13346-014-0206-y; Colilla M, 2008, INT J NANOMED, V3, P403; Dash R, 2014, CANCER RES, V74, P563, DOI 10.1158/0008-5472.CAN-13-1062; Dent P, 2010, PHARMACOL THERAPEUT, V128, P375, DOI 10.1016/j.pharmthera.2010.08.001; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; He YT, 2015, CHINESE J CANCER RES, V27, P29, DOI 10.3978/j.issn.1000-9604.2015.02.05; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Ishima Y, 2016, YAKUGAKU ZASSHI, V136, P39, DOI 10.1248/yakushi.15-00227-1; Koffie RM, 2011, P NATL ACAD SCI USA, V108, P18837, DOI 10.1073/pnas.1111405108; Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483; Lin QJ, 2015, WORLD J GASTROENTERO, V21, P7988, DOI 10.3748/wjg.v21.i26.7988; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; Michaud D S, 2004, Minerva Chir, V59, P99; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Patani N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-29; Takai E, 2015, WORLD J GASTRO ONCOL, V7, P250, DOI 10.4251/wjgo.v7.i10.250; Wang QB, 2015, INT J NANOMED, V10, P4479, DOI 10.2147/IJN.S84930; Yang XJ, 2013, P NATL ACAD SCI USA, V110, P13932, DOI 10.1073/pnas.1309629110; Yeo D, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2057-z; Yu XZ, 2015, INT J NANOMED, V10, P6825, DOI 10.2147/IJN.S93835; Zhou H, 2012, ANGIOGENESIS, V15, P391, DOI 10.1007/s10456-012-9268-y	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185507	10.1371/journal.pone.0185507	http://dx.doi.org/10.1371/journal.pone.0185507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985230	Green Submitted, gold, Green Published			2022-12-27	WOS:000412493000006
J	Castel, AD; Terzian, A; Hart, R; Rayeed, N; Kalmin, MM; Young, H; Greenberg, AE				Castel, Amanda D.; Terzian, Arpi; Hart, Rachel; Rayeed, Nabil; Kalmin, Mariah M.; Young, Heather; Greenberg, Alan E.		DC Cohort Executive Comm	Use of national standards to monitor HIV care and treatment in a high prevalence city-Washington, DC	PLOS ONE			English	Article							VIRAL SUPPRESSION; UNITED-STATES; MEDICAL-CARE; RETENTION; HOMELESSNESS; DISPARITIES; ENGAGEMENT; INDICATORS; GONORRHEA; HEALTH	We sought to benchmark the quality of HIV care being received by persons living with HIV in care in Washington, DC and identify individual-level and structural-level differences. Data from the DC Cohort, an observational HIV cohort of persons receiving outpatient care in DC, were used to estimate the Institute of Medicine (IOM) and Department of Health and Human Services (HHS) quality of care measures. Differences in care by demographics and clinic type were assessed using chi(2) tests and multivariable regression models. Among 8,047 participants, by HHS standards, 69% of participants were retained in care (RIC), 95% were prescribed antiretroviral therapy (ART), and 84% were virally suppressed (VS). By IOM standards, 84% were in continuous care; and 78% and 80% underwent regular CD4 and VL monitoring, respectively. Screening for syphilis, chlamydia, and gonorrhea was 51%, 31%, and 26%, respectively. Older participants were 1.5 times more likely to be RIC compared to younger participants (OR: 1.5; 95% CI: 1.3, 1.8). Participants enrolled in community-based clinics were more likely to be RIC (OR: 1.7; 95% CI: 1.4, 2.0) versus those enrolled at hospital-based clinics. Older participants were more likely to achieve VS than younger participants (OR: 1.8; 95% CI: 1.5, 2.2) while Black participants were less likely compared to white participants (OR: 0.4; 95% CI: 0.3, 0.5). Despite high measures of quality of care, disparities remain. Continued monitoring of the quality of HIV care and treatment can inform the development of public health programs and interventions to optimize care delivery.	[Castel, Amanda D.; Terzian, Arpi; Kalmin, Mariah M.; Young, Heather; Greenberg, Alan E.] George Washington Univ, Milken Inst, Dept Epidemiol & Biostat, Sch Publ Hlth, Washington, DC 20052 USA; [Hart, Rachel; Rayeed, Nabil] Cerner Corp, Kansas City, MO USA	George Washington University	Castel, AD (corresponding author), George Washington Univ, Milken Inst, Dept Epidemiol & Biostat, Sch Publ Hlth, Washington, DC 20052 USA.	acastel@gwu.edu		Castel, Amanda/0000-0002-9095-2413; Young, Heather/0000-0002-0225-4894	George Washington University (GWU) from the National Institutes of Health (NIH); GWU; NIH	George Washington University (GWU) from the National Institutes of Health (NIH); GWU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for the DC Cohort is received by George Washington University (GWU) from the National Institutes of Health (NIH). Subcontracts from GWU are issued to participating sites and to Cerner Corporation, a commercial affiliate. Through an established contract between GWU and Cerner Corporation, staff from Cerner are responsible for assisting with data collection, management and analyses. GWU therefore provided support in the form of salaries for Cerner authors [RH, NR]. NIH provided support in the form of salaries for authors [ADC, HAY, MK, AT, and AEG]. The specific roles of each author are articulated in the 'author contributions' section. The funder of the study, NIH, did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and or research materials.	Aidala AA, 2016, AM J PUBLIC HLTH, V7; Althoff KN, 2014, CLIN INFECT DIS, V58, P1185, DOI 10.1093/cid/ciu044; Berry SA, 2015, JAIDS-J ACQ IMM DEF, V70, P275, DOI 10.1097/QAI.0000000000000711; Burchell AN, 2015, JAIDS-J ACQ IMM DEF, V70, pE10, DOI 10.1097/QAI.0000000000000690; Castel A, 2015, INCREASING COMPLETEN; Castel AD, 2012, 19 INT AIDS CONFEREN; Castel AD, 2016, AIDS CARE, V28, P1355, DOI 10.1080/09540121.2016.1189496; Chu C, 2010, AIDS CARE, V22, P1522, DOI 10.1080/09540121.2010.484456; Cohen SM, 2014, JAIDS-J ACQ IMM DEF, V67, P519, DOI 10.1097/QAI.0000000000000349; Dean BB, 2015, JAIDS-J ACQ IMM DEF, V68, P133, DOI 10.1097/QAI.0000000000000406; District of Columbia Department of Health HIV/AIDS H STD and TB Administration, 2016, HIV CAR RYAN WHIT DY; District of Columbia Department of Health HIV/AIDS Hepatitis STDs and Tuberculosis Administration, 2015, DISTR COL DEP HLTH H; Dorsey K, 2016, C RETR OPP INF; Ford M, 2012, MONITORING HIV CARE, V1, P150; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Greenberg AE, 2016, J AM MED INFORM ASSN, V23, P635, DOI 10.1093/jamia/ocv176; Greer GA, 2015, AIDS PATIENT CARE ST, V29, P474, DOI 10.1089/apc.2015.0028; Hall H, 1824, JAIDS-J ACQ IMM DEF, V60, P77; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Health Resources Services Administration, HIV AIDS PROGR HAB P; Herwehe J, 2012, J AM MED INFORM ASSN, V19, P448, DOI 10.1136/amiajnl-2011-000412; Horberg M, 2016, CONTINUITY CARE TRAC; Korthuis PT, 2016, CLIN INFECT DIS, V62, P233, DOI 10.1093/cid/civ762; Lachowsky N., 2016, C RETR OPP INF; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mattson CL, 2017, CLIN INFECT DIS, V64, P629, DOI 10.1093/cid/ciw834; Milloy MJ, 2012, AIDS PATIENT CARE ST, V26, P60, DOI 10.1089/apc.2011.0169; Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U; Rebeiro P, 2016, PLOS ONE, V11; Rebeiro PF, 2015, AM J EPIDEMIOL, V182, P952, DOI 10.1093/aje/kwv181; Riley ED NT, 2012, PLOS ONE, V7; Sabharwal CJ, 2014, JAIDS-J ACQ IMM DEF, V65, P571, DOI 10.1097/QAI.0000000000000077; Schranz AJ, 2015, AIDS PATIENT CARE ST, V29, P117, DOI 10.1089/apc.2014.0199; Skinner JM, 2014, PUBLIC HEALTH REP, V129, P85, DOI 10.1177/00333549141291S113; Thakarar K, 2016, J HEALTH CARE POOR U, V27, P145, DOI 10.1353/hpu.2016.0020; Valdiserri Ronald O, 2013, Public Health Rep, V128, P354; Xia Q, 2016, JAIDS-J ACQ IMM DEF, V72, P552, DOI 10.1097/QAI.0000000000001008; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Yehia BR, 2015, JAIDS-J ACQ IMM DEF, V68, P413, DOI 10.1097/QAI.0000000000000489; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186036	10.1371/journal.pone.0186036	http://dx.doi.org/10.1371/journal.pone.0186036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982127	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300114
J	Chen, HH; Huang, CC; Cheng, EH; Lee, TH; Chien, LF; Lee, MS				Chen, Hsiu-Hui; Huang, Chun-Chia; Cheng, En-Hui; Lee, Tsung-Hsien; Chien, Lee-Feng; Lee, Maw-Sheng			Optimal timing of blastocyst vitrification after trophectoderm biopsy for preimplantation genetic screening	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; JUNCTION BIOGENESIS; BOVINE EMBRYOS; STAGE; CRYOPRESERVATION; DIAGNOSIS; DILUTION; CYCLES; BIRTHS; MOUSE	Is the timing of vitrification after trophectoderm (TE) biopsy associated with successful implantation and pregnancy after the embryo transfer of blastocysts subjected to preimplantation genetic screening (PGS)? In this retrospective cohort study, 1329 blastocysts from 223 patients were subjected to TE biopsy for performing array comparative genomic hybridization (CGH) tests. The PGS and frozen blastocyst transfer (FET) cycles were performed from December 2012 to May 2015. Only the good quality and expanded blastocysts on day 5 or 6 were selected for biopsy. After TE biopsy, the re-expansion grades relative to the original blastocoel were (1) collapsed blastocysts (CB), (2) 3/4 re-expansion but not full expansion (RE), and (3) full re-expansion or hatching (FE). All biopsied blastocysts were subjected to vitrification within 0.5-6 h after biopsy; the time intervals between TE biopsy and vitrification and the expansion grades at the time of vitrification were recorded. By combining two factors, namely the expansion grades and culture intervals between biopsy and vitrification, the patients were further divided into four groups, namely CB with a <3 h culture interval (n = 34 cycles, Group I), RE and FE blastocysts with a < 3 h culture interval (n = 10 cycles, Group II); CB blastocysts with a >= 3 h culture interval (n = 6 cycles, Group III); and RE or FE blastocysts with a >= 3 h culture interval (n = 173 cycles, Group IV). The implantation (63.7%, 179/281) and clinical pregnancy (74.0%, 128/173) rates in Group IV were significantly higher than those in Group I (45.3%, 24/53; 50.0%, 17/34; P = 0.012 and 0.005, respectively). According to our findings, optimal vitrification timing >3 hours to enable blastocysts to reach RE or FE provides improved implantation and pregnancy rates after FET.	[Chen, Hsiu-Hui; Huang, Chun-Chia; Cheng, En-Hui; Lee, Tsung-Hsien; Lee, Maw-Sheng] Lee Womens Hosp, Div Infertil, Taichung, Taiwan; [Chen, Hsiu-Hui; Chien, Lee-Feng] Natl Chung Hsing Univ, Coll Life Sci, Dept Life Sci, Taichung, Taiwan; [Lee, Tsung-Hsien; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Tsung-Hsien; Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Lee, Tsung-Hsien] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Taiwan University	Lee, MS (corresponding author), Lee Womens Hosp, Div Infertil, Taichung, Taiwan.; Chien, LF (corresponding author), Natl Chung Hsing Univ, Coll Life Sci, Dept Life Sci, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan.	lfchien@dragon.nchu.edu.tw; msleephd@gmail.com	Lee, Tsung-Hsien/X-1098-2019	Lee, Tsung-Hsien/0000-0001-8858-0916; Lee, Maw-Sheng/0000-0001-6234-5432				Ahlstrom A, 2013, HUM REPROD, V28, P1199, DOI 10.1093/humrep/det054; Baltz JM, 1997, ZYGOTE, V5, P1; Capalbo A, 2015, EUR J HUM GENET, V23, P901, DOI 10.1038/ejhg.2014.222; Capalbo A, 2013, HUM REPROD, V28, P2298, DOI 10.1093/humrep/det245; Cho HJ, 2002, HUM REPROD, V17, P2419, DOI 10.1093/humrep/17.9.2419; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Davidson AF, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-13; Du QY, 2016, FERTIL STERIL, V105, P910, DOI 10.1016/j.fertnstert.2015.12.014; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Eckert JJ, 2007, HUM REPROD, V22, P2214, DOI 10.1093/humrep/dem147; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Fragouli E, 2008, HUM REPROD, V23, P2596, DOI 10.1093/humrep/den287; Fragouli E, 2011, HUM REPROD, V26, P480, DOI 10.1093/humrep/deq344; Gajda B, 2002, CRYOLETTERS, V23, P385; Gardner DK, 1999, CURR OPIN OBSTET GYN, V11, P307, DOI 10.1097/00001703-199906000-00013; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; Gutnisky C, 2013, CRYOBIOLOGY, V67, P391, DOI 10.1016/j.cryobiol.2013.08.006; HARDY K, 1989, DEVELOPMENT, V107, P597; Harper JC, 2012, HUM GENET, V131, P175, DOI 10.1007/s00439-011-1056-z; Kader A, 2010, FERTIL STERIL, V93, P2640, DOI 10.1016/j.fertnstert.2009.07.991; Kaidi S, 1999, THERIOGENOLOGY, V52, P515, DOI 10.1016/S0093-691X(99)00148-X; Kokkali G, 2005, HUM REPROD, V20, P1855, DOI 10.1093/humrep/deh893; Lai D, 2015, HUM REPROD, V30, P37, DOI 10.1093/humrep/deu284; Leeh TH, 2008, HUM REPROD, V23, P160, DOI 10.1093/humrep/dem254; Marikawa Yusuke, 2012, Results Probl Cell Differ, V55, P165, DOI 10.1007/978-3-642-30406-4_9; McArthur SJ, 2005, FERTIL STERIL, V84, P1628, DOI 10.1016/j.fertnstert.2005.05.063; Oh YS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.138099; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI 10.1016/j.fertnstert.2009.10.015; Scott KL, 2013, FERTIL STERIL, V100, P608, DOI 10.1016/j.fertnstert.2013.07.004; Scott RT, 2012, FERTIL STERIL, V97, P870, DOI 10.1016/j.fertnstert.2012.01.104; Shu Y, 2009, FERTIL STERIL, V91, P401, DOI 10.1016/j.fertnstert.2007.11.083; Ugajin T, 2010, FERTIL STERIL, V93, P2723, DOI 10.1016/j.fertnstert.2009.06.056; Vanderzwalmen P, 2003, HUM REPROD, V18, P1504, DOI 10.1093/humrep/deg298; Vanderzwalmen P, 2002, HUM REPROD, V17, P744, DOI 10.1093/humrep/17.3.744; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Yavin S, 2007, THERIOGENOLOGY, V67, P81, DOI 10.1016/j.theriogenology.2006.09.029; Zheng WT, 2005, HUM REPROD, V20, P1615, DOI 10.1093/humrep/deh808	38	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185747	10.1371/journal.pone.0185747	http://dx.doi.org/10.1371/journal.pone.0185747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982142	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300065
J	Coetzee, J; Jewkes, R; Gray, GE				Coetzee, Jenny; Jewkes, Rachel; Gray, Glenda E.			Cross-sectional study of female sex workers in Soweto, South Africa: Factors associated with HIV infection	PLOS ONE			English	Article							DRIVEN SAMPLING METHODOLOGY; BEHAVIORAL SURVEILLANCE; RISK-FACTORS; CONDOM USE; WOMEN; EXPERIENCES; VIOLENCE; POWER; HIV/AIDS; PATTERNS	Introduction In South Africa, the rate of HIV in the sex worker (SW) population is exceedingly high, but critical gaps exist in our understanding of SWs and the factors that make them vulnerable to HIV. This study aimed to estimate HIV prevalence among female sex workers (FSWs) in Soweto, South Africa, and to describe their sexual behavior and other factors associated with HIV infection. Methods A cross-sectional, respondent-driven sampling (RDS) recruitment methodology was used to enroll 508 FSWs based in Soweto. Data were collected using a survey instrument, followed by two HIV rapid tests. Raw and RDS adjusted data were analyzed using a chi-squared test of association and multivariate logistic regression to show factors associated with HIV infection. Findings HIV prevalence among FSWs was 53.6% (95% CI 47.5-59.9). FSWs were almost exclusively based in taverns (85.6%) and hostels (52.0%). Less than a quarter (24.4%) were under 25 years of age. Non-partner violence was reported by 55.5%, 59.6% of whom were HIV-infected. Advancing age, incomplete secondary schooling, migrancy and multiple clients increased the likelihood of HIV acquisition: >30 years of age was associated with a 4.9 times (95% CI 2.6-9.3) increased likelihood of HIV; incomplete secondary schooling almost tripled the likelihood (AOR 2.8, 95% CI 1.6-5.0); being born outside of the Gauteng province increased the likelihood of HIV 2.3 times (95% CI 1.3-4.0); and having more than five clients per day almost doubled the likelihood (AOR 1.9, 95% CI 1.1-3.2). Conclusion Our findings highlight the extreme vulnerability of FSWs to HIV. Advancing age, limited education and multiple clients were risk factors associated with HIV, strongly driven by a combination of structural, biological and behavioral determinants. Evidence suggests that interventions need to be carefully tailored to the varying profiles of SW populations across South Africa. Soweto could be considered a microcosm of South Africa in terms of the epidemic of violence and HIV experienced by the SW population, which is influenced by factors often beyond an individual level of control. While describing a hitherto largely undocumented population of FSWs, our findings confirm the urgent need to scale up innovative HIV prevention and treatment programs for this population.	[Coetzee, Jenny; Gray, Glenda E.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa; [Coetzee, Jenny; Jewkes, Rachel] Univ Witwatersrand, Dept Publ Hlth, Johannesburg, South Africa; [Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; South African Medical Research Council	Coetzee, J (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Perinatal HIV Res Unit, Johannesburg, South Africa.; Coetzee, J (corresponding author), Univ Witwatersrand, Dept Publ Hlth, Johannesburg, South Africa.	coetzeej@phru.co.za		Jewkes, Rachel/0000-0002-4330-6267; Coetzee, Jenny/0000-0002-6145-6816	Medical Research Council of South Africa; National Department of Health/Public Health Enhancement Fund; Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of 'South Africa (NACOSA) [NAC-SW-2016-1]	Medical Research Council of South Africa(South African Medical Research Council); National Department of Health/Public Health Enhancement Fund; Albert Wessels' Trust; Global Fund; Networking HIV/AIDS Community of 'South Africa (NACOSA)	The study was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for the purpose of a PhD by the National Department of Health/Public Health Enhancement Fund, http://www.mrc.ac.za/researchdevelopment/opportunity.htm. In addition, funding was received through The Albert Wessels' Trust. The Global Fund and Networking HIV/AIDS Community of 'South Africa (NACOSA) provided support to the project, NAC-SW-2016-1.; The study was funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme, from funds provided for the purpose of a PhD by the National Department of Health/Public Health Enhancement Fund. In addition, funding was received through The Albert Wessels Trust. Both the Global Fund and the Networking HIV/AIDS Community of South Africa (NACOSA) also provided support for the project.	[Anonymous], 1992, BMJ, V304, P809; Arora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044094; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Cleland J., 2001, ILLUSTRATIVE QUESTIO; Coetzee J, 2016, AIDS 2016; Creighton D., 2003, HOUSING IN SOWETO; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Handcock MS, INVENTORSRDS ANAL SO; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Karamouzian M, 2016, CULT HEALTH SEX, V18, P58, DOI 10.1080/13691058.2015.1059487; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P1265, DOI 10.2105/AJPH.88.8.1265-a; Lane T, 2015, SAAIDS C; Leggett T., 2001, SOC TRANSITION, V32, P101; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Mchisa M, 2011, WAR HOME GBV INDICAT; Mmari K, 2013, J ADOLESCENT HEALTH, V53, P562, DOI 10.1016/j.jadohealth.2013.07.018; Morrell R, 2012, MEN MASC, V15, P11, DOI 10.1177/1097184X12438001; Myer L, 2006, AM J EPIDEMIOL, V163, P552, DOI 10.1093/aje/kwj071; Nattrass N, 2001, DAEDALUS, V130, P45; Ngugi EN, 2012, HUM ECOL, V40, P397, DOI 10.1007/s10745-012-9478-3; Pretorius G, 2011, J PSYCHOL AFR, V21, P33, DOI 10.1080/14330237.2011.10820427; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Richter M., 2008, EROTIC LABOUR HILLBR; Richter M, 2008, AJAR-AFR J AIDS RES, V7, P323, DOI 10.2989/AJAR.2008.7.3.9.656; Rosa EM, 2013, J FAM THEOR REV, V5, P243, DOI 10.1111/jftr.12022; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; SANAC, 2016, S AFR NAT SEX WORK H; SARACCO A, 1993, J ACQ IMMUN DEF SYND, V6, P497; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Shai NJ, 2010, AIDS CARE, V22, P1379, DOI 10.1080/09540121003758465; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shisana O., 2009, S AFRICAN NATL HIV P; Shisana O., 2014, AFRICAN NATL HIV P; Sinha S, 2015, SEX CULT, V19, P216, DOI 10.1007/s12119-014-9256-z; Stadler J, 2006, CULT HEALTH SEX, V8, P451, DOI 10.1080/13691050600872107; Statistics South Africa, 2016, COMMUNITY SURVEY 201; Statistics South Africa, 2016, Q LAB FORC SURV Q3 2; Stoebenhau K, 2011, GLOBALIZATION HLTH, V7; Thurman TR, 2006, AIDS BEHAV, V10, P627, DOI 10.1007/s10461-006-9104-8; UCSF Anova Health Institute Wits RHI, 2015, S AFR HLTH MON SURV; van Loggerenberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030669; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Volz E, 2012, INVENTORSRESPONDENT; Vuylsteke B, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P376, DOI 10.1016/B978-0-12-374235-3.00014-5; WHO, 2013, INTR HIV AIDS SEX TR; Williams BG, 2003, AIDS, V17, P2099, DOI 10.1097/00002030-200309260-00011; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; Wojcicki JM, 2002, CULT MED PSYCHIAT, V26, P339, DOI 10.1023/A:1021291922026; Wojcicki JM, 2002, MED ANTHROPOL Q, V16, P267, DOI 10.1525/maq.2002.16.3.267; World Health Organisation, 2013, MOD 4 INTR RESP DRIV; World Health Organisation, 2002, WHO MULT STUD WOM HL; World Health Organization, 2004, RAP HIV TESTS GUID U	65	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184775	10.1371/journal.pone.0184775	http://dx.doi.org/10.1371/journal.pone.0184775			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981511	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300017
J	Diana, A; Manzanilla, EG; Diaz, JAC; Leonard, FC; Boyle, LA				Diana, Alessia; Manzanilla, Edgar G.; Diaz, Julia A. Calderon; Leonard, Finola C.; Boyle, Laura A.			Do weaner pigs need in-feed antibiotics to ensure good health and welfare?	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SPACE ALLOWANCE; MEAT INSPECTION; ANIMAL HEALTH; TAIL; PERFORMANCE; RESPONSES; LESIONS; USAGE; PRODUCTIVITY	Antibiotics (AB) are used in intensive pig production systems to control infectious diseases and they are suspected to be a major source of antibiotic resistance. Following the ban on AB use as growth promoters in the EU, their prophylactic use in-feed is now under review. The aim of this study was to evaluate the effect of removing prophylactic in-feed AB on pig health and welfare indicators. Every Monday for six weeks, a subset of 70 pigs were weaned, tagged and sorted into two groups of 35 pigs according to weight (9.2 +/- 0.6 kg). AB were removed from the diet of one group (NO, n = 6) and maintained in the other group (AB, n = 6) for nine weeks. Ten focal pigs were chosen per group. After c. five weeks each group was split into two pens of c. 17 pigs for the following 4 weeks. Data were recorded weekly. Skin, tail, ear, flank and limb lesions of focal pigs were scored according to severity. The number of animals per group affected by health deviations was also recorded. The number of fights and harmful behaviours (ear, tail bites) per group was counted during 3x5min observations once per week. Data were analysed using mixed model equations and binomial logistic regression. At group level, AB pigs were more likely to have tail (OR = 1.70; P = 0.05) but less likely to have ear lesions than NO pigs (OR = 0.46; P<0.05). The number of ear bites (21.4 +/- 2.15 vs. 17.3 +/- 1.61; P<0.05) and fights (6.91 +/- 0.91 vs. 5.58 +/- 0.72; P = 0.09) was higher in AB than in NO pigs. There was no effect of treatment on health deviations and the frequency of these was low. Removing AB from the feed of weaner pigs had minimal effects on health and welfare indicators.	[Diana, Alessia; Manzanilla, Edgar G.; Diaz, Julia A. Calderon; Boyle, Laura A.] Teagasc Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [Diana, Alessia; Leonard, Finola C.] UCD, Sch Vet Med, Dublin 4, Ireland; [Diaz, Julia A. Calderon] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Anim Behav & Welf, Ul Postepu 36A, Jastrzebiec, Magdalenka, Poland	Teagasc; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Diana, A (corresponding author), Teagasc Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland.; Diana, A (corresponding author), UCD, Sch Vet Med, Dublin 4, Ireland.	alessia.diana@teagasc.ie	Diana, Alessia/W-2392-2019; Manzanilla, Edgar Garcia/B-2974-2012	Manzanilla, Edgar Garcia/0000-0002-2301-2560; Boyle, Laura/0000-0001-7080-1776; Diana, Alessia/0000-0002-8571-1295	Teagasc funds; Department of Agriculture Food and the Marine [PathSurvPigs 14/S/832]	Teagasc funds; Department of Agriculture Food and the Marine	This study was part of the WELPIG project which was funded from internal Teagasc funds. During the writing of this paper JACD's position was funded by the Department of Agriculture Food and the Marine under the Research Stimulus Fund (PathSurvPigs 14/S/832) as part of the National Development Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2005, BASIC CLIN PHARMACOL, V96, P271, DOI 10.1111/j.1742-7843.2005.pto960401.x; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Alban L, 2013, PREV VET MED, V108, P334, DOI 10.1016/j.prevetmed.2012.11.010; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; [Anonymous], 2005, EPA600R06021; Baxter M., 1985, SOCIAL SPACE DOMESTI, P116; Bengtsson B, 2014, UPSALA J MED SCI, V119, P96, DOI 10.3109/03009734.2014.901445; BLACKSHAW JK, 1981, ANIM PROD, V33, P325, DOI 10.1017/S000335610003172X; BLATCHFORD D, 1978, BRIT J PHARMACOL, V62, P241, DOI 10.1111/j.1476-5381.1978.tb08452.x; Breuer K, 2005, LIVEST PROD SCI, V93, P87, DOI 10.1016/j.livprodsci.2004.11.009; Burch D. G. S., 2012, THESIS; Chantziaras I, 2014, J ANTIMICROB CHEMOTH, V69, P827, DOI 10.1093/jac/dkt443; Conte S, 2010, THESIS; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Daera NIE, 2012, CODE PRACTICE WELFAR; Dawkins MS, 2006, TRENDS ECOL EVOL, V21, P77, DOI 10.1016/j.tree.2005.10.017; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; De Jong IC, 1998, PHYSIOL BEHAV, V64, P303, DOI 10.1016/S0031-9384(98)00066-3; de Koning R, 1985, THESIS; Demain AL, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P65; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Desrosiers R, 2013, LOND SWIN C MAN PROD; Diana A, 2016, 50 C INT SOC APPL ET; Diaz JAC, 2013, J ANIM SCI, V91, P3940, DOI 10.2527/jas.2012-5913; Ekkel ED, 1997, THESIS; Gibbons JF, 2016, ZOONOSES PUBLIC HLTH, V63, P241, DOI 10.1111/zph.12225; Harley S, 2012, VET REC, V171, P621, DOI 10.1136/vr.100986; Laine T, 2004, PREV VET MED, V66, P163, DOI 10.1016/j.prevetmed.2004.09.001; Lee C, 2005, LIVEST PROD SCI, V93, P255, DOI 10.1016/j.livprodsci.2004.10.003; Meyer-Hamme SEK1, 2015, ANIMAL, P1; Murphy D, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4666; O'Driscoll K, 2013, ANIMAL, V7, P1017, DOI 10.1017/S1751731112002431; Page SW, 2012, REV SCI TECH OIE, V31, P145; Petherick J. C., 1983, Farm animal housing and welfare. A Seminar in the CEC Programme of Coordination of Research on Animal Welfare, Aberdeen, Scotland, July 28-30, 1982, P103; Pettigrew JE, 2012, ECOLOGY ANIMAL HLTH, V2, P214; RANDOLPH JH, 1981, J ANIM SCI, V53, P922, DOI 10.2527/jas1981.534922x; Schokker D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116523; Sjolund M, 2016, PREV VET MED, V130, P41, DOI 10.1016/j.prevetmed.2016.06.003; Smulders D, 2008, ANIM WELFARE, V17, P61; Stein HH, 2002, ANIM BIOTECHNOL, V13, P85, DOI 10.1081/ABIO-120005772; Stukenborg A, 2011, THESIS; Taylor NR, 2010, VET J, V186, P137, DOI 10.1016/j.tvjl.2009.08.028; Turner SP, 2000, LIVEST PROD SCI, V66, P47, DOI 10.1016/S0301-6226(00)00159-7; Weissenbacher-Lang C, 2012, VET J, V194, P392, DOI 10.1016/j.tvjl.2012.05.026; Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066	46	32	32	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185622	10.1371/journal.pone.0185622	http://dx.doi.org/10.1371/journal.pone.0185622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982114	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300049
J	Hu, YC				Hu, Yi-Chung			A genetic-algorithm-based remnant grey prediction model for energy demand forecasting	PLOS ONE			English	Article							ELECTRICITY CONSUMPTION; NEURAL-NETWORK; CHINA; OPTIMIZATION; GM(1,1); TURKEY; NET	Energy demand is an important economic index, and demand forecasting has played a significant role in drawing up energy development plans for cities or countries. As the use of large datasets and statistical assumptions is often impractical to forecast energy demand, the GM(1,1) model is commonly used because of its simplicity and ability to characterize an unknown system by using a limited number of data points to construct a time series model. This paper proposes a genetic-algorithm-based remnant GM(1,1) (GARGM(1,1)) with sign estimation to further improve the forecasting accuracy of the original GM(1,1) model. The distinctive feature of GARGM(1,1) is that it simultaneously optimizes the parameter specifications of the original and its residual models by using the GA. The results of experiments pertaining to a real case of energy demand in China showed that the proposed GARGM (1,1) outperforms other remnant GM(1,1) variants.	[Hu, Yi-Chung] Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China; [Hu, Yi-Chung] Fujian Agr & Forestry Univ, Coll Tourism, Fuzhou, Fujian, Peoples R China; [Hu, Yi-Chung] Chung Yuan Christian Univ, Dept Business Adm, Taoyuan, Taiwan	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chung Yuan Christian University	Hu, YC (corresponding author), Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China.; Hu, YC (corresponding author), Fujian Agr & Forestry Univ, Coll Tourism, Fuzhou, Fujian, Peoples R China.; Hu, YC (corresponding author), Chung Yuan Christian Univ, Dept Business Adm, Taoyuan, Taiwan.	ychu@cycu.edu.tw	Hu, Yi-Chung/GON-3857-2022	Hu, Yi-Chung/0000-0003-3090-1515	Ministry of Science and Technology, Taiwan [MOST 104-2410-H-033-023-MY2, MOST 106-2410-H-033-006-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research is partially supported by the Ministry of Science and Technology, Taiwan under grant MOST 104-2410-H-033-023-MY2 and MOST 106-2410-H-033-006-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ENERGY TRANSFORMED S; Cantu-Paz E, 2000, COMPUT METHOD APPL M, V186, P221, DOI 10.1016/S0045-7825(99)00385-0; Chang CJ, 2016, J OPER RES SOC, V67, P1439, DOI 10.1057/jors.2016.31; Chiang JH, 1999, IEEE T FUZZY SYST, V7, P63, DOI 10.1109/91.746311; Cui J, 2013, APPL MATH MODEL, V37, P4399, DOI 10.1016/j.apm.2012.09.052; DENG JL, 1982, SYST CONTROL LETT, V1, P288, DOI 10.1016/S0167-6911(82)80025-X; Duran M, 2009, ENERG POLICY, P1181; Ediger VS, 2007, ENERG POLICY, V35, P1701, DOI 10.1016/j.enpol.2006.05.009; Ene S, 2017, TECHNOL FORECAST SOC, V115, P155, DOI 10.1016/j.techfore.2016.09.030; Feng SJ, 2012, ENERG SOURCE PART B, V7, P376, DOI 10.1080/15567240903330426; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Gonzalez PA, 2005, ENERG BUILDINGS, V37, P595, DOI 10.1016/j.enbuild.2004.09.006; Hsu CC, 2003, ENERG CONVERS MANAGE, V44, P2241, DOI 10.1016/S0196-8904(02)00248-0; Hsu CI, 1998, TRANSPORT PLAN TECHN, V22, P87, DOI 10.1080/03081069808717622; Hsu LC, 2003, TECHNOL FORECAST SOC, V70, P563, DOI 10.1016/S0040-1625(02)00195-6; Hu YC, 2016, J OPERATIONAL RES SO; HU YC, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071166; HU YC, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071228; Hu YC, 2007, NEUROCOMPUTING, V70, P2959, DOI 10.1016/j.neucom.2006.10.111; Hu YC, 2017, J OPER RES SOC, V68, P556, DOI 10.1057/s41274-016-0130-2; Hu YC, 2014, INFORM SCIENCES, V284, P18, DOI 10.1016/j.ins.2014.06.043; Hu YC, 2012, NEUROCOMPUTING, V91, P86, DOI 10.1016/j.neucom.2012.02.022; Ishibuchi H., 2004, CLASSIFICATION MODEL; Lauret P, 2008, ENERG CONVERS MANAGE, V49, P1156, DOI 10.1016/j.enconman.2007.09.009; Lee YS, 2011, ENERG CONVERS MANAGE, V52, P147, DOI 10.1016/j.enconman.2010.06.053; Lewis CD, 1982, IND BUSINESS FORECAS; Li DC, 2012, OMEGA-INT J MANAGE S, V40, P767, DOI 10.1016/j.omega.2011.07.007; Lim D, 2007, FUTURE GENER COMP SY, V23, P658, DOI 10.1016/j.future.2006.10.008; Liu S.F., 2006, GREY INFORM THEORY P; Liu YY, 2015, PARALLEL COMPUT, V46, P98, DOI 10.1016/j.parco.2014.04.008; Liu Zhenya, 2015, GLOBAL ENERGY INTERN; Lu JS, 2016, NEUROCOMPUTING, V177, P206, DOI 10.1016/j.neucom.2015.11.032; Mao MZ, 2006, TECHNOL FORECAST SOC, V73, P588, DOI 10.1016/j.techfore.2004.08.004; Osyczka A., 2003, EVOLUTIONARY ALGORIT; Pao Y.H., 1989, ADAPTIVE PATTERN REC; Pao Y.-H., 1992, IEEE COMPUT J, V25, P76, DOI DOI 10.1109/2.144401; Pi D, 2010, ENERG SOURCE PART A, V32, P1517, DOI 10.1080/15567030902780360; Suganthi L, 2012, RENEW SUST ENERG REV, V16, P1223, DOI 10.1016/j.rser.2011.08.014; Sun W, 2017, ENERGY, V118, P969, DOI 10.1016/j.energy.2016.10.120; Tsaur RC, 2007, INT J UNCERTAIN FUZZ, V15, P753, DOI 10.1142/S0218488507004984; Tsoulos IG, 2016, COMPUT PHYS COMMUN, V209, P183, DOI 10.1016/j.cpc.2016.09.006; Tutun S, 2015, ENERGY, V93, P2406, DOI 10.1016/j.energy.2015.10.064; Wang CH, 2008, APPL MATH COMPUT, V195, P256, DOI 10.1016/j.amc.2007.04.080; Wang ZX, 2016, APPL MATH MODEL, V40, P5745, DOI 10.1016/j.apm.2016.01.012; Wei JC, 2015, APPL MATH MODEL, V39, P924, DOI 10.1016/j.apm.2014.06.017; Wen K-. L, 2004, GREY SYSTEMS MODELIN; Xia CH, 2010, INT J ELEC POWER, V32, P743, DOI 10.1016/j.ijepes.2010.01.009; Xu N, 2017, ENERGY, V118, P473, DOI 10.1016/j.energy.2016.10.003; Yu WJ, 2017, APPL SOFT COMPUT, V59, P258, DOI 10.1016/j.asoc.2017.06.008	49	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185478	10.1371/journal.pone.0185478	http://dx.doi.org/10.1371/journal.pone.0185478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981548	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300042
J	Poncini, L; Wyrsch, I; Tendon, VD; Vorley, T; Boller, T; Geldner, N; Metraux, JP; Lehmann, S				Poncini, Lorenzo; Wyrsch, Ines; Tendon, Valerie Denervaud; Vorley, Thomas; Boller, Thomas; Geldner, Niko; Metraux, Jean-Pierre; Lehmann, Silke			In roots of Arabidopsis thaliana, the damage-associated molecular pattern AtPep1 is a stronger elicitor of immune signalling than flg22 or the chitin heptamer	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; PLANT DEFENSE; DISEASE-RESISTANCE; RECOGNITION RECEPTORS; TRANSCRIPTION FACTORS; FLAGELLIN PERCEPTION; EXPRESSION PATTERNS; OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY	Plants interpret their immediate environment through perception of small molecules. Microbe-associated molecular patterns (MAMPs) such as flagellin and chitin are likely to be more abundant in the rhizosphere than plant-derived damage-associated molecular patterns (DAMPs). We investigated how the Arabidopsis thaliana root interprets MAMPs and DAMPs as danger signals. We monitored root development during exposure to increasing concentrations of the MAMPs flg22 and the chitin heptamer as well as of the DAMP AtPep1. The tissue-specific expression of defence-related genes in roots was analysed using a toolkit of promoter:: YFPN lines reporting jasmonic acid (JA)-, salicylic acid (SA)-, ethylene (ET)-and reactive oxygen species (ROS)-dependent signalling. Finally, marker responses were analysed during invasion by the root pathogen Fusarium oxysporum. The DAMP AtPep1 triggered a stronger activation of the defence markers compared to flg22 and the chitin heptamer. In contrast to the tested MAMPs, AtPep1 induced SA-and JA-signalling markers in the root and caused a severe inhibition of root growth. Fungal attack resulted in a strong activation of defence genes in tissues close to the invading fungal hyphae. The results collectively suggest that AtPep1 presents a stronger danger signal to the Arabidopsis root than the MAMPs flg22 and chitin heptamer.	[Poncini, Lorenzo; Tendon, Valerie Denervaud; Vorley, Thomas; Metraux, Jean-Pierre; Lehmann, Silke] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Wyrsch, Ines; Boller, Thomas] Univ Basel, Dept Environm Sci, Basel, Switzerland; [Tendon, Valerie Denervaud; Geldner, Niko] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Lehmann, Silke] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of Fribourg; University of Basel; University of Lausanne; University of Warwick	Lehmann, S (corresponding author), Univ Fribourg, Dept Biol, Fribourg, Switzerland.; Lehmann, S (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	s.lehmann@warwick.ac.uk	Boller, Thomas/G-3500-2012; Geldner, Niko/Y-2481-2019	Boller, Thomas/0000-0001-6768-7503; Geldner, Niko/0000-0002-2300-9644	Swiss National Foundation [CRSII3_136278]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was made possible by funds to J.-P. Metraux, T. Boller and N. Geldner by the Swiss National Foundation (CRSII3_136278). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bartels S, 2015, J EXP BOT, V66, P5183, DOI 10.1093/jxb/erv180; Bartels S, 2013, J EXP BOT, V64, P5309, DOI 10.1093/jxb/ert330; Beck M, 2014, J EXP BOT, V65, P6487, DOI 10.1093/jxb/eru366; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; De Vleesschauwer D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00611; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Flury P, 2013, PLANT PHYSIOL, V161, P2023, DOI 10.1104/pp.113.216077; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gully K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00014; Gupta KJ, 2014, MOL PLANT MICROBE IN, V27, P307, DOI 10.1094/MPMI-06-13-0160-R; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Huffaker A, 2013, P NATL ACAD SCI USA, V110, P5707, DOI 10.1073/pnas.1214668110; Huffaker A, 2011, PLANT PHYSIOL, V155, P1325, DOI 10.1104/pp.110.166710; Jacobs S, 2011, PLANT PHYSIOL, V156, P726, DOI 10.1104/pp.111.176446; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; KISTLER HC, 1986, J BACTERIOL, V167, P587, DOI 10.1128/jb.167.2.587-593.1986; Klauser D, 2015, J EXP BOT, V66, P5327, DOI 10.1093/jxb/erv250; Klauser D, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25346; Krol E, 2010, J BIOL CHEM, V285, P13471, DOI 10.1074/jbc.M109.097394; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Liu ZX, 2013, P NATL ACAD SCI USA, V110, P6205, DOI 10.1073/pnas.1215543110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lori M, 2015, J EXP BOT, V66, P5315, DOI 10.1093/jxb/erv236; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Ma CL, 2014, J INTEGR PLANT BIOL, V56, P684, DOI 10.1111/jipb.12171; Ma Y, 2012, P NATL ACAD SCI USA, V109, P19852, DOI 10.1073/pnas.1205448109; MASACHIS S, 2016, NAT MICROBIOL, V1; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Michielse CB, 2009, MOL PLANT PATHOL, V10, P311, DOI [10.1111/J.1364-3703.2009.00538.X, 10.1111/j.1364-3703.2009.00538.x]; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nawrath Christiane, 2013, Arabidopsis Book, V11, pe0167, DOI 10.1199/tab.0167; Ortiz-Morea FA, 2016, P NATL ACAD SCI USA, V113, P11028, DOI 10.1073/pnas.1605588113; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; POTTER S, 1993, MOL PLANT MICROBE IN, V6, P680, DOI 10.1094/MPMI-6-680; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Ross A, 2014, EMBO J, V33, P62, DOI 10.1002/embj.201284303; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Seo PJ, 2008, PLANT CELL PHYSIOL, V49, P334, DOI 10.1093/pcp/pcn011; Sloan SS, 2015, CURR OPIN PLANT BIOL, V26, P32, DOI 10.1016/j.pbi.2015.05.026; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tintor N, 2013, P NATL ACAD SCI USA, V110, P6211, DOI 10.1073/pnas.1216780110; Tognolli M, 2002, GENE, V288, P129, DOI 10.1016/S0378-1119(02)00465-1; Trevors JT, 2010, ANTON LEEUW INT J G, V97, P99, DOI 10.1007/s10482-009-9397-5; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; Vermeer JEM, 2014, SCIENCE, V343, P178, DOI 10.1126/science.1245871; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wyrsch I, 2015, NEW PHYTOL, V206, P774, DOI 10.1111/nph.13280; Yamada K, 2016, EMBO J, V35, P46, DOI 10.15252/embj.201591807; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yamaguchi Y, 2011, CURR OPIN PLANT BIOL, V14, P351, DOI 10.1016/j.pbi.2011.05.001; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	74	42	44	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185808	10.1371/journal.pone.0185808	http://dx.doi.org/10.1371/journal.pone.0185808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973025	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900056
J	Zhang, HR; Kunadia, A; Lin, YF; Fondell, JD; Seidel, D; Fan, HZ				Zhang, Huirong; Kunadia, Anuj; Lin, Yingfu; Fondell, Joseph D.; Seidel, Daniel; Fan, Huizhou			Identification of a strong and specific antichlamydial N-acylhydrazone	PLOS ONE			English	Article							RESISTANT CHLAMYDIA-SUIS; SMALL-MOLECULE INHIBITOR; III SECRETION; PEPTIDE DEFORMYLASE; GENITAL-TRACT; TRACHOMATIS; MICE; INFECTION; GROWTH; ANTIBIOTICS	Sexually transmitted Chlamydia trachomatis is an extremely common infection and often leads to serious complications including infertility and pelvic inflammatory syndrome. Several broad-spectrum antibiotics are currently used to treat C. trachomatis. Although effective, they also kill beneficial vaginal lactobacilli. Two N-acylhydrazones, CF0001 and CF0002, have been shown previously to inhibit chlamydial growth without toxicity to human cells and Lactobacillus spp. Of particular significance, the rate of random mutation leading to resistance of these inhibitors appears to be extremely low. Here, we report three analogs of CF0001 and CF0002 with significantly stronger inhibitory effects on chlamydiae. Even though the new compounds (termed SF1, SF2 and SF3) displayed slightly decreased inhibition efficiencies for a rare Chlamydia variant selected for CF0001 resistance (Chlamydia muridarum MCR), they completely overcame the resistance when used at concentrations of 75 - 100 mu M. Importantly, SF1, SF2 and SF3 did not shown any toxic effect on lactobacilli, whereas SF3 was also well tolerated by human host cells. An effort to isolate SF3-resistant variants was unsuccessful. By comparison, variants resistant to rifampin or spectinomycin were obtained from smaller numbers of chlamydiae. Our findings suggest that SF3 utilizes an antichlamydial mechanism similar to that of CF0001 and CF0002, and will be more difficult for chlamydiae to develop resistance to, potentially making it a more effective antichlamydial agent.	[Zhang, Huirong; Fondell, Joseph D.; Fan, Huizhou] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Kunadia, Anuj; Lin, Yingfu; Seidel, Daniel] Rutgers State Univ, Sch Arts & Sci, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; State University System of Florida; University of Florida	Fan, HZ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.; Seidel, D (corresponding author), Rutgers State Univ, Sch Arts & Sci, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	seidel@chem.ufl.edu; huizhou.fan@rutgers.edu	Seidel, Daniel/G-3291-2018	Seidel, Daniel/0000-0001-6725-111X; FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [AI122034]; New Jersey Health Foundation [PC45-16]; Busch Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Health Foundation; Busch Biomedical Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (Grant # AI122034 to HF), New Jersey Health Foundation (PC45-16 to HF) and the Busch Biomedical Research Program (to HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1; Adams Deborah A, 2016, MMWR Morb Mortal Wkly Rep, V63, P1, DOI 10.15585/mmwr.mm6354a1; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Balakrishnan A, 2009, MICROBIOL RES, V164, P338, DOI 10.1016/j.micres.2007.05.002; Balin BJ, 2008, J ALZHEIMERS DIS, V13, P371; Bao XF, 2014, J BACTERIOL, V196, P2989, DOI 10.1128/JB.01677-14; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Burton MJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000460; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campbell LA, 1998, EMERG INFECT DIS, V4, P571, DOI 10.3201/eid0404.980407; CDC, 2013, MMWR-MORBID MORTAL W, V62, P424; CDC, 2014, CDC FACT SHEET STD T; CDC, 2013, CDC FACT SHEET STD T; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cotter TW, 1997, INFECT IMMUN, V65, P2067, DOI 10.1128/IAI.65.6.2067-2073.1997; Dan M, 2003, ISRAEL MED ASSOC J, V5, P629; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Donders GGG, 2010, GYNECOL OBSTET INVES, V70, P306, DOI 10.1159/000314022; Dutra LA, 2014, ANTIMICROB AGENTS CH, V58, P4837, DOI 10.1128/AAC.00052-14; Engstrom P, 2013, J BACTERIOL, V195, P4221, DOI 10.1128/JB.00506-13; Fan HZ, 2012, INVEST OPHTH VIS SCI, V53, P2560, DOI 10.1167/iovs.12-9835; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; HILL LVH, 1986, CAN MED ASSOC J, V134, P321; Joseph SJ, 2016, GENOME BIOL EVOL, V8, P2613, DOI 10.1093/gbe/evw182; Kauppi AM, 2003, ADV EXP MED BIOL, V529, P97; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Knight JL, 2005, BIOPHYS J, V88, P925, DOI 10.1529/biophysj.104.050187; Lange K, 2016, DIGEST DIS, V34, P260, DOI 10.1159/000443360; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Martin HL, 1998, J INFECT DIS, V178, P1053, DOI 10.1086/515654; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135295; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Pirotta MV, 2006, J CLIN MICROBIOL, V44, P3213, DOI 10.1128/JCM.00218-06; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rohde G, 2010, DTSCH ARZTEBL INT, V107, P174, DOI 10.3238/arztebl.2010.0174; Schachter J, 1999, CHLAMYDIA, P139; Shapiro RA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e72; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Spinillo A, 1999, AM J OBSTET GYNECOL, V180, P14, DOI 10.1016/S0002-9378(99)70141-9; Srivastava A, 2012, ANTIMICROB AGENTS CH, V56, P6250, DOI 10.1128/AAC.01060-12; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377	50	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185783	10.1371/journal.pone.0185783	http://dx.doi.org/10.1371/journal.pone.0185783			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973037	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900050
J	Sanchez-Del Cojo, M; Lopez-Huertas, MR; Diez-Fuertes, F; Rodriguez-Mora, S; Bermejo, M; Lopez-Campos, G; Mateos, E; Jimenez-Tormo, L; Gomez-Esquer, F; Diaz-Gil, G; Alcami, J; Coiras, M				Sanchez-Del Cojo, Maria; Rosa Lopez-Huertas, Maria; Diez-Fuertes, Francisco; Rodriguez-Mora, Sara; Bermejo, Mercedes; Lopez-Campos, Guillermo; Mateos, Elena; Jimenez-Tormo, Laura; Gomez-Esquer, Francisco; Diaz-Gil, Gema; Alcami, Jose; Coiras, Mayte			Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+T cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; CD4(+) T-LYMPHOCYTES; NONCODING RNAS; INFECTED-CELLS; CYCLE ARREST; RAT-BRAIN; C-JUN; PROTEIN; PATHWAY	HIV-1 induces changes in the miRNA expression profile of infected CD4+ T cells that could improve viral replication. HIV-1 regulator Tat modifies the cellular gene expression and has been appointed as an RNA silencing suppressor. Tat is a 101-residue protein codified by two exons that regulates the elongation of viral transcripts. The first exon of Tat (amino acids 1-72) forms the transcriptionally active protein Tat72, but the presence of the second exon (amino acids 73-101) results in a more competent regulatory protein (Tat101) with additional functions. Intracellular, full-length Tat101 induces functional and morphological changes in CD4+ T cells that contribute to HIV-1 pathogenesis such as delay in T-cell proliferation and protection against FasL-mediated apoptosis. But the precise mechanism by which Tat produces these changes remains unknown. We analyzed how the stable expression of intracellular Tat101 and Tat72 modified the miRNA expression profile in Jurkat cells and if this correlated with changes in apoptotic pathways and cell cycle observed in Tat-expressing cells. Specifically, the enhanced expression of hsa-miR-21 and hsa-miR-222 in Jurkat-Tat101 cells was associated with the reduced expression of target mRNAs encoding proteins related to apoptosis and cell cycle such as PTEN, PDCD4 and CDKN1B. We developed Jurkat cells with stable expression of hsa-miR-21 or hsa-miR-222 and observed a similar pattern to Jurkat-Tat101 in resistance to FasL-mediated apoptosis, cell cycle arrest in G2/M and altered cell morphology. Consequently, upregulation of hsa-miR-21 and hsa-miR-222 by Tat may contribute to protect against apoptosis and to anergy observed in HIV-infected CD4+ T cells.	[Sanchez-Del Cojo, Maria; Diez-Fuertes, Francisco; Rodriguez-Mora, Sara; Bermejo, Mercedes; Mateos, Elena; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain; [Rosa Lopez-Huertas, Maria; Jimenez-Tormo, Laura] Hosp Ramon & Cajal, IRYCIS, Dept Infect Dis, Madrid, Spain; [Rodriguez-Mora, Sara] UCL, Div Infect & Immun, London, England; [Lopez-Campos, Guillermo] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland; [Gomez-Esquer, Francisco; Diaz-Gil, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitario Ramon y Cajal; University of London; University College London; Queens University Belfast; Universidad Rey Juan Carlos	Alcami, J; Coiras, M (corresponding author), Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid, Spain.	ppalcami@iscii.es; mcoiras@isciii.es	Diaz-Gil, Gema/ABG-6454-2020; Esquer, Francisco Gomez/K-8236-2017; Alcami, Pepe/T-2242-2018; Campos, Guillermo H Lopez/G-2883-2015; Díez-Fuertes, Francisco/AAA-9427-2019; Coiras, Mayte/R-9530-2019; Lopez-Campos, Guillermo/O-4349-2017; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Díez-Fuertes, Francisco/0000-0003-2413-9229; Rodriguez Mora, Sara/0000-0003-2467-116X; Bermejo, Mercedes/0000-0001-9909-8578; Gomez-Esquer, Francisco/0000-0002-5426-4349; Lopez-Campos, Guillermo/0000-0003-3011-0940; Diaz Gil, Gema/0000-0003-3480-1490; Coiras, Mayte/0000-0001-6464-5770; Lopez Huertas, Maria Rosa/0000-0002-4183-2773	Spanish Ministry of Economy and Competitiveness [SAF2010-18388, SAF2013-44677-R, PI12/00506, PIE 13/00040]; Spanish AIDS Research Network [RD12/0017/0015]; ISCIII-Subdireccion General de Evaluacion; European Funding for Regional Development (FEDER); Fondo de Investigaciones Sanitarias [FI09/00347]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish AIDS Research Network; ISCIII-Subdireccion General de Evaluacion; European Funding for Regional Development (FEDER)(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by the Spanish Ministry of Economy and Competitiveness (SAF2010-18388, SAF2013-44677-R, PI12/00506, PIE 13/00040); the Spanish AIDS Research Network RD12/0017/0015 that is included in the Spanish I+D-I Plan and is co-financed by ISCIII-Subdireccion General de Evaluacion and European Funding for Regional Development (FEDER). The work of Maria Sanchez del Cojo is supported by a fellowship of Fondo de Investigaciones Sanitarias (FI09/00347). The Spanish Ministry of Economy and Competitiveness supported the work of Maria Rosa Lopez-Huertas (PIE 13/00040), Elena Mateos (SAF2010-18388), Sara Rodriguez-Mora (Sara Borrell fellowship) and Francisco Diez-Fuertes (Sara Borrell fellowship).	ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Bera A, 2013, CELL SIGNAL, V25, P2575, DOI 10.1016/j.cellsig.2013.08.005; Bruce-Keller AJ, 2003, J NEUROSCI, V23, P8417; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Coiras M, 2006, PROTEOMICS, V6, pS63, DOI 10.1002/pmic.200500437; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-100; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Cunningham L, 2012, P NATL ACAD SCI USA, V109, P14592, DOI 10.1073/pnas.1200037109; Detsika MG, 2012, AIDS REV, V14, P188; Di Leva G, 2010, TRENDS MOL MED, V16, P257, DOI 10.1016/j.molmed.2010.04.001; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Fevrier M, 2011, VIRUSES-BASEL, V3, P586, DOI 10.3390/v3050586; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gatignol A, 2000, Adv Pharmacol, V48, P209; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jiang L, 2013, EXP CELL RES, V319, P2254, DOI 10.1016/j.yexcr.2013.06.007; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim VN, 2005, MOL CELLS, V19, P1; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; KROWKA JF, 1989, J CLIN INVEST, V83, P1198, DOI 10.1172/JCI114001; Kumar A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0137-6; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Li JCB, 2007, IMMUNOLOGY, V121, P337, DOI 10.1111/j.1365-2567.2007.02580.x; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Lopez-Huertas MR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00069; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MADORE SJ, 1993, J VIROL, V67, P3703, DOI 10.1128/JVI.67.7.3703-3711.1993; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; MEYAARD L, 1993, IMMUNOL TODAY, V14, P161, DOI 10.1016/0167-5699(93)90279-T; Musgrove EA, 2004, J MAMMARY GLAND BIOL, V9, P55, DOI 10.1023/B:JOMG.0000023588.55733.84; Nagy G, 2006, J BIOL CHEM, V281, P34574, DOI 10.1074/jbc.M606301200; Nallamshetty S, 2005, FEBS LETT, V579, P6529, DOI 10.1016/j.febslet.2005.10.028; NARDELLI B, 1995, P NATL ACAD SCI USA, V92, P7312, DOI 10.1073/pnas.92.16.7312; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Panner A, 2010, CANCER RES, V70, P5046, DOI 10.1158/0008-5472.CAN-09-3979; Patel P, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0108-6; Popik W, 1996, MOL CELL BIOL, V16, P6532; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; RASHEED S, 1986, VIROLOGY, V154, P395, DOI 10.1016/0042-6822(86)90465-4; Reed M, 2010, J SURG ONCOL, V102, P282, DOI 10.1002/jso.21590; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rodriguez-Mora S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0203-3; Lopez-Huertas MR, 2013, J BIOL CHEM, V288, P7626, DOI 10.1074/jbc.M112.408294; Rosca A, 2016, J MED VIROL, V88, P2132, DOI 10.1002/jmv.24586; Ruelas DS, 2015, J BIOL CHEM, V290, P13736, DOI 10.1074/jbc.M115.641837; Sanghvi VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017246; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sgarbanti M, 2008, J VIROL, V82, P3632, DOI 10.1128/JVI.00599-07; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057652; Song LP, 2011, PROTEIN CELL, V2, P273, DOI 10.1007/s13238-011-1037-y; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; TAKEYA M, 1991, ACTA PATHOL JAPON, V41, P212; Thierry S, 2004, J VIROL, V78, P12198, DOI 10.1128/JVI.78.22.12198-12206.2004; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; VAGO L, 1993, J ACQ IMMUN DEF SYND, V6, P42; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Willard-Gallo KE, 2001, EUR J IMMUNOL, V31, P969, DOI 10.1002/1521-4141(200104)31:4<969::AID-IMMU969>3.0.CO;2-2; Wu YR, 2016, TUMOR BIOL, V37, P12061, DOI 10.1007/s13277-016-5074-2; Xiao HQ, 2009, AM J NEPHROL, V30, P34, DOI 10.1159/000200769; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339	93	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185677	10.1371/journal.pone.0185677	http://dx.doi.org/10.1371/journal.pone.0185677			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968466	Green Published, gold			2022-12-27	WOS:000412029600036
J	Bogdanov, P; Dereli, N; Dang, XH; Bassett, DS; Wymbs, NF; Grafton, ST; Singh, AK				Bogdanov, Petko; Dereli, Nazli; Dang, Xuan-Hong; Bassett, Danielle S.; Wymbs, Nicholas F.; Grafton, Scott T.; Singh, Ambuj K.			Learning about learning: Mining human brain sub-network biomarkers from fMRI data	PLOS ONE			English	Article							HUMAN PARIETAL OPERCULUM; FUNCTIONAL CONNECTIVITY; COMMUNICATION; CORTEX; AREAS; TESTS	Modeling the brain as a functional network can reveal the relationship between distributed neurophysiological processes and functional interactions between brain structures. Existing literature on functional brain networks focuses mainly on a battery of network properties in "resting state" employing, for example, modularity, clustering, or path length among regions. In contrast, we seek to uncover functionally connected subnetworks that predict or correlate with cohort differences and are conserved within the subjects within a cohort. We focus on differences in both the rate of learning as well as overall performance in a sensorimotor task across subjects and develop a principled approach for the discovery of discriminative subgraphs of functional connectivity based on imaging acquired during practice. We discover two statistically significant subgraph regions: one involving multiple regions in the visual cortex and another involving the parietal operculum and planum temporale. High functional coherence in the former characterizes sessions in which subjects take longer to perform the task, while high coherence in the latter is associated with high learning rate ( performance improvement across trials). Our proposed methodology is general, in that it can be applied to other cognitive tasks, to study learning or to differentiate between healthy patients and patients with neurological disorders, by revealing the salient interactions among brain regions associated with the observed global state. The discovery of such significant discriminative subgraphs promises a better data-driven understanding of the dynamic brain processes associated with high-level cognitive functions.	[Bogdanov, Petko] SUNY Albany, Dept Comp Sci, 1400 Washington Ave, Albany, NY 12222 USA; [Dereli, Nazli] Ticketmaster, Los Angeles, CA USA; [Dang, Xuan-Hong; Singh, Ambuj K.] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect Engn, Philadelphia, PA 19104 USA; [Wymbs, Nicholas F.] Johns Hopkins Med Inst, Dept Phys Med & Rehabil, Baltimore, MD 21205 USA; [Grafton, Scott T.] Univ Calif Santa Barbara, Dept Psychol, Santa Barbara, CA 93106 USA; [Grafton, Scott T.] Univ Calif Santa Barbara, UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Santa Barbara; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bogdanov, P (corresponding author), SUNY Albany, Dept Comp Sci, 1400 Washington Ave, Albany, NY 12222 USA.	pbogdanov@albany.edu		Bogdanov, Petko/0000-0001-6310-3224	National Science Foundation [IIS-1219254, BCS-1441502, CAREER PHY-1554488, BCS-1631550]; US National Institutes of Health [P01 NS044393]; Institute for Collaborative Biotechnologies from the U.S. Army Research Office [W911NF-09-0001]; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; Army Research Laboratory; Army Research Office [W911NF-10-2-0022, W911NF-14-1-0679]; National Institute of Health [2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, R21-M MH-106799]; Office of Naval Research	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Collaborative Biotechnologies from the U.S. Army Research Office; John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Army Research Office; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research)	AKS would like to acknowledge support from the National Science Foundation grant IIS-1219254. This data is based on support to STG by the US National Institutes of Health (grant: P01 NS044393) and the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the U.S. Army Research Office. DSB would also like to acknowledge support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Health (2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, and R21-M MH-106799), the Office of Naval Research, and the National Science Foundation (BCS-1441502, CAREER PHY-1554488, and BCS-1631550). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ND contributed to the manuscript while pursuing her MS degree at UCSB, thus, her current employer Ticketmaster did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript nor in providing financial support.; AKS would like to acknowledge support from the National Science Foundation grant IIS-1219254. This data is based on support to STG by the US National Institutes of Health (grant: P01 NS044393) and the Institute for Collaborative Biotechnologies through contract W911NF-09-0001 from the U.S. Army Research Office. DSB would also like to acknowledge support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the Army Research Laboratory and the Army Research Office through contract numbers W911NF-10-2-0022 and W911NF-14-1-0679, the National Institute of Health (2-R01-DC-009209-11, 1R01HD086888-01, R01-MH107235, R01-MH107703, R01MH109520, and R21-M MH-106799), the Office of Naval Research, and the National Science Foundation (BCS-1441502, CAREER PHY-1554488, and BCS-1631550). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Bassett D. S., 2011, P NATL ACAD SCI; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassett DS, 2016, NEUROSCIENT IN PRESS; BASSETTI C, 1993, NEUROLOGY, V43, P1942, DOI 10.1212/WNL.43.10.1942; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Boas P.R.V., 2010, J STAT MECH-THEORY E, V2010; Bogdanov P., 2011, Proceedings of the 2011 IEEE 11th International Conference on Data Mining (ICDM 2011), P81, DOI 10.1109/ICDM.2011.101; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Buch ER, 2016, NEUROSCIENTIST; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Caspers J, 2014, HUM BRAIN MAPP, V35, P2754, DOI 10.1002/hbm.22364; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Dang XH, 2014, MACHINE LEARNING KNO, P290; Davison EN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004029; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Duda R.O., 2000, PATTERN CLASSIFICATI; Dutkowski J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002180; Echtermeyer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015765; Eickhoff SB, 2006, CEREB CORTEX, V16, P268, DOI 10.1093/cercor/bhi106; Eickhoff SB, 2006, CEREB CORTEX, V16, P254, DOI 10.1093/cercor/bhi105; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Huang, 2006, P IEEE INT C AC SPEE, V3, pIII; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang CT, 2013, KNOWL ENG REV, V28, P75, DOI 10.1017/S0269888912000331; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kim J, 2015, NEUROIMAGE-CLIN, V9, P625, DOI 10.1016/j.nicl.2015.10.004; Kim JH, 2014, NEUROIMAGE, V101, P681, DOI 10.1016/j.neuroimage.2014.07.031; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; Li RH, 2015, P INT C DAT ENG ICDE; Lu XS, 2012, LECT NOTES COMPUT SC, V7338, P195, DOI 10.1007/978-3-642-31235-9_13; Mantzaris AV, 2013, J COMPLEX NETW, V1, P83, DOI 10.1093/comnet/cnt001; Maule F, 2013, CEREB CORTEX, V25, P528; Mazzola L, 2012, NEUROIMAGE, V60, P409, DOI 10.1016/j.neuroimage.2011.12.072; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mongiovi M, 2013, IEEE DATA MINING, P537, DOI 10.1109/ICDM.2013.106; Muhei-aldin O, 2014, J NEUROSCI METH, V227, P75, DOI 10.1016/j.jneumeth.2014.02.003; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Ranu S, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P509; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Ruben J, 2001, CEREB CORTEX, V11, P463, DOI 10.1093/cercor/11.5.463; Schmidt R.A., 2005, MOTOR CONTROL LEARNI, V4; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stephan KE, 2009, NEUROIMAGE, V47, P1628, DOI 10.1016/j.neuroimage.2009.05.096; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Summerfield C, 2006, PLOS BIOL, V4, P855, DOI 10.1371/journal.pbio.0040128; Sun FT, 2007, CEREB CORTEX, V17, P1227, DOI 10.1093/cercor/bhl033; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tibshirani RJ, 2011, ANN STAT, V39, P1335, DOI 10.1214/11-AOS878; Tomassini V, 2011, HUM BRAIN MAPP, V32, P494, DOI 10.1002/hbm.21037; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; van Diessen E, 2015, CLIN NEUROPHYSIOL, V126, P1468, DOI 10.1016/j.clinph.2014.11.018; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038; Yan XF, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P721, DOI 10.1109/ICDM.2002.1184038; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang ZT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157243	74	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184344	10.1371/journal.pone.0184344	http://dx.doi.org/10.1371/journal.pone.0184344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016686	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400006
J	Botwright, S; Holroyd, T; Nanda, S; Bloem, P; Griffiths, UK; Sidibe, A; Hutubessy, RCW				Botwright, Siobhan; Holroyd, Taylor; Nanda, Shreya; Bloem, Paul; Griffiths, Ulla K.; Sidibe, Anissa; Hutubessy, Raymond C. W.			Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; ROUTINE IMMUNIZATION; COUNTRIES	From 2012 to 2016, Gavi, the Vaccine Alliance, provided support for countries to conduct small-scale demonstration projects for the introduction of the human papillomavirus vaccine, with the aim of determining which human papillomavirus vaccine delivery strategies might be effective and sustainable upon national scale-up. This study reports on the operational costs and cost determinants of different vaccination delivery strategies within these projects across twelve countries using a standardized micro-costing tool. The World Health Organization Cervical Cancer Prevention and Control Costing Tool was used to collect costing data, which were then aggregated and analyzed to assess the costs and cost determinants of vaccination. Across the one-year demonstration projects, the average economic and financial costs per dose amounted to US$19.98 (standard deviation +/- 12.5) and US$8.74 (standard deviation +/- 5.8), respectively. The greatest activities representing the greatest share of financial costs were social mobilization at approximately 30% (range, 6-67%) and service delivery at about 25% (range, 3-46%). Districts implemented varying combinations of school-based, facility-based, or outreach delivery strategies and experienced wide variation in vaccine coverage, drop-out rates, and service delivery costs, including transportation costs and per diems. Size of target population, number of students per school, and average length of time to reach an outreach post influenced cost per dose. Although the operational costs from demonstration projects are much higher than those of other routine vaccine immunization programs, findings from our analysis suggest that HPV vaccination operational costs will decrease substantially for national introduction. Vaccination costs may be decreased further by annual vaccination, high initial investment in social mobilization, or introducing/strengthening school health programs. Our analysis shows that drivers of cost are dependent on country and district characteristics. We therefore recommend that countries carry out detailed planning at the national and district levels to define a sustainable strategy for national HPV vaccine roll-out, in order to achieve the optimal balance between coverage and cost.	[Botwright, Siobhan; Sidibe, Anissa] Gavi, Vaccine Implementat, Vaccine Alliance, Geneva, Switzerland; [Holroyd, Taylor; Nanda, Shreya; Hutubessy, Raymond C. W.] WHO, Initiat Vaccine Res, Geneva, Switzerland; [Bloem, Paul] WHO, Expanded Program Immunizat, Geneva, Switzerland; [Griffiths, Ulla K.] UNICEF, Hlth Sect, New York, NY USA; [Botwright, Siobhan] Stop TB Partnership, Strateg Initiat & Innovat Financing, Geneva, Switzerland; [Holroyd, Taylor] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Nanda, Shreya] Food Stand Agcy, London, England	World Health Organization; World Health Organization; UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hutubessy, RCW (corresponding author), WHO, Initiat Vaccine Res, Geneva, Switzerland.	hutubessyr@who.int		Holroyd, Taylor/0000-0003-1907-2218	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahanhanzo CD, 2015, VACCINE, V33, pA66, DOI 10.1016/j.vaccine.2014.12.069; [Anonymous], 2016, HPV VACC LESS LEARNT; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brenzel L, 2015, VACCINE, V33, pA93, DOI 10.1016/j.vaccine.2014.12.076; de Sanjose S, 2012, Vaccine, V30 Suppl 4, pD1, DOI 10.1016/S0264-410X(12)01435-1; Dorji T, 2015, VACCINE, V33, P3726, DOI 10.1016/j.vaccine.2015.05.078; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gavi The Vaccine Alliance, 2016, APPL FOR SUPP; Ginsberg GM, 2009, VACCINE, V27, P6060, DOI 10.1016/j.vaccine.2009.07.026; Hanson CM, 2015, VACCINES-BASEL, V3, P408, DOI 10.3390/vaccines3020408; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kabakama S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3517-8; Le Gargasson JB, 2015, VACCINE, V33, pA40, DOI 10.1016/j.vaccine.2014.12.081; Levin A, 2014, PLOS ONE, V9, P8; Maceira D, 2015, VALUE HEALTH, V18, pA746, DOI 10.1016/j.jval.2015.09.2881; Mvundura M, 2015, VACCINE, V33, P2697, DOI 10.1016/j.vaccine.2015.03.084; Ngabo F, 2015, VACCINE, V33, P7357, DOI 10.1016/j.vaccine.2015.10.022; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; Torres-Rueda S, 2016, SEX REPROD HEALTHC, V7, P46, DOI 10.1016/j.srhc.2015.11.006; Tsu V, 2016, NEW ENGL J MED, V374, P2509, DOI 10.1056/NEJMp1604113; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO, 2015, VACCINE, V33, P76, DOI 10.1016/j.vaccine.2014.05.040; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P561; World Health Organization, 2013, WHO UNICEF GUID DEV; World Health Organization, 2016, WHO CERV CANC PREV C	28	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0182663	10.1371/journal.pone.0182663	http://dx.doi.org/10.1371/journal.pone.0182663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016596	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400002
J	Cha, MJ; Kim, HS; Kim, SH; Park, JH; Cho, GY				Cha, Myung-Jin; Kim, Hyun-Sook; Kim, Seong Hwan; Park, Jae-Hyeong; Cho, Goo-Yeong			Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction (vol 12, e0174160, 2017)	PLOS ONE			English	Correction									[Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Cardiol,Cardiovasc Ctr, Seongnam, South Korea	Seoul National University (SNU)			Park, Jae-Hyeong/AAD-9015-2021					Cha MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174160	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186437	10.1371/journal.pone.0186437	http://dx.doi.org/10.1371/journal.pone.0186437			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016660	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400067
J	Thein, HH; Qiao, Y; Zaheen, A; Jembere, N; Sapisochin, G; Chan, KKW; Yoshida, EM; Earle, CC				Thein, Hla-Hla; Qiao, Yao; Zaheen, Ahmad; Jembere, Nathaniel; Sapisochin, Gonzalo; Chan, Kelvin K. W.; Yoshida, Eric M.; Earle, Craig C.			Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting	PLOS ONE			English	Article							QUALITY-OF-LIFE; EFFECTIVENESS ACCEPTABILITY CURVES; HEALTH-STATE UTILITIES; CHRONIC HEPATITIS-C; CASE-MIX GROUPS; TRANSARTERIAL CHEMOEMBOLIZATION; ECONOMIC-EVALUATION; PROPENSITY SCORE; CARE MANAGEMENT; STAGING SYSTEMS	Hepatocellular carcinoma (HCC) presentation is heterogeneous necessitating a variety of therapeutic interventions with varying efficacies and associated prognoses. Poor prognostic patients often undergo non-curative palliative interventions including transarterial chemoem-bolization (TACE), sorafenib, chemotherapy, or purely supportive care. The decision to pursue one of many palliative interventions for HCC is complex and an economic evaluation comparing these interventions has not been done. This study evaluates the cost-effectiveness of non-curative palliative treatment strategies such as TACE alone or TACE+sorafenib, sorafenib alone, and non-sorafenib chemotherapy compared with no treatment or best supportive care (BSC) among patients diagnosed with HCC between 2007 and 2010 in a Canadian setting. Using person-level data, we estimated effectiveness in life years and quality-adjusted life years (QALYs) along with total health care costs (2013 US dollars) from the health care payer's perspective (3% annual discount). A net benefit regression approach accounting for baseline covariates with propensity score adjustment was used to calculate incremental net benefit to generate incremental cost-effectiveness ratio (ICER) and uncertainty measures. Among 1,172 identified patients diagnosed with HCC, 4.5%, 7.9%, and 5.6%, received TACE alone or TACE+sorafenib, sorafenib, and non-sorafenib chemotherapy clone, respectively. Compared with no treatment or BSC (81.9%), ICER estimates for TACE alone or TACE+sorafenib was $6,665/QALY (additional QALY: 0.47, additional cost: $3,120; 95% CI: -$18,800-$34,500/QALY). The cost-effectiveness acceptability curve demonstrated that if the relevant threshold was $50,000/QALY, TACE alone or TACE+sorafenib, non-sorafenib chemotherapy, and sorafenib alone, would have a cost-effectiveness probability of 99.7%, 46.6%, and 5.5%, respectively. Covariates associated with the incremental net benefit of treatments are age, sex, comorbidity, and cancer stage. Findings suggest that TACE with or without sorafenib is currently the most cost-effective active non-curative palliative treatment approach to HCC. Further research into new combination treatment strategies that afford the best tumor response is needed.	[Thein, Hla-Hla; Qiao, Yao; Jembere, Nathaniel] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Thein, Hla-Hla; Earle, Craig C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Zaheen, Ahmad; Chan, Kelvin K. W.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Sapisochin, Gonzalo] Univ Toronto, Univ Hlth Network, Div Gen Surg, Multiorgan Transplant, Toronto, ON, Canada; [Chan, Kelvin K. W.] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada; [Chan, Kelvin K. W.; Earle, Craig C.] Canadian Ctr Appl Res Canc Control ARCC, Toronto, ON, Canada; [Yoshida, Eric M.] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada; [Earle, Craig C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Earle, Craig C.] Canc Care Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario	Thein, HH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Thein, HH (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	rosie.thein@utoronto.ca		Thein, Hla-Hla/0000-0003-4950-187X	Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program [IA-034]	Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Institute for Cancer Research; Ontario Institute for Cancer Research Health Services Research Program	This study was supported through provision of data by the Institute for Clinical Evaluative Sciences and Cancer Care Ontario and through funding support to Institute for Clinical Evaluative Sciences from an annual grant by the Ministry of Health and Long-Term Care, and from the Ontario Institute for Cancer Research. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by Institute for Clinical Evaluative Sciences, Cancer Care Ontario, Ontario Institute for Cancer Research or the Government of Ontario is intended or should be inferred. Hla-Hla Thein received a New Investigator Award IA-034 from the Ontario Institute for Cancer Research Health Services Research Program.	[Anonymous], 2010, TECHN APPR GUID 189; [Anonymous], 2006, LIF TABL CAN PROV TE; Ault Kimberly, 2012, MULTIPLE IMPUTATION; Barone C, 2013, ANN ONCOL S2, V24; Breunig IM, 2013, VALUE HEALTH, V16, P760, DOI 10.1016/j.jval.2013.03.1630; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burak KW, 2015, CAN J GASTROENTEROL, V29, P178, DOI 10.1155/2015/824263; Camma C, 2008, ALIMENT PHARM THER, V28, P62, DOI 10.1111/j.1365-2036.2008.03692.x; Camma C, 2013, HEPATOLOGY, V57, P1046, DOI 10.1002/hep.26221; Canadian Cancer Statistics, 2013, CAN CANC STAT 2013; Carr BI, 2010, J GASTROEN HEPATOL, V25, P1739, DOI 10.1111/j.1440-1746.2010.06404.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Clarke EA, 1991, IARC SCI PUBL, P246; Cucchetti A, 2013, J HEPATOL, V59, P300, DOI 10.1016/j.jhep.2013.04.009; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-52; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fleming ID, 2001, J SURG ONCOL, V77, P233, DOI 10.1002/jso.1101; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fu QH, 2014, J CANCER RES CLIN, V140, P1429, DOI 10.1007/s00432-014-1684-5; Gomaa AI, 2015, WORLD J HEPATOL, V7, P673, DOI 10.4254/wjh.v7.i4.673; Hoch JS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-68; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsu PC, 2012, J GASTROEN HEPATOL, V27, P149, DOI 10.1111/j.1440-1746.2011.06813.x; Jacobs P, USING CANADIAN ADM D; Jembere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040917; Levy AR, 2008, VALUE HEALTH, V11, P527, DOI 10.1111/j.1524-4733.2007.00297.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Muszbek N, 2008, CURR MED RES OPIN, V24, P3559, DOI 10.1185/03007990802563706 ; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Organization for Economic Co-Operation and Development, 2015, PPPS EXCH RAT; Peng SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112530; PINK GH, 1994, CAN MED ASSOC J, V150, P1255; PINK GH, 1994, CAN MED ASSOC J, V150, P889; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Shih YT, 2017, J CLIN ONCOL; Siebert U, 2001, HEPATOLOGY, V34; Siegel JE, 1997, PHARMACOECONOMICS, V11, P159, DOI 10.2165/00019053-199711020-00005; Statistics Canada, CANSIM TABL 326 0021; Thein HH, 2016, CURR ONCOL, V23, pE196, DOI 10.3747/co.23.2956; Thein HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138907; Thein HH, 2013, HEPATOLOGY, V58, P1375, DOI 10.1002/hep.26231; Vadot L, 2015, J CLIN PHARM THER, V40, P83, DOI 10.1111/jcpt.12230; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Woo G, 2012, CAN J GASTROENTEROL, V26, P445, DOI 10.1155/2012/736452; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Younossi ZM, 2001, AM J GASTROENTEROL, V96, P579; Zhang LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100305; Zhang PF, 2015, EUR J GASTROEN HEPAT, V27, P853, DOI 10.1097/MEG.0000000000000373	62	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185198	10.1371/journal.pone.0185198	http://dx.doi.org/10.1371/journal.pone.0185198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016627	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400015
J	Vorup, J; Pedersen, MT; Brahe, LK; Melcher, PS; Alstrom, JM; Bangsbo, J				Vorup, Jacob; Pedersen, Mogens Theisen; Brahe, Lena Kirchner; Melcher, Pia Sandfeld; Alstrom, Joachim Meno; Bangsbo, Jens			Effect of small-sided team sport training and protein intake on muscle mass, physical function and markers of health in older untrained adults: A randomized trial	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; INFLAMMATORY MARKERS; INSULIN SENSITIVITY; RESISTANCE EXERCISE; SKELETAL-MUSCLE; MEN; FOOTBALL; STRENGTH	The effect of small-sided team sport training and protein intake on muscle mass, physical function, and adaptations important for health in untrained older adults was examined. Forty-eight untrained older (72 +/- 6 (+/- standard deviation, SD) years men and women were divided into either a team sport group ingesting a drink high in protein (18 g) immediately and 3 h after each training session (TS-HP, n = 13), a team sport group ingesting an isocaloric drink with low protein content (3 g; TS-LP, n = 18), or a control group continuing their normal activities (CON, n = 17). The team sport training was performed as similar to 20 min of small-sided ball games twice a week over 12 weeks. After the intervention period, leg muscle mass was 0.6 kg higher (P = 0.047) in TS-HP, with no effect in TS-LP. In TS-HP, number of sit-to-stand repetitions increased (1.2 +/- 0.6, P = 0.054), time to perform 2.45 m up-and-go was lower (0.7 +/- 0.3 s, P = 0.03) and number of arm curl repetitions increased (3.5 +/- 1.2, P = 0.01), whereas in TS-LP only number of repetitions in sit-to-stand was higher (1.6 +/- 0.6, P = 0.01). In TS-LP, reductions were observed in total and abdominal fat mass (1.2 +/- 0.5 and 0.4 +/- 0.2 kg, P = 0.03 and P = 0.02, respectively), heart rate at rest (9 +/- 3 bpm, P = 0.002) and plasma C-reactive protein (1.8 +/- 0.8 mmol/L, P = 0.03), with no effects in TS-HP. Thus, team sport training improves functional capacity of untrained older adults and increases leg muscle mass only when ingesting proteins after training. Furthermore, team sport training followed by intake of drink with low protein content does lower fat mass, heart rate at rest and level of systemic inflammation.	[Vorup, Jacob; Pedersen, Mogens Theisen; Brahe, Lena Kirchner; Melcher, Pia Sandfeld; Alstrom, Joachim Meno; Bangsbo, Jens] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Sect Integrat Physiol, Copenhagen O, Denmark	University of Copenhagen	Bangsbo, J (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Sect Integrat Physiol, Copenhagen O, Denmark.	jbangsbo@nexs.ku.dk	Bangsbo, Jens/A-7192-2015; Pedersen, Mogens Theisen/C-6991-2015	Bangsbo, Jens/0000-0003-1305-9274; Pedersen, Mogens Theisen/0000-0002-3178-6320; Melcher, Pia Grethe Sandfeld/0000-0002-8980-2397	Nordea-fonden; municipality of Copenhagen	Nordea-fonden; municipality of Copenhagen	This study was supported by Nordea-fonden (http://nordeafonden.dk/) and the municipality of Copenhagen (http://www.kk.dk/). Protein drinks were provided by Nestle Health Science (https://www.nestlehealthscience.com/). The co-funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2015, CLIN LIVER DIS, V19, P439, DOI 10.1016/j.cger.2015.04.011; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P76, DOI 10.1111/sms.12245; Andersen TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148236; Areta JL, 2013, J PHYSIOL-LONDON, V591, P2319, DOI 10.1113/jphysiol.2012.244897; Bangsbo J, 2015, BRIT J SPORT MED, V49, P568, DOI 10.1136/bjsports-2015-094781; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bherer L., 2012, OXFORD HDB IN PRESS; Booth A, 2014, HORM MOL BIOL CLIN I, V17, P13, DOI 10.1515/hmbci-2014-0009; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Churchward-Venne TA, 2016, SPORTS MED, V46, P1205, DOI 10.1007/s40279-016-0504-2; Colbert LH, 2004, J AM GERIATR SOC, V52, P1098, DOI 10.1111/j.1532-5415.2004.52307.x; Cooney MT, 2010, AM HEART J, V159, P612, DOI 10.1016/j.ahj.2009.12.029; Dickinson JM, 2013, EXERC SPORT SCI REV, V41, P216, DOI 10.1097/JES.0b013e3182a4e699; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Harrison M, 2009, J APPL PHYSIOL, V106, P943, DOI 10.1152/japplphysiol.91367.2008; Hedayatpour N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/193741; Jones EJ, 2008, SPORTS MED, V38, P987, DOI 10.2165/00007256-200838120-00003; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Kelley GA, 2006, METABOLISM, V55, P1500, DOI 10.1016/j.metabol.2006.06.021; Krustrup P, 2009, BRIT J SPORT MED, V43, P825, DOI 10.1136/bjsm.2008.053124; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Lin X, 2015, J AM HEART ASS, V4; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; Moore DR, 2009, AM J CLIN NUTR, V89, P161, DOI 10.3945/ajcn.2008.26401; Narici M. V., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P161; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Newsom SA, 2010, J APPL PHYSIOL, V108, P554, DOI 10.1152/japplphysiol.01106.2009; Nybo L, 2010, MED SCI SPORT EXER, V42, P1951, DOI 10.1249/MSS.0b013e3181d99203; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pedersen MT, 2017, SCAND J MED SCI SPOR; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P80, DOI 10.1111/j.1600-0838.2010.01091.x; Skate J, 2014, J PHYS ACT HEALTH, V11, P76; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tipton KD, 2013, NESTLE NUTR WORKS SE, V76, P73, DOI 10.1159/000350259; Tudor-Locke C, 2013, J GERONTOL A-BIOL, V68, P1426, DOI 10.1093/gerona/glt116; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-80; Vorup J, 2016, SCAND J MED SCI SPOR; Welle S, 1998, AM J PHYSIOL-ENDOC M, V274, pE677, DOI 10.1152/ajpendo.1998.274.4.E677	43	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186202	10.1371/journal.pone.0186202	http://dx.doi.org/10.1371/journal.pone.0186202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016675	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400060
J	Kim, B; Pai, H; Choi, WS; Kim, Y; Kweon, KT; Kim, HA; Ryu, SY; Wie, SH; Kim, J				Kim, Bongyoung; Pai, Hyunjoo; Choi, Won Suk; Kim, Yeonjae; Kweon, Ki Tae; Kim, Hyun Ah; Ryu, Seong Yeol; Wie, Seong-Heon; Kim, Jieun			Current status of indwelling urinary catheter utilization and catheter-associated urinary tract infection throughout hospital wards in Korea: A multicenter prospective observational study	PLOS ONE			English	Article								To evaluate the frequency and appropriateness of indwelling urinary catheters (IUC) use and the incidence of catheter-associated urinary tract infections (CA-UTI), and explore the risk factors for CA-UTI in hospitals as a whole, we conducted a study. This study was divided into two parts; a point-prevalence study on Dec 12th 2012 and a prospective cohort study from Dec 13th 2012 to Jan 9th 2013 were performed in six hospitals in Korea. All hospitalized patients with newly-placed IUCs were enrolled and monitored weekly for 28 days after IUC placement. In the point-prevalence study, the IUCs were present in median 14.9/100 hospitalized patients (1Q 14, 3Q 16) across the six hospitals. In the prospective cohort study, the median IUC-days per patient was 5 (1Q 3, 3Q 10) and the median CA-UTI prevalence per 1,000 catheter days was 1.9 (1Q 0.7, 3Q 3.8) with significant inter-hospital variation. The proportion of patients with inappropriate IUC maintenance increased with number of IUC-days (8.5% on day 7, 9.4% on day 14, 16.3% on day 21, and 23.1% on day 28). Urinary output monitoring (23/36, 63.9%) was the most common indication for inappropriate use after 1 week of ICU placement. In multivariate analysis, IUC-days was significantly associated with the development of CA-UTI (odds ratio 1.122, 95% confidence interval 1.074-1.173, P < 0.001). IUC-days and CA-UTI rates vary between hospitals. IUC-days is a risk factor for CA-UTI, and is correlated with inappropriate use.	[Kim, Bongyoung] Eulji Univ, Coll Med, Dept Internal Med, Daejeon, South Korea; [Pai, Hyunjoo; Kim, Jieun] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, Won Suk] Korea Univ, Coll Med, Dept Internal Med, Ansan, South Korea; [Kim, Yeonjae] Natl Med Ctr, Dept Infect Dis, Seoul, South Korea; [Kweon, Ki Tae] Patima Hosp, Dept Infect Dis, Daegu, South Korea; [Kim, Hyun Ah; Ryu, Seong Yeol] Gyemyeong Univ, Coll Med, Dept Internal Med, Daegu, South Korea; [Wie, Seong-Heon] St Vincent Hosp, Dept Internal Med, Suwon, South Korea	Eulji University; Hanyang University; Korea University; Korea University Medicine (KU Medicine); National Medical Center - Korea	Kim, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	quidam76@hanyang.ac.kr	Choi, Won Suk/V-2730-2017	Choi, Won Suk/0000-0001-5874-4764; Kim, Jieun/0000-0002-6214-3889	Hanyang University	Hanyang University	This work was supported by the research fund of Hanyang University (HY-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2007, AM J INFECT CONTROL, V35, P594, DOI 10.1016/j.ajic.2006.11.007; BREITENBUCHER RB, 1984, ARCH INTERN MED, V144, P1585, DOI 10.1001/archinte.144.8.1585; 곽이경, 2015, [Korean Journal of Healthcare-Associated Infection Control and Prevention, 의료관련감염관리], V20, P49; Crouzet J, 2007, J HOSP INFECT, V67, P253, DOI 10.1016/j.jhin.2007.08.014; Elpern EH, 2009, AM J CRIT CARE, V18, P535, DOI 10.4037/ajcc2009938; Fakih MG, 2015, INFECT CONT HOSP EP, V29, P815; Gokula RM, 2007, AM J INFECT CONTROL, V35, P589, DOI 10.1016/j.ajic.2006.12.004; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; Jansen IAV, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-25; Janzen J, 2013, BMJ QUAL SAF, V22, P984, DOI 10.1136/bmjqs-2013-001908; Korean Society for Nosocomial Infection Control, 2012, KOR NOS INT SURV SYS; Lewis SS, 2013, INFECT CONT HOSP EP, V34, P744, DOI 10.1086/671000; Lo E, 2014, INFECT CONT HOSP EP, V35, P464, DOI [10.1086/675718, 10.1017/S0899823X00193845]; Meddings J, 2010, CLIN INFECT DIS, V51, P550, DOI 10.1086/655133; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; Saint S, 2000, AM J INFECT CONTROL, V28, P68, DOI 10.1016/S0196-6553(00)90015-4; Talaat M, 2010, AM J INFECT CONTROL, V38, P222, DOI 10.1016/j.ajic.2009.06.011; Tambyah PA, 2002, INFECT CONT HOSP EP, V23, P27, DOI 10.1086/501964; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Temiz E, 2012, SCAND J INFECT DIS, V44, P344, DOI 10.3109/00365548.2011.639031	20	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185369	10.1371/journal.pone.0185369	http://dx.doi.org/10.1371/journal.pone.0185369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991927	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800015
J	Mertens, F; Tavora, R; Nakano, EY; Castilhos, ZC				Mertens, Frederic; Tavora, Renata; Nakano, Eduardo Yoshio; Castilhos, Zuleica Carmen			Information sources, awareness and preventive health behaviors in a population at risk of Arsenic exposure: The role of gender and social networks	PLOS ONE			English	Article							TRUST; COMMUNICATION; KNOWLEDGE; INNOVATIONS; DIFFUSION; ATTITUDES	The population of Paracatu is at risk of Arsenic (As) exposure associated with long-term exploration of the largest open pit gold mine in Brazil. As part of the interdisciplinary research "The Paracatu project: Arsenic environmental contamination and human health risks assessment in Paracatu-MG", carried out between 2011 and 2013, we used data disaggregated by gender to identify the sources of As-related information being accessed by inhabitants of Paracatu and to examine if access to these sources was correlated to awareness of As health effects and adoption of behaviors to reduce risk of As exposure. Semistructured, face-to-face interviews were carried out with 460 participants (294 women and 166 men) to collect data on respondent's socio-demographic characteristics, use of mass media and social communication networks as sources of information on As issues, the trustworthiness of these information sources, awareness of As health effects, and adoption of behaviors to reduce As exposure. For both men and women, interpersonal communication was used and trusted more frequently than mass media to obtain information on As. Discussion of As issues occurred preferentially among individuals of the same gender and was associated with awareness of As health risks. There are marked differences in variables correlated with the adoption of behaviors to reduce the risk of As exposure between men and women. Discussing As issues with women was associated with adoption of risk-reduction practices for both genders. In contrast, men who discuss As issues with other men were less likely to adopt As exposure prevention behaviors. Finally, adoption was associated with awareness of As health effects for women, but this was not the case for men. Policy implications for decision makers, practitioners and researchers are discussed, based on concrete examples of how gender-specific approaches can effectively guide the formulation and implementation of health promotion campaigns and programs.	[Mertens, Frederic; Tavora, Renata] Univ Brasilia, Ctr Desenvolvimento Sustentavel, Brasilia, DF, Brazil; [Mertens, Frederic; Tavora, Renata; Castilhos, Zuleica Carmen] Community Practice Ecosyst Approaches Hlth Latin, Brasilia, DF, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil; [Castilhos, Zuleica Carmen] MCTI, Ctr Tecnol Mineral CETEM, Rio De Janeiro, RJ, Brazil	Universidade de Brasilia; Universidade de Brasilia	Mertens, F (corresponding author), Univ Brasilia, Ctr Desenvolvimento Sustentavel, Brasilia, DF, Brazil.; Mertens, F (corresponding author), Community Practice Ecosyst Approaches Hlth Latin, Brasilia, DF, Brazil.	mertens.br@gmail.com	Nakano, Eduardo Y/G-1660-2011; Mertens, Frédéric/AAZ-3379-2021	Nakano, Eduardo Y/0000-0002-9071-8512; Mertens, Frédéric/0000-0002-1449-8140	municipality of Paracatu, Minas Gerais, Brazil; International Development Research Centre of Canada; Latin America Caribbean	municipality of Paracatu, Minas Gerais, Brazil; International Development Research Centre of Canada(CGIAR); Latin America Caribbean	The authors received funding from the municipality of Paracatu, Minas Gerais, Brazil.; The present study is part of the research project "The Paracatu project: As environmental contamination and human health risks assessment in Paracatu-MG", coordinated by the Center for Mineral Technology, part of the Brazilian Science, Technology and Innovation Ministry, and carried out by several Brazilian institutions: Instituto Evandro Chagas, Universidade Federal Fluminense, Faculdade de Ciencias Medicas-Universidade de Campinas, FIOCRUZ-Escola Nacional de Saude Publica, Faculdade TECSOMA, Centro de Desenvolvimento Sustentavel-Universidade de Brasilia. The authors also thank the Community of Practice in Ecosystem Approaches to Health from Latin America & Caribbean and the International Development Research Centre of Canada for their support. Finally, the authors are grateful to Juliana Ferreira de Assis, Lucas Vieira da Silva, Marcela Dupont Britto, Marina Cazilda de Moura Alves, Sheila Lopes da Silva, undergraduate students from the University of Brasilia, for carrying out the interviews. We also thank Jordan Sky Oestreicher for English language editing of the manuscript.	Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; al-Taiar A, 2009, HEALTH POLICY PLANN, V24, P428, DOI 10.1093/heapol/czp034; Becker S, 1996, STUD FAMILY PLANN, V27, P291, DOI 10.2307/2138025; Boulay M, 1999, INT FAM PLAN PERSPEC, V25, P112, DOI 10.2307/2991959; Castilhos ZC, 2014, ONE CENTURY DISCOVER, P911; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Frewer LJ, 1996, RISK ANAL, V16, P473, DOI 10.1111/j.1539-6924.1996.tb01094.x; Go VF, 2006, DRUG ALCOHOL DEPEN, V84, P69, DOI 10.1016/j.drugalcdep.2005.12.006; Hadi A, 2003, HEALTH POLICY PLANN, V18, P93, DOI 10.1093/heapol/18.1.93; Hanchett S, 2002, HEALTH POLICY PLANN, V17, P393, DOI 10.1093/heapol/17.4.393; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huston SA, 2009, WOMEN HEALTH ISS, V19, P144, DOI 10.1016/j.whi.2009.01.004; Jin SQ, 2015, NJAS-WAGEN J LIFE SC, V72-73, P23, DOI 10.1016/j.njas.2014.10.003; Lima C. A, 2014, ONE CENTURY DISCOVER, P652; Lindstrom M, 2007, SCAND J PUBLIC HEALT, V35, P460, DOI 10.1080/14034940701246090; Liu RD, 2014, FOOD CONTROL, V46, P291, DOI 10.1016/j.foodcont.2014.05.033; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mergler D, 2012, NEUROTOXICOLOGY, V33, P644, DOI 10.1016/j.neuro.2012.05.009; Mertens Frederic, 2005, EcoHealth, V2, P113, DOI 10.1007/s10393-004-0162-y; Mertens F, 2015, ECOL SOC, V20, DOI 10.5751/ES-07483-200318; Mertens F, 2012, SOC SCI MED, V75, P643, DOI 10.1016/j.socscimed.2011.10.016; Moller JC, 2001, BACIA SAO FRANCISCO, P199; Oexmann MJ, 2000, ETHNIC DIS, V11, P817; Ostlin P, 2006, HEALTH PROMOT INT, V21, P25, DOI 10.1093/heapro/dal048; Perkins JM, 2015, SOC SCI MED, V125, P60, DOI 10.1016/j.socscimed.2014.08.019; Triana DRR, 2016, ECOHEALTH, V13, P535, DOI 10.1007/s10393-016-1141-9; SAINT -CHARLES J., 2012, WHAT DIFFERENCE SEX, P69; Singhal A., 2003, COMBATING AIDS COMMU; Valente T W, 1996, J Health Commun, V1, P247, DOI 10.1080/108107396128040; Valente T W, 1995, Sci Commun, V16, P242, DOI 10.1177/1075547095016003002; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Valente TW, 2006, SEX TRANSM DIS, V33, pS23, DOI 10.1097/01.olq.0000221018.32533.6d; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2003, AM J PUBLIC HEALTH, V93, P1837, DOI 10.2105/AJPH.93.11.1837; Valente TW, 1998, HUM COMMUN RES, V24, P366, DOI 10.1111/j.1468-2958.1998.tb00421.x; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Vlassoff C, 2002, SOC SCI MED, V54, P1713, DOI 10.1016/S0277-9536(01)00339-2; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Xiao N, 2014, DECIS SUPPORT SYST, V57, P417, DOI 10.1016/j.dss.2012.10.047; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001	41	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186130	10.1371/journal.pone.0186130	http://dx.doi.org/10.1371/journal.pone.0186130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016663	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800040
J	Qiao, WQ; Jia, ZQ; Liu, HY; Liu, QP; Zhang, T; Quo, WY; Li, P; Deng, M; Li, SQ				Qiao, Weiqiang; Jia, Zhiqiang; Liu, Heyang; Liu, Qipeng; Zhang, Ting; Quo, Wanying; Li, Peng; Deng, Miao; Li, Sanqiang			Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR TWIST; GENE-EXPRESSION; CARCINOMA; METASTASIS; SNAIL; RESISTANCE; PATHWAYS; SURVIVAL; INVASION; CADHERIN	Background Despite initial indications that the transcription factor Twist could be used as a breast cancer prognostic marker, there still exists some controversy about its reliability. Thus, the aim of the present study was to assess the relationship between Twist expression and prognosis in breast carcinoma. Materials and methods We identified eligible studies that reported an association between Twist expression and breast cancer prognosis by searching the literature in PubMed, Embase, the Cochrane Library, and Web of Science databases, through June 5, 2017. Studies investigating Twist protein or mRNA expression as well as reporting survival data in breast cancer were included. The pooled hazard ratio (HR) and odds radio (OR) with a 95% confidence interval (95% CI) were used to estimate associations. Results A total of 2,671 patients from seven included studies were assessed, and the data indicated that increased Twist expression significantly correlated with poor overall survival (OS) (HR, 1.15; 95% CI, 1.00-1.33; P = 0.04) in breast cancer. In addition, we also observed a significant correlation of elevated Twist expression with larger tumor size (OR, 1.92; 95% CI, 1.31-2.81; P = 0.0009), lymph node involvement (OR, 3.81; 95% CI, 1.16-12.54; P = 0.03), higher nuclear grade (OR, 1.45; 95% CI, 1.06-2.00; P = 0.02), and positive human epidermal growth factor receptor 2 (HER2) status (OR, 1.49; 95% CI, 1.06-2.09; P = 0.02). However, no correlation between Twist expression and disease-free survival (DFS), age, estrogen receptor (ER) status, and progesterone receptor (PR) status was observed. Conclusions Our results demonstrate that Twist over-expression is a statistically significant indicator of OS in breast cancer. In addition, our meta-analysis shows that increased Twist expression is significantly associated with larger tumor size, lymph node involvement, higher nuclear grade, and positive HER2 status.	[Qiao, Weiqiang; Liu, Qipeng; Zhang, Ting; Quo, Wanying; Li, Peng; Deng, Miao] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Breast Surg, Luoyang, Peoples R China; [Qiao, Weiqiang; Liu, Heyang; Liu, Qipeng; Zhang, Ting; Quo, Wanying; Li, Peng; Deng, Miao] Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China; [Jia, Zhiqiang] Henan Univ Sci & Technol, Affiliated Hosp 2, Dept Spinal Surg, Luoyang, Peoples R China; [Liu, Heyang] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, Luoyang, Peoples R China; [Li, Sanqiang] Henan Univ Sci & Technol, Med Coll, Mol Med Key Lab Liver Injury & Repair, Luoyang, Peoples R China	Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology	Deng, M (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Breast Surg, Luoyang, Peoples R China.; Deng, M (corresponding author), Henan Univ Sci & Technol, Coll Clin Med, Luoyang, Peoples R China.; Li, SQ (corresponding author), Henan Univ Sci & Technol, Med Coll, Mol Med Key Lab Liver Injury & Repair, Luoyang, Peoples R China.	dengmiao1973@163.com; sanqiangli2001@163.com		Qiao, Weiqiang/0000-0003-4178-4617; Deng, Miao/0000-0001-7146-0619	Program for Science &Technology Innovation teams in Universities of Henan Province [181RTSTHN026]; innovation team of Henan University of Science and Technology [2015XTD003]; Henan province's Key Project of tackle key problems of science and technology [172102310693]	Program for Science &Technology Innovation teams in Universities of Henan Province; innovation team of Henan University of Science and Technology; Henan province's Key Project of tackle key problems of science and technology	This work was supported by the Program for Science &Technology Innovation teams in Universities of Henan Province (#181RTSTHN026), the innovation team of Henan University of Science and Technology (#2015XTD003) and Henan province's Key Project of tackle key problems of science and technology (#172102310693). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Ehinger A, 2017, ACTA ONCOL, V56, P68, DOI 10.1080/0284186X.2016.1237778; Entz-Werle N, 2005, INT J CANCER, V117, P349, DOI 10.1002/ijc.21068; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grzegrzolka J, 2015, ANTICANCER RES, V35, P3961; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Inoue K, 2007, ONCOGENE, V26, P4329, DOI 10.1038/sj.onc.1210226; Kwilas AR, 2015, ONCOTARGET, V6, P28194, DOI 10.18632/oncotarget.4442; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Lim JCT, 2015, BREAST CANCER RES TR, V150, P19, DOI 10.1007/s10549-015-3296-4; Luo GQ, 2008, WORLD J GASTROENTERO, V14, P2487, DOI 10.3748/wjg.14.2487; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Markiewicz A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-226; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Ono M, 2017, CLIN BREAST CANCER, V17, P41, DOI 10.1016/j.clbc.2016.06.012; PARK S, 2017, MEDICINE, V96; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Ranganathan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141370; Riaz M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3317; Selmi A, 2015, CANCER LETT, V357, P412, DOI 10.1016/j.canlet.2014.11.056; Shamanin VA, 2004, MOL CELL BIOL, V24, P2144, DOI 10.1128/MCB.24.5.2144-2152.2004; Shiota M, 2011, BJU INT, V108, pE142, DOI 10.1111/j.1464-410X.2010.09810.x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; van Doorn R, 2004, CANCER RES, V64, P5578, DOI 10.1158/0008-5472.CAN-04-1253; Vasconcelos I, 2016, BREAST, V29, P181, DOI 10.1016/j.breast.2016.07.016; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Vesuna F, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3033-3; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wushou A, 2014, INT J MOL SCI, V15, P21621, DOI 10.3390/ijms151221621; Xu Y, 2017, ONCOGENE, V36, P1157, DOI 10.1038/onc.2016.286; Xu Y, 2014, INT J BIOL SCI, V10, P396, DOI 10.7150/ijbs.8193; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang P, 2014, EUR J CLIN INVEST, V44, P1072, DOI 10.1111/eci.12343; Zhang YQ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0135851, 10.1080/15592324.2015.1035851]; Zhao M, 2013, EXP THER MED, V6, P97, DOI 10.3892/etm.2013.1099	49	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186191	10.1371/journal.pone.0186191	http://dx.doi.org/10.1371/journal.pone.0186191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016671	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800045
J	Reinhold, D; Morrow, JD; Jacobson, S; Hu, JX; Ringel, B; Seibold, MA; Hersh, CP; Kechris, KJ; Bowler, RP				Reinhold, Dominik; Morrow, Jarrett D.; Jacobson, Sean; Hu, Junxiao; Ringel, Benjamin; Seibold, Max A.; Hersh, Craig P.; Kechris, Katerina J.; Bowler, Russell P.			Meta-analysis of peripheral blood gene expression modules for COPD phenotypes	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EPIDEMIOLOGY; RESPONSES; PROFILES; SMOKERS; CELLS	Chronic obstructive pulmonary disease (COPD) occurs typically in current or former smokers, but only a minority of people with smoking history develops the disease. Besides environmental factors, genetics is an important risk factor for COPD. However, the relationship between genetics, environment and phenotypes is not well understood. Sample sizes for genome-wide expression studies based on lung tissue have been small due to the invasive nature of sample collection. Increasing evidence for the systemic nature of the disease makes blood a good alternative source to study the disease, but there have also been few large-scale blood genomic studies in COPD. Due to the complexity and heterogeneity of COPD, examining groups of interacting genes may have more relevance than identifying individual genes. Therefore, we used Weighted Gene Co-expression Network Analysis to find groups of genes (modules) that are highly connected. However, module definitions may vary between individual data sets. To alleviate this problem, we used a consensus module definition based on two cohorts, COPDGene and ECLIPSE. We studied the relationship between the consensus modules and COPD phenotypes airflow obstruction and emphysema. We also used these consensus module definitions on an independent cohort (TESRA) and performed a meta analysis involving all data sets. We found several modules that are associated with COPD phenotypes, are enriched in functional categories and are overrepresented for cell-type specific genes. Of the 14 consensus modules, three were strongly associated with airflow obstruction (meta p <= 0.0002), and two had some association with emphysema (meta p <= 0.06); some associations were stronger in the case-control cohorts, and others in the cases-only subcohorts. Gene Ontology terms that were overrepresented included "immune response" and "defense response." The cell types whose type-specific genes were overrepresented in modules (p < 0.05) included natural killer cells, dendritic cells, and neutrophils. Together, this is the largest investigation of gene blood expression in COPD with 469 cases in COPDGene, ECLIPSE and TESRA combined, with 6267 genes common to all data sets. Additional, we have 42 and 83 controls in COPDGene and ECLIPSE, respectively.	[Reinhold, Dominik; Hu, Junxiao; Kechris, Katerina J.] Univ Colorado Denver, Dept Biostat & Informat, Colorado Sch Publ Hlth, Aurora, CO 80045 USA; [Morrow, Jarrett D.; Hersh, Craig P.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Jacobson, Sean; Bowler, Russell P.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Ringel, Benjamin; Seibold, Max A.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Dept Pediat, Denver, CO USA; [Seibold, Max A.] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Aurora, CO USA	Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Brigham & Women's Hospital; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Reinhold, D (corresponding author), Univ Colorado Denver, Dept Biostat & Informat, Colorado Sch Publ Hlth, Aurora, CO 80045 USA.	dominik.reinhold@ucdenver.edu		Kechris, Katerina/0000-0002-3725-5459; Morrow, Jarrett/0000-0002-5670-5865	National Institutes of Health/National Heart, Lung, and Blood Institute [P20 HL113445, R01 HL095432, R01 HL089856, R01 HL089897, R01HL125583, R01HL13051, P01HL1053392, 5R01HL128439, UL1 TR001082]; Butcher Seed Grant; Roche; ECLIPSE; GlaxoSmithKline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL136846, R01HL125583, R01HL130512] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Butcher Seed Grant; Roche(Roche Holding); ECLIPSE; GlaxoSmithKline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health/National Heart, Lung, and Blood Institute (https://www.nih.gov/ and https://www. nhibi.nih.gov) grants P20 HL113445 (DR, JH, KJK, RPB), R01 HL095432 (RPB), R01 HL089856 (RPB), R01 HL089897 (RPB), R01HL125583 (CPH), R01HL130512 (CPH), P01HL105339 (CPH), 5R01HL128439 (MAS), 5R01MD010443 (MAS), K25 HL136846 (JDM); National Center for Advancing Translational Sciences (http://ncats. nih.gov) UL1 TR001082 (DR, RPB); a Butcher Seed Grant (http://www.colorado.edu/biofrontier/ butcher-program) (KJK, RPB). TESRA was funded by Roche and ECLIPSE was funded by GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by National Institutes of Health/National Heart, Lung, and Blood Institute (https://www.nib.gov/ and https://www.nhlbi.nih.gov) grants P20 HL113445 (DR, JH, KJK, RPB), RO1 HL095432 (RPB), R01 HL089856 (RPB), R01 HL089897 (RPB), R01HL125583 (CPH), R01HL130512 (CPH), P01HL105339 (CPH), 5R01HL128439 (MAS), 5R01MD010443 (MAS), K25 HL136846 (JDM); National Center for Advancing Translational Sciences (https://ncats.nih.gov) UL1 TR001082 (DR, RPB); a Butcher Seed Grant (https:// biofrontiers.colorado.edu/butcher) (KJK, RPB). TESRA was funded by Roche and ECLIPSE was funded by GlaxoSmithKline.	Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahr TM, 2013, AM J RESP CELL MOL, V49, P316, DOI 10.1165/rcmb.2012-0230OC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharya Soumyaroop, 2011, J Clin Bioinforma, V1, P12, DOI 10.1186/2043-9113-1-12; Bhattacharya S, 2009, AM J RESP CELL MOL, V40, P359, DOI 10.1165/rcmb.2008-0114OC; Bowler RP, 2015, AM J RESP CRIT CARE, V191, P275, DOI 10.1164/rccm.201410-1771OC; Edmiston JS, 2010, BIOMARKERS, V15, P715, DOI 10.3109/1354750X.2010.512091; Fabbri LM, 2003, EUR RESPIR J, V22, P1, DOI 10.1183/09031936.03.00063703; Fortunel NO, 2003, SCIENCE, V302, P393; Francis SMS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-81; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; HORVATH S, 2008, PLOS COMPUTATIONAL B; Jones PW, 2011, AM J RESP CRIT CARE; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Liu D, 2007, BIOMETRICS, V63, P1079, DOI 10.1111/j.1541-0420.2007.00799.x; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Morrow JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44232; Morrow JD, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-014-0072-y; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Obeidat M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0558-1; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Poliska S, 2011, RESPIRATION, V81, P499, DOI 10.1159/000324297; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Roberts MEP, 2015, CHRON OBSTR PULM DIS, V2, P268, DOI 10.15326/jcopdf.2.4.2015.0131; Skrepnek GH, 2004, AM J MANAG CARE, V10, pS129; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wan ES, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0089-y; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	33	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185682	10.1371/journal.pone.0185682	http://dx.doi.org/10.1371/journal.pone.0185682			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016655	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800022
J	Chang, JY; Kim, SE; Kim, TH; Woo, SY; Ryu, MS; Joo, YH; Lee, KE; Lee, J; Lee, KH; Moon, CM; Jung, HK; Shim, KN; Jung, SA				Chang, Ji Young; Kim, Seong-Eun; Kim, Tae Hun; Woo, So-Youn; Ryu, Min Sun; Joo, Yang-Hee; Lee, Ko Eun; Lee, Jihyun; Lee, Kang Hoon; Moon, Chang Mo; Jung, Hye-Kyung; Shim, Ki-Nam; Jung, Sung-Ae			Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CROSS-RESISTANCE; RPOB MUTATIONS; MYCOBACTERIUM-TUBERCULOSIS; CLOSTRIDIUM-DIFFICILE; TRAVELERS DIARRHEA; IN-VITRO; AUREUS; RIFAMYCIN	Objectives Rifaximin, a poorly absorbed antibiotics, has gut-specific therapeutic effects. Although frequently prescribed to manipulate intestinal luminal bacterial population in various diseases, the possible induction of antibacterial cross-resistance to a target pathogen is a major concern in long-term rifaximin administration. We aimed to evaluate whether rifampin-resistant staphylococci could evolve after rifaximin treatment in cirrhotic patients. Method A total of 25 cirrhotic patients who were administered rifaximin for the prevention of hepatic encephalopathy were enrolled. Swabs from both hands and the perianal skin were acquired on day 0 (before rifaximin treatment), period 1 (1-7 weeks after treatment), and period 2 (8-16 weeks after treatment) the staphylococcal strain identification and rifampin-resistance testing. Results A total of 198 staphylococcal isolates from 15 species were identified. Staphylococcus epidermidis was isolated most frequently, and Staphylococcus haemolyticus was the most common resistant species both from hands and perianal skin. Eleven patients (44.0%) developed rifampin-resistant staphylococcal isolates in period 1. Among these patients, only six (54.5%) were found to have rifampin-resistant isolates in period 2, with no significant infectious events. Rifampin-resistant staphylococcal isolates were more frequently found in perianal skin than from the hands. No patients acquired a newly resistant strain in period 2. Conclusions About one-half of cirrhotic patients in this study developed rifampin-resistant staphylococcal isolates after rifaximin treatment. Although the resistant strains were no longer detected in about half of the patients in the short-term, the long-term influence of this drug treatment should be determined.	[Chang, Ji Young; Kim, Seong-Eun; Kim, Tae Hun; Ryu, Min Sun; Lee, Ko Eun; Lee, Jihyun; Lee, Kang Hoon; Moon, Chang Mo; Jung, Hye-Kyung; Shim, Ki-Nam; Jung, Sung-Ae] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Woo, So-Youn] Ewha Womans Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Joo, Yang-Hee] Ewha Womans Univ, Coll Med, Dept Ewha Med Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, SE; Kim, TH (corresponding author), Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimse@ewha.ac.kr; thkmewha@gmail.com						Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; BLUMBERG HM, 1991, J INFECT DIS, V163, P1279, DOI 10.1093/infdis/163.6.1279; CALVORI C, 1965, NATURE, V207, P417, DOI 10.1038/207417a0; Curry SR, 2009, CLIN INFECT DIS, V48, P425, DOI 10.1086/596315; DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51; Farrell DJ, 2013, J CLIN GASTROENTEROL, V47, P205, DOI 10.1097/MCG.0b013e31827559a3; Huang DB, 2005, J INFECTION, V50, P97, DOI 10.1016/j.jinf.2004.05.019; Kane JS, 2016, EXPERT REV GASTROENT, V10, P431, DOI 10.1586/17474124.2016.1140571; Kim ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103308; Kim MS, 2013, DIGEST DIS SCI, V58, P1676, DOI 10.1007/s10620-013-2675-0; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Lembo A, 2016, GASTROENTEROLOGY; LUCCHESI M, 1984, CHEMIOTERAPIA, V3, P371; Marchese A, 2000, CHEMOTHERAPY, V46, P253, DOI 10.1159/000007297; Mernelius S, 2016, EUR J CLIN MICROBIOL, V35, P1355, DOI 10.1007/s10096-016-2672-2; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; Mullen KD, 2014, CLIN GASTROENTEROL H, V12, P1390, DOI 10.1016/j.cgh.2013.12.021; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Rana F., 2013, INT J RES PHARM CHEM, V3, P83; Rivkin A, 2011, CLIN THER, V33, P812, DOI 10.1016/j.clinthera.2011.06.007; Rizzello F, 1998, EUR J CLIN PHARMACOL, V54, P91, DOI 10.1007/s002280050426; Robins GW, 2005, DRUGS, V65, P1697, DOI 10.2165/00003495-200565120-00011; Scarpellini E, 2007, ALIMENT PHARM THER, V25, P781, DOI 10.1111/j.1365-2036.2007.03259.x; Scarpignato C, 2005, CHEMOTHERAPY, V51, P36, DOI 10.1159/000081990; SENSI P, 1983, REV INFECT DIS, V5, pS402; Soro Ornella, 1997, Clin Microbiol Infect, V3, P147; Steffen R, 2003, AM J GASTROENTEROL, V98, P1073, DOI [10.1016/S0002-9270(02)06005-7, 10.1111/j.1572-0241.2003.07283.x]; The European Committee on Antimicrobial Susceptibility Testing, 2017, BREAKP TABL INT MICS; Valentin T, 2014, J INFECTION, V69, P295, DOI 10.1016/j.jinf.2014.04.003; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; Villar M, 2011, J ANTIMICROB CHEMOTH, V66, P997, DOI 10.1093/jac/dkr059; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; Yang B, 1998, J ANTIMICROB CHEMOTH, V42, P621, DOI 10.1093/jac/42.5.621; Zhou WJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-240	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186120	10.1371/journal.pone.0186120	http://dx.doi.org/10.1371/journal.pone.0186120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982166	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300127
J	Ellison, MA; Gearheart, CM; Porter, CC; Ambruso, DR				Ellison, Michael A.; Gearheart, Christy M.; Porter, Christopher C.; Ambruso, Daniel R.			IFN-gamma alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils	PLOS ONE			English	Article							MHC CLASS-II; CHRONIC GRANULOMATOUS-DISEASE; COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; NOD-LIKE RECEPTORS; INTERFERON-GAMMA; POLYMORPHONUCLEAR NEUTROPHILS; INNATE IMMUNITY; T-LYMPHOCYTES; RECOGNITION RECEPTOR	The cytokine interferon-gamma (IFN-gamma) is approved as a drug to treat chronic granulomatous disease (CGD) and osteopetrosis and is also used in hyperimmunoglobulin E syndromes. Patients with CGD have defects in proteins of the NOX2 NADPH oxidase system. This leads to reduced production of microbicidal ROS by PMNs and recurrent life threatening infections. The goal of this study was to better understand how IFN-gamma might support phagocyte function in these diseases, and to obtain information that might expand potential uses for IFN-gamma. Neutrophils mature in the bone marrow and then enter the blood where they quickly undergo apoptotic cell death with a half-life of only 5-10 hours. Therefore we reasoned that IFN-gamma might exert its effects on neutrophils via prolonged exposure to cells undergoing maturation in the marrow rather than by its brief exposure to short-lived circulating cells. To explore this possibility we made use of PLB-985 cells, a myeloblast-like myeloid cell line that can be differentiated into a mature, neutrophil-like state by treatment with various agents including DMSO. In initial studies we investigated transcription and protein expression in PLB-985 cells undergoing maturation in the presence or absence of IFN-gamma. We observed IFN-gamma induced differences in expression of genes known to be involved in classical aspects of neutrophil function (transmigration, chemotaxis, phagocytosis, killing and pattern recognition) as well as genes involved in apoptosis and other mechanisms that regulating neutrophil number. We also observed differences for genes involved in the major histocompatibility complex I (MHCI) and MHCII systems whose involvement in neutrophil function is controversial and not well defined. Finally, we observed significant changes in expression of genes encoding guanylate binding proteins (Gbps) that are known to have roles in immunity but which have not as yet been linked to neutrophil function. We propose that changes in the expression within these classes of genes could help explain the immune supportive effects of IFN-gamma. Next we explored if the effect of IFN-gamma on expression of these genes is dependent on whether the cells are undergoing maturation; to do this we compared the effects of IFN-gamma on cells cultured with and without DMSO. For a subset of genes the expression level changes caused by IFN-gamma were much greater in maturing cells than non-maturing cells. These findings indicate that developmental changes associated with cell maturation can modulate the effects of IFN-gamma but that this is gene specific. Since the effects of IFN-gamma depend on whether cells are maturing, the gene expression changes observed in this study must be due to more than just prolonged application of IFN-gamma and are instead the result of interplay between cell maturation and changes caused by the chemokine. This supports our hypothesis that the effects of IFN-gamma on developing neutrophils in the bone marrow may be very different from its effects on mature cells in the blood. Collectively the findings in this study enhance our understanding of the effects of IFN-gamma on maturing myeloid cells and indicate possible mechanisms by which this cytokine could support immune function.	[Ellison, Michael A.; Gearheart, Christy M.; Ambruso, Daniel R.] Univ Colorado Denver, Dept Pediat, Anschutz Med Campus, Aurora, CO 80204 USA; [Porter, Christopher C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Ambruso, Daniel R.] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA; [Ambruso, Daniel R.] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO 80045 USA; [Ambruso, Daniel R.] Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Ambruso, DR (corresponding author), Univ Colorado Denver, Dept Pediat, Anschutz Med Campus, Aurora, CO 80204 USA.; Ambruso, DR (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80204 USA.; Ambruso, DR (corresponding author), Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Transfus Serv, Aurora, CO 80045 USA.; Ambruso, DR (corresponding author), Hematol Oncol & Bone Marrow Transplantat Labs, Aurora, CO 80045 USA.	Daniel.ambruso@ucdenver.edu	Porter, Christopher/AAE-8918-2020	Porter, Christopher/0000-0001-8774-0180	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center [P30CA046934]	Horizon Pharma Ireland Ltd; Stacey True Memorial Trust; Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center	This work was supported by the Horizon Pharma Ireland Ltd to DRA, the Stacey True Memorial Trust to DRA and the Genomics and Microarray Shared Resource of Colorado's National Institute of Health/National Cancer Institute Cancer Center Support Grant P30CA046934. No funding to any authors, the funding was to the core facility where microarray studies were carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin A, 1997, BLOOD, V89, P3396, DOI 10.1182/blood.V89.9.3396; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Auvynet C, 2013, GLYCOBIOLOGY, V23, P32, DOI 10.1093/glycob/cws128; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERTON G, 1986, BIOCHEM BIOPH RES CO, V138, P1276, DOI 10.1016/S0006-291X(86)80421-1; Borges WG, 2000, J PEDIATR-US, V136, P176, DOI 10.1016/S0022-3476(00)70098-9; Brown SB, 1999, J IMMUNOL, V162, P480; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burns JA, 2001, J IMMUNOL, P166; Cabrini M, 2010, CURR OPIN HEMATOL, V17, P31, DOI 10.1097/MOH.0b013e3283333b29; CASSATELLA MA, 1988, IMMUNOLOGY, V63, P499; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; COLOTTA F, 1992, BLOOD, V80, P2012; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; Doerschuk C M, 2000, Respir Res, V1, P136, DOI 10.1186/rr24; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Ellison MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136766; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; Feuk-Lagerstedt E, 1999, J IMMUNOL, P163; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Harris ES, 2000, J BIOL CHEM, V275, P23409, DOI 10.1074/jbc.R000004200; Harton JA, 1999, SCIENCE, V285, P1402, DOI 10.1126/science.285.5432.1402; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huysamen C, 2009, FEMS MICROBIOL LETT, V290, P121, DOI 10.1111/j.1574-6968.2008.01418.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACK RM, 1988, J IMMUNOL, V140, P4286; Jozsef L, 2004, FASEB J, V18, P1776, DOI 10.1096/fj.04-2048fje; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KEY LL, 1992, J PEDIATR-US, V121, P119, DOI 10.1016/S0022-3476(05)82557-0; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KLEBANOFF SJ, 1992, BLOOD, V80, P225; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; KOEFFLER HP, 1984, P NATL ACAD SCI-BIOL, V81, P4080, DOI 10.1073/pnas.81.13.4080; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Langereis JD, 2013, CELL ADHES MIGR, V7, P476, DOI 10.4161/cam.27293; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liu ZH, 2005, MOL CANCER RES, V3, P21; LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Moldoveanu T, 2014, TRENDS BIOCHEM SCI, V39, P101, DOI 10.1016/j.tibs.2013.12.006; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Neildez-Nguyen TMA, 1998, BRIT J HAEMATOL, V103, P79, DOI 10.1046/j.1365-2141.1998.00931.x; NEUMAN E, 1992, J IMMUNOL, V148, P3520; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; Notarangelo L, 2006, J ALLERGY CLIN IMMUN, V117, P883, DOI 10.1016/j.jaci.2005.12.1347; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pfistershammer K, 2006, EUR J IMMUNOL, V36, P1104, DOI 10.1002/eji.200535344; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Reali E, 1996, J LEUKOCYTE BIOL, V60, P207, DOI 10.1002/jlb.60.2.207; Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Rupper AC, 2008, INFECT IMMUN, V76, P2304, DOI 10.1128/IAI.01437-07; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2002, J IMMUNOL, P168; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; TENNENBERG SD, 1993, J LEUKOCYTE BIOL, V53, P301, DOI 10.1002/jlb.53.3.301; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; TUCKER KA, 1987, BLOOD, V70, P372; Turner SM, 2011, BLOOD, V117, P6052, DOI 10.1182/blood-2010-12-322271; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; Wilkinson JC, 2004, MOL CELL BIOL, V24, P7003, DOI 10.1128/MCB.24.16.7003-7014.2004; WRIGHT SD, 1987, P NATL ACAD SCI USA, V84, P1965, DOI 10.1073/pnas.84.7.1965; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	104	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185956	10.1371/journal.pone.0185956	http://dx.doi.org/10.1371/journal.pone.0185956			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982143	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300097
J	Raya-Diaz, S; Sanchez-Rodriguez, AR; Segura-Fernandez, JM; del Campillo, MD; Quesada-Moraga, E				Raya-Diaz, Silvia; Sanchez-Rodriguez, Antonio Rafael; Manuel Segura-Fernandez, Jose; del Carmen del Campillo, Maria; Quesada-Moraga, Enrique			Entomopathogenic fungi-based mechanisms for improved Fe nutrition in sorghum plants grown on calcareous substrates	PLOS ONE			English	Article							ENDOPHYTIC BEAUVERIA-BASSIANA; METARHIZIUM-ANISOPLIAE; PHOSPHATE ADSORPTION; BIOCONTROL AGENTS; VICIA-FABA; IRON; SOIL; ROOT; COLONIZATION; TOLERANCE	Although entomopathogenic fungi (EPF) are best known for their ability to protect crops against insect pests, they may have other beneficial effects on their host plants. These effects, which include promoting plant growth and conferring resistance against abiotic stresses, have been examined in recent years to acquire a better understanding of them. The primary purposes of the present study were (i) to ascertain in vitro whether three different strains of EPF (viz., Metarhizium, Beauveria and Isaria) would increase the Fe bioavailability in calcareous or non-calcareous media containing various Fe sources (ferrihydrite, hematite and goethite) and (ii) to assess the influence of the EPF inoculation method (seed dressing, soil treatment or leaf spraying) on the extent of the endophytic colonization of sorghum and the improvement in the Fe nutrition of pot-grown sorghum plants on an artificial calcareous substrate. All the EPFs studied were found to increase the Fe availability during the in vitro assay. The most efficient EPF was M. brunneum EAMa 01/58-Su, which lowered the pH of the calcareous medium, suggesting that it used a different strategy (organic acid release) than the other two fungi that raised the pH of the non-calcareous medium. The three methods used to inoculate sorghum plants with B. bassiana and M. brunneum in the pot experiment led to differences in re-isolation from plant tissues and in the plant height. These three inoculation methods increased the leaf chlorophyll content of young leaves when the Fe deficiency symptoms were most apparent in the control plants (without fungal inoculation) as well as the Fe content of the above-ground biomass in the plants at the end of the experiment. The total root lengths and fine roots were also increased in response to fungal applications with the three inoculation methods. However, the soil treatment was the most efficient method; thus, its effect on the leaf chlorophyll content was the most persistent, and the effects on the total root length and fine roots were the most apparent. In conclusion, EPF improved the Fe nutrition of the sorghum plants, but their effects depended on the inoculation method.	[Raya-Diaz, Silvia; Manuel Segura-Fernandez, Jose; Quesada-Moraga, Enrique] Univ Cordoba, ETSIAM, Dept Ciencias & Recursos Agr & Forestales, Cordoba, Spain; [Sanchez-Rodriguez, Antonio Rafael] Environm Ctr Wales, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [del Carmen del Campillo, Maria] Univ Cordoba, ETSIAM, Dept Agron, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Sanchez-Rodriguez, AR (corresponding author), Environm Ctr Wales, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	l02saroa@uco.es	Raya, Silvia/AAI-1015-2019; QUESADA-MORAGA, ENRIQUE/K-3419-2014; Sánchez-Rodríguez, Antonio Rafael/K-9824-2014; del Campillo, Maria Carmen/C-3606-2015	Raya, Silvia/0000-0001-5641-5000; QUESADA-MORAGA, ENRIQUE/0000-0003-4021-3900; Sánchez-Rodríguez, Antonio Rafael/0000-0001-8734-2035; del Campillo, Maria Carmen/0000-0001-5098-2290	Innovation, Science and Enterprise Council of the Andalusian Regional Government [AGR- 7681]	Innovation, Science and Enterprise Council of the Andalusian Regional Government	This work was funded by the Innovation, Science and Enterprise Council of the Andalusian Regional Government (project AGR- 7681) to EQM, http://www.juntadeandalucia.es/servicios/ayudas/detalle/69962.html. The funders played no role in the study design, data collection and analysis.	Akello J, 2009, BIOL CONTROL, V49, P6, DOI 10.1016/j.biocontrol.2008.06.002; Akutse KS, 2013, FUNGAL ECOL, V6, P293, DOI 10.1016/j.funeco.2013.01.003; Bayat F, 2009, RUSS J PLANT PHYSL+, V56, P510, DOI 10.1134/S1021443709040104; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Behie SW, 2014, APPL ENVIRON MICROB, V80, P1553, DOI 10.1128/AEM.03338-13; Behl RK, 2007, J APPL BOT FOOD QUAL, V81, P95; Bennett AJ, 2003, SOIL BIOL BIOCHEM, V35, P1565, DOI 10.1016/j.soilbio.2003.08.001; Benton J, 1991, PLANT ANAL HDB GIORG; Bidochka MJ, 2001, APPL ENVIRON MICROB, V67, P1335, DOI 10.1128/AEM.67.3.1335-1342.2001; BING LA, 1991, ENVIRON ENTOMOL, V20, P1207, DOI 10.1093/ee/20.4.1207; Bouma TJ, 2000, PLANT SOIL, V218, P185, DOI 10.1023/A:1014905104017; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; CHEN Y, 1982, ADV AGRON, V35, P217, DOI 10.1016/S0065-2113(08)60326-0; COLOMBO C, 1994, GEOCHIM COSMOCHIM AC, V58, P1261, DOI 10.1016/0016-7037(94)90380-8; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DELCAMPILLO MC, 1992, COMMUN SOIL SCI PLAN, V23, P399, DOI 10.1080/00103629209368598; Elena G.J., 2011, ADV BIOL RES, V5, P22; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; Fomina M, 2005, APPL ENVIRON MICROB, V71, P371, DOI 10.1128/AEM.71.1.371-381.2005; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; Garrido-Jurado I, 2011, BIOL CONTROL, V58, P277, DOI 10.1016/j.biocontrol.2011.05.017; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Greenfield M, 2016, BIOL CONTROL, V95, P40, DOI 10.1016/j.biocontrol.2016.01.002; Gruber B, 2002, J PLANT NUTR SOIL SC, V165, P111, DOI 10.1002/1522-2624(200202)165:1<111::AID-JPLN111>3.0.CO;2-B; Grusak MA, 1999, FIELD CROP RES, V60, P41, DOI 10.1016/S0378-4290(98)00132-4; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Harman G, 2007, MECH APPL SYMBIOTIC; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Humber Richard A., 1997, P153, DOI 10.1016/B978-012432555-5/50011-7; Hummel I, 2007, NEW PHYTOL, V173, P313, DOI 10.1111/j.1469-8137.2006.01912.x; Hussein Rana H. M., 2014, Journal of Entomology, V11, P338, DOI 10.3923/je.2014.338.344; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Issaly N, 2005, PROCESS BIOCHEM, V40, P1425, DOI 10.1016/j.procbio.2004.06.029; Jaber LR, 2016, BIOL CONTROL, V103, P187, DOI 10.1016/j.biocontrol.2016.09.008; Jimenez C, 2004, KURU REV FORESTAL, V1; Jirakkakul J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu032; Joseph E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00270; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Katznelson H, 1940, SOIL SCI, V49, P211, DOI 10.1097/00010694-194003000-00006; Klepper B., 1991, PLANT ROOTS HIDDEN H, P265; Korcak R., 1987, IRON DEFICIENCY CHLO; Krasnoff SB, 2014, J NAT PROD, V77, P1685, DOI 10.1021/np500300s; Landa BB, 2013, J INVERTEBR PATHOL, V114, P128, DOI 10.1016/j.jip.2013.06.007; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; Lesuisse E, 2001, MICROBIOL-UK, V147, P289, DOI 10.1099/00221287-147-2-289; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep25313; Liao XG, 2014, APPL MICROBIOL BIOT, V98, P7089, DOI 10.1007/s00253-014-5788-2; Liaud N., 2014, FUNGAL BIOL BIOTECHN, V1, P1, DOI [DOI 10.1186/S40694-014-0001-Z, 10.1186/s40694-014-0001-z]; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Maniania NK, 2003, CROP PROT, V22, P553, DOI 10.1016/S0261-2194(02)00221-1; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Montilla I, 2003, PLANT SOIL, V257, P227, DOI 10.1023/A:1026289807917; Mukherjee PK, 2013, ANNU REV PHYTOPATHOL, V51, P105, DOI 10.1146/annurev-phyto-082712-102353; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; OLSEN SR, 1954, SOIL SCI, V78, P141, DOI 10.1097/00010694-195408000-00008; Otgonjargal K, 2015, BEAUVERIA BASSIANA G, V4; Padmavathi J, 2003, WORLD J MICROB BIOT, V19, P469, DOI 10.1023/A:1025151000398; Parsa S, 2016, PHASEOLUS VULGARIS B; Parsa S, 2013, JOVE-J VIS EXP, V74, P1; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Posada F, 2005, MYCOLOGIA, V97, P1195, DOI 10.3852/mycologia.97.6.1195; Quesada-Moraga E, 2006, MYCOPATHOLOGIA, V161, P323, DOI 10.1007/s11046-006-0014-0; Quesada-Moraga E., 2014, ADV ENDOPHYTIC RES, P85; Quesada-Moraga E, 2007, MYCOL RES, V111, P947, DOI 10.1016/j.mycres.2007.06.006; Quesada-Moraga E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089278; Rahmatullah, 2000, SOIL SCI, V165, P803, DOI 10.1097/00010694-200010000-00005; Resquin-Romero G, 2016, J INVERTEBR PATHOL, V136, P23, DOI 10.1016/j.jip.2016.03.003; Reyes I, 1997, SOIL SCI SOC AM J, V61, P1647, DOI 10.2136/sssaj1997.03615995006100060015x; Rombola AD, 2006, IRON NUTRITION IN PLANTS AND RHIZOSPHERIC MICROORGANISMS, P61, DOI 10.1007/1-4020-4743-6_3; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Salazar AM, 2007, AGR TEC, V67, P236; Sanchez-Rodriguez AR, 2015, SCI HORTIC-AMSTERDAM, V197, P193, DOI 10.1016/j.scienta.2015.09.029; Sanchez-Rodriguez AR, 2017, BIOL CONTROL; Sanchez-Rodriguez AR, 2016, PLANT SOIL, V406, P1; Sanvisens N., 2011, BIOL STARVATION HUMA, P245; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Sazanova K, 2015, CURR MICROBIOL, V70, P520, DOI 10.1007/s00284-014-0751-0; Scheepmaker JWA, 2010, BIOCONTROL SCI TECHN, V20, P503, DOI 10.1080/09583150903545035; SCHWERTMANN U., 1964, Zeitschrift fur Pflanzenernahrung, Dungung und Bodenkunde, V105, P194, DOI 10.1002/jpln.3591050303; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; Silva-Stenico ME, 2005, MICROBIOL RES, V160, P429, DOI 10.1016/j.micres.2005.03.007; Soundarapandian P., 2007, Research Journal of Microbiology, V2, P690; Tagliavini M, 2001, EUR J AGRON, V15, P71, DOI 10.1016/S1161-0301(01)00125-3; Tefera T, 2009, BIOCONTROL, V54, P663, DOI 10.1007/s10526-009-9216-y; TORRENT J, 1990, SOIL SCI SOC AM J, V54, P1007, DOI 10.2136/sssaj1990.03615995005400040012x; Torrent J., 2003, APPL STUDY CULTURAL, P377; Trevors JT, 1996, J MICROBIOL METH, V26, P53, DOI 10.1016/0167-7012(96)00843-3; Vega FE, 2012, INSECT PATHOLOGY, 2ND EDITION, P171, DOI 10.1016/B978-0-12-384984-7.00006-3; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; VEMPATI RK, 1986, J PLANT NUTR, V9, P1039, DOI 10.1080/01904168609363504; Villegas J, 1996, MYCORRHIZA, V6, P247, DOI 10.1007/s005720050132; Wahl S, 2000, NEW PHYTOL, V148, P459, DOI 10.1046/j.1469-8137.2000.00775.x; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Warcup J. H., 1950, TRAN BR MYCOL SOC, V34, P519; WINTERMANS JF, 1965, BIOCHIM BIOPHYS ACTA, V109, P448, DOI 10.1016/0926-6585(65)90170-6; Wraight S. P., 2001, Fungi as biocontrol agents: progress, problems and potential, P253, DOI 10.1079/9780851993560.0253; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0; ZASOSKI RJ, 1977, COMMUN SOIL SCI PLAN, V8, P425, DOI 10.1080/00103627709366735	101	30	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185903	10.1371/journal.pone.0185903	http://dx.doi.org/10.1371/journal.pone.0185903			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982140	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300083
J	Heininga, VE; van Roekel, E; Wichers, M; Oldehinkel, AJ				Heininga, Vera E.; van Roekel, Eeske; Wichers, Marieke; Oldehinkel, Albertine J.			Reward and punishment learning in daily life: A replication study	PLOS ONE			English	Article							POSITIVE EMOTIONS; MATCHING LAW; DEPRESSION; EXPERIENCE; STATES; ANHEDONIA; SEX	Day-to-day experiences are accompanied by feelings of Positive Affect (PA) and Negative Affect (NA). Implicitly, without conscious processing, individuals learn about the reward and punishment value of each context and activity. These associative learning processes, in turn, affect the probability that individuals will re-engage in such activities or seek out that context. So far, implicit learning processes are almost exclusively investigated in controlled laboratory settings and not in daily life. Here we aimed to replicate the first study that investigated implicit learning processes in real life, by means of the Experience Sampling Method (ESM). That is, using an experience-sampling study with 90 time points (three measurements over 30 days), we prospectively measured time spent in social company and amount of physical activity as well as PA and NA in the daily lives of 18-24-year-old young adults (n = 69 with anhedonia, n = 69 without anhedonia). Multilevel analyses showed a punishment learning effect with regard to time spent in company of friends, but not a reward learning effect. Neither reward nor punishment learning effects were found with regard to physical activity. Our study shows promising results for future research on implicit learning processes in daily life, with the proviso of careful consideration of the timescale used. Shortterm retrospective ESM design with beeps approximately six hours apart may suffer from mismatch noise that hampers accurate detection of associative learning effects over time.	[Heininga, Vera E.; van Roekel, Eeske; Wichers, Marieke; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [van Roekel, Eeske] Tilburg Univ, Dept Dev Psychol, Tilburg, Noord Brabant, Netherlands	University of Groningen; Tilburg University	Heininga, VE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	v.e.heininga@umcg.nl	Heininga, Vera/AAA-3738-2020; Wichers, Marieke/N-6667-2014; van Roekel, Eeske/E-7889-2012	Heininga, Vera/0000-0003-0889-8524; Wichers, Marieke/0000-0001-5024-9064; van Roekel, Eeske/0000-0002-0829-8089	Netherlands Organization for Scientific Research (NWO Vici) [016.001/002]; Brain Foundation fellowship [F2012(1)-03]	Netherlands Organization for Scientific Research (NWO Vici)(Netherlands Organization for Scientific Research (NWO)); Brain Foundation fellowship	Research reported in this publication was funded by a Vici grant from the Netherlands Organization for Scientific Research (NWO Vici 016.001/002; http://www.nwo.nl/) awarded to AJO, and the Brain Foundation fellowship grant (F2012(1)-03; https://wetenschap.hersenstichting.nl/subsidievormen/fellowships) awarded to MW.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; BAUM WM, 1974, J EXP ANAL BEHAV, V22, P231, DOI 10.1901/jeab.1974.22-231; Bennik E., 2015, EVERY DARK CLOUD HAS; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Chase HW, 2010, PSYCHOL MED, V40, P433, DOI 10.1017/S0033291709990468; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Daily Experience with Family and Friends: Contrasting Opportunity Systems, 1983, J MARRIAGE FAM, V45, p739 ; DAVISON MC, 1978, J EXP ANAL BEHAV, V29, P331, DOI 10.1901/jeab.1978.29-331; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; Hopko DR, 2008, BEHAV RES THER, V46, P1085, DOI 10.1016/j.brat.2008.05.002; Huys QJM, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-12; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; LARSON RW, 1990, J ABNORM PSYCHOL, V99, P92, DOI 10.1037/0021-843X.99.1.92; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Masselink M, DOMAINS PLEASURE SCA; MAYNARDSMITH J, 1975, NATURE, V254, P464; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Pavlov IP, 2010, ANN NEUROSCI, V17, P136, DOI 10.5214/ans.0972-7531.1017309; Peeters F, 2003, J ABNORM PSYCHOL, V112, P203, DOI 10.1037/0021-843X.112.2.203; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Pizzagalli DA, 2005, BIOL PSYCHIAT, V57, P319, DOI 10.1016/j.biopsych.2004.11.026; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Reed J, 2009, PSYCHOL SPORT EXERC, V10, P581, DOI 10.1016/j.psychsport.2009.05.009; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Silk JS, 2011, J EXP CHILD PSYCHOL, V110, P241, DOI 10.1016/j.jecp.2010.10.007; Skinner BF, 1938, PSYCHOL REC, P486; Thomsen KR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01409; Thomsen KR, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00049; Thorndike EL, 1927, AM J PSYCHOL, V6, p646 ; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; van Roekel E, 2016, STUDY PROTOCOL RAN D; van Roekel E, 2014, J RES ADOLESCENCE, V24, P350, DOI 10.1111/jora.12061; Veldman K., 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0101751; Vrieze E, 2013, BIOL PSYCHIAT, V73, P639, DOI 10.1016/j.biopsych.2012.10.014; Wichers M, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0129722; Wichers M, 2012, BRIT J CLIN PSYCHOL, V51, P206, DOI 10.1111/j.2044-8260.2011.02021.x; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x	42	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0180753	10.1371/journal.pone.0180753	http://dx.doi.org/10.1371/journal.pone.0180753			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28976985	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100001
J	Zholobenko, AV; Mouithys-Mickalad, A; Dostal, Z; Serteyn, D; Modriansky, M				Zholobenko, Aleksey V.; Mouithys-Mickalad, Ange; Dostal, Zdenek; Serteyn, Didier; Modriansky, Martin			On the causes and consequences of the uncoupler-like effects of quercetin and dehydrosilybin in H9c2 cells	PLOS ONE			English	Article							SERUM-ALBUMIN; MITOCHONDRIA; OXIDATION; FCCP; CARDIOPROTECTION; PERMEABILITY; ABSORPTION; BINDING; SILYBIN; DAMAGE	Quercetin and dehydrosilybin are polyphenols which are known to behave like uncouplers of respiration in isolated mitochondria. Here we investigated whether the effect is conserved in whole cells. Following short term incubation, neither compound uncouples mitochondrial respiration in whole H9c2 cells below 50aeM. However, following hypoxia, or long term incubation, leak (state IV with oligomycin) oxygen consumption is increased by quercetin. Both compounds partially protected complex I respiration, but not complex II in H9c2 cells following hypoxia. In a permeabilised H9c2 cell model, the increase in leak respiration caused by quercetin is lowered by increased [ADP] and is increased by adenine nucleotide transporter inhibitor, atractyloside, but not bongkrekic acid. Both quercetin and dehydrosilybin dissipate mitochondrial membrane potential in whole cells. In the case of quercetin, the effect is potentiated post hypoxia. Genetically encoded Ca++ sensors, targeted to the mitochondria, enabled the use of fluorescence microscopy to show that quercetin decreased mitochondrial [Ca++] while dehydrosilybin did not. Likewise, quercetin decreases accumulation of [Ca++] in mitochondria following hypoxia. Fluorescent probes were used to show that both compounds decrease plasma membrane potential and increase cytosolic [Ca++]. We conclude that the uncoupler-like effects of these polyphenols are attenuated in whole cells compared to isolated mitochondria, but downstream effects are nevertheless apparent. Results suggest that the effect of quercetin observed in whole and permeabilised cells may originate in the mitochondria, while the mechanism of action of cardioprotection by dehydrosilybin may be less dependent on mitochondrial uncoupling than originally thought. Rather, protective effects may originate due to interactions at the plasma membrane.	[Zholobenko, Aleksey V.; Dostal, Zdenek; Modriansky, Martin] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic; [Mouithys-Mickalad, Ange; Serteyn, Didier] Univ Liege, CORD, Inst Chim, Liege, Belgium; [Serteyn, Didier] Fac Med Vet, Sart Tilman Par Liege, Belgium	Palacky University Olomouc; University of Liege	Modriansky, M (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic.	martin.modriansky@upol.cz	Modriansky, Martin/A-6338-2008; DOSTÁL, Zdeněk/F-4510-2018	Modriansky, Martin/0000-0001-7692-0338; Dostal, Zdenek/0000-0002-4002-8468	GACR [16-16667S]; Czech Ministry of Education [LO1304]; FNRS; University of Liege	GACR(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege)	Funded by GACR (16-16667S), Czech Ministry of Education (LO1304), FNRS, University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULLO G, 1994, CANCER LETT, V87, P55, DOI 10.1016/0304-3835(94)90409-X; Akhlaghi M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/782321; Bartekova M, 2010, CAN J PHYSIOL PHARM, V88, P465, DOI [10.1139/y10-025, 10.1139/Y10-025]; Blasina F, 2015, NEUROCHEM INT, V89, P149, DOI 10.1016/j.neuint.2015.08.007; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Cho JY, 2006, NEUROSCI LETT, V404, P330, DOI 10.1016/j.neulet.2006.06.010; Day AJ, 2000, FREE RADICAL BIO MED, V29, P1234, DOI 10.1016/S0891-5849(00)00416-0; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Fiorani M, 2010, J NUTR BIOCHEM, V21, P397, DOI 10.1016/j.jnutbio.2009.01.014; Gabrielova E, 2015, PHYSIOL RES, V64, P79, DOI 10.33549/physiolres.932703; Gabrielova E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139208; Gabrielova E, 2010, J BIOENERG BIOMEMBR, V42, P499, DOI 10.1007/s10863-010-9319-2; Gabrielova E, 2010, BBA-BIOENERGETICS, V1797, P87, DOI 10.1016/j.bbabio.2010.04.262; Gazak R, 2013, TETRAHEDRON LETT, V54, P315, DOI 10.1016/j.tetlet.2012.11.049; Gurney AM, 2000, CELL CALCIUM, V27, P339, DOI 10.1054/ceca.2000.0124; Inal M, 2002, CELL BIOCHEM FUNCT, V20, P291, DOI 10.1002/cbf.953; Ishii K., 2014, NAT COMMUN, V5; Jaburek M, 2014, FREE RADICAL BIO MED, V76, pS82, DOI 10.1016/j.freeradbiomed.2014.10.290; Jagadeeswaran R, 2000, FITOTERAPIA, V71, P395, DOI 10.1016/S0367-326X(00)00138-6; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Khoo NKH, 2010, FREE RADICAL BIO MED, V49, P339, DOI 10.1016/j.freeradbiomed.2010.04.022; LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4; Lu XY, 2016, CIRC RES, V118, P834, DOI 10.1161/CIRCRESAHA.115.308093; Marhol P, 2015, J FUNCT FOODS, V14, P570, DOI 10.1016/j.jff.2015.02.031; Miyawaki H, 1997, AM J PHYSIOL-HEART C, V272, pH927, DOI 10.1152/ajpheart.1997.272.2.H927; Modriansky M, 2009, J BIOENERG BIOMEMBR, V41, P133, DOI 10.1007/s10863-009-9212-z; Nadtochiy SM, 2012, J BIOL CHEM, V287, P3573, DOI 10.1074/jbc.M111.298406; Nadtochiy SM, 2009, CARDIOVASC RES, V82, P333, DOI 10.1093/cvr/cvn323; Ortega R, 2009, J BIOENERG BIOMEMBR, V41, P41, DOI 10.1007/s10863-009-9198-6; Silva BA, 2010, NEUROTOX RES, V17, P75, DOI 10.1007/s12640-009-9082-5; Tang L, 2013, MOL CELL BIOCHEM, V382, P145, DOI 10.1007/s11010-013-1729-0; Terao J, 2014, ARCH BIOCHEM BIOPHYS, V559, P12, DOI 10.1016/j.abb.2014.04.002; To MS, 2010, ARCH BIOCHEM BIOPHYS, V495, P152, DOI 10.1016/j.abb.2010.01.004; Ulrichova J, 2016, J INT SOC ANTIOXID N, V3; Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185691	10.1371/journal.pone.0185691	http://dx.doi.org/10.1371/journal.pone.0185691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977033	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100037
J	Hulur, I; Skol, AD; Gamazon, ER; Cox, NJ; Onel, K				Hulur, Imge; Skol, Andrew D.; Gamazon, Eric R.; Cox, Nancy J.; Onel, Kenan			Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CUTANEOUS MALIGNANT-MELANOMA; TUMOR-SUPPRESSOR; ULTRAVIOLET-RADIATION; SUSCEPTIBILITY LOCUS; IDENTIFIES 3; RISK-FACTORS; COMMON SNPS; CELL-LINE; HERITABILITY	Melanoma is the deadliest form of skin cancer and presents a significant health care burden in many countries. In addition to ultraviolet radiation in sunlight, the main causal factor for melanoma, genetic factors also play an important role in melanoma susceptibility. Although genome-wide association studies have identified many single nucleotide polymorphisms associated with melanoma, little is known about the proportion of disease risk attributable to these loci and their distribution throughout the genome. Here, we investigated the genetic architecture of melanoma in 1,888 cases and 990 controls of European non-Hispanic ancestry. We estimated the overall narrow-sense heritability of melanoma to be 0.18 (P < 0.03), indicating that genetics contributes significantly to the risk of sporadically-occurring melanoma. We then demonstrated that only a small proportion of this risk is attributable to known risk variants, suggesting that much remains unknown of the role of genetics in melanoma. To investigate further the genetic architecture of melanoma, we partitioned the heritability by chromosome, minor allele frequency, and functional annotations. We showed that common genetic variation contributes significantly to melanoma risk, with a risk model defined by a handful of genomic regions rather than many risk loci distributed throughout the genome. We also demonstrated that variants affecting gene expression in skin account for a significant proportion of the heritability, and are enriched among melanoma risk loci. Finally, by incorporating skin color into our analyses, we observed both a shift in significance for melanoma-associated loci and an enrichment of expression quantitative trait loci among melanoma susceptibility variants. These findings suggest that skin color may be an important modifier of melanoma risk. We speculate that incorporating skin color and other non-genetic factors into genetic studies may allow for an improved understanding of melanoma susceptibility and guide future investigations to identify melanoma risk genes.	[Hulur, Imge] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Skol, Andrew D.; Gamazon, Eric R.; Cox, Nancy J.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Onel, Kenan] Hofstra Northwell Sch Med, Dept Pediat, Hempstead, NY 11549 USA; [Onel, Kenan] Feinstein Inst Med Res, Dept Genet & Genom, Manhasset, NY 11030 USA; [Hulur, Imge] Albert Einstein Coll Med, Dept Med, Div Dermatol, Bronx, NY 10467 USA; [Gamazon, Eric R.; Cox, Nancy J.] Vanderbilt Univ, Dept Med, Div Med Genet, Nashville, TN USA	University of Chicago; University of Chicago; Northwell Health; Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Vanderbilt University	Onel, K (corresponding author), Hofstra Northwell Sch Med, Dept Pediat, Hempstead, NY 11549 USA.; Onel, K (corresponding author), Feinstein Inst Med Res, Dept Genet & Genom, Manhasset, NY 11030 USA.	konel@northwell.edu	Gamazon, Eric/I-6873-2018	Gamazon, Eric/0000-0003-4204-8734; Hulur, Imge/0000-0001-6252-0771				Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; AITKEN JF, 1994, AM J EPIDEMIOL, V140, P961, DOI 10.1093/oxfordjournals.aje.a117203; American Cancer Society, 2016, CANC FACTS FIG 2015; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Brown KM, 2008, NAT GENET, V40, P838, DOI 10.1038/ng.163; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Chatzinasiou F, 2011, JNCI-J NATL CANCER I, V103, P1227, DOI 10.1093/jnci/djr219; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cormier JN, 2006, ARCH INTERN MED, V166, P1907, DOI 10.1001/archinte.166.17.1907; Cress RD, 1997, CANCER CAUSE CONTROL, V8, P246, DOI 10.1023/A:1018432632528; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Davis LK, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-3; Ekwueme DU, 2011, J AM ACAD DERM S1, V65, pS133; Gamazon ER, 2013, MOL PSYCHIATR, V18, P340, DOI 10.1038/mp.2011.174; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Geller AC, 2002, JAMA-J AM MED ASSOC, V288, P1719, DOI 10.1001/jama.288.14.1719; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Goldstein AM, 2001, ARCH DERMATOL, V137, P1493; Guy GP, 2012, AM J PREV MED, V43, P537, DOI 10.1016/j.amepre.2012.07.031; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jhappan C, 2003, ONCOGENE, V22, P3099, DOI 10.1038/sj.onc.1206450; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Law MH, 2015, NAT GENET, V47, P987, DOI 10.1038/ng.3373; Law MH, 2012, J INVEST DERMATOL, V132, P1763, DOI 10.1038/jid.2012.75; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lu Y, 2014, HUM MOL GENET, V23, P6112, DOI 10.1093/hmg/ddu312; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matichard E, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011536; Mitchell JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12473; MOLENDIJK A, 1987, IMMUNOLOGY, V62, P299; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; Newton-Bishop JA, 2011, EUR J CANCER, V47, P732, DOI 10.1016/j.ejca.2010.10.008; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; NOONAN FP, 1981, IMMUNOLOGY, V43, P527; Paco L, 2007, INT J CANCER, V121, P2023, DOI 10.1002/ijc.22925; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Robertson G, 1996, CANCER RES, V56, P4487; Robertson GP, 1999, ONCOGENE, V18, P3173, DOI 10.1038/sj.onc.1202664; Rouhani Panta, 2008, Cancer Control, V15, P248; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Shiina T, 2009, J HUM GENET, V54, P15, DOI 10.1038/jhg.2008.5; Song FJ, 2014, CARCINOGENESIS, V35, P2097, DOI 10.1093/carcin/bgu140; Stratigos AJ, 2006, J INVEST DERMATOL, V126, P399, DOI 10.1038/sj.jid.5700078; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Wheeler HE, 2013, CLIN CANCER RES, V19, P491, DOI 10.1158/1078-0432.CCR-12-2618; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	71	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185730	10.1371/journal.pone.0185730	http://dx.doi.org/10.1371/journal.pone.0185730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973033	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900043
J	Ibrahim, A; Singh, DKA; Shahar, S				Ibrahim, Azianah; Singh, Devinder Kaur Ajit; Shahar, Suzana			'Timed Up and Go' test: Age, gender and cognitive impairment stratified normative values of older adults	PLOS ONE			English	Article							EXECUTIVE FUNCTION; MILD; GAIT; PERFORMANCE; MOBILITY; SPEED; RISK; ASSOCIATION; SCALE; FALLS	Aims The aim of this study was to establish 'Timed up and Go' test (TUG) normative data among community dwelling older adults stratified based on cognitive status, gender and age groups. Methods A total of 2084 community dwelling older adults from wave I and II were recruited through a multistage random sampling method. TUG was performed using the standard protocol and scores were then stratified based on with and without mild cognitive impairment (MCI), gender and in a 5-year age groups ranging from ages of 60' s to 80's. Results 529(16%) participants were identified to have MCI. Past history of falls and medical history of hypertension, heart disease, joint pain, hearing and vision problem, and urinary incontinence were found to have influenced TUG performance. Cognitive status as a mediator, predicted TUG performance even when both gender and age were controlled for (B 0.24, 95% CI (0.02-0.47), beta 0.03, t 2.10, p = 0.36). Further descriptive analysis showed, participants with MCI, women and older in age took a longer time to complete TUG, as compared to men with MCI across all age groups with exceptions for some age groups. Conclusion These results suggested that MCI needs to be taken into consideration when testing older adults using TUG, besides age and gender factors. Data using fast speed TUG may be required among older adults with and without MCI for further understanding.	[Ibrahim, Azianah; Singh, Devinder Kaur Ajit] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Rehabil Sci, Physiotherapy Programme, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia; [Ibrahim, Azianah] Pantai Integrated Rehab Serv Sdn Bhd, Kuala Lumpur, Malaysia; [Shahar, Suzana] Univ Kebangsaan Malaysia, Fac Hlth Sci, Community Rehabil & Aging Res Ctr, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Singh, DKA (corresponding author), Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Rehabil Sci, Physiotherapy Programme, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, Malaysia.	devinder@ukm.edu.my	Singh, Devinder Kaur Ajit/W-5552-2018	Singh, Devinder Kaur Ajit/0000-0002-6551-0437	Longterm Research Grant Scheme (LRGS) by Ministry of Education Malaysia [LRGS/BU/2012/UKM-UKM/K/01]; Longterm Research Grant Scheme (LRGS) by Ministry of Education Malaysia through Universiti Kebangsaan Malaysia [LRGS/BU/2012/UKM-UKM/K/01]	Longterm Research Grant Scheme (LRGS) by Ministry of Education Malaysia; Longterm Research Grant Scheme (LRGS) by Ministry of Education Malaysia through Universiti Kebangsaan Malaysia	This study is funded using Longterm Research Grant Scheme (LRGS) provided by Ministry of Education Malaysia (LRGS/BU/2012/UKM-UKM/K/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants and research team for their support and assistance rendered in the study. We would also like to thank Mr. Indarpal Singh Didar Singh, who assisted in the proof reading and English language editing of this manuscript. This study was funded using Longterm Research Grant Scheme (LRGS) provided by Ministry of Education Malaysia (LRGS/BU/2012/UKM-UKM/K/01) through Universiti Kebangsaan Malaysia.	Aguero-Torres H, 2002, J CLIN EPIDEMIOL, V55, P1007, DOI 10.1016/S0895-4356(02)00461-4; Alexander NB, 2005, CLEVE CLIN J MED, V72; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Arbogast PG, 2013, DEV PROTOCOL OBSERVA; Bahureksa L, 2016, GERONTOLOGY, P77030; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Blackwood J, 2013, EXAMINATION EXECUTIV; BOSS GR, 1981, WESTERN J MED, V135, P434; Crepaldi G, 2005, J Endocrinol Invest, V28, P66; Daly RM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-71; DeOnis M, 2007, WHO CHILD GROWTH STA; Department of Statistics Malaysia, 2010, BANC PEND PER MAL 20; Department of Statistics Malaysia, 2011, POPULATION DISTRIBUT; Donoghue OA, 2012, J AM GERIATR SOC, V60, P1681, DOI 10.1111/j.1532-5415.2012.04120.x; Eggermont LH, 2010, ARCH PHYS MED REHAB, V91, P584, DOI 10.1016/j.apmr.2009.11.020; Greene BR, 2012, GERONTOLOGY, V58, P472, DOI 10.1159/000337259; He W, 2016, P95161 US CENS BUR, VP95, P16; Hofheinz M, 2010, CLIN REHABIL, V24, P831, DOI 10.1177/0269215510367993; Kayser Bárbara, 2014, Rev. dor, V15, P48, DOI 10.5935/1806-0013.20140011; Lee LK, 2012, ARCH GERONTOL GERIAT, V54, P185, DOI 10.1016/j.archger.2011.03.015; Lee SH, 2016, BIOL SPORT, V33, P57, DOI 10.5604/20831862.1185889; Levine RV, 1999, J CROSS CULT PSYCHOL, V30, P178, DOI 10.1177/0022022199030002003; McGough EL, 2011, PHYS THER, V91, P1198, DOI 10.2522/ptj.20100372; Ministry of Health, 2015, CLIN PRACT GUID; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Montero-Odasso M, 2014, J GERONTOL A-BIOL, V69, P1415, DOI 10.1093/gerona/glu155; NACSCOM, 2007, HIGH LEV M REG REV I; Odonkor CA, 2013, J GERONTOL A-BIOL, V68, P1532, DOI 10.1093/gerona/glt060; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pondal Margarita, 2008, J Geriatr Phys Ther, V31, P57; Reid KF, 2012, EUR J APPL PHYSIOL, V112, P2289, DOI 10.1007/s00421-011-2200-0; Rolenz E, 2016, J REHABIL RES DEV, V53, P511, DOI 10.1682/JRRD.2015.03.0042; Rosenberg PB, 2006, AM J PSYCHIAT, V163, P1884, DOI 10.1176/appi.ajp.163.11.1884; Schepker CA, 2016, J AM GERIATR SOC, V64, P138, DOI 10.1111/jgs.13869; Shahsavandi S, 2015, ADV VIROL, V2015, P1, DOI 10.1155/2015/675921; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Taki Y., 2011, PLOS ONE, V6; Van Uem JMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151997; Vassilaki M, 2015, J AM GERIATR SOC, V63, P1783, DOI 10.1111/jgs.13612; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; WHO, 2014, STAT 1 M IHR EM COMM	43	78	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185641	10.1371/journal.pone.0185641	http://dx.doi.org/10.1371/journal.pone.0185641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI6UJ	28972994	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900032
J	Tenan, S; Pedrini, P; Bragalanti, N; Groff, C; Sutherland, C				Tenan, Simone; Pedrini, Paolo; Bragalanti, Natalia; Groff, Claudio; Sutherland, Chris			Data integration for inference about spatial processes: A model-based approach to test and account for data inconsistency	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; CITIZEN SCIENCE; ECOLOGICAL RESEARCH; DENSITY-ESTIMATION; CAMERA TRAPS; ABUNDANCE; SELECTION; CONNECTIVITY; INFORMATION; POPULATIONS	Recently-developed methods that integrate multiple data sources arising from the same ecological processes have typically utilized structured data from well-defined sampling protocols (e.g., capture-recapture and telemetry). Despite this new methodological focus, the value of opportunistic data for improving inference about spatial ecological processes is unclear and, perhaps more importantly, no procedures are available to formally test whether parameter estimates are consistent across data sources and whether they are suitable for integration. Using data collected on the reintroduced brown bear population in the Italian Alps, a population of conservation importance, we combined data from three sources: traditional spatial capture-recapture data, telemetry data, and opportunistic data. We developed a fully integrated spatial capture-recapture (SCR) model that included a model-based test for data consistency to first compare model estimates using different combinations of data, and then, by acknowledging data-type differences, evaluate parameter consistency. We demonstrate that opportunistic data lend itself naturally to integration within the SCR framework and highlight the value of opportunistic data for improving inference about space use and population size. This is particularly relevant in studies of rare or elusive species, where the number of spatial encounters is usually small and where additional observations are of high value. In addition, our results highlight the importance of testing and accounting for inconsistencies in spatial information from structured and unstructured data so as to avoid the risk of spurious or averaged estimates of space use and consequently, of population size. Our work supports the use of a single modeling framework to combine spatially-referenced data while also accounting for parameter consistency.	[Tenan, Simone; Pedrini, Paolo; Bragalanti, Natalia] MUSE Museo Sci, Vertebrate Zool Sect, Corso Lavoro & Sci 3, I-38122 Trento, Italy; [Bragalanti, Natalia; Groff, Claudio] Serv Foreste & Fauna, Prov Autonoma Trento, Via Trener 3, I-38100 Trento, Italy; [Sutherland, Chris] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Tenan, S (corresponding author), MUSE Museo Sci, Vertebrate Zool Sect, Corso Lavoro & Sci 3, I-38122 Trento, Italy.	simone.tenan@muse.it	Tenan, Simone/N-5246-2014; Sutherland, Chris/H-6624-2019	Tenan, Simone/0000-0001-5055-9193; Sutherland, Chris/0000-0003-2073-1751				Besbeas P, 2002, BIOMETRICS, V58, P540, DOI 10.1111/j.0006-341X.2002.00540.x; Besbeas P, 2017, ASTA-ADV STAT ANAL; Bischof R, 2009, J ANIM ECOL, V78, P656, DOI 10.1111/j.1365-2656.2009.01524.x; Blanc L, 2014, J APPL ECOL, V51, P1733, DOI 10.1111/1365-2664.12319; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chandler RB, 2014, METHODS ECOL EVOL, V5, P1351, DOI 10.1111/2041-210X.12153; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Conroy MJ, 2008, ECOLOGY, V89, P3362, DOI 10.1890/07-2145.1; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; De Barba M, 2010, J APPL ECOL, V47, P172, DOI 10.1111/j.1365-2664.2009.01752.x; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dupre E, 2000, STUDIO FATTIBILITA R; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Fuller AK, 2016, ECOL APPL, V26, P1125, DOI 10.1890/15-0315; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gimenez O, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0698; Gopalaswamy AM, 2012, ECOLOGY, V93, P1741, DOI 10.1890/11-2110.1; Groff C, 2014, 2013 BEAR REPORT; Kamp J, 2016, DIVERS DISTRIB, V22, P1024, DOI 10.1111/ddi.12463; Linden D. W, 2017, BIORXIV; Murphy SM, 2016, J WILDLIFE MANAGE, V80, P1390, DOI 10.1002/jwmg.21144; Mustoni Andrea, 2003, Hystrix, V14, P3; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Popescu VD, 2014, ECOL EVOL, V4, P933, DOI 10.1002/ece3.997; R Core Team, 2012, R LANG ENV STAT COMP; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2016, POPUL ECOL, V58, P53, DOI 10.1007/s10144-015-0524-z; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2017, BIORXIV103341, V40, DOI [10.1111/ecog.03170, DOI 10.1111/ECOG.03170]; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sollmann R, 2013, J APPL ECOL, V50, P961, DOI 10.1111/1365-2664.12098; Sollmann R, 2013, ECOLOGY, V94, P553, DOI 10.1890/12-1256.1; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Sutherland CS, 2014, ECOLOGY, V95, P3149; Sutherland C, 2015, METHODS ECOL EVOL, V6, P169, DOI 10.1111/2041-210X.12316; Tenan S, 2016, CONSERV BIOL, V30, P1307, DOI 10.1111/cobi.12736; Tenan S, 2014, ECOL MODEL, V283, P62, DOI 10.1016/j.ecolmodel.2014.03.017; Tenan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049187; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; van Strien AJ, 2013, J APPL ECOL, V50, P1450, DOI 10.1111/1365-2664.12158; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woods JG, 1999, WILDLIFE SOC B, V27, P616	51	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185588	10.1371/journal.pone.0185588	http://dx.doi.org/10.1371/journal.pone.0185588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973034	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900028
J	Moruzzi, S; Guarini, P; Udali, S; Ruzzenente, A; Guglielmi, A; Conci, S; Pattini, P; Martinelli, N; Olivieri, O; Tammen, SA; Choi, SW; Friso, S				Moruzzi, Sara; Guarini, Patrizia; Udali, Silvia; Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone; Pattini, Patrizia; Martinelli, Nicola; Olivieri, Oliviero; Tammen, Stephanie A.; Choi, Sang-Woon; Friso, Simonetta			One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation	PLOS ONE			English	Article							DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-CYCLOHYDROLASE; PLASMA HOMOCYSTEINE LEVELS; NEURAL-TUBE DEFECTS; TRIFUNCTIONAL ENZYME; COLORECTAL-CANCER; METHIONINE SYNTHASE; METABOLIC PATHWAY; COMMON MUTATION; FOLATE; POLYMORPHISM	Several polymorphic gene variants within one-carbon metabolism, an essential pathway for nucleotide synthesis and methylation reactions, are related to cancer risk. An aberrant DNA methylation is a common feature in cancer but whether the link between one-carbon metabolism variants and cancer occurs through an altered DNA methylation is yet unclear. Aims of the study were to evaluate the frequency of one-carbon metabolism gene variants in hepato-cellular-carcinoma, cholangiocarcinoma and colon cancer, and their relationship to cancer risk together with global DNA methylation status. Genotyping for BHMT 716A>G, DHFR 19bp ins/del, MTHFD1 1958G>A, MTHFR 677C>T, MTR 2756A>G, MTRR 66A>G, RFC1 80G>A, SHMT1 1420C>T, TCII 776C>G and TS 2rpt-3rpt was performed in 102 cancer patients and 363 cancer-free subjects. Methylcytosine (mCyt) content was measured by LC/MS/MS in peripheral blood mononuclear cells (PBMCs) DNA. The MTHFD1 1958AA genotype was significantly less frequent among cancer patients as compared to controls (p = 0.007) and related to 63% reduction of overall cancer risk (p = 0.003) and 75% of colon cancer risk (p = 0.006). When considering PBMCs mCyt content, carriers of the MTHFD1 1958GG genotype showed a lower DNA methylation as compared to carriers of the A allele (p = 0.048). No differences were highlighted by evaluating a possible relationship between the other polymorphisms analyzed with cancer risk and DNA methylation. The MTHFD1 1958AA genotype is linked to a significantly reduced cancer risk. The 1958GG genotype is associated to PBMCs DNA hypomethylation as compared to the A allele carriership that may exert a protective effect for cancer risk by preserving from DNA hypomethylation.	[Moruzzi, Sara; Guarini, Patrizia; Pattini, Patrizia; Martinelli, Nicola; Olivieri, Oliviero; Friso, Simonetta] Univ Verona, Sch Med, Dept Med, Verona, Italy; [Ruzzenente, Andrea; Guglielmi, Alfredo; Conci, Simone] Univ Verona, Sch Med, Dept Surg, Div Gen & Hepatobiliary Surg, Verona, Italy; [Tammen, Stephanie A.; Choi, Sang-Woon] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA USA; [Choi, Sang-Woon] CHA Univ, Chaum Life Ctr, Seoul, South Korea	University of Verona; University of Verona; Tufts University; Pochon Cha University	Friso, S (corresponding author), Univ Verona, Sch Med, Dept Med, Verona, Italy.	simonetta.friso@univr.it	Friso, Simonetta/K-4715-2016; conci, simone/AAB-6516-2022; Ruzzenente, Andrea/R-5850-2019; Olivieri, Oliviero/A-9126-2008	conci, simone/0000-0001-7110-1974; Ruzzenente, Andrea/0000-0001-6911-563X; Olivieri, Oliviero/0000-0001-8209-9056				ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; Babyshkina N, 2013, GENE, V518, P397, DOI 10.1016/j.gene.2012.12.095; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; Chang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109235; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen J, 2004, INT J CANCER, V110, P617, DOI 10.1002/ijc.20148; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Christensen KE, 2013, HUM MOL GENET, V22, P3705, DOI 10.1093/hmg/ddt223; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Eussen SJPM, 2010, CANCER EPIDEM BIOMAR, V19, P1328, DOI 10.1158/1055-9965.EPI-09-0841; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Friso S, 2013, ONCOLOGY; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Han SS, 2012, CANCER EPIDEM BIOMAR, V21, P417, DOI 10.1158/1055-9965.EPI-11-0782; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hol FA, 1998, CLIN GENET, V53, P119; HUM DW, 1988, J BIOL CHEM, V263, P15946; Jacques PF, 2003, ATHEROSCLEROSIS, V166, P49, DOI 10.1016/S0021-9150(02)00204-6; Johnson WG, 2004, AM J MED GENET A, V124A, P339, DOI 10.1002/ajmg.a.20505; Klerk M, 2003, THROMB RES, V110, P87, DOI 10.1016/S0049-3848(03)00341-4; Lautner-Csorba O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069843; Levine AJ, 2010, CANCER EPIDEM BIOMAR, V19, P1812, DOI 10.1158/1055-9965.EPI-10-0151; Moruzzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167534; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Parle-McDermott A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Tammen SA, 2014, ALCOHOL CLIN EXP RES, V38, P2178, DOI 10.1111/acer.12477; Udali S, 2015, HEPATOLOGY, V62, P496, DOI 10.1002/hep.27823; Ulrich CM, 2002, CANCER RES, V62, P3361; Wang LN, 2007, CLIN CANCER RES, V13, P2526, DOI 10.1158/1078-0432.CCR-06-2293; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Zee RYL, 2013, CLIN CHIM ACTA, V418, P33, DOI 10.1016/j.cca.2012.11.030; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	41	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185792	10.1371/journal.pone.0185792	http://dx.doi.org/10.1371/journal.pone.0185792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968444	gold, Green Submitted, Green Published			2022-12-27	WOS:000412029600049
J	Reijnierse, EM; de van der Schueren, MAE; Trappenburg, MC; Doves, M; Meskers, CGM; Majer, AB				Reijnierse, Esmee M.; de van der Schueren, Marian A. E.; Trappenburg, Marijke C.; Doves, Marjan; Meskers, Carel G. M.; Majer, Andrea B.			Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management	PLOS ONE			English	Article							MUSCLE MASS; ELDERLY INDIVIDUALS; BODY-COMPOSITION; CONTROLLED-TRIAL; OLDER-PEOPLE; EXERCISE; SUPPLEMENTATION; RECOMMENDATIONS; HEALTH; OUTPATIENTS	Objectives Sarcopenia is an emerging clinical challenge in an ageing population and is associated with serious negative health outcomes. This study aimed to assess the current state of the art regarding the knowledge about the concept of sarcopenia and practice of the diagnostic strategy and management of sarcopenia in a cohort of Dutch healthcare professionals (physicians, physiotherapists, dietitians and others) attending a lecture cycle on sarcopenia. Material and methods This longitudinal study included Dutch healthcare professionals (n = 223) who were asked to complete a questionnaire before, directly after and five months after (n = 80) attending a lecture cycle on the pathophysiology of sarcopenia, diagnostic strategy and management of sarcopenia, i.e. interventions and collaboration. Results Before attendance, 69.7% of healthcare professionals stated to know the concept of sarcopenia, 21.4% indicated to know how to diagnose sarcopenia and 82.6% had treated patients with suspected sarcopenia. 47.5% used their clinical view as diagnostic strategy. Handgrip strength was the most frequently used objective diagnostic measure (33.9%). Five months after attendance, reported use of diagnostic tests was increased, i.e. handgrip strength up to 67.4%, gait speed up to 72.1% and muscle mass up to 20.9%. Bottlenecks during implementation of the diagnostic strategy were experienced by 67.1%; lack of awareness among other healthcare professionals, acquisition of equipment and time constraints to perform the diagnostic measures were reported most often. Before attendance, 36.4% stated not to consult a physiotherapists or exercise therapists (PT/ET) or dietitian for sarcopenia interventions, 10.5% consulted a PT/ET, 32.7% a dietitian and 20.5% both a PT/ET and dietitian. Five months after attendance, these percentages were 28.3%, 21.7%, 30.0% and 20.0% respectively. Conclusion The concept of sarcopenia is familiar to most Dutch healthcare professionals but application in practice is hampered, mostly by lack of knowledge, availability of equipment, time constraints and lack of collaboration.	[Reijnierse, Esmee M.; Trappenburg, Marijke C.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Sect Gerontol & Geriatr, Amsterdam, Netherlands; [Reijnierse, Esmee M.; Majer, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic, Australia; [de van der Schueren, Marian A. E.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Sect Nutr & Dietet, Amsterdam, Netherlands; [de van der Schueren, Marian A. E.] HAN Univ Appl Sci, Fac Hlth & Social Studies, Dept Nutr Sports & Hlth, Nijmegen, Netherlands; [Trappenburg, Marijke C.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Doves, Marjan] Univ Appl Sci Utrecht, Inst Human Movement Studies, Fac Hlth Care, Utrecht, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Meskers, Carel G. M.; Majer, Andrea B.] Vrije Univ, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Melbourne Hospital; University of Melbourne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam	Majer, AB (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic, Australia.; Majer, AB (corresponding author), Vrije Univ, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	andrea.maier@mh.org.au	Maier, Andrea B./Q-5548-2019; Maier, Andrea/W-7060-2019; de van der Schueren, Marian A.E./AAM-5713-2021	Maier, Andrea/0000-0001-7206-1724; de van der Schueren, Marian A.E./0000-0001-5693-0811; Meskers, Carel/0000-0002-5056-5611; Reijnierse, Esmee M./0000-0002-4197-4800	European Union's Horizon research program PreventIT [689238]; Marie Curie, Sklodowska, Innovative Training Network PANINI [675003]	European Union's Horizon research program PreventIT; Marie Curie, Sklodowska, Innovative Training Network PANINI	This study was supported by the European Union's Horizon 2020 research program PreventIT (No 689238) to Andrea B. Maier and the Marie Curie, Sklodowska, Innovative Training Network PANINI (No 675003) to Andrea B. Maier. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsis JA, 2014, EUR J CLIN NUTR, V68, P1001, DOI 10.1038/ejcn.2014.117; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Beaudart C, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-45; Bijlsma AY, 2013, J AM MED DIR ASSOC, V14, P493, DOI 10.1016/j.jamda.2013.02.001; Bonnefoy M, 2003, BRIT J NUTR, V89, P731, DOI 10.1079/BJN2003836; Bunout D, 2001, J NUTR, V131, p2441S, DOI 10.1093/jn/131.9.2441S; Bunout D, 2011, AUSTRALAS J AGEING, V30, P89, DOI 10.1111/j.1741-6612.2010.00448.x; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Green LW, 2008, FAM PRACT, V25, pI20, DOI 10.1093/fampra/cmn055; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim HK, 2012, J AM GERIATR SOC, V60, P16, DOI 10.1111/j.1532-5415.2011.03776.x; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Paddon-Jones D, 2009, CURR OPIN CLIN NUTR, V12, P86, DOI 10.1097/MCO.0b013e32831cef8b; Reijnierse EM, 2015, GERONTOLOGY, V61, P491, DOI 10.1159/000377699; Scott D, 2014, OSTEOPOROSIS INT, V25, P187, DOI 10.1007/s00198-013-2431-5; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; ter Beek L, 2016, CLIN NUTR, V35, P1450, DOI 10.1016/j.clnu.2016.03.023; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020	24	38	38	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185837	10.1371/journal.pone.0185837	http://dx.doi.org/10.1371/journal.pone.0185837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968456	gold, Green Published			2022-12-27	WOS:000412029600057
J	Zhou, WJ; Wan, YJ; Guo, RH; Deng, MT; Deng, KP; Wang, Z; Zhang, YL; Wang, F				Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng			Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; OFF-TARGET SITES; COWS MILK; HOMOLOGOUS RECOMBINATION; TRANSGENIC GOATS; IGE BINDING; GENE; SPECIFICITY; MICE; DNA	Goat's milk, considered a substitute for cow's milk, has a high nutritional value. However, goat's milk contains various allergens, predominantly beta-lactoglobulin (BLG). In this study, we employed the CRISPR/Cas9 system to target the BLG locus in goat fibroblasts for sgRNA optimization and generate BLG knock-out goats through co-injection of Cas9 mRNA and small guide RNAs (sgRNAs) into goat embryos at the one-cell stage. We firstly tested sgRNA editing efficiencies in goat fibroblast cells, and approximately 8.00% - 9.09% of the cells were modified in single sgRNA-guided targeting experiment. Among the kids, the genome-targeting efficiencies of single sgRNA were 12.5% (10 ng/mu L sg1) and 0% (10 ng/mu L sg2) and efficiencies of dual sgRNAs were 25.0% (25 ng/mu L sg2+sg3 group) and 28.6% (50 ng/mu L sg2+sg3 group). Relative expression of BLG in BLG knock-out goat mammary glands significantly (p < 0.01) decreased as well as other milk protein coding genes, such as CSN1S1, CSN1S2, CSN2, CSN3 and LALBA (p < 0.05). As expected, BLG protein had been abolished in the milk of the BLG knock-out goat. In addition, most of the targeted kids were chimeric (3/4), and their various body tissues were edited simultaneously. Our study thus provides a basis for optimizing the quality of goat milk, which can be applied to biomedical and agricultural research.	[Zhou, Wenjun; Wan, Yongjie; Guo, Rihong; Deng, Mingtian; Deng, Kaiping; Wang, Zhen; Zhang, Yanli; Wang, Feng] Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, F (corresponding author), Nanjing Agr Univ, Jiangsu Livestock Embryo Engn Lab, Nanjing, Jiangsu, Peoples R China.	caeet@njau.edu.cn	, 郭日红/AAX-3843-2020	Deng, Mingtian/0000-0003-0470-2432; Zhou, Wenjun/0000-0002-7329-8149	China National Program for Transgenic Animal [2014ZX08008-004]; National Nature Science Foundation of China [31272443]	China National Program for Transgenic Animal; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is financially supported by the China National Program for Transgenic Animal (2014ZX08008-004) and the National Nature Science Foundation of China (No. 31272443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bibikova M, 2002, GENETICS, V161, P1169; Cammuso C, 2000, ANIM BIOTECHNOL, V11, P1, DOI 10.1080/10495390009525943; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creamer L. K, 2002, ENCY DAIRY SCI, P1932; Crispo M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136690; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Ehn BM, 2005, J AGR FOOD CHEM, V53, P3743, DOI 10.1021/jf048121w; Ehn BM, 2004, J AGR FOOD CHEM, V52, P1398, DOI 10.1021/jf0304371; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gall H, 1996, J ALLERGY CLIN IMMUN, V97, P1304, DOI 10.1016/S0091-6749(96)70199-9; Gao F., 2016, NAT BIOTECHNOL; Gong L, 2015, GENOME ENG USING CRI, P197; Guo RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29855; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; Hallen E., 2008, J ANIMAL BREEDING GE, V107, P458; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Liu JY, 2014, METHODS, V69, P22, DOI 10.1016/j.ymeth.2014.04.010; Lv QY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25029; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Miura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12799; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi J, 2016, CELL RES; Rong ZL, 2014, PROTEIN CELL, V5, P258, DOI 10.1007/s13238-014-0032-5; Selo I, 1998, INT ARCH ALLERGY IMM, V117, P20, DOI 10.1159/000023986; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Song YN, 2016, CELL MOL LIFE SCI, V73, P2959, DOI 10.1007/s00018-016-2143-z; Tsiplakou E, 2015, J DAIRY RES, V82, P257, DOI 10.1017/S0022029915000333; Wal JM, 1998, ALLERGY, V53, P1013, DOI 10.1111/j.1398-9995.1998.tb03811.x; Wan YJ, 2016, CELL BIOL INT, V40, P74, DOI 10.1002/cbin.10540; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13878; WANG YX, 2015, SCI REP UK, V5; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Yuan L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22024	44	18	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186056	10.1371/journal.pone.0186056	http://dx.doi.org/10.1371/journal.pone.0186056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016691	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400052
J	da Silva, CMG; Franz-Montan, M; Limia, CEG; Ribeiro, LND; Braga, MA; Guilherme, VA; da Silva, CB; Casadei, BR; Cereda, CMS; de Paula, E				Goncalves da Silva, Camila Morais; Franz-Montan, Michelle; Gomez Limia, Cintia Elisabeth; de Morais Ribeiro, Ligia Nunes; Braga, Mario Antonio; Guilherme, Viviane Aparecida; da Silva, Camila Batista; Casadei, Bruna Renata; Saia Cereda, Cintia Maria; de Paula, Eneida			Encapsulation of ropivacaine in a combined (donor-acceptor, ionic-gradient) liposomal system promotes extended anesthesia time	PLOS ONE			English	Article							LOCAL-ANESTHETICS; BUPIVACAINE; DELIVERY; FORMULATION; ANALGESIA; PRILOCAINE; TOXICITY; RELEASE	Ropivacaine is a local anesthetic with similar potency but lower systemic toxicity than bupivacaine, the most commonly used spinal anesthetic. The present study concerns the development of a combined drug delivery system for ropivacaine, comprised of two types of liposomes: donor multivesicular vesicles containing 250 mM (NH4)(2)SO4 plus the anesthetic, and acceptor large unilamellar vesicles with internal pH of 5.5. Both kinds of liposomes were composed of hydrogenated soy-phosphatidylcholine: cholesterol (2: 1 mol%) and were prepared at pH 7.4. Dynamic light scattering, transmission electron microscopy and electron paramagnetic resonance techniques were used to characterize the average particle size, polydispersity, zeta potential, morphology and fluidity of the liposomes. In vitro dialysis experiments showed that the combined liposomal system provided significantly longer (72 h) release of ropivacaine, compared to conventional liposomes (similar to 45 h), or plain ropivacaine (similar to 4 h) (p<0.05). The pre-formulations tested were significantly less toxic to 3T3 cells, with toxicity increasing in the order: combined system < ropivacaine in donor or acceptor liposomes < ropivacaine in conventional liposomes < plain ropivacaine. The combined formulation, containing 2% ropivacaine, increased the anesthesia duration up to 9 h after subcutaneous infiltration in mice. In conclusion, a promising drug delivery system for ropivacaine was described, which can be loaded with large amounts of the anesthetic (2%), with reduced in vitro cytotoxicity and extended anesthesia time.	[Goncalves da Silva, Camila Morais; Gomez Limia, Cintia Elisabeth; de Morais Ribeiro, Ligia Nunes; Braga, Mario Antonio; Guilherme, Viviane Aparecida; Casadei, Bruna Renata; Saia Cereda, Cintia Maria; de Paula, Eneida] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, UNICAMP, Campinas, SP, Brazil; [Franz-Montan, Michelle; da Silva, Camila Batista] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	de Paula, E (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, UNICAMP, Campinas, SP, Brazil.	depaula@unicamp.br	Franz-Montan, Michelle/E-2865-2010; de Paula, Eneida/C-3031-2013; Ribeiro, Lígia/AAJ-2820-2020; Franz-Montan, Michelle/V-3301-2019; Franz-Montan, Michelle/AAN-1071-2021; Casadei, Bruna R/D-5658-2015; da Silva de Araujo Candido, Camila Batista/C-5918-2014; Guilherme, Viviane Ap./Q-4155-2017; Cereda, Cintia/E-4182-2013	de Paula, Eneida/0000-0003-4504-5723; Ribeiro, Lígia/0000-0001-6097-5449; Franz-Montan, Michelle/0000-0003-0760-1389; Franz-Montan, Michelle/0000-0003-0760-1389; Casadei, Bruna R/0000-0002-4103-0084; da Silva de Araujo Candido, Camila Batista/0000-0003-1897-3567; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/14457-5, 2011/21735-3]; Conselho Nacional de Ciencia e Tecnologia (CNPq) [464708/2014-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Ciencia e Tecnologia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant # 14/14457-5 and fellowship to CMGS # 2011/21735-3) and Conselho Nacional de Ciencia e Tecnologia (CNPq, # 464708/2014-1).	ADADE AB, 1984, J BIOENERG BIOMEMBR, V16, P353, DOI 10.1007/BF00743231; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Barenholz Y, Method of amphiphatic drug loading in liposomes by pH gradient. US Patent, Patent No. 51993192549; Barenholz Y, 2007, A liposomal combination and uses thereof. Patent, Patent No. 2007/; BROCKWAY MS, 1991, BRIT J ANAESTH, V66, P31, DOI 10.1093/bja/66.1.31; Cereda CMS, 2004, J PHARM PHARM SCI, V7, P235; Christie LE, 2014, BJA ED, P136; Cohen R, 2012, J CONTROL RELEASE, V160, P346, DOI 10.1016/j.jconrel.2011.12.030; Crepaldi Domingues C, 2009, J MEMBRANE BIOL, V227, P39, DOI 10.1007/s00232-008-9142-4; de Araujo DR, 2008, J PHARM PHARMACOL, V60, P1449, DOI 10.1211/jpp/60.11.0005; DE PAULA E, 1995, BBA-BIOMEMBRANES, V1240, P25, DOI 10.1016/0005-2736(95)00155-6; de Paula E, 2012, EXPERT OPIN DRUG DEL, V9, P1505, DOI 10.1517/17425247.2012.738664; de Paula Eneida, 2010, Recent Pat Drug Deliv Formul, V4, P23; Epstein-Barash H, 2009, P NATL ACAD SCI USA, V106, P7125, DOI 10.1073/pnas.0900598106; Fraceto LF, 2005, BIOPHYS CHEM, V115, P11, DOI 10.1016/j.bpc.2004.12.003; Franz-Montan M, 2013, J LIPOSOME RES, V23, P54, DOI 10.3109/08982104.2012.742536; Ginosar Y, 2016, ANESTH ANALG, V122, P1673, DOI 10.1213/ANE.0000000000001217; da Silva CMG, 2016, J LIPOSOME RES, V26, P1, DOI 10.3109/08982104.2015.1022555; Grant GJ, 2004, ANESTHESIOLOGY, V101, P133, DOI 10.1097/00000542-200407000-00021; Grant GJ, 1997, ACTA ANAESTH SCAND, V41, P204, DOI 10.1111/j.1399-6576.1997.tb04666.x; Grant Stuart A, 2002, Best Pract Res Clin Anaesthesiol, V16, P345, DOI 10.1053/bean.2002.0242; Gubernator J, 2011, EXPERT OPIN DRUG DEL, V8, P565, DOI 10.1517/17425247.2011.566552; Howell BA, 2009, ANESTH ANALG, V109, P678, DOI 10.1213/ane.0b013e3181a8da61; Malheiros SVP, 2004, BIOPHYS CHEM, V110, P213, DOI 10.1016/j.bpc.2004.01.013; Martinov T, 2013, JOVE-J VIS EXP, DOI 10.3791/51212; Mendyk A, 2007, EXPERT SYST APPL, V32, P1124, DOI 10.1016/j.eswa.2006.02.019; Mohanraj V. J., 2006, Tropical Journal of Pharmaceutical Research, V5, P561; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mowat JJ, 1996, ANESTHESIOLOGY, V85, P635, DOI 10.1097/00000542-199609000-00024; Papadopoulou V, 2006, INT J PHARMACEUT, V309, P44, DOI 10.1016/j.ijpharm.2005.10.044; PLANAS ME, 1992, ANESTH ANALG, V75, P615; Ribeiro LNM, 2016, EUR J PHARM SCI, V93, P192, DOI 10.1016/j.ejps.2016.08.030; Cereda CMS, 2013, J LIPOSOME RES, V23, P228, DOI 10.3109/08982104.2013.796975; SCHREIER S, 1978, BIOCHIM BIOPHYS ACTA, V515, P375; Shen Y, 2011, DRUG DELIV, V18, P361, DOI 10.3109/10717544.2011.557788; Tu S, 2010, J PHARM SCI-US, V99, P2672, DOI 10.1002/jps.22017; Wei YM, 2014, INT J NANOMED, V9, P3623, DOI 10.2147/IJN.S66312; Weiniger CF, 2010, EXPERT OPIN DRUG DEL, V7, P737, DOI 10.1517/17425241003767383; Wiles MD, 2010, ANAESTHESIA, V65, P22, DOI 10.1111/j.1365-2044.2009.06201.x; Zhang XK, 2009, J DRUG TARGET, V17, P399, DOI 10.1080/10611860902795407; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	41	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185828	10.1371/journal.pone.0185828	http://dx.doi.org/10.1371/journal.pone.0185828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982145	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300072
J	Iotzova-Weiss, G; Freiberger, SN; Johansen, P; Kamarachev, J; Guenova, E; Dziunycz, PJ; Roux, GA; Neu, J; Hofbauer, GFL				Iotzova-Weiss, Guergana; Freiberger, Sandra N.; Johansen, Pal; Kamarachev, Jivko; Guenova, Emmanuella; Dziunycz, Piotr J.; Roux, Guillaume A.; Neu, Johannes; Hofbauer, Gunther F. L.			TLR4 as a negative regulator of keratinocyte proliferation	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; H-CADHERIN EXPRESSION; UP-REGULATION; DIFFERENTIAL EXPRESSION; INHIBITS EXPRESSION; ATOPIC-DERMATITIS; MELANOMA-CELLS; TISSUE FACTOR; T-CADHERIN; SKIN	TLR4 is an innate immune receptor with expression in human skin, keratinocytes as well as squamous cell carcinoma (SCC) of the skin. In the present study we investigate the role of TLR4 as a negative regulator of keratinocyte proliferation. We present here that the expression of TLR4 increased with the differentiation of cultured keratinocytes in a passage-dependent manner or under calcium-rich conditions. Moreover, the down-regulation of TLR4 by specific knockdown increased the proliferation of HaCaT keratinocytes in vitro. In addition, subcutaneously injected HaCaT keratinocytes with shTLR4 formed growing tumors in nude mice. In contrast, we observed lower proliferation and increased migration in vitro of the SCC13 cell line stably overexpressing TLR4 in comparison to SCC13 TLR4 negative cells. In vivo, SCC13 TLR4-overexpressing tumors showed delayed growth in comparison to TLR4 negative tumors. The overexpression of TLR4 in SCC13 tumor cells was followed by phosphorylation of ERK1/2 and JNK and increased expression of ATF3. In gene expression arrays, the overexpression of TLR4 in tumor cells correlated with gene expression of ATF-3, IL-6, CDH13, CXCL-1 and TFPI. In summary, TLR4 negatively regulates the proliferation of keratinocytes and its overexpression reduces tumor growth of SCC cells.	[Iotzova-Weiss, Guergana; Freiberger, Sandra N.; Johansen, Pal; Kamarachev, Jivko; Guenova, Emmanuella; Dziunycz, Piotr J.; Roux, Guillaume A.; Neu, Johannes; Hofbauer, Gunther F. L.] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Iotzova-Weiss, G (corresponding author), Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland.	geri.weiss@web.de	Freiberger, Sandra/AAT-5527-2020; Hofbauer, Gunther/B-2671-2010; Guenova, Emmanuella/G-7441-2017	Hofbauer, Gunther/0000-0003-0542-7989; Johansen, Pal/0000-0002-5055-6299; Guenova, Emmanuella/0000-0001-5478-8735	Swiss National Fund [135766]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Fund, Grant Number 135766 (http://p3.snf.ch/Project-135766).	Almeida S, 2011, J INVEST DERMATOL, V131, P349, DOI 10.1038/jid.2010.329; Baker BS, 2003, BRIT J DERMATOL, V148, P670, DOI 10.1046/j.1365-2133.2003.05287.x; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Begon E, 2007, EUR J DERMATOL, V17, P497; Brooks YS, 2014, J CLIN INVEST, V124, P2260, DOI 10.1172/JCI72718; Calton CM, 2013, CELL MICROBIOL, V15, P1837, DOI 10.1111/cmi.12153; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Choi SR, 2014, EXP DERMATOL, V23, P718, DOI 10.1111/exd.12515; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; de Oliveira CB, 2015, REV INST MED TROP SP, V57, P57, DOI 10.1590/S0036-46652015000100008; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2011, CANCER RES, V71, P2029, DOI 10.1158/0008-5472.CAN-10-3750; Dziunycz PJ, 2014, J INVEST DERMATOL, V134, P1998, DOI 10.1038/jid.2014.77; Guenova E, 2015, P NATL ACAD SCI USA, V112, P2163, DOI 10.1073/pnas.1416922112; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Ilmarinen T, 2014, OTOLARYNGOL HEAD NEC; Ivanov VN, 2011, J CELL BIOCHEM, V112, P463, DOI 10.1002/jcb.22934; Kageshita T, 2002, PIGM CELL RES, V15, P212, DOI 10.1034/j.1600-0749.2002.01081.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Kuphal S, 2009, PIGM CELL MELANOMA R, V22, P296, DOI 10.1111/j.1755-148X.2009.00568.x; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lai YH, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0237-7; Lambertini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010369; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lim X, 2013, WNT SIGNALING SKIN D, V5; Loryman C, 2008, WOUND REPAIR REGEN, V16, P45, DOI 10.1111/j.1524-475X.2007.00290.x; Massi D, 2012, ADV EXP MED BIOL, V727, P131, DOI 10.1007/978-1-4614-0899-4_10; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Muehleisen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040754; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Okuyama R, 2008, J DERMATOL SCI, V49, P187, DOI 10.1016/j.jdermsci.2007.05.017; Panzer R, 2014, EXP DERMATOL, V23, P364, DOI 10.1111/exd.12383; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pivarcsi A, 2005, CURR ALLERGY ASTHM R, V5, P284, DOI 10.1007/s11882-005-0068-y; Prasad NB, 2014, MODERN PATHOL, V27, P945, DOI 10.1038/modpathol.2013.217; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Ruf W, 2003, PATHOPHYSIOL HAEMO T, V33, P28, DOI 10.1159/000073286; Ruf W, 2003, CANC RES, V63; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takazawa Y, 2014, TOHOKU J EXP MED, V234, P57, DOI 10.1620/tjem.234.57; Takeuchi T, 2002, MOL CARCINOGEN, V35, P173, DOI 10.1002/mc.10088; Takeuchi T, 2002, LAB INVEST, V82, P1023, DOI 10.1097/01.LAB.0000025391.35798.F1; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Toll A, 2013, J DERMATOL SCI, V72, P93, DOI 10.1016/j.jdermsci.2013.07.001; Weng H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-311; Widmer DS, 2013, J INVEST DERMATOL, V133, P2436, DOI 10.1038/jid.2013.115; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yusuf N, 2008, CANCER RES, V68, P615, DOI 10.1158/0008-5472.CAN-07-5219	54	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185668	10.1371/journal.pone.0185668	http://dx.doi.org/10.1371/journal.pone.0185668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982115	Green Published, gold, Green Accepted			2022-12-27	WOS:000412360300055
J	Liu, BZ; Ge, YE; Cao, K; Jiang, X; Meng, LY; Liu, D; Gao, YF				Liu, Bing-Zheng; Ge, Ying-En; Cao, Kai; Jiang, Xi; Meng, Lingyun; Liu, Ding; Gao, Yunfeng			Optimizing a desirable fare structure for a bus-subway corridor	PLOS ONE			English	Article							ASSIGNMENT MODEL; TRANSIT; SERVICE; COMPETITION; TRANSPORT; REGIMES; DESIGN; MARKET	This paper aims to optimize a desirable fare structure for the public transit service along a bus-subway corridor with the consideration of those factors related to equity in trip, including travel distance and comfort level. The travel distance factor is represented by the distance-based fare strategy, which is an existing differential strategy. The comfort level one is considered in the area-based fare strategy which is a new differential strategy defined in this paper. Both factors are referred to by the combined fare strategy which is composed of distance-based and area-based fare strategies. The flat fare strategy is applied to determine a reference level of social welfare and obtain the general passenger flow along transit lines, which is used to divide areas or zones along the corridor. This problem is formulated as a bilevel program, of which the upper level maximizes the social welfare and the lower level capturing traveler choice behavior is a variable-demand stochastic user equilibrium assignment model. A genetic algorithm is applied to solve the bi-level program while the method of successive averages is adopted to solve the lower-level model. A series of numerical experiments are carried out to illustrate the performance of the models and solution methods. Numerical results indicate that all three differential fare strategies play a better role in enhancing the social welfare than the flat fare strategy and that the fare structure under the combined fare strategy generates the highest social welfare and the largest resulting passenger demand, which implies that the more equity factors a differential fare strategy involves the more desirable fare structure the strategy has.	[Liu, Bing-Zheng] Dalian Univ Technol, Fac Infrastruct Engn, Sch Transportat & Logist, Dalian, Liaoning, Peoples R China; [Ge, Ying-En; Liu, Ding; Gao, Yunfeng] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China; [Cao, Kai] Shandong Univ Technol, Sch Transportat & Vehicle Engn, Zibo, Shandong, Peoples R China; [Jiang, Xi; Meng, Lingyun] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China	Dalian University of Technology; Shanghai Maritime University; Shandong University of Technology; Beijing Jiaotong University	Ge, YE; Gao, YF (corresponding author), Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China.	yege@shmtu.edu.cn; ghiltong@126.com	Ge, Ying-En/C-1123-2016	Ge, Ying-En/0000-0002-8435-0483	National Science Foundation of China [71431003, 71201009]; State Key Laboratory of Rail Traffic Control and Safety [RCS2014K005]; Lloyd's Register Foundation; Beijing Jiaotong University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Rail Traffic Control and Safety; Lloyd's Register Foundation; Beijing Jiaotong University	This study was supported by the National Science Foundation of China 71431003 Ying-en Ge; the National Science Foundation of China 71201009 Kai Cao; the State Key Laboratory of Rail Traffic Control and Safety RCS2014K005 Xi Jiang; the Lloyd's Register Foundation Ying-en Ge.; This work is partly supported by the National Science Foundation of China though grants numbered: 71431003 and 71201009, and partly by the State Key Laboratory of Rail Traffic Control and Safety (Contract No.: RCS2014K005), Beijing Jiaotong University. The authors are also grateful for the support of the Lloyd's Register Foundation, a charity that helps to protect life and property by supporting engineering-related education, public engagement, and the application of research.	Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Borndorfer R, 2012, DISCRETE APPL MATH, V160, P2591, DOI 10.1016/j.dam.2012.02.027; Chien SIJ, 2007, TRANSPORT PLAN TECHN, V30, P477, DOI 10.1080/03081060701599961; De Borger B, 1998, REG SCI URBAN ECON, V28, P163, DOI 10.1016/S0166-0462(97)00018-5; de Palma A, 2015, TRANSPORT RES B-METH, V71, P1, DOI 10.1016/j.trb.2014.10.001; EVANS A, 1987, J TRANSP ECON POLICY, V21, P7; Fleishman D., 1996, FARE POLICIES STRUCT; Ge YE, 2016, TRANSPORTMETRICA B, V4, P87, DOI 10.1080/21680566.2016.1147145; Ge YE, TRANSPORT IN PRESS; Ge YE, 2015, PROMET-ZAGREB, V27, P529, DOI 10.7307/ptt.v27i6.1734; GLAISTER S, 1978, J TRANSP ECON POLICY, V12, P304; Kaddoura I, 2015, TRANSPORTATION, V42, P1039, DOI 10.1007/s11116-014-9533-6; KOCUR G, 1982, TRANSPORT SCI, V16, P149, DOI 10.1287/trsc.16.2.149; LAM W, 1982, TRANSPORT Q, V36, P407; Lam WHK, 2000, TRANSPORT RES REC, P8, DOI 10.3141/1733-02; Li ZC, 2009, TRANSPORTATION AND TRAFFIC THEORY 2009: GOLDEN JUBILEE, P495, DOI 10.1007/978-1-4419-0820-9_25; Li ZC, 2009, NETW SPAT ECON, V9, P191, DOI 10.1007/s11067-007-9058-z; Ling JH, 1998, J ADV TRANSPORT, V32, P297, DOI 10.1002/atr.5670320304; Liu BZ, TRANSPORTS IN PRESS; Lu XS, 2015, TRANSPORT POLICY, V44, P76, DOI 10.1016/j.tranpol.2015.06.014; Msigwa RE, 2015, J INEQUAL APPL, DOI 10.1186/s13660-015-0759-4; NASH CA, 1978, J TRANSP ECON POLICY, V12, P70; Oppenheim N., 1995, URBAN TRAVEL DEMAND; Sheffi Y., 1985, URBAN TRANSPORTATION; SPIESS H, 1989, TRANSPORT RES B-METH, V23, P83, DOI 10.1016/0191-2615(89)90034-9; Stewart KJ, 2014, EUR J TRANSP INFRAST, V14, P30; Tang CY, 2017, J ADV TRANSPORT, DOI 10.1155/2017/7058789; Tirachini A, 2014, TRANSPORT RES B-METH, V61, P33, DOI 10.1016/j.trb.2014.01.003; Tong CO, 1999, TRANSPORT RES B-METH, V33, P107, DOI 10.1016/S0191-2615(98)00030-7; Tsai FM, 2013, J TRANSP ENG-ASCE, V139, P30, DOI 10.1061/(ASCE)TE.1943-5436.0000468; WILLIAMS HCWL, 1977, ENVIRON PLANN A, V9, P285, DOI 10.1068/a090285; Yang H, 2000, J TRANSP ENG-ASCE, V126, P419, DOI 10.1061/(ASCE)0733-947X(2000)126:5(419); Zhang JT, 2014, J APPL MATH, DOI 10.1155/2014/197515; Zhou J, 2005, TRANSPORT RES B-METH, V39, P519, DOI 10.1016/j.trb.2004.07.003	34	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184815	10.1371/journal.pone.0184815	http://dx.doi.org/10.1371/journal.pone.0184815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981508	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300019
J	Nagaty, A; Abd El-Wahab, EW				Nagaty, Ahmed; Abd El-Wahab, Ekram W.			Real-life results of sofosbuvir based therapy in chronic hepatitis C-naive and -experienced patients in Egypt	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 4 PATIENTS; VIRUS-INFECTION; CHRONIC HCV; COMBINATION THERAPY; PLUS RIBAVIRIN; INTERFERON THERAPY; INSULIN-RESISTANCE; LATE RELAPSE; PEGINTERFERON ALPHA-2A	Background More than ten million Egyptians are infected with HCV. Every one of them is going to infect about three to four persons every year. Treating those patients is a matter of national security. A dramatic improvement in hepatitis C virus (HCV) infection treatment was achieved in the last five years. A new era of direct-acting antivirals is now dawning in Egypt. Objective(s) We share in this report our clinical experience in treating chronic HCV Egyptian patients with Sofosbuvir based regimens to evaluate its safety and efficacy on real life practical ground. Methods A total of 205 chronic HCV patients (195 naive and 15 experienced) were enrolled in the study. Patient were treated with Sofosbuvir+Ribavirin 24 weeks as standard of care. Two interferon eligible patients were treated with PEG-INF+Sofosbuvir+Ribavirin for 12 weeks. The primary efficacy endpoint was the proportion of patients with sustained virologic response at 24 weeks after cessation of therapy. Results The overall response rate was 97.1%. Sustained virological response rate did not differ among treatment-naive patients and patients with previous history of IFN-based therapy. Portal hypertension, prediabetes, and lack of early virologic response were predictors of non response. No clinically significant treatment- emergent adverse effects were noted. No treatment discontinuation was encountered. Conclusion In the real-life setting, Sofosbuvir based regimens for 24 weeks has established an efficacious and well tolerated treatment in naive and experienced patients with chronic HCV genotype 4 infection; although shorter treatment durations may be possible. However, patient follow up should extent to at least 6 months post-treatment and verifying viral load on yearly basis is warranted to track any late relapse.	[Nagaty, Ahmed] Minist Hlth, Consultant Hepatol & Infect Dis, Alexandria, Egypt; [Abd El-Wahab, Ekram W.] Alexandria Univ, High Inst Publ Hlth, Trop Hlth Dept, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Alexandria University	Abd El-Wahab, EW (corresponding author), Alexandria Univ, High Inst Publ Hlth, Trop Hlth Dept, Alexandria, Egypt.	ekramwassim@mail.com	El-Wahab, Ekram Abd/V-8831-2017	El-Wahab, Ekram Abd/0000-0003-4220-5859				Abd El-Wahab EW, 2015, J MED VIROL, V87, P428, DOI 10.1002/jmv.24092; Abd El-Wahab EW, 2014, IRAN J PUBLIC HEALTH, V43, P1510; Abdel-Ghaffar TY, 2015, WORLD J HEPATOL, V7, P2792, DOI 10.4254/wjh.v7.i28.2792; Akahoshi T, 2002, J GASTROEN HEPATOL, V17, P59, DOI 10.1046/j.1440-1746.2002.02667.x; Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300; Butt AA, 2016, LIVER INT; Cheng W, 2014, J HEPATOL, V60, pS449, DOI 10.1016/S0168-8278(14)61272-1; Cholongitas E, 2014, ANN GASTROENTEROL, V27, P331; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Desbois AC, 2017, WORLD J GASTROENTERO, V23, P1697, DOI 10.3748/wjg.v23.i9.1697; Doss W, 2015, J HEPATOL, V63, P581, DOI 10.1016/j.jhep.2015.04.023; El Raziky M, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10069; El Sayed Nasr, 2012, Morbidity and Mortality Weekly Report, V61, P545; El-Akel W, 2017, J VIRAL HEPATITIS, V24, P262, DOI 10.1111/jvh.12668; El-Ghitany EM, 2015, LIVER INT, V35, P489, DOI 10.1111/liv.12617; El-Zanaty F, 2015, EGYPT HLTH ISSUE SUR; Elgharably A, 2017, INT J GEN MED, V10, P1, DOI 10.2147/IJGM.S119301; Elsharkawy A, 2017, ALIMENT PHARM THER, V45, P681, DOI 10.1111/apt.13923; Esmat G., 2012, Current Hepatitis Reports, V11, P250, DOI 10.1007/s11901-012-0146-2; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Feng B, 2014, WORLD J GASTROENTERO, V20, P15387, DOI 10.3748/wjg.v20.i41.15387; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hsu CS, 2013, NEW ENGL J MED, V369, P678, DOI 10.1056/NEJMc1307641; Inagaki Y, 2014, MOL MED REP, V9, P487, DOI 10.3892/mmr.2013.1856; Ioannou GN, 2016, GASTROENTEROLOGY, V151, P457, DOI 10.1053/j.gastro.2016.05.049; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Ji FP, 2013, BRAZ J INFECT DIS, V17, P601, DOI 10.1016/j.bjid.2013.02.004; Kamal SM, 2000, J HEPATOL, V32, P172, DOI 10.1016/S0168-8278(00)80207-X; Kedia S, 2012, ANN HEPATOL, V11, P921, DOI 10.1016/S1665-2681(19)31419-X; Khattab M, 2010, LIVER INT, V30, P447, DOI 10.1111/j.1478-3231.2009.02171.x; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Klag T, 2017, J HEPATOL, V66, P862, DOI 10.1016/j.jhep.2017.01.002; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Lalezari JP, 2013, J HEPATOL INT, V58; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Mangia A, 2014, DIGEST LIVER DIS, V46, pS179, DOI 10.1016/j.dld.2014.09.026; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Morihara D, 2009, HEPATOL RES, V39, P439, DOI 10.1111/j.1872-034X.2008.00481.x; Morimoto H, 2014, TRANSPL P, V46, P770, DOI 10.1016/j.transproceed.2013.12.034; Morisco F, 2013, WORLD J GASTROENTERO, V19, P2793, DOI 10.3748/wjg.v19.i18.2793; Murata K, 2008, HEPATO-GASTROENTEROL, V55, P1407; Parana R, 2001, HEPATOLOGY, V33, P1340, DOI 10.1053/jhep.2001.24451; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Ray SC, 2000, J INFECT DIS, V182, P698, DOI 10.1086/315786; Romero-Gomez M, 2006, WORLD J GASTROENTERO, V12, P7075, DOI 10.3748/wjg.v12.i44.7075; Ruane PJ, 2015, J HEPATOL, V62, P1040, DOI 10.1016/j.jhep.2014.10.044; Sarrazin C, 2017, CLIN INFECT DIS, V64, P44, DOI 10.1093/cid/ciw676; Serfaty L, 2015, LIVER INT, V35, P18, DOI 10.1111/liv.12722; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Steinebrunner N, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0328-9; Sterling RK, 2015, ALIMENT PHARM THER, V41, P671, DOI 10.1111/apt.13095; Tamai H, 2015, HEPATOL INT, V9, P67, DOI 10.1007/s12072-014-9586-9; Vallet-Pichard A, 2006, HEPATOLOGY, V44, P769, DOI 10.1002/hep.21334; World Health Organization, 2016, GUID SCREEN CAR TREA; Zeuzem S, 2015, ALIMENT PHARM THER, V42, P829, DOI 10.1111/apt.13342	64	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184654	10.1371/journal.pone.0184654	http://dx.doi.org/10.1371/journal.pone.0184654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981513	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300016
J	Wang, HH; Hung, SY; Chang, MY; Lee, YC; Lin, HF; Lin, TM; Yang, SP; Lin, HH; Yang, SC; Wang, JL				Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Lin, Hsiu-Fang; Lin, Tsun-Mei; Yang, Su-Pen; Lin, Hsi-Hsun; Yang, Su-Ching; Wang, Jiun-Ling			Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis patients-A prospective, randomized controlled trial	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CATHETER-RELATED INFECTIONS; GRAM-NEGATIVE BACTERIA; METHICILLIN-RESISTANT; NASAL CARRIAGE; MUPIROCIN OINTMENT; LOCAL APPLICATION; PREVENTION; STRATEGIES; BIOCIDES	Bacterial colonization patterns in daily chlorhexidine care at the exit site in peritoneal dialysis (PD) patients were not known. We performed a prospective, randomized controlled trial enrolling 89 PD patients. After stratification by initial Staphylococcus aureus (SA) carrier status, patients were randomly assigned to receive daily 4% chlorhexidine care (intervention group) or normal saline (control group) at the exit site. Monthly, we cultured bacteria from the exit site and nasal swabs for 1 year. The SA colonization rates at exit site at 6 and 12 months were significantly lower in the intervention group than the control group (5.0% vs. 22.9%, p = 0.023 and 8.6% vs. 28.1%, p = 0.037 for 6 and 12 months, respectively). The Methicillin-resistant SA (MRSA) colonization rate at exit site at 6 months was similar (5.7% vs. 2.5%, p = 0.596) in control and intervention group, but significantly lower in the intervention group than the control group at exit site at 12months (0% vs. 12.5%, p = 0.047). The gram-negative bacilli (GNB) colonization rates were similar between the intervention and control groups at 6 and 12 months. Genotyping of all MRSA isolates showed ST (sequence type) 59 was the most predominant clone. In conclusion, chlorhexidine care at the exit site in PD patients may be a good strategy for SA and MRSA decolonization.	[Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Yang, Su-Pen; Lin, Hsi-Hsun] E DA Hosp, Internal Med Dept, Kaohsiung, Taiwan; [Wang, Hsi-Hao; Hung, Shih-Yuan; Chang, Min-Yu; Lee, Yi-Che; Yang, Su-Pen; Lin, Hsi-Hsun] I Shou Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Hsiu-Fang; Lin, Tsun-Mei] I Shou Univ, E DA Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Yang, Su-Ching] Natl Tainan Inst Nursing, Dept Nursing, Tainan, Taiwan; [Wang, Jiun-Ling] Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan; [Wang, Jiun-Ling] Natl Cheng Kung Univ, Dept Med, Tainan, Taiwan	E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; National Cheng Kung University; National Cheng Kung University	Wang, JL (corresponding author), Natl Cheng Kung Univ, Dept Internal Med, Tainan, Taiwan.; Wang, JL (corresponding author), Natl Cheng Kung Univ, Dept Med, Tainan, Taiwan.	jiunlingwang@gmail.com	Wang, 竣令王 Jiun-Ling/L-9627-2015	Wang, 竣令王 Jiun-Ling/0000-0002-9465-8692	E-DA Hospital [EDAHP99020]; Taiwan National Science Council [100-2314-B-214-005]	E-DA Hospital; Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the E-DA Hospital (No. EDAHP99020) and Taiwan National Science Council (No. 100-2314-B-214-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the E-DA Hospital (No. EDAHP99020) and Taiwan National Science Council (No. 100-2314-B-214-005). The authors declare that there are no conflicts of interest in this study. Some content of this study has been presented in the 7th International Congress. of the Asia Pacific Society of Infection Control.	Akoh Jacob A, 2012, World J Nephrol, V1, P106, DOI 10.5527/wjn.v1.i4.106; Al-Hwiesh AK, 2013, INT J ARTIF ORGANS, V36, P473, DOI 10.5301/ijao.5000207; Bernardini J, 1996, AM J KIDNEY DIS, V27, P695, DOI 10.1016/S0272-6386(96)90105-5; Bernardini J, 2005, J AM SOC NEPHROL, V16, P539, DOI 10.1681/ASN.2004090773; Campbell D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004679.pub3; Chu KH, 2008, PERITON DIALYSIS INT, V28, P505; Crawford S, 2014, REN SOC AUSTRALAS J, V10, P116; DAVIES SJ, 1989, PERITON DIALYSIS INT, V9, P61; Derde LPG, 2012, INTENS CARE MED, V38, P931, DOI 10.1007/s00134-012-2542-z; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FUCHS J, 1990, DIALYSIS TRANSPLANT, V19, P81; Higgins CS, 2001, CLIN MICROBIOL INFEC, V7, P308, DOI 10.1046/j.1198-743x.2001.00253.x; Kang YC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-284; Lee SM, 2014, KIDNEY RES CLIN PRAC, V33, P144, DOI 10.1016/j.krcp.2014.05.030; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; McCormack K, 2007, HEALTH TECHNOL ASSES, V11, P1; McQuillan RF, 2012, CLIN J AM SOC NEPHRO, V7, P297, DOI 10.2215/CJN.07970811; Milstone AM, 2008, CLIN INFECT DIS, V46, P274, DOI 10.1086/524736; Mullany LC, 2008, PEDIATR INFECT DIS J, V27, P505, DOI 10.1097/INF.0b013e31816791a2; Mullany LC, 2012, PEDIATR INFECT DIS J, V31, P444, DOI 10.1097/INF.0b013e3182468ff0; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Piraino B, 2000, ASAIO J, V46, pS13, DOI 10.1097/00002480-200011000-00031; Piraino B, 2011, PERITON DIALYSIS INT, V31, P614, DOI 10.3747/pdi.2011.00057; Ques AAM, 2013, JBI DATABASE SYSTEMA, V11, P133; Ritzau J, 2001, PERITON DIALYSIS INT, V21, P471; Rosenblum A, 2014, AM J KIDNEY DIS, V63, P259, DOI 10.1053/j.ajkd.2013.08.019; Safdar N, 2014, CRIT CARE MED, V42, P1703, DOI 10.1097/CCM.0000000000000319; Sandri AM, 2006, INFECT CONT HOSP EP, V27, P185, DOI 10.1086/500625; Schaefer F, 1999, J AM SOC NEPHROL, V10, P136; Smith K, 2008, J MED MICROBIOL, V57, P966, DOI 10.1099/jmm.0.47668-0; STICKLER DJ, 1987, J HOSP INFECT, V10, P28, DOI 10.1016/0195-6701(87)90029-6; Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Thodis E, 1998, PERITON DIALYSIS INT, V18, P261; Thomas L, 2000, J HOSP INFECT, V46, P297, DOI 10.1053/jhin.2000.0851; Uttley L, 2004, J NEPHROL, V17, P242; Vychytil A, 1998, J AM SOC NEPHROL, V9, P669; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Wanten GJA, 1996, PERITON DIALYSIS INT, V16, P352; WONG FS-Y, 2002, HONG KONG J NEPHROL, V4, p54 ~ 9	40	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184859	10.1371/journal.pone.0184859	http://dx.doi.org/10.1371/journal.pone.0184859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981543	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300021
J	Holm, KL; Syljuasen, RG; Hasvold, G; Alsoe, L; Nilsen, H; Ivanauskiene, K; Collas, P; Shaposhnikov, S; Collins, A; Indrevaer, RL; Aukrust, P; Fevang, B; Blomhoff, HK				Holm, Kristine Lillebo; Syljuasen, Randi Gussgard; Hasvold, Grete; Alsoe, Lene; Nilsen, Hilde; Ivanauskiene, Kristina; Collas, Philippe; Shaposhnikov, Sergey; Collins, Andrew; Indrevaer, Randi Larsen; Aukrust, Pal; Fevang, Borre; Blomhoff, Heidi Kiil			TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency	PLOS ONE			English	Article							RETINOIC ACID; H2AX PHOSPHORYLATION; HISTONE H2AX; COMET ASSAY; RADIATION; REPAIR; GAMMA-H2AX; PROTOONCOGENES; LYMPHOCYTES; DEFICIENCY	In the present study, we address the important issue of whether B-cells protected from irradiation-induced cell death, may survive with elevated levels of DNA damage. If so, such cells would be at higher risk of gaining mutations and undergoing malignant transformation. We show that stimulation of B-cells with the TLR9 ligands CpG-oligodeoxynucleotides (CpG-ODN) prevents spontaneous and irradiation-induced death of normal peripheral blood B-cells, and of B-cells from patients diagnosed with Common variable immunodeficiency (CVID). The TLR9-mediated survival is enhanced by the vitamin A metabolite retinoic acid (RA). Importantly, neither stimulation of B-cells via TLR9 alone or with RA increases irradiation-induced DNA strand breaks and DNA damage responses such as activation of ATM and DNA-PKcs. We prove that elevated levels of gamma H2AX imposed by irradiation of stimulated B-cells is not due to induction of DNA double strand breaks, but merely reflects increased levels of total H2AX upon stimulation. Interestingly however, we unexpectedly find that TLR9 stimulation of B-cells induces low amounts of inactive p53, explained by transcriptional induction of TP53. Taken together, we show that enhanced survival of irradiated B-cells is not accompanied by elevated levels of DNA damage. Our results imply that TLR9-mediated activation of B-cells not only promotes cell survival, but may via p53 provide cells with a barrier against harmful consequences of enhanced activation and proliferation. As CVID-derived B-cells are more radiosensitive and prone to undergo apoptosis than normal B-cells, our data support treatment of CVID patients with CpG-ODN and RA.	[Holm, Kristine Lillebo; Ivanauskiene, Kristina; Collas, Philippe; Indrevaer, Randi Larsen; Blomhoff, Heidi Kiil] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Syljuasen, Randi Gussgard; Hasvold, Grete] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Radiumhosp, Oslo, Norway; [Alsoe, Lene; Nilsen, Hilde] Univ Oslo, Dept Clin Mol Biol, Lorenskog, Norway; [Alsoe, Lene; Nilsen, Hilde] Akershus Univ Hosp, Lorenskog, Norway; [Shaposhnikov, Sergey; Collins, Andrew] Norgenotech AS, Comet Biotech AS, Oslo, Norway; [Shaposhnikov, Sergey; Collins, Andrew] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Aukrust, Pal; Fevang, Borre] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Rikshosp, Oslo, Norway; [Aukrust, Pal; Fevang, Borre] Oslo Univ Hosp, Res Inst Internal Med, Rikshosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Blomhoff, HK (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway.	h.k.blomhoff@medisin.uio.no		Collins, Andrew/0000-0001-5916-6871; Shaposhnikov, Sergey/0000-0002-3957-703X	University of Oslo; Norwegian Cancer Society [420156]; Anders Jahre Foundation; Blix Family Foundation; Freia Foundation; Nansen Foundation; UNIFOR FRIMED Legacy	University of Oslo; Norwegian Cancer Society(Norwegian Cancer Society); Anders Jahre Foundation; Blix Family Foundation; Freia Foundation; Nansen Foundation; UNIFOR FRIMED Legacy	This work has been supported by the University of Oslo (vow; up no), the Norwegian Cancer Society (grant number 420156, krefiforeningen.no), the Anders Jahre Foundation (www.unifor.no/Fund.aspx?site=1&fund=290), the Blix Family Foundation, the Freia Foundation, the Nansen Foundation (www.nansenfondet.no) and the UNIFOR FRIMED Legacy (www.unifor.no/fund.aspx?fund=310). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this work. Norgenotech & Comet Biotech financial involvement in the study: salary for SS and coverage of the reagents, materials, lab rent and technical assistance connected with carrying out the experiments (these actual costs of Norgenotech were covered by the University of Oslo with no commercial profit or overheads).	Aghamohammadi A, 2008, IMMUNOBIOLOGY, V213, P447, DOI 10.1016/j.imbio.2007.10.018; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; AUKRUST P, 1994, CLIN EXP IMMUNOL, V97, P232; AUKRUST P, 1995, BLOOD, V86, P1383, DOI 10.1182/blood.V86.4.1383.bloodjournal8641383; Aukrust P, 2000, EUR J CLIN INVEST, V30, P252, DOI 10.1046/j.1365-2362.2000.00619.x; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen MC, 2014, BIOMEDICINE-TAIWAN, V4, DOI 10.7603/s40681-014-0022-1; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clemente A, 2013, CLIN EXP IMMUNOL, V174, P97, DOI 10.1111/cei.12150; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cunningham-Rundles C, 2006, J IMMUNOL, V176, P1978, DOI 10.4049/jimmunol.176.3.1978; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Grossman SA, 2015, J NATL COMPR CANC NE, V13, P1225, DOI 10.6004/jnccn.2015.0151; Heylmann D, 2014, BBA-REV CANCER, V1846, P121, DOI 10.1016/j.bbcan.2014.04.009; Holm KL, 2016, IMMUNOLOGY, V149, P62, DOI 10.1111/imm.12629; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Indrevaer RL, 2015, J IMMUNOL, V195, P2601, DOI 10.4049/jimmunol.1500250; Indrevaer RL, 2013, J IMMUNOL, V191, P3624, DOI 10.4049/jimmunol.1300213; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jirapongsananuruk O, 1999, CLIN EXP IMMUNOL, V118, P1; Kamran SC, 2016, CANCER-AM CANCER SOC, V122, P1809, DOI 10.1002/cncr.29841; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kilic SS, 2005, J CLIN IMMUNOL, V25, P275, DOI 10.1007/s10875-005-4090-6; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumar Y, 2013, EXPERT REV CLIN IMMU, V9, P959, DOI 10.1586/1744666X.2013.836967; Kuo LJ, 2008, IN VIVO, V22, P305; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Marechal A., 2013, COLD SPRING HARB PER, V5; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Qin M, 2014, IMMUNOPHARM IMMUNOT, V36, P251, DOI 10.3109/08923973.2013.861481; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAXON A, 1995, CLIN EXP IMMUNOL, V102, P17; SMELAND EB, 1988, EUR J IMMUNOL, V18, P1847, DOI 10.1002/eji.1830181131; Tanaka T, 2007, CYTOM PART A, V71A, P648, DOI 10.1002/cyto.a.20426; Tkacz-Stachowska K, 2011, RADIOTHER ONCOL, V101, P24, DOI 10.1016/j.radonc.2011.05.060; Tu WZ, 2013, FEBS LETT, V587, P3437, DOI 10.1016/j.febslet.2013.08.028; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Yazdani R, 2016, MOL IMMUNOL, V71, P1, DOI 10.1016/j.molimm.2015.12.016; Yu JE, 2009, J ALLERGY CLIN IMMUN, V124, P349, DOI 10.1016/j.jaci.2009.05.019; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	52	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185708	10.1371/journal.pone.0185708	http://dx.doi.org/10.1371/journal.pone.0185708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973009	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900038
J	Mitic, S; Strampraad, MJF; Hagen, WR; de Vries, S				Mitic, Sandra; Strampraad, Marc J. F.; Hagen, Wilfred R.; de Vries, Simon			Microsecond time-scale kinetics of transient biochemical reactions	PLOS ONE			English	Article								To afford mechanistic studies in enzyme kinetics and protein folding in the microsecond time domain we have developed a continuous-flow microsecond time-scale mixing instrument with an unprecedented dead-time of 3.8 +/- 0.3 mu s. The instrument employs a micromixer with a mixing time of 2.7 mu s integrated with a 30 mm long flow-cell of 109 nm optical path length constructed from two parallel sheets of silver foil; it produces ultraviolet-visible spectra that are linear in absorbance up to 3.5 with a spectral resolution of 0.4 nm. Each spectrum corresponds to a different reaction time determined by the distance from the mixer outlet, and by the fluid flow rate. The reaction progress is monitored in steps of 0.35 mu s for a total duration of similar to 600 mu s. As a proof of principle the instrument was used to study spontaneous protein refolding of pH-denatured cytochrome c. Three folding intermediates were determined: after a novel, extremely rapid initial phase with tau = 4.7 mu s, presumably reflecting histidine re-binding to the iron, refolding proceeds with time constants of 83 mu s and 345 mu s to a coordinatively saturated low-spin iron form in quasi steady state. The time-resolution specifications of our spectrometer for the first time open up the general possibility for comparison of real data and molecular dynamics calculations of biomacromolecules on overlapping time scales.	[Mitic, Sandra; Strampraad, Marc J. F.; Hagen, Wilfred R.; de Vries, Simon] Delft Univ Technol, Dept Biotechnol, Delft, Netherlands	Delft University of Technology	Hagen, WR (corresponding author), Delft Univ Technol, Dept Biotechnol, Delft, Netherlands.	w.r.hagen@tudelft.nl	Hagen, Wilfred R./H-8918-2017	Hagen, Wilfred R./0000-0002-1609-6671	NanoNed, the nanotechnology research and development initiative of Dutch government [TAC.6380]	NanoNed, the nanotechnology research and development initiative of Dutch government	This work was supported by NanoNed, the nanotechnology research and development initiative of Dutch government via a grant to S. de Vries (project TAC.6380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; BABUL J, 1972, BIOCHEMISTRY-US, V11, P1195, DOI 10.1021/bi00757a013; Brand K. G., 1996, J BIOL CHEM, V241, P4180; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Evans MR, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3263913; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Malinowski E. R., 1980, FACTOR ANAL CHEM; MARGOLIASH E., 1966, ADVANCE PROTEIN CHEM, V21, P113, DOI 10.1016/S0065-3233(08)60128-X; Mitic S, 2011, COMPREHENSIVE BIOPHYSICS, VOL 1: BIOPHYSICAL TECHNIQUES FOR STRUCTURAL CHARACTERIZATION OF MACROMOLECULES, P514, DOI 10.1016/B978-0-12-374920-8.00127-2; Mitic S, 2015, ANAL BIOCHEM, V469, P19, DOI 10.1016/j.ab.2014.10.003; Post CB, 2017, CURR OPIN STRUC BIOL, V43, pIV, DOI 10.1016/j.sbi.2017.04.008; Roder H, 2006, CHEM REV, V106, P1836, DOI 10.1021/cr040430y; ROSENBERG RC, 1976, J AM CHEM SOC, V98, P6364, DOI 10.1021/ja00436a049; Shastry MCR, 1998, BIOPHYS J, V74, P2714, DOI 10.1016/S0006-3495(98)77977-9; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; Spry DB, 2007, J PHYS CHEM A, V111, P230, DOI 10.1021/jp066041k; Takahashi S, 1997, NAT STRUCT BIOL, V4, P44, DOI 10.1038/nsb0197-44; Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51; Yeh SR, 1998, ACCOUNTS CHEM RES, V31, P727, DOI 10.1021/ar970084p; Yeh SR, 1998, NAT STRUCT BIOL, V5, P222, DOI 10.1038/nsb0398-222	20	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185888	10.1371/journal.pone.0185888	http://dx.doi.org/10.1371/journal.pone.0185888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973014	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900064
J	Laugeray, A; Herzine, A; Perche, O; Richard, O; Montecot-Dubourg, C; Menuet, A; Mazaud-Guittot, S; Lesne, L; Jegou, B; Mortaud, S				Laugeray, Anthony; Herzine, Ameziane; Perche, Olivier; Richard, Olivier; Montecot-Dubourg, Celine; Menuet, Arnaud; Mazaud-Guittot, Severine; Lesne, Laurianne; Jegou, Bernard; Mortaud, Stephane			In utero and lactational exposure to low-doses of the pyrethroid insecticide cypermethrin leads to neurodevelopmental defects in male mice-An ethological and transcriptomic study	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; OXIDATIVE STRESS; DEVELOPMENTAL NEUROTOXICITY; SOCIAL RECOGNITION; PRENATAL EXPOSURE; BRAIN-REGIONS; BEHAVIOR; DOPAMINE; DAMAGE; NEURODEGENERATION	Accumulating evidence suggests that developmental exposure to environmental chemicals may modify the course of brain development, ultimately leading to neuropsychiatric /neuro-degenerative disorders later in life. In the present study, we assessed the impact of one of the most frequently used pesticides in both residential and agricultural applications-the synthetic pyrethroid cypermethrin (CYP)-on developmental neurotoxicity (DNT). Female mice were perinatally exposed to low doses of CYP (5 and 20 mg/kg body weight) from gestation to postnatal day 15. Behavioral analyses were performed during the offspring's early life and during adulthood. Postnatal analyses revealed that perinatal exposure to CYP disturbed motor development without modifying sensory and communicative skills. We found that later in life, CYP-exposed offspring expressed maladaptive behaviors in response to highly challenging tasks and abnormal sociability. Transcriptomic analyses performed in the offspring's brain at the end of the exposure, highlighted mitochondrial dysfunction as a relevant pathomechanism underlying CYP-induced DNT. Interestingly, several genes involved in proteostasis maintenance were also shown to be dysregulated suggesting that alterations in biogenesis, folding, trafficking and degradation of proteins may significantly contribute to CYP-related DNT. From a regulatory perspective, this study highlights that behavioral and transcriptomic analyses are complementary tools providing useful direction for better DNT characterization, and as such, should be used together more systematically.	[Laugeray, Anthony; Herzine, Ameziane; Perche, Olivier; Richard, Olivier; Montecot-Dubourg, Celine; Menuet, Arnaud; Mortaud, Stephane] CNRS, Immunol & Neurogenet Expt & Mol, UMR7355, Orleans, France; [Perche, Olivier] CHR, Dept Genet, Orleans, France; [Mazaud-Guittot, Severine; Lesne, Laurianne; Jegou, Bernard] Univ Rennes 1, INSERM, IRSET, U 1085, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre Hospitalier Regional d'Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Laugeray, A; Mortaud, S (corresponding author), CNRS, Immunol & Neurogenet Expt & Mol, UMR7355, Orleans, France.	alaugeray@yahoo.fr; smortaud@cnrs-orleans.fr	Mazaud-Guittot, Severine/I-4694-2015; Jégou, Bernard/I-4742-2015; Laugeray, Anthony/AAJ-2919-2020; Lesne, Laurianne/AAD-6180-2019	Mazaud-Guittot, Severine/0000-0003-0566-4124; Lesne, Laurianne/0000-0003-3165-9986; Perche, Olivier/0000-0002-6513-5534; JEGOU, Bernard/0000-0003-0623-3609; Mortaud, Stephane/0000-0003-0873-4781	French National Research Agency ANR [CESA-10-007 - NEUROPEST]; Region Centre (Doctoral fellowship to Ameziane Herzine)	French National Research Agency ANR(French National Research Agency (ANR)); Region Centre (Doctoral fellowship to Ameziane Herzine)	This work was supported by the French National Research Agency ANR (CESA-10-007 - NEUROPEST; allocated to SM), and Region Centre (Doctoral fellowship to Ameziane Herzine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2015, MOL NEUROBIOL, V51, P448, DOI 10.1007/s12035-014-8696-7; Baden KN, 2007, J BIOL CHEM, V282, P34839, DOI 10.1074/jbc.M703528200; Bal-Price A, 2016, NEUROTOXICOLOGY; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bertoglio LJ, 2005, BEHAV BRAIN RES, V162, P99, DOI 10.1016/j.bbr.2005.03.010; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Bland ST, 2004, NEUROSCIENCE, V126, P705, DOI 10.1016/j.neuroscience.2004.04.025; Bonito-Oliva A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00290; CABIB S, 1994, J NEUROSCI, V14, P3333; Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dubovicky Michal, 2008, Interdiscip Toxicol, V1, P206, DOI 10.2478/v10102-010-0042-y; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; Farag AT, 2007, REPROD TOXICOL, V23, P560, DOI 10.1016/j.reprotox.2007.01.002; Ferrer I, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00163; Fonio E, 2012, NAT METHODS, V9, P1167, DOI 10.1038/nmeth.2252; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Herzine A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00191; Hohn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004; Huang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060885; HUSAIN R, 1992, B ENVIRON CONTAM TOX, V49, P402, DOI 10.1007/BF01239644; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Khazri A, 2015, ECOTOX ENVIRON SAFE, V115, P62, DOI 10.1016/j.ecoenv.2015.01.028; Kimata A, 2009, J OCCUP HEALTH, V51, P100, DOI 10.1539/joh.M7005; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kutluyer F, 2016, PESTIC BIOCHEM PHYS, V128, P63, DOI 10.1016/j.pestbp.2015.10.001; Landrigan PJ, 2005, ENVIRON HEALTH PERSP, V113, P1230, DOI 10.1289/ehp.7571; Laugeray A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00390; Laviola G, 2002, BEHAV BRAIN RES, V130, P117, DOI 10.1016/S0166-4328(01)00420-X; Lee I, 2015, TOXICOLOGY, V335, P1, DOI 10.1016/j.tox.2015.06.010; Lemasson M, 2005, BEHAV PROCESS, V68, P13, DOI 10.1016/j.beproc.2004.09.001; Liu WS, 2007, GENETICS, V176, P937, DOI 10.1534/genetics.107.071688; Lloyd RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069003; Lohle M, 2009, J NEURAL TRANSM, V116, P1483, DOI 10.1007/s00702-009-0274-1; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; MALAVIYA M, 1993, VET HUM TOXICOL, V35, P119; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Matsuda I, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0196-4; Maurya SK, 2014, PESTIC BIOCHEM PHYS, V111, P51, DOI 10.1016/j.pestbp.2014.03.005; Molavi M, 2016, VET RES FORUM, V7, P125; Morgan MK, 2007, ENVIRON RES, V104, P266, DOI 10.1016/j.envres.2006.11.011; Morgan MK, 2012, INT J ENV RES PUB HE, V9, P2964, DOI 10.3390/ijerph9082964; Mossa ATH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0740-2; Mun JY, 2005, TOXICOL MECH METHOD, V15, P399, DOI 10.1080/15376520500194742; Murgatroyd Chris, 2011, Front Psychiatry, V2, P16, DOI 10.3389/fpsyt.2011.00016; Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x; Nasuti C, 2007, TOXICOLOGY, V229, P194, DOI 10.1016/j.tox.2006.10.015; Nasuti C, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-7; Nasuti C, 2013, TOXICOLOGY, V303, P162, DOI 10.1016/j.tox.2012.09.016; Noack J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00152; OECD, 2007, OCED TEST NO 426 DEV; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rehling P, 2001, CRIT REV BIOCHEM MOL, V36, P291, DOI 10.1080/20014091074200; Rodriguez JL, 2016, ENVIRON RES, V146, P388, DOI 10.1016/j.envres.2016.01.023; Rodriguez-Estrada J, 2016, FISH PHYSIOL BIOCHEM, V42, P859, DOI 10.1007/s10695-015-0180-4; Romero A, 2016, ARCH TOXICOLOGY; Russell WMS., 1959, MED J AUSTRALIA; Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002; Santoni G, 1999, TOXICOLOGY, V138, P175, DOI 10.1016/S0300-483X(99)00103-1; Santoni G, 1997, TOXICOLOGY, V120, P231, DOI 10.1016/S0300-483X(97)03662-7; Schaefers ATU, 2016, WORLD J BIOL PSYCHIA, V17, P587, DOI 10.3109/15622975.2013.797104; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; Sharma Poonam, 2014, J Hum Reprod Sci, V7, P99, DOI 10.4103/0974-1208.138867; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Singh AK, 2011, TOXICOL SCI, V122, P526, DOI 10.1093/toxsci/kfr115; Singh AK, 2012, NEUROBIOL AGING, V33, P404, DOI 10.1016/j.neurobiolaging.2010.02.018; Singh A, 2016, MOL NEUROBIOL, V53, P3670, DOI 10.1007/s12035-015-9307-y; Singh A, 2015, MOL NEUROBIOL, V52, P741, DOI 10.1007/s12035-014-8903-6; Singh P, 2011, TOXICOL MECH METHOD, V21, P193, DOI 10.3109/15376516.2010.538939; Sun H, 2007, CHEMOSPHERE, V66, P474, DOI 10.1016/j.chemosphere.2006.05.059; Tadaiesky MT, 2008, NEUROSCIENCE, V156, P830, DOI 10.1016/j.neuroscience.2008.08.035; Tiwari MN, 2010, FREE RADICAL RES, V44, P1416, DOI 10.3109/10715762.2010.512041; Vardavas AI, 2016, LIFE SCI, V145, P114, DOI 10.1016/j.lfs.2015.12.026; Viel JF, 2015, ENVIRON INT, V82, P69, DOI 10.1016/j.envint.2015.05.009; Wang H, 2011, ENVIRON TOXICOL, V26, P382, DOI 10.1002/tox.20566; Wei KQ, 2015, FISH SHELLFISH IMMUN, V43, P510, DOI 10.1016/j.fsi.2015.01.013; Yee BK, 2007, J NEURAL TRANSM, V114, P431, DOI 10.1007/s00702-006-0548-9; Zhang YT, 2016, ACCIDENT ANAL PREV, V96, P185, DOI 10.1016/j.aap.2016.08.003; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	85	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184475	10.1371/journal.pone.0184475	http://dx.doi.org/10.1371/journal.pone.0184475			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020013	Green Published, gold, Green Submitted			2022-12-27	WOS:000412754400012
J	Angermann, S; Baumann, M; Steubl, D; Lorenz, G; Hauser, C; Suttmann, Y; Reichelt, AL; Satanovskij, R; Sonntag, F; Heemann, U; Grimmer, T; Schmaderer, C				Angermann, Susanne; Baumann, Marcus; Steubl, Dominik; Lorenz, Georg; Hauser, Christine; Suttmann, Yana; Reichelt, Anna-Lena; Satanovskij, Robin; Sonntag, Franziska; Heemann, Uwe; Grimmer, Timo; Schmaderer, Christoph			Cognitive impairment in hemodialysis patients: Implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-testfor feasible screening	PLOS ONE			English	Article							MINI-MENTAL STATE; DEMENTIA; ADULTS	Objective Reliable identification of cognitive impairment in hemodialysis patients is of utmost importance, as it is associated with poor outcomes including dialysis withdrawal and death. High prevalence of cognitive impairment has been demonstrated in several studies using brief screening instruments or neuropsychological test batteries. However, the relevance of cognitive impairment as well as the accuracy of screening procedures have never been studied in this patient population. Methods 151 chronic hemodialysis patients (mean age 65.78 +/- 14.88 years, 73,5% male) underwent cognitive testing under standardized conditions by the Montreal Cognitive Assessment (MoCA) and, in a second step, the Clinical Dementia Rating scale (CDR), an international standard to measure the severity of dementia. For calculating MoCA cut-off values on the basis of the CDR global score, receiver operator characteristics (ROC) analysis and c-statistic were applied. Results 49.0% of patients were categorized as 0.5 in the CDR global with memory being the predominantly affected domain (47.7% of patients scored >= 0.5). Youden's Index led to a threshold of 23.5 points for the MoCA test for optimal differentiation between cognitively normal (CDR global < 0.5) and impaired patients (CDR global >= 0.5) based on a sensitivity of approximately 99% and a specificity of approximately 74%. Conclusion Interference of cognitive impairment with patients' independence and daily life was shown using the CDR for the first time in hemodialysis patients. A MoCA score of 23.5 points turned out as optimal threshold to differentiate between patients with and without functional impairment in the CDR, thereby paving the way for implementation of the MoCA test as a quick and thus highly feasible screening instrument for periodic testing in clinical routine.	[Angermann, Susanne; Steubl, Dominik; Lorenz, Georg; Hauser, Christine; Suttmann, Yana; Reichelt, Anna-Lena; Satanovskij, Robin; Sonntag, Franziska; Heemann, Uwe; Schmaderer, Christoph] Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Bavaria, Germany; [Baumann, Marcus] Friedrich Alexander Univ Erlangen Nurnberg, Klinikum Ansbach, Dept Nephrol, Erlangen, Bavaria, Germany; [Grimmer, Timo] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychiat & Psychotherapy, Munich, Bavaria, Germany	Technical University of Munich; University of Erlangen Nuremberg; Technical University of Munich; University of Munich	Angermann, S; Schmaderer, C (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Nephrol, Munich, Bavaria, Germany.	Susanne.angermann@mri.tum.de; Christoph.Schmaderer@mri.tum.de	Lorenz, georg/AAK-4185-2021					American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Carrasco FR, 2009, TRANSPL P, V41, P2430, DOI 10.1016/j.transproceed.2009.06.166; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Kurella M, 2006, NEPHROL DIAL TRANSPL, V21, P2543, DOI 10.1093/ndt/gfl275; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Rakowski DA, 2006, CLIN J AM SOC NEPHRO, V1, P1000, DOI 10.2215/CJN.00470705; Schmaderer C, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0374-8; Sugarman J, 1998, J AM GERIATR SOC, V46, P517, DOI 10.1111/j.1532-5415.1998.tb02477.x; Tamura MK, 2010, CLIN J AM SOC NEPHRO, V5, P1429, DOI 10.2215/CJN.01090210; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tholen S, 2014, DEMENT GERIATR COGN, V38, P31, DOI 10.1159/000357803; Tiffin-Richards FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106700; World Health Organization, INT CLASS DIS ICD	17	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184589	10.1371/journal.pone.0184589	http://dx.doi.org/10.1371/journal.pone.0184589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016605	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400009
J	Pearce, A; Haas, M; Viney, R; Pearson, SA; Haywood, P; Brown, C; Ward, R				Pearce, Alison; Haas, Marion; Viney, Rosalie; Pearson, Sallie-Anne; Haywood, Philip; Brown, Chris; Ward, Robyn			Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; ADVERSE EVENTS; PATIENT PERCEPTIONS; BREAST-CANCER; SYMPTOMS; NAUSEA	Aim Chemotherapy side effects are often reported in clinical trials; however, there is little evidence about their incidence in routine clinical care. The objective of this study was to describe the frequency and severity of patient-reported chemotherapy side effects in routine care across treatment centres in Australia. Methods We conducted a prospective cohort study of individuals with breast, lung or colorectal cancer undergoing chemotherapy. Side effects were identified by patient self-report. The frequency, prevalence and incidence rates of side effects were calculated by cancer type and grade, and cumulative incidence curves for each side effect computed. Frequencies of side effects were compared between demographic subgroups using chi-squared statistics. Results Side effect data were available for 449 eligible individuals, who had a median follow-up of 5.64 months. 86% of participants reported at least one side effect during the study period and 27% reported a grade IV side effect, most commonly fatigue or dyspnoea. Fatigue was the most common side effect overall (85%), followed by diarrhoea (74%) and constipation (74%). Prevalence and incidence rates were similar across side effects and cancer types. Age was the only demographic factor associated with the incidence of side effects, with older people less likely to report side effects. Conclusion This research has produced the first Australian estimates of self-reported incidence of chemotherapy side effects in routine clinical care. Chemotherapy side effects in routine care are common, continue throughout chemotherapy and can be serious. This work confirms the importance of observational data in providing clinical practice-relevant information to decision-makers.	[Pearce, Alison; Haas, Marion; Viney, Rosalie; Haywood, Philip] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia; [Pearson, Sallie-Anne] Univ New South Wales, Med Policy Res Unit, Sydney, NSW, Australia; [Brown, Chris] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Ward, Robyn] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Ward, Robyn] Univ Queensland, Brisbane, Qld, Australia	University of Technology Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of Queensland	Pearce, A (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia.	Alson.pearce@chere.uts.edu.au	Brown, Chris/H-2797-2019; Haas, Marion Ruth/H-2732-2017; Pearce, Alison/AAC-3702-2019; Ward, Robyn/I-2313-2013	Brown, Chris/0000-0003-2506-4871; Pearce, Alison/0000-0002-5690-9542; Haywood, Philip/0000-0001-5031-8648; Viney, Rosalie/0000-0002-0039-9635; Ward, Robyn/0000-0002-6877-8906	National Health and Medical Research Council [455366]; University of Technology Sydney Doctoral Scholarship; NHMRC Health Services Research Grant [455366]; Cancer Institute NSW Career Development Fellowship [12/CDF/2-25]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Technology Sydney Doctoral Scholarship; NHMRC Health Services Research Grant(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Career Development Fellowship	The Elements of Cancer Care study was funded by the National Health and Medical Research Council (Health Services Research Grant ID 455366). AP was supported by a University of Technology Sydney Doctoral Scholarship, and a PhD top-up scholarship from NHMRC Health Services Research Grant (ID455366). SP is supported by a Cancer Institute NSW Career Development Fellowship (ID: 12/CDF/2-25). No funding organisation had any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Australian Bureau of Statistics, 2011, TABL 1 POST AR POA S; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Basch E, 2006, LANCET ONCOL, V7, P903, DOI 10.1016/S1470-2045(06)70910-X; Basch E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju244; Bent S, 2006, ANN INTERN MED, V144, P257, DOI 10.7326/0003-4819-144-4-200602210-00007; Bloechl-Daum B, 2006, J CLIN ONCOL, V24, P4472, DOI 10.1200/JCO.2006.05.6382; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; BONADONNA G, 1981, NEW ENGL J MED, V304, P10, DOI 10.1056/NEJM198101013040103; Cancer Institute NSW, EVIQ CANC TREATM ONL; Carelle N, 2002, CANCER-AM CANCER SOC, V95, P155, DOI 10.1002/cncr.10630; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; COATES A, 1983, EUR J CANCER CLIN ON, V19, P203, DOI 10.1016/0277-5379(83)90418-2; deBoerDennert M, 1997, BRIT J CANCER, V76, P1055, DOI 10.1038/bjc.1997.507; Di Maio M, 2015, J CLIN ONCOL, V33, P910, DOI 10.1200/JCO.2014.57.9334; Drummond MF, 1998, MED DECIS MAKING, V18, pS12, DOI 10.1177/0272989X98018002S03; Du X. L., 2002, J CLIN ONCOLOGY, V20; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; Fromme EK, 2004, J CLIN ONCOL, V22, P3485, DOI 10.1200/JCO.2004.03.025; Gallagher P, 2009, BEST PRACT RES CL GA, V23, P875, DOI 10.1016/j.bpg.2009.09.001; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Henry DH, 2008, SUPPORT CARE CANCER, V16, P791, DOI 10.1007/s00520-007-0380-2; Ihbe-Heffinger A, 2004, ANN ONCOL, V15, P526, DOI 10.1093/annonc/mdh110; Institute NC, 2010, COMMON TERMINOLOGY C; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; Kuo SH, 2008, BREAST, V17, P646, DOI 10.1016/j.breast.2008.05.006; Lopez-Jimenez J, 2006, HAEMATOLOGICA, V91, P84; OECD, 2005, HLTH TECHN DEC MAK; Pearce A, 2015, EXPERT REV PHARM OUT, V15, P215, DOI 10.1586/14737167.2015.990888; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Sanoff HK, 2012, CANCER-AM CANCER SOC, V118, P4309, DOI 10.1002/cncr.27422; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Ward RL, 2015, ASIA-PAC J CLIN ONCO, V11, P178, DOI 10.1111/ajco.12354; Wisnivesky JP, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4013; WOOD WC, 1994, NEW ENGL J MED, V330, P1253, DOI 10.1056/NEJM199405053301801	35	203	203	9	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184360	10.1371/journal.pone.0184360	http://dx.doi.org/10.1371/journal.pone.0184360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016607	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400007
J	Won, EJ; Choi, MJ; Shin, JH; Park, YJ; Byun, SA; Jung, JS; Kim, SH; Shin, MG; Suh, SP				Won, Eun Jeong; Choi, Min Ji; Shin, Jong Hee; Park, Yeon-Jun; Byun, Seung A.; Jung, Jee Seung; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon-Pal			Diversity of clinical isolates of Aspergillus terreus in antifungal susceptibilities, genotypes and virulence in Galleria mellonella model: Comparison between respiratory and ear isolates	PLOS ONE			English	Article							AMPHOTERICIN-B; MOLECULAR-IDENTIFICATION; DISSEMINATED INFECTION; OTOMYCOSIS; HOSPITALS; COMPLEX	We analyzed the antifungal susceptibility profiles, genotypes, and virulence of clinical Aspergillus terreus isolates from six university hospitals in South Korea. Thirty one isolates of A. terreus, comprising 15 respiratory and 16 ear isolates were assessed. Microsatellite genotyping was performed, and genetic similarity was assessed by calculating the Jaccard index. Virulence was evaluated by Galleria mellonella survival assay. All 31 isolates were susceptible to itraconazole, posaconazole, and voriconazole, while 23 (74.2%) and 6 (19.4%) showed amphotericin B (AMB) minimum inhibitory concentrations (MICs) of <= 1 mg/L and > 4 mg/L, respectively. Notably, respiratory isolates showed significantly higher geometric mean MICs than ear isolates to AMB (2.41 vs. 0.48 mg/L), itraconazole (0.40 vs. 0.19 mg/L), posaconazole (0.16 vs. 0.08 mg/L), and voriconazole (0.76 vs. 0.31 mg/L) (all, P < 0.05). Microsatellite genotyping separated the 31 isolates into 27 types, but the dendrogram demonstrated a closer genotypic relatedness among isolates from the same body site (ear or respiratory tract); in particular, the majority of ear isolates clustered together. Individual isolates varied markedly in their ability to kill infected G. mellonella after 72 h, but virulence did not show significant differences according to source (ear or respiratory tract), genotype, or antifungal susceptibility. The current study shows the marked diversity of clinical isolates of A. terreus in terms of antifungal susceptibilities, genotypes and virulence in the G. mellonella model, and ear isolates from Korean hospitals may have lower AMB or triazole MICs than respiratory isolates.	[Won, Eun Jeong; Choi, Min Ji; Shin, Jong Hee; Byun, Seung A.; Jung, Jee Seung; Kim, Soo Hyun; Shin, Myung Geun; Suh, Soon-Pal] Chonnam Natl Univ, Dept Lab Med, Med Sch, Gwangju, South Korea; [Park, Yeon-Jun] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul, South Korea	Chonnam National University; Catholic University of Korea	Shin, JH (corresponding author), Chonnam Natl Univ, Dept Lab Med, Med Sch, Gwangju, South Korea.	shinjh@chonnam.ac.kr	Won, Eun Jeong/AGX-7670-2022		Research of Korea Centers for Disease Control and Prevention [2015E4400100]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1A2B4008181, NRF-2016R1C1B1009746]	Research of Korea Centers for Disease Control and Prevention; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by a fund (2015E4400100) by Research of Korea Centers for Disease Control and Prevention to Jong Hee Shin and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2016R1A2B4008181 to Jong Hee Shin; NRF-2016R1C1B1009746 to Eun Jeong Won).	Al-Wathiqi F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-126; Alastruey-Izquierdo A, 2012, ANN NY ACAD SCI, V1273, P18, DOI 10.1111/j.1749-6632.2012.06822.x; Anaissie E, 1989, Infect Dis Clin North Am, V3, P867; Baddley JW, 2009, J CLIN MICROBIOL, V47, P3271, DOI 10.1128/JCM.00854-09; Baddley JW, 2003, J CLIN MICROBIOL, V41, P5525, DOI 10.1128/JCM.41.12.5525-5529.2003; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Blum G, 2008, CLIN MICROBIOL INFEC, V14, P1146, DOI 10.1111/j.1469-0691.2008.02099.x; Blum G, 2013, ANTIMICROB AGENTS CH, V57, P1583, DOI 10.1128/AAC.01283-12; Clinical Laboratory Standards Institute, 2008, REF METH BROTH DIL A; de Valk HA, 2008, MYCOSES, V51, P463, DOI 10.1111/j.1439-0507.2008.01538.x; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Escribano P, 2012, CLIN MICROBIOL INFEC, V18, pE24, DOI 10.1111/j.1469-0691.2011.03714.x; Espinel-Ingroff A, 2016, REV IBEROAM MICOL, V33, P63, DOI 10.1016/j.riam.2016.04.001; Gomez-Lopez A, 2003, ANTIMICROB AGENTS CH, V47, P3085, DOI 10.1128/AAC.47.10.3085-3088.2003; Heo MS, 2015, ANN LAB MED, V35, P602, DOI 10.3343/alm.2015.35.6.602; Ho HC, 2014, J LARYNGOL OTOL, V128, P547, DOI 10.1017/S0022215114001273; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kathuria S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118997; Kim MN, 2009, CLIN INFECT DIS, V48, pe57, DOI 10.1086/597108; Lackner M, 2016, CLIN MICROBIOL INFEC, V22, P270, DOI 10.1016/j.cmi.2015.10.021; LAHAM MN, 1982, AM REV RESPIR DIS, V125, P769; Lass-Florl C, 2005, BRIT J HAEMATOL, V131, P201, DOI 10.1111/j.1365-2141.2005.05763.x; Maurer E, 2015, VIRULENCE, V6, P603, DOI 10.1080/21505594.2015.1045183; Neal COS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-203; Paulussen C, 2017, MICROB BIOTECHNOL, V10, P296, DOI 10.1111/1751-7915.12367; Rougeron A, 2014, CLIN MICROBIOL INFEC, V20, P327, DOI 10.1111/1469-0691.12323; Speth C, 2013, MED MICROBIOL IMMUN, V202, P379, DOI 10.1007/s00430-013-0300-7; Tortorano AM, 2008, J CHEMOTHERAPY, V20, P756, DOI 10.1179/joc.2008.20.6.756; TRACY SL, 1983, AM J CLIN PATHOL, V80, P728, DOI 10.1093/ajcp/80.5.728; TRITZ DM, 1993, CLIN INFECT DIS, V16, P118, DOI 10.1093/clinids/16.1.118; Vennewald I, 2010, CLIN DERMATOL, V28, P202, DOI 10.1016/j.clindermatol.2009.12.003; Vesper SJ, 2007, J WATER HEALTH, V5, P427, DOI 10.2166/wh.2007.038; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210	33	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186086	10.1371/journal.pone.0186086	http://dx.doi.org/10.1371/journal.pone.0186086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016668	Green Submitted, gold, Green Published			2022-12-27	WOS:000412601800037
J	He, RY; Yang, KJ; Li, ZJ; Schadler, M; Yang, WQ; Wu, FZ; Tan, B; Zhang, L; Xu, ZF				He, Ruoyang; Yang, Kaijun; Li, Zhijie; Schaedler, Martin; Yang, Wanqin; Wu, Fuzhong; Tan, Bo; Zhang, Li; Xu, Zhenfeng			Effects of forest conversion on soil microbial communities depend on soil layer on the eastern Tibetan Plateau of China	PLOS ONE			English	Article							GROSS NITROGEN TRANSFORMATIONS; SUB-ALPINE FORESTS; NATURAL FOREST; SUBTROPICAL AUSTRALIA; BACTERIAL COMMUNITY; PINUS-SYLVESTRIS; WESTERN SICHUAN; BETULA-PENDULA; CARBON STOCK; MINERAL SOIL	Forest land-use changes have long been suggested to profoundly affect soil microbial communities. However, how forest type conversion influences soil microbial properties remains unclear in Tibetan boreal forests. The aim of this study was to explore variations of soil microbial profiles in the surface organic layer and subsurface mineral soil among three contrasting forests (natural coniferous forest, NF; secondary birch forest, SF and spruce plantation, PT). Soil microbial biomass, activity and community structure of the two layers were investigated by chloroform fumigation, substrate respiration and phospholipid fatty acid analysis (PLFA), respectively. In the organic layer, both NF and SF exhibited higher soil nutrient levels (carbon, nitrogen and phosphorus), microbial biomass carbon and nitrogen, microbial respiration, PLFA contents as compared to PT. However, the measured parameters in the mineral soils often did not differ following forest type conversion. Irrespective of forest types, the microbial indexes generally were greater in the organic layer than in the mineral soil. PLFAs biomarkers were significantly correlated with soil substrate pools. Taken together, forest land-use change remarkably altered microbial community in the organic layer but often did not affect them in the mineral soil. The microbial responses to forest land-use change depend on soil layer, with organic horizons being more sensitive to forest conversion.	[He, Ruoyang; Yang, Kaijun; Li, Zhijie; Yang, Wanqin; Wu, Fuzhong; Zhang, Li; Xu, Zhenfeng] Sichuan Agr Univ, Inst Ecol & Forest, Chengdu, Sichuan, Peoples R China; [Schaedler, Martin] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Tan, Bo] Sichuan Agr Univ, Coll Forestry, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Sichuan Agricultural University	Xu, ZF (corresponding author), Sichuan Agr Univ, Inst Ecol & Forest, Chengdu, Sichuan, Peoples R China.	xuzf@sicau.edu.cn	Schädler, Martin/H-3176-2011; Li, Zhijie/AAJ-7247-2020; 杨, 开军/AAQ-6563-2021	Schädler, Martin/0000-0001-9700-0311; 杨, 开军/0000-0003-0085-9395	National Key Research and Development Program of China [2016YFC0502505-03]; Natural Science Foundation of China [31570601, 31570445, 31500509]; China Postdoctoral Science Foundation Special Financial Grant [2014T70880]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation Special Financial Grant(China Postdoctoral Science Foundation)	This research was financially supported by the National Key Research and Development Program of China (no. 2016YFC0502505-03) and the Natural Science Foundation of China (no. 31570601, 31570445, 31500509) and China Postdoctoral Science Foundation Special Financial Grant (no. 2014T70880).	Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P1385, DOI 10.1016/S0038-0717(02)00070-6; Burton J, 2007, SOIL BIOL BIOCHEM, V39, P426, DOI 10.1016/j.soilbio.2006.08.011; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Chen FL, 2013, FOREST ECOL MANAG, V291, P65, DOI 10.1016/j.foreco.2012.11.016; Denef K, 2009, SOIL BIOL BIOCHEM, V41, P144, DOI 10.1016/j.soilbio.2008.10.008; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Gleixner G, 2005, ECOL STUD-ANAL SYNTH, V176, P165; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Han Shi-zhong, 2015, Yingyong Shengtai Xuebao, V26, P2151; Hu Jianli, 2009, Chinese Journal of Applied and Environmental Biology, V15, P313, DOI 10.3724/SP.J.1145.2009.00313; Huang ZQ, 2013, SOIL BIOL BIOCHEM, V62, P68, DOI 10.1016/j.soilbio.2013.03.008; IUSS, 2006, WORLD SOIL RESOURCES; Koranda M, 2013, SOIL BIOL BIOCHEM, V60, P95, DOI 10.1016/j.soilbio.2013.01.025; Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4; Li H, 2014, PLANT SOIL, V383, P203, DOI 10.1007/s11104-014-2165-y; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Liu Q, 2001, WORLD SCIENTIF TECHN, V2, P63, DOI [10.16507/j.issn.1006-6055.2001.02.024, DOI 10.16507/J.ISSN.1006-6055.2001.02.024]; [庞学勇 Pang Xueyong], 2002, [应用与环境生物学报, Chinese journal of applied and environmental biology], V8, P1; Priha O, 2001, BIOL FERT SOILS, V33, P17, DOI 10.1007/s003740000281; Priha O, 1999, FEMS MICROBIOL ECOL, V30, P187, DOI 10.1111/j.1574-6941.1999.tb00647.x; Romaniuk R, 2011, SOIL RES, V49, P733, DOI 10.1071/SR11147; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Tang Shi-shan, 2015, Yingyong Shengtai Xuebao, V26, P363; Tornberg K, 2003, BIOL FERT SOILS, V37, P190, DOI 10.1007/s00374-002-0574-1; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Ushio M, 2013, PLANT SOIL, V365, P157, DOI 10.1007/s11104-012-1365-6; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; White DC, 1996, J IND MICROBIOL, V17, P185, DOI 10.1007/BF01574692; Wu N, 1998, CHINESE J APPL ENV B, V4, P290; [邢韶华 XING Shaohua], 2010, [山地学报, Journal of Mountain Science], V28, P218; Xu WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06512; Xu ZF, 2010, APPL SOIL ECOL, V46, P291, DOI 10.1016/j.apsoil.2010.07.005; Xu ZF, 2015, GEODERMA, V239, P223, DOI 10.1016/j.geoderma.2014.10.018; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Xu ZH, 2008, J SOIL SEDIMENT, V8, P99, DOI 10.1065/jss2008.02.276; Yang K, 2013, PLANT SOIL, V368, P535, DOI 10.1007/s11104-012-1535-6; [Yang Wanqin 杨万勤], 2007, [生态学报, Acta Ecologica Sinica], V27, P4157; Yin K, 2016, SCI REP-UK, V6, DOI 10.1038/srep27066; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang YD, 2013, FOREST ECOL MANAG, V300, P88, DOI 10.1016/j.foreco.2012.06.010; Zhang ZH, 2017, ENVIRONMENTAL DATA ANALYSIS: METHODS AND APPLICATIONS, P1, DOI 10.1515/9783110424904-002; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	45	8	10	6	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186053	10.1371/journal.pone.0186053	http://dx.doi.org/10.1371/journal.pone.0186053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982191	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300116
J	Wu, BY; Sheng, XQ; Hao, Y				Wu, Bi-Yi; Sheng, Xin-Qing; Hao, Yang			Effective media properties of hyperuniform disordered composite materials	PLOS ONE			English	Article							FINITE-ELEMENT-METHOD; EFFECTIVE PERMITTIVITY; MIXTURES	The design challenge of new functional composite materials consisting of multiphase materials has attracted an increasing interest in recent years. In particular, understanding the role of distributions of ordered and disordered particles in a host media is scientifically and technologically important for designing novel materials and devices with superior spectral and angular properties. In this work, the effective medium property of disordered composite materials consisting of hyperuniformly distributed hard particles at different filling fractions is investigated. To accurately extract effective permittivity of a disordered composite material, a full-wave finite element method and the transmission line theory are used. Numerical results show that the theory of hyperuniformity can be conveniently used to design disordered composite materials with good accuracy compared with those materials with randomly dispersed particles. Furthermore, we demonstrate that a Luneburg lens based on the proposed hyperuniform media has superior radiation properties in comparison with previously reported metamaterial designs and it may open up a new avenue in electromagnetic materials-by-design.	[Wu, Bi-Yi; Hao, Yang] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England; [Wu, Bi-Yi; Sheng, Xin-Qing] Beijing Inst Technol, Sch Informat & Elect Engn, Ctr Electromgnet Simulat, Beijing, Peoples R China	University of London; Queen Mary University London; Beijing Institute of Technology	Hao, Y (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England.	y.hao@qmul.ac.uk	Hao, Yang/ABD-5658-2021; Hao, Yang/AAW-2220-2020	Hao, Yang/0000-0002-9949-7226	China Scholarship Council [201406030051]; Royal Society; EPSRC [EP/I034548/1]; Engineering and Physical Sciences Research Council [EP/I034548/1, EP/P005578/1, EP/N010493/1, 1589887] Funding Source: researchfish; EPSRC [EP/N010493/1, EP/P005578/1] Funding Source: UKRI	China Scholarship Council(China Scholarship Council); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	BW thanks the China Scholarship Council (No. 201406030051) during his visit to Queen Mary University of London, where this work was undertaken. YH would like to thank the Royal Society for the Wolfson Research Merit Award, the IET for AF Harvey Research Prize and the EPSRC for the QUEST Programme Grant (EP/I034548/1).; BW thanks for the China Scholarship Council (No.201406030051) during his visit to Queen Mary University of London, where this work was undertaken. YH would like to thank the Royal Society for the Wolfson Research Merit Award, the IET for AF Harvey Research Prize and the EPSRC for the QUEST Programme Grant (EP/I034548/1).	BAKERJARVIS J, 1990, IEEE T MICROW THEORY, V38, P1096, DOI 10.1109/22.57336; Bao D, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103023; BERNARD PA, 1991, IEEE T MICROW THEORY, V39, P592, DOI 10.1109/22.75310; Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636, DOI 10.1002/andp.19354160705; Cai W, 2010, OPTICAL METAMATERIALS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-1151-3; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Demetriadou A, 2011, OPT EXPRESS, V19, P19925, DOI 10.1364/OE.19.019925; Dyachenko PN, 2012, OPT LETT, V37, P2178, DOI 10.1364/OL.37.002178; Garnett JCM, 1904, PHILOS T R SOC LOND, V203, P385, DOI 10.1098/rsta.1904.0024; Hakki B.W., 1960, IRE T MICROW THEORY, V8, P402, DOI DOI 10.1109/TMTT.1960.1124749; Hao Y., 2008, FDTD MODELING METAMA; Karkkainen KK, 2000, IEEE T GEOSCI REMOTE, V38, P1303, DOI 10.1109/36.843023; Koledintseva MY, 2009, IEEE T DIELECT EL IN, V16, P793, DOI 10.1109/TDEI.2009.5128520; Lichtenecker K, 1931, PHYS Z, V32, P255; Malasi A, 2014, J OPTICS-UK, V16, DOI 10.1088/2040-8978/16/6/065001; Man WN, 2013, P NATL ACAD SCI USA, V110, P15886, DOI 10.1073/pnas.1307879110; Man WN, 2013, OPT EXPRESS, V21, P19972, DOI 10.1364/OE.21.019972; Myroshnychenko V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016701; Quevedo-Teruel O, 2013, SCI REP-UK, V3, DOI 10.1038/srep01903; Redding B, 2013, NAT PHOTONICS, V7, P746, DOI [10.1038/nphoton.2013.190, 10.1038/NPHOTON.2013.190]; Skoge M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041127; Torquato S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041113; Torquato S, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021020; Torquato S., 2013, RANDOM HETEROGENEOUS, V16; Tuncer E, 2001, J APPL PHYS, V89, P8092, DOI 10.1063/1.1372363; Uche OU, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031104; Uche OU, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046122; Volkov SN, 2012, J MOD OPTIC, V59, P954, DOI 10.1080/09500340.2012.685187; Vynck K, 2012, NAT MATER, V11, P1017, DOI [10.1038/nmat3442, 10.1038/NMAT3442]; Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/NPHOTON.2013.29, 10.1038/nphoton.2013.29]; Wu DG, 2007, J APPL PHYS, V102, DOI 10.1063/1.2756089; Zhou W, 2017, IEEE J SEL TOP QUANT, V23, DOI 10.1109/JSTQE.2016.2528125	32	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185921	10.1371/journal.pone.0185921	http://dx.doi.org/10.1371/journal.pone.0185921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982118	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300087
J	Li, CW; Ai, DH				Li, Chengwu; Ai, Dihao			Automatic crack detection method for loaded coal in vibration failure process	PLOS ONE			English	Article							SEGMENTATION; INSPECTION	In the coal mining process, the destabilization of loaded coal mass is a prerequisite for coal and rock dynamic disaster, and surface cracks of the coal and rock mass are important indicators, reflecting the current state of the coal body. The detection of surface cracks in the coal body plays an important role in coal mine safety monitoring. In this paper, a method for detecting the surface cracks of loaded coal by a vibration failure process is proposed based on the characteristics of the surface cracks of coal and support vector machine (SVM). A large number of cracked images are obtained by establishing a vibration-induced failure test system and industrial camera. Histogram equalization and a hysteresis threshold algorithm were used to reduce the noise and emphasize the crack; then, 600 images and regions, including cracks and non-cracks, were manually labelled. In the crack feature extraction stage, eight features of the cracks are extracted to distinguish cracks from other objects. Finally, a crack identification model with an accuracy over 95% was trained by inputting the labelled sample images into the SVM classifier. The experimental results show that the proposed algorithm has a higher accuracy than the conventional algorithm and can effectively identify cracks on the surface of the coal and rock mass automatically.	[Li, Chengwu; Ai, Dihao] China Univ Min & Technol, Fac Resources & Safety Engn, Beijing, Peoples R China	China University of Mining & Technology	Ai, DH (corresponding author), China Univ Min & Technol, Fac Resources & Safety Engn, Beijing, Peoples R China.	aixi1020@163.com			National Natural Science Foundation of China [51274206, 51404277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (51274206, 51404277). This support is greatly acknowledged and appreciated.	Abdel-Qader I, 2006, ADV ENG SOFTW, V37, P771, DOI 10.1016/j.advengsoft.2006.06.002; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cao S, 2015, J ROCK MECH ENG, V34, P3074; Chen S., 2010, METAL MINE, V11, P43; [陈新 Chen Xin], 2014, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V33, P1149; Cho HW, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16101646; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Hall MA, 1999, CORRELATION BASED FE, V19; Iyer S, 2005, IMAGE VISION COMPUT, V23, P921, DOI 10.1016/j.imavis.2005.05.017; Jiang Feng, 2017, Journal of Software, V28, P160, DOI 10.13328/j.cnki.jos.005136; [李德建 Li Dejian], 2014, [煤炭学报, Journal of China Coal Society], V39, P307; Li G, 2014, AUTOMAT CONSTR, V41, P83, DOI 10.1016/j.autcon.2013.10.021; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Nashat S, 2014, J FOOD ENG, V120, P233, DOI 10.1016/j.jfoodeng.2013.08.006; [彭守建 Peng Shoujian], 2015, [煤炭学报, Journal of China Coal Society], V40, P801; Scholkopf B., 1999, ADV KERNEL METHODS S; Senliol B, 2008, 23RD INTERNATIONAL SYMPOSIUM ON COMPUTER AND INFORMATION SCIENCES, P500; Sinha SK, 2006, AUTOMAT CONSTR, V15, P47, DOI 10.1016/j.autcon.2005.02.007; Sinha SK, 2006, AUTOMAT CONSTR, V15, P58, DOI 10.1016/j.autcon.2005.02.006; Sun H, 2016, INT J NUMER METH ENG, V105, P1014, DOI 10.1002/nme.5006; Sun H, 2014, INT J NUMER METH ENG, V100, P477, DOI 10.1002/nme.4741; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Talab AMA, 2016, OPTIK, V127, P1030, DOI 10.1016/j.ijleo.2015.09.147; Vapnik VN, STAT LEARNING THEORY, V1; XU Jiang, 2013, CHINESE J ROCK MECH, V32, P33; Zhang WY, 2014, SENSORS-BASEL, V14, P19307, DOI 10.3390/s141019307	26	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185750	10.1371/journal.pone.0185750	http://dx.doi.org/10.1371/journal.pone.0185750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973032	Green Submitted, gold, Green Published			2022-12-27	WOS:000412131900045
J	Song, SB; Bokkers, RPH; Luby, M; Edwardson, MA; Brown, T; Shah, S; Cox, RW; Saad, ZS; Reynolds, RC; Glen, DR; Cohen, LG; Latour, LL				Song, Sunbin; Bokkers, Reinoud P. H.; Luby, Marie; Edwardson, Matthew A.; Brown, Tyler; Shah, Shreyansh; Cox, Robert W.; Saad, Ziad S.; Reynolds, Richard C.; Glen, Daniel R.; Cohen, Leonardo G.; Latour, Lawrence L.			Temporal similarity perfusion mapping: A standardized and model-free method for detecting perfusion deficits in stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; INFARCT GROWTH; DCE-MRI; DIFFUSION; CT; PENUMBRA; TIME; SEGMENTATION; ASSOCIATION	Introduction Interpretation of the extent of perfusion deficits in stroke MRI is highly dependent on the method used for analyzing the perfusion-weighted signal intensity time-series after gadolinium injection. In this study, we introduce a new model-free standardized method of temporal similarity perfusion (TSP) mapping for perfusion deficit detection and test its ability and reliability in acute ischemia. Materials and methods Forty patients with an ischemic stroke or transient ischemic attack were included. Two blinded readers compared real-time generated interactive maps and automatically generated TSP maps to traditional TTP/MTT maps for presence of perfusion deficits. Lesion volumes were compared for volumetric inter-rater reliability, spatial concordance between perfusion deficits and healthy tissue and contrast-to-noise ratio (CNR). Results Perfusion deficits were correctly detected in all patients with acute ischemia. Inter-rater reliability was higher for TSP when compared to TTP/MTT maps and there was a high similarity between the lesion volumes depicted on TSP and TTP/MTT (r(18) = 0.73). The Pearson's correlation between lesions calculated on TSP and traditional maps was high (r(18) = 0.73, p< 0.0003), however the effective CNR was greater for TSP compared to TTP (352.3 vs 283.5, t(19) = 2.6, p< 0.03.) and MTT (228.3, t(19) = 2.8, p< 0.03). Discussion TSP maps provide a reliable and robust model-free method for accurate perfusion deficit detection and improve lesion delineation compared to traditional methods. This simple method is also computationally faster and more easily automated than model-based methods. This method can potentially improve the speed and accuracy in perfusion deficit detection for acute stroke treatment and clinical trial inclusion decision-making.	[Song, Sunbin; Cohen, Leonardo G.] NINDS, NIH, Human Cort Physiol & Neurorehabil Sect, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands; [Luby, Marie; Edwardson, Matthew A.; Brown, Tyler; Shah, Shreyansh; Latour, Lawrence L.] NINDS, NIH, Stroke Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cox, Robert W.; Saad, Ziad S.; Reynolds, Richard C.; Glen, Daniel R.] NIMH, NIH, Sci & Stat Comp Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Groningen; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bokkers, RPH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands.	r.p.h.bokkers@umcg.nl	Latour, Larry/AAH-5663-2021; Bokkers, Reinoud P H/ABD-2928-2020; Luby, Marie/AEX-9494-2022; Glen, Daniel/HCG-8456-2022	Latour, Larry/0000-0001-6160-5263; Bokkers, Reinoud P H/0000-0001-6130-7311; Shah, Shreyansh/0000-0001-8441-6326; Glen, Daniel/0000-0001-8456-5647; Edwardson, Matthew/0000-0002-0327-5531; Cox, Robert/0000-0002-0031-1568	Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health; Dutch Heart Foundation [2013T047]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003030, ZIANS003043, ZICNS003044] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health; Dutch Heart Foundation(Netherlands Heart Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. R.P.H. Bokkers receives support from the Dutch Heart Foundation (Grant 2013T047).	Barber PA, 1999, STROKE, V30, P2059, DOI 10.1161/01.STR.30.10.2059; Bivard A, 2013, RADIOLOGY, V267, P543, DOI 10.1148/radiol.12120971; Calamante F, 2006, MAGN RESON MED, V55, P1180, DOI 10.1002/mrm.20873; Copen WA, 2011, NEUROIMAG CLIN N AM, V21, P259, DOI 10.1016/j.nic.2011.02.007; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ferreira RM, 2010, AM J ROENTGENOL, V194, P1330, DOI 10.2214/AJR.09.2845; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Fransen PSS, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-343; Grandin CB, 2002, RADIOLOGY, V223, P361, DOI 10.1148/radiol.2232010673; Haacke EM, 2013, MAGN RESON IMAGING, V31, P481, DOI 10.1016/j.mri.2012.10.005; Ingrisch M, 2014, INVEST RADIOL, V49, P382, DOI 10.1097/RLI.0000000000000020; Karonen JO, 1999, STROKE, V30, P1583, DOI 10.1161/01.STR.30.8.1583; Kidwell CS, 2013, STROKE, V44, P73, DOI 10.1161/STROKEAHA.112.670034; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Li S, 2012, COMPUT MED IMAG GRAP, V36, P108, DOI 10.1016/j.compmedimag.2011.06.005; Neumann-Haefelin T, 1999, STROKE, V30, P1591, DOI 10.1161/01.STR.30.8.1591; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Schellinger PD, 2006, NEURORADIOLOGY, V48, P69, DOI 10.1007/s00234-005-0012-9; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Warach S, 1996, J CEREBR BLOOD F MET, V16, P53, DOI 10.1097/00004647-199601000-00006; Wismuller A, 2006, IEEE T MED IMAGING, V25, P62, DOI 10.1109/TMI.2005.861002; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; Zollner FG, 2015, MAGN RESON IMAGING, V33, P1345, DOI 10.1016/j.mri.2015.08.003	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185552	10.1371/journal.pone.0185552	http://dx.doi.org/10.1371/journal.pone.0185552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973000	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900024
J	Wang, GF; Zhang, PY; Liang, LW; Zhang, SQ				Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang			Evaluation of precipitation from CMORPH, GPCP-2, TRMM 3B43, GPCC, and ITPCAS with ground-based measurements in the QinlingDaba Mountains, China	PLOS ONE			English	Article							MEASURING MISSION TRMM; CLIMATOLOGY PROJECT; TEMPORAL RESOLUTION; PRODUCTS; VALIDATION; REGION; PERFORMANCE; DATASET; ASIA	The correspondence between five precipitation products, including CMORPH, GPCP-2, TRMM 3B43, GPCC, and ITPCAS, and ground-based measurements of precipitation were evaluated on annual, seasonal, and monthly scales during 2000-2014 in the Qinling-Daba Mountains over China, which is a significant area with vital value of climate and hydrology. Performances of the precipitation products in the relatively arid/humid years were also analyzed. In general, ITPCAS data displayed the highest accuracy, GPCP-2 and CMORPH data showed relatively poor performance, and GPCC and TRMM 3B43 data were average at different temporal scales among the five precipitation products. The Pearson correlation coefficient of each station had minor fluctuations for the five precipitation products. A larger deviation was found at Wudu station, most likely due to the undulating terrain. The performances of the precipitation products from highest to least accuracy are as follows: ITPCAS > TRMM 3B43 > GPCC > GPCP-2 > CMORPH. Except for CMORPH (-20.76%), the percentage precipitation differences (PPDs) of the other four precipitation products fluctuated in the range of 10% during the relatively arid (2001) and humid (2011) years. In addition, all precipitation products and ground gauge observed precipitation did not show an obvious gradient with altitude, which is different from that in other mountainous areas and is perhaps due to complex terrain, lack of observation in high altitudes, and precipitation undercatch. In consideration of the significance of Qinling-Daba Mountains as the geographic and ecological dividing lines, the present study may provide a new perspective for hydrological, climatic, and ecological researches and practices in local and other mountainous areas.	[Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang] Northwest Univ, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Shaanxi, Peoples R China; [Wang, Gefei; Zhang, Peiyun; Liang, Liwen; Zhang, Shiqiang] Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China	Northwest University Xi'an; Northwest University Xi'an	Zhang, SQ (corresponding author), Northwest Univ, Shaanxi Key Lab Earth Surface Syst & Environm Car, Xian, Shaanxi, Peoples R China.; Zhang, SQ (corresponding author), Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi, Peoples R China.	zhangsq@nwu.edu.cn		Zhang, Shiqiang/0000-0003-3407-6356	National Nature Science Foundation of China	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China, http://www. nsfc.gov.cn.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Almazroui M, 2011, ATMOS RES, V99, P400, DOI 10.1016/j.atmosres.2010.11.006; ARKIN PA, 1994, B AM METEOROL SOC, V75, P401, DOI 10.1175/1520-0477(1994)075<0401:TGPCPF>2.0.CO;2; Bai H., 2014, RESPONSE FOREST VEGE; [白红英 Bai Hongying], 2012, [地理学报, Acta Geographica Sinica], V67, P1443; Blacutt LA, 2015, ATMOS RES, V163, P117, DOI 10.1016/j.atmosres.2015.02.002; Chen GX, 2014, J CLIMATE, V27, P5517, DOI 10.1175/JCLI-D-14-00005.1; Chen M., 1983, CLIMATE ALGRICULTURE; Chen YY, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015921; Condom T, 2011, HYDROL PROCESS, V25, P1924, DOI 10.1002/hyp.7949; Dai Y, 2016, QUATERN INT, P1; Darand M, 2017, ATMOS RES, V190, P121, DOI 10.1016/j.atmosres.2017.02.011; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Feidas H, 2010, THEOR APPL CLIMATOL, V99, P193, DOI 10.1007/s00704-009-0135-8; Guo DL, 2013, J GEOPHYS RES-ATMOS, V118, P5216, DOI 10.1002/jgrd.50457; Guo H, 2015, REMOTE SENS-BASEL, V7, P7181, DOI 10.3390/rs70607181; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hu QF, 2014, INT J REMOTE SENS, V35, P1272, DOI 10.1080/01431161.2013.876118; [胡增运 Hu Zengyun], 2013, [干旱区地理, Arid Land Geography], V36, P700; Huang C, 2014, GUANGDONG METEOROLOG, V36, P19; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; Janjai S, 2015, PHYS GEOGR, V36, P282, DOI 10.1080/02723646.2015.1045286; Janowiak JE, 1998, J CLIMATE, V11, P2960, DOI 10.1175/1520-0442(1998)011<2960:ACOTNN>2.0.CO;2; Jiang SH, 2012, J HYDROL, V452, P213, DOI 10.1016/j.jhydrol.2012.05.055; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; [阚宝云 Kan Baoyun], 2013, [冰川冻土, Journal of Glaciology and Geocryology], V35, P710; Karaseva MO, 2012, THEOR APPL CLIMATOL, V108, P147, DOI 10.1007/s00704-011-0509-6; Kidd C, 2011, HYDROL EARTH SYST SC, V15, P1109, DOI 10.5194/hess-15-1109-2011; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Kummerow C, 2000, J APPL METEOROL, V39, P1965, DOI 10.1175/1520-0450(2001)040<1965:TSOTTR>2.0.CO;2; Leng GY, 2015, REG ENVIRON CHANGE, V15, P251, DOI 10.1007/s10113-014-0640-x; Liechti TC, 2012, HYDROL EARTH SYST SC, V16, P489, DOI 10.5194/hess-16-489-2012; [刘俊峰 LIU Junfeng], 2011, [水科学进展, Advances in Water Science], V22, P447; [刘宪锋 Liu Xianfeng], 2015, [地理学报, Acta Geographica Sinica], V70, P705; Lu ZhongYan, 2006, Journal of Nanjing Institute of Meteorology, V29, P408; Ma LJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011178; Mantas VM, 2015, ATMOS RES, V163, P132, DOI 10.1016/j.atmosres.2014.11.012; Michaelides S, 2009, ATMOS RES, V94, P512, DOI 10.1016/j.atmosres.2009.08.017; New M, 2001, INT J CLIMATOL, V21, P1899, DOI 10.1002/joc.680; Pan XD, 2014, J HYDROMETEOROL, V15, P1560, DOI 10.1175/JHM-D-13-0202.1; Pombo S, 2015, METEOROL APPL, V22, P395, DOI 10.1002/met.1467; Romilly TG, 2011, HYDROL EARTH SYST SC, V15, P1505, DOI 10.5194/hess-15-1505-2011; Sapiano MRP, 2009, J HYDROMETEOROL, V10, P149, DOI 10.1175/2008JHM1052.1; Scheel MLM, 2011, HYDROL EARTH SYST SC, V15, P2649, DOI 10.5194/hess-15-2649-2011; Schneider U., 2020, GPCC MONITORING PROD, DOI [10.5676/DWD_GPCC/MP_M_V2020_100, DOI 10.5676/DWD_GPCC/MP_M_V2020_100]; Schneider U, 2014, THEOR APPL CLIMATOL, V115, P15, DOI 10.1007/s00704-013-0860-x; Shen Y, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012097; Sun AJ, 1989, GEOGRAPH RES, V8, P32; [孙葭 Sun Jia], 2015, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V24, P1850; Tang M., 1985, ACTA GEOGRAPHICA SIN, V40, P323; Yamamoto MK, 2011, J METEOROL SOC JPN, V89, P597, DOI 10.2151/jmsj.2011-601; Yang D., 1988, J GLACIOL GEOCRYOL, V10, P384; Yang D, 1989, METEOROLOGICAL MONTH, V15, P22; Yang D., 1987, METEOROL MON, V13, P16; Yue LW, 2017, ISPRS J PHOTOGRAMM, V123, P20, DOI 10.1016/j.isprsjprs.2016.11.002; Yue TX, 2007, GEOMORPHOLOGY, V91, P161, DOI 10.1016/j.geomorph.2007.02.006; Zeweldi DA, 2009, J HYDROMETEOROL, V10, P300, DOI 10.1175/2008JHM1041.1; [赵天保 ZHAO TianBao], 2006, [气候与环境研究, Climatic and environmental research], V11, P14; [周旗 ZHOU Qi], 2011, [地理学报, Acta Geographica Sinica], V66, P1211; [朱智 Zhu Zhi], 2015, [冰川冻土, Journal of Glaciology and Geocryology], V37, P614	60	24	25	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185147	10.1371/journal.pone.0185147	http://dx.doi.org/10.1371/journal.pone.0185147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968442	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600014
J	Mastrolorenzo, G; Palladino, DM; Pappalardo, L; Rossano, S				Mastrolorenzo, Giuseppe; Palladino, Danilo M.; Pappalardo, Lucia; Rossano, Sergio			Probabilistic-numerical assessment of pyroclastic current hazard at Campi Flegrei and Naples city: Multi-VEI scenarios as a tool for "full-scale" risk management	PLOS ONE			English	Article							NEAPOLITAN-YELLOW-TUFF; CAMPANIAN IGNIMBRITE ERUPTION; MULTISOURCE VOLCANIC AREA; PHLEGRAEAN FIELDS; DENSITY CURRENTS; MAGMATIC SYSTEM; GRAIN-SIZE; CALDERA; DEPOSITS; FLOW	The Campi Flegrei volcanic field (Italy) poses very high risk to the highly urbanized Neapolitan area. Eruptive history was dominated by explosive activity producing pyroclastic currents (hereon PCs; acronym for Pyroclastic Currents) ranging in scale from localized base surges to regional flows. Here we apply probabilistic numerical simulation approaches to produce PC hazard maps, based on a comprehensive spectrum of flow properties and vent locations. These maps are incorporated in a Geographic Information System (GIS) and provide all probable Volcanic Explosivity Index (VEI) scenarios from different source vents in the caldera, relevant for risk management planning. For each VEI scenario, we report the conditional probability for PCs (i.e., the probability for a given area to be affected by the passage of PCs in case of a PC-forming explosive event) and related dynamic pressure. Model results indicate that PCs from VEI<4 events would be confined within the Campi Flegrei caldera, PC propagation being impeded by the northern and eastern caldera walls. Conversely, PCs from VEI 4-5 events could invade a wide area beyond the northern caldera rim, as well as part of the Naples metropolitan area to the east. A major controlling factor of PC dispersal is represented by the location of the vent area. PCs from the potentially largest eruption scenarios (analogous to the similar to 15 ka, VEI 6 Neapolitan Yellow Tuff or even the similar to 39 ka, VEI 7 Campanian Ignimbrite extreme event) would affect a large part of the Campanian Plain to the north and the city of Naples to the east. Thus, in case of renewal of eruptive activity at Campi Flegrei, up to 3 million people will be potentially exposed to volcanic hazard, pointing out the urgency of an emergency plan. Considering the present level of uncertainty in forecasting the future eruption type, size and location (essentially based on statistical analysis of previous activity), we suggest that appropriate planning measures should face at least the VEI 5 reference scenario (at least 2 occurrences documented in the last 10 ka).	[Mastrolorenzo, Giuseppe; Pappalardo, Lucia] Ist Nazl Geofis & Vulcanol, Osservatorio Vesuviano, Sez Napoli, Naples, Italy; [Palladino, Danilo M.] Sapienza Univ Roma, Dipartimento Sci Terra, Rome, Italy; [Rossano, Sergio] Univ Federico II, Ric Dinam Interna Sistemi Vulcan & Rischi Idrogeo, Naples, Italy	Istituto Nazionale Geofisica e Vulcanologia (INGV); Sapienza University Rome; University of Naples Federico II	Pappalardo, L (corresponding author), Ist Nazl Geofis & Vulcanol, Osservatorio Vesuviano, Sez Napoli, Naples, Italy.	lucia.pappalardo@ingv.it						Acocella V, 2015, REV GEOPHYS, V53, P896, DOI 10.1002/2015RG000492; Alberico I, 2011, NAT HAZARD EARTH SYS, V11, P1057, DOI 10.5194/nhess-11-1057-2011; [Anonymous], 1986, B VOLCANOL; Arienzo I, 2010, CHEM GEOL, V270, P135, DOI 10.1016/j.chemgeo.2009.11.012; BARBERI F, 1991, J VOLCANOL GEOTH RES, V48, P33, DOI 10.1016/0377-0273(91)90031-T; Baxter PJ, 2005, B VOLCANOL, V67, P292, DOI 10.1007/s00445-004-0365-7; BEGET JE, 1989, J VOLCANOL GEOTH RES, V39, P349, DOI 10.1016/0377-0273(89)90098-X; BEGET JE, 1988, B VOLCANOL, V50, P148, DOI 10.1007/BF01079679; Bevilacqua A, 2015, J GEOPHYS RES-SOL EA, V120, P2309, DOI 10.1002/2014JB011775; Bobrowsky P., 1985, ENCY NATURAL HAZARDS; BRISSETTE FP, 1990, B VOLCANOL, V53, P60, DOI 10.1007/BF00680320; Bursik MI, 1996, B VOLCANOL, V58, P175, DOI 10.1007/s004450050134; Calderas Lipman P., 2000, ENCY VOLCANOES, P643; Cannatelli C, 2012, MINER PETROL, V104, P29, DOI 10.1007/s00710-011-0182-6; Cashman KV, 2014, J VOLCANOL GEOTH RES, V288, P28, DOI 10.1016/j.jvolgeores.2014.09.007; Chiodini G, 2016, NATURE COMMUNICATION; Chiodini G, 2015, GEOLOGY, V43, P767, DOI 10.1130/G36905.1; Chiodini G, 2012, GEOLOGY, V40, P943, DOI 10.1130/G33251.1; Cioni R, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000642; Costa A, 2009, B VOLCANOL, V71, P259, DOI 10.1007/s00445-008-0220-3; D'Antonio M, 1999, J VOLCANOL GEOTH RES, V91, P247, DOI 10.1016/S0377-0273(99)00038-4; D'Auria L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13100; De Natale G, 2006, GEOL SOC SPEC PUBL, V269, P25, DOI 10.1144/GSL.SP.2006.269.01.03; de Vita S, 1999, J VOLCANOL GEOTH RES, V91, P269, DOI 10.1016/S0377-0273(99)00039-6; De Vivo B, 2001, MINER PETROL, V73, P47, DOI 10.1007/s007100170010; De Vivo B, 2010, MINER PETROL, V99, P1, DOI 10.1007/s00710-009-0098-6; de' Gennaro M, 1999, J VOLCANOL GEOTH RES, V91, P303, DOI 10.1016/S0377-0273(99)00040-2; Dellino P, 2004, J VOLCANOL GEOTH RES, V133, P211, DOI 10.1016/S0377-0273(03)00399-8; Dellino P, 2004, J VOLCANOL GEOTH RES, V133, P193, DOI 10.1016/S0377-0273(03)00398-6; Dellino P, 2001, B VOLCANOL, V63, P443; Dellino P, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005365; DeVivo B, 2006, DEV VOLCANO, V9, P1; Di Vito MA, 1999, J VOLCANOL GEOTH RES, V91, P221, DOI 10.1016/S0377-0273(99)00037-2; Di Vito M, 1987, B VOLCANOL, V49, P608, DOI 10.1007/BF01079966; Druitt TH, 1998, GEOL SOC SPEC PUBL, V145, P145, DOI 10.1144/GSL.SP.1996.145.01.08; Dvorak JJ, 1991, GEOL SOC AM SP PAP, V163, P47, DOI [10.1130/SPE263, DOI 10.1130/SPE263]; Fedele L, 2011, B VOLCANOL, V73, P1323, DOI 10.1007/s00445-011-0478-8; FISHER RV, 1993, J VOLCANOL GEOTH RES, V56, P205, DOI 10.1016/0377-0273(93)90017-L; Gottsman J, 2008, DEV VOLCANOLOGY, V10; Hsu K. J., 1989, PHYS PRINCIPLES SEDI; Isaia R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040513; Lirer L, 2010, B VOLCANOL, V72, P411, DOI 10.1007/s00445-009-0334-2; MALIN MC, 1982, SCIENCE, V217, P637, DOI 10.1126/science.217.4560.637; Marzocchi W, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003155; Marzocchi W, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005908; MASTIN LG, 1995, B VOLCANOL, V57, P85, DOI 10.1007/BF00301399; Mastrolorenzo G, 2006, EARTH PLANET SC LETT, V250, P164, DOI 10.1016/j.epsl.2006.07.040; Mastrolorenzo G, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006871; Mastrolorenzo G, 2006, GEOL SOC SPEC PUBL, V269, P159, DOI 10.1144/GSL.SP.2006.269.01.10; Mastrolorenzo G, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004954; MASTROLORENZO G, 1994, B VOLCANOL, V56, P561, DOI 10.1007/BF00302836; Mastrolorenzo G, 2001, J VOLCANOL GEOTH RES, V109, P41, DOI 10.1016/S0377-0273(00)00303-6; Mastrolorenzo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011127; MCEWEN AS, 1989, J VOLCANOL GEOTH RES, V37, P205, DOI 10.1016/0377-0273(89)90080-2; Mei ETW, 2013, J VOLCANOL GEOTH RES, V261, P348, DOI 10.1016/j.jvolgeores.2013.03.010; Mele D, 2015, J VOLCANOL GEOTH RES, V299, P35, DOI 10.1016/j.jvolgeores.2015.04.002; Neri A, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000508; Neri A, 2008, J VOLCANOL GEOTH RES, V178, P397, DOI 10.1016/j.jvolgeores.2008.05.014; Neri A, 2015, J GEOPHYS RES-SOL EA, V120, P2330, DOI 10.1002/2014JB011776; Newhall C.G., 1988, US GEOL SURV B, V1855, P1, DOI DOI 10.3133/B1855; Ongaro TE, 2008, J VOLCANOL GEOTH RES, V178, P378, DOI 10.1016/j.jvolgeores.2008.06.036; Oppenheimer C, 2005, SUPER ERUPTIONS GLOB; Orsi G, 2004, B VOLCANOL, V66, P514, DOI 10.1007/s00445-003-0336-4; Orsi G, 1996, J VOLCANOL GEOTH RES, V74, P179, DOI 10.1016/S0377-0273(96)00063-7; ORSI G, 1992, J VOLCANOL GEOTH RES, V53, P275, DOI 10.1016/0377-0273(92)90086-S; Orsi G, 2009, EARTH PLANET SC LETT, V287, P265, DOI 10.1016/j.epsl.2009.08.013; Palladino DM, 2002, J VOLCANOL GEOTH RES, V116, P97, DOI 10.1016/S0377-0273(02)00213-5; Palladino DM, 1995, J VOLCANOL GEOTH RES, V69, P343, DOI 10.1016/0377-0273(95)00036-4; Pappalardo L, 1999, J VOLCANOL GEOTH RES, V91, P141, DOI 10.1016/S0377-0273(99)00033-5; Pappalardo L, 2002, J VOLCANOL GEOTH RES, V114, P479, DOI 10.1016/S0377-0273(01)00302-X; Pappalardo L, 2002, J PETROL, V43, P1415, DOI 10.1093/petrology/43.8.1415; Pappalardo L, 2008, CONTRIB MINERAL PETR, V156, P1, DOI 10.1007/s00410-007-0270-0; Pappalardo L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00712; Pappalardo L, 2010, EARTH PLANET SC LETT, V296, P133, DOI 10.1016/j.epsl.2010.05.010; Passaro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22448; Perla R., 1980, AVALANCHE RELEASE, P397, DOI [DOI 10.1016/B978-0-12-179450-7.50012-7, 10.1016/B978-0-12-179450-7.50012-7]; Petrazzuoli SM, 2014, J VOLCANOL GEOTHERM, V133, p353 ; Robertson RM, 2012, ABS CITIES VOLCANOES, V7; Rolandi G, 2003, MINER PETROL, V79, P3, DOI 10.1007/s00710-003-0014-4; Rosi M, 1996, B VOLCANOL, V57, P541, DOI 10.1007/BF00304438; Rosi M, 1987, CNR QUAD RIC SCI, V114, P114; Rossano S, 1998, J VOLCANOL GEOTH RES, V82, P113, DOI 10.1016/S0377-0273(97)00060-7; Rossano S, 2004, J VOLCANOL GEOTH RES, V132, P1, DOI 10.1016/s0377-0273(03)00384-6; Rossano S, 1996, GEOPHYS RES LETT, V23, P3779, DOI 10.1029/96GL03570; SCARPATI C, 1993, B VOLCANOL, V55, P343, DOI 10.1007/BF00301145; Self S, 2006, PHILOS T R SOC A, V364, P2073, DOI 10.1098/rsta.2006.1814; Selva J., 2012, NAPLES J APPL VOLCAN, V1, P1, DOI [10.1186/2191-5040-1-1, DOI 10.1186/2191-5040-1-1]; Selva J, 2012, B VOLCANOL, V74, P497, DOI 10.1007/s00445-011-0528-2; Sheridan M. F., 1979, GEOL S AM S, V180, P125; SHERIDAN MF, 1983, J VOLCANOL GEOTH RES, V17, P187, DOI 10.1016/0377-0273(83)90067-7; Sigurdsson H., 1987, B VOLCANOL, V49, P467, DOI DOI 10.1007/BF01245474; Simakin AG, 2010, B VOLCANOL, V72, P85, DOI 10.1007/s00445-009-0306-6; SPARKS RSJ, 1976, SEDIMENTOLOGY, V23, P147, DOI 10.1111/j.1365-3091.1976.tb00045.x; Todesco M, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001314; Tonini R, 2015, NAT HAZARD EARTH SYS, V15, P409, DOI 10.5194/nhess-15-409-2015; Valentine GA, 1998, J VOLCANOL GEOTH RES, V87, P117, DOI 10.1016/S0377-0273(98)00094-8; VALENTINE GA, 1986, GEOLOGY, V14, P146, DOI 10.1130/0091-7613(1986)14<146:OOLDII>2.0.CO;2; Valentine GA, 1987, B VOLCANOL, V49, P616, DOI 10.1007/BF01079967; Voight B, 2000, J VOLCANOL GEOTH RES, V100, P69, DOI 10.1016/S0377-0273(00)00134-7; VOIGHT B, 1990, J VOLCANOL GEOTH RES, V44, P349, DOI 10.1016/0377-0273(90)90027-D; Voight B., 1988, EARTH MINER SCI, V57, p17 ; Voight B., 1996, MONITORING MITIGATIO, P719, DOI DOI 10.1007/978-3-642-80087-0_22; Wilson L., 1981, The 1980 eruptions of Mount St. Helens, Washington, P513; WOHLETZ K, 1995, J VOLCANOL GEOTH RES, V67, P263, DOI 10.1016/0377-0273(95)00002-C; Wohletz K.H., 1979, MODEL PYROCLASTIC SU, V180, P177, DOI DOI 10.1130/SPE180-P177; WOHLETZ KH, 1983, J VOLCANOL GEOTH RES, V17, P31, DOI 10.1016/0377-0273(83)90061-6; Woo JYL, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006913; Wu WN, 2015, AM MINERAL, V100, P2082, DOI 10.2138/am-2015-5274; YAMAMOTO T, 1993, B VOLCANOL, V55, P166, DOI 10.1007/BF00301514	109	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185756	10.1371/journal.pone.0185756	http://dx.doi.org/10.1371/journal.pone.0185756			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020018	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400044
J	Meyer, KA; Davis, TW; Watson, SB; Denef, VJ; Berry, MA; Dick, GJ				Meyer, Kevin Anthony; Davis, Timothy W.; Watson, Susan B.; Denef, Vincent J.; Berry, Michelle A.; Dick, Gregory J.			Genome sequences of lower Great Lakes Microcystis sp reveal strain-specific genes that are present and expressed in western Lake Erie blooms	PLOS ONE			English	Article							FORMING CYANOBACTERIUM MICROCYSTIS; HARMFUL ALGAL BLOOMS; RIBOSOMAL-RNA GENE; BLUE-GREEN-ALGAE; TOXIC CYANOBACTERIUM; PROCHLOROCOCCUS ECOTYPES; MARINE BACTERIOPLANKTON; NONTOXIC STRAINS; SINGLE-CELL; AERUGINOSA	Blooms of the potentially toxic cyanobacterium Microcystis are increasing worldwide. In the Laurentian Great Lakes they pose major socioeconomic, ecological, and human health threats, particularly in western Lake Erie. However, the interpretation of "omics" data is constrained by the highly variable genome of Microcystis and the small number of reference genome sequences from strains isolated from the Great Lakes. To address this, we sequenced two Microcystis isolates from Lake Erie (Microcystis aeruginosa LE3 and M. wesenbergii LE013-01) and one from upstream Lake St. Clair (M. cf aeruginosa LSC13-02), and compared these data to the genomes of seventeen Microcystis spp. from across the globe as well as one metagenome and seven metatranscriptomes from a 2014 Lake Erie Microcystis bloom. For the publically available strains analyzed, the core genome is similar to 1900 genes, representing similar to 11% of total genes in the pan-genome and similar to 45% of each strain's genome. The flexible genome content was related to Microcystis subclades defined by phylogenetic analysis of both housekeeping genes and total core genes. To our knowledge this is the first evidence that the flexible genome is linked to the core genome of the Microcystis species complex. The majority of strain-specific genes were present and expressed in bloom communities in Lake Erie. Roughly 8% of these genes from the lower Great Lakes are involved in genome plasticity (rapid gain, loss, or rearrangement of genes) and resistance to foreign genetic elements (such as CRISPR-Cas systems). Intriguingly, strain-specific genes from Microcystis cultured from around the world were also present and expressed in the Lake Erie blooms, suggesting that the Microcystis pangenome is truly global. The presence and expression of flexible genes, including strain-specific genes, suggests that strain-level genomic diversity may be important in maintaining Microcystis abundance during bloom events.	[Meyer, Kevin Anthony] Univ Michigan, CIGLR, Ann Arbor, MI USA; [Meyer, Kevin Anthony; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Davis, Timothy W.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI USA; [Watson, Susan B.] Environm & Climate Change Canada, Burlington, ON, Canada; [Denef, Vincent J.; Berry, Michelle A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; University of Michigan System; University of Michigan	Dick, GJ (corresponding author), Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA.	gdick@umich.edu	Dick, Gregory/D-8901-2012	Dick, Gregory/0000-0001-7666-6288	Erb Family Foundation through University of Michigan Water Center [N017871]; Environmental Protection Agency Great Lakes Restoration Initiative [2015-062a]; National Oceanic and Atmospheric Administration; University of Michigan [NA120AR4320071]; University of Michigan Office for Research MCubed program; Erb Family Foundation through University of Michigan Water Center	Erb Family Foundation through University of Michigan Water Center; Environmental Protection Agency Great Lakes Restoration Initiative; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Michigan(University of Michigan System); University of Michigan Office for Research MCubed program; Erb Family Foundation through University of Michigan Water Center	This work was supported by a grant from the Erb Family Foundation made through the University of Michigan Water Center (Grant N017871) and by an Environmental Protection Agency Great Lakes Restoration Initiative Grant (2015-062a). Funding was awarded to the Cooperative Institute for Limnology and Ecosystems Research through the National Oceanic and Atmospheric Administration Cooperative Agreement with the University of Michigan (NA120AR4320071). This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank NOAA-GLERL, specifically Duane Gossiaux and the Captains and crew of NOAA-GLERL R/V R4105 and to CIGLR, specifically Tom Johengen and Dack Stuart, for their assistance with field collection of samples. Thanks also to Paul Den Uyl and Sunit Jain of the University of Michigan for assistance with fieldwork and bioinformatics, respectively. This project was supported by grants from the University of Michigan Office for Research MCubed program and the Erb Family Foundation made through the University of Michigan Water Center. This manuscript is CIGLR publication number 1118 and NOAA GLERL publication number 1868.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2002, GENOME RES, V12, P1080; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Berry MA, 2017, ENVIRON MICROBIOL, V19, P1149, DOI 10.1111/1462-2920.13640; Briand E, 2009, ISME J, V3, P419, DOI 10.1038/ismej.2008.121; Bridgeman TB, 2013, J GREAT LAKES RES, V39, P83, DOI 10.1016/j.jglr.2012.11.004; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Buffalo V., 2014, SCYTHE BAYESIAN ADAP; Bullerjahn GS, 2016, HARMFUL ALGAE, V54, P223, DOI 10.1016/j.hal.2016.01.003; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Chen IMA, 2017, NUCLEIC ACIDS RES, V45, pD507, DOI 10.1093/nar/gkw929; Childs LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101710; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Crosbie ND, 2003, APPL ENVIRON MICROB, V69, P5716, DOI 10.1128/AEM.69.9.5716-5721.2003; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Davis TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106093; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ejnohova S A L, 2007, LIMNOL OCEANOGR, V52, P609; Felsenstein J., 2005, PHYLOGENY INFERENCE; FERGUSON RL, 1984, APPL ENVIRON MICROB, V47, P49, DOI 10.1128/AEM.47.1.49-55.1984; Fiore MF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00547-13; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gobler CJ, 2016, HARMFUL ALGAE, V54, P87, DOI 10.1016/j.hal.2016.01.010; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Harke MJ, 2012, MICROB ECOL, V63, P188, DOI 10.1007/s00248-011-9894-8; Horst GP, 2014, WATER RES, V54, P188, DOI 10.1016/j.watres.2014.01.063; Humbert JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070747; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Joshi N.A., SLIDING WINDOW ADAPT; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kuno S, 2014, MICROBIOL-SGM, V160, P903, DOI 10.1099/mic.0.073494-0; Kurmayer R, 2015, ISME J, V9, P909, DOI 10.1038/ismej.2014.189; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin S, 2011, GENE, V473, P139, DOI 10.1016/j.gene.2010.11.011; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Meyer KA, 2013, THESIS, V15, P5353; Mlouka A, 2004, J BACTERIOL, V186, P2355, DOI 10.1128/JB.186.8.2355-2365.2004; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Okano K, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00135-15; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Otten TG, 2012, ENVIRON SCI TECHNOL, V46, P3480, DOI 10.1021/es2041288; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Sandrini G, 2014, ISME J, V8, P589, DOI 10.1038/ismej.2013.179; Sant'Anna CL, 2011, NEUROTOX RES, V19, P389, DOI 10.1007/s12640-010-9177-z; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Shalapyonok A, 2001, DEEP-SEA RES PT II, V48, P1231, DOI 10.1016/S0967-0645(00)00137-5; Simm S, 2015, FRONT MICROBIOL, P6; Sinclair JL, 2008, ADV EXP MED BIOL, V619, P45; Sohm JA, 2016, ISME J, V10, P333, DOI 10.1038/ismej.2015.115; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Steffen MM, 2017, ENV SCI TECHNOL; Steffen MM, 2015, APPL ENV MICROBIOL; Steffen MM, 2014, ISME J, P1; Steffen MM, 2014, J GREAT LAKES RES, V40, P215, DOI 10.1016/j.jglr.2013.12.012; Stumpf RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042444; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanabe Y, 2011, PLOS ONE, V6; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; van Gremberghe I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019561; Van Wichelen J, 2016, HARMFUL ALGAE, V55, P97, DOI 10.1016/j.hal.2016.02.009; Vinuesa P, 2015, METHODS MOL BIOL, V1231, P203, DOI 10.1007/978-1-4939-1720-4_14; Visser PM, 2016, HARMFUL ALGAE, V54, P145, DOI 10.1016/j.hal.2015.12.006; Watson SB, 2016, HARMFUL ALGAE, V56, P44, DOI 10.1016/j.hal.2016.04.010; Welker M, 2003, ARCH HYDROBIOL, V157, P227, DOI 10.1127/0003-9136/2003/0157-0227; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Yang C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00394; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zurawell RW, 2005, J TOXICOL ENV HEAL B, V8, P1, DOI 10.1080/10937400590889412	100	26	26	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183859	10.1371/journal.pone.0183859	http://dx.doi.org/10.1371/journal.pone.0183859			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020009	gold, Green Published, Green Submitted			2022-12-27	WOS:000412754400008
J	Edmunds, PJ				Edmunds, Peter J.			Unusually high coral recruitment during the 2016 El Nino in Mo'orea, French Polynesia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; BLEACHING EVENT; CLIMATE-CHANGE; EASTERN PACIFIC; MALDIVIAN REEF; MORTALITY; RECOVERY; TEMPERATURE; REPRODUCTION	The negative implications of the thermal sensitivity of reef corals became clear with coral bleaching throughout the Caribbean in the 1980''s, and later globally, with the severe El Nino of 1998 and extensive seawater warming in 2005. These events have substantially contributed to declines in coral cover, and therefore the El Nino of 2016 raised concerns over the implications for coral reefs; on the Great Barrier Reef these concerns have been realized. A different outcome developed in Mo'orea, French Polynesia, where in situ seawater temperature from 15 March 2016 to 15 April 2016 was an average of 0.4 degrees C above the upper 95% CI of the decadal mean temperature, and the NOAA Degree Heating Weeks (DHW) metric supported a Level 1 bleaching alert (DHW >= 4.0). Starting 1 September 2016 and for the rest of the year (122 d), in situ seawater temperature was an average of 0.4 degrees C above the 95% CI of long-term values, although DHW remained at zero. Minor coral bleaching (0.2-2.6% of the coral) occurred on the outer reef (10-m and 17-m depth) in April 2016, by May 2016 it had intensified to affect 1.3-16.8% of the coral, but by August 2016, only 1.4-3.0% of the coral was bleached. Relative to the previous decade, recruitment of scleractinians to settlement tiles on the outer- (10 m) and back- (2 m) reef over 2016/17 was high, both from January 2016 to August 2016, and from August 2016 to January 2017, with increased relative abundances of pocilloporids on the outer reef, and acroporids in the back reef. The 2016 El Nino created a distinctive signature in seawater temperature for Mo'orea, but it did not cause widespread coral bleaching or mortality, rather, it was associated with high coral recruitment. While the 2016 El Nino has negatively affected other coral reefs in the Indo-Pacific, the coral communities of Mo'orea continue to show signs of resilience, thus cautioning against general statements regarding the effects of the 2015/16 El Nino on coral reefs in the region.	[Edmunds, Peter J.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA	California State University System; California State University Northridge	Edmunds, PJ (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	peter.edmunds@csun.edu		Edmunds, Peter/0000-0002-9039-9347	US National Science Foundation; Division Of Ocean Sciences [1619893] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was funded by the US National Science Foundation, https://www.nsf.gov.	Adam TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023717; Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Adjeroud M, 2002, MAR ECOL PROG SER, V237, P121, DOI 10.3354/meps237121; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Alldredge AL, 2009, CORAL REEFS, V28, P895, DOI 10.1007/s00338-009-0534-4; Ampou EE, 2017, BIOGEOSCIENCES, V14, P817, DOI 10.5194/bg-14-817-2017; Andrefouet S, 2017, ENVIRON CONSERV, P1; [Anonymous], 2017, SCI REP, V7, P4058; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bahr KD., 2015, PEERJ, V3, DOI DOI 10.1016/S0308-597X(03)00041-1; Bainbridge SJ, 2017, J OPER OCEANOGR, V10, P16, DOI 10.1080/1755876X.2017.1290863; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; Bouchon C., 1985, P 5 COR REEF C, V6, P279; Bramanti L, 2016, CORAL REEFS, V35, P543, DOI 10.1007/s00338-016-1413-4; Brown BE, 2015, MAR BIOL, V162, P479, DOI 10.1007/s00227-014-2596-2; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Bruno JF, 2001, CORAL REEFS, V20, P127, DOI 10.1007/s003380100151; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; DeCarlo TM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44586; Donnelly JP, 2007, NATURE, V447, P465, DOI 10.1038/nature05834; Edmunds PJ, 2001, MAR BIOL, V139, P981; ENFIELD DB, 1991, J CLIMATE, V4, P1137, DOI 10.1175/1520-0442(1991)004<1137:LFCIEN>2.0.CO;2; Fan TY, 2017, MAR ECOL PROG SER, V569, P117, DOI 10.3354/meps12071; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Galzin Rene, 1993, Galaxea, V11, P73; Gleason MG, 1996, J EXP MAR BIOL ECOL, V207, P79, DOI 10.1016/S0022-0981(96)02647-0; Glynn PW, 2017, CORAL REEFS WORLD, V8, P251, DOI 10.1007/978-94-017-7499-4_8; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; Glynn PW, 2000, MAR BIOL, V136, P785, DOI 10.1007/s002270000286; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Han XY, 2016, CORAL REEFS, V35, P999, DOI 10.1007/s00338-016-1423-2; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hochachka P.W., 2002, BIOCH ADAPTATIONS ME; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Kayal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047363; Kintisch E, 2016, SCIENCE, V352, P1501, DOI 10.1126/science.352.6293.1501; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Loch K, 2002, MAR ECOL-P S Z N I, V23, P219, DOI 10.1046/j.1439-0485.2002.02773.x; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Mapstone BD, 2007, MAR ECOL PROG SER, V332, P143, DOI 10.3354/meps332143; McClanahan TR, 2000, MAR POLLUT BULL, V40, P587, DOI 10.1016/S0025-326X(00)00064-3; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; McPhaden MJ, 2015, NAT CLIM CHANGE, V5, P791, DOI 10.1038/nclimate2775; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Monastersky R, 2016, NATURE, V529, P267, DOI 10.1038/529267a; Mumby PJ, 2001, MAR BIOL, V139, P183; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Normile D., 2017, SCIENCE; Normile D, 2016, SCIENCE, V352, P15, DOI 10.1126/science.352.6281.15; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Oliver J. K., 2009, V205, P21; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Pratchett MS, 2015, OCEANOGR MAR BIOL, V53, P215; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; Putnam HM, 2017, BIOL BULL, V215, P135, DOI DOI 10.2307/25470694; Rogers JS, 2015, J GEOPHYS RES-OCEANS, V120, P145, DOI 10.1002/2014JC010464; SALVAT B, 1992, CR ACAD SCI III-VIE, V314, P105; Schuhmacher H, 2005, FACIES, V51, P80, DOI 10.1007/s10347-005-0020-6; Sokal RR., 2011, BIOMETRY; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tamelander J, 2002, AMBIO, V31, P551, DOI 10.1639/0044-7447(2002)031[0551:CRFAMM]2.0.CO;2; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Tsounis G, 2016, PEERJ, V4, DOI 10.7717/peerj.2544; Wang CZ, 2017, CORAL REEFS WORLD, V8, P85, DOI 10.1007/978-94-017-7499-4_4; Wood S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12571; Xie JY, 2016, MAR POLLUT B; Zar JH., 2010, BIOSTAT ANAL, V5th	83	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185167	10.1371/journal.pone.0185167	http://dx.doi.org/10.1371/journal.pone.0185167			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016624	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400014
J	Cui, CX; Li, YY; Gao, H; Zhang, HY; Han, JJ; Zhang, DJ; Li, Y; Zhou, J; Lu, CY; Su, XR				Cui, Chenxi; Li, Yanyan; Gao, Hang; Zhang, Hongyan; Han, Jiaojiao; Zhang, Dijun; Li, Ye; Zhou, Jun; Lu, Chenyang; Su, Xiurong			Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; MONONUCLEAR-CELLS; GEN. NOV.; ACIDS; INFLAMMATION; PREVENTS; IMPACT; ASSOCIATION; SENSITIVITY	Previous studies confirmed that dietary supplements of fish oil and krill oil can alleviate obesity in mice, but the underlying mechanism remains unclear. This study aims to discern whether oil treatment change the structure of the gut microbiota during the obesity alleviation. The ICR mice received high-fat diet (HFD) continuously for 12 weeks after two weeks of acclimatization with a standard chow diet, and the mice fed with a standard chow diet were used as the control. In the groups that received HFD with oil supplementation, the weight gains were attenuated and the liver index, total cholesterol, triglyceride and low-density lipoprotein cholesterol were reduced stepwise compared with the HFD group, and the overall structure of the gut microbiota, which was modulated in the HFD group, was shifted toward the structure found in the control group. Moreover, eighty-two altered operational taxonomic units responsive to oil treatment were identified and nineteen of them differing in one or more parameters associated with obesity. In conclusion, this study confirmed the effect of oil treatment on obesity alleviation, as well as on the microbiota structure alterations. We proposed that further researches are needed to elucidate the causal relationship between obesity alleviation and gut microbiota modulation.	[Cui, Chenxi; Zhang, Hongyan; Han, Jiaojiao; Zhang, Dijun; Li, Ye; Zhou, Jun; Lu, Chenyang; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [Li, Yanyan] Cornell Univ, Dept Food Sci, New York, NY 10021 USA; [Gao, Hang] Jilin Univ, Bethune Hosp 1, Changchun, Jilin, Peoples R China	Ningbo University; Cornell University; Jilin University	Lu, CY; Su, XR (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China.	luchenyang@nbu.edu.cn; suxiurong_public@163.com	zhang, dijun/GQP-8906-2022	zhang, dijun/0000-0003-3417-9849	Key Specialty of Ningbo City; Ningbo University	Key Specialty of Ningbo City; Ningbo University	This work was supported by the the Key Specialty of Ningbo City (http://www.nbu.edu.cn) to XRS, the Talent project in Ningbo University (http://www.nbu.edu.cn) to XRS, the K.C.Wong Magna Fund in Ningbo University (ham//www.nbu.edu.cn) to CYL and XRS.	Albuquerque D, 2015, MOL GENET GENOMICS, V290, P1191, DOI 10.1007/s00438-015-1015-9; Antelo M, 2017, ECON HUM BIOL, V24, P61, DOI 10.1016/j.ehb.2016.11.002; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Bagga D, 2003, P NATL ACAD SCI USA, V100, P1751, DOI 10.1073/pnas.0334211100; Bashir S, 2016, J NUTR BIOCHEM, V33, P82, DOI 10.1016/j.jnutbio.2016.02.011; Bendtsen KMB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046231; Burri Lena, 2011, Frontiers in Genetics, V2, P45, DOI 10.3389/fgene.2011.00045; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017; Connolly HM, 1997, NEW ENGL J MED, V337, P1775; Dangol M, 2017, J CONTROLLED RELEASE; Dasilva G, 2016, FOOD CHEM, V205, P196, DOI 10.1016/j.foodchem.2016.03.020; De Boer AA, 2016, J NUTR BIOCHEM, V34, P61, DOI 10.1016/j.jnutbio.2016.04.004; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eknoyan Garabed, 2007, Curr Diab Rep, V7, P449, DOI 10.1007/s11892-007-0076-5; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRIDAY KE, 1989, DIABETES CARE, V12, P276, DOI 10.2337/diacare.12.4.276; Haider J, 2017, FOOD HYDROCOLLOID, V63, P27, DOI 10.1016/j.foodhyd.2016.08.020; Hasan M, 2017, NEUROSCIENCE, V343, P322, DOI 10.1016/j.neuroscience.2016.12.002; Honda K, 2013, ELSE KRONER FRESEN S, V4, P43, DOI 10.1159/000346523; Ibrahim A, 2011, CLIN NUTR, V30, P678, DOI 10.1016/j.clnu.2011.05.002; Iizukaa Y, 2016, TOXICOL REP, V3, P4, DOI 10.1016/j.toxrep.2015.11.003; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Klaring K, 2013, INT J SYST EVOL MICR, V63, P4606, DOI 10.1099/ijs.0.051441-0; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Le Grandois J, 2009, J AGR FOOD CHEM, V57, P6014, DOI 10.1021/jf900903e; Lee MF, 2015, J FUNCT FOODS, V19, P913, DOI 10.1016/j.jff.2014.10.015; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li BZ, 2017, FOOD CHEM, V218, P199, DOI 10.1016/j.foodchem.2016.09.059; Bargut TCL, 2015, J NUTR BIOCHEM, V26, P960, DOI 10.1016/j.jnutbio.2015.04.002; Lopez-Cervantes J, 2006, BIOMED CHROMATOGR, V20, P981, DOI 10.1002/bmc.676; Lu CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00905; Luo Qinfang, 2014, China patent, Patent No. [CN103976804A, 103976804A]; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maraninchi M, 2017, J CLIN LIPIDOL, V11, P495, DOI 10.1016/j.jacl.2017.02.012; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P834, DOI 10.1016/j.healun.2006.03.005; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Motoshima H, 2016, DIABETES RES CLIN PR, V120, pS83; Nascimento FAM, 2010, EXP TOXICOL PATHOL, V62, P17, DOI 10.1016/j.etp.2008.12.008; Norris GH, 2016, J NUTR BIOCHEM, V30, P93, DOI 10.1016/j.jnutbio.2015.12.003; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ruiz-Nunez B, 2013, J NUTR BIOCHEM, V24, P1183, DOI 10.1016/j.jnutbio.2013.02.009; Sakamoto M, 2007, INT J SYST EVOL MICR, V57, P342, DOI 10.1099/ijs.0.64709-0; Satil F, 2003, CHEM NAT COMPD+, V39, P322, DOI 10.1023/B:CONC.0000003408.63300.b5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Serini S, 2012, CURR ALZHEIMER RES, V9, P913, DOI 10.2174/156720512803251147; Shang QS, 2017, J FUNCT FOODS, V28, P138, DOI 10.1016/j.jff.2016.11.002; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Torres-Fuentes C, 2015, NUTR NEUROSCI, V18, P49, DOI 10.1179/1476830513Y.0000000099; Tuovinen E, 2013, ANAEROBE, V19, P70, DOI 10.1016/j.anaerobe.2012.11.002; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang B, 2017, INT J BIOL MACROMOL, V102, P104, DOI 10.1016/j.ijbiomac.2017.03.187; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yamazaki RK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-66; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yu HN, 2014, ARCH MED RES, V45, P195, DOI 10.1016/j.arcmed.2014.03.008; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang CH, 2015, EBIOMEDICINE, V2, P968, DOI 10.1016/j.ebiom.2015.07.007; Zhang WL, 2014, OBES REV, V15, P957, DOI 10.1111/obr.12228; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10559; Zhao JL, 2017, GEN COMP ENDOCR, V252, P48, DOI 10.1016/j.ygcen.2017.07.013; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	73	48	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186216	10.1371/journal.pone.0186216	http://dx.doi.org/10.1371/journal.pone.0186216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016689	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800046
J	Schuldenzucker, V; Schubert, R; Muratori, LM; Freisfeld, F; Rieke, L; Matheis, T; Schramke, S; Motlik, J; Kemper, N; Radespiel, U; Reilmann, R				Schuldenzucker, Verena; Schubert, Robin; Muratori, Lisa M.; Freisfeld, Frauke; Rieke, Lorena; Matheis, Tamara; Schramke, Sarah; Motlik, Jan; Kemper, Nicole; Radespiel, Ute; Reilmann, Ralf			Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study	PLOS ONE			English	Article							DISEASE; MODELS; PREMANIFEST; HD	Background Large animal models of Huntington's disease (HD) may increase the reliability of translating preclinical findings to humans. Long live expectancy offers opportunities particularly for disease modifying approaches, but also challenges. The transgenic (tg) HD minipig model assessed in this study exhibits a high genetic homology with humans, similar body weight, and comparable brain structures. To test long-term safety, tolerability, and efficacy of novel therapeutic approaches in this model reliable assessments applicable longitudinally for several years are warranted for all phenotypical domains relevant in HD. Objective To investigate whether the tests proposed assessing motor, cognitive and behavioral domains can be applied repetitively over a 3-year period in minipigs with acceptable variability or learning effects and whether tgHD minipigs reveal changes in these domains compared to wildtype (wt) minipigs suggesting the development of an HD phenotype. Methods A cohort of 14 tgHD and 18 wt minipigs was followed for three years. Tests applied every six months included a tongue coordination and hurdle test for the motor domain, a color discrimination test for cognition, and a dominance test for assessing behavior. Statistical analyses were performed using repeated ANOVA for longitudinal group comparisons and Wilcoxon-tests for intra-visit differences between tgHD and wt minipigs. Results All tests applied demonstrated feasibility, acceptable variance and good consistency during the three-year period. No significant differences between tgHD and wt minipigs were detected suggesting lack of a phenotype before the age of four years. Conclusions The assessment battery presented offers measures in all domains relevant for HD and can be applied in long-term phenotyping studies with tgHD minipigs. The observation of this cohort should be continued to explore the timeline of phenotype development and provide information for future interventional studies.	[Schuldenzucker, Verena; Schubert, Robin; Muratori, Lisa M.; Freisfeld, Frauke; Rieke, Lorena; Matheis, Tamara; Schramke, Sarah; Reilmann, Ralf] George Huntington Inst, Technol Park, Munster, Germany; [Schuldenzucker, Verena; Radespiel, Ute] Univ Vet Med Hannover, Inst Zool, Hannover, Germany; [Muratori, Lisa M.] SUNY Stony Brook, Sch Hlth Technol & Management, Dept Phys Therapy, Stony Brook, NY 11794 USA; [Freisfeld, Frauke; Reilmann, Ralf] Univ Munster, Dept Clin Radiol, Albert Schweitzer Campus 1, Munster, Germany; [Rieke, Lorena; Matheis, Tamara; Kemper, Nicole] Univ Vet Med Hannover, Inst Anim Hyg Anim Welf & Farm Anim Behav, Hannover, Germany; [Motlik, Jan] AS CR, Inst Anim Physiol & Genet, Lab Cell Regenerat & Plast, Vvi, Libechov, Czech Republic; [Reilmann, Ralf] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Reilmann, Ralf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany	University of Veterinary Medicine Hannover, Foundation; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Munster; University of Veterinary Medicine Hannover, Foundation; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Reilmann, R (corresponding author), George Huntington Inst, Technol Park, Munster, Germany.; Reilmann, R (corresponding author), Univ Munster, Dept Clin Radiol, Albert Schweitzer Campus 1, Munster, Germany.; Reilmann, R (corresponding author), Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany.; Reilmann, R (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany.	ratf.reilmann@ghi-muenster..de		Reilmann, Ralf/0000-0002-5904-9517; Kemper, Nicole/0000-0003-0092-4302	CHDI Foundation; team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany	CHDI Foundation; team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany	The George-Huntington-Institute has received grant support from the CHDI Foundation (www.chdifoundation.org) to conduct the work reported in this study to RR. We are grateful for additional relevant support provided by private donations of families affected by HD that would like to remain anonymous. The authors are not aware of any competing interests of these donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no other financial interests related to this manuscript. We thank the team of the Zentrale Tierexpermientelle Einrichtung (ZTE) of the University Hospital of Muenster, Muenster, Germany, for continuous support. We thank the team of the Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics, Libechov, Czech Republic, for providing the animals and intense scientific exchange and guidance.	Bang A, 2010, ANIM BEHAV, V79, P631, DOI 10.1016/j.anbehav.2009.12.009; Craufurd D, 2001, NEUROPSY NEUROPSY BE, V14, P219; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Dolezalova D, 2014, J COMP NEUROL, V522, P2784, DOI 10.1002/cne.23575; Dumas E., 2013, FRONT BIOSCI, P1; Fisher CA, 2014, J HUNTINGTONS DIS, V3, P319, DOI 10.3233/JHD-140127; Howland DS, 2014, MOVEMENT DISORD, V29, P1397, DOI 10.1002/mds.26008; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kieburtz K, 2017, RESULTS PHASE 2 DOUB, V88; Killoran A, 2014, MOVEMENT DISORD, V29, P1404, DOI 10.1002/mds.26014; Kim J, 2011, INT REV NEUROBIOL, V98, P419, DOI 10.1016/B978-0-12-381328-2.00016-X; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lione LA, 1999, J NEUROSCI, V19, P10428; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Monika B, 2013, J HUNTINGTONS DIS, P47; Morton AJ, 2013, J HUNTINGTONS DIS, V2, P3, DOI 10.3233/JHD-130050; Paulsen JS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00078; Reilmann R, 2015, MOV DISORD, V30; Reilmann R., 2009, AKTUELLE NEUROL, V36, pP474, DOI DOI 10.1055/S-0029-1238568; Reilmann R, 2015, MOVEMENT DISORD, V30, P427, DOI 10.1002/mds.26174; Reilmann R, 2012, BASAL GANGLIA, V2, P241, DOI 10.1016/j.baga.2012.09.004; Reilmann R, 2010, MOVEMENT DISORD, V25, P2195, DOI 10.1002/mds.23243; Schramke S, 2015, CESK SLOV NEUROL S2, V78, P55; Schramke S, 2016, J NEUROSCI METH, V265, P34, DOI 10.1016/j.jneumeth.2015.11.013; Schubert R, 2016, J NEUROSCI METH, V265, P46, DOI 10.1016/j.jneumeth.2015.11.017; Stout JC, 2012, J NEUROL NEUROSUR PS, V83, P687, DOI 10.1136/jnnp-2011-301940; SZEKELY S, 1983, APPL ANIM ETHOL, V9, P279, DOI 10.1016/0304-3762(83)90008-1; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Valekova Ivona, 2015, Methods Mol Biol, V1212, P39, DOI 10.1007/7651_2014_94; Venuto CS, 2012, MOVEMENT DISORD, V27, P31, DOI 10.1002/mds.23953; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; William Yang X., 2011, NEUROBIOLOGY HUNTING; Yang X. W., 2011, MOUSE MODELS VALIDAT	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185970	10.1371/journal.pone.0185970	http://dx.doi.org/10.1371/journal.pone.0185970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016656	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800033
J	Elmas, A; Wang, XD; Dresch, JM				Elmas, Abdulkadir; Wang, Xiaodong; Dresch, Jacqueline M.			The folded k-spectrum kernel: A machine learning approach to detecting transcription factor binding sites with gapped nucleotide dependencies	PLOS ONE			English	Article							CIS-REGULATORY MODULES; DNA RECOGNITION; DATABASE; SEQUENCES; PROTEINS; MODELS; CLASSIFICATION; IDENTIFICATION; PREDICTION; ALGORITHM	Understanding the molecular machinery involved in transcriptional regulation is central to improving our knowledge of an organism's development, disease, and evolution. The building blocks of this complex molecular machinery are an organism's genomic DNA sequence and transcription factor proteins. Despite the vast amount of sequence data now available for many model organisms, predicting where transcription factors bind, often referred to as 'motif detection' is still incredibly challenging. In this study, we develop a novel bioinformatic approach to binding site prediction. We do this by extending pre-existing SVM approaches in an unbiased way to include all possible gapped k-mers, representing different combinations of complex nucleotide dependencies within binding sites. We show the advantages of this new approach when compared to existing SVM approaches, through a rigorous set of cross-validation experiments. We also demonstrate the effectiveness of our new approach by reporting on its improved performance on a set of 127 genomic regions known to regulate gene expression along the anterio-posterior axis in early Drosophila embryos.	[Elmas, Abdulkadir; Wang, Xiaodong] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Dresch, Jacqueline M.] Clark Univ, Dept Math & Comp Sci, Worcester, MA 01610 USA	Columbia University; Clark University	Dresch, JM (corresponding author), Clark Univ, Dept Math & Comp Sci, Worcester, MA 01610 USA.	jdresch@clarku.edu	Elmas, Abdulkadir/AAH-5958-2021	Elmas, Abdulkadir/0000-0002-7999-5770	National Institutes of Health [GM110571]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by a National Institutes of Health (GM110571) grant (https://www.nih.gov) to JMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Attwood TK, 1998, NUCLEIC ACIDS RES, V26, P304, DOI 10.1093/nar/26.1.304; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Baird-Titus JM, 2006, J MOL BIOL, V356, P1137, DOI 10.1016/j.jmb.2005.12.007; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P189, DOI 10.1093/nar/24.1.189; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Benos PV, 2002, J MOL BIOL, V323, P701, DOI 10.1016/S0022-2836(02)00917-8; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Borok MJ, 2010, DEVELOPMENT, V137, P5, DOI 10.1242/dev.036160; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cristianini N, 2000, INTRO SUPPORT VECTOR; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; Dresch JM, 2016, GENE REGULATION SYST; Eddy S R, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P114; Erwin GD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003677; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Ghandi M., 2014, PLOS COMPUTATIONAL B, V10, P15, DOI DOI 10.1371/; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Jaakkola T, 2000, J COMPUT BIOL, V7, P95, DOI 10.1089/10665270050081405; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Leslie C., 2003, ADV NEURAL INFORMATI, P1417; Leslie Christina, 2002, Pac Symp Biocomput, P564; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; LIAO L, 2002, P 6 ANN INT C COMP M, P225, DOI DOI 10.1145/565196.565225; Liu B, 2015, J THEOR BIOL, V385, P153, DOI 10.1016/j.jtbi.2015.08.025; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Magbanua JP, 2014, PLOS ONE, V9; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Martinez CA, 2013, METHODS, V62, P91, DOI 10.1016/j.ymeth.2013.05.014; Mathelier A, 2013, J BIOINF COMPUT BIOL, V9; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathew J, 2015, IEEE IND ELEC, P1127, DOI 10.1109/IECON.2015.7392251; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Starr MO, 2011, DEV BIOL, V359, P290, DOI 10.1016/j.ydbio.2011.07.028; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Stringham JL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-298; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vapnik V., 1998, STAT LEARNING THEORY; VEROPOULOS K, 1999, P INT JOINT C ART IN, P55; Wang L, 2005, IEEE I CONF COMP VIS, P1355; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; WATERMAN MS, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P59; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wu X., 2004, P 10 ACM SIGKDD INT, P326, DOI [10.1145/1014052.1014089, DOI 10.1145/1014052.1014089]; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zadrozny B, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P435, DOI 10.1109/icdm.2003.1250950; Zellers RG, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0446-3; Zhang HQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00899-x; Zhou TY, 2013, NUCLEIC ACIDS RES, V41, pW56, DOI 10.1093/nar/gkt437; Zhu L, 2017, IEEE ACM T COMPUT BI	67	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185570	10.1371/journal.pone.0185570	http://dx.doi.org/10.1371/journal.pone.0185570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982128	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300046
J	Li, PC; Dong, HL; Zheng, CS; Sun, M; Liu, AZ; Wang, GP; Liu, SD; Zhang, SP; Chen, J; Li, YB; Pang, CY; Zhao, XH				Li, Pengcheng; Dong, Helin; Zheng, Cangsong; Sun, Miao; Liu, Aizhong; Wang, Guoping; Liu, Shaodong; Zhang, Siping; Chen, Jing; Li, Yabing; Pang, Chaoyou; Zhao, Xinhua			Optimizing nitrogen application rate and plant density for improving cotton yield and nitrogen use efficiency in the North China Plain	PLOS ONE			English	Article							FIELD-GROWN COTTON; PHOTOSYNTHETIC USE EFFICIENCY; POPULATION DENSITIES; IRRIGATED COTTON; LEAF SENESCENCE; COMPONENTS; LIGHT; ACCUMULATION; MANAGEMENT; QUALITY	Plant population density (PPD) and nitrogen (N) application rate (NAR) are two controllable factors in cotton production. We conducted field experiments to investigate the effects of PPD, NAR and their interaction (PPD x NAR) on yield, N uptake and N use efficiency (NUE) of cotton using a split-plot design in the North China Plain during 2013 and 2014. The main plots were PPDs (plants m(-2)) of 3.00 (low), 5.25 (medium) and 7.50 (high) and the subplots were NARs of 0 (N-free), 112.5 (low), 225.0 (moderate) and 337.5 (high). During both 2013 and 2014, biological yield and N uptake of cotton increased significantly, but harvesting index decreased significantly with NAR and PPD increasing. With NAR increasing, internal nitrogen use efficiency(NUE) decreased significantly under three PPDs and agronomical NUE, physiologilal NUE, nitrogen recovery efficiency(NRE) and partial factor productivity from applied nitrogen (PFPN) also decreased significantly under high PPD between two years. Lint yield increment varied during different PPDs and years, but NAR enhancement showed less function under higher PPD than lower PPD in general. Taken together, moderate NAR under medium PPD combined higher lint yield with higher agronomic NUE, physiological NUE, and NRE, while low NAR with high PPD would achieve a comparable yield with superior NRE and PFPN and high NAR under high PPD and medium PPD produced higher biological yield but lower harvest index, lint yield and NUE compared to moderate NAR with medium PPD. Our overall results indicated that, in this region, increasing PPD and decreasing NAR properly would enhance both lint yield and NUE of cotton.	[Li, Pengcheng; Dong, Helin; Zheng, Cangsong; Sun, Miao; Liu, Aizhong; Wang, Guoping; Liu, Shaodong; Zhang, Siping; Chen, Jing; Li, Yabing; Pang, Chaoyou; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Dong, HL; Zhao, XH (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	donghl668@sina.com; zhaoxinhua1968@126.com	Zheng, Cangsong/HCI-1365-2022; Yabing, Li/GLU-9964-2022	chen, jing/0000-0003-0644-5871	China Agricultural Research System of China [CARS-18-17]; National Natural Science Foundation of China [31371561]; Professional (Agricultural) Researching Project for Public Interests, China [201503121, 201203096]	China Agricultural Research System of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Professional (Agricultural) Researching Project for Public Interests, China	This work was supported by the earmarked fund of the China Agricultural Research System of China (CARS-18-17), the National Natural Science Foundation of China (31371561) and the Professional (Agricultural) Researching Project for Public Interests, China (201503121, 201203096). The funders Yabing Li and Guoping Wang took part in study design, data collection and analysis and preparation of the manuscript.	Chen BS, 1994, COTTON CULTIVATION P; CRI (Cotton Research Institute Chinese Academy of Agricultural Sciences), 2013, CULT COTT CHIN; Dai JL, 2015, FIELD CROP RES, V180, P207, DOI 10.1016/j.fcr.2015.06.008; Darawsheh MK, 2009, J FOOD AGRIC ENVIRON, V7, P258; Devkota M, 2013, SOIL TILL RES, V134, P72, DOI 10.1016/j.still.2013.07.009; Dong HZ, 2012, FIELD CROP RES, V126, P137, DOI 10.1016/j.fcr.2011.10.005; Dong HZ, 2010, FIELD CROP RES, V119, P106, DOI 10.1016/j.fcr.2010.06.019; Francisco E., 2013, Better Crops with Plant Food, V97, P15; Guo RQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33539; ISFAN D, 1990, J PLANT NUTR, V13, P907, DOI 10.1080/01904169009364125; Kakar N. U., 2012, Sarhad Journal of Agriculture, V28, P531; [李鹏程 Li Pengcheng], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P81; [刘瑞显 Liu Ruixian], 2010, [棉花学报, Cotton Science], V22, P634; [娄善伟 Lou Shanwei], 2010, [棉花学报, Cotton Science], V22, P260; Lou ShanWei, 2010, Plant Nutrition and Fertilizer Science, V16, P953; Lu DJ, 2015, FIELD CROP RES, V171, P157, DOI 10.1016/j.fcr.2014.10.012; Mao LL, 2015, FIELD CROP RES, V179, P63, DOI 10.1016/j.fcr.2015.04.011; Mei YJ, 2014, EUPHYTICA, V196, P95, DOI 10.1007/s10681-013-1016-x; NOVOA R, 1981, PLANT SOIL, V58, P177, DOI 10.1007/BF02180053; Rochester IJ, 2011, NUTR CYCL AGROECOSYS, V90, P147, DOI 10.1007/s10705-010-9418-9; Tan CS, 1992, HIGH QUALITY HIGH YI; [王子胜 Wang Zisheng], 2012, [棉花学报, Cotton Science], V24, P35; Witt C, 1999, FIELD CROP RES, V63, P113, DOI 10.1016/S0378-4290(99)00031-3; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Yang G., 2014, MATH PROBL ENG, V2014, P13; Yao HS, 2017, FIELD CROP RES, V203, P192, DOI 10.1016/j.fcr.2016.12.018; Yao HS, 2016, FIELD CROP RES, V188, P10, DOI 10.1016/j.fcr.2016.01.012; Yao HS, 2015, FIELD CROP RES, V184, P39, DOI 10.1016/j.fcr.2015.09.005; Yeates SJ, 2010, FIELD CROP RES, V116, P278, DOI 10.1016/j.fcr.2010.01.005; Zhang HJ, 2012, J AGRON CROP SCI, V198, P27, DOI 10.1111/j.1439-037X.2011.00481.x; Zhi XY, 2016, J INTEGR AGR, V15, P1469, DOI 10.1016/S2095-3119(15)61174-1	32	14	16	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185550	10.1371/journal.pone.0185550	http://dx.doi.org/10.1371/journal.pone.0185550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981538	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300043
J	Nishihara, M; Aoki, H; Ohno, S; Furusho, A; Hirakata, S; Nishida, N; Ito, S; Hayashi, M; Imaizumi, T; Fukumoto, Y				Nishihara, Michihide; Aoki, Hiroki; Ohno, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Ito, Sohei; Hayashi, Makiko; Imaizumi, Tsutomu; Fukumoto, Yoshihiro			The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice	PLOS ONE			English	Article							RECEPTOR ANTIBODY; INTERLEUKIN-6; MATRIX-METALLOPROTEINASE-9; EXPRESSION; REGRESSION; INFLAMMATION; INHIBITION; PROTEIN; BETA	Although the pathogenesis of abdominal aortic aneurysm (AAA) remains unclear, evidence is accumulating to support a central role for inflammation. Inflammatory responses are coordinated by various soluble cytokines of which IL-6 is one of the major proinflammatory cytokines. In this study we examined the role of IL-6 in the pathogenesis of experimental AAA induced by a periaortic exposure to CaCl2 in mice. We now report that the administration of MR16-1, a neutralizing monoclonal antibody specific for the mouse IL-6 receptor, mildly suppressed the development of AAA. The inhibition of IL-6 signaling provoked by MR16-1 also resulted in a suppression of Stat3 activity. Conversely, no significant changes in either NF kappa B activity, Jnk activity or the expression of matrix metalloproteinases (Mmp) -2 and -9 were identified. Transcriptome analyses revealed that MR16-1-sensitive genes encode chemokines and their receptors, as well as factors that regulate vascular permeability and cell migration. Imaging cytometric analyses then consistently demonstrated reduced cellular infiltration for MR16-1-treated AAA. These results suggest that IL-6 plays an important but limited role in AAA pathogenesis, and primarily regulates cell migration and infiltration. These data would also suggest that IL-6 activity may play an important role in scenarios of continuous cellular infiltration, possibly including human AAA.	[Nishihara, Michihide; Ohno, Satoko; Furusho, Aya; Hirakata, Saki; Nishida, Norifumi; Ito, Sohei; Hayashi, Makiko; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Kurume, Fukuoka, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan; [Imaizumi, Tsutomu] Int Univ Hlth & Welf, Fukuoka, Japan	Kurume University; Kurume University; International University of Health & Welfare	Aoki, H (corresponding author), Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka, Japan.	haoki@med.kurume-u.ac.jp		Ito, Sohei/0000-0003-1374-2946	Japan Society for the Promotion of Science [25861238, 21390367, 24390334, 24659640, 26670621, 16H05428]; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [15K10249] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/index.html) 25861238 (MN), 21390367 (HA), 24390334 (HA), 24659640 (HA), 26670621 (HA), 16H05428 (HA); Daiichi Sankyo Foundation of Life Science (http://www.ds-fdn.or.jp) (HA); Uehara Memorial Foundation (http://www.ueharazaidan.or.jp) (HA); Vehicle Racing Commemorative Foundation (http://www.vecof.or.jp) (HA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2016, MOUSE MODELS VASCULA, P211; Aoki H, 2007, J MOL MED, V85, P1077, DOI 10.1007/s00109-007-0213-2; Araki Y, 2016, ARTHRITIS RHEUMATOL, V68, P1111, DOI 10.1002/art.39563; Arnaoutoglou E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/945035; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Chen XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153811; Emeto TI, 2014, CURR DRUG TARGETS, V15, P860; Harrison SC, 2013, EUR HEART J, V34, P3707, DOI 10.1093/eurheartj/ehs354; Hartman MHT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167195; Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112; Henaut L, 2016, EXPERT OPIN THER TAR, V20, P89, DOI 10.1517/14728222.2015.1081685; Hingorani A, 1998, J VASC SURG, V28, P522, DOI 10.1016/S0741-5214(98)70139-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ijaz T, 2016, J THORAC DIS, V8, pE746, DOI 10.21037/jtd.2016.06.37; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kimura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04051; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Ma ZD, 2001, J IMMUNOL, V167, P5150, DOI 10.4049/jimmunol.167.9.5150; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Miyake T, 2007, CIRC RES, V101, P1175, DOI 10.1161/CIRCRESAHA.107.148668; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Nagahama KY, 2013, AM J RESP CELL MOL, V49, P582, DOI 10.1165/rcmb.2012-0460OC; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Rabkin SW, 2017, PROG MOL BIOL TRANSL, V147, P239, DOI 10.1016/bs.pmbts.2017.02.002; Senemaud J, 2017, ARTERIOSCLER THROMB; Shteinberg D, 2000, EUR J VASC ENDOVASC, V20, P462, DOI 10.1053/ejvs.2000.1210; Sporri B, 1999, INT IMMUNOL, V11, P1053, DOI 10.1093/intimm/11.7.1053; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Timlin H, 2014, EXPERT OPIN BIOL TH, V14, P893, DOI 10.1517/14712598.2014.900536; Wang YT, 2013, ATHEROSCLEROSIS, V226, P29, DOI 10.1016/j.atherosclerosis.2012.09.010; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Yoshida H, 2011, RHEUMATOL INT, V31, P1445, DOI 10.1007/s00296-010-1500-8; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621	36	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185923	10.1371/journal.pone.0185923	http://dx.doi.org/10.1371/journal.pone.0185923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982132	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300088
J	Ruiz-Blanco, YB; Almeida, Y; Sotomayor-Torres, CM; Garcia, Y				Ruiz-Blanco, Y. B.; Almeida, Y.; Sotomayor-Torres, C. M.; Garcia, Y.			Unveiled electric profiles within hydrogen bonds suggest DNA base pairs with similar bond strengths	PLOS ONE			English	Article							AB-INITIO CALCULATIONS; SINGLE-MOLECULE; NANOCONTACTS; RECOGNITION; CRISPR-CAS9; TRANSPORT; STACKING; DYNAMICS; ACID	Electrical forces are the background of all the interactions occurring in biochemical systems. From here and by using a combination of ab-initio and ad-hoc models, we introduce the first description of electric field profiles with intrabond resolution to support a characterization of single bond forces attending to its electrical origin. This fundamental issue has eluded a physical description so far. Our method is applied to describe hydrogen bonds (HB) in DNA base pairs. Numerical results reveal that base pairs in DNA could be equivalent considering HB strength contributions, which challenges previous interpretations of thermodynamic properties of DNA based on the assumption that Adenine/Thymine pairs are weaker than Guanine/Cytosine pairs due to the sole difference in the number of HB. Thus, our methodology provides solid foundations to support the development of extended models intended to go deeper into the molecular mechanisms of DNA functioning.	[Ruiz-Blanco, Y. B.] Univ Cent Marta Abreu Las Villas, Fac Quim & Farm, Santa Clara, Villa Clara, Cuba; [Almeida, Y.] Ctr Mol Immunol, Syst Biol Direct, Havana, Cuba; [Sotomayor-Torres, C. M.] CSIC, ICN2, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] BIST, Campus UAB, Barcelona, Spain; [Sotomayor-Torres, C. M.] ICREA, Barcelona, Spain; [Almeida, Y.] Hamburg Ctr Ultrafast Imaging, Hamburg, Germany; [Almeida, Y.] Univ Hamburg, Dept Chem, Inst Biochem & Mol Biol, Hamburg, Germany; [Garcia, Y.] Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain	Universidad Central "Marta Abreu" de Las Villas; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; ICREA; University of Hamburg; University of Hamburg; Universitat Politecnica de Catalunya	Garcia, Y (corresponding author), Univ Politecn Cataluna, Dept Math, ESAB, Esteve Terradas, Castelldefels, Spain.	yamila.garcia@uv.es	Blanco, Yasser Bruno Ruiz/U-1044-2019; Almeida-Hernandez, Yasser/AAH-9870-2020; Torres, Clivia M Sotomayor/E-8418-2010	Blanco, Yasser Bruno Ruiz/0000-0001-5400-4427; Almeida-Hernandez, Yasser/0000-0001-9832-3534; Torres, Clivia M Sotomayor/0000-0001-9986-2716	Spanish MINECO [FIS2015-70862-P]; programme Severo Ochoa [SEV-2013-0295]; CERCA Programme/Generalitat de Catalunya; Spanish MINECO [FIS2015-70862-P]; programme Severo Ochoa [SEV-2013-0295]; CERCA Programme/Generalitat de Catalunya	Spanish MINECO(Spanish Government); programme Severo Ochoa; CERCA Programme/Generalitat de Catalunya; Spanish MINECO(Spanish Government); programme Severo Ochoa; CERCA Programme/Generalitat de Catalunya	CMST acknowledges the financial support from the Spanish MINECO project PHENTOM (FIS2015-70862-P), the programme Severo Ochoa (Grant SEV-2013-0295) and funding from the CERCA Programme/Generalitat de Catalunya. Computational facilities have been provided by "Centro de Supercomputacion de Galicia" (CESGA).	Al Ahmad M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29089; Alberts B, 2003, NATURE, V421, P431, DOI 10.1038/nature01407; Arunan E, 2011, PURE APPL CHEM, V83, P1619, DOI 10.1351/PAC-REP-10-01-01; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Castro CE, 2015, NANOSCALE, V7, P5913, DOI 10.1039/c4nr07153k; Ceron-Carrasco JP, 2013, CHEM COMMUN, V49, P7578, DOI 10.1039/c3cc42593b; Chang S, 2009, NAT NANOTECHNOL, V4, P297, DOI [10.1038/nnano.2009.48, 10.1038/NNANO.2009.48]; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Frisch G. W., 2013, GAUSSIAN 09; Garcia Y, 2008, INT J QUANTUM CHEM, V108, P1637, DOI 10.1002/qua.21636; Garcia Y, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.041402; Garcia Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34616; Garcia Y, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2953459; Garcia Y, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3158606; Garcia Y, 2013, J MODERN PHYS, V4-4, P522; Gorodetskaya IA, 2015, NAT CHEM, V7, P541, DOI 10.1038/nchem.2290; Guerra CF, 1999, CHEM-EUR J, V5, P3581; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Ke YG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10935; Kelley SO, 2014, NAT NANOTECHNOL, V9, P969, DOI [10.1038/nnano.2014.261, 10.1038/NNANO.2014.261]; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poater J, 2014, ORG BIOMOL CHEM, V12, P4691, DOI 10.1039/c4ob00427b; Poater J, 2011, CHEM COMMUN, V47, P7326, DOI 10.1039/c0cc04707d; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sponer J, 2001, BIOPOLYMERS, V61, P3, DOI 10.1002/1097-0282(2001)61:1<3::AID-BIP10048>3.0.CO;2-4; Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U; Szatylowicz H, 2010, J CHEM INF MODEL, V50, P2151, DOI 10.1021/ci100288h; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502; Wong IY, 2013, GENE DEV, V27, P2397, DOI 10.1101/gad.226837.113; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	42	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185638	10.1371/journal.pone.0185638	http://dx.doi.org/10.1371/journal.pone.0185638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982182	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300052
J	Chizhov, AV; Amakhin, DV; Zaitsev, AV				Chizhov, Anton V.; Amakhin, Dmitry V.; Zaitsev, Aleksey V.			Computational model of interictal discharges triggered by interneurons	PLOS ONE			English	Article							IN-VITRO; CHLORIDE HOMEOSTASIS; SPREADING DEPRESSION; PREICTAL DISCHARGES; INTERSTITIAL SPACE; GAMMA-OSCILLATIONS; INHIBITORY NEURONS; GAP-JUNCTIONS; NETWORK; SYNCHRONIZATION	Interictal discharges (IIDs) are abnormal waveforms registered in the periods before or between seizures. IIDs that are initiated by GABAergic interneurons have not been mathematically modeled yet. In the present study, a mathematical model that describes the mechanisms of these discharges is proposed. The model is based on the experimental recordings of IIDs in pyramidal neurons of the rat entorhinal cortex and estimations of synaptic conductances during IIDs. IIDs were induced in cortico-hippocampal slices by applying an extracellular solution with 4-aminopyridine, high potassium, and low magnesium concentrations. Two different types of IIDs initiated by interneurons were observed. The first type of IID (IID1) was pure GABAergic. The second type of IID (IID2) was induced by GABAergic excitation and maintained by recurrent interactions of both GABA-and glutamatergic neuronal populations. The model employed the conductance-based refractory density (CBRD) approach, which accurately approximates the firing rate of a population of similar HodgkinHuxley- like neurons. The model of coupled excitatory and inhibitory populations includes AMPA, NMDA, and GABA-receptor-mediated synapses and gap junctions. These neurons receive both arbitrary deterministic input and individual colored Gaussian noise. Both types of IIDs were successfully reproduced in the model by setting two different depolarized levels for GABA-mediated current reversal potential. It was revealed that short-term synaptic depression is a crucial factor in ceasing each of the discharges, and it also determines their durations and frequencies.	[Chizhov, Anton V.] Ioffe Inst, Computat Phys Lab, St Petersburg, Russia; [Chizhov, Anton V.; Amakhin, Dmitry V.; Zaitsev, Aleksey V.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Lab Mol Mech Neural Interact, St Petersburg, Russia; [Zaitsev, Aleksey V.] Fed Almazov North West Med Res Ctr, Inst Expt Med, St Petersburg, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry; Almazov National Medical Research Centre; Institute of Experimental Medicine	Chizhov, AV (corresponding author), Ioffe Inst, Computat Phys Lab, St Petersburg, Russia.; Chizhov, AV (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, Lab Mol Mech Neural Interact, St Petersburg, Russia.	anton.chizhov@mail.loffe.ru	Zaitsev, Aleksey/A-5648-2008; Amakhin, Dmitry V/F-2783-2017; Chizhov, Anton V/C-1773-2014	Zaitsev, Aleksey/0000-0002-4503-0647; Chizhov, Anton V/0000-0002-7993-6770; Amakhin, Dmitry/0000-0002-7098-4768	Russian Science Foundation [16-15-10201]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (project 16-15-10201).	Alfonsa H, 2015, J NEUROSCI, V35, P7715, DOI 10.1523/JNEUROSCI.4105-14.2015; Amakhin DV, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00233; Antonio LL, 2016, J NEUROSCI METH, V260, P33, DOI 10.1016/j.jneumeth.2015.08.014; Avoli M, 2002, PROG NEUROBIOL, V68, P167, DOI 10.1016/S0301-0082(02)00077-1; Bandyopadhyay S, 2006, J NEUROPHYSIOL, V95, P1908, DOI 10.1152/jn.00881.2005; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Borg-Graham L.J., 1999, CEREBRAL CORTEX MODE, P19, DOI DOI 10.1007/978-1-4615-4903-1_2; Buchin A, 2016, J NEUROSCI, V36, P11619, DOI 10.1523/JNEUROSCI.4228-15.2016; Buzsaki G, 1991, Hippocampus, V1, P163, DOI 10.1002/hipo.450010205; Chizhov AV, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062704; Chizhov AV, 2014, J COMPUT NEUROSCI, V36, P297, DOI 10.1007/s10827-013-0473-5; Chizhov AV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011910; Chizhov AV, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011924; Chizhov AV, 2017, CURRENT BIOL CYBERNE; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; DeFazio RA, 2000, J NEUROSCI, V20, P8069; DeFazio RA, 2005, DEV BRAIN RES, V157, P83, DOI 10.1016/j.devbrainres.2005.03.008; Deisz RA, 2014, NEUROSCIENCE, V277, P831, DOI 10.1016/j.neuroscience.2014.07.037; Deisz RA, 2011, J PHYSIOL-LONDON, V589, P1317, DOI 10.1113/jphysiol.2010.201830; Dickson CT, 1997, J NEUROSCI, V17, P6729; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; FERTZIGER AP, 1970, EXP NEUROL, V26, P571, DOI 10.1016/0014-4886(70)90150-0; Frohlich F, 2008, NEUROSCIENTIST, V14, P422, DOI 10.1177/1073858408317955; Fu LY, 2007, J PHYSIOL-LONDON, V579, P445, DOI 10.1113/jphysiol.2002.019356; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gan J, 2017, NEURON, V93, P308, DOI 10.1016/j.neuron.2016.12.018; Glykys J, 2014, SCIENCE, V343, P670, DOI 10.1126/science.1245423; Grosser S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086250; Hamidi S, 2015, NEUROBIOL DIS, V79, P51, DOI 10.1016/j.nbd.2015.04.006; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Hubel N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003941; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kager H, 2007, J COMPUT NEUROSCI, V22, P105, DOI 10.1007/s10827-006-0001-y; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kaila K, 1997, J NEUROSCI, V17, P7662; Karlocai MR, 2014, BRAIN, V137, P463, DOI 10.1093/brain/awt348; Karus C, 2015, GLIA, V63, P936, DOI 10.1002/glia.22793; Khoshkhoo S, 2017, NEURON, V93, P291, DOI 10.1016/j.neuron.2016.11.043; Krishnan GP, 2015, J NEUROPHYSIOL, V113, P3356, DOI 10.1152/jn.00460.2014; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Kurbatova P, 2016, EXP NEUROL, V283, P57, DOI 10.1016/j.expneurol.2016.05.037; Loebel A, 2002, J COMPUT NEUROSCI, V13, P111, DOI 10.1023/A:1020110223441; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Neske GT, 2015, J NEUROSCI, V35, P1089, DOI 10.1523/JNEUROSCI.2279-14.2015; Owen JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073820; Pallud J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008065; Platkiewicz J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001129; Povysheva NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070553; Raimondo JV, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00419; Ratnadurai-Giridharan S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00002; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Sabolek HR, 2012, J NEUROSCI, V32, P3009, DOI 10.1523/JNEUROSCI.5853-11.2012; Scimemi A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00161; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; Song IS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1377; Stafstrom CE, 2011, EPILEPSY CURR, V11, P200, DOI 10.5698/1535-7511-11.6.200; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; TRAUB RD, 1985, NEUROSCIENCE, V15, P947, DOI 10.1016/0306-4522(85)90245-3; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Uva L, 2009, EUR J NEUROSCI, V29, P911, DOI 10.1111/j.1460-9568.2009.06672.x; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Viitanen T, 2014, J PHYSL, V588, P1527; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Wendling F, 2016, J NEUROSCI METH, V260, P233, DOI 10.1016/j.jneumeth.2015.03.027; Wendling F, 2012, EUR J NEUROSCI, V36, P2164, DOI 10.1111/j.1460-9568.2012.08039.x; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Wolfe J, 2010, CURR OPIN NEUROBIOL, V20, P306, DOI 10.1016/j.conb.2010.03.006; Yang QZ, 2001, BRAIN RES, V907, P139, DOI 10.1016/S0006-8993(01)02582-3; Yekhlef L, 2015, J NEUROPHYSIOL, V113, P1616, DOI 10.1152/jn.00841.2014; Yelhekar TD, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0019-17.2017; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198; Ziburkus J, 2013, J NEUROPHYSIOL, V109, P1296, DOI 10.1152/jn.00232.2012; Zsiros V, 2007, J PHYSIOL-LONDON, V578, P527, DOI 10.1113/jphysiol.2006.123463; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	84	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185752	10.1371/journal.pone.0185752	http://dx.doi.org/10.1371/journal.pone.0185752			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977038	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100042
J	Ree, IMC; Fustolo-Gunnink, SF; Bekker, V; Fijnvandraat, KJ; Steggerda, SJ; Lopriore, E				Ree, Isabelle M. C.; Fustolo-Gunnink, Suzanne F.; Bekker, Vincent; Fijnvandraat, Karin J.; Steggerda, Sylke J.; Lopriore, Enrico			Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors	PLOS ONE			English	Article							ORGANISM-SPECIFIC RESPONSE; INTENSIVE-CARE-UNIT; LATE-ONSET SEPSIS; PLATELET TRANSFUSIONS; INFANTS; THROMBOPOIESIS; MANAGEMENT; INSIGHTS	Objectives Thrombocytopenia is a frequent problem in neonatal sepsis and is among the most predictive, independent risk factors for sepsis-associated mortality. This study aims to clarify the occurrence, severity and duration of thrombocytopenia in neonatal sepsis. Study design A cohort study was carried out among all neonates with proven culture positive sepsis that were admitted to a tertiary NICU between 2006 and 2015 (n = 460). The occurrence, severity and duration of thrombocytopenia were recorded, as well as major bleedings and potential risk factors for mortality in neonatal sepsis. Results Sepsis was diagnosed in 460 of 6551 neonates (7%). Severe thrombocytopenia (platelets <= 50*10(9)/L) occurred in 20% (92/460) of septic neonates. The median time for platelets to rise >100*10(9) was 6.0 days (interquartile range 4.0-7.0). On multivariate analysis, maternal hypertension, intravascular thrombosis and Gram negative (as opposed to Gram positive) sepsis were independently associated with thrombocytopenia in neonatal sepsis. In severe thrombocytopenia, 10% (9/92) suffered a severe IVH, compared to 5% (20/356) in neonates with platelets >50*109/L (p = 0.125). 10% (9/92) suffered a pulmonary hemorrhage, compared to 2% (9/368) in neonates with platelets >50*109/L (p = 0.001). On multivariate analysis, thrombocytopenia and Gram negative (as opposed to Gram positive) sepsis were independently associated with neonatal mortality. Conclusions Thrombocytopenia is independently associated with maternal hypertension, intravascular thrombosis and Gram negative sepsis. Thrombocytopenia in neonatal sepsis increases the risk of mortality nearly four-fold, with another six-fold increase in mortality in case of Gram negative sepsis.	[Ree, Isabelle M. C.; Steggerda, Sylke J.; Lopriore, Enrico] Leiden Univ, Div Neonatol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Fustolo-Gunnink, Suzanne F.; Fijnvandraat, Karin J.] Acad Med Ctr, Dept Pediat Hematol, Amsterdam, Netherlands; [Fustolo-Gunnink, Suzanne F.] Sanquin Blood Supply, Dept Clin Transfus Res, Leiden, Netherlands; [Bekker, Vincent] Leiden Univ, Div Hematol Immunol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Fijnvandraat, Karin J.] Sanquin Blood Supply, Dept Plasma Prot, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ree, IMC (corresponding author), Leiden Univ, Div Neonatol, Dept Pediat, Med Ctr, Leiden, Netherlands.	i.m.c.ree@lumc.nl	Bekker, Vincent/GWU-6464-2022; Lopriore, Enrico/ABE-3576-2021	Bekker, Vincent/0000-0002-6543-5537; Lopriore, Enrico/0000-0002-3513-5066				Akarsu S, 2005, J TROP PEDIATRICS, V51, P388, DOI 10.1093/tropej/fmi031; Bhat MA, 2009, J PERINATOL, V29, P702, DOI 10.1038/jp.2009.72; Bolat F, 2012, PEDIATR HEMAT ONCOL, V29, P710, DOI 10.3109/08880018.2012.725454; Brown RE, 2008, PEDIATR RES, V64, P399, DOI 10.1203/PDR.0b013e318181ad49; CBO DIfHI, 2011, NAT GUID BLOOD TRANS; Christensen RD, 2006, J PERINATOL, V26, P348, DOI 10.1038/sj.jp.7211509; Claushuis TAM, 2016, BLOOD, V127, P3062, DOI 10.1182/blood-2015-11-680744; Eissa DS, 2013, PLATELETS, V24, P122, DOI 10.3109/09537104.2012.696748; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Gunnink SF, 2014, EXPERT REV HEMATOL, V7, P387, DOI 10.1586/17474086.2014.902301; Haque Khalid N, 2005, Pediatr Crit Care Med, V6, pS45, DOI 10.1097/01.PCC.0000161946.73305.0A; Kloosterman G J, 1969, Maandschr Kindergeneeskd, V37, P209; Levit O, 2014, PEDIATR INFECT DIS J, V33, P143, DOI 10.1097/INF.0000000000000024; Lieberman L, 2014, BLOOD, V123, P1146, DOI 10.1182/blood-2013-02-435693; Manzoni P, 2015, CLIN PERINATOL, V42, P587, DOI 10.1016/j.clp.2015.04.012; Manzoni P, 2009, PEDIATR INT, V51, P206, DOI 10.1111/j.1442-200X.2008.02689.x; Murray NA, 2002, TRANSFUSION MED, V12, P35, DOI 10.1046/j.1365-3148.2002.00343.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts I, 2008, BLOOD REV, V22, P173, DOI 10.1016/j.blre.2008.03.004; Sola-Visner M, 2016, TRANSFUS MED REV, V30, P183, DOI 10.1016/j.tmrv.2016.05.009; Sola-Visner M, 2009, SEMIN PERINATOL, V33, P43, DOI 10.1053/j.semperi.2008.10.008; Stanworth SJ, 2009, PEDIATRICS, V124, pE826, DOI 10.1542/peds.2009-0332; Venkatesh V, 2013, ARCH DIS CHILD-FETAL, V98, pF260, DOI 10.1136/archdischild-2012-302443; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4	24	37	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185581	10.1371/journal.pone.0185581	http://dx.doi.org/10.1371/journal.pone.0185581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977011	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100032
J	Ben Abdelkrim, A; Hattab, T; Fakhfakh, H; Belkadhi, MS; Gorsane, F				Ben Abdelkrim, Ahmed; Hattab, Tarek; Fakhfakh, Hatem; Belkadhi, Mohamed Sadok; Gorsane, Faten			A landscape genetic analysis of important agricultural pest species in Tunisia: The whitefly Bemisia tabaci	PLOS ONE			English	Article							HEMIPTERA ALEYRODIDAE BIOTYPES; MICROSATELLITE-LOCI; MITOCHONDRIAL-DNA; CLIMATE-CHANGE; HOST PLANTS; POPULATIONS; RANGE; DIVERSITY; PATTERNS; SURFACES	Combining landscape ecology and genetics provides an excellent framework to appreciate pest population dynamics and dispersal. The genetic architectures of many species are always shaped by environmental constraints. Because little is known about the ecological and genetic traits of Tunisian whitefly populations, the main objective of this work is to highlight patterns of biodiversity, genetic structure and migration routes of this pest. We used nuclear microsatellite loci to analyze B. tabaci populations collected from various agricultural areas across the country and we determine their biotype status. Molecular data were subsequently interpreted in an ecological context supplied from a species distribution model to infer habitat suitability and hereafter the potential connection paths between sampling localities. An analysis of landscape resistance to B. tabaci genetic flow was thus applied to take into account habitat suitability, genetic relatedness and functional connectivity of habitats within a varied landscape matrix. We shed light on the occurrence of three geographically delineated genetic groups with high levels of genetic differentiation within each of them. Potential migration corridors of this pest were then established providing significant advances toward the understanding of genetic features and the dynamic dispersal of this pest. This study supports the hypothesis of a long-distance dispersal of B. tabaci followed by infrequent long-term isolations. The Inference of population sources and colonization routes is critical for the design and implementation of accurate management strategies against this pest.	[Ben Abdelkrim, Ahmed; Fakhfakh, Hatem; Gorsane, Faten] Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia; [Ben Abdelkrim, Ahmed] Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 7592, Inst Jacques Monod, Paris, France; [Hattab, Tarek] IFREMER, UMR MARBEC 248, Inst Francais Rech Exploitat Mer, Ave Jean Monnet CS, Sete, France; [Fakhfakh, Hatem; Gorsane, Faten] Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia; [Belkadhi, Mohamed Sadok] Ctr Tech Cultures Protegees & Geotherm Gabes, Gabes, Tunisia	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Ifremer; Universite de Montpellier; Universite de Carthage	Gorsane, F (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia.; Gorsane, F (corresponding author), Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia.	fatengorsane@gmail.com	Ben Abdelkrim, Ahmed/X-2878-2018	Ben Abdelkrim, Ahmed/0000-0002-5721-0944; fakhfakh, hatem/0000-0002-0441-7511	Ministry of Higher Education and Scientific Research of Tunisia [LR 99 ES 12]; USA MERC (Middle East Research Coorporation) project [TA-MOU-08-M28-048]	Ministry of Higher Education and Scientific Research of Tunisia; USA MERC (Middle East Research Coorporation) project	This study was partially supported by the Ministry of Higher Education and Scientific Research of Tunisia (LR 99 ES 12) and the USA MERC (Middle East Research Coorporation) project TA-MOU-08-M28-048.	Abd-Rabou S, 2010, ENTOMOL NEWS, V121, P456, DOI 10.3157/021.121.0507; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bayhan E, 2006, J PEST SCI, V79, P233, DOI 10.1007/s10340-006-0139-4; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boivin G, 2006, INTRA INTERSPECIFIC, P123; Bosco D, 2006, PHYTOPARASITICA, V34, P243, DOI 10.1007/BF02980951; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boykin LM, 2014, PEST MANAG SCI, V70, P1454, DOI 10.1002/ps.3709; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Brown JK, 2010, POPULAR POLITICS RES, P31; Byrne DN, 1996, OECOLOGIA, V105, P320, DOI 10.1007/BF00328734; Cornuet JM, 1996, GENETICS, V144, P2001; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2005, MOL ECOL, V14, P3695, DOI 10.1111/j.1365-294X.2005.02700.x; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; Delatte H, 2006, GENET RES, V87, P109, DOI 10.1017/S0016672306008135; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Etherington TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088293; Fresia P, 2014, ACTA TROP, V138, pS34, DOI 10.1016/j.actatropica.2014.04.003; Frohlich D., 1999, MOL ECOL, V8, P1593, DOI DOI 10.1046/J.1365-294X.1999.00754.X; Gauthier N, 2008, MOL ECOL RESOUR, V8, P1004, DOI 10.1111/j.1755-0998.2008.02163.x; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734; Gorsane F, 2011, ENVIRON ENTOMOL, V40, P809, DOI 10.1603/EN10162; Hadjistylli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165105; Hall LA, 2014, LANDSCAPE ECOL, V29, P1487, DOI 10.1007/s10980-014-0082-3; Hattab T, 2017, DIVERS DISTRIB, V23, P806, DOI 10.1111/ddi.12566; Hattab T, 2014, GLOBAL ECOL BIOGEOGR, V23, P1417, DOI 10.1111/geb.12217; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Holderegger R, 2008, EVOLUTION, V62, P2922, DOI 10.1111/j.1558-5646.2008.00498.x; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Laarif A, 2015, PHYTOPARASITICA, V43, P135, DOI 10.1007/s12600-014-0437-y; Laloe D, 2007, GENET SEL EVOL, V39, P545, DOI 10.1051/gse:2007021; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; McKenzie CL, 2009, J ECON ENTOMOL, V102, P670, DOI 10.1603/029.102.0227; McKenzie CL, 2012, J ECON ENTOMOL, V105, P753, DOI 10.1603/EC11337; Mirande L, 2015, J PEST SCI, V88, P155, DOI 10.1007/s10340-014-0597-z; Naranjo SE, 2009, POPULATION DYNAMICS, P185; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; R Core Team, 2013, R LANG ENV STAT COMP, P3; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Russo IRM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29168; Saleh D, 2012, POPUL ECOL, V54, P261, DOI 10.1007/s10144-012-0303-z; Simon B, 2007, ENTOMOL EXP APPL, V124, P327, DOI 10.1111/j.1570-7458.2007.00586.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Stevenson-Holt CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112119; Tan XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28245; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Tsagkarakou A, 2012, B ENTOMOL RES, V102, P353, DOI 10.1017/S0007485311000757; Tsagkarakou A, 2003, MOL ECOL NOTES, V3, P196, DOI 10.1046/j.1471-8286.2003.00393.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xu J, 2011, J APPL ENTOMOL, V135, P771, DOI 10.1111/j.1439-0418.2010.01581.x; Zidon R, 2016, ECOL APPL, V26, P1198, DOI 10.1890/15-1045	67	7	7	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185724	10.1371/journal.pone.0185724	http://dx.doi.org/10.1371/journal.pone.0185724			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972992	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900042
J	Lin, YC; Lin, CY; Chee, SY; Yen, HR; Tsai, FJ; Chen, CY; Wang, CH				Lin, Yi-Chun; Lin, Chih-Ying; Chee, Siew-Yin; Yen, Hung-Rong; Tsai, Fuu-Jen; Chen, Chiu-Ying; Wang, Chung-Hsing			Improved final predicted height with the injection of leuprolide in children with earlier puberty: A retrospective cohort study	PLOS ONE			English	Article							PRECOCIOUS PUBERTY; HORMONE AGONIST; ANALOG TREATMENT; ADULT HEIGHT; GIRLS; GROWTH; DIAGNOSIS; ONSET; THERAPY; AGE	The adult height of children with early onset puberty is limited by the premature maturation of hypothalamic-pituitary-gonadal axis. To evaluate the effects of gonadotropin-releasing hormone analog (GnRHa) treatment on the final height (FH) and bone maturation rate (BMR) in girls with early puberty (EP) or idiopathic central precocious puberty (ICPP), we examined data from girls who were diagnosed with EP or ICPP and underwent GnRHa (Leuplin Depot: 3.75 mg/month) at China Medical University Hospital, in Taiwan, between 2006 and 2015. Patients were observed until the achievement of FH and divided into an "EP group" (T-ep) and "ICPP group" (T-icpp) according to the age of onset of puberty. Eighty-seven patients were enrolled (T-ep, N = 44, puberty onset at 8-10 years; T-icpp, N = 43, puberty onset before 8 years). The demographic data of girls with EP or IPP was characterized. BMR, change in predicted final height (PFH) after GnRHa treatment, target height (TH) and FH were measured. After GnRHa treatment, the study groups (T-ep: 160.24 +/- 6.18 cm, T-icpp: 158.99 +/- 5.92 cm) both had higher PFH than at initiation (T-ep: 159.83 +/- 7.19 cm, T-icpp: 158.58 +/- 5.93 cm). There was deceleration of BMR in both groups (T-ep: 0.57 +/- 0.39; T-icpp: 0.97 +/- 0.97) and a significant difference between the groups (p = 0.027). The gap in FH standard deviation scores (SDS) and TH SDS had a significant difference in T-ep (p = 0.045) but not in T-icpp. Moreover, there was no difference in the gap of PFH SDS between the 1st and final treatment in both groups. We concluded that GnRHa decelerated BMR in girls with earlier puberty. Further prospective clinical studies are warranted.	[Lin, Yi-Chun; Yen, Hung-Rong] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan; [Lin, Chih-Ying] China Med Univ, Dept Publ Hlth, Doctoral Program, Taichung, Taiwan; [Chee, Siew-Yin; Tsai, Fuu-Jen; Wang, Chung-Hsing] China Med Univ, Dept Genet & Metab, Childrens Hosp, Taichung, Taiwan; [Yen, Hung-Rong; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Res Ctr Tradit Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan; [Yen, Hung-Rong] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Chiu-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Wang, CH (corresponding author), China Med Univ, Dept Genet & Metab, Childrens Hosp, Taichung, Taiwan.; Chen, CY (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.	yichunlin1228@gmail.com; a2340961@yahoo.com.tw	Yen, Hung-Rong/M-1373-2013	Yen, Hung-Rong/0000-0002-0131-1658	China Medical University Hospital [DMR-103-040]	China Medical University Hospital	The study was supported by grants from the China Medical University Hospital (DMR-103-040).	Abreu AP, 2016, LANCET DIABETES ENDO, V4, P254, DOI 10.1016/S2213-8587(15)00418-0; [Anonymous], 2014, LANCET, V384, P1159, DOI DOI 10.1016/S0140-6736(14)61707-4; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; Bentham J, 2016, ELIFE, V5, DOI 10.7554/eLife.13410.001; Bouvattier C, 1999, J CLIN ENDOCR METAB, V84, P3575, DOI 10.1210/jc.84.10.3575; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassio A, 1999, ARCH DIS CHILD, V81, P329, DOI 10.1136/adc.81.4.329; Cesario SK, 2007, JOGNN-J OBST GYN NEO, V36, P263, DOI 10.1111/J.1552-6909.2007.00145.x; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; Chemaitilly W, 2001, CLIN ENDOCRINOL, V54, P289, DOI 10.1046/j.1365-2265.2001.01229.x; Chulani VL, 2014, PRIMARY CARE, V41, P465, DOI 10.1016/j.pop.2014.05.002; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; Galvao TF, 2014, J AFFECT DISORDERS, V155, P13, DOI 10.1016/j.jad.2013.10.034; Khadgawat R, 2016, INDIAN PEDIATR, V53, P383, DOI 10.1007/s13312-016-0857-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Latronico AC, 2016, LANCET DIABETES ENDO, V4, P265, DOI 10.1016/S2213-8587(15)00380-0; Martins CS, 2014, GROWTH HORM IGF RES, V24, P123, DOI 10.1016/j.ghir.2014.04.005; MARTORELL R, 1995, J NUTR, V125, pS1127, DOI 10.1093/jn/125.suppl_4.1127S; Mauras N, 2000, J CLIN ENDOCR METAB, V85, P3653, DOI 10.1210/jc.85.10.3653; Mogensen SS, 2011, J CLIN ENDOCR METAB, V96, P1393, DOI 10.1210/jc.2010-2745; Mul D, 2005, CLIN ENDOCRINOL, V63, P185, DOI 10.1111/j.1365-2265.2005.02323.x; Nacinovich R, 2016, MINERVA PEDIATR, V68, P11; Neely EK, 2014, CURR OPIN OBSTET GYN, V26, P332, DOI 10.1097/GCO.0000000000000099; NEELY EK, 1995, J PEDIATR-US, V127, P40, DOI 10.1016/S0022-3476(95)70254-7; Pienkowski C, 2016, ENDOCR DEV, V29, P214, DOI 10.1159/000438893; Pucarelli I, 2003, J PEDIATR ENDOCR MET, V16, P1005; Roberts C, 2016, LANCET DIABETES ENDO, V4, P195, DOI 10.1016/S2213-8587(16)00038-3; Sagodi Laszlo, 2012, Orvosi Hetilap, V153, P418, DOI 10.1556/OH.2012.29320; Savas-Erdeve S, 2016, J CLIN RES PEDIATR E, V8, P211, DOI 10.4274/jcrpe.2356; Schor KSSG, 2015, NELSON TXB PEDIAT DI; Somod ME, 2016, INT J PEDIATR ENDOCR, DOI 10.1186/s13633-016-0022-x; Sorensen K, 2012, HORM RES PAEDIAT, V77, P137, DOI 10.1159/000336325; Sun L, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0543-9; Tanner J M, 1987, Acta Paediatr Jpn, V29, P96; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40	36	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185080	10.1371/journal.pone.0185080	http://dx.doi.org/10.1371/journal.pone.0185080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973010	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900012
J	Chiang, HY; Chu, PH; Lee, TH				Chiang, Hou-Yu; Chu, Pao-Hsien; Lee, Ting-Hein			R1R2 peptide ameliorates pulmonary fibrosis in mice through fibrocyte migration and differentiation	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; CIRCULATING FIBROCYTES; MATRIX METALLOPROTEINASES; GELATINASE-A; I COLLAGEN; MOLECULAR-MECHANISMS; STREPTOCOCCUS-EQUI; BINDING DOMAIN; LUNG INJURY; FIBRONECTIN	Circulating fibrocytes play a key role in the pathogenesis of pulmonary fibrosis. Fibrocytes are bone marrow-derived leukocytes, which enter the lungs in response to their chemoattractant CXCL12 and differentiate into fibroblasts or myofibroblasts, leading to excess deposition of the collagen-rich extracellular matrix. Matrix metalloproteinase (MMP)-9 and MMP-2, secreted by fibrocytes, degrade the subendothelial basement membrane and promote fibrocyte influx into the lungs. Here, we demonstrate that R1R2, a novel peptide derived from the bacterial adhesin SFS, attenuates pulmonary fibrosis by preventing the differentiation of fibrocytes into myofibroblasts and by reducing the invasion of fibrocytes through basement membrane-like proteins. Moreover, our findings reveal dual regulation of R1R2 on MMP-9 through reduced enzymatic activity on gelatin and increased cleavage of CXCL12. These data suggest that R1R2 has potent anti-fibrotic effects against pulmonary fibrosis.	[Chiang, Hou-Yu; Lee, Ting-Hein] Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan; [Chiang, Hou-Yu; Lee, Ting-Hein] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Chiang, Hou-Yu; Chu, Pao-Hsien; Lee, Ting-Hein] Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Taoyuan, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Univ, Dept Anat, Coll Med, Taoyuan, Taiwan.; Lee, TH (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan.; Lee, TH (corresponding author), Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Taoyuan, Taiwan.	tingheinlee@mail.cgu.edu.tw	Chu, Pao-Hsien/P-5249-2019	Chu, Pao-Hsien/0000-0003-0361-6348; Lee, Ting-Hein/0000-0001-7077-3138	Chang Gung Memorial Hospital [CMRPD3E0051, CMRPD3E0052, CMRPD3E0053, CMRPD1F0271, CMRPD1F0272, BMRPE27, CMRPD1F0261, BMRPC00]; Ministry of Science and Technology, Taiwan [104-2320-B-182-003-MY2, 105-2320-B-182-002, 102-2320-B-182-007-MY3, 105-2320-B-182-022]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Chang Gung Memorial Hospital (CMRPD3E0051, CMRPD3E0052, CMRPD3E0053, CMRPD1F0271, CMRPD1F0272 and BMRPE27 to TL and CMRPD1F0261 and BMRPC00 to HC) and the Ministry of Science and Technology, Taiwan (104-2320-B-182-003-MY2 and 105-2320-B-182-002 to TL and 102-2320-B-182-007-MY3 and 105-2320-B-182 -022 to HC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Andersson-Sjoland A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-76; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bhan U, 2008, INFECT IMMUN, V76, P2895, DOI 10.1128/IAI.01489-07; BORKAKOTI N, 1999, PROG INFLAM RES, P1; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chesney J, 1998, J IMMUNOL, V160, P419; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Fernandez IE, 2012, LANCET, V380, P680, DOI 10.1016/S0140-6736(12)61144-1; FRIDMAN R, 1995, CANCER RES, V55, P2548; Garcia-de-Alba C, 2010, AM J RESP CRIT CARE, V182, P1144, DOI 10.1164/rccm.201001-0028OC; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; GOLDBERG GI, 1989, P NATL ACAD SCI USA, V86, P8207, DOI 10.1073/pnas.86.21.8207; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Herold S, 2013, AM J PHYSIOL-LUNG C, V305, pL665, DOI 10.1152/ajplung.00232.2013; Hong KM, 2007, J BIOL CHEM, V282, P22910, DOI 10.1074/jbc.M703597200; Hynes RO, 1990, FIBRONECTINS; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Keeley EC, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-2; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117356; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma WJ, 2015, J BIOL CHEM, V290, P4866, DOI 10.1074/jbc.M114.612259; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0; Monaco S, 2006, PROTEIN SCI, V15, P2805, DOI 10.1110/ps.062430706; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nho RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061017; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Wallace WAH, 2007, INT J EXP PATHOL, V88, P103, DOI 10.1111/j.1365-2613.2006.00515.x; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002	61	13	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185811	10.1371/journal.pone.0185811	http://dx.doi.org/10.1371/journal.pone.0185811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968441	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600052
J	Bardsley, N; Buchs, M; Schnepf, SV				Bardsley, Nicholas; Buchs, Milena; Schnepf, Sylke V.			Something from nothing: Estimating consumption rates using propensity scores, with application to emissions reduction policies	PLOS ONE			English	Article							ZERO EXPENDITURES; MODEL; UK	Consumption surveys often record zero purchases of a good because of a short observation window. Measures of distribution are then precluded and only mean consumption rates can be inferred. We show that Propensity Score Matching can be applied to recover the distribution of consumption rates. We demonstrate the method using the UK National Travel Survey, in which c.40% of motorist households purchase no fuel. Estimated consumption rates are plausible judging by households' annual mileages, and highly skewed. We apply the same approach to estimate CO2 emissions and outcomes of a carbon cap or tax. Reliance on means apparently distorts analysis of such policies because of skewness of the underlying distributions. The regressiveness of a simple tax or cap is overstated, and redistributive features of a revenue-neutral policy are understated.	[Bardsley, Nicholas] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Bardsley, Nicholas] Univ Reading, Walker Inst Climate Syst Res, Reading, Berks, England; [Buchs, Milena] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Buchs, Milena] Univ Leeds, Sustainabil Res Inst, Leeds, W Yorkshire, England; [Schnepf, Sylke V.] European Commiss, Joint Res Ctr, Ispra, Italy	University of Reading; University of Reading; University of Leeds; University of Leeds; European Commission Joint Research Centre; EC JRC ISPRA Site	Bardsley, N (corresponding author), Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England.; Bardsley, N (corresponding author), Univ Reading, Walker Inst Climate Syst Res, Reading, Berks, England.	n.o.bardsley@reading.ac.uk	Buchs, Milena/AAU-2581-2021	Buchs, Milena/0000-0001-6304-3196	ESRC [RES-000-22-4083]; Economic and Social Research Council [ES/H044086/1] Funding Source: researchfish; ESRC [ES/H044086/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by the ESRC, grant RES-000-22-4083 to MB.	AA, 2002, FUEL PRIC REP; Abadie A, 2008, ECONOMETRICA, V76, P1537, DOI 10.3982/ECTA6474; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barker T. S., 1998, IMPACT ASSESS PROJ A, V16, P123; Blaylock J., 1991, EC RES SERVICE; Blow L., 1997, COMMENTARY I FISCAL, V65; BLUNDELL R, 1987, J ECONOMETRICS, V34, P179, DOI 10.1016/0304-4076(87)90072-8; Brand C, 2008, ENERG POLICY, V36, P224, DOI 10.1016/j.enpol.2007.08.016; Buchs M, 2013, ECOL ECON, V90, P114, DOI 10.1016/j.ecolecon.2013.03.007; Buchs M, 2011, CRIT SOC POLICY, V31, P285, DOI 10.1177/0261018310396036; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Cohmar Sustainable Development Council, 2008, STUD PERS CARB ALL C; DEATON A, 1984, J PUBLIC ECON, V23, P59, DOI 10.1016/0047-2727(84)90067-7; DECC, 2011, 2011 GUID DEFR DECCS; DFT, 2012, TABL NTS0707 AD PERS; Dresner S, 2006, FISC STUD, V27, P47, DOI 10.1111/j.1475-5890.2006.00027.x; Dresner S., 2004, 19 PSI; Figari F, 2012, SOC INDIC RES, V105, P387, DOI 10.1007/s11205-010-9775-4; Gibson J, 2012, AM J AGR ECON, V94, P257, DOI 10.1093/ajae/aar135; Goodwin P, 2004, TRANSPORT REV, V24, P275, DOI 10.1080/0144164042000181725; Gough I., 2011, 152 CASE LOND SCH EC; Griffiths W, 1998, ADV E, V13, P75; Hansen James, 2009, STORMS MY GRANDCHILD; Hasegawa H, 2008, OXFORD B ECON STAT, V70, P535, DOI 10.1111/j.1468-0084.2008.00507.x; Jann Ben, 2013, U BERN SOCIAL SCI WO; Jappelli T, 2014, AM ECON J-MACROECON, V6, P107, DOI 10.1257/mac.6.4.107; KAY JA, 1984, J PUBLIC ECON, V23, P169, DOI 10.1016/0047-2727(84)90071-9; Keen M.J., 1986, J APPL ECONOMET, V1, P277, DOI [https://doi.org/10.1002/jae.3950010305, DOI 10.1002/JAE.3950010305]; Labeaga JM, 1997, APPL ECON, V29, P795, DOI 10.1080/000368497326714; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Lietz C, 2006, RES LABOR ECON, V25, P1, DOI 10.1016/S0147-9121(06)25001-5; LITTLE RJA, 1986, INT STAT REV, V54, P139, DOI 10.2307/1403140; Matone M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1016; Nordstrom J, 2009, J HEALTH ECON, V28, P622, DOI 10.1016/j.jhealeco.2009.02.005; OECD, 2013, WHAT AR EQ SCAL; Olson K, 2012, PUBLIC OPIN QUART, V76, P611, DOI 10.1093/poq/nfs024; Olson K, 2012, J OFF STAT, V28, P29; Pudney S, 1989, MODELLING INDIVIDUAL; Pudney S., 1990, MEASUREMENT MODELLIN, P267; REMI, 2014, EC CLIM FISC POW DEM; Reynolds C.L., 2009, HIGH ED HDB THEORY R, V24, P47, DOI [10.1007/978-1-4020-5666-6, DOI 10.1007/978-1-4020-5666-6, 10.1007/978-1-4020-9628-0_2, DOI 10.1007/978-1-4020-9628-0_2]; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Salgado MF, 2014, REV INCOME WEALTH, V60, pS177, DOI 10.1111/roiw.12035; Sorrell S, 2010, CLIM POLICY, V10, P481, DOI 10.3763/cpol.2009.0008; Symons E., 2002, EUROPEAN ENV, V12, P203, DOI DOI 10.1002/EET.293; Villanti AC, 2011, EVALUATION REV, V35, P571, DOI 10.1177/0193841X11435399	48	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185538	10.1371/journal.pone.0185538	http://dx.doi.org/10.1371/journal.pone.0185538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020029	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000412754400034
J	Ho, T; Oh, SR; Kim, H				Ho, ThienLuan; Oh, Seung-Rohk; Kim, HyunJin			A parallel approximate string matching under Levenshtein distance on graphics processing units using warp-shuffle operations	PLOS ONE			English	Article							MISMATCHES	Approximate string matching with k-differences has a number of practical applications, ranging from pattern recognition to computational biology. This paper proposes an efficient memory-access algorithm for parallel approximate string matching with k-differences on Graphics Processing Units (GPUs). In the proposed algorithm, all threads in the same GPUs warp share data using warp-shuffle operation instead of accessing the shared memory. Moreover, we implement the proposed algorithm by exploiting the memory structure of GPUs to optimize its performance. Experiment results for real DNA packages revealed that the performance of the proposed algorithm and its implementation archived up to 122.64 and 1.53 times compared to that of sequential algorithm on CPU and previous parallel approximate string matching algorithm on GPUs, respectively.	[Ho, ThienLuan; Oh, Seung-Rohk; Kim, HyunJin] Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea	Dankook University	Kim, H (corresponding author), Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea.	hyunjin2.kim@gmail.com		Kim, HyunJin/0000-0001-5017-3995	National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03030348]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education. (2017R1D1A1B03030348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GENOME DATABASE SACC; [Anonymous], 2017, NVIDIA CUDA C PROGR; [Anonymous], 2017, NVIDIA GFORCE GTX 66; Chen X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1725-6; Fredriksson K, 2013, EUR J COMBIN, V34, P38, DOI 10.1016/j.ejc.2012.07.013; Guo L, 2013, 2013 IEEE 8 INT C, P257; Herbordt MC, 2006, ANN IEEE SYM FIELD P, P217; Ho T, 2016, IEICE T FUND ELECTR, VE99A, P1726, DOI 10.1587/transfun.E99.A.1726; Ho T, 2016, IEICE T COMMUN, VE99B, P1523, DOI 10.1587/transcom.2015EBP3411; Inoue K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037739; Intel, 2017, E31270 XEON CPU; Kim H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163535; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lin CH, 2014, 2014 IEEE SYMPOSIUM ON COMPUTER APPLICATIONS AND COMMUNICATIONS (SCAC), P76, DOI 10.1109/SCAC.2014.23; Lin CH, 2013, IEEE T COMPUT, V62, P1906, DOI 10.1109/TC.2012.254; Liu Y, 2012, IEEE SYM PARA DISTR, P2414, DOI 10.1109/IPDPSW.2012.298; Man Duhu, 2013, 2013 IEEE 7th International Symposium on Embedded Multicore/Manycore System-on-Chip (MCSoC), P79, DOI 10.1109/MCSoC.2013.22; Mikami S, 2008, ITC CSCC INT TECHN C, P201; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Nunes LSN, 2016, INT SYMPOS COMPUT NE, P483, DOI [10.1109/CANDAR.2016.0090, 10.1109/CANDAR.2016.101]; Nunes LSN, 2015, INT SYMPOS COMPUT NE, P188, DOI 10.1109/CANDAR.2015.29; Prasad R., 2011, SCI RES ESSAYS, V6, P876, DOI DOI 10.5897/SRE10.895; Schulz MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041531; Shehab MA, 2017, INT CONF INFORM COMM, P12, DOI 10.1109/IACS.2017.7921938; Shirahata Koichi, 2010, Proceedings of the 2010 IEEE 2nd International Conference on Cloud Computing Technology and Science (CloudCom 2010), P733, DOI 10.1109/CloudCom.2010.55; Stothard P., 2017, BIOINFORMATICS; The Apache Software Foundation, 2017, AP SOFTW HOM PAG; Tran TT, 2016, PARALLEL COMPUT, V54, P128, DOI 10.1016/j.parco.2015.11.001; Van Court T, 2004, IEEE INT CONF ASAP, P354; Watanuki Yosuke, 2013, 2013 IEEE 6th International Workshop on Computational Intelligence and Applications (IWCIA), P137, DOI 10.1109/IWCIA.2013.6624801; Xu KF, 2013, PROCEDIA COMPUT SCI, V17, P523, DOI 10.1016/j.procs.2013.05.067; Zhong Cheng, 2004, Journal of Software, V15, P159; Zhou W, 2017, J AM CERAM SOC, V100, P1578, DOI 10.1111/jace.14691; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	35	24	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186251	10.1371/journal.pone.0186251	http://dx.doi.org/10.1371/journal.pone.0186251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016700	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400063
J	Ivanov, SM; Cawley, A; Huber, RG; Bond, PJ; Warwicker, J				Ivanov, Stefan M.; Cawley, Andrew; Huber, Roland G.; Bond, Peter J.; Warwicker, Jim			Protein-protein interactions in paralogues: Electrostatics modulates specificity on a conserved steric scaffold	PLOS ONE			English	Article							TOXIN-ANTITOXIN COMPLEX; CRYSTAL-STRUCTURE; CONFORMATIONAL ENTROPY; RECOGNITION SITES; PREDICT PROTEIN; BINDING-SITE; ACTIVE-SITE; BH3 DOMAINS; INTERFACES; DETERMINANTS	An improved knowledge of protein-protein interactions is essential for better understanding of metabolic and signaling networks, and cellular function. Progress tends to be based on structure determination and predictions using known structures, along with computational methods based on evolutionary information or detailed atomistic descriptions. We hypothesized that for the case of interactions across a common interface, between proteins from a pair of paralogue families or within a family of paralogues, a relatively simple interface description could distinguish between binding and non-binding pairs. Using binding data for several systems, and large-scale comparative modeling based on known template complex structures, it is found that charge-charge interactions (for groups bearing net charge) are generally a better discriminant than buried non-polar surface. This is particularly the case for paralogue families that are less divergent, with more reliable comparative modeling. We suggest that electrostatic interactions are major determinants of specificity in such systems, an observation that could be used to predict binding partners.	[Ivanov, Stefan M.; Cawley, Andrew; Warwicker, Jim] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England; [Huber, Roland G.; Bond, Peter J.] ASTAR, Bioinformat Inst, Matrix, Singapore, Singapore; [Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore	Warwicker, J (corresponding author), Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England.	jim.warwicker@manchester.ac.uk	Huber, Roland G/AAG-6353-2019	Huber, Roland G/0000-0001-5093-5988; Bond, Peter/0000-0003-2900-098X; Warwicker, Jim/0000-0002-1302-0815	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D526561/1]; Singapore A*STAR Manchester (UK) programme; A*STAR Graduate Academy (A*GA) Singapore	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Singapore A*STAR Manchester (UK) programme; A*STAR Graduate Academy (A*GA) Singapore	AC was in receipt of a PhD studentship from the UK Biotechnology and Biological Sciences Research Council (BBSRC, grant number BB/D526561/1). SMI received a PhD studentship from the Singapore A*STAR Manchester (UK) programme.; We gratefully acknowledge discussions with Nicholas Fowler, and thank the A*STAR Graduate Academy (A*GA) Singapore for funding. We also thank the Reviewers for their constructive comments.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Aiello D, 2012, J MOL BIOL, V423, P257, DOI 10.1016/j.jmb.2012.06.039; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Beglov D, 2012, PROTEINS, V80, P591, DOI 10.1002/prot.23222; Bougouffa S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-448; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cole C, 2002, PROTEIN SCI, V11, P2860, DOI 10.1110/ps.0222702; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Delgado-Soler L, 2012, J CHEM INF MODEL, V52, P2107, DOI 10.1021/ci3001666; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fox SJ, 2014, PROTEINS, V82, P3335, DOI 10.1002/prot.24686; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guharoy M, 2005, P NATL ACAD SCI USA, V102, P15447, DOI 10.1073/pnas.0505425102; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Im W, 2016, J MOL BIOL, V428, P2943, DOI 10.1016/j.jmb.2016.05.024; Ivanov SM, 2016, STRUCTURE, V24, P2024, DOI 10.1016/j.str.2016.09.006; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kar G, 2012, J PROTEOME RES, V11, P1196, DOI 10.1021/pr2009143; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2016, CHEM REV, V116, P4884, DOI 10.1021/acs.chemrev.5b00683; Kim JS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.118; KOEHL P, 1994, J MOL BIOL, V239, P249, DOI 10.1006/jmbi.1994.1366; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Min AB, 2012, PROTEIN SCI, V21, P1754, DOI 10.1002/pro.2161; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto T, 2012, J VIROL, V86, P11501, DOI 10.1128/JVI.01115-12; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Petukh M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004276; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rajan S, 2015, PROTEINS, V83, P1262, DOI 10.1002/prot.24816; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Shirts MR, 2003, J CHEM PHYS, V119, P5740, DOI 10.1063/1.1587119; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Soni N, 2017, CURR OPIN STRUC BIOL, V44, P179, DOI 10.1016/j.sbi.2017.04.006; Steinbrecher T, 2006, J MED CHEM, V49, P1837, DOI 10.1021/jm0505720; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Tuncbag N, 2017, METHODS MOL BIOL, V1558, P255, DOI 10.1007/978-1-4939-6783-4_12; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Warwicker J, 1999, PROTEIN SCI, V8, P418; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Winter C, 2012, J STRUCT BIOL, V179, P347, DOI 10.1016/j.jsb.2012.04.009; Xue LC, 2015, FEBS LETT, V589, P3516, DOI 10.1016/j.febslet.2015.10.003; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185928	10.1371/journal.pone.0185928	http://dx.doi.org/10.1371/journal.pone.0185928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016650	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400039
J	Kotowicz, B; Fuksiewicz, M; Jonska-Gmyrek, J; Berezowska, A; Radziszewski, J; Bidzinski, M; Kowalska, M				Kotowicz, Beata; Fuksiewicz, Malgorzata; Jonska-Gmyrek, Joanna; Berezowska, Alicja; Radziszewski, Jakub; Bidzinski, Mariusz; Kowalska, Maria			Clinical significance of pretreatment serum levels of VEGF and its receptors, IL-8, and their prognostic value in type I and II endometrial cancer patients	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CELL LUNG-CANCER; TUMOR ANGIOGENESIS; CA-125 LEVELS; INTERLEUKIN-8; EXPRESSION; PREDICTION; CARCINOMA; PROGRESSION; DISEASE	Objectives The study aimed to assess the usefulness of the determination of cytokines: IL-8, VEGF and its soluble receptors: VEGF-R1, VEGF-R2 in patients with endometrial cancer (EC). Material/Methods The study group consisted of 118 patients with EC subjected to surgical treatment. Before the treatment we determined the serum levels of cytokines IL-8, and VEGF as well as VEGFR1 and VEGFR2 receptors. For comparison, the concentration of CA 125 was also measured. VEGFR1 and CA 125 were determined in the COBAS e601 system using Roche Diagnostics kits, while IL-8, VEGF and VEGFR2 were measured by ELISA assay using R& D Systems kits. Results The concentrations of IL-8, VEGF, VEGFR1 and CA 125 allowed to distinguish patients for the control group. The highest diagnostic sensitivity has been shown for the concentrations of VEGF (AUC = 0.904) and IL-8 (AUC = 0.818). Among all studied parameters only CA125 concentrations increased with the clinical stage; being significantly higher in patients in FIGO III-IV, than FIGO I-IB. In patients at the FIGO stage I-IB, complementary determinations of CA 125 and VEGF resulted in the largest increase of diagnostic sensitivity. Patients with metastases to the para-aortic lymph nodes had significantly higher levels of VEGF compared to subjects without such lesions. The concentrations of IL-8 were an independent prognostic factor in the assessment of overall survival in patients with type I endometrial cancer, while the concentrations of VEGFR2 in those with type II. Conclusions In patients with endometrial cancer, the clinical usefulness of IL-8 and VEGFR2 measurements as the potential prognostic factors has been demonstrated. In type I, the concentrations of IL-8 determined before treatment can be helpful in predicting overall survival. In patients qualified to type II EC, the concentrations of VEGFR2 have the value of an independent prognostic factor for overall survival, this requires research on larger groups of patients. The increased levels of VEGF may be useful in the preoperative assessment of the status of para-aortic lymph nodes.	[Kotowicz, Beata; Fuksiewicz, Malgorzata; Berezowska, Alicja; Kowalska, Maria] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Pathol & Lab Diagnost, Lab Tumor Markers, Warsaw, Poland; [Jonska-Gmyrek, Joanna] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Urooncol, Warsaw, Poland; [Radziszewski, Jakub] Multidisciplinary Hosp, Dept Gen Vasc & Oncol Surg, Warsaw, Poland; [Bidzinski, Mariusz] Maria Sklodowska Curie Inst, Oncol Ctr, Dept Gynecol Oncol, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Kotowicz, B (corresponding author), Maria Sklodowska Curie Inst, Oncol Ctr, Dept Pathol & Lab Diagnost, Lab Tumor Markers, Warsaw, Poland.	hkotowicz@coi.pl	Radziszewski, Jakub/V-5663-2018; GMYREK, JOANNA JONSKA/S-9483-2019; Bidzinski, Mariusz/AAH-5019-2019	GMYREK, JOANNA JONSKA/0000-0001-8369-4594; Fuksiewicz, Malgorzata/0000-0001-9625-423X; Radziszewski, Jakub/0000-0002-4443-6653; kowalska, maria/0000-0003-0058-0976; Kotowicz, Beata/0000-0001-6790-3413; Mariusz, Bidzinski/0000-0003-4767-6369				Chen YL, 2011, AUST NZ J OBSTET GYN, V51, P397, DOI 10.1111/j.1479-828X.2011.01325.x; Chung HH, 2006, ACTA OBSTET GYN SCAN, V85, P1501, DOI 10.1080/00016340601022777; Ciortea R, 2014, ANTICANCER RES, V34, P379; Dobrzycka B, 2011, EUR CYTOKINE NETW, V22, P45, DOI 10.1684/ecn.2011.0276; Ewington L, 2012, CYTOKINE, V59, P417, DOI 10.1016/j.cyto.2012.04.036; Fujimoto J, 2002, ANN ONCOL, V13, P430, DOI 10.1093/annonc/mdf078; Fuksiewicz M, 2010, CLIN CHEM LAB MED, V48, P1481, DOI 10.1515/CCLM.2010.278; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kolbl AC, 2016, ONCOL LETT, V12, P2092, DOI 10.3892/ol.2016.4906; Kotowicz B, 2016, TUMOR BIOL, V37, P1271, DOI 10.1007/s13277-015-3914-0; Koukourakis MI, 2011, CYTOKINE, V53, P370, DOI 10.1016/j.cyto.2010.12.007; Larkins E, 2015, ONCOLOGIST, V20, P1320, DOI 10.1634/theoncologist.2015-0221; Lingli H, 2016, INT J GYNECOL CANCER, V26, P331; Ock CY, 2015, AM J CANCER RES, V5, P3376; Powell JL, 2005, J REPROD MED, V50, P585; Rutkowski P, 2002, INT J CANCER, V100, P463, DOI 10.1002/ijc.10496; Saarelainen SK, 2014, TUMOR BIOL, V35, P4651, DOI 10.1007/s13277-014-1609-6; Shaw E, 2016, RECENT RESULTS CANC, V208, P107, DOI 10.1007/978-3-319-42542-9_7; Shibuya M., 2011, CELL STRUCT FUNCT, V26, P25; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Sivridis E, 2002, J PATHOL, V196, P416, DOI 10.1002/path.1060; Skirnisdotir I, 2016, INT J ONCOL, V48, P998, DOI 10.3892/ijo.2016.3333; Sood AK, 1997, OBSTET GYNECOL, V90, P441, DOI 10.1016/S0029-7844(97)00286-X; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Yokoyama Y, 2000, GYNECOL ONCOL, V77, P413, DOI 10.1006/gyno.2000.5802; Yuan A, 2000, AM J RESP CRIT CARE, V162, P1957, DOI 10.1164/ajrccm.162.5.2002108	27	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184576	10.1371/journal.pone.0184576	http://dx.doi.org/10.1371/journal.pone.0184576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991928	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800008
J	Park, S; Shine, J				Park, Soowon; Shine, Jongho			The influence of anonymous peers on prosocial behavior	PLOS ONE			English	Article							NONCONSCIOUS GOAL PURSUIT; SOCIAL-INFLUENCE; SELF; ADOLESCENTS; CONSISTENCY; AGGRESSION; INTENTIONS; REVERSALS; CHILDHOOD; COGNITION	Background Peer influence on students' maladaptive behaviors has been well documented; however, the influence on positive development is less acknowledged. Purpose The purpose of this study was to examine anonymous peer influence on college students' prosocial behavior, specifically behavior for the improvement of society (i.e., donating money or participating in social campaigns) via an experimental approach. The effects of indirect peer influence (IP) and direct peer influence (DP) on college students' prosocial behavior were examined. Methods A total of 125 college students participated in an online survey and laboratory experiment. Self-reported helping behavior, social concern goals, and empathy were measured by the online survey. In the laboratory experiments, reading of a prosocial paragraph (IP) and confederates' prosocial behavior (DP) were manipulated. Participation in a signature campaign and money donation for illness were observed. Furthermore, 19 participants among those who donated were asked about their reasons for participating in such prosocial behavior. Results Prosocial behavior of anonymous peers (confederates) exerts a profound influence on college students' participation in a signature campaign and money donation, whereas the reading of a prosocial paragraph has no effect. Furthermore, no participants reported peer influence as a reason for engaging in prosocial behavior. Conclusion This finding supports and extends recent research examining the positive impacts of anonymous peers on prosocial behavior. Prosocial behavior is not only a foundational and consistent aspect of personality, as previous studies report, but is also highly malleable and unstable in response to immediate situations.	[Park, Soowon] Sejong Univ, Dept Educ, Seoul, South Korea; [Shine, Jongho] Seoul Natl Univ, Dept Educ, Seoul, South Korea	Sejong University; Seoul National University (SNU)	Park, S (corresponding author), Sejong Univ, Dept Educ, Seoul, South Korea.	spark@sejong.ac.kr		Park, Soowon/0000-0002-3348-940X	Sejong University; Seoul National University	Sejong University; Seoul National University	This work was supported by Soowon Park, Sejong University; and Jongho Shin, Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin LB, 2013, J PERS SOC PSYCHOL, V104, P635, DOI 10.1037/a0031578; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; BANDURA A, 1963, J ABNORM PSYCHOL, V66, P3, DOI 10.1037/h0048687; BANDURA A, 1969, J PERS SOC PSYCHOL, V13, P173, DOI 10.1037/h0028276; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Barnette JJ, 2000, EDUC PSYCHOL MEAS, V60, P361, DOI 10.1177/00131640021970592; Baron RA, 1997, PERS SOC PSYCHOL B, V23, P498, DOI 10.1177/0146167297235005; Barry CM, 2006, DEV PSYCHOL, V42, P153, DOI 10.1037/0012-1649.42.1.153; BARTAL D, 1979, CHILD DEV, V50, P1235, DOI 10.2307/1129357; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Berger C, 2012, SOC DEV, V21, P396, DOI 10.1111/j.1467-9507.2011.00628.x; BERNDT TJ, 1981, CHILD DEV, V52, P636, DOI 10.1111/j.1467-8624.1981.tb03090.x; Bond R, 1996, PSYCHOL BULL, V119, P111, DOI 10.1037/0033-2909.119.1.111; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Charlop-Christy MH, 2000, J AUTISM DEV DISORD, V30, P537, DOI 10.1023/A:1005635326276; Chekroun P, 2002, EUR J SOC PSYCHOL, V32, P853, DOI 10.1002/ejsp.126; Choukas-Bradley S, 2015, J YOUTH ADOLESCENCE, V44, P2197, DOI 10.1007/s10964-015-0373-2; Chung-Hall J, 2010, SOC DEV, V19, P659, DOI 10.1111/j.1467-9507.2009.00556.x; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cote S, 2002, J CHILD PSYCHOL PSYC, V43, P609, DOI 10.1111/1469-7610.00050; Davidio J, 2006, SOCIAL PSYCHOL PROSO; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deci E.L., 2012, HDB THEORIES SOCIAL, P416, DOI [10.4135/9781446201022, DOI 10.4135/9781446249215.N21]; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; DL McCollum, 2009, J COLL CHARACTER, V6; DODGE KA, 1984, CHILD DEV, V55, P163, DOI 10.1111/j.1467-8624.1984.tb00281.x; DODGE KA, 1980, CHILD DEV, V51, P162, DOI 10.1111/j.1467-8624.1980.tb02522.x; Eisenberg N, 1999, CHILD DEV, V70, P1360, DOI 10.1111/1467-8624.00100; Eisenberg N., 2007, HDB CHILD PSYCHOL; Elson M, 2014, EUR PSYCHOL, V19, P68, DOI 10.1027/1016-9040/a000185; Fiske ST, 2004, SCIENCE, V306, P1482, DOI 10.1126/science.1103788; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; Flynn E, 2015, SOC DEV, V24, P462, DOI 10.1111/sode.12100; Gachter S, 2013, J EUR ECON ASSOC, V11, P548, DOI 10.1111/jeea.12015; Gagne M, 2003, MOTIV EMOTION, V27, P199, DOI 10.1023/A:1025007614869; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Jo H., 2010, KOREAN J YOUTH STUDI, V17, P140; Jones K., 2004, SETTING MORAL COMPAS, P333; Jordan J, 2011, PERS SOC PSYCHOL B, V37, P701, DOI 10.1177/0146167211400208; Kant I., 1996, KANT METAPHYSICS MOR; Kundu P, 2013, SOC INFLUENCE, V8, P268, DOI 10.1080/15534510.2012.727767; Lee H., 1999, THESIS; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; LIEBERT R, 1988, EARLY WINDOW EFFECT; Loersch C, 2008, J EXP SOC PSYCHOL, V44, P1555, DOI 10.1016/j.jesp.2008.07.009; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Martin R, 2008, J ECON BEHAV ORGAN, V67, P228, DOI 10.1016/j.jebo.2007.08.001; Matsuda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159661; Meer J, 2011, J PUBLIC ECON, V95, P926, DOI 10.1016/j.jpubeco.2010.11.026; Mellor D, 2008, J SOC SERV RES, V34, P61, DOI 10.1080/01488370802162483; Mengel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094099; MILGRAM S, 1969, J PERS SOC PSYCHOL, V13, P79, DOI 10.1037/h0028070; Moran C. D., 2001, NASPA J, V38, P269, DOI DOI 10.2202/1949-6605.1147; Nantel-Vivier A, 2009, J CHILD PSYCHOL PSYC, V50, P590, DOI 10.1111/j.1469-7610.2008.02039.x; Niemi RG, 2000, POLIT BEHAV, V22, P45, DOI 10.1023/A:1006690417623; Oettingen G, 2006, J EXP SOC PSYCHOL, V42, P668, DOI 10.1016/j.jesp.2005.10.003; Paivio A., 1990, MENTAL REPRESENTATIO, P348, DOI [10.1093/acprof:oso/9780195066661.003.0004, DOI 10.1093/ACPROF:OSO/9780195066661.003.0004]; Paulhus DL, 2011, J PERS ASSESS, V93, P96, DOI 10.1080/00223891.2010.528483; Perkins HW, 2003, SOCIAL NORMS APPROAC, P3; PHILLIPS DC, 1983, PSYCHOL REV, V90, P158, DOI 10.1037/0033-295X.90.2.158; Prinstein MJ, 2011, DEV PSYCHOL, V47, P1167, DOI 10.1037/a0023274; Reinstein D, 2012, THEOR DECIS, V72, P221, DOI 10.1007/s11238-011-9245-8; Rodkin PC, 2013, DEV PSYCHOL, V49, P1139, DOI 10.1037/a0029389; Saha LJ, 2004, INT ED J, V5, P9; SCHRIESHEIM CA, 1991, EDUC PSYCHOL MEAS, V51, P67, DOI 10.1177/0013164491511005; Segrist D.J., 2007, N AM J PSYCHOL, V9, P307; Shantz A, 2009, ORGAN BEHAV HUM DEC, V109, P9, DOI 10.1016/j.obhdp.2009.01.001; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shidlovski D, 2011, PSYCHOL SCI, V22, P1381, DOI 10.1177/0956797611417135; Shin Jongho, 2014, [Korean Journal of Educational Psychology, 교육심리연구], V28, P455; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Smith AR, 2014, DEV PSYCHOL, V50, P1564, DOI 10.1037/a0035696; Smith S, 2015, ECON J, V125, P1053, DOI 10.1111/ecoj.12114; Stukas AA, 1999, PSYCHOL SCI, V10, P59, DOI 10.1111/1467-9280.00107; Tear MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068382; Thoni C, 2015, J ECON PSYCHOL, V48, P72, DOI 10.1016/j.joep.2015.03.001; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Van Der Linden S, 2011, ODE MAGAZINE, V86, P26; van Goethem AAJ, 2014, J APPL DEV PSYCHOL, V35, P94, DOI 10.1016/j.appdev.2013.12.003; van Hoorn J, 2016, J RES ADOLESCENCE, V26, P90, DOI 10.1111/jora.12173; Walton GM, 2012, J PERS SOC PSYCHOL, V102, P513, DOI 10.1037/a0025731; Weigard A, 2014, DEVELOPMENTAL SCI, V17, P71, DOI 10.1111/desc.12099; WOOD W, 1994, PSYCHOL BULL, V115, P323, DOI 10.1037/0033-2909.115.3.323; Yanovitzky I, 2006, COMMUN THEOR, V16, P1, DOI 10.1111/j.1468-2885.2006.00002.x	90	11	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185521	10.1371/journal.pone.0185521	http://dx.doi.org/10.1371/journal.pone.0185521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016612	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800019
J	Geyer, J; Kreft, S; Jeltsch, F; Ibisch, PL				Geyer, Juliane; Kreft, Stefan; Jeltsch, Florian; Ibisch, Pierre L.			Assessing climate change-robustness of protected area management plans-The case of Germany	PLOS ONE			English	Article							CHANGE ADAPTATION STRATEGIES; NATURAL-RESOURCE MANAGEMENT; BIODIVERSITY CONSERVATION; BIOLOGICAL DIVERSITY; GLOBAL CHANGE; FRAMEWORK; QUALITY; IMPLEMENTATION; BRANDENBURG; DIRECTIONS	Protected areas are arguably the most important instrument of biodiversity conservation. To keep them fit under climate change, their management needs to be adapted to address related direct and indirect changes. In our study we focus on the adaptation of conservation management planning, evaluating management plans of 60 protected areas throughout Germany with regard to their climate change-robustness. First, climate change-robust conservation management was defined using 11 principles and 44 criteria, which followed an approach similar to sustainability standards. We then evaluated the performance of individual management plans concerning the climate change-robustness framework. We found that climate change-robustness of protected areas hardly exceeded 50 percent of the potential performance, with most plans ranking in the lower quarter. Most Natura 2000 protected areas, established under conservation legislation of the European Union, belong to the sites with especially poor performance, with lower values in smaller areas. In general, the individual principles showed very different rates of accordance with our principles, but similarly low intensity. Principles with generally higher performance values included holistic knowledge management, public accountability and acceptance as well as systemic and strategic coherence. Deficiencies were connected to dealing with the future and uncertainty. Lastly, we recommended the presented principles and criteria as essential guideposts that can be used as a checklist for working towards more climate change-robust planning.	[Geyer, Juliane; Kreft, Stefan; Ibisch, Pierre L.] Eberswalde Univ Sustainable Dev, Fac Forest & Environm, Ctr Econ & Ecosyst Management, Eberswalde, Germany; [Jeltsch, Florian] Potsdam Univ, Inst Biochem & Biol, Potsdam, Germany	Eberswalde University for Sustainable Development; University of Potsdam	Geyer, J (corresponding author), Eberswalde Univ Sustainable Dev, Fac Forest & Environm, Ctr Econ & Ecosyst Management, Eberswalde, Germany.	juliane.geyer@hnee.de	Kreft, Stefan/AAE-5558-2021	Ibisch, Pierre/0000-0001-9820-9272	Faculty of Forest and Environment of the Eberswalde University; German Academic Scholarship Foundation; Potsdam University; Lincoln University (New Zealand); German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation; German Federal Ministry of Education and Research (project INKA BB); Eberswalde University	Faculty of Forest and Environment of the Eberswalde University; German Academic Scholarship Foundation; Potsdam University; Lincoln University (New Zealand); German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation; German Federal Ministry of Education and Research (project INKA BB); Eberswalde University	This research has been funded by contributions of several funders: Faculty of Forest and Environment of the Eberswalde University for Sustainable Development, German Academic Scholarship Foundation, Potsdam University, Lincoln University (New Zealand), German Federal Ministry for Environment, Nature Conservation, Building and Nuclear Safety through German Federal Agency for Nature Conservation, German Federal Ministry of Education and Research (project INKA BB). PI co-authored the study in the framework of his long-term research programme facilitated by the research professorships 'Biodiversity and natural resource management under global change' (2009-2015) as well as 'Ecosystem-based sustainable development' (since 2015) granted by Eberswalde University for Sustainable Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is one output of the cooperative graduate programme "Adaptive Nature Conservation under Climate Change" of the Eberswalde University for Sustainable Development, Potsdam University and Potsdam Institute for Climate Impact Research (PIK). We thank the Faculty of Forest and Environment at Eberswalde University for Sustainable Development for logistic support of the study. Pierre Ibisch co-conceived and supervised the study in the framework of his long-term research program facilitated by the research professorships "Biodiversity and Natural Resource Management under Global Change" (2009-2015) as well as "Ecosystem-based Sustainable Development" (since 2015) granted by Eberswalde University for Sustainable Development. We also thank all staff of protected area and other administrations that provided access to requested management plans. We cordially thank Lena Strixner, Daniela Aschenbrenner and Isabelle Wagner for their technical assistance in plan evaluation and Lisa Biber-Freudenberger for helping in the statistical analysis of the obtained data. We are also grateful to Kevin Beiler for substantial editing, to BrynErin Keverin for assistance in language revision as well as to three anonymous reviewers and the managing editor for constructive comments that greatly helped to improve the manuscript.	Amt fur das Biospharenreservat Schaalsee, 2003, RAHM REG AG; [Anonymous], 2016, IUCN GREEN LIST PROT; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Aschenbrenner D, 2012, REGIONALE ANPASSUNG, P168; Baker I, 2012, LANDSCAPE URBAN PLAN, V107, P127, DOI 10.1016/j.landurbplan.2012.05.009; Baron JS, 2009, ENVIRON MANAGE, V44, P1033, DOI 10.1007/s00267-009-9296-6; Baynham M, 2014, J ENVIRON PLANN MAN, V57, P557, DOI 10.1080/09640568.2012.756805; BfN, 2008, NAT DAT 2008; Brody SD, 2003, POPUL ENVIRON, V24, P511, DOI 10.1023/A:1025078715216; CBD, 2000, COP 5 DEC V 6; Clarke P., 2010, PRINCIPLES PRACTICE; Corson C, 2014, CONSERV SOC, V12, P190, DOI 10.4103/0972-4923.138421; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Cross MS, 2013, CONSERV BIOL, V27, P4, DOI 10.1111/j.1523-1739.2012.01954.x; Cross MS, 2012, ENVIRON MANAGE, V50, P341, DOI 10.1007/s00267-012-9893-7; Cybulla F, 2012, REGIONALE ANPASSUNG, P194; Dudley N., 2010, NATURAL SOLUTIONS PR; Ellwanger G, 2012, NATURSCHUTZ BIOL VIE; European Commission, 2017, NAT 2000 2017; Fazey I, 2006, ENVIRON CONSERV, V33, P1, DOI 10.1017/S037689290600275X; Federal Agency for Nature Conservation, 2014, MAN NAT 2000; Federal Agency for Nature Conservation, 2015, NAT 2000; Federal Agency for Nature Conservation, 2010, PROT AR; Fee E, 2009, J NAT CONSERV, V17, P212, DOI 10.1016/j.jnc.2009.04.005; Felton A, 2009, BIODIVERS CONSERV, V18, P2243, DOI 10.1007/s10531-009-9652-0; Forest Stewardship Council, 2019, POL PEST FSC; Geldmann J, 2015, BIOL CONSERV, V191, P692, DOI 10.1016/j.biocon.2015.08.029; Geyer J, 2015, REG ENVIRON CHANGE, V15, P139, DOI 10.1007/s10113-014-0609-9; Gillingham PK, 2015, BIOL J LINN SOC, V115, P707, DOI 10.1111/bij.12506; Godschalk D., 1999, NATURAL HAZARD MITIG; Hagerman S, 2010, GLOBAL ENVIRON CHANG, V20, P192, DOI 10.1016/j.gloenvcha.2009.10.005; Hallegatte S, 2009, GLOBAL ENVIRON CHANG, V19, P240, DOI 10.1016/j.gloenvcha.2008.12.003; Halpin PN, 1997, ECOL APPL, V7, P828; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Heiland S, 2013, MANAGEMENTQUALITAT D; Heller NE, 2014, CONSERV BIOL, V28, P696, DOI 10.1111/cobi.12269; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hockings M., 2006, EVALUATING EFFECTIVE, Vxiv; Huntley B., 2007, COUNCIL OF EUROPE; IBISCH P, 2008, ANLIEGEN NATUR, V32, P3; Ibisch P L., 2012, REGIONALE ANPASSUNG, P214; Ibisch P.L., 2011, CARPATHIAN BIOSPHERE; Ibisch P L., 2012, REGIONALE ANPASSUNG; Ibisch Pierre L., 2014, GUIDEBOOK RISK ROBUS; Ibisch PL, 2010, INTERDEPENDENCE BIOD, P15; Ibisch PL, 2015, LESSONS CASE STUDIES; Ibisch PL, 2009, STIMMT KLIMA NATURSC, P51; Ibisch PL, 2012, SERIES ECONICS ECOSY, P131; Ibisch PL, 2014, ANPASSUNG NATURSCHUT; Kharouba HM, 2010, BIOL CONSERV, V143, P1094, DOI 10.1016/j.biocon.2010.02.002; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Kreft S, 2013, NATURSCHUTZ HANDELN, P70; Kreft S, 2013, SCHUTZGEBIETE DEUTSC, P177; Kumar P, 2015, LAND USE POLICY, V42, P210, DOI 10.1016/j.landusepol.2014.07.016; Kunze B, 2013, NATURSCHUTZ BIOL VIE, V129, P123; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lemieux C. J., 2010, 19 CCEA; Lemieux CJ, 2005, CAN GEOGR-GEOGR CAN, V49, P384, DOI 10.1111/j.0008-3658.2005.00103.x; LEVERINGTON F, 2008, 1 TNC WWF IUCNWCPA U; Leverington F, 2010, MANAGEMENT EFFECTIVE; LfU (Landesamt fu E r Umwelt), 2016, HDB MAN FFH GEB LAND; Lyles W, 2014, J PLAN EDUC RES, V34, P433, DOI 10.1177/0739456X14549752; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Moser SC, 2010, P NATL ACAD SCI USA, V107, P22026, DOI 10.1073/pnas.1007887107; Nolte C., 2010, PROTECTED AREA MANAG; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Pfeffer J, 1999, CALIF MANAGE REV, V42, P83, DOI 10.2307/41166020; Poiani KA, 2011, BIODIVERS CONSERV, V20, P185, DOI 10.1007/s10531-010-9954-2; Preston BL, 2011, MITIG ADAPT STRAT GL, V16, P407, DOI 10.1007/s11027-010-9270-x; R Development Core Team, R LANG ENV STAT COMP; Radtke Laura, 2015, Naturschutz und Landschaftsplanung, V47, P201; Reyer C, 2012, REG ENVIRON CHANGE, V12, P523, DOI 10.1007/s10113-011-0269-y; RSPO, 2013, PRINC CRIT PROD SUST; Sarmadi D., 2015, WENIG NATURSCHUTZ EU; Schaalsee Biosphere Reserve, 2016, UNESCO BIOSPH SCHAAL; Schick A, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1002/ehs2.1267; Sieck Mungla, 2011, BMC Ecology, V11, P12, DOI 10.1186/1472-6785-11-12; Stein B.A., 2014, CLIMATE SMART CONSER; Stein BA, 2013, FRONT ECOL ENVIRON, V11, P502, DOI 10.1890/120277; Stevens MR, 2014, J PLAN EDUC RES, V34, P77, DOI 10.1177/0739456X13513614; Stevens MR, 2013, J PLAN EDUC RES, V33, P471, DOI 10.1177/0739456X13505649; Stoll-Kleemann Susanne, 2012, Naturschutz und Landschaftsplanung, V44, P37; Stolton S, 2011, MANAGING CLIMATE CHA; Tang ZH, 2010, J ENVIRON PLANN MAN, V53, P41, DOI 10.1080/09640560903399772; Tang ZH, 2009, ENVIRON PLANN B, V36, P522, DOI 10.1068/b34076; The Nature Conservancy Parks in Peril Program, 2002, MEAS SUCC PARKS PER; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; TNC, 2009, CONS ACT PLANN GUID; Umweltplan GmbH, 2008, REG BEW KLIM ENTW KL; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Weidenhammer S., 2007, KRITERIEN ANERKENNUN; Welch D., 2005, G WRIGHT FORUM, V22, P75; Wilby RL, 2010, WEATHER, V65, P180, DOI 10.1002/wea.543; Wilke C., 2011, NATURSCHUTZ BIOL VIE, V109; Wilke C, 2014, ADV GLOB CHANGE RES, V58, P159, DOI 10.1007/978-94-007-7960-0_10	95	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185972	10.1371/journal.pone.0185972	http://dx.doi.org/10.1371/journal.pone.0185972			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982187	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300100
J	Govender, K; Cowden, RG; Asante, KO; George, G; Reardon, C				Govender, Kaymarlin; Cowden, Richard G.; Asante, Kwaku Oppong; George, Gavin; Reardon, Candice			Validation of the child and youth resilience measure among South African adolescents	PLOS ONE			English	Article							FIT INDEXES; SCHOOL CONNECTEDNESS; PARENTING PRACTICES; MENTAL-HEALTH; RISK-FACTORS; HIV; PREVALENCE; BEHAVIORS; CYRM-28; CONTEXT	Resilience is a dynamic, interactive process between resources that contribute to safeguarding a person and the adversities they experience. Within this promotional framework of resilience, this study sought to validate the Child and Youth Resilience Measure (CYRM-28) among a sample of South African adolescents (N = 1854). Confirmatory factor analysis supported a superior level of fit for a 24-item, three-factor model (i.e., individual/social, familial, and community/spiritual). Internal consistency and test-retest reliability estimates at a 12-month interval (N = 648) supported the reliability of the scales. Higher scores on the scales were associated with feeling more connected at school, greater parental monitoring perceptions, and lower sexual risk, confirming the convergent and criterion validity of the instrument. Partial discriminative power was evidenced based on selected scale distinctions according to age and sex groupings. Collectively, the findings suggest the 24-item CYRM is a valid and reliable self-report measure to assess the availability of resources associated with resilience in South African youth.	[Govender, Kaymarlin; Asante, Kwaku Oppong] Univ KwaZulu Natal, Sch Appl Human Sci, Discipline Psychol, Durban, Kwazulu Natal, South Africa; [Govender, Kaymarlin; George, Gavin; Reardon, Candice] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, Kwazulu Natal, South Africa; [Cowden, Richard G.] North West Univ, Inst Psychol & Wellbeing, Sch Psychosocial Behav Sci, Potchefstroom, North West, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; North West University - South Africa	Cowden, RG (corresponding author), North West Univ, Inst Psychol & Wellbeing, Sch Psychosocial Behav Sci, Potchefstroom, North West, South Africa.	richardgregorycowden@gmail.com	Asante, Kwaku Oppong/B-1310-2014; Cowden, Richard Gregory G/K-7389-2018; George, Gavin L/N-5756-2013; Govender, Kaymarlin/M-1660-2019	Asante, Kwaku Oppong/0000-0002-0206-3326; Cowden, Richard Gregory G/0000-0002-9027-4253; George, Gavin L/0000-0001-7258-8470; govender, kaymarlin/0000-0002-9586-1510				[Anonymous], 2009, HDB POSITIVE PSYCHOL; Aschan L, 2013, J AFFECT DISORDERS, V150, P441, DOI 10.1016/j.jad.2013.04.037; Basterfield C., 2014, International Journal of Men's Health, V13, P101; Baumgartner JN, 2009, INT PERSPECT SEX R H, V35, P21, DOI 10.1363/ifpp.35.021.09; Booker K.C., 2007, URBAN REV, V39, P301, DOI [10.1007/s11256-007-0053-y, DOI 10.1007/S11256-007-0053-Y]; Capuzzi D, 2014, YOUTH RISK PREVENTIO; CHINN S, 1991, THORAX, V46, P454, DOI 10.1136/thx.46.6.454; Chou C-P., 1995, STRUCTURAL EQUATION, P37, DOI DOI 10.2307/2988418; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowden R, 2016, J PSYCHOEDUC ASSESS; Daigneault I, 2013, CHILD ABUSE NEGLECT, V37, P160, DOI 10.1016/j.chiabu.2012.06.004; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Essau CA., 2006, J CHILD FAM STUD, V15, P595, DOI [10.1007/s10826-006-9036-y, DOI 10.1007/S10826-006-9036-Y]; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Frick P.J., 1991, ALABAMA PARENTING QU; George D, 2003, SPSS WINDOWS STEP ST, V4th, DOI DOI 10.1080/13803395.2011.614598; GOODENOW C, 1993, PSYCHOL SCHOOLS, V30, P79, DOI 10.1002/1520-6807(199301)30:1<79::AID-PITS2310300113>3.0.CO;2-X; Govender K, 2013, J SCHOOL HEALTH, V83, P614, DOI 10.1111/josh.12073; Hawes D.J., 2006, J CHILD FAM STUD, V15, P554, DOI [10.1007/s10826-006-9029-x, DOI 10.1007/S10826-006-9029-X]; Hoe S. L., 2008, J QUANTITATIVE METHO, P76; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kenny D.A., 2020, MEASURING MODEL FIT; Kharsany ABM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2179-2; Kia-Keating Maryam, 2007, Clin Child Psychol Psychiatry, V12, P29, DOI 10.1177/1359104507071052; Kline R.B., 2011, PRINCIPLES PRACTICE; Lerner RM, 2005, J EARLY ADOLESCENCE, V25, P10, DOI 10.1177/0272431604273211; Lewis R, 2006, YOUTH RISK PREVENTIO, P35; Liebenberg L, 2012, RES SOCIAL WORK PRAC, V22, P219, DOI 10.1177/1049731511428619; Makiwane M, 2010, AJAR-AFR J AIDS RES, V9, P17, DOI 10.2989/16085906.2010.484538; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Masten AS, 2014, CHILD DEV, V85, P6, DOI 10.1111/cdev.12205; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Merrell KW, 2011, J CHILD FAM STUD, V20, P529, DOI 10.1007/s10826-010-9425-0; Mistry R, 2009, PREV MED, V48, P291, DOI 10.1016/j.ypmed.2008.12.013; Mueller J, 2011, TROP MED INT HEALTH, V16, P57, DOI 10.1111/j.1365-3156.2010.02682.x; Munro B., 2005, STAT METHOD HLTH CAR; Parry C. D. H., 1996, TRANSCULT PSYCHIATRY, V33, P173, DOI [DOI 10.1177/136346159603300203, 10.1177/136346159603300203]; Resilience Research Center, 2019, CHILD YOUTH RES MEAS; Resilience Research Centre, 2013, CHILD YOUTH RES MEAS; Rigdon EE, 1996, STRUCT EQU MODELING, V3, P369, DOI 10.1080/10705519609540052; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rubin Leah H, 2007, J Undergrad Neurosci Educ, V5, pA71; Rutten BPF, 2013, ACTA PSYCHIAT SCAND, V128, P3, DOI 10.1111/acps.12095; Sanchez B, 2005, J YOUTH ADOLESCENCE, V34, P619, DOI 10.1007/s10964-005-8950-4; Sanders J, 2015, RES SOC WORK PRACT; Shaffer A, 2013, J ABNORM CHILD PSYCH, V41, P199, DOI 10.1007/s10802-012-9670-3; Shelton KK, 1996, J CLIN CHILD PSYCHOL, V25, P317, DOI 10.1207/s15374424jccp2503_8; Shochet IM, 2006, J CLIN CHILD ADOLESC, V35, P170, DOI 10.1207/s15374424jccp3502_1; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Sumter SR, 2009, J ADOLESCENCE, V32, P1009, DOI 10.1016/j.adolescence.2008.08.010; Themessl-Huber M., 2014, PSYCHOL TEST ASSESS, V3, P219; Theron LC, 2013, J BLACK PSYCHOL, V39, P63, DOI 10.1177/0095798412454675; Theron Linda C., 2010, S. Afr. j. sci., V106, P1; Ungar M, 2008, BRIT J SOC WORK, V38, P218, DOI 10.1093/bjsw/bc1343; Ungar M, 2013, SCHOOL PSYCHOL INT, V34, P514, DOI 10.1177/0143034312472761; Ungar M, 2013, TRAUMA VIOLENCE ABUS, V14, P255, DOI 10.1177/1524838013487805; Ungar M, 2013, CHILD ABUSE NEGLECT, V37, P150, DOI 10.1016/j.chiabu.2012.05.007; Ungar M, 2011, J MIX METHOD RES, V5, P126, DOI 10.1177/1558689811400607; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	61	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185815	10.1371/journal.pone.0185815	http://dx.doi.org/10.1371/journal.pone.0185815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982195	gold, Green Published			2022-12-27	WOS:000412360300070
J	Hobbs, MT; Brehme, CS				Hobbs, Michael T.; Brehme, Cheryl S.			An improved camera trap for amphibians, reptiles, small mammals, and large invertebrates	PLOS ONE			English	Article							PHOTO IDENTIFICATION; WILDLIFE; OCCUPANCY; LANDSCAPE; FEATURES; DESIGN	Camera traps are valuable sampling tools commonly used to inventory and monitor wildlife communities but are challenged to reliably sample small animals. We introduce a novel active camera trap system enabling the reliable and efficient use of wildlife cameras for sampling small animals, particularly reptiles, amphibians, small mammals and large invertebrates. It surpasses the detection ability of commonly used passive infrared (PIR) cameras for this application and eliminates problems such as high rates of false triggers and high variability in detection rates among cameras and study locations. Our system, which employs a HALT trigger, is capable of coupling to digital PIR cameras and is designed for detecting small animals traversing small tunnels, narrow trails, small clearings and along walls or drift fencing.	[Brehme, Cheryl S.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA	United States Department of the Interior; United States Geological Survey		mhobbs2928@gmail.com		Hobbs, Michael/0000-0001-8469-1037; Brehme, Cheryl/0000-0001-8904-3354	California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA); Stanford Habitat Conservation Plan	California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA); Stanford Habitat Conservation Plan	The author received funding for the second field test conducted during seasonal breeding migrations of the California tiger salamander (Ambystoma californiense) (CTS) in the foothills at Stanford University (Santa Clara County, CA). This field test was funded by the Stanford Habitat Conservation Plan.	Barros CS, 2015, ZOOLOGIA-CURITIBA, V32, P334, DOI 10.1590/S1984-46702015000500002; Bluett Robert D., 2013, Transactions of the Illinois State Academy of Science, V106, P15; Brooks RT, 1996, WILDLIFE SOC B, V24, P298; Burnham K P, 2003, MODEL SELECT MULTIMO; Carbone C, 2001, ANIMAL CONSERVATION, V4; Cusack JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126373; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Edwards KE, 2014, WILDLIFE SOC B, V38, P530, DOI 10.1002/wsb.419; Enge KM, 2001, J HERPETOL, V35, P467, DOI 10.2307/1565965; Faber Lieke, 2013, Herpetological Review, V44, P600; Fisher R, 2008, HERPETOLOGICAL MONIT; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Hamel S, 2013, METHODS ECOL EVOL, V4, P105, DOI 10.1111/j.2041-210x.2012.00262.x; Harlow HJ, 2010, INT J ZOOLOGY, V2010; Hines J., 2006, PRESENCE2 SOFTWARE E; Hughson DL, 2010, CALIF FISH GAME, V96, P101; Jenkins Christopher L., 2003, Herpetological Review, V91, P39; KUCERA TE, 1993, WILDLIFE SOC B, V21, P505; Lang SB, 2005, PHYS TODAY, V58, P31, DOI 10.1063/1.2062916; Luo  R.C., 2008, P IEEE WORKSH ADV RO, P1; Marcus Rowcliffe J, 2011, METHODS ECOLOGY EVOL, V2; McDonald PJ, 2015, BIOL CONSERV, V191, P93, DOI 10.1016/j.biocon.2015.06.027; Meek P, 2012, INTRO CAMERA TRAPPIN; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Nebel S, 2013, NATURE ED KNOWLEDGE, V4, P3; Pagnucco KS, 2011, HERPETOL CONSERV BIO, V6, P277; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; RICE CG, 1995, WILDLIFE SOC B, V23, P110; Rovero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103300; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rovero Francesco, 2010, Abc Taxa, V8, P100; Ryan TJ, 2002, FOREST ECOL MANAG, V167, P83, DOI 10.1016/S0378-1127(01)00692-2; Schoen Alan, 2015, Herpetological Review, V46, P188; Sharifi M, 2013, RUSS J HERPETOL, V20, P264; Swann DE, 2004, WILDLIFE SOC B, V32, P357, DOI 10.2193/0091-7648(2004)32[357:ICFDWA]2.0.CO;2; Swinnen KRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098881; Tchernihovski N, 1997, United States patent US, Patent No. [5,693,943, 5693943]; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Todd BD, 2007, AM MIDL NAT, V158, P292, DOI 10.1674/0003-0031(2007)158[292:GTDETE]2.0.CO;2; Welbourne DJ., 2013, PLOS ONE, V6; Yun J, 2014, SENSORS-BASEL, V14, P8057, DOI 10.3390/s140508057	41	27	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185026	10.1371/journal.pone.0185026	http://dx.doi.org/10.1371/journal.pone.0185026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981533	Green Published, gold			2022-12-27	WOS:000412360300026
J	Nash, M; Davies, A; Moore, R				Nash, Meredith; Davies, Amanda; Moore, Robyn			What style of leadership do women in STEMM fields perform? Findings from an international survey	PLOS ONE			English	Article							FEMALE LEADERS; GENDER BIAS; IDENTITY; METAANALYSIS; COMPLEXITY; EDUCATION	It is widely acknowledged that women in science, technology, engineering, mathematics, and medicine (STEMM) fields are underrepresented in leadership globally. However, little is known about how leadership styles of women in STEMM relate to this underrepresentation. This article discusses findings from a survey examining how 61 women in STEMM define leadership and describe their own leadership styles. Using content analysis and drawing on Full Range Leadership Model factors, findings suggest that women define leadership and describe their own leadership styles using transformational factors. However, there was no consistency in how participants defined ideal leadership or how they defined their own leadership styles. This finding unsettles ideas of distinctly gendered leadership styles. We argue that expectations that leadership will be performed in distinctly gendered styles may be contributing to the underrepresentation of women in leadership roles in STEMM.	[Nash, Meredith; Moore, Robyn] Univ Tasmania, Sch Social Sci, Hobart, Tas, Australia; [Davies, Amanda] Curtin Univ, Sch Built Environm, Perth, WA, Australia	University of Tasmania; Curtin University	Nash, M (corresponding author), Univ Tasmania, Sch Social Sci, Hobart, Tas, Australia.	Meredith.Nash@utas.edu.au	Nash, Meredith/D-8217-2014; Nash, Meredith/O-6178-2019	Nash, Meredith/0000-0002-7429-4924; Nash, Meredith/0000-0002-7429-4924; Davies, Amanda/0000-0003-1892-9128				[Anonymous], 2010, LEADERSHIP MANAGEMEN, DOI DOI 10.1061/(ASCE)LM.1943-5630.0000080; Antonakis J, 2003, LEADERSHIP QUART, V14, P261, DOI 10.1016/S1048-9843(03)00030-4; Avolio B. J., 1991, FULL RANGE LEADERSHI; Barbuto JE, 2007, SEX ROLES, V56, P71, DOI 10.1007/s11199-006-9152-6; Bilimoria D, 2014, WOMEN IN STEM CAREERS: INTERNATIONAL PERSPECTIVES ON INCREASING WORKFORCE PARTICIPATION, ADVANCEMENT AND LEADERSHIP, P146; Bosak J, 2011, SEX ROLES, V65, P234, DOI 10.1007/s11199-011-0012-7; Burns J. M., 1978, LEADERSHIP; Buse KR, 2014, CONSULTING PSYCHOL J, V60, P348; Coffey A, 1996, MAKING SENSE QUALITA; Davies A, 2007, RURAL SOC, V17, P139, DOI 10.5172/rsj.351.17.2.139; Debebe G, 2016, J MANAG EDUC, V40, P231, DOI 10.1177/1052562916639079; DeRue DS, 2010, ACAD MANAGE REV, V35, P627, DOI 10.5465/AMR.2010.53503267; EAGLY AH, 1990, PSYCHOL BULL, V108, P233, DOI 10.1037/0033-2909.108.2.233; Eagly AH, 2003, PSYCHOL BULL, V129, P569, DOI 10.1037/0033-2909.129.4.569; Eagly AH, 2001, J SOC ISSUES, V57, P781, DOI 10.1111/0022-4537.00241; Eagly AH, 2007, PSYCHOL WOMEN QUART, V31, P1, DOI 10.1111/j.1471-6402.2007.00326.x; Eagly AH, 2016, LEADERSHIP QUART, V27, P349, DOI 10.1016/j.leaqua.2016.04.002; Ellemers N, 2004, BRIT J SOC PSYCHOL, V43, P315, DOI 10.1348/0144666042037999; Ellemers Naomi, 1993, EUROPEAN REV SOCIAL, V4, P27, DOI DOI 10.1080/14792779343000013; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Elsesser KM, 2011, HUM RELAT, V64, P1555, DOI 10.1177/0018726711424323; Ely R.F., 2010, HDB LEADERSHIP THEOR, P377; Ely RJ, 2011, ACAD MANAG LEARN EDU, V10, P474, DOI 10.5465/amle.2010.0046; Hall LJ, 2013, BRIT J SOC PSYCHOL, V52, P631, DOI 10.1111/j.2044-8309.2012.02114.x; Harris CA, 2012, ADV DEV HUM RESOUR, V14, P28, DOI 10.1177/1523422311428747; Hay I., 2015, QUALITATIVE RES METH; Hogue M, 2007, LEADERSHIP QUART, V18, P370, DOI 10.1016/j.leaqua.2007.04.006; Holvino E, 2010, GENDER WORK ORGAN, V17, P248, DOI 10.1111/j.1468-0432.2008.00400.x; Hoyt CL, 2016, LEADERSHIP QUART, V27, P387, DOI 10.1016/j.leaqua.2015.11.002; Krippendorff K. H., 2013, CONTENT ANAL INTRO I; Lauber D., 2014, THESIS; Lester PB, 2011, ACAD MANAG LEARN EDU, V10, P409, DOI 10.5465/amle.2010.0047; Lowe KB, 1996, LEADERSHIP QUART, V7, P385, DOI 10.1016/S1048-9843(96)90027-2; Lumby J, 2010, SCH LEADERSH MANAG, V30, P3, DOI 10.1080/13632430903509717; Marinelli M, 2014, WOMEN IN STEM CAREERS: INTERNATIONAL PERSPECTIVES ON INCREASING WORKFORCE PARTICIPATION, ADVANCEMENT AND LEADERSHIP, P101; Meyerson DE, 2000, HARVARD BUS REV, V78, P126; Moorosi P, 2014, EDUC MANAG ADM LEAD, V42, P792, DOI 10.1177/1741143213494888; O'Neil DA, 2015, J APPL BEHAV SCI, V51, P253, DOI 10.1177/0021886315575550; Oberfield ZW, 2014, J PUBL ADM RES THEOR, V24, P407, DOI 10.1093/jopart/mus060; Powell G., 2011, LEADING PEOPLE WOMEN; Richardson A., 2008, INT J LEADERSHIP STU, V3, P142; ROSENER JB, 1990, HARVARD BUS REV, V68, P119; Rosser S. V., 2004, NWSA J, V16, P50, DOI [DOI 10.1353/NWSA.2004.0040, 10.1353/nwsa.2004.0040]; Sanchez-Hucles JV, 2010, AM PSYCHOL, V65, P171, DOI 10.1037/a0017459; Singh V., 2002, J CHANGE MANAGEMENT, V3, P294, DOI DOI 10.1080/714023846; Stempel CR, 2015, LEADERSHIP-LONDON, V11, P259, DOI 10.1177/1742715015590468; Stempel CR, 2015, LEADERSHIP, V11, P263; Switzer JY, 2006, WOMEN COLL PRESIDENT, P21; van den Brink M, 2009, GENDER WORK ORGAN, V16, P451, DOI 10.1111/j.1468-0432.2008.00428.x; van Engen ML, 2004, PSYCHOL REP, V94, P3, DOI 10.2466/pr0.94.1.3-18; Vial AC, 2016, LEADERSHIP QUART, V27, P400, DOI 10.1016/j.leaqua.2015.12.004; Vinkenburg CJ, 2011, LEADERSHIP QUART, V22, P10, DOI 10.1016/j.leaqua.2010.12.003; Yoder JD, 2001, J SOC ISSUES, V57, P815, DOI 10.1111/0022-4537.00243	53	8	8	7	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185727	10.1371/journal.pone.0185727	http://dx.doi.org/10.1371/journal.pone.0185727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982147	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000412360300061
J	Shin, HJ; Franco, LH; Nair, VR; Collins, AC; Shiloh, MU				Shin, Hyun-Jin; Franco, Luis H.; Nair, Vidhya R.; Collins, Angela C.; Shiloh, Michael U.			A baculovirus-conjugated mimotope vaccine targeting Mycobacterium tuberculosis lipoarabinomannan	PLOS ONE			English	Article							PEPTIDE MIMOTOPES; IMMUNE-RESPONSES; ANTIBODIES; PROTECTION; CELLS; POLYSACCHARIDES; ARABINOMANNAN; INDUCTION; INFECTION; VIRULENT	Mycobacterium tuberculosis, the causative agent of tuberculosis, is a major cause of morbidity and mortality worldwide. However, an effective vaccine for M. tuberculosis is lacking. We panned a phage display library using monoclonal antibodies against M. tuberculosis liporabinomannan (LAM), an important component of the M. tuberculosis cell wall, and identified two peptide sequences, HSFKWLDSPRLR or SGVYKVAYDWQH, with high antibody affinity after multiple rounds of panning. Only the HSFKWLDSPRLR peptide induced an anti-LAM response when conjugated to either keyhole limpet hemocyanin (KLH) or to the baculovirus Autographa californica multicapsid nucleopolyherovirus (AcMNPV) when introduced into mice by injection or via intranasal inoculation, respectively. Vaccination with AcMNPV conjugated HSFKWLDSPRLR peptide delayed mortality in a mouse model of tuberculosis. Thus, we report a proof of principle M. tuberculosis vaccination strategy combining an anti-LAM mimotope with a baculovirus delivery system.	[Shin, Hyun-Jin; Nair, Vidhya R.; Collins, Angela C.; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Franco, Luis H.] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Nair, Vidhya R.; Shiloh, Michael U.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Shin, Hyun-Jin] Chungnam Natl Univ, Coll Vet Med, 220 Gungdong, Yuseong, Daejon, South Korea	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chungnam National University	Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Shiloh, MU (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Shiloh@utsouthwestern.edu	Shiloh, Michael/AAS-8883-2020; Franco, Luis H/M-4636-2017	Shiloh, Michael/0000-0003-4329-2253; Franco, Luis H/0000-0002-8143-1384; Collins, Angela/0000-0001-6392-7151	UT Southwestern Medical Center; NIH [AI099439, AI125939, AI111023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099439, U01AI125939, R21AI111023] Funding Source: NIH RePORTER	UT Southwestern Medical Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a High Risk-High Impact Award from UT Southwestern Medical Center, and NIH grants AI099439, AI125939, AI111023 (M.U.S.). Dr. Shiloh is a Disease Oriented Clinical Scholar at UT Southwestern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Ahi YS, 2011, CURR GENE THER, V11, P307; Bailo R, 2015, BIOCHEM PHARMACOL, V96, P159, DOI 10.1016/j.bcp.2015.05.001; Bakhshinejad B, 2016, AMINO ACIDS, V48, P2699, DOI 10.1007/s00726-016-2329-6; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Barenholz A, 2007, J MED MICROBIOL, V56, P579, DOI 10.1099/jmm.0.46920-0; Baumann R, 2014, J INFECTION, V69, P581, DOI 10.1016/j.jinf.2014.05.014; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; Chen ZJ, 2015, MOL PHARMACEUT, V12, P2180, DOI 10.1021/acs.molpharmaceut.5b00177; Collins AC, 2015, CELL HOST MICROBE, V17, P820, DOI 10.1016/j.chom.2015.05.005; Diaz-Perlas C, 2016, BIOPOLYMERS; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2017.08.005, 10.1016/j.chom.2016.11.002]; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Gevorkian G, 2005, BIOCHEM J, V387, P411, DOI 10.1042/BJ20041139; Grosse S, 2016, ANGEW CHEM INT EDIT, V55, P11266, DOI 10.1002/anie.201601603; Guo GN, 2016, BIOTECHNOL LETT, V38, P1867, DOI 10.1007/s10529-016-2172-6; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Hartman ZC, 2008, VIRUS RES, V132, P1, DOI 10.1016/j.virusres.2007.10.005; Hsu CS, 2004, BIOTECHNOL BIOENG, V88, P42, DOI 10.1002/bit.20213; Hu YC, 2006, ADV VIRUS RES, V68, P287, DOI 10.1016/S0065-3527(06)68008-1; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Jacobs AJ, 2016, TUBERCULOSIS, V101, P102, DOI 10.1016/j.tube.2016.08.001; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Jordan KR, 2009, CURR PROTOC IMMUNOL; Kaufmann SH, 2016, INT J INFECT DIS; Kim JJP, 2009, CURR OPIN STRUC BIOL, V19, P534, DOI 10.1016/j.sbi.2009.09.002; Li H, 2017, P NATL ACAD SCI USA, V114, P5023, DOI 10.1073/pnas.1611776114; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Nair VR, 2016, CELL REP, V16, P1253, DOI 10.1016/j.celrep.2016.06.080; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; Prados-Rosales R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006250; Principi N, 2015, TUBERCULOSIS, V95, P6, DOI 10.1016/j.tube.2014.10.004; Ren LN, 2016, BIOCHEM PHARMACOL, V107, P91, DOI 10.1016/j.bcp.2016.03.004; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Schlesinger LS, 1996, J IMMUNOL, V157, P4568; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; Sharma A, 2006, CLIN VACCINE IMMUNOL, V13, P1143, DOI 10.1128/CVI.00127-06; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; WHO, 2016, GLOB TUB REP; Williams A, 2004, IMMUNOLOGY, V111, P328, DOI 10.1111/j.1365-2567.2004.01809.x; Wilson S, 2008, VACCINE, V26, P2451, DOI 10.1016/j.vaccine.2008.03.027; Xing Z, 2014, CHEST, V146, P804, DOI 10.1378/chest.14-0439; XU SM, 1994, J IMMUNOL, V153, P2568; Yu X, 2012, CLIN VACCINE IMMUNOL, V19, P198, DOI 10.1128/CVI.05550-11; Zacharia VM, 2013, MBIO, V4, DOI 10.1128/mBio.00721-13; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	56	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185945	10.1371/journal.pone.0185945	http://dx.doi.org/10.1371/journal.pone.0185945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982200	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300094
J	Vaiciukynas, E; Verikas, A; Gelzinis, A; Bacauskiene, M				Vaiciukynas, Evaldas; Verikas, Antanas; Gelzinis, Adas; Bacauskiene, Marija			Detecting Parkinson's disease from sustained phonation and speech signals	PLOS ONE			English	Article							AUTOMATIC DETECTION	This study investigates signals from sustained phonation and text-dependent speech modalities for Parkinson's disease screening. Phonation corresponds to the vowel /a/ voicing task and speech to the pronunciation of a short sentence in Lithuanian language. Signals were recorded through two channels simultaneously, namely, acoustic cardioid (AC) and smart phone (SP) microphones. Additional modalities were obtained by splitting speech recording into voiced and unvoiced parts. Information in each modality is summarized by 18 well-known audio feature sets. Random forest (RF) is used as a machine learning algorithm, both for individual feature sets and for decision-level fusion. Detection performance is measured by the out-of-bag equal error rate (EER) and the cost of log-likelihood-ratio. Essentia audio feature set was the best using the AC speech modality and YAAFE audio feature set was the best using the SP unvoiced modality, achieving EER of 20.30% and 25.57%, respectively. Fusion of all feature sets and modalities resulted in EER of 19.27% for the AC and 23.00% for the SP channel. Non-linear projection of a RF-based proximity matrix into the 2D space enriched medical decision support by visualization.	[Vaiciukynas, Evaldas; Verikas, Antanas; Gelzinis, Adas; Bacauskiene, Marija] Kaunas Univ Technol, Dept Elect Power Syst, Kaunas, Lithuania; [Vaiciukynas, Evaldas] Kaunas Univ Technol, Dept Informat Syst, Kaunas, Lithuania; [Verikas, Antanas] Halmstad Univ, CAISR, Halmstad, Sweden	Kaunas University of Technology; Kaunas University of Technology; Halmstad University	Vaiciukynas, E (corresponding author), Kaunas Univ Technol, Dept Elect Power Syst, Kaunas, Lithuania.; Vaiciukynas, E (corresponding author), Kaunas Univ Technol, Dept Informat Syst, Kaunas, Lithuania.	evaldas.vaiciukynas@ktu.lt		Vaiciukynas, Evaldas/0000-0002-4769-4527; verikas, antanas/0000-0003-2185-8973	Research Council of Lithuania [MIP-075/2015]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. MIP-075/2015) from the Research Council of Lithuania (http://www.lmt.lt/en) to Antanas Verikas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora G, 2013, P IEEE, V101, P2470, DOI 10.1109/JPROC.2013.2262913; An G., 2015, 16 ANN C INT SPEECH; Arora S, 2015, PARKINSONISM RELAT D, V21, P650, DOI 10.1016/j.parkreldis.2015.02.026; Belalcazar-Bolanos E. A., 2013, Natural and Artificial Models in Computation and Biology. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings, Part I: LNCS 7930, P283, DOI 10.1007/978-3-642-38637-4_29; Bogdanov D., 2013, 14 C INT SOC MUSIC I, P493; Bot BM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.11; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brummer N, 2013, ARXIV PREPRINT ARXIV; Caesarendra W, 2015, IEEE ASME INT C ADV, P802, DOI 10.1109/AIM.2015.7222636; Crysandt H, 2004, 3 MUSICNETWORK OP WO; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Ellis D. P., 2005, PLP RASTA MFCC INVER; Eyben F., 2013, P 21 ACM INT C MULT, P835, DOI 10.1145/2502081.2502224; Faundez-Zanuy M, 2005, IEEE AERO EL SYS MAG, V20, P7, DOI 10.1109/MAES.2005.1432568; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gelzinis A, 2008, COMPUT METH PROG BIO, V91, P36, DOI 10.1016/j.cmpb.2008.01.008; Harel B, 2004, BRAIN COGNITION, V56, P24, DOI 10.1016/j.bandc.2004.05.002; Hariharan M, 2014, COMPUT METH PROG BIO, V113, P904, DOI 10.1016/j.cmpb.2014.01.004; Heinmerling D, 2016, INTERSPEECH, P1190, DOI 10.21437/Interspeech.2016-1062; Jaiantilal A., 2012, RANDOM FOREST; Khan T, 2014, BIOCYBERN BIOMED ENG, V34, P25, DOI 10.1016/j.bbe.2013.06.001; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Little MA, 2009, IEEE T BIO-MED ENG, V56, P1015, DOI 10.1109/TBME.2008.2005954; Ma C, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/985789; Mathieu B., 2010, P 11 INT SOC MUSIC I, P441; McEnnis D., 2006, P 7 INT C MUS ISMIR, P385; Memedi M, 2015, SENSORS-BASEL, V15, P23727, DOI 10.3390/s150923727; Naranjo L, 2016, EXPERT SYST APPL, V46, P286, DOI 10.1016/j.eswa.2015.10.034; Orozco-Arroyave JR, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P95; Orozco-Arroyave JR, 2016, J ACOUST SOC AM, V139, P481, DOI 10.1121/1.4939739; Ramani R. G., 2011, INT J COMPUT APPL, V32, P17, DOI DOI 10.5120/3932-5571]; Revett Kenneth, 2009, Proceedings of the 2009 International Multiconference on Computer Science and Information Technology (IMCSIT), P425, DOI 10.1109/IMCSIT.2009.5352688; Saenz-Lechon N, 2006, BIOMED SIGNAL PROCES, V1, P120, DOI 10.1016/j.bspc.2006.06.003; Sakar CO, 2010, J MED SYST, V34, P591, DOI 10.1007/s10916-009-9272-y; Tsanas A., 2012, ACCURATE TELEMONITOR; Tsanas A, 2014, IEEE T NEUR SYS REH, V22, P181, DOI 10.1109/TNSRE.2013.2293575; Tsanas A, 2012, IEEE T BIO-MED ENG, V59, P1264, DOI 10.1109/TBME.2012.2183367; Vaiciukynas E, 2016, FUSING VARIOUS AUDIO, P328; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vasquez-Correa JC, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P105; Verikas A, 2015, MED ENG PHYS, V37, P210, DOI 10.1016/j.medengphy.2014.12.005; Villa-Canas T, 2014, 19 S IM SIGN PROC AR, V1, P146; Wattenberg M, 2016, USE TSNE EFFECTIVELY; Yang SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088825	44	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185613	10.1371/journal.pone.0185613	http://dx.doi.org/10.1371/journal.pone.0185613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982171	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300047
J	Oh, E; Jeong, HM; Kwon, MJ; Ha, SY; Park, HK; Song, JY; Kim, YJ; Choi, JS; Lee, EH; Lee, J; Choi, YL; Shin, YK				Oh, Ensel; Jeong, Hae Min; Kwon, Mi Jeong; Ha, Sang Yun; Park, Hyung Kyu; Song, Ji-Young; Kim, Yu Jin; Choi, Jong-Sun; Lee, Eun Hee; Lee, Jeeyun; Choi, Yoon-La; Shin, Young Kee			Unforeseen clonal evolution of tumor cell population in recurrent and metastatic dermatofibrosarcoma protuberans	PLOS ONE			English	Article							KRAS MUTATION STATUS; EGFR T790M MUTATION; LUNG-CANCER; COLORECTAL-CANCER; RESISTANCE; SEQUENCES; IMATINIB; FUSION; CHROMOSOME-22; REARRANGEMENT	Dermatofibrosarcoma protuberans (DFSP) is a very rare soft tissue sarcoma, generally of low-grade malignancy. DFSP is locally aggressive with a high recurrence rate, but metastasis occurs rarely. To investigate the mechanism of metastasis in DFSP, we analyzed the whole exome sequencing data of serial tumor samples obtained from a patient who had a 10-year history of recurrent and metastatic DFSP. Tracking various genomic alterations, namely somatic mutations, copy number variations, and chromosomal rearrangements, we observed a dramatic change in tumor cell population during the occurrence of metastasis in this DFSP case. The new subclone that emerged in metastatic DFSP harbored a completely different set of somatic mutations and new focal amplifications, which had not been observed in the primary clone before metastasis. The COL1A1-PDGFB fusion, characteristic of DFSP, was found in all of the serial samples. Moreover, the break position on the fusion gene was identical in all samples. Based on these observations, we suggest a clonal evolution model to explain the mechanism underlying metastasis in DFSP and identified several candidate target genes responsible for metastatic DFSP by utilizing The Cancer Genome Atlas database. This is the first study to observe clonal evolution in metastatic DFSP and provide insight for a possible therapeutic strategy for imatinib-resistant or metastatic DFSP.	[Oh, Ensel; Song, Ji-Young; Kim, Yu Jin; Choi, Yoon-La] Samsung Med Ctr, Lab Canc Genom & Mol Pathol, Seoul, South Korea; [Oh, Ensel; Choi, Yoon-La] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea; [Jeong, Hae Min; Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Lab Mol Pathol & Canc Genom, Seoul, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Kwon, Mi Jeong] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Daegu, South Korea; [Ha, Sang Yun; Park, Hyung Kyu; Choi, Yoon-La] Sungkyunkwan Univ, Dept Pathol & Translat Genom, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Choi, Jong-Sun; Shin, Young Kee] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Lee, Eun Hee] Sungkyunkwan Univ, Changwon Samsung Hosp, Dept Pathol, Sch Med, Chang Won, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol,Samsung Med Ctr, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, YL (corresponding author), Samsung Med Ctr, Lab Canc Genom & Mol Pathol, Seoul, South Korea.; Choi, YL (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.; Shin, YK (corresponding author), Seoul Natl Univ, Coll Pharm, Lab Mol Pathol & Canc Genom, Seoul, South Korea.; Choi, YL (corresponding author), Sungkyunkwan Univ, Dept Pathol & Translat Genom, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Shin, YK (corresponding author), Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Mol Med & Biopharmaceut Sci, Seoul, South Korea.	ylachoi@skku.edu; ykeeshin@snu.ac.kr	Lee, Jee Yun/C-9646-2011; Park, Hyung Kyu/AAA-4004-2019; Shin, Young Kee/C-8929-2011	Park, Hyung Kyu/0000-0002-5972-3516; Shin, Young Kee/0000-0003-0896-718X; Kwon, Mi Jeong/0000-0002-7599-878X	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3C8A1078501, 2013M3C8A1079312, 2016R1A5A2945889]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the R&D Program for the Society of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3C8A1079312, 2013M3C8A1078501 and 2016R1A5A2945889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the R&D Program for the Society of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3C8A1079312, 2013M3C8A1078501 and 2016R1A5A2945889).	Abbott JJ, 2006, MODERN PATHOL, V19, P1512, DOI 10.1038/modpathol.3800695; AIBA S, 1992, BRIT J DERMATOL, V127, P79, DOI 10.1111/j.1365-2133.1992.tb08036.x; Arribas J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157761; Arribas J, 2015, APOPTOSIS, V20, P1338, DOI 10.1007/s10495-015-1155-8; Chang CK, 2004, EJSO, V30, P341, DOI 10.1016/j.ejso.2003.12.005; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Ha SY, 2013, HUM PATHOL, V44, P1300, DOI 10.1016/j.humpath.2012.09.021; Kiuru-Kuhlefelt S, 2001, CYTOGENET CELL GENET, V92, P192, DOI 10.1159/000056901; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lindner NJ, 1999, EUR J SURG ONCOL, V25, P392, DOI 10.1053/ejso.1999.0663; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Maki RG, 2002, INT J CANCER, V100, P623, DOI 10.1002/ijc.10535; McArthur GA, 2005, J CLIN ONCOL, V23, P866, DOI 10.1200/JCO.2005.07.088; Mumenthaler SM, 2011, MOL PHARMACEUT, V8, P2069, DOI 10.1021/mp200270v; NAEEM R, 1995, AM J PATHOL, V147, P1553; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oh E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144162; Pappa KI, 2006, GYNECOL ONCOL, V100, P596, DOI 10.1016/j.ygyno.2005.09.029; Patel KU, 2008, HUM PATHOL, V39, P184, DOI 10.1016/j.humpath.2007.06.009; PEDEUTOUR F, 1995, CANCER RES, V55, P2400; Pedeutour F, 1996, CYTOGENET CELL GENET, V72, P171, DOI 10.1159/000134178; Rutkowski P, 2010, J CLIN ONCOL, V28, P1772, DOI 10.1200/JCO.2009.25.7899; Shimizu A, 1999, CANCER RES, V59, P3719; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Sjoblom T, 2001, CANCER RES, V61, P5778; Stacchiotti S, 2015, CLIN CANC RES; Stacchiotti S, 2016, MOL CANCER RES, V14, P820, DOI 10.1158/1541-7786.MCR-16-0068; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Watanabe M, 2015, CLIN CANCER RES, V21, P3552, DOI 10.1158/1078-0432.CCR-14-2151; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	34	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185826	10.1371/journal.pone.0185826	http://dx.doi.org/10.1371/journal.pone.0185826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977029	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100048
J	Lee, JE; Lim, JH; Jang, HM; Kim, YS; Kang, SW; Yang, CW; Kim, NH; Kwon, E; Kim, HJ; Park, JM; Jung, HY; Choi, JY; Park, SH; Kim, CD; Cho, JH; Kim, YL				Lee, Ji-Eun; Lim, Jeong-Hoon; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim		Clinical Res Center End Stage	Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study	PLOS ONE			English	Article							MINERAL METABOLISM; HEMODIALYSIS-PATIENTS; KIDNEY-DISEASE; HYPOPHOSPHATEMIA; CALCIUM; CONSEQUENCES; PHOSPHORUS; OUTCOMES; DEATH; CKD	Background The role of mineral metabolism in mortality among dialysis patients has received increased attention, but some aspects remain unclear. The aim of the present study was to investigate the prognostic value of serum calcium and phosphate levels for all-cause mortality and cause-specific mortality in dialysis patients. Methods Patients on hemodialysis and peritoneal dialysis were enrolled from a multicenter prospective cohort study in Korea (NCT00931970). The patients were divided into low, normal, and high groups according to their baseline serum calcium or phosphate levels. Cox proportional analysis and a proportional hazards model for the subdistribution of a competing risk were used to calculate hazard ratios (HRs) for the association of serum calcium and phosphate levels with all-cause and cause-specific mortality. Time- dependent values of calcium and phosphate were also evaluated to assess the effect of longitudinal change in mineral metabolism parameters on mortality types. Results A total of 3,226 dialysis patients were followed up for a mean of 19.8 +/- 8.2 months. Infection was the most common cause of death. Low serum phosphate was significantly associated with all-cause and infection-related death using time-dependent values (HR, 1.43 [95% confidence interval (CI), 1.06-1.93], P = 0.02, and HR, 1.66 [95% CI, 1.02-2.70], P = 0.04, respectively). Low serum phosphate was associated with significantly higher infectionrelated mortality, especially in patients older than 65 years or on dialysis more than one year or with serum albumin lower than 3.9 g/dL (HR, 2.06 [95% CI, 1.13-3.75], P = 0.02, HR, 2.19 [95% CI, 1.20-4.01], P = 0.01, and HR, 1.77 [95% CI, 1.00-3.13], P = 0.05, respectively). Multinomial logistic regression analysis results suggested that low serum albumin, creatinine, and body mass index correlated with low serum phosphate. Conclusions Low serum phosphate in dialysis patients was an independent risk factor for infectionrelated death, especially in elderly patients. Persistently low serum phosphate might be a nutritional biomarker to predict increased susceptibility to infection and in turn worse outcomes in dialysis patients.	[Lee, Ji-Eun; Lim, Jeong-Hoon; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Lee, Ji-Eun; Jang, Hye Min; Kim, Yon Su; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Kwon, Eugene; Kim, Hyun-Ji; Park, Jeung-Min; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Chan-Duck; Cho, Jang-Hee; Kim, Yong-Lim] Clin Res Ctr End Stage Renal Dis, Daegu, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University	Cho, JH; Kim, YL (corresponding author), Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea.; Cho, JH; Kim, YL (corresponding author), Clin Res Ctr End Stage Renal Dis, Daegu, South Korea.	jh-cho@knu.ac.kr; ylkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Lim, Jeong-Hoon/ABE-6003-2020; Park, Sun/GSD-9620-2022	Cho, Jang-hee/0000-0002-7031-5214; Lim, Jeong-Hoon/0000-0001-5517-9886; Jung, Hee-Yeon/0000-0003-0232-7202	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001, HC15C1129]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant numbers: HI15C0001 and HC15C1129, URL: https://www.khidi.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Chung S, 2012, OPEN J INT MED, V2, P89, DOI [DOI 10.4236/OJIM.2012.22018, 10.4236/ojim.2012.2201]; Collins AJ, 2009, AM J KIDNEY DIS, V55, pS1; Eknoyan G, 2003, AM J KIDNEY DIS, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haglin L, 2001, POSTGRAD MED J, V77, P305, DOI 10.1136/pmj.77.907.305; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Koch M, 2000, NEPHRON, V86, P552, DOI 10.1159/000045869; Liamis G, 2010, QJM-INT J MED, V103, P449, DOI 10.1093/qjmed/hcq039; Lin Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/430185; Locatelli F, 2002, NEPHROL DIAL TRANSPL, V17, P563, DOI 10.1093/ndt/17.4.563; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Mazzaferro S, 2014, SEMIN NEPHROL, V34, P598, DOI 10.1016/j.semnephrol.2014.09.006; McDonald S, 2012, ANZDATA REGISTRY REP; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Movilli E, 2005, NEPHRON CLIN PRACT, V101, pC161, DOI 10.1159/000087391; Noordzij M, 2005, AM J KIDNEY DIS, V46, P925, DOI 10.1053/j.ajkd.2005.08.013; Noordzij M, 2008, BLOOD PURIFICAT, V26, P231, DOI 10.1159/000118847; OECD Publishing, 2014, OECD OB UPD 2014; Panichi V, 2008, NEPHROL DIAL TRANSPL, V23, P2337, DOI 10.1093/ndt/gfm951; Reffelmann T, 2011, ATHEROSCLEROSIS, V219, P280, DOI 10.1016/j.atherosclerosis.2011.05.038; Rivara MB, 2015, J AM SOC NEPHROL, V26, P1671, DOI 10.1681/ASN.2014050472; Saleh FN, 2003, EUR HEART J, V24, P2054, DOI 10.1016/j.ehj.2003.09.010; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Shinaberger CS, 2008, AM J CLIN NUTR, V88, P1511, DOI 10.3945/ajcn.2008.26665; Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x; Tangri N, 2011, AM J KIDNEY DIS, V57, P415, DOI 10.1053/j.ajkd.2010.08.037; US Renal Data System, 2013, USRDS 2013 ANN DAT R; Wald R, 2008, AM J KIDNEY DIS, V52, P531, DOI 10.1053/j.ajkd.2008.05.020; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	33	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185853	10.1371/journal.pone.0185853	http://dx.doi.org/10.1371/journal.pone.0185853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973026	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900062
J	Petersen, SE; Sanghvi, MM; Aung, N; Cooper, JA; Paiva, JM; Zemrak, F; Fung, K; Lukaschuk, E; Lee, AM; Carapella, V; Kim, YJ; Piechnik, SK; Neubauer, S				Petersen, Steffen E.; Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Zemrak, Filip; Fung, Kenneth; Lukaschuk, Elena; Lee, Aaron M.; Carapella, Valentina; Kim, Young Jin; Piechnik, Stefan K.; Neubauer, Stefan			The impact of cardiovascular risk factors on cardiac structure and function: Insights from the UK Biobank imaging enhancement study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CONGESTIVE-HEART-FAILURE; PROGNOSTIC IMPLICATIONS; CORONARY; ATHEROSCLEROSIS; DISEASE; MORTALITY; MIDDLE; VOLUME; DEATH	Aims The UK Biobank is a large-scale population-based study utilising cardiovascular magnetic resonance (CMR) to generate measurements of atrial and ventricular structure and function. This study aimed to quantify the association between modifiable cardiovascular risk factors and cardiac morphology and function in individuals without known cardiovascular disease. Methods Age, sex, ethnicity (non-modifiable) and systolic blood pressure, diastolic blood pressure, smoking status, exercise, body mass index (BMI), high cholesterol, diabetes, alcohol intake (modifiable) were considered important cardiovascular risk factors. Multivariable regression models were built to ascertain the association of risk factors on left ventricular (LV), right ventricular (RV), left atrial (LA) and right atrial (RA) CMR parameters. Results 4,651 participants were included in the analysis. All modifiable risk factors had significant effects on differing atrial and ventricular parameters. BMI was the modifiable risk factor most consistently associated with subclinical changes to CMR parameters, particularly in relation to higher LV mass (+8.3% per SD [4.3 kg/m2], 95% CI: 7.6 to 8.9%), LV (EDV: +4.8% per SD, 95% CI: 4.2 to 5.4%); ESV: +4.4% per SD, 95% CI: 3.5 to 5.3%), RV (EDV: +5.3% per SD, 95% CI: 4.7 to 5.9%; ESV: +5.4% per SD, 95% CI: 4.5 to 6.4%) and LA maximal (+8.6% per SD, 95% CI: 7.4 to 9.7%) volumes. Increases in SBP were associated with higher LV mass (+6.8% per SD, 95% CI: 5.9 to 7.7%), LV (EDV: +4.5% per SD, 95% CI: 3.6 to 5.4%; ESV: +2.0% per SD, 95% CI: 0.8 to 3.3%) volumes. The presence of diabetes or high cholesterol resulted in smaller volumes and lower ejection fractions. Conclusions Modifiable risk factors are associated with subclinical alterations in structure and function in all four cardiac chambers. BMI and systolic blood pressure are the most important modifiable risk factors affecting CMR parameters known to be linked to adverse outcomes.	[Petersen, Steffen E.; Sanghvi, Mihir M.; Aung, Nay; Cooper, Jackie A.; Paiva, Jose Miguel; Zemrak, Filip; Fung, Kenneth; Lee, Aaron M.] Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England; [Lukaschuk, Elena; Carapella, Valentina; Kim, Young Jin; Piechnik, Stefan K.; Neubauer, Stefan] Univ Oxford, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Kim, Young Jin] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea	University of London; Queen Mary University London; University of Oxford; Yonsei University; Yonsei University Health System	Petersen, SE (corresponding author), Queen Mary Univ London, William Harvey Res Inst, NIHR Biomed Res Ctr Barts, Charterhouse Sq, London, England.	s.e.petersen@quml.ac.uk	Petersen, Steffen E/A-8389-2011; Kim, Young-jin/GSD-3168-2022	Petersen, Steffen E/0000-0003-4622-5160; Aung, Nay/0000-0001-5095-1611; Sanghvi, Mihir/0000-0002-1914-4149; Paiva, Jose Miguel/0000-0002-9369-6785; Zemrak, Filip/0000-0001-6730-4955; Carapella, Valentina/0000-0001-9750-9425; Neubauer, Stefan/0000-0001-9017-5645; Lee, Aaron/0000-0001-6008-5366	Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts; London School of Medicine and Dentistry; NIHR Cardiovascular Biomedical Research Centre at Barts; EPSRC [EP/P001009/1]; Oxford NIHR Biomedical Research Centre; Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council [MR/L016311/1]; Wellcome Trust [203553/Z/Z]; British Heart Foundation (BHF) [PG/14/89/31194]; British Heart Foundation [PG/14/89/31194] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/P001009/1] Funding Source: researchfish; Medical Research Council [MC_qA137853] Funding Source: researchfish; MRC [MR/L016311/1] Funding Source: UKRI	Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts; London School of Medicine and Dentistry; NIHR Cardiovascular Biomedical Research Centre at Barts; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford British Heart Foundation Centre of Research Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following institutions: KF is supported by The Medical College of Saint Bartholomew's Hospital Trust, an independent registered charity that promotes and advances medical and dental education and research at Barts and The London School of Medicine and Dentistry. AL and SEP acknowledge support from the NIHR Cardiovascular Biomedical Research Centre at Barts and from the "SmartHeart" EPSRC program grant (EP/P001009/1). SN and SKP are supported by the Oxford NIHR Biomedical Research Centre and the Oxford British Heart Foundation Centre of Research Excellence. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (g rant number MR/L016311/1). NA is supported by a Wellcome Trust Research Training Fellowship (203553/Z/Z). The authors SEP, SN and SKP acknowledge the British Heart Foundation (BHF) for funding the manual analysis to create a cardiovascular magnetic resonance imaging reference standard for the UK Biobank imaging resource in 5000 CMR scans (PG/14/89/31194).	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bombelli M, 2013, CURR HYPERTENS REP, V15, P238, DOI 10.1007/s11906-013-0348-1; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Environment RCT, 2015, R LANG STAT COMP VIE; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GARDIN JM, 1995, CIRCULATION, V92, P380, DOI 10.1161/01.CIR.92.3.380; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; GHALI JK, 1992, ANN INTERN MED, V117, P831, DOI 10.7326/0003-4819-117-10-831; Health and Social Care Information Centre, 2016, STAT SMOK ENGL 2016; Health CO on S and. Smoking and Tobacco Use, FACT SHEET; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Laukkanen JA, 2005, ARCH INTERN MED, V165, P1788, DOI 10.1001/archinte.165.15.1788; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lip GYH, 2007, HEART, V93, P542, DOI 10.1136/hrt.2006.110791; Lorell BH, 2000, CIRCULATION, P102; McGill HC, 2008, CIRCULATION, P117; McManus DD, 2009, J AM SOC ECHOCARDIOG, V22, P190, DOI 10.1016/j.echo.2008.11.005; Nham E, 2016, INT J CARDIOVAS IMAG, V32, pS173, DOI 10.1007/s10554-016-0885-1; PETERSEN SE, 2017, J CARD MAGN RES, V19; Petersen SE, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0227-4; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; POLAK JF, 1983, J AM COLL CARDIOL, V2, P217, DOI 10.1016/S0735-1097(83)80156-9; Rider OJ, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002454; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; ROSE G, 1977, LANCET, V1, P105; Sallach JA, 2009, JACC-CARDIOVASC IMAG, V2, P527, DOI 10.1016/j.jcmg.2009.01.012; SHAH PK, 1986, AM J CARDIOL, V58, P387, DOI 10.1016/0002-9149(86)90001-9; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Taylor HA, 2005, ETHNIC DIS, V15, pS4; TEJADA C, 1968, LAB INVEST, V18, P509; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; unpuu S, 2004, LANCET, V364, P937; Voelkel NF, 2006, CIRCULATION, P114; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; World Health Organization, 2016, CARDIOVASCULAR DIS	43	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185114	10.1371/journal.pone.0185114	http://dx.doi.org/10.1371/journal.pone.0185114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973022	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900013
J	Belcher, DA; Banerjee, U; Baehr, CM; Richardson, KE; Cabrales, P; Berthiaume, F; Palmer, AF				Belcher, Donald Andrew; Banerjee, Uddyalok; Baehr, Christopher Michael; Richardson, Kristopher Emil; Cabrales, Pedro; Berthiaume, Francois; Palmer, Andre Francis			Mixtures of tense and relaxed state polymerized human hemoglobin regulate oxygen affinity and tissue construct oxygenation	PLOS ONE			English	Article							HOLLOW-FIBER BIOREACTOR; BLOOD SUBSTITUTES; NITRIC-OXIDE; ENCAPSULATED HEMOGLOBIN; BIOPHYSICAL PROPERTIES; BOVINE HEMOGLOBINS; GASEOUS LIGANDS; CARRIER; BINDING; LIVER	Pure tense (T) and relaxed (R) quaternary state polymerized human hemoglobins (PolyhHbs) were synthesized and their biophysical properties characterized, along with mixtures of T-and R-state PolyhHbs. It was observed that the oxygen affinity of PolyhHb mixtures varied linearly with T-state mole fraction. Computational analysis of PolyhHb facilitated oxygenation of a single fiber in a hepatic hollow fiber (HF) bioreactor was performed to evaluate the oxygenation potential of T-and R-state PolyhHb mixtures. PolyhHb mixtures with T-state mole fractions greater than 50% resulted in hypoxic and hyperoxic zones occupying less than 5% of the total extra capillary space (ECS). Under these conditions, the ratio of the pericentral volume to the perivenous volume in the ECS doubled as the T-state mole fraction increased from 50 to 100%. These results show the effect of varying the T/R-state PolyhHb mole fraction on oxygenation of tissue-engineered constructs and their potential to oxygenate tissues.	[Belcher, Donald Andrew; Banerjee, Uddyalok; Richardson, Kristopher Emil; Palmer, Andre Francis] Ohio State Univ, Coll Engn, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Baehr, Christopher Michael] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Cabrales, Pedro] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Berthiaume, Francois] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Rutgers State University New Brunswick	Palmer, AF (corresponding author), Ohio State Univ, Coll Engn, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA.	palmer.351@osu.edu	Banerjee, Uddyalok/J-4284-2019; Berthiaume, Francois/ABD-2139-2020; Belcher, Donald/ABC-7359-2020; Cabrales, Pedro/A-1930-2014	Banerjee, Uddyalok/0000-0002-8697-5129; Cabrales, Pedro/0000-0002-8794-2839	National Institutes of Health [R56HL123015, R01HL126945, R01EB021926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126945, R56HL123015, R01HL138116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB021926] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grant R56HL123015, R01HL126945, and R01EB021926 to AFP (https://www.nih.gov/)	AABB, 2013, CIRC INF US HUM BLOO, P1; Ali AA, 2001, ANESTH ANALG, P863; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Arifin DR, 2003, BIOTECHNOL PROGR, V19, P1798, DOI 10.1021/bp034120x; Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Boykins RA, 2005, PROTEINS, V59, P840, DOI 10.1002/prot.20453; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buehler PW, 2010, BIOMATERIALS, V31, P3723, DOI 10.1016/j.biomaterials.2010.01.072; Buehler PW, 2005, ANTIOXID REDOX SIGN, V7, P1755, DOI 10.1089/ars.2005.7.1755; Buehler PW, 2005, ANAL CHEM, V77, P3466, DOI 10.1021/ac050064y; Carmichael FJL, 2000, CRIT CARE MED, V28, P2283, DOI 10.1097/00003246-200007000-00017; Carpentier B, 2009, GUT, V58, P1690, DOI 10.1136/gut.2008.175380; Chen G, 2009, BIOTECHNOL BIOENG, V102, P1603, DOI 10.1002/bit.22200; Day TK, 2003, J VET EMERG CRIT CAR, V13, P77, DOI 10.1046/j.1435-6935.2003.00084.x; deFigueiredo LFP, 1997, J TRAUMA, V42, P847; DULING BR, 1972, CIRC RES, V31, P481, DOI 10.1161/01.RES.31.4.481; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Hawk P.B., 1965, HAWKS PHYSL CHEM; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; JACKSON WF, 1989, AM J PHYSIOL, V257, pH1565, DOI 10.1152/ajpheart.1989.257.5.H1565; Jia YP, 2004, BIOCHEM J, V384, P367, DOI 10.1042/BJ20040612; Kietzmann T, 2017, REDOX BIOL, V11, P622, DOI 10.1016/j.redox.2017.01.012; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; Marcucci C, 2004, BRIT MED BULL, V70, P15, DOI 10.1093/bmb/ldh023; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; Moore EE, 2003, J AM COLL SURGEONS, V196, P1, DOI 10.1016/S1072-7515(02)01704-0; Mozzarelli A, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P1, DOI 10.1002/9781119975427; Napolitano LM, 2009, CRIT CARE CLIN, V25, P279, DOI 10.1016/j.ccc.2009.01.003; Olsen KW, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P327; Olson JS, 2003, HEMOGLOBIN DISORDERS; Palmer AF, 2011, J TRAUMA, V71, P798, DOI 10.1097/TA.0b013e3182028ab0; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P1803, DOI 10.1002/btpr.265; Palmer AF, 2009, BIOTECHNOL PROGR, V25, P189, DOI 10.1002/btpr.119; Rameez S, 2012, BIOTECHNOL PROGR, V28, P636, DOI 10.1002/btpr.1532; Rameez S, 2012, MACROMOLECULES, V45, P2385, DOI 10.1021/ma202739f; Rameez S, 2011, LANGMUIR, V27, P8829, DOI 10.1021/la201246m; Sakai H, 2000, AM J PHYSIOL-HEART C, V279, pH908, DOI 10.1152/ajpheart.2000.279.3.H908; Sakai H, 2010, ADV EXP MED BIOL, V662, P433, DOI 10.1007/978-1-4419-1241-1_62; Sawicki CA, PROPERTIES T STATE H; Simoni J, 2009, ARTIF ORGANS, V33, P92, DOI 10.1111/j.1525-1594.2008.00691.x; Stamati K, 2011, J TISSUE ENG, V2, DOI 10.1177/2041731411432365; Sullivan JP, 2006, BIOTECHNOL BIOENG, V93, P306, DOI 10.1002/bit.20673; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vajpayee N., 2011, HENRYS CLIN DIAGNOSI, P509; Whitaker BI, 2011, 2009 NATL BLOOD COLL; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; Zhang N, 2011, TISSUE ENG PT A, V17, P927, DOI [10.1089/ten.TEA.2010.0353, 10.1089/ten.tea.2010.0353]; Zhou Y., 2011, THESIS; Zhou YP, 2011, BIOTECHNOL PROGR, V27, P1172, DOI 10.1002/btpr.624	51	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185988	10.1371/journal.pone.0185988	http://dx.doi.org/10.1371/journal.pone.0185988			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020036	Green Submitted, gold, Green Published			2022-12-27	WOS:000412754400055
J	Kim, H; Cheang, UK; Kim, MJ				Kim, Hoyeon; Cheang, U. Kei; Kim, Min Jun			Autonomous dynamic obstacle avoidance for bacteria-powered microrobots (BPMs) with modified vector field histogram	PLOS ONE			English	Article							MAGNETIC MICROROBOTS	In order to broaden the use of microrobots in practical fields, autonomous control algorithms such as obstacle avoidance must be further developed. However, most previous studies of microrobots used manual motion control to navigate past tight spaces and obstacles while very few studies demonstrated the use of autonomous motion. In this paper, we demonstrated a dynamic obstacle avoidance algorithm for bacteria-powered microrobots (BPMs) using electric field in fluidic environments. A BPM consists of an artificial body, which is made of SU-8, and a high dense layer of harnessed bacteria. BPMs can be controlled using externally applied electric fields due to the electrokinetic property of bacteria. For developing dynamic obstacle avoidance for BPMs, a kinematic model of BPMs was utilized to prevent collision and a finite element model was used to characteristic the deformation of an electric field near the obstacle walls. In order to avoid fast moving obstacles, we modified our previously static obstacle avoidance approach using a modified vector field histogram (VFH) method. To validate the advanced algorithm in experiments, magnetically controlled moving obstacles were used to intercept the BPMs as the BPMs move from the initial position to final position. The algorithm was able to successfully guide the BPMs to reach their respective goal positions while avoiding the dynamic obstacles.	[Kim, Hoyeon; Kim, Min Jun] Southern Methodist Univ, Dept Mech Engn, Dallas, TX 75275 USA; [Cheang, U. Kei] South Univ Sci & Technol, Dept Mech Engn & Energy Engn, Shenzhen, Guangdong, Peoples R China	Southern Methodist University; Southern University of Science & Technology	Kim, MJ (corresponding author), Southern Methodist Univ, Dept Mech Engn, Dallas, TX 75275 USA.	mjkin@lyle.smu.edu	Cheang, U Kei/GWC-1944-2022	Cheang, U Kei/0000-0002-2324-6391; KIM, MINJUN/0000-0002-0819-1644	National Science Foundation (NSF) (DMR) [1306794]; National Science Foundation (NSF) (CMMI) [1712096]; Army Research Office [W911NF-11-1-0490]; Korea Evaluation Institute of Industrial Technology (KEIT) - Ministry of Trade, Industry, and Energy (MOTIE) [10052980]	National Science Foundation (NSF) (DMR)(National Science Foundation (NSF)); National Science Foundation (NSF) (CMMI)(National Science Foundation (NSF)); Army Research Office; Korea Evaluation Institute of Industrial Technology (KEIT) - Ministry of Trade, Industry, and Energy (MOTIE)	This work was funded by National Science Foundation (NSF) (DMR#1306794 and CMMI#1712096), Army Research Office (W911NF-11-1-0490), and Korea Evaluation Institute of Industrial Technology (KEIT) funded by the Ministry of Trade, Industry, and Energy (MOTIE#10052980).	Abbott JJ, 2007, IEEE ROBOT AUTOM MAG, V14, P92, DOI 10.1109/MRA.2007.380641; Behkam B, 2007, LECT NOTES ARTIF INT, V4850, P154; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BORENSTEIN J, 1991, IEEE T ROBOTIC AUTOM, V7, P278, DOI 10.1109/70.88137; Charreyron S, 2015, INT ROB SYST IROS 20; Copeland MF, 2009, SOFT MATTER, V5, P1174, DOI 10.1039/b812146j; Dauge M, 2007, SENSOR ACTUAT A-PHYS, V138, P239, DOI 10.1016/j.sna.2007.04.057; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; Diller E, 2013, INT J ROBOT RES, V32, P614, DOI 10.1177/0278364913483183; Fox D, 1997, IEEE ROBOT AUTOM MAG, V4, P23, DOI 10.1109/100.580977; Hassan U, 2013, 2013 TRANSD EUR 17 I; Honda T, 1996, IEEE T MAGN, V32, P5085, DOI 10.1109/20.539498; Jeong S, 2016, MED ENG PHYS; Julius AA, 2009, ROB AUT ICRA 2009 IE; Kim D, 2011, ROB AUT ICRA 2011 IE; Kim H, 2015, INT ROB SYST IROS 20; Kim H-S, 2014, BIOMED RES INT, V2014, P7, DOI DOI 10.3947/IC.2014.46.2.94; Kim H, 2016, IEEE T ROBOT, V32, P125, DOI 10.1109/TRO.2015.2504370; Kim H, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4918978; Li H, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/2/027001; Linder V, 2005, SMALL, V1, P730, DOI 10.1002/smll.200400159; Martel S, 2006, 2006 BIOM NAN C; MURRAY PR, 1994, ENTEROBACTERIACEAE, P227; Parmar J, 2016, SCI TECHNOL ADV MAT; Pieters R, 2015, ROB AUT ICRA 2015 IE; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Sakar MS, 2010, ROB AUT ICRA 2010 IE; Steager E, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752721; Steager EB, 2013, INT J ROBOT RES, V32, P346, DOI 10.1177/0278364912472381; Steager EB, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/3/035001; Wong D, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824840; Yesin KB, 2006, INT J ROBOT RES, V25, P527, DOI 10.1177/0278364906065389; Zhang L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079655	33	3	3	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185744	10.1371/journal.pone.0185744	http://dx.doi.org/10.1371/journal.pone.0185744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020016	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400043
J	Anderson-Berry, A; Thoene, M; Wagner, J; Lyden, E; Jones, G; Kaufmann, M; Van Ormer, M; Hanson, C				Anderson-Berry, Ann; Thoene, Melissa; Wagner, Julie; Lyden, Elizabeth; Jones, Glenville; Kaufmann, Martin; Van Ormer, Matthew; Hanson, Corrine			Randomized trial of two doses of vitamin D-3 in preterm infants < 32 weeks: Dose impact on achieving desired serum 25(OH)D-3 in a NICU population	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BIRTH-WEIGHT INFANTS; FORMULA-FED INFANTS; D DEFICIENCY; 25-HYDROXYVITAMIN D; PREGNANT-WOMEN; CORD BLOOD; D SUPPLEMENTATION; HIGH PREVALENCE; D LEVEL	Background Recommendations for vitamin D supplementation for preterm infants span a wide range of doses. Response to vitamin D supplementation and impact on outcomes in preterm infants is not well understood. Objective Evaluate serum 25(OH)D-3 concentration changes after 4 weeks in response to two different doses of vitamin D-3 supplementation in a population of premature infants and quantify the impact on NICU outcomes. Design 32 infants born at 24-32 weeks gestation were prospectively randomized to receive 400 or 800 IU/day vitamin D3 supplementation. Serum 25(OH) D3 levels were measured every 4 weeks. The Wilcoxon signed rank test was used to compare serum levels of 25(OH)D-3 at 4 weeks and each subsequent time point. A p-value of <0.05 was considered statistically significant. Results Serum 25(OH)D-3 levels at birth were 41.9 and 42.9 nmol/l for infants in the 400 IU group and 800 IU group, respectively (p = 0.86). Cord 25(OH)D-3 concentrations significantly correlated with gestational age (r = 0.40, p = 0.04). After 4 weeks of D-3 supplementation, median 25(OH)D-3 levels increased in both groups (84.6vs. 105.3 nmol/l for 400 vs. 800 IU/day respectively, with significantly more improvement in the higher dose (p = 0.048). Infants in the 400 IU group were significantly more likely to have dual energy x-ray absorptiometry (DEXA) bone density measurements <10 percentile (56% vs 16%, p = 0.04). Conclusions Improvement in 25(OH)D-3 levels at 4 weeks, bone density, and trends towards improvement in linear growth support consideration of a daily dose of 800 IU of vitamin D for infants <32 weeks cared for in the NICU.	[Anderson-Berry, Ann; Van Ormer, Matthew] Univ Nebraska, Dept Pediat, Med Ctr, Omaha, NE 68182 USA; [Thoene, Melissa] Nebraska Med Ctr, Neonatal Intens Care Unit, Omaha, NE USA; [Wagner, Julie] CHI Hlth, Omaha, NE USA; [Lyden, Elizabeth] Univ Nebraska, Med Ctr, Coll Publ Hlth, Omaha, NE 68182 USA; [Jones, Glenville; Kaufmann, Martin] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Hanson, Corrine] Univ Nebraska, Med Ctr, Div Med Nutr Educ, Sch Allied Hlth Profess, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Queens University - Canada; University of Nebraska System; University of Nebraska Medical Center	Hanson, C (corresponding author), Univ Nebraska, Med Ctr, Div Med Nutr Educ, Sch Allied Hlth Profess, Omaha, NE 68182 USA.	ckhanson@unmc.edu		Hanson, Corrine/0000-0002-5118-591X	Edna lttner Pediatric Research Support Fund through the University of Nebraska Medical Center; National Institute of Standards and Technology [NIST-60NANB13D203]	Edna lttner Pediatric Research Support Fund through the University of Nebraska Medical Center; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA)	Funding was provided in part by the Edna lttner Pediatric Research Support Fund through the University of Nebraska Medical Center (www.unmc.edu/vcr/funding/index.html) [MB, CH], and in part by a grant from the National Institute of Standards and Technology (www.nist.gov, NIST-60NANB13D203) [GJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2013, PEDIATRICS, V131, pE1676, DOI 10.1542/peds.2013-0420; Adamkin D H, 2007, Minerva Pediatr, V59, P369; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Baek JH, 2014, J PEDIATR-US, V165, P849, DOI 10.1016/j.jpeds.2014.06.058; Ben-Shoshan M, 2012, INT J VITAM NUTR RES, V82, P237, DOI 10.1024/0300-9831/a000117; Bhatia J, 2013, J PEDIATR-US, V162, pS48, DOI 10.1016/j.jpeds.2012.11.053; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Burris HH, 2014, PEDIATR RES, V75, P75, DOI 10.1038/pr.2013.174; Cho SY, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0361-0; Dawodu A, 2011, PEDIATR INT, V53, P207, DOI 10.1111/j.1442-200X.2010.03209.x; DELVIN EE, 1982, ARCH DIS CHILD, V57, P754, DOI 10.1136/adc.57.10.754; Dinerstein A, 2006, J PERINATOL, V26, P436, DOI 10.1038/sj.jp.7211539; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Elmadfa I, 2012, INT J VITAM NUTR RES, V82, P342, DOI 10.1024/0300-9831/a000129; Fewtrell M, 2011, CURR OPIN CLIN NUTR, V14, P297, DOI 10.1097/MCO.0b013e328345361b; Food and Nutrition Board, 2000, DIETARY REFERENCE IN; Fort P, 2016, J PEDIATR-US, V174, P132, DOI 10.1016/j.jpeds.2016.03.028; Friel JK, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-43; Gallo S, 2013, JAMA-J AM MED ASSOC, V309, P1785, DOI 10.1001/jama.2013.3404; Gartner LM, 2003, PEDIATRICS, V111, P908, DOI 10.1542/peds.111.4.908; Giapros VI, 2012, EUR J CLIN NUTR, V66, P224, DOI 10.1038/ejcn.2011.158; Greer FR, 2008, AM J CLIN NUTR, V88, p529S, DOI 10.1093/ajcn/88.2.529S; Hanson C, 2011, J AM DIET ASSOC, V111, P1836, DOI 10.1016/j.jada.2011.09.010; Heaney RP, 2014, J ENDOCRINOL INVEST; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Jansen RB, 2014, INT J VITAM NUTR RES, V84, P45, DOI 10.1024/0300-9831/a000192; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Kara C, 2014, PEDIATRICS, V133, pE240, DOI 10.1542/peds.2013-0711; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Kislal FM, 2008, PEDIATR INT, V50, P204, DOI 10.1111/j.1442-200X.2008.02553.x; Lee JM, 2007, CLIN PEDIATR, V46, P42, DOI 10.1177/0009922806289311; Luczynska A, 2014, EUR J EPIDEMIOL, V29, P585, DOI 10.1007/s10654-014-9918-z; Maguire JL, 2014, JAMA PEDIATR, V168, P383, DOI 10.1001/jamapediatrics.2013.5379; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; McCarthy RA, 2013, BRIT J NUTR, V110, P156, DOI 10.1017/S0007114512004722; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Monangi N, 2014, ARCH DIS CHILD-FETAL, V99, pF166, DOI 10.1136/archdischild-2013-303999; Natarajan CK, 2014, PEDIATRICS, V133, pE628, DOI 10.1542/peds.2012-3395; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; Rack B, 2012, J PERINATOL, V32, P218, DOI 10.1038/jp.2011.82; Rigo J, 1998, J PEDIATR GASTR NUTR, V27, P184, DOI 10.1097/00005176-199808000-00011; Schnadower D, 2006, PEDIATRICS, V118, P2226, DOI 10.1542/peds.2006-1170; Scriver C, 2001, METABOLIC MOL BASES, P4235; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Stocklin E, 2013, INT J VITAM NUTR RES, V83, P92, DOI 10.1024/0300-9831/a000151; Taylor SN, 2006, BREASTFEED MED, V1, P156, DOI 10.1089/bfm.2006.1.156; Tergestina M, 2014, J PEDIATR GASTR NUTR, V58, P661, DOI 10.1097/MPG.0000000000000296; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Weisberg P, 2004, AM J CLIN NUTR, V80, p1697S, DOI 10.1093/ajcn/80.6.1697S; Williams JE, 2012, ARCH DIS CHILD, V97, P822, DOI 10.1136/archdischild-2011-301326; World Health Organization, GUID OPT FEED LOW BI; Wuertz C, 2013, BRIT J NUTR, V110, P1895, DOI 10.1017/S0007114513001438	57	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185950	10.1371/journal.pone.0185950	http://dx.doi.org/10.1371/journal.pone.0185950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016653	gold, Green Submitted, Green Published			2022-12-27	WOS:000412627400042
J	Leapman, MS; Westphalen, AC; Ameli, N; Lawrence, HJ; Febbo, PG; Cooperberg, MR; Carroll, PR				Leapman, Michael S.; Westphalen, Antonio C.; Ameli, Niloufar; Lawrence, H. Jeffrey; Febbo, Phillip G.; Cooperberg, Matthew R.; Carroll, Peter R.			Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa)	PLOS ONE			English	Article							ULTRASOUND-GUIDED BIOPSY; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; OUTCOMES; AGGRESSIVENESS; RECURRENCE	Background We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate Score (GPS) among individuals who were candidates for active surveillance with low and intermediate risk prostate cancer (PCa). Patients and methods We evaluated the association between GPS results (scale 0-100) and endorectal mpMRI findings in men with clinically localized PCa. MR studies were reviewed to a five-tier scale of increasing suspicion of malignancy. Mean apparent diffusion coefficient (ADC) was calculated from a single dominant lesion. Mean rank of the GPS (0-100) among MRI strata was compared with the Kruskal-Wallis test and Dunn's multiple comparison test. Spearman's correlation was performed to examine the association between mean ADC and scaled GPS. Results Of 186 patients who received GPS testing, 100 were identified who received mpMRI. Mean GPS results differed between mpMRI categories (p = 0.001); however a broad range was observed in all mpMRI categories. Among men with biopsy Gleason pattern 3+3, mean GPS results were not significantly different among MRI groups (p = 0.179), but GPS differences were seen among MRI categories for patients with pattern 3+4 (p = 0.010). Mean ADC was weakly associated with GPS (sigma = -0.151). Stromal response (p = 0.015) and cellular organization (p = 0.045) gene group scores differed significantly by MRI findings, but no differences were seen among androgen signaling or proliferation genes. Conclusions Although a statistically significant association was observed between GPS results and MRI scores, a wide range of GPS values were observed across imaging categories suggesting that mpMRI and genomic profiling may offer non-overlapping clinical insights.	[Leapman, Michael S.; Cooperberg, Matthew R.] Yale Univ, Sch Med, Dept Urol, New Haven, CT 06520 USA; [Leapman, Michael S.; Ameli, Niloufar; Carroll, Peter R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Westphalen, Antonio C.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Lawrence, H. Jeffrey; Febbo, Phillip G.] Genom Hlth Inc, Redwood City, CA USA; [Cooperberg, Matthew R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Genomic Health; University of California System; University of California San Francisco	Leapman, MS (corresponding author), Yale Univ, Sch Med, Dept Urol, New Haven, CT 06520 USA.; Leapman, MS (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	michael.leapman@yale.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685	Genomic Health Inc.	Genomic Health Inc.	The authors H. Jeffrey Lawrence, MD (HJL) and Phillip Febbo, MD (PF) are full-time employees of Genomic Health Inc, Redwood City, CA. PF and HJL reviewed the manuscript prior to submission. Genomic Health Inc. did not play a role in the study design, data collection, analysis, decision to publish, and only provided financial support in the form of the authors' salaries. The specific roles of these authors are articulated in the `author contributions' section.	Abd-Alazeez M, 2014, UROL ONCOL-SEMIN ORI, V32, P741, DOI 10.1016/j.urolonc.2014.01.008; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bishoff JT, 2014, J UROLOGY, V192, P409, DOI 10.1016/j.juro.2014.02.003; Brand TC, 2016, UROLOGY, V89, P69, DOI 10.1016/j.urology.2015.12.008; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Cullen J, 2014, EUR UROL; Cullen J, 2015, EUR UROL, V68, P123, DOI 10.1016/j.eururo.2014.11.030; Dianat SS, 2015, UROLOGY, V85, P147, DOI 10.1016/j.urology.2014.06.085; Donati OF, 2014, RADIOLOGY, V271, P143, DOI 10.1148/radiol.13130973; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Flavell RR, 2014, ABDOM IMAGING, V39, P1027, DOI 10.1007/s00261-014-0136-7; Gondo T, 2014, EUR RADIOL, V24, P3161, DOI 10.1007/s00330-014-3367-7; Gupta RT, 2014, UROL ONCOL-SEMIN ORI, V32, P1292, DOI 10.1016/j.urolonc.2014.04.017; Inoue LYT, 2014, STAT MED, V33, P930, DOI 10.1002/sim.6003; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Morlacco A, 2017, EUR UROL, V71, P701, DOI 10.1016/j.eururo.2016.08.015; Park JJ, 2014, AM J ROENTGENOL, V202, pW459, DOI 10.2214/AJR.13.11381; Pickles MD, 2006, J MAGN RESON IMAGING, V23, P130, DOI 10.1002/jmri.20477; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Renard-Penna R, 2015, J UROL; Salami SS, 2014, CANCER-AM CANCER SOC, V120, P2876, DOI 10.1002/cncr.28790; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Somford DM, 2013, J UROLOGY, V190, P1728, DOI 10.1016/j.juro.2013.05.021; Stoyanova R., 2016, ONCOTARGET; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003	30	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185535	10.1371/journal.pone.0185535	http://dx.doi.org/10.1371/journal.pone.0185535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016610	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400022
J	Maritati, F; Alberici, F; Oliva, E; Urban, ML; Palmisano, A; Santarsia, F; Andrulli, S; Pavone, L; Pesci, A; Grasselli, C; Santi, R; Tumiati, B; Manenti, L; Buzio, C; Vaglio, A				Maritati, Federica; Alberici, Federico; Oliva, Elena; Urban, Maria L.; Palmisano, Alessandra; Santarsia, Francesca; Andrulli, Simeone; Pavone, Laura; Pesci, Alberto; Grasselli, Chiara; Santi, Rosaria; Tumiati, Bruno; Manenti, Lucio; Buzio, Carlo; Vaglio, Augusto			Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial	PLOS ONE			English	Article							CHURG-STRAUSS-SYNDROME; POOR-PROGNOSIS FACTORS; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY 1990 CRITERIA; EOSINOPHILIC GRANULOMATOSIS; WEGENERS-GRANULOMATOSIS; RENAL VASCULITIS; AZATHIOPRINE; RITUXIMAB; CLASSIFICATION	Objectives The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance. Methotrexate is a widely used immunosuppressant but only a few studies explored its role for maintenance in AAV. This trial investigated the efficacy and safety of methotrexate as maintenance therapy for AAV. Methods In this single-centre, open-label, randomised trial we compared methotrexate and cyclophosphamide for maintenance in AAV. We enrolled patients with granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA), the latter with poor-prognosis factors and/or peripheral neuropathy. Remission was induced with cyclophosphamide. At remission, the patients were randomised to receive methotrexate or to continue with cyclophosphamide for 12 months; after treatment, they were followed for another 12 months. The primary end-point was relapse; secondary end-points included renal outcomes and treatment-related toxicity. Results Of the 94 enrolled patients, 23 were excluded during remission-induction or did not achieve remission; the remaining 71 were randomised to cyclophosphamide (n = 33) or methotrexate (n = 38). Relapse frequencies at months 12 and 24 after randomisation were not different between the two groups (p = 1.00 and 1.00). Relapse-free survival was also comparable (log-rank test p = 0.99). No differences in relapses were detected between the two treatments when GPA+MPA and EGPA were analysed separately. There were no differences in eGFR at months 12 and 24; proteinuria declined significantly (from diagnosis to month 24) only in the cyclophosphamide group (p = 0.0007). No significant differences in adverse event frequencies were observed. Conclusions MTX may be effective and safe for remission-maintenance in AAV.	[Maritati, Federica; Oliva, Elena; Urban, Maria L.; Palmisano, Alessandra; Santarsia, Francesca; Manenti, Lucio; Buzio, Carlo; Vaglio, Augusto] Univ Hosp Parma, Nephrol Unit, Parma, Italy; [Alberici, Federico] San Carlo Borromeo Hosp, Nephrol & Immunol Unit, ASST Santi Paolo & Carlo, Milan, Italy; [Andrulli, Simeone] A Manzoni Hosp, Nephrol & Dialysis Unit, Lecce, Italy; [Pavone, Laura] IRCCS Fdn Ca Granda Maggiore Policlin Hosp, Nephrol Unit, Milan, Italy; [Pesci, Alberto] Bicocca Univ, Pneumol, Milan, Italy; [Grasselli, Chiara; Santi, Rosaria; Tumiati, Bruno] Arcispedale Santa Maria Nuova, Internal Med, Reggio Emilia, Italy	University of Parma; University Hospital of Parma; San Carlo Borromeo Hospital; University of Milano-Bicocca; IRCCS Arcispedale S. Maria Nuova	Vaglio, A (corresponding author), Univ Hosp Parma, Nephrol Unit, Parma, Italy.	augusto.vaglio@virgilio.it	Maritati, Federica/AFV-5907-2022; Vaglio, Augusto/AHE-8117-2022; Andrulli, Simeone/GSD-5643-2022; Alberici, Federico/AAC-5289-2022; Manenti, Lucio/AAF-6437-2020	Vaglio, Augusto/0000-0002-3814-9172; Alberici, Federico/0000-0002-1686-5709; Urban, Maria Letizia/0000-0003-1334-9538				Alberici F, 2014, NEPHROL DIAL TRANSPL, V29, P1151, DOI 10.1093/ndt/gft318; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; Cattaneo L, 2007, J NEUROL NEUROSUR PS, V78, P1119, DOI 10.1136/jnnp.2006.111013; Cohen P, 2007, ARTHRIT RHEUM-ARTHR, V57, P686, DOI 10.1002/art.22679; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778; Groh M, 2015, EUR J INTERN MED, V26, P545, DOI 10.1016/j.ejim.2015.04.022; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Guillevin L, 1996, MEDICINE, V75, P17, DOI 10.1097/00005792-199601000-00003; Hiemstra TF, 2010, JAMA-J AM MED ASSOC, V304, P2381, DOI 10.1001/jama.2010.1658; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne D, 2001, CURR OPIN RHEUMATOL, V13, P48, DOI 10.1097/00002281-200101000-00008; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; LEAVITT RY, 1990, ARTHRITIS RHEUM, V33, P1101, DOI 10.1002/art.1780330807; LUQMANI RA, 1994, Q J MED, V87, P671; Mahr A, 2013, ANN RHEUM DIS, V72, P1003, DOI 10.1136/annrheumdis-2012-201750; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Ribi C, 2008, ARTHRITIS RHEUM-US, V58, P586, DOI 10.1002/art.23198; Romao VC, 2014, IMMUNOL RES, V60, P289, DOI 10.1007/s12026-014-8564-6; Samson M, 2014, AUTOIMMUN REV, V13, P945, DOI 10.1016/j.autrev.2014.08.002; Samson M, 2013, J AUTOIMMUN, V43, P60, DOI 10.1016/j.jaut.2013.03.003; Sinico RA, 2005, ARTHRITIS RHEUM, V52, P2926, DOI 10.1002/art.21250; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Walsh M, 2014, CLIN J AM SOC NEPHRO, V9, P1571, DOI 10.2215/CJN.00100114; Westman K, 2015, NEPHROL DIAL TRANSPL, V30, pi60, DOI 10.1093/ndt/gfu392	27	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185880	10.1371/journal.pone.0185880	http://dx.doi.org/10.1371/journal.pone.0185880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016646	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400033
J	Mosconi, L; Berti, V; Guyara-Quinn, C; McHugh, P; Petrongolo, G; Osorio, RS; Connaughty, C; Pupi, A; Vallabhajosula, S; Isaacson, RS; de Leon, MJ; Swerdlow, RH; Brinton, RD				Mosconi, Lisa; Berti, Valentina; Guyara-Quinn, Crystal; McHugh, Pauline; Petrongolo, Gabriella; Osorio, Ricardo S.; Connaughty, Christopher; Pupi, Alberto; Vallabhajosula, Shankar; Isaacson, Richard S.; de Leon, Mony J.; Swerdlow, Russell H.; Brinton, Roberta Diaz			Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; COGNITIVE DECLINE; NORMAL INDIVIDUALS; APOLIPOPROTEIN-E; FAMILY-HISTORY; DISEASE; PET; TRANSITION; MODEL; AGE	After advanced age, female sex is the major risk factor for Alzheimer's disease (AD). The biological mechanisms underlying the increased AD risk in women remain largely undetermined. Preclinical studies identified the perimenopause to menopause transition, a neuroendocrine transition state unique to the female, as a sex-specific risk factor for AD. In animals, estrogenic regulation of cerebral glucose metabolism (CMRglc) falters during perimenopause. This is evident in glucose hypometabolism and decline in mitochondrial efficiency which is sustained thereafter. This study bridges basic to clinical science to characterize brain bioenergetics in a cohort of forty-three, 40-60 year-old clinically and cognitively normal women at different endocrine transition stages including premenopause (controls, CNT, n = 15), perimenopause (PERI, n = 14) and postmenopause (MENO, n = 14). All participants received clinical, laboratory and neuropsychological examinations, F-18-fluoro-deoxyglucose (FDG)Positron Emission Tomography (PET) FDG-PET scans to estimate CMRglc, and platelet mitochondrial cytochrome oxidase (COX) activity measures. Statistical parametric mapping and multiple regression models were used to examine clinical, CMRglc and COX data across groups. As expected, the MENO group was older than PERI and controls. Groups were otherwise comparable for clinical measures and distribution of APOE4 genotype. Both MENO and PERI groups exhibited reduced CMRglc in AD-vulnerable regions which was correlated with decline in mitochondrial COX activity compared to CNT (p's<0.001). A gradient in biomarker abnormalities was most pronounced in MENO, intermediate in PERI, and lowest in CNT (p<0.001). Biomarkers correlated with immediate and delayed memory scores (Pearson's 0.26 <= r <= 0.32, p <= 0.05). These findings validate earlier preclinical findings and indicate emergence of bioenergetic deficits in perimenopausal and postmenopausal women, suggesting that the optimal window of opportunity for therapeutic intervention in women is early in the endocrine aging process.	[Mosconi, Lisa; Isaacson, Richard S.] Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA; [Mosconi, Lisa; Guyara-Quinn, Crystal; McHugh, Pauline; Petrongolo, Gabriella; Osorio, Ricardo S.; Connaughty, Christopher; de Leon, Mony J.] NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA; [Berti, Valentina; Pupi, Alberto] Univ Florence, Nucl Med Unit, Dept Clin Pathophysiol, Florence, Italy; [Vallabhajosula, Shankar] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Swerdlow, Russell H.] Univ Kansas, Sch Med, Dept Neurol, Kansas City, KS USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Pharmacol, Tucson, AZ 85724 USA; [Brinton, Roberta Diaz] Univ Arizona, Coll Med, Dept Neurol, Tucson, AZ USA	Cornell University; New York University; University of Florence; Cornell University; University of Kansas; University of Kansas Medical Center; University of Arizona; University of Arizona	Mosconi, L (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA.; Mosconi, L (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY 10003 USA.	lim2035@med.cornell.edu	Berti, Valentina/AAB-7426-2019; de Leon, Mony/AAP-7890-2021	de Leon, Mony/0000-0003-2245-4380; Osorio, Ricardo/0000-0002-2735-9609	National Institute of Health/National Institute on Aging (NIH/NIA) [AG035137, P01AG026572, AG13616, P30 AG035982]; Dept. of Neurology at Weill Cornell Medical College; NATIONAL INSTITUTE ON AGING [R01AG022374, P30AG035982, P30AG008051, P01AG026572] Funding Source: NIH RePORTER	National Institute of Health/National Institute on Aging (NIH/NIA); Dept. of Neurology at Weill Cornell Medical College; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute of Health/National Institute on Aging (NIH/NIA) grants AG035137 to LM, P01AG026572 to RDB, AG13616 to MJdL, and P30 AG035982 to RHS; funding from the Dept. of Neurology at Weill Cornell Medical College; and philanthropic support to the Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Berti V, 2014, PET CLIN, V9, P129, DOI 10.1016/j.cpet.2013.10.006; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; de Leon MJ, 2001, P NATL ACAD SCI USA, V98, P10966, DOI 10.1073/pnas.191044198; De Santi S, 2008, NEUROPSYCHOLOGY, V22, P469, DOI 10.1037/0894-4105.22.4.469; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Espeland MA, 2015, NEUROLOGY, V85, P1131, DOI 10.1212/WNL.0000000000001816; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Greendale GA, 2011, OBSTET GYN CLIN N AM, V38, P519, DOI 10.1016/j.ogc.2011.05.007; Harlow SD, 2012, MENOPAUSE, V19, P387, DOI 10.1097/gme.0b013e31824d8f40; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Hodis HN, 2015, MENOPAUSE, V22, P391, DOI [10.1097/GME.0000000000000343, 10.1097/gme.0000000000000343]; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; KAMPEN DL, 1994, OBSTET GYNECOL, V83, P979, DOI 10.1097/00006250-199406000-00017; Kanazawa M, 2017, J NUCL MED, V58, P1111, DOI 10.2967/jnumed.116.189159; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Maki PM, 2000, NEUROBIOL AGING, V21, P373, DOI 10.1016/S0197-4580(00)00123-8; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Miller WL, 2013, MOL CELL ENDOCRINOL, V379, P62, DOI 10.1016/j.mce.2013.04.014; Mosconi L, 2011, Q J NUCL MED MOL IM, V55, P250; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2014, NEUROLOGY, V82, P752, DOI 10.1212/WNL.0000000000000181; Mosconi L, 2011, J ALZHEIMERS DIS, V27, P483, DOI 10.3233/JAD-2011-110866; Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Rasgon NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089095; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Rentz DM, 2016, MENOPAUSE; Rettberg JR, 2016, NEUROBIOL AGING, V40, P155, DOI 10.1016/j.neurobiolaging.2016.01.011; Santoro N, 2011, OBSTET GYN CLIN N AM, V38, pXVII, DOI 10.1016/j.ogc.2011.07.002; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Silverman DHS, 2011, PSYCHONEUROENDOCRINO, V36, P502, DOI 10.1016/j.psyneuen.2010.08.002; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Ungar L, 2014, BRAIN IMAGING BEHAV, V8, P262, DOI 10.1007/s11682-013-9272-x; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Yao J, 2012, ADV PHARMACOL, V64, P327, DOI 10.1016/B978-0-12-394816-8.00010-6; Yao J, 2012, NEUROBIOL AGING, V33, P1507, DOI 10.1016/j.neurobiolaging.2011.03.001; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013	59	74	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185926	10.1371/journal.pone.0185926	http://dx.doi.org/10.1371/journal.pone.0185926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016679	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400038
J	Szabo, SM; Hirji, I; Johnston, KM; Juarez-Garcia, A; Connors, JM				Szabo, Shelagh M.; Hirji, Ishan; Johnston, Karissa M.; Juarez-Garcia, Ariadna; Connors, Joseph M.			Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; CLAIMS DATA; RISK; THERAPY; PROGRAM; IMPACT	Objectives Although brentuximab vedotin (BV) has changed the management of patients with relapsed or refractory Hodgkin lymphoma (RRHL), little information is available on routine clinical practice. We identified treatment patterns and costs of care among RRHL patients in the United States (US) treated with BV. Methods A retrospective observational study of adults initiating BV for RRHL from 2011 - 2015, with >= 6 months of data prior to and following BV initiation, was conducted. Treatments were classified based on dispensations and chemotherapy administration. Median total and monthly costs were estimated based on all-cause healthcare resource use in 2015 US dollars (USD). Results The cohort comprised 289 patients (59% male; mean age at diagnosis, 42 years) with a mean follow-up of 250 weeks. Eleven percent had BV salvage therapy prior to ASCT, and 32% had BV for a relapse post-ASCT. 43% received treatment post-BV, most commonly allogeneic stem cell transplant (SCT) and bendamustine (both 10.2%). Median (IQR) total costs from BV initiation to censoring were 294,790 (142,110-483,360) USD; and were highest among those treated with BV prior to ASCT (up to 421,900 [300,940-778,970] USD). Median monthly costs were almost 20,000 USD per month, and up to 25,000 USD per month among those with BV and ASCT. Medications were the greatest driver of median monthly costs. Conclusions Median total all-cause costs were almost 300,000 USD, and median monthly costs approximately 20,000 USD, per patient treated. Patients requiring treatment following BV continue to incur high costs, highlighting the economic burden associated with managing patients in the RRHL setting.	[Szabo, Shelagh M.; Johnston, Karissa M.] Broadstr HEOR, Vancouver, BC, Canada; [Hirji, Ishan; Juarez-Garcia, Ariadna] Bristol Myers Squibb Co, Princeton, NJ USA; [Connors, Joseph M.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada	Bristol-Myers Squibb; British Columbia Cancer Agency	Szabo, SM (corresponding author), Broadstr HEOR, Vancouver, BC, Canada.	sszabo@broadstreetheor.com	Connors, Joseph/AAF-5284-2019	Connors, Joseph/0000-0002-1361-7531; Szabo, Shelagh M/0000-0002-9044-3192	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This research was sponsored by Bristol-Myers Squibb; and two co-authors (IH and AJG) were employees of BMS at the time of the conduct of the study; AJG is presently an employee of BMS. While both IH and AJG participated in the study design, interpretation of the findings, and development of the manuscript, the publication of the research was not contingent on the sponsors approval or censorship of the manuscript.	Andrews AL, 2017, ACAD PEDIATR, V17, P212, DOI 10.1016/j.acap.2016.10.016; [Anonymous], 2013, NCCN CLIN PRACT GUID; Broulette Jonah Y H, 2013, INCIDENCE RATE EC BU; Calip GS, 2017, J ONCOL PRACT; Chen R, 2016, BLOOD, V128, P1562, DOI 10.1182/blood-2016-02-699850; Elsamadicy AA, 2017, NEUROMODULATION; Eyre TA, 2013, BRIT J HOSP MED, V74, P612, DOI 10.12968/hmed.2013.74.11.612; Garciaz S, 2014, HEMATOL ONCOL, V32, P187, DOI 10.1002/hon.2119; Gibson TB, 2014, AM J MANAG CARE, V20, pE208; Gobbi PG, 2013, CRIT REV ONCOL HEMAT, V85, P216, DOI 10.1016/j.critrevonc.2012.07.002; Gopal AK, 2015, BLOOD, V125, P1236, DOI 10.1182/blood-2014-08-595801; Hansen R.N., 2014, COST RELAPSE HODGKIN; Hess LM, 2016, GASTRIC CANCER, V19, P607, DOI 10.1007/s10120-015-0486-z; Kuo DZ, 2015, PEDIATRICS, V136, pE1521, DOI 10.1542/peds.2015-0871; Kuruvilla J, 2011, BLOOD, V117, P4208, DOI 10.1182/blood-2010-09-288373; Kutikova L, 2006, LEUKEMIA LYMPHOMA, V47, P1535, DOI 10.1080/10428190600573325; Lin J, 2017, CLIN THER, V39, P303, DOI 10.1016/j.clinthera.2016.12.010; Lip GYH, 2016, INT J CLIN PRACT, V70, P752, DOI 10.1111/ijcp.12863; Macalalad AR, 2015, CURR MED RES OPIN, V31, P537, DOI 10.1185/03007995.2015.1008131; Majhail NS, 2006, BIOL BLOOD MARROW TR, V12, P1065, DOI 10.1016/j.bbmt.2006.06.006; Mediwake H, 2017, INTERNAL MED J; Moskowitz CH, 2015, LANCET, V385, P1853, DOI 10.1016/S0140-6736(15)60165-9; Schneeweiss S, 2009, DERMATOLOGY, V219, P7, DOI 10.1159/000209289; Shao C, 2016, UTILIZATION PATTERNS; Shao C, 2016, REAL WORLD TREATMENT; Siddiqi T, 2014, PHARMACOGEN PERS MED, V7, P79, DOI 10.2147/PGPM.S57700; Szabo SM, 2017, LINES THERAPY COSTS; Truven Health Analytics, 2011, MULT MED DAT US GUID; U.S. Food & Drug Administration, 2016, ADCETRIS BRENT VED F; Vassilakopoulos TP, 2013, SEMIN HEMATOL, V50, P4, DOI 10.1053/j.seminhematol.2013.02.002; Yasenchak CA, 2015, LEUKEMIA LYMPHOMA, V56, P3143, DOI 10.3109/10428194.2015.1030639; Zinzani PL, 2016, CRIT REV ONCOL HEMAT, V104, P65, DOI 10.1016/j.critrevonc.2016.04.019; Zinzani PL, 2015, CRIT REV ONCOL HEMAT, V95, P359, DOI 10.1016/j.critrevonc.2015.03.011	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0180261	10.1371/journal.pone.0180261	http://dx.doi.org/10.1371/journal.pone.0180261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991893	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800002
J	Brandt, LP; Albers, J; Hejhal, T; Catalano, A; Wild, PJ; Frew, IJ				Brandt, Laura P.; Albers, Joachim; Hejhal, Tomas; Catalano, Antonella; Wild, Peter J.; Frew, Ian J.			Oncogenic Hras(G12V) expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma	PLOS ONE			English	Article							CANCER; SYSTEM; MOUSE; CELLS; MODEL	The uterine corpus represents the most common site for tumour development in the female genital system. Uterine neoplasms are categorised as epithelial, mesenchymal, mixed epithelial-mesenchymal or trophoblastic tumours. In this study we employed a mouse genetic approach using the MuLE lentiviral gene regulatory system to functionally test the ability of ecotropic lentiviruses to model epithelial and mesenchymal uterine malignancies ex vivo and in vivo. We discovered that MuLE lentiviruses efficiently infect uterine stromal cells but not endometrial epithelial cells when injected into the uterus of cycling, pseudopregnant or ovarectomized mice. Consistent with this cellular infection spectrum, we show that intrauterine injection of ecotropic MuLE viruses expressing oncogenic Hras(G12V) together with knockdown of Cdkn2a induce high-grade endometrial stromal sarcomas. These findings establish this approach as an efficient method of generating autochthonous mouse models of uterine sarcomas and in general for performing genetic manipulations of uterine stromal cells in vivo.	[Brandt, Laura P.; Albers, Joachim; Hejhal, Tomas; Catalano, Antonella; Frew, Ian J.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Brandt, Laura P.; Frew, Ian J.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Catalano, Antonella; Frew, Ian J.] Univ Freiburg, Med Ctr, Fac Med, Clin Internal Med Hematol Oncol & Stem Cell Trans, Freiburg, Germany; [Wild, Peter J.] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Freiburg; University of Freiburg; University of Zurich; University Zurich Hospital	Frew, IJ (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Frew, IJ (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.; Frew, IJ (corresponding author), Univ Freiburg, Med Ctr, Fac Med, Clin Internal Med Hematol Oncol & Stem Cell Trans, Freiburg, Germany.	ian.frew@uniklinik-freiburg.de		Frew, Ian/0000-0003-2735-5509; Albers, Joachim/0000-0003-0582-1863; Wild, Peter Johannes/0000-0002-1017-3744				Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; [Anonymous], 2014, UNDIFFERENTIATED UTE, V290, P993; [Anonymous], 2009, MOL BIOL ENDOMETRICA, V16, P8; [Anonymous], 2012, DIAGNOSIS TREATMENT, V51, P694; [Anonymous], 1991, TRANSPORT CATIONIC A, V352, P725; [Anonymous], 1998, PTEN MUTATIONS MICRO, V58, P3254; [Anonymous], 2015, UTERINE SARCOMAS S2, V131, pS105; [Anonymous], 2006, ANAL FUMARATE HYDRAT, V119, P283; [Anonymous], 2011, FREQUENCY KNOWN GENE, V35, P1364; [Anonymous], 2005, LOSS DNA COPY NUMBER, V161, P20; [Anonymous], 1997, ONCOGENIC RAS PROVOK, V88, P593; [Anonymous], 2000, ELSEVIER, P273; [Anonymous], 2012, HIGH GRADE UNDIFFERE, V127, P27; [Anonymous], 1997, MUC1 OTH SIAL INH AD, V17, P422; [Anonymous], 2007, AKT MTOR PATHWAY PLA, V13, P748; [Anonymous], 2011, CONG HYP FEM PAX8 DE, V148, P719; [Anonymous], 2012, GENOMICS GENETICS EN, V2, P33; [Anonymous], 2015, MODELLING BREAST CAN, V6, P6927; [Anonymous], 2013, REV TREATMENT UTERIN, V15, P581; Beauparlant SL, 2004, GYNECOL ONCOL, V94, P713, DOI 10.1016/j.ygyno.2004.06.008; Bertsch E, 2014, MODERN PATHOLOGY, P1; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Eritja N, 2010, AM J PATHOL, V176, P2722, DOI 10.2353/ajpath.2010.090974; Fadare O, 2006, AM J SURG PATHOL, V30, P1519, DOI 10.1097/01.pas.0000213296.88778.db; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grant KS, 2003, BIOL REPROD, V69, P1091, DOI 10.1095/biolreprod.103.015495; Joshi A, 2011, EXP CELL RES, V317, P1580, DOI 10.1016/j.yexcr.2011.03.006; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim TH, 2010, J ONCOL, V2010, DOI 10.1155/2010/139087; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186102	10.1371/journal.pone.0186102	http://dx.doi.org/10.1371/journal.pone.0186102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982163	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000412360300122
J	Chen, YC; Zhao, JL; Deng, QQ; Duan, FQ				Chen, Yucong; Zhao, Junli; Deng, Qingqiong; Duan, Fuqing			3D craniofacial registration using thin-plate spline transform and cylindrical surface projection	PLOS ONE			English	Article							FACE RECONSTRUCTION; RECOGNITION; SKULL	Craniofacial registration is used to establish the point-to-point correspondence in a unified coordinate system among human craniofacial models. It is the foundation of craniofacial reconstruction and other craniofacial statistical analysis research. In this paper, a non-rigid 3D craniofacial registration method using thin-plate spline transform and cylindrical surface projection is proposed. First, the gradient descent optimization is utilized to improve a cylindrical surface fitting (CSF) for the reference craniofacial model. Second, the thin-plate spline transform (TPST) is applied to deform a target craniofacial model to the reference model. Finally, the cylindrical surface projection (CSP) is used to derive the point correspondence between the reference and deformed target models. To accelerate the procedure, the iterative closest point ICP algorithm is used to obtain a rough correspondence, which can provide a possible intersection area of the CSP. Finally, the inverse TPST is used to map the obtained corresponding points from the deformed target craniofacial model to the original model, and it can be realized directly by the correspondence between the original target model and the deformed target model. Three types of registration, namely, reflexive, involutive and transitive registration, are carried out to verify the effectiveness of the proposed craniofacial registration algorithm. Comparison with the methods in the literature shows that the proposed method is more accurate.	[Chen, Yucong; Deng, Qingqiong; Duan, Fuqing] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Zhao, Junli] Qingdao Univ, Sch Data Sci & Software Engn, Qingdao, Peoples R China	Beijing Normal University; Qingdao University	Duan, FQ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China.	fqduan@bnu.edu.cn		Zhao, Junli/0000-0002-2034-6426	National Natural Science Foundation of China [61572078, 61702293]; Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application [MEOBNUEVRA201601]; Program for New Century Excellent Talents in University [NCET-13-0051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was funded by the National Natural Science Foundation of China (No. 61572078, No. 61702293) and the Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application (MEOBNUEVRA201601). It was also partially supported by grants from the Program for New Century Excellent Talents in University (NCET-13-0051).	Alyuz N, 2012, LECT NOTES COMPUT SC, V7585, P557, DOI 10.1007/978-3-642-33885-4_56; Alyuz N, 2010, IEEE T INF FOREN SEC, V5, P425, DOI 10.1109/TIFS.2010.2054081; Amberg Brian, 2007, CVPR '07. IEEE Conference on Computer Vision and Pattern Recognition, P1; [Anonymous], 2003, ACM T GRAPHIC, V22, P587; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Booth J, 2016, PROC CVPR IEEE, P5543, DOI 10.1109/CVPR.2016.598; Brown BJ, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1276377.1276404; Cao C, 2014, IEEE T VIS COMPUT GR, V20, P413, DOI 10.1109/TVCG.2013.249; Chui HL, 2003, COMPUT VIS IMAGE UND, V89, P114, DOI 10.1016/S1077-3142(03)00009-2; Deng QQ, 2011, FORENSIC SCI INT, V208, P95, DOI 10.1016/j.forsciint.2010.11.011; Duan FQ, 2015, NEUROCOMPUTING, V151, P674, DOI [10.1016/j.neucom.2014.04.989, 10.1016/j.neucom.2014.04.089]; Duan FQ, 2014, IEEE T INF FOREN SEC, V9, P1322, DOI 10.1109/TIFS.2014.2332981; Guo JY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-232; Hu Y, 2009, INT J COMPUTER GAMES, V2009, P3; Hu YL, 2013, MULTIMED TOOLS APPL, V64, P345, DOI 10.1007/s11042-012-1005-4; Hutton T. J., 2003, BMVC 03 P 14 BRIT MA, P439; Mahoor MH, 2009, PATTERN RECOGN, V42, P445, DOI 10.1016/j.patcog.2008.08.012; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Schneider DC, 2010, J VIRTUAL REALITY BR, V7, P1; Song ML, 2012, IEEE T IMAGE PROCESS, V21, P2887, DOI 10.1109/TIP.2012.2183882; Spreeuwers L, 2011, INT J COMPUT VISION, V93, P389, DOI 10.1007/s11263-011-0426-2; Wang S, 2007, IEEE T PATTERN ANAL, V29, P1209, DOI 10.1109/TPAMI.2007.1050; Yang JL, 2013, IEEE I CONF COMP VIS, P1457, DOI 10.1109/ICCV.2013.184; Yin LJ, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P211	25	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185567	10.1371/journal.pone.0185567	http://dx.doi.org/10.1371/journal.pone.0185567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982117	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300045
J	d'Hooghe, JNS; Goorsenberg, AWM; de Bruin, DM; Roelofs, JJTH; Annema, JT; Bonta, PI				d'Hooghe, Julia N. S.; Goorsenberg, Annika W. M.; de Bruin, Daniel M.; Roelofs, Joris J. T. H.; Annema, Jouke T.; Bonta, Peter I.			Optical coherence tomography for identification and quantification of human airway wall layers	PLOS ONE			English	Article							BRONCHIAL THERMOPLASTY; ASTHMA; LUNG	Background High-resolution computed tomography has limitations in the assessment of airway wall layers and related remodeling in obstructive lung diseases. Near infrared-based optical coherence tomography (OCT) is a novel imaging technique that combined with bronchoscopy generates highly detailed images of the airway wall. The aim of this study is to identify and quantify human airway wall layers both ex-vivo and in-vivo by OCT and correlate these to histology. Methods Patients with lung cancer, prior to lobectomy, underwent bronchoscopy including in-vivo OCT imaging. Ex-vivo OCT imaging was performed in the resected lung lobe after needle insertion for matching with histology. Airway wall layer perimeters and their corresponding areas were assessed by two independent observers. Airway wall layer areas (total wall area, mucosal layer area and submucosal muscular layer area) were calculated. Results 13 airways of 5 patients were imaged by OCT. Histology was matched with 51 ex-vivo OCT images and 39 in-vivo OCT images. A significant correlation was found between ex-vivo OCT imaging and histology, in-vivo OCT imaging and histology and ex-vivo OCT imaging and in-vivo OCT imaging for all measurements (p < 0.0001 all comparisons). A minimal bias was seen in Bland-Altman analysis. High inter-observer reproducibility with intra-class correlation coefficients all above 0.90 were detected. Conclusions OCT is an accurate and reproducible imaging technique for identification and quantification of airway wall layers and can be considered as a promising minimal-invasive imaging technique to identify and quantify airway remodeling in obstructive lung diseases.	[d'Hooghe, Julia N. S.; Goorsenberg, Annika W. M.; Annema, Jouke T.; Bonta, Peter I.] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, Amsterdam, Netherlands; [de Bruin, Daniel M.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Bonta, PI (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, Amsterdam, Netherlands.	p.i.bonta@amc.nl		Roelofs, Joris/0000-0001-9595-6571; de Bruin, Daniel Martijn/0000-0003-3047-3637; Bonta, Peter/0000-0002-0429-4988	Dutch Lung Foundation [5.2.13.064JO]; Netherlands Organization for Health Research and Development (ZonMw grant) [90713477]	Dutch Lung Foundation; Netherlands Organization for Health Research and Development (ZonMw grant)	This study is funded by the Dutch Lung Foundation (Grant number: 5.2.13.064JO) and The Netherlands Organization for Health Research and Development (ZonMw grant number: 90713477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1424; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Chatterjee Shailja, 2014, J Oral Maxillofac Pathol, V18, pS111, DOI 10.4103/0973-029X.141346; Chen Y, 2015, RESP MED, V109, P1446, DOI 10.1016/j.rmed.2015.09.006; Coxson HO, 2008, AM J RESP CRIT CARE, V177, P1201, DOI 10.1164/rccm.200712-1776OC; Ding M, 2016, CHEST, V150, P1281, DOI 10.1016/j.chest.2016.07.033; Hariri LP, 2013, JOVE-J VIS EXP, DOI 10.3791/3855; Hariri LP, 2013, CHEST, V143, P64, DOI 10.1378/chest.11-2797; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; James AL, 2007, EUR RESPIR J, V30, P134, DOI 10.1183/09031936.00146905; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Kirby M, 2015, BIOMED OPT EXPRESS, V6, P4365, DOI 10.1364/BOE.6.004365; Kirby M, 2015, EUR RESPIR J, V46, P859, DOI 10.1183/09031936.00016815; Koustenis A, 2017, BRIT J OPHTHALMOL, V101, P16, DOI 10.1136/bjophthalmol-2016-309389; Lee AMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100145; Patel BD, 2008, AM J RESP CRIT CARE, V178, P500, DOI 10.1164/rccm.200801-059OC; Pitris C, 1998, AM J RESP CRIT CARE, V157, P1640, DOI 10.1164/ajrccm.157.5.9707075; Pretolani M, 2014, AM J RESP CRIT CARE, V190, P1452, DOI 10.1164/rccm.201407-1374LE; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Sotomi Y, 2016, INT J CARDIOVASCULAR; Tsuboi M, 2005, LUNG CANCER, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Yang Y, 2004, PHYS MED BIOL, V49, P1247, DOI 10.1088/0031-9155/49/7/012	22	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184145	10.1371/journal.pone.0184145	http://dx.doi.org/10.1371/journal.pone.0184145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981500	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300007
J	Islam, S; Nazeer, G; Ying, ZC; Islam, Z; Manzoor, R				Islam, Shamsul; Nazeer, Ghazala; Ying, Zhou Chao; Islam, Ziaul; Manzoor, Raheela			Transitions in the flow patterns and aerodynamic characteristics of the flow around staggered rows of cylinders	PLOS ONE			English	Article							SIDE SQUARE CYLINDERS; CIRCULAR-CYLINDERS; PAIR; INTERFERENCE	A two-dimensional numerical study of flow across rows of identical square cylinders arranged in staggered fashion is carried out. This study will unreveal complex flow physics depending upon the Reynolds number (R-e) and gap spacing (g) between the cylinders. The combined effect of Reynolds number and gap spacing on the flow physics around staggered rows of cylinders are numerically studied for 20 <= Re <= 140 and 1 <= g <= 6. We use the lattice Boltzmann method for numerical computations. It is found that with increase in gap spacing between the cylinders the critical Reynolds number for the onset of vortex shedding also increases. We observed a strong effect of Reynolds number at g = 2 and 4. Secondary cylinder interaction frequency disappears for large Reynolds number at g = 6 and 5 and the flow around cylinders are fully dominated by the primary vortex shedding frequency. This ensures that at large gap spacing with an increase in the Reynolds number the wakes interaction between and behind the cylinders is weaken. Furthermore, it also ensures that the wake interaction behind the cylinders is strongly influenced by the jets in the gap spacing between the cylinders. We also found that g = 2 is the critical gap spacing for flow across rows of staggered square cylinders for the considered range of Reynolds number. Depending on the Reynolds number we observed; synchronous, quasi-periodic-I, quasi-periodic-II, and chaotic flow patterns. In synchronous flow pattern, an in-phase and anti-phase characteristics of consecutive cylinders has been observed. The important physical parameters are also analyzed and discussed in detail.	[Islam, Shamsul; Nazeer, Ghazala] COMSATS Inst Informat Technol Islamabad, Math Dept, Islamabad, Pakistan; [Ying, Zhou Chao] Shenzhen Univ Town, Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Islam, Ziaul] Swedish Inst Technol, Mech Engn Dept, Rawalpindi, Pakistan; [Manzoor, Raheela] Sardar Bakhadur Khan Womens Univ, Math Dept, Quetta, Baluchistan, Pakistan	COMSATS University Islamabad (CUI); Harbin Institute of Technology; University Town of Shenzhen	Islam, S (corresponding author), COMSATS Inst Informat Technol Islamabad, Math Dept, Islamabad, Pakistan.	islam_shams@comsats.edu.pk	Nazeer, Ghazala/K-3109-2019					Abbasi WS, 2014, J MECH SCI TECHNOL, V28, P539, DOI 10.1007/s12206-013-1121-8; Agrawal A, 2006, COMPUT FLUIDS, V35, P1093, DOI 10.1016/j.compfluid.2005.05.008; Alam MM, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4817670; BEARMAN PW, 1973, J FLUID MECH, V61, P499, DOI 10.1017/S0022112073000832; Chatterjee D, 2015, J WIND ENG IND AEROD, V136, P1, DOI 10.1016/j.jweia.2014.10.019; CHAUVE MP, 1992, PHYSICA D, V58, P407, DOI 10.1016/0167-2789(92)90127-9; Chen S, 1998, ANNU REV FLUID MECH, V30, P329, DOI 10.1146/annurev.fluid.30.1.329; DAVIS RW, 1982, J FLUID MECH, V116, P475, DOI 10.1017/S0022112082000561; Gera B., 2010, International Journal of Applied Engineering Research, V1, P602; Gu ZF, 1999, J WIND ENG IND AEROD, V80, P287, DOI 10.1016/S0167-6105(98)00205-0; Guillaume DW, 1999, EXP FLUIDS, V27, P145, DOI 10.1007/s003480050339; Guo ZL, 2008, J COMPUT PHYS, V227, P4955, DOI 10.1016/j.jcp.2008.01.024; Inoue O, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2714080; Islam SU, 2016, ALEX ENG J, V55, P2351, DOI 10.1016/j.aej.2016.05.003; Kang SM, 2004, KSME INT J, V18, P1869, DOI 10.1007/BF02984335; Khanduri AC, 1998, ENG STRUCT, V20, P617, DOI 10.1016/S0141-0296(97)00066-7; Kruger T, 2017, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-319-44649-3; Kumar SR, 2008, J FLUID MECH, V606, P369, DOI 10.1017/S0022112008001924; Mizushima J, 1996, J PHYS SOC JPN, V65, P1673, DOI 10.1143/JPSJ.65.1673; Mohammad A.A., 2011, LATTICE BOLTZMANN ME; Moussaoui MA, 2011, INT J THERM SCI, V50, P1532, DOI 10.1016/j.ijthermalsci.2011.03.011; Norberg C., 1995, 12 AUSTR FLUID MECH, P517; Rahman H, 2015, KSCE J CIV ENG, V19, P233, DOI 10.1007/s12205-012-0535-7; Ravoux JF, 2003, THEOR COMP FLUID DYN, V16, P433, DOI 10.1007/s00162-003-0090-4; Saha AK, 2000, J ENG MECH-ASCE, V126, P523, DOI 10.1061/(ASCE)0733-9399(2000)126:5(523); Sewatkar CM, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3210769; Succi S., 2000, LATTICE BOLTZMANN EQ; Sukop M.C., 2007, LATTICE BOLTZMANN MO; Ul Islam S, 2016, OCEAN ENG, V119, P1, DOI 10.1016/j.oceaneng.2016.04.022; Ul Islam S, 2012, J MECH SCI TECHNOL, V26, P1027, DOI 10.1007/s12206-012-0328-4; Ul Islam S, 2016, J BRAZ SOC MECH SCI, V38, P843, DOI 10.1007/s40430-014-0297-x; WILLIAMSON CHK, 1985, J FLUID MECH, V159, P1, DOI 10.1017/S002211208500307X; Yan WW, 2016, EUR J MECH B-FLUID, V60, P48, DOI 10.1016/j.euromechflu.2016.07.006; Zhang HJ, 2001, PHYS FLUIDS, V13, P3675, DOI 10.1063/1.1412245; Zhang Y, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2014-6; Zhou Y, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3275846	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184169	10.1371/journal.pone.0184169	http://dx.doi.org/10.1371/journal.pone.0184169			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981539	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300008
J	Pruyne, D				Pruyne, David			Probing the origins of metazoan formin diversity: Evidence for evolutionary relationships between metazoan and non-metazoan formin subtypes	PLOS ONE			English	Article							ACTIN NUCLEATION; PROTEIN; DOMAIN; BINDING; RHO; PHYLOGENY; ALIGNMENT; DELPHILIN; FILAMENTS; DYNAMICS	Formins are proteins that assist in regulating cytoskeletal organization through interactions with actin filaments and microtubules. Metazoans encode nine distinct formin subtypes based on sequence similarity, potentially allowing for great functional diversity for these proteins. Through the evolution of the eukaryotes, formins are believed to have repeatedly undergone rounds of gene duplications, followed by diversification and domain shuffling, but previous phylogenetic analyses have shed only a little light on the specific origins of different formin subtypes. To improve our understanding of this in the case of the metazoan formins, phylogenetic comparisons were made here of a broad range of metazoan and non-metazoan formin sequences. This analysis suggests a model in which eight of the nine metazoan formin subtypes arose from two ancestral proteins that were present in an ancient unikont ancestor. Additionally, evidence is shown suggesting the common ancestor of unikonts and bikonts was likely to have encoded at least two formins, a canonical Drf-type protein and a formin bearing a PTEN-like domain.	[Pruyne, David] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Pruyne, D (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	pruyned@upstate.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR064760-01A1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064760] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, https://www.niams.nih.gov/, Grant# 1R01AR064760-01A1 (DP).	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Brown MW, 2009, MOL BIOL EVOL, V26, P2699, DOI 10.1093/molbev/msp185; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carlier MF, 2013, CYTOSKELETON, V70, P540, DOI 10.1002/cm.21124; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Cvrckova F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-44; Cvrckova F, 2015, INT J MOL SCI, V16, P1, DOI 10.3390/ijms16010001; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grikscheit K, 2016, TRENDS BIOCHEM SCI, V41, P148, DOI 10.1016/j.tibs.2015.12.002; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Gunning PW, 2015, J CELL SCI, V128, P2009, DOI 10.1242/jcs.165563; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-272; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuda K, 2006, J BIOL CHEM, V281, P25577, DOI 10.1074/jbc.M602044200; Miyagi Y, 2002, J NEUROSCI, V22, P803, DOI 10.1523/JNEUROSCI.22-03-00803.2002; Nei M., 2000, MOL EVOLUTION PHYLOG; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Paps J, 2013, PROTIST, V164, P2, DOI 10.1016/j.protis.2012.09.002; Pruyne D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164067; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186081	10.1371/journal.pone.0186081	http://dx.doi.org/10.1371/journal.pone.0186081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982189	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300121
J	Schmid, BC; Carlson, J; Rezniczek, GA; Wyllie, J; Jaaback, K; Vencovsky, F				Schmid, Bernd C.; Carlson, Jamie; Rezniczek, Gunther A.; Wyllie, Jessica; Jaaback, Kenneth; Vencovsky, Filip			Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination	PLOS ONE			English	Article							HEALTH; QUALITY	In this study, we examined the perceptual associations women hold with regard to cervical cancer testing and vaccination across two countries, the U.S. and Australia. In a large-scale online survey, we presented participants with 'trigger' words, and asked them to state sequentially other words that came to mind. We used this data to construct detailed term cooccurrence network graphs, which we analyzed using basic topological ranking techniques. The results showed that women hold divergent perceptual associations regarding trigger words relating to cervical cancer screening tools, i.e. human papillomavirus (HPV) testing and vaccination, which indicate health knowledge deficiencies with non-HPV related associations emerging from the data. This result was found to be consistent across the country groups studied. Our findings are critical in optimizing consumer education and public service announcements to minimize misperceptions relating to HPV testing and vaccination in order to maximize adoption of cervical cancer prevention tools.	[Schmid, Bernd C.] Royal Hosp Women, Dept Gynaecol Oncol, Randwick, NSW, Australia; [Carlson, Jamie; Wyllie, Jessica] Univ Newcastle, Fac Business & Law, Newcastle Business Sch, Newcastle, NSW, Australia; [Rezniczek, Gunther A.] Ruhr Univ Bochum, Marien Hosp Herne, Dept Obstet & Gynecol, Dungelstr 33, Herne, Germany; [Jaaback, Kenneth] Univ Newcastle, Dept Gynaecol Oncol, Sch Med & Publ Hlth, John Hunter Hosp, New Lambton Hts, Australia; [Vencovsky, Filip] Univ Econ, Fac Informat & Stat, Prague, Czech Republic	University of Newcastle; Ruhr University Bochum; St. Marien Hospital; John Hunter Hospital; University of Newcastle; Prague University of Economics & Business	Carlson, J (corresponding author), Univ Newcastle, Fac Business & Law, Newcastle Business Sch, Newcastle, NSW, Australia.	Jamie.carlson@newcastle.edu.au	Carlson, Jamie/AAP-5387-2020; Carlson, Jamie/G-7535-2013; Rezniczek, Günther/AAO-2963-2020; Rezniczek, Günther/Q-9318-2016	Carlson, Jamie/0000-0002-1622-5939; Rezniczek, Günther/0000-0002-0852-6002; Rezniczek, Günther/0000-0002-0852-6002; Schmid, Bernd C./0000-0003-2510-0537; Wyllie, Jessica/0000-0001-5178-8860				American Cancer Society, WHAT AR RISK FACT CE; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Belei N, 2012, J MARKETING RES, V49, P900, DOI 10.1509/jmr.10.0155; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Binka C, 2016, J CANCER EDUC, V31, P322, DOI 10.1007/s13187-015-0852-x; Boh B, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1280-x; Bruni L, 2017, ICO INFORM CTR HPV C; CDC, CERV CANC SCREEN GUI; Centre for Disease, HUM PAP HPV HPV VACC; Choi D, 2014, INT INTERDISCIPLINAR, V14, P3583; Culotta A, 2016, MARKET SCI, V35, P343, DOI 10.1287/mksc.2015.0968; De Deyne S, 2013, P 35 ANN C COGN SCI, P2142; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Driscoll SD, 2016, WOMEN HEALTH, V56, P448, DOI 10.1080/03630242.2015.1101742; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Janssen E, 2011, BRIT J HEALTH PSYCH, V16, P92, DOI 10.1348/135910710X514120; John DR, 2006, J MARKETING RES, V43, P549, DOI 10.1509/jmkr.43.4.549; Kitchens B, 2014, DECIS SUPPORT SYST, V57, P454, DOI 10.1016/j.dss.2012.10.050; Lee TY, 2011, J MARKETING RES, V48, P881, DOI 10.1509/jmkr.48.5.881; Leon-Maldonado L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153367; Li HJ, 2016, PHYSICA A, V450, P657, DOI 10.1016/j.physa.2016.01.017; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; McColl-Kennedy JR, 2012, J SERV RES-US, V15, P370, DOI 10.1177/1094670512442806; Narayanan A, 2016, BIG DATA-US, V4, P31, DOI 10.1089/big.2016.0010; NORTHOUSE P G, 1987, Journal of Psychosocial Oncology, V5, P17; OECD, 2013, CANC CAR ASS QUAL IM; Organization WH, GUID PREV CONTR CERV; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; Prah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135203; Schermel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086000; Schneider F, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1863; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Song H, 2016, J MED INTERNET RES, V18, DOI [10.2196/jmir.4193, 10.21075/kacsn.2016.18.1.1]; Spanakis G, 2016, LECT NOTES COMPUT SC, V9545, P43, DOI 10.1007/978-3-319-29175-8_5; Sweeney JC, 2015, J SERV RES-US, V18, P318, DOI 10.1177/1094670515572128; Totet M., 2016, LETS PLAY GEPHI UNDE; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; U. S. Preventative Services, CERV CANC SCREEN; Van Rensbergen B, 2015, PSYCHON B REV, V22, P1717, DOI 10.3758/s13423-015-0832-5; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Widder S, 2014, P NATL ACAD SCI USA, V111, P12799, DOI 10.1073/pnas.1411723111; Wyllie J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163914; Youn H, 2016, P NATL ACAD SCI USA, V113, P1766, DOI 10.1073/pnas.1520752113	46	1	1	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185669	10.1371/journal.pone.0185669	http://dx.doi.org/10.1371/journal.pone.0185669			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982130	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300056
J	Young, BE; Auer, S; Ormes, M; Rapacciuolo, G; Schweitzer, D; Sears, N				Young, Bruce E.; Auer, Stephanie; Ormes, Margaret; Rapacciuolo, Giovanni; Schweitzer, Dale; Sears, Nicole			Are pollinating hawk moths declining in the Northeastern United States? An analysis of collection records	PLOS ONE			English	Article							ORCHID PLATANTHERA-PRAECLARA; CONCINNATA MEIGEN DIPTERA; AMERICAN BUMBLE BEES; SPECIES RICHNESS; SATURNIIDAE CERATOCAMPINAE; SPHINGIDAE LEPIDOPTERA; NORTH-AMERICA; MANDUCA-SEXTA; NEW-ENGLAND; PRAIRIE	Increasing attention to pollinators and their role in providing ecosystem services has revealed a paucity of studies on long-term population trends of most insect pollinators in many parts of the world. Because targeted monitoring programs are resource intensive and unlikely to be performed on most insect pollinators, we took advantage of existing collection records to examine long-term trends in northeastern United States populations of 26 species of hawk moths (family Sphingidae) that are presumed to be pollinators. We compiled over 6,600 records from nine museum and 14 private collections that spanned a 112-year period, and used logistic generalized linear mixed models (GLMMs) to examine long-term population trends. We controlled for uneven sampling effort by adding a covariate for list length, the number of species recorded during each sampling event. We found that of the 22 species for which there was sufficient data to assess population trends, eight species declined and four species increased in detection probability (the probability of a species being recorded during each year while accounting for effort, climate, and spatial effects in the GLMMs). Of the four species with too few records to statistically assess, two have disappeared from parts of their ranges. None of the four species with diurnal adults showed a trend in detection probability. Two species that are pests of solanaceous crops declined, consistent with a seven-fold drop in the area planted in tobacco and tomato crops. We found some evidence linking susceptibility to parasitoidism by the introduced fly Compsilura concinnata (Tachinidae) to declines. Moths with larvae that feed on vines and trees, where available evidence indicates that the fly is most likely to attack, had a greater propensity to decline than species that use herbs and shrubs as larval host plants. Species that develop in the spring, before Compsilura populations have increased, did not decline. However, restricting the analysis to hawk moth records from areas outside of a "refuge" area where Compsilura does not occur did not significantly increase the intensity of the declines as would be predicted if Compsilura was the primary cause of declines. Forests have recovered over the study period across most of the northeastern U.S., but this does not appear to have been a major factor because host plants of several of the declining species have increased in abundance with forest expansion and maturation. Climate variables used in the GLMMs were not consistently related to moth detection probability. Hawk moth declines may have ecological effects on both the plants pollinated by these species and vertebrate predators of the moths.	[Young, Bruce E.; Auer, Stephanie; Ormes, Margaret; Rapacciuolo, Giovanni; Schweitzer, Dale; Sears, Nicole] NatureServe, Arlington, VA 22203 USA; [Rapacciuolo, Giovanni] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Nature Conservancy; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Young, BE (corresponding author), NatureServe, Arlington, VA 22203 USA.	bruce_young@natureserve.org		Rapacciuolo, Giovanni/0000-0003-1494-9017	Sarah K. de Coizart Perpetual Charitable Trust; U.S. National Science Foundation [1136586]	Sarah K. de Coizart Perpetual Charitable Trust; U.S. National Science Foundation(National Science Foundation (NSF))	This study was supported by the Sarah K. de Coizart Perpetual Charitable Trust and the U.S. National Science Foundation (award 1136586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2016, USDA CENS AGR HIST A; [Anonymous], 2012, US GEOL SURV DATA SE, DOI DOI 10.1016/J.MIMET.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; ARNAUD P H JR, 1978, U S Department of Agriculture Miscellaneous Publication, P1; Atwater MM, 2013, J NAT HIST, V47, P2719, DOI 10.1080/00222933.2013.791944; Banza P, 2015, INSECT CONSERV DIVER; Barnes M, 2015, DIVERS DISTRIB, V21, P368, DOI 10.1111/ddi.12274; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Bent A. C, 1940, LIFE HIST N AM BIRDS; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boettner GH, 2000, CONSERV BIOL, V14, P1798, DOI 10.1046/j.1523-1739.2000.99193.x; Borkowsky C, 2009, J LEPID SOC, V63, P110; Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/nclimate1663, 10.1038/NCLIMATE1663]; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Colla SR, 2012, BIODIVERS CONSERV, V21, P3585, DOI 10.1007/s10531-012-0383-2; Coyle JR, 2016, GLOBAL ECOL BIOGEOGR, V25, P406, DOI 10.1111/geb.12420; Cuthrell DL, 1997, THESIS; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Elkinton JS, 2006, ECOLOGY, V87, P2664, DOI 10.1890/0012-9658(2006)87[2664:IAIGPI]2.0.CO;2; Faegri K., 1979, PRINCIPLES POLLINATI; Federal Pollinator Health Task Force, 2015, NAT STRAT PROM HLTH; Foster DR., 1995, PRINCIPLES PATTERNS, P253; Fox K, 2015, ANN ENTOMOL SOC AM, V108, P1000, DOI 10.1093/aesa/sav093; Fox K, 2013, BIOL CONSERV, V167, P316, DOI 10.1016/j.biocon.2013.08.026; Goldstein PZ, 2015, P ENTOMOL SOC WASH, V117, P347, DOI 10.4289/0013-8797.117.3.347; Goldstein Paul Z., 2010, Journal of Research on the Lepidoptera, V42, P34; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; Grunert LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127988; HABER WA, 1989, BIOTROPICA, V21, P155, DOI 10.2307/2388706; Hahn M, 2016, ARTHROPOD-PLANT INTE, V10, P21, DOI 10.1007/s11829-016-9414-3; Hayes MB, 2015, INSECT SCI, V22, P424, DOI 10.1111/1744-7917.12109; HESSEL S A, 1976, Atala, V4, P19; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Isaac NJB, 2014, METHODS ECOL EVOL, V5, P1052, DOI 10.1111/2041-210X.12254; Isaac NJ, 2015, BIOL J LINN SOC, P115; Ives AR, 2006, ECOL APPL, V16, P20, DOI 10.1890/04-0702; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Johnson SD, 2016, FUNCT ECOL; Karuppaiah V., 2012, World Journal of Agricultural Sciences, V8, P240; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kellogg SK, 2003, ENVIRON ENTOMOL, V32, P1019, DOI 10.1603/0046-225X-32.5.1019; Klots A. B., 1964, Journal of the New York Entomological Society, V72, P142; KRITSKY G, 1991, American Entomologist, V37, P206; Lovfll JH, 1900, AM NAT, V34, P37; Macgregor CJ, 2015, ECOL ENTOMOL, V40, P187, DOI 10.1111/een.12174; Macgregor CJ, 2016, GLOB CHANG BIOL; McCarthy MA, 1998, BIOL CONSERV, V83, P9, DOI 10.1016/S0006-3207(97)00048-7; Miller William E., 1997, Journal of the Lepidopterists' Society, V51, P9; MuMIn K., 2015, MMUMIN MULTIMODEL IN; National Aeronautics and Space Administration (NASA), 2012, NASA VIS EARTH NIGHT; National Oceanic and Atmospheric Administration (NOAA), 2016, DEF MET SAT PROGR DM; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peacock JW, 1998, ENVIRON ENTOMOL, V27, P450, DOI 10.1093/ee/27.2.450; Petersen FT, 2003, BIODIVERS CONSERV, V12, P687, DOI 10.1023/A:1022464710930; Potts S.G., 2016, SUMM POL ASS REP INT; PRISM Climate Group, 2013, PRISM GRIDD CLIM DAT; Rapacciuolo G., 2017, BIODIVERS CONSERV, P1; Roberts RL, 2007, ANIM CONSERV, V10, P332, DOI 10.1111/j.1469-1795.2007.00117.x; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SCHREIBER H, 1978, BIOGEOGRAPHICA, V10; Schweitzer D., 1988, News of the Lepidopterists' Society, V1988, P4; SCHWEITZER D. F., 2011, RARE DECLINING POORL; Schweitzer D, 2014, J INSECT CONSERV, V18, P561, DOI 10.1007/s10841-014-9658-0; Schweitzer Dale F., 2006, Journal of the Lepidopterists' Society, V60, P101; SHEVIAK CJ, 1986, RHODORA, V88, P267; St Laurent R, 2016, J LEPID SOC, V70, P9, DOI 10.18473/lepi.70i1.a3; Szabo JK, 2010, ECOL APPL, V20, P2157, DOI 10.1890/09-0877.1; Tartaglia Elena S., 2014, Journal of Pollination Ecology, V13, P184; TUTTLE JP, 2007, HAWK MOTHS N AM; USDA National Agricultural Statistics Service (USDA-NASS), 2014, CROPL DAT LAYER 2014; van Strien AJ, 2013, BIODIVERS CONSERV, V22, P673, DOI 10.1007/s10531-013-0436-1; Wagner, 2012, NEWS LEPID SOC, V54, P52; Wagner D.L., 2015, BIOL CONTROL EMERALD, P15; Watanabe ME, 2013, BIOSCIENCE, V64, P5; Wehi PM, 2012, MOL ECOL, V21, P3103, DOI 10.1111/j.1365-294X.2012.05589.x; WESELOH RM, 1982, CAN ENTOMOL, V114, P617, DOI 10.4039/Ent114617-7; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; Zeilinger AR, 2017, ECOL APPL	86	10	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185683	10.1371/journal.pone.0185683	http://dx.doi.org/10.1371/journal.pone.0185683			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982152	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300058
J	Bjorkum, AA; Oveland, E; Stuhr, L; Havnes, MB; Berven, F; Gronning, M; Hope, A				Bjorkum, Alvhild Alette; Oveland, Eystein; Stuhr, Linda; Havnes, Marianne Bjordal; Berven, Frode; Gronning, Marit; Hope, Arvid			Fast hyperbaric decompression after heliox saturation altered the brain proteome in rats	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CYCLIN-DEPENDENT KINASE-5; S100B PROTEIN; WHITE-MATTER; SPINAL-CORD; SICKNESS; DIVERS; MRI; INJURY; CDK5	Better understanding of the physiological mechanisms and neurological symptoms involved in the development of decompression sickness could contribute to improvements of diving procedures. The main objective of the present study was to determine effects on the brain proteome of fast decompression (1 bar/20 s) compared to controls (1 bar/10 min) after heliox saturation diving, using rats in a model system. The protein S100B, considered a biomarker for brain injury, was not significantly different in serum samples from one week before, immediately after, and one week after the dive. Alterations in the rat brain proteome due to fast decompression were investigated using both iontrap and orbitrap LC-MS, and 967 and 1062 proteins were quantified, respectively. Based on the significantly regulated proteins in the iontrap (56) and orbitrap (128) datasets, the networks "synaptic vesicle fusion and recycling in nerve terminals" and "translation initiation" were significantly enriched in a system biological database analysis (Metacore). Ribosomal proteins (RLA2, RS10) and the proteins hippocalcin-like protein 4 and proteasome subunit beta type-7 were significantly upregulated in both datasets. The heat shock protein 105 kDa, Rho-associated protein kinase 2 and Dynamin-1 were significantly downregulated in both datasets. Another main effect of hyperbaric fast decompression in our experiment is inhibition of endocytosis and stimulation of exocytosis of vesicles in the presynaptic nerve terminal. In addition, fast decompression affected several proteins taking parts in these two main mechanisms of synaptic strength, especially alteration in CDK5/calcineurin are associated with a broad range of neurological disorders. In summary, fast decompression after heliox saturation affected the brain proteome in a rat model for diving, potentially disturbing protein homeostasis, e.g. in synaptic vesicles, and destabilizing cytoskeletal components. Data are available via ProteomeXchange with identifier PXD006349	[Bjorkum, Alvhild Alette] Western Norway Univ Appl Sci, Dept Biomed Lab Sci & Chem Engn, Bergen, Norway; [Oveland, Eystein; Berven, Frode] Univ Bergen, Fac Med & Dent, Dept Biomed, Prote Unit, Bergen, Norway; [Oveland, Eystein; Gronning, Marit] Univ Bergen, Fac Med & Dent, Dept Clin Med, Bergen, Norway; [Stuhr, Linda] Univ Bergen, Fac Med & Dent, Dept Biomed, Bergen, Norway; [Havnes, Marianne Bjordal] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway; [Gronning, Marit] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Hope, Arvid] NUI AS, Bergen, Norway	Western Norway University of Applied Sciences; University of Bergen; University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital	Bjorkum, AA (corresponding author), Western Norway Univ Appl Sci, Dept Biomed Lab Sci & Chem Engn, Bergen, Norway.	Alvhild.Bjorkum@hvl.no	Oveland, Eystein/X-6006-2019	Oveland, Eystein/0000-0003-2206-1480	Norwegian Research Council [220546]; NUI AS	Norwegian Research Council(Research Council of NorwayEuropean Commission); NUI AS	The project was supported by grants from the Norwegian Research Council (project number 220546). NUI AS did provide support in the form of salary for Arvid Hope, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestra C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00696; Berle M, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-8; Berle M, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-19; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dutka AJ, 2003, PHYSL MED DIVING; Eftedal I, 2013, PHYSIOL GENOMICS, V45, P965, DOI 10.1152/physiolgenomics.00164.2012; Fassio Anna, 2016, Front Synaptic Neurosci, V8, P10, DOI 10.3389/fnsyn.2016.00010; Ferrazzano PA, 2008, MAGNETIC RESONANCE I; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Forestier A, 2015, HEMOGLOBIN, V39, P438, DOI 10.3109/03630269.2015.1065882; Gempp E, 2014, DIVING HYPERB MED, V44, P26; Gronning M, 2005, UNDERSEA HYPERBAR M, V32, P397; Gronning M, 2011, J NEUROL SCI, V304, P17, DOI 10.1016/j.jns.2011.01.021; Haslene-Hox H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019217; Havnes MB, 2013, EUR J APPL PHYSIOL, V113, P1405, DOI 10.1007/s00421-012-2565-8; Hemelryck W, 2014, SCAND J MED SCI SPOR, V24, P928, DOI 10.1111/sms.12100; Hennedige T, 2012, J MED IMAG RADIAT ON, V56, P282, DOI 10.1111/j.1754-9485.2012.02386.x; Hope A, 2006, 1993 CONS C REV; Hope A, 2015, UNDERSEA HYPERBAR M, V42, P57; Jallul S, 2007, SPINAL CORD, V45, P116, DOI 10.1038/sj.sc.3101923; KAJIMOTO Y, 1993, J NEUROCHEM, V61, P1091, DOI 10.1111/j.1471-4159.1993.tb03624.x; Kei PL, 2007, J NEUROIMAGING, V17, P378, DOI 10.1111/j.1552-6569.2007.00122.x; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; McLinden Kristina A, 2012, Brain Disord Ther, V2012, P001; Moen G, 2010, ACTA RADIOL, V51, P1050, DOI 10.3109/02841851.2010.515245; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roy PK, 2015, COMPUT MED IMAG GRAP, V45, P102, DOI 10.1016/j.compmedimag.2015.08.005; Skogland S, 2002, J APPL PHYSIOL, V92, P2633, DOI 10.1152/japplphysiol.00795.2001; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; TODNEM K, 1991, BRIT J IND MED, V48, P258; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Yardan T, 2011, J PAK MED ASSOC, V61, P276	43	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185765	10.1371/journal.pone.0185765	http://dx.doi.org/10.1371/journal.pone.0185765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977037	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100043
J	Kondili, LA; Gaeta, GB; Brunetto, MR; Di Leo, A; Iannone, A; Santantonio, TA; Giammario, A; Raimondo, G; Filomia, R; Coppola, C; Amoruso, DC; Blanc, P; Del Pin, B; Chemello, L; Cavalletto, L; Morisco', F; Donnarummall, L; Rumi, MG; Gasbarrini, A; Siciliane, M; Massari, M; Corsini, R; Cocoa, B; Madonia, S; Cannizzaro, M; Zignego, AL; Monti, M; Russo, FP; Zanetto, A; Persico, M; Masarone, M; Villa, E; Bernabucci, V; Taliani, G; Biliotti, E; Chessa, L; Pasetto, MC; Andreone, P; Margotti, M; Brancaccio, G; Leluzzi, D; Borgia', G; Zappuloll, E; Calvaruso, V; Petta, S; Falzano, L; Quaranta, MG; Weimer, LE; Rosato, S; Vella, S; Giannini, EG				Kondili, Loreta A.; Gaeta, Giovanni Battista; Brunetto, Maurizia Rossana; Di Leo, Alfredo; Iannone, Andrea; Santantonio, Teresa Antonia; Giammario, Adele; Raimondo, Giovanni; Filomia, Roberto; Coppola, Carmine; Amoruso, Daniela Caterina; Blanc, Pierluigi; Del Pin, Barbara; Chemello, Liliana; Cavalletto, Luisa; Morisco', Filomena; Donnarummall, Laura; Rumi, Maria Grazia; Gasbarrini, Antonio; Siciliano, Massimo; Massari, Marco; Corsini, Romina; Coco, Barbara; Madonia, Salvatore; Cannizzaro, Marco; Zignego, Anna Linda; Monti, Monica; Russo, Francesco Paolo; Zanetto, Alberto; Persico, Marcello; Masarone, Mario; Villa, Erica; Bernabucci, Veronica; Taliani, Gloria; Biliotti, Elisa; Chessa, Luchino; Pasetto, Maria Cristina; Andreone, Pietro; Margotti, Marzia; Brancaccio, Giuseppina; Leluzzi, Donatella; Borgia', Guglielmo; Zappuloll, Emanuela; Calvaruso, Vincenza; Petta, Salvatore; Falzano, Loredana; Quaranta, Maria Giovanna; Weimer, Liliana Elena; Rosato, Stefano; Vella, Stefano; Giannini, Edoardo Giovanni			Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; SOFOSBUVIR PLUS RIBAVIRIN; ALL-CAUSE MORTALITY; HCV INFECTION; CIRRHOSIS; RISK; FIBROSIS; OUTCOMES; ERADICATION	Background Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure. Aim To evaluate DAA failure incidence and the retreatment clinical impact in patients treated in the advanced liver disease stage. Methods Data on HCV genotype, liver disease severity, and first and second line DAA regimens were prospectively collected in consecutive patients who reached the 12-week post-treatment and retreatment evaluations from January 2015 to December 2016 in 23 of the PITER network centers. Results Among 3,830 patients with advanced fibrosis (F3) or cirrhosis, 139 (3.6%) failed to achieve SVR. Genotype 3, bilirubin levels > 1.5mg/dl, platelet count < 120,000/mm(3) and the sofosbuvir+ribavirin regimen were independent predictors of failure by logistic regression analysis. The failure rate was 7.6% for patients treated with regimens that are no longer recommended or considered suboptimal (sofosbuvir+ ribavirin or simeprevir+sofosbuvir +/- ribavirin), whereas 1.4% for regimens containing sofosbuvir combined with daclatasvir or ledipasvir or other DAAs. Of the patients who failed to achieve SVR, 72 (51.8%) were retreated with a second DAA regimen, specifically 38 (52.7%) with sofosbuvir+ daclatasvir, 27 (37.5%) with sofosbuvir+ ledipasvir, and 7 (9.7%) with other DAAs +/- ribavirin. Among these, 69 (96%) patients achieved SVR12 and 3 (4%) failed. During a median time of 6 months (range: 5-14 months) between failure and the second DAA therapy, the Child-Pugh class worsened in 12 (16.7%) patients: from A to B in 10 patients (19.6%) and from B to C in 2 patients (10.5%), whereas it did not change in the remaining 60 patients. Following the retreatment SVR12 (median time of 6 months; range: 3 +/- 12 months), the Child-Pugh class improved in 17 (23.6%) patients: from B to A in 14 (19.4%) patients, from C to A in 1 patient (1.4%) and from C to B in 2 (2.9%) patients; it remained unchanged in 53 patients (73.6%) and worsened in 2 (2.8%) patients. Of patients who were retreated, 3 (4%) had undergone OLT before retreatment (all reached SVR12 following retreatment) and 2 (2.8%) underwent OLT after having achieved retreatment SVR12. Two (70%) of the 3 patients who failed to achieve SVR12 after retreatment, and 2 (2.8%) of the 69 patients who achieved retreatment SVR12 died from liver failure (Child-Pugh class deteriorated from B to C) or HCC complications. Conclusions Failure rate following the first DAA regimen in patients with advanced disease is similar to or lower than that reported in clinical trials, although the majority of patients were treated with suboptimal regimens. Interim findings showed that worsening of liver function after failure, in terms of Child Pugh class deterioration, was improved by successful retreatment in about one third of retreated patients within a short follow-up period; however, in some advanced liver disease patients, clinical outcomes (Child Pugh class, HCC development, liver failure and death) were independent of viral eradication.	[Kondili, Loreta A.; Falzano, Loredana; Quaranta, Maria Giovanna; Weimer, Liliana Elena; Rosato, Stefano; Vella, Stefano] Ist Super Sanit, Rome, Italy; [Gaeta, Giovanni Battista; Brancaccio, Giuseppina] Univ Naples 2, Naples, Italy; [Brunetto, Maurizia Rossana; Coco, Barbara] Univ Hosp Pisa, Pisa, Italy; [Brunetto, Maurizia Rossana] Univ Pisa, Pisa, Italy; [Di Leo, Alfredo; Iannone, Andrea] Univ Bari, Bari, Italy; [Santantonio, Teresa Antonia; Giammario, Adele] Univ Foggia, Foggia, Italy; [Raimondo, Giovanni; Filomia, Roberto] Univ Hosp Messina, Messina, Italy; [Coppola, Carmine; Amoruso, Daniela Caterina] Gragnano Hosp, Gragnano, Italy; [Blanc, Pierluigi; Del Pin, Barbara] SM Annunziata Hosp, Florence, Italy; [Chemello, Liliana; Cavalletto, Luisa] Univ Hosp Padua, Padua, Italy; [Morisco', Filomena; Donnarummall, Laura; Borgia', Guglielmo; Zappuloll, Emanuela] Univ Naples Federico II, Naples, Italy; [Rumi, Maria Grazia] Univ Milan, Milan, Italy; [Gasbarrini, Antonio; Siciliano, Massimo] Univ Cattolica Sacro Cuore, Rome, Italy; [Massari, Marco; Corsini, Romina] Arcispedale S Maria Nuova IRCCS, Reggio Emilia, Italy; [Madonia, Salvatore; Cannizzaro, Marco] Villa Sofia Cervello Hosp, Palermo, Italy; [Zignego, Anna Linda; Monti, Monica] Univ Florence, Florence, Italy; [Russo, Francesco Paolo; Zanetto, Alberto] Univ Padua, Padua, Italy; [Persico, Marcello; Masarone, Mario] Univ Salerno, Salerno, Italy; [Villa, Erica; Bernabucci, Veronica] Univ Modena & Reggio Emilia, Modena, Italy; [Taliani, Gloria; Biliotti, Elisa] Sapienza Univ Rome, Rome, Italy; [Chessa, Luchino; Pasetto, Maria Cristina] Univ Cagliari, Cagliari, Italy; [Andreone, Pietro; Margotti, Marzia] Univ Bologna, Bologna, Italy; [Leluzzi, Donatella] Univ Hosp Verona, Verona, Italy; [Calvaruso, Vincenza; Petta, Salvatore] Univ Palermo, Palermo, Italy; [Giannini, Edoardo Giovanni] Univ Genoa, Genoa, Italy	Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa; Universita degli Studi di Bari Aldo Moro; University of Foggia; AOU Policlinico Gaetano Martino; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Naples Federico II; University of Milan; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Arcispedale S. Maria Nuova; University of Florence; University of Padua; University of Salerno; Universita di Modena e Reggio Emilia; Sapienza University Rome; University of Cagliari; University of Bologna; University of Palermo; University of Genoa	Kondili, LA (corresponding author), Ist Super Sanit, Rome, Italy.	loreta.kondili@iss.it	Gaeta, Giovanni/AAQ-4294-2021; KONDILI, LORETA/J-8784-2016; Chessa, Luchino/K-4255-2019; Brunetto, Maurizia/AAU-2906-2020; persico, marcello/AAB-3562-2019; Filomia, Roberto/AIA-8302-2022; chemello, liliana/AAU-9414-2020; Gasbarrini, Antonio/AAB-8487-2019; Vella, Stefano/GZM-0519-2022; Corsini, Romina/ABB-4619-2021; VELLA, STEFANO/ABI-3368-2020; Massari, Marco/AAA-9907-2021; VELLA, STEFANO/V-8440-2019; Morisco, Filomena/AHI-0851-2022; Andreone, Pietro/K-8050-2016; Zignego, Anna Linda/AAL-8205-2021; Villa, Erica/A-7576-2012; Kondili, Loreta/AAY-6360-2020; Masarone, Mario/H-8633-2017; Giannini, Edoardo Giovanni/E-1120-2012; RUSSO, FRANCESCO PAOLO/AAO-4597-2020	KONDILI, LORETA/0000-0003-2656-224X; Chessa, Luchino/0000-0002-9474-0995; Brunetto, Maurizia/0000-0001-8364-9152; Massari, Marco/0000-0002-0745-7519; VELLA, STEFANO/0000-0003-2347-5984; Andreone, Pietro/0000-0002-4794-9809; Villa, Erica/0000-0001-6388-7022; Masarone, Mario/0000-0003-0550-8201; Giannini, Edoardo Giovanni/0000-0001-8526-837X; RUSSO, FRANCESCO PAOLO/0000-0003-4127-8941; Di Leo, Alfredo/0000-0003-2026-1200; IANNONE, ANDREA/0000-0002-5468-9515; Crisanti, Andrea/0000-0002-2406-4426; zappulo, emanuela/0000-0002-7660-7939; Gasbarrini, Antonio/0000-0003-4863-6924; Persico, Marcello/0000-0002-1399-6498; Filomia, Roberto/0000-0002-8335-6816; Brancaccio, Giuseppina/0000-0001-5643-0139; Zanetto, Alberto/0000-0002-6734-7178	Italian Ministry of health Grant "Research project PITER" [RF-2010-2315839]; Bristol-Myers Squibb; Merck (MSD Italia)	Italian Ministry of health Grant "Research project PITER"; Bristol-Myers Squibb(Bristol-Myers Squibb); Merck (MSD Italia)	The authors received no specific funding for this work. However, the PITER platform has been supported by Italian Ministry of health Grant "Research project PITER2010" RF-2010-2315839 to SV and by unconditioned partial support from Bristol-Myers Squibb and Merck (MSD Italia).	AASLD, REC TEST MAN TREAT H; [Anonymous], 2016, J HEPATOL; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Belli LS, 2016, J HEPATOL, V65, P524, DOI 10.1016/j.jhep.2016.05.010; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruno S, 2009, AM J GASTROENTEROL, V104, P1147, DOI 10.1038/ajg.2009.31; Calvaruso V, EASL INT LIV C AMST; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; D'Ambrosio R, 2012, HEPATOLOGY, V56, P532, DOI 10.1002/hep.25606; Di Marco V, 2016, GASTROENTEROLOGY, V151, P130, DOI 10.1053/j.gastro.2016.03.036; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Kondili LA, 2015, DIGEST LIVER DIS, V47, P741, DOI 10.1016/j.dld.2015.05.022; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu M, 2016, J VIRAL HEPATITIS, V23, P718, DOI 10.1111/jvh.12538; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Modi AA, 2016, LIVER TRANSPLANT, V22, P281, DOI 10.1002/lt.24324; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Petta S, 2016, LIVER INT, V36, P1765, DOI 10.1111/liv.13156; Pol S, 2016, J HEPATOL, V65, P734, DOI DOI 10.1016/J.JHEP.2016.05.045; Prenner S, 2017, J HEPATOL; Rosen HR, 2017, HEPATOLOGY, V65, P341, DOI 10.1002/hep.28848; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simmons B, 2015, CLIN INFECT DIS, V61, P730, DOI 10.1093/cid/civ396; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; van der Meer AJ, 2014, JAMA-J AM MED ASSOC, V312, P1927, DOI 10.1001/jama.2014.12627; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; WHO, GLOB HLTH SECT STRAT; World Health Organization, HEPATITIS C; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	35	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185728	10.1371/journal.pone.0185728	http://dx.doi.org/10.1371/journal.pone.0185728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977040	Green Submitted, gold, Green Published			2022-12-27	WOS:000412163100039
J	Myung, DS; Kweon, SS; Lee, J; Shin, IS; Kim, SW; Seo, GS; Kim, HS; Joo, YE				Myung, Dae-Seong; Kweon, Sun-Seog; Lee, Jun; Shin, Ik-Sang; Kim, Sang-Wook; Seo, Geom-Seog; Kim, Hyun-Soo; Joo, Young-Eun			Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID)	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; TERM-FOLLOW-UP; MUCOSAL RESECTION; CLINICAL-OUTCOMES; NEOPLASIA; CANCER; PREVALENCE; PROGNOSIS; SUBTYPES; STRATEGY	Background and aims Laterally spreading colorectal tumors (LSTs) are divided into four subtypes, including homogenous (HG), nodular mixed (NM), flat elevated (FE), and pseudo-depressed (PD), based on their different endoscopic morphologies. The aim of this study was to investigate the clinicopathological significance of LST subtypes and their association with advanced histology. Methods We investigated the medical records of consecutive patients with LST who initially underwent endoscopic resection at five university hospitals in Honam province of South Korea between January 2012 and December 2013. A total of 566LST lesions removed via endoscopic procedures were collected retrospectively for data analysis. Results The PD, FE, and NM subtypes were more common in the distal colon and the HG subtype in the proximal colon. The PD subtype had the biggest tumor size, followed by the NM subtype. The frequency of adenomatous pit pattern was significantly higher in the HG, NM, and FE subtypes than in the PD subtype. In contrast, the frequency of cancerous pit pattern was significantly higher in the PD subtype than in the other three subtypes. The rate of advanced histology (high-grade dysplasia or carcinoma) among the LSTs was 36.0%. The risk of advanced histology increased in the distal colon compared with the proximal colon. The PD subtype had the highest incidence of villous component, advanced histology, submucosal invasion, and postprocedure perforation among the four subtypes. The distal colon as tumor site, larger tumor size, PD subtype, and villous component were associated with a statistically significant increased risk of advanced histology. Conclusion Our results indicate that the location, size, endoscopic subtype, and histologic component of the LSTs are associated with an increased risk of advanced histology. Therefore, these clinicopathological parameters may be useful in selecting therapeutic strategies in the clinical setting.	[Myung, Dae-Seong; Kim, Hyun-Soo; Joo, Young-Eun] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Med Sch, Dept Prevent Med, Gwangju, South Korea; [Lee, Jun] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea; [Shin, Ik-Sang; Kim, Sang-Wook] Chonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea; [Seo, Geom-Seog] Wonkwang Univ, Coll Med, Dept Internal Med, Iksan, South Korea	Chonnam National University; Chonnam National University; Chosun University; Jeonbuk National University; Wonkwang University	Joo, YE (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea.	yejoo@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021; Lee, Jun/AAC-6941-2022	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Jun/0000-0002-8060-9646				Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Choi Y, 2017, SEMIN ONCOL, V44, P34, DOI 10.1053/j.seminoncol.2017.02.002; Cong ZJ, 2016, GASTROINTEST ENDOSC, V83, P800, DOI 10.1016/j.gie.2015.08.043; De Ceglie A, 2016, CRIT REV ONCOL HEMAT, V104, P138, DOI 10.1016/j.critrevonc.2016.06.008; Dixon MF, 2002, GUT, V51, P130, DOI 10.1136/gut.51.1.130; Facciorusso A, 2015, WORLD J GASTROENTERO, V21, P5149, DOI 10.3748/wjg.v21.i17.5149; Hamilton SR, 2000, WHO CLASSIFICATION T, P314; Huang YL, 2009, INT J COLORECTAL DIS, V24, P1441, DOI 10.1007/s00384-009-0749-4; Imai K, 2014, SURG ENDOSC, V28, P2167, DOI [10.1007/s00464-014-3855-5, 10.1007/s00464-014-3449-2]; Jung DH, 2015, GASTROINTEST ENDOSC, V81, P614, DOI 10.1016/j.gie.2014.09.001; Kaku E, 2011, CLIN GASTROENTEROL H, V9, P503, DOI 10.1016/j.cgh.2011.03.018; Kim BC, 2011, ENDOSCOPY, V43, P100, DOI 10.1055/s-0030-1256027; Kim KO, 2013, INT J COLORECTAL DIS, V28, P1661, DOI 10.1007/s00384-013-1741-6; Kobayashi N, 2009, J GASTROEN HEPATOL, V24, P1387, DOI 10.1111/j.1440-1746.2009.05893.x; Kudo S, 2001, ENDOSCOPY, V33, P367; Kudo Shin-ei, 2008, Gastrointest Endosc Clin N Am, V18, P581, DOI 10.1016/j.giec.2008.05.013; Lambert R, 2012, EUR J GASTROEN HEPAT, V24, P1123, DOI 10.1097/MEG.0b013e328355e2d9; Mahasneh A, 2017, EXP MOL PATHOL, V102, P475, DOI 10.1016/j.yexmp.2017.05.005; Metz AJ, 2013, EUR J GASTROEN HEPAT, V25, P319, DOI 10.1097/MEG.0b013e32835b57e7; Miyamoto H, 2014, INT J COLORECTAL DIS, V29, P1069, DOI 10.1007/s00384-014-1931-x; Nishiyama H, 2010, SURG ENDOSC, V24, P2881, DOI 10.1007/s00464-010-1071-5; Oka S, 2009, DIGEST ENDOSC, V21, pS43, DOI 10.1111/j.1443-1661.2009.00869.x; Rotondano G, 2011, ENDOSCOPY, V43, P856, DOI 10.1055/s-0030-1256639; Saito Y, 2007, GASTROINTEST ENDOSC, V66, P966, DOI 10.1016/j.gie.2007.02.053; Sugimoto T, 2010, INT J CANCER, V127, P1562, DOI 10.1002/ijc.25180; Tantau AI, 2008, J GASTROINTEST LIVER, V17, P419; Terasaki M, 2012, J GASTROEN HEPATOL, V27, P734, DOI 10.1111/j.1440-1746.2011.06977.x; Toyonaga T, 2010, ENDOSCOPY, V42, P714, DOI 10.1055/s-0030-1255654; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Xu MD, 2013, INT J COLORECTAL DIS, V28, P63, DOI 10.1007/s00384-012-1543-2; Yoon JY, 2013, SURG ENDOSC, V27, P487, DOI 10.1007/s00464-012-2462-6; Zhao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094552	32	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184205	10.1371/journal.pone.0184205	http://dx.doi.org/10.1371/journal.pone.0184205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977010	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100005
J	Faria, NS; Urbano, JJ; Santos, IR; Silva, AS; Perez, EA; Souza, AH; Nascimento, OA; Jardim, JR; Insalaco, G; Oliveira, LVF; Stirbulov, R				Faria Junior, Newton Santos; Urbano, Jessica Julioti; Santos, Israel Reis; Silva, Anderson Soares; Perez, Eduardo Araujo; Souza, Angela Honda; Nascimento, Oliver Augusto; Jardim, Jose Roberto; Insalaco, Giuseppe; Franco Oliveira, Luis Vicente; Stirbulov, Roberto			Evaluation of obstructive sleep apnea in non-cystic fibrosis bronchiectasis: A crosssectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; DAYTIME SLEEPINESS; PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; SYMPTOMS; ADULTS; EPIDEMIOLOGY; ASSOCIATION; PREDICTORS; MORTALITY	The relationship between sleep disorders and bronchiectasis has not been well described. We hypothesize that, due to the irreversible dilatation of the bronchi, the presence of secretions, and airflow obstruction, patients with non-cystic fibrosis bronchiectasis may be predisposed to hypoxemia during sleep, or to symptoms that may lead to arousal. A cross-sectional observational study was performed involving 49 patients with a clinical diagnosis of non-cystic fibrosis bronchiectasis (NCFB). All patients underwent clinical evaluation, spirometry, and polysomnography, and were evaluated for the presence of excessive daytime sleepiness (EDS) and risk of obstructive sleep apnea (OSA). The mean age of the participants was 50.3 +/- 13.6 years; 51.1% of patients were male and had a mean body mass index of 23.8 +/- 3.4 kg/m(2). The mean total sleep time (TST) was 325.15 +/- 64.22 min with a slight reduction in sleep efficiency (84.01 +/- 29.2%). Regarding sleep stages, stage 1 sleep and REM sleep were abnormal. OSA was present in 40.82% of the patients. The mean arousal index was 5.6 +/- 2.9/h and snoring was observed in 71.43% of the patients. The oxygen desaturation index (ODI) was 14.35 +/- 15.36/h, mean minimum oxygen saturation (SpO(2) nadir) was 83.29 +/- 7.99%, and mean TST with an SpO(2) less than 90% was 30.21 +/- 60.48 min. EDS was exhibited by 53.06% of the patients and 55.1% were at high risk of developing OSA. The patients infected by Pseudomonas aeruginosa had higher apnea-hypopnea indices, ODI, and TST with SpO(2) < 90%, and lower values of SpO(2) nadir. Adult patients with clinically stable NCFB, especially those infected by Pseudomonas aeruginosa, display EDS and a high prevalence of OSA, associated with considerable oxygen desaturation during sleep.	[Faria Junior, Newton Santos; Perez, Eduardo Araujo; Stirbulov, Roberto] Santa Casa Sao Paulo Sch Med Sci, FCMSCSP, Masters Degree & PhD Program Surg Res, Sao Paulo, SP, Brazil; [Urbano, Jessica Julioti; Santos, Israel Reis; Silva, Anderson Soares] Nove de Julho Univ UNINOVE, Rehabil Sci Masters Degree & PhD Program, Sao Paulo, SP, Brazil; [Souza, Angela Honda; Nascimento, Oliver Augusto; Jardim, Jose Roberto] Univ Fed Sao Paulo, Pulm Rehabil Ctr, UNIFESP, Sao Paulo, Brazil; [Insalaco, Giuseppe] Natl Res Council Italy, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, SI, Italy; [Franco Oliveira, Luis Vicente] Univ Ctr Anapolis UniEVANGELICA, Med Sch, Anapolis, Go, Brazil	Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Centro Universitario de Anapolis	Faria, NS (corresponding author), Santa Casa Sao Paulo Sch Med Sci, FCMSCSP, Masters Degree & PhD Program Surg Res, Sao Paulo, SP, Brazil.	nsdfj@yahoo.com.br	Nascimento, Oliver A./B-3039-2011; Júnior, Newton Santos Faria/K-7191-2016; Oliveira, Luis V F/K-8838-2013; Santos, Israel dos Reis dos/AAQ-8941-2021; Insalaco, Giuseppe/AAY-3841-2020	Nascimento, Oliver A./0000-0003-3138-2219; Júnior, Newton Santos Faria/0000-0002-6817-2576; Oliveira, Luis V F/0000-0002-3852-9415; 	Nove de Julho University (Sao Paulo, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [313053/2014-6]; JJU; EAP; ASS; CAPES	Nove de Julho University (Sao Paulo, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); JJU; EAP; ASS; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The sleep laboratory received funding from the Nove de Julho University (Sao Paulo, Brazil). LVFO receive grants of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research productivity modality PQIB; process no. 313053/2014-6) and JJU, EAP, ASS and NSFJ receive grants by CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; American Academy of Sleep Medicine, 2007, AASM MAN SCOR SLEEP; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Bouka A, 2012, RESP MED, V106, P1244, DOI 10.1016/j.rmed.2012.06.010; Boyton RJ, 2012, MEDICINE, V40, P267, DOI DOI 10.1016/J.MPMED.2012.02.003; BRADLEY TD, 1986, AM REV RESPIR DIS, V134, P920, DOI 10.1164/arrd.1986.134.5.920; CHAOUAT A, 1995, AM J RESP CRIT CARE, V151, P82, DOI 10.1164/ajrccm.151.1.7812577; COOKE JC, 1987, THORAX, V42, P272, DOI 10.1136/thx.42.4.272; Dancey DR, 2002, EUR RESPIR J, V19, P504, DOI 10.1183/09031936.02.00088702; Erdem E, 2011, PEDIATR PULM, V46, P919, DOI 10.1002/ppul.21454; Fan LC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0872-5; Faria NS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008183; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gao Y, 2014, PLOS ONE, V9, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10; Guan WJ, 2015, J THORAC DIS, V7, P625, DOI 10.3978/j.issn.2072-1439.2015.04.04; Jankelowitz L, 2005, CHEST, V127, P1593, DOI 10.1378/chest.127.5.1593; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Katz ES, 2014, CLIN CHEST MED, V35, P495, DOI 10.1016/j.ccm.2014.06.005; Kim Jung-Soo, 2007, COPD, V4, P163, DOI 10.1080/15412550701341228; King P, 2011, PAEDIATR RESPIR REV, V12, P104, DOI 10.1016/j.prrv.2010.10.011; KLINK ME, 1994, CHEST, V105, P151, DOI 10.1378/chest.105.1.151; Krishnan V, 2008, CHEST, V134, P693, DOI 10.1378/chest.08-0173; Lambrecht BN, 2011, EUR RESPIR MONOGR, P11, DOI 10.1183/1025448x.10003210; Larsson LG, 2001, RESP MED, V95, P423, DOI 10.1053/rmed.2001.1054; Loebinger MR, 2009, EUR RESPIR J, V34, P843, DOI 10.1183/09031936.00003709; Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC; Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739; Martinez-Garcia MA, 2014, EUR RESPIR J, V43, P1357, DOI 10.1183/09031936.00026313; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Milross Maree A, 2002, Sleep Med, V3, P205, DOI 10.1016/S1389-9457(01)00157-5; Moreira José da Silva, 2003, J. Pneumologia, V29, P258, DOI 10.1590/S0102-35862003000500003; NAIDICH DP, 1982, J COMPUT ASSIST TOMO, V6, P437, DOI 10.1097/00004728-198206000-00001; Naqvi SK, 2008, SLEEP BREATH, V12, P77, DOI 10.1007/s11325-007-0123-0; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; O'Donnell AE, 2008, CHEST, V134, P815, DOI 10.1378/chest.08-0776; O'Donnell AE, 2012, CLIN CHEST MED, V33, P381, DOI 10.1016/j.ccm.2012.03.005; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pereira CAC, 2002, J PNEUMOL S3, V28, pS1; Perin C, 2012, SLEEP BREATH, V16, P1041, DOI 10.1007/s11325-011-0599-5; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.12273; Santos Carlos Eduardo Ventura Gaio dos, 2003, J. Pneumologia, V29, P69, DOI 10.1590/S0102-35862003000200005; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Scharf SM, 2011, INT J CHRONIC OBSTR, V6, P1, DOI 10.2147/COPD.S15666; Shen TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128461; Slater G, 2012, J THORAC DIS, V4, P608, DOI 10.3978/j.issn.2072-1439.2012.10.07; Stranges S, 2012, SLEEP, V35, P1173, DOI 10.5665/sleep.2012; Tufik S, 2010, SLEEP MED, V11, P441, DOI 10.1016/j.sleep.2009.10.005; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Venkateswaran S, 2014, SINGAP MED J, V55, P488, DOI 10.11622/smedj.2014117; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weitzenblum E, 2004, SLEEP MED REV, V8, P281, DOI 10.1016/j.smrv.2004.03.006; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed; Wong C, 2012, LANCET, V380, P660, DOI 10.1016/S0140-6736(12)60953-2; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zen V, 2012, AM J CARDIOVASC DIS, V2, P323	66	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185413	10.1371/journal.pone.0185413	http://dx.doi.org/10.1371/journal.pone.0185413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972989	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900016
J	Leandro-Munoz, ME; Tixier, P; Germon, A; Rakotobe', V; Phillips-Moral, W; Maximova, S; Avelino, J				Leandro-Munoz, Mariela E.; Tixier, Philippe; Germon, Amandine; Rakotobe', Veromanitra; Phillips-Moral, Wilbert; Maximova, Siela; Avelino, Jacques			Effects of microclimatic variables on the symptoms and signs onset of Moniliophthora roreri, causal agent of Moniliophthora pod rot in cacao	PLOS ONE			English	Article							MONILIA-RORERI; FROSTY POD; COCOA; TEMPERATURE; DISEASES; ECUADOR; MODELS; LATENT	Moniliophthora Pod Rot (MPR) caused by the fungus Moniliophthora roreri (Cif.) Evans et al., is one of the main limiting factors of cocoa production in Latin America. Currently insufficient information on the biology and epidemiology of the pathogen limits the development of efficient management options to control MPR. This research aims to elucidate MPR development through the following daily microclimatic variables: minimum and maximum temperatures, wetness frequency, average temperature and relative humidity in the highly susceptible cacao clone Pound-7 (incidence = 86% 2008-2013 average). A total of 55 cohorts totaling 2,268 pods of 3-10 cm length, one to two months of age, were tagged weekly. Pods were assessed throughout their lifetime, every one or two weeks, and classified in 3 different categories: healthy, diseased with no sporulation, diseased with sporulating lesions. As a first step, we used Generalized Linear Mixed Models (GLMM) to determine with no a priori the period (when and for how long) each climatic variable was better related with the appearance of symptoms and sporulation. Then the significance of the candidate variables was tested in a complete GLMM. Daily average wetness frequency from day 14 to day 1, before tagging, and daily average maximum temperature from day 4 to day 21, after tagging, were the most explanatory variables of the symptoms appearance. The former was positively linked with the symptoms appearance when the latter exhibited a maximum at 30 degrees C. The most important variables influencing sporulation were daily average minimum temperature from day 35 to day 58 and daily average maximum temperature from day 37 to day 48, both after tagging. Minimum temperature was negatively linked with the sporulation while maximum temperature was positively linked. Results indicated that the fungal microclimatic requirements vary from the early to the late cycle stages, possibly due to the pathogen's long latent period. This information is valuable for development of new conceptual models for MPR and improvement of control methods.	[Leandro-Munoz, Mariela E.; Tixier, Philippe; Phillips-Moral, Wilbert; Avelino, Jacques] Trop Agr Res & Higher Educ Ctr, Div Res & Dev, Agroforestry & Sustainable Agr Dept, Turrialba, Cartago, Costa Rica; [Tixier, Philippe] CIRAD, UPR GECO, Montpellier, France; [Germon, Amandine] ENSAIA, Vandoeuvre Les Nancy, France; [Germon, Amandine; Rakotobe', Veromanitra; Avelino, Jacques] CIRAD, UPR Bioagresseurs, Montpellier, France; [Rakotobe', Veromanitra] AgroSup Dijon, Dijon, France; [Maximova, Siela] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Avelino, Jacques] IICA PROMECAFE, Guatemala City, Guatemala	CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CIRAD; Universite de Lorraine; CIRAD; Institut Agro; AgroSup Dijon; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Leandro-Munoz, ME (corresponding author), Trop Agr Res & Higher Educ Ctr, Div Res & Dev, Agroforestry & Sustainable Agr Dept, Turrialba, Cartago, Costa Rica.	mleandro@catie.ac.cr	Tixier, Philippe/C-2119-2008; Germon, Amandine/M-4403-2015; Avelino, Jacques/C-5624-2009	Tixier, Philippe/0000-0001-5147-9777; Germon, Amandine/0000-0001-8687-294X; Avelino, Jacques/0000-0003-1983-9431; Leandro-Munoz, Mariela E./0000-0001-6153-8662	Centre de cooperation internationale en recherche agronomique pour le developpement	Centre de cooperation internationale en recherche agronomique pour le developpement	This research was fully funded by Centre de cooperation internationale en recherche agronomique pour le developpement, http://www.cirad.fr/, within the framework of the doctoral thesis of ML, with the co-advising of JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AMPUERO C. E., 1967, Cocoa Growers' Bulletin, P15; Anco DJ, 2013, PLANT DIS, V97, P579, DOI 10.1094/PDIS-07-12-0666-RE; Aranzazu LF, 2000, SCOBA BRUJA COLOMBIA, P85; AYLOR DE, 1990, ANNU REV PHYTOPATHOL, V28, P73, DOI 10.1146/annurev.py.28.090190.000445; Barros Nieves O., 1977, C INT INV CAC; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bejarano Villacreces G., 1961, METODOS INOCULACION; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowers J.H., 2001, PLANT HLTH PROGR; Bugaud C, 2015, J SCI FOOD AGR; Campuzano H., 1981, 8 INT COC RES C CART, P493; Campuzano Londono H., 1980, CACAOTERO COLOMBIANO, P21; Carval D, 2015, J APPL ENTOMOL, V139, P510, DOI 10.1111/jen.12190; Castro O., 1989, 8 C AGR NAC 1989 SAN, P29; Chacin L., 1975, ALGUNOS ASPECTOS BIO; Desrosiers R, 1957, 6 C INT CAC, P331; Desrosiers R, 1974, MONILIA POD ROT CACA, P273; Enriquez G, 2004, CACAO ORGANICO GUIA, P360; Evans H. C., 1981, Phytopathological Papers; EVANS H C, 1977, PANS (Pest Articles and News Summaries), V23, P68; EVANS HC, 1978, CAN J BOT, V56, P2528, DOI 10.1139/b78-305; EVANS HC, 1987, OUTLOOK AGR, V16, P35, DOI 10.1177/003072708701600106; Galindo J., 1985, 25 REUN AN AM PHYT S; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Garrett KA, 2004, PHYTOPATHOLOGY, V94, P999, DOI 10.1094/PHYTO.2004.94.9.999; Hawker L.E., 1950, PHYSL OF FUNGI; Herrera F., 1986, U AGR NAC C SOC AM C; Herrera F., 1988, EFECTO FACTORES NUTR; Holdridge LR, 1967, LIFE ZONE ECOLOGY; ICCO, 2014, ICCO ANN REP 2012 20; Lalancette N, 2003, PHYTOPATHOLOGY, V93, P1165, DOI 10.1094/PHYTO.2003.93.9.1165; Leach AW, 2002, CROP PROT, V21, P317, DOI 10.1016/S0261-2194(01)00148-X; LOPEZ F. R., 1954, Cacao en Colombia, V3, P183; Lopez-Bravo DF, 2012, CROP PROT, V38, P21, DOI 10.1016/j.cropro.2012.03.011; Maddison AC, 1995, PLANT PATHOL, V44, P982, DOI 10.1111/j.1365-3059.1995.tb02657.x; Merchan V. V. M., 1981, Cacaotero Colombiano, P26; Merchan VM, 1978, FITOPATOLOGIA COLOMB, V7, P127; Naundorf G., 1954, CONTRIBUCIONES PROBL; Ndoumbe-Nkeng M, 2009, CAN J PLANT PATHOL, V31, P309, DOI 10.1080/07060660909507605; Phillips W., 1986, EVALUACION RESISTENC; Phillips-Mora W., 2013, CATALOGUE CACAO CLON; Phillips-Mora W, 2006, 15 INT COC RES C SAN; Phillips-Mora W, 2003, THESIS U READING REA; PHILLIPSMORA W, 2007, PHYTOPATHOLOGY, V97, P1644, DOI DOI 10.1094/PHYTO-97-12-1644; PORRAS VH, 1985, PHYTOPATHOLOGY, V75, P1178; Porras VH, 1998, AVANCE MONILIASIS CA; Ram A, 1989, THESIS U LONDON LOND; Rorer JB, 1918, ENFERMEDADES PLAGAS, P17; SCHERM H, 1994, PHYTOPATHOLOGY, V84, P853, DOI 10.1094/Phyto-84-853; Schmitz WH, 1984, STUDIES ATLANTIC COA; Suarez C., 1971, ESTUDIO MECANISMO PE; Thevenin JM, 1996, MONILIOSE CACAOYER M, P397; TOMERLIN JR, 1983, PHYTOPATHOLOGY, V73, P414, DOI 10.1094/Phyto-73-414; de la Cruz MT, 2011, J PLANT PATHOL, V93, P31; Zuur Alain F., 2009, P1; [No title captured]; [No title captured]	58	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184638	10.1371/journal.pone.0184638	http://dx.doi.org/10.1371/journal.pone.0184638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972981	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900006
J	Oklander, LI; Mino, CI; Fernandez, G; Caputo, M; Corach, D				Ines Oklander, Luciana; Isabel Mino, Carolina; Fernandez, Gabriela; Caputo, Mariela; Corach, Daniel			Genetic structure in the southernmost populations of black-and-gold howler monkeys (Alouatta caraya) and its conservation implications	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; HABITAT FRAGMENTATION; MICROSATELLITE LOCI; GUARIBA-CLAMITANS; ATLANTIC FOREST; SOFTWARE; SIZE; GROWTH; DEFORESTATION; NEUTRALITY	Black-and-gold howler monkeys Alouatta caraya, are arboreal primates, inhabitants of Neotropical forests, highly susceptible to the yellow fever virus, considered early 'sentinels' of outbreaks, and thus, of major epidemiological importance. Currently, anthropogenic habitat loss and modifications threatens their survival. Habitat modification can prevent, reduce or change dispersal behavior, which, in turn, may influence patterns of gene flow. We explored past and contemporary levels of genetic diversity, elucidated genetic structure and identified its possible drivers, in ten populations (n = 138) located in the southernmost distribution range of the species in South America, in Argentina and Paraguay. Overall, genetic variability was moderate (ten microsatellites: 3.16 +/- 0.18 alleles per locus, allelic richness of 2.93 +/- 0.81, 0.443 +/- 0.025 unbiased expected heterozygosity; 22 haplotypes of 491-bp mitochondrial Control Region, haplotypic diversity of 0.930 +/- 0.11, and nucleotide diversity of 0.01 +/- 0.007). Significant evidence of inbreeding was found in a population that was, later, decimated by yellow fever. Population-based gene flow measures (FST = 0.13;. ST = 018), hierarchical analysis of molecular variance and Bayesian clustering methods revealed significant genetic structure, grouping individuals into four clusters. Shared haplotypes and lack of mitochondrial differentiation (non-significant. ST) among some populations seem to support the hypothesis of historical dispersal via riparian forests. Current resistance analyses revealed a significant role of landscape features in modeling contemporary gene flow: continuous forest and riparian forests could promote genetic exchange, whereas disturbed forests or crop/grassland fields may restrict it. Estimates of effective population size allow anticipating that the studied populations will lose 75% of heterozygosity in less than 50 generations. Our findings suggest that anthropogenic modifications on native forests, increasingly ongoing in Northeastern Argentina, Southern Paraguay and Southeastern Brazil, might prevent the dispersal of howlers, leading to population isolation. To ensure long-term viability and maintain genetic connectivity of A. caraya remnant populations, we recommend preserving and restoring habitat continuity. To conserve the species genetic pool, as well, the four genetic clusters identified here should be considered separate Management Units and given high conservation priority. In light of our findings and considering complementary non-genetic information, we suggest upgrading the international conservation status of A. caraya to "Vulnerable".	[Ines Oklander, Luciana; Isabel Mino, Carolina] Univ Nacl Misiones UNaM, CONICET, Inst Biol Subtrop IBS, Nodo Iguazu, Puerto Iguazu, Misiones, Argentina; [Ines Oklander, Luciana; Isabel Mino, Carolina] Asociac Civil Ctr Invest Bosque Atlantico CeIBA, Puerto Iguazu, Misiones, Argentina; [Ines Oklander, Luciana; Isabel Mino, Carolina; Fernandez, Gabriela] Univ Nacl Noroeste Prov Buenos Aires UNNOBA, CONICET, Ctr Bioinvest CeBio, Buenos Aires, DF, Argentina; [Caputo, Mariela; Corach, Daniel] Univ Buenos Aires, CONICET, Fac Farm & Bioquim, Serv Huellas Digitales Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Oklander, LI (corresponding author), Univ Nacl Misiones UNaM, CONICET, Inst Biol Subtrop IBS, Nodo Iguazu, Puerto Iguazu, Misiones, Argentina.; Oklander, LI (corresponding author), Asociac Civil Ctr Invest Bosque Atlantico CeIBA, Puerto Iguazu, Misiones, Argentina.; Oklander, LI (corresponding author), Univ Nacl Noroeste Prov Buenos Aires UNNOBA, CONICET, Ctr Bioinvest CeBio, Buenos Aires, DF, Argentina.	lioklander@conicet.gov.ar	Miño, Carolina Isabel/K-7120-2019; Oklander, Luciana/O-6818-2019	Oklander, Luciana/0000-0003-1751-6313; Mino, Carolina Isabel/0000-0002-9098-583X	PIP CONICET Research Grant [114 201101 00322]	PIP CONICET Research Grant	This project was funded by a PIP CONICET Research Grant to LIO (no. 114 201101 00322; www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamack AT, 2014, METHODS ECOL EVOL, V5, P384, DOI 10.1111/2041-210X.12158; Agostini I., 2012, LIBRO ROJO MAMIFEROS, P81; Agostini I, 2015, INT J PRIMATOL, V36, P244, DOI 10.1007/s10764-015-9821-9; Aguirre LF, 2009, LIBRO ROJO FAUNA SIL, P204; Alfaro JWL, 2015, MOL PHYLOGENET EVOL, V82, P518, DOI 10.1016/j.ympev.2014.09.027; Allendorf FW, 2010, CONSERV GENET, P587; Anderson DE, 2013, GLOBAL ENV QUATERNAR, V2, P424; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Ascunce MS, 2007, MOL PHYLOGENET EVOL, V43, P202, DOI 10.1016/j.ympev.2006.10.004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Bauni V., 2015, REMOTE SENSING APPL, V1, P50, DOI [10.1016/J.RSASE.2015.06.003, DOI 10.1016/J.RSASE.2015.06.003]; Bicca-Marques JC, 2013, PRIMATES FRAGMENTS C, P283; Bicca-Marques JC, 2017, SCI ADV E LETT; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Boletta PE, 2006, FOREST ECOL MANAG, V228, P108, DOI 10.1016/j.foreco.2006.02.045; Brown A., 1994, VIDA SILVESTRE NEOTR, V3, P30; Chiappero MB, 2016, J MAMMAL, V97, P424, DOI 10.1093/jmammal/gyv186; Soto-Calderon ID, 2014, MOL PHYLOGENET EVOL, V81, P61, DOI 10.1016/j.ympev.2014.08.018; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Estrada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600946; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez-Duque E., 2008, IUCN RED LIST THREAT; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Fu YX, 1997, GENETICS, V147, P915; Goncalves EC, 2004, MOL ECOL NOTES, V4, P406, DOI 10.1111/j.1471-8286.2004.00667.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green M. R., 2012, MOL CLONING LAB MANU, V4, P47; Groves CP., 2005, MAMMAL SPECIES WORLD, P148; HARPENDING HC, 1994, HUM BIOL, V66, P591; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Holzmann I, 2010, AM J PRIMATOL, V72, P475, DOI 10.1002/ajp.20796; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Gasparri NI, 2009, FOREST ECOL MANAG, V258, P913, DOI 10.1016/j.foreco.2009.02.024; Oklander LI, 2010, INT J PRIMATOL, V31, P813, DOI 10.1007/s10764-010-9430-6; Kean S, 2017, SCIENCE, V357, P637, DOI 10.1126/science.357.6352.637; Kowalewski MM, 2010, AM J PRIMATOL, V72, P734, DOI 10.1002/ajp.20838; Lecompte E, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22660; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Ludwig G, 1812, AVALIAC ALOUATTA CAR, P1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Milton K, 2009, CONSERV GENET, V10, P347, DOI 10.1007/s10592-008-9584-3; Moreno ES, 2015, MEM I OSWALDO CRUZ, V110, P865, DOI 10.1590/0074-02760150075; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Oklander LI, 2007, MOL ECOL NOTES, V7, P117, DOI 10.1111/j.1471-8286.2006.01529.x; Oklander Luciana Ines, 2004, Neotropical Primates, V12, P59; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paviolo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37147; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R Core Team, 2021, R LANGUAGE ENV STAT; Ramesh V, 2017, BIOL CONSERV, V210, P205, DOI 10.1016/j.biocon.2017.03.019; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Grau HR, 2008, ECOL SOC, V13; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Garcia M, 2016, PHYLOGENY MOL POPULA, P669; RUMIZ DI, 1990, AM J PRIMATOL, V21, P279, DOI 10.1002/ajp.1350210404; Silva FE, 2013, DEV PRIMATOL-PROG PR, P137, DOI 10.1007/978-1-4614-8839-2_10; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Belle S, 2012, AM J PRIMATOL, V74, P948, DOI 10.1002/ajp.22047; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigilant L, 2009, PRIMATES, V50, P105, DOI 10.1007/s10329-008-0124-z; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang WR, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22635; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Willoughby JR, 2015, BIOL CONSERV, V191, P495, DOI 10.1016/j.biocon.2015.07.025; Winkler LA, 2004, INT J PRIMATOL, V25, P197, DOI 10.1023/B:IJOP.0000014650.86577.b4; Zunino G. E., 2001, PRIMATE REPORT; Zunino GE, 2007, AM J PRIMATOL, V69, P966, DOI 10.1002/ajp.20389	82	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185867	10.1371/journal.pone.0185867	http://dx.doi.org/10.1371/journal.pone.0185867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968440	Green Submitted, gold, Green Published			2022-12-27	WOS:000412029600062
J	Rosset, C; Vairo, F; Bandeira, IC; Correia, RL; de Goes, FV; da Silva, RTB; Bueno, LSM; Gomes, MCSD; Galvao, HDCR; Neri, JICF; Achatz, MI; Netto, CBO; Ashton-Prolla, P				Rosset, Clevia; Vairo, Filippo; Bandeira, Isabel Cristina; Correia, Rudinei Luis; de Goes, Fernanda Veiga; Boy da Silva, Raquel Tavares; Mario Bueno, Larissa Souza; Silva de Miranda Gomes, Mireille Caroline; Reis Galvao, Henrique de Campos; Neri, Joao I. C. F.; Achatz, Maria Isabel; Oliveira Netto, Cristina Brinckmann; Ashton-Prolla, Patricia			Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis	PLOS ONE			English	Article							MUTATIONAL ANALYSIS; CONSENSUS CONFERENCE; COMPLEX; IDENTIFICATION; SEVERITY; GENETICS; DISEASE	Tuberous sclerosis complex (TSC) is an autosomal dominant multisystem disorder characterized by the development of multiple hamartomas in many organs and tissues. It occurs due to inactivating mutations in either of the two genes, TSC1 and TSC2, following a second hit in a tumor suppressor gene in most hamartomas. Comprehensive screening for mutations in both the TSC1 and TSC2 loci has been performed in several cohorts of patients and a broad spectrum of pathogenic mutations have been described. In Brazil, there is no data regarding incidence and prevalence of tuberous sclerosis and mutations in TSC1 and TSC2. We analyzed both genes in 53 patients with high suspicion of tuberous sclerosis using multiplex-ligation dependent probe amplification and a customized next generation sequencing panel. Confirmation of all variants was done by the Sanger method. We identified 50 distinct variants in 47 (89%) of the patients. Five were large rearrangements and 45 were point mutations. The symptoms presented by our series of patients were not different between male and female individuals, except for the more common occurrence of shagreen patch in women (p = 0.028). In our series, consistent with other studies, TSC2 mutations were associated with a more severe phenotypic spectrum than TSC1 mutations. This is the first study that sought to characterize the molecular spectrum of Brazilian individuals with tuberous sclerosis.	[Rosset, Clevia; Bandeira, Isabel Cristina; Correia, Rudinei Luis; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Lab Med Genom, Porto Alegre, RS, Brazil; [Rosset, Clevia; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Vairo, Filippo; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil; [de Goes, Fernanda Veiga] Fundacao Osvaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, RJ, Brazil; [Boy da Silva, Raquel Tavares] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil; [Mario Bueno, Larissa Souza] Complexo Hosp Prof Edgard Santos, Salvador, BA, Brazil; [Silva de Miranda Gomes, Mireille Caroline] Univ Estadual Campinas, Hosp Clin, Campinas, SP, Brazil; [Reis Galvao, Henrique de Campos] Hosp Canc Barretos, Barretos, SP, Brazil; [Neri, Joao I. C. F.] Ctr Especializado Reabilitacao & Habilitacao, Natal, RN, Brazil; [Achatz, Maria Isabel] AC Camargo Canc Ctr, Sao Paulo, SP, Brazil; [Achatz, Maria Isabel] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA; [Oliveira Netto, Cristina Brinckmann; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Estadual de Campinas; Hospital de Cancer de Barretos; A.C.Camargo Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal do Rio Grande do Sul	Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Lab Med Genom, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	pprolla@hcpa.edu.tr	Ashton-Prolla, Patricia/H-2927-2012; Rosset, Clévia/AFX-0221-2022; Ashton-Prolla, Patricia/T-3515-2019; Achatz, Maria Isabel/C-5751-2013	Achatz, Maria Isabel/0000-0001-6894-1219; Vairo, Filippo/0000-0001-6030-1903; VEIGA DE GOES, FERNANDA/0000-0001-9670-0631	Fundo de Incentivo a Pesquisa e Eventos (FIPE) of Hospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institute do Cancer Infantil (ICI)	Fundo de Incentivo a Pesquisa e Eventos (FIPE) of Hospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute do Cancer Infantil (ICI)	We would like to thank Fundo de Incentivo a Pesquisa e Eventos (FIPE) of Hospital de Clinicas de Porto Alegre, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Institute do Cancer Infantil (ICI) for financial support.	Aicher LD, 2001, J BIOL CHEM, V276, P21017, DOI 10.1074/jbc.C100136200; Aronow ME, 2012, OPHTHALMOLOGY, V119, P1917, DOI 10.1016/j.ophtha.2012.03.020; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Blyth M, 2010, J NEUROL NEUROSUR PS, V81, P350, DOI 10.1136/jnnp.2009.179689; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Gomez M. R., 1999, TUBEROUS SCLEROSIS C; Hoogeveen-Westerveld M, 2013, HUM MUTAT, V34, P167, DOI 10.1002/humu.22202; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Jagadeesh K, 2016, NATURE GENETICS; Jansen AC, 2006, ANN NEUROL, V60, P528, DOI 10.1002/ana.21037; Jones AC, 1999, AM J HUM GENET, V64, P1305, DOI 10.1086/302381; Kacerovska D, 2009, AM J DERMATOPATH, V31, P532, DOI 10.1097/DAD.0b013e3181970e44; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kothare SV, 2014, EPILEPSIA, V55, P1025, DOI 10.1111/epi.12680; Le Caignec C, 2009, EUR J HUM GENET, V17, P1165, DOI 10.1038/ejhg.2009.28; Longa L, 2001, HUM GENET, V108, P156, DOI 10.1007/s004390100460; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Napolioni V, 2008, CURR GENOMICS, V9, P475, DOI 10.2174/138920208786241243; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Qin JY, 2016, J BIOL CHEM, V291, P8591, DOI 10.1074/jbc.M115.701870; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Vail EA, 2009, CLIN GENET, V75, P282, DOI 10.1111/j.1399-0004.2008.01129.x; van Eeghen AM, 2013, EPILEPSY RES, V103, P83, DOI 10.1016/j.eplepsyres.2012.07.007; van Slegtenhorst M, 1998, HUM MOL GENET, V14, p401 ; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; You JB, 2013, INDIAN J DERMATOL VE, V79, P104, DOI 10.4103/0378-6323.104680	35	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185713	10.1371/journal.pone.0185713	http://dx.doi.org/10.1371/journal.pone.0185713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968464	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600038
J	Nguyen, VL; Truong, CT; Nguyen, BCQ; Vo, TNV; Dao, TT; Nguyen, VD; Trinh, DTT; Huynh, HK; Bui, CB				Van-Linh Nguyen; Cong-Tri Truong; Binh Cao Quan Nguyen; Thanh-Niem Van Vo; Trong-Thuc Dao; Van-Dan Nguyen; Dieu-Thuong Thi Trinh; Hieu Kim Huynh; Bui, Chi-Bao			Anti-inflammatory and wound healing activities of calophyllolide isolated from Calophyllum inophyllum Linn	PLOS ONE			English	Article							GROWTH-FACTOR; INFLAMMATION	Due to the high-cost and limitations of current wound healing treatments, the search for alternative approaches or drugs, particularly from medicinal plants, is of key importance. In this study, we report anti-inflammatory and wound healing activities of the major calophyllolide (CP) compound isolated from Calophyllum inophyllum Linn. The results showed that CP had no effect on HaCaT cell viability over a range of concentrations. CP reduced fibrosis formation and effectively promoted wound closure in mouse model without causing body weight loss. The underlying molecular mechanisms of wound repair by CP was investigated. CP markedly reduced MPO activity, and increased M2 macrophage skewing, as shown by up-regulation of M2-related gene expression, which is beneficial to the wound healing process. CP treatment prevented a prolonged inflammatory process by down-regulation of the pro-inflammatory cytokines D IL-1 beta, IL-6, TNF-alpha, but up-regulation of the anti-inflammatory cytokine, IL-10. This study is the first to indicate a plausible role for CP in accelerating the process of wound healing through anti-inflammatory activity mechanisms, namely, by regulation of inflammatory cytokines, reduction in MPO, and switching of macrophages to an M2 phenotype. These findings may enable the utilization of CP as a potent therapeutic for cutaneous wound healing.	[Van-Linh Nguyen] Can Tho Univ, Biotechnol Res & Dev Inst, Can Tho City, Vietnam; [Van-Linh Nguyen; Thanh-Niem Van Vo; Trong-Thuc Dao; Van-Dan Nguyen; Hieu Kim Huynh; Bui, Chi-Bao] Univ Med & Pharm Ho Chi Minh City, Ctr Mol Biomed, Lab Cutaneous Res, Ho Chi Minh City, Vietnam; [Cong-Tri Truong] Univ Med & Pharm Ho Chi Minh City, Fac Pharm, Nanoprod Lab, Ho Chi Minh City, Vietnam; [Binh Cao Quan Nguyen] CuuLong Delta Rice Res Inst, Genet & Plant Breeding Dept, Can Tho City, Vietnam; [Binh Cao Quan Nguyen] PAK Res Ctr, Okinawa, Okinawa, Japan; [Van-Dan Nguyen; Dieu-Thuong Thi Trinh] Univ Med & Pharm Ho Chi Minh City, Fac Tradit Med, Ho Chi Minh City, Vietnam	Can Tho University; Hochiminh City University of Medicine & Pharmacy; Hochiminh City University of Medicine & Pharmacy; Hochiminh City University of Medicine & Pharmacy	Bui, CB (corresponding author), Univ Med & Pharm Ho Chi Minh City, Ctr Mol Biomed, Lab Cutaneous Res, Ho Chi Minh City, Vietnam.	bcbao@ump.edu.vn	Bui, Bao/GYE-1294-2022; Bui, Bao Chi/ABH-2694-2020	Bui, Bao/0000-0002-7937-1634; Bui, Bao Chi/0000-0002-7937-1634; Nguyen, Van-Dan/0000-0001-6975-8897	Soc Trang Department of Science and Development, Viet Nam [21/H/SKHCN-QLKHCN]	Soc Trang Department of Science and Development, Viet Nam	This research was supported by a grant from Soc Trang Department of Science and Development, Viet Nam (21/H/SKHCN-QLKHCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A., 2017, MICROBIOL INFECT DIS, V51, P15; Abu-Seida Ashraf M, 2015, Vet Med Int, V2015, P672643, DOI 10.1155/2015/672643; ARORA RB, 1962, J PHARM PHARMACOL, V14, P534, DOI 10.1111/j.2042-7158.1962.tb11133.x; Asadi SY, 2013, INT J SURG, V11, P332, DOI 10.1016/j.ijsu.2013.02.014; BHALLA TN, 1980, INDIAN J MED RES, V72, P762; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Canesso MCC, 2014, J IMMUNOL, V193, P5171, DOI 10.4049/jimmunol.1400625; Chereddy KK, 2013, J CONTROL RELEASE, V171, P208, DOI 10.1016/j.jconrel.2013.07.015; Chong BF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0839-3; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; Ebaid H, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-31; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Han D, 2007, J MICROBIOL BIOTECHN, V17, P1661; Hasmann A, 2013, ANN CLIN BIOCHEM, V50, P245, DOI 10.1258/acb.2011.010249; Ito C, 2006, J PHARM PHARMACOL, V58, P975, DOI 10.1211/jpp.58.7.0013; Jinnin M, 2005, J CELL PHYSIOL, V202, P510, DOI 10.1002/jcp.20154; Johnstone Carolyn C, 2005, Nurs Stand, V19, P59; Kolomytkin OV, 2002, AM J PHYSIOL-CELL PH, V282, pC1254, DOI 10.1152/ajpcell.01166.2000; Leguillier T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138602; Liu WH, 2015, MOLECULES, V20, P12314, DOI 10.3390/molecules200712314; Loi DT, 2004, CALOPHYLLUM INOPHYLL, P106; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murthy S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/972028; Papakonstantinou E, 2003, CYTOKINE, V24, P25, DOI 10.1016/S1043-4666(03)00253-9; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Pazyar N, 2014, SKIN PHARMACOL PHYS, V27, P303, DOI 10.1159/000357477; Praveena C, 2013, NAT PROD CHEM RES, V1; Qian LW, 2016, WOUND REPAIR REGEN, V24, P26, DOI 10.1111/wrr.12381; Rohl J, 2015, WOUND PRACT RES, V23, P8; Shen YC, 2003, CHEM PHARM BULL, V51, P802, DOI 10.1248/cpb.51.802; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Strodtbeck F, 2001, NEWBORN INFANT NURS, V1, P43, DOI [10.1053/nbin.2001.23176, DOI 10.1053/NBIN.2001.23176]; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsai SC, 2012, ONCOL REP, V28, P1096, DOI 10.3892/or.2012.1873; Wang XJ, 2006, J INVEST DERM SYMP P, V11, P112, DOI 10.1038/sj.jidsymp.5650004; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yimdjo MC, 2004, PHYTOCHEMISTRY, V65, P2789, DOI 10.1016/j.phytochem.2004.08.024; Young A., 2011, SURGERY, V29, P475, DOI DOI 10.1016/J.MPSUR.2011.06.011; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	41	49	49	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185674	10.1371/journal.pone.0185674	http://dx.doi.org/10.1371/journal.pone.0185674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020015	gold, Green Submitted, Green Published			2022-12-27	WOS:000412754400041
J	Chen, JQ; Cai, WJ; Lin, Y; Chen, YM; Zheng, QF; Pan, JJ; Chen, CB				Chen, Junqiang; Cai, Wenjie; Lin, Yu; Chen, Yuanmei; Zheng, Qingfeng; Pan, Jianji; Chen, Chuanben			Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POSTOPERATIVE RADIOTHERAPY; CURATIVE RESECTION; GASTRIC-CANCER; SURVIVAL; RECURRENCE; THERAPY	Aim To determine the rate of abdominal lymph node metastasis after radical surgery for esophageal cancer and define the radiotherapy target area. Methods Of the 1593 patients who underwent R0 radical esophagectomy for thoracic esophageal squamous cell carcinoma (TE-SCC), 148 developed abdominal lymph node (LN) metastases within three years of surgery. During that time interval, patients were examined by various imaging methods (enhanced computer tomography, magnetic resonance imaging, and positron emission tomography-CT) at set time points. The emerging recurrence pattern, preferred sites for abdominal metastasis, and correlation with added clinical factors were carefully recorded, to permit for delineation of a target area for radiotherapy. Results We found postoperative metastatic abdominal LNs in 9.3% of the patients treated for esophageal cancer. Lesions in the upper, middle, and lower esophageal segments metastasized to abdominal LNs at 2.3%, 7.8%, and 26.6% (P < 0.0001), respectively. Of all cases, 4.8% had fewer than two affected LNs, while 20.1% had more than three metastatic LNs (P < 0.0001). The metastasis rates of negative and positive celiac LNs were 4.6% and 22.7%, respectively. Abdominal LN metastasis rates for the following LNs: 16a2 and 16a1 of paraaortic, celiac artery, posterior surface of the pancreatic head and common hepatic artery were 64.9%, 41.2%, 37.8%, 32.4%, and 20.9%, respectively. The overall rate of metastasis to these groups of LNs was 91.9%. Conclusion This study determined that stations 16a1 and 16a2 of the para-aortic, truncus coeliacus, posterior surface of the pancreatic head, and arteria hepatica communis lymph nodes were the preferred sites for abdominal LN metastasis, thus defining target areas for postoperative radiotherapy.	[Chen, Junqiang; Lin, Yu; Pan, Jianji; Chen, Chuanben] Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China; [Chen, Junqiang; Lin, Yu; Chen, Yuanmei; Zheng, Qingfeng; Pan, Jianji; Chen, Chuanben] Fujian Med Univ, Canc Hosp, Fuzhou, Fujian, Peoples R China; [Cai, Wenjie] Fujian Med Univ, Dept Radiat Oncol, Hosp Quanzhou Affiliated 1, Quanzhou, Fujian, Peoples R China; [Chen, Yuanmei; Zheng, Qingfeng] Fujian Canc Hosp, Dept Surg, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Chen, JQ (corresponding author), Fujian Canc Hosp, Dept Radiat Oncol, Fuzhou, Fujian, Peoples R China.; Chen, JQ (corresponding author), Fujian Med Univ, Canc Hosp, Fuzhou, Fujian, Peoples R China.	cjq122316@sina.com		Pan, Jianji/0000-0002-3211-7874	Natural Science Foundation of Fujian Province [2015J01377]; Science and Technology Foundation of Fujian Province [2011Y0014]; Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C	This study is supported by grants from the Natural Science Foundation of Fujian Province (2015J01377), the Key Project of Science and Technology Foundation of Fujian Province (2011Y0014) to Junqiang Chen, and the Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.	Bedard ELR, 2001, CANCER-AM CANCER SOC, V91, P2423, DOI 10.1002/1097-0142(20010615)91:12<2423::AID-CNCR1277>3.0.CO;2-1; Cai WJ, 2010, RADIOTHER ONCOL, V96, P104, DOI 10.1016/j.radonc.2010.04.029; Chen JQ, 2013, INT J RADIAT ONCOL, V86, P671, DOI 10.1016/j.ijrobp.2013.03.026; Chen JQ, 2010, ANN THORAC SURG, V90, P435, DOI 10.1016/j.athoracsur.2010.04.002; Chen JQ, 2009, EUR J CARDIO-THORAC, V36, P480, DOI 10.1016/j.ejcts.2009.03.056; Doki Y, 2005, WORLD J SURG, V29, P700, DOI 10.1007/s00268-005-7596-4; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ge H, 2005, CHINESE CLIN ONCOLOG, V10, P526; Heye T, 2006, EUR RADIOL, V16, P2401, DOI 10.1007/s00330-006-0318-y; Kato H, 2004, BRIT J SURG, V91, P1004, DOI 10.1002/bjs.4595; Kim HJ, 2005, RADIOLOGY, V236, P879, DOI 10.1148/radiol.2363041101; Kim SK, 2006, EUR J NUCL MED MOL I, V33, P148, DOI 10.1007/s00259-005-1887-8; Liu M, 2014, RADIOTHER ONCOL, V113, P175, DOI 10.1016/j.radonc.2014.11.022; [刘文健 Liu Wenjian], 2010, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V37, P1358; Nakagawa S, 2004, J AM COLL SURGEONS, V198, P205, DOI 10.1016/j.jamcollsurg.2003.10.005; Qiao XY, 2008, INT J RADIAT ONCOL, V70, P396, DOI 10.1016/j.ijrobp.2007.06.031; TENIERE P, 1991, SURG GYNECOL OBSTET, V173, P123; Xiao Z, 2002, CHINESE CLIN ONCOLOG, V6, P608; Xiao ZF, 2005, INT J RADIAT ONCOL, V62, P82, DOI 10.1016/j.ijrobp.2004.08.046; [章文成 Zhang Wencheng], 2012, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V21, P38	20	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185424	10.1371/journal.pone.0185424	http://dx.doi.org/10.1371/journal.pone.0185424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016614	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400018
J	Ohn, JH; Hwang, JY; Moon, MK; Ahn, HY; Kim, HH; Do Koo, Y; Kim, KI; Chang, HJ; Lee, HS; Jang, HC; Parka, YJ				Ohn, Jung Hun; Hwang, Ji Yeon; Moon, Min Kyong; Ahn, Hwa Young; Kim, Hwan Hee; Do Koo, Young; Kim, Kwang-Ii; Chang, Hyuk Jae; Lee, Hye Seung; Jang, Hak Chul; Park, Young Joo			Small heterodimer partner (SHP) deficiency protects myocardia from lipid accumulation in high fat diet-fed mice	PLOS ONE			English	Article							ORPHAN-NUCLEAR-RECEPTOR; CARDIAC-HYPERTROPHY; ACID OXIDATION; HEART-FAILURE; EXPRESSION PROFILES; GENE-EXPRESSION; METABOLISM; LIVER; CARDIOMYOPATHY; RESISTANCE	The small heterodimer partner (SHP) regulates fatty acid oxidation and lipogenesis in the liver by regulating peroxisome proliferator-activated receptor (PPAR) gamma expression. SHP is also abundantly expressed in the myocardium. We investigated the effect of SHP expression on myocardia assessing not only heart structure and function but also lipid metabolism and related gene expression in a SHP deletion animal model. Transcriptional profiling with a microarray revealed that genes participating in cell growth, cytokine signalling, phospholipid metabolism, and extracellular matrix are up-regulated in the myocardia of SHP knockout (KO) mice compared to those of wild-type (WT) mice (nominal p value < 0.05). Consistent with these gene expression changes, the left ventricular masses of SHP KO mice were significantly higher than WT mice (76.8 +/- 20.5 mg vs. 52.8 +/- 6.8 mg, P = 0.0093). After 12 weeks of high fat diet (HFD), SHP KO mice gained less weight and exhibited less elevation in serum-free fatty acid and less ectopic lipid accumulation in the myocardium than WT mice. According to microarray analysis, genes regulated by PPAR gamma 1 and PPAR alpha were down-regulated in myocardia of SHP KO mice compared to their expression in WT mice after HFD, suggesting that the reduction in lipid accumulation in the myocardium resulted from a decrease in lipogenesis regulated by PPAR gamma. We confirmed the reduced expression of PPAR gamma 1 and PPARa target genes such as CD36, medium-chain acyl-CoA dehydrogenase, long-chain acyl-CoA dehydrogenase, and very long-chain acyl-CoA dehydrogenase by SHP KO after HFD.	[Ohn, Jung Hun; Hwang, Ji Yeon; Kim, Kwang-Ii; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seoul, South Korea; [Hwang, Ji Yeon] Seoul Natl Univ, Bundang Hosp, Preclin Res Ctr, Biomed Res Inst, Seoul, South Korea; [Moon, Min Kyong; Do Koo, Young; Kim, Kwang-Ii; Jang, Hak Chul; Park, Young Joo] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Min Kyong] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Ahn, Hwa Young] Chung Ang Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Hwan Hee; Do Koo, Young] Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea; [Chang, Hyuk Jae] Yonsei Univ, Coll Med, Div Cardiol, Yonsei Cardiovasc Ctr, Seoul, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Seoul National University (SNU)	Moon, MK (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Moon, MK (corresponding author), Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	mkmoon@snu.ac.kr	Moon, Min Kyong/AAE-7663-2020; LEE, WON-YOUNG/C-7249-2018; Lee, Hye Seung/G-6419-2011; Kim, Kwang-il/D-8024-2012; Kim, Kwang-il/AAP-7315-2021	Moon, Min Kyong/0000-0002-5460-2846; LEE, WON-YOUNG/0000-0002-1082-7592; Lee, Hye Seung/0000-0002-1667-7986; Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Chang, Hyuk-Jae/0000-0002-6139-7545	Korean Diabetes Association	Korean Diabetes Association	This work was supported by a grant (Y.J. P., 2010) from the Korean Diabetes Association. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Fang CX, 2008, AM J PHYSIOL-HEART C, V295, pH1206, DOI 10.1152/ajpheart.00319.2008; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Hartman HB, 2009, J LIPID RES, V50, P193, DOI 10.1194/jlr.M800323-JLR200; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004; Lee IK, 2014, DIABETES METAB J, V38, P181, DOI 10.4093/dmj.2014.38.3.181; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nam YS, 2014, CIRC RES, V115, P493, DOI 10.1161/CIRCRESAHA.115.304388; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Osorio JC, 2002, CIRCULATION, V106, P606, DOI 10.1161/01.CIR.0000023531.22727.C1; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Rodriguez-Calvo R, 2017, BBA-MOL CELL BIOL L, V1862, P541, DOI 10.1016/j.bbalip.2017.02.006; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang L, 2003, J BIOL CHEM, V278, P44475, DOI 10.1074/jbc.M305258200; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Wang Z, 2015, METABOLISM, V64, P917, DOI 10.1016/j.metabol.2015.04.010; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006	29	0	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186021	10.1371/journal.pone.0186021	http://dx.doi.org/10.1371/journal.pone.0186021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016649	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400049
J	Sarlah, A; Vilfan, A				Sarlah, Andreja; Vilfan, Andrej			Minimum requirements for motility of a processive motor protein	PLOS ONE			English	Article							AAA PLUS RING; MICROTUBULE-BINDING DOMAIN; CYTOPLASMIC DYNEIN; CRYSTAL-STRUCTURE; COILED-COIL; MYOSIN-V; KINESIN; MECHANISM; WALK; MOVEMENT	Motor proteins generally have a two-way coupling between the ATP hydrolysis site, the lever movement and the binding affinity for their track, which allows them to perform efficient stepping. Here we explore the minimal requirements for directed motility based on simpler schemes in which the binding/unbinding from the track is decoupled from the ATPase cycle. We show that a directed power stroke alone is not sufficient for motility, but combined with an asymmetry in force-induced unbinding rates it can generate stepping. The energetic efficiency of such stepping is limited to approximately 20%. We conclude that the allosteric coupling between the ATP hydrolysis and the track binding is not strictly necessary for motility, but it greatly improves its efficiency.	[Sarlah, Andreja] Univ Ljubljana, Fac Math & Phys, Ljubljana, Slovenia; [Vilfan, Andrej] J Stefan Inst, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Sarlah, A (corresponding author), Univ Ljubljana, Fac Math & Phys, Ljubljana, Slovenia.; Vilfan, A (corresponding author), J Stefan Inst, Ljubljana, Slovenia.	andreja.sarlah@fmf.uni-lj.si; andrej.vilfan@ijs.si	Vilfan, Andrej/B-1042-2008; Šarlah, Andreja/J-6884-2013	Vilfan, Andrej/0000-0001-8985-6072; Šarlah, Andreja/0000-0003-4913-4811	Slovenian Research Agency [J1-5437, J1-7441, P1-0099]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency, Grants J1-5437 (AV, AS), J1-7441 (AS) and P1-0099 (AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bierbaum V, 2011, BIOPHYS J, V100, P1747, DOI 10.1016/j.bpj.2011.02.012; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chowdhury D, 2013, PHYS REP, V529, P1, DOI 10.1016/j.physrep.2013.03.005; Cleary FB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5587; Derenyi I, 1996, P NATL ACAD SCI USA, V93, P6775, DOI 10.1073/pnas.93.13.6775; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Duke T, 1996, BIOPHYS J, V71, P1235, DOI 10.1016/S0006-3495(96)79323-2; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Hoffmann PM, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/3/032601; HOLZBAUR ELF, 1989, BIOCHEMISTRY-US, V28, P7010, DOI 10.1021/bi00443a034; Howard J., 2001, MECH MOTOR PROTEINS; Imamula K, 2007, P NATL ACAD SCI USA, V104, P16134, DOI 10.1073/pnas.0702370104; Kikkawa M, 2013, J CELL BIOL, V202, P15, DOI 10.1083/jcb.201304099; Kolomeisky AB, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/46/463101; Kon T, 2012, NATURE, V484, P345, DOI 10.1038/nature10955; Kon T, 2009, NAT STRUCT MOL BIOL, V16, P325, DOI 10.1038/nsmb.1555; Liepelt S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258102; Lippert LG, 2017, P NATL ACAD SCI USA, V114, pE4564, DOI 10.1073/pnas.1620149114; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Nicholas MP, 2015, P NATL ACAD SCI USA, V112, P6371, DOI 10.1073/pnas.1417422112; Nicholas MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7206; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Redwine WB, 2012, SCIENCE, V337, P1532, DOI 10.1126/science.1224151; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Samii L, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021106; Sarlah A, 2014, BIOPHYS J, V107, P662, DOI 10.1016/j.bpj.2014.06.022; Schmidt H, 2015, BIOESSAYS, V37, P532, DOI 10.1002/bies.201400215; Schmidt H, 2012, NAT STRUCT MOL BIOL, V19, P492, DOI 10.1038/nsmb.2272; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Subramanian R, 2007, J GEN PHYSIOL, V130, P445, DOI 10.1085/jgp.200709866; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Thomas N, 2001, P ROY SOC B-BIOL SCI, V268, P2113, DOI 10.1098/rspb.2001.1764; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Tsygankov D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050098; von Delius M, 2010, NAT CHEM, V2, P96, DOI [10.1038/NCHEM.481, 10.1038/nchem.481]	42	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185948	10.1371/journal.pone.0185948	http://dx.doi.org/10.1371/journal.pone.0185948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016643	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400041
J	Kitamura, K; Watanabe, Y; Nakamura, K; Takahashi, A; Takachi, R; Oshiki, R; Kobayashi, R; Saito, T; Tsugane, S; Sasaki, A				Kitamura, Kaori; Watanabe, Yumi; Nakamura, Kazutoshi; Takahashi, Akemi; Takachi, Ribeka; Oshiki, Rieko; Kobayashi, Ryosaku; Saito, Toshiko; Tsugane, Shoichiro; Sasaki, Ayako			Weight loss from 20 years of age is associated with cognitive impairment in middle-aged and elderly individuals	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION-BASED COHORT; GREEN TEA CONSUMPTION; ALZHEIMER-DISEASE; DEMENTIA RISK; LATE-LIFE; JAPANESE; METAANALYSIS; PROJECT; MIDLIFE	Background Few empirical studies have been conducted to identify modifiable factors that may affect cognitive impairment in Japanese individuals. The present study aimed to clarify whether body mass and lifestyle are associated with cognitive impairment in Japanese middle-aged and elderly individuals. Methods Subjects were 1814 community-dwelling individuals aged 44-79 years, all of whom were participants of the Murakami Cohort Study baseline survey conducted in 2011-2013. Cognitive function was assessed using the Mini-Mental State Examination (MMSE) in 2014-2016, and cognitive impairment, the outcome measure, was defined as an MMSE score <24. Predictor variables were body mass index (BMI), long-term weight changes from 20 years of age, and lifestyle factors, such as smoking, drinking, and physical activity levels, which were obtained from a self-administered questionnaire in the baseline survey. Covariates were sex, age, education level, and histories of stroke and diabetes. Multiple logistic regression analysis was used to calculate the adjusted odds ratios (ORs). Results The prevalence of overall cognitive impairment was 6.2%. The adjusted ORs of cognitive impairment in the lowest (<[-4] kg) (OR = 2.70, 95% CI, 1.18-6.20) and second ([-4]-[0] kg) (OR = 2.37, 95% CI, 1.04-5.37) quintiles for long-term weight change were significantly higher than the reference 4th quintile ([+4]-[+7] kg). The adjusted OR in the highest quintile >=[+8] kg) was 2.24 (95% CI, 0.99-5.04). Current BMI was not associated with cognitive impairment. Conclusions Long-term weight loss is associated with cognitive impairment in Japanese middle-aged and elderly individuals. Because the present study was retrospective in nature, prospective studies should also be conducted for further characterization of this association.	[Kitamura, Kaori; Watanabe, Yumi; Nakamura, Kazutoshi; Takachi, Ribeka] Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Niigata, Japan; [Takahashi, Akemi; Oshiki, Rieko] Niigata Univ Rehabil, Dept Phys Therapy, Murakami, Niigata, Japan; [Takachi, Ribeka] Nara Womens Univ, Grad Sch Humanities & Sci, Dept Food Sci & Nutr, Nara, Japan; [Kobayashi, Ryosaku] Niigata Univ Hlth & Welf, Dept Phys Therapy, Niigata, Japan; [Saito, Toshiko] Niigata Univ Hlth & Welf, Dept Hlth & Nutr, Niigata, Japan; [Tsugane, Shoichiro] Natl Canc Ctr, Ctr Publ Hlth Sci, Tokyo, Japan; [Sasaki, Ayako] Murakami Publ Hlth Ctr, Murakami, Niigata, Japan	Niigata University; Nara Womens University; Niigata University; Niigata University; National Cancer Center - Japan	Nakamura, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Med, Niigata, Japan.	kazun@med.niigata-u.ac.jp	Tsugane, Shoichiro/A-2424-2015	Tsugane, Shoichiro/0000-0003-4105-2774	JSPS KAKENHI [JP26860436, JP15H04782, 17K09198]; National Cancer Center [23-A31[toku], 26-A-2]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center	This work was supported by JSPS KAKENHI Grants (JP26860436, JP15H04782 and 17K09198) and the National Cancer Center Research and Development Fund (23-A31[toku] and 26-A-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS457, DOI 10.1097/00005768-200009001-00004; Alhurani RE, 2016, JAMA NEUROL, V73, P439, DOI 10.1001/jamaneurol.2015.4756; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Bagger YZ, 2004, OBES RES, V12, P1519, DOI 10.1038/oby.2004.189; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; Buchman AS, 2005, NEUROLOGY, V65, P892, DOI 10.1212/01.wnl.0000176061.33817.90; Burns JM, 2010, ARCH NEUROL-CHICAGO, V67, P428, DOI 10.1001/archneurol.2010.38; Di Marco LY, 2014, J ALZHEIMERS DIS, V42, P119, DOI 10.3233/JAD-132225; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Fan YC, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0236-z; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii H, 2011, DIABETOL INT, V2, P47, DOI 10.1007/s13340-011-0025-z; Garcia-Ptacek S, 2014, EUR J CLIN NUTR, V68, P1204, DOI 10.1038/ejcn.2014.199; Health Labour and Welfare Statistics Association, 2016, KOK NO FUK TO KAIG N; Inoue M, 2005, BRIT J CANCER, V92, P182, DOI 10.1038/sj.bjc.6602277; Kitamura K, 2016, DEMENT GER COGN D EX, V6, P341, DOI 10.1159/000447963; Kuriyama S, 2006, AM J CLIN NUTR, V83, P355; Lin JS, 2013, SCREENING COGNITIVE, P25; Maki N, 2000, DEMENT GERIATR COGN, V11, P193, DOI 10.1159/000017236; Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013; Okamoto N, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-77; Ozawa M, 2014, J AM GERIATR SOC, V62, P1224, DOI 10.1111/jgs.12887; Pedditizi E, 2016, AGE AGEING, V45, P14, DOI 10.1093/ageing/afv151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Qizilbash N, 2015, LANCET DIABETES ENDO, V3, P431, DOI 10.1016/S2213-8587(15)00033-9; Taniguchi Yu, 2015, Nihon Ronen Igakkai Zasshi, V52, P86, DOI 10.3143/geriatrics.52.86; Tomata Y, 2016, AM J GERIAT PSYCHIAT, V24, P881, DOI 10.1016/j.jagp.2016.07.009; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Vidoni ED, 2011, NEUROLOGY, V77, P1913, DOI 10.1212/WNL.0b013e318238eec1; Xu W, 2017, EUR J EPIDEMIOL, V32, P31, DOI 10.1007/s10654-017-0225-3	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185960	10.1371/journal.pone.0185960	http://dx.doi.org/10.1371/journal.pone.0185960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982190	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300099
J	Cebron, D; Viroulet, S; Vidal, J; Masson, JP; Viroulet, P				Cebron, David; Viroulet, Sylvain; Vidal, Jerernie; Masson, Jean-Paul; Viroulet, Philippe			Experimental and theoretical study of magnetohydrodynamic ship models (vol 12, e0178599, 2017)	PLOS ONE			English	Correction													Vidal, Jérémie/M-6382-2019; Viroulet, Sylvain/M-2408-2017; Cebron, David/A-9625-2014	Vidal, Jérémie/0000-0002-3654-6633; Viroulet, Sylvain/0000-0002-8204-1425; Cebron, David/0000-0002-3579-8281				Cebron D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178599	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0186166	10.1371/journal.pone.0186166	http://dx.doi.org/10.1371/journal.pone.0186166			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977028	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100059
J	Salvagioni, DAJ; Melanda, FN; Mesas, AE; Gonzalez, AD; Gabani, FL; de Andrade, SM				Jodas Salvagioni, Denise Albieri; Melanda, Francine Nesello; Mesas, Arthur Eumann; Gonzalez, Alberto Duran; Gabani, Flavia Lopes; de Andrade, Selma Maffei			Physical, psychological and occupational consequences of job burnout: A systematic review of prospective studies	PLOS ONE			English	Review							DEMANDS-RESOURCES MODEL; NEWCASTLE-OTTAWA SCALE; CORONARY-HEART-DISEASE; WORK ENGAGEMENT; DEPRESSIVE SYMPTOMS; RISK-FACTORS; DISCRIMINANT VALIDITY; TEMPORAL RELATIONSHIP; MUSCULOSKELETAL PAIN; TEACHER BURNOUT	Burnout is a syndrome that results from chronic stress at work, with several consequences to workers' well-being and health. This systematic review aimed to summarize the evidence of the physical, psychological and occupational consequences of job burnout in prospective studies. The PubMed, Science Direct, PsycInfo, SciELO, LILACS and Web of Science data-bases were searched without language or date restrictions. The Transparent Reporting of Systematic Reviews and Meta-Analyses guidelines were followed. Prospective studies that analyzed burnout as the exposure condition were included. Among the 993 articles initially identified, 61 fulfilled the inclusion criteria, and 36 were analyzed because they met three criteria that must be followed in prospective studies. Burnout was a significant predictor of the following physical consequences: hypercholesterolemia, type 2 diabetes, coronary heart disease, hospitalization due to cardiovascular disorder, musculoskeletal pain, changes in pain experiences, prolonged fatigue, headaches, gastrointestinal issues, respiratory problems, severe injuries and mortality below the age of 45 years. The psychological effects were insomnia, depressive symptoms, use of psychotropic and antidepressant medications, hospitalization for mental disorders and psychological ill-health symptoms. Job dissatisfaction, absenteeism, new disability pension, job demands, job resources and presenteeism were identified as professional outcomes. Conflicting findings were observed. In conclusion, several prospective and high-quality studies showed physical, psychological and occupational consequences of job burnout. The individual and social impacts of burnout highlight the need for preventive interventions and early identification of this health condition in the work environment.	[Jodas Salvagioni, Denise Albieri] Inst Fed Parana, Dept Nursing, Londrina, Parana, Brazil; [Melanda, Francine Nesello] Univ Estadual Londrina, Dept Pathol Sci, Londrina, Parana, Brazil; [Mesas, Arthur Eumann; Gonzalez, Alberto Duran; de Andrade, Selma Maffei] Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil; [Gabani, Flavia Lopes] Univ Estadual Londrina, Dept Nursing, Londrina, Parana, Brazil	Instituto Federal do Parana; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina	de Andrade, SM (corresponding author), Univ Estadual Londrina, Dept Publ Hlth, Londrina, Parana, Brazil.	selmaffei@gmail.com	Mesas, Arthur Eumann/P-5879-2018; Gabani, Flavia Lopes/AAW-9258-2020; De Andrade, Selma M/B-2822-2008; Mesas, Arthur/AAK-3361-2021; Mesas, Arthur Eumann/AAG-9545-2020; de Andrade, Selma Maffei/U-3809-2019; Gonzalez, Alberto/A-3581-2011	Mesas, Arthur Eumann/0000-0002-0088-8607; Gabani, Flavia Lopes/0000-0002-9442-4896; De Andrade, Selma M/0000-0001-6843-8330; Mesas, Arthur/0000-0002-0088-8607; Mesas, Arthur Eumann/0000-0002-0088-8607; Gonzalez, Alberto/0000-0002-4203-9400	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghilinejad M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.9066; Ahola K, 2005, J AFFECT DISORDERS, V88, P55, DOI 10.1016/j.jad.2005.06.004; Ahola K, 2009, OCCUP ENVIRON MED, V66, P284, DOI 10.1136/oem.2008.038935; Ahola K, 2009, J AFFECT DISORDERS, V115, P150, DOI 10.1016/j.jad.2008.09.021; Ahola K, 2007, J AFFECT DISORDERS, V104, P103, DOI 10.1016/j.jad.2007.03.004; Ahola K, 2006, ADDICTION, V101, P1438, DOI 10.1111/j.1360-0443.2006.01539.x; Ahola K, 2013, J OCCUP HEALTH, V55, P450, DOI 10.1539/joh.13-0021-OA; Ahola K, 2012, J OCCUP ENVIRON MED, V54, P17, DOI 10.1097/JOM.0b013e31823ea9d9; Ahola K, 2010, J PSYCHOSOM RES, V69, P51, DOI 10.1016/j.jpsychores.2010.01.002; [Anonymous], 2013, EPIDEMIOLOGY; APPELS A, 1991, BEHAV MED, V17, P53, DOI 10.1080/08964289.1991.9935158; Armon G, 2008, J PSYCHOSOM RES, V65, P5, DOI 10.1016/j.jpsychores.2008.01.012; Armon G, 2008, J OCCUP HEALTH PSYCH, V13, P43, DOI 10.1037/1076-8998.13.1.43; Armon G, 2014, HEALTH PSYCHOL, V33, P264, DOI 10.1037/a0033712; Armon G, 2010, J OCCUP HEALTH PSYCH, V15, P399, DOI 10.1037/a0020726; Armon G, 2009, STRESS HEALTH, V25, P333, DOI 10.1002/smi.1266; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Bianchi R, 2015, SCAND J WORK ENV HEA, V41, P565, DOI 10.5271/sjweh.3522; Borritz M, 2006, OCCUP ENVIRON MED, V63, P98, DOI 10.1136/oem.2004.019364; Borritz M, 2010, J OCCUP ENVIRON MED, V52, P964, DOI 10.1097/JOM.0b013e3181f12f95; Brand S, 2010, WORLD J BIOL PSYCHIA, V11, P744, DOI 10.3109/15622971003624205; Burke RJ, 1996, ANXIETY STRESS COPIN, V9, P261, DOI 10.1080/10615809608249406; BURKE RJ, 1995, HUM RELAT, V48, P187, DOI 10.1177/001872679504800205; Campanini MZ, 2017, SLEEP MED, V35, P27, DOI 10.1016/j.sleep.2017.04.004; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Cresswell SL, 2006, J SPORT SCI, V24, P209, DOI 10.1080/02640410500131431; Danhof-Pont MB, 2011, J PSYCHOSOM RES, V70, P505, DOI 10.1016/j.jpsychores.2010.10.012; de Beer LT, 2016, ANXIETY STRESS COPIN, V29, P387, DOI 10.1080/10615806.2015.1061123; de Beer LT, 2013, SA J IND PSYCHOL, V39, DOI 10.4102/sajip.v39i1.1055; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2009, CAREER DEV INT, V14, P50, DOI 10.1108/13620430910933574; Dubois CA, 2014, INT J ENV RES PUB HE, V11, P187, DOI 10.3390/ijerph110100187; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Figueiredo-Ferraz H, 2012, PSICOTHEMA, V24, P271; Goering D. D., 2017, BURNOUT RES, V5, P21, DOI [DOI 10.1016/J.BURN.2017.05.003, 10.1016/j.burn.2017.05.003]; Grossi G, 2009, STRESS HEALTH, V25, P297, DOI 10.1002/smi.1281; Hakanen JJ, 2008, WORK STRESS, V22, P224, DOI 10.1080/02678370802379432; Hakanen JJ, 2012, J AFFECT DISORDERS, V141, P415, DOI 10.1016/j.jad.2012.02.043; Hallsten L, 2011, WORK, V38, P181, DOI [10.3233/WOR-2011-01120, 10.3233/WOR-2011-1120]; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Huang J, 2016, EUR J WORK ORGAN PSY, V25, P849, DOI 10.1080/1359432X.2016.1167682; Idris MA, 2014, J OCCUP HEALTH PSYCH, V19, P291, DOI 10.1037/a0036599; Innstrand ST, 2008, WORK STRESS, V22, P1, DOI 10.1080/02678370801975842; Jansson-Frojmark M, 2011, INT J BEHAV MED, V17, P306, DOI 10.1007/s12529-010-9107-8; Jarde A, 2012, AN PSICOL-SPAIN, V28, P617, DOI 10.6018/analesps.28.2.148911; Jarde A, 2013, INT J CLIN HLTH PSYC, V13, P138, DOI 10.1016/S1697-2600(13)70017-6; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Kadzielski JJ, 2012, J HAND SURG-AM, V37A, P1812, DOI 10.1016/j.jhsa.2012.05.023; Khamisa N, 2016, INT J NURS PRACT, V22, P538, DOI 10.1111/ijn.12455; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Kim H, 2011, SOC WORK, V56, P258, DOI 10.1093/sw/56.3.258; Kitaoka-Higashiguchi K, 2009, J OCCUP HEALTH, V51, P123, DOI 10.1539/joh.L8104; Lee J, 2011, PROF PSYCHOL-RES PR, V42, P252, DOI 10.1037/a0023319; Leiter MP, 2013, J ORGAN BEHAV, V34, P959, DOI 10.1002/job.1830; LEITER MP, 1994, ANXIETY STRESS COPIN, V7, P357, DOI 10.1080/10615809408249357; Leone SS, 2009, STRESS HEALTH, V25, P365, DOI 10.1002/smi.1280; Lizano EL, 2015, CHILD YOUTH SERV REV, V55, P18, DOI 10.1016/j.childyouth.2015.05.005; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Madsen IEH, 2015, J PSYCHIATR RES, V65, P47, DOI 10.1016/j.jpsychires.2015.04.004; Makikangas A, 2012, ANXIETY STRESS COPIN, V25, P93, DOI 10.1080/10615806.2011.565411; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; McManus IC, 2002, LANCET, V359, P2089, DOI 10.1016/S0140-6736(02)08915-8; Melamed S, 2006, PSYCHOSOM MED, V68, P863, DOI 10.1097/01.psy.0000242860.24009.f0; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Melamed S, 2009, STRESS HEALTH, V25, P313, DOI 10.1002/smi.1265; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Mohren DCL, 2003, J PSYCHOSOM RES, V55, P201, DOI 10.1016/S0022-3999(02)00517-2; Pellegrino ABW, 2017, CEPHALALGIA; Roelen CAM, 2015, INT ARCH OCC ENV HEA, V88, P467, DOI 10.1007/s00420-014-0981-2; Rudman A, 2012, INT J NURS STUD, V49, P988, DOI 10.1016/j.ijnurstu.2012.03.010; Rudman A, 2011, INT J NURS STUD, V48, P292, DOI 10.1016/j.ijnurstu.2010.07.012; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Schaufeli WB, 2015, CAREER DEV INT, V20, P446, DOI 10.1108/CDI-02-2015-0025; Schaufeli WB, 2011, J OCCUP ORGAN PSYCH, V84, P248, DOI 10.1111/j.2044-8325.2010.02013.x; Schaufeli WB, 2009, J ORGAN BEHAV, V30, P893, DOI 10.1002/job.595; Schonfeld IS, 2016, J CLIN PSYCHOL, V72, P22, DOI 10.1002/jclp.22229; Seidler A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-10; Shamliyan T, 2010, J CLIN EPIDEMIOL, V63, P1061, DOI 10.1016/j.jclinepi.2010.04.014; Shin H, 2013, J EMPLOYMENT COUNS, V50, P124, DOI 10.1002/j.2161-1920.2013.00031.x; Shirom A, 1997, J Occup Health Psychol, V2, P275, DOI 10.1037/1076-8998.2.4.275; Shirom A, 2013, APPL PSYCHOL-HLTH WE, V5, P79, DOI 10.1111/j.1758-0854.2012.01071.x; Shoji K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136730; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tadic M, 2015, J OCCUP ORGAN PSYCH, V88, P702, DOI 10.1111/joop.12094; Tang CSK, 2001, J ORGAN BEHAV, V22, P887, DOI 10.1002/job.120; The Joanna Briggs Institute, 2016, CHECKL COH STUD AD; Toker S, 2012, PSYCHOSOM MED, V74, P840, DOI 10.1097/PSY.0b013e31826c3174; Toker S, 2012, J APPL PSYCHOL, V97, P699, DOI 10.1037/a0026914; Toppinen-Tanner S, 2005, BEHAV MED, V31, P18, DOI 10.3200/BMED.31.1.18-32; Toppinen-Tanner S, 2009, STRESS HEALTH, V25, P287, DOI 10.1002/smi.1282; Travis DJ, 2016, BRIT J SOC WORK, V46, P1076, DOI 10.1093/bjsw/bct205; Vinokur AD, 2009, STRESS HEALTH, V25, P355, DOI 10.1002/smi.1264; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Waldie KE, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-60; Wang YS, 2016, SOC BEHAV PERSONAL, V44, P247, DOI 10.2224/sbp.2016.44.2.247; Wells G., 2014, NEWCASTLE OTTAWA SCA; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WOLPIN J, 1991, HUM RELAT, V44, P193, DOI 10.1177/001872679104400205; Wright TA, 1997, J ORGAN BEHAV, V18, P491, DOI 10.1002/(SICI)1099-1379(199709)18:5<491::AID-JOB804>3.0.CO;2-I; Wright TA, 1998, J APPL PSYCHOL, V83, P486, DOI 10.1037/0021-9010.83.3.486; Ybema JF, 2010, EUR J WORK ORGAN PSY, V19, P102, DOI 10.1080/13594320902793691	106	399	419	55	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185781	10.1371/journal.pone.0185781	http://dx.doi.org/10.1371/journal.pone.0185781			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977041	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100044
J	Paul-Hus, A; Diaz-Faes, AA; Sainte-Marie, M; Desrochers, N; Costas, R; Lariviere, V				Paul-Hus, Adele; Diaz-Faes, Adrian A.; Sainte-Marie, Maxime; Desrochers, Nadine; Costas, Rodrigo; Lariviere, Vincent			Beyond funding: Acknowledgement patterns in biomedical, natural and social sciences	PLOS ONE			English	Article							SCIENTIFIC PUBLICATIONS; CO-AUTHORSHIP; COLLABORATION; COMMUNICATION; 20TH-CENTURY; SOCIOLOGY; KNOWLEDGE	For the past 50 years, acknowledgments have been studied as important paratextual traces of research practices, collaboration, and infrastructure in science. Since 2008, funding acknowledgments have been indexed by Web of Science, supporting large-scale analyses of research funding. Applying advanced linguistic methods as well as Correspondence Analysis to more than one million acknowledgments from research articles and reviews published in 2015, this paper aims to go beyond funding disclosure and study the main types of contributions found in acknowledgments on a large scale and through disciplinary comparisons. Our analysis shows that technical support is more frequently acknowledged by scholars in Chemistry, Physics and Engineering. Earth and Space, Professional Fields, and Social Sciences are more likely to acknowledge contributions from colleagues, editors, and reviewers, while Biology acknowledgments put more emphasis on logistics and fieldwork-related tasks. Conflicts of interest disclosures (or lack of thereof) are more frequently found in acknowledgments from Clinical Medicine, Health and, to a lesser extent, Psychology. These results demonstrate that acknowledgment practices truly do vary across disciplines and that this can lead to important further research beyond the sole interest in funding.	[Paul-Hus, Adele; Sainte-Marie, Maxime; Desrochers, Nadine; Lariviere, Vincent] Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada; [Diaz-Faes, Adrian A.] Univ Politecn Valencia, INGENIO, CSIC, Valencia, Spain; [Costas, Rodrigo] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Costas, Rodrigo] Stellenbosch Univ, Ctr Res Evaluat Sci & Technol, Stellenbosch, South Africa; [Lariviere, Vincent] Univ Quebec, OST, CIRST, Montreal, PQ, Canada	Universite de Montreal; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Gestion de la Innovacion y del Conocimiento (INGENIO); Leiden University; Leiden University - Excl LUMC; Stellenbosch University; University of Quebec; University of Quebec Montreal	Paul-Hus, A (corresponding author), Univ Montreal, Ecole Bibliothecon & Sci Informat, Montreal, PQ, Canada.	adele.paul-hus@umontreal.ca	Sainte-Marie, Maxime/R-6734-2017; Lariviere, Vincent/AAF-3179-2019; Diaz-Faes, Adrian A./H-9085-2019; Paul-Hus, Adele/C-8134-2015	Sainte-Marie, Maxime/0000-0002-0760-0290; Diaz-Faes, Adrian A./0000-0003-1928-4608; Costas, Rodrigo/0000-0002-7465-6462; Paul-Hus, Adele/0000-0002-4572-5385	Social Sciences and Humanities Research Council of Canada: Joseph-Armand Bombardier CGS Doctoral Scholarships; Social Sciences and Humanities Research Council of Canada: Insight Development Grant [430-2014-0617]; Department of Science and Technology, Republic of South Africa, Centre of Excellence in Scientometrics and STI Policy (SciSTIP)	Social Sciences and Humanities Research Council of Canada: Joseph-Armand Bombardier CGS Doctoral Scholarships; Social Sciences and Humanities Research Council of Canada: Insight Development Grant; Department of Science and Technology, Republic of South Africa, Centre of Excellence in Scientometrics and STI Policy (SciSTIP)	Adele Paul-Hus was supported by the Social Sciences and Humanities Research Council of Canada: Joseph-Armand Bombardier CGS Doctoral Scholarships. Nadine Desrochers and Vincent Lariviere acknowledge the Social Sciences and Humanities Research Council of Canada: Insight Development Grant [grant number 430-2014-0617]. Rodrigo Costas acknowledges a grant by Department of Science and Technology, Republic of South Africa, Centre of Excellence in Scientometrics and STI Policy (SciSTIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the anonymous reviewers for their insightful suggestions. This research was supported by the Social Sciences and Humanities Research Council of Canada, Joseph-Armand Bombardier CGS Doctoral Scholarships, Paul-Hus; Insight Development [grant number 430-2014-0617], Lariviere and Desrochers; as well as by funding from the South African DST-NRF Centre of Excellence in Scientometrics and Science, Technology and Innovation Policy (SciSTIP), Rodrigo Costas.	Beh EJ, 2014, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118762875; Benzecri J.P., 1992, CORRES ANAL HDB; Bird S., 2009, NATURAL LANGUAGE PRO; Birnholtz JP, 2006, J AM SOC INF SCI TEC, V57, P1758, DOI 10.1002/asi.20380; BOURDIEU P, 1975, SOC SCI INFORM, V14, P19, DOI 10.1177/053901847501400602; Costas R, 2012, J AM SOC INF SCI TEC, V63, P1647, DOI 10.1002/asi.22692; CRAWFORD ET, 1970, SOC SC INFORM, V9, P51; Cronin B, 2004, J AM SOC INF SCI TEC, V55, P160, DOI 10.1002/asi.10353; Cronin B, 2003, J AM SOC INF SCI TEC, V54, P855, DOI 10.1002/asi.10278; CRONIN B, 1993, J AM SOC INFORM SCI, V44, P406, DOI 10.1002/(SICI)1097-4571(199308)44:7<406::AID-ASI6>3.0.CO;2-8; Cronin B., 2005, HAND SCI ACAD WRITIN; Cronin B., 1995, REV ESPA OLA DOCUMEN, V18, P172, DOI [10.3989/redc.1995.v18.i2.654, DOI 10.3989/REDC.1995.V18.I2.654]; Desrochers N., 2017, J ASS INFORM SCI TEC; Desrochers N, 2016, THEORIES OF INFORMETRICS AND SCHOLARLY COMMUNICATION: A FESTSCHRIFT IN HONOR OF BLAISE CRONIN, P225; Diaz-Faes AA, 2014, J ASSOC INF SCI TECH, V65, P1834, DOI 10.1002/asi.23081; Edge D, 1979, Hist Sci, V17, P102; Genette Gerard, 1997, PARATEXTS THRESHOLDS, DOI DOI 10.1017/CBO9780511549373; Giles CL, 2004, P NATL ACAD SCI USA, V101, P17599, DOI 10.1073/pnas.0407743101; Greenacre M., 2007, CORRES ANAL PRACTICE; Hefter MH, 2015, LEARN INSTR, V39, P11, DOI 10.1016/j.learninstruc.2015.05.002; Henriksen D, 2016, SCIENTOMETRICS, V107, P455, DOI 10.1007/s11192-016-1849-x; Khabsa Madian, 2012, Social Computing, Behavioral-Cultural Modeling and Prediction. Proceedings of the 5th International Conference, SBP 2012, P357, DOI 10.1007/978-3-642-29047-3_43; Khabsa M., 2012, P 12 ACM IEEE CS JOI, P185; Kim S. N., 2010, P 23 INT C COMP LING, P572; Lariviere V, 2016, SOC STUD SCI, V46, P417, DOI 10.1177/0306312716650046; Lariviere V, 2015, J ASSOC INF SCI TECH, V66, P1323, DOI 10.1002/asi.23266; Laudel G, 2002, RES EVALUAT, V11, P3, DOI 10.3152/147154402781776961; Lewison G, 2010, RES EVALUAT, V19, P129, DOI 10.3152/095820210X510098; Lukas J, 2015, MOL THER, V23, P456, DOI 10.1038/mt.2014.224; Marcus M.P., 1993, COMPUTATIONAL LINGUI, V19, P313, DOI DOI 10.1080/07494460903404410; Marusic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023477; MCCAIN KW, 1991, SCI TECHNOL HUM VAL, V16, P491, DOI 10.1177/016224399101600404; National Science Foundation, 2006, SCI ENG IND; Novick D, 2015, NEUROPSYCH DIS TREAT, V11, P197, DOI 10.2147/NDT.S75498; Pasiarski M, 2015, POSTEP HIG MED DOSW, V69, P1435; PATEL N, 1973, SOC SCI INFORM, V12, P77; Paul-Hus A, 2016, P 21 INT C SCI TECHN; Paul-Hus A, 2017, J INFORMETR, V11, P80, DOI 10.1016/j.joi.2016.11.005; Paul-Hus A, 2016, SCIENTOMETRICS, V108, P167, DOI 10.1007/s11192-016-1953-y; Ponomariov B, 2016, SCIENTOMETRICS, V109, P1939, DOI 10.1007/s11192-016-2127-7; Pontille D., 2004, SIGNATURE SCI SOCIOL; Pouget JG, 2015, PHARMACOGENOMICS, V16, P5, DOI [10.2217/PGS.14.158, 10.2217/pgs.14.158]; Rigby J, 2013, SCIENTOMETRICS, V94, P57, DOI 10.1007/s11192-012-0779-5; Salager-Meyer F, 2011, SCIENTOMETRICS, V86, P763, DOI 10.1007/s11192-010-0329-y; Sarbova V, 2015, CARBOHYD POLYM, V124, P117, DOI 10.1016/j.carbpol.2015.01.080; Tang L, 2017, J ASSOC INF SCI TECH, V68, P790, DOI 10.1002/asi.23713; Toutanova K, 2003, HLT-NAACL 2003: HUMAN LANGUAGE TECHNOLOGY CONFERENCE OF THE NORTH AMERICAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE MAIN CONFERENCE, P252, DOI 10.3115/1073445.1073478; Toutanova K, 2000, PROCEEDINGS OF THE 2000 JOINT SIGDAT CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND VERY LARGE CORPORA, P63, DOI 10.3115/1117794.1117802; Vicente-Villardon JL, 2014, MULTIBIPLOT PACKAGE; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Xu X, 2015, SCIENTOMETRICS, V104, P673, DOI 10.1007/s11192-015-1633-3; Zhang R, 2015, GENES GENET SYST, V90, P99, DOI 10.1266/ggs.90.99; Zhou P, 2014, SCIENTOMETRICS, V99, P695, DOI 10.1007/s11192-013-1212-4	54	18	18	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185578	10.1371/journal.pone.0185578	http://dx.doi.org/10.1371/journal.pone.0185578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28976996	Green Published, gold			2022-12-27	WOS:000412163100030
J	Zhu, HJ; Xu, Y; Gong, FY; Shan, GL; Yang, HB; Xu, K; Zhang, DX; Cheng, XQ; Zhang, ZH; Chen, S; Wang, LJ; Pan, H				Zhu, Huijuan; Xu, Yuan; Gong, Fengying; Shan, Guangliang; Yang, Hongbo; Xu, Ke; Zhang, Dianxi; Cheng, Xinqi; Zhang, Zhihao; Chen, Shi; Wang, Linjie; Pan, Hui			Reference ranges for serum insulin-like growth factor I (IGF-I) in healthy Chinese adults	PLOS ONE			English	Article							FACTOR BINDING-PROTEIN-3 CONCENTRATIONS; BINDING PROTEIN-3 IGFBP-3; BODY-MASS INDEX; REFERENCE INTERVALS; CLINICAL-PRACTICE; ANOREXIA-NERVOSA; CENTILE CURVES; LIFE-STYLE; LMS METHOD; POPULATION	Purpose To determine serum insulin-like growth factor 1 (IGF-I) levels in healthy Chinese adults, establish reference ranges for serum IGF-I levels and observe the effects of age, sex, body mass index (BMI) and geographical region on serum IGF-I levels. Methods In total, 2791 healthy adults (1339 males and 1452 females) from the north (Beijing) and south (Guizhou Province) of China were recruited following a questionnaire survey, physical examination and laboratory examination. Both sexes were divided into 13 groups according to age (18, 19, 20-24, 25-29, 30-34, 35-39, 40-44, 45-49, 50-54, 55-59, 60-64, 65-69 and -70 years). The serum IGF-I levels were measured by performing a chemiluminescent assay (Immulite 2000 (R)), and the LMS (Lambda-Mu-Sigma) method was applied to construct smooth centile curves of age-specific IGF-I levels. Results Serum IGF-I levels in the adults gradually decreased with increasing age from 18 to 70 years in both the male and female participants. Although the decrease in the level of IGF-1 was more pronounced in females than in males, no significant difference was observed between the sexes, except in the 60-to 64-year-old age group (P = 0.0329). The multiple linear regression model showed that there was an inverse relationship between the serum IGF-I level and BMI (P<0.001), and the serum IGF-I level in the Guizhou population was higher than that in the Beijing population (P<0.05). Conclusion The normal reference ranges for age- and sex-specific serum IGF-I levels were established for the first time in a large sample of Chinese adults. The serum IGF-I levels were significantly influenced by age, BMI and geographical region.	[Zhu, Huijuan; Gong, Fengying; Yang, Hongbo; Xu, Ke; Chen, Shi; Wang, Linjie; Pan, Hui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China; [Zhu, Huijuan; Xu, Yuan; Gong, Fengying; Shan, Guangliang; Yang, Hongbo; Xu, Ke; Zhang, Dianxi; Cheng, Xinqi; Chen, Shi; Wang, Linjie; Pan, Hui] Peking Union Med Coll, Beijing, Peoples R China; [Xu, Yuan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Surg, Beijing, Peoples R China; [Shan, Guangliang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing, Peoples R China; [Zhang, Dianxi; Cheng, Xinqi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China; [Zhang, Zhihao] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Zhang, Zhihao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Pan, H (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China.	panhui20111111@163.com	Zhang, Zhihao/I-8570-2019; wang, lin/HHM-2225-2022	Zhang, Zhihao/0000-0003-2643-6841; 	National Natural Science Foundation of China [81400774, 81673184]; National Science & Technology Pillar Program [2012BAI37B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program	This work was supported by National Natural Science Foundation of China (CN), 81400774, Hongbo Yang, National Natural Science Foundation of China, 81673184, Prof. Hui Pan, National Science & Technology Pillar Program during the Twelfth Five-year Plan Period, 2012BAI37B02, Guangliang Shan. Those funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2013, CLIN CHEM, V59, P1187, DOI 10.1373/clinchem.2013.205070; Bayram F, 2011, ENDOCRINE, V40, P304, DOI 10.1007/s12020-011-9476-z; Bidlingmaier M, 2014, J CLIN ENDOCR METAB, V99, P1712, DOI 10.1210/jc.2013-3059; Borofsky ND, 2002, CLIN CHEM, V48, P2248; Bradbury KE, 2015, GROWTH HORM IGF RES, V25, P90, DOI 10.1016/j.ghir.2015.01.001; Chanson P, 2016, J CLIN ENDOCR METAB, P2016; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cook DM, 2009, ENDOCR PRACT, V15, P580, DOI 10.4158/EP.15.6.580; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; DeLellis K, 2004, CANCER EPIDEM BIOMAR, V13, P1444; Elkazaz AY, 2015, ENDOCRINE, V48, P272, DOI 10.1007/s12020-014-0290-2; Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112; Faupel-Badger JM, 2009, ANN EPIDEMIOL, V19, P841, DOI 10.1016/j.annepidem.2009.08.005; Friedrich N, 2008, GROWTH HORM IGF RES, V18, P228, DOI 10.1016/j.ghir.2007.09.005; GoodmanGruen D, 1997, AM J EPIDEMIOL, V145, P970, DOI 10.1093/oxfordjournals.aje.a009065; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Harris TB, 1997, J AM GERIATR SOC, V45, P133, DOI 10.1111/j.1532-5415.1997.tb04497.x; HILL KK, 1993, J AM COLL NUTR, V12, P475, DOI 10.1080/07315724.1993.10718338; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P862; Hong Y, 1997, J ENDOCRINOL, V153, P251, DOI 10.1677/joe.0.1530251; Isojima T, 2012, ENDOCR J, V59, P771, DOI 10.1507/endocrj.EJ12-0110; JUUL A, 1994, J CLIN ENDOCR METAB, V78, P744, DOI 10.1210/jc.78.3.744; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Kwan AYM, 2007, PITUITARY, V10, P151, DOI 10.1007/s11102-007-0028-8; Kwee TC, 2006, PEDIATR RADIOL, V36, P8, DOI 10.1007/s00247-005-0011-3; Landin-Wilhelmsen K, 2004, HORM RES, V62, P8, DOI 10.1159/000080753; LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x; Leite DB, 2011, AFR J BIOTECHNOL, V10, P18027, DOI 10.5897/AJB11.2323; Leung KC, 2004, ENDOCR REV, V25, P693, DOI 10.1210/er.2003-0035; Liao ZH, 2016, ENDOCR J, V63, P1081, DOI 10.1507/endocrj.EJ16-0144; Lukanova A, 2002, CANCER CAUSE CONTROL, V13, P509, DOI 10.1023/A:1016392129279; McGreevy K, 2005, UROLOGY, V66, P587, DOI 10.1016/j.urology.2005.03.070; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Probst-Hensch NM, 2003, CANCER EPIDEM BIOMAR, V12, P739; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Rosario PW, 2010, ARQ BRAS ENDOCRINOL, V54, P477, DOI 10.1590/S0004-27302010000500008; SALMON WD, 1957, J LAB CLIN MED, V49, P825; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schernhammer ES, 2007, ENDOCR-RELAT CANCER, V14, P721, DOI 10.1677/ERC-06-0080; Teramukai S, 2002, AM J EPIDEMIOL, V156, P344, DOI 10.1093/aje/kwf069; Vu HTV, 2002, COMPUT STAT DATA AN, V40, P173, DOI 10.1016/S0167-9473(01)00099-8; Wang CT, 2012, CONTRACEPTION, V85, P570, DOI 10.1016/j.contraception.2011.10.014	45	39	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185561	10.1371/journal.pone.0185561	http://dx.doi.org/10.1371/journal.pone.0185561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976993	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100029
J	Zhou, WY; Wang, HY; Yu, WZ; Xie, WK; Zhao, M; Huang, LZ; Li, XX				Zhou, Weiyan; Wang, Hongya; Yu, Wenzhen; Xie, Wankun; Zhao, Min; Huang, Lvzhen; Li, Xiaoxin			The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; TUMOR ANGIOGENESIS; AXON GUIDANCE; NEOVASCULARIZATION; ROUNDABOUT; MIGRATION; RECEPTOR; PATHOGENESIS; ADHESION	Purpose The Slit-Robo signal has an important role in vasculogenesis and angiogenesis. Our study examined the expression of Slit2 and its receptor, Robo1, in a rat model of streptozotocininduced diabetes and in patients with proliferative diabetic retinopathy. Methods Diabetes was induced in male Sprague-Dawley rats via a single, intraperitoneal injection of streptozotocin. The rats were sacrificed 1, 3 or 6 months after the injection. The expression of Slit2 and Robo1 in retinal tissue was measured by real-time reverse transcription polymerase chain reaction (RT-PCR), and protein levels were measured by western blotting and immunohistochemistry. Recombinant N-Slit2 protein was used to study the effects of Slit2 on the expression of VEGF in vivo. The concentration of Slit2 protein in human eyes was measured by enzyme-linked immunosorbent assay in 27 eyes with proliferative diabetic retinopathy and 28 eyes in control group. The expression of Slit2, Robo1 and VEGF in the excised human fibrovascular membranes was examined by fluorescence immunostaining and semi-quantitative RT-PCR. Results The expression of Slit2 and Robo1 in the retina was altered after STZ injection. Recombinant N-Slit2 protein did not increase the retinal VEGF expression. Vitreous concentrations of Slit2 were significantly higher in the study group than in the control group. In the human fibrovascular membranes of the study group, the co-localization of VEGF with the markers for Slit2 and Robo1was observed. The expression of Slit2 mRNA, Robo1 mRNA, and VEGF mRNA was significantly higher in human fibrovascular proliferative diabetic retinopathy membranes than in the control membranes. Conclusions The alteration of Slit2 and Robo1 expression in the retinas of diabetic rats and patients with proliferative diabetic retinopathy suggests a role for the Slit-Robo signal in the various stages diabetic retinopathy. Further studies should address the possible involvement of the Slit-Robo signal in the pathophysiological progress of diabetic retinopathy.	[Zhou, Weiyan] Shandong Univ, Dept Ophthalmol, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Zhou, Weiyan; Yu, Wenzhen; Xie, Wankun; Zhao, Min; Huang, Lvzhen; Li, Xiaoxin] Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China; [Wang, Hongya] Shandong Univ, Dept Clin Lab, Shandong Prov Hosp, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Peking University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Yu, WZ (corresponding author), Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China.	wenzhen_yu@sina.com	Xie, Wankun/K-8623-2017	Xie, Wankun/0000-0003-0178-3361; Zhao, Min/0000-0003-0521-9186	Peking University People's Hospital Research and Development Fund [RDB2009-44]; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund [BS2014YY060]; National Basic Research Program of China (973 Program) [2011CB510200]	Peking University People's Hospital Research and Development Fund; Shangdong Province Young and Middle-Aged Scientists Research Awards Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Peking University People's Hospital Research and Development Fund (RDB2009-44); Shangdong Province Young and Middle-Aged Scientists Research Awards Fund (No.BS2014YY060); National Basic Research Program of China (973 Program, 2011CB510200).	Ahsan H, 2015, DIABETES METAB SYND, V9, P51, DOI 10.1016/j.dsx.2014.09.011; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Hammes HP, 1998, DIABETES, V47, P401, DOI 10.2337/diabetes.47.3.401; Huang LZ, 2010, INVEST OPHTH VIS SCI, V51, P3193, DOI 10.1167/iovs.09-3779; Huang LZ, 2009, CURR EYE RES, V34, P1019, DOI 10.3109/02713680903308495; Huang LZ, 2009, MOL VIS, V15, P1057; Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/186736; Liu ZJ, 2003, CANCER CELL, V4, P1, DOI 10.1016/S1535-6108(03)00166-1; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Matsuoka M, 2006, JPN J OPHTHALMOL, V50, P116, DOI 10.1007/s10384-005-0294-9; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Murugeswari P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107551; Paiva TF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1648-4; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Park K, 2009, DIABETES, V58, P1902, DOI 10.2337/db08-1327; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Rangasamy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108508; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Tao Y, 2010, INVEST OPHTH VIS SCI, V51, P4237, DOI 10.1167/iovs.09-4466; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wang LJ, 2008, CANCER SCI, V99, P510, DOI 10.1111/j.1349-7006.2007.00721.x; Yang XC, 2017, ACTA DIABETOL, V54, P73, DOI 10.1007/s00592-016-0914-5; Yu DY, 2001, CLIN EXP OPHTHALMOL, V29, P164; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13517; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; Zhao Y, 2016, MOL MED REP, V14, P1901, DOI 10.3892/mmr.2016.5518; Zhou WY, 2011, MOL VIS, V17, P1526	37	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185795	10.1371/journal.pone.0185795	http://dx.doi.org/10.1371/journal.pone.0185795			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973045	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900052
J	Chun, JH; Lee, CB				Chun, Jung-Hwa; Lee, Chang-Bae			Disentangling the local-scale drivers of taxonomic, phylogenetic and functional diversity in woody plant assemblages along elevational gradients in South Korea	PLOS ONE			English	Article							TROPICAL TREE COMMUNITIES; SPECIES-RICHNESS; BETA-DIVERSITY; SPATIAL SCALES; PATTERNS; MECHANISMS; TRAITS; DETERMINISM; TEMPERATE; FORESTS	Recently, new alternative matrices of biodiversity such as phylogenetic and functional diversity as a complement to species diversity have provided new insights into the mechanisms of community assembly. In this study, we analyzed the phylogenetic signals of five functional traits and the relative contribution of environmental variables and distance matrices to the alpha and beta components of taxonomic, phylogenetic and functional diversity in woody plant assemblages along four local elevational transects on two different mountains. We observed low but significant phylogenetic signals of functional traits, which suggest that phylogenetic dispersion can provide a rough approximation of functional dispersion but not perfect correlations between phylogenetic and functional diversity. Taxonomic alpha diversity showed a monotonic decline with elevation, and climatic variables were the main drivers of this pattern along all studied transects. Furthermore, although the phylogenetic and functional alpha dispersions showed different elevational patterns including increase, decrease and no relationship, the underlying processes driving the patterns of both types of alpha dispersion could be explained by the gradients of climatic and habitat variables as well as biotic interactions such as competition. These results suggest that both alpha dispersion patterns may be significantly controlled by niche-based deterministic processes such as biotic interactions and environmental filtering in our study areas. Moreover, the beta diversity with geographical distances showed distance-decay relationships for all transects. Although the relative importance of the environmental and geographical distances for beta diversity varied across the three facets of diversity and the transects, we generally found that environmental distances were more important for the beta components of the three facets of diversity. However, we cannot discriminate the effects of both distances on the three facets of diversity. Therefore, our study suggests that niche-based deterministic processes, potentially combined with neutral processes such as dispersal limitation and demographic stochasticity, may influence patterns of woody plant assemblage turnover in our study areas.	[Chun, Jung-Hwa] Natl Inst Forest Sci, Div Forest Ecol, Seoul, South Korea; [Lee, Chang-Bae] Korea Forestry Promot Inst, Global Resources Div, Seoul, South Korea	Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea	Lee, CB (corresponding author), Korea Forestry Promot Inst, Global Resources Div, Seoul, South Korea.	cblee@kofpi.or.kr		Lee, Chang-Bae/0000-0002-3543-6440	Korea Green Promotion Agency, Korea Forest Service	Korea Green Promotion Agency, Korea Forest Service(Korea Forest Service)	This paper forms part of the Korea Big Tree Project funded by the Korea Green Promotion Agency, Korea Forest Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Braun-Blanquet J., PLANT SOCIOLOGY STUD; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; CHO H J, 1991, Journal of Korean Forestry Society, V80, P42; Chun JH, 2013, KOREAN J AGR FOR MET, V15, P291; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Culmsee H, 2013, J BIOGEOGR, V40, P1997, DOI 10.1111/jbi.12138; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Eiserhardt WL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01164; Garnier E., 2016, PLANT FUNCTIONAL DIV, DOI DOI 10.1093/ACPROF:OSO/9780198757368.001.0001; Gonzalez-Caro S, 2014, J PLANT ECOL, V7, P145, DOI 10.1093/jpe/rtt076; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Hall JS, 2004, ECOLOGY, V85, P2171, DOI 10.1890/03-0043; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kitagawa R, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv134; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kong W. S., 2007, BIOGEOGRAPHY KOREA P; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Lee CB, 2014, NORD J BOT, V32, P347, DOI 10.1111/j.1756-1051.2013.00181.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Li XH, 2014, J SYST EVOL, V52, P280, DOI 10.1111/jse.12027; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Ordonez A, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1237; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P577, DOI 10.1111/geb.12026; Qian H, 2014, J PLANT ECOL, V7, P154, DOI 10.1093/jpe/rtt072; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rowe R, 2009, ECOGRAPHY, V32, P411, DOI 10.1111/j.1600-0587.2008.05538.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stephenson NL, 2011, SCIENCE, V334, DOI 10.1126/science.1205740; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Storch D, 2005, SCIENCE, V307, P684, DOI 10.1126/science.1106935; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Tilman D., 1982, Monographs in Population Biology, pi; Wang JJ, 2012, ENV MICROBIOL REP, V4, P217, DOI 10.1111/j.1758-2229.2011.00324.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weinstein BG, 2014, AM NAT, V184, P211, DOI 10.1086/676991; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10068; Yang J, 2014, FUNCT ECOL, V28, P520, DOI 10.1111/1365-2435.12176; Yun Jin, 2010, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V12, P63	64	15	15	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185763	10.1371/journal.pone.0185763	http://dx.doi.org/10.1371/journal.pone.0185763			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968448	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600044
J	Hanefeld, M; Engelmann, K; Appelt, D; Sandner, D; Weigmann, I; Ganz, X; Pistrosch, F; Kohler, C; Gasparic, A; Birkenfeld, AL				Hanefeld, Markolf; Engelmann, Katrin; Appelt, Dieter; Sandner, Dirk; Weigmann, Ingo; Ganz, Xenia; Pistrosch, Frank; Koehler, Carsta; Gasparic, Antje; Birkenfeld, Andreas L.			Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes	PLOS ONE			English	Article							MACULAR DEGENERATION; INTRAVITREAL INJECTION; PLASMA-LEVELS; VEGF LEVELS; GLYCEMIC CONTROL; SERUM; RANIBIZUMAB; BEVACIZUMAB; THERAPY; EXPRESSION	Increased levels of systemic vascular endothelial growth factors (VEGFs) in patients with diabetes are associated with increased risk of microvessel disease. On the other hand, low VEGF levels after intravitreal antibody application may be associated with acute cardiovascular complications and treatment failure. Individual levels of systemic VEGF vary in a wide range depending on analytical methods and quality of diabetes control. So far only limited information exists on intraindividual fluctuations over longer periods and circadian rhythms. We analysed the intraindividual variance of VEGF-A, VEGF-C and placental growth factor (PLGF) in CTAD (citrate-theophylline-adenine-dipyridamol) plasma as well as VEGF-A in serum over a period of 6 months in patients with stable controlled type 2 diabetes (10 M, 10 F) and age and sex matched subjects with normal glucose tolerance (NGT). Furthermore, circadian levels of VEGFs were controlled hourly from 7: 30 a. m. to 7: 30 p. m. under standardized metabolic ward conditions. In addition, the relationship to metabolic, hormonal and inflammatory biomarkers was analyzed. VEGF-A, VEGF-C and PLGF remained stable in plasma and VEGF-A in serum over 6 months in both groups. No circadian change was observed in VEGF-A serum and plasma concentrations. A minor decrease of VEGF-C plasma levels was evident after 5 p. m. in both groups and a significant peak of PLGF concentrations occurred after lunch, which was more pronounced in T2DM. In multivariate analysis, only serum VEGF-A correlated to diabetes duration, whereas VEGF-C only correlated to HbA1c and fasting blood glucose. We did not observe significant intraindividual variances for VEGF-A in serum and VEGF-A, VEGF-C and PLGF in CTAD plasma over a period of 6 months. Taken together, a single morning measurement of systemic VEGF levels after 7: 30 am appears to be a reliable parameter for the individual risk associated with abnormal VEGF concentrations in blood.	[Hanefeld, Markolf; Appelt, Dieter; Weigmann, Ingo; Ganz, Xenia; Pistrosch, Frank; Birkenfeld, Andreas L.] GWT TU Dresden GmbH, Study Ctr Metab Vasc Med, Dresden, Germany; [Hanefeld, Markolf; Pistrosch, Frank; Birkenfeld, Andreas L.] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Clin 3, Dresden, Germany; [Engelmann, Katrin] Klinikum Chemnitz gGmbH, Chemnitz, Germany; [Engelmann, Katrin] Tech Univ Dresden, Inst Anat, Expt Ophthalmol, Dresden, Germany; [Sandner, Dirk] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Clin Ophthalmol, Dresden, Germany; [Koehler, Carsta; Gasparic, Antje] GWT TU Dresden GmbH, Med Consulting, Dresden, Germany; [Birkenfeld, Andreas L.] Tech Univ Dresden, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Univ Hosp, Dresden, Germany; [Birkenfeld, Andreas L.] Tech Univ Dresden, Fac Med, Dresden, Germany; [Birkenfeld, Andreas L.] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Birkenfeld, Andreas L.] Kings Coll London, Sect Diabet & Nutr Sci, Rayne Inst, Denmark Hill Campus, London, England	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Chemnitz Clinic; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of London; King's College London	Hanefeld, M (corresponding author), GWT TU Dresden GmbH, Study Ctr Metab Vasc Med, Dresden, Germany.; Hanefeld, M (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Clin 3, Dresden, Germany.	Hanefeld@gwtonline-zks.de	Pistrosch, Frank/J-1398-2019; Birkenfeld, Andreas L./U-3954-2019	Birkenfeld, Andreas L./0000-0003-1407-9023; Pistrosch, Frank/0000-0001-8866-321X	Novartis Pharma	Novartis Pharma	This work was supported by an unrestricted grant from Novartis Pharma.	Avery RL, 2016, JAMA OPHTHALMOL, V134, P21, DOI 10.1001/jamaophthalmol.2015.4070; Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Davidovic SP, 2012, EUR J OPHTHALMOL, V22, P792, DOI 10.5301/ejo.5000118; Gattu AK, 2012, ACTA DIABETOL, V49, pS161, DOI 10.1007/s00592-012-0397-y; Hanefeld M, 2016, HORM METAB RES, V48, P529, DOI 10.1055/s-0042-106295; Hanefeld M, 2016, REV ENDOCR METAB DIS, V17, P5, DOI 10.1007/s11154-016-9345-4; Hetland ML, 2008, DIS MARKERS, V24, P1; Licht P, 2002, EXP CLIN ENDOCR DIAB, V110, P130, DOI 10.1055/s-2002-29090; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mirhafez SR, 2015, BRIT J NUTR, V113, P1911, DOI 10.1017/S0007114515001038; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Moshfeghi AA, 2006, OPHTHALMOLOGY, V113, P2002, DOI 10.1016/j.ophtha.2006.05.070; Nandy D, 2010, J INVEST MED, V58, P804, DOI 10.231/JIM.0b013e3181e96203; Sahebkar A, 2015, METABOLISM, V64, P1466, DOI 10.1016/j.metabol.2015.08.002; Salven P, 1999, CLIN CANCER RES, V5, P487; Schiavetti A, 2012, ANTICANCER RES, V32, P3565; Schlich R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/982458; Schlingemann RO, 2013, DIABETES CARE, V36, P1629, DOI 10.2337/dc12-1951; Schroeder C, 2006, J AM COLL CARDIOL, V48, P516, DOI 10.1016/j.jacc.2006.04.073; Thomeas V, 2014, J CLIN PHARMACOL, V54, P682, DOI 10.1002/jcph.254; Walz JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145375; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110531; Wang XY, 2014, AM J OPHTHALMOL, V158, P738, DOI 10.1016/j.ajo.2014.06.009; Zehetner C, 2013, ACTA OPHTHALMOL, V91, pe470, DOI 10.1111/aos.12081; Zehetner C, 2013, BRIT J OPHTHALMOL, V97, P454, DOI 10.1136/bjophthalmol-2012-302451; Zhao B, 2006, BRIT J OPHTHALMOL, V90, P1052, DOI 10.1136/bjo.2006.091215; Zhou MW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146993; Zhou ZW, 2015, ENDOCR J, V62, P879, DOI 10.1507/endocrj.EJ15-0152	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184234	10.1371/journal.pone.0184234	http://dx.doi.org/10.1371/journal.pone.0184234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991900	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800005
J	Yap, SH; Abdullah, NK; McStea, M; Takayama, K; Chong, ML; Crisci, E; Larsson, M; Azwa, I; Kamarulzaman, A; Leong, KH; Woo, YL; Rajasuriar, R				Yap, Siew Hwei; Abdullah, Noor Kamila; McStea, Megan; Takayama, Kozo; Chong, Meng Li; Crisci, Elisa; Larsson, Marie; Azwa, Iskandar; Kamarulzaman, Adeeba; Leong, Kok Hoong; Woo, Yin Ling; Rajasuriar, Reena			HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; T-CELL-ACTIVATION; SIMPLEX-VIRUS TYPE-2; MICROBIAL TRANSLOCATION; ANTIRETROVIRAL THERAPY; CYTOMEGALOVIRUS; CATABOLISM; MORTALITY; INDIVIDUALS; RECOVERY	Background Co-infections with human herpesvirus (HHV) have been associated with residual chronic inflammation in antiretroviral (ART)-treated human immunodeficiency virus (HIV)-infected individuals. However, the role of HHV in modulating the tryptophan-kynurenine pathway and clinical outcomes in HIV-infected individuals is poorly understood. Thus, we investigated the seroprevalence of four common HHVs among treated HIV-infected participants and their impact on kynurenine/tryptophan (K/T) ratio and long-term CD4 T-cell recovery in HIV/HHV co-infected participants. Method In this cross-sectional study, HIV-infected participants receiving suppressive ART for a minimum of 12 months were recruited from the University Malaya Medical Centre (UMMC), Malaysia. Stored plasma was analyzed for CMV, VZV, HSV-1 and HSV-2 IgG antibody levels, immune activation markers (interleukin-6, interferon-gamma, neopterin and sCD14), kynurenine and tryptophan concentrations. The influence of the number of HHV co-infection and K/T ratio on CD4 T-cell recovery was assessed using multivariate Poisson regression. Results A total of 232 HIV-infected participants were recruited and all participants were seropositive for at least one HHV; 96.1% with CMV, 86.6% with VZV, 70.7% with HSV-1 and 53.9% with HSV-2. K/T ratio had a significant positive correlation with CMV (rho = 0.205, p = 0.002), VZV (rho = 0.173, p = 0.009) and a tendency with HSV-2 (rho = 0.120, p = 0.070), with CMV antibody titer demonstrating the strongest modulating effect on K/T ratio among the four HHVs assessed in SOM analysis. In multivariate analysis, higher K/T ratio (p = 0.03) and increasing number of HHV co-infections (p<0.001) were independently associated with poorer CD4 T-cell recovery following 12 months of ART initiation. Conclusion Multiple HHV co-infections are common among ART-treated HIV-infected participants in the developing country setting and associated with persistent immune activation and poorer CD4 T-cell recovery.	[Yap, Siew Hwei; Abdullah, Noor Kamila; McStea, Megan; Chong, Meng Li; Azwa, Iskandar; Kamarulzaman, Adeeba; Woo, Yin Ling; Rajasuriar, Reena] Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takayama, Kozo] Hoshi Univ, Dept Pharmaceut, Tokyo, Japan; [Crisci, Elisa; Larsson, Marie] Univ Linkoping, Dept Clin & Expt Med, Linkoping, Sweden; [Azwa, Iskandar; Kamarulzaman, Adeeba] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Leong, Kok Hoong; Rajasuriar, Reena] Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia; [Woo, Yin Ling] Univ Malaya, Dept Obstet & Gynecol, Kuala Lumpur, Malaysia; [Rajasuriar, Reena] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Universiti Malaya; Hoshi University; Linkoping University; Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Melbourne	Rajasuriar, R (corresponding author), Univ Malaya, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.; Rajasuriar, R (corresponding author), Univ Malaya, Dept Pharm, Kuala Lumpur, Malaysia.; Rajasuriar, R (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	reena@um.edu.my	McStea, Megan/M-7721-2019; Crisci, Elisa/AAF-9263-2020; Rajasuriar, Reena/B-9569-2010; Leong, Kok Hoong/J-1956-2015; Azwa, Iskandar/N-9186-2017; Woo, Yin Ling/B-5198-2010; Woo, Yin Ling/GPX-0086-2022	McStea, Megan/0000-0002-1241-7845; Crisci, Elisa/0000-0002-4235-8508; Rajasuriar, Reena/0000-0003-3756-0629; Leong, Kok Hoong/0000-0002-7317-6117; Azwa, Iskandar/0000-0003-1977-6709; Woo, Yin Ling/0000-0003-1742-1066; Woo, Yin Ling/0000-0003-1742-1066; Larsson, Marie/0000-0002-4524-0177	High Impact Research/Ministry of Higher Education, Malaysia (HIR/MOHE) [H-20001-E000001]; UMRG [RP029-14HTM]; University of Malaya [PG164-2015B]; Swedish Research Council; Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova [A152731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	High Impact Research/Ministry of Higher Education, Malaysia (HIR/MOHE); UMRG; University of Malaya(Universiti Malaya); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; SIDA SARC; VINNMER for Vinnova(Vinnova); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by High Impact Research/Ministry of Higher Education Research Grant, Malaysia (HIR/MOHE; H-20001-E000001) to AK and RR; UMRG RP029-14HTM and the Postgraduate Research Grant (PG164-2015B), University of Malaya to RR, SHY, AK and YLW; The Swedish Research Council, The Swedish International Development Cooperation Agency, SIDA SARC, VINNMER for Vinnova (A152731) to ML.	Baran H, 2012, INT J TRYPTOPHAN RES, V5, P49, DOI 10.4137/IJTR.S10627; Barrett L, 2014, AIDS, V28, P2045, DOI 10.1097/QAD.0000000000000405; Bipath P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1087-5; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; Brunt SJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/947432; Byakwaga H, 2014, J INFECT DIS, V210, P383, DOI 10.1093/infdis/jiu115; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Chen Jinhu, 2014, Int J Endocrinol, V2014, P203930, DOI 10.1155/2014/203930; Conde-Glez C, 2013, VACCINE, V31, P5067, DOI 10.1016/j.vaccine.2013.08.077; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Crisci E, 2016, J VIROL, V90, P4939, DOI 10.1128/JVI.00224-16; Dagenais-Lussier X, 2016, J VIROL, V90, P7967, DOI 10.1128/JVI.00994-16; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fletcher JM, 2005, J IMMUNOL, V175, P8218, DOI 10.4049/jimmunol.175.12.8218; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gianella S, 2015, J INFECT DIS, V212, P845, DOI 10.1093/infdis/jiv148; Gianella S, 2014, J VIROL, V88, P7818, DOI 10.1128/JVI.00831-14; Hechter RC, 2012, ATHEROSCLEROSIS, V223, P433, DOI 10.1016/j.atherosclerosis.2012.03.002; Huang Y, 2013, BIOANALYSIS; Hunt PW, 2016, J INFECT DIS, V214, pS44, DOI 10.1093/infdis/jiw275; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jenabian M-A, 2013, PLOS ONE, V8; Jenabian MA, 2015, J INFECT DIS, V212, P355, DOI 10.1093/infdis/jiv037; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, HIV AS PAC UNAIDS RE; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kohonen T., 2001, SELF ORG MAPS; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lee SA, 2016, AIDS, V30, P1807, DOI 10.1097/QAD.0000000000001124; Leng SX, 2015, CURR HIV-AIDS REP, V12, P25, DOI 10.1007/s11904-014-0247-3; Letendre S, 2012, 19 C RETR OPP INF; Lichtner M, 2014, J INFECT DIS; Masia M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105442; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; McNally JM, 2001, J VIROL, V75, P5965, DOI 10.1128/JVI.75.13.5965-5976.2001; Mehraj V, 2015, INT J TRYPTOPHAN RES, V8, P41, DOI 10.4137/IJTR.S26862; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Rajasuriar R, 2017, AIDS LOND ENGL; Rajasuriar R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0391-6; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Redd AD, 2015, SEX TRANSM INFECT, V91, P485, DOI 10.1136/sextrans-2014-051867; Romanowski B, 2009, SEX TRANSM DIS, V36, P165, DOI 10.1097/OLQ.0b013e31818d3fb6; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; Sheth PM, 2008, J INFECT DIS, V197, P1394, DOI 10.1086/587697; Singh R, 2003, CLIN EXP IMMUNOL, V133, P97, DOI 10.1046/j.1365-2249.2003.02183.x; Smith MZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-100; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; van de Berg PJ, 2010, J INFECT DIS, V202, P690, DOI 10.1086/655472; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Yang S. Y., 2016, J STROKE CEREBROVASC; Yen YF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151684	58	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186000	10.1371/journal.pone.0186000	http://dx.doi.org/10.1371/journal.pone.0186000			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016635	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800035
J	Chen, C; Xia, SL; Deng, RB; Liu, CF; Shi, GR				Chen, Chu; Xia, Shenglan; Deng, Rubo; Liu, Caifeng; Shi, Gangrong			AhIRT1 and AhNRAMP1 metal transporter expression correlates with Cd uptake in peanuts under iron deficiency	PLOS ONE			English	Article							ARACHIS-HYPOGAEA L.; HYPERACCUMULATOR THLASPI-CAERULESCENS; 2 CONTRASTING ECOTYPES; DURUM-WHEAT CULTIVARS; CADMIUM ACCUMULATION; ROOT MORPHOLOGY; SEDUM-ALFREDII; GAS-EXCHANGE; ELEVATED CO2; TRANSLOCATION	Fe deficiency may increase Cd accumulation in peanuts. However, the mechanisms are not yet fully understood. In the present study, two contrasting peanut cultivars, Luhua 8 (low seed-Cd cultivar) and Zhenghong 3 (high seed-Cd cultivar) were used to investigate the effect of Fe deficiency on the uptake and accumulation of cadmium (Cd) by hydroponic experiments. Under Fe-sufficient conditions, compared with Luhua 8, Zhenghong 3 had higher specific root length (SRL) and proportion of fine roots with a lower K-m for Cd and showed slightly higher expression of AhIRT1 and AhNRAMP1 in the roots. These traits may be responsible for high capacity for Cd accumulation in Zhenghong 3. Under Fe deficiency, the increase of Cd accumulation was much larger in Zhenghong 3 than in Luhua 8. Kinetics studies revealed that the V-max for Cd influx was 1.56-fold higher in Fe-deficient plants than in Fe-sufficient plants for Zhenghong 3, versus 0.48-fold higher for Luhua 8. Moreover, the increased expression levels of AhIRT1 and AhNRAMP1 induced by Fe deficiency was higher in Zhenghong 3 than in Luhua 8. Yeast complementation assays suggested that the AhIRT1 and AhNRAMP1 may function as transporters involved in Cd uptake. In conclusion, the different Cd accumulation between the two cultivars under Fe deficiency may be correlated with V-max value for Cd uptake and the expression levels of AhIRT1 and AhNRAMP1 in the roots.	[Chen, Chu; Xia, Shenglan; Deng, Rubo; Liu, Caifeng; Shi, Gangrong] Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China	Huaibei Normal University	Shi, GR (corresponding author), Huaibei Normal Univ, Coll Life Sci, Huaibei, Peoples R China.	swsgr@126.com			National Natural Science Foundation of China [31671599, 31370515]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support from the National Natural Science Foundation of China (No. 31671599, 31370515) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ronghua Xu (Anhui Science and Technology University) for kindly providing the vector pYES2 and the yeast strain BY4741. Financial support from the National Natural Science Foundation of China (No. 31671599, 31370515) is gratefully acknowledged.	Astolfi S, 2012, J EXP BOT, V63, P1241, DOI 10.1093/jxb/err344; Bell MJ, 1997, AUST J AGR RES, V48, P1151, DOI 10.1071/A97038; Berkelaar E, 2000, CAN J BOT, V78, P381, DOI 10.1139/cjb-78-3-381; Cohen CK, 1998, PLANT PHYSIOL, V116, P1063, DOI 10.1104/pp.116.3.1063; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Ding H, 2010, J PLANT PHYSIOL, V167, P996, DOI 10.1016/j.jplph.2009.12.019; Eissenstat DM, 1997, ADV ECOL RES, V27, P60; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Han F, 2006, PLANT SOIL, V289, P355, DOI 10.1007/s11104-006-9145-9; Harris Neil S., 2004, BMC Plant Biology, V4, P4, DOI 10.1186/1471-2229-4-4; Hart JJ, 1998, PLANT PHYSIOL, V116, P1413, DOI 10.1104/pp.116.4.1413; He JY, 2007, BIOL PLANTARUM, V51, P791, DOI 10.1007/s10535-007-0162-1; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Kumari V, 2014, CROP J, V2, P110, DOI 10.1016/j.cj.2014.03.002; Li TQ, 2012, PLANT SOIL, V354, P325, DOI 10.1007/s11104-011-1068-4; Li TQ, 2005, J ENVIRON SCI HEAL A, V40, P1081, DOI 10.1081/ESE-200056163; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lombi E, 2002, PLANT PHYSIOL, V128, P1359, DOI 10.1104/pp.010731; Lombi E, 2001, NEW PHYTOL, V149, P53, DOI 10.1046/j.1469-8137.2001.00003.x; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Lu ZW, 2013, ECOTOX ENVIRON SAFE, V91, P147, DOI 10.1016/j.ecoenv.2013.01.017; McLaughlin MJ, 2000, PLANT SOIL, V222, P51, DOI 10.1023/A:1004771712840; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; Redjala T, 2009, ENVIRON EXP BOT, V67, P235, DOI 10.1016/j.envexpbot.2009.05.012; ROMHELD V, 1981, PHYSIOL PLANTARUM, V53, P354, DOI 10.1111/j.1399-3054.1981.tb04512.x; Shi GR, 2015, ENVIRON EXP BOT, V111, P127, DOI 10.1016/j.envexpbot.2014.11.008; Shi GR, 2014, ECOTOX ENVIRON SAFE, V110, P174, DOI 10.1016/j.ecoenv.2014.09.003; Shi GR, 2014, PLANT SOIL, V375, P99, DOI 10.1007/s11104-013-1953-0; Siedlecka A, 1996, PLANT PHYSIOL BIOCH, V34, P833; Su GQ, 2013, PLANT SOIL, V365, P337, DOI 10.1007/s11104-012-1394-1; Su Y, 2014, ENVIRON EXP BOT, V97, P40, DOI 10.1016/j.envexpbot.2013.10.001; Su Y, 2013, PLANT SOIL, V363, P201, DOI 10.1007/s11104-012-1310-8; Takahashi R, 2011, PLANT SIGNAL BEHAV, V6, P1813, DOI 10.4161/psb.6.11.17587; Takkar P, 1984, J PLANT NUTR; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Wang RG, 2012, ENVIRON EARTH SCI, V67, P1, DOI 10.1007/s12665-011-1475-0; Wang SS, 2014, ECOTOX ENVIRON SAFE, V108, P23, DOI 10.1016/j.ecoenv.2014.06.029; Xiong HC, 2012, J EXP BOT, V63, P4437, DOI 10.1093/jxb/ers117; Zamboni A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-101; Zhang Z, 2013, ACTA PHYSIOL PLANT, V35, P2105, DOI 10.1007/s11738-013-1247-4; Zhao FJ, 2006, NEW PHYTOL, V172, P646, DOI 10.1111/j.1469-8137.2006.01867.x; Zhao FJ, 2002, J EXP BOT, V53, P535, DOI 10.1093/jexbot/53.368.535	46	9	9	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185144	10.1371/journal.pone.0185144	http://dx.doi.org/10.1371/journal.pone.0185144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981520	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300028
J	Fayyaz, SSK; Liu, XYC; Zhang, GH				Fayyaz, S. Kiavash S.; Liu, Xiaoyue Cathy; Zhang, Guohui			An efficient General Transit Feed Specification (GTFS) enabled algorithm for dynamic transit accessibility analysis	PLOS ONE			English	Article							K-SHORTEST PATHS; PHYSICAL ACCESSIBILITY; PUBLIC TRANSPORT; NETWORK; GIS; PATTERNS; BENEFITS; JUSTICE; EQUITY	The social functions of urbanized areas are highly dependent on and supported by the convenient access to public transportation systems, particularly for the less privileged populations who have restrained auto ownership. To accurately evaluate the public transit accessibility, it is critical to capture the spatiotemporal variation of transit services. This can be achieved by measuring the shortest paths or minimum travel time between origin-destination (OD) pairs at each time-of-day (e.g. every minute). In recent years, General Transit Feed Specification (GTFS) data has been gaining popularity for between-station travel time estimation due to its interoperability in spatiotemporal analytics. Many software packages, such as ArcGIS, have developed toolbox to enable the travel time estimation with GTFS. They perform reasonably well in calculating travel time between OD pairs for a specific time-of-day (e.g. 8: 00 AM), yet can become computational inefficient and unpractical with the increase of data dimensions (e.g. all times-of-day and large network). In this paper, we introduce a new algorithm that is computationally elegant and mathematically efficient to address this issue. An open-source toolbox written in C++ is developed to implement the algorithm. We implemented the algorithm on City of St. George's transit network to showcase the accessibility analysis enabled by the toolbox. The experimental evidence shows significant reduction on computational time. The proposed algorithm and toolbox presented is easily transferable to other transit networks to allow transit agencies and researchers perform high resolution transit performance analysis.	[Fayyaz, S. Kiavash S.; Liu, Xiaoyue Cathy] Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA; [Zhang, Guohui] Univ Hawaii Manoa, Dept Civil & Environm Engn, Honolulu, HI USA	Utah System of Higher Education; University of Utah; University of Hawaii System; University of Hawaii Manoa	Liu, XYC (corresponding author), Univ Utah, Dept Civil & Environm Engn, Salt Lake City, UT 84112 USA.	cathy.liu@utah.edu			First Mile Last Mile Strategies for Transit Systems - U.S. Department of Transportation University Transportation Center [MPC-466]; UTA; Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers	First Mile Last Mile Strategies for Transit Systems - U.S. Department of Transportation University Transportation Center; UTA; Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers	This work was supported by MPC-466 First Mile Last Mile Strategies for Transit Systems, http://www.mountain-plains.org/research/projects/list.php?year=2014, sponsored by U.S. Department of Transportation University Transportation Center, PI: XL.; This paper is based on the research project entitled First Mile Last Mile Strategies for Transit Systems, jointly sponsored by UTA and the Mountain Plain Consortium (MPC) of the U.S. DOT University Transportation Centers program. The authors would like to thank Ali Shafiee Ardestani and Meysam Taassori for their input and feedback on the computing toolbox development. The work presented in this paper remains the sole responsibility of the authors.	Anderson P. A., 2013, 92 ANN M TRANSP RES; Barbeau SJ, 2011, TECHNICAL REPORT; Bauer R., 2009, J EXPT ALGORITHMICS, V14; Benenson I, 2010, TRANSPORT RES REC, P28, DOI 10.3141/2144-04; Bhat C., 2000, TX01749381 TEX DEP T; Bhat CR, 05178P3 TXDOT U TEX; Burns L. D., 1979, TRANSPORTATION TEMPO; Cao J, 2013, J TRANSP GEOGR, V28, P12, DOI 10.1016/j.jtrangeo.2012.10.008; Catal? M., 2011, EXPANDING GOOGLE TRA; Chen YL, 2004, COMPUT OPER RES, V31, P499, DOI 10.1016/S0305-0548(02)00230-7; Chuang TN, 2005, COMPUT OPER RES, V32, P1409, DOI 10.1016/j.cor.2003.11.011; Coffel K, 2012, 153 TCRP TRANSP RES; Delling D, 2009, LECT NOTES COMPUT SC, V5868, P182, DOI 10.1007/978-3-642-05465-5_7; Desaulniers G, 2003, INT J FLEX MANUF SYS, V15, P309, DOI 10.1023/B:FLEX.0000036032.41757.3d; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dill J., 2013, P 92 ANN M TRANSP RE; El-Geneidy A.M., ACCESS DESTINATIONS; Fan Y, IMPACT LIGHT RAIL IM; Farber S, 2016, TRAVEL BEHAV SOC, V4, P40, DOI 10.1016/j.tbs.2016.01.001; Farber S, 2014, APPL GEOGR, V53, P149, DOI 10.1016/j.apgeog.2014.06.012; Fayyaz SK, 2017, J TRANSP GEOGR, V59, P27, DOI 10.1016/j.jtrangeo.2017.01.006; Foth N, 2013, J TRANSP GEOGR, V29, P1, DOI 10.1016/j.jtrangeo.2012.12.008; Fransen K, 2015, J TRANSP GEOGR, V48, P176, DOI 10.1016/j.jtrangeo.2015.09.008; GEERTMAN SCM, 1995, INT J GEOGR INF SYST, V9, P67, DOI 10.1080/02693799508902025; Geurs K., 2001, ACCESSIBILITY MEASUR; Geurs K.T., 2004, J TRANSP GEOGR, V12, P127, DOI [10.1016/j.jtrangeo.2003.10.005, DOI 10.1016/J.JTRANGEO.2003.10.005]; Golub A, 2014, J TRANSP GEOGR, V41, P10, DOI 10.1016/j.jtrangeo.2014.07.014; Granat J, 2003, EUR J OPER RES, V151, P103, DOI 10.1016/S0377-2217(02)00594-5; Gutierrez J., 2001, J TRANSP GEOGR, V9, P229, DOI [DOI 10.1016/S0966-6923(01)00017-5, 10.1016/S0966-6923(01)00017-5]; Gutierrez J., 1996, J TRANSP GEOGR, V4, P227, DOI DOI 10.1016/S0966-6923(96)00033-6; HANSEN WG, 1959, J AM I PLANNERS, V25, P73, DOI 10.1080/01944365908978307; Jariyasunant J, 2011, TRANSPORT RES REC, P34, DOI 10.3141/2256-05; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Koenig JG, 1980, TRANSPORTATION, P9; Krizek K., ACCESS DESTINATIONS; Lei TL, 2010, INT J GEOGR INF SCI, V24, P283, DOI 10.1080/13658810902835404; Litman T, 2003, AM J HEALTH PROMOT, V18, P103, DOI 10.4278/0890-1171-18.1.103; Litman T, 1999, TRANSPORT RES REC, V1670, P8, DOI DOI 10.3141/1670-02; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2014, J TRANSP ENG, V140, DOI 10.1061/(ASCE)TE.1943-5436.0000714; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Martens K., 2009, 88 ANN M TRANSP RES, P11; Martens K, 2012, TRANSPORT RES A-POL, V46, P684, DOI 10.1016/j.tra.2012.01.004; Mavoa S, 2012, J TRANSP GEOGR, V20, P15, DOI 10.1016/j.jtrangeo.2011.10.001; Miller HJ, 1999, GEOGR ANAL, V31, P1, DOI 10.1111/j.1538-4632.1999.tb00408.x; O'Sullivan D, 2000, INT J GEOGR INF SCI, V14, P85, DOI 10.1080/136588100240976; O'Sullivan S., 1996, TRANSPORT RES REC, V1538, P19, DOI DOI 10.3141/1538-03; Okada S, 2004, FUZZY SET SYST, V142, P335, DOI 10.1016/S0165-0114(03)00225-2; Owen A, 2015, TRANSPORT RES A-POL, V74, P110, DOI 10.1016/j.tra.2015.02.002; Pallottino S, 2003, OPER RES LETT, V31, P149, DOI 10.1016/S0167-6377(02)00192-X; Pettie S, 2004, THEOR COMPUT SCI, V312, P47, DOI 10.1016/S0304-3975(03)00402-X; Polzin SE, 2002, TRANSPORT RES REC, P35, DOI 10.3141/1799-05; Puchalsky C. M., 2012, 91 ANN M TRANSP RES; Pyrga E., 2007, J EXP ALGORITHMICS, V12, P1, DOI [10.1145/1227161.1227166, DOI 10.1145/1227161.1227166]; Sallis JF, 2004, TRANSPORT RES A-POL, V38, P249, DOI 10.1016/j.tra.2003.11.003; Scheuren J.M., 2007, ACCESSIBILITY MEASUR, P52; Schrijver A., 2002, SPRINGER SCI BU 1210; Shannon T, 2006, TRANSPORT POLICY, P13; Tan MC, 2007, J ADV TRANSPORT, V41, P285, DOI 10.1002/atr.5670410305; Thorup M., 2003, P 35 ANN ACM S THEOR, P149, DOI DOI 10.1016/J.JCSS.2004.04.003; Tremblay N, 2001, PARALLEL COMPUT, V27, P1569, DOI 10.1016/S0167-8191(01)00107-7; van der Zijpp NJ, 2005, TRANSPORT RES B-METH, V39, P545, DOI 10.1016/j.trb.2004.07.004; Van Wee B., 2001, J TRANSP GEOGR, V9, P199, DOI [10.1016/S0966-6923(01)00010-2, DOI 10.1016/S0966-6923(01)00010-2]; VICKERMARW, 1974, ENVIRON PLANN A, V6, P675; WACHS M, 1973, SOCIO ECON PLAN SCI, V7, P437, DOI 10.1016/0038-0121(73)90041-4; Wong JC, THESIS; Xu WT, 2012, COMPUT OPER RES, V39, P1812, DOI 10.1016/j.cor.2010.02.005; Zhao LY, 2008, LECT NOTES ARTIF INT, V5009, P747, DOI 10.1007/978-3-540-79721-0_99	68	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185333	10.1371/journal.pone.0185333	http://dx.doi.org/10.1371/journal.pone.0185333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981544	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300034
J	Ihara, K; Fukuda, S; Enkhtaivan, B; Trujillo, R; Perez-Bello, D; Nelson, C; Randolph, A; Alharbi, S; Hanif, H; Herndon, D; Prough, D; Enkhbaatar, P				Ihara, Koji; Fukuda, Satoshi; Enkhtaivan, Baigalmaa; Trujillo, Raul; Perez-Bello, Dannelys; Nelson, Christina; Randolph, Anita; Alharbi, Suzan; Hanif, Hira; Herndon, David; Prough, Donald; Enkhbaatar, Perenlei			Adipose-derived stem cells attenuate pulmonary microvascular hyperpermeability after smoke inhalation	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; STROMAL CELLS; BONE-MARROW; OXIDATIVE STRESS; NEUTROPHIL ACTIVATION; COMBINED BURN; NITRIC-OXIDE; SHEEP; SEPSIS	Background Pulmonary edema is a hallmark of acute respiratory distress syndrome (ARDS). Smoke inhalation causes ARDS, thus significantly increasing the mortality of burn patients. Adipose-derived stem cells (ASCs) exert potent anti-inflammatory properties. The goal of the present study was to test the safety and ecfficacy of ASCs, in a well-characterized clinically relevant ovine model of ARDS. Methods Female sheep were surgically prepared. ARDS was induced by cooled cotton smoke inhalation. Following injury, sheep were ventilated, resuscitated with lactated Ringer's solution, and cardiopulmonary hemodynamics were monitored for 48 hours in a conscious state. Pulmonary microvascular hyper-permeability was assessed by measuring lung lymph flow, extravascular lung water content, protein content in plasma and lung lymph fluid. Sheep were randomly allocated to two groups: 1) ASCs: infused with 200 million of ASCs in 200mL of PlasmaLyteA starting 1 hours post-injury, n = 5; 2) control, treated with 200mL of PlasmaLyteA in a similar pattern, n = 5. Results Lung lymph flow increased 9-fold in control sheep as compared to baseline. Protein in the plasma was significantly decreased, while it was increased in the lung lymph. The treatment with ASCs significantly attenuated these changes. Treatment with ASCs almost led to the reversal of increased pulmonary vascular permeability and lung water content. Pulmonary gas exchange was significantly improved by ASCs. Infusion of the ASCs did not negatively affect pulmonary artery pressure and other hemodynamic variables. Conclusions ASCs infusion was well tolerated. The results suggest that intravenous ASCs modulate pulmonary microvascular hyper-permeability and prevent the onset of ARDS in our experimental model.	[Ihara, Koji; Fukuda, Satoshi; Enkhtaivan, Baigalmaa; Trujillo, Raul; Perez-Bello, Dannelys; Nelson, Christina; Randolph, Anita; Alharbi, Suzan; Hanif, Hira; Prough, Donald; Enkhbaatar, Perenlei] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Ihara, Koji] Kagoshima City Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan; [Ihara, Koji] Tokyo Womens Med Sch, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Herndon, David] Shriners Hosp Children, Dept Surg, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; Kagoshima City Hospital; Tokyo Women's Medical University; University of Texas System; University of Texas Medical Branch Galveston	Ihara, K (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.; Ihara, K (corresponding author), Kagoshima City Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan.; Ihara, K (corresponding author), Tokyo Womens Med Sch, Dept Plast & Reconstruct Surg, Tokyo, Japan.	ihara.koji@twmu.ac.jp	Prough, Donald S/G-5793-2013; Herndon, David/AAC-3354-2020; Alharbi, Suzan Abdulkarim/AAT-7519-2021	Prough, Donald S/0000-0001-7994-532X; Alharbi, Suzan Abdulkarim/0000-0002-4572-856X; Fukuda, Satoshi/0000-0003-3739-6494	Shriners of North America [SHC84050, 85100]	Shriners of North America	This study was supported by the Shriners of North America (grants SHC84050 and 85100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen S, 2014, THORAX, V69, P819, DOI 10.1136/thoraxjnl-2013-204980; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Cox RA, 2005, EXP LUNG RES, V31, P819, DOI 10.1080/01902140600574967; Cox RA, 2007, PULM PHARMACOL THER, V20, P172, DOI 10.1016/j.pupt.2006.03.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Enkhbaatar P, 2004, CLIN SCI, V107, P137, DOI 10.1042/CS20040135; Enkhbaatar P, 2003, AM J RESP CRIT CARE, V167, P1021, DOI 10.1164/rccm.200209-1031PP; Enkhbaatar P, 2016, LANCET, V388, P1437, DOI 10.1016/S0140-6736(16)31458-1; Fang XH, 2015, J IMMUNOL, V195, P875, DOI 10.4049/jimmunol.1500244; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Hao Q, 2015, STEM CELL TRANSL MED, V4, P832, DOI 10.5966/sctm.2015-0006; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; KIMURA R, 1988, J APPL PHYSIOL, V64, P1107, DOI 10.1152/jappl.1988.64.3.1107; Lai TS, 2015, CHINESE MED J-PEKING, V128, P361, DOI 10.4103/0366-6999.150106; Lange M, 2012, SHOCK, V37, P468, DOI 10.1097/SHK.0b013e31824b1793; Lange M, 2012, EXP LUNG RES, V38, P157, DOI 10.3109/01902148.2012.663453; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Liu KD, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0022-z; Manning E, 2010, HUM GENE THER, V21, P713, DOI 10.1089/hum.2009.147; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mohammadzadeh M, 2012, CELL STRESS CHAPERON, V17, P553, DOI 10.1007/s12192-012-0331-9; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pati S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025171; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rehberg S, 2013, CRIT CARE MED, V41, pE439, DOI 10.1097/CCM.0b013e318298ad3a; Rehberg Sebastian, 2009, Expert Rev Respir Med, V3, P283, DOI 10.1586/ers.09.21; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Soejima K, 2001, AM J RESP CRIT CARE, V163, P745, DOI 10.1164/ajrccm.163.3.9912052; Soejima K, 2001, AM J PHYSIOL-LUNG C, V280, pL1233, DOI 10.1152/ajplung.2001.280.6.L1233; STAUB NC, 1975, J SURG RES, V19, P315, DOI 10.1016/0022-4804(75)90056-6; Traber DL, 2005, SHOCK, V24, P82, DOI 10.1097/01.shk.0000191338.39154.73; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6; Wang Q, 2013, AM J RESP CELL MOL, V48, P610, DOI 10.1165/rcmb.2012-0274OC; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]; Zhang SJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt161	46	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185937	10.1371/journal.pone.0185937	http://dx.doi.org/10.1371/journal.pone.0185937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982177	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300092
J	Khan, NB; Ibrahim, Z; Nguyen, LTT; Javed, MF; Jameel, M				Khan, Niaz Bahadur; Ibrahim, Zainah; Linh Tuan The Nguyen; Javed, Muhammad Faisal; Jameel, Mohammed			Numerical investigation of the vortex-induced vibration of an elastically mounted circular cylinder at high Reynolds number (Re=10(4)) and low mass ratio using the RANS code	PLOS ONE			English	Article							LARGE-EDDY SIMULATION; VERY-LOW MASS; OSCILLATING CYLINDER; FLOW; TURBULENT; DYNAMICS; SMOOTH	This study numerically investigates the vortex-induced vibration (VIV) of an elastically mounted rigid cylinder by using Reynolds-averaged Navier-Stokes (RANS) equations with computational fluid dynamic (CFD) tools. CFD analysis is performed for a fixed-cylinder case with Reynolds number (Re) = 10 4 and for a cylinder that is free to oscillate in the transverse direction and possesses a low mass-damping ratio and Re = 10(4). Previously, similar studies have been performed with 3-dimensional and comparatively expensive turbulent models. In the current study, the capability and accuracy of the RANS model are validated, and the results of this model are compared with those of detached eddy simulation, direct numerical simulation, and large eddy simulation models. All three response branches and the maximum amplitude are well captured. The 2-dimensional case with the RANS shear-stress transport k-w model, which involves minimal computational cost, is reliable and appropriate for analyzing the characteristics of VIV.	[Khan, Niaz Bahadur; Ibrahim, Zainah] Univ Malaya, Fac Engn, Dept Civil, Kuala Lumpur, Malaysia; [Linh Tuan The Nguyen] PetroVietnam Explorat & Prod Co, Hanoi, Vietnam; [Javed, Muhammad Faisal] COMSATS Inst Informat Technol, Dept Civil Engn, Abbottabad, Pakistan; [Jameel, Mohammed] Lords Inst Engn & Technol, Civil Engn Dept, Hyderabad, Andhra Pradesh, India	Universiti Malaya; COMSATS University Islamabad (CUI)	Khan, NB; Ibrahim, Z (corresponding author), Univ Malaya, Fac Engn, Dept Civil, Kuala Lumpur, Malaysia.	n_bkhan@yahoo.com; zainah@um.edu.my	IBRAHIM, ZAINAH/GQU-0237-2022; IBRAHIM, ZAINAH/C-1117-2010; Khan, Niaz B/C-5539-2016; MOHAMMED JAMEEL, MOHAMMED JAMEEL/B-9057-2010; Javed, Muhammad Faisal/AFD-8149-2022; Khan, Niaz Bahadur/ACU-7263-2022; IBRAHIM, ZAINAH/R-5259-2019; Javed, Muhammad/AAM-8277-2021	IBRAHIM, ZAINAH/0000-0002-0748-9190; IBRAHIM, ZAINAH/0000-0002-0748-9190; Khan, Niaz B/0000-0003-4141-5600; MOHAMMED JAMEEL, MOHAMMED JAMEEL/0000-0001-5968-6623; Javed, Muhammad Faisal/0000-0001-5478-9324; Khan, Niaz Bahadur/0000-0003-4141-5600; IBRAHIM, ZAINAH/0000-0002-0748-9190; 	Ministry of Education, Malaysia [FP004-2014B]; University Malaya Research Grant (UMRG) [RP004E-13AET]; University Malaya Postgraduate Research Fund [PG102-2014B]; PetroVietnam, Exploration and Production Company, a commercial company	Ministry of Education, Malaysia; University Malaya Research Grant (UMRG); University Malaya Postgraduate Research Fund; PetroVietnam, Exploration and Production Company, a commercial company	The authors gratefully acknowledged the support given by Fundamental Research Grant Scheme, Ministry of Education, Malaysia (FRGS - Project No. FP004-2014B), University Malaya Research Grant (UMRG - Project No. RP004E-13AET), University Malaya Postgraduate Research Fund (PPP - Project No. PG102-2014B). PetroVietnam, Exploration and Production Company, a commercial company, provided support in the form of salary for author Linh Tuan The Nguyen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANSYS, 2016, ANS FLUENT MAN R; Bearman PW, 2011, J FLUID STRUCT, V27, P648, DOI 10.1016/j.jfluidstructs.2011.03.021; Behara S, 2016, J FLUID STRUCT, V66, P54, DOI 10.1016/j.jfluidstructs.2016.07.005; Bishop R, 1964, P ROYAL SOC LOND MAT; Breuer M, 1998, INT J NUMER METH FL, V28, P1281, DOI 10.1002/(SICI)1097-0363(19981215)28:9<1281::AID-FLD759>3.0.CO;2-#; Dong S, 2006, J FLUID MECH, V569, P185, DOI 10.1017/S0022112006002606; Dong S, 2005, J FLUID STRUCT, V20, P519, DOI 10.1016/j.jfluidstructs.2005.02.004; Fang Y.Y., 2011, APPL MECH MAT; Franke J, 2002, J WIND ENG IND AEROD, V90, P1191, DOI 10.1016/S0167-6105(02)00232-5; Gopalkrishnan R, 1993, VORTEX INDUCED FORCE; Guilmineau E, 2004, J FLUID STRUCT, V19, P449, DOI 10.1016/j.jfluidstructs.2004.02.004; Hover FS, 1997, J FLUID STRUCT, V11, P307, DOI 10.1006/jfls.1996.0079; Islam SU, 2016, ARAB J SCI ENG, P1; Jauvtis N, 2004, J FLUID MECH, V509, P23, DOI 10.1017/S0022112004008778; Jie S, 2006, INT J COMPUT FLUID D, V20, P301, DOI 10.1080/10618560600898437; Khalak A, 1996, J FLUID STRUCT, V10, P455, DOI 10.1006/jfls.1996.0031; Khalak A, 1997, J FLUID STRUCT, V11, P973, DOI 10.1006/jfls.1997.0110; Khan NB, 2016, ASME 2016 35 INT C O; Li W, 2014, OCEANS 2014 TAIPEI; LIANGJIE M, 2014, PLOS ONE, V0009; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Nguyen VT, 2016, J FLUID STRUCT, V63, P103, DOI 10.1016/j.jfluidstructs.2016.02.004; Norberg C, 2003, J FLUID STRUCT, V17, P57, DOI 10.1016/S0889-9746(02)00099-3; Pan ZY, 2007, J FLUID STRUCT, V23, P23, DOI 10.1016/j.jfluidstructs.2006.07.007; Parkinson G., 1989, PROGR AEROSPACE SCI, V26, P169, DOI [10.1016/0376-0421(89)90008-0, DOI 10.1016/0376-0421(89)90008-0]; Placzek A, 2009, COMPUT FLUIDS, V38, P80, DOI 10.1016/j.compfluid.2008.01.007; Sarpkaya T, 2004, J FLUID STRUCT, V19, P389, DOI 10.1016/j.jfluidstructs.2004.02.005; Tutar M, 2000, J FLUID ENG-T ASME, V122, P694, DOI 10.1115/1.1287270; Ul Islam S, 2012, J MECH SCI TECHNOL, V26, P1027, DOI 10.1007/s12206-012-0328-4; Williamson C.H.K., 1988, J FLUIDS STRUCT, V2, P355, DOI [10.1016/S0889-9746(88)90058-8, DOI 10.1016/S0889-9746(88)90058-8, 10.1016/s0889-9746(88)90058-8]; Williamson CHK, 2004, ANNU REV FLUID MECH, V36, P413, DOI 10.1146/annurev.fluid.36.050802.122128; Wornom S, 2011, COMPUT FLUIDS, V47, P44, DOI 10.1016/j.compfluid.2011.02.011; ZDRAVKOVICH MM, 1990, J WIND ENG IND AEROD, V33, P53, DOI 10.1016/0167-6105(90)90020-D; Zhao M, 2014, J FLUID STRUCT, V50, P292, DOI 10.1016/j.jfluidstructs.2014.05.016	34	51	53	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185832	10.1371/journal.pone.0185832	http://dx.doi.org/10.1371/journal.pone.0185832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982172	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300074
J	Martin, PM; Palhiere, I; Ricard, A; Tosser-Klopp, G; Rupp, R				Martin, Pauline Marie; Palhiere, Isabelle; Ricard, Anne; Tosser-Klopp, Gwenola; Rupp, Rachel			Genome Wide Association Study Identifies New Loci Associated with Undesired Coat Color Phenotypes in Saanen Goats (vol 11, e0152426, 2016)	PLOS ONE			English	Correction														TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673	Region Midi-Pyrenees; Animal Genetics Department from INRA; GENOMCAP; INRA; APIS-GENE; ALLICE; CAPGENES; FCEL	Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); Animal Genetics Department from INRA; GENOMCAP; INRA; APIS-GENE; ALLICE; CAPGENES; FCEL	PMM received a doctoral research grant from "Region Midi-Pyrenees", Animal Genetics Department from INRA and GENOMCAP research program including INRA, APIS-GENE, ALLICE (formerly UNCEIA), CAPGENES and FCEL.	Martin PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152426	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186029	10.1371/journal.pone.0186029	http://dx.doi.org/10.1371/journal.pone.0186029			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982168	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300112
J	Sasaki, Y; Kojima, A; Shibata, Y; Mitsuzawa, H				Sasaki, Yoshie; Kojima, Ayumi; Shibata, Yuriko; Mitsuzawa, Hiroshi			Filamentous invasive growth of mutants of the genes encoding ammonia-metabolizing enzymes in the fission yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GLUTAMATE SYNTHASE; CANDIDA-ALBICANS; TRANSPORTERS; TRANSITION; STARVATION; PERMEASES; STRAINS; MARKER; FAMILY	The fission yeast Schizosaccharomyces pombe undergoes a switch from yeast to filamentous invasive growth in response to certain environmental stimuli. Among them is ammonium limitation. Amt1, one of the three ammonium transporters in this yeast, is required for the ammonium limitation-induced morphological transition; however, the underlying molecular mechanism remains to be understood. Cells lacking Amt1 became capable of invasive growth upon increasing concentrations of ammonium in the medium, suggesting that the ammonium taken up into the cell or a metabolic intermediate in ammonium assimilation might serve as a signal for the ammonium limitation-induced morphological transition. To investigate the possible role of ammonium-metabolizing enzymes in the signaling process, deletion mutants were constructed for the gdh1, gdh2, gln1, and glt1 genes, which were demonstrated by enzyme assays to encode NADP-specific glutamate dehydrogenase, NAD-specific glutamate dehydrogenase, glutamine synthetase, and glutamate synthase, respectively. Growth tests on various nitrogen sources revealed that a gln1. mutant was a glutamine auxotroph and that a gdh1. mutant had a defect in growth on ammonium, particularly at high concentrations. The latter observation indicates that the NADP-specific glutamate dehydrogenase of S. pombe plays a major role in ammonium assimilation under high ammonium concentrations. Invasive growth assays showed that gdh1. and glt1. mutants underwent invasive growth to a lesser extent than did wild-type strains. Increasing the ammonium concentration in the medium suppressed the invasive growth defect of the glt1. mutant, but not the gdh1. mutant. These results suggest that the nitrogen status of the cell is important in the induction of filamentous invasive growth in S. pombe.	[Sasaki, Yoshie] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Fujisawa, Kanagawa, Japan; [Kojima, Ayumi; Shibata, Yuriko] Nihon Univ, Coll Bioresource Sci, Dept Food Biosci & Biotechnol, Fujisawa, Kanagawa, Japan; [Mitsuzawa, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Biosci Daily Life, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University	Mitsuzawa, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Biosci Daily Life, Fujisawa, Kanagawa, Japan.	mitsuzawa.hiroshi@nihon-u.ac.jp		Mitsuzawa, Hiroshi/0000-0001-6328-0247				Amoah-Buahin E, 2005, EUKARYOT CELL, V4, P1287, DOI 10.1128/EC.4.7.1287-1297.2005; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Bahn YS, 2007, NAT REV MICROBIOL, V5, P57, DOI 10.1038/nrmicro1578; BAREL I, 1988, CURR GENET, V13, P487, DOI 10.1007/BF02427754; BAREL I, 1993, FEMS MICROBIOL LETT, V113, P267, DOI 10.1016/0378-1097(93)90216-O; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Bozsik A, 2002, YEAST, V19, P485, DOI 10.1002/yea.853; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dodgson J, 2010, EUKARYOT CELL, V9, P1788, DOI 10.1128/EC.00084-10; Doherty D., 1970, METHOD ENZYMOL, V17, P850, DOI DOI 10.1016/0076-6879(71)17294-1; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GOLD S, 1994, GENE DEV, V8, P2805, DOI 10.1101/gad.8.23.2805; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; Lee SC, 2012, EUKARYOT CELL, V11, P1391, DOI 10.1128/EC.00242-12; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mitsuzawa H, 2006, GENES CELLS, V11, P1183, DOI 10.1111/j.1365-2443.2006.01014.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; PERYSINAKIS A, 1994, CURR GENET, V26, P315, DOI 10.1007/BF00310495; PERYSINAKIS A, 1995, CURR MICROBIOL, V30, P367, DOI 10.1007/BF00369864; Prevorovsky M, 2009, FEMS MICROBIOL LETT, V293, P130, DOI 10.1111/j.1574-6968.2009.01515.x; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; ROON RJ, 1974, J BACTERIOL, V118, P89, DOI 10.1128/JB.118.1.89-95.1974; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; Sipiczki M, 1998, MICROBIOL-SGM, V144, P3475, DOI 10.1099/00221287-144-12-3475; Sipiczki M, 1998, MICROBIOL-SGM, V144, P1319, DOI 10.1099/00221287-144-5-1319; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3; WADDELL S, 1995, NUCLEIC ACIDS RES, V23, P1836, DOI 10.1093/nar/23.10.1836	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186028	10.1371/journal.pone.0186028	http://dx.doi.org/10.1371/journal.pone.0186028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982178	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300111
J	Velarde, C; Robledo, A				Velarde, Carlos; Robledo, Alberto			Rank distributions: Frequency vs. magnitude	PLOS ONE			English	Article							LAWS	We examine the relationship between two different types of ranked data, frequencies and magnitudes. We consider data that can be sorted out either way, through numbers of occurrences or size of the measures, as it is the case, say, of moon craters, earthquakes, billionaires, etc. We indicate that these two types of distributions are functional inverses of each other, and specify this link, first in terms of the assumed parent probability distribution that generates the data samples, and then in terms of an analog (deterministic) nonlinear iterated map that reproduces them. For the particular case of hyperbolic decay with rank the distributions are identical, that is, the classical Zipf plot, a pure power law. But their difference is largest when one displays logarithmic decay and its counterpart shows the inverse exponential decay, as it is the case of Benford law, or viceversa. For all intermediate decay rates generic differences appear not only between the power-law exponents for the midway rank decline but also for small and large rank. We extend the theoretical framework to include thermodynamic and statistical-mechanical concepts, such as entropies and configuration.	[Velarde, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City, DF, Mexico; [Robledo, Alberto] Univ Nacl Autonoma Mexico, Inst Fis & Ctr Ciencias Complejidad, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Robledo, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis & Ctr Ciencias Complejidad, Mexico City, DF, Mexico.	robledo@fisica.unam.mx	; Velarde, Carlos/R-9890-2016	Robledo, Alberto/0000-0002-6853-1487; Velarde, Carlos/0000-0001-8381-0823	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico (UNAM)	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico (UNAM)	This work was supported by Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Universidad Nacional Autonoma de Mexico (UNAM) (http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit-IN104417-Prof. Alberto Robledo).	Altamirano C, 2011, EUR PHYS J B, V81, P345, DOI 10.1140/epjb/e2011-10968-5; [Anonymous], RANK SIZ DISTR; [Anonymous], FREQ RANK DISTR; [Anonymous], QUANT FUNCT; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Callen H. B, 1993, THERMODYNAMICS INTRO; Yalcin GC, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00045; Egghe L, 2011, INFORM PROCESS MANAG, V47, P238, DOI 10.1016/j.ipm.2010.03.009; Forest Fires Data, FOR FIR DAT CLAUS HO; HU B, 1982, PHYS REV LETT, V48, P1645, DOI 10.1103/PhysRevLett.48.1645; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; Robledo A, 2011, CHINESE SCI BULL, V56, P3643, DOI 10.1007/s11434-011-4827-y; Schuster H. G., 1988, INTRODUCTION; Tisza L., 1993, GEN THERMODYNAMICS; Wikipedia, BENF LAW; Yalcin GC, 2014, P NATL ACAD SCI USA, V111, P14082, DOI 10.1073/pnas.1412093111; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	18	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186015	10.1371/journal.pone.0186015	http://dx.doi.org/10.1371/journal.pone.0186015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982160	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300108
J	Megias, DA; Anderson, SC; Smith, RJ; Verissimo, D				Megias, Diane A.; Anderson, Sean C.; Smith, Robert J.; Verissimo, Diogo			Investigating the impact of media on demand for wildlife: A case study of Harry Potter and the UK trade in owls	PLOS ONE			English	Article							INTERNATIONAL-TRADE	In recent decades, a substantial number of popular press articles have described an increase in demand for certain species in the pet trade due to films such as "Finding Nemo", "Ninja turtles", and "Harry Potter". Nevertheless, such assertions are largely supported only by anecdotal evidence. Given the role of the wildlife trade in the spread of pathogens and zoonosis, the introduction of invasive species, the overexploitation of biodiversity, and the neglect of animal welfare, it is crucial to understand what factors drive demand for a species. Here, we investigate the effect the movie industry may have on wildlife trade by examining the relationship between the "Harry Potter" cultural phenomenon and the trade in owls within the United Kingdom (UK). We gathered data from the UK box office, book sales, and newspaper mentions, and examined their relationship with data from three independent sources reflecting the legal ownership of owls in the UK, which is likely to involve several thousands of animals. Additionally, we conducted a questionnaire survey with UK animal sanctuaries to study the presumed mass abandonment of pet owls when the film series ended. Counter to common assertions, we find no evidence that the "Harry Potter" phenomenon increased the legal trade in owls within the UK, even when possible time-lag effects were taken into account. Only one indicator, the number of movie tickets sold, showed a weak but contradictory relationship with demand for owls, with a recorded drop of 13% (95% CI: 3-27%) per 1 SD in tickets sold in the original analysis but an increase of 4% (95% CI: 0-8%) with a one-year lag. In addition, our results suggest that the end of the Harry Potter series did not have a noticeable impact on the number of owls abandoned in UK wildlife sanctuaries, as only two of the 46 animal sanctuaries we contacted independently stated they had seen an increase in owls received and believed this was due to the Harry Potter series. We highlight the importance of further research on the drivers of demand for wildlife to better manage this global trade, and discuss the potential to use films to positively influence behaviour.	[Megias, Diane A.; Smith, Robert J.; Verissimo, Diogo] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Anderson, Sean C.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Verissimo, Diogo] Johns Hopkins Univ, Dept Geog & Environm Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	University of Kent; University of Washington; University of Washington Seattle; Johns Hopkins University	Megias, DA; Verissimo, D (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.; Verissimo, D (corresponding author), Johns Hopkins Univ, Dept Geog & Environm Engn, Whiting Sch Engn, Baltimore, MD 21218 USA.	dm323@kent.ac.uk; verissimodiogo@gmail.com	Smith, Robert J/D-9660-2011; Anderson, Sean C./AFN-3267-2022	Smith, Robert J/0000-0003-1599-9171; Anderson, Sean C./0000-0001-9563-1937; Verissimo, Diogo/0000-0002-3519-6782	David H. Smith Conservation Fellowship	David H. Smith Conservation Fellowship	We would like thank the British Bird Council, the Independent Bird Register and Nielsen Book Services for sharing their valuable data with us. Diogo Verissimo and Sean C. Anderson are funded by a David H. Smith Conservation Fellowship.	[Anonymous], 2010, WEEK; [Anonymous], 2009, TELEGRAPH; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Balmer DE, 2000, 250 BRIT TRUST ORN, P23; Bennett NJ, 2016, BIOL CONSERVATION; British Broadcasting Corporation, 2001, POTT SPARK PET OWL D; British Broadcasting Corporation, 2012, HARR POTT FILMS BLAM; British Broadcasting Corporation (BBC), 2010, BBC NEWS; Brown S, 2010, PSYCHOL MARKET, V27, P541, DOI 10.1002/mar.20343; Buncombe A., 2010, INDEPENDENT; Carter I., 2016, ECOHEALTH, V14, P1; Challender DWS, 2014, CONSERV LETT, V7, P484, DOI 10.1111/conl.12082; Child, 2016, GUARDIAN; Denham J., 2015, INDEPENDENT; Denham Jess, INDEPENDENT; Department for Environment FaRA, 2015, CAPT BRED BIRDS CHAN; Fox N, 2007, FALCONRY UK AUDIT CU, P42; Green M, 2001, REINTRODUCTION REPOR; Gunelius Susan, 2008, HARRY POTTER STORY G; Hinsley A, 2015, BIOL CONSERV, V190, P80, DOI 10.1016/j.biocon.2015.05.010; Militz TA, 2017, FISH FISHER IN PRESS; Militz TA, 2017, FISH FISHERIES; Moorhouse TP, 2016, CONSERVATION LETT; Nijman V, 2017, GLOB ECOL CONSERV, V11, P84, DOI 10.1016/j.gecco.2017.04.004; Oldfield S., 2014, TRADE WILDLIFE REGUL; Paul D., 2012, THE DAILY MIRROR; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; R Core Team, R LANG ENV STAT COMP; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Shairp R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0134787; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; The Cinema Exhibitors' Association, 2013, UK CIN AV TICK PRIC; UNEP-WCMC, 2013, CHECKL CIT SPEC; Verissimo D., 2016, NATL GEOGRAPHIC VOIC; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yong DL, 2011, TROP CONSERV SCI, V4, P244, DOI 10.1177/194008291100400302	36	18	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0182368	10.1371/journal.pone.0182368	http://dx.doi.org/10.1371/journal.pone.0182368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976986	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000412163100002
J	Bannon, CC; Campbell, DA				Bannon, Catherine C.; Campbell, Douglas A.			Sinking towards destiny: High throughput measurement of phytoplankton sinking rates through time-resolved fluorescence plate spectroscopy	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; MARINE DIATOMS; GENETIC-STRUCTURE; OCEAN; VARIABILITY; BUOYANCY; SILICA; ENERGY	Diatoms are marine primary producers that sink in part due to the density of their silica frustules. Sinking of these phytoplankters is crucial for both the biological pump that sequesters carbon to the deep ocean and for the life strategy of the organism. Sinking rates have been previously measured through settling columns, or with fluorimeters or video microscopy arranged perpendicularly to the direction of sinking. These side-view techniques require large volumes of culture, specialized equipment and are difficult to scale up to multiple simultaneous measures for screening. We established a method for parallel, large scale analysis of multiple phytoplankton sinking rates through top-view monitoring of chlorophyll a fluorescence in microtitre well plates. We verified the method through experimental analysis of known factors that influence sinking rates, including exponential versus stationary growth phase in species of different cell sizes; Thalassiosira pseudonana CCMP1335, chain-forming Skeletonema marinoi RO5A and Coscinodiscus radiatus CCMP312. We fit decay curves to an algebraic transform of the decrease in fluorescence signal as cells sank away from the fluorometer detector, and then used minimal mechanistic assumptions to extract a sinking rate (m d(-1)) using an RStudio script, SinkWORX. We thereby detected significant differences in sinking rates as larger diatom cells sank faster than smaller cells, and cultures in stationary phase sank faster than those in exponential phase. Our sinking rate estimates accord well with literature values from previously established methods. This well plate-based method can operate as a high throughput integrative phenotypic screen for factors that influence sinking rates including macromolecular allocations, nutrient availability or uptake rates, chain-length or cell size, degree of silification and progression through growth stages. Alternately the approach can be used to phenomically screen libraries of mutants.	[Bannon, Catherine C.; Campbell, Douglas A.] Mt Allison Univ, Biol Dept, Sackville, NB, Canada	Mount Allison University	Campbell, DA (corresponding author), Mt Allison Univ, Biol Dept, Sackville, NB, Canada.	cicampbell@mta.ca	Campbell, Douglas A./B-3768-2010	Campbell, Douglas A./0000-0001-8996-5463; Bannon, Catherine/0000-0002-8581-1069	Natural Sciences and Engineering Research Council of Canada; New Brunswick Innovation Foundation; Mount Allison University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); New Brunswick Innovation Foundation; Mount Allison University	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery grant (DC), http://nserccrsng.gc/; New Brunswick Innovation Foundation (DC), http://nbif.ca/en; and Mount Allison University (CB), www.mta.ca.	[Anonymous], 2021, LANG ENV STAT COMP; BIENFANG PK, 1981, CAN J FISH AQUAT SCI, V38, P1289, DOI 10.1139/f81-173; Boyd CM, 2002, MAR BIOL, V141, P605, DOI 10.1007/s00227-002-0872-z; Campbell D, 1998, MICROBIOL MOL BIOL R; Champely S., 2018, PACKAGE PWR; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P191, DOI [10.1016/0022-0981(67)90014-7, DOI 10.1016/0022-0981(67)90014-7]; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Forster RM, 2004, MAR ECOL PROG SER, V284, P9, DOI 10.3354/meps284009; Fox J., 2019, R COMPANION APPL REG, V.; Gemmell BJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1126; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Iversen MH, 2013, BIOGEOSCIENCES, V10, P4073, DOI 10.5194/bg-10-4073-2013; Kahm M., 2010, J STAT SOFTW, V33; Lavaud J, 2016, PHOTOSYNTH RES, V127, P189, DOI 10.1007/s11120-015-0172-3; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; McQuoid MR, 2002, EUR J PHYCOL, V37, P191, DOI 10.1017/S0967026202003670; Morales M, 2012, COMMUNITY GEN ADVICE; Muggeo V.M., 2008, R NEWS, V8, P20; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Richardson TL, 1995, MAR ECOL PROG SER, V128, P77, DOI 10.3354/meps128077; Round F. E., 1990, DIATOMS BIOL MORPHOL; Serodio J, 2004, AQUAT MICROB ECOL, V36, P137, DOI 10.3354/ame036137; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sommer U, 2016, J PLANKTON RES; Treguer P, 2000, NATURE, V406, P358, DOI 10.1038/35019236; Waite A, 1997, MAR ECOL PROG SER, V157, P97, DOI 10.3354/meps157097; WAITE AM, 1992, LIMNOL OCEANOGR, V37, P468, DOI 10.4319/lo.1992.37.3.0468; Walsh J. J., 1983, CONTINENT SHELF RES, V12, P1; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WISEMAN SW, 1983, BRIT PHYCOL J, V18, P425, DOI 10.1080/00071618300650401	36	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185166	10.1371/journal.pone.0185166	http://dx.doi.org/10.1371/journal.pone.0185166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972987	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900014
J	Brossas, JY; Gulin, JEN; Bisio, MMC; Chapelle, M; Marinach-Patrice, C; Bordessoules, M; Ruiz, GP; Vion, J; Paris, L; Altcheh, J; Mazier, D				Brossas, Jean-Yves; Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Chapelle, Manuel; Marinach-Patrice, Carine; Bordessoules, Mallaury; Ruiz, George Palazon; Vion, Jeremy; Paris, Luc; Altcheh, Jaime; Mazier, Dominique			Secretome analysis of Trypanosoma cruzi by proteomics studies	PLOS ONE			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; EXPRESSION; POPULATIONS; BIOMARKERS; EFFICACY; PROTEIN	Background Chagas disease is a debilitating often fatal disease resulting from infection by the protozoan parasite Trypanosoma cruzi. Chagas disease is endemic in 21 countries of the Americas, and it is an emerging disease in other countries as a result of migration. Given the chronic nature of the infection where intracellular parasites persist for years, the diagnosis of T. cruzi by direct detection is difficult, whereas serologic tests though sensitive may yield falsepositive results. The development of new rapid test based on the identification of soluble parasitic antigens in serum would be a real innovation in the diagnosis of Chagas disease. Methods To identify new soluble biomarkers that may improve diagnostic tests, we investigated the proteins secreted by T. cruzi using mass spectrometric analyses of conditioned culture media devoid of serum collected during the emergence of trypomastigotes from infected Vero cells. In addition, we compared the secretomes of two T. cruzi strains from DTU Tc VI (VD and CL Brener). Results Analysis of the secretome collected during the emergence of trypomastigotes from Vero cells led to the identification of 591 T. cruzi proteins. Three hundred sixty three proteins are common to both strains and most belong to different multigenic super families (i. e. TcS, GP63, MASP, and DGF1). Ultimately we have established a list of 94 secreted proteins, common to both DTU Tc VI strains that do not belong to members of multigene families. Conclusions This study provides the first comparative analysis of the secretomes from two distinct T. cruzi strains of DTU TcVI. This led us to identify a subset of common secreted proteins that could potentially serve as serum markers for T. cruzi infection. Their potential could now be evaluated, with specific antibodies using sera collected from patients and residents from endemic regions.	[Brossas, Jean-Yves; Marinach-Patrice, Carine; Bordessoules, Mallaury; Ruiz, George Palazon; Vion, Jeremy; Mazier, Dominique] INSERM, U1135, Ctr Immunol & Malad Infect, Paris, France; [Brossas, Jean-Yves; Marinach-Patrice, Carine; Bordessoules, Mallaury; Paris, Luc; Mazier, Dominique] UPMC Univ Paris 06, Sorbonne Univ, Paris, France; [Brossas, Jean-Yves; Paris, Luc; Mazier, Dominique] Hop La Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France; [Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Altcheh, Jaime] Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol & Enfermedad Chagas, Buenos Aires, DF, Argentina; [Nicolas Gulin, Julian Ernesto; Catalina Bisio, Margarita Maria; Altcheh, Jaime] Consejo Nacl Invest Cient & Tecn, Inst Invest Patol Pediat, Buenos Aires, DF, Argentina; [Chapelle, Manuel] Bruker Daltonics Inc, Champs Sur Marne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Brossas, JY (corresponding author), INSERM, U1135, Ctr Immunol & Malad Infect, Paris, France.; Brossas, JY (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, Paris, France.; Brossas, JY (corresponding author), Hop La Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Paris, France.	jean-yves.brossas@upmc.fr		Altcheh, jaime/0000-0002-5865-7991	Ecos-Sud [A13S03]	Ecos-Sud	The Bruker Society provided support in the form of salary for M. Chapelle, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of M. Chapelle is articulated in the author contributions section. The study was also supported by Ecos-Sud (Grant number: A13S03; URL: www.univ-paris13.fr/cofecub-ecos/ecos-sud). Ecos-Sud had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Cestari I, 2012, J IMMUNOL, V188, P1942, DOI 10.4049/jimmunol.1102053; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; de Araujo FF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003451; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fernandez-Villegas A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-206; Franzen O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000984; FRASCH ACC, 1991, PARASITOL TODAY, V7, P148, DOI 10.1016/0169-4758(91)90284-U; FREILIJ H, 1995, CLIN INFECT DIS, V21, P551, DOI 10.1093/clinids/21.3.551; Freitas LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025914; FREVERT U, 1992, INFECT IMMUN, V60, P2349, DOI 10.1128/IAI.60.6.2349-2360.1992; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Grisard EC, 2014, GENOME ANNOUNC, V2; Gulin JEN, 2013, J ANTIMICROB CHEMOTH, V68, P888, DOI 10.1093/jac/dks478; HULKA BS, 1991, CANCER EPIDEM BIOMAR, V1, P13; Jain P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/852645; KRAUTZ GM, 1995, J CLIN MICROBIOL, V33, P2086, DOI 10.1128/JCM.33.8.2086-2090.1995; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Martin DL, 2014, AM J TROP MED HYG, V90, P1074, DOI 10.4269/ajtmh.13-0391; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Meira WSF, 2004, J CLIN MICROBIOL, V42, P707, DOI 10.1128/JCM.42.2.707-712.2004; Mercier SK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003700; Messenger LA, 2015, ACTA TROP, V151, P150, DOI 10.1016/j.actatropica.2015.05.007; De Pablos LM, 2012, INFECT IMMUN, V80, P2258, DOI 10.1128/IAI.06225-11; Risso MG, 2004, J INFECT DIS, V189, P2250, DOI 10.1086/420831; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Segovia M, 2013, EMERG INFECT DIS, V19, P1098, DOI 10.3201/eid1907.121576; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Stahl AL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004619; Steverding D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-317; Thezenas ML, 2013, J PROTEOME RES, V12, P1211, DOI 10.1021/pr300858g; Tibayrenc M, 2015, ACTA TROP, V151, P156, DOI 10.1016/j.actatropica.2015.05.006; Tonelli RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000864; Umezawa ES, 2001, DIAGN MICR INFEC DIS, V39, P169, DOI 10.1016/S0732-8893(01)00216-4; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	43	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185504	10.1371/journal.pone.0185504	http://dx.doi.org/10.1371/journal.pone.0185504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972996	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900022
J	Khan, MAH; Ullah, R; Rehman, A; Rehman, L; Shareef, PAA; Abidi, SMA				Khan, M. A. Hannan; Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Shareef, Ahammed P. A.; Abidi, S. M. A.			Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica	PLOS ONE			English	Article							EXCRETORY-SECRETORY PRODUCTS; LINKED-IMMUNOSORBENT-ASSAY; INDIAN WATER-BUFFALO; GIGANTOCOTYLE-EXPLANATUM; GASTROTHYLAX-CRUMENIFER; MONOCLONAL-ANTIBODIES; CYSTEINE PROTEINASE; SCHISTOSOMA-MANSONI; DIAGNOSTIC EFFICACY; OVINE FASCIOLIASIS	The digenetic trematode Fasciola gigantica is a parasite of great agricultural and economic importance. Along with Fasciola hepatica, F. gigantica incurs huge economic losses to the agricultural sector. Because of unavailability of an effective and commercial vaccine, the earliest diagnosis of the disease is the only way to control the disease. The conventional coprological techniques are able to detect the disease only after the parasites get matured and starts releasing their eggs with the faeces of host, therefore prepatent infection remain undiagnosed. The alternative method is by serological tests that uses circulatory antigens. Despite high sensitivity, their reliability is quite low because of the common antigens shared between different helminth parasites. To overcome this, investigation was shifted to identify the copro-antigens which could be more sensitive and reliable. In the present study, we tried to identify some of the immunodominant proteins from the Excretory Secretory (ES) product of F. gigantica which can be further characterized and used for early detection of infection and also as drug and vaccine candidates. The ES products of F. gigantica were collected and used for raising the polyclonal antibody in rabbit. The polypeptide profile was generated as well as immunogenic polypeptides were identified. The Source of ES antigen was immunolocalized using confocal microscopy and dot blot assay was performed to diagnose field infection. The polypeptide profile of ES products revealed a total of 24 polypeptides out of which 12 immunogenic polypeptides were identified by western blotting. Confocal micrographs showed the immunolocalization of antigens in the intestinal caecae, vitalline glands, gonads as well as in the tegument of the worm. The dot blot assay confirmed the utility of ES products for the detection of field infection. Subsequently, cross reactivity was found negative with Gigantocotyle explanatum; an amphitome parasite of same habitat. However, the cross reactivity with other helminths needs to be worked out.	[Khan, M. A. Hannan; Ullah, Rizwan; Rehman, Abdur; Rehman, Lubna; Shareef, Ahammed P. A.; Abidi, S. M. A.] Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India; [Khan, M. A. Hannan] BGSB Univ, Dept Zool, Sch Biosci & Biotechnol, Rajouri, JK, India	Aligarh Muslim University	Khan, MAH (corresponding author), Aligarh Muslim Univ, Sect Parasitol, Dept Zool, Aligarh, Uttar Pradesh, India.; Khan, MAH (corresponding author), BGSB Univ, Dept Zool, Sch Biosci & Biotechnol, Rajouri, JK, India.	hannan7334@gmail.com	Khan, M. A. Hannan/AAE-7567-2019	Khan, M. A. Hannan/0000-0002-0742-1372				Abdel-Rahman S, 1999, PARASITE IMMUNOL, V21, P279, DOI 10.1046/j.1365-3024.1999.00191.x; Adedokun Oyeduntan Adejoju, 2008, Veterinarski Arhiv, V78, P411; Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Ahammad Shareef PA, 2014, THESIS; Alirahmi Heshmatollah, 2010, Acta Med Iran, V48, P367; Anuracpreeda P, 2006, ACTA TROP, V100, P31, DOI 10.1016/j.actatropica.2006.09.006; Anuracpreeda P, 2013, ACTA TROP, V127, P38, DOI 10.1016/j.actatropica.2013.03.020; Anuracpreeda P, 2011, EXP PARASITOL, V127, P340, DOI 10.1016/j.exppara.2010.08.012; Anuracpreeda P, 2009, EXP PARASITOL, V123, P334, DOI 10.1016/j.exppara.2009.08.014; Beckham SA, 2009, INT J BIOCHEM CELL B, V41, P1601, DOI 10.1016/j.biocel.2009.02.003; Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012; Cakici O, 2013, B ENVIRON CONTAM TOX, V91, P96, DOI 10.1007/s00128-013-1010-y; Cancela M, 2004, PARASITOL RES, V92, P441, DOI 10.1007/s00436-003-1059-3; Cervi L, 1999, PARASITOLOGY, V119, P627, DOI 10.1017/S003118209900517X; Chantree P, 2012, EXP PARASITOL, V132, P249, DOI 10.1016/j.exppara.2012.07.011; CORNELISSEN JBWJ, 1992, VET QUART, V14, P152, DOI 10.1080/01652176.1992.9694354; Demerdash ZA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-176; Dixit AK, 2002, VET PARASITOL, V109, P233, DOI 10.1016/S0304-4017(02)00202-9; DUNN TS, 1987, INT J PARASITOL, V17, P1141, DOI 10.1016/0020-7519(87)90166-4; El Ridi R, 2007, VET PARASITOL, V149, P219, DOI 10.1016/j.vetpar.2007.08.024; Endah Estuningsih S, 2004, Trop Biomed, V21, P51; FAGBEMI BO, 1995, VET PARASITOL, V57, P309, DOI 10.1016/0304-4017(94)00684-5; FAGBEMI BO, 1991, VET PARASITOL, V40, P217, DOI 10.1016/0304-4017(91)90102-2; Ghosh S, 2005, VET RES COMMUN, V29, P123, DOI 10.1023/B:VERC.0000047497.57392.8c; HANNA REB, 1988, INT J PARASITOL, V18, P513, DOI 10.1016/0020-7519(88)90016-1; Hassan Aly A., 2008, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V38, P115; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; Intapan Pewpan M., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P713; Kamel HH, 2013, KOREAN J PARASITOL, V51, P177, DOI 10.3347/kjp.2013.51.2.177; Khan M A Hannan, 2017, J Parasit Dis, V41, P423, DOI 10.1007/s12639-016-0820-3; Khan YA, 2014, J PARASIT DIS; Krailas D, 1999, ASIAN PAC J ALLERGY, V17, P53; Krailas Duangduen, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P92; Kumar N, 2008, PARASITOL RES, V103, P141, DOI 10.1007/s00436-008-0941-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latchumikanthan A., 2012, Tamilnadu Journal of Veterinary and Animal Sciences, V8, P14; Leenaars M, 2005, ILAR J, V46, P269, DOI 10.1093/ilar.46.3.269; Mahmoud MM, 2010, PARASITOL UNITED J, V3, P39; Markakpo US, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0931-y; MARRERO CAR, 1988, J PARASITOL, V74, P646, DOI 10.2307/3282184; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; Meemon K, 2004, MOL BIOCHEM PARASIT, V136, P1, DOI 10.1016/j.molbiopara.2004.02.010; Meemon K, 2010, EXP PARASITOL, V125, P371, DOI 10.1016/j.exppara.2010.03.003; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Molina E. C, 2005, THESIS; Morphew RM, 2012, J PROTEOME RES, V11, P5876, DOI 10.1021/pr300654w; O'Neill SM, 1999, AM J TROP MED HYG, V60, P749, DOI 10.4269/ajtmh.1999.60.749; PETERS PA, 1980, AM J TROP MED HYG, V29, P217, DOI 10.4269/ajtmh.1980.29.217; Raina OK, 2006, ACTA TROP, V98, P145, DOI 10.1016/j.actatropica.2006.03.004; RODRIGUEZPEREZ J, 1995, VET PARASITOL, V56, P57, DOI 10.1016/0304-4017(94)00666-Z; Saifullah MK, 2000, J HELMINTHOL, V74, P271; Saifullah MK, 1999, DEV BIOCH STUDIES SO; Saifullah MK, 2013, VET PARASITOL, V191, P66, DOI 10.1016/j.vetpar.2012.08.019; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sethadavit M, 2009, ACTA TROP, V112, P164, DOI 10.1016/j.actatropica.2009.07.016; Shareef PAA, 2014, ACTA TROP, V136, P108, DOI 10.1016/j.actatropica.2014.04.011; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Spithill TW, 1999, FASCIOLOSIS, P465; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ullah R, 2017, PLOS ONE, V12; Velusamy R, 2004, VET PARASITOL, V119, P187, DOI 10.1016/j.vetpar.2003.09.023; White RR, 2012, VIRULENCE, V3, P668, DOI 10.4161/viru.22832; WIEDOSARI E, 1991, J COMP PATHOL, V105, P147, DOI 10.1016/S0021-9975(08)80070-9; Wilson RA, 2011, INT J PARASITOL, V41, P1347, DOI 10.1016/j.ijpara.2011.08.003; Yadav C. L., 2009, Journal of Veterinary Parasitology, V23, P135	65	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185870	10.1371/journal.pone.0185870	http://dx.doi.org/10.1371/journal.pone.0185870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973017	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900063
J	Omulo, S; Thumbi, SM; Lockwood, S; Verani, JR; Bigogo, G; Masyongo, G; Call, DR				Omulo, Sylvia; Thumbi, Samuel M.; Lockwood, Svetlana; Verani, Jennifer R.; Bigogo, Godfrey; Masyongo, Geoffrey; Call, Douglas R.			Evidence of superficial knowledge regarding antibiotics and their use: Results of two cross-sectional surveys in an urban informal settlement in Kenya	PLOS ONE			English	Article							SOCIOECONOMIC-FACTORS; INCOME COUNTRIES; SURVEILLANCE; RESISTANCE; COMMUNITY; CHILDREN; AFRICA	We assessed knowledge and practices related to antibiotic use in Kibera, an urban informal settlement in Kenya. Surveys was employed at the beginning (entry) and again at the end (exit) of a 5-month longitudinal study of AMR. Two-hundred households were interviewed at entry, of which 149 were also interviewed at exit. The majority (> 65%) of respondents in both surveys could name at least one antibiotic, with amoxicillin and cotrimoxazole jointly accounting for 85% and 77% of antibiotics mentioned during entry and exit, respectively. More than 80% of respondents felt antibiotics should not be shared or discontinued following the alleviation of symptoms. Nevertheless, 66% and 74% of respondents considered antibiotics effective for treating colds and flu in the entry and exit surveys, respectively. There was a high (87%, entry; 70% exit) level of reported antibiotic use (past 12 months) mainly for colds/ flu, coughs and fever, with > 80% of respondents obtaining antibiotics from health facilities and pharmacies. Less than half of respondents remembered getting information on the correct use of antibiotics, although 100% of those who did reported improved attitudes towards antibiotic use. Clinicians and community pharmacists were highly trusted information sources. Paired household responses (n = 149) generally showed improved knowledge and attitudes by the exit survey although practices were largely unchanged. Weak agreement (K = -0.003 to 0.22) between survey responses suggest both that unintended learning had not occurred, and that participant responses were not based on established knowledge or behaviors. Targeted public education regarding antibiotics is needed to address this gap.	[Omulo, Sylvia; Thumbi, Samuel M.; Lockwood, Svetlana; Call, Douglas R.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Omulo, Sylvia; Call, Douglas R.] Washington State Univ, Community Hlth Analyt Initiat, Pullman, WA 99164 USA; [Thumbi, Samuel M.; Bigogo, Godfrey; Masyongo, Geoffrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Verani, Jennifer R.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Call, Douglas R.] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania	Washington State University; Washington State University; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Nelson Mandela African Institution of Science & Technology	Call, DR (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.; Call, DR (corresponding author), Washington State Univ, Community Hlth Analyt Initiat, Pullman, WA 99164 USA.; Call, DR (corresponding author), Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania.	drcall@wsc.edu	Mwangi, Thumbi/L-2216-2019; Bigogo, Godfrey/W-3591-2019	Mwangi, Thumbi/0000-0002-5754-0556; Call, Douglas/0000-0001-6791-055X	Paul G. Allen School for Global Animal Health at Washington State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Paul G. Allen School for Global Animal Health at Washington State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the Paul G. Allen School for Global Animal Health at Washington State University. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abera B, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-26; Aly HAA, 2015, WHO TECH REP SER, V994, P1; APHRC, 2014, POP HLTH DYN NAIR IN; Baker S, 2015, SCIENCE, V347, P1064, DOI 10.1126/science.aaa2868; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Breiman RF, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0827-x; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Chandy SJ, 2013, J ANTIMICROB CHEMOTH, V68, P229, DOI 10.1093/jac/dks355; Ecumenical Pharmaceutical Network, 2010, EXPL PIL STUD KNOWL; Enato EFO, 2011, INT J HEAL RES, V4, P37; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Feikin DR, 2011, PLOS ONE, P6; Genga EK, 2017, AFR J RESPIR MED, V12, P3; Henricson K, 1998, EUR J CLIN PHARMACOL, V54, P653, DOI 10.1007/s002280050529; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Kalungia AC, 2016, EXPERT REV ANTI-INFE, V14, P1215, DOI 10.1080/14787210.2016.1227702; Kandelaki Ketevan, 2015, BMC Res Notes, V8, P495, DOI 10.1186/s13104-015-1477-1; Kehinde OO., 2013, W AFR J PHARM, V24, P49; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kheder SI, 2013, INT J BIOASSAYS, V2, P751; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Njuguna HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058437; Omulo S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-014-0041-4; Padget M, 2016, INT J ANTIMICROB AG, V48, P27, DOI 10.1016/j.ijantimicag.2016.04.024; R Core Team, 2016, R FDN STAT COMP; Ramin B, 2009, B WORLD HEALTH ORGAN, V87, P886, DOI 10.2471/BLT.09.073445; Thrane N, 2003, J ANTIMICROB CHEMOTH, V51, P683, DOI 10.1093/jac/dkg118; Vialle-Valentin CE, 2012, TROP MED INT HEALTH, V17, P211, DOI 10.1111/j.1365-3156.2011.02895.x; Wafula FN, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-223; Wise J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6117	30	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185827	10.1371/journal.pone.0185827	http://dx.doi.org/10.1371/journal.pone.0185827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968447	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600054
J	Braveman, P; Heck, K; Egerter, S; Dominguez, TP; Rinki, C; Marchi, KS; Curtis, M				Braveman, Paula; Heck, Katherine; Egerter, Susan; Dominguez, Tyan Parker; Rinki, Christine; Marchi, Kristen S.; Curtis, Michael			Worry about racial discrimination: A missing piece of the puzzle of Black-White disparities in preterm birth?	PLOS ONE			English	Article							SELF-REPORTED EXPERIENCES; AFRICAN-AMERICAN; MATERNAL STRESS; LIFE-COURSE; PSYCHOSOCIAL FACTORS; HEALTH; PREGNANCY; RISK; WEIGHT; PATHWAYS	Objectives The causes of the large and persistent Black-White disparity in preterm birth (PTB) are unknown. It is biologically plausible that chronic stress across a woman's life course could be a contributor. Prior research suggests that chronic worry about experiencing racial discrimination could affect PTB through neuroendocrine, vascular, or immune mechanisms involved in both responses to stress and the initiation of labor. This study aimed to examine the role of chronic worry about racial discrimination in Black-White disparities in PTB. Methods The data source was cross-sectional California statewide-representative surveys of 2,201 Black and 8,122 White, non-Latino, U.S.-born postpartum women with singleton live births during 2011-2014. Chronic worry about racial discrimination (chronic worry) was defined as responses of "very often" or "somewhat often" (vs. "not very often" or "never") to the question: "Overall during your life until now, how often have you worried that you might be treated or viewed unfairly because of your race or ethnic group?" Prevalence ratios (PRs) with 95% Confidence Intervals (CI) were calculated from sequential logistic regression models, before and after adjustment for multiple social/demographic, behavioral, and medical factors, to estimate the magnitude of: (a) PTB risks associated with chronic worry among Black women and among White women; and (b) Black-White disparities in PTB, before and after adjustment for chronic worry. Results Among Black and White women respectively, 36.9 (95% CI 32.9-40.9)% and 5.5 (95% CI 4.5-6.5) % reported chronic worry about racial discrimination; rates were highest among Black women of higher income and education levels. Chronic worry was significantly associated with PTB among Black women before (PR 1.73, 95% CI 1.12-2.67) and after (PR 2.00, 95% CI 1.33-3.01) adjustment for covariates. The unadjusted Black-White disparity in PTB (PR 1.59, 95% CI 1.21-2.09) appeared attenuated and became non-significant after adjustment for chronic worry (PR 1.30, 95% CI 0.93-1.81); it appeared further attenuated after adding the covariates (PR 1.17, 95% CI 0.85-1.63). Conclusions Chronic worry about racial discrimination may play an important role in Black-White disparities in PTB and may help explain the puzzling and repeatedly observed greater PTB disparities among more socioeconomically-advantaged women. Although the single measure of experiences of racial discrimination used in this study precluded examination of the role of other experiences of racial discrimination, such as overt incidents, it is likely that our findings reflect an association between one or more experiences of racial discrimination and PTB. Further research should examine a range of experiences of racial discrimination, including not only chronic worry but other psychological and emotional states and both subtle and overt incidents as well. These dramatic results from a large statewide-representative study add to a growing-but not widely known-literature linking racism-related stress with physical health in general, and shed light on the links between racism-related stress and PTB specifically. Without being causally definitive, this study's findings should stimulate further research and heighten awareness of the potential role of unmeasured social variables, such as diverse experiences of racial discrimination, in racial disparities in health.	[Braveman, Paula; Heck, Katherine; Egerter, Susan; Marchi, Kristen S.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Braveman, Paula; Heck, Katherine; Egerter, Susan; Marchi, Kristen S.] Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA; [Dominguez, Tyan Parker] Univ Southern Calif, Sch Social Work, Los Angeles, CA USA; [Rinki, Christine; Curtis, Michael] Calif Dept Publ Hlth, Maternal Child & Adolescent Hlth Div, Sacramento, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; California Department of Public Health	Braveman, P (corresponding author), Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA.; Braveman, P (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA.	paula.braveman@ucsf.edu						Blondel B, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P725; Blumberg SJ, 1999, AM J PUBLIC HEALTH, V89, P1231, DOI 10.2105/AJPH.89.8.1231; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Braveman PA, 2015, AM J PUBLIC HEALTH, V105, P694, DOI 10.2105/AJPH.2014.302008; Cole ER, 2003, J SOC ISSUES, V59, P785, DOI 10.1046/j.0022-4537.2003.00090.x; Colen CG, 2006, AM J PUBLIC HEALTH, V96, P2032, DOI 10.2105/AJPH.2005.076547; Collins JW, 2000, EPIDEMIOLOGY, V11, P337, DOI 10.1097/00001648-200005000-00019; Collins JW, 1997, EPIDEMIOLOGY, V8, P315, DOI 10.1097/00001648-199705000-00015; Dole N, 2004, AM J PUBLIC HEALTH, V94, P1358, DOI 10.2105/AJPH.94.8.1358; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; Dominguez TP, 2008, HEALTH PSYCHOL, V27, P194, DOI 10.1037/0278-6133.27.2.194; Dominguez TP, 2009, SOC SCI MED, V69, P258, DOI 10.1016/j.socscimed.2009.03.022; Dunkel-Schetter C, 1998, PRENAT NEONAT MED, V3, P39; Foster HW, 2000, J NATL MED ASSOC, V92, P213; Fuller-Rowell TE, 2015, PSYCHOSOM MED, V77, P33, DOI 10.1097/PSY.0000000000000128; Giurgescu C, 2012, JOGNN-J OBST GYN NEO, V41, pE51, DOI 10.1111/j.1552-6909.2012.01409.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Heino A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149252; Hilmert CJ, 2014, HEALTH PSYCHOL, V33, P43, DOI 10.1037/a0031160; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Hoffman MC, 2016, OBSTET GYNECOL, V127, P545, DOI 10.1097/AOG.0000000000001287; Hudson DL, 2012, J MENS HEALTH, V9, P127, DOI 10.1016/j.jomh.2012.03.006; Jackson FM, 2012, WOMEN HEALTH ISS, V22, pE329, DOI 10.1016/j.whi.2012.01.003; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Knight AK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7040015; Korte JE, 1999, THESIS, P60; Kramer MS, 2013, PAEDIATR PERINAT EP, V27, P237, DOI 10.1111/ppe.12042; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N, 2014, INT J HEALTH SERV, V44, P643, DOI 10.2190/HS.44.4.b; Landrine H, 2006, J BEHAV MED, V29, P79, DOI 10.1007/s10865-005-9029-0; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Lilliecreutz C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0775-x; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Lu MC, 2010, ETHNIC DIS, V20, P62; Margerison-Zilko CE, 2017, MATERN CHILD HLTH J, V21, P648, DOI 10.1007/s10995-016-2151-5; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McDonald SW, 2014, ARCH WOMEN MENT HLTH, V17, P559, DOI 10.1007/s00737-014-0436-5; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MCGRADY GA, 1992, AM J EPIDEMIOL, V136, P266, DOI 10.1093/oxfordjournals.aje.a116492; McNeilly M D, 1996, Ethn Dis, V6, P154; Misra D, 2010, PAEDIATR PERINAT EP, V24, P546, DOI 10.1111/j.1365-3016.2010.01148.x; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Murrell N L, 1996, J Natl Black Nurses Assoc, V8, P45; Mustillo S, 2004, AM J PUBLIC HEALTH, V94, P2125, DOI 10.2105/AJPH.94.12.2125; Myers HF, 2003, HDB RACIAL ETHNIC MI, DOI 10.4135/9781412976008.n19; Nuru-Jeter A, 2009, MATERN CHILD HLTH J, V13, P29, DOI 10.1007/s10995-008-0357-x; O'Campo P, 2016, SSM-POPUL HLTH, V2, P850, DOI 10.1016/j.ssmph.2016.10.014; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Rankin KM, 2011, ETHNIC DIS, V21, P370; Rosenberg L, 2002, EPIDEMIOLOGY, V13, P646, DOI 10.1097/00001648-200211000-00008; Rubens CE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009871; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Shuey KM, 2008, RES AGING, V30, P200, DOI 10.1177/0164027507311151; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Tsai HJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005899; Vidal AC, 2014, GENET EPIGENETICS, V6, P37, DOI 10.4137/GEG.S18067; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Williams DR, 2013, AM BEHAV SCI, V57, P1152, DOI 10.1177/0002764213487340; Witt WP, 2014, AM J PUBLIC HEALTH, V104, pS73, DOI 10.2105/AJPH.2013.301688; Yaktine AL, 2009, WEIGHT GAIN PREGNANC; Yao YL, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0121-6	62	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186151	10.1371/journal.pone.0186151	http://dx.doi.org/10.1371/journal.pone.0186151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020025	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400073
J	Yum, KS; Chang, JY; Jeong, WJ; Lee, S; Jeong, JH; Yeo, MJ; Hong, JH; Park, HK; Chung, I; Kim, BJ; Bang, JS; Bae, HJ; Han, MK				Yum, Kyu Sun; Chang, Jun Young; Jeong, Won Joo; Lee, Sangkil; Jeong, Jin-Heon; Yeo, Min-Ju; Hong, Jeong-Ho; Park, Hong-Kyun; Chung, Inyoung; Kim, Beom Joon; Bang, Jae Seung; Bae, Hee-Joon; Han, Moon-Ku			Effect of statin on progression of symptomatic basilar artery stenosis and subsequent ischemic stroke	PLOS ONE			English	Article							INTRACRANIAL ATHEROSCLEROSIS; THERAPY	Background and objective Symptomatic basilar artery stenosis (BAS) is associated with high risk of ischemic stroke recurrence. We aimed to investigate whether statin therapy might prevent the progression of symptomatic BAS and stroke recurrence. Methods We retrospectively analyzed the data of patients with acute ischemia with symptomatic BAS, which was assessed using magnetic resonance angiogram (MRA) imaging on admission day, and 1 year later (or the day of the clinical event). The clinical endpoints were recurrent ischemic stroke and its composites, transient ischemic attack, coronary disease, and vascular death. Results Of the 153 patients with symptomatic BAS, 114 (74.5%) were treated with a statin after experiencing a stroke. Statin therapy significantly prevented the progression of symptomatic BAS (7.0% vs 28.2%) and induced regression (22.8% vs 15.4%) compared to non-statin users (p = 0.002). There were 31 ischemic stroke incidences and 38 composite vascular events. Statin users showed significantly lower stroke recurrence (14.9% vs 35.9%, p = 0.05) and composite vascular events (17.5% vs 46.2%; odds ratio [OR], 0.29; 95% confidence interval [CI], 0.13-0.64) than those not using statins did. Recurrent stroke in the basilar territory and composite vascular events were more common in patients with progression of BAS than they were in other patients (OR, 5.16; 95% CI, 1.63-16.25 vs OR, 4.2; 95% CI, 1.56-11.34). Conclusion Our study suggests that statin therapy may prevent the progression of symptomatic BAS and decrease the risk of subsequent ischemic stroke. Large randomized trials are needed to confirm this result.	[Yum, Kyu Sun; Lee, Sangkil; Park, Hong-Kyun; Chung, Inyoung; Kim, Beom Joon; Bae, Hee-Joon; Han, Moon-Ku] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea; [Chang, Jun Young] Gyeongsang Natl Univ, Changwon Hosp, Dept Neurol, Chang Won, South Korea; [Jeong, Won Joo] Seoul Natl Univ, Bundang Hosp, Dept Crit Care, Seongnam, South Korea; [Jeong, Jin-Heon] Dong A Univ Hosp, Dept Intens Care Med & Neurol, Busan, South Korea; [Yeo, Min-Ju] Chungbuk Natl Univ Hosp, Dept Neurol, Chungju, South Korea; [Hong, Jeong-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Neurol, Daegu, South Korea; [Bang, Jae Seung] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seongnam, South Korea	Seoul National University (SNU); Gyeongsang National University; Seoul National University (SNU); Dong A University; Chungbuk National University; Chungbuk National University Hospital; Keimyung University; Seoul National University (SNU)	Han, MK (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea.	mkhan@snu.ac.kr	Hong, Jeong-Ho/T-8099-2018; JEONG, JIN-HEON/O-3734-2017; Hong, Jeong-Ho/AAE-1002-2022; Kim, Beom Joon/C-2904-2011	Hong, Jeong-Ho/0000-0002-8235-9855; JEONG, JIN-HEON/0000-0002-5878-9206; Hong, Jeong-Ho/0000-0002-8235-9855; Kim, Beom Joon/0000-0002-2719-3012; Park, Hong-Kyun/0000-0002-8120-2469; Chung, Inyoung/0000-0002-3586-4162; Chang, Jun Young/0000-0003-4880-9258				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akins PT, 1998, STROKE, V29, P433, DOI 10.1161/01.STR.29.2.433; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 1998, PROGR PAT SYMPT VERT, V29, P1389; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; Arenillas JF, 2011, STROKE, V42, pS20, DOI 10.1161/STROKEAHA.110.597278; Caplan L, 2000, STROKE, V31, P2011, DOI 10.1161/01.STR.31.8.2011; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Kang J, 2014, J STROKE, V16, P36, DOI 10.5853/jos.2014.16.1.36; Kang S, 2004, ATHEROSCLEROSIS, V177, P433, DOI 10.1016/j.atherosclerosis.2004.08.005; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kim YJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-171; NISHIMARU K, 1984, STROKE, V15, P56, DOI 10.1161/01.STR.15.1.56; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Noyes AM, 2014, ATHEROSCLEROSIS, V234, P75, DOI 10.1016/j.atherosclerosis.2014.02.007; Qiao Y, 2016, STROKE, V47, P434, DOI 10.1161/STROKEAHA.115.009955; Savitz SI, 2005, NEW ENGL J MED, V352, P2618, DOI 10.1056/NEJMra041544; Tan TY, 2009, J NEUROL, V256, P187, DOI 10.1007/s00415-009-0960-9; Turan TN, 2014, CEREBROVASC DIS, V37, P203, DOI 10.1159/000358120; Wong KS, 2002, STROKE, V33, P532, DOI 10.1161/hs0202.102602; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Woolfenden A R, 2000, J Stroke Cerebrovasc Dis, V9, P57, DOI 10.1053/jscd.2000.0090057; Zhou PY, 2014, CLIN NEUROL NEUROSUR, V120, P6, DOI 10.1016/j.clineuro.2014.02.001	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183798	10.1371/journal.pone.0183798	http://dx.doi.org/10.1371/journal.pone.0183798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020008	gold, Green Submitted, Green Published			2022-12-27	WOS:000412754400007
J	Quintero-Ronderos, P; Mercier, E; Fukuda, M; Gonzalez, R; Suarez, CF; Patarroyo, MA; Vaiman, D; Gris, JC; Laissue, P				Quintero-Ronderos, Paula; Mercier, Eric; Fukuda, Michiko; Gonzalez, Ronald; Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel; Vaiman, Daniel; Gris, Jean-Christophe; Laissue, Paul			Novel genes and mutations in patients affected by recurrent pregnancy loss	PLOS ONE			English	Article							HUMAN EMBRYO IMPLANTATION; FACTOR-V; ADHESION MOLECULES; THROMBOMODULIN; MISCARRIAGE; POLYMORPHISMS; IMPACT; DOMAIN; ENDOTHELIUM; MECHANISMS	Recurrent pregnancy loss is a frequently occurring human infertility-related disease affecting similar to 1% of women. It has been estimated that the cause remains unexplained in >50% cases which strongly suggests that genetic factors may contribute towards the phenotype. Concerning its molecular aetiology numerous studies have had limited success in identifying the disease's genetic causes. This might have been due to the fact that hundreds of genes are involved in each physiological step necessary for guaranteeing reproductive success in mammals. In such scenario, next generation sequencing provides a potentially interesting tool for research into recurrent pregnancy loss causative mutations. The present study involved whole-exome sequencing and an innovative bioinformatics analysis, for the first time, in 49 unrelated women affected by recurrent pregnancy loss. We identified 27 coding variants (22 genes) potentially related to the phenotype (41% of patients). The affected genes, which were enriched by potentially deleterious sequence variants, belonged to distinct molecular cascades playing key roles in implantation/pregnancy biology. Using a quantum chemical approach method we established that mutations in MMP-10 and FGA proteins led to substantial energetic modifications suggesting an impact on their functions and/or stability. The next generation sequencing and bioinformatics approaches presented here represent an efficient way to find mutations, having potentially moderate/strong functional effects, associated with recurrent pregnancy loss aetiology. We consider that some of these variants (and genes) represent probable future biomarkers for recurrent pregnancy loss.	[Quintero-Ronderos, Paula; Laissue, Paul] Univ Rosario, Sch Med & Hlth Sci, GENIUROS Res Grp, Ctr Res Genet & Genom CIGGUR, Bogota, Colombia; [Mercier, Eric; Gris, Jean-Christophe] Univ Montpellier, Univ Hosp, Fac Pharm & Biol Sci, Dept Haematol, Montpellier, France; [Mercier, Eric; Gris, Jean-Christophe] Univ Montpellier, Res Team EA 2992, Montpellier, France; [Fukuda, Michiko] Natl Inst Adv Ind Sci & Technol, Lab Drug Discovery, Tsukuba, Ibaraki, Japan; [Gonzalez, Ronald; Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Fernando Suarez, Carlos] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, Colombia; [Fernando Suarez, Carlos; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Basic Sci Dept, Bogota, Colombia; [Vaiman, Daniel] Univ Paris 05, CNRS, Inst Cochin, UMR 8104, Paris, France; [Vaiman, Daniel] INSERM, U1016, Paris, France	Universidad del Rosario; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; National Institute of Advanced Industrial Science & Technology (AIST); Universidad del Rosario; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Laissue, P (corresponding author), Univ Rosario, Sch Med & Hlth Sci, GENIUROS Res Grp, Ctr Res Genet & Genom CIGGUR, Bogota, Colombia.	paul.laissue@urosario.edu.co	Vaiman, Daniel/O-6030-2015; Martínez, Carlos Fernando Suárez/ABH-7784-2020; GRIS, Jean-Christophe/AAA-2923-2019; Patarroyo, Manuel A/I-8046-2016; Fukuda, Michiko/M-2748-2018; Laissue, Paul/C-6787-2012	Vaiman, Daniel/0000-0002-1915-0717; Martínez, Carlos Fernando Suárez/0000-0001-8423-408X; GRIS, Jean-Christophe/0000-0002-9899-9910; Patarroyo, Manuel A/0000-0002-4751-2500; Fukuda, Michiko/0000-0001-8549-1555; QUINTERO-RONDEROS, PAULA/0000-0003-2925-7734; Laissue, Paul/0000-0003-4180-4796; Mercier, Eric/0000-0001-7917-1918	Universidad del Rosario [CS/ABN062/GENIUR0S 017]	Universidad del Rosario	The work of Laissue's lab is supported by the Universidad del Rosario (grant: CS/ABN062/GENIUR0S 017).	Acharya SS, 2008, HAEMOPHILIA, V14, P1151, DOI 10.1111/j.1365-2516.2008.01831.x; Anifandis G, 2014, INT J MOL SCI, V15, P12972, DOI 10.3390/ijms150712972; Asselta R, 2006, J THROMB HAEMOST, V4, P26, DOI 10.1111/j.1538-7836.2005.01590.x; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Casini A, 2015, J THROMB HAEMOST, V13, P909, DOI 10.1111/jth.12916; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Daher S, 2012, AM J REPROD IMMUNOL, V67, P341, DOI 10.1111/j.1600-0897.2012.01123.x; Diejomaoh MFE, 2015, MED PRIN PRACT, V24, P38, DOI 10.1159/000365973; Erdogan E, 2008, J THROMB HAEMOST, V6, P118; Fukuda MN, 2008, J OBSTET GYNAECOL RE, V34, P129, DOI 10.1111/j.1447-0756.2008.00776.x; Fukuda Michiko N., 2012, Shengli Xuebao, V64, P247; Isermann B, 2003, NAT MED, V9, P331, DOI 10.1038/nm825; Fonseca DJ, 2015, FERTIL STERIL, V104, P154, DOI 10.1016/j.fertnstert.2015.04.016; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; Kolte AM, 2011, MOL HUM REPROD, V17, P379, DOI 10.1093/molehr/gar003; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; L'Hote D, 2007, GENETICS, V176, P1907, DOI 10.1534/genetics.107.072157; L'Hote D, 2010, BIOESSAYS, V32, P132, DOI 10.1002/bies.200900027; Laissue P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160109; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Lissalde-Lavigne G, 2005, J THROMB HAEMOST, V3, P2178, DOI 10.1111/j.1538-7836.2005.01581.x; Martin FA, 2013, AM J PHYSIOL-HEART C, V304, pH1585, DOI 10.1152/ajpheart.00096.2013; MARUYAMA I, 1985, J CELL BIOL, V101, P363, DOI 10.1083/jcb.101.2.363; Mercier E, 2007, NEW ENGL J MED, V357, P1984, DOI 10.1056/NEJMc071528; Peng W, 2005, J THROMB HAEMOST, V3, P351, DOI 10.1111/j.1538-7836.2004.01083.x; Puscheck EE, 2007, CURR OPIN OBSTET GYN, V19, P222, DOI 10.1097/GCO.0b013e32813e3ff0; Renaud SJ, 2014, J BIOL CHEM, V289, P5025, DOI 10.1074/jbc.M113.523746; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Simcox LE, 2015, INT J MOL SCI, V16, P28418, DOI 10.3390/ijms161226104; Sood R, 2008, BLOOD, V112, P585, DOI 10.1182/blood-2007-09-111302; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Stortoni P, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-1; Su MT, 2011, HUM REPROD UPDATE, V17, P803, DOI 10.1093/humupd/dmr027; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Vaiman D, 2015, BIOMED J, V38, P11, DOI 10.4103/2319-4170.133777; Vatin M, 2014, AM J PATHOL, V184, P362, DOI 10.1016/j.ajpath.2013.10.024; Vatin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043356; Vu D, 2007, J THROMB HAEMOST, V5, P125, DOI 10.1111/j.1538-7836.2007.02465.x; Walters-Sen LC, 2015, MOL GENET GENOM MED, V3, P99, DOI 10.1002/mgg3.116; Wang L, 2010, REPROD SCI, V17, P578, DOI 10.1177/1933719110364248; White MD, 2015, CURR TOP DEV BIOL, V112, P1, DOI 10.1016/bs.ctdb.2014.11.022; Zhao YL, 2010, FERTIL STERIL, V94, P2264, DOI 10.1016/j.fertnstert.2010.01.068	45	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186149	10.1371/journal.pone.0186149	http://dx.doi.org/10.1371/journal.pone.0186149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016666	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400056
J	Fernandez-Aguilar, X; Cabezon, O; Frey, J; Velarde, R; Serrano, E; Colom-Cadena, A; Gelormini, G; Marco, I; Mentaberre, G; Lavin, S; Lopez-Olvera, JR				Fernandez-Aguilar, Xavier; Cabezon, Oscar; Frey, Joachim; Velarde, Roser; Serrano, Emmanuel; Colom-Cadena, Andreu; Gelormini, Giuseppina; Marco, Ignasi; Mentaberre, Gregorio; Lavin, Santiago; Lopez-Olvera, Jorge Ramon			Long-term dynamics of Mycoplasma conjunctivae at the wildlife-livestock interface in the Pyrenees	PLOS ONE			English	Article							RUPICAPRA-R.-RUPICAPRA; BORDER DISEASE VIRUS; INFECTIOUS KERATOCONJUNCTIVITIS; ALPINE CHAMOIS; IDENTIFYING RESERVOIRS; BIGHORN SHEEP; TRANSMISSION; POPULATION; CAPRINAE; IBEX	Functional roles of domestic and wild host populations in infectious keratoconjunctivitis (IKC) epidemiology have been extensively discussed claiming a domestic reservoir for the more susceptible wild hosts, however, based on limited data. With the aim to better assess IKC epidemiology in complex host-pathogen alpine systems, the long-term infectious dynamics and molecular epidemiology of Mycoplasma conjunctivae was investigated in all host populations from six study areas in the Pyrenees and one in the Cantabrian Mountains (Northern Spain). Detection of M. conjunctivae was performed by qPCR on 3600 eye swabs collected during seven years from hunted wild ungulates and sympatric domestic sheep (n = 1800 animals), and cluster analyses of the strains were performed including previous reported local strains. Mycoplasma conjunctivae was consistently detected in three Pyrenean chamois (Rupicapra p. pyrenaica) populations, as well as in sheep flocks (17.0% of sheep) and occasionally in mouflon (Ovis aries musimon) from the Pyrenees (22.2% in one year/area); statistically associated with ocular clinical signs only in chamois. Chamois populations showed different infection dynamics with low but steady prevalence (4.9%) and significant yearly fluctuations (0.0%- 40.0%). Persistence of specific M. conjunctivae strain clusters in wild host populations is demonstrated for six and nine years. Cross-species transmission between chamois and sheep and chamois and mouflon were also sporadically evidenced. Overall, independent M. conjunctivae sylvatic and domestic cycles occurred at the wildlife-livestock interface in the alpine ecosystems from the Pyrenees with sheep and chamois as the key host species for each cycle, and mouflon as a spill-over host. Host population characteristics and M. conjunctivae strains resulted in different epidemiological scenarios in chamois, ranging from the fading out of the mycoplasma to the epidemic and endemic long-term persistence. These findings highlight the capacity of M. conjunctivae to establish diverse interactions and persist in host populations, also with different transmission conditions.	[Fernandez-Aguilar, Xavier; Cabezon, Oscar; Velarde, Roser; Serrano, Emmanuel; Colom-Cadena, Andreu; Marco, Ignasi; Mentaberre, Gregorio; Lavin, Santiago; Lopez-Olvera, Jorge Ramon] Univ Autonoma Barcelona, Dept Med & Cirurgia, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain; [Fernandez-Aguilar, Xavier; Cabezon, Oscar; Colom-Cadena, Andreu] UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus, Bellaterra, Spain; [Frey, Joachim; Gelormini, Giuseppina] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Serrano, Emmanuel] UA, Dept Biol & Cesam, Aveiro, Portugal	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA; University of Bern; Universidade de Aveiro	Fernandez-Aguilar, X; Lopez-Olvera, JR (corresponding author), Univ Autonoma Barcelona, Dept Med & Cirurgia, Serv Ecopatol Fauna Salvatge SEFaS, Bellaterra, Spain.; Fernandez-Aguilar, X (corresponding author), UAB, IRTA, Ctr Recerca Sanitat Anim CReSA, Campus, Bellaterra, Spain.	xfdezagullar@gmail.com; joroli.lopez.olvera@uab.cat	SERRANO-FERRON, Emmanuel/J-4489-2013; Marco, Ignasi/E-8633-2015; Lavín, Santiago/L-5975-2014; Fernandez Aguilar, Xavier/P-9919-2017; Mentaberre, Gregorio/AAB-5912-2020; Velarde, Roser/M-1614-2014; Cabezón, Oscar/AAV-7876-2020; Mentaberre, Gregorio A/H-4629-2015; Cabezon, Oscar/L-3812-2014	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Marco, Ignasi/0000-0001-7479-3419; Lavín, Santiago/0000-0001-5655-588X; Fernandez Aguilar, Xavier/0000-0002-4939-6048; Mentaberre, Gregorio/0000-0001-9542-7514; Velarde, Roser/0000-0003-3332-6405; Mentaberre, Gregorio A/0000-0001-9542-7514; Cabezon, Oscar/0000-0001-7543-8371	FI-DGR program from the Government of Catalonia; postdoctoral programme of the Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/96637/2013]; University of Aveiro (Department of Biology); FCT/MEC [UID/AMB/50017]; FEDER, within the PT2020 Partnership Agreement	FI-DGR program from the Government of Catalonia; postdoctoral programme of the Fundacao para a Ciencia e a Tecnologia, Portugal; University of Aveiro (Department of Biology); FCT/MEC; FEDER, within the PT2020 Partnership Agreement	This study was funded by the research projects CGL2009-11631 and CGL2012-40043-C02-02 of the Spanish MICINN (to JRL). X. Fernandez-Aguilar and A. Colom-Cadena were supported by the FI-DGR program from the Government of Catalonia. E. Serrano was supported by the postdoctoral programme (SFRH/BPD/96637/2013) of the Fundacao para a Ciencia e a Tecnologia, Portugal, the University of Aveiro (Department of Biology) and FCT/MEC through financial support to CESAM RU (UID/AMB/50017) and, where applicable, co-financed by the FEDER, within the PT2020 Partnership Agreement.; We are grateful to the rangers and directors of the National Game Reserves for their support in collecting the samples from wild ungulates and to the livestock owners that agreed to the sheep sampling. We also would like to thank the invaluable support of several colleagues from SEFaS research group and students from the Universitat Autonoma de Barcelona that occasionally assist in the sample collection, as well as the technical assistance of Amandine Ruffieux, from the Institute of Veterinary Bacteriology, University of Bern.	Arnal M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061887; Baker SE, 2001, VET REC, V104, P1998; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Belloy L, 2003, APPL ENVIRON MICROB, V69, P1913, DOI 10.1128/AEM.69.4.1913-1919.2003; Belloy L, 2003, MICROBIOL-SGM, V149, P185, DOI 10.1099/mic.0.25864-0; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Corlatti L, 2015, ZOOLOGY, V118, P213, DOI 10.1016/j.zool.2015.01.003; Crawley J. M., 2013, R BOOK; DAGNALL GJR, 1994, EPIDEMIOL INFECT, V112, P561, DOI 10.1017/S0950268800051268; Darmon G, 2012, ECOGRAPHY, V35, P44, DOI 10.1111/j.1600-0587.2011.06664.x; Degiorgis MP, 2000, SCHWEIZ ARCH TIERH, V142, P520; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Fernandez-Aguilar X, 2016, VET REC, V178, P586, DOI 10.1136/vr.103577; Fernandez-Aguilar X, 2017, VET REC; Fernandez-Aguilar X, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00690-17; Fernandez-Aguilar X, 2014, EMERG INFECT DIS, V20, P1062, DOI 10.3201/eid2006.130961; Fernandez-Aguilar X, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-253; Fernandez-Sirera L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051031; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gauthier D, 1991, ETUDE EPIDEMIOLOGIQU; Gelormini G, 2016, 12 C EUR WILDL DIS A, P18; Giacometti M, 1998, VET MICROBIOL, V61, P279, DOI 10.1016/S0378-1135(98)00186-2; Giacometti M, 2002, J WILDLIFE DIS, V38, P297, DOI 10.7589/0090-3558-38.2.297; Giacometti M, 2002, REV SCI TECH OIE, V21, P335, DOI 10.20506/rst.21.2.1338; Grattarola C, 1999, VET REC, V145, P588, DOI 10.1136/vr.145.20.588; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Holzwarth N, 2011, J VET DIAGN INVEST, V23, P333, DOI 10.1177/104063871102300223; J-P Crampe, 1992, TAUX SURVIE CARACTER; Janovsky M, 2001, VET MICROBIOL, V83, P11, DOI 10.1016/S0378-1135(01)00407-2; Jansen BD, 2006, J WILDLIFE DIS, V42, P407, DOI 10.7589/0090-3558-42.2.407; Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lauvergne J-J, 1977, ANN GENETIQUE SELECT, V9, P151; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Loison A, 1996, J WILDLIFE MANAGE, V60, P517, DOI 10.2307/3802069; Loison A, 1999, J MAMMAL, V80, P620, DOI 10.2307/1383306; Luzzago C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168232; Manlove KR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2331; Marco I, 1991, VET EN PRAX, V6, P57; Marco I, 2009, J WILDLIFE DIS, V45, P1; Marco I, 2009, EMERG INFECT DIS, V15, P448, DOI 10.3201/eid1503.081155; Mavrot F, 2012, J WILDLIFE DIS, V48, P619, DOI 10.7589/0090-3558-48.3.619; Mayer D, 1997, J WILDLIFE DIS, V33, P413, DOI 10.7589/0090-3558-33.3.413; NICOLET J, 1975, ZBL VET MED B, V22, P302; Panella P, 2010, HYSTRIX, V21, P183, DOI 10.4404/Hystrix-21.2-4558; Pepin D, 2008, ANIM BEHAV, V75, P361, DOI 10.1016/j.anbehav.2006.09.030; QGIS Development Team, 2016, QGIS GEOG INF SYST; R Development Core Team, 2015, LANG ENV STAT COMP; Richomme C, 2006, EPIDEMIOL INFECT, V134, P21, DOI 10.1017/S0950268805004693; Ryser-Degiorgis Marie-Pierre, 2002, Hystrix, V13, P1; Ryser-Degiorgis MP, 2009, VET MICROBIOL, V134, P368, DOI 10.1016/j.vetmic.2008.08.005; Sanchez-Belda A, 1985, S INT CHER INF CAM, P73; Serrano E, 2011, EPIDEMIOL INFECT, V139, P1626, DOI 10.1017/S0950268811000951; Serrano E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01307; Sokal R. R., 1973, PRINCIPLES PRACTICE; Swinton J, 2009, ECOLOGY WILDLIFE DIS, P83; Sydenstricker KV, 2005, J WILDLIFE DIS, V41, P326, DOI 10.7589/0090-3558-41.2.326; TERLAAK EA, 1988, VET QUART, V10, P217, DOI 10.1080/01652176.1988.9694175; TERLAAK EA, 1988, VET QUART, V10, P73, DOI 10.1080/01652176.1988.9694153; TROTTER SL, 1977, INFECT IMMUN, V18, P816, DOI 10.1128/IAI.18.3.816-822.1977; Tschopp R, 2005, VET REC, V157, P13, DOI 10.1136/vr.157.1.13; Viana M, 2014, TRENDS ECOL EVOL, V29, P270, DOI 10.1016/j.tree.2014.03.002; Vilei EM, 2007, J MICROBIOL METH, V70, P384, DOI 10.1016/j.mimet.2007.05.007; Williams PD, 2014, J EVOLUTION BIOL, V27, P1271, DOI 10.1111/jeb.12379; WILSMORE AJ, 1990, VET REC, V127, P229; Wood S.N., 2006, TEXTS STAT SCI, Vxvii, P392, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X; Zimmermann L, 2008, WILDLIFE BIOL, V14, P118, DOI 10.2981/0909-6396(2008)14[118:SOMCSF]2.0.CO;2; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	70	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186069	10.1371/journal.pone.0186069	http://dx.doi.org/10.1371/journal.pone.0186069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016676	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800036
J	Miiro, G; DeCelles, J; Rutakumwa, R; Nakiyingi-Miiro, J; Muzira, P; Ssembajjwe, W; Musoke, S; Gibson, LJ; Hershow, RB; Francis, S; Torondel, B; Ross, DA; Weiss, HA				Miiro, George; DeCelles, Jeff; Rutakumwa, Rwamahe; Nakiyingi-Miiro, Jessica; Muzira, Philip; Ssembajjwe, Wilber; Musoke, Saidat; Gibson, Lorna J.; Hershow, Rebecca B.; Francis, Suzanna; Torondel, Belen; Ross, David A.; Weiss, Helen A.		MENISCUS Project	Soccer-based promotion of voluntary medical male circumcision: A mixed-methods feasibility study with secondary students in Uganda	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SOUTH-AFRICA; ACCEPTABILITY; INTERVENTION; PREVENTION	The Ugandan government is committed to scaling-up proven HIV prevention strategies including safe male circumcision, and innovative strategies are needed to increase circumcision uptake. The aim of this study was to assess the acceptability and feasibility of implementing a soccer-based intervention ("Make The Cut") among schoolboys in a peri-urban district of Uganda. The intervention was led by trained, recently circumcised "coaches" who facilitated a 60-minute session delivered in schools, including an interactive penalty shoot-out game using metaphors for HIV prevention, sharing of the coaches' circumcision story, group discussion and ongoing engagement from the coach to facilitate linkage to male circumcision. The study took place in four secondary schools in Entebbe sub-district, Uganda. Acceptability of safe male circumcision was assessed through a cross-sectional quantitative survey. The feasibility of implementing the intervention was assessed by piloting the intervention in one school, modifying it, and implementing the modified version in a second school. Perceptions of the intervention were assessed with in-depth interviews with participants. Of the 210 boys in the cross-sectional survey, 59% reported being circumcised. Findings showed high levels of knowledge and generally favourable perceptions of circumcision. The initial implementation of Make The Cut resulted in 6/58 uncircumcised boys (10.3%) becoming circumcised. Changes made included increasing engagement with parents and improved liaison with schools regarding the timing of the intervention. Following this, uptake improved to 18/69 (26.1%) in the second school. In-depth interviews highlighted the important role of family and peer support and the coach in facilitating the decision to circumcise. This study showed that the modified Make The Cut intervention may be effective to increase uptake of safe male circumcision in this population. However, the intervention is time-intensive, and further work is needed to assess the cost-effectiveness of the intervention conducted at scale.	[Miiro, George; Ssembajjwe, Wilber; Musoke, Saidat] Uganda Virus Res Inst, Entebbe, Uganda; [DeCelles, Jeff; Muzira, Philip] Grassroot Soccer, Cape Town, South Africa; [DeCelles, Jeff; Hershow, Rebecca B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Rutakumwa, Rwamahe; Nakiyingi-Miiro, Jessica] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Gibson, Lorna J.; Francis, Suzanna; Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Med Res Council, Trop Epidemiol Grp, London, England; [Torondel, Belen] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Ross, David A.] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland	Uganda Virus Research Institute; University of North Carolina; University of North Carolina Chapel Hill; Uganda Virus Research Institute; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Weiss, HA (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Med Res Council, Trop Epidemiol Grp, London, England.	helen.weiss@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Francis, Suzanna Carter/0000-0002-3724-4813	UK Medical Research Council [MC_PC_14098]; World Health Organisation [WCCPRD3992640 2016/599225]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat [MR/K012126/1]; European Union; MRC [MC_PC_14098, G1002369] Funding Source: UKRI; Medical Research Council [G1002369, MC_PC_14098, MR/K012126/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Health Organisation(World Health Organization); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a research grant MC_PC_14098 from the UK Medical Research Council and the World Health Organisation (WCCPRD3992640 2016/599225). HAW was supported in part by a grant jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) (MR/K012126/1) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PURSUIT PIVOT REACHI; Barnabas RV, 2016, LANCET HIV, V3, pE212, DOI 10.1016/S2352-3018(16)00020-5; DeCelles J, 2016, JAIDS-J ACQ IMM DEF, V72, pS304, DOI 10.1097/QAI.0000000000001172; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Kaufman ZA, 2014, 20 INT AIDS C MELB A; Kaufman ZA, 2016, J ACQ IMMUN DEF SYND, V72, P292; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Montague C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096468; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Thirumurthy H, 2016, JAIDS-J ACQ IMM DEF, V72, pS309, DOI 10.1097/QAI.0000000000001045; Thirumurthy H, 2014, JAMA-J AM MED ASSOC, V312, P703, DOI 10.1001/jama.2014.9087; UNAIDS, 2014, UG HIV AIDS COUNTR P; UNAIDS, 2014, UG HIV EP PROF; UNAIDS, 2016, GLOB AIDS UPD; UNAIDS, 2011, JOINT STRAT ACT FRAM; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Weiss SM, 2015, LANCET HIV, V2, pE181, DOI 10.1016/S2352-3018(15)00042-9; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization, 2016, VOL MED MAL CIRC HIV; Wouabe ED, 2013, SCOPING REPORT INTER	23	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185929	10.1371/journal.pone.0185929	http://dx.doi.org/10.1371/journal.pone.0185929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016651	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000412601800026
J	Montalto, GJ; Sawe, FK; Miruka, A; Maswai, J; Kiptoo, I; Aoko, A; Oreyo, C; Obiero, E; Korir, S; Bii, SK; Song, KX; Kunz, AN				Montalto, Gregg Joseph; Sawe, Fredrick K.; Miruka, Argwings; Maswai, Jonah; Kiptoo, Ignatius; Aoko, Appolonia; Oreyo, Chrispine; Obiero, Eunice; Korir, Sheila; Bii, Stephen K.; Song, Katherine X.; Kunz, Anjali N.			Diagnosis disclosure to adolescents living with HIV in rural Kenya improves antiretroviral therapy adherence and immunologic outcomes: A retrospective cohort study	PLOS ONE			English	Article							INFECTED CHILDREN; BARRIERS; FACILITATORS; PREVALENCE; TIME	Background & aims Emphasis on adolescent HIV has increased worldwide as antiretroviral treatment has greatly extended life expectancies of HIV-positive children. Few evidence-based guidelines exist on the optimal time to disclose to an adolescent living with HIV (ALHIV); little is known about the medical effects of disclosure. This study looked to determine whether disclosure is associated with improved medical outcomes in ALHIV. Prior work has tended to be qualitative, cross-sectional, and with an emphasis on psychosocial outcomes. This paper addresses the adolescent cohort retrospectively (longitudinally), building upon what is already known about disclosure. Methods Retrospective, longitudinal clinical record reviews of ALHIV seen at Kericho District Hospital between April 2004 and November 2012 were performed. Patient demographics and clinical outcomes were systematically extracted. The student's t-test was used to calculate changes in mean CD4 count, antiretroviral therapy (ART), and cotrimoxazole adherence pre-vs. post-disclosure. Linear regression modelling assessed for trends in those clinical outcomes associated with age of disclosure. Results Ninety-six ALHIV (54 female, 42 male) were included; most (73%) entered care through the outpatient department. Nearly half were cared for by parents, and 20% experienced a change in their primary caregiver. The mean time in the study was 2.47 years; mean number of visits 10.97 per patient over the mean time in the study. Mean disclosure age was 12.34 years. An increase in mean ART adherence percentage was found with disclosure (0.802 vs. 0.917; p = 0.0015). Younger disclosure age was associated with significantly higher mean CD4 counts over the course of the study (p = 0.001), and a nonsignificant trend toward a higher mean ART adherence percentage (p = 0.055). Conclusion ART adherence and improved immunologic status are both associated with disclosure of HIV infection to adolescent patients. Disclosure of an HIV diagnosis to an adolescent is an important means to improve HIV care.	[Montalto, Gregg Joseph] Naval Med Ctr San Diego, Div Adolescent Med, Dept Pediat, San Diego, CA 92134 USA; [Sawe, Fredrick K.; Miruka, Argwings; Maswai, Jonah; Kiptoo, Ignatius; Aoko, Appolonia; Oreyo, Chrispine] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Obiero, Eunice; Korir, Sheila; Bii, Stephen K.] Kericho Dist Hosp, Minist Med Serv, Kericho, Kenya; [Song, Katherine X.] US Mil HIV Res Program, Rockville, MD USA; [Kunz, Anjali N.] Madigan Army Med Ctr, Dept Pediat, Joint Base Lewis Mcchord, WA USA	United States Department of Defense; United States Navy; Naval Medical Center San Diego; Kenya Medical Research Institute; Walter Reed Army Institute of Research (WRAIR); Madigan Army Medical Center	Montalto, GJ (corresponding author), Naval Med Ctr San Diego, Div Adolescent Med, Dept Pediat, San Diego, CA 92134 USA.	gregg.j.montalo.mil@mail.mil			Global Emerging Infections Surveillance and Response System (DoD - GEIS); Walter Reed Army Institute of Research (WRAIR)	Global Emerging Infections Surveillance and Response System (DoD - GEIS); Walter Reed Army Institute of Research (WRAIR)	A small grant was provided by the Global Emerging Infections Surveillance and Response System (DoD - GEIS). This grant paid for the travel of GJM to the research site in Kericho, to hire non-study (i.e. independent) personnel for data collection from the medical records at Kericho District Hospital, and for office supplies. Funding was also provided by the Walter Reed Army Institute of Research (WRAIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, KEN FAST TRACK PLAN; [Anonymous], 2014, KEN AIDS RESP PROGR; Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Biadgilign S, 2009, SAHARA J-J SOC ASP H, V6, P148, DOI 10.1080/17290376.2009.9724943; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Brown BJ, 2011, AIDS CARE, V23, P1053, DOI 10.1080/09540121.2011.554523; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; Domek GJ, 2010, J TROP PEDIATRICS, V56, P440, DOI 10.1093/tropej/fmq013; Ferrand R, 2010, B WORLD HEALTH ORGAN, V88, P428, DOI 10.2471/BLT.09.066126; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; John-Stewart GC, 2013, AIDS CARE, V25, P1067, DOI 10.1080/09540121.2012.749333; Kidia KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087322; Mavedzenge SMN, 2011, J ADOLESCENT HEALTH, V49, P568, DOI 10.1016/j.jadohealth.2011.02.007; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Sirengo M, 2010, KENYA SERVICE PROVIS, P171; Spiegel Hans M L, 2011, Adolesc Med State Art Rev, V22, P277; Taddeo D, 2008, PAED CHILD HEALT-CAN, V13, P19, DOI 10.1093/pch/13.1.19; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086616; Vreeman RC, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18466; Vreeman RC, 2010, AIDS PATIENT CARE ST, V24, P639, DOI 10.1089/apc.2010.0079; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2011, GUID HIV DISCL COUNS; World Population Prospects, 2013, WORLD POP PROSP 2012, VII	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0183180	10.1371/journal.pone.0183180	http://dx.doi.org/10.1371/journal.pone.0183180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991913	Green Submitted, gold, Green Published			2022-12-27	WOS:000412601800004
J	Amo, C; De Santiago, L; Lucianez, DZ; Alonso-Cortes, JML; Alonso-Alonso, M; Barea, R; Boquete, L				Amo, Carlos; De Santiago, Luis; Zarza Lucianez, Daniel; Leon Alonso-Cortes, Jose Miguel; Alonso-Alonso, Miguel; Barea, Rafael; Boquete, Luciano			Induced gamma band activity from EEG as a possible index of training-related brain plasticity in motor tasks	PLOS ONE			English	Article							CORTICAL PLASTICITY; MOVEMENT; OSCILLATIONS; REPRESENTATION; EXERCISE; CORTEX; HAND	The aim of this study was proposing gamma band activity (GBA) as an index of training-related brain plasticity in the motor cortex. Sixteen controls underwent an experimental session where electroencephalography (EEG) activity was recorded at baseline (resting) and during a motor task (hand movements). GBA was obtained from the EEG data at baseline and during the task. Index of plasticity (IP) was defined as the relationship between GBA at the end of the motor task (GBA(M)_(FIN)), divided by GBA at the beginning of the task (GBA(M)_(INI)) for movements of both hands. There was a significant increase in GBA at the end of the task, compared to the initial GBA for the motor task (GBA(M)_(FIN) > GBA(M)_(INI)). No differences were found at baseline (GBA(B)_(FIN) approximate to GBA(B)_(INI)). Individual IP values had a positive (r = 0.624) and significant correlation with subject's handedness. Due to plastic changes, GBA could indirectly but objectively reveal changes in cerebral activity related to physical training. This method could be used as a future diagnostic test in the follow-up of patients undergoing rehabilitation. It could also have potential applications in the fields of sports medicine.	[Amo, Carlos; De Santiago, Luis; Barea, Rafael; Boquete, Luciano] Univ Alcala De Henares, Dept Elect, Alcala De Henares, Spain; [Amo, Carlos] Ecnis Sigma SL, Res Dept Clin Neurophysiol, Madrid, Spain; [Zarza Lucianez, Daniel] Hosp Nisa Pardo Aravaca, Dept Clin Neurophysiol, Madrid, Spain; [Leon Alonso-Cortes, Jose Miguel] Complejo Asistencial Univ Palencia, Hosp Rio Carr, Dept Clin Neurophysiol, Palencia, Spain; [Alonso-Alonso, Miguel] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Study Nutr Med, Lab Bariatr & Nutr Neurosci, Boston, MA USA	Universidad de Alcala; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Boquete, L (corresponding author), Univ Alcala De Henares, Dept Elect, Alcala De Henares, Spain.	luciano.boquete@uah.es	Boquete, Luciano/GXN-4674-2022	Alonso-Alonso, Miguel/0000-0003-3372-9933; Boquete, Luciano/0000-0001-8591-6103	Universidad de Alcala [UAH GC2016-004]; ISCIII [RETICS RD16/0008/0020]	Universidad de Alcala; ISCIII(Instituto de Salud Carlos III)	This research was partially supported by Universidad de Alcala grant: "Diagnostic precoz de neuropatias opticas mediante analisis de registros de potenciales evocados visuales multifocales" UAH GC2016-004 and ISCIII grant RETICS RD16/0008/0020 to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amo C, 2007, AM J PHYS MED REHAB, V86, P304, DOI 10.1097/PHM.0b013e3180383c0d; Amo C, 2006, ARQ NEURO-PSIQUIAT, V64, P394, DOI 10.1590/S0004-282X2006000300008; Amo C, 2016, MOTOR CONTROL, V20, P409, DOI 10.1123/mc.2015-0010; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; Boninger ML, 2014, AM J PHYS MED REHAB, V93, pS145, DOI 10.1097/PHM.0000000000000128; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Ermutlu N, 2015, COGN NEURODYNAMICS, V9, P257, DOI 10.1007/s11571-014-9320-2; ETNIER JL, 1995, SPORTS MED, V19, P81, DOI 10.2165/00007256-199519020-00001; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Huang X, 2017, MOL PSYCHIATR, V22, P1274, DOI 10.1038/mp.2017.143; KARNI A, 1995, NATURE, V377, P155; Lardon MT, 1996, BIOL PSYCHOL, V44, P19, DOI 10.1016/S0301-0511(96)05198-8; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Ramon, 1899, TEXTURA SISTEMA NERV; Rossini P M, 2007, Eura Medicophys, V43, P241; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shibata T, 1999, NEUROSCI RES, V33, P215, DOI 10.1016/S0168-0102(99)00003-6; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062	25	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186008	10.1371/journal.pone.0186008	http://dx.doi.org/10.1371/journal.pone.0186008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982173	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300105
J	Haruna, K; Ismail, MA; Damiasih, D; Sutopo, J; Herawan, T				Haruna, Khalid; Ismail, Maizatul Akmar; Damiasih, Damiasih; Sutopo, Joko; Herawan, Tutut			A collaborative approach for research paper recommender system	PLOS ONE			English	Article							TIES	Research paper recommenders emerged over the last decade to ease finding publications relating to researchers' area of interest. The challenge was not just to provide researchers with very rich publications at any time, any place and in any form but to also offer the right publication to the right researcher in the right way. Several approaches exist in handling paper recommender systems. However, these approaches assumed the availability of the whole contents of the recommending papers to be freely accessible, which is not always true due to factors such as copyright restrictions. This paper presents a collaborative approach for research paper recommender system. By leveraging the advantages of collaborative filtering approach, we utilize the publicly available contextual metadata to infer the hidden associations that exist between research papers in order to personalize recommendations. The novelty of our proposed approach is that it provides personalized recommendations regardless of the research field and regardless of the user's expertise. Using a publicly available dataset, our proposed approach has recorded a significant improvement over other baseline methods in measuring both the overall performance and the ability to return relevant and useful publications at the top of the recommendation list.	[Haruna, Khalid] Bayero Univ, Fac Comp Sci & Informat Technol, Dept Comp Sci, Kano, Nigeria; [Haruna, Khalid; Ismail, Maizatul Akmar] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia; [Damiasih, Damiasih] Sekolah Tinggi Pariwisata Ambarrukmo, Yogyakarta, Indonesia; [Sutopo, Joko; Herawan, Tutut] Univ Teknol Yogyakarta, Fac Informat Technol & Business, Yogyakarta, Indonesia; [Herawan, Tutut] AMCS Res Ctr, Yogyakarta, Indonesia	Bayero University; Universiti Malaya	Ismail, MA (corresponding author), Univ Malaya, Fac Comp Sci & Informat Technol, Dept Informat Syst, Kuala Lumpur, Malaysia.	maizatul@um.edu.my	Damiasih, Damiasih/ABA-5059-2021; ISMAIL, MAIZATUL AKMAR/B-8922-2010; Sutopo, Joko/GQA-6821-2022; Herawan, Tutut/AAB-6534-2021; Haruna, Khalid/AAH-8372-2019	ISMAIL, MAIZATUL AKMAR/0000-0003-1877-7128; Herawan, Tutut/0000-0001-9262-9137; sutopo, joko/0000-0003-1532-1723				Agarwal N, 2005, LECT NOTES COMPUT SC, V3739, P475; [Anonymous], 2015, RECOMMENDER SYSTEMS, DOI DOI 10.1007/978-1-4899-7637-6_13; Aral S, 2014, MANAGE SCI, V60, P1352, DOI 10.1287/mnsc.2014.1936; Asabere N. Y., 2017, IEEE T AFFECTIVE COM; Asabere NY, 2015, INT J PARALLEL EMERG, V30, P211, DOI 10.1080/17445760.2014.904859; Azaria A., 2013, P 7 ACM C REC SYST, P121; Backstrom L, 2006, P 12 ACM SIGKDD INT, P44, DOI DOI 10.1145/1150402.1150412; Beel J, 2013, ACM-IEEE J CONF DIG, P459; Chandrasekaran K, 2008, LECT NOTES COMPUT SC, V5149, P83, DOI 10.1007/978-3-540-70987-9_11; Chua F. C. T., 2011, P SIAM INT C DAT MIN, P367; Fano R. M., 1956, DOCUMENTATION ACTION, P238; Feng Xia, 2016, IEEE Transactions on Big Data, V2, P101, DOI 10.1109/TBDATA.2016.2555318; Giles C. L., 1998, Digital 98 Libraries. Third ACM Conference on Digital Libraries, P89, DOI 10.1145/276675.276685; Gipp B., 2009, P INT C EM TRENDS CO, P309; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOLDBERG D, 1992, COMMUN ACM, V35, P61, DOI 10.1145/138859.138867; Gori M, 2006, 2006 IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, (WI 2006 MAIN CONFERENCE PROCEEDINGS), P778, DOI 10.1109/WI.2006.149; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hariri N., 2012, P 6 ACM C REC SYST, P131, DOI DOI 10.1145/2365952.2365979; Haruna K., 2016, KNOWL MAN INT C KMIC, P29; Haruna K., 2016, INT J SOFT COMPUTING, V11, P96; Hildreth C. R., 2001, Information Research, V6; Jonnalagedda N, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.63; Konstan JA, 1997, COMMUN ACM, V40, P77, DOI 10.1145/245108.245126; Konstas I, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P195, DOI 10.1145/1571941.1571977; Krackhardt D., 2003, NETWORKS KNOWLEDGE E, P82, DOI [10.1093/oso/9780195159509.003.0008, DOI 10.1093/OSO/9780195159509.003.0008]; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Liu HF, 2017, IEEE SYST J, V11, P295, DOI 10.1109/JSYST.2015.2427193; Liu HF, 2015, IEEE ACCESS, V3, P1695, DOI 10.1109/ACCESS.2015.2481320; Ma H, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P203, DOI 10.1145/1571941.1571978; Ma Hao, 2011, ACM WSDM, P287; MARSHAKOVA IV, 1973, NAUCH-TEKHN INFORM 2, P3; McNee S.M., 2002, P 2002 ACM C COMP SU, P116, DOI DOI 10.1145/587078.587096; Middleton SE, 2004, ACM T INFORM SYST, V22, P54, DOI 10.1145/963770.963773; Nascimento C., 2011, P 11 ANN INT ACM IEE, P297, DOI DOI 10.1145/1998076.1998132; Colombo-Mendoza LO, 2015, EXPERT SYST APPL, V42, P1202, DOI 10.1016/j.eswa.2014.09.016; Panniello U., USER MODELING USER A, V24, P35; Pennock D.M., 2000, P 16 C UNC ART INT, P473; Philip S., 2014, INT J ADV COMPUTER S, V5; Pirolli P, 2009, COMPUTER, V42, P33, DOI 10.1109/MC.2009.94; Prahalad C., 2004, CRM CK PRAHALAD PRED; Pudhiyaveetil Ajith Kodakateri, 2009, P 3 ACM C REC SYST, P241; Resnick P., 1994, Transcending Boundaries, CSCW '94. Proceedings of the Conference on Computer Supported Cooperative Work, P175, DOI 10.1145/192844.192905; Shardanand U., 1995, Human Factors in Computing Systems. CHI'95 Conference Proceedings, P210, DOI 10.1145/223904.223931; Sibaroni Y., 2015, INF TECHN SYST INN I, P1; Skillen Kerry-Louise, 2012, Ubiquitous Computing and Ambient Intelligence. 6th International Conference, UCAmI 2012. Proceedings, P261, DOI 10.1007/978-3-642-35377-2_36; Song T., 2017, INFORM MANAGEMENT; Steffes EM, 2009, INTERNET RES, V19, P42, DOI 10.1108/10662240910927812; Sugiyama K., 2011, P 11 ANN INT ACM IEE, P307, DOI [10.1145/1998076.1998133, DOI 10.1145/1998076.1998133]; Sugiyama K., 2010, P 10 ANN JOINT C DIG, P29, DOI DOI 10.1145/1816123.1816129; Sugiyama K, 2015, INT J DIGIT LIBRARIE, V16, P91, DOI 10.1007/s00799-014-0122-2; Sugiyama K, 2013, ACM-IEEE J CONF DIG, P153; Torres R, 2004, ACM-IEEE J CONF DIG, P228, DOI 10.1145/996350.996402; Xia F, 2017, IEEE T BIG DATA, V3, P18, DOI 10.1109/TBDATA.2016.2641460; Xia F, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P781, DOI 10.1145/2567948.2579239; Yu ZW, 2007, LECT NOTES COMPUT SC, V4611, P898	56	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184516	10.1371/journal.pone.0184516	http://dx.doi.org/10.1371/journal.pone.0184516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981512	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300013
J	Lamb, CT; Mowat, G; Gilbert, SL; McLellan, BN; Nielsen, SE; Boutin, S				Lamb, Clayton T.; Mowat, Garth; Gilbert, Sophie L.; McLellan, Bruce N.; Nielsen, Scott E.; Boutin, Stan			Density-dependent signaling: An alternative hypothesis on the function of chemical signaling in a non-territorial solitary carnivore	PLOS ONE			English	Article							GRIZZLY BEAR POPULATION; URSUS-ARCTOS; BROWN BEARS; ALBERTA; PROSPECTUS; BLACK	Brown bears are known to use rubbing behavior as a means of chemical communication, but the function of this signaling is unclear. One hypothesis that has gained support is that male bears rub to communicate dominance to other males. We tested the communication of dominance hypothesis in a low-density brown bear population in southeast British Columbia. We contrasted rubbing rates for male and female bears during and after the breeding season using ten years of DNA-mark-recapture data for 643 individuals. Here we demonstrate that male brown bears rub 60% more during the breeding than the non-breeding season, while female rubbing had no seasonal trends. Per capita rub rates by males were, on average, 2.7 times higher than females. Our results suggest that the function of rubbing in the Rocky Mountains may not only be to communicate dominance, but also to self-advertise for mate attraction. We propose that the role of chemical communication in this species may be density-dependent, where the need to self-advertise for mating is inversely related to population density and communicating for dominance increases with population density. We suggest that future endeavors to elucidate the function of rubbing should sample the behavior across a range of population densities using camera trap and genotypic data.	[Lamb, Clayton T.; Gilbert, Sophie L.; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mowat, Garth; McLellan, Bruce N.] Minist Forests Lands & Nat Resource Operat, Nelson, BC, Canada; [Mowat, Garth] Univ British Columbia, Dept Earth Environm & Geog Sci, Okanagan Campus, Kelowna, BC, Canada; [Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta; University of British Columbia; University of Alberta	Lamb, CT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ctlamb@ualberta.ca	Nielsen, Scott/C-2842-2013; Lamb, Clayton/H-9158-2019; Nielsen, Scott/O-7482-2019; Boutin, Stan/A-2619-2014	Nielsen, Scott/0000-0002-9754-0630; Lamb, Clayton/0000-0002-1961-0509; Nielsen, Scott/0000-0002-9754-0630; Boutin, Stan/0000-0001-6317-038X; Gilbert, Sophie/0000-0002-9974-5146	Vanier Canada Graduate Scholarships; Natural Science and Engineering Research Council of Canada; Ministry of Forests, Lands and Natural Resource Operations; Habitat Conservation Trust Foundation; Safari Club International; Columbia Basin Trust Fund; BP Canada; BC Conservation Corps; Teck Coal; Columbia Basin Trust Foundation	Vanier Canada Graduate Scholarships; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministry of Forests, Lands and Natural Resource Operations; Habitat Conservation Trust Foundation; Safari Club International; Columbia Basin Trust Fund; BP Canada; BC Conservation Corps; Teck Coal; Columbia Basin Trust Foundation	Funded by Vanier Canada Graduate Scholarships, Natural Science and Engineering Research Council of Canada, Ministry of Forests, Lands and Natural Resource Operations, Habitat Conservation Trust Foundation, Safari Club International, Columbia Basin Trust Fund, BP Canada, BC Conservation Corps and Teck Coal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many people who helped collect these data and to Kate Broadley and Abbey Wilson for insightful comments on this work. Gordon Stenhouse kindly provided information and data pertaining to grizzly bear movements and breeding season behavior. Thanks to Bill and Sue Hanlon for providing logistical support in the field. The following funders graciously provided funding for this work: Vanier Canada Graduate Scholarships, Natural Science and Engineering Research Council of Canada, Ministry of Forests, Lands and Natural Resource Operations, Habitat Conservation Trust Foundation, Safari Club International, Columbia Basin Trust Foundation, BP Canada, BC Conservation Corps and Teck Coal. The authors of this work have no competing interests to disclose.	Apps CD, 2016, J WILDLIFE MANAGE, V80, P396, DOI 10.1002/jwmg.1037; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Clapham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035404; Dumond M, 2015, WILDLIFE SOC B, V39, P390, DOI 10.1002/wsb.520; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Graham Karen, 2014, Canadian Field-Naturalist, V128, P223; Green GI, 2003, WILDLIFE BIOL, V9, P1; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Karamanlidis AA, 2007, URSUS, V18, P54, DOI 10.2192/1537-6176(2007)18[54:USAPPT]2.0.CO;2; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall KC, 2008, NONINVASIVE SURVEY M, P135; Lamb CT, 2017, J ANIM ECOL, V86, P55, DOI 10.1111/1365-2656.12589; Lamb CT, 2016, URSUS, V27, P31, DOI 10.2192/URSUS-D-15-00025.1; Martin J, 2007, FUNCT ECOL, V21, P568, DOI 10.1111/j.1365-2435.2007.01262.x; McLellan B., 2011, CAN J ZOOL, V558, P546, DOI DOI 10.1139/Z11-026; MCLELLAN BN, 1995, CAN J ZOOL, V73, P704, DOI 10.1139/z95-082; MCLELLAN BN, 1989, CAN J ZOOL, V67, P1856, DOI 10.1139/z89-264; Monnin T, 2002, NATURE, V419, P61, DOI 10.1038/nature00932; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; MOWAT G, 2013, S ROCKIES FLATHEAD G; MOWAT G, 2016, POPULATION STATUS S; Mowat G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082757; Nevin OT, 2003, INFLUENCE PREY ABUND; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Roberts DR, 2014, ECOL APPL, V24, P1144, DOI 10.1890/13-0829.1; Sato Y, 2014, ACTA THERIOL, V59, P129, DOI 10.1007/s13364-013-0143-z; Sawaya MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034777; Schwartz C.C. S.D., 2003, WILD MAMMALS N AM BI, P556; Sergiel A, 2017, SCI REP, V7, P1; SERYODKIN I. V., 2014, ACHIEVEMENTS LIFE SC, V8, P153, DOI DOI 10.1016/J.ALS.2015.04.006; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Tattoni C, 2015, ITAL J MAMMAL ONLINE, V26, P1; Woods JG, 1999, WILDLIFE SOC B, V27, P616	35	11	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184176	10.1371/journal.pone.0184176	http://dx.doi.org/10.1371/journal.pone.0184176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981540	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300009
J	Neu, E; Featherston, J; Rees, J; Debener, T				Neu, Enzo; Featherston, Jonathan; Rees, Jasper; Debener, Thomas			A draft genome sequence of the rose black spot fungus Diplocarpon rosae reveals a high degree of genome duplication	PLOS ONE			English	Article							DISEASE RESISTANCE; GENETIC-ANALYSIS; TRIGGERED IMMUNITY; SIZE DETERMINATION; MASSIVE ANALYSIS; FLOW-CYTOMETRY; PHI-BASE; EVOLUTIONARY; DATABASE; ANNOTATION	Background Black spot is one of the most severe and damaging diseases of garden roses. We present the draft genome sequence of its causative agent Diplocarpon rosae as a working tool to generate molecular markers and to analyze functional and structural characteristics of this fungus. Results The isolate DortE4 was sequenced with 191x coverage of different read types which were assembled into 2457 scaffolds. By evidence supported genome annotation with the MAKER pipeline 14,004 gene models were predicted and transcriptomic data indicated that 88.5% of them are expressed during the early stages of infection. Analyses of k-mer distributions resulted in unexpectedly large genome size estimations between 72.5 and 91.4 Mb, which cannot be attributed to its repeat structure and content of transposable elements alone, factors explaining such differences in other fungal genomes. In contrast, different lines of evidences demonstrate that a huge proportion (approximately 80%) of genes are duplicated, which might indicate a whole genome duplication event. By PCR-RFLP analysis of six paralogous gene pairs of BUSCO orthologs, which are expected to be single copy genes, we could show experimentally that the duplication is not due to technical error and that not all isolates tested possess all of the paralogs. Conclusions The presented genome sequence is still a fragmented draft but contains almost the complete gene space. Therefore, it provides a useful working tool to study the interaction of D. rosae with the host and the influence of a genome duplication outside of the model yeast in the background of a phytopathogen.	[Neu, Enzo; Debener, Thomas] Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany; [Featherston, Jonathan; Rees, Jasper] Agr Res Council, Biotechnol Platform, Pretoria, South Africa	Leibniz University Hannover; Agricultural Research Council of South Africa	Debener, T (corresponding author), Leibniz Univ Hannover, Inst Plant Genet, Hannover, Germany.	debener@genetik.uni-hannover.de	Rees, David Jasper Gilbert/AAZ-8073-2020; Debener, Thomas/AAJ-9056-2020	Rees, David Jasper Gilbert/0000-0003-3321-1325; Debener, Thomas/0000-0002-2012-2246	DFG GRK [GRK 1798/1]; South Africa/Germany agreement on cooperation in science and technology [SUA 09/030]	DFG GRK(German Research Foundation (DFG)); South Africa/Germany agreement on cooperation in science and technology	This work was funded by the DFG GRK 1798 "Signaling at the Plant-Soil Interface (GRK 1798/1) (EK, TD) and the joint research grant under the South Africa/Germany agreement on cooperation in science and technology (SUA 09/030) (JF, JR, TD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; [Anonymous], 2016, NATURE REV GENETICS, V17, P379; Aragona M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-313; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Blechert O, 2005, PLANT PATHOL, V54, P82, DOI 10.1111/j.1365-3059.2005.01118.x; Bock CH, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0161-y; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; del Pozo JC, 2015, J EXP BOT, V66, P6991, DOI 10.1093/jxb/erv432; Chand R, 2015, CURRENT SCI, V109; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; D'Hondt L, 2011, MOL PLANT PATHOL, V12, P815, DOI [10.1111/j.1364-3703.2011.00711.x, 10.1111/J.1364-3703.2011.00711.X]; Da Maia LC, 2008, INT J PLANT GENOMICS; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debener T, 1998, PLANT BREEDING, V117, P267, DOI 10.1111/j.1439-0523.1998.tb01937.x; Debener T, 2014, PLANT SCI, V228, P107, DOI 10.1016/j.plantsci.2014.04.005; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FraissinetTachet L, 1996, CURR GENET, V29, P496, DOI 10.1007/BF02221520; Gachomo EW, 2006, PHYSIOL MOL PLANT P, V69, P86, DOI 10.1016/j.pmpp.2007.02.002; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Gao S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0951-y; Grandaubert J, 2014, ADV BOT RES, V70, P79, DOI 10.1016/B978-0-12-397940-7.00003-3; Green P, PHRED 0 020425 C; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Hattendorf A, 2004, ACTA HORTIC, P123, DOI 10.17660/ActaHortic.2004.651.14; Horst R.K., 2007, COMPENDIUM ROSE DIS, V2nd ed.; Jiang C, 2014, AUSTRALAS PLANT PATH, V43, P615, DOI 10.1007/s13313-014-0316-5; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karaoglu H, 2005, MOL BIOL EVOL, V22, P639, DOI [10.1093/molbev/mis057, 10.1093/molbev/msi057]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kaufmann H, 2003, MOL GENET GENOMICS, V268, P666, DOI 10.1007/s00438-002-0784-0; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Menz I, 2017, MOL PLANT PATHOLOGY; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Munnekhoff AK, 2017, PLANT PATHOLOGY; Naumov GI, 2000, SYST APPL MICROBIOL, V23, P442, DOI 10.1016/S0723-2020(00)80076-4; Okuno M, 2016, DNA RES, V23, P67, DOI 10.1093/dnares/dsv037; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Pedro H, 2016, NUCLEIC ACIDS RES, V44, pD688, DOI 10.1093/nar/gkv1052; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Sharma KK, 2016, CRIT REV BIOTECHNOL, V36, P743, DOI 10.3109/07388551.2015.1015959; Shirke MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162458; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smit A, REPEATMASKER OPEN 4; Smit AFA., REPEATMODELER OPEN 1; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stukenbrock EH, 2014, FUNGAL BIOL REV, V28, P1, DOI 10.1016/j.fbr.2014.02.001; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Team RC. R, R LANG ENV STAT COMP; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Terefe-Ayana D, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00035; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Veselska T, 2014, CYTOM PART A, V85A, P854, DOI 10.1002/cyto.a.22500; von Malek B, 1998, THEOR APPL GENET, V96, P228, DOI 10.1007/s001220050731; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Weber E, 1992, BIBLIOTHECA MYCOLOGI, V140, P1; Whitaker VM, 2010, PLANT PATHOL, V59, P745, DOI 10.1111/j.1365-3059.2010.02281.x; Whitaker VM, 2010, THEOR APPL GENET, V120, P573, DOI 10.1007/s00122-009-1177-0; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Williams TA, 2016, MOL BIOL EVOL, V33, P2002, DOI 10.1093/molbev/msw083; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zajac BK, 2015, FORENSIC SCI INT-GEN, V15, P137, DOI 10.1016/j.fsigen.2014.11.013; Zawada AM, 2014, EPIGENETICS-US, V9, P161, DOI 10.4161/epi.26931; Zhu S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-382	93	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185310	10.1371/journal.pone.0185310	http://dx.doi.org/10.1371/journal.pone.0185310			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981525	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300032
J	Kang, C; Zhang, Q; Zhu, WF; Cai, CZ; Sun, XM; Jin, ML				Kang, Chao; Zhang, Qiang; Zhu, Weifeng; Cai, Chengzhi; Sun, Xiaomei; Jin, Meilin			Transcription analysis of the responses of porcine heart to Erysipelothrix rhusiopathiae	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INDUCIBLE PROTEIN-10; ADHESION MOLECULES; PLATELETS; DAMAGE; TLR4	Erysipelothrix rhusiopathiae (E. rhusiopathiae) is the causative agent of swine erysipelas. This microbe has caused great economic losses in China and in other countries. In this study, high-throughput cDNA microarray assays were employed to evaluate the host responses of porcine heart to E. rhusiopathiae and to gain additional insights into its pathogenesis. A total of 394 DE transcripts were detected in the active virulent E. rhusiopathiae infection group compared with the PBS group at 4 days post-infection. Moreover, 262 transcripts were upregulated and 132 transcripts were downregulated. Differentially expressed genes were involved in many vital functional classes, including inflammatory and immune responses, signal transduction, apoptosis, transport, protein phosphorylation and dephosphorylation, metabolic processes, chemotaxis, cell adhesion, and innate immune responses. Pathway analysis demonstrated that the most significant pathways were Chemokine signaling pathway, NF-kappa B signaling pathway, TLR pathway, CAMs, systemic lupus erythematosus, chemokine signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Phagosome, HTLV-I infection, Measles, Rheumatoid arthritis and natural-killer-cell-mediated cytotoxicity. The reliability of our microarray data was verified by performing quantitative real-time PCR. This study is the first to document the response of piglet heart to E. rhusiopathiae infection. The observed gene expression profile could help screen potential host agents that can reduce the prevalence of E. rhusiopathiae. The profile might also provide insights into the underlying pathological changes that occur in pigs infected with E. rhusiopathiae.	[Kang, Chao; Zhang, Qiang; Zhu, Weifeng; Cai, Chengzhi; Jin, Meilin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Hubei, Peoples R China; [Sun, Xiaomei; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Jin, ML (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Hubei, Peoples R China.; Jin, ML (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China.	jml8328@126.com			National Natural Science Fund of China [31472220]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was supported by funding from the National Natural Science Fund of China (31472220). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the National Natural Science Fund of China (31472220).	Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Arjmandi A, 2009, J NEUROPATH EXP NEUR, V68, P300, DOI 10.1097/NEN.0b013e31819a8dd1; Brooke CJ, 1999, J MED MICROBIOL, V48, P789, DOI 10.1099/00222615-48-9-789; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; GORBY GL, 1988, REV INFECT DIS, V10, P317; Hashimoto K, 2009, J CARDIOVASC PHARM, V54, P57, DOI 10.1097/FJC.0b013e3181ab373d; Horseman MA, 2016, CURR CARDIOL REV; Ishizuka K, 1997, NEUROREPORT, V8, P1215, DOI 10.1097/00001756-199703240-00031; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klimiuk PA, 2002, ANN RHEUM DIS, V61, P804, DOI 10.1136/ard.61.9.804; Kwok AHY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-176; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Libby P, 2002, SCI AM, V286, P47; McCarthy CG, 2014, AM J PHYSIOL-HEART C, V306, pH184, DOI 10.1152/ajpheart.00328.2013; Menghini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099053; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; REBOLI AC, 1989, CLIN MICROBIOL REV, V2, P354, DOI 10.1128/CMR.2.4.354-359.1989; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Sahingur SE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00214; Shimoji Y, 2002, J VET MED SCI, V64, P173, DOI 10.1292/jvms.64.173; Shimoji Y, 1997, INFECT IMMUN, V62, P2806; Tanja Opriessnig, 2012, DIS SWINE, P2746; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Wang QN, 2010, VET MICROBIOL, V140, P405, DOI 10.1016/j.vetmic.2009.08.012; Wang QN, 2005, VET MICROBIOL, V107, P265, DOI 10.1016/j.vetmic.2005.01.022; Wang T, 2012, EURASIP J WIREL COMM, P1, DOI 10.1186/1687-1499-2012-111; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Zhuang HY, 2014, ARTHRITIS RHEUMATOL, V66, P140, DOI 10.1002/art.38189	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185548	10.1371/journal.pone.0185548	http://dx.doi.org/10.1371/journal.pone.0185548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976997	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100028
J	Menegon, M; Cantaloni, C; Rodriguez-Prieto, A; Centomo, C; Abdelfattah, A; Rossato, M; Bernardi, M; Xumerle, L; Loader, S; Delledonne, M				Menegon, Michele; Cantaloni, Chiara; Rodriguez-Prieto, Ana; Centomo, Cesare; Abdelfattah, Ahmed; Rossato, Marzia; Bernardi, Massimo; Xumerle, Luciano; Loader, Simon; Delledonne, Massimo			On site DNA barcoding by nanopore sequencing	PLOS ONE			English	Article							6TH MASS EXTINCTION; BIODIVERSITY; LEPIDOPTERA; SHORTFALLS; KNOWLEDGE; PROMISE	Biodiversity research is becoming increasingly dependent on genomics, which allows the unprecedented digitization and understanding of the planet's biological heritage. The use of genetic markers i.e. DNA barcoding, has proved to be a powerful tool in species identification. However, full exploitation of this approach is hampered by the high sequencing costs and the absence of equipped facilities in biodiversity-rich countries. In the present work, we developed a portable sequencing laboratory based on the portable DNA sequencer from Oxford Nanopore Technologies, the MinION. Complementary laboratory equipment and reagents were selected to be used in remote and tough environmental conditions. The performance of the MinION sequencer and the portable laboratory was tested for DNA barcoding in a mimicking tropical environment, as well as in a remote rainforest of Tanzania lacking electricity. Despite the relatively high sequencing error-rate of the MinION, the development of a suitable pipeline for data analysis allowed the accurate identification of different species of vertebrates including amphibians, reptiles and mammals. In situ sequencing of a wild frog allowed us to rapidly identify the species captured, thus confirming that effective DNA barcoding in the field is possible. These results open new perspectives for real-time-on-site DNA sequencing thus potentially increasing opportunities for the understanding of biodiversity in areas lacking conventional laboratory facilities.	[Menegon, Michele; Rodriguez-Prieto, Ana; Bernardi, Massimo] Sci Museum Trento, Trop Biodivers sect, Trento, Italy; [Cantaloni, Chiara; Abdelfattah, Ahmed; Xumerle, Luciano; Delledonne, Massimo] Personal Genom Srl, Verona, Italy; [Cantaloni, Chiara; Centomo, Cesare; Rossato, Marzia; Xumerle, Luciano; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, Verona, Italy; [Loader, Simon] Univ Basel, Dept Environm Sci, Biogeog Res Grp, Basel, Switzerland; [Loader, Simon] Univ Roehampton, Dept Life Sci, London, England	University of Verona; University of Basel; Roehampton University	Delledonne, M (corresponding author), Personal Genom Srl, Verona, Italy.; Delledonne, M (corresponding author), Univ Verona, Dept Biotechnol, Funct Genom Ctr, Verona, Italy.	massimo.delledonne@univr.it	Abdelfattah, Ahmed/P-1943-2015; Delledonne, Massimo/O-8685-2017; Rossato, Marzia/AAB-7827-2019	Abdelfattah, Ahmed/0000-0001-6090-7200; Rossato, Marzia/0000-0002-6101-1550; Delledonne, Massimo/0000-0002-7100-4581; Xumerle, Luciano/0000-0003-4518-3958	Fondazione Caritro; 'Gino Zobele fund for Research'	Fondazione Caritro(Fondazione Caritro); 'Gino Zobele fund for Research'	This work was partly funded by Fondazione Caritro (http://www.fondazionecaritro.it) and by the 'Gino Zobele fund for Research'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Personal Genomics provided support only in the form of salaries for authors CC, AA and LX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth D, 2017, NUCLEIC ACIDS RES, V45, P1649, DOI 10.1093/nar/gkw1248; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Bohm M, 2015, CONSERV BIOL, V29, P1290, DOI 10.1111/cobi.12529; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Diniz JAF, 2013, TRENDS ECOL EVOL, V28, P689, DOI 10.1016/j.tree.2013.09.003; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; JAIN M, 2016, GENOME BIOL, V17; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555; McCarthy C., 1996, CHROMAS VERSION 1 45; Myers G, 2014, LECT N BIOINFORMAT, V8701, P52, DOI 10.1007/978-3-662-44753-6_5; Palumbi Stephen R., 1996, P205; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; San Mauro D, 2004, MOL PHYLOGENET EVOL, V33, P413, DOI 10.1016/j.ympev.2004.05.014; Sawada Y, 2012, J INT DEV, V24, P316, DOI 10.1002/jid.1685; Schneider D, 1999, Z NATURFORSCH C, V54, P1119; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Tucker CM, 2012, CONSERV BIOL, V26, P593, DOI 10.1111/j.1523-1739.2012.01845.x; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105	38	59	63	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184741	10.1371/journal.pone.0184741	http://dx.doi.org/10.1371/journal.pone.0184741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977016	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100010
J	Miettinen, ME; Smart, MC; Kinnunen, L; Harjutsalo, V; Reinert-Hartwall, L; Ylivinkka, I; Surcel, HM; Lamberg-Allardt, C; Hitman, GA; Tuomilehto, J				Miettinen, Maija E.; Smart, Melissa C.; Kinnunen, Leena; Harjutsalo, Valma; Reinert-Hartwall, Linnea; Ylivinkka, Irene; Surcel, Helja-Marja; Lamberg-Allardt, Christel; Hitman, Graham A.; Tuomilehto, Jaakko			Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child	PLOS ONE			English	Article							VITAMIN-D STATUS; COD-LIVER OIL; ISLET AUTOIMMUNITY; RISK-FACTORS; ASSOCIATION; METABOLISM; YOUNG; METAANALYSIS; VARIANTS; DISEASE	Objective The in utero environment plays an important role in shaping development and later life health of the fetus. It has been shown that maternal genetic factors in the metabolic pathway of vitamin D associate with type 1 diabetes in the child. In this study we analyzed the genetic determinants of serum 25-hydroxyvitamin D (25OHD) concentration during pregnancy in mothers whose children later developed type 1 diabetes and in control mothers. Study design 474 mothers of type 1 diabetic children and 348 mothers of non-diabetic children were included in the study. We previously selected 7 single nucleotide polymorphisms (SNPs) in four genes in the metabolic pathway of vitamin D vitamin based on our previously published data demonstrating an association between genotype and serum 25OHD concentration. In this re-analysis, possible differences in strength in the association between the SNPs and serum 25OHD concentration in mothers of type 1 diabetic and non-diabetic children were investigated. Serum 25OHD concentrations were previously shown to be similar between the mothers of type 1 diabetic and non-diabetic children and vitamin D deficiency prevalent in both groups. Results Associations between serum 25OHD concentration and 2 SNPs, one in the vitamin D receptor (VDR) gene (rs4516035) and one in the group-specific component (GC) gene (rs12512631), were stronger during pregnancy in mothers whose children later developed type 1 diabetes than in mothers whose children did not (p(interaction) = 0.03, 0.02, respectively). Conclusions We show for the first time that there are differences in the strength of genetic determinants of serum 25OHD concentration during pregnancy between the mothers of type 1 diabetic and non-diabetic children. Our results emphasize that the in utero environment including maternal vitamin D metabolism should be important lines of investigation when searching for factors that lead to early programming of type 1 diabetes.	[Miettinen, Maija E.; Harjutsalo, Valma; Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Smart, Melissa C.; Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Smart, Melissa C.] Univ Essex, Colchester, Essex, England; [Kinnunen, Leena] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Harjutsalo, Valma] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland; [Harjutsalo, Valma] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland; [Harjutsalo, Valma] Helsinki Univ Hosp, Helsinki, Finland; [Harjutsalo, Valma] Res Program Unit, Diabet & Obes, Helsinki, Finland; [Reinert-Hartwall, Linnea] Natl Inst Hlth & Welf, Vaccinat Programme Unit, Helsinki, Finland; [Ylivinkka, Irene] Univ Helsinki, Translat Canc Biol Res Program, Helsinki, Finland; [Surcel, Helja-Marja] Natl Inst Hlth & Welf, Impact Assessment Unit, Oulu, Finland; [Lamberg-Allardt, Christel] Dept Food & Environm Sci, Helsinki, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Ctr Vasc Prevent, Krems, Austria; [Tuomilehto, Jaakko] South Ostrobothnia Cent Hosp, Seinajoki, Finland; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait	Finland National Institute for Health & Welfare; University of London; Queen Mary University London; University of Essex; Finland National Institute for Health & Welfare; Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; Danube University Krems; King Abdulaziz University	Miettinen, ME (corresponding author), Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland.	maija.miettinen@thl.fi	Kinnunen, Leena/B-7059-2012; Harjutsalo, Valma/AAL-6588-2021	Kinnunen, Leena/0000-0001-8739-4812; Harjutsalo, Valma/0000-0003-3568-9779; Lamberg-Allardt, Christel/0000-0001-7326-1904; Ylivinkka, Irene/0000-0001-5035-0445; Miettinen, Maija E/0000-0002-5587-7227; Smart, Melissa/0000-0002-2655-3880	Finnish Academy [127219]; European Foundation for the Study of Diabetes; Novo Nordisk Foundation; Diabetes Research Foundation; South Ostrobothnia Central Hospital [EV01107]; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Suoma Loimaranta-Airila Fund; Onni and Hilja Tuovinen Foundation; Juho Vainio Foundation; Orion Research Foundation; Kyllikki and Uolevi Lehikoinen Foundation	Finnish Academy(Academy of Finland); European Foundation for the Study of Diabetes; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Diabetes Research Foundation; South Ostrobothnia Central Hospital; Biomedicum Helsinki Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Suoma Loimaranta-Airila Fund; Onni and Hilja Tuovinen Foundation; Juho Vainio Foundation; Orion Research Foundation; Kyllikki and Uolevi Lehikoinen Foundation	Funded by The Finnish Academy (Grant No. 127219) (http://www.aka.fi/en/); The European Foundation for the Study of Diabetes (http://www. europeandiabetesfoundation.org); Novo Nordisk Foundation (http://novonordisklonderi.dk/en); Diabetes Research Foundation (https://www. diabetestutkiMUS.fi/); South Ostrobothnia Central Hospital (EV01107) (http://www.epshp.fi/en); Biomedicum Helsinki Foundation (http://www. biomecacum.fi/index.php?page=112& Jalmari and Rauha Ahokas Foundation (http:// www.ahokkaansaatio.org/); Yrjo Jahnsson Foundation (http://www.yjs.fi/ent); Suoma Loimaranta-Airila Fund (http://www.european-funding-guide.eu/scholarship/14903-scholarship); Onni and Hilja Tuovinen Foundation (http://www.tuovisensaatio.fi/); Juho Vainio Foundation (http:// juhovainionsaatio.fi/en/juho-vainio-foundation/); Orion Research Foundation (http://www.orion.fi/tutkimus/orionin-tutkimussaatiol; Kyllikki and Uolevi Lehikoinen Foundation (http://www.aurora-tietokanta.fi/grant/details/id/4096 /refc/foundation/refa/details). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Ahn J, 2009, CARCINOGENESIS, V30, P769, DOI 10.1093/carcin/bgp055; Altieri B, 2017, REV ENDOCR METAB DIS, V18, P335, DOI 10.1007/s11154-016-9405-9; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; [Anonymous], 2016, LANCET, V387, P2331; Bailey R, 2007, DIABETES, V56, P2616, DOI 10.2337/db07-0652; BARKER DJP, 1986, LANCET, V1, P1077; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; DAHLQUIST G, 1994, INT J EPIDEMIOL, V23, P1234, DOI 10.1093/ije/23.6.1234; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; Elfving M, 2008, EXP DIABETES RES, DOI 10.1155/2008/271958; Frederiksen B, 2013, J STEROID BIOCHEM, V133, P51, DOI 10.1016/j.jsbmb.2012.08.012; Frederiksen BN, 2013, J CLIN ENDOCR METAB, V98, pE1845, DOI 10.1210/jc.2013-2256; Gale EAM, 2005, DIABETOLOGIA, V48, P1435, DOI 10.1007/s00125-005-1833-0; Goulielmos GN, 2016, PEDIATR RHEUMATOL, V14, DOI 10.1186/s12969-016-0087-3; Hansen CHF, 2014, DIABETES, V63, P2821, DOI 10.2337/db13-1612; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jacobsen R, 2016, DIABETOLOGIA, V59, P1871, DOI 10.1007/s00125-016-4002-8; Marjamaki L, 2010, DIABETOLOGIA, V53, P1599, DOI 10.1007/s00125-010-1734-8; McGrath JJ, 2010, J STEROID BIOCHEM, V121, P471, DOI 10.1016/j.jsbmb.2010.03.073; MENSER MA, 1978, LANCET, V1, P57; Miettinen ME, 2012, DIABETOLOGIA, V55, P1291, DOI 10.1007/s00125-012-2458-8; Miettinen ME, 2015, DIABETOLOGIA, V58, P2278, DOI 10.1007/s00125-015-3675-8; Nejentsev S, 2004, DIABETES, V53, P2709, DOI 10.2337/diabetes.53.10.2709; Nissen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089907; Orton SM, 2008, AM J CLIN NUTR, V88, P441, DOI 10.1093/ajcn/88.2.441; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Ramos-Lopez E, 2007, DIABETES-METAB RES, V23, P631, DOI 10.1002/dmrr.719; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Siljander HTA, 2009, DIABETES, V58, P2835, DOI 10.2337/db08-1305; Sorensen IM, 2012, DIABETES, V61, P175, DOI 10.2337/db11-0875; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Taylor AE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004799; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Zella JB, 2003, ARCH BIOCHEM BIOPHYS, V417, P77, DOI 10.1016/S0003-9861(03)00338-2; Zerwekh JE, 2004, ANN CLIN BIOCHEM, V41, P272, DOI 10.1258/0004563041201464	47	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184942	10.1371/journal.pone.0184942	http://dx.doi.org/10.1371/journal.pone.0184942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976992	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000412163100014
J	Goto, H; Takayasu, H; Takayasu, M				Goto, Hayato; Takayasu, Hideki; Takayasu, Misako			Estimating risk propagation between interacting firms on inter-firm complex network	PLOS ONE			English	Article							SCALING BEHAVIOR; INTERNET; GROWTH; RESILIENCE; CENTRALITY; DYNAMICS	We derive a stochastic function of risk propagation empirically from comprehensive data of chain-reaction bankruptcy events in Japan from 2006 to 2015 over 5,000 pairs of firms. The probability is formulated by firm interaction between the pair of firms; it is proportional to the product of alpha-th power of the size of the first bankrupt firm and beta-th power of that of the chainreaction bankrupt firm. We confirm that a is positive and beta is negative throughout the observing period, meaning that the probability of cascading failure is higher between a larger first bankrupt firm and smaller trading firm. We additionally introduce a numerical model simulating the whole ecosystem of firms and show that the interaction kernel is a key factor to express complexities of spreading bankruptcy risks on real ecosystems.	[Goto, Hayato; Takayasu, Misako] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan; [Takayasu, Hideki; Takayasu, Misako] Tokyo Inst Technol, Inst Innovat Res, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, 3-14-13 Higashigotanda, Tokyo 1410022, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Takayasu, M (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.; Takayasu, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	takayasu.m.aa@m.titech.ac.jp	Takayasu, Misako/H-9890-2014	Takayasu, Misako/0000-0002-2467-614X	Teikoku Databank, Ltd.; Center for TDB Advanced Data Analysis and Modeling; JST, Strategic International Collaborative Research Program (SICORP) on the topic of "ICT for a Resilient Society" by Japan [26310207]; JST, Strategic International Collaborative Research Program (SICORP) on the topic of "ICT for a Resilient Society" by Israel [26310207]; MEXT as "Exploratory Challenges on Post-K computer (Study on multilayered multiscale spacetime simulations for social and economical phenomena)"	Teikoku Databank, Ltd.; Center for TDB Advanced Data Analysis and Modeling; JST, Strategic International Collaborative Research Program (SICORP) on the topic of "ICT for a Resilient Society" by Japan; JST, Strategic International Collaborative Research Program (SICORP) on the topic of "ICT for a Resilient Society" by Israel; MEXT as "Exploratory Challenges on Post-K computer (Study on multilayered multiscale spacetime simulations for social and economical phenomena)"	The authors appreciate Teikoku Databank, Ltd., Center for TDB Advanced Data Analysis and Modeling for providing both the data and financial support. This study is partially supported by the Grant-in-Aid for Scientific Research (B), Grant Number 26310207 and JST, Strategic International Collaborative Research Program (SICORP) on the topic of "ICT for a Resilient Society" by Japan and Israel. This research was partially supported by MEXT as "Exploratory Challenges on Post-K computer (Study on multilayered multiscale spacetime simulations for social and economical phenomena)" (Grant Recipient: MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coauthor Hideki Takayasu is employed by Sony Computer Science Laboratories. Sony Computer Science Laboratories provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 1997, J PHYS I, V7, P621; [Anonymous], 2008, ANN REPORT EARTH SIM; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bardoscia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163825; Bardoscia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130406; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chopra S, 2004, MIT SLOAN MANAGE REV, V46, P53; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cornelius SP, 2013, NATURE COMMUN, P4; Fu DF, 2005, P NATL ACAD SCI USA, V102, P18801, DOI 10.1073/pnas.0509543102; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; Goto H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05362-5; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kawamoto H, 2014, SOC MODEL SIMUL ECOP, P119; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Miura W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168701; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Ohsawa Y, 2006, CHANCE DISCOVERIES R, P30; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Ponomarov SY, 2009, INT J LOGIST MANAG, V20, P124, DOI 10.1108/09574090910954873; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sieczka P, 2011, EUR PHYS J B, V82, P257, DOI 10.1140/epjb/e2011-10757-2; Sieczka P, 2009, EUR PHYS J B, V71, P461, DOI 10.1140/epjb/e2009-00322-1; Smerlak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130948; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; Takayasu H, 1998, FRACTALS, V6, P67, DOI 10.1142/S0218348X98000080; Takayasu M, 2014, J STAT PHYS, V155, P47, DOI 10.1007/s10955-014-0956-4; Tamura Koutarou, 2012, International Journal of Modern Physics: Conference Series, V16, P93, DOI 10.1142/S2010194512007805; Thun JH, 2011, INT J PROD ECON, V131, P242, DOI 10.1016/j.ijpe.2009.10.010; Watanabe H, 2013, PHYSICA A, V392, P741, DOI 10.1016/j.physa.2012.10.020; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang SA, 2015, MANAGE SCI, V61, P2320, DOI 10.1287/mnsc.2014.2079	48	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185712	10.1371/journal.pone.0185712	http://dx.doi.org/10.1371/journal.pone.0185712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972998	Green Submitted, gold, Green Published			2022-12-27	WOS:000412131900039
J	Rodriguez-Ferreiro, J; Barberia, I				Rodriguez-Ferreiro, Javier; Barberia, Itxaso			The moral foundations of illusory correlation	PLOS ONE			English	Article							SOCIAL CATEGORIZATION; CONSERVATIVES; PERCEPTION; INTUITIONS; IDEOLOGY; LIBERALS	Previous research has studied the relationship between political ideology and cognitive biases, such as the tendency of conservatives to form stronger illusory correlations between negative infrequent behaviors and minority groups. We further explored these findings by studying the relation between illusory correlation and moral values. According to the moral foundations theory, liberals and conservatives differ in the relevance they concede to different moral dimensions: Care, Fairness, Loyalty, Authority, and Purity. Whereas liberals consistently endorse the Care and Fairness foundations more than the Loyalty, Authority and Purity foundations, conservatives tend to adhere to the five foundations alike. In the present study, a group of participants took part in a standard illusory correlation task in which they were presented with randomly ordered descriptions of either desirable or undesirable behaviors attributed to individuals belonging to numerically different majority and minority groups. Although the proportion of desirable and undesirable behaviors was the same in the two groups, participants attributed a higher frequency of undesirable behaviors to the minority group, thus showing the expected illusory correlation effect. Moreover, this effect was specifically associated to our participants' scores in the Loyalty subscale of the Moral Foundations Questionnaire. These results emphasize the role of the Loyalty moral foundation in the formation of attitudes towards minorities among conservatives. Our study points out the moral system as a useful fine- grained framework to explore the complex interaction between basic cognitive processes and ideology.	[Rodriguez-Ferreiro, Javier; Barberia, Itxaso] Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain; [Rodriguez-Ferreiro, Javier] Univ Barcelona, Inst Neurociencies, Barcelona, Spain	University of Barcelona; University of Barcelona	Rodriguez-Ferreiro, J (corresponding author), Univ Barcelona, Dept Cognicio Desenvolupament & Psicol Educ, Barcelona, Spain.; Rodriguez-Ferreiro, J (corresponding author), Univ Barcelona, Inst Neurociencies, Barcelona, Spain.	rodriguezferreiro@ub.edu	Rodríguez-Ferreiro, Javier/B-5232-2011; BARBERIA, ITXASO/L-8477-2014	Rodríguez-Ferreiro, Javier/0000-0001-9828-8302; BARBERIA, ITXASO/0000-0003-3045-2289	Agencia Estatal de Investigacion of the Spanish government [PSI2016-80061-R, PSI2016-75776-R]; European Regional Development Fund; Universitat de Barcelona program supporting open access (Ajuts de la Universitat de Barcelona per publicar en acces obert)	Agencia Estatal de Investigacion of the Spanish government; European Regional Development Fund(European Commission); Universitat de Barcelona program supporting open access (Ajuts de la Universitat de Barcelona per publicar en acces obert)	JRF and IB were respectively supported by grants PSI2016-80061-R (AEI/FEDER, UE) and PSI2016-75776-R (AEI/FEDER, UE) from Agencia Estatal de Investigacion of the Spanish government and the European Regional Development Fund. Article publication was funded by the Universitat de Barcelona program supporting open access (Ajuts de la Universitat de Barcelona per publicar en acces obert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron J, 2010, SYNTHESE, V172, P7, DOI 10.1007/s11229-009-9478-z; Brandt MJ, 2015, PSYCHOL SCI, V26, P189, DOI 10.1177/0956797614559730; Carraro L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096312; Carraro L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026456; Castelli L, 2011, J EXP SOC PSYCHOL, V47, P1013, DOI 10.1016/j.jesp.2011.03.016; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050092; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; HAMILTON DL, 1976, J EXP SOC PSYCHOL, V12, P392, DOI 10.1016/S0022-1031(76)80006-6; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Imhoff R, 2009, PERS SOC PSYCHOL B, V35, P309, DOI 10.1177/0146167208328166; Jackson JW, 2000, TEACH PSYCHOL, V27, P273; Koleva SP, 2012, J RES PERS, V46, P184, DOI 10.1016/j.jrp.2012.01.006; Larrick R., 2004, BLACKWELL HDB JUDGME; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Lundqvist D., 1998, KAROLINSKA DIRECTED; Malka A, 2014, J PERS SOC PSYCHOL, V106, P1031, DOI 10.1037/a0036170; McAdams DP, 2008, J PERS SOC PSYCHOL, V95, P978, DOI 10.1037/a0012650; McLean SP, 2014, POLIT PSYCHOL, V35, P831, DOI 10.1111/pops.12056; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; SCHALLER M, 1989, J PERS SOC PSYCHOL, V56, P709, DOI 10.1037/0022-3514.56.5.709; SCHALLER M, 1991, EUR J SOC PSYCHOL, V21, P25, DOI 10.1002/ejsp.2420210103; Sidanius J., 1999, SOCIAL DOMINANCE INT; Stern C, 2016, PERS SOC PSYCHOL B, V42, P1466, DOI 10.1177/0146167216664058; Stern C, 2014, PSYCHOL SCI, V25, P137, DOI 10.1177/0956797613500796; Stroessner SJ, 2001, COGNITIVE SOCIAL PSYCHOLOGY, P247; van Leeuwen F, 2009, PERS INDIV DIFFER, V47, P169, DOI 10.1016/j.paid.2009.02.017; Weber CR, 2013, POLIT PSYCHOL, V34, P107, DOI 10.1111/j.1467-9221.2012.00922.x	30	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185758	10.1371/journal.pone.0185758	http://dx.doi.org/10.1371/journal.pone.0185758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FI6UJ	28972990	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900046
J	Hajek, P; Henriques, R				Hajek, Petr; Henriques, Roberto			Modelling innovation performance of European regions using multi-output neural networks	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; PRODUCT-INNOVATION; PERIPHERAL REGIONS; FEATURE-SELECTION; GLOBAL PIPELINES; KNOWLEDGE; IMPACT; SYSTEMS; GROWTH; SPILLOVERS	Regional innovation performance is an important indicator for decision-making regarding the implementation of policies intended to support innovation. However, patterns in regional innovation structures are becoming increasingly diverse, complex and nonlinear. To address these issues, this study aims to develop a model based on a multi-output neural network. Both intra-and inter-regional determinants of innovation performance are empirically investigated using data from the 4th and 5th Community Innovation Surveys of NUTS 2 (Nomenclature of Territorial Units for Statistics) regions. The results suggest that specific innovation strategies must be developed based on the current state of input attributes in the region. Thus, it is possible to develop appropriate strategies and targeted interventions to improve regional innovation performance. We demonstrate that support of entrepreneurship is an effective instrument of innovation policy. We also provide empirical support that both business and government R&D activity have a sigmoidal effect, implying that the most effective R&D support should be directed to regions with below-average and average R&D activity. We further show that the multi-output neural network outperforms traditional statistical and machine learning regression models. In general, therefore, it seems that the proposed model can effectively reflect both the multiple-output nature of innovation performance and the interdependency of the output attributes.	[Hajek, Petr] Univ Pardubice, Inst Syst Engn & Informat, Fac Econ & Adm, Studentska 84, Pardubice, Czech Republic; [Henriques, Roberto] Univ Nova Lisboa, ISEGI, Lisbon, Portugal	University of Pardubice; Universidade Nova de Lisboa	Hajek, P (corresponding author), Univ Pardubice, Inst Syst Engn & Informat, Fac Econ & Adm, Studentska 84, Pardubice, Czech Republic.	petr.hajek@upce.cz	Henriques, Roberto/AAA-2271-2019	Henriques, Roberto/0000-0002-4862-8177; Hajek, Petr/0000-0001-5579-1215	Czech Sciences Foundation [14-02836S]	Czech Sciences Foundation(Grant Agency of the Czech Republic)	This work was supported by the Czech Sciences Foundation (https://gacr.cz), Grant No: 14-02836S to PH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibugi D, 2009, TECHNOL FORECAST SOC, V76, P917, DOI 10.1016/j.techfore.2009.01.002; Artz KW, 2010, J PROD INNOVAT MANAG, V27, P725, DOI 10.1111/j.1540-5885.2010.00747.x; Bathelt H, 2004, PROG HUM GEOG, V28, P31, DOI 10.1191/0309132504ph469oa; Bottazzi L, 2003, EUR ECON REV, V47, P687, DOI 10.1016/S0014-2921(02)00307-0; Brem A, 2009, TECHNOVATION, V29, P351, DOI 10.1016/j.technovation.2008.06.003; Brenner T, 2011, IND INNOV, V18, P7, DOI 10.1080/13662716.2010.528927; Buesa M, 2010, RES POLICY, V39, P722, DOI 10.1016/j.respol.2010.02.016; Caloghirou Y, 2004, TECHNOVATION, V24, P29, DOI 10.1016/S0166-4972(02)00051-2; Cappelen A, 2003, J COMMON MARK STUD, V41, P621, DOI 10.1111/1468-5965.00438; Casi L, 2014, PAP REG SCI, V93, DOI 10.1111/pirs.12100; Chien SC, 2010, EXPERT SYST APPL, V37, P1086, DOI 10.1016/j.eswa.2009.06.107; Chu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152015; Cooke P, 2002, ROUTLEDGE STUDIES IN; Crescenzi R, 2012, PAP REG SCI, V91, P487, DOI 10.1111/j.1435-5957.2012.00439.x; D'Ambrosio A, 2017, J TECHNOL TRANSFER, V42, P389, DOI 10.1007/s10961-016-9501-8; De Bruijn P, 2005, EUR PLAN STUD, V13, P1153, DOI 10.1080/09654310500336519; de la Paz-Marin M, 2012, TECHNOL FORECAST SOC, V79, P1731, DOI 10.1016/j.techfore.2012.06.001; DeTienne KB, 2003, ORGAN RES METHODS, V6, P236, DOI 10.1177/1094428103251907; Di Cagno D, 2016, TECHNOL FORECAST SOC, V108, P83, DOI 10.1016/j.techfore.2016.04.021; Dijkstra L, 2011, WORKING PAPERS; Doloreux D., 2003, INT J INNOVATION MAN, V7, P67, DOI [10.1142/S1363919603000738, DOI 10.1142/S1363919603000738]; Frenz M, 2009, RES POLICY, V38, P1125, DOI 10.1016/j.respol.2009.05.002; Fritsch M, 2001, REV IND ORGAN, V19, P335, DOI 10.1023/A:1011856020135; Fritsch M, 2010, ANN REGIONAL SCI, V45, P87, DOI 10.1007/s00168-009-0292-9; Gomez J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152743; Grillitsch M, 2015, ANN REGIONAL SCI, V54, P299, DOI 10.1007/s00168-014-0655-8; Gurney K., 2018, INTRO NEURAL NETWORK; Hajek P, 2015, IEEE INT CONF INNOV, P35, DOI 10.1109/INNOVATIONS.2015.7381511; Hajek P, 2014, TECHNOL FORECAST SOC, V84, P197, DOI 10.1016/j.techfore.2013.07.013; Hajek P, 2013, KNOWL-BASED SYST, V51, P72, DOI 10.1016/j.knosys.2013.07.008; Hollanders H., 2013, GLOB INNOV INDEX 201, P79; Hollanders H., 2006, 2006 EUROPEAN REGION, P15; Huang LY, 2012, REG STUD, V46, P583, DOI 10.1080/00343404.2010.520694; Huggins R, 2015, SMALL BUS ECON, V45, P103, DOI 10.1007/s11187-015-9643-3; Huggins R, 2014, EXPERT SYST APPL, V41, P5573, DOI 10.1016/j.eswa.2014.02.008; Inoue H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121973; Ketata I, 2014, R D MANAG; KRAFT K, 1990, APPL ECON, V22, P1029, DOI 10.1080/00036849000000132; Kumar LR, 1991, 1991 P 24 ANN HAW IN, P124; Lau AKW, 2015, TECHNOL FORECAST SOC, V92, P99, DOI 10.1016/j.techfore.2014.11.005; Laursen K, 2006, STRATEGIC MANAGE J, V27, P131, DOI 10.1002/smj.507; Lundvall B.-A., 2007, IND INNOV, V14, P95, DOI [10.1080/13662710601130863, DOI 10.1080/13662710601130863]; Mention AL, 2011, TECHNOVATION, V31, P44, DOI 10.1016/j.technovation.2010.08.002; Mitze T, 2015, ANN REGIONAL SCI, V55, P555, DOI 10.1007/s00168-015-0719-4; More J. J., 1978, Proceedings of the Biennial Conference on numerical analysis, P105; Morrison A, 2013, ECON GEOGR, V89, P77, DOI 10.1111/j.1944-8287.2012.01167.x; Munari F, 2015, J BUS VENTURING, V30, P205, DOI 10.1016/j.jbusvent.2014.07.009; Navarro M, 2009, ENVIRON PLANN C, V27, P815, DOI 10.1068/c0884r; OECD, 2002, FRASC MAN PROP STAND; Pakath R, 1995, DECISION SCI, V26, P749, DOI 10.1111/j.1540-5915.1995.tb01574.x; Qi M, 2008, IEEE T NEURAL NETWOR, V19, P808, DOI 10.1109/TNN.2007.912308; Radosevic S., 2002, J TECHNOLOGY TRANSFE, V27, P87, DOI DOI 10.1023/A:1013152721632; Rao Y, 2010, B ECON RES, V62, P209, DOI 10.1111/j.1467-8586.2009.00327.x; Rodriguez-Pose A, 2008, REG STUD, V42, P51, DOI 10.1080/00343400701654186; Roper S, 2017, RES POLICY, V46, P43, DOI 10.1016/j.respol.2016.10.004; Rumelhart DE, 1986, COMPUTATIONAL MODELS; Saberi S, 2012, NEURAL COMPUT APPL, V21, P1191, DOI 10.1007/s00521-010-0507-0; Saenz-Royo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126076; Samara E, 2012, TECHNOVATION, V32, P624, DOI 10.1016/j.technovation.2012.06.002; Sheela KG, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/425740; Sleuwaegen L, 2014, RES POLICY, V43, P1508, DOI 10.1016/j.respol.2014.03.014; Tavassoli S, 2014, SMALL BUS ECON, V43, P493, DOI 10.1007/s11187-014-9547-7; Todtling F, 2005, RES POLICY, V34, P1203, DOI 10.1016/j.respol.2005.01.018; Tsai CF, 2010, DECIS SUPPORT SYST, V50, P258, DOI 10.1016/j.dss.2010.08.028; Vega-Jurado J, 2008, RES POLICY, V37, P616, DOI 10.1016/j.respol.2008.01.001; Vila LE, 2015, TECHNOL ECON DEV ECO, V21, P539, DOI 10.3846/20294913.2013.876687; Wang TY, 2006, TECHNOVATION, V26, P635, DOI 10.1016/j.technovation.2004.11.001; Yang KP, 2010, IEEE T ENG MANAGE, V57, P103, DOI 10.1109/TEM.2009.2023452; Zabala-Iturriagagoitia JM, 2007, REG STUD, V41, P661, DOI 10.1080/00343400601120270; Zeng XQ, 2001, IEEE T NEURAL NETWOR, V12, P1358, DOI 10.1109/72.963772	70	21	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185755	10.1371/journal.pone.0185755	http://dx.doi.org/10.1371/journal.pone.0185755			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968449	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600043
J	Rivera-Gutierrez, HF; Martens, T; Pinxten, R; Eens, M				Fabio Rivera-Gutierrez, Hector; Martens, Tine; Pinxten, Rianne; Eens, Marcel			Learning speed is affected by personality and reproductive investment in a songbird	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; GREAT TITS; EXPLORATORY-BEHAVIOR; NEST DEFENSE; PARUS-MAJOR; HABITUATION; INFORMATION; POPULATIONS; AGGRESSION; ANIMALS	Individuals from different taxa, including songbirds, differ consistently in behaviour and personality when facing different situations. Although our understanding of animal behaviour has increased, knowledge about between-individual differences in cognitive abilities is still limited. By using an experimental approach and a free-living songbird (Parus major) as a model, we attempted to understand between-individual differences in habituation to playbacks (as a proxy of learning speed), by investigating the role of personality, age and reproductive investment (clutch size). Pre-breeding males were tested for exploration (a proxy of personality) in standardized conditions. In addition, the same individuals were exposed to three playbacks in the field during incubation. Birds significantly moved less, stayed further away and overlapped less the playback with successive playback stimulation. While a decrease in the locomotor behaviour can be explained by personality, differences in habituation of overlapping were predicted by both reproductive investment and personality. Fast explorers habituated less. Moreover, males paired to females with larger clutches did not vary the intensity of overlapping. Since habituation requires information for recognition of non-threatening signals, personality may bias information gathering. While fast explorers may collect less information from the environment, slow explorers (reactive birds) seem to pay attention to environmental clues and collect detailed information. We provided evidence that the rate of habituation of behavioural responses, a proxy of cognitive abilities, may be affected by different factors and in a complex way.	[Fabio Rivera-Gutierrez, Hector] Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Grp Ecol & Evoluc Vertebrados, Inst Biol, Medellin, Colombia; [Fabio Rivera-Gutierrez, Hector; Martens, Tine; Pinxten, Rianne; Eens, Marcel] Univ Antwerp, Behav Ecol & Ecophysiol Grp, Campus Drie Eiken,Univ Pl 1, Antwerp, Belgium; [Pinxten, Rianne] Univ Antwerp, Fac Social Sci, Res Unit Didact, Venusstr 35, Antwerp, Belgium	Universidad de Antioquia; University of Antwerp; University of Antwerp	Rivera-Gutierrez, HF (corresponding author), Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Grp Ecol & Evoluc Vertebrados, Inst Biol, Medellin, Colombia.; Rivera-Gutierrez, HF (corresponding author), Univ Antwerp, Behav Ecol & Ecophysiol Grp, Campus Drie Eiken,Univ Pl 1, Antwerp, Belgium.	fabio.rivera@udea.edu.co	Rivera-Gutierrez, Hector/AAE-7879-2020; Eens, Marcel/AAC-8466-2020	Rivera-Gutierrez, Hector/0000-0001-6025-3470; 	University of Antwerp; FWO-Flanders; Universidad de Antioquia	University of Antwerp; FWO-Flanders(FWO); Universidad de Antioquia	Financial support was provided by University of Antwerp and FWO-Flanders to ME. Universidad de Antioquia provides financial support to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1633, DOI 10.1007/s00265-008-0592-6; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Carere C, 2005, BEHAVIOUR, V142, P1149, DOI 10.1163/156853905774539436; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; David M, 2015, BEHAV ECOL SOCIOBIOL, V69, P1085, DOI 10.1007/s00265-015-1921-1; Deecke VB, 2002, NATURE, V420, P171, DOI 10.1038/nature01030; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dong S, 2009, NEUROBIOL LEARN MEM, V92, P183, DOI 10.1016/j.nlm.2008.09.009; Rivera-Gutierrez HF, 2015, BEHAVIOUR, V152, P1277, DOI 10.1163/1568539X-00003278; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Griffin AS, 2015, TRENDS ECOL EVOL, V30, P207, DOI 10.1016/j.tree.2015.01.012; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; KREBS JR, 1976, BEHAV ECOL SOCIOBIOL, V1, P215, DOI 10.1007/BF00299198; LAMBRECHTS MM, 1992, NATO ADV SCI I A-LIF, V228, P135; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Nussey DH, 2008, FUNCT ECOL, V22, P393, DOI 10.1111/j.1365-2435.2008.01408.x; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Peeke H. V. S., 1984, HABITUATION SENSITIZ, P393; Poesel A, 2005, ANIM BEHAV, V70, P1419, DOI 10.1016/j.anbehav.2005.04.004; Radford AN, 2000, P ROY SOC B-BIOL SCI, V267, P535, DOI 10.1098/rspb.2000.1033; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Redmond LJ, 2009, WILSON J ORNITHOL, V121, P1, DOI 10.1676/07-166.1; Rivera-Gutierrez HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016003; Rivera-Gutierrez HF, 2012, ANIM BEHAV, V83, P1279, DOI 10.1016/j.anbehav.2012.03.001; Rivera-Gutierrez HF, 2011, BIOL LETTERS, V7, P339, DOI 10.1098/rsbl.2010.0962; Searcy WA, 2009, ANIM BEHAV, V78, P1281, DOI 10.1016/j.anbehav.2009.08.011; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Stoddard Philip Kraft, 1996, P356; Thompson RF, 2009, NEUROBIOL LEARN MEM, V92, P127, DOI 10.1016/j.nlm.2008.07.011; Thys B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08001-1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Overveld T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054199; VANBALEN JH, 1967, ARDEA, V55, P1; Verbeek MEM, 1996, BEHAVIOUR, V133, P945, DOI 10.1163/156853996X00314; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344	47	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185410	10.1371/journal.pone.0185410	http://dx.doi.org/10.1371/journal.pone.0185410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020028	gold, Green Submitted, Green Published			2022-12-27	WOS:000412754400030
J	Guan, QJ; Liao, X; He, ML; Li, XF; Wang, ZY; Ma, HY; Yu, S; Liu, SK				Guan, Qingjie; Liao, Xu; He, Mingliang; Li, Xiufeng; Wang, Zhenyu; Ma, Haiyan; Yu, Song; Liu, Shenkui			Tolerance analysis of chloroplast OsCu/Zn-SOD overexpressing rice under NaCl and NaHCO3 stress	PLOS ONE			English	Article							COPPER/ZINC SUPEROXIDE-DISMUTASE; ENHANCED TOLERANCE; REACTIVE OXYGEN; SALT STRESS; EXPRESSION; PLANT; GENE; IDENTIFICATION; TRANSFORMATION; H2O2	The 636-bp-long cDNA sequence of OsCu/Zn-SOD (AK059841) was cloned from Oryza sativa var. Longjing 11 via reverse transcription polymerase chain reaction (RT-PCR). The encoded protein comprised of 211 amino acids is highly homologous to Cu/Zn-SOD proteins from tuscacera rice and millet. Quantitative RT-PCR revealed that in rice, the level of OsCu/ Zn-SOD gene expression was lowest in roots and was highest in petals and during the S5 leaf stage. Moreover, the expression level of OsCu/Zn-SOD gene expression decreased during the L5 leaf stage to maturity. The level of OsCu/Zn-SOD gene expression, however, was increased under saline-sodic stress and NaHCO3 stress. Germination tests under 125, 150, and 175 mM NaCl revealed that OsCu/Zn-SOD-overexpressing lines performed better than the non-transgenic (NT) Longjing11 lines in terms of germination rate and height. Subjecting seedlings to NaHCO3 and water stress revealed that OsCu/Zn-SOD-overexpressing lines performed better than NT in terms of SOD activity, fresh weight, root length, and height. Under simulated NaHCO3 stress, OsCu/Zn-SOD-overexpressing lines performed better than NT in terms of survival rate (25.19% > 6.67%) and yield traits (average grain weight 20.6 > 18.15 g). This study showed that OsCu/Zn-SOD gene overexpression increases the detoxification capacity of reactive oxygen species in O. sativa and reduces salt-induced oxidative damage. We also revealed the regulatory mechanism of OsCu/Zn-SOD enzyme in saline-sodic stress resistance in O. sativa. Moreover, we provided an experimental foundation for studying the mechanism of OsCu/Zn-SOD enzymes in the chloroplast.	[Guan, Qingjie; Liao, Xu; He, Mingliang; Ma, Haiyan; Yu, Song; Liu, Shenkui] Northeast Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Harbin, Heilongjiang, Peoples R China; [Li, Xiufeng; Wang, Zhenyu] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Lab Soybean Mol Biol & Mol Breeding, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Liu, SK (corresponding author), Northeast Forestry Univ, ASNESC, Minist Educ, Key Lab Saline Alkali Vegetat Ecol Restorat SAVER, Harbin, Heilongjiang, Peoples R China.	shenkuiliu@nefu.edu.cn	Liu, Shenkui/AAC-5405-2019; ma, haiyan/GWQ-7425-2022	Liu, Shenkui/0000-0001-5294-4765; 	Fundamental Research Funds for the Central Universities [2572016EAJ6]; National Key Research and Development Program of China [2016YFC0501203]; Heilongjiang Postdoctoral Scientific Research Developmental Fund [LBH408 Q15004]; Program for Chang jiang Scholars and Innovative Research Team in University [IRT13053]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program of China; Heilongjiang Postdoctoral Scientific Research Developmental Fund; Program for Chang jiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Fundamental Research Funds for the Central Universities (Grant no. 2572016EAJ6); The National Key Research and Development Program of China (2016YFC0501203); The Heilongjiang Postdoctoral Scientific Research Developmental Fund (LBH408 Q15004) and the Program for Chang jiang Scholars and Innovative Research Team in University (IRT13053).	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Badawi GH, 2004, PLANT SCI, V166, P919, DOI 10.1016/j.plantsci.2003.12.007; Bubliy O. A., 2005, CORRELATED RESPONSES; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Ding YR, 2012, BIOPOLYMERS, V97, P864, DOI 10.1002/bip.22093; Filiz E, 2015, TURK J BIOL, V39, P49, DOI 10.3906/biy-1403-9; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Gopavajhula VR, 2013, GENET MOL BIOL, V36, P225, DOI [10.1590/S1415-47572013005000023, 10.1590/s1415-47572013005000023]; Hasanuzzaman M., 2014, BIOMED RES INT; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hussain S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-10; Izawa T, 1996, TRENDS PLANT SCI, V1, P95, DOI 10.1016/S1360-1385(96)80041-0; Jing XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00023; Lee SH, 2007, J PLANT PHYSIOL, V164, P1626, DOI 10.1016/j.jplph.2007.01.003; Lv BS, 2013, AGRON J, V105, P1889, DOI 10.2134/agronj2013.0017er; Martin CS, 1996, J STUD ALCOHOL, V57, P549, DOI 10.15288/jsa.1996.57.549; McKersie BD, 2000, PLANT PHYSIOL, V122, P1427, DOI 10.1104/pp.122.4.1427; Melchiorre M, 2009, PLANT GROWTH REGUL, V57, P57, DOI 10.1007/s10725-008-9322-3; Merlino A, 2010, J STRUCT BIOL, V172, P343, DOI 10.1016/j.jsb.2010.08.008; Nath K, 2014, GENES GENOM, V36, P45, DOI 10.1007/s13258-013-0138-9; Ohtsubo K, 2007, J AGR FOOD CHEM, V55, P1501, DOI 10.1021/jf062737z; [Pan Xiaoyun 潘晓云], 2002, [生态学报, Acta Ecologica Sinica], V22, P1902; Pedersen HL, 2009, ACTA CRYSTALLOGR F, V65, P84, DOI 10.1107/S1744309109001110; Prashanth SR, 2008, TRANSGENIC RES, V17, P281, DOI 10.1007/s11248-007-9099-6; Rubio MC, 2002, PHYSIOL PLANTARUM, V115, P531, DOI 10.1034/j.1399-3054.2002.1150407.x; Sambrook J., 2002, MOL CLONING LAB MANU, P461; Sambrook J, 1989, MOL CLONING LAB MANU, P1566; Sheng L Q., 2006, SCI TECHNOLOGY W CHI, P14; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Upadhyaya NM, 2000, AUST J PLANT PHYSIOL, V27, P201; [王慧中 Wang Huizhong], 2002, [科技通报, Bulletin of Science and Technology], V18, P441; Wang YH, 2004, PLANT SCI, V167, P671, DOI 10.1016/j.plantsci.2004.03.032; Wang YC, 2010, MOL BIOL REP, V37, P1119, DOI 10.1007/s11033-009-9884-9; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Wu JH, 2016, PLANT GROWTH REGUL, V79, P55, DOI 10.1007/s10725-015-0110-6; Yang JH, 2013, GENE, V518, P388, DOI 10.1016/j.gene.2012.12.101; Yang Y, 2012, BIORESOURCE TECHNOL, V116, P190, DOI 10.1016/j.biortech.2012.03.126; Zhang HaiNa, 2008, Acta Agronomica Sinica, V34, P1403, DOI 10.3724/SP.J.1006.2008.01403; Zhang YM, 2009, PLANT CELL ENVIRON, V32, P509, DOI 10.1111/j.1365-3040.2009.01945.x; Zhao KF, 2002, B BIOL FR BELG, V37, P7; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	46	43	51	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186052	10.1371/journal.pone.0186052	http://dx.doi.org/10.1371/journal.pone.0186052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020034	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400061
J	Agusti, A; Compte, A; Fener, R; Garcia-Aymerich, J; Noell, G; Cosio, BG; Rodriguez-Roisin, R; Cell, B; Anto, JM				Agusti, Alvar; Compte, Albert; Fener, Rosa; Garcia-Aymerich, Judith; Noell, Guillaume; Cosio, Borja G.; Rodriguez-Roisin, Robert; Cell, Bartolome; Maria Anto, Josep			The EASI model: A first integrative computational approximation to the natural history of COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION DECLINE; AIR-FLOW OBSTRUCTION; MEDICINE; SPIROMETRY; MANAGEMENT; PERCEPTION; MECHANISMS; SYMPTOMS; DYSPNEA	The natural history of chronic obstructive pulmonary disease (COPD) is still not well understood. Traditionally believed to be a self-inflicted disease by smoking, now we know that not all smokers develop COPD, that other inhaled pollutants different from cigarette smoke can also cause it, and that abnormal lung development can also lead to COPD in adulthood. Likewise, the inflammatory response that characterizes COPD varies significantly between patients, and not all of them perceive symptoms (mostly breathlessness) similarly. To investigate the variability and determinants of different "individual natural histories" of COPD, we developed a theoretical, multi-stage, computational model of COPD (EASI) that integrates dynamically and represents graphically the relationships between exposure (E) to inhaled particles and gases (smoking), the biological activity (inflammatory response) of the disease (A), the severity (S) of airflow limitation (FEV1) and the impact (I) of the disease (breathlessness) in different clinical scenarios. EASI shows that the relationships between E, A, S and I vary markedly within individuals (through life) and between individuals (at the same age). It also helps to delineate some potentially relevant, but often overlooked concepts, such as disease progression, susceptibility to COPD and issues related to symptom perception. In conclusion, EASI is an initial conceptual model to interpret the longitudinal and cross-sectional relationships between E, A, S and I in different clinical scenarios. Currently, it does not have any direct clinical application, thus it requires experimental validation and further mathematical development. However, it has the potential to open novel research and teaching alternatives.	[Agusti, Alvar; Rodriguez-Roisin, Robert] Univ Barcelona, Resp Inst, Hosp Clin, Barcelona, Spain; [Agusti, Alvar; Compte, Albert; Fener, Rosa; Noell, Guillaume; Rodriguez-Roisin, Robert] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Agusti, Alvar; Fener, Rosa; Noell, Guillaume; Cosio, Borja G.; Rodriguez-Roisin, Robert] CIBER Enfermedades Respiratorias CIBERES, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] Hosp Mar, IMIM, Med Res Inst, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] Univ Pompeu Fabra, Barcelona, Spain; [Garcia-Aymerich, Judith; Maria Anto, Josep] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Cosio, Borja G.] Hosp Univ Son Espases IdISBa, Palma De Mallorca, Spain; [Cell, Bartolome] Harvard Med Sch, Boston, MA USA	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; ISGlobal; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Harvard University; Harvard Medical School	Agusti, A (corresponding author), Univ Barcelona, Resp Inst, Hosp Clin, Barcelona, Spain.; Agusti, A (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.; Agusti, A (corresponding author), CIBER Enfermedades Respiratorias CIBERES, Barcelona, Spain.	AAGUSTI@clinic.cat	J, Garcia-Aymerich/G-6867-2014; G.Cosio, Borja/P-4963-2017; Anto, J M/H-2676-2014; Agusti Garcia-Navarro, Alvar/F-4474-2015; Compte, Albert/A-2491-2009	J, Garcia-Aymerich/0000-0002-7097-4586; G.Cosio, Borja/0000-0002-6388-8209; Anto, J M/0000-0002-4736-8529; Faner, Rosa/0000-0002-8159-0115; Agusti Garcia-Navarro, Alvar/0000-0003-3271-3788; Compte, Albert/0000-0001-6594-6946	Institute de Salud Carlos III FEDER [PI15/00799, CP16/00039]; SEPAR [PI065/2013]; IDIBAPS Cellex; IDIBAPS-Cellex; Institute de Salud Carlos III FEDER (COPD research program of CIBERES)	Institute de Salud Carlos III FEDER; SEPAR; IDIBAPS Cellex; IDIBAPS-Cellex; Institute de Salud Carlos III FEDER (COPD research program of CIBERES)	This work was supported, in part, by Institute de Salud Carlos III FEDER (PI15/00799 to AA, CP16/00039 and the COPD research program of CIBERES), SEPAR (PI065/2013) and IDIBAPS Cellex.; Supported, in part, by Instituto de Salud Carlos III FEDER (PI15/00799, CP16/00039 and the COPD research program of CIBERES), SEPAR (PI065/2013) and IDIBAPS-Cellex. None of the authors has any conflict of interest with the content of this article.	Agusti A, 2011, EUR RESPIR J, V38, P749, DOI 10.1183/09031936.00062211; Agusti A, 2014, THORAX, V69, P857, DOI 10.1136/thoraxjnl-2014-205507; Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Barreiro E, 2004, EUR RESPIR J, V24, P219, DOI 10.1183/09031936.04.00074703; Bush A, 2016, ANN AM THORAC SOC, V13, pS438, DOI 10.1513/AnnalsATS.201602-112AW; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Diez D, 2014, AM J RESP CRIT CARE, V190, P981, DOI 10.1164/rccm.201403-0421PP; Dransfield MT, 2016, AM J RESP CRITICAL C; Dratva J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145127; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Jones PW, 2006, EUR RESPIR J, V27, P822, DOI 10.1183/09031936.06.00145104; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Laforest L, 2009, ANN ALLERG ASTHMA IM, V102, P378, DOI 10.1016/S1081-1206(10)60508-X; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Scioscia G, 2017, THORAX, V72, P117, DOI 10.1136/thoraxjnl-2016-208332; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2010, AM J RESP CRIT CARE, V182, P863, DOI 10.1164/rccm.201004-0602ED; Vogelmeier C, 2017, GLOBAL STRATEGY DIAG; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; Zafari Z, 2016, CAN MED ASSOC J, V188, P1004, DOI 10.1503/cmaj.151483	34	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185502	10.1371/journal.pone.0185502	http://dx.doi.org/10.1371/journal.pone.0185502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016620	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400021
J	Michaels, J; Chaumillon, R; Nguyen-Tri, D; Watanabe, D; Hirsch, P; Bellavance, F; Giraudet, G; Bernardin, D; Faubert, J				Michaels, Jesse; Chaumillon, Romain; Nguyen-Tri, David; Watanabe, Donald; Hirsch, Pierro; Bellavance, Francois; Giraudet, Guillaume; Bernardin, Delphine; Faubert, Jocelyn			Driving simulator scenarios and measures to faithfully evaluate risky driving behavior: A comparative study of different driver age groups	PLOS ONE			English	Article							OLDER DRIVERS; WORKING-MEMORY; PERFORMANCE; ABILITY; IMPAIRMENT; PREDICTORS; INSIGHTS; VISION; SAFETY; CRASH	To investigate the links between mental workload, age and risky driving, a cross-sectional study was conducted on a driving simulator using several established and some novel measures of driving ability and scenarios of varying complexity. A sample of 115 drivers was divided into three age and experience groups: young inexperienced (18-21 years old), adult experienced (25-55 years old) and older adult (70-86 years old). Participants were tested on three different scenarios varying in mental workload from low to high. Additionally, to gain a better understanding of individuals' ability to capture and integrate relevant information in a highly complex visual environment, the participants' perceptual-cognitive capacity was evaluated using 3-dimensional multiple object tracking (3D-MOT). Results indicate moderate scenario complexity as the best suited to highlight well-documented differences in driving ability between age groups and to elicit naturalistic driving behavior. Furthermore, several of the novel driving measures were shown to provide useful, non-redundant information about driving behavior, complementing more established measures. Finally, 3D-MOT was demonstrated to be an effective predictor of elevated crash risk as well as decreased naturally-adopted mean driving speed, particularly among older adults. In sum, the present experiment demonstrates that in cases of either extreme high or low task demands, drivers can become overloaded or under aroused and thus task measures may lose sensitivity. Moreover, insights from the present study should inform methodological considerations for future driving simulator research. Importantly, future research should continue to investigate the predictive utility of perceptual-cognitive tests in the domain of driving risk assessment.	[Michaels, Jesse; Chaumillon, Romain; Nguyen-Tri, David; Watanabe, Donald; Giraudet, Guillaume; Bernardin, Delphine; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada; [Hirsch, Pierro] Virage Simulat, Montreal, PQ, Canada; [Bellavance, Francois] HEC Montreal, Interuniv Res Ctr Enterprise Networks Logist & Tr, Montreal, PQ, Canada; [Bellavance, Francois] HEC Montreal, Dept Management Sci, Montreal, PQ, Canada; [Giraudet, Guillaume] Essilor Inc Corp, R&D, Paris, France; [Bernardin, Delphine] Essilor Canada Ltd, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; HEC Montreal; Universite de Montreal; HEC Montreal; Essilor International; Essilor International	Michaels, J (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	jesse.michaels@umontreal.ca	Faubert, Jocelyn/E-2207-2011	Michaels, Jesse/0000-0002-3580-9243	Societe de I'assurance automobile Quebec/Fonds de recherche Societe et culture [2012-0U-146156]; Natural Sciences and Engineering Research Council of Canada/Essilor; Industrial Research Chair awarded [IRCPJ305729-13]	Societe de I'assurance automobile Quebec/Fonds de recherche Societe et culture; Natural Sciences and Engineering Research Council of Canada/Essilor; Industrial Research Chair awarded	This research was supported by the Societe de I'assurance automobile Quebec/Fonds de recherche Societe et culture (2012-0U-146156) (https://saaq.gouv.qc.ca./en/ & http://www.frqsc.gouv.qc.ca/en/), with continued work funded by Natural Sciences and Engineering Research Council of Canada/Essilor (http://www.nserc-crsng.gc.ca/index_eng.asp & www.essilor.ca.) Industrial Research Chair awarded to JF (IRCPJ305729-13). The funders provided support in the form of salaries for authors DB, GG and PH, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adrian J, 2011, ACCIDENT ANAL PREV, V43, P1652, DOI 10.1016/j.aap.2011.03.023; Aksan N, 2015, ACCIDENT ANAL PREV, V75, P236, DOI 10.1016/j.aap.2014.12.007; Anstey KJ, 2011, NEUROPSYCHOLOGY, V25, P613, DOI 10.1037/a0023835; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K, 1993, J Am Optom Assoc, V64, P71; Bedard M, 2008, TRAFFIC INJ PREV, V9, P336, DOI 10.1080/15389580802117184; Blickensderfer B., 2005, SIMULATION BASED TRA; Bolstad CA, 2000, SITUATION AWARENESS ANALYSIS AND MEASUREMENT, P277; Borowsky A, 2013, ACCIDENT ANAL PREV, V59, P548, DOI 10.1016/j.aap.2013.07.008; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Bowers A., 2011, PROC 6 INT DRIV S HU, P307; Bowers AR, 2013, ACCIDENT ANAL PREV, V59, P537, DOI 10.1016/j.aap.2013.06.037; Braver ER, 2004, INJURY PREV, V10, P27, DOI 10.1136/ip.2003.002923; Brayne C, 2000, INT J EPIDEMIOL, V29, P704, DOI 10.1093/ije/29.4.704; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; Cuenen A, 2016, TRANSPORT RES F-TRAF, V42, P15, DOI 10.1016/j.trf.2016.06.012; Cuenen A, 2016, TRANSPORT RES F-TRAF, V39, P65, DOI 10.1016/j.trf.2015.05.007; Cuenen A, 2015, ACCIDENT ANAL PREV, V77, P12, DOI 10.1016/j.aap.2015.01.011; De Waard D., 1996, MEASUREMENT DRIVERS; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Dufour R., 2010, ASSESSING FEASIBILIT; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Evans L., 2004, TRAFFIC SAFETY; Fastenmeier W., 1995, NEUE WEGE BEWERTUNG, P27; Fastenmeier W, 2007, SAFETY SCI, V45, P952, DOI 10.1016/j.ssci.2006.08.023; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Fildes Brian, 2007, Annu Proc Assoc Adv Automot Med, V51, P559; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guerrier JH, 1999, APPL ERGON, V30, P109, DOI 10.1016/S0003-6870(98)00017-9; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Hatakka M., 2002, TRANSPORT RES F-TRAF, V5, P201, DOI DOI 10.1016/S1369-8478(02)00018-9; Helland A, 2013, ACCIDENT ANAL PREV, V53, P9, DOI 10.1016/j.aap.2012.12.042; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Hu P.S., 2004, SUMMARY TRAVEL TREND; Janke M. K., 2003, TEEN SENIOR DRIVERS; JONAH BA, 1986, ACCIDENT ANAL PREV, V18, P255, DOI 10.1016/0001-4575(86)90041-2; Kahneman D., 1997, ATTENTION EFFORT; Karali S, 2016, ERGONOMICS, P1, DOI DOI 10.1080/; Keskinen E., 1996, REFERATE ESTEN INTER; Lee HC, 2003, J SAFETY RES, V34, P453, DOI 10.1016/j.jsr.2003.09.007; Lochner MJ, 2014, ATTEN PERCEPT PSYCHO, V76, P2326, DOI 10.3758/s13414-014-0694-3; Mackenzie A. K., 2016, J EXPT PSYCHOL HUMAN; Makishita H, 2008, ACCIDENT ANAL PREV, V40, P567, DOI 10.1016/j.aap.2007.08.012; Matas N, 2016, ADV TRANSP STUD, V39, P69; Matas NA, 2014, ACCIDENT ANAL PREV, V70, P74, DOI 10.1016/j.aap.2014.03.011; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Matthews G., 2011, HDB DRIVING SIMULATI, P389; Meijman T. F., 2000, TRANSPORT RES F-TRAF, V3, P123, DOI DOI 10.1016/S1369-8478(00)00021-8; Meister  D., 1976, BEHAV FDN SYSTEM DEV; Miles GH, 1934, HUM FACTOR-LONDON, V8, P245; Mullen N., 2011, HDB DRIVING SIMULATI, V13-18, P13; Mullen N. W., 2008, ADV TRANSPORTATION S, P31; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Owsley C., 2002, GERONTECHNOLOGY, V1, P220, DOI [10.4017/gt.2002.01.04.002.00, DOI 10.4017/GT.2002.01.04.002.00, https://doi.org/10.4017/gt.2002.01.04.002.00]; Owsley C, 2015, SURV OPHTHALMOL, V60, P250, DOI 10.1016/j.survophthal.2015.01.005; Owsley C, 2013, VISION RES, V90, P52, DOI 10.1016/j.visres.2012.11.014; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Pacaux-Lemoine M.P., 2011, ADV TRANSP STUD, P159; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Paxion J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01344; Peng YY, 2013, ACCIDENT ANAL PREV, V50, P628, DOI 10.1016/j.aap.2012.06.013; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Ramaekers JG, 2003, J CLIN PSYCHIAT, V64, P20, DOI 10.4088/JCP.v64n0106; Ryan GA, 1998, ACCIDENT ANAL PREV, V30, P379, DOI 10.1016/S0001-4575(97)00098-5; Salthouse T. A., 1994, NEUROPSYCHOLOGY, V8, P535, DOI [10.1037/0894-4105.8.4.535, DOI 10.1037/0894-4105.8.4.535]; Schultheis MT, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P127, DOI 10.1016/B978-0-12-381984-0.10010-4; Shanmugaratnam S, 2010, ACCIDENT ANAL PREV, V42, P802, DOI 10.1016/j.aap.2009.10.002; STELMACH GE, 1992, HUM FACTORS, V34, P53, DOI 10.1177/001872089203400107; Steyvers FJJM, 2000, ERGONOMICS, V43, P223, DOI 10.1080/001401300184576; Stinchcombe A, 2011, TRAFFIC INJ PREV, V12, P576, DOI 10.1080/15389588.2011.607479; Taylor M. C., 2000, EFFECT DRIVERS SPEED; Teesdale N., 2009, P 5 INT DRIV S HUM F; Vanlaar W., 2014, P HUM FACT ERG SOC A, V58, P2048; Verhaegen P. K., 1988, P HUM FACT ERG SOC A, V32, P185; Verster JC, 2014, HUM PSYCHOPHARM CLIN, V29, P322, DOI 10.1002/hup.2406; Wickens Christopher D., 1984, PROCESSING RESOURCES, P63; Wilcox R. R., 2012, INTRO ROBUST ESTIMAT; Wilcox RR, 2006, COMPUT STAT DATA AN, V50, P2933, DOI 10.1016/j.csda.2005.04.017; Williams A. F., 2006, INJURY PREVENTION; Wood JM, 2012, OPTOMETRY VISION SCI, V89, P373, DOI 10.1097/OPX.0b013e31824c17ee; Wood Joanne M, 2002, Clin Exp Optom, V85, P214	83	38	39	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185909	10.1371/journal.pone.0185909	http://dx.doi.org/10.1371/journal.pone.0185909			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016693	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400036
J	Sun, YB; Jiang, CY; Li, QF				Sun, Yangbai; Jiang, Chaoyin; Li, Qingfeng			A systematic review and meta-analysis comparing combined intravenous and topical tranexamic acid with intravenous administration alone in THA	PLOS ONE			English	Review							TOTAL KNEE ARTHROPLASTY; REDUCES BLOOD-LOSS; TOTAL HIP-ARTHROPLASTY; DOUBLE-BLIND; REPLACEMENT; EFFICACY; PLACEBO	Purpose To compare the effectiveness and safety of combined intravenous and topical tranexamic acid with intravenous use alone in THA. Methods The electronic databases MEDLINE, EMBASE, BIOSIS, Cochrane central, and further adapted for Google and Google Scholar internet, last updated on Dec 30, 2016, were searched. Evaluated outcomes included total blood loss, transfusion rate, maximum postoperative Hb drop, and incidence of thromboembolic complications. The standard mean difference (SMD) or the relative risk (RR) was calculated for continuous or dichotomous data respectively. The quality of the trial was assessed, and meta-analyses were performed with the Cochrane Collaboration's RevMan 5.0 software. Results Five RCTs with 457 patients were included. Combined TXA administration reduced blood loss (SMD, 1.39; 95% CI, 0.55 to 2.23; P<0.00001, I-2 = 94%), hemoglobin decline (SMD, 0.84; 95% CI, 0.13 to 1.54; P=0.01, I-2 = 83%) and the need for transfusion (RR, 2.58; 95% CI, 1.59 to 4.18; P=0.65, I-2 = 0%) without increasing the rate of thromboembolic complications significantly (RR, 0.83; 95% CI, 0.27 to 2.54; P = 0.81, I-2 = 0%). Conclusion The present study has emphasized that combined TXA administration can effectively reduce blood loss, hemoglobin decline and the need for transfusion without increasing the rate of thromboembolic complications.	[Sun, Yangbai; Li, Qingfeng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Jiang, Chaoyin] Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, QF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.	dr.liqingfeng@shsmu.edu.cn						Alshryda S, 2014, BONE JOINT J, V96B, P1005, DOI 10.1302/0301-620X.96B8.33745; Alshryda S, 2013, J BONE JOINT SURG AM, V95A, P1969, DOI 10.2106/JBJS.L.00908; Barrachina B, 2016, ANESTH ANALG, V122, P986, DOI 10.1213/ANE.0000000000001159; Chang CH, 2014, CLIN ORTHOP RELAT R, V472, P1552, DOI 10.1007/s11999-013-3446-0; Chen SB, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0923-0; Hanna SA, 2016, ORTHOP REV, V8, P75, DOI 10.4081/or.2016.6792; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Huang ZY, 2014, J ARTHROPLASTY, V29, P2342, DOI 10.1016/j.arth.2014.05.026; Kim C, 2015, J BLOOD MED, V6, P239, DOI 10.2147/JBM.S61915; Lin ZLX, 2016, ORTHOPEDICS, V39, P119, DOI 10.3928/01477447-20160301-05; Machin JT, 2014, ACTA ORTHOP BELG, V80, P228; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Melvin JS, 2015, J AM ACAD ORTHOP SUR, V23, P732, DOI 10.5435/JAAOS-D-14-00223; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moskal JT, 2016, ORTHOPEDICS, V39, pE883, DOI 10.3928/01477447-20160526-02; Nielsen CS, 2016, J BONE JOINT SURG AM, V98, P835, DOI 10.2106/JBJS.15.00810; Oremus M, 2001, DEMENT GERIATR COGN, V12, P232, DOI 10.1159/000051263; Poeran J, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4829; Rajesparan K, 2009, J BONE JOINT SURG BR, V91B, P776, DOI 10.1302/0301-620X.91B6.22393; Shang JE, 2016, INT J SURG, V36, P324, DOI 10.1016/j.ijsu.2016.11.033; Sukeik M, 2011, J BONE JOINT SURG BR, V93B, P39, DOI 10.1302/0301-620X.93B1.24984; Sun S-W, 2016, CHINESE J TISSUE ENG, V20, P7149; Sun X, 2016, INT J SURG, V32, P10, DOI 10.1016/j.ijsu.2016.05.064; Ueno M, 2016, J ORTHOP SCI, V21, P44, DOI 10.1016/j.jos.2015.10.011; Wang H, 2014, KNEE, V21, P987, DOI 10.1016/j.knee.2014.09.010; Wu YG, 2016, J ARTHROPLASTY; Xie J, 2015, HIP INT J CLIN EXPT, V26, P481; Yue C, 2014, J ARTHROPLASTY, V29, P2452, DOI 10.1016/j.arth.2014.03.032; Zeng Y, 2016, J BONE JOINT SURG AM, V98, P983, DOI 10.2106/JBJS.15.00638; Zhang L, 2015, J PRACT MED, V31, P3358; Zhang P, 2016, CROP PROT, V90, P1, DOI 10.1016/j.cropro.2016.07.028; Zhang XQ, 2016, INT J SURG, V38, P15	32	14	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186174	10.1371/journal.pone.0186174	http://dx.doi.org/10.1371/journal.pone.0186174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016673	gold, Green Submitted, Green Published			2022-12-27	WOS:000412627400058
J	Cepeda, RE; Pardo, RV; Macaya, CC; Sarrazin, AF				Cepeda, Rodrigo E.; Pardo, Renato V.; Macaya, Constanza C.; Sarrazin, Andres F.			Contribution of cell proliferation to axial elongation in the red flour beetle Tribolium castaneumlee	PLOS ONE			English	Article							SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; ANCESTRAL ROLE; GROWTH ZONE; DROSOPHILA; DYNAMICS; GENES; EMBRYOGENESIS; EXPRESSION; GERMBAND	Most arthropods generate their posterior bodies by adding segments periodically, as the embryo grows, from a posteriorly located region called the segment addition zone. This mode of segmentation is shared with vertebrates and relies on oscillatory mechanisms, where the temporal periodicity of a clock is translated into repetitive spatial patterns. This ordered anterior-to-posterior pattern is achieved at the same time as the tissue elongates, opening the question of the functional coordination between the mechanisms of segmental patterning and posterior growth. The study of these processes in different arthropods has played an important role in unravelling some of the molecular mechanisms of segment formation. However, the behavior of cells during elongation and how cellular processes affect this segmental patterning has been poorly studied. Cell proliferation together with cell rearrangements are presumed to be the major forces driving axis elongation in the red flour beetle Tribolium castaneum. However, there still no strong evidence about the role and distribution of cell proliferation within the embryo. In this study, we propose to address these questions by using whole embryo cultures and pharmacological manipulation. We show that considerable cell proliferation occurs during germband elongation, measured by incorporation of the nucleoside analog of thymidine 5-Ethynyl-2'-deoxyuridine, EdU. Moreover, proliferating cells appeared to be spread along the elongating embryo with a posterior bias at early segmentation. In addition, when we blocked cell division, treated germbands were always shorter than controls and in some cases not able to fully elongate, even when control embryos already started to retract and leg buds are evident. Finally, we found that the absence of cell proliferation has no apparent effect on segmental patterning, as evidenced by Tc-engrailed (Tc-en) gene expression.	[Cepeda, Rodrigo E.; Pardo, Renato V.; Macaya, Constanza C.; Sarrazin, Andres F.] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Sarrazin, AF (corresponding author), Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile.	andres.sarrazin@pucv.cl		Sarrazin, Andres/0000-0002-4307-1744; Macaya Ramos, Constanza/0000-0003-3075-0948	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130824]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1130824) grant to AFS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman T, 2017, DEVELOPMENT, V144, P1896, DOI 10.1242/dev.142091; Beermann A, 2011, DEVELOPMENT, V138, P2793, DOI 10.1242/dev.063644; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29; Benton MA, 2016, CURR BIOL, V26, P1609, DOI 10.1016/j.cub.2016.04.055; Benton Matthew A, 2014, Bioarchitecture, V4, P16, DOI 10.4161/bioa.27815; Benton MA, 2013, DEVELOPMENT, V140, P3210, DOI 10.1242/dev.096271; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; Bolognesi R, 2009, DEV GENES EVOL, V219, P369, DOI 10.1007/s00427-009-0299-3; Bonner J, 2008, DEV BIOL, V313, P398, DOI 10.1016/j.ydbio.2007.10.041; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brown S. J., 2009, COLD SPRING HARB PRO; BROWN SJ, 1994, DEV GENET, V15, P7, DOI 10.1002/dvg.1020150103; Brusca R. C., 2016, INVERTEBRATES; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; da Silva SM, 2007, DEVELOPMENT, V134, P3049, DOI 10.1242/dev.004911; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; El-Sherif E, 2012, DEVELOPMENT, V139, P4341, DOI 10.1242/dev.085126; Fasulo B, 2012, MOL BIOL CELL, V23, P1047, DOI 10.1091/mbc.E11-10-0832; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Macaya CC, 2016, DEV GENES EVOL, V226, P53, DOI 10.1007/s00427-015-0524-1; Nakamoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7635; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Oberhofer G, 2014, DEVELOPMENT, V141, P4740, DOI 10.1242/dev.112797; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schmidt-Ott U, 2016, CURR OPIN GENET DEV, V39, P116, DOI 10.1016/j.gde.2016.06.004; Schulz C, 1998, DEV GENES EVOL, V208, P283, DOI 10.1007/s004270050183; Stelzer E. H. K., 2014, DEVELOPMENT, P1; SUGINO A, 1980, P NATL ACAD SCI-BIOL, V77, P7049, DOI 10.1073/pnas.77.12.7049; Williams TA, 2017, ARTHROPOD STRUCT DEV, V46, P380, DOI 10.1016/j.asd.2016.10.003; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	37	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186159	10.1371/journal.pone.0186159	http://dx.doi.org/10.1371/journal.pone.0186159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016664	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800042
J	Handel, MN; Larsen, SC; Rohde, JF; Stougaard, M; Olsen, NJ; Heitmann, BL				Handel, Mina Nicole; Larsen, Sofus Christian; Rohde, Jeanett Friis; Stougaard, Maria; Olsen, Nanna Julie; Heitmann, Bent Lilienthal			Effects of the Healthy Start randomized intervention trial on physical activity among normal weight preschool children predisposed to overweight and obesity	PLOS ONE			English	Article							CHILDHOOD OBESITY; PREVENTION; PROGRAMS; BEHAVIOR; TRACKING; YOUTH	Background There is limited evidence to support the effectiveness of primary interventions aiming to prevent excess weight gain among young children. Evaluating behavioral changes, such as physical activity (PA), may add to future development of efficient interventions. The objective was to evaluate the effect on PA outcomes of the 15 month Healthy Start intervention that focused on changing diet, PA, sleep and stress management among normal weight but obesity-prone preschool children. Children were defined as obesity-prone if they had a birth weight > 4,000 g, mothers with a pre-pregnancy body mass index of > 28 kg/m(2), or mothers with <= 10 years of schooling. Method From a baseline study population of 635 normal weight 2-6 year old preschool children from the greater Copenhagen area, parents of 307 children had given information on PA at both the baseline and follow-up examinations. PA was obtained from a 7 days recording in the Children's Physical Activity Questionnaire. Time used for sport activities were combined with outdoor playing time to achieve a proxy of total PA level of moderate to vigorous intensity. Results Linear regression analyses revealed that at follow-up the intervention group spent more time on sports and outdoor activities combined per week than the control group (ITT analyses: intervention: 400 min/week; 95% confidence interval (CI): 341, 459 versus control: 321 min/week; 95% CI: 277, 366; p = 0.02), although no significant intervention effects were seen for each of the subcategories, e.g. sports participation, outdoor activities, screen time, or commuting frequency. Conclusion Our results suggest that the overall time spent on sports and outdoor activities combined was increased at follow-up among normal weight obesity-prone children, as a result of the Healthy Start intervention.	[Handel, Mina Nicole] Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense Univ Hosp, Dept Clin Res, Odense, Denmark; [Handel, Mina Nicole; Larsen, Sofus Christian; Rohde, Jeanett Friis; Stougaard, Maria; Olsen, Nanna Julie; Heitmann, Bent Lilienthal] Bispebjerg & Frederiksberg Hosp, Res Unit Dietary Studies, Parker Inst, Frederiksberg, Denmark; [Handel, Mina Nicole; Larsen, Sofus Christian; Rohde, Jeanett Friis; Stougaard, Maria; Olsen, Nanna Julie; Heitmann, Bent Lilienthal] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Heitmann, Bent Lilienthal] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Heitmann, Bent Lilienthal] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Copenhagen	Handel, MN (corresponding author), Univ Southern Denmark, Odense Patient Data Explorat Network OPEN, Odense Univ Hosp, Dept Clin Res, Odense, Denmark.; Handel, MN (corresponding author), Bispebjerg & Frederiksberg Hosp, Res Unit Dietary Studies, Parker Inst, Frederiksberg, Denmark.; Handel, MN (corresponding author), Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark.	Mina.Nicola.Holmgaard.Handel@regonh.dk	Olsen, Nanna Julie/G-6723-2016; Larsen, Sofus Christian/AAO-5894-2020; Handel, Mina Nicole/G-4591-2016	Larsen, Sofus Christian/0000-0002-0838-9378; Rohde, Jeanett Friis/0000-0002-9300-9009; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Stougaard, Maria/0000-0002-5573-4971; Olsen, Nanna Julie/0000-0001-5765-3000; Handel, Mina Nicole/0000-0001-8256-8756	Tryg Foundation [7984-07, 7106-09, 7-10-0330]; Danish Medical Research Council [271-07-0281]; Health Foundation [20086101]	Tryg Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Foundation	The Healthy Start study was funded by the Tryg Foundation (grant no.: 7984-07, 7106-09, and 7-10-0330) (www.trygfonden.dk) (BLH), the Danish Medical Research Council (grant no.: 271-07-0281) (http://ufm.wdkw/forskning-og-innavation/rad-op-udvalg/det-frie-forskningsrad?set_language=da&cl=da) (BLH), and the Health Foundation (grant no.: 20086101) (http://www.helsefonden.dk/ (BLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PHYS ACTIVITY MANUAL, P1; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Blake-Lamb TL, 2016, AM J PREV MED, V50, P780, DOI 10.1016/j.amepre.2015.11.010; Carver A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-126; Chillon P, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-10; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corder K, 2012, PREV MED, V55, P201, DOI 10.1016/j.ypmed.2012.06.021; Corder K, 2009, AM J CLIN NUTR, V89, P862, DOI 10.3945/ajcn.2008.26739; Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Fitzgibbon ML, 2011, OBESITY, V19, P994, DOI 10.1038/oby.2010.314; Fitzgibbon ML, 2002, PREV MED, V34, P289, DOI 10.1006/pmed.2001.0977; Francis SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-100; Harvey-Berino J, 2003, OBES RES, V11, P606, DOI 10.1038/oby.2003.87; Herrington S, 2015, CURR OBES REP, V4, P477, DOI 10.1007/s13679-015-0179-2; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Janz KF, 2010, MED SCI SPORT EXER, V42, P1072, DOI 10.1249/MSS.0b013e3181c619b2; Jones RA, 2013, AM J PREV MED, V44, P651, DOI 10.1016/j.amepre.2013.03.001; Kjonniksen L, 2009, SCAND J MED SCI SPOR, V19, P646, DOI 10.1111/j.1600-0838.2008.00850.x; Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5; Ling JY, 2016, INT J NURS STUD, V53, P270, DOI 10.1016/j.ijnurstu.2015.10.017; Mahoney JL, 2012, J RES ADOLESCENCE, V22, P409, DOI 10.1111/j.1532-7795.2012.00808.x; Morris JN, 1997, SPORTS MED, V23, P306, DOI 10.2165/00007256-199723050-00004; Olsen NJ, 2012, CURR OBES REP, V1, DOI 10.1007/s13679-011-0004-5; Olsen NJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-590; Ottosen MH, 2014, FAERD OG TRIVSEL, P1; Peirson Leslea, 2015, CMAJ Open, V3, pE23, DOI 10.9778/cmajo.20140053; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Rollnick S, 1996, INT J OBESITY, V20, pS22; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sarker Hrishov, 2015, BMC Res Notes, V8, P735, DOI 10.1186/s13104-015-1648-0; Seburg EM, 2015, CURR OBES REP, V4, P157, DOI 10.1007/s13679-015-0160-0; Showell NN, 2013, PEDIATRICS, V132, pE193, DOI 10.1542/peds.2013-0786; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Taber DR, 2009, ANN EPIDEMIOL, V19, P316, DOI 10.1016/j.annepidem.2009.01.001; Telama R, 2014, MED SCI SPORT EXER, V46, P955, DOI 10.1249/MSS.0000000000000181; The Danish Board of Technology, 2011, TARG PREV OB MOR EFF; Wang Y, 2015, OBES REV, V16, P547, DOI 10.1111/obr.12277; Washington RL, 2001, PEDIATRICS, V107, P1459; WHO, 2016, REP COMM END CHILDH; Yavuz HM, 2015, J CHILD PSYCHOL PSYC, V56, P677, DOI 10.1111/jcpp.12330	40	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185266	10.1371/journal.pone.0185266	http://dx.doi.org/10.1371/journal.pone.0185266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991907	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800014
J	Alhassan, RK; Beyere, CB; Nketiah-Amponsah, E; Mwini-Nyaledzigbor, PP				Alhassan, Robert Kaba; Beyere, Christopher B.; Nketiah-Amponsah, Edward; Mwini-Nyaledzigbor, Prudence P.			Perceived needs of health tutors in rural and urban health training institutions in Ghana: Implications for health sector staff internal migration control	PLOS ONE			English	Article								Background The population of Ghana is increasingly becoming urbanized with about 70% of the estimated 27 million people living in urban and peri-urban areas. Nonetheless, eight out of the ten regions in Ghana remain predominantly rural where only 32% of the national health sector workforce works. Moreover, the rural-urban disparities in the density of health tutors (staff responsible for pre-service training of health professionals) are enormous. This paper explores perceived needs of health tutors in rural and urban health training institutions in Ghana. Methods This is a descriptive qualitative study conducted in the Greater Accra and Northern regions of Ghana. The Study used the deductive thematic and sub-thematic analysis approaches. Five health training institutions were randomly sampled, and 72 tutors engaged in separate focus group discussions with an average size of 14 participants per group in each training institution. Results Perceived rural-urban disparities among health tutors were found in the payment of extra duty allowances; school infrastructure including libraries and internet connectivity; staff accommodation; and opportunities for scholarships and higher education. Health tutors in rural areas generally expressed more frustration with these work conditions than those in urban areas. Conclusions There is the need to initiate and sustain work incentives that promote motivation of rural health tutors to control ongoing rural-urban migration of qualified staff. It is recommended the following incentives be prioritized to promote retention of qualified health tutors in rural health training schools: payment of research, book and rural allowances; early promotion of rural staff; prioritizing rural tutors for scholarships, and introduction of national best health tutor awards.	[Alhassan, Robert Kaba; Mwini-Nyaledzigbor, Prudence P.] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Ho, Ghana; [Beyere, Christopher B.] Minist Hlth Headquarters, Human Resources Hlth Directorate, Hlth Training Inst Unit, Accra, Ghana; [Nketiah-Amponsah, Edward] Univ Ghana Legon, Dept Econ, Accra, Ghana		Alhassan, RK (corresponding author), Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Ho, Ghana.	arkabason@gmail.com	Budhathoki, Shyam Sundar/X-5167-2018; Nketiah-Amponsah, Edward/S-9239-2019	Budhathoki, Shyam Sundar/0000-0002-8614-1087; Alhassan, Robert Kaba/0000-0003-4227-4854; Nketiah-Amponsah, Edward/0000-0002-9754-1983				Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Alhassan RK, 2015, PLOS ONE, V19, P1; Alhassan RK, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1438-y; Alhassan RK, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-37; Blumenthal D S, 1994, J Rural Health, V10, P109, DOI 10.1111/j.1748-0361.1994.tb00217.x; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; Franco LM, 2000, 3 ABT ASS INC PARTN; Ghana Health Workers Observatory (GHWO), 2011, HUM RES HLTH COUNTR; Johnson JC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-300; Kwansah J, 2012, HLTH POLICY PLANNING, V27, P1; Lori JR, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-17; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Ministry of health (MOH), 2007, POL STRAT REV HUM RE; Mutale W, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-8; Rowe A. K., 2005, LANCET; Rowe AK, 2005, 1 ABT ASS INC PHR PR; Stalker P., 2000, WORKERS FRONTIERS IM; Stilwell B, 2004, B WORLD HEALTH ORGAN, V82, P595; Twumasi-ankrah K, 1995, J Soc Dev Afr, V10, P13; WHO, 2006, WORK TOG HLTH WORLD; Wibulpolprasert S, 1999, HUMAN RESOURCES DEV, V3, P1; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247	22	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185748	10.1371/journal.pone.0185748	http://dx.doi.org/10.1371/journal.pone.0185748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982194	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300066
J	De Carolis, E; Paoletti, S; Nagel, D; Vella, A; Mello, E; Palucci, I; De Angelis, G; D'Inzeo, T; Sanguinetti, M; Posteraro, B; Spanu, T				De Carolis, Elena; Paoletti, Silvia; Nagel, Domenico; Vella, Antonietta; Mello, Enrica; Palucci, Ivana; De Angelis, Giulia; D'Inzeo, Tiziana; Sanguinetti, Maurizio; Posteraro, Brunella; Spanu, Teresa			A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; IDENTIFICATION; MICROBIOLOGY	Background Nowadays, the global spread of resistance to oxyimino-cephalosporins in Enterobacteriaceae implies the need for novel diagnostics that can rapidly target resistant organisms from these bacterial species. Methods In this study, we developed and evaluated a Direct Mass Spectrometry assay for Beta-Lactamase (D-MSBL) that allows direct identification of (oxyimino) cephalosporin-resistant Escherichia coli or Klebsiella pneumoniae from positive blood cultures (BCs), by using the matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) technology. Results The D-MSBL assay was performed on 93 E. coli or K. pneumoniae growing BC samples that were shortly co-incubated with cefotaxime (CTX) as the indicator cephalosporin. Susceptibility and resistance defining peaks from the samples' mass spectra were analyzed by a novel algorithm for bacterial organism classification. The D-MSBL assay allowed discrimination between E. coli and K. pneumoniae that were resistant or susceptible to CTX with a sensitivity of 86.8% and a specificity of 98.2%. Conclusion The proposed algorithm-based D-MSBL assay, if integrated in the routine laboratory diagnostic workflow, may be useful to enhance the establishment of appropriate antibiotic therapy and to control the threat of oxyimino-cephalosporin resistance in hospital.	[De Carolis, Elena; Paoletti, Silvia; Nagel, Domenico; Vella, Antonietta; Mello, Enrica; Palucci, Ivana; De Angelis, Giulia; D'Inzeo, Tiziana; Sanguinetti, Maurizio; Spanu, Teresa] Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin, Rome, Italy; [Posteraro, Brunella] Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Publ Hlth, Sect Hyg,Fdn Policlin, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Sanguinetti, M (corresponding author), Univ Agostino Gemelli, Univ Cattolica Sacro Cuore, Inst Microbiol, Fdn Policlin, Rome, Italy.	maurizio.sanguinetti@unicatt.it	Posteraro, Brunella/K-8499-2018; Sanguinetti, Maurizio/A-1453-2019; Vella, Antonietta/ABH-7693-2020; Vella, Antonietta/K-2816-2018; De+Carolis, Elena/ABD-9703-2020; De Angelis, Giulia/G-1905-2018; palucci, ivana/J-8542-2018	Posteraro, Brunella/0000-0002-1663-7546; Sanguinetti, Maurizio/0000-0002-9780-7059; Vella, Antonietta/0000-0002-0495-8959; De+Carolis, Elena/0000-0003-4757-7256; De Angelis, Giulia/0000-0002-7087-7399; palucci, ivana/0000-0003-2106-1761				Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; De Carolis E, 2014, J INFECT DEV COUNTR, V8, P1081, DOI 10.3855/jidc.3623; EUCAST, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control (ECDC), TABL ANT RES SURV EU; Fiori B, 2016, J CLIN MICROBIOL, V54, P576, DOI 10.1128/JCM.02590-15; Hawkey PM, 2015, J HOSP INFECT, V89, P241, DOI 10.1016/j.jhin.2015.01.008; Jung JS, 2014, J CLIN MICROBIOL, V52, P924, DOI 10.1128/JCM.02691-13; Kronenberg A, 2013, EURO SURVEILL, V18; Livermore DM, 2008, CLIN MICROBIOL INFEC, V14, P3, DOI 10.1111/j.1469-0691.2007.01857.x; Oviano M, 2014, CLIN MICROBIOL INFEC, V20, P1146, DOI 10.1111/1469-0691.12729; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Sanguinetti M, 2016, EXPERT REV PROTEOMIC, V13, P965, DOI 10.1080/14789450.2016.1231578; Sparbier K, 2016, METHODS, V104, P48, DOI 10.1016/j.ymeth.2016.01.008; Sparbier K, 2012, J CLIN MICROBIOL, V50, P927, DOI 10.1128/JCM.05737-11; Stewardson AJ, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.33.30319; Tuite N, 2014, J ANTIMICROB CHEMOTH, V69, P1729, DOI 10.1093/jac/dku083; van der Steen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138088; Ye QH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00096	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185935	10.1371/journal.pone.0185935	http://dx.doi.org/10.1371/journal.pone.0185935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982134	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300091
J	Foveau, A; Vaz, S; Desroy, N; Kostylev, VE				Foveau, Aurelie; Vaz, Sandrine; Desroy, Nicolas; Kostylev, Vladimir E.			Process-driven and biological characterisation and mapping of seabed habitats sensitive to trawling	PLOS ONE			English	Article							ENGLISH-CHANNEL; NORTH-SEA; BENTHIC COMMUNITIES; TAXONOMIC SUFFICIENCY; FISHING DISTURBANCE; SCOTIAN SHELF; IMPACT; BAY; BIODIVERSITY; MACROFAUNA	The increase of anthropogenic pressures on the marine environment together with the necessity of a sustainable management of marine living resources have underlined the need to map and model coastal environments, particularly for the purposes of spatial planning and for the implementation of integrated ecosystem-based management approach. The present study compares outputs of a process-driven benthic habitat sensitivity (PDS) model to the structure, composition and distribution of benthic invertebrates in the Eastern English Channel and southern part of the North Sea. Trawl disturbance indicators (TDI) computed from species biological traits and benthic community composition were produced from samples collected with a bottom trawl. The TDI was found to be highly correlated to the PDS further validating the latter's purpose to identify natural process-driven pattern of sensitivity. PDS was found to reflect an environmental potential that may no longer be fully observable in the field and difference with in situ biological observations could be partially explained by the spatial distribution of fishery pressure on the seafloor. The management implication of these findings are discussed and we suggest that, used in conjunction with TDI approaches, PDS may help monitor management effort by evaluating the difference between the current state and the presumed optimal environmental status of marine benthic habitats.	[Foveau, Aurelie; Desroy, Nicolas] IFREMER, Lab Environm & Ressources Bretagne Nord, Dinard, France; [Vaz, Sandrine] IFREMER, UMR MARBEC, Sete, France; [Kostylev, Vladimir E.] Nat Resources Canada, Geol Survey Canada Atlantic, Dartmouth, NS, Canada	Ifremer; Ifremer; Universite de Montpellier; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Foveau, A (corresponding author), IFREMER, Lab Environm & Ressources Bretagne Nord, Dinard, France.	aurelie.foveau@ifremer.fr		Foveau, Aurelie/0000-0001-6283-2214; Vaz, Sandrine/0000-0002-7365-8335; Nicolas, Desroy/0000-0002-9047-5637	INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management); French research agency (ANR), through project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel) [ANR-2010-STRA-010]; European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management)	INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management); French research agency (ANR), through project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel)(French National Research Agency (ANR)); European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management)	This study was partly supported by the INTERREG IV A project CHARM III (CHannel integrated Approach for marine Resource Management), the French research agency (ANR), through the project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel) - ANR-2010-STRA-010.; The authors are grateful to all the scientists who brought help for the research of environmental layers, the projects leaders of CGFS, IBTS and CAMANOC scientific surveys, the scientific staff and vessel crews who participated to these surveys. They also acknowledge anonymous reviewers that provide great help in improving the manuscript. This study was partly supported by the European Union under INTERREG IVA CHARM III project (Channel integrated Approach for marine Resource Management) and the French research agency (ANR), through the project COMANCHE (Ecosystem interactions and anthropogenic impacts on great scallop populations in the English Channel)-ANR-2010-STRA-010.	Bacci T, 2009, MAR ECOL-EVOL PERSP, V30, P13, DOI 10.1111/j.1439-0485.2009.00324.x; BILYARD GR, 1987, MAR POLLUT BULL, V18, P581, DOI 10.1016/0025-326X(87)90277-3; Bolam SG, 2014, J SEA RES, V88, P47, DOI 10.1016/j.seares.2014.01.001; Bolam SG, 2014, J SEA RES, V85, P162, DOI 10.1016/j.seares.2013.05.003; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borja A, 2011, MAR POLLUT BULL, V62, P889, DOI 10.1016/j.marpolbul.2011.03.031; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Bremner J, 2006, J MARINE SYST, V60, P302, DOI 10.1016/j.jmarsys.2006.02.004; Brind'Amour A, 2014, CONT SHELF RES, V72, P1, DOI 10.1016/j.csr.2013.10.015; Brind'Amour A, 2009, CONT SHELF RES, V29, P1189, DOI 10.1016/j.csr.2009.01.003; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CABIOCH L, 1968, CAH BIOL MAR, V9, P493; Capasso E, 2010, J MAR BIOL ASSOC UK, V90, P1161, DOI 10.1017/S0025315409991020; Carpentier A., 2009, ATLAS HABITATS RESSO; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Collie JS, 1997, MAR ECOL PROG SER, V155, P159, DOI 10.3354/meps155159; Coppin F., 1989, CGFS CHANNEL GROUND; Currie DR, 1999, CAN J FISH AQUAT SCI, V56, P539, DOI 10.1139/cjfas-56-4-539; CURRY D, 1989, Proceedings of the Geologists' Association, V100, P339; Dauvin JC, 2003, MAR POLLUT BULL, V46, P552, DOI 10.1016/S0025-326X(03)00033-X; Dauvin JC, 2015, J SEA RES, V100, P32, DOI 10.1016/j.seares.2014.11.005; Dauvin JC, 2012, MAR POLLUT BULL, V64, P463, DOI 10.1016/j.marpolbul.2011.12.010; Davies JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124815; de Juan S, 2013, ESTUAR COAST SHELF S, V117, P199, DOI 10.1016/j.ecss.2012.11.012; de Juan S, 2012, ECOL INDIC, V18, P183, DOI 10.1016/j.ecolind.2011.11.020; de Juan S, 2009, MAR POLICY, V33, P472, DOI 10.1016/j.marpol.2008.11.005; Demestre M., 2000, P121; Dinmore TA, 2003, ICES J MAR SCI, V60, P371, DOI 10.1016/S1054-3139(03)00010-9; Dolbeth M, 2007, MAR POLLUT BULL, V54, P576, DOI 10.1016/j.marpolbul.2006.12.005; Eastwood PD, 2007, ICES J MAR SCI, V64, P453, DOI 10.1093/icesjms/fsm001; Ehler C, 2009, MARINE SPATIAL PLANN, P53; Eigaard OR, 2016, ICES J MAR SCI, V73, P27, DOI 10.1093/icesjms/fsv099; EISMA D, 1987, J GEOL SOC LONDON, V144, P161, DOI 10.1144/gsjgs.144.1.0161; Ellis JR, DISTRIBUTION STRUCTU; European Union, MAR SPAT PLANN 2010; Fisher JAD, 2011, ICES J MAR SCI, V68, P2096, DOI 10.1093/icesjms/fsr147; Forbes E., 1958, PHYS ATLAS NATURAL P; Foster Smith B, MESH GUIDE WHAT IS H; Foveau A, 2016, ENGLISH CHANNEL PROC; Foveau A, 2016, LIFE HIST TRAITS SCO; Frid CLJ, 2000, ICES J MAR SCI, V57, P1303, DOI 10.1006/jmsc.2000.0900; Galparsoro I, 2013, ESTUAR COAST SHELF S, V131, P194, DOI 10.1016/j.ecss.2013.07.007; Garcia C., 2010, U LILLE, V1, P1; Girardin R, 2015, OCEAN COAST MANAGE, V106, P124, DOI 10.1016/j.ocecoaman.2015.01.017; Glegg G, 2015, MAR POLLUT BULL, V95, P707, DOI 10.1016/j.marpolbul.2015.02.020; Gogina M, 2010, J SEA RES, V64, P313, DOI 10.1016/j.seares.2010.04.005; GREEN MO, 1995, CONT SHELF RES, V15, P889, DOI 10.1016/0278-4343(95)80001-T; Gregr EJ, 2008, GEOHAB MARINE GEOLOG; Gregr EJ., 2016, CAN TECH REP HYDROGR, V312; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; GUNTHER CP, 1992, NETH J SEA RES, V30, P45, DOI 10.1016/0077-7579(92)90044-F; Habitats Foveau A., 2009, THESIS; HALL SJ, 1990, NETH J SEA RES, V27, P119, DOI 10.1016/0077-7579(90)90040-N; HALL SJ, 1994, OCEANOGR MAR BIOL, V32, P179; Heap AD, 2011, CONT SHELF RES, V31, pS1, DOI 10.1016/j.csr.2010.09.015; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; Hiscock K., 1999, ASSESSING SEABED SPE; Hjulstrom F., 1935, ETUD RHOD, V11, P255; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huston M. A., 1994, BIOL DIVERSITY; ICES, 2017, ICES ADV 2016; ICES, 2015, 2015ICESCM2015SSGEPI; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2012, ICES J MAR SCI, V69, P51, DOI 10.1093/icesjms/fsr173; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Kaiser MJ, 2000, J ANIM ECOL, V69, P494, DOI 10.1046/j.1365-2656.2000.00412.x; KAISER MJ, 1994, MAR ECOL PROG SER, V112, P41, DOI 10.3354/meps112041; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kostylev VE, 2015, CAN TECH REP HYDROGR, V305; Kostylev VE, 2005, BENTHIC HABITATS EFF, P890; Kroncke I, 2011, ESTUAR COAST SHELF S, V94, P1, DOI 10.1016/j.ecss.2011.04.008; Kube J, 1996, ARCH HYDROBIOL, V138, P213; La Riviere M, 2015, METHODOLOGIE EVALUAT, P69; Laffoley DA, 2000, NATL IMPORTANT SEASC; Lambert GI, 2011, MAR ECOL PROG SER, V430, P71, DOI 10.3354/meps09112; Lambert GI, 2014, J APPL ECOL, V51, P1326, DOI 10.1111/1365-2664.12277; LARSONNEUR C, 1982, SEDIMENTOLOGY, V29, P851, DOI 10.1111/j.1365-3091.1982.tb00088.x; Le Pape O, 2007, J SEA RES, V57, P126, DOI 10.1016/j.seares.2006.08.011; Lee J, 2010, ICES J MAR SCI, V67, P1260, DOI 10.1093/icesjms/fsq010; Legendre L, 1999, J PLANKTON RES, V21, P2067, DOI 10.1093/plankt/21.11.2067; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEPROVOST C, 1985, J PHYS OCEANOGR, V15, P1009, DOI 10.1175/1520-0485(1985)015<1008:TSOTEC>2.0.CO;2; Lesourd S, 2001, ESTUARIES, V24, P940, DOI 10.2307/1353008; MAC ARTHUR ROBERT H., 1967; Marchal P., 2014, MECH CHANGE HUMAN BE, P193; Margalef R., 1979, P89; Martin CS, 2009, AQUAT LIVING RESOUR, V22, P499, DOI 10.1051/alr/2009051; McCullagh P., 1990, GEN LINEAR MODELS, V2nd; Mear Y, 2006, CONT SHELF RES, V26, P2335, DOI 10.1016/j.csr.2006.06.009; Nedelec C, 1990, DEFINITION CLASSIFIC, P222; Negrello OA, 2013, ZOOLOGIA-CURITIBA, V30, P266, DOI 10.1590/S1984-46702013000300003; O'Boyl R, DEV ECOSYSTEM BASED; Oksanen J., 2017, COMMUNITY ECOLOGY PA; OSPAR. Annex V to the OSPAR Convention, 200303171E OSPAR; Paphitis D, 2010, MICROPALEAEONTOLOGIC, P99, DOI 10.1144/TMS004.6; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; PINGREE RD, 1978, J GEOPHYS RES-OCEANS, V83, P4615, DOI 10.1029/JC083iC09p04615; PINGREE RD, 1980, OCEANOL ACTA, V3, P227; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; Ramsay K, 1996, MAR ECOL PROG SER, V144, P63, DOI 10.3354/meps144063; Rees E.I.S., 1977, European Marine Biology Symposium, P465; Rees HL, 1999, ICES J MAR SCI, V56, P228, DOI 10.1006/jmsc.1998.0438; Rees HL, 2007, STRUCTURE DYNAMICS N; Reiss H, 2009, MAR ECOL PROG SER, V394, P201, DOI 10.3354/meps08243; Reynolds CS, 1999, AQUAT SCI, V61, P183, DOI 10.1007/s000270050061; Rice J, 24334 EUR EN; Rijnsdorp A.D., 2015, ICES J MAR SCI, V73, P27; Rijnsdorp AD, 1998, ICES J MAR SCI, V55, P403, DOI 10.1006/jmsc.1997.0326; Rivier A., 2010, EVALUATION ACTION HO; Roberts C., 2010, UNNATURAL HIST SEA; Roff JC, 2003, AQUAT CONSERV, V13, P77, DOI 10.1002/aqc.525; Salomon J. C., 1991, OCEANOL ACTA, V11, P47; Sanchez P, 2000, ICES J MAR SCI, V57, P1352, DOI 10.1006/jmsc.2000.0928; Sanvicente-Anorve L, 2002, BIODIVERS CONSERV, V11, P265, DOI 10.1023/A:1014583122765; Shephard S, 2009, FISH RES, V95, P206, DOI 10.1016/j.fishres.2008.08.021; Shumchenia EJ, 2010, CONT SHELF RES, V30, P1717, DOI 10.1016/j.csr.2010.07.007; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Svane I, 2009, ESTUAR COAST SHELF S, V82, P621, DOI 10.1016/j.ecss.2009.03.009; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tillin H.M., 2010, DEV SENSITIVITY MATR; Tillin HM, 2014512B JNCC; Todd BJ, 2011, CONT SHELF RES, V31, pS54, DOI 10.1016/j.csr.2010.07.008; Travers-Trolet M, 2014, CAMANOC CRUISE RV TH; Tyler-Walters H, 2005, IMPACT HUMAN ACTIVIT; Van Hoey G, 2010, MAR POLLUT BULL, V60, P2187, DOI 10.1016/j.marpolbul.2010.09.015; Vanstaen K, 2008, SCALE ANDIMPACT FISH; Venables WN., 2002, MODERN APPL STAT S, V4; Verin Y, 1992, IBTS INT BOTTOM TRAW; Vermard Y, 2010, ECOL MODEL, V221, P1757, DOI 10.1016/j.ecolmodel.2010.04.005; Webber NB, 1980, SOLENT ESTUARINE SYS, P25	136	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184486	10.1371/journal.pone.0184486	http://dx.doi.org/10.1371/journal.pone.0184486			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981504	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300012
J	Heffer, T; Willoughby, T				Heffer, Taylor; Willoughby, Teena			A count of coping strategies: A longitudinal study investigating an alternative method to understanding coping and adjustment	PLOS ONE			English	Article							SELF-ESTEEM; PSYCHOLOGICAL ADJUSTMENT; UNIVERSITY-STUDENTS; DEPRESSIVE SYMPTOMS; EMOTION REGULATION; SUICIDE IDEATION; STRESSFUL EVENTS; COLLEGE-STUDENTS; FLEXIBILITY; METAANALYSIS	Researchers recently have suggested that coping flexibility (i.e., an individual's ability to modify and change coping strategies depending on the context) may be an important way to investigate coping. The availability of numerous coping strategies may be an important precursor to coping flexibility, given that flexibility can only be obtained if an individual is able to access and use different coping strategies. Typically, studies examining the use of coping strategies compute means-based analyses, which assess not only what strategies are used but also how much they are used. Thus, there is limited ability to differentiate between individuals who use a lot of strategies infrequently, and individuals who use only one or two strategies a lot. One way to address this confound is to count the number of strategies that an individual uses without attention to how frequently they use them (i.e., a count-based approach). The present longitudinal study compares a count-based model and a means-based model of coping and adjustment among undergraduates (N = 1132). An autoregressive cross-lagged path analysis revealed that for the count-based approach, using a greater number of positive coping strategies led to more positive adjustment and less suicide ideation over time than using a smaller number of positive coping strategies. Further, engagement in a greater number of negative coping strategies predicted more depressive symptoms and poorer emotion regulation over time. In comparison, the means-based model revealed identical results for negative coping strategies; however, engagement in more frequent positive coping strategies did not predict better positive adjustment over time. Thus, a count-based approach offers a novel way to examine how the number of coping strategies that individuals use can help promote adjustment among university students.	[Heffer, Taylor; Willoughby, Teena] Brock Univ, Dept Psychol, St Catharines, ON, Canada	Brock University	Heffer, T (corresponding author), Brock Univ, Dept Psychol, St Catharines, ON, Canada.	th10ww@brocku.ca			Social Sciences and Humanities Research Council [435-2014-1929]	Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by Social Sciences and Humanities Research Council, Grant Number: 435-2014-1929 (TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; American College Health Association, 2015, AM COLL HLTH ASS NAT; Ano GG, 2005, J CLIN PSYCHOL, V61, P461, DOI 10.1002/jclp.20049; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; BLANCHARDFIELDS F, 1991, SEX ROLES, V25, P645, DOI 10.1007/BF00289569; Bonanno GA, 2013, PERSPECT PSYCHOL SCI, V8, P591, DOI 10.1177/1745691613504116; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cheng C, 2014, PSYCHOL BULL, V140, P1582, DOI 10.1037/a0037913; Fields L, 1997, CLIN PSYCHOL REV, V17, P937, DOI 10.1016/S0272-7358(97)00033-0; Finset A, 2000, BRAIN INJURY, V14, P887; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Frydenberg E, 2014, AUST J PSYCHOL, V66, P82, DOI 10.1111/ajpy.12051; Galaif ER, 2003, J YOUTH ADOLESCENCE, V32, P243, DOI 10.1023/A:1023028809718; Galatzer-Levy IR, 2012, J SOC CLIN PSYCHOL, V31, P542; Garlow SJ, 2008, DEPRESS ANXIETY, V25, P482, DOI 10.1002/da.20321; Glaser D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-99; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Griva F, 2010, PSYCHOL REP, V107, P795, DOI 10.2466/02.20.PR0.107.6.795-804; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Hankin BL, 2001, COGNITIVE THER RES, V25, P607, DOI 10.1023/A:1005561616506; Horwitz AG, 2011, J ADOLESCENCE, V34, P1077, DOI 10.1016/j.adolescence.2010.10.004; Howerton A., 2009, INT J STRESS MANAGE, V16, P333, DOI [10.1037/a0016843, DOI 10.1037/A0016843]; Hu TQ, 2015, J SOC CLIN PSYCHOL, V34, P304, DOI 10.1521/jscp.2015.34.4.304; Kadison R, 2004, COLL OVERWHELMED CAM, V46; Kato T, 2012, J COUNS PSYCHOL, V59, P262, DOI 10.1037/a0027770; Kim SSM, 2013, ANXIETY STRESS COPIN, V27, P37; Lam CB, 2007, SEX ROLES, V56, P159, DOI 10.1007/s11199-006-9159-z; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lee C, 2014, J SOC CLIN PSYCHOL, V33, P560, DOI 10.1521/jscp.2014.33.6.560; MacCann C, 2011, CONTEMP EDUC PSYCHOL, V36, P60, DOI 10.1016/j.cedpsych.2010.11.002; Mahmoud Jihan Saber Raja, 2012, Issues Ment Health Nurs, V33, P149, DOI 10.3109/01612840.2011.632708; Mann M, 2004, HEALTH EDUC RES, V19, P357, DOI 10.1093/her/cyg041; MANTZICOPOULOS P, 1990, PSYCHOL SCHOOLS, V27, P138, DOI 10.1002/1520-6807(199004)27:2<138::AID-PITS2310270208>3.0.CO;2-8; Mirkovic B, 2015, CAN J PSYCHIAT, V60, P37; Orth U, 2009, J PERS SOC PSYCHOL, V97, P307, DOI 10.1037/a0015645; Osman A., 2002, SUICIDE BEHAV QUESTI; Parrish BP, 2011, J SOC CLIN PSYCHOL, V30, P270, DOI 10.1521/jscp.2011.30.3.270; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Regehr C, 2013, J AFFECT DISORDERS, V148, P1, DOI 10.1016/j.jad.2012.11.026; Riolli L, 2010, INT J STRESS MANAGE, V17, P97, DOI 10.1037/a0018041; Rosenberg M., 1965, SOC ADOLESCENT SELF, V148; Sargent JT, 2006, J SOC CLIN PSYCHOL, V25, P628, DOI 10.1521/jscp.2006.25.6.628; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SCHOTTE DE, 1982, J CONSULT CLIN PSYCH, V50, P690, DOI 10.1037/0022-006X.50.5.690; Seiffge-Krenke I, 2000, J ADOLESCENCE, V23, P675, DOI 10.1006/jado.2000.0352; Smedema SM, 2010, REHABIL COUNS BULL, V53, P131, DOI 10.1177/0034355209358272; Statistics Canada, POP SEL ETHN OR; Stoeber J, 2011, ANXIETY STRESS COPIN, V24, P477, DOI 10.1080/10615806.2011.562977; Vaez M, 2008, SOC BEHAV PERSONAL, V36, P183, DOI 10.2224/sbp.2008.36.2.183; Vinkers CH, 2014, DEPRESS ANXIETY, V31, P737, DOI 10.1002/da.22262; Watson JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-41; Yao YS, 2014, CHILD CARE HLTH DEV, V40, P747, DOI 10.1111/cch.12142; ZEIDNER M, 1995, EDUC PSYCHOL, V30, P123, DOI 10.1207/s15326985ep3003_3	56	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186057	10.1371/journal.pone.0186057	http://dx.doi.org/10.1371/journal.pone.0186057			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982138	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300117
J	Karmous, I; Trevisan, R; El Ferjani, E; Chaoui, A; Sheehan, D				Karmous, Ines; Trevisan, Rafael; El Ferjani, Ezzeddine; Chaoui, Abdelilah; Sheehan, David			Redox biology response in germinating Phaseolus vulgaris seeds exposed to copper: Evidence for differential redox buffering in seedlings and cotyledon	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; HYDROGEN-PEROXIDE; THIOREDOXIN H; ANTIOXIDATIVE ENZYMES; GLUTATHIONE CYCLE; PLANT-RESPONSES; PISUM-SATIVUM; PROTEOMICS; PROTEINS; CADMIUM	In agriculture, heavy metal contamination of soil interferes with processes associated with plant growth, development and productivity. Here, we describe oxidative and redox changes, and deleterious injury within cotyledons and seedlings caused by exposure of germinating (Phaseolus vulgaris L. var. soisson nain hatif) seeds to copper (Cu). Cu induced a marked delay in seedling growth, and was associated with biochemical disturbances in terms of intracellular oxidative status, redox regulation and energy metabolism. In response to these alterations, modulation of activities of antioxidant proteins (thioredoxin and glutathione reductase, peroxiredoxin) occurred, thus preventing oxidative damage. In addition, oxidative modification of proteins was detected in both cotyledons and seedlings by one- and two-dimensional electrophoresis. These modified proteins may play roles in redox buffering. The changes in activities of redox proteins underline their fundamental roles in controlling redox homeostasis. However, observed differential redox responses in cotyledon and seedling tissues showed a major capacity of the seedlings' redox systems to protect the reduced status of protein thiols, thus suggesting quantitatively greater antioxidant protection of proteins in seedlings compared to cotyledon. To our knowledge, this is the first comprehensive redox biology investigation of the effect of Cu on seed germination.	[Karmous, Ines; El Ferjani, Ezzeddine; Chaoui, Abdelilah] Fac Sci Bizerte, Plant Toxicol & Mol Biol Microorganisms, Zarzouna, Tunisia; [Trevisan, Rafael] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Sheehan, David] Khalifa Univ Sci & Technol, Coll Sci, Abu Dhabi, U Arab Emirates; [Sheehan, David] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland	Universite de Carthage; Duke University; Khalifa University of Science & Technology; University College Cork	Sheehan, D (corresponding author), Khalifa Univ Sci & Technol, Coll Sci, Abu Dhabi, U Arab Emirates.; Sheehan, D (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.	david.sheehan@kustar.ac.ae	Trevisan, Rafael/E-3235-2019; Sheehan, David/ABB-5315-2020; Chaoui, Abdelilah/Q-8292-2016	Trevisan, Rafael/0000-0003-4145-8299; Chaoui, Abdelilah/0000-0001-8168-6582				Aalen RB, 1999, SEED SCI RES, V9, P285, DOI 10.1017/S096025859900029X; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Ahsan N, 2007, CHEMOSPHERE, V67, P1182, DOI 10.1016/j.chemosphere.2006.10.075; Ahsan N, 2009, PROTEOMICS, V9, P2602, DOI 10.1002/pmic.200800935; Alkhalfioui F, 2007, PLANT PHYSIOL, V144, P1559, DOI 10.1104/pp.107.098103; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bouazizi H, 2008, ACTA BIOL HUNG, V59, P233, DOI 10.1556/ABiol.59.2008.2.9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown JE, 1998, BIOCHEM J, V330, P1173; Chaoui A, 2005, CR BIOL, V328, P23, DOI 10.1016/j.crvi.2004.10.001; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Chaoui A, 1997, PLANT SCI, V126, P21, DOI 10.1016/S0168-9452(97)00090-3; Chora S, 2010, CHEMOSPHERE, V81, P1212, DOI 10.1016/j.chemosphere.2010.09.038; Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9; Cuypers A, 2000, PHYSIOL PLANTARUM, V110, P512, DOI 10.1111/j.1399-3054.2000.1100413.x; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FIELDING JL, 1978, J EXP BOT, V29, P969, DOI 10.1093/jxb/29.4.969; FLEMMING CA, 1989, WATER AIR SOIL POLL, V44, P143, DOI 10.1007/BF00228784; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Garnczarska M, 2008, ACTA PHYSIOL PLANT, V30, P427, DOI 10.1007/s11738-008-0138-6; GREEN LS, 1991, PLANT PHYSL, V96; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; ISHIDA A, 1987, PLANT CELL PHYSIOL, V28, P723; Ishiwatari Y, 2000, PHYSIOL PLANTARUM, V109, P90, DOI 10.1034/j.1399-3054.2000.100113.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Janas KM, 2010, J PLANT PHYSIOL, V167, P270, DOI 10.1016/j.jplph.2009.09.016; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Karmous I, 2014, PLANT PHYSIOL BIOCH, V76, P77, DOI 10.1016/j.plaphy.2013.12.025; Karmous Ines, 2012, Physiology and Molecular Biology of Plants, V18, P337, DOI 10.1007/s12298-012-0128-4; Karmous I, 2011, BIOL TRACE ELEM RES, V144, P1251, DOI 10.1007/s12011-011-9115-9; Kranner I, 2013, FUNCT PLANT BIOL, V40, P848, DOI 10.1071/FP13017; Kultz D, 2007, J EXP BIOL, V210, P1593, DOI 10.1242/jeb.000141; Kumar Mukesh, 2014, Annals of Biology (Hissar), V30, P593; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavid N, 2001, PLANTA, V212, P323, DOI 10.1007/s004250000400; Lemaire SD, 2004, PHOTOSYNTH RES, V79, P305, DOI 10.1023/B:PRES.0000017174.60951.74; Leon AM, 2002, PLANT PHYSIOL BIOCH, V40, P813, DOI 10.1016/S0981-9428(02)01444-4; Lin TK, 2002, J BIOL CHEM, V277, P17048, DOI 10.1074/jbc.M110797200; Lozano RM, 1996, PLANTA, V200, P100, DOI 10.1007/BF00196655; Maksymiec W, 2002, J PLANT PHYSIOL, V159, P509, DOI 10.1078/0176-1617-00610; Matsumura H., 1980, METHOD ENZYMOL, V69, P465, DOI DOI 10.1016/S0076-6879(80)69045-4; Mattioni C, 1997, J PLANT PHYSIOL, V150, P173, DOI 10.1016/S0176-1617(97)80198-8; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Monferran MV, 2009, ENVIRON POLLUT, V157, P2570, DOI 10.1016/j.envpol.2009.02.034; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; Nagalakshmi N, 2001, PLANT SCI, V160, P291, DOI 10.1016/S0168-9452(00)00392-7; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Posmyk MM, 2009, ECOTOX ENVIRON SAFE, V72, P596, DOI 10.1016/j.ecoenv.2008.04.024; Printz B, 2013, J PROTEOME RES, V12, P5160, DOI 10.1021/pr400590d; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rouhier N, 2002, FEBS LETT, V511, P145, DOI 10.1016/S0014-5793(01)03302-6; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sergiev I, 1997, COMPTES RENDUS IACAD, V51, P121, DOI DOI 10.1046/J.1365-3040.2001.00778.X; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Tedesco S, 2010, COMP BIOCHEM PHYS C, V151, P167, DOI 10.1016/j.cbpc.2009.10.002; Traverso JA, 2007, PLANT PHYSIOL, V143, P300, DOI 10.1104/pp.106.089524; Wang SH, 2011, J AGRON CROP SCI, V197, P418, DOI 10.1111/j.1439-037X.2011.00476.x; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yruela Inmaculada, 2005, Braz. J. Plant Physiol., V17, P145, DOI 10.1590/S1677-04202005000100012; Zhang HX, 2010, J HAZARD MATER, V178, P834, DOI 10.1016/j.jhazmat.2010.02.014; ZHAO ZF, 1987, PLANT PHYSIOL, V84, P987, DOI 10.1104/pp.84.4.987	70	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184396	10.1371/journal.pone.0184396	http://dx.doi.org/10.1371/journal.pone.0184396			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981522	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300011
J	Peters, J; van Dam, R; van Doorn, R; Katerere, D; Berthiller, F; Haasnoot, W; Nielen, MWF				Peters, Jeroen; van Dam, Ruud; van Doorn, Ronald; Katerere, David; Berthiller, Franz; Haasnoot, Willem; Nielen, Michel W. F.			Mycotoxin profiling of 1000 beer samples with a special focus on craft beer	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CONJUGATED FUSARIUM MYCOTOXINS; LINKED-IMMUNOSORBENT-ASSAY; IMMUNOAFFINITY CLEANUP; IMPORTED BEERS; FUMONISIN B-1; DEOXYNIVALENOL; ZEARALENONE; OCHRATOXIN; BARLEY	Currently beer is booming, mainly due to the steady rise of craft breweries worldwide. Previous surveys for occurrence of mycotoxins in beer, were mainly focussed on industrial produced beer. The present survey reports the presence of mycotoxins in craft beer and how this compares to industrial produced beer. More than 1000 beers were collected from 47 countries, of which 60% were craft beers. A selection of 1000 samples were screened for the presence of aflatoxin B-1, ochratoxin A (OTA), zearalenone (ZEN), fumonisins (FBs), T-2 and HT-2 toxins (T-2 and HT-2) and deoxynivalenol (DON) using a mycotoxin 6-plex immunoassay. For confirmatory analysis, a liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and applied. The 6-plex screening showed discrepancies with the LC-MS/MS analysis, possibly due to matrix interference and/or the presence of unknown mycotoxin metabolites. The major mycotoxins detected were DON and its plant metabolite deoxynivalenol-3-beta-D-glucopyranoside (D3G). The 6-plex immunoassay reported the sum of DON and D3G (DON+D3G) contaminations ranging from 10 to 475 mu g/L in 406 beers, of which 73% were craft beers. The popular craft beer style imperial stout, had the highest percentage of samples suspected positive (83%) with 29% of all imperial stout beers having DON+D3G contaminations above 100 mu g/L. LC-MS/MS analysis showed that industrial pale lagers from Italy and Spain, predominantly contained FBs (3-69 mu g/L). Besides FBs, African traditional beers also contained aflatoxins (0.1-1.2 mu g/L). The presence of OTA, T-2, HT-2, ZEN, beta-zearalenol, 3/15-acetyl-DON, nivalenol and the conjugated mycotoxin zearalenone 14-sulfate were confirmed in some beers. This study shows that in 27 craft beers, DON+D3G concentrations occurred above (or at) the Tolerable Daily Intake (TDI). Exceeding the TDI, may have a health impact. A better control of brewing malts for craft beer, should be put in place to circumvent this potential problem.	[Peters, Jeroen; van Dam, Ruud; Haasnoot, Willem; Nielen, Michel W. F.] RIKILT Wageningen Univ & Res, Inst Food Safety, Wageningen, Netherlands; [van Doorn, Ronald] Innosieve Diagnost BV, Wageningen, Netherlands; [Katerere, David] Tshwane Univ Technol, Dept Pharmaceut Sci, Pretoria, South Africa; [Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Christian Doppler Lab Mycotoxin Metab, Vienna, Tulln, Austria; [Berthiller, Franz] Univ Nat Resources & Life Sci, Dept Agrobiotechnol IFA Tulln, Ctr Analyt Chem, Vienna, Tulln, Austria; [Nielen, Michel W. F.] Wageningen Univ, Lab Organ Chem, Wageningen, Netherlands	Wageningen University & Research; Tshwane University of Technology; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Wageningen University & Research	Peters, J (corresponding author), RIKILT Wageningen Univ & Res, Inst Food Safety, Wageningen, Netherlands.	jeroen.peters@wur.nl		Berthiller, Franz/0000-0001-5883-2879; Katerere, David/0000-0002-4606-294X	Dutch Ministry of Economic Affairs; SenterNovem; Province of Gelderland; Innosieve Diagnostics	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); SenterNovem; Province of Gelderland; Innosieve Diagnostics	Our research was partially financed by the Dutch Ministry of Economic Affairs, SenterNovem and the Province of Gelderland. There was no additional external funding received for this study. Innosieve Diagnostics provided support in the form of salary for author Ronald van Doom, whose role was limited to the collection of craft beer samples and valuable contributions to the introduction considering craft beer. Innosieve Diagnostics did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.365; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2197; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; [Anonymous], EFSA J; [Anonymous], 2013, FOOD CONTROL; [Anonymous], 1999, TOXIC EFFECTS MYCOTO; Bauer JI, 2016, FOOD CONTROL, V63, P135, DOI 10.1016/j.foodcont.2015.11.040; Berthiller F, 2009, FOOD ADDIT CONTAM A, V26, P207, DOI 10.1080/02652030802399034; Berthiller F, 2011, TOXICOL LETT, V206, P264, DOI 10.1016/j.toxlet.2011.08.006; Bertuzzi T, 2011, FOOD CONTROL, V22, P2059, DOI 10.1016/j.foodcont.2011.06.002; Bonnet MS, 2012, TOXINS, V4, P1120, DOI 10.3390/toxins4111120; Burdaspal PA, 2013, WORLD MYCOTOXIN J, V6, P93, DOI 10.3920/WMJ2012.1465; Cano-Sancho G, 2012, FOOD ADDIT CONTAM A, V29, P799, DOI 10.1080/19440049.2011.644813; Claudia AM, 2009, REV APPL CANC RESE, V29, P102; EFSA, 2013, M20130260 EFSA; Fink-Gremmels J, 1999, VET QUART, V21, P115, DOI 10.1080/01652176.1999.9695005; FRANCESCHI S, 1990, J NATL CANCER I, V82, P1407, DOI 10.1093/jnci/82.17.1407; Fredlund E, 2013, INT J FOOD MICROBIOL, V167, P276, DOI 10.1016/j.ijfoodmicro.2013.06.026; Gratz SW, 2013, APPL ENVIRON MICROB, V79, P1821, DOI 10.1128/AEM.02987-12; Gumus T, 2004, J I BREWING, V110, P146, DOI 10.1002/j.2050-0416.2004.tb00194.x; Herias MV, 1999, CLIN EXP IMMUNOL, V116, P283; Hlywka JJ, 1999, FOOD ADDIT CONTAM, V16, P319, DOI 10.1080/026520399283885; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC, V80, P1, DOI DOI 10.1002/FOOD.19940380335; Kirui M.C., 2014, KENYA AFR J BIOTECHN, V13, P2675, DOI DOI 10.5897/AJB2014.13754; Kostelanska M, 2009, J AGR FOOD CHEM, V57, P3187, DOI 10.1021/jf803749u; Lasram S, 2013, FOOD ADDIT CONTAM B, V6, P1, DOI 10.1080/19393210.2012.716453; Lattanzio VMT, 2012, J MASS SPECTROM, V47, P466, DOI 10.1002/jms.2980; Mably M, 2005, FOOD ADDIT CONTAM A, V22, P1252, DOI 10.1080/02652030500241884; Maenetje PW, 2007, J ENVIRON SCI HEAL B, V42, P229, DOI 10.1080/03601230601125644; Mateo EM, 2011, INT J FOOD MICROBIOL, V149, P118, DOI 10.1016/j.ijfoodmicro.2011.06.006; Matumba L, 2014, FOOD CONTROL, V36, P253, DOI 10.1016/j.foodcont.2013.08.032; Medina A, 2005, J CHROMATOGR A, V1083, P7, DOI 10.1016/j.chroma.2005.05.089; Medina A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00348; Mngqawa P, 2016, FOOD ADDIT CONTAM B, V9, P38, DOI 10.1080/19393210.2015.1121928; Muller HM, 1997, MYCOPATHOLOGIA, V137, P185, DOI 10.1023/A:1006805717043; Nagl V, 2014, TOXICOL LETT, V229, P190, DOI 10.1016/j.toxlet.2014.06.032; Nakajima M, 1999, J AOAC INT, V82, P897; Nkwe DO, 2005, MYCOPATHOLOGIA, V160, P177, DOI 10.1007/s11046-005-6867-9; Odhav B, 2002, FOOD ADDIT CONTAM, V19, P55, DOI 10.1080/02652030110053426; OKOYE ZSC, 1986, J FOOD SAFETY, V7, P233, DOI 10.1111/j.1745-4565.1986.tb00545.x; Olivi G, 2011, PEDIATRIC LASER DENTISTRY: A USER'S GUIDE, P1; Papadopoulou-Bouraoui A, 2004, FOOD ADDIT CONTAM A, V21, P607, DOI 10.1080/02652030410001677745; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Peters J, 2014, ANALYST, V139, P3968, DOI [10.1039/c4an00368c, 10.1039/C4AN00368C]; Peters J, 2013, ANAL BIOANAL CHEM, V405, P7783, DOI 10.1007/s00216-013-7095-7; Piacentini KC, 2015, FOOD CONTROL, V50, P925, DOI 10.1016/j.foodcont.2014.10.038; Protz R., 2014, CAMRAS GOOD BEER GUI; Rodriguez-Carrasco Y, 2015, FOOD CHEM, V178, P149, DOI 10.1016/j.foodchem.2015.01.092; Roger DD, 2011, AFR J MICROBIOL RES, V5, P1565; Scientific Committee on Food (SCF), 2003, UPD OP SCI COMM FOOD; SEGAL I, 1988, BRIT J CANCER, V58, P681, DOI 10.1038/bjc.1988.286; Shephard GS, 2005, J AGR FOOD CHEM, V53, P9634, DOI 10.1021/jf0516080; Stockmann-Juvala H, 2008, HUM EXP TOXICOL, V27, P799, DOI 10.1177/0960327108099525; Torres MR, 1998, INT J FOOD MICROBIOL, V39, P139, DOI 10.1016/S0168-1605(97)00113-X; Tralamazza SM, 2016, FOOD CHEM, V196, P445, DOI 10.1016/j.foodchem.2015.09.063; Uhlig S, 2013, TOXINS, V5, P1682, DOI 10.3390/toxins5101682; Varga E, 2013, FOOD ADDIT CONTAM A, V30, P137, DOI 10.1080/19440049.2012.726745; Vendl O, 2010, FOOD ADDIT CONTAM A, V27, P1148, DOI 10.1080/19440041003801166; Versilovskis A, 2008, WORLD MYCOTOXIN J, V1, P161, DOI 10.3920/WMJ2008.x012; Visconti A, 2000, J CHROMATOGR A, V888, P321, DOI 10.1016/S0021-9673(00)00549-5; Webb T, 2012, WORLD ATLAS BEER; WHO, 1993, IARC MONOGR EVAL CAR, V56, P246; Wu JW, 2011, FOOD ADDIT CONTAM B, V4, P52, DOI 10.1080/19393210.2010.535909; Yoshinari T, 2014, J FOOD PROTECT, V77, P1940, DOI 10.4315/0362-028X.JFP-14-185; Zachariasova M, 2008, ANAL CHIM ACTA, V625, P77, DOI 10.1016/j.aca.2008.07.014; Zachariasova M, 2012, J AGR FOOD CHEM, V60, P9280, DOI 10.1021/jf302069z; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Zollner P, 2000, J CHROMATOGR B, V738, P233, DOI 10.1016/S0378-4347(99)00521-6	68	56	56	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185887	10.1371/journal.pone.0185887	http://dx.doi.org/10.1371/journal.pone.0185887			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982162	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300080
J	Pourchez, J; Leclerc, L; Girardot, F; Riffard, S; Prevot, N; Allegra, S				Pourchez, Jeremie; Leclerc, Lara; Girardot, Francoise; Riffard, Serge; Prevot, Nathalie; Allegra, Severine			Experimental human-like model to assess the part of viable Legionella reaching the thoracic region after nebulization	PLOS ONE			English	Article							MICROBIAL RISK-ASSESSMENT; INTRASINUS DRUG DEPOSITION; ACOUSTIC AIR-FLOW; LEGIONNAIRES-DISEASE; GUINEA-PIGS; AEROSOL DEPOSITION; DOSE-RESPONSE; PNEUMOPHILA; INFECTION; EXPOSURE	The incidence of Legionnaires' disease (LD) in European countries and the USA has been constantly increasing since 1998. Infection of humans occurs through aerosol inhalation. To bridge the existing gap between the concentration of Legionella in a water network and the deposition of bacteria within the thoracic region (assessment of the number of viable Legionella), we validated a model mimicking realistic exposure through the use of (i) recent technology for aerosol generation and (ii) a 3D replicate of the human upper respiratory tract. The model's sensitivity was determined by monitoring the deposition of (i) aerosolized water and Tc-99m radio-aerosol as controls, and (ii) bioaerosols generated from both Escherichia coli and Legionella pneumophila sg 1 suspensions. The numbers of viable Legionella prior to and after nebulization were provided by culture, flow cytometry and qPCR. This study was designed to obtain more realistic data on aerosol inhalation (vs. animal experimentation) and deposition at the thoracic region in the context of LD. Upon nebulization, 40% and 48% of the initial Legionella inoculum was made of cultivable and non-cultivable cells, respectively; 0.7% of both populations reached the filter holder mimicking the thoracic region in this setup. These results are in agreement with experimental data based on quantitative microbial risk assessment methods and bring new methods that may be useful for preventing LD.	[Pourchez, Jeremie; Leclerc, Lara] Univ Lyon, Ecole Natl Super Mines St Etienne, CIS EMSE, SAINBIOSE,INSERM U1059, St Etienne, France; [Girardot, Francoise; Riffard, Serge; Allegra, Severine] Univ Lyon, UJM St Etienne, CNRS, EVS ISTHME UMR 5600, St Etienne, France; [Prevot, Nathalie] Univ Hosp St Etienne, Nucl Med Dept, St Etienne, France	IMT - Institut Mines-Telecom; Mines Saint-Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National des Sciences Appliquees de Lyon - INSA Lyon; CHU de St Etienne	Allegra, S (corresponding author), Univ Lyon, UJM St Etienne, CNRS, EVS ISTHME UMR 5600, St Etienne, France.	severine.allegra@univ-st-etienne.fr	PREVOT, Nathalie/AAG-7682-2021; Pourchez, Jeremie/F-4976-2011; POURCHEZ, Jérémie/AAC-4612-2019	PREVOT, Nathalie/0000-0001-8442-2515; Pourchez, Jeremie/0000-0002-4573-6711; POURCHEZ, Jérémie/0000-0002-4573-6711; Severine, ALLEGRA/0000-0002-5894-3509; Leclerc, Lara/0000-0002-3467-659X	Jean Monnet University, France	Jean Monnet University, France	This study was supported by a grant from Jean Monnet University, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra S, 2011, J APPL MICROBIOL, V110, P952, DOI 10.1111/j.1365-2672.2011.04955.x; Allegra S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33998; Allegra S, 2011, APPL ENVIRON MICROB, V77, P1268, DOI 10.1128/AEM.02225-10; Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; [Anonymous], 2013, RELATIF PRESCRIPTION; [Anonymous], 2005, 81992005 ISO; Ari A, 2014, EURASIAN J PULMONOL, V16, P1, DOI 10.5152/ejp.2014.00087; Armstrong TW, 2007, RISK ANAL, V27, P1581, DOI 10.1111/j.1539-6924.2007.00990.x; Armstrong TW, 2007, J OCCUP ENVIRON HYG, V4, P634, DOI 10.1080/15459620701487539; Bakker-Woudenberg IAJM, 2003, J MICROBIOL METH, V54, P295, DOI 10.1016/S0167-7012(03)00118-0; BASKERVILLE A, 1983, J PATHOL, V139, P349, DOI 10.1002/path.1711390310; Baskerville A, 1981, LANCET LOND ENG 1219, P2; Beer KD, 2015, MMWR-MORBID MORTAL W, V64, P849, DOI 10.15585/mmwr.mm6431a3; BERENDT RF, 1980, J INFECT DIS, V141, P186, DOI 10.1093/infdis/141.2.186; Blatny Janet Martha, 2011, Front Biosci (Elite Ed), V3, P1300; BREIMAN RF, 1987, J EXP MED, V165, P799, DOI 10.1084/jem.165.3.799; Buse HY, 2012, WATER RES, V46, P921, DOI 10.1016/j.watres.2011.12.022; Chen DQ, 2006, PLASMID, V56, P167, DOI 10.1016/j.plasmid.2006.05.008; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Deloge-Abarkan M, 2007, J ENVIRON MONITOR, V9, P91, DOI [10.1039/B610737K, 10.1039/b610737k]; Durand M, 2011, INT J PHARMACEUT, V421, P63, DOI 10.1016/j.ijpharm.2011.09.023; Epalle T, 2015, MICROB ECOL, V69, P215, DOI 10.1007/s00248-014-0470-x; Escoll P, 2014, CURR TOP MICROBIOL, V376, P1, DOI 10.1007/82_2013_351; European Centre for Disease Prevention and Control, 2016, LEG DIS EUR; FITZGEORGE RB, 1983, J HYG-CAMBRIDGE, V90, P81, DOI 10.1017/S0022172400063877; Gorny RL, 1999, ANN AGR ENV MED, V6, P105; Hines SA, 2014, WATER RES, V56, P203, DOI 10.1016/j.watres.2014.02.013; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Khodr A, 2016, INFECT GENET EVOL, V43, P108, DOI 10.1016/j.meegid.2016.04.033; Kohler R, 2000, MOL GEN GENET, V262, P1060, DOI 10.1007/PL00008649; Le Guellec S, 2014, PHARM RES-DORDR, V31, P228, DOI 10.1007/s11095-013-1157-6; Leclerc L, 2015, INT J PHARMACEUT, V494, P227, DOI 10.1016/j.ijpharm.2015.08.025; Mathieu L, 2006, J INFECT DIS, V193, P1333, DOI 10.1086/503115; Mustapha P, 2015, MONITORING LEGIONELL; Navarro L, 2015, PHARM RES       1230; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; Perinel S, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0395-7; Portier E, 2014, ENV MICROBIOL; Prasad B, 2016, RISK ANAL OFF P 0526; Robertson P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00670; Schoen ME, 2011, WATER RES, V45, P5826, DOI 10.1016/j.watres.2011.08.031	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186042	10.1371/journal.pone.0186042	http://dx.doi.org/10.1371/journal.pone.0186042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982141	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300115
J	Smith, JM; Moss, JA; Srinivasan, P; Butkyavichene, I; Gunawardana, M; Fanter, R; Miller, CS; Sanchez, D; Yang, F; Ellis, S; Zhang, JN; Marzinke, MA; Hendrix, CW; Kapoor, A; Baum, MM				Smith, James M.; Moss, John A.; Srinivasan, Priya; Butkyavichene, Irina; Gunawardana, Manjula; Fanter, Rob; Miller, Christine S.; Sanchez, Debbie; Yang, Flora; Ellis, Shanon; Zhang, Jining; Marzinke, Mark A.; Hendrix, Craig W.; Kapoor, Amita; Baum, Marc M.			Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; SEXUALLY-TRANSMITTED INFECTIONS; CONTRACEPTIVE VAGINAL RING; HERPES-SIMPLEX VIRUS-2; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL PROPHYLAXIS; REVERSE-TRANSCRIPTASE; SIMULTANEOUS DELIVERY; SUSTAINED DELIVERY	Globally, women bear an uneven burden for sexual HIV acquisition. Results from two clinical trials evaluating intravaginal rings (IVRs) delivering the antiretroviral agent dapivirine have shown that protection from HIV infection can be achieved with this modality, but high adherence is essential. Multipurpose prevention technologies (MPTs) can potentially increase product adherence by offering protection against multiple vaginally transmitted infections and unintended pregnancy. Here we describe a coitally independent, long-acting pod-IVR MPT that could potentially prevent HIV and HSV infection as well as unintended pregnancy. The pharmacokinetics of MPT pod-IVRs delivering tenofovir alafenamide hemifumarate (TAF(2)) to prevent HIV, acyclovir (ACV) to prevent HSV, and etonogestrel (ENG) in combination with ethinyl estradiol (EE), FDA-approved hormonal contraceptives, were evaluated in pigtailed macaques (N = 6) over 35 days. Pod IVRs were exchanged at 14 days with the only modification being lower ENG release rates in the second IVR. Plasma progesterone was monitored weekly to determine the effect of ENG/EE on menstrual cycle. The mean in vivo release rates (mg d(-1)) for the two formulations over 30 days ranged as follows: TAF(2) 0.35-0.40; ACV 0.56-0.70; EE 0.03-0.08; ENG (high releasing) 0.63; and ENG (low releasing) 0.05. Mean peak progesterone levels were 4.4 +/- 1.8 ng mL(-1) prior to IVR insertion and 0.075 +/- 0.064 ng mL(-1) for 5 weeks after insertion, suggesting that systemic EE/ENG levels were sufficient to suppress menstruation. The TAF2 and ACV release rates and resulting vaginal tissue drug concentrations (medians: TFV, 2.4 ng mg(-1); ACV, 0.2 ng mg(-1)) may be sufficient to protect against HIV and HSV infection, respectively. This proof of principle study demonstrates that MPT-pod IVRs could serve as a potent biomedical prevention tool to protect women's sexual and reproductive health and may increase adherence to HIV PrEP even among younger high-risk populations.	[Smith, James M.; Srinivasan, Priya] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS, Div HIV AIDS Prevent, Lab Branch,Viral Hepatitis STD & TB Prevent, Atlanta, GA USA; [Moss, John A.; Butkyavichene, Irina; Gunawardana, Manjula; Fanter, Rob; Miller, Christine S.; Sanchez, Debbie; Yang, Flora; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA; [Ellis, Shanon; Zhang, Jining] Libra Management Grp, Decatur, GA USA; [Marzinke, Mark A.; Hendrix, Craig W.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Pathol, Sheikh Zayed Tower, Baltimore, MD USA; [Kapoor, Amita] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Capitol Court, Madison, WI USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison	Baum, MM (corresponding author), Oak Crest Inst Sci, Dept Chem, Monrovia, CA 91016 USA.	m.baum@oak-crest.org	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Moss, John/0000-0001-8091-3245; Baum, Marc/0000-0003-1558-5649	Oak Crest Institute of Science; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI113048]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health	Oak Crest Institute of Science; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part through institutional funds at the Oak Crest Institute of Science and the Centers for Disease Control and Prevention. Additional support was provided by the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) of the National Institutes of Health under Award Number U19AI113048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Libra Management Group, a commercial company, is the employer of several authors of this manuscript (SE and JZ). The funder provided support in the form of salaries for authors (SE and JZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; Research reported in this publication was supported in part by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amico KR, 2016, AIDS BEHAV, DOI http://dx.doi.org/10.1007/s10461-016-1458-y; Andrei G, 2011, CELL HOST MICROBE, V10, P379, DOI 10.1016/j.chom.2011.08.015; Babusis D, 2013, MOL PHARMACEUT, V10, P459, DOI 10.1021/mp3002045; Baeten J, 2015, 2015 C RETR OPP INF; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten J.M., 2016, N ENGL J MED; Balimane PV, 1998, BIOCHEM BIOPH RES CO, V250, P246, DOI 10.1006/bbrc.1998.9298; Bam RA, 2014, ANTIVIR THER, V19, P669, DOI 10.3851/IMP2767; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Baum MM, 2012, J PHARM SCI-US, V101, P2833, DOI 10.1002/jps.23208; Birkus G, 2008, MOL PHARMACOL, V74, P92, DOI 10.1124/mol.108.045526; Birx DL, 2014, DELIVERING AIDS FREE; Boonstra H, 2014, BJOG-INT J OBSTET GY, V121, P23, DOI 10.1111/1471-0528.12851; Boyd P, 2016, INT J PHARMACEUT, V511, P619, DOI 10.1016/j.ijpharm.2016.07.051; Brache V, 2010, CONTRACEPTION, V82, P418, DOI 10.1016/j.contraception.2010.04.012; Brady M, 2013, ANTIVIR RES, V100, pS25, DOI 10.1016/j.antiviral.2013.09.019; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Clark JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088509; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; De Clercq E, 2016, BIOCHEM PHARMACOL, V119, P1, DOI 10.1016/j.bcp.2016.04.015; Dobard C, 2012, J VIROL, V86, P718, DOI 10.1128/JVI.05842-11; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Friend DR, 2016, EXPERT OPIN DRUG DEL, V13, P533, DOI 10.1517/17425247.2016.1134485; Friend DR, 2012, EXPERT OPIN DRUG DEL, V9, P417, DOI 10.1517/17425247.2012.668183; Friend DR, 2010, ANTIVIR RES, V88, pS47, DOI 10.1016/j.antiviral.2010.09.005; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Ganapathy ME, 1998, BIOCHEM BIOPH RES CO, V246, P470, DOI 10.1006/bbrc.1998.8628; Gibson AK, 2016, ANN PHARMACOTHER, V50, P942, DOI 10.1177/1060028016660812; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunawardana M, 2015, ANTIMICROB AGENTS CH; Gunawardana M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077340; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Keller MJ, 2012, J ANTIMICROB CHEMOTH, V67, P2005, DOI 10.1093/jac/dks151; KRUSE W, 1991, EUR J CLIN PHARMACOL, V41, P589, DOI 10.1007/BF00314990; Kutilek Victoria D., 2003, Current Drug Targets - Infectious Disorders, V3, P295, DOI 10.2174/1568005033481079; Lee WA, 2005, ANTIMICROB AGENTS CH, V49, P1898, DOI 10.1128/AAC.49.5.1898-1906.2005; Liu D., 2014, Patent US, Patent No. [8,754,065, 8754065]; Louissaint NA, 2013, AIDS RES HUM RETROV, V29, P1443, DOI [10.1089/aid.2013.0044, 10.1089/AID.2013.0044]; Casado JL, 2016, AIDS REV, V18, P59; Madden T, 2007, CLIN OBSTET GYNECOL, V50, P878, DOI 10.1097/GRF.0b013e318159c07e; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V71, P413, DOI 10.1097/QAI.0000000000000881; Margot NA, 2016, ANTIVIR RES, V132, P50, DOI 10.1016/j.antiviral.2016.05.012; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I, 2015, FUTURE VIROL, V10, P1163, DOI 10.2217/fvl.15.83; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MILLER WH, 1980, J BIOL CHEM, V255, P7204; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Molina J-M, 2016, 2016 C RETR OPP INF; MORSE GD, 1993, CLIN PHARMACOKINET, V24, P101, DOI 10.2165/00003088-199324020-00002; Moss JA, 2016, ANTIMICROB AGENTS CH, V60, P3759, DOI 10.1128/AAC.00391-16; Moss JA, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P221; Moss JA, 2014, ANTIMICROB AGENTS CH, V58, P5125, DOI 10.1128/AAC.02871-14; Moss JA, 2013, ANTIMICROB AGENTS CH, V57, P3994, DOI 10.1128/AAC.00547-13; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P5952, DOI 10.1128/AAC.01198-12; Moss JA, 2012, AIDS, V26, P707, DOI 10.1097/QAD.0b013e3283509abb; Moss JA, 2012, ANTIMICROB AGENTS CH, V56, P875, DOI 10.1128/AAC.05662-11; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Nixon B, 2014, ANTIMICROB AGENTS CH, V58, P1153, DOI 10.1128/AAC.01818-13; Oddsson K, 2005, CONTRACEPTION, V71, P176, DOI 10.1016/j.contraception.2004.09.001; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Perry CM, 1996, DRUGS, V52, P754, DOI 10.2165/00003495-199652050-00009; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Polis CB, 2016, AIDS, V30, P2571, DOI 10.1097/QAD.0000000000001229; Promadej-Lanier N, 2009, J MED PRIMATOL, V38, P263, DOI 10.1111/j.1600-0684.2009.00354.x; Quaife M, 2017, LANCET INFECT DIS, V17, P21, DOI 10.1016/S1473-3099(16)30550-3; Ray AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009; Renzi C, 2003, J INFECT DIS, V187, P19, DOI 10.1086/345867; Reynolds SJ, 2003, J INFECT DIS, V187, P1513, DOI 10.1086/368357; Rollenhagen C, 2014, MUCOSAL IMMUNOL, V7, P1165, DOI 10.1038/mi.2014.3; Roumen F, 2002, EUR J CONTRACEP REPR, V7, P19; ROWE PJ, 1990, CONTRACEPTION, V41, P105, DOI 10.1016/0010-7824(90)90141-H; Sahota J, 1999, ADV CONTRACEPT, V15, P313, DOI 10.1023/A:1006748626008; Seidman D, 2016, SEMIN REPROD MED, V34, P159, DOI 10.1055/s-0036-1571436; Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X; Smith JM, 2013, P NATL ACAD SCI USA, V110, P16145, DOI 10.1073/pnas.1311355110; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Srinivasan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157061; Terris-Prestholt F, 2016, HEALTH ECON, V25, P116, DOI 10.1002/hec.3297; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thurman Andrea Ries, 2011, Infect Dis Obstet Gynecol, V2011, P1, DOI 10.1155/2011/429403; Ugaonkar SR, 2015, J CONTROL RELEASE, V213, P57, DOI 10.1016/j.jconrel.2015.06.018; UNAIDS, 2016, PREV GAP REP; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; VANDYKE RB, 1982, AM J MED, V73, P172, DOI 10.1016/0002-9343(82)90085-7; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196; Woodsong C, 2015, ADV DRUG DELIVER REV, V92, P146, DOI 10.1016/j.addr.2015.02.004; Yeaw J, 2009, J MANAGE CARE PHARM, V15, P728, DOI 10.18553/jmcp.2009.15.9.728	93	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185946	10.1371/journal.pone.0185946	http://dx.doi.org/10.1371/journal.pone.0185946			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982161	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300095
J	Kaneshige, T; Haryu, E				Kaneshige, Toshinori; Haryu, Etsuko			Infants predict expressers' cooperative behavior through facial expressions	PLOS ONE			English	Article							INTERMODAL PERCEPTION; EMOTIONAL EXPRESSION; NEGATIVITY BIAS; DISCRIMINATION; RECOGNITION; IMITATION	This study investigated infants' ability to use facial expressions to predict the expressers' subsequent cooperative behavior. To explore this problem, Experiment 1 tested 10-and 14-month-olds (N = 16, respectively) by using a violation-of-expectation procedure. In the experiment, all infants were first familiarized with two models, one with a happy facial expression and the other with an angry expression. They were also familiarized with an event in which a duck puppet tried to open a box but failed. During the test phase, infants in the helping condition saw two test scenes; one in which the happy model helped the duck open the box, and the other in which the angry model helped the duck. Infants in the hindering condition saw a test scene in which the happy model hindered the duck and the other test scene in which the angry model hindered the duck. The results demonstrated that both 10-and 14-month-olds looked longer at the angry model than at the happy model in the helping condition, whereas they looked at the happy model as long as the angry model in the hindering condition. Experiment 2 tested 6-month-olds (N = 16) with a slightly modified procedure and found the same tendency as shown by 10-and 14-month-olds. These results suggest that infants as early as at 6 months do not predict that a person with an angry expression will help others. However at the same time, they do not clearly understand the incongruence between happy expressions and hindering behavior. The results were discussed by referring to a negativity bias and human environment in which infants grow up.	[Kaneshige, Toshinori; Haryu, Etsuko] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaneshige, T (corresponding author), Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan.	kanesige@yb3.so-net.ne.jp		Haryu, Etsuko/0000-0003-4165-3633	JSPS KAKENHI [24650131]; CEDEP SEEDS PROJECT FY	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CEDEP SEEDS PROJECT FY	Etsuko Haryu was supported by JSPS KAKENHI Grant Number 24650131 (https://www.jsps.go.jp/j-grantsinaid/index.html) and CEDEP SEEDS PROJECT FY2015 (http://www.cedep.p.utokyo.ac.jp/) for thi sresearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WHY WE COOPERATE; Barna J, 2005, COGNITION EMOTION, V19, P53, DOI 10.1080/02699930341000021; Bornstein MH, 2003, DEVELOPMENTAL SCI, V6, P585, DOI 10.1111/1467-7687.00314; Cohen L. B., 2000, HABIT 2000 NEW PROGR; Dobel C, 2008, PSYCHOL RES-PSYCH FO, V72, P580, DOI 10.1007/s00426-007-0132-4; Ekman P., 2003, UNMASKING FACE GUIDE; FIELD TM, 1982, SCIENCE, V218, P179, DOI 10.1126/science.7123230; FIELD TM, 1983, INFANT BEHAV DEV, V6, P485, DOI 10.1016/S0163-6383(83)90316-8; Flom R, 2007, DEV PSYCHOL, V43, P238, DOI 10.1037/0012-1649.43.1.238; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P196; Hepach R, 2013, J EXP CHILD PSYCHOL, V115, P16, DOI 10.1016/j.jecp.2012.12.013; Kaneshige T, 2015, JPN PSYCHOL RES, V57, P135, DOI 10.1111/jpr.12075; Keltner D, 1999, COGNITION EMOTION, V13, P505, DOI 10.1080/026999399379168; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; Montepare JM, 2003, J NONVERBAL BEHAV, V27, P237, DOI 10.1023/A:1027332800296; Nelson CA, 1998, PERCEPTUAL DEV VISUA, P287; Phillips AT, 2002, COGNITION, V85, P53, DOI 10.1016/S0010-0277(02)00073-2; Serrano JM, 1995, INFANT BEHAV DEV, V18, P477, DOI 10.1016/0163-6383(95)90036-5; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; SOKEN NH, 1992, CHILD DEV, V63, P787; SORCE JF, 1985, DEV PSYCHOL, V21, P195, DOI 10.1037/0012-1649.21.1.195; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Vaish A, 2010, INFANT BEHAV DEV, V33, P79, DOI 10.1016/j.infbeh.2009.11.003; WALKER AS, 1982, J EXP CHILD PSYCHOL, V33, P514, DOI 10.1016/0022-0965(82)90063-7; Walker-Andrews A. S., 1988, ADV INFANCY RES, P173; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; WALKERANDREWS AS, 1986, DEV PSYCHOL, V22, P373, DOI 10.1037/0012-1649.22.3.373	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185840	10.1371/journal.pone.0185840	http://dx.doi.org/10.1371/journal.pone.0185840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977026	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100050
J	Miuccio, M; Liu, KY; Lau, H; Peters, MAK				Miuccio, Michael; Liu, Ka-yuet; Lau, Hakwan; Peters, Megan A. K.			Six-fold over-representation of graduates from prestigious universities does not necessitate unmeritocratic selection in the faculty hiring process	PLOS ONE			English	Article							ACADEMIC JOB MARKET; ADVANTAGE; MOBILITY; SUCCESS; INDEX; RACE		[Miuccio, Michael; Lau, Hakwan; Peters, Megan A. K.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Liu, Ka-yuet] Univ Calif Los Angeles, Dept Sociol, Los Angeles, CA 90024 USA; [Liu, Ka-yuet] Univ Calif Los Angeles, Calif Ctr Populat Res, Los Angeles, CA 90024 USA; [Lau, Hakwan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Lau, Hakwan] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Peters, Megan A. K.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Hong Kong; University of California System; University of California Riverside	Peters, MAK (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.; Peters, MAK (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	mpeters@engr.ucr.edu		Peters, Megan/0000-0002-0248-0816	National Institute of Neurological Disorders and Stroke [R01NS08862801]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke (R01NS08862801) to HL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; [Anonymous], 1967, HDB METHODS APPL STA; Bedeian AG, 2010, ACAD MANAG LEARN EDU, V9, P11, DOI 10.5465/AMLE.2010.48661188; Burris V, 2004, AM SOCIOL REV, V69, P239, DOI 10.1177/000312240406900205; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Frank Robert, 1996, WINNER TAKE ALL SOC; Green DM, 1966, SIGNAL DETECTION THE; Headworth S, 2015, SOC FORCES, P1; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Macmillan N. A., 2004, DETECTION THEORY USE; Merritt DJ, 1997, COLUMBIA LAW REV, V97, P199, DOI 10.2307/1123365; Miller CC, 2005, J ORGAN BEHAV, V26, P489, DOI 10.1002/job.325; Misra J, 1999, SOCIOL PERSPECT, V42, P215, DOI 10.2307/1389628; ROSEN S, 1981, AM ECON REV, V71, P845; van Dijk D, 2014, CURR BIOL, V24, pR516, DOI 10.1016/j.cub.2014.04.039; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0	19	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185900	10.1371/journal.pone.0185900	http://dx.doi.org/10.1371/journal.pone.0185900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977022	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100053
J	Issler, MVC; Mombach, JCM				Issler, Maria Vitoria C.; Mombach, Jose Carlos M.			MicroRNA-16 feedback loop with p53 and Wip1 can regulate cell fate determination between apoptosis and senescence in DNA damage response	PLOS ONE			English	Article							PHOSPHATASE; MIR-16; MECHANISM; ARREST; MDM2	Cell fate regulation is an open problem whose comprehension impacts several areas of the biosciences. DNA damage induces cell cycle checkpoints that activate the p53 pathway to regulate cell fate mechanisms such as apoptosis or senescence. Experiments with different cell types show that the p53 pathway regulates cell fate through a switch behavior in its dynamics. For low DNA damage the pathway presents an oscillatory pattern associated with intense DNA damage repair while for high damage there are no oscillations and either p53 concentration increases inducing apoptosis or the cell enters a senescence state. Apoptosis and senescence phenotypes seem to have compensatory functions in tissues and the microRNA 16-1 (miR-16) is involved in the regulation of the fate between both phenotypes in cancer cells. To investigate the regulation of cell fate we developed a logical model of the G1/S checkpoint in DNA damage response that takes into account different levels of damage and contemplates the influence of miR-16 through its positive feedback loop formed with p53 and Wip1. The model reproduces the observed cellular phenotypes in experiments: oscillatory (for low DNA damage) regulated by negative feedback loops involving mainly p53 and Mdm2 and apoptotic or senescent (for high DNA damage) regulated by the positive p53/Wip1/miR-16 feedback loop. We find good agreement between the level of DNA damage and the probability of the phenotype produced according to experiments. We also find that this positive feedback makes senescent and apoptotic phenotypes to be determined stochastically (bistable), however controlling the expression level of miR-16 allows the control of fate determination as observed experimentally.	[Issler, Maria Vitoria C.; Mombach, Jose Carlos M.] Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM)	Mombach, JCM (corresponding author), Univ Fed Santa Maria, Dept Phys, Santa Maria, RS, Brazil.	jcmombach@ufsm.br	Mombach, Jose C. M./L-1484-2013	Mombach, Jose C. M./0000-0002-6602-3905				Abou-Jaoude W, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00094; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen X, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-73; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; de Oliveira LR, 2015, MOL BIOSYST, V11, P2955, DOI 10.1039/c5mb00230c; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Flobak A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004426; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gobbini E, 2013, DNA REPAIR, V12, P791, DOI 10.1016/j.dnarep.2013.07.009; Grieco L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003286; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Kitadate A, 2016, ONCOGENE, V35, P3692, DOI 10.1038/onc.2015.435; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Le Novere N, 2015, NAT REV GENET, V16, P146, DOI 10.1038/nrg3885; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lu X, 2007, CANCER CELL, V12, P1535; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mendes ND, 2014, QUANTIFICATION REACH; Mobarra N, 2012, IN VITRO CELL DEV, V51; Mombach JCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125217; Mombach JCM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S7; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Olivieri F, 2013, AGEING RES REV, V12, P1056, DOI 10.1016/j.arr.2013.05.001; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sun T, 2005, FEBS LETT, V588, P815; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Thieffry D, 2007, BRIEF BIOINFORM, V8, P220, DOI 10.1093/bib/bbm028; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043908; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	36	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185794	10.1371/journal.pone.0185794	http://dx.doi.org/10.1371/journal.pone.0185794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968438	Green Submitted, gold, Green Published			2022-12-27	WOS:000412029600050
J	Lin, GL; Ting, HJ; Tseng, TC; Juang, V; Lo, YL				Lin, Guan-Liang; Ting, Huei-Ju; Tseng, Ta-Chien; Juang, Vivian; Lo, Yu-Li			Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells	PLOS ONE			English	Article							CYCLIN D1; C-MYC; ANTIMICROBIAL PEPTIDE; BETA-CATENIN; HELA-CELLS; ANTIGEN R; IN-VITRO; EXPRESSION; APOPTOSIS; GROWTH	HuR (ELAVL1), a RNA-binding protein, plays a key role in posttranscriptional regulation of multidrug resistance (MDR)-related genes. Among various HuR-regulated oncogenic transcripts, the activation of galectin-3/beta-catenin survival pathway is critical to induce transcription of cyclin D1, P-glycoprotein (P-gp) and/or multidrug resistance-associated proteins (MRPs). In this study, we aim to elucidate the HuR-regulating pathways related to epirubi-cin-mediated resistance in human colorectal carcinoma cells. The effects and mechanisms of epirubicin treatment on the expressions of upstream survival signals (e.g., beta-catenin) and downstream MDR transporters (e.g., P-gp) and anti-apoptotic pathways (e.g., Bcl-2) were assessed with or without HuR knockdown (siHuR) or overexpression (overHuR; ectopic HuR or pcDNA3/HA-HuR). Our results showed that siHuR decreased transcriptional expressions of galectin-3, beta-catenin, cyclin D1, Bcl-2, P-gp, MRP1, and MRP2 in epirubicintreated colon cancer cells. Consistently, the co-treatment of epirubicin and siHuR diminished the expressions of galectin-3, beta-catenin, c-Myc, P-gp and MRP1. HuR silencing enhanced the intracellular accumulation of epirubicin in colon cancer cells. On the other hand, overHuR abolished such effects. Furthermore, siHuR significantly intensified epirubicin-mediated apoptosis via increasing reactive oxygen species and thus promoted the cytotoxic effect of epirubicin. The combined treatments of siHuR and epirubicin significantly reduced the expression of Bcl-2, but increased the expression of Bax, as well as activity and expression levels of caspase-3 and -9. In contrast, overHuR abrogated these effects. Our findings provide insight into the mechanisms by which siHuR potentiated epirubicin-induced cytotoxicity via inhibiting galectin-3/beta-catenin signaling, suppressing MDR transporters and provoking apoptosis. To our best knowledge, this is an innovative investigation linking the post-transcriptional control by HuR silencing to survival signaling repression, efflux transporter reversal and apoptosis induction. Our study thus provides a powerful regimen for circumventing MDR in colon cancer cells.	[Lin, Guan-Liang; Ting, Huei-Ju] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan; [Tseng, Ta-Chien] Natl Cheng Kung Univ, Inst Bioinformat & Biosignaling Transduct, Tainan, Taiwan; [Juang, Vivian; Lo, Yu-Li] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan	National University Tainan; National Cheng Kung University; National Yang Ming Chiao Tung University	Lo, YL (corresponding author), Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan.	yuilio@ym.edu.tw	Tseng, Joseph Ta-Chien/I-2850-2018	Tseng, Joseph Ta-Chien/0000-0002-3304-6086; Ting, Huei-Ju/0000-0003-3709-5755; Juang, Vivian/0000-0002-3389-1829; Lo, Yu-Li/0000-0002-6548-3280	Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-004-MY2, MOST 106-2320-B-010-005]; Veterans General Hospitals; University System of Taiwan [VGHUST106-G7-7-3]; Ministry of Education; National Yang-Ming University [103AC-D112]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals; University System of Taiwan; Ministry of Education; National Yang-Ming University	This project was financially supported by grants from Ministry of Science and Technology of Taiwan (MOST 104-2320-B-010-004-MY2; MOST 106-2320-B-010-005), Veterans General Hospitals and University System of Taiwan (VGHUST106-G7-7-3), the Ministry of Education (Aiming for the Top University Plan), and National Yang-Ming University (103AC-D112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was financially supported by grants from Ministry of Science and Technology of Taiwan (MOST 104-2320-B-010-004-MY2; MOST 106-2320-B-010-005), Veterans General Hospitals and University System of Taiwan (VGHUST106-G7-7-3), Ministry of Education of Taiwan (Aiming for the Top University Plan), and National Yang-Ming University (103AC-D112).	Aguado A, 2016, J HYPERTENS, V34, P253, DOI 10.1097/HJH.0000000000000801; Bai DN, 2015, BIOCHEM BIOPH RES CO, V463, P1273, DOI 10.1016/j.bbrc.2015.06.101; Biliran H, 2007, CLIN CANCER RES, V13, P2811, DOI 10.1158/1078-0432.CCR-06-1844; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dharmapuri G, 2015, LEUKEMIA RES, V39, P696, DOI 10.1016/j.leukres.2015.02.013; Do SI, 2008, TUMORI, V94, P347; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Hong SH, 2012, ONCOL REP, V27, P114, DOI 10.3892/or.2011.1451; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Huang YH, 2016, CANCER RES, V76, P1549, DOI 10.1158/0008-5472.CAN-15-2073; Hung TH, 2014, ONCOTARGET, V5, P12273, DOI 10.18632/oncotarget.2631; Juang V, 2016, INT J NANOMED, V11, P6047, DOI 10.2147/IJN.S117618; Kim I, 2012, NUCLEIC ACIDS RES, V40, P6863, DOI 10.1093/nar/gks331; Lage H, 2008, CELL MOL LIFE SCI, V65, P3145, DOI 10.1007/s00018-008-8111-5; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082478; Lo YL, 2015, CHEM-BIOL INTERACT, V242, P13, DOI 10.1016/j.cbi.2015.08.023; Lo YL, 2015, INT J MOL SCI, V16, P22711, DOI 10.3390/ijms160922711; Lo YL, 2013, CHEM-BIOL INTERACT, V205, P188, DOI 10.1016/j.cbi.2013.07.003; Lo YL, 2012, TOXICOLOGY, V302, P221, DOI 10.1016/j.tox.2012.08.003; Marbeuf-Gueye C, 2000, EUR J PHARMACOL, V391, P207, DOI 10.1016/S0014-2999(00)00047-9; Perrone EE, 2012, J SURG RES, V178, P155, DOI 10.1016/j.jss.2012.02.029; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Prislei S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-72; Raspaglio G, 2010, CANCER RES, V70, P5891, DOI 10.1158/0008-5472.CAN-09-4656; Romeo C, 2016, MOL CANCER RES, V14, P599, DOI 10.1158/1541-7786.MCR-15-0448; Serini S, 2011, J NUTR BIOCHEM, V22, P874, DOI 10.1016/j.jnutbio.2010.08.004; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Vanella L, 2013, ONCOL REP, V30, P2804, DOI 10.3892/or.2013.2757; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; Yu C, 2014, MOL BIOL REP, V41, P1141, DOI 10.1007/s11033-013-2960-1; Yuan Z, 2011, ONCOL REP, V26, P237, DOI 10.3892/or.2011.1271; Zhang JJ, 2012, TOXICOL APPL PHARM, V263, P218, DOI 10.1016/j.taap.2012.06.012; Zhu XC, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0588-9; Zhu ZP, 2013, TUMOR BIOL, V34, P2299, DOI 10.1007/s13277-013-0774-3; Ziegeler G, 2010, J BIOL CHEM, V285, P15408, DOI 10.1074/jbc.M110.113365	40	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185625	10.1371/journal.pone.0185625	http://dx.doi.org/10.1371/journal.pone.0185625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968471	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600031
J	Thomas, NA; Churches, O; White, I; Mohr, C; Schrag, Y; Obucina, S; Nicholls, MER				Thomas, Nicole A.; Churches, Owen; White, Ian; Mohr, Christine; Schrag, Yann; Obucina, Sabrina; Nicholls, Michael E. R.			An investigation of left/right driving rules on deviations while walking	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; RIGHTWARD COLLISIONS; SPATIAL ATTENTION; FAR SPACE; PSEUDONEGLECT; NEGLECT; GAIT; TASK; PARAMETERS; BEHAVIOR	When traversing through an aperture, such as a doorway, people characteristically deviate towards the right. This rightward deviation can be explained by a rightward attentional bias which leads to rightward bisections in far space. It is also possible, however, that left or right driving practices affect the deviation. To explore this possibility, Australian (left-side drivers) and Swiss (right-side drivers) participants (n = 36 & 34) walked through the middle of an aperture. To control for the sway of the body, participants started with either their left or right foot. Sway had a significant effect on participants' position in the doorway and the amount of sway was greater for Australians-perhaps due to national differences in gait. There was a significant rightward deviation for the Swiss, but not for the Australians. It is suggested that driving practices have a small additive effect on rightward attentional biases whereby the bias is increased for people who drive on the right and reduced in people who drive on the left.	[Thomas, Nicole A.; Churches, Owen; White, Ian; Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia; [Mohr, Christine; Schrag, Yann; Obucina, Sabrina] Univ Lausanne, Inst Psychol, Lausanne, Switzerland	Flinders University South Australia; University of Lausanne	Nicholls, MER (corresponding author), Flinders Univ S Australia, Sch Psychol, Adelaide, SA, Australia.	mike.nicholls@flinders.edu.au		Mohr, Christine/0000-0002-3720-7115; Nicholls, Mike/0000-0002-7072-3744; Churches, Owen/0000-0002-2571-4849; Thomas, Nicole/0000-0002-1112-9024	Australian Research Council [DP 160100757]	Australian Research Council(Australian Research Council)	This research was supported with a grant from the Australian Research Council (DP 160100757; http://www.arc.gov.au/) to MN and NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obaidi S, 2003, J REHABIL RES DEV, V40, P361, DOI 10.1682/JRRD.2003.07.0361; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; Bonato M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00195; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Cai Q, 2013, P NATL ACAD SCI USA, V110, pE322, DOI 10.1073/pnas.1212956110; Cho SH, 2004, CLIN BIOMECH, V19, P145, DOI 10.1016/j.clinbiomech.2003.10.003; Cinelli ME, 2009, Q J EXP PSYCHOL, V62, P483, DOI 10.1080/17470210802168583; Cromie S, 2007, LATERALITY, V12, P500, DOI 10.1080/13576500701575140; Ebersbach G, 2000, MOVEMENT DISORD, V15, P1145, DOI 10.1002/1531-8257(200011)15:6<1145::AID-MDS1013>3.0.CO;2-C; Fujikake H, 2011, EXP BRAIN RES, V210, P195, DOI 10.1007/s00221-011-2621-3; Hatin B, 2012, CORTEX, V48, P997, DOI 10.1016/j.cortex.2011.05.015; Iyer S., 2012, INT J ENG SCI TECHNO, V4, P4571; Jang S. - L., 2009, CYBERPSYCHOLOGY BEHA, V12, P81, DOI [10.1089/cpb.2008.9999.abs, DOI 10.1089/CPB.2008.9999.ABS]; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Mattingley JB, 2004, NEUROPSYCHOLOGIA, V42, P387, DOI 10.1016/j.neuropsychologia.2003.07.007; MATTINGLEY JB, 1992, BRAIN, V115, P1849, DOI 10.1093/brain/115.6.1849; Mohr C, 2004, BEHAV BRAIN RES, V151, P321, DOI 10.1016/j.bbr.2003.09.006; Mohr C, 2007, LATERALITY, V12, P172, DOI 10.1080/13576500601051580; Nicholls ME, 2016, J EXPT PSYCHOL APPL; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; Nicholls MER, 2013, CORTEX, V49, P2914, DOI 10.1016/j.cortex.2013.02.002; Nicholls MER, 2011, BRAIN COGNITION, V76, P349, DOI 10.1016/j.bandc.2011.04.006; Nicholls MER, 2010, ATTEN PERCEPT PSYCHO, V72, P1576, DOI 10.3758/APP.72.6.1576; Robertson JS, 2014, ATTEN PERCEPT PSYCHO, V77, P830; Ryu T, 2006, INT J IND ERGONOM, V36, P1023, DOI 10.1016/j.ergon.2006.09.013; SELTZER C, 1990, J COMP PSYCHOL, V104, P159, DOI 10.1037/0735-7036.104.2.159; Simon-Dack SL, 2013, NEUROREPORT, V24, P827, DOI 10.1097/WNR.0b013e328364125b; Slagter HA, 2010, NEUROPSYCHOLOGIA, V48, P1265, DOI 10.1016/j.neuropsychologia.2009.12.027; Thomas NA, 2009, J INT NEUROPSYCH SOC, V15, P225, DOI 10.1017/S1355617709090328; Turnbull OH, 1998, BRAIN COGNITION, V37, P31; WEINTRAUB S, 1988, J NEUROL NEUROSUR PS, V51, P1481, DOI 10.1136/jnnp.51.12.1481; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531	35	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186171	10.1371/journal.pone.0186171	http://dx.doi.org/10.1371/journal.pone.0186171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020027	Green Published, Green Accepted, gold			2022-12-27	WOS:000412754400076
J	Kala, P; Kanovsky, J; Novakova, T; Miklik, R; Bocek, O; Poloczek, M; Jerabek, P; Prymkova, L; Ondrus, T; Jarkovsky, J; Blaha, M; Mintz, GS				Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas; Jarkovsky, Jiri; Blaha, Milan; Mintz, Gary S.			Radial artery neointimal hyperplasia after transradial PCI-Serial optical coherence tomography volumetric study	PLOS ONE			English	Article							CORONARY-ANGIOGRAPHY; ACCESS SITE; INTERVENTION; ULTRASOUND; BENEFIT; INJURY	Aims Transradial catheterization (TRC) is a dominant access site for coronary catheterization and percutaneous coronary interventions (PCI) in many centers. Previous studies reported higher intimal thickness of the radial artery (RA) wall in patients with a previous history of TRC. In this investigation the aim was to assess the intimal changes of RA using the optical coherence tomography (OCT) intravascular imaging in a serial manner. Methods and results 100 patients with the diagnosis of non-ST-elevation myocardial infarction (nSTEMI) treated by PCI were enrolled (6 patients were excluded from this analysis because of occluded RA at follow-up [2 patients] and insufficient quality of OCT images [4 patients]). An 54mm long OCT run of the RA was performed immediately after the index PCI and repeated 9 months later. Volumetric analyses of the intimal layer and lumen changes were conducted. Median intimal volume at baseline versus 9 months was 33.9mm(3) (19.0; 69.4) versus 39.0mm(3) (21.7; 72.6) (p<0.001); and median arterial lumen volume was 356.3mm(3) (227.8; 645.3) versus 304.7mm(3) (186.1; 582.7) (p<0.001). There was no significant difference in the effect of any clinical factor on the RA volume changes. Conclusions OCT volumetric analyses at baseline and 9 months showed a significant increase in the radial artery intimal layer volume and a decrease in lumen volume after transradial PCI. No significant factors affecting this process were identified.	[Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Kanovsky, Jan; Novakova, Tereza; Miklik, Roman; Bocek, Otakar; Poloczek, Martin; Jerabek, Petr; Prymkova, Lenka; Ondrus, Tomas] Masaryk Univ Brno, Med Fac, Brno, Czech Republic; [Jarkovsky, Jiri; Blaha, Milan] Masaryk Univ Brno, Inst Biostat & Anal, Brno, Czech Republic; [Mintz, Gary S.] Cardiovasc Res Fdn, New York, NY USA	University Hospital Brno; Masaryk University Brno; Institute of Biostatistics & Analyses; Masaryk University Brno; Cardiovascular Research Foundation (CRF)	Kanovsky, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Kanovsky, J (corresponding author), Masaryk Univ Brno, Med Fac, Brno, Czech Republic.	kanovsky.jan@fnbrno.cz	Ondrus, Tomas/AAV-2604-2021; Kanovsky, Jan/ABC-1404-2021	Ondrus, Tomas/0000-0002-6621-0364; Kanovsky, Jan/0000-0003-1352-6274	Internal Grant Agency of the Ministry of Health of the Czech Republic [NT/13830-4]	Internal Grant Agency of the Ministry of Health of the Czech Republic	This study was supported by the grant of the Internal Grant Agency of the Ministry of Health of the Czech Republic NT/13830-4.	Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013; Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Burris NS, 2008, ANN THORAC SURG, V85, P1271, DOI 10.1016/j.athoracsur.2007.12.044; CAMPEAU L, 1989, CATHETER CARDIO DIAG, V16, P3, DOI 10.1002/ccd.1810160103; Caputo RP, 2011, CATHETER CARDIO INTE, V78, P823, DOI 10.1002/ccd.23052; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220; Mamas MA, 2014, EUROINTERVENTION, V10, P824, DOI 10.4244/EIJV10I7A142; Mattea V, 2017, IJC HEART VASC, V14, P46, DOI 10.1016/j.ijcha.2016.12.003; Nakata T, 2015, INT HEART J, V56, P489, DOI 10.1536/ihj.15-094; Novakova T, 2016, BIOMED PAP, V160, P393, DOI 10.5507/bp.2016.035; Wakeyama T, 2003, J AM COLL CARDIOL, V41, P1109, DOI 10.1016/S0735-1097(03)00089-5; Yonetsu T, 2010, EUR HEART J, V31, P1608, DOI 10.1093/eurheartj/ehq102	14	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185404	10.1371/journal.pone.0185404	http://dx.doi.org/10.1371/journal.pone.0185404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016632	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400017
J	D'Andrea, R; O'Dwyer, JP				D'Andrea, Rafael; O'Dwyer, James P.			Can editors save peer review from peer reviewers?	PLOS ONE			English	Article								Peer review is the gold standard for scientific communication, but its ability to guarantee the quality of published research remains difficult to verify. Recent modeling studies suggest that peer review is sensitive to reviewer misbehavior, and it has been claimed that referees who sabotage work they perceive as competition may severely undermine the quality of publications. Here we examine which aspects of suboptimal reviewing practices most strongly impact quality, and test different mitigating strategies that editors may employ to counter them. We find that the biggest hazard to the quality of published literature is not selfish rejection of high-quality manuscripts but indifferent acceptance of low-quality ones. Bypassing or blacklisting bad reviewers and consulting additional reviewers to settle disagreements can reduce but not eliminate the impact. The other editorial strategies we tested do not significantly improve quality, but pairing manuscripts to reviewers unlikely to selfishly reject them and allowing revision of rejected manuscripts minimize rejection of above-average manuscripts. In its current form, peer review offers few incentives for impartial reviewing efforts. Editors can help, but structural changes are more likely to have a stronger impact.	[D'Andrea, Rafael; O'Dwyer, James P.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	D'Andrea, R (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	rdandrea@illinois.edu	D'Andrea, Rafael/I-2588-2019	D'Andrea, Rafael/0000-0001-9687-6178	Simons Foundation [376199]; McDonnell Foundation [220020439]	Simons Foundation; McDonnell Foundation	J.OD. acknowledges the Simons Foundation Grant #376199 and McDonnell Foundation Grant #220020439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the two anonymous reviewers for helping to improve the manuscript. J.OD. acknowledges the Simons Foundation Grant #376199 and McDonnell Foundation Grant #220020439.	Aktipis CA, 2010, ADAPT BEHAV, V18, P448, DOI 10.1177/1059712310384281; Allesina S, 2012, IDEAS ECOL EVOL, V5, P27, DOI 10.4033/iee.2012.5b.8.f; Bianchi F, 2015, P 2015 WINT SIM C WS, V2015, P779; Cabota J. B., 2014, P 28 EUR C MOD SIM, P725; Csiszar A, 2016, NATURE, V532, P306, DOI 10.1038/532306a; Fox J., 2010, B ECOL SOC AM, V91, P325, DOI DOI 10.1890/0012-9623-91.3.325; Grimaldo F, 2013, ADV COMPLEX SYST, V16, DOI 10.1142/S0219525913500045; Groves T, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6424; Hauser M, 2007, PLOS BIOL, V5, P703, DOI 10.1371/journal.pbio.0050107; Henneken EA, 2006, J ELECT PUBLISHING, V9, P11; Hucul D, 2015, NATURE, V11; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000016.pub3; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Khan K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6425; Kovanis M., 2017, SCIENTOMETRICS, P1; Kovanis M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166387; Kriegeskorte N, 2012, FRONT COMPUT NEUROSC, V6, DOI [10.3389/fncom.2012.00079, 10.3389/fncom.2012.00094]; Lee CJ, 2013, J AM SOC INF SCI TEC, V64, P2, DOI 10.1002/asi.22784; Mahoney M.J., 1977, COGNITIVE THER RES, V1, P161, DOI [10.1007/BF01173636, DOI 10.1007/BF01173636]; Mulligan A, 2013, J AM SOC INF SCI TEC, V64, P132, DOI 10.1002/asi.22798; Myers D. J., 2009, CHRON HIGHER EDUC, V56, pB4; Paolucci M, 2014, SCIENTOMETRICS, V99, P663, DOI 10.1007/s11192-014-1239-1; Roebber PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018680; Ross-Hellauer Tony, 2017, F1000Res, V6, P588, DOI 10.12688/f1000research.11369.2; Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964; Squazzoni F, 2013, JASSS-J ARTIF SOC S, V16, P1; Squazzoni F, 2017, NATURE, V546, P352, DOI 10.1038/546352a; Squazzoni F, 2012, J INFORMETR, V6, P265, DOI 10.1016/j.joi.2011.12.005; Tennant JP, 2017, F1000RESEARCH, P1; Thorngate W, 2014, ADV INTELL SYST, V229, P177, DOI 10.1007/978-3-642-39829-2_16; Thurner S, 2011, EUR PHYS J B, V84, P707, DOI 10.1140/epjb/e2011-20545-7; van Rooyen S, 1999, BRIT MED J, V318, P23; Wang W, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2601-y; WARE M, 2011, NEW REV INFORM NETWO, V16, P23, DOI DOI 10.1080/13614576.2011.566812; Ware M., 2008, PEER REV BENEFITS PE, P20	35	28	28	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186111	10.1371/journal.pone.0186111	http://dx.doi.org/10.1371/journal.pone.0186111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016678	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800038
J	Kwon, S; Solomon, GEA; Youtie, J; Porter, AL				Kwon, Seokbeom; Solomon, Gregg E. A.; Youtie, Jan; Porter, Alan L.			A measure of knowledge flow between specific fields: Implications of interdisciplinarity for impact and funding	PLOS ONE			English	Article							COGNITIVE-SCIENCE; TECHNOLOGY; SOCIETY	Encouraging knowledge flow between mutually relevant disciplines is a worthy aim of research policy makers. Yet, it is less clear what types of research promote cross-disciplinary knowledge flow and whether such research generates particularly influential knowledge. Empirical questions remain as to how to identify knowledge-flow mediating research and how to provide support for this research. This study contributes to addressing these gaps by proposing a new way to identify knowledge-flow mediating research at the individual research article level, instead of at more aggregated levels. We identify journal articles that link two mutually relevant disciplines in three ways-aggregating, bridging, and diffusing. We then examine the likelihood that these papers receive subsequent citations or have funding acknowledgments. Our case study of cognitive science and educational research knowledge flow suggests that articles that aggregate knowledge from multiple disciplines are cited significantly more often than are those whose references are drawn primarily from a single discipline. Interestingly, the articles that meet the criteria for being considered knowledge-flow mediators are less likely to reflect funding, based on reported acknowledgements, than were those that did not meet these criteria. Based on these findings, we draw implications for research policymakers.	[Kwon, Seokbeom; Porter, Alan L.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Solomon, Gregg E. A.] Natl Sci Fdn, Directorate Educ & Human Resources, 4201 Wilson Blvd, Arlington, VA 22230 USA; [Youtie, Jan] Georgia Inst Technol, Enterprise Innovat Inst, Atlanta, GA 30332 USA; [Porter, Alan L.] Search Technol Inc, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; National Science Foundation (NSF); NSF - Directorate for STEM Education (EDU); University System of Georgia; Georgia Institute of Technology	Kwon, S (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	skwon61@gatech.edu	porter, alan l/A-7013-2009; Kwon, Seok Beom/AAK-2635-2021	porter, alan l/0000-0002-4520-6518; Kwon, Seokbeom/0000-0003-4074-9342	U.S. National Science Foundation (NSF); Connections: STEM Educational Research Communities and Knowledge Transfer [DRL-1348765]; NSF; US National Science Foundation, Division of Research on Learning [DRL-1348765]; IR/D; Direct For Education and Human Resources [1348765] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Connections: STEM Educational Research Communities and Knowledge Transfer; NSF(National Science Foundation (NSF)); US National Science Foundation, Division of Research on Learning; IR/D; Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	Funding for this study came in the form of a research award by the U.S. National Science Foundation (NSF) to Search Technology, Inc., with a sub-award to Georgia Tech. [Search Technology, Inc., did not fund this research.] (Award # DRL-1348765 -"Connections: STEM Educational Research Communities and Knowledge Transfer"). The findings and observations contained in this paper are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders did not influence study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors, Alan Porter, is jointly affiliated with Search Technology as Director of R&D, and also as Co-Director of the Program in Science, Technology & Innovation Policy at Georgia Tech. His salary for work on this project was paid by Search, from NSF funding. Search Technology, Inc. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; This work was supported by a grant from the US National Science Foundation, Division of Research on Learning (DRL-1348765) to Georgia Tech. While serving at the National Science Foundation, G.S. was supported by the IR/D program. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect those of the National Science Foundation.; One of the authors, Alan Porter, is jointly affiliated with Search Technology as Director of R&D, and also as Co-Director of the Program in Science, Technology & Innovation Policy at Georgia Tech. His salary for work on this project was paid by Search, from NSF funding. Search Technology, Inc. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Boyack KW, 2011, 13 C INT SOC SCI INF; Bromham L, 2016, NATURE, V534, P684, DOI 10.1038/nature18315; Carley S, 2012, SCIENTOMETRICS, V90, P407, DOI 10.1007/s11192-011-0528-1; Chavarro D, 2014, RES EVALUAT, V23, P195, DOI 10.1093/reseval/rvu012; Chubin DE, 1982, SCI ESTABLISHMENTS H, P293; COZZENS SE, 1985, SCIENTOMETRICS, V7, P431, DOI 10.1007/BF02017159; EGGHE L, 1992, INFORM PROCESS MANAG, V28, P201, DOI 10.1016/0306-4573(92)90046-3; GLANZEL W, 1995, J INFORM SCI, V21, P37, DOI 10.1177/016555159502100104; Glanzel W, 1999, SCIENTOMETRICS, V44, P427, DOI 10.1007/BF02458488; Goldstone RL, 2006, COGNITIVE SCI, V30, P983, DOI 10.1207/s15516709cog0000_96; Grassano N, 2016, J ASS INFORM SCI TEC; Kwon S, 2016, SCIENTOMETRICS, V106, P1057, DOI 10.1007/s11192-015-1826-9; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Leydesdorff L, 2014, J ASSOC INF SCI TECH, V65, P164, DOI 10.1002/asi.22953; Metzger N, 1999, SCIENCE, V283, P642, DOI 10.1126/science.283.5402.642; Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326; Nichols LG, 2014, SCIENTOMETRICS, V100, P741, DOI 10.1007/s11192-014-1319-2; PORTER AL, 1985, SCI TECHNOL HUM VAL, P33; Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2; Porter AL, 2008, RES EVALUAT, V17, P273, DOI 10.3152/095820208X364553; Price D.J., 1970, COMMUNICATION SCI EN, P3; Rafols I., 2014, MEASURING SCHOLARLY, P169, DOI [10.1007/978-3-319-10377-8_8, DOI 10.1007/978-3-319-10377-8_8, DOI 10.1007/978-3-319-10377-8]; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Schunn CD, 1998, COGNITIVE SCI, V22, P107, DOI 10.1016/S0364-0213(99)80036-6; Stirling A, 2007, J R SOC INTERFACE, V4, P707, DOI 10.1098/rsif.2007.0213; Yegros-Yegros A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135095; Youtie J, 2017, RES EVALUAT, V26, P242, DOI 10.1093/reseval/rvx020	27	16	18	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185583	10.1371/journal.pone.0185583	http://dx.doi.org/10.1371/journal.pone.0185583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016631	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800020
J	Jakobsen, AS; Speyer, H; Norgaard, HCB; Karlsen, M; Birk, M; Hjorthoj, C; Mors, O; Krogh, J; Gluud, C; Pisinger, C; Nordentoft, M				Jakobsen, Ane Storch; Speyer, Helene; Norgaard, Hans Christian Brix; Karlsen, Mette; Birk, Merete; Hjorthoj, Carsten; Mors, Ole; Krogh, Jesper; Gluud, Christian; Pisinger, Charlotta; Nordentoft, Merete			Effect of lifestyle coaching versus care coordination versus treatment as usual in people with severe mental illness and overweight: Two-years follow-up of the randomized CHANGE trial	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INTERVENTION; VALIDITY; HEALTH; SCHIZOPHRENIA; RELIABILITY; PREVENTION; MORTALITY; IMPACT	The objective of this trial was to assess the long-term effect of the CHANGE lifestyle coaching intervention for 428 people with abdominal obesity and schizophrenia spectrum disorders on cardiovascular risk. In this randomized, superiority, multi-center clinical trial, participants were randomized to 12 months of either lifestyle coaching plus care coordination (N = 138), care coordination alone, (N = 142) or treatment as usual (N = 148). There was no effect after 12 months, but we hypothesized that there might have been a delayed treatment effect. Our primary outcome at two-year follow-up was 10-year risk of cardiovascular disease standardized to 60 years of age. After two-years the mean 10-year cardiovascular-disease risk was 8.7% (95% confidence interval (CI) 7.6 +/- 9.9%) in the CHANGE group, 7.7% (95% CI 6.5 +/- 8.9%) in the care coordination group, and 8.9% (95% CI 6.9 +/- 9.2%) in the treatment as usual group (P = 0.24). Also, there were no intervention effects for any secondary or exploratory outcomes, including cardiorespiratory fitness, weight, physical activity, diet and smoking. No reported adverse events could be ascribed to the intervention. We conclude that there was neither any direct nor any long-term effect of individual lifestyle coaching or care coordination on cardiovascular risk factors in people with abdominal obesity and schizophrenia spectrum disorders. The trial was approved by the Ethics Committee of Capitol Region Copenhagen, Denmark (registration number: H-4-2012-051) and the Danish Data Protection Agency (registration number: 01689 RHP-2012-007). The trial was funded by the Mental Health Services of the Capital Region of Denmark, the Lundbeck Foundation, the Tryg Foundation, the Danish Ministry of Health, and the Daehnfeldts Foundation.	[Jakobsen, Ane Storch; Speyer, Helene; Karlsen, Mette; Hjorthoj, Carsten; Krogh, Jesper; Nordentoft, Merete] Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Jakobsen, Ane Storch; Speyer, Helene; Karlsen, Mette; Krogh, Jesper; Nordentoft, Merete] Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark; [Norgaard, Hans Christian Brix; Birk, Merete; Mors, Ole] Aarhus Univ Hosp, Psychosis Res Unit, Risskov, Denmark; [Norgaard, Hans Christian Brix; Birk, Merete] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Mors, Ole] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, Copenhagen, Denmark; [Pisinger, Charlotta] Capitol Reg, Res Ctr Prevent & Hlth, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Rigshospitalet; University of Copenhagen	Jakobsen, AS (corresponding author), Copenhagen Univ Hosp, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark.; Jakobsen, AS (corresponding author), Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark.	ane.storch.jakobsen@regionh.dk	Gluud, Christian/HGB-3191-2022; Nordentoft, Merete/AAH-3253-2019; Gluud, Christian/AAY-1027-2021	Gluud, Christian/0000-0002-8861-0799; Nordentoft, Merete/0000-0003-4895-7023; Krogh, Jesper/0000-0003-4834-6724; Pisinger, Charlotta/0000-0002-7970-3168	Mental Health Services of the Capital Region of Denmark; Lundbeck Foundation; Tryg Foundation; Danish Ministry of Health; Daehnfeldts Foundation; Lundbeck Foundation [R155-2014-1724, R108-2012-10620] Funding Source: researchfish	Mental Health Services of the Capital Region of Denmark; Lundbeck Foundation(Lundbeckfonden); Tryg Foundation; Danish Ministry of Health; Daehnfeldts Foundation; Lundbeck Foundation(Lundbeckfonden)	The trial was funded by the Mental Health Services of the Capital Region of Denmark, the Lundbeck Foundation, the Tryg Foundation, the Danish Ministry of Health, and the Daehnfeldts Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2010, SCAND J PUBLIC HEALT, V38, P707, DOI 10.1177/1403494810380099; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Bartels SJ, 2015, AM J PSYCHIAT, V172, P344, DOI 10.1176/appi.ajp.2014.14030357; Beary M., 2012, J PSYCHOPHARMACOL; BEATON GH, 1994, AM J CLIN NUTR, V59, p253S, DOI 10.1093/ajcn/59.1.253S; Bjorkman T, 2005, NORD J PSYCHIAT, V59, P302, DOI 10.1080/08039480500213733; Bly M. J., 2014, BIPOLAR DISORD; Bruins J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112276; Daumit GL, 2013, NEW ENGL J MED, V368, P1594, DOI 10.1056/NEJMoa1214530; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dombrowski SU, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2646; Etter JF, 1999, ADDICTION, V94, P269, DOI 10.1046/j.1360-0443.1999.94226910.x; Firth J, 2016, PSYCHOL MED, V46, P2869, DOI 10.1017/S0033291716001732; Froelicher ES, 1999, FUND CL CAR, V38, P187; Hjorthoj C., 2017, LANCET PSYCHIAT, V366, P1; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Mastellos N., 2014, COCHRANE DB SYST REV, P1; Miller WR, 2014, CONTEMP CLIN TRIALS, V37, P234, DOI 10.1016/j.cct.2014.01.005; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Neubeck L, 2015, NAT REV CARDIOL, V12, P350, DOI 10.1038/nrcardio.2015.34; Osborn D.P.J, 2014, JAMA PSYCHIAT, P1; Pedersen G, 2007, COMPR PSYCHIAT, V48, P88, DOI 10.1016/j.comppsych.2006.03.008; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Riemsma RP, 2003, BMJ-BRIT MED J, V326, P1175, DOI 10.1136/bmj.326.7400.1175; Speyer H., 2016, WORLD PSYCHIAT; Speyer H, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0465-2; Stahl S. M., 2009, ACTA PSYCHIAT SCANDI; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Thomsen TF, 2001, J CARDIOVASC RISK, V8, P291, DOI 10.1097/00043798-200110000-00008; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Traeden U. Ischiel, 2003, DIS PREVENTION HLTH; Wing JK, 1998, DIAGNOSIS CLIN MEASU; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; World Health Organization, 2008, WAIST CIRCUMFERENCE; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b	39	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185881	10.1371/journal.pone.0185881	http://dx.doi.org/10.1371/journal.pone.0185881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ1QR	28985228	Green Published, Green Submitted, gold			2022-12-27	WOS:000412493000012
J	Sureda, A; Bibiloni, MD; Julibert, A; Aparicio-Ugarriza, R; Ble, GPL; Pons, A; Gonzalez-Gross, M; Tur, JA				Sureda, Antoni; del Mar Bibiloni, Maria; Julibert, Alicia; Aparicio-Ugarriza, Raquel; Palacios-Le Ble, Gonzalo; Pons, Antoni; Gonzalez-Gross, Marcela; Tur, Josep A.			Trace element contents in toenails are related to regular physical activity in older adults	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ACTIVITY QUESTIONNAIRE; SELENIUM STATUS; RISK; BIOMARKERS; CHILDREN; CADMIUM; EXPOSURE; CANCER; VALIDATION	The aim was to assess the trace element contents in toenails of older adults and its association with regular physical activity. Cross-sectional multicentre study in Spain, collecting data from a random sample of 380 participants (54% female) aged 55-80 years (men) and 60-80 years (women) with no previously documented cardiovascular disease. Physical activity performed was measured using the Minnesota Leisure-time Physical Activity Questionnaire. The 25 most inactive and 25 most active individuals for each sex were selected for this study (final sample n = 100). Anthropometric measurements were performed and toenail samples collected for calcium (Ca), chromium (Cr), iron (Fe), cobalt (Co), nickel (Ni), zinc (Zn), selenium (Se) and mercury (Hg) analysis. Significant differences between sexes were reported in Ca concentrations, women having lower concentrations than men. No differences were reported in trace element contents between active and inactive men. Active women showed higher Ca, Cr, Fe, Co, and Zn and lower Hg contents than their inactive peers (all p < 0.05). Inactive women showed lower Ca and Co levels (735.0 mg/kg and 4.5 mu g/kg, respectively) than inactive men (1170.0 mg/kg and 7.9 mu g/kg, respectively). Active women had lower Ca and higher levels of Cr (936.0 mg/kg and 1230.0 mu g/kg, respectively) than active men (1070.0 mg/kg and 522.0 mu g/kg, respectively). The present data added new information on the element contents in toenails of healthy Spanish older adults. The concentration of trace elements was similar in both sexes except for Ca which were lower in women. The trace element contents in women's toenails, but not in men, were markedly influenced by physical activity, with higher levels of Ca and Fe and lower Hg among active females.	[Sureda, Antoni; del Mar Bibiloni, Maria; Julibert, Alicia; Pons, Antoni; Tur, Josep A.] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain; [Sureda, Antoni; del Mar Bibiloni, Maria; Julibert, Alicia; Aparicio-Ugarriza, Raquel; Palacios-Le Ble, Gonzalo; Pons, Antoni; Gonzalez-Gross, Marcela; Tur, Josep A.] Inst Salud Carlos III, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain; [Aparicio-Ugarriza, Raquel; Palacios-Le Ble, Gonzalo; Gonzalez-Gross, Marcela] Tech Univ Madrid, Fac Phys Act & Sport Sci INEF, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad Politecnica de Madrid	Tur, JA (corresponding author), Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, Palma De Mallorca, Spain.; Tur, JA (corresponding author), Inst Salud Carlos III, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.	pep.tur@uib.es	Tur, Josep/AAE-5748-2020; Aparicio-Ugarriza, Raquel/AAE-8946-2020; , Antoni/AAB-5250-2019; Gonzalez-Gross, Marcela/W-8000-2018; Gomila, Antonio Sureda/L-7191-2014; Pons, Antoni/L-4844-2014; julibert, Alicia/AAE-2070-2019; Sureda, Antoni/N-9588-2019; del Mar Bibiloni, Maria/M-3123-2014	Tur, Josep/0000-0002-6940-0761; , Antoni/0000-0001-8656-6838; Gomila, Antonio Sureda/0000-0003-2101-616X; Pons, Antoni/0000-0003-2447-3868; julibert, Alicia/0000-0002-6040-0482; Sureda, Antoni/0000-0001-8656-6838; del Mar Bibiloni, Maria/0000-0001-8926-9206	Institute of Health Carlos III [11/01791, 14/00636]; Institute of Health Carlos III (Red Predimed-RETIC) [RD06/0045/1004]; Institute of Health Carlos III (CIBEROBN) [CB12/03/30038]; Balearic Islands Gov. [35/2011]; EU-COST ACTION [CA16112]; EU FEDER	Institute of Health Carlos III(Instituto de Salud Carlos III); Institute of Health Carlos III (Red Predimed-RETIC); Institute of Health Carlos III (CIBEROBN); Balearic Islands Gov.; EU-COST ACTION(European Cooperation in Science and Technology (COST)European Commission); EU FEDER(European Commission)	This work was supported by the Institute of Health Carlos III (Projects 11/01791 and 14/00636, Red Predimed-RETIC RD06/0045/1004, and CIBEROBN CB12/03/30038), Grant of support to research groups no. 35/2011 (Balearic Islands Gov.), EU-COST ACTION CA16112, and EU FEDER funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghadir AH, 2016, BIOL TRACE ELEM RES, V172, P299, DOI 10.1007/s12011-015-0601-3; Alghadir AH, 2016, CLIN INTERV AGING, V11, P265, DOI 10.2147/CIA.S100566; Anderson RA, 1997, DIABETES, V46, P1786, DOI 10.2337/diabetes.46.11.1786; Anic GM, 2013, CANCER CAUSE CONTROL, V24, P2051, DOI 10.1007/s10552-013-0281-2; Bellisle F, 1999, PUBLIC HEALTH NUTR, V2, P357, DOI 10.1017/S1368980099000488; Bergomi M, 2005, J TRACE ELEM MED BIO, V19, P69, DOI 10.1016/j.jtemb.2005.06.002; Bergomi M, 2002, ENVIRON RES, V89, P116, DOI 10.1006/enrs.2002.4361; Blaauw M, 1997, ANAL CHEM, V69, P2247, DOI 10.1021/ac961280x; Blazewicz A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3178784; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Bonaccorsi G, 2013, EUR J CLIN NUTR, V67, P155, DOI 10.1038/ejcn.2012.195; Cai D, 2015, BIOL TRACE ELEM RES, V165, P18, DOI 10.1007/s12011-015-0233-7; Cashman MW, 2010, CLIN DERMATOL, V28, P420, DOI 10.1016/j.clindermatol.2010.03.037; Coelho P, 2014, ENVIRON GEOCHEM HLTH, V36, P255, DOI 10.1007/s10653-013-9562-7; Czeczuk A, 2012, ADV CLIN EXP MED, V21, P645; Diyabalanage S, 2017, J TRACE ELEM MED BIO, V39, P62, DOI 10.1016/j.jtemb.2016.08.003; Donma MM, 2010, TURK J MED SCI, V40, P323, DOI 10.3906/sag-0811-33; Downer MK, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-016-0435-8; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Feys J, 2016, R J, V8, P367; Forte G, 2014, EXP GERONTOL, V60, P197, DOI 10.1016/j.exger.2014.10.016; Fraga Cesar G, 2005, Mol Aspects Med, V26, P233, DOI 10.1016/j.mam.2005.07.014; GARLAND M, 1993, CANCER EPIDEM BIOMAR, V2, P493; Gennari C, 2001, Public Health Nutr, V4, P547; Ghazali AR, 2013, BIOL TRACE ELEM RES, V153, P16, DOI 10.1007/s12011-013-9642-7; Gibb H, 2011, J OCCUP ENVIRON HYG, V8, P187, DOI 10.1080/15459624.2011.556984; Hambidge M, 2003, J NUTR, V133, p948S, DOI 10.1093/jn/133.3.948S; He K, 2011, EUR J CLIN INVEST, V41, P98, DOI 10.1111/j.1365-2362.2010.02373.x; Higgins JJ, 1990, ANN C APPL STAT AGR; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Knight E, 2014, PHYSICIAN SPORTSMED, V42, P30, DOI 10.3810/psm.2014.11.2089; KOK FJ, 1989, JAMA-J AM MED ASSOC, V261, P1161, DOI 10.1001/jama.261.8.1161; Lee S, 2011, BIOL TRACE ELEM RES, V144, P396, DOI 10.1007/s12011-011-9108-8; Li YH, 2012, BIOL TRACE ELEM RES, V145, P158, DOI 10.1007/s12011-011-9187-6; Martens IBG, 2015, NUTRITION, V31, P1339, DOI 10.1016/j.nut.2015.05.005; Martin-Moreno JM, 2003, BRIT J NUTR, V89, P673, DOI 10.1079/BJN2003825; Martinez E, 2010, BRIT J NUTR, V103, P1657, DOI 10.1017/S0007114509993576; Mataix J, 2006, EUR J NUTR, V45, P349, DOI 10.1007/s00394-006-0605-z; Maughan RJ, 1999, BRIT MED BULL, V55, P683, DOI 10.1258/0007142991902556; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; O'Rorke MA, 2012, INT J CANCER, V131, P1882, DOI 10.1002/ijc.27434; Ohgitani S, 2005, J BONE MINER METAB, V23, P318, DOI 10.1007/s00774-005-0606-7; Rodriguez JCO, 2009, PSICOTHEMA, V21, P152; Park K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070424; Park K, 2012, DIABETES CARE, V35, P1544, DOI 10.2337/dc11-2136; PIKE J, 1995, INT J VITAM NUTR RES, V65, P117; Puchau B, 2010, BIOL TRACE ELEM RES, V133, P304, DOI 10.1007/s12011-009-8443-5; Ren Y, 2014, ASIAN PAC J CANCER P, V15, P5187, DOI 10.7314/APJCP.2014.15.13.5187; ROGERS MAM, 1993, CANCER EPIDEM BIOMAR, V2, P305; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Speich M, 2001, CLIN CHIM ACTA, V312, P1, DOI 10.1016/S0009-8981(01)00598-8; Takiguchi Masufumi, 2006, Environmental Sciences, V13, P107; Torres-Escribano S, 2011, J SCI FOOD AGR, V91, P981, DOI 10.1002/jsfa.4241; Tosato M, 2007, CLIN INTERV AGING, V2, P401; Trunova VA, 2009, TOXICOL MECH METHOD, V19, P1, DOI 10.1080/15376510801891310; VANDENBRANDT PA, 1993, CANCER RES, V53, P4860; Vinceti M, 2015, J TRACE ELEM MED BIO, V29, P145, DOI 10.1016/j.jtemb.2014.07.017; Wallin M, 2016, J BONE MINER RES, V31, P732, DOI 10.1002/jbmr.2743; WILHELM M, 1991, SCI TOTAL ENVIRON, V103, P199, DOI 10.1016/0048-9697(91)90145-5; Xun PC, 2011, ENVIRON RES, V111, P514, DOI 10.1016/j.envres.2011.01.016; Zhuo HJ, 2004, CANCER EPIDEM BIOMAR, V13, P771	64	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185318	10.1371/journal.pone.0185318	http://dx.doi.org/10.1371/journal.pone.0185318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985222	Green Published, Green Submitted, gold			2022-12-27	WOS:000412493000004
J	Brindle, E; Lillis, L; Barney, R; Hess, SY; Wessells, KR; Ouedraogo, CT; Stinca, S; Kalnoky, M; Peck, R; Tyler, A; Lyman, C; Boyle, DS				Brindle, Eleanor; Lillis, Lorraine; Barney, Rebecca; Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.; Stinca, Sara; Kalnoky, Michael; Peck, Roger; Tyler, Abby; Lyman, Christopher; Boyle, David S.			Simultaneous assessment of iodine, iron, vitamin A, malarial antigenemia, and inflammation status biomarkers via a multiplex immunoassay method on a population of pregnant women from Niger	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; C-REACTIVE PROTEIN; ENZYME-IMMUNOASSAY; DEFICIENCY ANEMIA; FERRITIN INDEX; DIFFERENTIAL-DIAGNOSIS; CHILD UNDERNUTRITION; MICRONUTRIENT STATUS; PLASMA RETINOL	Deficiencies of vitamin A, iron, and iodine are major public health concerns in many low- and middle-income countries, but information on their status in populations is often lacking due to high costs and logistical challenges associated with assessing micronutrient status. Accurate, user-friendly, and low-cost analytical tools are needed to allow large-scale population surveys on micronutrient status. We present the expansion of a 7-plex protein microarray tool for the simultaneous measurement of up to seven biomarkers with relevance to the assessment of the key micronutrients iron, iodine, and vitamin A, and inflammation and malaria biomarkers: a-1-acid glycoprotein, C-reactive protein, ferritin, retinol binding protein 4, soluble transferrin receptor, thyroglobulin, and histidine-rich protein II. Assay performance was assessed using international reference standards and then verified by comparing the multiplexed and conventional immunoassay results on a training panel of plasma samples collected from US adults. These data were used to assign nominal concentrations to the calibrators of the assay to further improve performance which was then assessed by interrogating plasma samples from a cohort of pregnant women from Niger. The correlation between assays for each biomarker measured from this cohort was typically good, with the exception of thyroglobulin, and the sensitivity ranged from 74% to 93%, and specificity from 81% to 98%. The 7-Plex micronutrient assay has the potential for use as an affordable tool for population surveillance of vitamin A, iron, and iodine deficiencies as well as falciparum malarial parasitemia infectivity and inflammation. The assay is easy-to-use, requires minimal sample volume, and is scalable, rapid, and accurate-needing only a low-cost reader and basic equipment present in most reference laboratory settings and so may be employed by low and middle income countries for micronutrient surveillance to inform on status in keypopulations. Micronutrient deficiencies including iron, iodine, and vitamin A affect a significant portion of the world's population. Efforts to assess the prevalence of these deficiencies in vulnerable populations are challenging, partly due to measurement tools that are inadequate for assessing multiple micronutrients in large-scale population surveys. We have developed a 7-plex immunoassay for the simultaneous measurement of seven biomarkers relevant to assessing iodine, iron, and vitamin A status, inflammation and Plasmodium falciparum parasitemia by measuring levels of thyroglobulin, ferritin, soluble transferrin receptor, retinol binding protein 4, alpha-1-acid glycoprotein, C-reactive protein, and histidine-rich protein II. This 7-plex immunoassay technique has potential as a rapid and effective tool for use in large-scale surveys and assessments of nutrition intervention programs in low-and middle-income countries.	[Brindle, Eleanor] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Lillis, Lorraine; Barney, Rebecca; Kalnoky, Michael; Peck, Roger; Boyle, David S.] PATH, Seattle, WA 98121 USA; [Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.] Univ Calif Davis, Dept Nutr, Program Int & Community Nutr, Davis, CA 95616 USA; [Ouedraogo, Cesaire T.] Helen Keller Int, Niamey, Niger; [Stinca, Sara] Swiss Fed Inst Technol, Lab Human Nutr, Zurich, Switzerland; [Tyler, Abby; Lyman, Christopher] Quansys Biosci, Logan, UT USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich	Boyle, DS (corresponding author), PATH, Seattle, WA 98121 USA.	dboyle@path.org	Brindle, Eleanor/AAK-5028-2021	Brindle, Eleanor/0000-0002-4272-0909; Hess, Sonja/0000-0002-4661-277X	Bill and Melinda Gates Foundation [OPP1110874, OPP1154343]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for this research came from the Bill and Melinda Gates Foundation (OPP1110874 and OPP1154343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 1999, SCAND J CLIN LAB INV, V59, P77, DOI 10.1080/00365519950185788; Almekinder J, 2000, SCAND J CLIN LAB INV, V60, P199, DOI 10.1080/003655100750044848; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bresnahan KA, 2014, ADV NUTR, V5, P702, DOI 10.3945/an.114.006361; Brindle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115164; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Cermak J, 1998, EUR J HAEMATOL, V61, P210; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Cotton F, 2000, CLIN BIOCHEM, V33, P263, DOI 10.1016/S0009-9120(00)00071-0; Davies C., IMMUNOASSAY HDB ORY, P11; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Ervasti M, 2004, CLIN LAB HAEMATOL, V26, P205, DOI 10.1111/j.1365-2257.2004.00600.x; Freedman LP, 2016, BIOTECHNIQUES, V61, P16, DOI 10.2144/000114431; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hess S. Y., 2016, PUBLIC HEALTH NUTR, P1; Hikawa A, 1996, CLIN CHIM ACTA, V254, P159, DOI 10.1016/0009-8981(96)06375-9; Hix J, 2004, AM J CLIN NUTR, V79, P93; Horton R, 2008, LANCET, V371, P179, DOI 10.1016/S0140-6736(07)61869-8; ISHIKAWA K, 1982, CLIN CHIM ACTA, V123, P73, DOI 10.1016/0009-8981(82)90115-2; Larson L, 2017, AM J CLIN NUTR, V106, p390S; Ma ZF, 2014, THYROID, V24, P1195, DOI 10.1089/thy.2014.0052; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; Mei Z, 2017, AM J CLIN NUTR; Namaste SMI, 2017, AM J CLIN NUTR; NG RH, 1983, CLIN CHEM, V29, P1109; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Rohner F, 2017, AM J CLIN NUTR; Rohner F, 2014, J NUTR, V144, p1322S, DOI 10.3945/jn.113.181974; Rosales FJ, 1996, J LIPID RES, V37, P962; Rosser CJ, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-24; Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108; Stenman UH, 2001, CLIN CHEM, V47, P815; Stinca S, 2017, J CLIN ENDOCR METAB, V102, P23, DOI 10.1210/jc.2016-2829; Stinca S, 2015, THYROID, V25, P1297, DOI 10.1089/thy.2015.0428; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; Thorpe SJ, 1997, CLIN CHEM, V43, P1582; Thorpe SJ, 2010, CLIN CHEM LAB MED, V48, P815, DOI 10.1515/CCLM.2010.167; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; Tuffrey V., 2016, BMC NUTR, V2, P1, DOI [10.1186/s40795-016-0054-x, DOI 10.1186/S40795-016-0054-X]; Tuffrey V, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0045-z; Wessells KR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050430; Wessells KR, 2014, J NUTR, V144, P2050, DOI 10.3945/jn.114.200345; WHO Centers for disease control and prevention, 2007, ASS IR STAT POP; Wians FH, 2001, CLIN CHIM ACTA, V303, P75, DOI 10.1016/S0009-8981(00)00376-4; Wilson DH, 2005, CLIN CHEM, V51, P684, DOI 10.1373/clinchem.2004.042358; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	52	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185868	10.1371/journal.pone.0185868	http://dx.doi.org/10.1371/journal.pone.0185868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982133	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300078
J	Cilek, EE; Ozturk, H; Dedeoglu, BG				Cilek, Emine Ezel; Ozturk, Hakime; Dedeoglu, Bala Gur			Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines	PLOS ONE			English	Article							MICRORNA FUNCTION; METASTASIS; BIOGENESIS; WEBGESTALT; RESISTANCE; PATHWAY; DISEASE	Trastuzumab is a monoclonal antibody frequently used to prevent the progression of HER2+ breast cancers, which constitute approximately 20% of invasive breast cancers. microRNAs (miRNAs) are small, non-coding RNA molecules that are known to be involved in gene regulation. With their emerging roles in cancer, they are recently promoted as potential candidates to mediate therapeutic actions by targeting genes associated with drug response. In this study we explored miRNA-mediated regulation of trastuzumab mechanisms by identifying the important miRNAs responsible for the drug response via homogenous network analysis. Our network model enabled us to simplify the complexity of miRNA interactions by connecting them through their common pathways. We outlined the functionally relevant miRNAs by constructing pathway-based miRNA-miRNA networks in SKBR3 and BT474 cells, respectively. Identification of the most targeted genes revealed that trastuzumab responsive miRNAs favourably regulate the repression of targets with longer 3'UTR than average considered to be key elements, while the miRNA-miRNA networks highlighted central miRNAs such as hsa-miR-3976 and hsa-miR-3671 that showed strong interactions with the remaining members of the network. Furthermore, the clusters of the miRNA-miRNA networks showed that trastuzumab response was mostly established through cancer related and metabolic pathways. hsa-miR-216b was found to be the part of the most powerful interactions of metabolic pathways, which was defined in the largest clusters in both cell lines. The network based representation of miRNA-miRNA interactions through their shared pathways provided a better understanding of miRNA-mediated drug response and could be suggested for further characterization of miRNA functions.	[Cilek, Emine Ezel; Dedeoglu, Bala Gur] Ankara Univ, Biotechnol Inst, Ankara, Turkey; [Ozturk, Hakime] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey	Ankara University; Bogazici University	Dedeoglu, BG (corresponding author), Ankara Univ, Biotechnol Inst, Ankara, Turkey.	bdedeoglu@ankara.edu.tr	Dedeoglu, Bala Gur/ABC-2436-2020; Öztürk, Hakime/J-6103-2018; Dedeoglu, Bala Gur/O-1604-2014	Dedeoglu, Bala Gur/0000-0002-4320-5685; Dedeoglu, Bala Gur/0000-0002-4320-5685; Ozturk, Hakime/0000-0002-2146-5638; Cilek, Emine Ezel/0000-0002-4829-4891	Ankara University BAP [14L0415001]; L'Oreal-UNESCO Women in Science Programme; TUBITAK [BIDEB 2211]	Ankara University BAP(Ankara University); L'Oreal-UNESCO Women in Science Programme; TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study was funded by Ankara University BAP (Award no:14L0415001) (http://bap.ankara.edu.tr/); L'Oreal-UNESCO Women in Science Programme (http://www.forwomeninscience.com/en/) and it was supported by TUBITAK-BIDEB 2211 Scholarship Programme (https://www.tubitak.gov.tr/tr/burslar/).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Cao YZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/724715; Cheng C, 2009, BMC GENOMICS, V10, P6; Chu HW, 2014, HUM MOL GENET, V23, P355, DOI 10.1093/hmg/ddt426; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/nmeth.3440, 10.1038/NMETH.3440]; De Mattos-Arruda L, 2015, ONCOTARGET, P4; Gligorijevic V, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0571; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jauffret-Charafe E, 2004, GENE EXPRESSION PROF, P2273; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kao J., 2009, MOL PROFILING BREAST; Kataoka Y, 2009, ASS GAIN OF FUNCTION, P255; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li J., 2016, ASIA COMMUN PHOTONIC, P1, DOI [10.1364/ACPC.2016.AF2A.157, DOI 10.1364/ACPC.2016.AF2A.157]; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma T, 2015, ONCOL REP, V33, P1215, DOI 10.3892/or.2015.3713; Margeli M, 2014, LONG HER STUDY CLIN; Mari G, 2017, DRUG SCREENING GENOM; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Muller V, 2014, BREAST CANCER RES TR, V147, P61, DOI 10.1007/s10549-014-3079-3; Nahta Rita, 2012, ISRN Oncol, V2012, P428062, DOI 10.5402/2012/428062; Ozturk H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117874; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Parrella P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-142; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Saxena R, 2011, ERBB FAMILY RECEPTOR, P166; Scaglione KM, 2013, UBIQUITIN CONJUGATIN, P18784; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Witkos TM, 2011, CURR MOL MED, V11, P93; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Ye XM, 2014, BMB REP, V47, P268, DOI 10.5483/BMBRep.2014.47.5.165; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang JP, 2016, MOL BIOSYST, V12, P454, DOI 10.1039/c5mb00562k; Zhou JD, 2013, ONCOL REP, V30, P1275, DOI 10.3892/or.2013.2592	50	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185558	10.1371/journal.pone.0185558	http://dx.doi.org/10.1371/journal.pone.0185558			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981542	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300044
J	Concha-Marambio, L; Maldonado, P; Lagos, R; Monasterio, O; Montecinos-Franjola, F				Concha-Marambio, Luis; Maldonado, Paula; Lagos, Rosalba; Monasterio, Octavio; Montecinos-Franjola, Felipe			Thermal adaptation of mesophilic and thermophilic FtsZ assembly by modulation of the critical concentration	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; GTPASE ACTIVITY; THERMODYNAMIC ANALYSIS; STRUCTURAL INSIGHTS; NUCLEOTIDE TURNOVER; LIGHT-SCATTERING; ANTARCTIC FISHES; IN-VITRO	Cytokinesis is the last stage in the cell cycle. In prokaryotes, the protein FtsZ guides cell constriction by assembling into a contractile ring-shaped structure termed the Z-ring. Constriction of the Z-ring is driven by the GTPase activity of FtsZ that overcomes the energetic barrier between two protein conformations having different propensities to assemble into polymers. FtsZ is found in psychrophilic, mesophilic and thermophilic organisms thereby functioning at temperatures ranging from subzero to >100 degrees C. To gain insight into the functional adaptations enabling assembly of FtsZ in distinct environmental conditions, we analyzed the energetics of FtsZ function from mesophilic Escherichia coli in comparison with FtsZ from thermophilic Methanocaldococcus jannaschii. Presumably, the assembly may be similarly modulated by temperature for both FtsZ orthologs. The temperature dependence of the first-order rates of nucleotide hydrolysis and of polymer disassembly, indicated an entropy-driven destabilization of the FtsZ-GTP intermediate. This destabilization was true for both mesophilic and thermophilic FtsZ, reflecting a conserved mechanism of disassembly. From the temperature dependence of the critical concentrations for polymerization, we detected a change of opposite sign in the heat capacity, that was partially explained by the specific changes in the solvent-accessible surface area between the free and polymerized states of FtsZ. At the physiological temperature, the assembly of both FtsZ orthologs was found to be driven by a small positive entropy. In contrast, the assembly occurred with a negative enthalpy for mesophilic FtsZ and with a positive enthalpy for thermophilic FtsZ. Notably, the assembly of both FtsZ orthologs is characterized by a critical concentration of similar value (1-2 mu M) at the environmental temperatures of their host organisms. These findings suggest a simple but robust mechanism of adaptation of FtsZ, previously shown for eukaryotic tubulin, by adjustment of the critical concentration for polymerization.	[Concha-Marambio, Luis; Maldonado, Paula; Lagos, Rosalba; Monasterio, Octavio; Montecinos-Franjola, Felipe] Univ Chile, Lab Biol Estruct & Mol, Dept Biol, Fac Ciencias, Santiago, Chile; [Concha-Marambio, Luis] Ampr Inc, 11175 Flintkote Ave, San Diego, CA 92121 USA; [Maldonado, Paula] Francis Crick Inst, Lymphocyte Biol Lab, 1 Midland Rd, London NW1 1AT, England; [Montecinos-Franjola, Felipe] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Cytoskeletal Dynam, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA	Universidad de Chile; Francis Crick Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Monasterio, O; Montecinos-Franjola, F (corresponding author), Univ Chile, Lab Biol Estruct & Mol, Dept Biol, Fac Ciencias, Santiago, Chile.; Montecinos-Franjola, F (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Cytoskeletal Dynam, Div Basic & Translat Biophys, NIH, Bethesda, MD 20892 USA.	monaster@uchile.cl; felipe.montecinos@nih.gov	Montecinos, Felipe/HHS-7232-2022; Franjola, Felipe A Montecinos/R-3907-2017; Concha-Marambio, Luis/V-3247-2019	Montecinos, Felipe/0000-0002-1823-103X; Franjola, Felipe A Montecinos/0000-0002-1823-103X; Concha-Marambio, Luis/0000-0002-9454-8389	Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion; Comision Nacional de Investigacion Cientifica y Tecnologica [24090139]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130711]	Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FMF received funding from Becas Chile and Programa de Mejoramiento de la Calidad y Equidad de la Educacion, and was supported by Comision Nacional de Investigacion Cientifica y Tecnologica grant 24090139. OM received financial support from Fondo Nacional de Desarrollo Cientifico y Tecnologico grant 1130711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2002, J BIOL CHEM, V277, P43262, DOI 10.1074/jbc.M206723200; Bertrand S, 2005, J MOL BIOL, V346, P319, DOI 10.1016/j.jmb.2004.11.054; Busiek KK, 2011, MOL MICROBIOL, V82, P535, DOI 10.1111/j.1365-2958.2011.07833.x; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; CHOUDHURY GG, 1987, BIOCHEM CELL BIOL, V65, P558, DOI 10.1139/o87-072; Detrich HW, 1997, COMP BIOCHEM PHYS A, V118, P501, DOI 10.1016/S0300-9629(97)00012-1; Detrich HW, 2000, J BIOL CHEM, V275, P37038, DOI 10.1074/jbc.M005699200; Duggin IG, 2015, NATURE, V519, P362, DOI 10.1038/nature13983; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 2009, P NATL ACAD SCI USA, V106, P9238, DOI 10.1073/pnas.0902258106; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; JOHNSON KA, 1979, J MOL BIOL, V133, P199, DOI 10.1016/0022-2836(79)90530-8; KASAI M, 1969, BIOCHIM BIOPHYS ACTA, V180, P399, DOI 10.1016/0005-2728(69)90124-8; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; Lente G, 2005, NEW J CHEM, V29, P759, DOI 10.1039/b501687h; Lindas AC, 2013, NAT REV MICROBIOL, V11, P627, DOI 10.1038/nrmicro3077; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martin-Galiano AJ, 2010, J BIOL CHEM, V285, P22554, DOI 10.1074/jbc.M110.117127; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Montecinos-Franjola F, 2014, BBA-PROTEINS PROTEOM, V1844, P1193, DOI 10.1016/j.bbapap.2014.03.012; Montecinos-Franjola F, 2012, BIOPHYS J, V102, P2176, DOI 10.1016/j.bpj.2012.03.064; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 2001, J BACTERIOL, V183, P7190, DOI 10.1128/JB.183.24.7190-7197.2001; Ng KH, 2013, ARCHAEA, V2013, DOI 10.1155/2013/104147; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Nova E, 2007, ARCH BIOCHEM BIOPHYS, V465, P315, DOI 10.1016/j.abb.2007.06.032; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2014, ELS; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Sossong TM, 1999, BIOCHEMISTRY-US, V38, P14843, DOI 10.1021/bi990917e; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vulevic B, 1997, BIOPHYS J, V72, P1357, DOI 10.1016/S0006-3495(97)78782-4; WILLIAMS RC, 1985, BIOCHEMISTRY-US, V24, P2790, DOI 10.1021/bi00332a029	55	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185707	10.1371/journal.pone.0185707	http://dx.doi.org/10.1371/journal.pone.0185707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982174	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300060
J	Latham, S; Hughes, E; Budged, B; Mechinaud, F; Crock, C; Ekert, H; Campbell, P; Morley, A				Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Mechinaud, Francoise; Crock, Catherine; Ekert, Henry; Campbell, Peter; Morley, Alexander			Sources of error in measurement of minimal residual disease in childhood acute lymphoblastic leukemia	PLOS ONE			English	Article							PERIPHERAL-BLOOD; BONE-MARROW; CHILDREN; INDUCTION; THERAPY; SAMPLES	Introduction The level of minimal residual disease (MRD) in marrow predicts outcome and guides treatment in childhood acute lymphoblastic leukemia (ALL) but accurate prediction depends on accurate measurement. Methods Forty-one children with ALL were studied at the end of induction. Two samples were obtained from each iliac spine and each sample was assayed twice. Assay, sample and side-to-side variation were quantified by analysis of variance and presumptively incorrect decisions related to high-risk disease were determined using the result from each MRD assay, the mean MRD in the patient as the measure of the true value, and each of 3 different MRD cut-off levels which have been used for making decisions on treatment. Results Variation between assays, samples and sides each differed significantly from zero and the overall standard deviation for a single MRD estimation was 0.60 logs. Multifocal residual disease seemed to be at least partly responsible for the variation between samples. Decision errors occurred at a frequency of 13-14% when the mean patient MRD was between 10(-2) and 10(-5). Decision errors were observed only for an MRD result within 1 log of the cut-off value used for assessing high risk. Depending on the cut-off used, 31-40% of MRD results were within 1 log of the cut-off value and 21 -16% of such results would have resulted in a decision error. Conclusion When the result obtained for the level of MRD is within 1 log of the cut-off value used for making decisions, variation in the assay and/or sampling may result in a misleading assessment of the true level of marrow MRD. This may lead to an incorrect decision on treatment.	[Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Morley, Alexander] Flinders Univ S Australia, Dept Haematol & Genet Pathol, Bedford Pk, SA, Australia; [Latham, Sue; Hughes, Elizabeth; Budged, Bradley; Morley, Alexander] Med Ctr, Bedford Pk, SA, Australia; [Mechinaud, Francoise; Ekert, Henry] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia; [Crock, Catherine] Royal Childrens Hosp, Clin Haematol Dept, Parkville, Vic, Australia; [Campbell, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	Flinders University South Australia; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Wellcome Trust Sanger Institute	Morley, A (corresponding author), Flinders Univ S Australia, Dept Haematol & Genet Pathol, Bedford Pk, SA, Australia.; Morley, A (corresponding author), Med Ctr, Bedford Pk, SA, Australia.	alec.morley@flinders.edu.au		Budgen, Brad/0000-0001-9634-3996	Monoquant; Financial Markets for Children	Monoquant; Financial Markets for Children	The research support from Monoquant and the Financial Markets for Children involved grants to Flinders University. These grants provided support in the form of salaries for SL, EH and BB. AM, SL, EH and BB have equity in Monoquant. Neither of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baum C. F., 2006, INTRO MODERN ECONOME, p[136, 66]; Brisco MJ, 1997, BRIT J HAEMATOL, V99, P314, DOI 10.1046/j.1365-2141.1997.3723186.x; Brisco MJ, 2000, CANCER RES, V60, P5092; BRISCO MJ, 1994, LANCET, V343, P196, DOI 10.1016/S0140-6736(94)90988-1; Campbell PJ, 2003, BRIT J HAEMATOL, V122, P30, DOI 10.1046/j.1365-2141.2003.04356.x; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Coustan-Smith E, 2002, BLOOD, V100, P2399, DOI 10.1182/blood-2002-04-1130; Coustan-Smith E, 1998, LANCET, V351, P550, DOI 10.1016/S0140-6736(97)10295-1; GraphPad Software Inc, 2016, GRUBBS TEST DET OUTL; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Marchenko Y, 2006, STATA J, V6, P1; MATHE G, 1966, BMJ-BRIT MED J, V1, P640, DOI 10.1136/bmj.1.5488.640; Morley AA, 2009, J MOL DIAGN, V11, P201, DOI 10.2353/jmoldx.2009.080048; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; StataCorp, 2016, STAT STAT SOFTW REL; Sykes PJ, 1998, BRIT J HAEMATOL, V103, P60; Tukey JW, 1977, EXPLORATORY DATA ANA; van der Velden VHJ, 2006, BRIT J HAEMATOL, V133, P382, DOI 10.1111/j.1365-2141.2006.06056.x; van der Velden VHJ, 2002, LEUKEMIA, V16, P1432, DOI 10.1038/sj.leu.2402636; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6	20	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185556	10.1371/journal.pone.0185556	http://dx.doi.org/10.1371/journal.pone.0185556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973007	Green Published, gold			2022-12-27	WOS:000412131900025
J	Villalpando, DM; Rojas, MM; Garcia, HS; Ferrer, M				Villalpando, Diva M.; Rojas, Mibsam M.; Garcia, Hugo S.; Ferrer, Mercedes			Dietary docosahexaenoic acid supplementation prevents the formation of cholesterol oxidation products in arteries from orchidectomized rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; CARDIOVASCULAR-DISEASES; MESENTERIC-ARTERY; HUMAN PLASMA; ORAL SUPPLEMENTATION; DIABETES-MELLITUS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY	Testosterone deficiency has been correlated with increased cardiovascular diseases, which in turn has been associated with increased oxidative stress. Several studies have considered cholesterol oxidation products (COPs) as oxidative stress biomarkers, since some of them play pro-oxidant and pro-inflammatory roles. We have previously described the cardio-protective effects of a dosahexaenoic acid (DHA) supplemented diet on the aortic and mesenteric artery function of orchidectomized rats. The aim of this study was to investigate whether impaired gonadal function alters the formation of COPs, as well as the potential preventive role of a DHA-supplemented diet on that effect. For this purpose, aortic and mesenteric artery segments obtained from control and orchidectomized rats, fed with a standard or supplemented with DHA, were used. The content of the following COPs: 7 alpha-hydroxycholesterol, 7 beta-hydroxycholesterol, 7-ketocholesterol, 5,6 alpha-epoxycholesterol, 5,6 beta-epoxycholesterol, cholestanetriol and 25-hydroxycholesterol, were analyzed by gas chromatography. The results showed that orchidectomy increased the formation of COPs in arteries from orchidectomized rats, which may participate in the orchidectomy-induced structural and functional vascular alterations already reported. The fact that the DHA-supplemented diet prevented the orchidectomy-induced COPs increase confirms the cardiovascular protective actions of DHA, which could be of special relevance in mesenteric arterial bed, since it importantly controls the systemic vascular resistance.	[Villalpando, Diva M.; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Rojas, Mibsam M.; Garcia, Hugo S.] Inst Tecnol Veracruz, Unidad Invest & Desarrollo Alimentos, Veracruz, Mexico	Autonomous University of Madrid	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Garcia, HS (corresponding author), Inst Tecnol Veracruz, Unidad Invest & Desarrollo Alimentos, Veracruz, Mexico.	hugosgg@gmail.com; mercedes.ferrer@uam.es	Ferrer, Mercedes/E-3556-2018; Parra, Mercedes Ferrer/AAE-1746-2020; Villalpando, Diva/AAG-6337-2020	Parra, Mercedes Ferrer/0000-0002-4670-7146; 	CONACyT (Mexico); Comunidad de Madrid ("INSPIRA1-CM") [S2013/ABI 2783]; Fondo Europeo de Desarrollo Regional	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comunidad de Madrid ("INSPIRA1-CM")(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission)	This study was supported by fellowships (to DMV and to MMR) from the CONACyT (Mexico) and grants (to MF) from Comunidad de Madrid (S2013/ABI 2783, INSPIRA1-CM) and Fondo Europeo de Desarrollo Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Abo K, 2000, CLIN BIOCHEM, V33, P541, DOI 10.1016/S0009-9120(00)00167-3; Alba G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042195; Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013; Ares MPS, 2000, ATHEROSCLEROSIS, V153, P23, DOI 10.1016/S0021-9150(00)00380-4; Blanco-Rivero J, 2006, J VASC RES, V43, P101, DOI 10.1159/000089791; Blanco-Rivero J, 2005, J VASC RES, V42, P526, DOI 10.1159/000088342; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Burban M, 2016, SHOCK, V46, P549, DOI 10.1097/SHK.0000000000000624; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cao Jian, 2010, Chinese Medical Sciences Journal, V25, P44; de Medina P, 2010, P NATL ACAD SCI USA, V107, P13520, DOI 10.1073/pnas.1002922107; Debbabi M, 2017, CHEM PHYS LIPIDS; Deckert V, 2002, BRIT J PHARMACOL, V137, P655, DOI 10.1038/sj.bjp.0704920; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frenoux JMR, 2001, J NUTR, V131, P39, DOI 10.1093/jn/131.1.39; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Guardiola F, 1996, FOOD CHEM TOXICOL, V34, P193, DOI 10.1016/0278-6915(95)00094-1; Guardiola F, 2007, ANAL BIOANAL CHEM, V389, P277, DOI 10.1007/s00216-007-1413-x; Haider A, 2016, VASC HEALTH RISK MAN, V12, P251, DOI 10.2147/VHRM.S108947; Hernandez-Diaz G, 2010, PROSTAG LEUKOTR ESS, V82, P105, DOI 10.1016/j.plefa.2009.12.004; HIGLEY NA, 1984, FOOD CHEM TOXICOL, V22, P983, DOI 10.1016/0278-6915(84)90148-0; Hodis HN, 2000, HYPERTENSION, V36, P436, DOI 10.1161/01.HYP.36.3.436; Khatib S, 2014, BIOCHEM BIOPH RES CO, V446, P709, DOI 10.1016/j.bbrc.2013.12.116; Kiss L, 2006, INT J MOL MED, V18, P1113; Klapcinska B, 2008, J PHYSIOL SCI, V58, P173, DOI 10.2170/physiolsci.RP002208; Kulig W, 2016, CHEM PHYS LIPIDS, V199, P144, DOI 10.1016/j.chemphyslip.2016.03.001; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Luchetti F, 2015, STEROIDS, V99, P204, DOI 10.1016/j.steroids.2015.02.008; Ma WW, 2015, NEUROCHEM RES, V40, P758, DOI 10.1007/s11064-015-1524-2; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Menendez-Carreno M, 2008, LIPIDS, V43, P383, DOI 10.1007/s11745-008-3163-8; Menendez-Carreno M, 2012, ANAL BIOANAL CHEM, V402, P2023, DOI 10.1007/s00216-011-5432-2; Mitic T, 2013, BIOCHIMIE, V95, P548, DOI 10.1016/j.biochi.2012.08.007; Mol MJTM, 1997, ATHEROSCLEROSIS, V129, P169, DOI 10.1016/S0021-9150(96)06022-4; Molavi B, 2004, CURR OPIN CARDIOL, V19, P488, DOI 10.1097/01.hco.0000133657.77024.bd; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nishio E, 1996, BIOCHEM BIOPH RES CO, V226, P928, DOI 10.1006/bbrc.1996.1452; Nury T, 2015, STEROIDS, V99, P194, DOI 10.1016/j.steroids.2015.02.003; Ou ZJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE781, DOI 10.1152/ajpendo.00218.2016; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; PENG SK, 1979, AM J CLIN NUTR, V32, P1033, DOI 10.1093/ajcn/32.5.1033; Plasen Duangporn, 2010, J Med Assoc Thai, V93 Suppl 2, pS59; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; ROSESALLIN C, 1995, J AGR FOOD CHEM, V43, P935, DOI 10.1021/jf00052a017; Ryan E, 2005, BRIT J NUTR, V94, P443, DOI 10.1079/BJN20051500; Sagredo A, 2011, JOINT M EUR SOC MICR; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SEVANIAN A, 1986, FOOD CHEM TOXICOL, V24, P1103, DOI 10.1016/0278-6915(86)90295-4; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Song EA, 2017, INT J BIOCHEM CELL B, V88, P60, DOI 10.1016/j.biocel.2017.05.011; Soto-Rodriguez I, 2008, J FOOD COMPOS ANAL, V21, P489, DOI 10.1016/j.jfca.2008.03.008; Soto-Rodriguez I, 2012, INFLAMMATION, V35, P1302, DOI 10.1007/s10753-012-9442-9; Soto-Rodriguez I, 2009, J APPL TOXICOL, V29, P715, DOI 10.1002/jat.1463; Sottero B, 2009, CURR MED CHEM, V16, P685, DOI 10.2174/092986709787458353; Steffen Y, 2012, NITRIC OXIDE-BIOL CH, V27, P176, DOI 10.1016/j.niox.2012.06.006; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; Tesoriere L, 2015, BRIT J NUTR, V114, P368, DOI 10.1017/S0007114515002111; Testa G, 2016, REDOX BIOL, V10, P24, DOI 10.1016/j.redox.2016.09.001; Uemura M, 2002, EUR J PHARMACOL, V456, P29, DOI 10.1016/S0014-2999(02)02639-0; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; Vaya J, 2001, FREE RADICAL RES, V34, P485, DOI 10.1080/10715760100300431; Vericel E, 2015, THROMB HAEMOSTASIS, V114, P289, DOI 10.1160/TH14-12-1003; Villalpando DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168841; Villalpando DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142039; Virginio VWM, 2015, FREE RADICAL RES, V49, P199, DOI 10.3109/10715762.2014.992894; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719; Zarrouk A., 2017, CURR ALZHEIMER RES; Zarrouk A, 2015, STEROIDS, V99, P238, DOI 10.1016/j.steroids.2015.01.018; Zhang L, 2011, MOL MED REP, V4, P1183, DOI 10.3892/mmr.2011.539	79	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185805	10.1371/journal.pone.0185805	http://dx.doi.org/10.1371/journal.pone.0185805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968462	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600051
J	Bang, C; Vierbuchen, T; Gutsmann, T; Heine, H; Schmitz, RA				Bang, Corinna; Vierbuchen, Tim; Gutsmann, Thomas; Heine, Holger; Schmitz, Ruth A.			Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides	PLOS ONE			English	Article							7TH ORDER; METHANOGENIC ARCHAEON; RECOGNITION; DIVERSITY; GENOMICS; LIPIDS	The methanogenic archaeon Methanomassiliicoccus luminyensis strain B10(T) was isolated from human feces just a few years ago. Due to its remarkable metabolic properties, particularly the degradation of trimethylamines, this strain was supposed to be used as "Archaebiotic" during metabolic disorders of the human intestine. However, there is still no data published regarding adaptations to the natural habitat of M. luminyensis as it has been shown for the other two reported mucosa-associated methanoarchaea. This study aimed at unraveling susceptibility of M. luminyensis to antimicrobial peptides as well as its immunogenicity. By using the established microtiter plate assay adapted to the anaerobic growth requirements of methanogenic archaea, we demonstrated that M. luminyensis is highly sensitive against LL32, a derivative of human cathelicidin (MIC = 2 mu M). However, the strain was highly resistant against the porcine lysin NK-2 (MIC = 10 mu M) and the synthetic antilipopolysaccharide peptide (Lpep) (MIC>10 mu M) and overall differed from the two other methanoarchaea, Methanobrevibacter smithii and Methanosphaera stadtmanae in respect to AMP sensitivity. Moreover, only weak immunogenic potential of M. luminyensis was demonstrated using peripheral blood mononuclear cells (PBMCs) and monocyte-derived dendritic cells (moDCs) by determining release of pro-inflammatory cytokines. Overall, our findings clearly demonstrate that the archaeal gut inhabitant M. luminyensis is susceptible to the release of human-derived antimicrobial peptides and exhibits low immunogenicity towards human immune cells in vitro-revealing characteristics of a typical commensal gut microbe.	[Bang, Corinna; Schmitz, Ruth A.] Christian Albrechts Univ Kiel, Inst Gen Microbiol, Kiel, Germany; [Vierbuchen, Tim; Heine, Holger] German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Innate Immun, Borstel, Germany; [Gutsmann, Thomas] Res Ctr Borstel, Div Biophys, Borstel, Germany	University of Kiel; Forschungszentrum Borstel; Forschungszentrum Borstel	Schmitz, RA (corresponding author), Christian Albrechts Univ Kiel, Inst Gen Microbiol, Kiel, Germany.	rschmitz@ifam.uni-kiel.de	Vierbuchen, Tim/O-2525-2019; Heine, Holger/H-4552-2012	Vierbuchen, Tim/0000-0003-3110-4155; Heine, Holger/0000-0001-8128-5068; Bang, Corinna/0000-0001-6814-6151; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	German research foundation [SCHM1051/11-2, HH2758/4-1]	German research foundation(German Research Foundation (DFG))	CB and TV were funded by the German research foundation (www.dfg.de; SCHM1051/11-2, HH2758/4-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra J, 2007, BIOCHEM J, V406, P297, DOI 10.1042/BJ20070279; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Andra J, 2011, J BIOL CHEM, V286, P18692, DOI 10.1074/jbc.M111.226886; Bang C, 2012, ANTIMICROB AGENTS CH, V56, P4123, DOI 10.1128/AAC.00661-12; Bang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099411; Becker KW, 2016, APPL ENVIRON MICROB, V82, P4505, DOI 10.1128/AEM.00772-16; Blais-Lecours P, 2011, PLOS ONE, V6; Blais-Lecours P, 2014, PLOS ONE, V9; Borrel G, 2013, GENOME ANNOUNCEMENTS, V1; Borrel G, 2017, ISME J, V11, P2059, DOI 10.1038/ismej.2017.72; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; Borrel G, 2012, J BACTERIOL, V194, P6944, DOI 10.1128/JB.01867-12; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Brugere JF, 2014, GUT MICROBES, V5, P5, DOI 10.4161/gmic.26749; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dridi B, 2012, CLIN MICROBIOL INFEC, V18, P825, DOI 10.1111/j.1469-0691.2012.03952.x; Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0; Ehlers C, 2002, J BACTERIOL, V184, P1028, DOI 10.1128/jb.184.4.1028-1040.2002; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gutsmann T, 2001, BIOPHYS J, V80, P2935, DOI 10.1016/S0006-3495(01)76259-5; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Konig H, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P1; KONIG H, 1988, CAN J MICROBIOL, V34, P395, DOI 10.1139/m88-071; Lotz M, 2007, INT J MED MICROBIOL, V297, P379, DOI 10.1016/j.ijmm.2007.03.010; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mackay Richard J, 2011, Clin Biochem Rev, V32, P33; MILLER TL, 1985, ARCH MICROBIOL, V141, P116, DOI 10.1007/BF00423270; MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Turpin J, 1986, J Clin Apher, V3, P111, DOI 10.1002/jca.2920030207; Ulrih NP, 2009, APPL MICROBIOL BIOT, V84, P249, DOI 10.1007/s00253-009-2102-9; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	35	14	15	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185919	10.1371/journal.pone.0185919	http://dx.doi.org/10.1371/journal.pone.0185919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982164	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300086
J	Ladlow, P; Nightingale, TE; McGuigan, MP; Bennett, AN; Phillip, R; Bilzon, JLJ				Ladlow, Peter; Nightingale, Tom E.; McGuigan, M. Polly; Bennett, Alexander N.; Phillip, Rhodri; Bilzon, James L. J.			Impact of anatomical placement of an accelerometer on prediction of physical activity energy expenditure in lower-limb amputees	PLOS ONE			English	Article							HEART-RATE RESPONSE; LONG-TERM HEALTH; SELF-REPORT; PEOPLE; OUTCOMES; AMPUTATIONS; MOBILITY; ADULTS; COST	Purpose To assess the influence of the anatomical placement of a tri-axial accelerometer on the prediction of physical activity energy expenditure (PAEE) in traumatic lower-limb amputees during walking and to develop valid population-specific prediction algorithms. Methods Thirty participants, consisting of unilateral (n = 10), and bilateral (n = 10) amputees, and non-injured controls (n = 10) volunteered to complete eight activities; resting in a supine position, walking on a flat (0.48, 0.67, 0.89, 1.12, 1.34 m.s(-1)) and an inclined (3 and 5% gradient at 0.89 m.s(-1)) treadmill. During each task, expired gases were collected and an Actigraph GT3X+ accelerometer was worn on the right hip, left hip and lumbar spine. Linear regression analyses were conducted between outputs from each accelerometer site and criterion PAEE (indirect calorimetry). Mean bias +/- 95% limits of agreement were calculated. Additional covariates were incorporated to assess whether they improved the prediction accuracy of regression models. Subsequent mean absolute error statistics were calculated for the derived models at all sites using a leave-one out cross-validation analysis. Results Predicted PAEE at each anatomical location was significantly (P<0.01) correlated with criterion PAEE (P<0.01). Wearing the GT3X+ on the shortest residual limb demonstrates the strongest correlation (unilateral; r = 0.86, bilateral; r = 0.94), smallest +/- 95% limits of agreement (unilateral; +/- 2.15, bilateral +/- 1.99 kcal.min(-1)) and least absolute percentage error (unilateral; 22 +/- 17%, bilateral 17 +/- 14%) to criterion PAEE. Conclusions We have developed accurate PAEE population specific prediction models in lower-limb amputees using an ActiGraph GT3X+ accelerometer. Of the 3 anatomical locations considered, wearing the accelerometer on the side of the shortest residual limb provides the most accurate prediction of PAEE with the least error in unilateral and bilateral traumatic lower-limb amputees.	[Ladlow, Peter; Nightingale, Tom E.; McGuigan, M. Polly; Bilzon, James L. J.] Univ Bath, Dept Hlth, Bath, Avon, England; [Ladlow, Peter; Bennett, Alexander N.; Phillip, Rhodri] Def Med Rehabil Ctr DMRC Headley Court, Acad Dept Mil Rehabil, Surrey, England; [Phillip, Rhodri] Imperial Coll London, Heart & Lung Inst, Fac Med, London, England	University of Bath; Imperial College London	Bilzon, JLJ (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	J.Bilzon@Bath.ac.uk	Nightingale, Tom E/Q-8525-2019	Nightingale, Tom E/0000-0003-2947-4931; Ladlow, Peter/0000-0002-9891-9714; Bilzon, James/0000-0002-6701-7603	EPSRC [EP/M023281/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M023281/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bussmann HBJ, 1998, PHYS THER, V78, P989, DOI 10.1093/ptj/78.9.989; Bussmann JB, 2004, ARCH PHYS MED REHAB, V85, P240, DOI 10.1016/S0003-9993(03)00485-4; Bussmann JBJ, 2001, BEHAV RES METH INS C, V33, P349, DOI 10.3758/BF03195388; Bussmann JB, 2008, ARCH PHYS MED REHAB, V89, P430, DOI 10.1016/j.apmr.2007.11.012; Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Czerniecki JM, 2017, DISABIL REHABIL, V39, P143, DOI 10.3109/09638288.2015.1095948; Foote CE, 2015, QUAL LIFE RES, V24, P2853, DOI 10.1007/s11136-015-1029-0; Gaunaurd IA, 2013, J REHABIL RES DEV, V50, P969, DOI 10.1682/JRRD.2013.02.0035; Hale LA, 2008, ARCH PHYS MED REHAB, V89, P1765, DOI 10.1016/j.apmr.2008.02.027; Hastie Y., 2009, ELEMENTS STAT LEARNI; Intille SS, 2012, MED SCI SPORT EXER, V44, pS24, DOI 10.1249/MSS.0b013e3182399c7d; Jarvis HL, 2017, ARCH PHYS MED REHAB, V98, P1389, DOI 10.1016/j.apmr.2016.09.134; Ladlow P, 2016, J BONE JOINT SURG AM, V98, P1996, DOI 10.2106/JBJS.15.01210; Ladlow P, 2015, ARCH PHYS MED REHAB, V96, P2048, DOI 10.1016/j.apmr.2015.07.016; Lyden K, 2011, EUR J APPL PHYSIOL, V111, P187, DOI 10.1007/s00421-010-1639-8; Miller WC, 2001, ARCH PHYS MED REHAB, V82, P1432, DOI 10.1053/apmr.2001.25987; Nightingale T E, 2015, BMJ Open Sport Exerc Med, V1; Nightingale TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126086; Nightingale TE, 2014, MED SCI SPORT EXER, V46, P1849, DOI 10.1249/MSS.0000000000000291; Parker K, 2010, ARCH PHYS MED REHAB, V91, P543, DOI 10.1016/j.apmr.2009.12.009; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Robbins CB, 2009, MIL MED, V174, P588, DOI 10.7205/MILMED-D-00-0608; Sagawa Y, 2011, GAIT POSTURE, V33, P511, DOI 10.1016/j.gaitpost.2011.02.003; Stepien JM, 2007, ARCH PHYS MED REHAB, V88, P896, DOI 10.1016/j.apmr.2007.03.016; Stewart IJ, 2015, CIRCULATION, V132, P2126, DOI 10.1161/CIRCULATIONAHA.115.016950; Su PF, 2007, J REHABIL RES DEV, V44, P491, DOI 10.1682/JRRD.2006.10.0135; Traballesi M, 2008, GAIT POSTURE, V27, P70, DOI 10.1016/j.gaitpost.2007.01.006; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	33	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185731	10.1371/journal.pone.0185731	http://dx.doi.org/10.1371/journal.pone.0185731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982199	gold, Green Submitted, Green Published			2022-12-27	WOS:000412360300062
J	Mantovani, A; Rigolon, R; Pichiri, I; Bonapace, S; Morani, G; Zoppini, G; Bonora, E; Targher, G				Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Bonapace, Stefano; Morani, Giovanni; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni			Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus	PLOS ONE			English	Article							PROLONGED PR INTERVAL; CARDIOVASCULAR-DISEASE; PREVALENCE; DYSFUNCTION; OUTCOMES	Recent studies suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiac tachyarrhythmias (mainly atrial fibrillation) in patients with and without type 2 diabetes mellitus. The aim of this study was to examine whether an association also exists between NAFLD and heart block. We have retrospectively evaluated a hospital-based cohort of 751 patients with type 2 diabetes discharged from our Division of Diabetes and Endocrinology during years 2007-2014. Standard electrocardiograms were performed on all patients. Diagnosis of NAFLD was based on ultrasonography, whereas the severity of advanced hepatic fibrosis was based on the fibrosis (FIB)-4 score and other non-invasive fibrosis markers. Overall, 524 (69.8%) patients had NAFLD and 202 (26.9%) had heart block (defined as at least one block among first-degree atrio-ventricular block, second-degree block, third-degree block, left bundle branch block, right bundle branch block, left anterior hemi-block or left posterior hemi-block) on electrocardiograms. Patients with NAFLD had a remarkably higher prevalence of any persistent heart block than those without NAFLD (31.3% vs. 16.7%, p<0.001); this prevalence was particularly increased among those with higher FIB-4 score. NAFLD was associated with a threefold increased risk of prevalent heart block (adjusted-odds ratio 3.04, 95% CI 1.81-5.10), independently of age, sex, hypertension, prior ischemic heart disease, hemoglobin A1c, microvascular complication status, use of medications and other potentially confounding factors. In conclusion, this is the largest cross-sectional study to show that NAFLD and its severity are independently associated with an increased risk of prevalent heart block in hospitalized patients with type 2 diabetes.	[Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Mantovani, Alessandro; Rigolon, Riccardo; Pichiri, Isabella; Zoppini, Giacomo; Bonora, Enzo; Targher, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy; [Bonapace, Stefano] Sacro Cuore Hosp, Div Cardiol, Verona, Italy; [Morani, Giovanni] Univ Verona, Dept Med, Sect Cardiol, Verona, Italy; [Morani, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Targher, G (corresponding author), Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.; Targher, G (corresponding author), Azienda Osped Univ Integrata Verona, Verona, Italy.	giovanni.targher@univr.it	Bonora, Enzo/AAA-5300-2022; Mantovani, Alessandro/AAB-9015-2019; zoppini, giacomo/AAA-9000-2022; Targher, Giovanni/AAB-9008-2019; Morani, Giovanni/AAX-7857-2020	Mantovani, Alessandro/0000-0002-7271-6329; zoppini, giacomo/0000-0003-1085-554X; Targher, Giovanni/0000-0002-4325-3900; Bonapace, Stefano/0000-0001-9122-2642				Adams LA, 2017, GUT, V66, P1138, DOI 10.1136/gutjnl-2017-313884; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Bussink BE, 2013, EUR HEART J, V34, P138, DOI 10.1093/eurheartj/ehs291; Byrne CD, 2016, GASTROENTEROLOGY, V150, P7, DOI 10.1053/j.gastro.2015.11.016; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Coumbe AG, 2013, HEART, V99, P334, DOI 10.1136/heartjnl-2012-302770; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hung CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001820; Karajamaki AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142937; Kuehl M, 2012, NAT REV ENDOCRINOL, V8, P405, DOI 10.1038/nrendo.2012.21; Kwok CS, 2016, HEART, V102, P672, DOI 10.1136/heartjnl-2015-308956; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061803; Lonardo A, 2016, METABOLISM, V65, P1136, DOI 10.1016/j.metabol.2015.09.017; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Mangi MA, 2017, CUREUS, V9, DOI 10.7759/cureus.1107; Mantovani A, 2016, DIABETES CARE, V39, P1416, DOI 10.2337/dc16-0091; Mantovani A, 2016, DIGEST DIS SCI, V61, P1246, DOI 10.1007/s10620-016-4040-6; Mantovani A, 2015, METABOLISM, V64, P879, DOI 10.1016/j.metabol.2015.04.003; Marchesini G, 2016, J HEPATOL, V64, P1388, DOI 10.1016/j.jhep.2015.11.004; McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Pokorney SD, 2016, AM HEART J, V171, P25, DOI 10.1016/j.ahj.2015.09.004; Prineas RJ, 2010, MINNESOTA CODE MANUA; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Targher G, 2014, NUTR METAB CARDIOVAS, V24, P663, DOI 10.1016/j.numecd.2014.01.005; Targher G, 2013, CLIN SCI, V125, P301, DOI 10.1042/CS20130036; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2012, DIABETES CARE, V35, P2347, DOI 10.2337/dc12-0259; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; VanWagner LB, 2015, HEPATOLOGY, V62, P773, DOI 10.1002/hep.27869; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185459	10.1371/journal.pone.0185459	http://dx.doi.org/10.1371/journal.pone.0185459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981521	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300040
J	Reber, LL; Starkl, P; Balbino, B; Sibilano, R; Gaudenzio, N; Rogalla, S; Sensarn, S; Kang, DM; Raghu, H; Sokolove, J; Robinson, WH; Contag, CH; Tsai, M; Galli, SJ				Reber, Laurent L.; Starkl, Philipp; Balbino, Bianca; Sibilano, Riccardo; Gaudenzio, Nicolas; Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Raghu, Harini; Sokolove, Jeremy; Robinson, William H.; Contag, Christopher H.; Tsai, Mindy; Galli, Stephen J.			The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; RHEUMATOID-ARTHRITIS; IN-VIVO; MANAGEMENT; EFFICACY; STI571	Gouty arthritis is caused by the deposition of monosodium urate (MSU) crystals in joints. Despite many treatment options for gout, there is a substantial need for alternative treatments for patients unresponsive to current therapies. Tyrosine kinase inhibitors have demonstrated therapeutic benefit in experimental models of antibody-dependent arthritis and in rheumatoid arthritis in humans, but to date, the potential effects of such inhibitors on gouty arthritis has not been evaluated. Here we demonstrate that treatment with the tyrosine kinase inhibitor imatinib mesylate (imatinib) can suppress inflammation induced by injection of MSU crystals into subcutaneous air pouches or into the ankle joint of wild type mice. Moreover, imatinib treatment also largely abolished the lower levels of inflammation which developed in IL-1R1(-/-) or Kit(W-sh/W-sh) mice, indicating that this drug can inhibit IL-1-independent pathways, as well as mast cell-independent pathways, contributing to pathology in this model. Imatinib treatment not only prevented ankle swelling and synovial inflammation when administered before MSU crystals but also diminished these features when administrated after the injection of MSU crystals, a therapeutic protocol more closely mimicking the clinical situation in which treatment occurs after the development of an acute gout flare. Finally, we also assessed the efficiency of local intra-articular injections of imatinib-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles in this model of acute gout. Treatment with low doses of this long-acting imatinib: PLGA formulation was able to reduce ankle swelling in a therapeutic protocol. Altogether, these results raise the possibility that tyrosine kinase inhibitors might have utility in the treatment of acute gout in humans.	[Reber, Laurent L.; Starkl, Philipp; Sibilano, Riccardo; Gaudenzio, Nicolas; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Reber, Laurent L.; Starkl, Philipp; Sibilano, Riccardo; Gaudenzio, Nicolas; Tsai, Mindy; Galli, Stephen J.] Stanford Univ, Sch Med, Sean N Parker Ctr Allergy Res, Stanford, CA 94305 USA; [Reber, Laurent L.; Balbino, Bianca] Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France; [Reber, Laurent L.; Balbino, Bianca] INSERM, Paris, France; [Balbino, Bianca] Univ Paris 06, Paris, France; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Bioengn, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Radiol, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford Univ, Sch Med, Div Neonatol, Dept Pediat, Stanford, CA 94305 USA; [Rogalla, Stephan; Sensarn, Steven; Kang, Dongmin; Contag, Christopher H.] Stanford, Mol Imaging Program, Stanford, CA USA; [Kang, Dongmin] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Raghu, Harini; Sokolove, Jeremy; Robinson, William H.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Raghu, Harini; Sokolove, Jeremy; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA USA; [Contag, Christopher H.; Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Starkl, Philipp] Austrian Acad Sci, Res Ctr Mol Med, CeMM, Vienna, Austria; [Starkl, Philipp] Med Univ Vienna, Dept Med 1, Res Lab Infect Biol, Vienna, Austria; [Gaudenzio, Nicolas] Univ Toulouse, INSERM, UDEAR, UMR 1056, Toulouse, France	Stanford University; Stanford University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University; Stanford University; Stanford University; Ewha Womans University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Reber, LL; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Reber, LL; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Sean N Parker Ctr Allergy Res, Stanford, CA 94305 USA.; Reber, LL (corresponding author), Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France.; Reber, LL (corresponding author), INSERM, Paris, France.; Galli, SJ (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	laurent.reber@pasteur.fr; sgalli@stanford.edu	Reber, Laurent L/K-4148-2014	Reber, Laurent L/0000-0003-3384-6769; Starkl, Philipp/0000-0001-7521-129X; Tsai, Mindy/0000-0002-8421-4721; Kang, Dongmin/0000-0001-5997-625X; Gaudenzio, Nicolas/0000-0002-5648-509X; Robinson, William/0000-0003-4385-704X; Contag, Christopher/0000-0002-1011-8278	Arthritis National Research Foundation (ANRF), National Institutes of Health [K99 AI110645]; European Commission [H2020-MSCA-IF-2014 656086]; Institut National de la Sante et de Ia Recherche Medicale (INSERM); Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund (FWF) [J3399-B21]; Pasteur - Paris University (PPU) International Ph.D. Program; Lucile Packard Foundation for Children's Health; Stanford NIH/NCRR CTSA award [UL1 RR025744]; French "Fondation pour la Recherche Medicale FRM"; George Will Foundation; Chambers Family Foundation Fund for Excellence in Pediatric Research; Child Health Research Institute at Stanford; National Institutes of Health [U19 AI104209, NS 080062, R01 AR067145]; Department of Pathology, Stanford University School of Medicine	Arthritis National Research Foundation (ANRF), National Institutes of Health; European Commission(European CommissionEuropean Commission Joint Research Centre); Institut National de la Sante et de Ia Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Max Kade Fellowship of the Max Kade Foundation; Austrian Academy of Sciences; Schroedinger Fellowship of the Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Pasteur - Paris University (PPU) International Ph.D. Program; Lucile Packard Foundation for Children's Health; Stanford NIH/NCRR CTSA award; French "Fondation pour la Recherche Medicale FRM"(Fondation pour la Recherche Medicale); George Will Foundation; Chambers Family Foundation Fund for Excellence in Pediatric Research; Child Health Research Institute at Stanford; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, Stanford University School of Medicine	L.L.R. acknowledges support from the Arthritis National Research Foundation (ANRF), National Institutes of Health grant K99 AI110645, the European Commission (Marie Skfodowska-Curie Individual Fellowship H2020-MSCA-IF-2014 656086) and the Institut National de la Sante et de Ia Recherche Medicale (INSERM); P.S. was supported by a Max Kade Fellowship of the Max Kade Foundation and the Austrian Academy of Sciences and a Schroedinger Fellowship of the Austrian Science Fund (FWF): J3399-B21; B.B. was supported by a stipend from the Pasteur - Paris University (PPU) International Ph.D. Program; R.S. was supported by the Lucile Packard Foundation for Children's Health and the Stanford NIH/NCRR CTSA award number UL1 RR025744; N.G. was the recipient of a fellowship from the French "Fondation pour la Recherche Medicale FRM"; S.R. was supported in part by the George Will Foundation; C.H.C. acknowledges the Chambers Family Foundation Fund for Excellence in Pediatric Research, and the Child Health Research Institute at Stanford for their generous support; S.J.G. acknowledges support from National Institutes of Health grants U19 AI104209, NS 080062, and R01 AR067145 and the Department of Pathology, Stanford University School of Medicine.	Breccia M, 2013, LEUKEMIA RES, V37, P713, DOI 10.1016/j.leukres.2013.01.021; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Committee FA, 2011, SUMM MIN ARTHR ADV C, V21, P2011; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eklund KK, 2003, ANN MED, V35, P362, DOI 10.1080/07853890310001339; Fels E, 2008, CURR OPIN RHEUMATOL, V20, P198, DOI 10.1097/BOR.0b013e3282f4eff5; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Higaki M, 2005, ANN RHEUM DIS, V64, P1132, DOI 10.1136/ard.2004.030759; Juurikivi A, 2005, ANN RHEUM DIS, V64, P1126, DOI 10.1136/ard.2004.029835; Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mitroulis I, 2013, SEMIN IMMUNOPATHOL, V35, P501, DOI 10.1007/s00281-013-0361-0; Miyachi K, 2003, CLIN RHEUMATOL, V22, P329, DOI 10.1007/s10067-003-0716-3; Paniagua RT, 2006, J CLIN INVEST, V116, P2633, DOI 10.1172/JCI28546; Reber LL, 2014, ARTHRITIS RHEUMATOL, V66, P2881, DOI 10.1002/art.38747; Schlesinger N, 2011, DRUGS, V71, P1413, DOI 10.2165/11592290-000000000-00000; SIMKIN PA, 1994, J RHEUMATOL, V21, P2320; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; Wolff NC, 2004, CLIN CANCER RES, V10, P3528, DOI 10.1158/1078-0432.CCR-0957-03; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	23	8	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185704	10.1371/journal.pone.0185704	http://dx.doi.org/10.1371/journal.pone.0185704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982129	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300059
J	Hsu, AP; Tseng, CH; Barrat, J; Lee, SH; Shih, YH; Wasniewski, M; Mahl, P; Chang, CC; Lin, CT; Chen, RS; Tu, WJ; Cliquet, F; Tsai, HJ				Hsu, Ai-Ping; Tseng, Chun-Hsien; Barrat, Jacques; Lee, Shu-Hwae; Shih, Yu-Hua; Wasniewski, Marine; Mahl, Philippe; Chang, Chia-Chia; Lin, Chun-Ta; Chen, Re-Shang; Tu, Wen-Jane; Cliquet, Florence; Tsai, Hsiang-Jung			Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers	PLOS ONE			English	Article							FOXES VULPES-VULPES; RED FOX; VIRUS; DOGS; IMMUNIZATION	Since 2013, rabies cases have been reported among Formosan ferret badgers in Taiwan, and they have been shown to be the major reservoirs for Taiwanese enzootics. To control and eradicate rabies, the authorities plan to implement a vaccination programme. Before distributing live vaccines in the field, this study assessed the safety, efficacy, and immunogenicity of SAG2 vaccine on ferret badgers by direct oral instillation. After application of 10(9) TCID50/dose, no virus was excreted into the oral cavity 1-7 days post-application, and safety was also satisfactorily verified over a 266-day period. Moreover, despite the low level of rabies virus neutralising antibodies induced after vaccination of a 10(8) TCID50/dose, the efficacy assessment revealed a 100% survival rate (15/15) of vaccinees and an 87.5% fatality rate (7/8) in control animals after a challenge on the 198th day post-vaccination. The immunisation and protection rates obtained more than 6 months after a single vaccination dose demonstrated that SAG2 is an ideal vaccine candidate to protect Formosan ferret badgers against rabies in Taiwan.	[Hsu, Ai-Ping; Tseng, Chun-Hsien; Shih, Yu-Hua; Chen, Re-Shang; Tu, Wen-Jane] Council Agr, Anim Hlth Res Inst, Div Biol, New Taipei, Taiwan; [Hsu, Ai-Ping; Shih, Yu-Hua; Tsai, Hsiang-Jung] Natl Taiwan Univ, Grad Inst Vet Med, Sch Vet Med, Taipei, Taiwan; [Barrat, Jacques; Wasniewski, Marine; Cliquet, Florence] French Agcy Food Environm & Occupat Hlth & Safety, Nancy OIE WHO EU Lab Rabies & Wildlife, Technopole Agr & Vet, Domaine De Pixerecourt, Malzeville, France; [Lee, Shu-Hwae; Chang, Chia-Chia; Lin, Chun-Ta] Council Agr, Anim Hlth Res Inst, Anim Drugs Inspect Branch, Gongguan Township, Miaoli County, Taiwan; [Mahl, Philippe] VIRBAC Labs, Carros, France; [Tsai, Hsiang-Jung] Natl Taiwan Univ, Sch Vet Med, Zoonoses Res Ctr, Taipei, Taiwan	National Taiwan University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Grad Inst Vet Med, Sch Vet Med, Taipei, Taiwan.; Cliquet, F (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Nancy OIE WHO EU Lab Rabies & Wildlife, Technopole Agr & Vet, Domaine De Pixerecourt, Malzeville, France.; Tsai, HJ (corresponding author), Natl Taiwan Univ, Sch Vet Med, Zoonoses Res Ctr, Taipei, Taiwan.	florence.cliquet@anses.fr; tsaihj@ntu.edu.tw	WASNIEWSKI, Marine/AAX-8945-2020	CLIQUET, Florence/0000-0003-2237-1243	Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan;  [MOST 103-3114-Y-518-001];  [MOST 104-3114-Y518-002];  [1052101011001-10100562]	Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan; ; ; 	The grants for this study were provided by Bureau of Animal and Plant Health Inspection and Quarantine, Council of Agriculture, Taiwan (https://www.baphiq.gov.tw/en/). The authors received the grants were respectively HT (grant No. MOST 103-3114-Y-518-001), CT (grant No. MOST 104-3114-Y518-002 and grant No. 1052101011001-10100562). VIRBAC Laboratories provided support in the form of salaries for author [PM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Artois M, 1997, VET REC, V140, P57, DOI 10.1136/vr.140.3.57; Bingham J, 1999, VACCINE, V17, P551, DOI 10.1016/S0264-410X(98)00233-3; Bingham J, 1997, VACCINE, V15, P937, DOI 10.1016/S0264-410X(97)00009-1; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Bureau of Animal and Plant Health Inspection and Quarantine, 2016, TAIW RES RAB EPID SU; Cliquet F, 2008, DEV BIOLOGICALS, V131, P257; Cliquet F, 2007, VACCINE, V25, P3409, DOI 10.1016/j.vaccine.2006.12.054; Cliquet F, 2006, VACCINE, V24, P4386, DOI 10.1016/j.vaccine.2006.02.057; Cliquet F, 2000, VACCINE, V18, P3272, DOI 10.1016/S0264-410X(00)00127-4; Cliquet F, 2004, DEV BIOLOGICALS, V119, P185; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Cliquet F, 2014, EXPERT REV ANTI-INFE, V12, P905, DOI 10.1586/14787210.2014.921570; Dean D.J., 1996, LAB TECHNIQUES RABIE, P83; Dyer JL, 2014, JAVMA-J AM VET MED A, V245, P1111, DOI 10.2460/javma.245.10.1111; European Medicines Agency, 2004, RAB SAG2 EUR PUBL AS; Follmann EH, 2004, J WILDLIFE DIS, V40, P328, DOI 10.7589/0090-3558-40.2.328; Franka R, 2013, ANTIVIR RES, V100, P220, DOI 10.1016/j.antiviral.2013.07.004; Gong ZY, 2004, CHIN J VECTOR BIO CO, V15, P59; Hammami S, 1999, VET RES, V30, P353; Hanlon CA, 2002, J WILDLIFE DIS, V38, P420, DOI 10.7589/0090-3558-38.2.420; Hanlon CA, 1998, J WILDLIFE DIS, V34, P228, DOI 10.7589/0090-3558-34.2.228; Hsu Yung-Hsiang, 2006, Kaohsiung Journal of Medical Sciences, V22, P94, DOI 10.1016/S1607-551X(09)70227-X; Hu RL, 2008, EPIDEMIOL INFECT, V136, P1556, DOI 10.1017/S0950268807000131; Huang ASE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132160; LAFAY F, 1994, VACCINE, V12, P317, DOI 10.1016/0264-410X(94)90095-7; Lambot M, 2001, VACCINE, V19, P1827, DOI 10.1016/S0264-410X(00)00321-2; Mahl P, 2014, VET RES, V45, DOI 10.1186/s13567-014-0077-8; Menezes R, 2008, CAN MED ASSOC J, V178, P564, DOI 10.1503/cmaj.071488; Muller T, 2012, RABIES CONTROL SUSTA, P31; OIE (Office International des Epizooties/World Organization for Animal Health), 2004, MANUAL DIAGNOSTIC TE; Orciari LA, 2001, VACCINE, V19, P4511, DOI 10.1016/S0264-410X(01)00186-4; Robardet E, 2012, J WILDLIFE DIS, V48, P858, DOI 10.7589/2011-07-205; SCHUMACHER CL, 1993, ONDERSTEPOORT J VET, V60, P459; Vigilato MAN, 2013, EMERG INFECT DIS, V19, P678, DOI 10.3201/eid1904.121482; Webster W. A., 1996, P96; Weng HY, 2010, VET RES, V41, DOI 10.1051/vetres/2009059; WHO, 1992, WHO EXP COMM RAB 8 R; World Health Organization, 2013, WHO EXP CONS RAB 2 R; World Health Organization, 2005, WHO EXP CONS RAB 1 R; World Organization for Animal Health, 2013, HAB CHIN TAIP WEEKL; Yakobson B, 1999, 10 ANN RAB AM M SAN; Zhao JH, 2014, J WILDLIFE DIS, V50, P374, DOI 10.7589/2013-01-020	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184831	10.1371/journal.pone.0184831	http://dx.doi.org/10.1371/journal.pone.0184831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977009	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100013
J	Liu, GS; Bratton, BP; Gital, Z; Shaevitz, JW				Liu, George S.; Bratton, Benjamin P.; Gital, Zemer; Shaevitz, Joshua W.			The effect of antibiotics on protein diffusion in the Escherichia coli cytoplasmic membrane	PLOS ONE			English	Article							PENICILLIN-BINDING-PROTEINS; IN-VIVO; MREB; TRANSPORT; MOBILITY	Accumulating evidence suggests that molecular motors contribute to the apparent diffusion of molecules in cells. However, current literature lacks evidence for an active process that drives diffusive-like motion in the bacterial membrane. One possible mechanism is cell wall synthesis, which involves the movement of protein complexes in the cell membrane circumferentially around the cell envelope and may generate currents in the lipid bilayer that advectively transport other transmembrane proteins. We test this hypothesis in Escherichia coli using drug treatments that slow cell wall synthesis and measure their effect on the diffusion of the transmembrane protein mannitol permease using fluorescence recovery after photobleaching. We found no clear decrease in diffusion in response to vancomycin and no decrease in response to mecillinam treatment. These results suggest that cell wall synthesis is not an active contributor to mobility in the cytoplasmic membrane.	[Liu, George S.; Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Bratton, Benjamin P.; Gital, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ USA; [Liu, George S.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Princeton University; Princeton University; Princeton University; Stanford University	Liu, GS; Shaevitz, JW (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.; Shaevitz, JW (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Liu, GS (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	gliu2@stanford.edu; shaevitz@princeton.edu	Bratton, Benjamin/AAB-9189-2021	Bratton, Benjamin/0000-0003-1128-2560; Liu, George/0000-0002-2066-5734	National Science Foundation, an NIH [CAREER PHY-844466, P50 GM071508]; Glenn Centers for Aging Research; Princeton University Department of Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP1AI124669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107384] Funding Source: NIH RePORTER	National Science Foundation, an NIH; Glenn Centers for Aging Research; Princeton University Department of Physics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Science Foundation (www.nsf.gov) CAREER PHY-844466 toJ WS (J.W.S.,B.P.B.), an NIH grant (P50 GM071508) (B.P.B.), the Glenn Centers for Aging Research (B.P.B.), and a Treiman Fellowship from the Princeton University Department of Physics (G.S.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean GJ, 2009, BIOCHEMISTRY-US, V48, P4852, DOI 10.1021/bi900014d; Brangwynne CP, 2009, TRENDS CELL BIOL, V19, P423, DOI 10.1016/j.tcb.2009.04.004; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bratton BP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134616; Caspi A, 2000, PHYS REV LETT, V85, P5655, DOI 10.1103/PhysRevLett.85.5655; DELAROSA EJ, 1985, P NATL ACAD SCI USA, V82, P5632; DiezGonzalez F, 1997, FEMS MICROBIOL LETT, V151, P71, DOI 10.1111/j.1574-6968.1997.tb10396.x; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Elowitz MB, 1999, COLI J BACTERIOL, V181; Fakhri N, 2014, SCIENCE, V344, P1031, DOI 10.1126/science.1250170; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; HATFIELD D, 1969, J BACTERIOL, V98, P559, DOI 10.1128/JB.98.2.559-567.1969; Javer A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4854; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; KOCH AL, 1955, J BIOL CHEM, V217, P947; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lin CP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11814; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; NOGUCHI H, 1979, EUR J BIOCHEM, V100, P41, DOI 10.1111/j.1432-1033.1979.tb02031.x; Oswald F, 2016, BIOPHYS J, V110, P1139, DOI 10.1016/j.bpj.2016.01.010; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; SAMPSON BA, 1989, GENETICS, V122, P491; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185	34	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185810	10.1371/journal.pone.0185810	http://dx.doi.org/10.1371/journal.pone.0185810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977034	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100047
J	Michael, B; Howard, M				Michael, Brendan; Howard, Matthew			Activity recognition with wearable sensors on loose clothing	PLOS ONE			English	Article							MOTION; GAIT	Observing human motion in natural everyday environments (such as the home), has evoked a growing interest in the development of on-body wearable sensing technology. However, wearable sensors suffer from motion artefacts introduced by the non-rigid attachment of sensors to the body, and the prevailing view is that it is necessary to eliminate these artefacts. This paper presents findings that suggest that these artefacts can, in fact, be used to distinguish between similar motions, by exploiting additional information provided by the fabric motion. An experimental study is presented whereby factors of both the motion and the properties of the fabric are analysed in the context of motion similarity. It is seen that while standard rigidly attached sensors have difficultly in distinguishing between similar motions, sensors mounted onto fabric exhibit significant differences (p < 0.01). An evaluation of the physical properties of the fabric shows that the stiffness of the material plays a role in this, with a trade-off between additional information and extraneous motion. This effect is evaluated in an online motion classification task, and the use of fabric-mounted sensors demonstrates an increase in prediction accuracy over rigidly attached sensors.	[Michael, Brendan; Howard, Matthew] Kings Coll London, Dept Informat, London, England	University of London; King's College London	Michael, B (corresponding author), Kings Coll London, Dept Informat, London, England.	brendan.michael@kcl.ac.uk		Michael, Brendan/0000-0002-5631-9913; Howard, Matthew/0000-0003-2534-4865	King's College London	King's College London	Open access for this article was funded by King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Open access for this article was funded by King's College London.	Alper SE, 2005, J MICROELECTROMECH S, V14, P707, DOI 10.1109/JMEMS.2005.845400; Andersen LL, 2010, PHYS THER, V90, P538, DOI 10.2522/ptj.20090167; Attal F, 2015, SENSORS-BASEL, V15, P31314, DOI 10.3390/s151229858; Banaee H, 2013, SENSORS-BASEL, V13, P17472, DOI 10.3390/s131217472; Bonmassar G, 2002, NEUROIMAGE, V16, P1127, DOI 10.1006/nimg.2002.1125; Chen F, 2016, TEXT RES J; Cooper S., 2016, STAGING DANCE; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; Deyle TJ, 2005, LOW COST INERTIAL ME; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Galar M, 2011, PATTERN RECOGN, V44, P1761, DOI 10.1016/j.patcog.2011.01.017; Gillette R., 2015, P 14 ACM SIGGRAPHEUR, P17, DOI [10.1145/2786784.2786789, DOI 10.1145/2786784.2786789]; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Helmich RC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0378-8; InvenSense, 2013, MPU 6500 PROD SPEC; James J., 2006, P 14 ACM INT C MULT, P470; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kaldor JM, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778842; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Li L., 2009, TEXTILE RES J; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Mandel MI, 2005, P INT SOC MUS INF RE, V2005, P594; Michael B, 2015, NEURAL SYSTEMS REHAB, P1; Minton SC, 2007, HUMAN KINETICS; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Peng C., 2016, INTELL SYST TECHNOL, V8, P30, DOI [10.1145/2972957, DOI 10.1145/2972957]; Roetenberg Daniel, 2009, 1 XSENS MOT TECHN BV, V1, P1; Singh G, 2016, IEEE SENS J, V16, P2666, DOI 10.1109/JSEN.2015.2491225; Slyper R., 2008, P 2008 ACM SIGGRAPHE, P193, DOI DOI 10.2312/SCA/SCA08/193-199; Subasi A, 2013, COMPUT BIOL MED, V43, P576, DOI 10.1016/j.compbiomed.2013.01.020; Such O, 2007, P ANN INT IEEE EMBS, P1542, DOI 10.1109/IEMBS.2007.4352597; Tang M, 2016, COMPUT GRAPH FORUM, V35, P511, DOI 10.1111/cgf.12851; Watanabe K, 2009, IEEE SENS J, V9, P1847, DOI 10.1109/JSEN.2009.2030987; Wright JR, 2012, TEXT RES J, V82, P645, DOI 10.1177/0040517512436824; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	36	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184642	10.1371/journal.pone.0184642	http://dx.doi.org/10.1371/journal.pone.0184642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976978	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100008
J	Casuso, RA; Plaza-Diaz, J; Ruiz-Ojeda, FJ; Aragon-Vela, J; Robles-Sanchez, C; Nordsborg, NB; Hebberecht, M; Salmeron, LM; Huertas, JR				Casuso, Rafael A.; Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Aragon-Vela, Jeronimo; Robles-Sanchez, Candido; Nordsborg, Nikolai B.; Hebberecht, Marina; Salmeron, Luis M.; Huertas, Jesus R.			High-intensity high-volume swimming induces more robust signaling through PGC-1 alpha and AMPK activation than sprint interval swimming in m. triceps brachii	PLOS ONE			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; REACTIVE OXYGEN; EXERCISE; PHOSPHORYLATION; ADAPTATIONS; MECHANISMS; EXPRESSION; INCREASES; SIRT3	We aimed to test whether high-intensity high-volume training (HIHVT) swimming would induce more robust signaling than sprint interval training (SIT) swimming within the m. triceps brachii due to lower metabolic and oxidation. Nine well-trained swimmers performed the two training procedures on separate randomized days. Muscle biopsies from m. triceps brachii and blood samples were collected at three different time points: a) before the intervention (pre), b) immediately after the swimming procedures (post) and c) after 3 h of rest (3 h). Hydroperoxides, creatine kinase (CK), and lactate dehydrogenase (LDH) were quantified from blood samples, and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and the AMPK (pTHR172)/AMPK ratio were quantified by Western blot analysis. PGC-1 alpha, sirtuin 3 (SIRT3), superoxide-dismutase 2 (SOD2), and vascular endothelial growth factor (VEGF) mRNA levels were also quantified. SIT induced a higher release of LDH (p < 0.01 at all time points) and CK (p < 0.01 at post) than HIHVT, but neither SIT nor HIHVT altered systemic hydroperoxides. Additionally, neither SIRT3 nor SOD2 mRNA levels increased, while PGC-1a transcription increased at 3 h after SIT (p < 0.01) and after HIHVT (p < 0.001). However, PGC-1a protein was higher after HIHVT than after SIT (p < 0.05). Moreover, the AMPK(pTHR172)/AMPK ratio increased at post after SIT (p < 0.05), whereas this effect was delayed after HIHVT as it increased after 3 h (p < 0.05). In addition, VEGF transcription was higher in response to HIHVT (p < 0.05). In conclusion, SIT induces higher muscular stress than HIHVT without increasing systemic oxidation. In addition, HIHVT may induce more robust oxidative adaptations through PGC-1 alpha and AMPK.	[Casuso, Rafael A.; Aragon-Vela, Jeronimo; Huertas, Jesus R.] Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain; [Casuso, Rafael A.; Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Aragon-Vela, Jeronimo; Robles-Sanchez, Candido; Huertas, Jesus R.] Univ Granada, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain; [Plaza-Diaz, Julio; Ruiz-Ojeda, Francisco J.; Robles-Sanchez, Candido] Univ Granada, Sch Pharm, Dept Biochem & Mol Biol 2, Granada, Spain; [Nordsborg, Nikolai B.] Univ Copenhagen, Sect Human Physiol, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Hebberecht, Marina; Salmeron, Luis M.] San Cecilio Univ Hosp, Granada, Spain	University of Granada; University of Granada; University of Granada; University of Copenhagen; Hospital Universitario San Cecilio	Casuso, RA (corresponding author), Univ Granada, Sch Pharm, Dept Physiol, Granada, Spain.; Casuso, RA (corresponding author), Univ Granada, Inst Nutr & Food Technol Jose Mataix, Biomed Res Ctr, Granada, Spain.	casusopt@gmail.com	Plaza-Diaz, Julio/C-8094-2016; Huertas, Jesus Francisco Rodriguez/G-8188-2015; Aragón-Vela, Jerónimo/AAA-9889-2019; Casuso, Rafael/E-9617-2016; Ojeda, Francisco Javier Ruiz/D-1228-2016; Nordsborg, Nikolai/O-6173-2014	Plaza-Diaz, Julio/0000-0002-5171-9408; Huertas, Jesus Francisco Rodriguez/0000-0002-7446-0857; Aragón-Vela, Jerónimo/0000-0002-2550-6695; Casuso, Rafael/0000-0002-4482-3186; Ojeda, Francisco Javier Ruiz/0000-0002-4452-0855; Nordsborg, Nikolai/0000-0001-7077-9265				Anderson KA, 2011, CELL, V159, P956; Ansari A, 2017, AGING CELL, V16, P4, DOI 10.1111/acel.12538; Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Bartlett JD, 2012, J APPL PHYSIOL, V112, P1135, DOI 10.1152/japplphysiol.01040.2011; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Brandauer J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00085; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Casuso RA, 2017, HIGH ALT MED BIOL, V18, P46, DOI 10.1089/ham.2016.0046; Casuso RA, 2014, J SPORT SCI MED, V13, P958; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Combes A, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12462; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Edgett BA, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12879; Edgett BA, 2016, EXP PHYSIOL, V101, P1101, DOI 10.1113/EP085744; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Figueiredo P, 2013, APPL PHYSIOL NUTR ME, V38, P716, DOI 10.1139/apnm-2012-0263; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P3391, DOI 10.1113/jphysiol.2012.235127; Gibala MJ, 2009, J APPL PHYSIOL, V106, P929, DOI 10.1152/japplphysiol.90880.2008; Halson SL, 2014, SPORTS MED, V44, pS139, DOI 10.1007/s40279-014-0253-z; Henriquez-Olguin C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00282; Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117; Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009; Jackson MJ, 2015, J APPL PHYSIOL, V119, P163, DOI 10.1152/japplphysiol.00760.2014; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Johnson ML, 2015, J GERONTOL A-BIOL, V70, P1386, DOI 10.1093/gerona/glu221; Kabasakalis A, 2011, J STRENGTH COND RES, V25, P805, DOI 10.1519/JSC.0b013e3181d0b109; Knab AM, 2013, INT J SPORT NUTR EXE, V23, P150, DOI 10.1123/ijsnem.23.2.150; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kristensen DE, 2015, J PHYSIOL-LONDON, V593, P2053, DOI 10.1113/jphysiol.2014.283267; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Larsen FJ, 2016, FASEB J, V30, P417, DOI 10.1096/fj.15-276857; Lu ZB, 2010, ANTIOXID REDOX SIGN, V13, P1011, DOI 10.1089/ars.2009.2940; Maglischo EW, 2003, SWIMMING FASTEST ESE; Morales-Alamo D, 2016, FREE RADICAL BIO MED, V98, P68, DOI 10.1016/j.freeradbiomed.2016.01.012; Morales-Alamo D, 2013, J APPL PHYSIOL, V114, P566, DOI 10.1152/japplphysiol.01246.2012; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Nordsborg NB, 2015, J APPL PHYSIOL, V119, P116, DOI 10.1152/japplphysiol.00101.2015; Powers SK, 2010, INT J SPORT NUTR EXE, V20, P2, DOI 10.1123/ijsnem.20.1.2; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ramamoorthy TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10210; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112; Zinner C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00426	50	12	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185494	10.1371/journal.pone.0185494	http://dx.doi.org/10.1371/journal.pone.0185494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973039	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900020
J	Omodaka, K; Kikawa, T; Shiga, Y; Tsuda, S; Yokoyama, Y; Sato, H; Ohuchi, J; Matsumoto, A; Takahashi, H; Akiba, M; Nakazawa, T				Omodaka, Kazuko; Kikawa, Tsutomu; Shiga, Yukihiro; Tsuda, Satoru; Yokoyama, Yu; Sato, Haruka; Ohuchi, Junko; Matsumoto, Akiko; Takahashi, Hidetoshi; Akiba, Masahiro; Nakazawa, Toru			Usefulness of axonal tract-dependent OCT macular sectors for evaluating structural change in normal-tension glaucoma	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; RETINAL GANGLION-CELLS; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD; DIAGNOSTIC-VALUE; DOMAIN OCT; THICKNESS; PROGRESSION; DAMAGE	Purpose To identify sectors of the optical coherence tomography (OCT) macular map that could be used to effectively assess structural progression in patients with normal-tension glaucoma (NTG). Methods This study examined 117 eyes of 117 NTG patients to establish axonal tract-dependent macular sectors, and also examined a separate group of 122 eyes of 81 NTG patients to evaluate the ability of these sectors to reveal glaucoma progression. Longitudinal data, including macular maps from at least 5 OCT examinations performed over at least 2 years, was available for all patients in this group. Circumpapillary retinal nerve fiber layer thickness (cpRNFLT), temporal clockwise sector scans (from 7 to 11 o'clock), macular retinal nerve fiber layer thickness (mRNFLT), and macular ganglion cell layer plus inner plexiform layer thickness (mGCIPLT) were measured with spectral-domain OCT (3D OCT-2000, TOP-CON). The axonal tract-dependent macular sectors were identified by calculating Spearman's rank correlation coefficient for each point on a grid overlaid on the macular map and cpRNFLT in each clockwise scan sector. Trend and event analyses for the slope of progression in each sector and macular map were performed. Visual field progression in the macula was defined by the presence of more than 2 progressive test points in the 16 central test points of the Humphrey field analyzer SITA standard 24-2 program, evaluated with Progressor software. Results The slope of progression in the entire macular area was -0.22 +/- 0.58 mu m/year for mRNFLT and -0.35 +/- 0.52 mu m/year for mGCIPLT. The fastest-progressing mRNFLT sector (-1.00 +/- 0.84 mu m/year, p < 0.001) and mGCIPLT sector (-1.16 +/- 0.63 mu m/year, p < 0.001) progressed significantly faster than the overall macula. Classifying patients according to visual field progression showed that baseline mRNFLT in the inferior hemifield, 7 and 8 o'clock sectors, as well as baseline mGCIPLT in the overall macular map, inferior hemifield, and 8 o'clock sector, were significantly lower in progressors (22 eyes) than non-progressors (100 eyes). There were significant differences in mRNFLT slope in 8 o'clock sector and in the fastest progressing sector in progressors and non-progressors, but mGCIPLT did not differ, even in the fastest-progressing sector. Event analysis showed that progression occurred most frequently in inferior mRNFLT and superior mGCIPLT in this study. Conclusion Axonal tract-dependent OCT macular sectors could effectively reveal structural change in patients with NTG. Furthermore, mRNFLT slope was consistent with visual field progression. This method promises to open new avenues for the OCT-based evaluation of glaucoma progression.	[Omodaka, Kazuko; Shiga, Yukihiro; Tsuda, Satoru; Yokoyama, Yu; Sato, Haruka; Ohuchi, Junko; Takahashi, Hidetoshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan; [Kikawa, Tsutomu; Matsumoto, Akiko; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Takahashi, Hidetoshi] Tohoku Med & Pharmaceut Univ, Dept Med, Div Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Topcon Corporation; Tohoku Medical & Pharmaceutical University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalm Imaging & Informat Analyt, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp			JST grant from JSPS KAKENHI [TN 17H04349, TN 16K15730]; JST Center for Revitalization Promotion; Topcon Corporation; KAKENHI [K0 17K16957]; Public Trust Suda Memorial Fund for Glaucoma Research	JST grant from JSPS KAKENHI; JST Center for Revitalization Promotion; Topcon Corporation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Public Trust Suda Memorial Fund for Glaucoma Research	Topcon Corporation provided support in the form of salaries for authors TK, AM, and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This paper was supported in part by a JST grant from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (TN 17H04349) and for Exploratory Research (TN 16K15730), and by the JST Center for Revitalization Promotion and KAKENHI Grant-in Aid for young scientists (B) (K0 17K16957) and Public Trust Suda Memorial Fund for Glaucoma Research, and joint research project with Topcon Corporation.	Anraku A, 2014, GRAEF ARCH CLIN EXP, V252, P109, DOI 10.1007/s00417-013-2527-9; ARAIE M, 1995, JPN J OPHTHALMOL, V39, P60; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P352, DOI 10.1136/bjo.82.4.352; Hood DC, 2017, PROG RETIN EYE RES, V57, P46, DOI 10.1016/j.preteyeres.2016.12.002; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Kanamori A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1500, DOI 10.1001/archopht.126.11.1500; Kanamori A, 2013, INVEST OPHTH VIS SCI, V54, P6401, DOI 10.1167/iovs.13-12805; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim HS, 2016, J GLAUCOMA, V25, P472, DOI 10.1097/IJG.0000000000000285; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Kim YK, 2017, J GLAUCOMA, V26, P126, DOI 10.1097/IJG.0000000000000576; Kim YK, 2015, OPHTHALMOLOGY, V122, P2252, DOI 10.1016/j.ophtha.2015.07.013; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Lee EJ, 2011, INVEST OPHTH VIS SCI, V52, P1138, DOI 10.1167/iovs.10-5975; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leung CKS, 2012, OPHTHALMOLOGY, V119, P731, DOI 10.1016/j.ophtha.2011.10.010; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; Mayama C, 2002, OPHTHALMOLOGY, V109, P2072, DOI 10.1016/S0161-6420(02)01175-2; Mayama C, 2015, INVEST OPHTH VIS SCI, V56, P5681, DOI 10.1167/iovs.15-17208; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Miki A, 2014, OPHTHALMOLOGY, V121, P1350, DOI 10.1016/j.ophtha.2014.01.017; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Niles PI, 2012, EYE, V26, P983, DOI 10.1038/eye.2012.76; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Omodaka K, 2014, CLIN EXPT OPHTHALMOL, V43, P279; Omodaka K, 2015, CURR EYE RES, V40, P744, DOI 10.3109/02713683.2014.956371; Omodaka K, 2013, JPN J OPHTHALMOL, V57, P457, DOI 10.1007/s10384-013-0258-4; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Raza AS, 2014, INVEST OPHTH VIS SCI, V55, P612, DOI 10.1167/iovs.13-12351; Sehi M, 2013, AM J OPHTHALMOL, V155, P73, DOI 10.1016/j.ajo.2012.07.005; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Sjostrand J, 1999, GRAEF ARCH CLIN EXP, V237, P1014, DOI 10.1007/s004170050338; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Suzuki Y, 2001, J GLAUCOMA, V10, P121, DOI 10.1097/00061198-200104000-00009; Takada N, 2015, CLIN EXP OPHTHALMOL, V43, P291, DOI 10.1111/ceo.12429; Takahashi M, 2013, CURR EYE RES, V38, P1133, DOI 10.3109/02713683.2013.807932; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185649	10.1371/journal.pone.0185649	http://dx.doi.org/10.1371/journal.pone.0185649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973002	gold, Green Submitted, Green Published			2022-12-27	WOS:000412131900034
J	Park, TY; Chong, S; Jung, JW; Park, IW; Choi, BW; Lim, C; Lee, CU; Kim, YS; Choi, HW; Choi, JC				Park, Tae Yun; Chong, Semin; Jung, Jae-Woo; Park, In Won; Choi, Byoung Whui; Lim, Changwon; Lee, Chang Un; Kim, Yang Soo; Choi, Hye Won; Choi, Jae Chol			Natural course of the nodular bronchiectatic form of Mycobacterium Avium complex lung disease: Long-term radiologic change without treatment	PLOS ONE			English	Article							PULMONARY-DISEASE; INTRACELLULARE COMPLEX; CT FINDINGS; PREVALENCE; DIAGNOSIS; KOREA	Background/Purpose Although the incidence of Mycobacterium avium complex (MAC) lung disease is increasing, the long-term natural course of the nodular bronchiectatic form of MAC lung disease is not well described. The objective of our study is to evaluate long-term radiologic changes in untreated MAC lung disease by analyzing serial chest computed tomography (CT) scan findings. Methods Of 104 patients with MAC lung disease, we selected 40 untreated nodular bronchiectatic MAC patients who underwent serial chest CTs without treatment for at least four years (mean = 6.23 years). Majority of patients have minimal symptoms. Two chest radiologists retrospectively reviewed initial and final chest CT scans. Each chest CT scan was scored for presence and extent of bronchiectasis, cellular bronchiolitis, consolidation, cavity, and nodule (maximum score: 30). Results Of 40 patients, 39 (97.5%) experienced a significant increase in overall CT score (overall difference = 4.89, p<0.001). On repeated measure analysis of variance analysis, cavity yielded the largest increase compared with cellular bronchiolitis (p = 0.013), nodule (p< 0.001), and consolidation (p = 0.004). However, there was no significant difference in mean score change between cavity and bronchiectasis (p = 0.073). In analysis between radiologic parameters and the absolute number of involved segments, bronchiectasis showed most significant change compared with nodule (p< 0.001) and consolidation (p< 0.001). Conclusions Most untreated nodular bronchiectatic MAC lung disease cases showed radiologic deterioration over long-term observation periods when we compared serial chest CT scans. Careful monitoring of MAC lung disease with serial chest CT scan can be beneficial in these untreated patients.	[Park, Tae Yun; Jung, Jae-Woo; Park, In Won; Choi, Byoung Whui; Choi, Jae Chol] Chung Ang Univ, Chung Ang Univ Coll Med, Div Pulm Med, Dept Internal Med, Seoul, South Korea; [Chong, Semin; Lee, Chang Un; Kim, Yang Soo; Choi, Hye Won] Chung Ang Univ Hosp, Chung Ang Univ Coll Med, Dept Radiol, Seoul, South Korea; [Lim, Changwon] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University	Choi, JC (corresponding author), Chung Ang Univ, Chung Ang Univ Coll Med, Div Pulm Med, Dept Internal Med, Seoul, South Korea.	medics27@cau.ac.kr		Chong, Semin/0000-0002-7429-2566				Cole P., 1985, EUR J RESP DIS S, V147, P6; Daley CL, 2010, INT J TUBERC LUNG D, V14, P665; Fujita J, 2003, RESP MED, V97, P933, DOI 10.1016/S0954-6111(03)00120-3; Gochi M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008058; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hwang JA, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00537-2016; Ito Y, 2012, INT J TUBERC LUNG D, V16, P408, DOI 10.5588/ijtld.11.0148; Kim JS, 2005, CHEST, V128, P3863, DOI 10.1378/chest.128.6.3863; Kim SJ, 2014, INT J TUBERC LUNG D, V18, P730, DOI 10.5588/ijtld.13.0792; Kitada S, 2012, INT J TUBERC LUNG D, V16, P660, DOI 10.5588/ijtld.11.0534; Kobashi Y, 2007, RESP MED, V101, P130, DOI 10.1016/j.rmed.2006.04.002; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2008, KOREAN J MED, V74, P120; Kuroishi S, 2008, EUR RESPIR J, V32, P147, DOI 10.1183/09031936.00074207; Lam PK, 2006, AM J RESP CRIT CARE, V173, P1283, DOI 10.1164/rccm.200509-1531OC; Lee G, 2013, AM J ROENTGENOL, V201, P764, DOI 10.2214/AJR.12.9897; Lee Geewon, 2013, Ann Am Thorac Soc, V10, P299, DOI 10.1513/AnnalsATS.201303-062OC; LEWIS AG, 1960, ANN INTERN MED, V53, P273, DOI 10.7326/0003-4819-53-2-273; Min J, 2015, INT J TUBERC LUNG D, V19, P1239, DOI 10.5588/ijtld.14.0139; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Song JW, 2008, AM J ROENTGENOL, V191, pW160, DOI 10.2214/AJR.07.3505; Yoo JW, 2012, TUBERC RESPIR DIS, V72, P409, DOI 10.4046/trd.2012.72.5.409	26	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185774	10.1371/journal.pone.0185774	http://dx.doi.org/10.1371/journal.pone.0185774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968457	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600047
J	Joyce, TW; Durban, JW; Claridge, DE; Dunn, CA; Fearnbach, H; Parsons, KM; Andrews, RD; Ballance, LT				Joyce, Trevor W.; Durban, John W.; Claridge, Diane E.; Dunn, Charlotte A.; Fearnbach, Holly; Parsons, Kim M.; Andrews, Russel D.; Ballance, Lisa T.			Physiological, morphological, and ecological tradeoffs influence vertical habitat use of deep-diving toothed-whales in the Bahamas	PLOS ONE			English	Article							SPERM-WHALES; BODY-SIZE; PHYSETER-MACROCEPHALUS; OPTIMAL ALLOCATION; FORAGING BEHAVIOR; SKELETAL-MUSCLE; SEX DETERMINATION; METABOLIC-RATES; WEDDELL SEALS; KILLER WHALES	Dive capacity among toothed whales (suborder: Odontoceti) has been shown to generally increase with body mass in a relationship closely linked to the allometric scaling of metabolic rates. However, two odontocete species tagged in this study, the Blainville's beaked whale Mesoplodon densirostris and the Cuvier's beaked whale Ziphius cavirostris, confounded expectations of a simple allometric relationship, with exceptionally long (mean: 46.1 min & 65.4 min) and deep dives (mean: 1129 m & 1179 m), and comparatively small body masses (med.: 842.9 kg & 1556.7 kg). These two species also exhibited exceptionally long recovery periods between successive deep dives, or inter-deep-dive intervals (M. densirostris: med. 62 min; Z. cavirostris: med. 68 min). We examined competing hypotheses to explain observed patterns of vertical habitat use based on body mass, oxygen binding protein concentrations, and inter-deep-dive intervals in an assemblage of five sympatric toothed whales species in the Bahamas. Hypotheses were evaluated using dive data from satellite tags attached to the two beaked whales (M. densirostris, n = 12; Z. cavirostris, n = 7), as well as melon-headed whales Peponocephala electra (n = 13), short-finned pilot whales Globicephala macrorhynchus (n = 15), and sperm whales Physeter macrocephalus (n = 27). Body mass and myoglobin concentration together explained only 36% of the variance in maximum dive durations. The inclusion of inter-deep-dive intervals, substantially improved model fits (R-2 = 0.92). This finding supported a hypothesis that beaked whales extend foraging dives by exceeding aerobic dive limits, with the extension of inter-deep-dive intervals corresponding to metabolism of accumulated lactic acid. This inference points to intriguing tradeoffs between body size, access to prey in different depth strata, and time allocation within dive cycles. These tradeoffs and resulting differences in habitat use have important implications for spatial distribution patterns, and relative vulnerabilities to anthropogenic impacts.	[Joyce, Trevor W.; Ballance, Lisa T.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Joyce, Trevor W.; Durban, John W.; Ballance, Lisa T.] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA; [Claridge, Diane E.; Dunn, Charlotte A.] Bahamas Marine Mammal Res Org, Marsh Harbor, Abaco, Bahamas; [Claridge, Diane E.; Dunn, Charlotte A.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Fearnbach, Holly] SR3 SeaLife Response Rehabil & Res, Mukilteo, WA USA; [Parsons, Kim M.] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Andrews, Russel D.] Marine Ecol & Telemetry Res, Seabeck, WA USA; [Joyce, Trevor W.] Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA; University of St Andrews; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; Oregon State University	Joyce, TW (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.; Joyce, TW (corresponding author), NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92037 USA.; Joyce, TW (corresponding author), Oregon State Univ, Hatfield Marine Sci Ctr, Marine Mammal Inst, Newport, OR 97365 USA.	trevorwjoyce@gmail.com	Ballance, Lisa/AAF-5472-2020	Andrews, Russel/0000-0002-4545-137X; Dunn, Charlotte/0000-0002-4274-7239	United States (U.S.) Navy Office of Naval Research [N000140710120]; Naval Facilities Engineering Command [N002441110021, N002441210007, N6660413P2671]; Strategic Environmental Research and Development Program [RC-2114]; NOAA Fisheries Acoustic Program; U.S. National Science Foundation Graduate Research Fellowship Program	United States (U.S.) Navy Office of Naval Research; Naval Facilities Engineering Command; Strategic Environmental Research and Development Program; NOAA Fisheries Acoustic Program; U.S. National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The research reported here was financially supported by the United States (U.S.) Navy Office of Naval Research (grant N000140710120; www.onr.navy.mil), the Naval Facilities Engineering Command (grants N002441110021, N002441210007 and contract N6660413P2671; www.navfac.navy.mil), the Strategic Environmental Research and Development Program (award RC-2114; www.serdp.org), and the NOAA Fisheries Acoustic Program (http://www.nmfs.noaa.gov/pr/acoustics/). Graduate student funding support for the first author was provided by the U.S. National Science Foundation Graduate Research Fellowship Program (www.nsfgrfp.org). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2004, MODEL SELECTION MULT, V2nd; Andrews RD, 2008, POLAR BIOL, V31, P1461, DOI 10.1007/s00300-008-0487-z; ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; [Anonymous], 2008, CANADIAN ACOUSTICS; Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; BAILEY TG, 1986, MAR BIOL, V91, P131, DOI 10.1007/BF00397578; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; BUTLER PJ, 1982, ADV COMP PHYSIOL BIO, V8, P179; Carbone C, 1996, ANIM BEHAV, V51, P1247, DOI 10.1006/anbe.1996.0129; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Childress JJ, 1973, DEEP SEA RES OCEANOG, P1093; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Costa DP, 2001, COMP BIOCHEM PHYS A, V129, P771, DOI 10.1016/S1095-6433(01)00346-4; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DREWS GA, 1961, J HISTOCHEM CYTOCHEM, V9, P206, DOI 10.1177/9.2.206; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Gage J. D., 1991, DEEP SEA BIOL NATURA; Georges JY, 2000, POLAR BIOL, V23, P59, DOI 10.1007/s003000050008; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; HAYSSEN V, 1985, COMP BIOCHEM PHYS A, V81, P741, DOI 10.1016/0300-9629(85)90904-1; Hazen EL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500469; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2001, MAMMAL REV, V31, P81, DOI 10.1046/j.1365-2907.2001.00080.x; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; Jerlov N.G., 1968, OPTICAL OCEANOGRAPHY; Jimenez AG, 2011, J EXP BIOL, V214, P3688, DOI 10.1242/jeb.060301; Johnson D, 2013, CRAWL FIT CONTINUOUS; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; JOHNSON MW, 1948, J MAR RES, V7, P443; Johnston IA, 2004, J EXP BIOL, V207, P4343, DOI 10.1242/jeb.01292; Joyce TW, 2016, MAR MAMMAL SCI, V32, P1044, DOI 10.1111/mms.12323; Kielhorn CE, 2013, J MORPHOL, V274, P663, DOI 10.1002/jmor.20124; KLEIBER M, 1975, J THEOR BIOL, V53, P199, DOI 10.1016/0022-5193(75)90110-1; KOOYMAN GL, 1983, J COMP PHYSIOL, V151, P171, DOI 10.1007/BF00689915; KOOYMAN GL, 1980, J COMP PHYSIOL, V138, P335, DOI 10.1007/BF00691568; Laidre KL, 2002, CAN J ZOOL, V80, P624, DOI 10.1139/Z02-041; Lang TG., 1966, WHALES DOLPHINS PORP, P410; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MARSHALL N. B., 1965, DEEP SEA RES OCEANOGR ABSTR, V12, P299, DOI 10.1016/0011-7471(65)90004-5; Martin AR, 1999, CAN J ZOOL, V77, P1783, DOI 10.1139/cjz-77-11-1783; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McCarthy E, 2011, MAR MAMMAL SCI, V27, pE206, DOI 10.1111/j.1748-7692.2010.00457.x; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; McClintock BT, 2015, METHODS ECOL EVOL, V6, P266, DOI 10.1111/2041-210X.12311; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Mirceta S, 2013, SCIENCE, V340, DOI 10.1126/science.1234192; Moretti D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085064; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Mori Y, 1999, BEHAV ECOL, V10, P155, DOI 10.1093/beheco/10.2.155; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEMETH PM, 1984, J HISTOCHEM CYTOCHEM, V32, P1211, DOI 10.1177/32.11.6491255; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; Noren SR, 2000, COMP BIOCHEM PHYS A, V126, P181, DOI 10.1016/S1095-6433(00)00182-3; OHMAN MD, 1983, SCIENCE, V220, P1404, DOI 10.1126/science.220.4604.1404; Pabst DA, 2016, INTEGR COMP BIOL, V56, P1337, DOI 10.1093/icb/icw126; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Ponganis PJ, 2011, J EXP BIOL, V214, P3325, DOI 10.1242/jeb.031252; Ponganis PJ, PHYSIOL; Reisinger RR, 2015, J EXP MAR BIOL ECOL, V473, P90, DOI 10.1016/j.jembe.2015.08.008; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; Rosen DAS, 2015, J EXP MAR BIOL ECOL, V469, P93, DOI 10.1016/j.jembe.2015.04.017; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Schorr GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092633; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Scott Michael D., 2001, Journal of Cetacean Research and Management, V3, P87; Sharp JG, 1953, WHALEMEAT PRODUCTION; Sierra E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15909; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith SC, 2000, MAR MAMMAL SCI, V16, P315, DOI 10.1111/j.1748-7692.2000.tb00927.x; SNYDER GK, 1983, RESP PHYSIOL, V54, P269, DOI 10.1016/0034-5687(83)90072-5; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; STICKNEY DG, 1989, MAR BIOL, V103, P13, DOI 10.1007/BF00391060; Teloni V, 2008, J EXP MAR BIOL ECOL, V354, P119, DOI 10.1016/j.jembe.2007.10.010; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Velten BP, 2013, J EXP BIOL, V216, P1862, DOI 10.1242/jeb.081323; Villemereuil P.D., 2014, MODERN PHYLOGENETIC, P287, DOI [10.1007/978-3-662-43550-2_11, DOI 10.1007/978-3-662-43550-2_11]; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; WATKINS WA, 1993, MAR MAMMAL SCI, V9, P55, DOI 10.1111/j.1748-7692.1993.tb00426.x; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; WELLS RE, 1962, J CLIN INVEST, V41, P1591, DOI 10.1172/JCI104617; WESTGATE AJ, 1995, CAN J FISH AQUAT SCI, V52, P1064, DOI 10.1139/f95-104; Zuur Alain F., 2009, P1	99	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185113	10.1371/journal.pone.0185113	http://dx.doi.org/10.1371/journal.pone.0185113			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020021	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400021
J	Korkola, JE; Collisson, EA; Heiser, LM; Oates, C; Bayani, N; Itani, S; Esch, A; Thompson, W; Griffith, OL; Wang, NJ; Kuo, WL; Cooper, B; Billig, J; Ziyad, S; Hung, JL; Jakkula, L; Feiler, H; Lu, YL; Mills, GB; Spellman, PT; Tomlin, C; Mukherjee, S; Gray, JW				Korkola, James E.; Collisson, Eric A.; Heiser, Laura M.; Oates, Chris; Bayani, Nora; Itani, Sleiman; Esch, Amanda; Thompson, Wallace; Griffith, Obi L.; Wang, Nicholas J.; Kuo, Wen-Lin; Cooper, Brian; Billig, Jessica; Ziyad, Safiyyah; Hung, Jenny L.; Jakkula, Lakshmi; Feiler, Heidi; Lu, Yiling; Mills, Gordon B.; Spellman, Paul T.; Tomlin, Claire; Mukherjee, Sach; Gray, Joe W.			Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer (vol 10, e0133219, 2015)	PLOS ONE			English	Correction													Gray, Joe/AAX-9549-2020	Mills, Gordon/0000-0002-0144-9614				Korkola JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133219	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186551	10.1371/journal.pone.0186551	http://dx.doi.org/10.1371/journal.pone.0186551			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020035	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400105
J	Galvao, EL; Rabello, A; Cota, GF				Galvao, Endi Lanza; Rabello, Ana; Cota, Glaucia Fernandes			Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis	PLOS ONE			English	Review							WORLD CUTANEOUS LEISHMANIASIS; CONTROLLED CLINICAL-TRIAL; DOUBLE-BLIND; ITRACONAZOLE; KETOCONAZOLE; FLUCONAZOLE; BRAZILIENSIS; EXPERIENCE; FAILURE; PHARMACOKINETICS	Background Several controlled and uncontrolled studies addressing azole antifungal drugs for cutaneous and mucosal leishmaniasis have been published with inconclusive results. We conducted a systematic literature review of studies evaluating the efficacy and toxicity associated with azole therapy for tegumentary leishmaniasis. Methodology PRISMA guidelines for systematic reviews and the Cochrane manual were followed, and the review methodology was registered (PROSPERO; CRD42016048668). Sources included the EMBASE, Web of Science, MEDLINE, LILACS, and IBECS databases along with a manual search of references from evaluated studies. Additional resources such as Google Scholar and clinicaltrials. gov were also searched. We included all studies reporting cure rate after cutaneous or mucosal leishmaniasis treatment with systemic azole drugs, regardless of their design. R software was used to estimate global rates of success and adverse events with each drug. The main outcome of interest was clinical cure, defined as complete re-epithelialization of all lesions. Results A total of 37 studies involving 1259 patients that reported outcomes after fluconazole (9), ketoconazole (14) and itraconazole (15) treatments were included. Only 14 (38%) were randomized controlled trials (RCT). The pooled azole final efficacy rate was 64% (CI95%: 57-70%) for all studies and 60% (CI95%: 50-70%) (p = 0.41) if only RCTs studies were considered. Twenty-four studies were conducted in the Old World and 13 studies in the Americas. The final efficacy rate according to New and Old World were 62% (CI95%: 43-77%) and 66% (CI95%: 58-73%), respectively. The final efficacy rate of azoles according to species were 89% (CI95%: 50-98%) for L. mexicana; 88% for L. infantum (CI95%: 27-99%); 80% for L. donovani; 53% (CI95%: 29-76%) for L. major; 49% for L. braziliensis (CI95%: 21-78%); and 15% (CI95%: 1-84%) for L. tropica. The cure rates were similar among the fluconazole, ketoconazole and itraconazole group arms (p = 0.89), specifically 61% (CI95%: 48-72%), 64% (CI95%: 44-80%) 65% (CI95%: 56-72%), respectively. Adverse events during fluconazole, itraconazole and ketoconazole therapy were reported in 7% (CI95%: 3-14%), 12% (CI95% 8-19%) and 13% (CI95%: 6-29%) of treated patients, respectively, without difference among them (p = 0.35). This systematic review included studies with small samples and both non-comparative and non-randomized studies and the main limitation was the low quality of the available studies. Conclusions Available evidence suggests that fluconazole, ketoconazole and itraconazole have similar and modest efficacy rates for tegumentary leishmaniasis treatment. There is insufficient evidence to support the exclusive use of azole therapy as a single agent for leishmaniasis treatment.	[Galvao, Endi Lanza; Rabello, Ana; Cota, Glaucia Fernandes] Fiocruz MS, Rachou Fundacao Oswaldo Cruz, Pesquisa Clin & Polit Publ Doencas Infectoparasit, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Galvao, EL (corresponding author), Fiocruz MS, Rachou Fundacao Oswaldo Cruz, Pesquisa Clin & Polit Publ Doencas Infectoparasit, Belo Horizonte, MG, Brazil.	endi.lanza@cpqrr.fiocruz.br	Cota, Glaucia/ABC-5378-2020	Cota, Glaucia/0000-0003-0538-7403; Galvao, Endi Lanza/0000-0002-5648-3932	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]; FAPEMIG (Foundation for Research Support of the State of Minas Gerais)	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Foundation for Research Support of the State of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	AR is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). ELG is a Ph.D. student and is receiving a scholarship from FAPEMIG (Foundation for Research Support of the State of Minas Gerais). The authors received no specific funding for this work.	Al-Mutairi N, 2009, INT J DERMATOL, V48, P862, DOI 10.1111/j.1365-4632.2008.04010.x; ALFOUZAN AS, 1991, INT J DERMATOL, V30, P519, DOI 10.1111/j.1365-4362.1991.tb04878.x; Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882; ALSALEH QA, 1995, INT J DERMATOL, V34, P495, DOI 10.1111/j.1365-4362.1995.tb00622.x; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amato  V S, 2000, Int J Infect Dis, V4, P153, DOI 10.1016/S1201-9712(00)90077-8; Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x; Baron S, 2004, CLIN EXP DERMATOL, V29, P546, DOI 10.1111/j.1365-2230.2004.01561.x; BEACH DH, 1988, MOL BIOCHEM PARASIT, V31, P149, DOI 10.1016/0166-6851(88)90166-1; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cabrejos Pita Jose Gabriel, 2002, Rev Med Hered, V13, P144; Calvopina M, 2004, INT J DERMATOL, V43, P659, DOI 10.1111/j.1365-4632.2004.02183.x; Chahed MK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005090; Consigli J, 2006, INT J DERMATOL, V45, P46, DOI 10.1111/j.1365-4632.2004.02429.x; Cota GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149697; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; DEDET JP, 1986, T ROY SOC TROP MED H, V80, P176, DOI 10.1016/0035-9203(86)90239-7; DOGRA J, 1994, INT J ANTIMICROB AG, V4, P309, DOI 10.1016/0924-8579(94)90031-0; Dogra J, 1996, INT J PARASITOL, V26, P1413, DOI 10.1016/S0020-7519(96)00128-2; DOGRA J, 1990, INT J DERMATOL, V29, P661, DOI 10.1111/j.1365-4362.1990.tb02593.x; Emad M, 2011, J AM ACAD DERMATOL, V64, P606, DOI 10.1016/j.jaad.2010.04.014; Gonzalez U, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD004834; Gonzalez U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005067.pub3; Gurel MS, 2005, INT J DERMATOL, V44, P933, DOI 10.1111/j.1365-4632.2004.02225.x; HEYKANTS J, 1989, MYCOSES, V32, P67, DOI 10.1111/j.1439-0507.1989.tb02296.x; JOLLIFFE DS, 1986, CLIN EXP DERMATOL, V11, P62, DOI 10.1111/j.1365-2230.1986.tb00425.x; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Khan W, 2014, IRAN J PARASITOL, V9, P365; Khatami A, 2007, J AM ACAD DERMATOL, V57, P335, DOI 10.1016/j.jaad.2007.01.016; LAROSA E, 1986, EUR J OBSTET GYN R B, V23, P85, DOI 10.1016/0028-2243(86)90109-7; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Momeni AZ, 1996, ARCH DERMATOL, V132, P784, DOI 10.1001/archderm.132.7.784; Morizot G, 2007, AM J TROP MED HYG, V76, P48; Mosimann V, 2013, INFECTION, V41, P1177, DOI 10.1007/s15010-013-0500-5; Nassiri-Kashani M, 2005, J EUR ACAD DERMATOL, V19, P80, DOI 10.1111/j.1468-3083.2004.01133.x; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; Netto E M, 1989, Rev Soc Bras Med Trop, V22, P105, DOI 10.1590/S0037-86821989000200011; NORTON SA, 1992, ARCH DERMATOL, V128, P83, DOI 10.1001/archderm.128.1.83; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130; Ozgoztasi O, 1997, INT J DERMATOL, V36, P61, DOI 10.1046/j.1365-4362.1997.00022.x; Prates FVD, 2017, CLIN INFECT DIS, V64, P67, DOI 10.1093/cid/ciw662; Rafaa M, 2007, ANN DERMATOL VENER, V134, P682, DOI 10.1016/S0151-9638(07)91833-5; Restrepo M, 1987, ACTA MED COLOMB, V12, P294; Reveiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061843; SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L; Saleem K, 2007, JCPSP-J COLL PHYSICI, V17, P713, DOI 12.2007/JCPSP.713716; Salmanpour R, J DERMATOLOG TREAT, V12, P159; Santos I, 1995, AN BRAS DERMATOL, V70; Santos MF, 1988, AN BRAS DERMATOL, V63; Scorza J. V., 1988, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V28, P32; Shokri A, 2017, ACTA TROP, V167, P73, DOI 10.1016/j.actatropica.2016.12.027; Siddiqui MA, 1998, J DERMATOL TREAT, V9, P235, DOI 10.3109/09546639809160701; Silva CB, 2012, THESIS; Singh KK, 1993, INDIAN J DERMATOL VE, V59, P120; SINGH S, 1995, INT J DERMATOL, V34, P120, DOI 10.1111/j.1365-4362.1995.tb03595.x; Sousa AQ, 2011, CLIN INFECT DIS, V53, P693, DOI 10.1093/cid/cir496; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; VANDENENDEN E, 1994, INT J DERMATOL, V33, P285, DOI 10.1111/j.1365-4362.1994.tb01049.x; Viriyavejakul Parnpen, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P558; Vita GF, 2016, REV INST MED TROP SP, V58, DOI [10.1590/S1678-9946201658071, 10.1590/s1678-9946201658071]; WEINRAUCH L, 1983, ARCH DERMATOL RES, V275, P353, DOI 10.1007/BF00417211; Wells GA, 2011, NEWCASTLE OTTAWA SCA; WHO, 2010, WHO TECH REP SER, V949, P1; Willard RJ, 2005, J AM ACAD DERMATOL, V52, P977, DOI 10.1016/j.jaad.2005.01.109; ZAHAF A, 1987, MED MALADIES INFECT, V17, P420, DOI 10.1016/S0399-077X(87)80054-9; Zeegelaar JE, 2005, CLIN EXP DERMATOL, V30, P1, DOI 10.1111/j.1365-2230.2004.01677.x	69	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186117	10.1371/journal.pone.0186117	http://dx.doi.org/10.1371/journal.pone.0186117			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016694	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800039
J	Hambrook, DA; Ilievski, M; Mosadeghzad, M; Tata, M				Hambrook, Dillon A.; Ilievski, Marko; Mosadeghzad, Mohamad; Tata, Matthew			A Bayesian computational basis for auditory selective attention using head rotation and the interaural time-difference cue	PLOS ONE			English	Article							BINAURAL SOUND LOCALIZATION; SPEECH SEGREGATION; MOVEMENTS; SYSTEM; DIRECTION; TRACKING; HEARING	The process of resolving mixtures of several sounds into their separate individual streams is known as auditory scene analysis and it remains a challenging task for computational systems. It is well-known that animals use binaural differences in arrival time and intensity at the two ears to find the arrival angle of sounds in the azimuthal plane, and this localization function has sometimes been considered sufficient to enable the un-mixing of complex scenes. However, the ability of such systems to resolve distinct sound sources in both space and frequency remains limited. The neural computations for detecting interaural time difference (ITD) have been well studied and have served as the inspiration for computational auditory scene analysis systems, however a crucial limitation of ITD models is that they produce ambiguous or "phantom" images in the scene. This has been thought to limit their usefulness at frequencies above about 1khz in humans. We present a simple Bayesian model and an implementation on a robot that uses ITD information recursively. The model makes use of head rotations to show that ITD information is sufficient to unambiguously resolve sound sources in both space and frequency. Contrary to commonly held assumptions about sound localization, we show that the ITD cue used with high-frequency sound can provide accurate and unambiguous localization and resolution of competing sounds. Our findings suggest that an "active hearing" approach could be useful in robotic systems that operate in natural, noisy settings. We also suggest that neurophysiological models of sound localization in animals could benefit from revision to include the influence of top-down memory and sensorimotor integration across head rotations.	[Hambrook, Dillon A.; Ilievski, Marko; Mosadeghzad, Mohamad; Tata, Matthew] Univ Lethbridge, Dept Neurosci, Lethbridge, AB, Canada	University of Lethbridge	Hambrook, DA (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB, Canada.	dillon.hambrook@uleth.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [G2463]; NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) [Discovery grant number G2463]. Support for the authors was provided by the NSERC Colloborative Research and Training Experience program [Biological Information Processing: From Genome to Systems Level program]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JC, 2011, J NEUROSCI, V31, P10872, DOI 10.1523/JNEUROSCI.0622-11.2011; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Baumann C, 2015, J ACOUST SOC AM, V138, P635, DOI 10.1121/1.4923448; Blauert J., 1997, SPATIAL HEARING PSYC; Boersma Paul, 2002, GLOT INT, V5, P341; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brimijoin WO, 2012, I-PERCEPTION, V3, P179, DOI 10.1068/i7173sas; Burger J., 1958, ACTA ACUST UNITED AC, V8, P301; CAIRD D, 1983, EXP BRAIN RES, V52, P385; CAIRD D, 1987, EXP BRAIN RES, V68, P379; Cao SY, 2011, J ACOUST SOC AM, V129, P2227, DOI 10.1121/1.3559707; CARR CE, 1990, J NEUROSCI, V10, P3227; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Dietz M, 2011, SPEECH COMMUN, V53, P592, DOI 10.1016/j.specom.2010.05.006; Even J, 2014, IEEE INT CONF ROBOT, P677, DOI 10.1109/ICRA.2014.6906927; Franken TP, 2015, NAT NEUROSCI, V18, P444, DOI 10.1038/nn.3948; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Hill PA, 2000, RESOLUTION FRONT D B; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Kallakuri N, 2013, IEEE INT CONF ROBOT, P2270, DOI 10.1109/ICRA.2013.6630884; Kleiner M, WHATS NEW PSYCHTOOLB; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; Kumon Makoto, 2010, Journal of Biomechanical Science and Engineering, V6, P26, DOI 10.1299/jbse.6.26; Lewald J, 2000, J NEUROPHYSIOL, P84; Li P, 2010, COMPUT SPEECH LANG, V24, P30, DOI 10.1016/j.csl.2008.05.005; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Lyon R. F., 2010, 2010 IEEE International Symposium on Circuits and Systems. ISCAS 2010, P3809, DOI 10.1109/ISCAS.2010.5537724; Lyon R. F., 1983, Proceedings of ICASSP 83. IEEE International Conference on Acoustics, Speech and Signal Processing, P1148; Ma N, 2015, INT CONF ACOUST SPEE, P2699, DOI 10.1109/ICASSP.2015.7178461; Martinson E, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P1140; May T, 2015, INT CONF ACOUST SPEE, P2679, DOI 10.1109/ICASSP.2015.7178457; McAlpine D, 2005, J PHYSIOL-LONDON, V566, P21, DOI 10.1113/jphysiol.2005.083113; McCloy DR, 2013, THE PN NC CORPUS; Nakadai K, 2001, IROS 2001: PROCEEDINGS OF THE 2001 IEEE/RJS INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1395, DOI 10.1109/IROS.2001.977176; Perrett S, 1997, J ACOUST SOC AM, V102, P2325, DOI 10.1121/1.419642; Roman N, 2004, INT CONF ACOUST SPEE, P373; Roman N, 2003, J ACOUST SOC AM, V114, P2236, DOI 10.1121/1.1610463; Roman N, 2008, IEEE T AUDIO SPEECH, V16, P728, DOI 10.1109/TASL.2008.918978; Shao Y, 2010, COMPUT SPEECH LANG, V24, P77, DOI 10.1016/j.csl.2008.03.004; THURLOW WR, 1967, J ACOUST SOC AM, V42, P480, DOI 10.1121/1.1910604; THURLOW WR, 1967, J ACOUST SOC AM, V42, P489, DOI 10.1121/1.1910605; Valin JM, 2007, ROBOT AUTON SYST, V55, P216, DOI 10.1016/j.robot.2006.08.004; Valin JM, 2004, IEEE INT CONF ROBOT, P1033, DOI 10.1109/ROBOT.2004.1307286; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; Wallach H, 1939, J ACOUST SOC AM, V10, P270, DOI 10.1121/1.1915985; Wallach H, 1940, J EXP PSYCHOL, V27, P339, DOI 10.1037/h0054629; Wightman FL, 1999, J ACOUST SOC AM, V105, P2841, DOI 10.1121/1.426899; Wilber AA, 2014, J NEUROSCI, V34, P5431, DOI 10.1523/JNEUROSCI.0511-14.2014; YIN TCT, 1984, J ACOUST SOC AM, V76, P1401, DOI 10.1121/1.391457	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186104	10.1371/journal.pone.0186104	http://dx.doi.org/10.1371/journal.pone.0186104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982139	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300123
J	Odoyo-June, E; Agot, K; Grund, JM; Onchiri, F; Musingila, P; Mboya, E; Emusu, D; Onyango, J; Ohaga, S; Soo, L; Otieno-Nyunya, B				Odoyo-June, Elijah; Agot, Kawango; Grund, Jonathan M.; Onchiri, Frankline; Musingila, Paul; Mboya, Edward; Emusu, Donath; Onyango, Jacob; Ohaga, Spala; Soo, Leonard; Otieno-Nyunya, Boaz			Predictors of voluntary medical male circumcision prevalence among men aged 25-39 years in Nyanza region, Kenya: Results from the baseline survey of the TASCO study	PLOS ONE			English	Article							HIV PREVENTION; KISUMU; TRIAL	Introduction Uptake of voluntary medical male circumcision (VMMC) as an intervention for prevention of HIV acquisition has been low among men aged >= 25 years in Nyanza region, western Kenya. We conducted a baseline survey of the prevalence and predictors of VMMC among men ages 25-39 years as part of the preparations for a cluster randomized controlled trial (cRCT) called the Target, Speed and Coverage (TASCO) Study. The TASCO Study aimed to assess the impact of two demand creation interventions D interpersonal communication (IPC) and dedicated service outlets (DSO), delivered separately and together (IPC + DSO) D on VMMC uptake. Methods As part of the preparatory work for implementation of the cRCT to evaluate tailored interventions to improve uptake of VMMC, we conducted a survey of men aged 25-39 years from a traditionally non-circumcising Kenyan ethnic community within non-contiguous locations selected as study sites. We determined their circumcision status, estimated the baseline circumcision prevalence and assessed predictors of being circumcised using univariate and multivariate logistic regression. Results A total of 5,639 men were enrolled of which 2,851 (50.6%) reported being circumcised. The odds of being circumcised were greater for men with secondary education (adjusted Odds Ratio (aOR) = 1.65; 95% CI: 1.45-1.86, p< 0.001), post-secondary education (aOR = 1.72; 95% CI: 1.44-2.06, p < 0.001), and those employed (aOR = 1.32; 95% CI: 1.18-1.47, p < 0.001). However, the odds were lower for men with a history of being married (currently married, divorced, separated, or widowed). Conclusion Among adult men in the rural Nyanza region of Kenya, men with post-primary education and employed were more likely to be circumcised. VMMC programs should focus on specific sub-groups of men, including those aged 25-39 years who are married, divorced/separated/widowed, and of low socio-economic status (low education and unemployed).	[Odoyo-June, Elijah; Onchiri, Frankline; Musingila, Paul; Emusu, Donath; Soo, Leonard; Otieno-Nyunya, Boaz] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB DGHT, Nairobi, Kenya; [Agot, Kawango; Mboya, Edward; Onyango, Jacob; Ohaga, Spala] Impact Res & Dev Org, Kisumu, Kenya; [Grund, Jonathan M.] US Ctr Dis Control & Prevent CDC, Div Global HIV & TB DGHT, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Odoyo-June, E (corresponding author), US Ctr Dis Control & Prevent CDC, Div Global HIV & TB DGHT, Nairobi, Kenya.	yed0@cdc.gov			President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) [5U01GH00518]	President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC)	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the US Centers for Disease Control and Prevention (CDC) under the terms of the Cooperative Agreement Number 5U01GH00518. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the funding agencies.	[Anonymous], 2007, FHI360; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Centers for Disease Control and Prevention, 2015, VMMC 2015 PROGR DAT; Evens E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098221; Galbraith JS, 2014, JAIDS-J ACQ IMM DEF, V66, pS37, DOI 10.1097/QAI.0000000000000121; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hatzold K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085051; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; National AIDS and STI Control Programme (NASCOP), 2009, KEN NAT STRAT VOL ME; National AIDS and STI Control Programme (NASCOP), 2014, KEN AIDS IND SURV 20; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Peltzer K, 2014, AFR J TRADIT COMPLEM, V11, P126, DOI 10.4314/ajtcam.v11i4.19; StataCorp, 2015, STAT STAT SOFTW REL; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; World Health Organization, VOL MED MAL CIRC HIV	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185872	10.1371/journal.pone.0185872	http://dx.doi.org/10.1371/journal.pone.0185872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982175	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300079
J	Wang, XC; Jiang, HB; Wang, XM; Liu, HY; Zhou, L; Lu, XW				Wang, Xichen; Jiang, Hongbo; Wang, Xuemei; Liu, Hongyu; Zhou, Ling; Lu, Xiwei			ESMPE: A combined strategy for school tuberculosis prevention and control proposed by Dalian, China	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; STUDENTS; EXPERIENCES; OUTBREAK	Background Although China has paid more attention on the prevention and control of tuberculosis (TB) in schools, several unsolved questions in this field still threaten the progress of TB control. Therefore, there is an urgent need to develop a systematic and practical strategy for Chinese school TB prevention and control system. In this study, we aimed to assess the feasibility of a combined strategy named ESMPE (examination, screening, monitoring, prevention and education) that adhere to the basic principles of Chinese schools TB control strategy. Methods The ESMPE strategy included five sections, namely TB screening during physical examination for the school freshmen entrances, screening of close contacts, monitoring of high-risk schools, preventive treatment and TB education. The effectiveness of ESMPE strategy was evaluated from 2011 to 2016. The original data were provided by the Dalian Tuberculosis Hospital. Descriptive analysis and nonparametric tests were used for comparing statistical differences of results between different years. Results The detection rate of active pulmonary TB in school freshmen was decreased from 2011 to 2016 (chi(2) = 41.941, P = 6.0551E-8). 97.22% (17,043/17,530) of close contacts experienced close contacts screening, and the secondary attack rate (SAR) of TB in schools fell by 146.35/10 5 from 2011 to 2012, and finally reduced to 85.57/10 5 in 2016. There was a significant correlation between SAR of student TB and the rate of screened close contacts (r = -0.924, P = 0.009). TB incidence of five monitored schools had a substantial decline after receiving monitoring, and this declining trend continued in 2016. Due to the TB education and advanced screening methods, the mean of diagnostic delay time in students with TB was shortened (15.71 days), while still fewer latent TB infection students received preventive treatment (30.38%). Conclusions The ESMPE strategy has shown a favorable effect on TB prevention and control in Dalian schools. More systematic evidence is needed on the effect of this strategy in reducing the incidence of TB in schools from other settings prior to its further scaling-up in China.	[Wang, Xichen; Liu, Hongyu; Zhou, Ling] Dalian Med Univ, Sch Publ Hlth, Dalian, Liaoning, Peoples R China; [Jiang, Hongbo; Wang, Xuemei; Lu, Xiwei] Dalian TB Hosp, Off Epidem Surveillance, Dalian, Liaoning, Peoples R China	Dalian Medical University	Zhou, L (corresponding author), Dalian Med Univ, Sch Publ Hlth, Dalian, Liaoning, Peoples R China.; Lu, XW (corresponding author), Dalian TB Hosp, Off Epidem Surveillance, Dalian, Liaoning, Peoples R China.	zhouling0609@163.com; yiluxiwei@126.com	Wang, Xuemei/GXF-3702-2022					Chen Q, 2015, BIOMED ENVIRON SCI, V28, P611, DOI 10.3967/bes2015.085; Chen W, 2012, J INT MED RES, V40, P1830, DOI 10.1177/030006051204000521; Chen W, 2013, CHIN J ANTITUBERCULO, V35, P949; Dobler CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048900; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Garcia MJ, 2016, CLIN INFECT DIS, V62, P1401, DOI 10.1093/cid/ciw132; Huang~ Y, 2016, PEDIATRIA POLSKA, V91, P541, DOI [DOI 10.1016/J.PEPO.2016.09.005, 10.1016/j.pepo.2016.09.005, DOI 10.1016/j.pepo.2016.09.005]; López G., 2011, Rev. esp. sanid. penit., V13, P3, DOI 10.4321/s1575-06202011000100002; Ma MJ, 2015, INFECT GENET EVOL, V32, P148, DOI 10.1016/j.meegid.2015.03.001; Machiyama K, 2016, INT J PUBLIC HEALTH, V61, P603, DOI 10.1007/s00038-015-0768-6; Organization WH, 2016, GLOBAL TUBERCULOSIS; Pandit S, 2009, LUNG INDIA, V26, P109, DOI 10.4103/0970-2113.56343; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Song SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100267; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Verhagen LM, 2010, INFECTION, V38, P443; Wei XL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-21; Zhang SR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2077-y	18	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185646	10.1371/journal.pone.0185646	http://dx.doi.org/10.1371/journal.pone.0185646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973001	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900033
J	Aminov, A; Rogers, JM; Johnstone, SJ; Middleton, S; Wilson, PH				Aminov, Anna; Rogers, Jeffrey M.; Johnstone, Stuart J.; Middleton, Sandy; Wilson, Peter H.			Acute single channel EEG predictors of cognitive function after stroke	PLOS ONE			English	Article							FRONTAL-MIDLINE THETA; ISCHEMIC-STROKE; QUANTITATIVE EEG; DELTA/ALPHA RATIO; POWER; POSTSTROKE; RELIABILITY; IMPAIRMENT; PREVALENCE; DEPRESSION	Background Early and accurate identification of factors that predict post-stroke cognitive outcome is important to set realistic targets for rehabilitation and to guide patients and their families accordingly. However, behavioral measures of cognition are difficult to obtain in the acute phase of recovery due to clinical factors (e.g. fatigue) and functional barriers (e.g. language deficits). The aim of the current study was to test whether single channel wireless EEG data obtained acutely following stroke could predict longer-term cognitive function. Methods Resting state Relative Power (RP) of delta, theta, alpha, beta, delta/alpha ratio (DAR), and delta/ theta ratio (DTR) were obtained from a single electrode over FP1 in 24 participants within 72 hours of a first-ever stroke. The Montreal Cognitive Assessment (MoCA) was administered at 90-days post-stroke. Correlation and regression analyses were completed to identify relationships between 90-day cognitive function and electrophysiological data, neurological status, and demographic characteristics at admission. Results Four acute qEEG indices demonstrated moderate to high correlations with 90-day MoCA scores: DTR (r = -0.57, p = 0.01), RP theta (r = 0.50, p = 0.01), RP delta (r = -0.47, p = 0.02), and DAR (r = -0.45, p = 0.03). Acute DTR (b = -0.36, p < 0.05) and stroke severity on admission (b = -0.63, p < 0.01) were the best linear combination of predictors of MoCA scores 90days post-stroke, accounting for 75% of variance. Conclusions Data generated by a single pre-frontal electrode support the prognostic value of acute DAR, and identify DTR as a potential marker of post-stroke cognitive outcome. Use of single channel recording in an acute clinical setting may provide an efficient and valid predictor of cognitive function after stroke.	[Aminov, Anna] Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia; [Rogers, Jeffrey M.] South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Johnstone, Stuart J.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Middleton, Sandy] St Vincents Hlth Australia, Nursing Res Inst, Sydney, NSW, Australia; [Middleton, Sandy] Australian Catholic Univ, Sydney, NSW, Australia; [Wilson, Peter H.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Wilson, Peter H.] Australian Catholic Univ, Ctr Disabil & Dev Res, Melbourne, Vic, Australia	Australian Catholic University; University of Wollongong; Australian Catholic University; Australian Catholic University; Australian Catholic University	Rogers, JM (corresponding author), South Eastern Sydney Local Hlth Dist, Sydney, NSW, Australia.	jeffrey.regers@health.nsw.gov.au	Middleton, Sandy/J-5526-2015; Wilson, Peter H./E-2881-2018	Middleton, Sandy/0000-0002-7201-4394; Wilson, Peter H./0000-0003-3747-0287; Rogers, Jeffrey M/0000-0002-0320-969X; Aminov, Anna/0000-0003-4805-5476	Australian Catholic University Faculty Research Grant; Australian Postgraduate Award	Australian Catholic University Faculty Research Grant; Australian Postgraduate Award(Australian Government)	This research was supported by an Australian Catholic University Faculty Research Grant provided to authors JR, SM, and SJ and an Australian Postgraduate Award provided to AA, https://research.acu.edu.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari MH, 2017, BRAIN, V140, P1068, DOI 10.1093/brain/awx021; Alcott D, 1997, DISABIL REHABIL, V19, P355, DOI 10.3109/09638289709166551; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Andreassi J. L., 2013, PSYCHOPHYSIOLOGY HUM, V4th; [Anonymous], CLIN NEUROPSYCHOLOGY; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; Bhalla A, 2013, STROKE, V44, P2174, DOI 10.1161/STROKEAHA.113.001263; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carducci F, 2016, INT J PSYCHOPHYSIOL, V103, P110; Chi Yu Mike, 2010, IEEE Rev Biomed Eng, V3, P106, DOI 10.1109/RBME.2010.2084078; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crichton SL, 2016, J NEUROL NEUROSUR PS, V87, P1091, DOI 10.1136/jnnp-2016-313361; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; Cumming TB, 2010, CEREBROVASC DIS, V30, P7, DOI 10.1159/000313438; Cummins TDR, 2008, INT J PSYCHOPHYSIOL, V70, P75, DOI 10.1016/j.ijpsycho.2008.06.002; Cummins TDR, 2007, INT J PSYCHOPHYSIOL, V66, P10, DOI 10.1016/j.ijpsycho.2007.05.008; Cuspineda E, 2007, CLIN EEG NEUROSCI, V38, P155, DOI 10.1177/155005940703800312; de Haan EH, 2006, CURR OPIN NEUROL, V19, P559, DOI 10.1097/01.wco.0000247612.21235.d9; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Ekandem JI, 2012, ERGONOMICS, V55, P592, DOI 10.1080/00140139.2012.662527; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Felberg R A, 2000, CNS Spectr, V5, P52; Finnigan S, 2016, CLIN NEUROPHYSIOL, V127, P1452, DOI 10.1016/j.clinph.2015.07.014; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; Finnigan S, 2011, PSYCHOPHYSIOLOGY, V48, P1083, DOI 10.1111/j.1469-8986.2010.01173.x; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Fong KNK, 2001, BRAIN INJURY, V15, P443, DOI 10.1080/02699050010005940; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Gargiulo G, 2010, CLIN NEUROPHYSIOL, V121, P686, DOI 10.1016/j.clinph.2009.12.025; George S, 2017, UNDERGRAD RES J, P3; Hashimoto R, 2017, BRAIN STIMUL, V10, P426, DOI DOI 10.1016/J.BRS.2017.01.267; He W, 2017, BRAIN STIMUL, V10, P363; Hewetson R, 2017, APHASIOLOGY, P1; Hofgren C, 2007, ACTA NEUROL SCAND, V115, P73, DOI 10.1111/j.1600-0404.2006.00768.x; Hosking SG, 2000, AGING NEUROPSYCHOL C, V7, P205, DOI 10.1076/anec.7.4.205.798; Johnstone SJ, 2012, CLIN EEG NEUROSCI, V43, P112, DOI 10.1177/1550059411435857; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071; Kober SE, 2017, APPL PSYCHOPHYS BIOF, V42, P69, DOI 10.1007/s10484-017-9353-5; KOPRUNER V, 1984, PROG BRAIN RES, V62, P29; Le HH, 2017, BIOSYST BIOROBOT, V15, P369, DOI 10.1007/978-3-319-46669-9_62; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Lezak M, 2012, NEUROPSYCHOLOGICAL A; Li J, 2017, EXP THER MED, V13, P909, DOI 10.3892/etm.2017.4035; Lindow J, 2015, CLIN NEUROPHYSIOL, V126, pe93; Lithfous S, 2015, NEUROBIOL AGING, V36, P2821, DOI 10.1016/j.neurobiolaging.2015.07.007; Livingston-Thomas J, 2016, NEUROTHERAPEUTICS, V13, P395, DOI 10.1007/s13311-016-0423-9; Makedonov I, 2016, NEUROBIOL AGING, V37, P12, DOI 10.1016/j.neurobiolaging.2015.09.010; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moriya M, 2016, ADV EXP MED BIOL, V923, P203, DOI 10.1007/978-3-319-38810-6_27; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Nesto R W, 1987, Am J Cardiol, V59, p23C; Ni L, 2017, SCI REP, P7; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Planton M, 2012, EUR J NEUROL, V19, P212, DOI 10.1111/j.1468-1331.2011.03450.x; RANKIN J, 1957, Scott Med J, V2, P200; Renton T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177290; Rijsdijk M, 2008, NETH J CRIT CARE, V12, P157; Rogers JM, 2016, INT J PSYCHOPHYSIOL, V106, P87, DOI 10.1016/j.ijpsycho.2016.06.006; Rogers JM, 2015, NEUROREPORT, V26, P903, DOI 10.1097/WNR.0000000000000445; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schleiger E, 2014, INT J PSYCHOPHYSIOL, V94, P19, DOI 10.1016/j.ijpsycho.2014.06.012; Strauss E., 2006, COMPENDIUM NEUROPSYC; Toth B, 2014, NEUROBIOL LEARN MEM, V114, P58, DOI 10.1016/j.nlm.2014.04.009; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; van Zandvoort MJE, 2005, CLIN NEUROL NEUROSUR, V107, P385, DOI 10.1016/j.clineuro.2004.10.012; Ward SA, 2017, INT J STROKE, V12, P108, DOI 10.1177/1747493016669848	74	28	30	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185841	10.1371/journal.pone.0185841	http://dx.doi.org/10.1371/journal.pone.0185841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968458	Green Published, gold			2022-12-27	WOS:000412029600058
J	Dou, JF; Guo, HM; Cheng, F; Huang, HQ; Fu, LY; Li, LN; Yang, C; Ye, L; Wen, LL; Cheng, YY; Tang, LL; Zhu, CH; Zhu, ZW; Wang, WJ; Sheng, YJ; Wang, ZX; Liu, SX; Fan, X; Zuo, XB; Zhou, FS; Sun, LD; Zheng, XD; Zhang, XJ				Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Li, Longnian; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun			Genotype combination contributes to psoriasis: An exhaustive algorithm perspective	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANALYSIS IDENTIFIES 3; SUSCEPTIBILITY LOCI; DISEASE; POPULATION; VARIANTS	Researchers have learned that nearly all conditions and diseases have a genetic component. With the benefit of technological advances, many single-nucleotide polymorphisms (SNPs) have been found to be associated with the risk of complex disorders by using genome wide association studies (GWASs). Disease-associated SNPs are sometimes shared by healthy controls and cannot clearly distinguish affected individuals from unaffected ones. The combined effects of multiple independent SNPs contribute to the disease process, but revealing the relationship between genotype and phenotype based on the combinations remains a great challenge. In this study, by considering the disease prevalence rate, we conducted an exhaustive process to identify whether a genotype combination pattern would have a decisive effect on complex disorders. Based on genotype data for 68 reported SNPs in 8,372 psoriasis patients and 8,510 healthy controls, we found that putative causal genotype combination patterns (CGCPs) were only present in psoriasis patients, not in healthy subjects. These results suggested that psoriasis might be contributed by combined genotypes, complementing the traditional modest susceptibility of a single variant in a single gene for a complex disease. This work is the first systematic study to analyze genotype combinations based on the reported susceptibility genes, considering each individual among the cases and controls from the Chinese population, and could potentially advance disease-gene mapping and precision medicine due to the causality relationship between the candidate CGCPs and complex diseases.	[Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Dou, Jinfa; Guo, Huimin; Cheng, Fang; Huang, Hequn; Fu, Liying; Yang, Chao; Ye, Lei; Wen, Leilei; Cheng, Yuyan; Tang, Lili; Zhu, Caihong; Zhu, Zhengwei; Wang, Wenjun; Sheng, Yujun; Wang, Zaixing; Liu, Shengxiu; Fan, Xing; Zuo, Xianbo; Zhou, Fusheng; Sun, Liangdan; Zheng, Xiaodong; Zhang, Xuejun] Anhui Med Univ, Key Lab Dermatol, Minist Educ, Hefei, Anhui, Peoples R China; [Li, Longnian] Gannan Med Univ, Affiliated Hosp 1, Dept Dermatol, Ganzhou, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Gannan Medical University	Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China.; Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China.; Zheng, XD; Zhang, XJ (corresponding author), Anhui Med Univ, Key Lab Dermatol, Minist Educ, Hefei, Anhui, Peoples R China.	zhengxiaodong.1234@163.com; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022		First Affiliated Hospital of Anhui Medical University [2010KJ11]; Natural Science Foundation of Anhui province [1708085QH211]; National Natural Science Foundation of China [81130031]	First Affiliated Hospital of Anhui Medical University; Natural Science Foundation of Anhui province(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of the National Natural Science Foundation of China (81130031), Youth Fund of the First Affiliated Hospital of Anhui Medical University (2010KJ11) and the Natural Science Foundation of Anhui province (1708085QH211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-8; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Chen HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019454; Ding XL, 2012, EUR J DERMATOL, V22, P663, DOI 10.1684/ejd.2012.1802; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Johnson BA, 2013, AM J PSYCHIAT, V170, P1020, DOI 10.1176/appi.ajp.2013.12091163; Knight J, 2012, HUM MOL GENET, V21, P5185, DOI 10.1093/hmg/dds344; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Olden K, 2011, HEALTH AFFAIR, V30, P833, DOI 10.1377/hlthaff.2011.0078; Phillips TJ, 1999, PSYCHOPHARMACOLOGY, V147, P5, DOI 10.1007/s002130051128; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071934; Yin XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125369; Yin XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7916; Zakharov S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-569; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhang YT, 2014, ANN MATH, V179, P1121, DOI 10.4007/annals.2014.179.3.7	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186067	10.1371/journal.pone.0186067	http://dx.doi.org/10.1371/journal.pone.0186067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020033	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400063
J	Montesano, G; Allegrini, D; Colombo, L; Rossetti, LM; Pece, A				Montesano, Giovanni; Allegrini, Davide; Colombo, Leonardo; Rossetti, Luca M.; Pece, Alfredo			Features of the normal choriocapillaris with OCT-angiography: Density estimation and textural properties	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; LIVING HUMAN EYE; IMAGE ARTIFACTS; VASCULATURE	The main objective of our work is to perform an in depth analysis of the structural features of normal choriocapillaris imaged with OCT Angiography. Specifically, we provide an optimal radius for a circular Region of Interest (ROI) to obtain a stable estimate of the subfoveal choriocapillaris density and characterize its textural properties using Markov Random Fields. On each binarized image of the choriocapillaris OCT Angiography we performed simulated measurements of the subfoveal choriocapillaris densities with circular Regions of Interest (ROIs) of different radii and with small random displacements from the center of the Foveal Avascular Zone (FAZ). We then calculated the variability of the density measure with different ROI radii. We then characterized the textural features of choriocapillaris binary images by estimating the parameters of an Ising model. For each image we calculated the Optimal Radius (OR) as the minimum ROI radius required to obtain a standard deviation in the simulation below 0.01. The density measured with the individual OR was 0.52 +/- 0.07 (mean +/- STD). Similar density values (0.51 +/- 0.07) were obtained using a fixed ROI radius of 450 mu m. The Ising model yielded two parameter estimates (beta = 0.34 +/- 0.03; gamma = 0.003 +/- 0.012; mean +/- STD), characterizing pixel clustering and white pixel density respectively. Using the estimated parameters to synthetize new random textures via simulation we obtained a good reproduction of the original choriocapillaris structural features and density. In conclusion, we developed an extensive characterization of the normal subfoveal choriocapillaris that might be used for flow analysis and applied to the investigation pathological alterations.	[Montesano, Giovanni; Rossetti, Luca M.] Univ Milan, Sch Ophthalmol, Milan, Italy; [Montesano, Giovanni; Colombo, Leonardo; Rossetti, Luca M.] ASST Santi Paolo & Carloeye Clin, Milan, Italy; [Montesano, Giovanni] City Univ London, Optometry & Visual Sci, London, England; [Allegrini, Davide] Humanitas Univ, Eye Clin, Humanitas Gavazzeni, Milan, Italy; [Pece, Alfredo] Melegnano Hosp, Eye Clin, Vizzolo, Predabissi, Italy	University of Milan; City University London; Humanitas University; Istituto Clinico Humanitas Gavazzeni	Montesano, G (corresponding author), Univ Milan, Sch Ophthalmol, Milan, Italy.; Montesano, G (corresponding author), ASST Santi Paolo & Carloeye Clin, Milan, Italy.; Montesano, G (corresponding author), City Univ London, Optometry & Visual Sci, London, England.	giovmontesano@gmail.com	Montesano, Giovanni/AAS-9356-2020	Montesano, Giovanni/0000-0002-9148-2804; Colombo, Leonardo/0000-0002-9556-994X	Retina 3000 Foundation	Retina 3000 Foundation	The Retina 3000 Foundation (http://www.fondazioneretina3000.it/ covered the costs for publication. Retina 3000 Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; Baierlein R., 1999, THERMAL PHYS, VXIII; Bansal R, 2017, MAGN RESON IMAGING, V35, P98, DOI 10.1016/j.mri.2016.08.002; BESAG J, 1975, J ROY STAT SOC D-STA, V24, P179, DOI 10.2307/2987782; Chan SY, 2016, RETINA-J RET VIT DIS, V36, P2051, DOI 10.1097/IAE.0000000000001064; Chen FK, 2016, CLIN EXP OPHTHALMOL, V44, P388, DOI 10.1111/ceo.12683; Choi W, 2015, OPHTHALMOLOGY, V122, P2532, DOI 10.1016/j.ophtha.2015.08.029; Cole ED, 2016, INVESTIGATIVE OPHTHA, V57; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Gorczynska I, 2016, BIOMED OPT EXPRESS, V7, P911, DOI 10.1364/BOE.7.000911; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125477; Jia YL, 2015, P NATL ACAD SCI USA, V112, pE2395, DOI 10.1073/pnas.1500185112; Kim DY, 2013, P NATL ACAD SCI USA, V110, P14354, DOI 10.1073/pnas.1307315110; Montesano G, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00077; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Odstrcilik J, 2014, COMPUT MED IMAG GRAP, V38, P508, DOI 10.1016/j.compmedimag.2014.05.005; Parisot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144200; Rodriguez DA, 2016, INVEST OPHTH VIS SCI, V57, P6474, DOI 10.1167/iovs.16-20138; Santos M, 2015, IEEE ENG MED BIO, P8147, DOI 10.1109/EMBC.2015.7320285; Siden P, 2017, NEUROIMAGE, V146, P211, DOI 10.1016/j.neuroimage.2016.11.040; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Vincent T, 2010, IEEE T MED IMAGING, V29, P1059, DOI 10.1109/TMI.2010.2042064; Wang Q, 2016, AM J OPHTHALMOLOGY; Zhang M, 2016, BIOMED OPT EXPRESS, V7, P816, DOI 10.1364/BOE.7.000816	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185256	10.1371/journal.pone.0185256	http://dx.doi.org/10.1371/journal.pone.0185256			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020026	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000412754400023
J	Arthurs, C; Murtaza, BN; Thomson, C; Dickens, K; Henrique, R; Patel, HRH; Beltran, M; Millar, M; Thrasivoulou, C; Ahmed, A				Arthurs, Callum; Murtaza, Bibi Nazia; Thomson, Calum; Dickens, Kerry; Henrique, Rui; Patel, Hitendra R. H.; Beltran, Mariana; Millar, Michael; Thrasivoulou, Christopher; Ahmed, Aamir			Expression of ribosomal proteins in normal and cancerous human prostate tissue	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; DIFFERENTIAL EXPRESSION; MESSENGER-RNAS; OVEREXPRESS	Few quantifiable tissue biomarkers for the diagnosis and prognosis of prostate cancer exist. Using an unbiased, quantitative approach, this study evaluates the potential of three proteins of the 40S ribosomal protein complex as putative biomarkers of malignancy in prostate cancer. Prostate tissue arrays, constructed from 82 patient samples (245 tissue cores, stage pT3a or pT3b), were stained for antibodies against three ribosomal proteins, RPS19, RPS21 and RPS24. Semi-automated Ox-DAB signal quantification using ImageJ software revealed a significant change in expression of RPS19, RPS21 and RPS24 in malignant vs non-malignant tissue (p < 0.0001). Receiver operating characteristics curves were calculated to evaluate the potential of each protein as a biomarker of malignancy in prostate cancer. Positive likelihood ratios for RPS19, RPS21 and RPS24 were calculated as 2.99, 4.21, and 2.56 respectively, indicating that the overexpression of the protein is correlated with the presence of disease. Triple-labelled, quantitative, immunofluorescence (with RPS19, RPS21 and RPS24) showed significant changes (p < 0.01) in the global intersection coefficient, a measure of how often two fluorophore signals intersect, for RPS19 and RPS24 only. No change was observed in the co-localization of any other permutations of the three proteins. Our results show that RPS19, RPS21 or RPS24 are upregulated in malignant tissue and may serve as putative biomarkers for prostate cancer.	[Arthurs, Callum; Murtaza, Bibi Nazia; Dickens, Kerry; Ahmed, Aamir] Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England; [Murtaza, Bibi Nazia; Ahmed, Aamir] UCL, Div Surg, London, England; [Thomson, Calum] Univ Dundee, Dundee Imaging Facil, Coll Life Sci, Dundee, Scotland; [Henrique, Rui] Portuguese Oncol Inst, Dept Pathol, Oporto, Portugal; [Henrique, Rui] Univ Porto, Dept Pathol & Mol Immunol, Abel Salazar Inst Biomed Sci, Oporto, Portugal; [Patel, Hitendra R. H.] Univ Hosp Northern Norway, Div Surg Oncol Urol & Womens Hlth, Tromso, Norway; [Patel, Hitendra R. H.] Princess Alexandra Hosp NHS Trust, Dept Urol, Harlow, Essex, England; [Beltran, Mariana] Aquila Biomed, Edinburgh, Midlothian, Scotland; [Millar, Michael] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Thrasivoulou, Christopher] UCL, Res Dept Cell & Dev Biol, Ctr Cell & Mol Dynam, Rockefeller Bldg, London, England	University of London; King's College London; University College London; University of London; University College London; University of Dundee; Portuguese Institute of Oncology; Universidade do Porto; UiT The Arctic University of Tromso; University Hospital of North Norway; Princess Alexandra Hospital NHS Trust; University of Edinburgh; University of London; University College London	Ahmed, A (corresponding author), Kings Coll London, Prostate Canc Res Ctr, Ctr Stem Cells & Regenerat Med, London, England.; Ahmed, A (corresponding author), UCL, Div Surg, London, England.	aamir.ahmed@kcl.ac.uk	Henrique, Rui Manuel Ferreira/I-2757-2013; Thrasivoulou, Christopher/F-7087-2010	Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Thrasivoulou, Christopher/0000-0001-9425-8624; Ahmed, Aamir/0000-0001-7405-5336	Prostate Cancer Research Centre charity [1156027, AA1]; King's College London; Aquila Biomedical	Prostate Cancer Research Centre charity; King's College London(General Electric); Aquila Biomedical	This research was funded by the Prostate Cancer Research Centre charity (registered UK charity no. 1156027), Grant Number AA1. Open access for this article was funded by King's College London. Aquila Biomedical provided support in the form of salaries for author (MB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arya M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124395; BARNARD GF, 1993, CANCER RES, V53, P4048; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; CHESTER KA, 1989, BIOCHIM BIOPHYS ACTA, V1009, P297, DOI 10.1016/0167-4781(89)90119-X; FernandezPol JA, 1997, ANTICANCER RES, V17, P1519; Giuliano A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161103; HALPERIN DS, 1989, AM J PEDIAT HEMATOL, V11, P380; HENRY JL, 1993, CANCER RES, V53, P1403; KONDOH N, 1992, CANCER RES, V52, P791; Lai MD, 2007, CURR GENOMICS, V8, P43; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Lopez CD, 2002, CANCER LETT, V180, P195, DOI 10.1016/S0304-3835(02)00024-1; Nariculam J, 2009, ASIAN J ANDROL, V11, P109, DOI 10.1038/aja.2008.22; Presti JC, 2009, UROL ONCOL-SEMIN ORI, V27, P312, DOI 10.1016/j.urolonc.2008.10.029; Rasband W.S., 1997, IMAGEJ; Roehl KA, 2002, J UROLOGY, V167, P2435, DOI 10.1016/S0022-5347(05)64999-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Symes AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084295; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; Wang M, 2017, BIORXIV; Wang Q, 2001, GENE, V263, P205, DOI 10.1016/S0378-1119(00)00570-9; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Wang Y, 2015, GENE, V571, P286, DOI 10.1016/j.gene.2015.06.084; Yong WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141334; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	28	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186047	10.1371/journal.pone.0186047	http://dx.doi.org/10.1371/journal.pone.0186047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016636	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400050
J	de Jong, RCM; Ewing, MM; de Vries, MR; Karper, JC; Bastiaansen, AJNM; Peters, HAB; Baghana, F; van den Elsen, PJ; Gongora, C; Jukema, JW; Quax, PHA				de Jong, Rob C. M.; Ewing, Mark M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; van den Elsen, Peter J.; Gongora, Celine; Jukema, J. Wouter; Quax, Paul H. A.			The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development	PLOS ONE			English	Article							FACTOR-KAPPA-B; PERCUTANEOUS CORONARY INTERVENTIONS; ACCELERATED ATHEROSCLEROSIS; ACETYLTRANSFERASE PCAF; HISTONE ACETYLATION; GENETIC-VARIATION; IN-VIVO; DISEASE; INJURY; RESTENOSIS	Objective Genetic P300/CBP-associated factor (PCAF) variation affects restenosis-risk in patients. PCAF has lysine acetyltransferase activity and promotes nuclear factor kappa-beta (NF kappa B)mediated inflammation, which drives post-interventional intimal hyperplasia development. We studied the contributing role of PCAF in post-interventional intimal hyperplasia. Methods and results PCAF contribution to inflammation and intimal hyperplasia was assessed in leukocytes, macrophages and vascular smooth muscle cells (vSMCs) in vitro and in a mouse model for intimal hyperplasia, in which a cuff is placed around the femoral artery. PCAF deficiency downregulate CCL2, IL-6 and TNF-alpha expression, as demonstrated on cultured vSMCs, leukocytes and macrophages. PCAF KO mice showed a 71.8% reduction of vSMC-rich intimal hyperplasia, a 73.4% reduction of intima/media ratio and a 63.7% reduction of luminal stenosis after femoral artery cuff placement compared to wild type (WT) mice. The association of PCAF and vascular inflammation was further investigated using the potent natural PCAF inhibitor garcinol. Garcinol treatment reduced CCL2 and TNF-alpha expression, as demonstrated on cultured vSMCs and leukocytes. To assess the effect of garcinol treatment on vascular inflammation we used hypercholesterolemic ApoE*3-Leiden mice. After cuff placement, garcinol treatment resulted in reduced arterial leukocyte and macrophage adherence and infiltration after three days compared to untreated animals. Conclusions These results identify a vital role for the lysine acetyltransferase PCAF in the regulation of local inflammation after arterial injury and likely the subsequent vSMC proliferation, responsible for intimal hyperplasia.	[de Jong, Rob C. M.; Ewing, Mark M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; Quax, Paul H. A.] LUMC, Dept Surg, Leiden, Netherlands; [de Jong, Rob C. M.; de Vries, Margreet R.; Karper, Jacco C.; Bastiaansen, Antonius J. N. M.; Peters, Hendrika A. B.; Baghana, Fabiana; Jukema, J. Wouter; Quax, Paul H. A.] LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Ewing, Mark M.; Jukema, J. Wouter] LUMC, Dept Cardiol, Leiden, Netherlands; [van den Elsen, Peter J.] LUMC, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [van den Elsen, Peter J.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Gongora, Celine] Univ Montpellier 2, Montpellier, France; [Gongora, Celine] Inst Rech Cancerol Montpellier, INSERM, U89, Montpellier, France	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Quax, PHA (corresponding author), LUMC, Dept Surg, Leiden, Netherlands.; Quax, PHA (corresponding author), LUMC, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.	P.H.A.Quax@lumc.nl	de Vries, Margreet/Z-5653-2019; Jukema, J. Wouter/ABD-6503-2021; Quax, Paul/ABD-5294-2020; Quax, Paul/W-8520-2019	Jukema, J. Wouter/0000-0002-3246-8359; Quax, Paul/0000-0002-6853-5760; GONGORA, Celine/0000-0001-9034-4031	Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation [CVON2011-19]; Netherlands CardioVascular Research Initiative: Dutch Federation of University Medical Centres [CVON2011-19]; Netherlands CardioVascular Research Initiative: Netherlands Organisation for Health Research and Development [CVON2011-19]; Netherlands CardioVascular Research Initiative: Royal Netherlands Academy of Sciences [CVON2011-19]	Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative: Dutch Federation of University Medical Centres; Netherlands CardioVascular Research Initiative: Netherlands Organisation for Health Research and Development; Netherlands CardioVascular Research Initiative: Royal Netherlands Academy of Sciences	This work was supported by the Netherlands CardioVascular Research Initiative: "the Dutch Heart Foundation, Dutch Federation of University Medical Centres, the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences" for the GENIUS project "Generating the best evidence-based pharmaceutical targets for atherosclerosis" (CVON2011-19).	Ahmad Aamir, 2011, Front Biosci (Elite Ed), V3, P1483; Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bastiaansen AJNM, 2013, ARTERIOSCL THROM VAS, V33, P1902, DOI 10.1161/ATVBAHA.113.301579; Chen X, 2012, NUTR CANCER, V64, P1211, DOI 10.1080/01635581.2012.718032; de Vries MR, 2013, J MOL CELL CARDIOL, V64, P51, DOI 10.1016/j.yjmcc.2013.08.009; Duclot F, 2010, NEUROSCIENCE, V167, P850, DOI 10.1016/j.neuroscience.2010.02.055; Duclot F, 2010, NEUROSCI LETT, V475, P179, DOI 10.1016/j.neulet.2010.03.077; Egashira K, 2002, CIRC RES, V90, P1167, DOI 10.1161/01.RES.0000020561.03244.7E; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Han YS, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0169-6; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Huang J, 2015, EPIGENETICS-US, V10, P62, DOI 10.4161/15592294.2014.990780; Kim WJH, 2003, BIOCHEM BIOPH RES CO, V310, P936, DOI 10.1016/j.bbrc.2003.09.088; Lardenoye JHP, 2000, CIRC RES, V87, P248, DOI 10.1161/01.RES.87.3.248; Lee MS, 2004, J PATHOL, V203, P861, DOI 10.1002/path.1598; Liu CQ, 2015, CANCER LETT, V362, P8, DOI 10.1016/j.canlet.2015.03.019; Matsumoto K, 2003, BIOL PHARM BULL, V26, P569, DOI 10.1248/bpb.26.569; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Monraats PS, 2005, FASEB J, V19, P1998, DOI 10.1096/fj.05-4634com; Monraats PS, 2005, CIRCULATION, V112, P2417, DOI 10.1161/CIRCULATIONAHA.105.536268; Niida T, 2012, CARDIOVASC RES, V93, P371, DOI 10.1093/cvr/cvr323; Pearson T, 2015, WORKPLACE HEALTH SAF, V63, P376, DOI 10.1177/2165079915593032; Pires NMM, 2006, VASC PHARMACOL, V44, P257, DOI 10.1016/j.vph.2006.01.011; Pons D, 2007, THROMB HAEMOSTASIS, V98, P1323, DOI 10.1160/TH07-04-0301; Pons D, 2011, HEART, V97, P143, DOI 10.1136/hrt.2010.199927; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Shoji M, 2014, J ATHEROSCLER THROMB, V21, P304, DOI 10.5551/jat.19414; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Simsekyilmaz S, 2015, THROMB HAEMOSTASIS, V113, P464, DOI 10.1160/TH14-07-0599; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zimmerman MA, 2002, AM J PHYSIOL-REG I, V283, pR505, DOI 10.1152/ajpregu.00033.2002	41	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185820	10.1371/journal.pone.0185820	http://dx.doi.org/10.1371/journal.pone.0185820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016683	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400031
J	Ellmore, TM; Ng, K; Reichert, CP				Ellmore, Timothy M.; Ng, Kenneth; Reichert, Chelsea P.			Early and late components of EEG delay activity correlate differently with scene working memory performance	PLOS ONE			English	Article							ALPHA-ACTIVITY; BRAIN OSCILLATIONS; GAMMA-ACTIVITY; SHORT-TERM; THETA; DESYNCHRONIZATION; SYNCHRONIZATION; MAINTENANCE; DYNAMICS; CORTEX	Sustained and elevated activity during the working memory delay period has long been considered the primary neural correlate for maintaining information over short time intervals. This idea has recently been reinterpreted in light of findings generated from multiple neural recording modalities and levels of analysis. To further investigate the sustained or transient nature of activity, the temporal-spectral evolution (TSE) of delay period activity was examined in humans with high density EEG during performance of a Sternberg working memory paradigm with a relatively long six second delay and with novel scenes as stimuli. Multiple analyses were conducted using different trial window durations and different baseline periods for TSE computation. Sensor level analyses revealed transient rather than sustained activity during delay periods. Specifically, the consistent finding among the analyses was that high amplitude activity encompassing the theta range was found early in the first three seconds of the delay period. These increases in activity early in the delay period correlated positively with subsequent ability to distinguish new from old probe scenes. Source level signal estimation implicated a right parietal region of transient early delay activity that correlated positively with working memory ability. This pattern of results adds to recent evidence that transient rather than sustained delay period activity supports visual working memory performance. The findings are discussed in relation to synchronous and desynchronous intra-and inter-regional neural transmission, and choosing an optimal baseline for expressing temporal-spectral delay activity change.	[Ellmore, Timothy M.; Ng, Kenneth; Reichert, Chelsea P.] CUNY City Coll, Dept Psychol, New York, NY 10031 USA; [Ellmore, Timothy M.; Reichert, Chelsea P.] CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY 10016 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Ellmore, TM (corresponding author), CUNY City Coll, Dept Psychol, New York, NY 10031 USA.; Ellmore, TM (corresponding author), CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY 10016 USA.	tellmore@ccny.cany.edu	Ellmore, Timothy M./I-3760-2019	Ellmore, Timothy M./0000-0001-6125-0044; Reichert, Chelsea/0000-0001-9662-6179	PSC-CUNY [TRAD-45-104]; National Institute of General Medical Sciences of the National Institutes of Health [SC2GM109346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM109346] Funding Source: NIH RePORTER	PSC-CUNY; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PSC-CUNY award TRAD-45-104 (to TME). Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number SC2GM109346 (to TME). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bashivan P, 2014, EUR J NEUROSCI, V40, P3774, DOI 10.1111/ejn.12749; Berger Barbara, 2015, Biology-Basel, V4, P1, DOI 10.3390/biology4010001; Brain Products, 2016, PROD APPL; Burke JF, 2013, J NEUROSCI, V33, P292, DOI 10.1523/JNEUROSCI.2057-12.2013; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DASILVA FHL, 1999, EVENT RELATED DESYNC, V6; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fellner MC, 2013, NEUROIMAGE, V79, P361, DOI 10.1016/j.neuroimage.2013.04.121; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hanslmayr S, 2009, CEREB CORTEX, V19, P1631, DOI 10.1093/cercor/bhn197; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hsieh LT, 2011, J NEUROSCI, V31, P10803, DOI 10.1523/JNEUROSCI.0828-11.2011; Hussar CR, 2013, J NEUROSCI, V33, P972, DOI 10.1523/JNEUROSCI.4075-12.2013; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Jafarpour A, 2013, NEUROPSYCHOLOGIA, V51, P772, DOI 10.1016/j.neuropsychologia.2012.04.002; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Kaiser J, 2001, NEUROSCI LETT, V312, P149, DOI 10.1016/S0304-3940(01)02217-0; Khader PH, 2010, NEUROSCI LETT, V468, P339, DOI 10.1016/j.neulet.2009.11.028; Khursheed F, 2011, NEUROIMAGE, V56, P1773, DOI 10.1016/j.neuroimage.2011.02.062; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lisman J, 2010, CURR BIOL, V20, pR490, DOI 10.1016/j.cub.2010.04.011; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lundqvist M, 2016, NEURON, V90, P152, DOI 10.1016/j.neuron.2016.02.028; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2012, PSYCHOPHYSIOLOGY, V49, P549, DOI 10.1111/j.1469-8986.2011.01320.x; Meeuwissen EB, 2011, HUM BRAIN MAPP, V32, P2045, DOI 10.1002/hbm.21167; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Offen S, 2009, VISION RES, V49, P1352, DOI 10.1016/j.visres.2007.12.022; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Papp N, 1977, Biomed Sci Instrum, V13, P135; Pfurtscheller G, 2001, VISION RES, V41, P1257, DOI 10.1016/S0042-6989(00)00235-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Richards JE, 2016, NEUROIMAGE, V124, P1254, DOI 10.1016/j.neuroimage.2015.04.055; Roberts BM, 2013, NEUROPSYCHOLOGIA, V51, P349, DOI 10.1016/j.neuropsychologia.2012.10.009; Rose NS, 2016, SCIENCE, V354, P1136, DOI 10.1126/science.aah7011; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Teplan M., 2002, MEASUREMENT SCI REV, V2, P1, DOI DOI 10.1021/PR070350L; Tuladhar AM, 2007, HUM BRAIN MAPP, V28, P785, DOI 10.1002/hbm.20306; Wolff MJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00123; Xiao J, 2010, CVPR 2010 IEEE C; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	64	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186072	10.1371/journal.pone.0186072	http://dx.doi.org/10.1371/journal.pone.0186072			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016657	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400054
J	Li, HY; Luo, XN; Ke, XY; Dai, Q; Zheng, W; Zhang, CJ; Cassidy, RM; Soares, JC; Zhang, XY; Ning, YP				Li, Haiyan; Luo, Xinni; Ke, Xiaoyin; Dai, Qing; Zheng, Wei; Zhang, Chanjuan; Cassidy, Ryan M.; Soares, Jair C.; Zhang, XiangYang; Ning, Yuping			Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population	PLOS ONE			English	Article							PREVALENCE; IDEATION; VALIDATION; VALIDITY; HOPELESSNESS; INTERVIEW; SEVERITY; PEOPLE; PHQ-15; RATES	Background Somatic complaints are often the presenting symptoms of major depressive disorder (MDD) in the outpatient context, because this may go unrecognized. It is well understood that MDD carries an increased risk of suicide. This study aimed to identify the risk factors and association with both MDD and suicidality among Han Chinese outpatients. Methods A multicenter study was carried out in 5189 outpatient adults (>= 18 years old) in four general hospitals in Guangzhou, China. The 1392 patients who had the Patient Health Question-naire-9 (PHQ-9) score >= 5, indicating depressive symptoms were offered an interview with a psychiatrist by the Mini International Neuropsychiatric Interview (MINI); 819 patients consented and completed the MINI interview. MINI module B was used to assess suicidality. Stepwise binary logistic models were used to estimate the relationship between a significant risk factor and suicide or MDD. According to with or without MDD, the secondary analysis was performed using the logistic regression model for the risk of suicidility. Results The current prevalence of MDD and the one month prevalence of suicidality were 3.7% and 2.3% respectively. The odds ratio of suicidality in women was more than twice that in men (OR = 2.62; 95% CI 1.45-4.76). Other risk factors which were significantly associated with suicidality were: living alone, higher education, self-reported depression, getting psychiatric diagnoses (MDD, anxiety disorders, and bipolar disorders). Significant risk factors for MDD were also noticed, such as comorbid anxiety disorders, self-reported anxiety, insomnia, suicidal ideation. Limitation It's a cross-sectional study in outpatient clinics using self-report questionnaires. Conclusion This study provides valuable data about the risk factors and association of MDD and suicide risk in adult outpatients in Han Chinese. Those factors allow better the employment of preventative measures.	[Li, Haiyan; Ning, Yuping] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Li, Haiyan; Luo, Xinni; Ke, Xiaoyin; Dai, Qing; Zheng, Wei; Zhang, Chanjuan; Ning, Yuping] Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Haiyan; Ning, Yuping] Natl Clin Res Ctr Mental Disorders, Changsha, Hunan, Peoples R China; [Cassidy, Ryan M.; Soares, Jair C.; Zhang, XiangYang] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Southern Medical University - China; Guangzhou Medical University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Ning, YP (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Ning, YP (corresponding author), Guangzhou Med Univ, Guangzhou Huiai Hosp, Affiliated Brain Hosp, Guangzhou, Guangdong, Peoples R China.; Ning, YP (corresponding author), Natl Clin Res Ctr Mental Disorders, Changsha, Hunan, Peoples R China.	ningjeny@126.com		Cassidy, Ryan Michael/0000-0003-4100-0413; Soares, Jair C./0000-0002-5466-5628	National Key Research and Development Plan "Precision Medical Research" Project [2016YFC0906302]; Guangzhou Medical and Health Science and Technology Major Projects [20151A031003]; National Science and Technologic Program of China [2015BA1131302]; First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine; Guangzhou Panyu Central Hospital; Southern Medical University; Third Affiliated Hospital of Sun Yet-Sen University	National Key Research and Development Plan "Precision Medical Research" Project; Guangzhou Medical and Health Science and Technology Major Projects; National Science and Technologic Program of China; First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine; Guangzhou Panyu Central Hospital; Southern Medical University; Third Affiliated Hospital of Sun Yet-Sen University	This study was funded through National Key Research and Development Plan "Precision Medical Research" 2016 Project (2016YFC0906302) to YPN; Guangzhou Medical and Health Science and Technology Major Projects (20151A031003) to YPN; the National Science and Technologic Program of China(2015BA1131302) to YPN. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; It was conducted in and supported by these participating hospitals (The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou Panyu Central Hospital, Southern Medical University, The Third Affiliated Hospital of Sun Yet-Sen University). The authors would also like to thank Bin Sun and Prof. Robert A. Rosenheck.	Agarwal A, 2016, ASIAN J ANDROL, V18, P163, DOI 10.4103/1008-682X.172638; ASNIS GM, 1993, AM J PSYCHIAT, V150, P108; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Baldwin David S, 2002, Psychopharmacol Bull, V36 Suppl 2, P158; Britton PC, 2008, AM J GERIAT PSYCHIAT, V16, P736, DOI 10.1097/JGP.0b013e31817b609a; Chan WSC, 2009, SOC PSYCH PSYCH EPID, V44, P278, DOI 10.1007/s00127-008-0434-x; Chen SL, 2010, INT J GERIATR PSYCH, V25, P1127, DOI 10.1002/gps.2442; Chen Y, 2017, PSYCHOL MED, V47, P958, DOI 10.1017/S0033291716002889; Cheung YB, 2006, J AFFECT DISORDERS, V90, P193, DOI 10.1016/j.jad.2005.11.018; Cigognini MA, 2006, REV BRAS PSIQUIATR, V28, P97, DOI 10.1590/S1516-44462006000200005; Cohen AD, 2006, J AM ACAD DERMATOL, V54, P94, DOI 10.1016/j.jaad.2005.09.019; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Duhoux A, 2013, J AFFECT DISORDERS, V151; Eikelenboom M, 2012, J PSYCHIATR RES, V46, P608, DOI 10.1016/j.jpsychires.2012.01.025; Fava M, 2006, CAN J PSYCHIAT, V51, P823, DOI 10.1177/070674370605101304; Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637; Jenkinson C, 1997, J Health Serv Res Policy, V2, P14; Katon Wayne J, 2011, Dialogues Clin Neurosci, V13, P7; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Law Samuel, 2008, Curr Psychiatry Rep, V10, P80; [李献云 LI Xianyun], 2010, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V36, P65; Liu KY, 2006, PSYCHOL MED, V36, P1759, DOI 10.1017/S0033291706009032; Liu XC, 2000, SLEEP, V23, P27; Ma X, 2009, AUST NZ J PSYCHIAT, V43, P158, DOI 10.1080/00048670802607170; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Olver JS, 2013, MED J AUSTRALIA, V199, P9, DOI 10.5694/mjao12.10597; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Qin P, 2013, J INTERN MED, V273, P48, DOI 10.1111/j.1365-2796.2012.02572.x; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Sartorius N, 1996, BRIT J PSYCHIAT, V168, P38, DOI 10.1192/S0007125000298395; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; [司天梅 SI Tian-Mei], 2009, [中国心理卫生杂志, Chinese Mental Health Journal], V23, P493; Siu AL, 2016, JAMA-J AM MED ASSOC, V315, P380, DOI 10.1001/jama.2015.18392; Sokero TP, 2003, J CLIN PSYCHIAT, V64, P1094, DOI 10.4088/JCP.v64n0916; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tong X, 2016, EPILEPSY RES, V120, P31, DOI 10.1016/j.eplepsyres.2015.11.019; Wang JL, 2010, J AFFECT DISORDERS, V123, P158, DOI 10.1016/j.jad.2009.07.016; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whittier AB, 2016, J AFFECT DISORDERS, V197, P58, DOI 10.1016/j.jad.2016.02.052; World Health Organization, 2014, PREV SUIC PREV SUIC; World Health Organization (WHO), 2016, WOONC; Zhang L, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0798-5	48	42	50	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186143	10.1371/journal.pone.0186143	http://dx.doi.org/10.1371/journal.pone.0186143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016669	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400055
J	Wilbers, RHP; van Raaij, DR; Westerhof, LB; Bakker, J; Smant, G; Schots, A				Wilbers, Ruud H. P.; van Raaij, Debbie R.; Westerhof, Lotte B.; Bakker, Jaap; Smant, Geert; Schots, Arjen			Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain	PLOS ONE			English	Article							INTERLEUKIN-10 RECEPTOR COMPLEX; HUMAN NEUTROPHILS; T-CELLS; EXPRESSION; MACROPHAGES; MECHANISMS; PATHWAY; BINDING; MODEL; SOCS3	Interleukin-10 (IL-10) is an anti-inflammatory cytokine that plays a key role in maintaining immune homeostasis. IL-10-mediated responses are triggered upon binding to a heterodimeric receptor complex consisting of IL-10 receptor (IL-10R) 1 and IL-10R2. Engagement of the IL-10R complex activates the intracellular kinases Jak1 and Tyk2, but the exact roles of IL-10R2 and IL-10R2-associated signaling via Tyk2 remain unclear. To elucidate the contribution of IL-10R2 and its signaling to IL-10 activity, we re-evaluated IL-10-mediated responses on bone marrow-derived dendritic cells, macrophages and mast cells. By using bone marrow from IL-10R(-/-) mice it was revealed that IL-10-mediated responses depend on both IL-10R1 and IL-10R2 in all three cell types. On the contrary, bone marrow-derived cells from Tyk2(-/-) mice showed similar responses to IL-10 as wild-type cells, indicating that signaling via this IL-10R2-associated kinase only plays a limited role. Tyk2 was shown to control the amplitude of STAT3 activation and the up-regulation of downstream SOCS3 expression. SOCS3 up-regulation was found to be cell-type dependent and correlated with the lack of early suppression of LPS-induced TNF-alpha in dendritic cells. Further investigation of the IL10R complex revealed that both the extracellular and intracellular domains of IL-10R2 influence the conformation of IL-10R1 and that both domains were required for transducing IL10 signals. This observation highlights a novel role for the intracellular domain of IL-10R2 in the molecular mechanisms of IL-10R activation.	[Wilbers, Ruud H. P.; van Raaij, Debbie R.; Westerhof, Lotte B.; Bakker, Jaap; Smant, Geert; Schots, Arjen] Wageningen Univ & Res, Plant Sci Grp, Lab Nematol, Wageningen, Netherlands	Wageningen University & Research	Wilbers, RHP (corresponding author), Wageningen Univ & Res, Plant Sci Grp, Lab Nematol, Wageningen, Netherlands.	ruud.wilbers@wur.nl	Schots, Arjen/U-1839-2017; Wilbers, Ruud/S-8796-2017; Wilbers, Ruud/O-1844-2019; Schots, Arjen/ABF-8014-2020	Schots, Arjen/0000-0002-6036-7088; Wilbers, Ruud/0000-0003-1149-9268; Wilbers, Ruud/0000-0003-1149-9268; Schots, Arjen/0000-0002-6036-7088	Synthon BV, Nijmegen, The Netherlands	Synthon BV, Nijmegen, The Netherlands	This work was partly funded by Synthon BV, Nijmegen, The Netherlands. There was no additional external funding received for this study.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; Ding YZ, 2001, J IMMUNOL, V167, P6884, DOI 10.4049/jimmunol.167.12.6884; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; HO ASY, 1995, MOL CELL BIOL, V15, P5043; Josephson K, 2000, J BIOL CHEM, V275, P25054; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kotenko SV, 1997, EMBO J, V16, P5894, DOI 10.1093/emboj/16.19.5894; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; Pang XD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002427; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Qasimi P, 2006, J BIOL CHEM, V281, P6316, DOI 10.1074/jbc.M508608200; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Shaw MH, 2006, J IMMUNOL, V176, P7263, DOI 10.4049/jimmunol.176.12.7263; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; TAN JC, 1995, J BIOL CHEM, V270, P12906, DOI 10.1074/jbc.270.21.12906; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; Vogl C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-199; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wilbers RHP, 2016, PLANT BIOTECHNOL J, V14, P670, DOI 10.1111/pbi.12414; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	35	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186317	10.1371/journal.pone.0186317	http://dx.doi.org/10.1371/journal.pone.0186317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016674	Green Submitted, gold, Green Published			2022-12-27	WOS:000412627400066
J	Paraschiv, S; Banica, L; Nicolae, I; Niculescu, I; Abagiu, A; Jipa, R; Pineda-Pena, AC; Pingarilho, M; Neaga, E; Theys, K; Libin, P; Otelea, D; Abecasis, A				Paraschiv, Simona; Banica, Leontina; Nicolae, Ionelia; Niculescu, Iulia; Abagiu, Adrian; Jipa, Raluca; Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Neaga, Emil; Theys, Kristof; Libin, Pieter; Otelea, Dan; Abecasis, Ana			Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users	PLOS ONE			English	Article							HEPATITIS-C; MOLECULAR EPIDEMIOLOGY; VIRUS-INFECTION; HIGH PREVALENCE; SUBTYPE F1; PEOPLE; SEQUENCES; GENOTYPES; SPREAD; RISK	Co-infections with HIV and HCV are very frequent among people who inject drugs (PWID). However, very few studies comparatively reconstructed the transmission patterns of both viruses in the same population. We have recruited 117 co-infected PWID during a recent HIV outbreak in Romania. Phylogenetic analyses were performed on HIV and HCV sequences in order to characterize and compare transmission dynamics of the two viruses. Three large HIV clusters (2 subtype F1 and one CRF14_BG) and thirteen smaller HCV transmission networks (genotypes 1a, 1b, 3a, 4a and 4d) were identified. Eighty (65%) patients were both in HIV and HCV transmission chains and 70 of those shared the same HIV and HCV cluster with at least one other patient. Molecular clock analysis indicated that all identified HIV clusters originated around 2006, while the origin of the different HCV clusters ranged between 1980 (genotype 1b) and 2011 (genotypes 3a and 4d). HCV infection preceded HIV infection in 80.3% of cases. Coincidental transmission of HIV and HCV was estimated to be rather low (19.65%) and associated with an outbreak among PWID during detention in the same penitentiary. This study has reconstructed and compared the dispersion of these two viruses in a PWID population.	[Paraschiv, Simona; Banica, Leontina; Nicolae, Ionelia; Neaga, Emil; Otelea, Dan] Natl Inst Infect Dis Matei Bals, Mol Diagnost Lab, Bucharest, Romania; [Niculescu, Iulia; Abagiu, Adrian; Jipa, Raluca] Natl Inst Infect Dis Matei Bals, Clin Dept, Bucharest, Romania; [Niculescu, Iulia] SMZ Sud Kaiser Franz Josef Spital, 4 Med Abt, Vienna, Austria; [Pineda-Pena, Andrea-Clemencia; Pingarilho, Marta; Abecasis, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Mol Biol & Immunol Dept, Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Pineda-Pena, Andrea-Clemencia] Univ Rosario, Basic Sci Dept, Bogota, Colombia; [Theys, Kristof; Libin, Pieter; Abecasis, Ana] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Libin, Pieter] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Iab, Brussels, Belgium	National Institute for Infectious Diseases "Matei Bals"; National Institute for Infectious Diseases "Matei Bals"; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidad del Rosario; Universidad del Rosario; KU Leuven; Vrije Universiteit Brussel	Paraschiv, S (corresponding author), Natl Inst Infect Dis Matei Bals, Mol Diagnost Lab, Bucharest, Romania.	mona_manaila@yahoo.com	Otelea, Dan/AAV-6467-2021; Jipa, Raluca/P-2044-2017; Paraschiv, Simona/AAW-5691-2021; Abecasis, Ana/ABF-6657-2020; Abecasis, Ana/B-6295-2009; Pineda-Peña, Andrea-Clemencia/N-9809-2015; Paraschiv, Simona/N-6991-2015	Abecasis, Ana/0000-0002-3903-5265; Abecasis, Ana/0000-0002-3903-5265; Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; Pereira Pingarilho, Marta Sofia/0000-0002-7928-3087; Otelea, Dan/0000-0002-0821-6346; Banica, Leontina/0000-0001-9956-951X; Libin, Pieter/0000-0003-3906-758X; Paraschiv, Simona/0000-0001-6707-3720	Executive Agency for Higher Education, Research, Development and Innovation Funding [BEST-HOPE 4-003/2012, HIV-ID 260/2015]; National Authority for Scientific Research; GreenVac project [5SEE/2014]; POSCCE program CRCBABI project [642/2014]; ational Authority for Scientific Research(ANCS) [POSDRU/1591/1.5/S/135760-CERO]; Fonds Wetenschappelijk Onderzoek Vlaanderen	Executive Agency for Higher Education, Research, Development and Innovation Funding; National Authority for Scientific Research; GreenVac project; POSCCE program CRCBABI project; ational Authority for Scientific Research(ANCS); Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO)	This study was supported by the Executive Agency for Higher Education, Research, Development and Innovation Funding (http:// uefiscdi.gov.ro/) grant BEST-HOPE 4-003/2012 (DO) and project HIV-ID 260/2015 (SP). The National Authority for Scientific Research (http:// research.ro/en) partially supported this work, GreenVac project, 5SEE/2014 (DO) and POSCCE program CRCBABI project (642/2014). EN was supported by National Authority for Scientific Research(ANCS), grant POSDRU/1591/1.5/S/135760-CERO. PL was supported by PhD grant of the Fonds Wetenschappelijk Onderzoek Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abagiu A, 2012, UPDATE COUNTRY SITUA, V11; [Anonymous], 2013, UNAIDS 2013 GLOB REP, P30; [Anonymous], 2014, ROMANIAN HIV AIDS NA, P20; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Botescu A, 2012, HIV AIDS INJECTING D, P5; Butler IF, 2007, CURR HIV RES, V5, P23, DOI 10.2174/157016207779316297; Chen JY, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.17; Ciccozzi M, 2012, J MED VIROL, V84, P1613, DOI 10.1002/jmv.23384; de Bruijne J, 2009, J CLIN MICROBIOL, V47, P3832, DOI 10.1128/JCM.01146-09; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Fernandez-Arcas N, 2006, J MED VIROL, V78, P1429, DOI 10.1002/jmv.20706; Gheorghe L, 2010, J GASTROINTEST LIVER, V19, P373; Grigorescu M, 2009, J GASTROINTEST LIVER, V18, P45; Guide for HIV/ AIDS clinical care, 2014, GUIDE HIV AIDS CLIN; Guimaraes ML, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-39; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Katsoulidou A, 2006, J VIRAL HEPATITIS, V13, P19, DOI 10.1111/j.1365-2893.2005.00649.x; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Maher L, 2007, AUST NZ J PUBL HEAL, V31, P30, DOI 10.1111/j.1753-6405.2007.00007.x; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; Ng KT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15198; Niculescu I, 2015, AIDS RES HUM RETROV, V31, P488, DOI 10.1089/aid.2014.0189; Paraskevis D, 2015, INFECT GENET EVOL, V35, P109, DOI 10.1016/j.meegid.2015.08.004; Perez-Alvarez L, 2014, J ANTIMICROB CHEMOTH, V69, P246, DOI 10.1093/jac/dkt305; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A., 2016, VIRUS EVOL, V2; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stockman JK, 2010, JAIDS-J ACQ IMM DEF, V55, pS17, DOI 10.1097/QAI.0b013e3181f9c04c; Sultana C, 2011, CENT EUR J MED, V6, P672, DOI 10.2478/s11536-011-0073-6; United Nations Office of Drug Control, 2015, WORLD DRUG REP; Uuskula A, 2007, INT J STD AIDS, V18, P41, DOI 10.1258/095646207779949907; Vallet S, 2011, ANTIVIR THER, V16, P1093, DOI 10.3851/IMP1900; van Asten L, 2004, J INFECT DIS, V189, P292, DOI 10.1086/380821; Walsh N, 2012, CURR OPIN HIV AIDS, V7, P339, DOI 10.1097/COH.0b013e328354131e; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	48	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185866	10.1371/journal.pone.0185866	http://dx.doi.org/10.1371/journal.pone.0185866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016621	Green Published, gold			2022-12-27	WOS:000412601800024
J	Andersson, E; Bergemalm, D; Kruse, R; Neumann, G; D'Amato, M; Repsilber, D; Halfvarson, J				Andersson, Erik; Bergemalm, Daniel; Kruse, Robert; Neumann, Gunter; D'Amato, Mauro; Repsilber, Dirk; Halfvarson, Jonas			Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; ULCERATIVE-COLITIS; CROHNS-DISEASE; RECEPTOR; S100A12; ASSOCIATION; BIOMARKERS; REMISSION; CHEMOKINE	Objective Genetic and immunological data indicate that inflammatory bowel disease (IBD) are characterized by specific inflammatory protein profiles. However, the serum proteome of IBD is still to be defined. We aimed to characterize the inflammatory serum protein profiles of Crohn's disease (CD) and ulcerative colitis (UC), using the novel proximity extension assay. Methods A panel of 91 inflammatory proteins were quantified in a discovery cohort of CD (n = 54), UC patients (n = 54), and healthy controls (HCs; n = 54). We performed univariate analyses by t-test, with false discovery rate correction. A sparse partial least-squares (sPLS) approach was used to identify additional discriminative proteins. The results were validated in a replication cohort. Results By univariate analysis, 17 proteins were identified with significantly different abundances in CD and HCs, and 12 when comparing UC and HCs. Additionally, 64 and 45 discriminant candidate proteins, respectively, were identified with the multivariate approach. Correspondingly, significant cross-validation error rates of 0.12 and 0.19 were observed in the discovery cohort. Only FGF-19 was identified from univariate comparisons of CD and UC, but 37 additional discriminant candidates were identified using the multivariate approach. The observed cross-validation error rate for CD vs. UC remained significant when restricting the analyses to patients in clinical remission. Using univariate comparisons, 16 of 17 CD-associated proteins and 8 of 12 UC-associated proteins were validated in the replication cohort. The area under the curve for CD and UC was 0.96 and 0.92, respectively, when the sPLS model from the discovery cohort was applied to the replication cohort. Conclusions By using the novel PEA method and a panel of inflammatory proteins, we identified proteins with significantly different quantities in CD patients and UC patients compared to HCs. Our data highlight the potential of the serum IBD proteome as a source for identification of future diagnostic biomarkers.	[Andersson, Erik; Kruse, Robert; Neumann, Gunter] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden; [Bergemalm, Daniel; Halfvarson, Jonas] Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden; [D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [D'Amato, Mauro] BioDonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Orebro University; Orebro University; Karolinska Institutet; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science	Halfvarson, J (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden.	jonas.halfvarson@regionorebrolan.se	D'Amato, Mauro/F-2450-2010; D'Amato, Mauro/B-5050-2019; Halfvarson, Jonas/AAU-4687-2020; Neumann, Gunter/S-1165-2019	D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; 	Orebro University Hospital Research Foundation [OLL-507001, OLL-526131]; Swedish Foundation For Strategic Research [RB13-016]; Swedish Research Council [521-2011-2764]	Orebro University Hospital Research Foundation; Swedish Foundation For Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was independently funded by Orebro University Hospital Research Foundation, grant numbers OLL-507001 to JH, OLL-526131 to DB; the Swedish Foundation For Strategic Research, grant number RB13-016 to JH; and Swedish Research Council, grant number 521-2011-2764 to JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Beigel F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093498; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Cleynen I, 2016, LANCET, V387, P156, DOI 10.1016/S0140-6736(15)00465-1; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Dabritz J, 2013, INFLAMM BOWEL DIS, V19, P1130, DOI 10.1097/MIB.0b013e318280b1cd; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Ek WE, 2014, ANN GASTROENTEROL, V27, P294; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847; Fransen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072739; Grip O, 2000, EUR J GASTROEN HEPAT, V12, P761, DOI 10.1097/00042737-200012070-00008; HARVEY RF, 1980, LANCET, V1, P514; Hedl M, 2015, GUT; Hormi K, 2000, GROWTH FACTORS, V18, P79, DOI 10.3109/08977190009003235; Jungbeck M, 2009, IMMUNOLOGY, V128, P451, DOI 10.1111/j.1365-2567.2009.03131.x; Kaiser T, 2007, GUT, V56, P1706, DOI 10.1136/gut.2006.113431; Korolkova OY, 2015, CLIN MED INSIGHTS-GA, V8, P29, DOI 10.4137/CGast.S20612; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lacher M, 2007, BIOCHEM BIOPH RES CO, V363, P701, DOI 10.1016/j.bbrc.2007.09.020; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Li N, 2012, MOL BIOL REP, V39, P5659, DOI 10.1007/s11033-011-1373-2; Rodriguez-Peralvarez ML, 2012, INFLAMM BOWEL DIS, V18, P1864, DOI 10.1002/ibd.22865; Mehmood T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-327; Meuwis MA, 2007, BIOCHEM PHARMACOL, V73, P1422, DOI 10.1016/j.bcp.2006.12.019; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Nolan JD, 2015, J CROHNS COLITIS, V9, P125, DOI 10.1093/ecco-jcc/jju022; Ray S, 2011, PROTEOMICS, V11, P2139, DOI 10.1002/pmic.201000460; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singh UP, 2016, CYTOKINE, V77, P44, DOI 10.1016/j.cyto.2015.10.008; Stanislawowski M, 2014, J CROHNS COLITIS, V8, P802, DOI 10.1016/j.crohns.2013.12.021; Subramanian S, 2017, GUT, V66, P362, DOI 10.1136/gutjnl-2016-312673; Torres J, LANCET; Townsend P, 2015, INFLAMM BOWEL DIS, V21, P1935, DOI 10.1097/MIB.0000000000000445; Ungaro R, LANCET; Wasinger VC, 2016, MOL CELL PROTEOMICS, V15, P256, DOI 10.1074/mcp.M115.055095; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186142	10.1371/journal.pone.0186142	http://dx.doi.org/10.1371/journal.pone.0186142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982144	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300129
J	Callcut, RA; Moore, S; Wakam, G; Hubbard, AE; Cohen, MJ				Callcut, Rachael A.; Moore, Sara; Wakam, Glenn; Hubbard, Alan E.; Cohen, Mitchell J.			Finding the signal in the noise: Could social media be utilized for early hospital notification of multiple casualty events?	PLOS ONE			English	Article							EMERGENCY-PREPAREDNESS	Introduction Delayed notification and lack of early information hinder timely hospital based activations in large scale multiple casualty events. We hypothesized that Twitter real-time data would produce a unique and reproducible signal within minutes of multiple casualty events and we investigated the timing of the signal compared with other hospital disaster notification mechanisms. Methods Using disaster specific search terms, all relevant tweets from the event to 7 days post-event were analyzed for 5 recent US based multiple casualty events (Boston Bombing [BB], SF Plane Crash [SF], Napa Earthquake [NE], Sandy Hook [SH], and Marysville Shooting [MV]). Quantitative and qualitative analysis of tweet utilization were compared across events. Results Over 3.8 million tweets were analyzed (SH 1.8 m, BB 1.1m, SF 430k, MV 250k, NE 205k). Peak tweets per min ranged from 209-3326. The mean followers per tweeter ranged from 3382-9992 across events. Retweets were tweeted a mean of 82-564 times per event. Tweets occurred very rapidly for all events (<2 mins) and represented 1% of the total event specific tweets in a median of 13 minutes of the first 911 calls. A 200 tweets/min threshold was reached fastest with NE (2 min), BB (7 min), and SF (18 mins). If this threshold was utilized as a signaling mechanism to place local hospitals on standby for possible large scale events, in all case studies, this signal would have preceded patient arrival. Importantly, this threshold for signaling would also have preceded traditional disaster notification mechanisms in SF, NE, and simultaneous with BB and MV. Conclusions Social media data has demonstrated that this mechanism is a powerful, predictable, and potentially important resource for optimizing disaster response. Further investigated is warranted to assess the utility of prospective signally thresholds for hospital based activation.	[Callcut, Rachael A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Moore, Sara; Hubbard, Alan E.] Univ Calif Berkeley, Dept Biostat, Berkeley, CA 94720 USA; [Wakam, Glenn] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Cohen, Mitchell J.] Univ Colorado, Dept Surg, Denver, CO USA; [Cohen, Mitchell J.] Denver Hlth, Denver, CO USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Denver; Denver Health Medical Center	Callcut, RA (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	Rachael.Callcut@ucsf.edu	Callcut, Rachael/ABE-1484-2021		Career Development Award (K01) from the Big Data to Knowledge Initiative of the National Institute of Health [K01 ES026834]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES026834] Funding Source: NIH RePORTER	Career Development Award (K01) from the Big Data to Knowledge Initiative of the National Institute of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work received support from K01 ES026834 Career Development Award (K01) from the Big Data to Knowledge Initiative of the National Institute of Health, Administered by the National Institute of Environmental Health Sciences (RC), https://commonfund.nih.gov/bd2k/fundedresearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleaziz Hamed, 2016, CHP OFFICER STABBED; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], HIST POWER TRACK; Barnes MD, 2008, AM J PUBLIC HEALTH, V98, P604, DOI 10.2105/AJPH.2007.112235; Campion EM, 2016, JAMA SURG, V151, P512, DOI 10.1001/jamasurg.2015.5107; Ecker UKH, 2011, Q J EXP PSYCHOL, V64, P283, DOI 10.1080/17470218.2010.497927; Greenwood S, 2016, SOCIAL MEDIA UPDATE; Gribble KD, 2013, DISASTERS, V37, P80, DOI 10.1111/j.1467-7717.2012.01289.x; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Huang CM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-57; Keim Mark E, 2011, Am J Disaster Med, V6, P47; Lowrey W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-97; Massachusetts Emergency Management Agency & multi-jurisdictional Project Management Team, 2015, ACT REP RESP 2013 BO; Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591; National Transportation Safety Board, 2014, DESC BEL VIS GLID IM; Ooms J, 2014, ARXIV14032805; Perrin A, 2015, SOCIAL MEDIA USAGE 2; Pew Research Center, SOC MED FACT SHEET; Rodrguez H., 2007, HDB DISASTER RES, DOI [10.1007/978-0-387-32353-4_29, DOI 10.1007/978-0-387-32353-4_29]; Snohomish County Multiple Agency Response Team, 2015, MPHS SHOOT; Stanley Jeremy, 2015, TIDYJSON GRAMMAR TUR; State of Connecticut Department of Emergency Services and Public Protection, 2013, PRIM INV REP SAND HO; U. S. Geological Survey National Earthquake Information Center, 2014, M 6 0 6KM NW AM CANY	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186118	10.1371/journal.pone.0186118	http://dx.doi.org/10.1371/journal.pone.0186118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982201	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300126
J	Clark, DB; Clark, DA; Oberbauer, SF; Kellner, JR				Clark, David B.; Clark, Deborah A.; Oberbauer, Steven F.; Kellner, James R.			Multidecadal stability in tropical rain forest structure and dynamics across an old-growth landscape	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; SCALE DISTRIBUTIONS; LA-SELVA; BIOMASS; CARBON; MORTALITY; FIELD; HETEROGENEITY; PRODUCTIVITY; LIMITATION	Have tropical rain forest landscapes changed directionally through recent decades? To answer this question requires tracking forest structure and dynamics through time and across within-forest environmental heterogeneity. While the impacts of major environmental gradients in soil nutrients, climate and topography on lowland tropical rain forest (TRF) structure and function have been extensively analyzed, the effects of the shorter environmental gradients typical of mesoscale TRF landscapes remain poorly understood. To evaluate multi-decadal performance of an old-growth TRF at the La Selva Biological Station, Costa Rica, we established 18 0.5-ha annually-censused forest inventory plots in a stratified-random design across major landscape edaphic gradients. Over the 17-year study period, there were moderate differences in stand dynamics and structure across these gradients but no detectable difference in woody productivity. We found large effects on forest structure and dynamics from the mega-Nino event at the outset of the study, with subdecadal recovery and subsequent stabilization. To extend the timeline to >40 years, we combined our findings with those from earlier studies at this site. While there were annual to multiannual variations in the structure and dynamics, particularly in relation to local disturbances and the mega-Nino event, at the longer temporal scale and broader spatial scale this landscape was remarkably stable. This stability contrasts notably with a current hypothesis of increasing biomass and dynamics of TRF, which we term the Bigger and Faster Hypothesis (B&FHo). We consider possible reasons for the contradiction and conclude that it is currently not possible to independently assess the vast majority of previously published B&FHo evidence due to restricted data access.	[Clark, David B.; Clark, Deborah A.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Oberbauer, Steven F.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI USA	University of Missouri System; University of Missouri Saint Louis; State University System of Florida; Florida International University; Brown University	Clark, DB (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	dbclark50@yahoo.com		Clark, Deborah/0000-0002-4000-4925	U.S. National Science Foundation of the CARBONO project, from NSF LTREB [NSF 1357177]; U.S. Department of Energy [DE-FG02-96ER62289]; Tropical Ecosystems Ecology and Monitoring Project of Conservation International; Direct For Biological Sciences [1544438, 1357112] Funding Source: National Science Foundation	U.S. National Science Foundation of the CARBONO project, from NSF LTREB; U.S. Department of Energy(United States Department of Energy (DOE)); Tropical Ecosystems Ecology and Monitoring Project of Conservation International; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the U.S. National Science Foundation (www.nsf.gov/) for long-term funding of the CARBONO project, most recently from NSF LTREB NSF 1357177 to David B. Clark, Deborah A. Clark and James Kellner. Additional funding was provided by the U.S. Department of Energy DE-FG02-96ER62289 (https://energy.gov/) and the Tropical Ecosystems Ecology and Monitoring Project of Conservation International (http://www.teamnetworkorg/).	Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Brown S., 1997, 134 FAO, V134; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; CLARK DA, 1995, ECOLOGY, V76, P2581, DOI 10.2307/2265829; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2010, GLOBAL CHANGE BIOL, V16, P747, DOI 10.1111/j.1365-2486.2009.02004.x; Clark DB, 1996, J TROP ECOL, V12, P735, DOI 10.1017/S0266467400009937; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Clark DA, 2011, BIOTROPICA, V43, P31, DOI 10.1111/j.1744-7429.2010.00654.x; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hartshorn GS, 1988, TROPICAL RAINFORESTS, P281; Johnson MO, 2016, GLOBAL CHANGE BIOL, V22, P3996, DOI 10.1111/gcb.13315; Jones MM, 2007, J VEG SCI, V18, P13, DOI 10.1111/j.1654-1103.2007.tb02511.x; Jones MM, 2006, J ECOL, V94, P181, DOI 10.1111/j.1365-2745.2005.01071.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; Kennedy LM, 2008, BIOTROPICA, V40, P11, DOI 10.1111/j.1744-7429.2007.00334.x; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P451; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; LIEBERMAN D, 1985, J ECOL, V73, P915, DOI 10.2307/2260157; LIEBERMAN D, 1987, J TROP ECOL, V3, P347, DOI 10.1017/S0266467400002327; Lieberman Milton, 1994, P106; Manokaran N, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P585; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; McNutt M, 2016, SCIENCE, V351, P1024, DOI 10.1126/science.aad7048; Meyer V., 2013, Biogeosciences, V10, P5421, DOI 10.5194/bg-10-5421-2013; Muller-Landau H.C., 2014, FORESTS GLOBAL CHANG, P381, DOI DOI 10.1017/CBO9781107323506.018; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Parker Geoffrey G., 1994, P54; Phillips OL, 2014, FORESTS GLOBAL CHANG, P77, DOI DOI 10.1017/CBO9781107323506.006; Phillips OL, 2016, ECOL STUD-ANAL SYNTH, V227, P191, DOI 10.1007/978-3-662-49902-3_10; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Sheil D, 1996, J ECOL, V84, P91, DOI 10.2307/2261703; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009	48	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183819	10.1371/journal.pone.0183819	http://dx.doi.org/10.1371/journal.pone.0183819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981502	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300006
J	Elliott, M; Maignel, J; Liu, SM; Favre-Guilmard, C; Mir, I; Farrow, P; Hornby, F; Marlin, S; Palan, S; Beard, M; Krupp, J				Elliott, Mark; Maignel, Jacquie; Liu, Sai Man; Favre-Guilmard, Christine; Mir, Imran; Farrow, Paul; Hornby, Fraser; Marlin, Sandra; Palan, Shilpa; Beard, Matthew; Krupp, Johannes			Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; SYNAPTOTAGMIN-II; NEUROTRANSMITTER RELEASE; STRUCTURAL-ANALYSIS; CERVICAL DYSTONIA; LIGHT-CHAIN; LOW PH; BINDING; TOXIN; TRANSLOCATION	Botulinum neurotoxins (BoNTs) are used extensively as therapeutic agents. Serotypes A and B are available as marketed products. Higher doses of BoNT/B are required to reach an efficacy similar to that of products containing BoNT/A. Advances in our understanding of BoNT/B mechanism of action have afforded the opportunity to make rational modifications to the toxin aimed at increasing its activity. Recently, a mutation in the light chain of BoNT/B (S201P) was described that increases the catalytic activity of the isolated BoNT/B light chain in biochemical assays. In this study, we have produced two full-length recombinant BoNT/B toxins in E. coli-one wild type (rBoNT/B1) and one incorporating the S201P mutation (rBoNT/B1((S201P))). We have compared the activity of these two molecules along with a native BoNT/B1 in biochemical cell-free assays and in several biological systems. In the cell-free assay, which measured light-chain activity alone, rBoNT/B1((S201P)) cleaved VAMP2 and VAMP-1 substrate with an activity 3-4-fold higher than rBoNT/B1. However, despite the enhanced catalytic activity of rBoNT/B1((S201P)), there was no significant difference in potency between the two molecules in any of the in vitro cell-based assays, using either rodent spinal cord neurons or cortical neurons. Similarly in ex vivo tissue preparations rBoNT/B1((S201P)) was not significantly more potent than rBoNT/B1 at inhibiting either diaphragm or detrusor (bladder) muscle activity in C57BL/6N and CD1 mice. Finally, no differences between rBoNT/B1 and rBoNT/B1((S201P)) were observed in an in vivo digit abduction score (DAS) assay in C57BL/6N mice, either in efficacy or safety parameters. The lack of translation from the enhanced BoNT/B1((S201P)) catalytic activity to potency in complex biological systems suggests that the catalytic step is not the rate-limiting factor for BoNT/B to reach maximum efficacy. In order to augment the efficacy of BoNT/B in humans, strategies other than enhancing light chain activity may need to be considered.	[Elliott, Mark; Liu, Sai Man; Mir, Imran; Farrow, Paul; Hornby, Fraser; Marlin, Sandra; Palan, Shilpa; Beard, Matthew] Ipsen Bioinnovat, 102 Pk Dr,Milton Pk, Abingdon, Oxon, England; [Maignel, Jacquie; Favre-Guilmard, Christine; Krupp, Johannes] Ipsen Innovat, Les Ulis, France	Ipsen	Elliott, M (corresponding author), Ipsen Bioinnovat, 102 Pk Dr,Milton Pk, Abingdon, Oxon, England.	mark.elliott@ipsen.com		Maignel, Jacquie/0000-0002-2512-5593	Ipsen	Ipsen(Ipsen)	This research was funded by Ipsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; Aoki KR, 2001, TOXICON, V39, P1815, DOI 10.1016/S0041-0101(01)00101-5; Atassi MZ, 2014, PROTEIN J, V33, P278, DOI 10.1007/s10930-014-9557-y; Bentivoglio AR, 2015, TOXICON, V107, P77, DOI 10.1016/j.toxicon.2015.08.001; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brin MF, 2008, MOVEMENT DISORD, V23, P1353, DOI 10.1002/mds.22157; Broide RS, 2013, TOXICON, V71, P18, DOI 10.1016/j.toxicon.2013.05.004; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Chen S, 2012, TOXINS, V4, P913, DOI 10.3390/toxins4100913; Chen S, 2012, BIOCHEMISTRY-US, V51, P3941, DOI 10.1021/bi3000098; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dressler D, 2005, J NEUROL, V252, P904, DOI 10.1007/s00415-005-0774-3; Fischer A, 2013, TOXICON, V75, P101, DOI 10.1016/j.toxicon.2013.01.007; Guo JB, 2013, TOXICON, V74, P158, DOI 10.1016/j.toxicon.2013.08.055; JANKOVIC J, 1995, NEUROLOGY, V45, P1743, DOI 10.1212/WNL.45.9.1743; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lawrence GW, 2010, J PHARMACOL EXP THER, V334, P1080, DOI 10.1124/jpet.110.169342; Liu Y, 2011, J PHYSIOL-LONDON, V589, P1603, DOI 10.1113/jphysiol.2010.201939; Maignel-Ludop J, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.289; Marques RE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004315.pub3; Naumann M, 2013, J NEURAL TRANSM, V120, P275, DOI 10.1007/s00702-012-0893-9; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; Palea S, 2012, EUR J PHARMACOL, V690, P202, DOI 10.1016/j.ejphar.2012.06.036; PAPINI E, 1993, J BIOL CHEM, V268, P1567; Peng LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004177; Pirazzini M, 2016, BBA-BIOMEMBRANES, V1858, P467, DOI 10.1016/j.bbamem.2015.08.014; Pirazzini M, 2014, CELL REP, V8, P1870, DOI 10.1016/j.celrep.2014.08.017; Pirazzini M, 2013, FEBS LETT, V587, P3831, DOI 10.1016/j.febslet.2013.10.010; Rasetti-Escargueil C, 2011, TOXICON, V57, P1008, DOI 10.1016/j.toxicon.2011.04.003; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Rummel A, 2006, INVENTORTRANSPORT PR; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200; Sikorra S, 2016, J MOL BIOL, V428, P372, DOI 10.1016/j.jmb.2015.10.024; Sloop RR, 1997, NEUROLOGY, V49, P189, DOI 10.1212/WNL.49.1.189; Sun SH, 2012, BIOCHEMISTRY-US, V51, P5655, DOI 10.1021/bi3004928; Sun SH, 2011, CELL HOST MICROBE, V10, P237, DOI 10.1016/j.chom.2011.06.012; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Takahashi R, 2012, J UROLOGY, V188, P1993, DOI 10.1016/j.juro.2012.07.001; Tao L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00064-y; Yamamoto H, 2012, MICROBIOL IMMUNOL, V56, P245, DOI 10.1111/j.1348-0421.2012.00434.x	46	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185628	10.1371/journal.pone.0185628	http://dx.doi.org/10.1371/journal.pone.0185628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982136	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300051
J	Gatti, P; Ghislieri, C; Cortese, CG				Gatti, Paola; Ghislieri, Chiara; Cortese, Claudio G.			Relationships between followers' behaviors and job satisfaction in a sample of nurses	PLOS ONE			English	Article							DEMANDS-RESOURCES MODEL; LEADER-MEMBER EXCHANGE; PSYCHOSOCIAL WORK-ENVIRONMENT; REGISTERED NURSES; FAMILY CONFLICT; EMPLOYEE VOICE; ORGANIZATIONAL CITIZENSHIP; PROACTIVE PERSONALITY; NURSING PROFESSION; SAFETY CLIMATE	The study investigated two followership behaviors, followers' active engagement and followers' independent critical thinking, and their relationship with job satisfaction in a sample of nurses. In addition, the study also considered a number of control variables and classical job demands and job resources-workload and emotional dissonance for job demands, and meaningful work for job resources-which have an impact on well-being at work. A paper-and-pencil questionnaire was administered to 425 nurses in an Italian hospital, and a hierarchical multiple regression was used to test the hypotheses. In addition to the job demands and job resources considered, followers' active engagement had a significant impact on job satisfaction. Moreover, it showed a significant linear and curvilinear relationship with the outcome variable. Followers' independent critical thinking has a non significant relationship with job satisfaction, confirming the mixed results obtained in the past for this dimension. These findings bore out the importance of analyzing followers' behaviors as potential resources that people can use on the job to increase their own well-being. Looking at followers not just as passive recipients but as active and proactive employees can also benefit the organization.	[Gatti, Paola; Ghislieri, Chiara; Cortese, Claudio G.] Univ Turin, Dept Psychol, Turin, Italy	University of Turin	Gatti, P; Ghislieri, C (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	p.gatti@unito.it; chiara.ghislieri@unito.it	Ghislieri, Chiara/F-8547-2013	Ghislieri, Chiara/0000-0003-4002-8756				Agho A.O., 2009, J LEADERSH ORG STUD, V16, P159, DOI [DOI 10.1177/1548051809335360, 10.1177/1548051809335360]; Arnold KA, 2007, J OCCUP HEALTH PSYCH, V12, P193, DOI 10.1037/1076-8998.12.3.193; Ashmos DP, 2000, J MANAGE INQUIRY, V9, P134, DOI 10.1177/105649260092008; Atefi N, 2014, INT NURS REV, V61, P352, DOI 10.1111/inr.12112; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker A. B., 2011, OXFORD HDB POSITIVE, P178, DOI 10.13140/2.1.1145.472.3; Bakker AB, 2004, HUM RESOUR MANAGE-US, V43, P83, DOI 10.1002/hrm.20004; Bakker Arnold B., 2006, INT J STRESS MANAGE, V13, P423, DOI [DOI 10.1037/1072-5245.13.4.423, 10.1037/1072-5245.13.4.423]; Blanchard AL, 2009, PSYCHOL-MANAG J, V12, P111, DOI 10.1080/10887150902888718; BLEGEN MA, 1993, NURS RES, V42, P36; Bradley JR, 2002, INT J STRESS MANAGE, V9, P163, DOI 10.1023/A:1015567731248; Burns J. M., 1978, LEADERSHIP; Carsten MK, 2010, LEADERSHIP QUART, V21, P543, DOI 10.1016/j.leaqua.2010.03.015; Chung-Yan GA, 2011, CAN J BEHAV SCI, V43, P279, DOI 10.1037/a0024501; Clark A.E., 1997, LABOUR ECON, V4, P341, DOI DOI 10.1016/S0927-5371(97)00010-9; Collinson D, 2006, LEADERSHIP QUART, V17, P179, DOI 10.1016/j.leaqua.2005.12.005; Cortese CG, 2007, MED LAV, V98, P175; Cortese CG, 2014, MED LAV, V105, P37; Cortese Claudio G, 2007, J Nurs Manag, V15, P303, DOI 10.1111/j.1365-2834.2007.00694.x; Cortese CG, 2013, ASSIST INFERM RIC, V32, P20, DOI 10.1702/1267.13987; Cottingham MD, 2015, SEX ROLES, V72, P377, DOI 10.1007/s11199-014-0419-z; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; Demerouti E, 2011, SA J IND PSYCHOL, V37, DOI 10.4102/sajip.v37i2.974; Detert JR, 2007, ACAD MANAGE J, V50, P869; Djukic M, 2014, RES NURS HEALTH, V37, P312, DOI 10.1002/nur.21606; Dulebohn JH, 2012, J MANAGE, V38, P1715, DOI 10.1177/0149206311415280; FRIED Y, 1987, PERS PSYCHOL, V40, P287, DOI 10.1111/j.1744-6570.1987.tb00605.x; Gatti P., 2014, BPA APPL PSYCHOL B, V62; Gatti P, 2014, TPM-TEST PSYCHOM MET, V21, P67, DOI 10.4473/TPM21.1.5; Ghislieri C., 2015, BPA APPL PSYCHOL B, V63; Ghislieri C, 2017, J NURS MANAGE, V25, P65, DOI 10.1111/jonm.12442; Ghislieri C, 2012, LEADERSHIP-LONDON, V8, P257, DOI 10.1177/1742715012441177; Grant AM, 2009, PERS PSYCHOL, V62, P31, DOI 10.1111/j.1744-6570.2008.01128.x; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Hall GB, 2013, ANXIETY STRESS COPIN, V26, P355, DOI 10.1080/10615806.2012.700477; Han K, 2015, J CLIN NURS, V24, P3224, DOI 10.1111/jocn.12987; Hansbrough TK, 2015, LEADERSHIP QUART, V26, P220, DOI 10.1016/j.leaqua.2014.11.006; Harris KJ, 2006, J SOC PSYCHOL, V146, P65, DOI 10.3200/SOCP.146.1.65-84; Hesselgreaves H, 2014, HUM RESOUR MANAG J, V24, P459, DOI 10.1111/1748-8583.12042; Hills D, 2012, EVAL HEALTH PROF, V35, P47, DOI 10.1177/0163278710397339; Hochwarter W, 2005, J BUS PSYCHOL, V19, P505, DOI 10.1007/s10869-005-4522-6; Janssen O, 2001, ACAD MANAGE J, V44, P1039, DOI 10.2307/3069447; Jonsson S, 2012, SCAND J CARING SCI, V26, P236, DOI 10.1111/j.1471-6712.2011.00924.x; Joyce C, 2015, J HEALTH SERV RES PO, V20, P224, DOI 10.1177/1355819615591022; KATZ R, 1978, ADMIN SCI QUART, V23, P204, DOI 10.2307/2392562; Kelley R. E., 1992, POWER FOLLOWERSHIP C; Kelley R.E., 2008, ART FOLLOWERSHIP GRE, P5; KELLEY RE, 1988, HARVARD BUS REV, V66, P142; Kinicki AJ, 2002, J APPL PSYCHOL, V87, P14, DOI 10.1037//0021-9010.87.1.14; Kirpal S., 2004, CAREER DEV INT, V9, P274, DOI [DOI 10.1108/13620430410535850, 10.1108/13620430410535850]; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; LePine JA, 2001, J APPL PSYCHOL, V86, P326, DOI 10.1037//0021-9010.86.2.326; Lewig K. A., 2003, EUR J WORK ORGAN PSY, V12, P366; Li J, 2010, SCAND J PUBLIC HEALT, V38, P69, DOI 10.1177/1403494809354361; Li N, 2010, J APPL PSYCHOL, V95, P395, DOI 10.1037/a0018079; Lieff SJ, 2009, ACAD MED, V84, P1383, DOI 10.1097/ACM.0b013e3181b6bd54; Locke E. A., 1976, HDB IND ORG PSYCHOL, P1297, DOI DOI 10.1207/S15427633SCC0304; Lord RG, 2016, ORGAN BEHAV HUM DEC, V136, P119, DOI 10.1016/j.obhdp.2016.03.001; Magee W, 2013, SEX ROLES, V69, P308, DOI 10.1007/s11199-013-0297-9; Mauno S, 2006, WORK STRESS, V20, P210, DOI 10.1080/02678370600999969; Morrison EW, 2011, ACAD MANAG ANN, V5, P373, DOI 10.1080/19416520.2011.574506; Morton JL, 2012, J NURS MANAGE, V20, P579, DOI 10.1111/j.1365-2834.2012.01476.x; Mushonga S.M., 2008, REV BUSINESS RES, V8, P185; Nielsen MB, 2011, SCAND J PSYCHOL, V52, P465, DOI 10.1111/j.1467-9450.2011.00885.x; Nunnally J., 1978, PSYCHOMETRIC THEORY; Parker SK, 2007, HUM RELAT, V60, P403, DOI 10.1177/0018726707076684; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Qin X, 2014, J ORGAN BEHAV, V35, P1018, DOI 10.1002/job.1948; ROBINSON SL, 1994, J ORGAN BEHAV, V15, P245, DOI 10.1002/job.4030150306; Schaufeli W.B., 2014, BRIDGING OCCUPATIONA, P43; Schluter PJ, 2011, INT NURS REV, V58, P28, DOI 10.1111/j.1466-7657.2010.00849.x; Shamir B., 2007, FOLLOWER CTR PERSPEC, P9; Singhapakdi A, 2014, J BUS RES, V67, P1257, DOI 10.1016/j.jbusres.2013.04.004; Steger J A, 1982, Manage Rev, V71, P22; Stuart EH, 2008, J CLIN NURS, V17, P3012, DOI 10.1111/j.1365-2702.2008.02316.x; Tangirala S, 2008, ACAD MANAGE J, V51, P1189, DOI 10.5465/AMJ.2008.35732719; Tanoff G. F., 2002, CONSULTING PSYCHOL J, V54, P157, DOI DOI 10.1037/1061-4087.54.3.157; Uhl-Bien M, 2014, LEADERSHIP QUART, V25, P83, DOI 10.1016/j.leaqua.2013.11.007; Van Dyne L, 1998, ACAD MANAGE J, V41, P108, DOI 10.2307/256902; van Veldhoven MJPM, 2012, J SOC ISSUES, V68, P665, DOI 10.1111/j.1540-4560.2012.01770.x; Warr P., 1987, WORK UNEMPLOYMENT ME; WILLIAMS LJ, 1991, J MANAGE, V17, P601, DOI 10.1177/014920639101700305; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zangaro GA, 2007, RES NURS HEALTH, V30, P445, DOI 10.1002/nur.20202; Zapf D., 1999, EUR J WORK ORGAN PSY, V8, P371, DOI DOI 10.1080/135943299398230; Zeytinoglu IU, 2007, CAN PUBLIC POL, V33, pS31, DOI 10.3138/0560-6GV2-G326-76PT; Zito M, 2016, J NURS MANAGE, V24, P1	87	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185905	10.1371/journal.pone.0185905	http://dx.doi.org/10.1371/journal.pone.0185905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982186	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300084
J	Li, HZ; Nykoluk, M; Li, L; Liu, LR; Omange, RW; Soule, G; Schroeder, LT; Toledo, N; Kashem, MA; Correia-Pinto, JF; Liang, BH; Schultz-Darken, N; Alonso, MJ; Whitney, JB; Plummer, FA; Luo, M				Li, Hongzhao; Nykoluk, Mikaela; Li, Lin; Liu, Lewis R.; Omange, Robert W.; Soule, Geoff; Schroeder, Lukas T.; Toledo, Nikki; Kashem, Mohammad Abul; Correia-Pinto, Jorge F.; Liang, Binhua; Schultz-Darken, Nancy; Alonso, Maria J.; Whitney, James B.; Plummer, Francis A.; Luo, Ma			Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; HUMAN ENDOGENOUS RETROVIRUSES; T-CELL RESPONSES; DNA VACCINE TRIAL; CLASS-I ALLELES; HIV-1 INFECTION; RHESUS MACAQUES; CATALYTIC ANTIBODIES; VIREMIA	Cynomolgus macaques are an increasingly important nonhuman primate model for HIV vaccine research. SIV-free animals without pre-existing anti-SIV immune responses are generally needed to evaluate the effect of vaccine-induced immune responses against the vaccine epitopes. Here, in order to select such animals for vaccine studies, we screened 108 naive female Mauritian cynomolgus macaques for natural (baseline) antibodies to SIV antigens using a Bio-Plex multiplex system. The antigens included twelve 20mer peptides overlapping the twelve SIV protease cleavage sites (-10/+10), respectively (PCS peptides), and three non-PCS Gag or Env peptides. Natural antibodies to SIV antigens were detected in subsets of monkeys. The antibody reactivity to SIV was further confirmed by Western blot using purified recombinant SIV Gag and Env proteins. As expected, the immunization of monkeys with PCS antigens elicited anti-PCS antibodies. However, unexpectedly, antibodies to non-PCS peptides were also induced, as shown by both Bio-Plex and Western blot analyses, while the non-PCS peptides do not share sequence homology with PCS peptides. The presence of natural and vaccine cross-inducible SIV antibodies in Mauritian cynomolgus macaques should be considered in animal selection, experimental design and result interpretation, for their best use in HIV vaccine research.	[Li, Hongzhao; Li, Lin; Liu, Lewis R.; Omange, Robert W.; Schroeder, Lukas T.; Toledo, Nikki; Kashem, Mohammad Abul; Plummer, Francis A.; Luo, Ma] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Nykoluk, Mikaela; Soule, Geoff; Liang, Binhua; Plummer, Francis A.; Luo, Ma] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Correia-Pinto, Jorge F.; Alonso, Maria J.] Univ Santiago Compostela, CIMUS Res Inst, La Coruna, Spain; [Liang, Binhua] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Schultz-Darken, Nancy] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA; [Whitney, James B.] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	University of Manitoba; Public Health Agency of Canada; Universidade de Santiago de Compostela; University of Manitoba; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Luo, M (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.; Luo, M (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Ma.Luo@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022; Alonso, Maria Jose/K-3893-2014; Correia-Pinto, Jorge/B-3344-2012; Omange, Were/F-1454-2016	Correia-Pinto, Jorge/0000-0002-9265-6896; Kashem, Mohammad/0000-0002-6472-3676; Omange, Were/0000-0002-0421-110X; Alonso, Maria Jose/0000-0001-7187-9567; liang, binhua/0000-0002-1108-6407	National Institute of Allergy and Infectious Diseases grant [R01AI111805]; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant; National Microbiology Laboratory of Canada; NIH [R01AI111805]; CIHR/CHVI bridging grant	National Institute of Allergy and Infectious Diseases grant; Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant; National Microbiology Laboratory of Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CHVI bridging grant	This study was supported by the following funding awarded to ML: a National Institute of Allergy and Infectious Diseases grant, with grant number: R01AI111805 and URL: https://www.niaid.nih.gov/; a Canadian Institutes of Health Research/Canadian HIV Vaccine Initiative Bridging grant (no grant number available), with URL: http://www.cihr-irsc.gc.ca/e/42458.html; and funding from National Microbiology Laboratory of Canada (no grant number available), with URL: https://www.nml-lnm.gc.ca/index-eng.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the VTS staff at Canadian Science Centre for Human and Animal Health, Christine De Graff, Julie Kubay, Michelle French, Stephanie Kucas, Kimberly Azaransky, Carissa EmburyHyatt and Valerie Smid, and the staff of the Mass Spectrometry and Proteomics Core Facility at the National Microbiology Laboratory, Dr. Garrett Westmacott, Dr. Christopher C. R. Grant, and Stuart McCorrister, for tremendous technical support. We would also like to thank Dr. Jon Warren and Dr. Nancy Miller, NIH Vaccine Research Program, for providing the SIVmac251 Desrosiers" 2010-Day 8 viral stock. We recognize Dr. Stuart Shapiro, NIH Vaccine Research Program, and Dr. Matthew Gilmour, National Microbiology Laboratory of Canada, for important support and discussion. This work was supported by an NIH grant (R01AI111805), a CIHR/CHVI bridging grant and funding from National Microbiology Laboratory of Canada.	Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Arimi M M, 2006, East Afr Med J, V83, P106; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Carnathan DG, 2015, P NATL ACAD SCI USA, V112, P518, DOI 10.1073/pnas.1407466112; Chen YX, 2014, VACCINES, V2, P138, DOI 10.3390/vaccines2010138; Cho K, 2008, SHOCK, V30, P105, DOI 10.1097/SHK.0b013e31816a363f; Chowdhury A, 2015, J VIROL, V89, P8677, DOI 10.1128/JVI.00869-15; Contreras-Galindo R, 2007, AIDS RES HUM RETROV, V23, P116, DOI 10.1089/aid.2006.0117; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; Craig L, 1998, J MOL BIOL, V281, P183, DOI 10.1006/jmbi.1998.1907; Cutts T, 2016, J INFECT DIS, V214, pS218, DOI 10.1093/infdis/jiw289; Dewannieux M, 2010, BIOLOGICALS, V38, P366, DOI 10.1016/j.biologicals.2010.01.006; Escalera-Zamudio M, 2016, APMIS, V124, P44, DOI 10.1111/apm.12489; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Gonzalez-Hernandez MJ, 2012, J VIROL, V86, P7790, DOI 10.1128/JVI.07215-11; Greene JM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0066-z; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Jones RB, 2012, J CLIN INVEST, V122, P4473, DOI 10.1172/JCI64560; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Laderoute MP, 2007, AIDS, V21, P2417, DOI 10.1097/QAD.0b013e3282f14d64; Langat DK, 1999, J REPROD IMMUNOL, V42, P41, DOI 10.1016/S0165-0378(98)00043-6; LAWLER SH, 1995, AM J PHYS ANTHROPOL, V96, P133, DOI 10.1002/ajpa.1330960203; Li HZ, 2017, J MED PRIMATOL, V46, P137, DOI 10.1111/jmp.12300; Lu S, 1996, J VIROL, V70, P3978, DOI 10.1128/JVI.70.6.3978-3991.1996; Lu S, 1997, VACCINE, V15, P920, DOI 10.1016/S0264-410X(96)00282-4; Lu S, 2010, CURR HIV RES, V8, P622, DOI 10.2174/157016210794088290; Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057; Luo M, 2012, J VIROL, V86, P1166, DOI 10.1128/JVI.05721-11; O'Connor SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000524; Paces J, 2013, NEW BIOTECHNOL, V30, P314, DOI 10.1016/j.nbt.2012.11.009; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Paul S, 2012, ADV EXP MED BIOL, V750, P56, DOI 10.1007/978-1-4614-3461-0_5; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Saadatian-Elahi M, 2016, VACCINE, V34, P3923, DOI 10.1016/j.vaccine.2016.06.020; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14; SenGupta D, 2011, J VIROL, V85, P6977, DOI 10.1128/JVI.00179-11; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sui Y., 2013, CURR PROTOC IMMUNOL, V102, P12, DOI DOI 10.1002/0471142735.IM1214S102; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Whitney JB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-96; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Whitney JB, 2009, AIDS, V23, P1453, DOI 10.1097/QAD.0b013e32832b43d9; Whitney JB, 2002, J VIROL, V76, P8958, DOI 10.1128/JVI.76.17.8958-8962.2002; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wiseman RW, 2013, ILAR J, V54, P196, DOI 10.1093/ilar/ilt036; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yates NL, 2011, AIDS, V25, P2089, DOI 10.1097/QAD.0b013e32834b348e	54	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186079	10.1371/journal.pone.0186079	http://dx.doi.org/10.1371/journal.pone.0186079			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982126	Green Published, gold			2022-12-27	WOS:000412360300119
J	Serra-Casas, E; Manrique, P; Ding, XC; Carrasco-Escobar, G; Alava, F; Gave, A; Rodriguez, H; Contreras-Mancilla, J; Rosas-Aguirre, A; Speybroeck, N; Gonzalez, IJ; Rosanas-Urgell, A; Gamboa, D				Serra-Casas, Elisa; Manrique, Paulo; Ding, Xavier C.; Carrasco-Escobar, Gabriel; Alava, Freddy; Gave, Anthony; Rodriguez, Hugo; Contreras-Mancilla, Juan; Rosas-Aguirre, Angel; Speybroeck, Niko; Gonzalez, Iveth J.; Rosanas-Urgell, Anna; Gamboa, Dionicia			Loop-mediated isothermal DNA amplification for asymptomatic malaria detection in challenging field settings: Technical performance and pilot implementation in the Peruvian Amazon	PLOS ONE			English	Article							PLASMODIUM-VIVAX-MALARIA; ELIMINATION; FALCIPARUM; DIAGNOSIS; TRANSMISSION; INFECTIONS; LAMP; KIT; PCR	Background Loop-mediated isothermal DNA amplification (LAMP) methodology offers an opportunity for point-of-care (POC) molecular detection of asymptomatic malaria infections. However, there is still little evidence on the feasibility of implementing this technique for population screenings in isolated field settings. Methods Overall, we recruited 1167 individuals from terrestrial ('road') and hydric ('riverine') communities of the Peruvian Amazon for a cross-sectional survey to detect asymptomatic malaria infections. The technical performance of LAMP was evaluated in a subgroup of 503 samples, using real-time Polymerase Chain Reaction (qPCR) as reference standard. The operational feasibility of introducing LAMP testing in the mobile screening campaigns was assessed based on field-suitability parameters, along with a pilot POC-LAMP assay in a riverine community without laboratory infrastructure. Results LAMP had a sensitivity of 91.8% (87.7-94.9) and specificity of 91.9% (87.8-95.0), and the overall accuracy was significantly better among samples collected during road screenings than riverine communities (p <= 0.004). LAMP-based diagnostic strategy was successfully implemented within the field-team logistics and the POC-LAMP pilot in the riverine community allowed for a reduction in the turnaround time for case management, from 12-24 hours to less than 5 hours. Specimens with haemolytic appearance were regularly observed in riverine screenings and could help explaining the hindered performance/interpretation of the LAMP reaction in these communities. Conclusions LAMP-based molecular malaria diagnosis can be deployed outside of reference laboratories, providing similar performance as qPCR. However, scale-up in remote field settings such as riverine communities needs to consider a number of logistical challenges (e.g. environmental conditions, labour-intensiveness in large population screenings) that can influence its optimal implementation.	[Serra-Casas, Elisa; Rosanas-Urgell, Anna] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Manrique, Paulo; Carrasco-Escobar, Gabriel; Alava, Freddy; Gave, Anthony; Contreras-Mancilla, Juan; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru; [Ding, Xavier C.; Gonzalez, Iveth J.] FIND, Geneva, Switzerland; [Alava, Freddy; Rodriguez, Hugo] Direcc Reg Salud DIRESA, Loreto, Peru; [Rosas-Aguirre, Angel; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, Brussels, Belgium; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru	Institute of Tropical Medicine (ITM); Universidad Peruana Cayetano Heredia; Foundation For Innovative New Diagnostics; Universidad Peruana Cayetano Heredia; Universite Catholique Louvain; Universidad Peruana Cayetano Heredia	Rosanas-Urgell, A (corresponding author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima, Peru.	arosanas@itg.be; dionigamboa@yahoo.com	Aguirre, Angel Rosas/A-5054-2016; Manrique, Paulo/ABF-6218-2020	Aguirre, Angel Rosas/0000-0002-3271-7028; Carrasco-Escobar, Gabriel/0000-0002-6945-0419; Gamboa, Dionicia/0000-0002-1420-7729; Speybroeck, Niko/0000-0003-3322-3502; ALAVA AREVALO, FREDDY FRANCO/0000-0002-1402-2556; Contreras Mancilla, Juan Jose/0000-0003-0447-0926	FIND through German Government (Kreditanstalt fur Wiederaufbau); Belgian Directorate-General for Development Cooperation (DGD); Peruvian National Council of Science Concytec [008-2014-FONDECYT]; Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD); Fundacion Alfonso Martin Escudero grant	FIND through German Government (Kreditanstalt fur Wiederaufbau); Belgian Directorate-General for Development Cooperation (DGD); Peruvian National Council of Science Concytec; Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD); Fundacion Alfonso Martin Escudero grant	This work was supported by FIND, through a grant from the German Government (Kreditanstalt fur Wiederaufbau) to Dr Iveth J Gonzalez. There was also a partial funding contribution to Dr Prof Anna Rosanas-Urgell from the Belgian Directorate-General for Development Cooperation (DGD) through the collaborative framework agreement 3 (FA3-DGD programme) between IMTAvH/UPCH (Peru) and ITM (Belgium), the Peruvian National Council of Science Concytec (008-2014-FONDECYT) to Prof Dionicia Gamboa - and the Academie de Recherche et d'Enseignement Superieur Commission de la Cooperation au Developpement of Belgium (ARES-CCD, PRD-Peru 2014-2019) to Prof Niko Speybroeck. ESC was supported by Fundacion Alfonso Martin Escudero grant. Funding sources had no direct involvement on the study design, analysis, report writing or decision to submit for publication.	Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000396; [Anonymous], 2012, MAN STAND OP PROC MA; [Anonymous], 2013, 522013 SE MIN SALUD, P1088; Aydin-Schmidt B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169037; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Cheng Q, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003413; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cook J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0573-y; Esposito A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003780; FIND, NEG PROD PRIC LOOPAM; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Hanscheid T, 2002, TRENDS PARASITOL, V18, P395, DOI 10.1016/S1471-4922(02)02348-6; Hayashida K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1949-8; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Instituto Nacional de Estad o A stica e Informa A tica, 2014, AN EST AMB 2013; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Marti H, 2015, TRAVEL MED INFECT DI, V13, P167, DOI 10.1016/j.tmaid.2014.12.016; McMorrow ML, 2011, CLIN MICROBIOL INFEC, V17, P1624, DOI 10.1111/j.1469-0691.2011.03639.x; Ministerio de Salud del Peru (MINSA), 2010, NORM TECN SALUD CONT; Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2; Morris U, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0731-2; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Olliaro PL, 2016, AM J TROP MED HYG, V95, P4, DOI 10.4269/ajtmh.16-0160; Perera RS, 2017, PLOS ONE, P12; Polley SD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0558-x; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Rosas-Aguirre A, 2016, AM J TROP MED HYG, V95, P133, DOI 10.4269/ajtmh.16-0268; Rosas-Aguirre A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0868-4; Rovira-Vallbona E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005674; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Tegegne B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1692-4; Tietje K, 2014, TRENDS PARASITOL, V30, P259, DOI 10.1016/j.pt.2014.03.003; VALLEJO AF, 2015, PLOS NEGLECT TROP D, V9; World Health Organization, 2016, MAL MICR QUAL ASS MA	45	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185742	10.1371/journal.pone.0185742	http://dx.doi.org/10.1371/journal.pone.0185742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982155	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300063
J	Shin, MS; An, M; Kim, S; Shim, JL; Park, JK; Kim, J				Shin, Mi-Seung; An, Minjeong; Kim, Sunhwa; Shim, Jae Lan; Park, Jin-Kyu; Kim, JinShil			Concomitant diastolic dysfunction further interferes with cognitive performance in moderate to severe systolic heart failure	PLOS ONE			English	Article							LOW EJECTION FRACTION; SELF-CARE; IMPAIRMENT; DISEASE; ASSOCIATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DETERMINANTS; DEFICITS; ADULTS	Background Studies of the relevance of cardiac functional markers to cognitive performance in heart failure (HF) have primarily focused on systolic markers. In this study, we examine whether concomitant diastolic dysfunction further interferes with cognitive performance in memory, attention, and executive function in patients with HF. Methods and results In this cross-sectional correlational study, 82 patients completed face-to-face interviews for neuropsychological testing for cognitive evaluation. Echocardiographic data were obtained from a review of medical records. Mild to moderate (ejection fraction [EF] >= 30%) and severe (EF < 30%) systolic dysfunction were present in 55 (67.1%) and 27 (32.9%) patients, respectively, while 21 (26.3%) had diastolic dysfunction (E/e' > 15). Those patients who had severe systolic dysfunction had significantly lower attention scores (Digit Span Test [DST] backward, t = 2.62, p = 0.011), while those with concomitant severe diastolic dysfunction had significantly lower verbal fluency (t = 2.84, p = 0.006) and executive function (Korean-Trail Making Test Part B) (t = -2.14, p = 0.036) scores than those without severe diastolic dysfunction. After controlling for age and education, systolic patients with HF with concomitant severe diastolic dysfunction had worse cognitive performance in verbal fluency than those without severe diastolic dysfunction (F = 4.33, p = 0.041, partial eta = 0.057). Concomitant moderate to severe systolic and severe diastolic dysfunction further reduced verbal fluency (F = 8.42, p = 0.005, partial eta = 0.106). Conclusions Cognitive performance, particularly executive function, was worse in patients with HF with systolic dysfunction when diastolic dysfunction was concomitantly present. Routine monitoring of and surveillance for diastolic dysfunction and cognitive screening are warranted in the management of patients with HF.	[Shin, Mi-Seung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [An, Minjeong] Chonnam Natl Univ, Coll Nursing, Gwangju, South Korea; [Kim, Sunhwa; Shim, Jae Lan] Doowon Tech Univ, Dept Nursing, Seoul, South Korea; [Park, Jin-Kyu] Hanyang Univ, Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, JinShil] Gachon Univ, Coll Nursing, Incheon, South Korea	Gachon University; Chonnam National University; Hanyang University; Gachon University	Kim, J (corresponding author), Gachon Univ, Coll Nursing, Incheon, South Korea.	kimj317503@gmail.com		AN, MINJEONG/0000-0003-4318-8755	National Research Foundation of Korea [NRF-2014R1A1A2055948]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea, Grant number: NRF-2014R1A1A2055948 (URL: http://www.nrf.re. kr/index) to JSK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by a grant from the National Research Foundation of Korea (Grant #NRF-2014R1A1A2055948).	Almeida OP, 2012, EUR HEART J, V33, P1769, DOI 10.1093/eurheartj/ehr467; Angermann CE, 2012, EUR HEART J, V33, P1721, DOI 10.1093/eurheartj/ehs128; Ausili D, 2016, INT J NURS STUD, V63, P18, DOI 10.1016/j.ijnurstu.2016.08.006; Baynard T, 2008, OBESITY, V16, P1277, DOI 10.1038/oby.2008.212; Beer C, 2009, INTERN MED J, V39, P600, DOI 10.1111/j.1445-5994.2008.01790.x; Center for Continuing Education, 2014, DEF ET 2014; Cocchieri A, 2015, EUR J CARDIOVASC NUR, V14, P126, DOI 10.1177/1474515113518443; Davis KK, 2015, J CARDIOVASC NURS, V30, P152, DOI 10.1097/JCN.0000000000000130; de Roos A, 2017, CIRCULATION, V135, P2178, DOI 10.1161/CIRCULATIONAHA.116.021978; Eggermont LHP, 2012, HEART, V98, P1334, DOI 10.1136/heartjnl-2012-301682; Fenk S, 2015, INT HEART J, V56, P196, DOI 10.1536/ihj.14-261; Festa JR, 2011, ARCH NEUROL-CHICAGO, V68, P1021, DOI 10.1001/archneurol.2011.163; Gottesman RF, 2009, BEHAV NEUROL, V22, P63, DOI 10.3233/BEN-2009-0261; Gure TR, 2012, J AM GERIATR SOC, V60, P1724, DOI 10.1111/j.1532-5415.2012.04097.x; Hansen A, 2001, J AM COLL CARDIOL, V37, P1049, DOI 10.1016/S0735-1097(00)01211-0; Kang Y, 2012, PROFESSIONAL MANUAL; Kang Yeonwook, 2002, Korean Journal of Clinical Psychology, V21, P911; Koenig Julian, 2015, Biomed Sci Instrum, V51, P85; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leto L, 2014, J GERIATR CARDIOL, V11, P316, DOI 10.11909/j.issn.1671-5411.2014.04.007; Lim SL, 2016, KOREAN J INTERN MED, V31, P1, DOI 10.3904/kjim.2016.31.1.1; Luers C, 2017, CLIN CARDIOL, P1; Nagueh SF, 2016, EUR HEART J-CARD IMG, V17, P1321, DOI 10.1093/ehjci/jew082; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; O'Donnell M, 2012, EUR HEART J, V33, P1777, DOI 10.1093/eurheartj/ehs053; Park Jaeseol, 2007, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V6, P12; Pressler SJ, 2010, J CARD FAIL, V16, P750, DOI 10.1016/j.cardfail.2010.04.007; Pressler SJ, 2010, J CARDIOVASC NURS, V25, P189, DOI 10.1097/JCN.0b013e3181ca36fe; Pressler SJ, 2010, NURS RES, V59, P127, DOI 10.1097/NNR.0b013e3181d1a747; Riegel B, 2009, CIRCULATION, V120, P1141, DOI 10.1161/CIRCULATIONAHA.109.192628; Roy B, 2017, EUR J HEART IN PRESS; SPSS Statistics, 2016, SPSS STAT 23 0 WIND; van den Hurk K, 2011, EUR J HEART FAIL, V13, P1362, DOI 10.1093/eurjhf/hfr138; Wiegers SE, 2011, CIRC-CARDIOVASC IMAG, V4, P460, DOI 10.1161/CIRCIMAGING.111.968131; Yi H, 2007, DEMENT NEUROCOGNITIV, V6, P54	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184981	10.1371/journal.pone.0184981	http://dx.doi.org/10.1371/journal.pone.0184981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977012	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100015
J	Cai, XL; Akber, M; Spirov, A; Baumgartner, S				Cai, Xiaoli; Akber, Mira; Spirov, Alexander; Baumgartner, Stefan			Cortical movement of Bicoid in early Drosophila embryos is actin- and microtubule-dependent and disagrees with the SDD diffusion model	PLOS ONE			English	Article							MESSENGER-RNA; MORPHOGEN GRADIENT; HYPOXIA TOLERANCE; ANTERIOR PATTERN; F-ACTIN; ORGANIZATION; LOCALIZATION; NUCLEAR; PROTEIN; MELANOGASTER	The Bicoid (Bcd) protein gradient in Drosophila serves as a paradigm for gradient formation in textbooks. The SDD model (synthesis, diffusion, degradation) was proposed to explain the formation of the gradient. The SDD model states that the bcd mRNA is located at the anterior pole of the embryo at all times and serves a source for translation of the Bicoid protein, coupled with diffusion and uniform degradation throughout the embryo. Recently, the ARTS model (active RNA transport, synthesis) challenged the SDD model. In this model, the mRNA is transported at the cortex along microtubules to form a mRNA gradient which serves as template for the production of Bcd, hence little Bcd movement is involved. To test the validity of the SDD model, we developed a sensitive assay to monitor the movement of Bcd during early nuclear cycles. We observed that Bcd moved along the cortex and not in a broad front towards the posterior as the SDD model would have predicted. We subjected embryos to hypoxia where the mRNA remained strictly located at the tip at all times, while the protein was allowed to move freely, thus conforming to an ideal experimental setup to test the SDD model. Unexpectedly, Bcd still moved along the cortex. Moreover, cortical Bcd movement was sparse, even under longer hypoxic conditions. Hypoxic embryos treated with drugs compromising microtubule and actin function affected Bcd cortical movement and stability. Vinblastine treatment allowed the simulation of an ideal SDD model whereby the protein moved throughout the embryo in a broad front. In unfertilized embryos, the Bcd protein followed the mRNA which itself was transported into the interior of the embryo utilizing a hitherto undiscovered microtubular network. Our data suggest that the Bcd gradient formation is probably more complex than previously anticipated.	[Cai, Xiaoli; Akber, Mira; Baumgartner, Stefan] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Spirov, Alexander] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Spirov, Alexander] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	Lund University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Baumgartner, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Stefan.Baumgartner@med.lu.se	Spirov, Alexander V/G-4806-2010; Baumgartner, Stefan/A-5879-2011	Spirov, Alexander V/0000-0002-0509-6203; Baumgartner, Stefan/0000-0001-5320-8321	Swedish Research Council; RFBR [15-04-07800, 15-04-06480]	Swedish Research Council(Swedish Research CouncilEuropean Commission); RFBR(Russian Foundation for Basic Research (RFBR))	This work was supported by the Swedish Research Council (https://www.vr.se/) (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Eric Philipp Sorensen Stiftelse (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Byggmastare Olle Engkvist Stiftelse (Stefan Baumgartner: study design, data collection and analysis, decision to publish, or preparation of the manuscript); Russian Foundation for Basic Research (Alexander Spirov: study design, data collection and analysis). A.V.S. is partially supported by RFBR grants 15-04-07800 and 15-04-06480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov T, 2008, J ELECTR COMPUT ENG, V2008, DOI 10.1155/2008/825758; Ali-Murthy Z, 2016, ELIFE, P5, DOI [10.7554/eLife.13222.441, DOI 10.7554/ELIFE.13222.441]; Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Callaini G, 1997, CELL MOTIL CYTOSKEL, V37, P300; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; Douglas RM, 2001, AM J PHYSIOL-REG I, V280, pR1555, DOI 10.1152/ajpregu.2001.280.5.R1555; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drocco JA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055004; Fahmy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112053; Florian S, 2016, METHODS MOL BIOL, V1413, P403, DOI 10.1007/978-1-4939-3542-0_25; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; FOE VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2008, DEV BIOL, V316, P350, DOI 10.1016/j.ydbio.2008.01.039; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grimm O, 2010, DEVELOPMENT, V137, P2857, DOI 10.1242/dev.052589; Grimm O, 2010, DEVELOPMENT, V137, P2253, DOI 10.1242/dev.032409; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HATANAKA K, 1991, DEVELOPMENT, V111, P909; Heinrich EC, 2011, J EXP BIOL, V214, P1419, DOI 10.1242/jeb.051904; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mavrakis M, 2009, DEV CELL, V16, P93, DOI 10.1016/j.devcel.2008.11.003; Namba R, 1997, DEVELOPMENT, V124, P1393; PAPASSIDERI I, 1991, TISSUE CELL, V23, P567, DOI 10.1016/0040-8166(91)90014-K; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Petkova MD, 2014, CURR BIOL, V24, P1283, DOI 10.1016/j.cub.2014.04.028; Rand MD, 2014, JOVE-J VIS EXP, DOI 10.3791/51634; Rand MD, 2010, INSECT BIOCHEM MOLEC, V40, P792, DOI 10.1016/j.ibmb.2010.07.007; Riparbelli MG, 2007, DEV DYNAM, V236, P662, DOI 10.1002/dvdy.21062; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Schulman VK, 2013, FLY, V7, P193, DOI 10.4161/fly.25438; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; WARN RM, 1984, J CELL BIOL, V98, P156, DOI 10.1083/jcb.98.1.156; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Weil TT, 2010, DEVELOPMENT, V137, P169, DOI 10.1242/dev.044867; Zalokar M, 1976, J MICROSCOPIE BIOL C, V25; Zhao HW, 2011, PLACENTA, V32, pS104, DOI 10.1016/j.placenta.2010.11.017; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185443	10.1371/journal.pone.0185443	http://dx.doi.org/10.1371/journal.pone.0185443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973031	gold, Green Published, Green Submitted			2022-12-27	WOS:000412131900018
J	Franco, MEE; Lopez, SMY; Medina, R; Lucentini, CG; Troncozo, MI; Pastorino, GN; Saparrat, MCN; Balatti, PA				Ernesto Franco, Mario Emilio; Yanil Lopez, Silvina Marianela; Medina, Rocio; Gustavo Lucentini, Cesar; Ines Troncozo, Maria; Noemi Pastorino, Graciela; Nazareno Saparrat, Mario Carlos; Alberto Balatti, Pedro			The mitochondrial genome of the plant-pathogenic fungus Stemphylium lycopersici uncovers a dynamic structure due to repetitive and mobile elements	PLOS ONE			English	Article							OPEN READING FRAME; GROUP-I INTRON; CYTOCHROME-C-OXIDASE; HOMING ENDONUCLEASES; HORIZONTAL TRANSFER; COMPLETE SEQUENCE; GENE CONTENT; EVOLUTION; DNA; PHYLOGENY	Stemphylium lycopersici (Pleosporales) is a plant-pathogenic fungus that has been associated with a broad range of plant-hosts worldwide. It is one of the causative agents of gray leaf spot disease in tomato and pepper. The aim of this work was to characterize the mitochondrial genome of S. lycopersici CIDEFI-216, to use it to trace taxonomic relationships with other fungal taxa and to get insights into the evolutionary history of this phytopathogen. The complete mitochondrial genome was assembled into a circular double-stranded DNA molecule of 75,911 bp that harbors a set of 37 protein-coding genes, 2 rRNA genes (rns and rnl) and 28 tRNA genes, which are transcribed from both sense and antisense strands. Remarkably, its gene repertoire lacks both atp8 and atp9, contains a free-standing gene for the ribosomal protein S3 (rps3) and includes 13 genes with homing endonuclease domains that are mostly located within its 15 group I introns. Strikingly, subunits 1 and 2 of cytochrome oxidase are encoded by a single continuous open reading frame (ORF). A comparative mitogenomic analysis revealed the large extent of structural rearrangements among representatives of Pleosporales, showing the plasticity of their mitochondrial genomes. Finally, an exhaustive phylogenetic analysis of the subphylum Pezizomycotina based on mitochondrial data reconstructed their relationships in concordance with several studies based on nuclear data. This is the first report of a mitochondrial genome belonging to a representative of the family Pleosporaceae.	[Ernesto Franco, Mario Emilio; Yanil Lopez, Silvina Marianela; Medina, Rocio; Gustavo Lucentini, Cesar; Alberto Balatti, Pedro] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Fitopatol, Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina; [Ines Troncozo, Maria; Noemi Pastorino, Graciela; Nazareno Saparrat, Mario Carlos; Alberto Balatti, Pedro] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Catedra Microbiol Agr, La Plata, Buenos Aires, Argentina; [Nazareno Saparrat, Mario Carlos] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Inst Bot Carlos Spegazzini, La Plata, Buenos Aires, Argentina; [Nazareno Saparrat, Mario Carlos] Univ Nacl La Plata, Consejo Nacl Invest Cient & Tecn, Inst Fisiol Vegetal, Fac Ciencias Nat & Museo,Fac Ciencias Agr & Fores, La Plata, Buenos Aires, Argentina	Comision de Investigaciones Cientificas; National University of La Plata; National University of La Plata; National University of La Plata; Museo La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Balatti, PA (corresponding author), Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Ctr Invest Fitopatol, Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina.; Balatti, PA (corresponding author), Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Catedra Microbiol Agr, La Plata, Buenos Aires, Argentina.	pbalatti@gmail.com	Medina, Rocio/AAS-8532-2020; Balatti, Pedro/P-7598-2017	Lucentini, Cesar Gustavo/0000-0002-6278-5291; Medina, Rocio/0000-0001-5385-6441; Lopez, Silvina Marianela Yanil/0000-0001-6613-7243; Balatti, Pedro/0000-0002-5163-4084; Pastorino, Graciela/0000-0001-7517-8258; Franco, Mario Emilio Ernesto/0000-0002-4959-1257; Troncozo, Maria Ines/0000-0001-9553-3093	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva [PICT 2012-2760]; PICT [2015-1620]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva; PICT(ANPCyT)	This research was partially supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) of the Ministro de Ciencia, Tecnologia e Innovacion Productiva through the projects PICT 2012-2760 (PAB) and PICT 2015-1620 (MCNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, COMPENDIUM TOMATO DI; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bowen Nathan J., 2002, Current Issues in Molecular Biology, V4, P65; Bullerwell CE, 2000, TRENDS BIOCHEM SCI, V25, P363, DOI 10.1016/S0968-0004(00)01612-1; Bullerwell CE, 2005, CURR OPIN MICROBIOL, V8, P362, DOI 10.1016/j.mib.2005.06.009; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P1614, DOI 10.1093/nar/gkg264; Bullerwell CE, 2003, NUCLEIC ACIDS RES, V31, P759, DOI 10.1093/nar/gkg134; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; BURGER G, 1995, J MOL BIOL, V245, P522, DOI 10.1006/jmbi.1994.0043; BURKE JM, 1982, CELL, V31, P509, DOI 10.1016/0092-8674(82)90307-5; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Camara MPS, 2002, MYCOLOGIA, V94, P660, DOI 10.2307/3761717; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cho YR, 1999, MOL BIOL EVOL, V16, P1155, DOI 10.1093/oxfordjournals.molbev.a026206; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgell DR, 2009, CURR BIOL, V19, pR115, DOI 10.1016/j.cub.2008.12.019; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farr DF, 2022, FUNGAL DATABASES; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Formey D, 2012, NEW PHYTOL, V196, P1217, DOI 10.1111/j.1469-8137.2012.04283.x; Foury F, 1998, FEBS LETT, V440, P325, DOI 10.1016/S0014-5793(98)01467-7; Franco MEE, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01069-15; Francois Monique E, 2017, Eur J Appl Physiol, V117, P1607, DOI 10.1007/s00421-017-3649-2; Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023; Goodwin SB, 2016, FUNGAL BIOL-UK, V120, P961, DOI 10.1016/j.funbio.2016.05.003; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; GROOT GSP, 1979, MOL GEN GENET, V174, P339, DOI 10.1007/BF00267808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas Brian J, 2011, Mycology, V2, P118; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Joardar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-698; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim BS, 2004, PLANT PATHOLOGY J, V20, P85, DOI DOI 10.5423/PPJ.2004.20.2.085; Kim YS, 2003, PHYTOPATHOLOGY, V93, P891, DOI 10.1094/PHYTO.2003.93.7.891; Kouvelis VN, 2008, MYCOL RES, V112, P829, DOI 10.1016/j.mycres.2008.01.016; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuberl A, 2011, J BIOTECHNOL, V154, P312, DOI 10.1016/j.jbiotec.2011.04.014; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lang BF, 2014, MITOCHONDRIAL GENOME, P1; Li FW, 2017, CURR MICROBIOL, V74, P532, DOI 10.1007/s00284-017-1220-3; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lonergan KM, 1996, J MOL BIOL, V257, P1019, DOI 10.1006/jmbi.1996.0220; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma L, 2013, FASEB J, V27, P1962, DOI 10.1096/fj.12-224444; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Magnan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162363; Nasehi A, 2014, EUR J PLANT PATHOL, V140, P261, DOI 10.1007/s10658-014-0460-3; Nasehi Abbas, 2014, Archives of Phytopathology and Plant Protection, V47, P1658, DOI 10.1080/03235408.2013.853905; Nishi N, 2009, J GEN PLANT PATHOL, V75, P80, DOI 10.1007/s10327-008-0133-1; Pantou MP, 2006, CURR GENET, V50, P125, DOI 10.1007/s00294-006-0079-9; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Pellizzari R, 1997, BBA-BIOENERGETICS, V1320, P1, DOI 10.1016/S0005-2728(97)00010-8; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; Repar J, 2017, GENETICS, V205, P1641, DOI 10.1534/genetics.116.199059; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Santamaria M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S15; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Sethuraman J, 2009, J MOL EVOL, V69, P372, DOI 10.1007/s00239-009-9291-9; Shen XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116466; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Talla E, 2005, FEBS LETT, V579, P30, DOI 10.1016/j.febslet.2004.10.106; Tomioka Keisuke, 1997, Annals of the Phytopathological Society of Japan, V63, P337, DOI 10.3186/jjphytopath.63.337; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; van de Sande WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038654; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wu BJ, 2014, G3-GENES GENOM GENET, V4, P605, DOI 10.1534/g3.113.009910; Yao YR, 2016, MITOCHONDRIAL DNA A, V27, P3246, DOI 10.3109/19401736.2015.1007367; Zhang YJ, 2015, FUNGAL GENET BIOL, V77, P95, DOI 10.1016/j.fgb.2015.04.009	92	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185545	10.1371/journal.pone.0185545	http://dx.doi.org/10.1371/journal.pone.0185545			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972995	Green Published, gold			2022-12-27	WOS:000412131900023
J	Fusaro, L; Palma, A; Salvatori, E; Basile, A; Maresca, V; Karam, EA; Manes, F				Fusaro, Lina; Palma, Adriano; Salvatori, Elisabetta; Basile, Adriana; Maresca, Viviana; Karam, Elham Asadi; Manes, Fausto			Functional indicators of response mechanisms to nitrogen deposition, ozone, and their interaction in two Mediterranean tree species	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; OXIDATIVE STRESS; QUERCUS-ILEX; PHOTOSYNTHETIC RESPONSES; CHLOROPHYLL FLUORESCENCE; STOMATAL UPTAKE; CLIMATE-CHANGE; AIR-POLLUTION; MATURE TREES; WATER-STRESS	The effects of nitrogen (N) deposition, tropospheric ozone (O-3) and their interaction were investigated in two Mediterranean tree species, Fraxinus ornus L. (deciduous) and Quercus ilex L. (evergreen), having different leaf habits and resource use strategies. An experiment was conducted under controlled condition to analyse how nitrogen deposition affects the ecophysiological and biochemical traits, and to explore how the nitrogen-induced changes influence the response to O-3. For both factors we selected realistic exposures (20 kg N ha(-1) yr(-1) and 80 ppb h for nitrogen and O-3, respectively), in order to elucidate the mechanisms implemented by the plants. Nitrogen addition resulted in higher nitrogen concentration at the leaf level in F. ornus, whereas a slight increase was detected in Q. ilex. Nitrogen enhanced the maximum rate of assimilation and ribulose 1,5-bisphosphate regeneration in both species, whereas it influenced the light harvesting complex only in the deciduous F. ornus that was also affected by O-3 (reduced assimilation rate and accelerated senescence-related processes). Conversely, Q. ilex developed an avoidance mechanism to cope with O-3, confirming a substantial O-3 tolerance of this species. Nitrogen seemed to ameliorate the harmful effects of O-3 in F. ornus: the hypothesized mechanism of action involved the production of nitrogen oxide as the first antioxidant barrier, followed by enzymatic antioxidant response. In Q. ilex, the interaction was not detected on gas exchange and photosystem functionality; however, in this species, nitrogen might stimulate an alternative antioxidant response such as the emission of volatile organic compounds. Antioxidant enzyme activity was lower in plants treated with both O-3 and nitrogen even though reactive oxygen species production did not differ between the treatments.	[Fusaro, Lina; Palma, Adriano; Salvatori, Elisabetta; Manes, Fausto] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Basile, Adriana; Maresca, Viviana] Univ Naples Federico II, Biol Dept, Naples, Italy; [Karam, Elham Asadi] Shahid Bahonar Univ Kerman, Biol Dept, Kerman, Iran	Sapienza University Rome; University of Naples Federico II; Shahid Bahonar University of Kerman (SBUK)	Fusaro, L (corresponding author), Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.	lina.fusaro@uniroma1.it	BASILE, Adriana/ABC-8500-2021; Fusaro, Lina/Q-4369-2017; Salvatori, Elisabetta/F-8931-2010; Palma, Adriano/AAL-6622-2020; Maresca, Viviana/AEP-6443-2022; Maresca, Viviana/AAW-9990-2021	BASILE, Adriana/0000-0002-2001-8959; Fusaro, Lina/0000-0003-3316-707X; Maresca, Viviana/0000-0002-4656-320X; Palma, Adriano/0000-0002-8100-2977; MANES, Fausto/0000-0002-4563-4272; SALVATORI, ELISABETTA/0000-0002-5603-5064	MIUR, Rome, Project PRIN TreeCity [20109E8F95]; Avvio alla Ricerca, Sapienza Research Project [C26N15CHHN]; Sapienza Ateneo Research Project [RM116154C90A4EAD, RM116154C9CFDE3B]; Accademia Nazionale delle Scienze detta dei XL	MIUR, Rome, Project PRIN TreeCity(Ministry of Education, Universities and Research (MIUR)); Avvio alla Ricerca, Sapienza Research Project; Sapienza Ateneo Research Project; Accademia Nazionale delle Scienze detta dei XL	This research has been supported by the following grants: MIUR, Rome, Project PRIN 2010-2011 TreeCity (Prot. no. 20109E8F95); Avvio alla Ricerca, Sapienza Research Project 2015 (Prot.No. C26N15CHHN) to Lina Fusaro; Sapienza Ateneo Research Project 2016 (Prot.No. RM116154C90A4EAD) to Fausto Manes; Sapienza Ateneo Research Project 2016 (RM116154C9CFDE3B); Accademia Nazionale delle Scienze detta dei XL (2012 Grants) to Fausto Manes. We thank Dr. Antonietta Siciliano for providing support for antioxidant analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah IG, 2004, TREE PHYSIOL, V24, P1099, DOI 10.1093/treephys/24.10.1099; [Anonymous], MAN METH CRIT MOD MA; Aranda I, 2004, ACTA OECOL, V25, P187, DOI 10.1016/j.actao.2004.01.003; Azuchi F, 2014, ENVIRON POLLUT, V184, P481, DOI 10.1016/j.envpol.2013.09.025; Bassin S, 2013, ECOSYSTEMS, V16, P1105, DOI 10.1007/s10021-013-9670-3; Beligni MV, 1999, PLANTA, V208, P337, DOI 10.1007/s004250050567; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Borghetti M, 2017, TREE PHYSIOL, V37, P4, DOI 10.1093/treephys/tpw087; Bussotti F, 2008, GLOBAL CHANGE BIOL, V14, P2727, DOI 10.1111/j.1365-2486.2008.01677.x; Bussotti F, 2011, ENVIRON EXP BOT, V73, P116, DOI 10.1016/j.envexpbot.2010.10.023; Bytnerowicz A, 2007, ENVIRON POLLUT, V147, P438, DOI 10.1016/j.envpol.2006.08.028; Calatayud V, 2007, WATER AIR SOIL POLL, V185, P239, DOI 10.1007/s11270-007-9446-5; Calatayud V, 2011, ENVIRON POLLUT, V159, P55, DOI 10.1016/j.envpol.2010.09.024; Calvete-Sogo H, 2016, OECOLOGIA, V181, P1055, DOI 10.1007/s00442-016-3628-z; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Cotrozzi L, 2016, PHYSIOL PLANTARUM, V157, P69, DOI 10.1111/ppl.12402; Crous KY, 2017, NEW PHYTOL, V215, P992, DOI 10.1111/nph.14591; Das P, 2015, FRONT ENV SCI, P2; de la Riva EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148788; de Pinto MC, 1999, PROTOPLASMA, V209, P90, DOI 10.1007/BF01415704; de Vries W, 2014, PLANT SOIL, V380, P1, DOI 10.1007/s11104-014-2056-2; Dezi S, 2010, GLOBAL CHANGE BIOL, V16, P1470, DOI 10.1111/j.1365-2486.2009.02102.x; Dirnbock T, 2014, GLOBAL CHANGE BIOL, V20, P429, DOI 10.1111/gcb.12440; Edwards EJ, 2014, J ECOL, V102, P328, DOI 10.1111/1365-2745.12209; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fares S, 2008, PLANT BIOLOGY, V10, P44, DOI 10.1055/s-2007-965257; Fares S, 2013, ENVIRON SCI TECHNOL, V47, P11073, DOI 10.1021/es4022156; Feng YL, 2007, OECOLOGIA, V153, P501, DOI 10.1007/s00442-007-0759-2; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Ferretti M, 2014, GLOBAL CHANGE BIOL, V20, P3423, DOI 10.1111/gcb.12552; Fleischer K, 2013, GLOBAL BIOGEOCHEM CY, V27, P187, DOI 10.1002/gbc.20026; Fusaro L, 2016, PLANT BIOLOGY, V18, P13, DOI 10.1111/plb.12383; Garcia-Gomez H, 2014, SCI TOTAL ENVIRON, V485, P450, DOI 10.1016/j.scitotenv.2014.03.112; Guidi L, 2008, TREE PHYSIOL, V28, P873, DOI 10.1093/treephys/28.6.873; Guidi L, 2010, ENVIRON POLLUT, V158, P3164, DOI 10.1016/j.envpol.2010.06.037; Hikosaka K, 2001, OECOLOGIA, V126, P174, DOI 10.1007/s004420000517; Camarero J, 2017, TREE PHYSIOL, V37, P1, DOI 10.1093/treephys/tpw111; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Li P, 2016, TREE PHYSIOL, V36, P1105, DOI 10.1093/treephys/tpw042; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Loreto F, 2004, TREE PHYSIOL, V24, P361, DOI 10.1093/treephys/24.4.361; Loustau D, 1999, TREE PHYSIOL, V19, P707; Manes F, 2003, SCI TOTAL ENVIRON, V308, P133, DOI 10.1016/S0048-9697(02)00633-2; Manes F, 2001, PHYSIOL PLANTARUM, V113, P249, DOI 10.1034/j.1399-3054.2001.1130213.x; Manes F, 2007, ENVIRON EXP BOT, V59, P235, DOI 10.1016/j.envexpbot.2005.12.001; Marzuoli R, 2016, TREES-STRUCT FUNCT, V30, P1995, DOI 10.1007/s00468-016-1427-0; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Mills G, 2016, ENVIRON POLLUT, V208, P898, DOI 10.1016/j.envpol.2015.09.038; Mills G, 2009, GLOBAL CHANGE BIOL, V15, P1522, DOI 10.1111/j.1365-2486.2008.01798.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nali C, 2004, ATMOS ENVIRON, V38, P2247, DOI 10.1016/j.atmosenv.2003.11.043; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Niinemets U, 2014, TREE PHYSIOL, V34, P1301, DOI 10.1093/treephys/tpu099; Ochoa-Hueso R, 2017, ENVIRON POLLUT, V227, P194, DOI 10.1016/j.envpol.2017.04.062; Palmroth S, 2014, OECOLOGIA, V175, P457, DOI 10.1007/s00442-014-2923-9; Paoletti E, 2009, SCI TOTAL ENVIRON, V407, P1631, DOI 10.1016/j.scitotenv.2008.11.061; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Pivovaroff AL, 2016, OECOLOGIA, V181, P721, DOI 10.1007/s00442-016-3609-2; Ribas A, 2005, ATMOS ENVIRON, V39, P685, DOI 10.1016/j.atmosenv.2004.10.022; Ribas A, 2005, ENVIRON POLLUT, V134, P291, DOI 10.1016/j.envpol.2004.07.026; Salvatori E, 2015, PLANT PHYSIOL BIOCH, V97, P368, DOI 10.1016/j.plaphy.2015.10.027; Salvatori E, 2014, PLANT PHYSIOL BIOCH, V85, P105, DOI 10.1016/j.plaphy.2014.11.002; Santurtun A, 2015, ATMOS ENVIRON, V101, P10, DOI 10.1016/j.atmosenv.2014.11.005; Scalet M, 1995, ENVIRON EXP BOT, V35, P417, DOI 10.1016/0098-8472(95)00001-3; Scholz FG, 2007, REMOVAL NUTR LIMITAT; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Strasser RJ, 2010, BBA-BIOENERGETICS, V1797, P1313, DOI 10.1016/j.bbabio.2010.03.008; Takashima T, 2004, PLANT CELL ENVIRON, V27, P1047, DOI 10.1111/j.1365-3040.2004.01209.x; Thomas VFD, 2005, ENVIRON POLLUT, V137, P507, DOI 10.1016/j.envpol.2005.02.002; TRETIACH M, 1993, ACTA OECOL, V14, P341; Tulloss EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156685; Uscola M, 2014, EUR J FOREST RES, V133, P235, DOI 10.1007/s10342-013-0749-3; Vainonen JP, 2015, PLANT CELL ENVIRON, V38, P240, DOI 10.1111/pce.12273; Valladares F, 2000, NEW PHYTOL, V148, P79, DOI 10.1046/j.1469-8137.2000.00737.x; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Volk M, 2016, BIOGEOSCIENCES, V13, P3807, DOI 10.5194/bg-13-3807-2016; Wildt J, 1997, J GEOPHYS RES-ATMOS, V102, P5919, DOI 10.1029/96JD02968; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yamaguchi M, 2007, TREES-STRUCT FUNCT, V21, P707, DOI 10.1007/s00468-007-0163-x; Yamaguchi Masahiro, 2011, Asian Journal of Atmospheric Environment, V5, P65; Yao XQ, 2006, PLANT GROWTH REGUL, V50, P165, DOI 10.1007/s10725-006-9116-4; Zhang WW, 2012, ENVIRON POLLUT, V163, P149, DOI 10.1016/j.envpol.2011.12.035	84	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185836	10.1371/journal.pone.0185836	http://dx.doi.org/10.1371/journal.pone.0185836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973038	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900059
J	Queller, PS; Murphy, TG				Queller, Philip S.; Murphy, Troy G.			Seasonal variation in the utility of a status signaling system: Plumage ornament predicts foraging success only during periods of high competition	PLOS ONE			English	Article							SEXUAL SELECTION; SOCIAL COMPETITION; FOOD ABUNDANCE; SIZE; TESTOSTERONE; EVOLUTION; DOMINANCE; TERRITORIALITY; AGGRESSION; COLORATION	Status signals allow competitors to assess each other's resource holding potential and reduce the occurrence of physical fights. Because status signals function to mediate competition over resources, a change in the strength of competition may affect the utility of a status signaling system. Status signals alter competitor behavior during periods of high competition, and thus determine access to resources; however, when competition is reduced, we expect these signals to become disassociated from access to resources. We investigated seasonal changes in status signaling of the male black-crested titmouse (Baeolophus atricristatus), a species that experiences substantial changes in population density and competition for food over the annual cycle. We compared the size of the prominent head-crest to foraging success at community-used feeding stations; we tested this relationship when competition was seasonally high, and when competition was seasonally low. We then experimentally decreased the number of feeders to increase competition (during the season of low-competition), and again tested whether male crest size predicted access to feeders. When competition was seasonally high, males with longer crests had greater access to feeders, but this pattern was not apparent when competition was seasonally low. When competition was experimentally increased, males with longer crests were again more successful at maintaining access to feeders. These findings provide evidence of a contextdependent status signaling system, where the status signal only mediates access to resources during periods of high competition. We discuss possible hypotheses for why the signaling system may not be functional, or detectable, during periods of low competition, including that competitors may interact less frequently and so have reduced opportunity for signaling, or that status signals are disregarded by receivers during periods of low competition because signalers are unlikely to escalate a contest into a fight. In any case, these results indicate that resource availability affects a status signaling system, and that the potential for status signaling persists in this system between seasons, even though such signaling may not be overtly present or detectable during periods of low competition.	[Queller, Philip S.; Murphy, Troy G.] Trinity Univ, Dept Biol, San Antonio, TX 78212 USA; [Queller, Philip S.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Trinity University; University of Texas System; University of Texas Austin	Murphy, TG (corresponding author), Trinity Univ, Dept Biol, San Antonio, TX 78212 USA.	troy.murphy@trinity.edu	Murphy, Troy/A-7092-2008	Murphy, Troy/0000-0001-7239-2160	Trinity University; Texas Ecolab	Trinity University; Texas Ecolab	PSQ was supported by the Biology Summer Undergraduate Research Fellowship and the Mach Fellowship provided by Trinity University. TGM was supported by a grant from Texas Ecolab, and by a Faculty Development Grant from Trinity University.	Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; [Anonymous], 2004, BIOPHOT INT, V11, P36; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Bridge ES, 2011, J FIELD ORNITHOL, V82, P52, DOI 10.1111/j.1557-9263.2010.00307.x; Briffa M, 2005, ANIM BEHAV, V70, P119, DOI 10.1016/j.anbehav.2004.10.013; Briffa M, 2004, P ROY SOC B-BIOL SCI, V271, P373, DOI 10.1098/rspb.2003.2633; Brown J. L., 1964, Wilson Bulletin, V76, P160; CARPENTER FL, 1987, AM ZOOL, V27, P387; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Chaine AS, 2011, ANIM BEHAV, V81, P447, DOI 10.1016/j.anbehav.2010.11.016; Crowhurst CJ, 2012, ETHOLOGY, V118, P63, DOI 10.1111/j.1439-0310.2011.01986.x; Dearborn DC, 1998, BIOTROPICA, V30, P306, DOI 10.1111/j.1744-7429.1998.tb00064.x; Dey CJ, 2013, P R SOC B, V281; DOLMAN PM, 1995, OECOLOGIA, V102, P511, DOI 10.1007/BF00341364; Emaresi G, 2014, AM NAT, V183, P269, DOI 10.1086/674444; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; EVANS MR, 1992, BEHAV ECOL SOCIOBIOL, V29, P413; FINCK P, 1990, OECOLOGIA, V83, P68, DOI 10.1007/BF00324636; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Grant JWA, 2002, ANIM BEHAV, V63, P323, DOI 10.1006/anbe.2001.1891; HANSEN AJ, 1986, ANIM BEHAV, V34, P69, DOI 10.1016/0003-3472(86)90007-2; HENDERSON IG, 1995, J AVIAN BIOL, V26, P217, DOI 10.2307/3677322; LEMEL J, 1993, ANIM BEHAV, V45, P549, DOI 10.1006/anbe.1993.1065; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIGON JD, 1990, ANIM BEHAV, V40, P367, DOI 10.1016/S0003-3472(05)80932-7; Ligon RA, 2014, BEHAV ECOL SOCIOBIOL, V68, P1007, DOI 10.1007/s00265-014-1713-z; Lyon BE, 2012, PHILOS T R SOC B, V367, P2266, DOI 10.1098/rstb.2012.0012; Maynard Smith J., 1982, pi; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; Miyai CA, 2011, ZOOLOGY, V114, P335, DOI 10.1016/j.zool.2011.07.001; MOLLER AP, 1987, ANIM BEHAV, V35, P1637, DOI 10.1016/S0003-3472(87)80056-8; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Moses SP, 2000, KENTUCKY WARBLER, V76, P48; Murphy TG, 2009, BEHAV ECOL, V20, P1348, DOI 10.1093/beheco/arp140; Murphy TG, 2009, BEHAV ECOL, V20, P1000, DOI 10.1093/beheco/arp089; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Patten MA, 2008, BLACK CRESTED TITMOU; Piault R, 2009, AM NAT, V174, P548, DOI 10.1086/605374; Pryke SR, 2003, ANIM BEHAV, V66, P217, DOI 10.1006/anbe.2003.2193; Pryke SR, 2003, BEHAV ECOL SOCIOBIOL, V53, P393, DOI 10.1007/s00265-003-0587-2; Quinn MA, 2000, THESIS; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.1111/j.1558-5646.1975.tb00853.x; ROHWER S, 1978, ANIM BEHAV, V26, P1012, DOI 10.1016/0003-3472(78)90090-8; ROHWER S, 1982, AM ZOOL, V22, P531; Rylander RJ, 2015, THESIS; Searcy WA, 2006, EVOLUTION ANIMAL COM, V31, P794; Senar JC, 1998, P ROY SOC B-BIOL SCI, V265, P1515, DOI 10.1098/rspb.1998.0466; Senar Juan Carlos, 2006, P87; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; Tarvin KA, 2016, FRONTIERS IN ECOLOGY; Taylor PW, 2001, BEHAV ECOL SOCIOBIOL, V50, P403, DOI 10.1007/s002650100390; Tibbetts EA, 2014, INETGR COMP BIOL, P1, DOI [10.1093/icb/icu083Society, DOI 10.1093/ICB/ICU083SOCIETY]; Tibbetts EA, 2008, P ROY SOC B-BIOL SCI, V275, P2201, DOI 10.1098/rspb.2008.0477; Vedder O, 2010, FUNCT ECOL, V24, P417, DOI 10.1111/j.1365-2435.2009.01660.x; Vergara P, 2012, HORM BEHAV, V62, P407, DOI 10.1016/j.yhbeh.2012.07.007; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; Yasukawa K, 2009, ANIM BEHAV, V77, P531, DOI 10.1016/j.anbehav.2008.11.013	62	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185584	10.1371/journal.pone.0185584	http://dx.doi.org/10.1371/journal.pone.0185584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973029	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900027
J	Richards, C; Otani, S; Mikaelyan, A; Poulsen, M				Richards, Callum; Otani, Saria; Mikaelyan, Aram; Poulsen, Michael			Pycnoscelus surinamensis cockroach gut microbiota respond consistently to a fungal diet without mirroring those of fungus-farming termites	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; PROFILES; DIVERSITY; ANTS; WOOD	The gut microbiotas of cockroaches and termites play important roles in the symbiotic digestion of dietary components, such as lignocellulose. Diet has been proposed as a primary determinant of community structure within the gut, acting as a selection force to shape the diversity observed within this "bioreactor", and as a key factor for the divergence of the termite gut microbiota from the omnivorous cockroach ancestor. The gut microbiota in most termites supports primarily the breakdown of lignocellulose, but the fungus-farming subfamily of higher termites has become similar in gut microbiota to the ancestral omnivorous cockroaches. To assess the importance of a fungus diet as a driver of community structure, we compare community compositions in the guts of experimentally manipulated Pycnoscelus surinamensis cockroaches fed on fungus cultivated by fungus-farming termites. MiSeq amplicon analysis of gut microbiotas from 49 gut samples showed a step-wise gradient pattern in community similarity that correlated with an increase in the proportion of fungal material provided to the cockroaches. Comparison of the taxonomic composition of manipulated communities to that of gut communities of a fungus-feeding termite species showed that although some bacteria OTUs shared by P. surinamensis and the farming termites increased in the guts of cockroaches on a fungal diet, cockroach communities remained distinct from those of termites. These results demonstrate that a fungal diet can play a role in structuring gut community composition, but at the same time exemplifies how original community compositions constrain the magnitude of such change.	[Richards, Callum; Otani, Saria; Poulsen, Michael] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Ctr Social Evolut, Copenhagen East, Denmark; [Mikaelyan, Aram] Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA; [Mikaelyan, Aram] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, VU Stn B, Nashville, TN 37235 USA; [Richards, Callum] Imperial Coll London, Dept Life Sci, London, England	University of Copenhagen; Vanderbilt University; Vanderbilt University; Imperial College London	Poulsen, M (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Ctr Social Evolut, Copenhagen East, Denmark.	MPoulsen@bio.ku.dk	Poulsen, Michael/C-6276-2012; Mikaelyan, Aram/I-6071-2015	Poulsen, Michael/0000-0002-2839-1715; Mikaelyan, Aram/0000-0002-7276-0194	Erasmus student exchange program, as part of Imperial College London's Biology; Research Abroad degree; Department of Biology, University of Copenhagen; Danish National Research Foundation Centre of Excellence Centre for Social Evolution [DNRF57]; Villum Kann Rasmussen Young Investigator Fellowship [VKR10101]; Villum Fonden [00010101] Funding Source: researchfish	Erasmus student exchange program, as part of Imperial College London's Biology; Research Abroad degree; Department of Biology, University of Copenhagen; Danish National Research Foundation Centre of Excellence Centre for Social Evolution; Villum Kann Rasmussen Young Investigator Fellowship; Villum Fonden(Villum Fonden)	The work was funded by an Erasmus student exchange program, as part of Imperial College London's Biology with Research Abroad degree to CR; a PhD stipend to SO funded by the Department of Biology, University of Copenhagen, and the Danish National Research Foundation Centre of Excellence Centre for Social Evolution (DNRF57) to Jacobus J. Boomsma, and a Villum Kann Rasmussen Young Investigator Fellowship (VKR10101) to MP.; We thank Harriette Carrington from the Microbial Systems molecular biology lab at the University of Michigan Medical School for laboratory assistance with MiSeq library, and Sylvia Mathiasen and Panagiotis Sapountzis for laboratory assistance. The work was funded by an Erasmus student exchange program, as part of Imperial College London's Biology with a Research Abroad degree to CR, for which we thank course coordinator Prof. Dave Hartley for guidance throughout the project, and Victoria L. Challinor, Rafael R. da Costa, and Dave Hartley for comments on a draft of this manuscript; a PhD stipend to SO funded by the Department of Biology, University of Copenhagen, and the Danish National Research Foundation Centre of Excellence Centre for Social Evolution (DNRF57) to Jacobus J. Boomsma, and a Villum Kann Rasmussen Young Investigator Fellowship (VKR10101) to MP.	Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bourguignon T, 2015, MOL BIOL EVOL, V32, P406, DOI 10.1093/molbev/msu308; Brune A, 2015, ANNU REV MICROBIOL, V69, P145, DOI 10.1146/annurev-micro-092412-155715; BUXTON RD, 1981, OECOLOGIA, V51, P379, DOI 10.1007/BF00540909; Carrasco P, 2014, INT MICROBIOL, V17, P99, DOI 10.2436/20.1501.01.212; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Douglas AE, 2015, ANNU REV ENTOMOL, P6017; Perez-Cobas AE, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv022; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Gade B, 1997, J EVOLUTION BIOL, V10, P479, DOI 10.1007/s000360050037; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hongoh Y, 2007, APPL ENVIRON MICROB, V73, P6270, DOI 10.1128/AEM.00750-07; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Inward D, 2007, BIOL LETTERS, V3, P331, DOI 10.1098/rsbl.2007.0102; Ji R, 2005, SOIL BIOL BIOCHEM, V37, P1648, DOI 10.1016/j.soilbio.2005.01.026; Ji R, 2001, BIOL FERT SOILS, V33, P166, DOI 10.1007/s003740000310; Kohler T, 2008, ENVIRON MICROBIOL, V10, P1260, DOI 10.1111/j.1462-2920.2007.01540.x; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Komatsu N, 2015, TROP BIOMED, V32, P98; Korb J, 2012, J INSECT PHYSIOL, V58, P376, DOI 10.1016/j.jinsphys.2011.12.016; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lanan MC, 2016, ISME J, V10, P1866, DOI 10.1038/ismej.2015.264; LEUTHOLD RH, 1989, INSECT SOC, V36, P328, DOI 10.1007/BF02224884; Li HJ, 2012, J INSECT PHYSIOL, V58, P1368, DOI 10.1016/j.jinsphys.2012.07.012; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mikaelyan A, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw210; Mikaelyan A, 2016, APPL ENVIRON MICROB, V82, P1256, DOI 10.1128/AEM.03700-15; Mikaelyan A, 2015, SYST APPL MICROBIOL, V38, P472, DOI 10.1016/j.syapm.2015.07.004; Mikaelyan A, 2015, MOL ECOL, V24, P5284, DOI 10.1111/mec.13376; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Oksanen J., **DATA OBJECT**; Otani S, 2016, MICROB ECOL, V71, P207, DOI 10.1007/s00248-015-0692-6; Otani S, 2014, MOL ECOL, V23, P4631, DOI 10.1111/mec.12874; Poulsen M, 2015, ENVIRON MICROBIOL, V17, P2562, DOI 10.1111/1462-2920.12765; R Core Team, 2021, R LANGUAGE ENV STAT; R Core Team, R LANG ENV STAT COMP; Rahman NA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0067-8; ROTH LM, 1974, ANN ENTOMOL SOC AM, V67, P215, DOI 10.1093/aesa/67.2.215; Sachs JL, 2011, P NATL ACAD SCI USA, V108, P10800, DOI 10.1073/pnas.1100304108; Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611; Sapountzis P, 2015, APPL ENVIRON MICROB, V81, P5527, DOI 10.1128/AEM.00961-15; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt-Wagner D, 1999, APPL ENVIRON MICROB, V65, P4490; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Su SW, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iev152	51	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185745	10.1371/journal.pone.0185745	http://dx.doi.org/10.1371/journal.pone.0185745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973021	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900044
J	Visone, V; Han, WY; Perugino, G; del Monaco, G; She, QX; Rossi, M; Valenti, A; Ciaramella, M				Visone, Valeria; Han, Wenyuan; Perugino, Giuseppe; del Monaco, Giovanni; She, Qunxin; Rossi, Mose; Valenti, Anna; Ciaramella, Maria			In vivo and in vitro protein imaging in thermophilic archaea by exploiting a novel protein tag	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; DNA-ALKYLATION-DAMAGE; REVERSE GYRASE; SULFOLOBUS-SOLFATARICUS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; DIRECTED EVOLUTION; FUSION PROTEINS; TOPOISOMERASE; EXPRESSION; METHYLTRANSFERASE	Protein imaging, allowing a wide variety of biological studies both in vitro and in vivo, is of great importance in modern biology. Protein and peptide tags fused to proteins of interest provide the opportunity to elucidate protein location and functions, detect protein-protein interactions, and measure protein activity and kinetics in living cells. Whereas several tags are suitable for protein imaging in mesophilic organisms, the application of this approach to microorganisms living at high temperature has lagged behind. Archaea provide an excellent and unique model for understanding basic cell biology mechanisms. Here, we present the development of a toolkit for protein imaging in the hyperthermophilic archaeon Sulfolobus islandicus. The system relies on a thermostable protein tag (H5) constructed by engineering the alkylguanine-DNA-alkyl-transferase protein of Sulfolobus solfataricus, which can be covalently labeled using a wide range of small molecules. As a suitable host, we constructed, by CRISPR-based genome-editing technology, a S. islandicus mutant strain deleted for the alkylguanine-DNA-alkyl-transferase gene (triangle ogt). Introduction of a plasmidborne H5 gene in this strain led to production of a functional H5 protein, which was successfully labeled with appropriate fluorescent molecules and visualized in cell extracts as well as in.ogt live cells. H5 was fused to reverse gyrase, a peculiar thermophile-specific DNA topoisomerase endowed with positive supercoiling activity, and allowed visualization of the enzyme in living cells. To the best of our knowledge, this is the first report of in vivo imaging of any protein of a thermophilic archaeon, filling an important gap in available tools for cell biology studies in these organisms.	[Visone, Valeria; Perugino, Giuseppe; del Monaco, Giovanni; Rossi, Mose; Valenti, Anna; Ciaramella, Maria] Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy; [Han, Wenyuan; She, Qunxin] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Copenhagen	Valenti, A; Ciaramella, M (corresponding author), Natl Res Council Italy, Inst Biosci & Bioresources, Naples, Italy.	anna.valenti@ibbr.cnr.it; maria.ciaramella@ibbr.cnr.it	She, Qunxin/E-4311-2012; Perugino, Giuseppe/P-8147-2016; Han, Wenyuan/AAE-1995-2021; Ciaramella, Maria/O-1152-2015	She, Qunxin/0000-0002-4448-6669; DEL MONACO, Giovanni/0000-0003-0332-9306; Ciaramella, Maria/0000-0003-1583-1694; Perugino, Giuseppe/0000-0003-3266-4744	Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic; Research Fund Denmark [DFF-0602-02196]	Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic; Research Fund Denmark	This work was supported by a) Italian Ministry of Education and Research, Firb-Futuro in Ricerca, Nematic to AV; b) Research Fund Denmark, DFF-0602-02196 to QS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliye N, 2015, APPL MICROBIOL BIOT, V99, P1205, DOI 10.1007/s00253-014-5975-1; Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Contursi P, 2006, EXTREMOPHILES, V10, P615, DOI 10.1007/s00792-006-0017-2; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Grogan DW, 2009, BIOCHEM SOC T, V37, P88, DOI 10.1042/BST0370088; Gronemeyer T, 2006, PROTEIN ENG DES SEL, V19, P309, DOI 10.1093/protein/gzl014; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Han WY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071340; Hinner MJ, 2010, CURR OPIN BIOTECH, V21, P766, DOI 10.1016/j.copbio.2010.09.011; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Jamroze A, 2014, J BIOL CHEM, V289, P3231, DOI 10.1074/jbc.M113.517649; Johnsson N, 2003, CHEMBIOCHEM, V4, P803, DOI 10.1002/cbic.200200603; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Li YJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1044; Lipscomb GL, 2017, EXTREMOPHILES, V21, P603, DOI 10.1007/s00792-017-0929-z; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Miggiano R, 2013, J BACTERIOL, V195, P2728, DOI 10.1128/JB.02298-12; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; NADAL M, 1994, J BIOL CHEM, V269, P5255; Napoli A, 2005, NUCLEIC ACIDS RES, V33, P564, DOI 10.1093/nar/gki202; Napoli A, 2004, J BIOL CHEM, V279, P33192, DOI 10.1074/jbc.M402619200; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Peng N, 2017, SCI CHINA LIFE SCI, V60, P370, DOI 10.1007/s11427-016-0355-8; Peng N, 2012, APPL ENVIRON MICROB, V78, P5630, DOI 10.1128/AEM.00855-12; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Perugino G, 2015, NUCLEIC ACIDS RES, V43, P8801, DOI 10.1093/nar/gkv774; Perugino G, 2012, J BIOL CHEM, V287, P4222, DOI 10.1074/jbc.M111.308320; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Schneider AFL, 2017, CURR OPIN BIOTECH, V48, P61, DOI 10.1016/j.copbio.2017.03.012; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Valenti A, 2006, NUCLEIC ACIDS RES, V34, P2098, DOI 10.1093/nar/gkl115; Valenti A, 2010, J BIOL CHEM, V285, P36532, DOI 10.1074/jbc.M110.169029; Valenti A, 2009, NUCLEIC ACIDS RES, V37, P4287, DOI 10.1093/nar/gkp386; Vettone A, 2016, EXTREMOPHILES, V20, P1, DOI 10.1007/s00792-015-0791-9; Visone V, 2014, INT J MOL SCI, V15, P17162, DOI 10.3390/ijms150917162; Zhang CY, 2013, BIOCHEM SOC T, V41, P405, DOI 10.1042/BST20120285	42	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185791	10.1371/journal.pone.0185791	http://dx.doi.org/10.1371/journal.pone.0185791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973046	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900051
J	Weiss, B; Pollack, AA				Weiss, Bahr; Pollack, Arnie Alley			Barriers to global health development: An international quantitative survey	PLOS ONE			English	Article							CHALLENGES	Background Global health's goal of reducing low-and-middle-income country versus high-income country health disparities faces complex challenges. Although there have been discussions of barriers, there has not been a broad-based, quantitative survey of such barriers. Methods 432 global health professionals were invited via email to participate in an online survey, with 268 (62%) participating. The survey assessed participants' (A) demographic and global health background, (B) perceptions regarding 66 barriers' seriousness, (C) detailed ratings of barriers designated most serious, (D) potential solutions. Results Thirty-four (of 66) barriers were seen as moderately or more serious, highlighting the widespread, significant challenges global health development faces. Perceived barrier seriousness differed significantly across domains: Resource Limitations mean = 2.47 (0-4 Likert scale), Priority Selection mean = 2.20, Corruption, Lack of Competence mean = 1.87, Social and Cultural Barriers mean = 1.68. Some system-level predictors showed significant but relatively limited relations. For instance, for Global Health Domain, HIV and Mental Health had higher levels of perceived Social and Cultural Barriers than other GH Domains. Individual- level global health experience predictors had small but significant effects, with seriousness of (a) Corruption, Lack of Competence, and (b) Priority Selection barriers positively correlated with respondents' level of LMIC-oriented (e.g., weeks/year spent in LMIC) but Academic Global Health Achievement (e.g., number of global health publications) negatively correlated with overall barrier seriousness. Conclusions That comparatively few system-level predictors (e.g., Organization Type) were significant suggests these barriers may be relatively fundamental at the system-level. Individual-level and system-level effects do have policy implications; e.g., Priority Selection barriers were among the most serious, yet effects on seriousness of how LMIC-oriented a professional was versus level of academic global health achievement ran in opposite directions, suggesting increased discussion of priorities between LMIC- based and other professionals may be useful. It is hoped the 22 suggested solutions will provide useful ideas for addressing global health barriers.	[Weiss, Bahr; Pollack, Arnie Alley] Vanderbilt Univ, Dept Psychol & Human Dev, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Weiss, B (corresponding author), Vanderbilt Univ, Dept Psychol & Human Dev, 221 Kirkland Hall, Nashville, TN 37235 USA.	bahr.weiss@vanderbilt.edu			U.S. NIH Fogarty International Center [D43TW009089]; FOGARTY INTERNATIONAL CENTER [D43TW009089] Funding Source: NIH RePORTER	U.S. NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported in part by the U.S. NIH Fogarty International Center under Grant D43TW009089. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD GEOGR REG; [Anonymous], FACTOR ANAL; Bassat Q, 2016, MALAR J, V15; Berndtson K, 2007, PLOS MED, V4, P1445, DOI 10.1371/journal.pmed.0040268; Corrigan P. W., 2014, STIGMA DIS DISABILIT; Frenk J, 2013, NEW ENGL J MED, V368, P936, DOI 10.1056/NEJMra1109339; Gopinathan U, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0128-6; Harzing AW, 2013, EUR J INT MANAG, V7, P112, DOI 10.1504/EJIM.2013.052090; Kapilashrami A, 2014, GLOB PUBLIC HEALTH, V9, P160, DOI 10.1080/17441692.2014.881524; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kishore SP, 2015, HEALTH AFFAIR, V34, P1569, DOI 10.1377/hlthaff.2015.0375; Lim J.W., 2016, EUR J CANC CARE; Miller E, 2015, NANOBIOMEDICINE, V1; Murray CJL, 2007, LANCET, V370, P1018, DOI 10.1016/S0140-6736(07)61458-5; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; Rose-Ackerman S., 2016, CORRUPTION GOVT CAUS; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sheskin DJ, 2011, HDB PARAMETRIC NONPA; Sue VM, 2013, CONDUCTING ONLINE SU; Urdang E., 2016, HUMAN BEHAV SOCIAL E; Wallace Barbara C, 2008, EQUITY HLTH NEW GLOB; Weiss Bahr, 2011, Psychol Stud (Mysore), V56, P185; Weiss Bahr, 2012, Int Perspect Psychol, V1, P63; Yamey G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-11	24	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0184846	10.1371/journal.pone.0184846	http://dx.doi.org/10.1371/journal.pone.0184846			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972971	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900008
J	Sun, RY; Mendez, D				Sun, Ruoyan; Mendez, David			An application of the Continuous Opinions and Discrete Actions (CODA) model to adolescent smoking initiation	PLOS ONE			English	Article							SOCIAL-INFLUENCE; TOBACCO SMOKING; CESSATION; DYNAMICS; NETWORK	We investigated the impact of peers' opinions on the smoking initiation process among adolescents. We applied the Continuous Opinions and Discrete Actions (CODA) model to study how social interactions change adolescents' opinions and behaviors about smoking. Through agent-based modeling (ABM), we simulated a population of 2500 adolescents and compared smoking prevalence to data from 9 cohorts of adolescents in the National Survey on Drug Use and Health (NSDUH) from year 2001 till 2014. Our model adjusts well for NSDUH data according to pseudo R-2 values, which are at least 96%. Optimal parameter values indicate that adolescents exhibit imitator characteristics with regard to smoking opinions. The imitator characteristics suggests that teenagers tend to update their opinions consistently according to what others do, and these opinions later translate into smoking behaviors. As a result, peer influence from social networks plays a big role in the smoking initiation process and should be an important driver in policy formulation.	[Sun, Ruoyan; Mendez, David] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sun, RY (corresponding author), Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	sunry@umich.edu	PAN, ZEQIANG/X-6341-2018	Sun, Ruoyan/0000-0001-8412-7727				Bruch E, 2013, SOCIOMETHODS RES; CDC, 2008, MMWR-MORBID MORTAL W, V57, P1226; CDC Services U. S. D. o. H. a. H, 2004, HLTH CONS SMOK REP S; Centers for Disease Control and Prevention (US) National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health (US), 2010, TOB SMOK CAUS DIS BI; Chew D, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/237834; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Freedman KS, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110037; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S., 2013, GLOBAL ECON REV, V18, P2, DOI [DOI 10.1016/S2340-1540(13)70002-1, 10.1016/S2340-1540(13)70002-1]; Haas SA, 2014, J HEALTH SOC BEHAV, V55, P126, DOI 10.1177/0022146514532817; Hammond RA, 2014, ANN NY ACAD SCI, V1331, P34, DOI 10.1111/nyas.12344; Hennessy E, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150414; Heo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098683; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Huang GC, 2014, AM J PUBLIC HEALTH, V104, pE51, DOI 10.2105/AJPH.2014.302038; Karimi E, 2015, HEALTH CARE MANAG SC, V18, P318, DOI 10.1007/s10729-014-9310-2; Lakon CM, 2015, AM J PUBLIC HEALTH, V105, P2438, DOI 10.2105/AJPH.2015.302789; Levy David T, 2002, Health Care Manag Sci, V5, P113, DOI 10.1023/A:1014476916361; Martins ACR, 2008, INT J MOD PHYS C, V19, P617, DOI 10.1142/S0129183108012339; Martins ACR, 2010, ADV COMPLEX SYST, V13, P621, DOI 10.1142/S0219525910002773; Martins ACR, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036104; Mendez D, 2017, WORKING PAPER; Moore TW, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-40462-y; Samet JM, 2013, THORAC SURG CLIN, V23, P103, DOI 10.1016/j.thorsurg.2013.01.009; Scherrer JF, 2012, ADDICT BEHAV, V37, P240, DOI 10.1016/j.addbeh.2011.10.005; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; The Institute of Medicine, 2015, ASS US AG BAS MOD TO, P157; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Xu X, 2015, AM J PREV MED, V48, P326, DOI 10.1016/j.amepre.2014.10.012	29	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186163	10.1371/journal.pone.0186163	http://dx.doi.org/10.1371/journal.pone.0186163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ4ZX	29020024	gold, Green Published, Green Submitted			2022-12-27	WOS:000412754400075
J	Abdulghani, HM; Irshad, M; Haque, S; Ahmed, T; Satter, K; Khalil, MS				Abdulghani, Hamza Mohammad; Irshad, Mohammad; Haque, Shafiul; Ahmed, Tauseef; Satter, Kamran; Khalil, Mahmoud Salah			Effectiveness of longitudinal faculty development programs on MCQs items writing skills: A follow-up study	PLOS ONE			English	Article							MULTIPLE-CHOICE QUESTIONS; QUALITY; STUDENTS; IMPACT; UNIVERSITY; ACHIEVEMENT; FELLOWSHIP; EDUCATION; IMPROVE; TESTS	This study examines the long-term impact of the faculty development programs on the multiple choice question (MCQ) items' quality leading to study its effect on the students' overall competency level during their yearly academic assessment. A series of longitudinal highly constructed faculty development workshops were conducted to improve the quality of the MCQs items writing skills. A total of 2207 MCQs were constructed by 58 participants for the assessment of 882 students' cognitive competency level during the academic years 2012- 2015. The MCQs were analyzed for the difficulty index (P-value), discriminating index (DI), presence/absence of item writing flaws (IWFs), and non-functioning distractors (NFDs), Bloom's taxonomy cognitive levels, test reliability, and the rate of students' scoring. Significant improvement in the difficulty index and DI were noticed during each successive academic year. Easy and poor discriminating questions, NFDs and IWFs were decreased significantly, whereas distractor efficiency (DE) mean score and high cognitive level (K2) questions were increased substantially during the each successive academic year. Improved MCQs' quality leaded to increased competency level of the borderline students. Overall, the longitudinal faculty development workshops help in improving the quality of the MCQs items writing skills of the faculty that leads to students' high competency levels.	[Abdulghani, Hamza Mohammad; Ahmed, Tauseef; Satter, Kamran; Khalil, Mahmoud Salah] King Saud Univ, Dept Med Educ, Coll Med, Riyadh, Saudi Arabia; [Irshad, Mohammad] Kuwait Univ, Hlth Sci Ctr, Fac Dent, Dept Bioclin Sci,Oral Microbiol Lab, Safat, Kuwait; [Haque, Shafiul] Jazan Univ, Coll Nursing & Allied Hlth Sci, Res & Sci Studies Unit, Jazan, Saudi Arabia	King Saud University; Kuwait University; College Nursing & Allied Health Science Saudi Arabia; Jazan University	Abdulghani, HM (corresponding author), King Saud Univ, Dept Med Educ, Coll Med, Riyadh, Saudi Arabia.	hamzaabg@gmail.com	Irshad, Mohammad/HCG-8571-2022; , KAMRAN/R-1298-2017; HAQUE, SHAFIUL/AAN-2946-2020; Ahmad, Dr Tauseef/AAF-9641-2019	Irshad, Mohammad/0000-0002-7520-0221; , KAMRAN/0000-0003-4820-3483; HAQUE, SHAFIUL/0000-0002-2989-121X; Ahmad, Dr Tauseef/0000-0001-6769-1617; ABDULGHANI, HAMZA/0000-0002-9826-5781	COM, Research Centre, Deanship of Scientific Research, KSU, Riyadh, Saudi Arabia	COM, Research Centre, Deanship of Scientific Research, KSU, Riyadh, Saudi Arabia	The financial support for this study was provided by the COM, Research Centre, Deanship of Scientific Research, KSU, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed AA, 2005, SAUDI MED J, V26, P1505; Abdulghani H., 2014, J HLTH SPECIALTIES, V2, P148, DOI [DOI 10.4103/1658-600X.142784, 10.4103/1658-600X.142784]; Abdulghani HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09556; Abdulghani HM, 2014, MED TEACH, V36, pS24, DOI 10.3109/0142159X.2014.886012; Al-Drees AA, 2015, SAUDI MED J, V36, P341, DOI 10.15537/smj.2015.3.10216; AlFaris E, 2015, J DENT EDUC, V79, P1305; Baig M, 2014, PAK J MED SCI, V30, P3, DOI 10.12669/pjms.301.4458; Bauer D, 2011, ADV HEALTH SCI EDUC, V16, P211, DOI 10.1007/s10459-010-9256-1; Bloom B.S., 1956, HANDBOOK; CALDWELL DJ, 2013, AM J PHARM EDUC, V77; Case SM., 2002, CONSTRUCTING WRITTEN, V3rd ed; Cherdsak Iramaneerat, 2012, Siriraj Medical Journal, V64, P178; Cilliers FJ, 2012, ADV HEALTH SCI EDUC, V17, P39, DOI 10.1007/s10459-011-9292-5; Clifton SL, 2010, NURS EDUC, V35, P12, DOI 10.1097/NNE.0b013e3181c41fa3; Coderre Sylvain P, 2004, BMC Med Educ, V4, P23, DOI 10.1186/1472-6920-4-23; Collins J, 2006, RADIOGRAPHICS, V26, P543, DOI 10.1148/rg.262055145; Considine Julie, 2005, Collegian, V12, P19, DOI 10.1016/S1322-7696(08)60478-3; Dickinson M., 2011, LEARNING SOLUTIONS M; Downing SM, 2005, ADV HEALTH SCI EDUC, V10, P133, DOI 10.1007/s10459-004-4019-5; Ebrahimi S, 2012, ARCH IRAN MED, V15, P79, DOI 012152/AIM.005; El-Uri Fahmi Ishaq, 2013, Qatar Med J, V2013, P3, DOI 10.5339/qmj.2013.1; Elliot DL, 1999, TEACH LEARN MED, V11, P52, DOI 10.1207/S15328015TLM1101_12; Gajjar Sanju, 2014, Indian J Community Med, V39, P17, DOI 10.4103/0970-0218.126347; Gjerde CL, 2008, FAM MED, V40, P579; Gorjian B, 2009, INT J PEDAGOG LEARN, V5, P11, DOI 10.5172/ijpl.5.1.11; Gozu A, 2008, MED EDUC, V42, P684, DOI 10.1111/j.1365-2923.2008.03090.x; Hingorjo MR, 2012, J PAK MED ASSOC, V62, P142; Jozefowicz RF, 2002, ACAD MED, V77, P156, DOI 10.1097/00001888-200202000-00016; Kasule OH, 2013, J TAIBAH UNIV MED SC, V8, P72, DOI 10.1016/j.jtumed.2013.07.001; Khafagy G, 2016, ED PRIM CARE, V17, P1; Knight AM, 2005, J GEN INTERN MED, V20, P721, DOI 10.1111/j.1525-1497.2005.0145.x; Linn R.L., 2000, MEASUREMENT ASSESSME; McAndrew M, 2013, J DENT EDUC, V77, P716; Moss E, 2001, Curr Opin Anaesthesiol, V14, P661, DOI 10.1097/00001503-200112000-00011; Naeem N., 2016, CREATIVE ED, V7, P870, DOI DOI 10.4236/ce.2016.76091; Naeem N, 2012, ADV HEALTH SCI EDUC, V17, P369, DOI 10.1007/s10459-011-9315-2; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Palmer Edward J, 2007, BMC Med Educ, V7, P49, DOI 10.1186/1472-6920-7-49; Pololi L, 2001, MED TEACH, V23, P276, DOI 10.1080/01421590120043053; Rodriguez M. C., 1997, ART SCI ITEM WRITING; Schuwirth LWT, 2004, MED EDUC, V38, P974, DOI 10.1111/j.1365-2929.2004.01916.x; Segers M, 2006, STUD EDUC EVAL, V32, P223, DOI [DOI 10.1016/J.STUEDUC.2006.08.004, 10.1016/j.stueduc.2006.08.004]; Segers M, 2008, EDUC STUD-UK, V34, P35, DOI 10.1080/03055690701785269; Singh T, 2013, MED TEACH, V35, P359, DOI 10.3109/0142159X.2013.769672; Tarrant M, 2009, BMC MED EDUC, P9; Tarrant M, 2008, MED EDUC, V42, P198, DOI 10.1111/j.1365-2923.2007.02957.x; Tarrant M, 2006, NURS EDUC TODAY, V26, P662, DOI 10.1016/j.nedt.2006.07.006; Tarrant M, 2012, NURS EDUC, V37, P98, DOI 10.1097/NNE.0b013e31825041d0; Vanderbilt AA, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.20644; Wallach PM, 2006, ADV HEALTH SCI EDUC, V11, P61, DOI 10.1007/s10459-004-7515-8; Zimmaro DM, 2010, WRITING GOOD MULTIPL	51	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185895	10.1371/journal.pone.0185895	http://dx.doi.org/10.1371/journal.pone.0185895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016659	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400035
J	Wu, GC; Li, HW; Tey, WG; Lin, CJ; Chang, CF				Wu, Guan-Chung; Li, Hau-Wen; Tey, Wei-Guan; Lin, Chien-Ju; Chang, Ching-Fong			Expression profile of amh/Amh during bidirectional sex change in the protogynous orange-spotted grouper Epinephelus coioides	PLOS ONE			English	Article							PROTANDROUS BLACK PORGY; MULLERIAN-INHIBITING SUBSTANCE; GERM-CELLS; HORMONE; FEMALE; DIFFERENTIATION; FISH; PROLIFERATION; MEDAKA; GENE	Gonadal differentiation is tightly regulated by the initial sex determining gene and the downstream sex-related genes in vertebrates. However, sex change in fish can alter the sexual fate from one sex to the other. Chemical-induced maleness in the protogynous orange-spotted grouper is transient, and a reversible sex change occurs after the chemical treatment is withdrawn. We used these characteristics to study Amh signaling during bi-directional sex change in the grouper. We successfully induced the female-to-male sex change by chemical (aromatase inhibitor, AI, or methyltestosterone, MT) treatment. A dormant gonad (a low proliferation rate of early germ cells and no characteristics of both sexes) was found during the transient phase of reversible male-to-female sex change after the withdrawal of chemical administration. Our results showed that amh (anti-mullerian hormone) and its receptor amhr2 (anti-mullerian hormone receptor type 2) were significantly increased in the gonads during the process of female-to-male sex change. Amh is expressed in the Sertoli cells surrounding the type A spermatogonia in the female-to-male grouper. Male-related gene (dmrt1 and sox9) expression was immediately decreased in MT-terminated males during the reversible male-to-female sex change. However, Amh expression was found in the surrounding cells of type A spermatogonia-like cells during the transient phase of reversible male-to-female sex change. This phenomenon is correlated with the dormancy of type A spermatogonia-like cells. Thus, Amh signaling is suggested to play roles in regulating male differentiation during the female-to-male sex change and in inhibiting type-A spermatogonia-like cell proliferation/ differentiation during the reversible male-to-female sex change. We suggest that Amh signaling might play dual roles during bi-directional sex change in grouper.	[Wu, Guan-Chung; Li, Hau-Wen; Tey, Wei-Guan; Lin, Chien-Ju; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan; [Wu, Guan-Chung; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung, Taiwan.; Wu, GC; Chang, CF (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan.	gcwu@mail.ntou.edu.tw; B0044@email.ntou.edu.tw		Lin, Chien-Ju/0000-0002-9050-6181	Ministry of Science and Technology [105-2811-B-019-006-MY3, 105-2313-B-019-008MY3]; Ministry of Education, Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by the Ministry of Science and Technology project number 105-2811-B-019-006-MY3 and 105-2313-B-019-008MY3, and Ministry of Education, Taiwan.; The English was edited by the American Journal Experts. This work was supported by the Ministry of Science and Technology Project no. 105-2811-B-019-006-MY3 and no. 105-2313B-019-008-MY3, and the Ministry of Education, Taiwan.	Alam MA, 2006, MOL REPROD DEV, V73, P206, DOI 10.1002/mrd.20393; [Anonymous], 2010, GEN COMP ENDOCR, V165, P352; Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; Eicher EM, 2001, J EXP ZOOL, V290, P322, DOI 10.1002/jez.1072; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lee YH, 2004, BIOL REPROD, V71, P1270, DOI 10.1095/biolreprod.104.030221; Liu W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2130-z; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Miura T, 2002, DEVELOPMENT, V129, P2689; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Murata R, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115378; Nakamura S, 2012, DEVELOPMENT, V139, P2283, DOI 10.1242/dev.076307; Nishimura T, 2015, SCIENCE, V349, P328, DOI 10.1126/science.aaa2657; Nozu R, 2013, FISH PHYSIOL BIOCHEM, V39, P47, DOI 10.1007/s10695-012-9632-2; Pfennig F, 2015, GEN COMP ENDOCR, V223, P87, DOI 10.1016/j.ygcen.2015.09.025; POLICANSKY D, 1982, ANNU REV ECOL SYST, V13, P471, DOI 10.1146/annurev.es.13.110182.002351; Ren WY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005180; Rocha A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137547; de Mitcheson YS, 2008, FISH FISH, V9, P1, DOI 10.1111/j.1467-2979.2007.00266.x; Shiraishi E, 2008, ENDOCRINOLOGY, V149, P1813, DOI 10.1210/en.2007-1535; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Skaar KS, 2011, ENDOCRINOLOGY, V152, P3527, DOI 10.1210/en.2010-1469; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wu GC, 2016, PLOS ONE, V10; Wu GC, 2017, GEN COMP ENDOCRINOL; Wu GC, 2008, BIOL REPROD, V78, P200, DOI 10.1095/biolreprod.107.062612; Wu GC, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126953; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Wu GC, 2013, FISH PHYSIOL BIOCHEM, V39, P33, DOI 10.1007/s10695-012-9618-0; Wu GC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095695; Wu GC, 2010, BIOL REPROD, V83, P443, DOI 10.1095/biolreprod.110.084681; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Yoshizaki G., 2010, Animal Reproduction, V7, P187; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0	42	20	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185864	10.1371/journal.pone.0185864	http://dx.doi.org/10.1371/journal.pone.0185864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016690	gold, Green Published, Green Submitted			2022-12-27	WOS:000412627400032
J	Chu, Q; Yan, ZX; Zhang, J; Usman, T; Zhang, Y; Liu, H; Wang, HH; Geng, AL; Liu, HG				Chu, Qin; Yan, Zhixun; Zhang, Jian; Usman, Tahir; Zhang, Yao; Liu, Hui; Wang, Haihong; Geng, Ailian; Liu, Huagui			Association of SNP rs80659072 in the ZRS with polydactyly in Beijing You chickens	PLOS ONE			English	Article							TRIPHALANGEAL THUMB; SHH; MUTATION; EXPRESSION; INHERITANCE; FOWL	The Beijing You chicken is a Chinese native breed with superior meat quality and a unique appearance. The G/T mutation of SNP rs80659072 in the Shh long-range regulator of GGA2 is highly associated with the polydactyly phenotype in some chicken breeds. In the present study, this SNP was genotyped using the TaqMan detection method, and its association with the number of toes was analyzed in a flock of 158 birds of the Beijing You population maintained at the Beijing Academy of Agriculture and Forestry Sciences. Furthermore, the skeletal structure of the digits was dissected and assembled in 113 birds. The findings revealed that the toes of Beijing You chickens were rich and more complex than expected. The plausible mutation rs80659072 in the zone of polarizing activity regulatory sequence (ZRS) in chickens was an essential but not sufficient condition for polydactyly and polyphalangy in Beijing You chickens. Several individuals shared the T allele but showed normal four-digit conformations. However, breeding trials demonstrated that the T allele could serve as a strong genetic marker for five-toe selection in Beijing You chickens.	[Chu, Qin; Yan, Zhixun; Zhang, Jian; Zhang, Yao; Liu, Hui; Wang, Haihong; Geng, Ailian; Liu, Huagui] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Usman, Tahir] Abdul Wali Khan Univ Mardan, Coll Vet Sci & Anim Husb, Garden Campus, Mardan, Pakistan	Beijing Academy of Agriculture & Forestry	Liu, HG (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China.	liuhuagui66@163.com	Geng, Ailian/GZA-8751-2022; Usman, Tahir/GZB-2259-2022	Geng, Ailian/0000-0002-3721-7356; Usman, Tahir/0000-0002-8192-5800	Youth Program of the National Natural Science Foundation of China [31402060]; Earmarked Fund for Modern Agroindustry Technology Research System [nycytx-41-Z01]; Innovation Program of Beijing Academy of Agriculture and Forestry Sciences [KJCX20170105]	Youth Program of the National Natural Science Foundation of China; Earmarked Fund for Modern Agroindustry Technology Research System; Innovation Program of Beijing Academy of Agriculture and Forestry Sciences	This work was supported by the Youth Program of the National Natural Science Foundation of China (31402060, http:www.nsfc gov.cn/), the Earmarked Fund for Modern Agroindustry Technology Research System (nycytx-41-Z01, http://www.zgrj.org/) and the Innovation Program of Beijing Academy of Agriculture and Forestry Sciences (KJCX20170105, http://www.baafs.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuisson J, 2011, CLIN GENET, V79, P371, DOI 10.1111/j.1399-0004.2010.01465.x; [Anonymous], [No title captured]; Bahr C, 2003, DEUT TIERARZTL WOCH, V110, P333; Bouldin CM, 2009, DEV BIOL, V334, P133, DOI 10.1016/j.ydbio.2009.07.009; Brenig B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129208; Bridgham JT, 2016, SCIENCE, V354, P289, DOI 10.1126/science.aai7394; Chu Q, 2012, CHINESE J ANIMAL SCI, V48, P13; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Girisha KM, 2014, AM J MED GENET A, V164, P898, DOI 10.1002/ajmg.a.36367; Gorbach D, 2010, J HERED, V101, P469, DOI 10.1093/jhered/esq037; He C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176113; Johnson EJ, 2014, DEV BIOL, V392, P209, DOI 10.1016/j.ydbio.2014.05.025; JOHNSON JL, 1981, J HERED, V72, P205, DOI 10.1093/oxfordjournals.jhered.a109473; Kropatsch R, 2015, PLOS ONE, V10; LANDAUER W, 1948, GENETICS, V33, P133; Laurell T, 2012, HUM MUTAT, V33, P1063, DOI 10.1002/humu.22097; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu ZH, 2017, MOL MED REP, V15, P793, DOI 10.3892/mmr.2016.6092; Matsubara H, 2017, DEV DYNAM, V246, P417, DOI 10.1002/dvdy.24493; Metzger J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2844-6; Nie Q, 2002, J HERED, V93, P277, DOI 10.1093/jhered/93.4.277; Norbnop P, 2014, J HUM GENET, V59, P467, DOI 10.1038/jhg.2014.50; Pitel F, 2000, GENET SEL EVOL, V32, P73, DOI 10.1051/gse:2000107; Robb EA, 2012, CYTOGENET GENOME RES, V136, P50, DOI 10.1159/000335005; Sturkle PD, 1943, J EXP ZOOL, V93, P325, DOI 10.1002/jez.1400930302; Sun YF, 2014, G3-GENES GENOM GENET, V4, P1167, DOI 10.1534/g3.114.011338; Wang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep38500; Warren DC, 1944, GENETICS, V29, P217; Yang K, 2013, ANIM GENET, V44, P118, DOI 10.1111/j.1365-2052.2012.02369.x; Yang N, 2005, WORLD POULTRY SCI J, V61, P373, DOI [10.1079/WPS200463, 10.1079/WPS200563]; Zhang LF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099946, 10.1371/journal.pone.0084950]; Zhang R, 2017, G3-GENES GENOM GENET, V7, P851, DOI 10.1534/g3.116.033019; Zhang ZB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149010	34	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185953	10.1371/journal.pone.0185953	http://dx.doi.org/10.1371/journal.pone.0185953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016641	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800030
J	Jia, YP; Wang, K; Zhang, ZJ; Tong, YN; Han, D; Hu, CY; Li, Q; Xiang, Y; Mao, XH; Tang, B				Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin			TLR2/TLR4 activation induces Tregs and suppresses intestinal inflammation caused by Fusobacterium nucleatum in vivo	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; NEGATIVE PERIODONTAL BACTERIA; CYTOKINE PRODUCTION; COLON-CANCER; TOLL-LIKE-RECEPTOR-4; STIMULATION; MICROBIOTA; IMMUNITY; INNATE	Toll-like receptors (TLRs) 2 and 4 play critical roles in intestinal inflammation caused by Fusobacterium nucleatum (F. nucleatum) infection, but the role of TLR2/TLR4 in regulation of proinflammatory cytokines remains unknown. In this study, through microarray analysis and qRT-PCR, we showed that TLR2/TLR4 are involved in the F. nucleatum-induced inflammatory signaling pathway in Caco-2 cells, C57BL/6 mice and human clinical specimens. In TLR2(-/-) and TLR4(-/-) mice, F. nucleatum infection resulted in increased colonization of the bacteria and production of the proinflammatory cytokines IL-8, IL-1 beta and TNF-alpha. In addition, the ratio of Foxp3(+) CD4(+) T cells in the total CD4(+) T cells in TLR2(-/-) and TLR4(-/-) mice was less than that in wild-type mice, and the ratio in hybrid mice was more than that in knockout mice, which suggested that TLR2/TLR4 mediated the number of Tregs. Furthermore, it was observed that inflammatory cytokine levels were reduced in TLR2(-/-) mice after Treg transfer. Thus, these data indicate that TLR2/TLR4 regulate F. nucleatum-induced inflammatory cytokines through Tregs in vivo.	[Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin] Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China; [Jia, Yin-ping; Wang, Kun; Zhang, Zhu-jun; Tong, Ya-nan; Han, Dan; Hu, Chun-yu; Li, Qian; Xiang, Yang; Mao, Xu-hu; Tang, Bin] Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China; [Tang, Bin] PLA Rocket Force, Emei Sanat, Emeishan, Peoples R China	Army Medical University; Army Medical University	Tang, B (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Clin Microbiol & Immunol, Chongqing, Peoples R China.; Tang, B (corresponding author), Third Mil Med Univ, Coll Med Lab Sci, Chongqing, Peoples R China.; Tang, B (corresponding author), PLA Rocket Force, Emei Sanat, Emeishan, Peoples R China.	tangbin811012@163.com	bin, tang/AAK-9399-2020	bin, tang/0000-0002-1762-3883	National Natural Science Foundation of China (NSFC) [81501796]; project of medical science and technology for training youth scholars of PLA [14QNP054]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); project of medical science and technology for training youth scholars of PLA	This work was supported by Grant Nos. 81501796 (for Q.L.) from National Natural Science Foundation of China (NSFC,), and the project of medical science and technology for training youth scholars of PLA (14QNP054) (for B.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Bashir A, 2016, TUMOR BIOL, V37, P2805, DOI 10.1007/s13277-015-4724-0; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; LaRue H, 2013, NAT REV UROL, V10, P537, DOI 10.1038/nrurol.2013.153; Liu HQ, 2007, J IMMUNOL, V179, P2501, DOI 10.4049/jimmunol.179.4.2501; Liu PC, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0106-3; Marcato LG, 2008, ORAL MICROBIOL IMMUN, V23, P353, DOI 10.1111/j.1399-302X.2008.00432.x; Nawijn MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055307; Park SR, 2014, INFECT IMMUN, V82, P1914, DOI 10.1128/IAI.01226-13; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Song JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20077; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165701; Tang B, 2012, AUTOPHAGY, V8, P1045, DOI 10.4161/auto.20159; Tietze K, 2006, J PERIODONTAL RES, V41, P447, DOI 10.1111/j.1600-0765.2006.00890.x; Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925; Zhang G, 2011, J PERIODONTAL RES, V46, P558, DOI 10.1111/j.1600-0765.2011.01373.x	25	28	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186179	10.1371/journal.pone.0186179	http://dx.doi.org/10.1371/journal.pone.0186179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016688	Green Published, gold, Green Submitted			2022-12-27	WOS:000412601800044
J	de Gouveia, NM; Rodrigues, WF; de Sousa, RMF; Calabria, LK; Mundim, AV; Miguel, CB; Oliveira, CJF; Lazo-Chica, JE; de Oliveira, A; Lago, JHG; dos Santos, VB; do Lago, CL; Espindola, FS				de Gouveia, Neire M.; Rodrigues, Wellington F.; de Sousa, Raquel M. F.; Calabria, Luciana K.; Mundim, Antonio V.; Miguel, Camila B.; Oliveira, Carlo J. F.; Lazo-Chica, Javier E.; de Oliveira, Alberto; Lago, Joao H. G.; dos Santos, Vagner B.; do Lago, Claudimir L.; Espindola, Foued S.			Phytochemical characterization of the Vochysia rufa (Vochysiaceae) extract and its effects on oxidative stress in the pancreata of streptozotocin-induced diabetic rats	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; ANTIOXIDANT ACTIVITIES; LIPID-PEROXIDATION; BETA-CELL; IN-VIVO; POLYSACCHARIDES; MICE; GLUCOSE; LIVER; ACID	Aqueous extract of macerated Vochysia rufa stem bark has been commonly used in the treatment of diabetes. Therefore, we evaluated the antihyperglycemic and antioxidant effects of an extract of V. rufa on the pancreata of streptozotocin (STZ)-induced diabetic rats. Animals received one of the following treatments daily by oral gavage: water (diabetic- control), V. rufa extract (diabetic- V. rufa), or glibenclamide (diabetic- GBD). Total antioxidant capacity; levels of thiobarbituric acid reactive substances, reduced glutathione, and sulfhydryls; and superoxide dismutase, catalase, and glutathione peroxidase (GPx) activities were measured in the pancreas. Biochemical analysis of serum total cholesterol and fractions, triglycerides, creatinine, urea, acid uric, ALP,gamma-GT, AST, and ALT was performed, and pancreatic beta-cells positive for insulin were evaluated by immunohistochemistry. Rats treated with extract exhibited a decrease in fasting blood glucose compared with levels in diabetic control rats. GPx activity and sulfhydryl levels were significantly lower in diabetic-V. rufa rats compared with those of diabetic- control rats. V. rufa extract acted to normalize the biochemical alterations found in diabetic rats (diabetic- controls), as demonstrated by increases in urea, HDL, ALP, AST, and ALT. Reduction in blood glucose was independent of an increase in insulin. The V. rufa extract was found to be composed of free sugars (inositol, galactose, glucose, mannose, sucrose, arabinose, and ribose) as the main metabolites. Thus, aqueous extract of the stem bark of V. rufa is capable of reducing blood glucose, resulting in an antioxidant effect on the pancreatic tissue of STZ-diabetic rats.	[de Gouveia, Neire M.; Rodrigues, Wellington F.; Calabria, Luciana K.; Espindola, Foued S.] Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil; [de Gouveia, Neire M.] Fac Morgana Potrich, Dept Ciencias Biofuncionais, Goiania, Go, Brazil; [Rodrigues, Wellington F.; Miguel, Camila B.; Lazo-Chica, Javier E.] Univ Fed Triangulo Mineiro, Curso Posgrad Ciencias Saude, Uberaba, MG, Brazil; [de Sousa, Raquel M. F.; de Oliveira, Alberto] Univ Fed Uberlandia, Inst Quin, Uberlandia, MG, Brazil; [Calabria, Luciana K.] Univ Fed Uberlandia, Fac Ciencias Integradas Pontal, Ituiutaba, MG, Brazil; [Mundim, Antonio V.] Univ Fed Uberlandia, Fac Med Vet, Uberlandia, MG, Brazil; [Miguel, Camila B.] Ctr Univ Mineiros, UNIFIMES, Lab Morfofunc, Goiania, Go, Brazil; [Oliveira, Carlo J. F.; Lazo-Chica, Javier E.] Univ Fed Triangulo Mineiro, Inst Ciencias Biol & Nat, Uberaba, MG, Brazil; [Lago, Joao H. G.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [dos Santos, Vagner B.; do Lago, Claudimir L.] Univ Sao Paulo, Inst Quim, Sao Paulo, SP, Brazil	Universidade Federal de Uberlandia; Universidade Federal do Triangulo Mineiro; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal do Triangulo Mineiro; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Espindola, FS (corresponding author), Univ Fed Uberlandia, Inst Genet & Bioquim, Uberlandia, MG, Brazil.	foued@ufu.br	Botelho Miguel, Camila/GNP-5269-2022; Sousa, Raquel M. F./W-9238-2019; Espindola, Foued Salmen/C-5324-2013; santos, vagner B/D-3443-2013; Lago, Joao/W-5238-2019; Rodrigues, Wellington/AEW-3823-2022; Oliveira, Carlo Jose Freire/AAY-8751-2020; de Oliveira, Alberto/P-9884-2019; dos santos, Vagner Bezerra/GQQ-5338-2022; do Lago, Claudimir Lucio/A-1852-2008	Sousa, Raquel M. F./0000-0003-1509-2721; Espindola, Foued Salmen/0000-0002-6937-1411; santos, vagner B/0000-0002-9426-6197; Lago, Joao/0000-0002-1193-8374; Rodrigues, Wellington/0000-0002-3426-2186; de Oliveira, Alberto/0000-0002-7210-164X; dos santos, Vagner Bezerra/0000-0002-9426-6197; do Lago, Claudimir Lucio/0000-0003-1542-4343; Lazo Chica, Javier Emilio/0000-0003-1950-1895; Mundim, Antonio/0000-0003-1081-0544	Foundation for Research Support of Minas Gerais State [FAPEMIG-APQ-01271-10/APQ-01856-14]; CAPES/PNPD [007277/2011-01]; National Postdoctoral Program of Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES); CNPq [308965/2015-9]	Foundation for Research Support of Minas Gerais State; CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Postdoctoral Program of Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a Foundation for Research Support of the Minas Gerais State (FAPEMIG-APQ-01271-10/APQ-01856-14), CAPES/PNPD (007277/2011-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WFR receives, and NMG, LKC received, post-doctoral fellowships from National Postdoctoral Program of the Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES). FSE is grant recipient of CNPq (308965/2015-9).; The authors gratefully acknowledge the Pro-Rectory of Research and Graduate Studies and the technical assistance of Felipe Cezar Gonsalves, Helen Lara Machado, Alice Vieira da Costa, Izabela Barbosa Moraes, Camilla Manzan Martins, Douglas Carvalho Caixeta, Aline Borges Rodovalho and Alexandre Azenha Alves de Rezende, of Federal University of Uberlandia. WFR receives, and NMG, LKC received, post-doctoral fellowships form National Postdoctoral Program of the Coordination for the Improvement of Higher Education Personnel (Social Demand/PNPD/CAPES). FSE is grant recipient of CNPq (308965/2015-9).	AEBI H, 1968, BIOCHEM GENET, V2, P245, DOI 10.1007/BF01474764; ALMDAL TP, 1988, DIABETOLOGIA, V31, P114, DOI 10.1007/BF00395558; Ardestani A, 2008, J MED FOOD, V11, P525, DOI 10.1089/jmf.2006.0230; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabria LK, 2013, ISRN NEUROSCI, V2013, P1; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; CHRISTOPHERSEN BO, 1968, BIOCHIM BIOPHYS ACTA, V164, P35, DOI 10.1016/0005-2760(68)90068-4; Christophersen BO, 1969, BIOCHIM BIOPHYS ACTA, V176, P4463; Cumaoglu A, 2011, EUR J PHARMACOL, V654, P80, DOI 10.1016/j.ejphar.2010.11.035; da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Gouveia NM, 2014, J MED FOOD, V17, P915, DOI 10.1089/jmf.2013.0044; DOBRINA A, 1986, J CLIN INVEST, V78, P462, DOI 10.1172/JCI112598; Erejuwa OO, 2010, ANN ENDOCRINOL-PARIS, V71, P291, DOI 10.1016/j.ando.2010.03.003; Faure P., 1995, P237; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FORTSON WC, 1985, J CLIN GASTROENTEROL, V7, P502, DOI 10.1097/00004836-198512000-00012; Gomes RD, 2009, J ETHNOPHARMACOL, V121, P466, DOI 10.1016/j.jep.2008.11.013; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; HESS SC, 1995, J ETHNOPHARMACOL, V47, P97, DOI 10.1016/0378-8741(95)01260-K; HULTCRANTZ R, 1986, SCAND J GASTROENTERO, V21, P109, DOI 10.3109/00365528609034632; HUNT JV, 1990, DIABETES, V39, P1420, DOI 10.2337/diabetes.39.11.1420; Ilhan N, 2001, CELL BIOCHEM FUNCT, V19, P207, DOI 10.1002/cbf.912; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Jiang S, 2013, INT J BIOL MACROMOL, V55, P118, DOI 10.1016/j.ijbiomac.2012.12.035; KAKKAR R, 1995, MOL CELL BIOCHEM, V151, P113, DOI 10.1007/BF01322333; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Liu YT, 2013, FOOD CHEM TOXICOL, V57, P39, DOI 10.1016/j.fct.2013.03.001; Loomis TA, 1996, ESSENTIALS TOXICOLOG; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moraes I. B., 2015, EVID-BASED COMPL ALT, V2015, P8; Pandikumar P, 2009, J ETHNOPHARMACOL, V124, P111, DOI 10.1016/j.jep.2009.04.001; Robertson RP, 2007, FEBS LETT, V581, P3743, DOI 10.1016/j.febslet.2007.03.087; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; SAXENA AK, 1993, BIOCHEM PHARMACOL, V45, P539, DOI 10.1016/0006-2952(93)90124-F; Schultes R. E., 1990, HEALING FOREST MED T; Weniger B, 2005, PHYTOTHER RES, V19, P75, DOI 10.1002/ptr.1613; Wu CM, 2011, PHYTOMEDICINE, V18, P292, DOI 10.1016/j.phymed.2010.07.005; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xue SX, 2009, CARBOHYD POLYM, V75, P415, DOI 10.1016/j.carbpol.2008.08.003; Yazdanparast R, 2007, J ETHNOPHARMACOL, V112, P13, DOI 10.1016/j.jep.2007.01.030; Zhang D, 2012, INT J BIOL MACROMOL, V50, P720, DOI 10.1016/j.ijbiomac.2011.12.020; Zhao LY, 2011, PHYTOMEDICINE, V18, P661, DOI 10.1016/j.phymed.2011.01.001; Zou S, 2010, CARBOHYD POLYM, V80, P1161, DOI 10.1016/j.carbpol.2010.01.038; Zucaro YL, 2000, J BRAZIL CHEM SOC, V11, P241, DOI 10.1590/S0103-50532000000300007	49	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184807	10.1371/journal.pone.0184807	http://dx.doi.org/10.1371/journal.pone.0184807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981518	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300018
J	Lee, MR; Canales-Aguirre, CB; Nunez, D; Perez, K; Hernandez, CE; Brante, A				Lee, Matthew R.; Canales-Aguirre, Cristian B.; Nunez, Daniela; Perez, Karla; Hernandez, Crisitan E.; Brante, Antonio			The identification of sympatric cryptic free-living nematode species in the Antarctic intertidal	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MARINA COMPLEX NEMATODA; DNA-SEQUENCES; SSU RDNA; DIVERSITY; EVOLUTION; DISTINCT; BIODIVERSITY; DELIMITATION; COMMUNITIES	The diversity of free-living nematodes in the beaches of two Antarctic islands, King George and Deception islands was investigated. We used morphological and molecular (LSU, and two fragments of SSU sequences) approaches to evaluate 236 nematodes. Specimens were assigned to at least genera using morphology and were assessed for the presence of cryptic speciation. The following genera were identified: Halomonhystera, Litoditis, Enoploides, Chromadorita, Theristus, Oncholaimus, Viscosia, Gammanema, Bathylaimus, Choanolaimus, and Paracanthonchus; along with specimens from the families Anticomidae and Linhomoeidae. Cryptic speciation was identified within the genera Halomonhystera and Litoditis. All of the cryptic species identified live sympatrically. The two cryptic species of Halomonhystera exhibited no significant morphological differences. However, Litoditis species 2 was significantly larger than Litoditis species 1. The utility of molecular data in confirming the identifications of some of the morphologically more challenging families of nematodes was demonstrated. In terms of which molecular sequences to use for the identification of free-living nematodes, the SSU sequences were more variable than the LSU sequences, and thus provided more resolution in the identification of cryptic speciation. Finally, despite the considerable amount of time and effort required to put together genetic and morphological data, the resulting advance in our understanding of diversity and ecology of free-living marine nematodes, makes that effort worthwhile.	[Lee, Matthew R.; Canales-Aguirre, Cristian B.; Nunez, Daniela] Univ Lagos, Ctr I Mar, Puerto Montt, Chile; [Perez, Karla; Brante, Antonio] Univ Catolica Santisima Concepcion, Dept Ecol, Concepcion, Chile; [Hernandez, Crisitan E.] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Lab Ecol Evolut & Filoinformat, Concepcion, Chile; [Brante, Antonio] Univ Catolica Santisima Concepcion, CIBAS, Concepcion, Chile	Universidad de Los Lagos; Universidad Catolica de la Santisima Concepcion; Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion	Lee, MR (corresponding author), Univ Lagos, Ctr I Mar, Puerto Montt, Chile.	matthew.lee@ulagos.cl	Lee, Matthew/B-6360-2008; Hernández, Cristián E./AAS-1286-2020; Hernández, Cristián E./GLS-1111-2022	Lee, Matthew/0000-0001-9675-9908; Hernández, Cristián E./0000-0002-9811-2881; Hernández, Cristián E./0000-0002-9811-2881; Perez-Araneda, karla/0000-0002-5073-5975; Nunez Rivera, Daniela Alejandra/0000-0002-8056-9461; Brante, Antonio/0000-0002-2699-9700	Instituto Antartico Chileno (INACH) Project [T_13-10]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140692, 3150456]; INACh Project [T_13-10]; FONDECYT [1140692, 3150456]	Instituto Antartico Chileno (INACH) Project; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); INACh Project; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This project was funded by Instituto Antartico Chileno (INACH) Project T_13-10, to M. R.L, C.E.H. and A.B. C.E.H. and C.B.C.A. are grateful for funding from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants 1140692 and 3150456 respectiviely. The Institute Antartico Chileno provided logistical support in Antarctica. Fondo Nacional de Desarrollo Cientifico y Tecnologico had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Marcela Riveros and Jorge Avaria-Llautureo for help in the field. Thanks to the Instituto Nacional de Antartica Chilena (INACh) staff, both in Punta Arenas and in Antarctica for their logistical support. Thanks to the Comandante and Crew of the Chilean Navy Ice-breaker AP-46 "Almirante Oscar Viel". This project was funded by INACh Project T_13-10. C.E.H. is grateful for funding from FONDECYT grant 1140692, C.B.C.A. was funded by FONDECYT grant 3150456.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrassy Istvan, 2006, Meiofauna Marina, V15, P11; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Ardila-Garcia AM, 2012, EUKARYOT CELL, V11, P1544, DOI 10.1128/EC.00228-12; Arikan M., 2016, PLANT OMICS TRENDS A, P109, DOI DOI 10.1007/978-3-319-31703-8_5; Armenteros M, 2014, NEMATOLOGY, V16, P979, DOI 10.1163/15685411-00002824; Armenteros M, 2014, ZOOL J LINN SOC-LOND, V171, P1, DOI 10.1111/zoj12126; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Boufahja F, 2015, J NEMATOL, V47, P198; Canales-Aguirre CB, 2011, REV BIOL MAR OCEANOG, V46, P89, DOI 10.4067/S0718-19572011000100014; Carugati L, 2015, MAR GENOM, V24, P11, DOI 10.1016/j.margen.2015.04.010; Coomans A, 2002, NEMATOLOGY, V4, P573, DOI 10.1163/15685410260438836; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Meester N, 2016, OECOLOGIA, V182, P559, DOI 10.1007/s00442-016-3677-3; De Meester N, 2015, J EXP MAR BIOL ECOL, V472, P54, DOI 10.1016/j.jembe.2015.07.002; De Meester N, 2015, OIKOS, V124, P561, DOI 10.1111/oik.01779; de Oliveira DAS, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0908-0; Dell'Anno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144928; Deprez T, 2005, NEMYS; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2006, GENETICA, V128, P307, DOI 10.1007/s10709-006-6944-0; Derycke S, 2016, MOL ECOL, V25, P2093, DOI 10.1111/mec.13597; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gallucci F, 2005, MAR ECOL PROG SER, V304, P167, DOI 10.3354/meps304167; GERLACH SA, 1971, MAR BIOL, V9, P274, DOI 10.1007/BF00351390; Grosemans T, 2016, ECOL EVOL, V6, P1854, DOI 10.1002/ece3.1975; Gutzmann E, 2004, DEEP-SEA RES PT II, V51, P1617, DOI 10.1016/j.dsr2.2004.06.026; Hauquier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022240; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hentschel U, 1999, MAR ECOL PROG SER, V183, P149, DOI 10.3354/meps183149; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hut RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0433; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; JENSEN P, 1995, MAR BIOL, V123, P131, DOI 10.1007/BF00350331; Pereira TJ, 2010, MAR BIOL, V157, P1665, DOI 10.1007/s00227-010-1439-z; Kim J, 2017, MOL PHYLOGENET EVOL, V107, P90, DOI 10.1016/j.ympev.2016.10.010; Krehenwinkel H, 2017, METHODS ECOL EVOL, V8, P126, DOI 10.1111/2041-210X.12647; Kuklinski P, 2014, J SEA RES, V85, P542, DOI 10.1016/j.seares.2013.09.002; Kwong S, 2012, CLADISTICS, V28, P639, DOI 10.1111/j.1096-0031.2012.00408.x; Markmann M, 2005, PHILOS T R SOC B, V360, P1917, DOI 10.1098/rstb.2005.1723; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Meyer-Wachsmuth I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107688; Moens T, 1999, MAR BIOL, V134, P585, DOI 10.1007/s002270050573; Moens T, 2005, J MAR BIOL ASSOC UK, V85, P1401, DOI 10.1017/S0025315405012580; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Moens T, 2006, FEEDING ECOLOGY FREE; Moens T, 2014, HBK ZOOL, P109; Mullin PG, 2003, NEMATOLOGY, V5, P699, DOI 10.1163/156854103322746878; Muthumbi AW, 1998, HYDROBIOLOGIA, V364, P155; Nunn G.B., 1992, NEMATODE MOL EVOLUTI; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Perez-Portela R, 2013, SCI REP-UK, V3, DOI 10.1038/srep03197; Pfannkuche O, 1988, INTRO STUDY MEIOFAUN; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers T, 2004, ANNU REV PHYTOPATHOL, V42, P367, DOI 10.1146/annurev.phyto.42.040803.140348; R Core Team, 2021, R LANGUAGE ENV STAT; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rusin LY, 2001, MOL BIOL+, V35, P778, DOI 10.1023/A:1012394808661; Schander C, 2005, MAR BIOL RES, V1, P79, DOI 10.1080/17451000510018962; Seesao Y, 2016, J MICROBIOLOGICAL ME, V102, P69; Sinniger F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00092; Smith KL, 2003, DEEP-SEA RES PT II, V50, P1595, DOI 10.1016/S0967-0645(03)00081-X; TAJIMA F, 1983, GENETICS, V105, P437; Tchesunov AV, 2015, HELGOLAND MAR RES, V69, P57, DOI 10.1007/s10152-014-0416-1; Toprak Z, 2016, MOL PHYLOGENET EVOL, V102, P1, DOI 10.1016/j.ympev.2016.05.024; Urban-Malinga B, 2009, POLAR BIOL, V32, P243, DOI 10.1007/s00300-008-0525-x; Valderrama-Aravena N, 2014, REV BIOL MAR OCEANOG, V49, P147, DOI 10.4067/S0718-19572014000100017; Van Campenhout J, 2014, J ZOOL SYST EVOL RES, V52, P203, DOI [10.1111/jzs.12054, DOI 10.1111/JZS.12054]; Van Campenhout J, 2016, GENOME BIOL EVOL, V8, P51, DOI 10.1093/gbe/evv242; Van Campenhout J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111889; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; vanVoorhies WA, 1996, EVOLUTION, V50, P1259, DOI 10.2307/2410666; Velasco-Castrillon A, 2014, SOIL BIOL BIOCHEM, V70, P272, DOI 10.1016/j.soilbio.2013.12.016; Vermeeren H, 2004, DEEP-SEA RES PT II, V51, P1643, DOI 10.1016/j.dsr2.2004.06.028; Viltrop T, 2010, ANAL BIOCHEM, V398, P260, DOI 10.1016/j.ab.2009.11.026; Wang NF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01188; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warwick R, 1998, SYNOPSES BRIT FAUNA, V53, P1; WARWICK RM, 1979, ESTUAR COAST MAR SCI, V9, P257, DOI 10.1016/0302-3524(79)90039-2; WIESER W., 1953, ARKIV ZOOL, V4, P439; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	93	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186140	10.1371/journal.pone.0186140	http://dx.doi.org/10.1371/journal.pone.0186140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982192	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300128
J	Risselada, M; Linder, KE; Griffith, E; Roberts, BV; Davidson, G; Zamboni, WC; Messenger, KM				Risselada, Marije; Linder, Keith E.; Griffith, Emily; Roberts, Brittney V.; Davidson, Gigi; Zamboni, William C.; Messenger, Kristen M.			Pharmacokinetics and toxicity of subcutaneous administration of carboplatin in poloxamer 407 in a rodent model pilot study	PLOS ONE			English	Article							IN-VITRO; ANAL SAC; CLINICAL PHARMACOKINETICS; ADJUVANT CARBOPLATIN; DOGS; CHEMOTHERAPY; TUMORS; ADENOCARCINOMA; PLATINUM; RELEASE	The objectives of this study were to assess the pharmacokinetics and safety of subcutaneously delivered carboplatin in poloxamer 407 in rats. Carboplatin (5mg/rat) in 0.5ml poloxamer 407 (1.0 ml total volume) was administered subcutaneously in a right subcutaneous perineal incision in all 12 treatment rats. Three control rats received 1.0 ml of poloxamer 407. Total platinum was measured in plasma q24hrs from 0 to 168hrs. Protein-unbound platinum was measured in plasma at 168hrs. After sacrifice on day 7, total platinum was determined in wound bed muscle. Platinum concentrations in all samples were measured by ICP-MS. Wounds were visually assessed daily for 7 days. Perineal tissues (full wound bed including muscle, subcutis, skin) were assessed histologically and scored. Total platinum was detectable in plasma from 24 to 168 hrs. Total plasma platinum AUC and C-max were 9,165.3 ng/mL.h and 129.4 ng/mL. Day 7 total platinum concentration in muscle was approximately 10-fold higher than total plasma platinum concentration. No unbound platinum was detected in plasma samples at 168 hours. No wound healing complications were detected at any time point, nor was tissue necrosis observed histologically. The results of this study suggest that subcutaneous carboplatin in poloxamer 407 can be used in vivo providing direct tissue exposure to carboplatin without significant local effects or systemic absorption and without wound healing complications.	[Risselada, Marije; Griffith, Emily] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA; [Risselada, Marije] Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA; [Linder, Keith E.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Griffith, Emily] North Carolina State Univ, Coll Agr & Life Sci, Dept Stat, Raleigh, NC 27695 USA; [Roberts, Brittney V.; Zamboni, William C.] Univ North Carolina Chapel Hill, UNC Lineberger Comprehens Canc Ctr, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Davidson, Gigi] North Carolina State Univ, Coll Vet Med, CPS, Raleigh, NC USA; [Messenger, Kristen M.] North Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Risselada, M (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 4700 Hillsborough St, Raleigh, NC 27695 USA.; Risselada, M (corresponding author), Purdue Univ, Coll Vet Med, Dept Vet Clin Sci, W Lafayette, IN 47907 USA.	mrissela@purdue.edu		Davidson, Gigi/0000-0002-0322-9607	NCSU, CVM intramural grant competition	NCSU, CVM intramural grant competition	Funding for this study was through the 2014 NCSU, CVM intramural grant competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JJ, 2008, VET RADIOL ULTRASOUN, V49, P85, DOI 10.1111/j.1740-8261.2007.00322.x; Bennett PE, 2002, J VET INTERN MED, V16, P100, DOI 10.1892/0891-6640(2002)016&lt;0100:CASACP&gt;2.3.CO;2; Chun R., 2007, WITHROW MACEWENS SMA, P163; Emms SG, 2005, AUST VET J, V83, P340, DOI 10.1111/j.1751-0813.2005.tb15626.x; Exner AA, 2005, J CONTROL RELEASE, V106, P188, DOI 10.1016/j.jconrel.2005.04.015; Gabrielsson J. L., 2006, PHARMACOKINETIC PHAE; Gibaldi M, 1982, PHARMACOKINETICS; Holmes KE, 2015, VET COMP ONCOL, V13, P166, DOI 10.1111/vco.12031; Hsu YH, 2014, INT J NANOMED, V9, P4347, DOI 10.2147/IJN.S66526; Johansen Mary J, 2002, J Exp Ther Oncol, V2, P163, DOI 10.1046/j.1359-4117.2002.01019.x; Kim ST, 2014, RES J BIOTECHNOL, V9, P1; Kozicki AR, 2015, VET COMP ONCOL, V13, P229, DOI 10.1111/vco.12040; Mathews KG, 2009, AM J VET RES, V70, P640, DOI 10.2460/ajvr.70.5.640; Morrison JG, 2000, J PHARMACEUT BIOMED, V24, P1, DOI 10.1016/S0731-7085(00)00377-0; NIH NCIatFrederick [Internet], EQ SURF AR DOS CONV; OGURI S, 1988, J CLIN PHARMACOL, V28, P208, DOI 10.1002/j.1552-4604.1988.tb03134.x; Risselada M, 2016, AM J VET RES, V77, P1381, DOI 10.2460/ajvr.77.12.1381; ROSS JT, 1991, J AM ANIM HOSP ASSOC, V27, P349; Saam DE, 2011, JAVMA-J AM VET MED A, V238, P195, DOI 10.2460/javma.238.2.195; Selmic LE, 2014, J VET INTERN MED, V28, P554, DOI 10.1111/jvim.12313; Simcock JO, 2012, JAVMA-J AM VET MED A, V241, P608, DOI 10.2460/javma.241.5.608; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Skorupski KA, 2016, VET COMP ONCOL, V14, P81, DOI 10.1111/vco.12069; Sonoda A, 2010, CARDIOVASC INTER RAD, V33, P135, DOI 10.1007/s00270-009-9741-1; VANDERVIJGH WJF, 1991, CLIN PHARMACOKINET, V21, P242, DOI 10.2165/00003088-199121040-00002; Wouda RM, 2016, VET COMP ONCOL, V14, P67, DOI 10.1111/vco.12068; Yu CH, 2012, EUR SPINE J, V21, P971, DOI 10.1007/s00586-011-2098-6; Zamboni WC, 2002, CLIN CANCER RES, V8, P2992; Zhang K, 2015, DRUG DELIV, V22, P375, DOI 10.3109/10717544.2014.891272	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186018	10.1371/journal.pone.0186018	http://dx.doi.org/10.1371/journal.pone.0186018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982137	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300110
J	Somanath, P; Klein, RH; Knoepfler, PS				Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.			CRISPR-mediated HDAC2 disruption identifies two distinct classes of target genes in human cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; HISTONE DEACETYLASE INHIBITORS; CANCER; NURD; PLURIPOTENCY; COMPLEX; MEMORY	The transcriptional functions of the class I histone deacetylases (HDACs) HDAC1 and HDAC2 are mainly viewed as both repressive and redundant based on murine knockout studies, but they may have additional independent roles and their physiological functions in human cells are not as clearly defined. To address the individual epigenomic functions of HDAC2, here we utilized CRISPR-Cas9 to disrupt HDAC2 in human cells. We find that while HDAC2 null cells exhibited signs of cross-regulation between HDAC1 and HDAC2, specific epigenomic phenotypes were still apparent using RNA-seq and ChIP assays. We identified specific targets of HDAC2 repression, and defined a novel class of genes that are actively expressed in a partially HDAC2-dependent manner. While HDAC2 was required for the recruitment of HDAC1 to repressed HDAC2-gene targets, HDAC2 was dispensable for HDAC1 binding to HDAC2-activated targets, supporting the notion of distinct classes of targets. Both active and repressed classes of gene targets demonstrated enhanced histone acetylation and methylation in HDAC2-null cells. Binding of the HDAC1/2-associated SIN3A corepressor was altered at most HDAC2-targets, but without a clear pattern. Overall, our study defines two classes of HDAC2 targets in human cells, with a dependence of HDAC1 on HDAC2 at one class of targets, and distinguishes unique functions for HDAC2.	[Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA; [Somanath, Priyanka; Klein, Rachel Herndon; Knoepfler, Paul S.] Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA.; Knoepfler, PS (corresponding author), Shriners Hosp Children Northern Calif, Inst Pediat Regenerat Med, Sacramento, CA USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	National Institute of General Medical Sciences [5R01GM100782-05, 1R01GM116919-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782, R01GM116919] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, grants 5R01GM100782-05 to PSK, and 1R01GM116919-01 to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Bush KM, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-7; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; Kidder BL, 2012, NUCLEIC ACIDS RES, V40, P2925, DOI 10.1093/nar/gkr1151; Kim JK, 2013, MOL CANCER RES, V11, P62, DOI 10.1158/1541-7786.MCR-12-0332; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Noh JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028103; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Phelps MP, 2016, P NATL ACAD SCI USA; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Seto E, 2014, COLD SPRING HARB PER, V6; Smith KT, 2009, INT J BIOCHEM CELL B, V41, P21, DOI 10.1016/j.biocel.2008.09.008; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tung PY, 2013, STEM CELLS, V31, P2330, DOI 10.1002/stem.1526; Varlakhanova N, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-20; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wei T, 2015, NUCLEIC ACIDS RES, P1; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185627	10.1371/journal.pone.0185627	http://dx.doi.org/10.1371/journal.pone.0185627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982113	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300050
J	Travassos, AG; Netto, E; Xavier-Souza, E; Nobrega, I; Adami, K; Timbo, M; Abbehusen, K; Fernandes, S; Duran, C; Haguihara, T; Ferreira, F; Brites, C				Travassos, Ana Gabriela; Netto, Eduardo; Xavier-Souza, Eveline; Nobrega, Isabella; Adami, Karina; Timbo, Maiara; Abbehusen, Karen; Fernandes, Sheyla; Duran, Camila; Haguihara, Tatiana; Ferreira, Fabio; Brites, Carlos			Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; RISK HUMAN-PAPILLOMAVIRUS; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; VIRAL SUPPRESSION; CERVICAL-CANCER; PERSISTENCE; INTEGRATION; PREVALENCE; RESPONSES	Persistent infection with high-risk human papillomavirus (HR-HPV) is necessary for the development of precursor lesions and cervical cancer. HPV infection among women living with HIV/AIDS (WLHA) occurs more frequently, presents a higher rate of persistent infections and an earlier progression to cancer. We aimed to evaluate HR-HPV prevalence, incidence and clearance, and its association with HIV viral suppression, immunological response and other risk factors among WLHA followed at an STD/HIV reference center. This was a cohort study conducted at a reference center for STD/AIDS in Northeastern Brazil from September 2013 to September 2015. Follow-up visits were conducted at 6 and 12 months after enrolment, where socio-epidemiological data were obtained. Cervical samples were collected for conventional cytology and HPV DNA research (PCR COBAS (R) Roche) in addition to blood samples for CD4+ T lymphocyte count and HIV viral load. We prospectively evaluated 333 women. HR-HPV DNA prevalence was 33.3% at baseline. HPV-16 was present in 5.1%, HPV-18 in 3.9% and 29.4% WLHA had other HR-HPV (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68). The HR-HPV incidence during the follow-up was 10.8%, at the 6-month visit was 7.7% and at the 12-month visit was 3.7%. Variables associated with HRHPV incidence were: nulliparity, combined oral contraceptive use and detectable HIV viral load. The HR-HPV clearance rate was 41.7% and was associated with age > 30 years and lymphocyte T CD4 count >500 cells/mm3 at enrolment. These findings contribute to the knowledge about a group of women that need more careful HPV screening and describe the association between an efficient immunological response and HIV viral suppression with lower incidence and increased clearance of HR-HPV.	[Travassos, Ana Gabriela; Nobrega, Isabella; Adami, Karina; Abbehusen, Karen; Fernandes, Sheyla; Haguihara, Tatiana] Secretaria Saude Estado Bahia, CEDAP, Salvador, BA, Brazil; [Travassos, Ana Gabriela] Univ Estadual Bahia, Colegiado Med, Dept Ciencias Vida, Salvador, BA, Brazil; [Netto, Eduardo; Xavier-Souza, Eveline; Timbo, Maiara; Brites, Carlos] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Duran, Camila] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Ferreira, Fabio] Lab Cent Saude Publ Prof Goncalo Moniz, Salvador, BA, Brazil	Universidade Federal da Bahia; Escola Bahiana de Medicina e Saude Publica	Travassos, AG (corresponding author), Secretaria Saude Estado Bahia, CEDAP, Salvador, BA, Brazil.; Travassos, AG (corresponding author), Univ Estadual Bahia, Colegiado Med, Dept Ciencias Vida, Salvador, BA, Brazil.	atravassos@uneb.br	Travassos, Ana Gabriela A/E-6809-2016; Brites, Carlos/D-1353-2013; Travassos, Ana Gabriela/AGE-0622-2022; Netto, Eduardo/D-1432-2013	Travassos, Ana Gabriela A/0000-0001-9242-828X; Brites, Carlos/0000-0002-4673-6991; Travassos, Ana Gabriela/0000-0001-9242-828X; Netto, Eduardo/0000-0003-1691-6761; de Sa Adami Goncalves Brandao, Karina/0000-0003-3928-7507				ACOG, 2014, AM COLL OBSTET GYNEC, V123, P1118; Adler DH, 2010, CURR HIV RES, V8, P493, DOI 10.2174/157016210793499240; [Anonymous], 2014, MANUAL TECNICO DIAGN; Blitz S, 2013, J INFECT DIS, V208, P454, DOI 10.1093/infdis/jit181; Bornstein J, 2012, OBSTET GYNECOL, V120, P166, DOI 10.1097/AOG.0b013e318254f90c; Branca M, 2003, INT J STD AIDS, V14, P417, DOI 10.1258/095646203765371321; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST Aids e Hepatites Virais., 2015, PROT CLIN DIR TER AT, P120; Brickman C, 2015, CURR HIV-AIDS REP, V12, P6, DOI 10.1007/s11904-014-0254-4; Cambou MC, 2015, INT J INFECT DIS, V41, P17, DOI 10.1016/j.ijid.2015.10.017; Castellsague A X, 2003, J NATL CANC I MONOGR, P20; Castilho JL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1486-4; Centers for Disease Control and Prevention (CDC), 1993, MMWR REC REP MORB MO; da Silva L, 2015, BRAZ J INFECT DIS, V19, P557, DOI 10.1016/j.bjid.2015.07.001; de Abreu ALP, 2016, AM J CANCER RES, V6, P1371; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Geraets DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080382; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Instituto Nacional de ca A ncer (INCA), 2011, DIR RASTR CANC COL U; Jaisamrarn U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079260; Keller MJ, 2015, CLIN INFECT DIS, V61, P1573, DOI 10.1093/cid/civ569; Kitchener HC, 2006, VACCINE, V24, P63, DOI 10.1016/j.vaccine.2006.05.113; Konopnicki D, 2013, J INFECT DIS, V207, P1723, DOI 10.1093/infdis/jit090; Ministry of Land Infrastructure transport and tourism and Ministry of economy trade and industry of Japan, 2006, IN LAT CAR DES SOST, P1; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; Money DM, 2016, VACCINE, V34, P4799, DOI 10.1016/j.vaccine.2016.08.016; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Palefsky JM, 2016, CURR OPIN HIV AIDS, V1; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Ramanakumar AV, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011371; Rosa MI, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.033; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Secretaria de Vigilancia em Saude, 2013, PROT CLIN DIR TER MA; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shrestha S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-295; Martins AES, 2014, MEM I OSWALDO CRUZ, V109, P738, DOI 10.1590/0074-0276140070; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Sudenga SL, 2013, INT J INFECT DIS, V17, pE216, DOI 10.1016/j.ijid.2012.12.027; Thorsteinsson K, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2881-1; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vaccarella S, 2008, INT J EPIDEMIOL, V37, P536, DOI 10.1093/ije/dyn033; Ceccato BPV, 2015, REV BRAS GINECOL OBS, V37, P178, DOI 10.1590/SO100-720320150005184; vonKarsa L, 2015, EUROPEAN GUIDELINES; Vriend HJ, 2015, CANCER MED-US, V4, P1589, DOI 10.1002/cam4.496; WHO, 2012, WHOHIV201212, V1; Williams VM, 2011, FUTURE VIROL, V6, P45, DOI 10.2217/FVL.10.73; Wongworawat YC, 2016, AM J CANCER RES, V6, P764; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Zhu HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003077	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185423	10.1371/journal.pone.0185423	http://dx.doi.org/10.1371/journal.pone.0185423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981551	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300038
J	Aoun, SM; Rumbold, B; Howting, D; Bolleter, A; Breen, LJ				Aoun, Samar M.; Rumbold, Bruce; Howting, Denise; Bolleter, Amanda; Breen, Lauren J.			Bereavement support for family caregivers: The gap between guidelines and practice in palliative care	PLOS ONE			English	Article							ADVANCE DIRECTIVES; WESTERN-AUSTRALIA; NEEDS-ASSESSMENT; INTERVENTION; PREDICTORS; NETWORK; PEOPLE	Background Standards for bereavement care propose that support should be matched to risk and need. However, studies in many countries demonstrate that palliative care services continue to adopt a generic approach in offering support to bereaved families. Objective To identify patterns of bereavement support in palliative care services based upon the experience of bereaved people from a population based survey and in relation to clinical practice guidelines. Design An anonymous postal survey collected information from clients of six funeral providers in four Australian states (2014-15), 6 to 24 months after the death of their family member or friend, with 1,139 responding. Responses from 506 bereaved relatives of people who had terminal illnesses were analysed. Of these, 298 had used palliative care services and 208 had not. Results More people with cancer (64%) had received palliative care in comparison to other illnesses such as heart disease, dementia and organ failure (4-10%). The support for family caregivers before and after their relative's death was not considered optimal. Only 39.4% of the bereaved reported being specifically asked about their emotional/psychological distress pre-bereavement, and just half of the bereaved perceived they had enough support from palliative care services. Half of the bereaved had a follow up contact from the service at 3-6 weeks, and a quarter had a follow-up at 6 months. Their qualitative feedback underlined the limited helpfulness of the blanket approach to bereavement support, which was often described as "not personal" or "generic", or "just standard practice". Conclusions Timeliness and consistency of relationship is crucial to building rapport and trust in the service's ability to help at post-bereavement as well as a focus on the specific rather than the generic needs of the bereaved. In light of these limitations, palliative care services might do better investing their efforts principally in assessing and supporting family caregivers during the pre-bereavement period and developing community capacity and referral pathways for bereavement care. Our findings suggest that bereavement support in Australian palliative care services has only a tenuous relationship with guidelines and assessment tools, a conclusion also drawn in studies from other countries, emphasizing the international implications of our study.	[Aoun, Samar M.; Howting, Denise] Curtin Univ, Fac Hlth Sci, Sch Nursing Midwifery & Paramed, Perth, WA, Australia; [Rumbold, Bruce] La Trobe Univ, Palliat Care Unit, Dept Publ Hlth, Melbourne, Vic, Australia; [Bolleter, Amanda] Hlth Dept WA, WA Canc & Palliat Care Network, Perth, WA, Australia; [Breen, Lauren J.] Curtin Univ, Sch Psychol & Speech Pathol, Fac Hlth Sci, Perth, WA, Australia	Curtin University; La Trobe University; Curtin University	Aoun, SM (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Nursing Midwifery & Paramed, Perth, WA, Australia.	s.aoun@curtin.edu.au	Rumbold, Bruce/AAJ-5261-2020; Breen, Lauren J/B-8746-2013; Howting, Denise Ann/GWU-5045-2022	Rumbold, Bruce/0000-0001-6733-6201; Breen, Lauren J/0000-0002-0463-0363; Howting, Denise Ann/0000-0001-8753-5849; Aoun, Samar/0000-0002-4073-4805	WA Cancer and Palliative Care Network, Health Department of Western Australia	WA Cancer and Palliative Care Network, Health Department of Western Australia	The authors acknowledge the financial support of the WA Cancer and Palliative Care Network, Health Department of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors acknowledge the financial support of the WA Cancer and Palliative Care Network, Health Department of Western Australia, the cooperation of funeral providers who assisted with the recruitment of participants, and the bereaved families who agreed to complete the survey and contributed to our understanding in this field.	Abbott J, 2008, AUST J CANC NURS, V9, P12; Agnew A, 2010, PALLIATIVE MED, V24, P46, DOI 10.1177/0269216309107013; Aoun S, 2015, PLOS ONE, P10; Aoun S, 2010, J PALLIAT MED, V13, P653, DOI 10.1089/jpm.2009.0318; Aoun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121101; Aoun SM, 2014, AUST NZ J PUBL HEAL, V38, P473, DOI 10.1111/1753-6405.12177; Aoun SM, 2012, AUST NZ J PUBL HEAL, V36, P14, DOI 10.1111/j.1753-6405.2012.00825.x; Auerbach AD, 2008, J HOSP MED, V3, P437, DOI 10.1002/jhm.369; Australian Bureau of Statistics, 2015, 33030 AUSTR BUR STAT; Australian Institute for Health and Welfare, 2016, PALL CAR OUTC; Bergman EJ, 2009, J PALLIAT MED, V12, P170, DOI 10.1089/jpm.2008.0237; Breen LJ, 2017, AM J HOSP PALLIAT ME, V34, P275, DOI 10.1177/1049909115615568; Breen LJ, 2014, DEATH STUD, V38, P54, DOI 10.1080/07481187.2012.725451; Burns CM, 2013, PALLIATIVE MED, V27, P608, DOI 10.1177/0269216313483664; Calanzani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146134; Foliart DE, 2001, DEATH STUD, V25, P461, DOI 10.1080/074811801750257545; Ghesquiere A, 2016, AM J HOSP PALLIAT ME, V33, P124, DOI 10.1177/1049909114555155; Grande GE, 2017, BMJ SUPPORT PALLIAT, V7, P326, DOI 10.1136/bmjspcare-2014-000829; Guldin M., 2015, EUR J PALLIAT CARE, V22, P185; Hall C., 2012, BEREAVEMENT SUPPORT; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hudson P., 2010, CLIN PRACTICE GUIDEL; Hunt KJ, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-3; Lewis E, 2016, PALLIATIVE MED, V30, P807, DOI 10.1177/0269216316637239; Mather MA, 2008, MED J AUSTRALIA, V188, P228, DOI 10.5694/j.1326-5377.2008.tb01590.x; McNamara B, 2006, J PAIN SYMPTOM MANAG, V32, P5, DOI 10.1016/j.jpainsymman.2005.12.018; National Hospice and Palliative Care Organization, 2008, GUID BER CAR HOSP; Nielsen MK, 2017, J PAIN SYMPTOM MANAG, V53, P540, DOI 10.1016/j.jpainsymman.2016.09.013; Office for National Statistics (UK), 2012, NAT BER SURV VOICES; Onwuteaka-Philipsen BD, 2012, PALLIATIVE MED, V26, P656; Palliative Care Australia, 2005, STAND PROV QUAL PALL; Pautex S, 2008, PALLIATIVE MED, V22, P835, DOI 10.1177/0269216308094336; Pidgeon TM, 2017, PALLIAT SUPPORT CARE, P1; Rosenwax LK, 2006, PALLIATIVE MED, V20, P439, DOI 10.1191/0269216306pm1146oa; Rumbold B, 2015, BEREAVE CARE, V34, P99, DOI 10.1080/02682621.2015.1115185; Rumbold B, 2014, PROG PALLIAT CARE, V22, P131, DOI 10.1179/1743291X13Y.0000000079; Schut H, 2001, HDB BEREAVEMENT RES, P705, DOI DOI 10.1037/10436-029; Sealey M, 2015, BMC PALLIAT CARE, V14, DOI 10.1186/s12904-015-0046-7; Stroebe M, 2015, PALLIATIVE MED, V29, P574, DOI 10.1177/0269216315585952; Toye C, 2016, INT J NURS STUD, V64, P32, DOI 10.1016/j.ijnurstu.2016.09.012; Walter T., 1999, BEREAVEMENT CULTURE; White B, 2014, INTERN MED J, V44, P975, DOI 10.1111/imj.12549; Williams BR, 2008, DEATH STUD, V32, P197, DOI 10.1080/07481180701881297; World Health Organization, 2007, WHO GUID EFF PROGR P	44	66	68	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184750	10.1371/journal.pone.0184750	http://dx.doi.org/10.1371/journal.pone.0184750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977013	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100011
J	Wasielica-Poslednik, J; Schmeisser, J; Hoffmann, EM; Weyer-Elberich, V; Bell, K; Lorenz, K; Pfeiffer, N				Wasielica-Poslednik, Joanna; Schmeisser, Julian; Hoffmann, Esther M.; Weyer-Elberich, Veronika; Bell, Katharina; Lorenz, Katrin; Pfeiffer, Norbert			Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; INDEPENDENT RISK-FACTOR; INTERVENTION; TRIAL; EYES	Purpose Intraocular pressure (IOP) fluctuation is considered as a risk factor for glaucoma progression. We investigated IOP values and IOP fluctuation before and after trabeculectomy (TE) with mitomycin C (MMC) measured by 48-hour diurnal-nocturnal-IOP-profiles (DNP). Methods Pre-and postoperative DNPs of 92 eyes undergoing primary TE with MMC were analysed. Each 48-hour IOP-profile involved 10 IOP measurements (8:00 a.m., 2:00 p.m., 6:00 p.m., and 9:00 p.m. in sitting and at 00: 00 in supine position). The "preoperative DNP" was performed a few weeks before TE. The "postoperative DNP" was performed at least six months (range: 6 months-2 years) after TE. Mean IOP values and IOP fluctuations were calculated. Results After TE with MMC mean IOP was reduced from 16.94 +/- 3.83 to 11.26 +/- 3.77 mmHg at daytime and from 18.17 +/- 4.26 to 11.76 +/- 3.90 mmHg at night. At daytime mean IOP-fluctuation decreased from 8.61 +/- 4.19 to 4.92 +/- 2.52 mmHg, at night from 3.15 +/- 2.95 to 1.99 +/- 1.82 mmHg. Mean IOP was lower on the second day of the preoperative DNP. This effect was not present in the postoperative DNP. Preoperatively, IOP was controlled in all eyes with a mean of 3.22 +/- 0.94 antiglaucomatous agents. Postoperatively, IOP <= 15 mmHg was achieved in 71.7%, IO <= 18 mmHg in 77.1% and a decrease in IOP of >30% in 47.8% without antiglaucomatous therapy. Postoperatively, pseudophakia was associated by a higher mean IOP-fluctuation compared to the phakic eyes. Conclusions TE with MMC significantly reduces both mean IOP-values and IOP-fluctuations at day and night at least 6 months postoperatively. The effect of TE on the IOP fluctuation was less pronounced in pseudophakic eyes.	[Wasielica-Poslednik, Joanna; Schmeisser, Julian; Hoffmann, Esther M.; Bell, Katharina; Lorenz, Katrin; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Weyer-Elberich, Veronika] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Wasielica-Poslednik, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	joanna.wasielica-poslednik@unimedizin-mainz.de	Hoffmann, Esther/AAY-3575-2020; Hoffmann, Esther/AAO-5968-2021; Weyer-Elberich, Veronika/AAB-8993-2020; Bell, Katharina/T-5802-2019; Pfeiffer, Norbert/AAO-7586-2020	Hoffmann, Esther/0000-0002-0949-4268; 				Asrani S, 2000, J GLAUCOMA, V9, P134; Bengtsson B, 2005, GRAEF ARCH CLIN EXP, V243, P513, DOI 10.1007/s00417-004-1103-8; Bengtsson B, 2007, OPHTHALMOLOGY, V114, P205, DOI 10.1016/j.ophtha.2006.07.060; Bergea B, 1999, OPHTHALMOLOGY, V106, P997, DOI 10.1016/S0161-6420(99)00523-0; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Clement CI, 2014, SURV OPHTHALMOL, V59, P615, DOI 10.1016/j.survophthal.2014.04.001; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Daugeliene L, 1999, GRAEF ARCH CLIN EXP, V237, P105, DOI 10.1007/s004170050203; European Glaucoma Society, 2021, GUIDELINESEUROPEAN G, P97; Fischer N, 2013, OPHTHALMOLOGE, V110, P755, DOI 10.1007/s00347-012-2774-x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Klink T, 2012, OPHTHALMOLOGICA, V227, P160, DOI 10.1159/000333099; Konstas AGP, 2016, ADV THER, V33, P481, DOI 10.1007/s12325-016-0302-0; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P4439, DOI 10.1167/iovs.03-0349; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Mosaed Sameh, 2009, Trans Am Ophthalmol Soc, V107, P127; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; PFEIFFER N, 1992, INT OPHTHALMOL, V16, P391, DOI 10.1007/BF00917998; Pfeiffer N., 2005, GLAUKOM OKULAERE HYP; SAIZ A, 1990, OPHTHALMIC SURG LAS, V21, P799; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Wilensky J T, 1994, Trans Am Ophthalmol Soc, V92, P377	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185246	10.1371/journal.pone.0185246	http://dx.doi.org/10.1371/journal.pone.0185246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977004	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100018
J	Zhang, B; Zhao, JS; Chen, X; Wu, JH				Zhang, Bo; Zhao, Jiasheng; Chen, Xiao; Wu, Jianhuang			ECG data compression using a neural network model based on multi-objective optimization	PLOS ONE			English	Article							CLASSIFICATION; METHODOLOGY; PROGRAM; SIGNALS	Electrocardiogram (ECG) data analysis is of great significance to the diagnosis of cardiovascular disease. ECG compression should be processed in real time, and the data should be based on lossless compression and have high predictability. In terms of the real time aspect, short-time Fourier transformation is applied to the processing of signal wave for reducing computational time. For the lossless compression requirement, wavelet-transformation that is a coding algorithm can be used to avoid loss of data. In practice, compression is required to avoid storing redundant recording data that are not useful in the diagnosis platform. The obtained data can be preprocessed to remove noise by using wavelet transform, and then a multi-objective optimize neural network model is used to extract feature information. Compared with the existing traditional methods such as direct data processing method and transform method, our proposed compression model has self-learning ability to achieve high data compression ratio at 1: 19 without losing important ECG information and compromising quality. Upon testing, we demonstrated that the proposed ECG data compression method based on multi-objective optimization neural network is effective and efficient in clinical practice.	[Zhang, Bo] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Ultrasound Med, Shanghai, Peoples R China; [Zhao, Jiasheng; Wu, Jianhuang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Chen, Xiao] Univ Technol Sydney, Sch Comp & Commun, Fac Engn & Informat Technol, Sydney, NSW, Australia	Tongji University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Technology Sydney	Zhang, B (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Ultrasound Med, Shanghai, Peoples R China.; Wu, JH (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	zhangbodongfang@qq.com; jh.wu@siat.ac.cn		Zhang, Bo/0000-0002-6085-111X	National Natural Science Foundation of China [61672510, 81571693, 81401428]; Guangdong Natural Science Foundation [2014A030313690]; Shenzhen Science and Technology Program [SGG20150602143414338, JCYJ20160331191401141]; Guangdong Science and Technology Program [2016A020220016]; Pudong New Area Committee of Science and Technology [PKJ2015-Y17]; Academic Leaders Training Program of Pudong Health Bureau of Shanghai [PWRd2013-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Program; Guangdong Science and Technology Program; Pudong New Area Committee of Science and Technology; Academic Leaders Training Program of Pudong Health Bureau of Shanghai	This work was supported in part by National Natural Science Foundation of China (No.61672510, 81571693, 81401428), Guangdong Natural Science Foundation (No. 2014A030313690), Shenzhen Science and Technology Program (No. SGG20150602143414338, No. JCYJ20160331191401141), Guangdong Science and Technology Program (No.2016A020220016), Pudong New Area Committee of Science and Technology (No.PKJ2015-Y17), and the Academic Leaders Training Program of Pudong Health Bureau of Shanghai (grant No. PWRd2013-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmeda SM, 2001, MED ENG PHYS, V23, P117, DOI 10.1016/S1350-4533(01)00026-1; Belciug S, 2015, J BIOMED INFORM, V53, P261, DOI 10.1016/j.jbi.2014.11.010; Bin G, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Braojos R, 2014, SENSORS-BASEL, V14, P22532, DOI 10.3390/s141222532; BROHET CR, 1990, METHOD INFORM MED, V29, P403; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Chaturvedi A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056023; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Clifford GD, 2012, PHYSIOL MEAS, V33, P1419, DOI 10.1088/0967-3334/33/9/1419; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; DASSEN WRM, 1993, J ELECTROCARDIOL, V26, P61; Devoe LD, 2011, CLIN OBSTET GYNECOL, V54, P56, DOI 10.1097/GRF.0b013e31820a0ee7; Ditzler G, 2015, IEEE T NANOBIOSCI, V14, P608, DOI 10.1109/TNB.2015.2461219; Dranca L, 2009, PHYSIOL MEAS, V30, P983, DOI 10.1088/0967-3334/30/9/009; Dubra A, 2004, APPL OPTICS, V43, P1108, DOI 10.1364/AO.43.001108; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Fearon WF, 2000, J AM COLL CARDIOL, V35, P1206, DOI 10.1016/S0735-1097(00)00518-0; Fira CM, 2008, IEEE T BIO-MED ENG, V55, P1319, DOI 10.1109/TBME.2008.918465; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Heaton LLM, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021905; IWATA A, 1990, IEEE ENG MED BIOL, V9, P53, DOI 10.1109/51.59214; KORS JA, 1992, J ELECTROCARDIOL, V25, P263, DOI 10.1016/0022-0736(92)90031-T; KORS JA, 1992, AM J CARDIOL, V70, P96, DOI 10.1016/0002-9149(92)91397-M; Ledezma CA, 2014, IEEE ENG MED BIO, P2738, DOI 10.1109/EMBC.2014.6944189; Li RJ, 2014, LECT NOTES COMPUT SC, V8675, P305, DOI 10.1007/978-3-319-10443-0_39; Li X, 2010, IEEE T SYST MAN CY B, V40, P125, DOI 10.1109/TSMCB.2009.2021573; Manor R, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00146; MARCUS M, 1987, J ELECTROCARDIOL, V20, P91; PARK J, 2015, IEEE ENG MED BIO, P5191; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Sharma LN, 2012, IEEE T INF TECHNOL B, V16, P730, DOI 10.1109/TITB.2012.2195322; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P317, DOI 10.1055/s-0038-1634807; Xue Y, 2018, SOFT COMPUT, V22, P2935, DOI 10.1007/s00500-017-2547-1; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061	34	6	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0182500	10.1371/journal.pone.0182500	http://dx.doi.org/10.1371/journal.pone.0182500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972986	Green Published, Green Submitted, gold			2022-12-27	WOS:000412131900002
J	Hack, NL; Iyengar, VK				Hack, Nicole L.; Iyengar, Vikram K.			Big wigs and small wigs: Time, sex, size and shelter affect cohabitation in the maritime earwig (Anisolabis maritima)	PLOS ONE			English	Article							EUROPEAN EARWIG; AGGREGATION BEHAVIOR; FORFICULA-AURICULARIA; DERMAPTERA; PHEROMONE; SUCCESS	Animal aggregations can occur for a variety of abiotic factors, such as resource limitation, or biotic factors, including group foraging and protection from predators. In our study, we examined whether time, sex, body size or shelter availability affected aggregation behavior of the maritime earwig, Anisolabis maritima (Order Dermaptera), an insect found globally at high densities under driftwood. Specifically, we monitored the distribution of two individuals in arenas with either two shelters (no habitat limitation) or one shelter (habitat limitation) to determine their propensity for cohabitation at times of peak activity and times of quiescence. Females, whose high levels of aggression are often associated with maternal care, were particularly averse to cohabitation, whereas males were generally more tolerant of other earwigs. Females initially preferred not to cohabitate when placed with a male, but were more tolerant of cohabitation later, regardless of the number of shelters. Same-sex pairs, on the other hand, were less likely to cohabitate with only one shelter present, but males were again more tolerant of conspecifics than females regardless of habitat limitation. When competition for one shelter did not lead to cohabitation, the lone occupant was more likely to be the larger individual in same-sex trials and females in mixed-sex trials. Understanding the tolerance for close proximity under these varying conditions may provide insight into aggregative behavior and spatial distribution patterns in the maritime earwig.	[Hack, Nicole L.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA USA; [Iyengar, Vikram K.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA	California State University System; California Polytechnic State University San Luis Obispo; Villanova University	Iyengar, VK (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.	vikram.iyengar@villanova.edu			Villanova University; National Science Foundation [DBI 1262239]; Direct For Biological Sciences [1262239] Funding Source: National Science Foundation	Villanova University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by grants from Villanova University (to VKI) and the National Science Foundation (DBI 1262239; https://www.nsf.gov/; to VKI and NLH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist Goran, 2005, pUnpaginated; Bennett C., 1904, PSYCHE, V11, P47; Briceuo R.D., 1995, SMITHSON CONTRIB ZOO, V555, P1, DOI DOI 10.5479/SI.00810282.555; Earley Ryan L., 2010, P285; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Evans KA, 1996, 2 INT C INS PESTS UR, P163; Hehar G, 2008, CAN ENTOMOL, V140, P674, DOI [10.4039/n08-026, 10.4039/N08-026]; Hincks W. D., 1947, ANN MAG NAT HIST, V11, P517, DOI [10.1080/00222934708654662, DOI 10.1080/00222934708654662]; HOGLUND J, 1990, BEHAV ECOL SOCIOBIOL, V26, P173; Kaseda Y, 1996, APPL ANIM BEHAV SCI, V47, P163, DOI 10.1016/0168-1591(95)00675-3; Kendall-Bar JM, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-016-2233-9; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LANGSTON RL, 1974, PAN-PAC ENTOMOL, V50, P28; Lordan J, 2014, CROP PROT, V65, P71, DOI 10.1016/j.cropro.2014.07.005; Miller JS, 2012, ANIM BEHAV, V83, P1387, DOI 10.1016/j.anbehav.2012.03.006; Miller JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1873, DOI 10.1007/s00265-011-1196-0; Moerkens R, 2009, ENTOMOL EXP APPL, V130, P198, DOI 10.1111/j.1570-7458.2008.00808.x; Munoz NE, 2012, ETHOLOGY, V118, P943, DOI 10.1111/j.1439-0310.2012.02086.x; ORING LW, 1978, IBIS, V120, P348; Raveh S, 2014, ETHOLOGY, V120, P776, DOI 10.1111/eth.12249; SAUPHANOR B, 1992, ENTOMOL EXP APPL, V62, P285, DOI 10.1007/BF00353448; SAUPHANOR B, 1993, OECOLOGIA, V96, P360, DOI 10.1007/BF00317506; Scudder S. H., 1876, B US GEOLOGICAL SURV, V2, P249, DOI [10.3133/70159432, DOI 10.3133/70159432]; SHUSTER SM, 2003, MG BEH ECOL, pR7; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Torney CJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002194; van Lieshout E, 2009, BEHAV ECOL, V20, P258, DOI 10.1093/beheco/arp013; VANCASSEL M, 1984, ADV STUD BEHAV, V14, P51, DOI 10.1016/S0065-3454(08)60299-5; WALKER KA, 1993, J CHEM ECOL, V19, P2029, DOI 10.1007/BF00983805; Wiley HR, 1971, COOPERATIVE ROLES MI, V88, P881; ZIMMERFAUST RK, 1987, J EXP MAR BIOL ECOL, V105, P57, DOI 10.1016/S0022-0981(87)80029-1	31	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185754	10.1371/journal.pone.0185754	http://dx.doi.org/10.1371/journal.pone.0185754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968460	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600042
J	Hajek, A; Bock, JO; Konig, HH				Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut			Psychosocial correlates of unintentional weight loss in the second half of life in the German general population	PLOS ONE			English	Article							NUTRITIONAL RISK; ELDERLY-PEOPLE; OLDER-ADULTS; SATISFACTION; MORTALITY; FRAILTY; HOME	Background Unintentional weight loss (UWL) is common in older age and associated with adverse outcomes including mortality. The aim of the present study was to determine psychosocial correlates of UWL. Methods Data were derived from a large, nationally representative study of community-dwelling individuals in the second half of life (40 years and over) in Germany in 2014 (n = 7,933). Data on UWL were assessed in face-to-face interviews as unintentional loss of more than 5kg (11 pounds) in weight in the past 12 months, and data on psychosocial factors were recorded in self-administered questionnaires. Results Multiple logistic regressions revealed that UWL was positively associated with depressive symptoms and positive affect, whereas it was negatively associated with self-esteem. Individuals with UWL were more likely to feel lonely and perceive themselves as socially excluded. Conclusion The findings of important psychosocial correlates of UWL may help to identify individuals at risk for UWL in older age. This is in particular important since interventions to treat this phenomenon in older age are available that reduce adverse consequences resulting from UWL.	[Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany.	a.hajek@uke.de	König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745				Alibhai SMH, 2005, CAN MED ASSOC J, V172, P773, DOI 10.1503/cmaj.1031527; Bailey TC, 2007, J POSIT PSYCHOL, V2, P168, DOI [10.1080/17439760701409546, DOI 10.1080/17439760701409546]; Bude H, 2006, KOLNER Z SOZIOL SOZ, V58, P233, DOI 10.1007/s11575-006-0054-1; Callen BL, 2005, PUBLIC HEALTH NURS, V22, P138, DOI 10.1111/j.0737-1209.2005.220207.x; Carmel S, 2013, PSYCHOL AGING, V28, P1115, DOI 10.1037/a0034649; Gierveld JD, 2006, RES AGING, V28, P582, DOI 10.1177/0164027506289723; Engstler H, 2015, DTSCH ALTERSSURVEY D; Engstler H, 2017, GERMAN AGEING SURVEY; Ernsberger P, 1999, J SOC ISSUES, V55, P221, DOI 10.1111/0022-4537.00114; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Kanapuru B, 2009, AM J MED, V122, P605, DOI 10.1016/j.amjmed.2009.01.030; Klaus D, 2016, ALTERN WANDEL, P25, DOI DOI 10.1007/978-3-658-12502-8_2; Klaus Daniela, 2017, Int J Epidemiol, V46, P1105, DOI 10.1093/ije/dyw326; Kvamme JM, 2011, QUAL LIFE RES, V20, P575, DOI 10.1007/s11136-010-9788-0; Langkamp DL, 2010, ACAD PEDIATR, V10, P205, DOI 10.1016/j.acap.2010.01.005; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; Martin CT, 2006, J GERONTOL A-BIOL, V61, P927, DOI 10.1093/gerona/61.9.927; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; McMinn J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1732; MELTZER AA, 1995, AM J EPIDEMIOL, V142, P1039, DOI 10.1093/oxfordjournals.aje.a117557; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Schiel S., 2015, METHODENBERICHT DURC; Schilp J, 2011, BRIT J NUTR, V106, P708, DOI 10.1017/S0007114511000717; Skovlund E, 2001, J CLIN EPIDEMIOL, V54, P86, DOI 10.1016/S0895-4356(00)00264-X; Smith K, 2007, GERIATR AGING, V10, P91; Sorbye LW, 2008, J NUTR HEALTH AGING, V12, P10, DOI 10.1007/BF02982158; Stajkovic S, 2011, CAN MED ASSOC J, V183, P443, DOI 10.1503/cmaj.101471; Stenholm S, 2013, J GERONTOL A-BIOL; THOMPSON MP, 1991, J AM GERIATR SOC, V39, P497, DOI 10.1111/j.1532-5415.1991.tb02496.x; Wallace JI, 2002, INT J CARDIOL, V85, P15, DOI 10.1016/S0167-5273(02)00246-2; Wallis DJ, 2009, APPETITE, V52, P355, DOI 10.1016/j.appet.2008.11.007; Wannamethee SG, 2005, ARCH INTERN MED, V165, P1035, DOI 10.1001/archinte.165.9.1035; Wanous JP, 1997, J APPL PSYCHOL, V82, P247, DOI 10.1037/0021-9010.82.2.247; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wikby K, 2004, SCAND J CARING SCI, V18, P120, DOI 10.1111/j.1471-6712.2004.00259.x	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185749	10.1371/journal.pone.0185749	http://dx.doi.org/10.1371/journal.pone.0185749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968437	gold, Green Published, Green Submitted			2022-12-27	WOS:000412029600041
J	Koga, M; Toyomaki, A; Miyazaki, A; Nakai, Y; Yamaguchi, A; Kubo, C; Suzuki, J; Ohkubo, I; Shimizu, M; Musashi, M; Kiso, Y; Kusumi, I				Koga, Minori; Toyomaki, Atsuhito; Miyazaki, Akane; Nakai, Yukiei; Yamaguchi, Atsuko; Kubo, Chizuru; Suzuki, Junko; Ohkubo, Iwao; Shimizu, Mari; Musashi, Manabu; Kiso, Yoshinobu; Kusumi, Ichiro			Mediators of the effects of rice intake on health in individuals consuming a traditional Japanese diet centered on rice	PLOS ONE			English	Article							VERSION; VALIDITY; LIFE; NUTRIENTS; MICE; FOOD	Although the Japanese diet is believed to be balanced and healthy, its benefits have been poorly investigated, especially in terms of effects on mental health. We investigated dietary patterns and physical and mental health in the Japanese population using an epidemiological survey to determine the health benefits of the traditional Japanese diet. Questionnaires to assess dietary habits, quality of life, sleep quality, impulsivity, and depression severity were distributed to 550 randomly selected middle-aged and elderly individuals. Participants with any physical or mental disease were excluded. Two-hundred and seventy-eight participants were selected for the final statistical analysis. We determined rice to be one of the most traditional foods in Japanese cuisine. Scores for each questionnaire were computed, and the correlations between rice intake and health indices were assessed. When analyzing the direct correlations between rice intake and health indices, we found only two correlations, namely those with quality of life (vitality) and sleep quality. Path analysis using structural equation modeling was performed to investigate the association between rice intake and health, with indirect effects included in the model. Additional associations between rice intake and health were explained using this model when compared to those using direct correlation analysis. Path analysis was used to identify mediators of the rice-health association. These mediators were miso (soybean paste) soup, green tea, and natto (fermented soybean) intake. Interestingly, these mediators have been major components of the Japanese diet since 1975, which has been considered one of the healthiest diets since the 1960s. Our results indicate that the combination of rice with other healthy foods, which is representative of the traditional Japanese diet, may contribute to improvements in physical and mental health.	[Koga, Minori; Toyomaki, Atsuhito; Miyazaki, Akane; Nakai, Yukiei; Kusumi, Ichiro] Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Yamaguchi, Atsuko; Kubo, Chizuru; Suzuki, Junko; Ohkubo, Iwao; Shimizu, Mari; Musashi, Manabu] Tenshi Coll, Dept Nutr, Sapporo, Hokkaido, Japan; [Kiso, Yoshinobu] Hokkaido Univ, Inst Promot Business Reg Collaborat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Koga, M (corresponding author), Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan.	mkoga@med.hokudai.ac.jp	Kiso, Yoshinobu/D-5424-2012		Integration Research for Agriculture and Interdisciplinary Fields [14538872]; Ministry of Agriculture, Forestry and Fisheries	Integration Research for Agriculture and Interdisciplinary Fields; Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Integration Research for Agriculture and Interdisciplinary Fields (Grant 14538872), the Ministry of Agriculture, Forestry and Fisheries (IK); https://www.s.affrc.go.jp/docs/kibonkeikaku/pdf/h27plan_en pdf.	Bolla KN, 2015, INT J SCI TECHNOL RE, V4, P50; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Ganmaa D, 2003, MED HYPOTHESES, V60, P724, DOI 10.1016/S0306-9877(03)00047-1; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Iso H, 2008, CIRCULATION, V118, P2725, DOI 10.1161/CIRCULATIONAHA.107.750117; Isshiki K., 2007, FOODS FOOD INGREDIEN, V212; Kakutani Y, 2015, J NUTR SCI VITAMINOL, V61, P55, DOI 10.3177/jnsv.61.55; Kohara Y, 2015, PHYSIOL BEHAV, V140, P15, DOI 10.1016/j.physbeh.2014.12.005; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Matsuyama T, 2008, OBESITY, V16, P1338, DOI 10.1038/oby.2008.60; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Nagao T, 2009, OBESITY, V17, P310, DOI 10.1038/oby.2008.505; Nakaji S, 2002, EUR J NUTR, V41, P244, DOI 10.1007/s00394-002-0380-4; Sasaki S, 1998, J Epidemiol, V8, P203; Shiwaku K, 2004, LANCET, V363, P1737, DOI 10.1016/S0140-6736(04)16274-0; Someya T, 2001, PSYCHIAT CLIN NEUROS, V55, P111, DOI 10.1046/j.1440-1819.2001.00796.x; Tokuda Y, 2009, VALUE HEALTH, V12, P568, DOI 10.1111/j.1524-4733.2008.00449.x; Tomata Y, 2016, J GERONTOLOGY A; Yamamoto K, 2016, NUTRITION, V32, P122, DOI 10.1016/j.nut.2015.07.002; Yamamura K., 1987, POLITICAL EC JAPAN; Yoneyama S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105198; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154	23	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185816	10.1371/journal.pone.0185816	http://dx.doi.org/10.1371/journal.pone.0185816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968452	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600053
J	Sun, KS; Lam, TP; Lame, KF; Piterman, L; Lo, TL; Chao, DVK; Lam, EWW				Sun, Kai Sing; Lam, Tai Pong; Lame, Kwok Fai; Piterman, Leon; Lo, Tak Lam; Chao, David Vai Kiong; Lam, Edmund Wing Wo			Help-seeking behaviours for psychological distress amongst Chinese patients	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; ANXIETY DISORDERS; SPIRITUALITY; MEDICINE; OUTCOMES; RELIGION	Background The stepped care model for psychological distress has been promoted in recent years, leading to the enhancing roles of primary care professionals and alternative sources of help. However, most of the research findings come from Western countries. This study investigates help-seeking behaviours of Chinese patients among different types of professional and alternative sources for psychological distress in Hong Kong. Methods A questionnaire survey was conducted with 1626 adult primary care attenders from 13 private and 6 public clinics, 650 (40.0%) reported that they had ever experienced psychological distress. Their help-seeking behaviours, demographic background and current distress level (measured by GHQ-12) were analysed. Results Among the respondents with experience of psychological distress, 48.2% had sought help from professional and/or alternative sources for their distress [10.2% from professionals only, 12.6% from alternative sources only, and 25.4% from both]. Those who had sought help from professionals only were more likely to be less educated and with lower income. In contrast, those using alternative sources only were more likely to be younger, better educated, and have higher income. Allowing multiple responses, psychiatrists (22.3%) was reported to be the most popular professional source, followed by primary care physicians (17.5%), clinical psychologists (12.8%) and social workers/counsellors (12.0%). Family members/friends (28.6%) was the top alternative source, followed by exercise/sports (21.8%), religious/spiritual support (16.9%) and self-help websites/books/pamphlets (8.9%). Conclusion While psychiatrists remain the most popular professional source of help to the Chinese patients in Hong Kong, primary care professionals and alternative sources also play significant roles. Distressed patients who are younger, better educated and have higher income are more likely to use alternative sources only. The outcomes need further research.	[Sun, Kai Sing; Lam, Tai Pong; Lo, Tak Lam; Chao, David Vai Kiong; Lam, Edmund Wing Wo] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Lame, Kwok Fai] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Hong Kong, Peoples R China; [Piterman, Leon] Monash Univ, Gen Practice, Melbourne, Vic, Australia; [Lo, Tak Lam] Kwai Chung Hosp, Hong Kong, Hong Kong, Peoples R China; [Chao, David Vai Kiong] United Christian Hosp, Dept Family Med & Primary Hlth Care, Hong Kong, Hong Kong, Peoples R China; [Chao, David Vai Kiong] Tseung Kwan O Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Monash University; United Christian Hospital	Lam, TP (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	tplam@hku.hk	Lam, Edmund/C-1853-2009	Lam, Edmund/0000-0001-6268-950X; Lam, Kwok/0000-0001-5453-994X	Hong Kong Special Administrative Region, China [10111371]	Hong Kong Special Administrative Region, China	T.P. Lam was supported by a grant from the Health and Medical Research Fund of the Hong Kong Special Administrative Region, China (Project No. 10111371). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Burgess PM, 2009, AUST NZ J PSYCHIAT, V43, P615, DOI 10.1080/00048670902970858; CHAN DW, 1985, PSYCHOL MED, V15, P147, DOI 10.1017/S0033291700021012; Chen J, 2016, ADM POLICY MENT HLTH, V43, P535, DOI 10.1007/s10488-015-0657-6; Moura AMD, 2015, CNS NEUROL DISORD-DR, V14, P1184, DOI 10.2174/1871527315666151111121259; Drapeau A, 2011, MENTAL ILLNESSES UND, p134 ; Food and Health Bureau, 2017, MENT HLTH REV REP FO; Funk M., 2008, INT MENT HLTH PRIM C; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; GOLDBERG DP, 1995, MENTAL ILLNESS GEN H, P323; Henderson C, 2012, PSYCHIAT SERV, V63, P451, DOI 10.1176/appi.ps.201100422; Horwitz BN, 2015, PERS RELATIONSHIP, V22, P79, DOI 10.1111/pere.12063; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Lagomarsino G, 2009, LANCET, V374, P1577, DOI 10.1016/S0140-6736(09)61241-1; Lam LCW, 2015, SOC PSYCH PSYCH EPID, V50, P1379, DOI 10.1007/s00127-015-1014-5; Lam TP, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1080-6; Lau, 2016, S CHINA MORNING POST; Lewis C, 2012, BRIT J PSYCHIAT, V200, P15, DOI 10.1192/bjp.bp.110.084756; Liu P, 2012, AUST DENT J, V57, P493, DOI 10.1111/j.1834-7819.2012.01722.x; Lok IH, 2004, AM J OBSTET GYNECOL, V191, P546, DOI 10.1016/j.ajog.2004.01.003; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; National Institute for Health and Care Excellence (NICE), 2011, STEPP CAR APPR COMM; Oliver MI, 2005, BRIT J PSYCHIAT, V186, P297, DOI 10.1192/bjp.186.4.297; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Reavley NJ, 2011, EARLY INTERV PSYCHIA, V5, P335, DOI 10.1111/j.1751-7893.2011.00292.x; Rickwood DJ, 2014, MED J AUSTRALIA, V200, P108, DOI 10.5694/mja13.11235; Rudell K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-207; Seekles W, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-171; Sun KS, 2016, J AFFECT DISORDERS, V196, P164, DOI 10.1016/j.jad.2016.02.041; U. S. Census Bureau, 2010, ASIAN POPULATION 201; van Straten A, 2015, PSYCHOL MED, V45, P231, DOI 10.1017/S0033291714000701; Walters K, 2008, BRIT J GEN PRACT, V58, P694, DOI 10.3399/bjgp08X342174; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Weber SR, 2014, CURR OPIN PSYCHIATR, V27, P358, DOI 10.1097/YCO.0000000000000080; Wong DF, SOC PSYCHIAT PSYCHIA, V47, P1235; Wun YT, 2011, FAM PRACT, V28, P49, DOI 10.1093/fampra/cmq064; Yap MB, 2012, AUST NZ J PSYCHIAT, V46, P541, DOI 10.1177/0004867411435288	37	8	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185831	10.1371/journal.pone.0185831	http://dx.doi.org/10.1371/journal.pone.0185831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI5MY	28968453	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600055
J	Rodriguez, J; Waichert, C; von Dohlen, CD; Pitts, JP				Rodriguez, Juanita; Waichert, Cecilia; von Dohlen, Carol D.; Pitts, James P.			The geological record and phylogeny of spider wasps (Hymenoptera: Pompilidae): A revision of fossil species and their phylogenetic placement	PLOS ONE			English	Article							CHUBUTOLITHES-GAIMANENSIS; MOLECULAR PHYLOGENY; OLIGOCENE; DEPOSITS; CTENOCERINAE; ABERNESSIA; BIBIONIDAE; ARGENTINA; COLORADO; INSECTS	Accurate fossil identification has become increasingly relevant with the widespread use of phylogenetic divergence time estimation methods, which rely on fossil data to determine clade hard-minimum ages. Here we revise, diagnose and illustrate known spider wasp (Hymenoptera: Pompilidae) fossil species and place them within the latest Pompilidae phylogenetic hypothesis. Ceropalites infelix Cockerell, from the Florissant Fossil Beds (Priabonian), is no longer recognized as Pompilidae, but as Aulacidae. Agenioideus saxigenus (Cockerell) comb. nov., Deuteragenia wettweri (Statz) comb. nov., Caputelus scudderi (Cockerell, 1906) comb. nov., Pepsinites avitula (Cockerell, 1941) comb. nov., Pepsinites contentus (Theobald, 1937) comb. nov., Pepsinites florissantensis (Cockerell, 1906) comb. nov., Pepsinites laminarum (Rohwer, 1909) comb. nov., Pepsinites scelerosus (Meunier, 1919) comb. nov., Pepsinites cockerellae (Rohwer, 1909) comb. nov., Pompilinites coquandi (Theobald, 1937) comb. nov., Pompilinites depressus (Statz, 1936) comb. nov., Pompilites incertus (Theobald, 1937) comb. nov., Pompilites induratus (Heer, 1849) comb. nov., Pompilites fasciatus (Theobald, 1937) comb. nov., and Pompilites senex comb. nov. are new combinations. Twenty-three fossil species of spider wasps are now recognized in 13 genera. Four new genera are proposed: Caputelus Waichert & Pitts gen. nov., Pompilites Rodriguez gen. nov., Pompilinites Rodriguez & Waichert gen. nov., and Pepsinites Rodriguez & Waichert gen. nov., of which the three latter are collective-group names for fossils with taxonomic uncertainty. One species of fossil spider wasp is described: Deuteragenia catalunyia Rodriguez, Waichert & Pitts sp. nov., from the Bellver deposits in Catalonia, Spain. Five of the 23 known species can be used to determine hard-minimum age for calibrations of genera stem-groups (Agenioideus, Anoplius, Cryptocheilus, Deuteragenia, Priocnemis). The fossil belonging to the stem-group of the tribe Ageniellini (Chubutholites) is not recommended for calibration because of the high uncertainty in its age and taxonomy. The remaining taxa can be assigned to the lineage comprising Pompilinae + Pepsinae (12 species) or crown-group Pompilidae (four species).	[Rodriguez, Juanita] Australian Natl Insect Collect, CSIRO, Acton, ACT, Australia; [Waichert, Cecilia] Univ Fed Espirito Santo, Programa Posgrad Ciencias Biol, Dept Ciencias Biol, Vitoria Es, Brazil; [von Dohlen, Carol D.; Pitts, James P.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade Federal do Espirito Santo; Utah System of Higher Education; Utah State University	Rodriguez, J (corresponding author), Australian Natl Insect Collect, CSIRO, Acton, ACT, Australia.	Juanita.Rodriguez@csiro.au	Waichert, Cecilia/C-5759-2019; Rodriguez, Juanita/M-6973-2016	Waichert, Cecilia/0000-0003-1841-7405; Rodriguez, Juanita/0000-0001-9922-1978; von Dohlen, Carol/0000-0002-3961-251X	Center for Women and Gender, Utah State University; Utah Agricultural Experiment Station, Utah State University UAES [8490]; National Science Foundation [DEB-0743763]; FAPES/CAPES [71026436/15]	Center for Women and Gender, Utah State University; Utah Agricultural Experiment Station, Utah State University UAES; National Science Foundation(National Science Foundation (NSF)); FAPES/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Graduate Student Travel Grant from the Center for Women and Gender, Utah State University supported CW's visit to the MCZ collection. The Utah Agricultural Experiment Station, Utah State University UAES #8490, supported this research. The National Science Foundation award DEB-0743763 to JPP and CDvD also supported this work. FAPES/CAPES (#71026436/15) supported CW's postdoctoral fellowship.	Aleksandrova GN, 2008, STRATIGR GEO CORREL+, V16, P528, DOI 10.1134/S0869593808050067; [Anonymous], 1993, HYMENOPTERA WORLD ID; [Anonymous], 1977, SOVIET GEOLOGY; Arillo Antonio, 2001, Coloquios de Paleontologia, V52, P79; Bellosi E.S., 2010, PALEONTOLOGY GRAN BA, P19; Berger JP, 2005, INT J EARTH SCI, V94, P711, DOI 10.1007/s00531-005-0479-y; BOWN TM, 1988, J PALEONTOL, V62, P163, DOI 10.1017/S0022336000029802; Brady Sean, 2011, American Entomologist, V57, P56; Chateauneuf J.J., 1995, GEOL FR, V2, P43; Cockerell T. D. A., 1906, Bulletin of the Museum of Comparative Zoology at Harvard College, V50; Cockerell TDA, 1941, AM J SCI, V239, P354, DOI 10.2475/ajs.239.5.354; Cockerell TDA, 1914, J GEOL, V22, P714, DOI 10.1086/622186; Collomb FM, 2008, ANN SOC ENTOMOL FR, V44, P161, DOI 10.1080/00379271.2008.10697553; Cookerell TDA, 1908, AM J SCI, V25, P309; Day CM, 1988, R ENTOM SOC LONDON, V6, P1; Engel MS, 2006, J KANSAS ENTOMOL SOC, V79, P359, DOI 10.2317/0604.26.1; Epis R. C., 1974, US GOVT PRINT OFF, P1; Evanoff Emmett, 2001, Proceedings of the Denver Museum of Nature & Science, V4, P1; Evans HE, 1998, J NAT HIST, V32, P1411, DOI 10.1080/00222939800770711; Fikacek M, 2010, ACTA GEOL SIN-ENGL, V84, P732, DOI 10.1111/j.1755-6724.2010.00239.x; FREEMAN BE, 1991, J PALEONTOL, V65, P702, DOI 10.1017/S0022336000030845; Genise JF, 2004, J KANSAS ENTOMOL SOC, V77, P626, DOI 10.2317/E-25.1; Grimaldi David, 2005, pi; Heer O., 1849, ZWEITER THEIL HEUSCH; HIPPOLYTE JC, 1993, TECTONOPHYSICS, V226, P15, DOI 10.1016/0040-1951(93)90108-V; Holbourn A, 2014, GEOLOGY, V42, P19, DOI 10.1130/G34890.1; Huber John T., 1993, Agriculture Canada Publication, V1894E, P13; International Commission on Zoological Nomenclature, 2000, INT CODE ZOOLOGICAL; Iturralde-Vinent MA, 2001, CARIBB J SCI, V37, P141; Kay RF, 1999, P NATL ACAD SCI USA, V96, P13235, DOI 10.1073/pnas.96.23.13235; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kosmowska-Ceranowicz B., 2012, BURSZTYN POLSCE NA S; LELEJ AS, 2012, FAR EAST ENTOMOL NOV, P1; Lutz Herbert, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V203, P173; Meunier F., 1917, Tijdschrift voor Entomologie, V60; Meunier F., 1915, NOUVELLES RECHERCHES, V18, P1; Nury D., 1987, OLIGOCENE PROVENCE M; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Prothero DR, 2008, GEOL S AM S, V435, P71; RITZKOWSKI S., 1997, METALLA BOCHUM, V66, P19; Rodriguez J, 2016, ACTA PALAEONTOL POL, V61, P89, DOI 10.4202/app.00073.2014; Rodriguez J, 2016, MOL PHYLOGENET EVOL, V94, P55, DOI 10.1016/j.ympev.2015.08.014; Rohwer S. A., 1909, Psyche Boston Mass, V16, DOI 10.1155/1909/20351; Schiller W., 1925, AN MUS LA PLATA, V11, P11; Schoberlin E, 1888, SOC ENTOMOLOGICA, V3, P68; Selmeier A, 1990, KLASSISCHE FUNDSTELL, P214; Sharkey MJ, 2002, ZOOL SCR, V31, P57, DOI 10.1046/j.0300-3256.2001.00081.x; Shimizu Akira, 2000, Entomological Science, V3, P499; Shimizu A, 2009, ENTOMOL SCI, V12, P238, DOI 10.1111/j.1479-8298.2009.00327.x; Simpson G. G., 1935, AM MUS NOVIT, V775; Skartveit J, 2017, ZOOTAXA, V4225, P1, DOI 10.11646/zootaxa.4225.1.1; Statz G., 1938, Decheniana Bonn, V98A, P71; Statz G., 1936, Decheniana Bonn, V93, P256; Sustera Oldrieh, 1912, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V62; Theobald N., 1937, MEM SOC SCI NANCY, V473, P1; Vardy C. R., 2005, Zoologische Mededelingen (Leiden), V79, P1; Wahis R., 1986, CATALOGUE SYSTE MATI; Waichert C, 2011, ANN ENTOMOL SOC AM, V104, P1279, DOI 10.1603/AN11093; Waichert C, 2015, ZOOL J LINN SOC-LOND, V175, P271, DOI 10.1111/zoj.12272; Waichert C, 2013, ZOOKEYS, P71, DOI 10.3897/zookeys.353.6223; Wasbauer MS, 1985, CALIFORNIA SPIDER WA; Wolf H., 1999, BEMERKUNGEN EINIGEN	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0185379	10.1371/journal.pone.0185379	http://dx.doi.org/10.1371/journal.pone.0185379			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020022	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400029
J	Pedroza-Gutierrez, C; Hernandez, JM				Pedroza-Gutierrez, Carmen; Hernandez, Juan M.			Social networks, market transactions, and reputation as a central resource. The Mercado del Mar, a fish market in central Mexico	PLOS ONE			English	Article							TRUST; MANAGEMENT; COMMITMENT; EVOLUTION; QUALITY	Fish consumption in Mexico is considered low (around 12 kg per person per year) and non-homogeneously distributed across the country. One of the reasons for this situation is the scarcity of wholesale selling sites. In this context, the Mercado del Mar (MM), located in Guadalajara city, Jalisco, is the second biggest wholesale fish market in Mexico, with a distribution of about 500 tons per day and a variety of about 350 different species of fish. In this paper, we argue that MM has accumulated social capital, which is formed from two main resources: buyer and seller relationships, and reputation. Specifically, the MM manages a broad and intensive interaction among business actors and the already achieved reputation allows the MM to adapt to market changes. To validate our hypotheses, an empirical study was conducted in 2015 by means of interviews to fish wholesalers in the MM and a sample of their suppliers and buyers. For simplicity we have only considered fresh water fish. We have followed snow-ball sampling as the survey strategy. Results show that the MM has responded to fish market dynamics organizing a complex network of buyers and suppliers whose relationships can be explained in the form of strong and weak ties. At the same time, reputation has been the central resource to build this social capital and also gives place to market transactions. Additionally, the strategic position of Guadalajara city and the well-connected routes have facilitated fish bulking and distribution in the region.	[Pedroza-Gutierrez, Carmen] Univ Nacl Autonoma Mexico, Coordinac Humanidades, Unidad Acad Estudios Reg, Jiquilpan, Mexico; [Hernandez, Juan M.] Univ Las Palmas Gran Canaria, Dept Quantitat Methods Econ & Management, Inst Tourism & Sustainable Econ Dev TIDES, Las Palmas Gran Canaria, Gran Canaria, Spain	Universidad Nacional Autonoma de Mexico; Universidad de Las Palmas de Gran Canaria	Pedroza-Gutierrez, C (corresponding author), Univ Nacl Autonoma Mexico, Coordinac Humanidades, Unidad Acad Estudios Reg, Jiquilpan, Mexico.	pedrozacarmen@yahoo.com	Hernandez, Juan M./D-7096-2013; Pedroza-Gutiérrez, Carmen/D-1267-2017	Hernandez, Juan M./0000-0001-6897-5179; Pedroza-Gutierrez, Carmen/0000-0002-1048-434X	Universidad Nacional Autonoma de Mexico (UNAM) [PAPIIT IA300215]; Government of Spain [EC02014-59067-P]	Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Government of Spain(Spanish Government)	The study was funded by the Universidad Nacional Autonoma de Mexico (UNAM) under grant PAPIIT IA300215, which financed the field study and part of the travel expenses of both researchers, and the Government of Spain under grant EC02014-59067-P financed part of the travels of Dr. Juan Hernandez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achrol RS, 1997, J ACAD MARKET SCI, V25, P56, DOI 10.1007/BF02894509; Ahuja G, 2000, STRATEGIC MANAGE J, V21, P317, DOI 10.1002/(SICI)1097-0266(200003)21:3<317::AID-SMJ90>3.0.CO;2-B; Anand BN, 2000, STRATEGIC MANAGE J, V21, P295, DOI 10.1002/(SICI)1097-0266(200003)21:3<295::AID-SMJ91>3.0.CO;2-O; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Benjamin BA, 1999, ADMIN SCI QUART, V44, P563, DOI 10.2307/2666962; Bennett R, 2001, J BUS IND MARK, V16, P424, DOI 10.1108/EUM0000000006018; Bestor TC, 2004, TSUKIJI FISH MARKET, V11; BOWERSOX DJ, 1990, HARVARD BUS REV, V68, P36; Braunscheidel MJ, 2009, J OPER MANAG, V27, P119, DOI 10.1016/j.jom.2008.09.006; Burt R. S, 1992, STRUCTURAL HOLES; Casalo LV, 2007, J MARK COMMUN, V13, P1, DOI 10.1080/13527260600951633; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Choi TY, 2001, J OPER MANAG, V19, P351, DOI 10.1016/S0272-6963(00)00068-1; Cuesta J A, 2015, SCI REPORTS; Dasgupta P., 2000, TRUST MAKING BREAKIN, V4, P49; Ding H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162781; Ebbers JJ, 2010, STRATEG ORGAN, V8, P255, DOI 10.1177/1476127010381102; Fluvia M, 2012, FISH RES, V127, P18, DOI 10.1016/j.fishres.2012.04.010; Fombrun Charles., 2004, FAME FORTUNE SUCCESS; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Giulioni G, 2011, J ECON BEHAV ORGAN, V80, P34, DOI 10.1016/j.jebo.2011.01.012; Graddy K, 2006, J ECON PERSPECT, V20, P207, DOI 10.1257/jep.20.2.207; GRADDY K, 1995, RAND J ECON, V26, P75, DOI 10.2307/2556036; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Gray ER, 1998, LONG RANGE PLANN, V31, P695, DOI 10.1016/S0024-6301(98)00074-0; Gulati R., 2007, MANAGING NETWORK RES; Harner J, 2010, GEOGR REV, V100, P494, DOI 10.1111/j.1931-0846.2010.00055.x; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; IBARRA H, 1993, ACAD MANAGE REV, V18, P56, DOI 10.5465/AMR.1993.3997507; INEC,, 2010, CENS POBL VIV; Kim Y, 2011, J OPER MANAG, V29, P194, DOI 10.1016/j.jom.2010.11.001; Lee PM, 2004, J FINANC ECON, V73, P375, DOI 10.1016/j.jfineco.2003.09.003; Michell P, 1998, J MARKET MANAG, V14, P159, DOI DOI 10.1362/026725798784959417; MOORMAN C, 1992, J MARKETING RES, V29, P314, DOI 10.1177/002224379202900303; Moreno JA Islas, 2007, TCPRLA3111 INFOPESCA; Musiolik J, 2012, TECHNOL FORECAST SOC, V79, P1032, DOI 10.1016/j.techfore.2012.01.003; Neville BA, 2005, EUR J MARKETING, V39, P1184, DOI 10.1108/03090560510610798; Newman M.E.J., 2010, NETWORKS INTRO; Pels J., 1992, EUR J MARKETING, V26, P5; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Schweizer T. S., 1999, CORPORATE REPUTATION, V2, P249, DOI DOI 10.1057/palgrave.crr.1540083; Scott J., 2012, SOCIAL NETWORK ANAL; SHAPIRO C, 1983, Q J ECON, V98, P659, DOI 10.2307/1881782; Simatupang T.M., 2002, INT J LOGIST MANAG, V13, P15, DOI [10.1108/09574090210806333, DOI 10.1108/09574090210806333]; Tirole J, 1996, REV ECON STUD, V63, P1, DOI 10.2307/2298112; van Woerkum CMJ, 2007, BRIT FOOD J, V109, P355, DOI 10.1108/00070700710746777; Wang CJ, 2017, APPL MATH COMPUT, V293, P18, DOI 10.1016/j.amc.2016.06.026; Wasserman S, 1994, SOCIAL NETWORK ANAL; Wassmer U., 2008, J MANAGE; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070	50	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186063	10.1371/journal.pone.0186063	http://dx.doi.org/10.1371/journal.pone.0186063			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016637	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400053
J	Reniers, G; Blom, S; Lieber, J; Herbst, AJ; Calvert, C; Bor, J; Barnighausen, T; Zaba, B; Li, ZHR; Clark, SJ; Grant, AD; Lessells, R; Eaton, JW; Hosegood, V				Reniers, Georges; Blom, Sylvia; Lieber, Judith; Herbst, Abraham J.; Calvert, Clara; Bor, Jacob; Barnighausen, Till; Zaba, Basia; Li, Zehang R.; Clark, Samuel J.; Grant, Alison D.; Lessells, Richard; Eaton, Jeffrey W.; Hosegood, Victoria			Tuberculosis mortality and the male survival deficit in rural South Africa: An observational community cohort study	PLOS ONE			English	Article							WOMEN LIVE LONGER; ANTIRETROVIRAL THERAPY; SEX-DIFFERENCES; VERBAL AUTOPSY; HIV-INFECTION; LIFE; PATTERNS; TRENDS; DEATH; PREVALENCE	Background Women live on average five years longer than men, and the sex difference in longevity is typically lower in populations with high mortality. South Africa-a high mortality population with a large sex disparity-is an exception, but the causes of death that contribute to this difference are not well understood. Methods Using data from a demographic surveillance system in rural KwaZulu-Natal (2000-2014), we estimate differences between male and female adult life expectancy by HIV status. The contribution of causes of death to these life expectancy differences are computed with demographic decomposition techniques. Cause of death information comes from verbal autopsy interviews that are interpreted with the InSilicoVA tool. Results Adult women lived an average of 10.4 years (95% confidence Interval 9.0-11.6) longer than men. Sex differences in adult life expectancy were even larger when disaggregated by HIV status: 13.1 (95% confidence interval 10.7-15.3) and 11.2 (95% confidence interval 7.5-14.8) years among known HIV negatives and positives, respectively. Elevated male mortality from pulmonary tuberculosis (TB) and external injuries were responsible for 43% and 31% of the sex difference in life expectancy among the HIV negative population, and 81% and 16% of the difference among people living with HIV. Conclusions The sex differences in adult life expectancy in rural KwaZulu-Natal are exceptionally large, atypical for an African population, and largely driven by high male mortality from pulmonary TB and injuries. This is the case for both HIV positive and HIV negative men and women, signalling a need to improve the engagement of men with health services, irrespective of their HIV status.	[Reniers, Georges; Blom, Sylvia; Lieber, Judith; Calvert, Clara; Zaba, Basia] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Reniers, Georges; Clark, Samuel J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Blom, Sylvia] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Herbst, Abraham J.; Barnighausen, Till; Grant, Alison D.; Lessells, Richard; Hosegood, Victoria] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Africa Hlth Res Inst, Durban, South Africa; [Bor, Jacob] Boston Univ, Dept Global Hlth, Boston, MA 02215 USA; [Barnighausen, Till] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Cambridge, MA 02138 USA; [Barnighausen, Till] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Li, Zehang R.] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Clark, Samuel J.] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA; [Grant, Alison D.; Lessells, Richard] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Eaton, Jeffrey W.] Imperial Coll, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England; [Hosegood, Victoria] Univ Southampton, Social Stat & Demog, Southampton, Hants, England	University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Cornell University; Africa Health Research Institute; University of Kwazulu Natal; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Southampton	Reniers, G (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, London, England.; Reniers, G (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	georges.reniers@lshtm.ac.uk	Herbst, Abraham J/E-4848-2010; Clark, Samuel J/A-8419-2009; Bärnighausen, Till/Y-2388-2019	Herbst, Abraham J/0000-0002-5436-9386; Clark, Samuel J/0000-0002-4929-6231; Eaton, Jeffrey/0000-0001-7728-728X; Li, Zehang/0000-0001-9551-9638; Reniers, Georges/0000-0001-6582-1692; Lessells, Richard/0000-0003-0926-710X	Wellcome Trust [65377, 085477/Z/08/Z]; Bill and Melinda Gates Foundation [BMGF-OPP1082114, BMGF-OPP1120138]; K01 award from the National Institutes of Health [K01-MH10532001A1]; Alexander von Humboldt Foundation; Wellcome Trust; NICHD of NIH [R01-HD084233]; NIAID of NIH [R01-A1124389, R01-A1112339]; FIC of NIH [D43-TW009775]; NIA of NIH [P01-AG041710]; Medical Research Council [MR/K010174/1B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084233] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112339, R01AI124389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH105320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041710] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); K01 award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Wellcome Trust(Wellcome Trust); NICHD of NIH; NIAID of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC of NIH; NIA of NIH; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was made possible with support from the Wellcome Trust to the Africa Centre for Health and Population Studies (65377), support from the Wellcome Trust (085477/Z/08/Z) and the Bill and Melinda Gates Foundation (BMGF-OPP1082114) to the ALPHA Network, and support from the Bill and Melinda Gates Foundation to the MeSH Consortium (BMGF-0PP1120138). Jacob Bor was supported by a K01 award from the National Institutes of Health (K01-MH10532001A1). Till Barnighausen was supported by the Alexander von Humboldt Foundation, the Wellcome Trust, and NICHD of NIH (R01-HD084233), NIAID of NIH (R01-A1124389 and R01-A1112339), FIC of NIH (D43-TW009775), and NIA of NIH (P01-AG041710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was made possible with support from the Wellcome Trust to the Africa Centre for Health and Population Studies (65377), support from the Wellcome Trust (085477/Z/08/Z) and the Bill and Melinda Gates Foundation (BMGF-OPP1082114) to the ALPHA Network, and support from the Bill and Melinda Gates Foundation to the MeSH Consortium (BMGFOPP1120138). Jacob Bor was supported by a K01 award from the National Institutes of Health (K01-MH105320-01A1). Till Barnighausen was supported by the Alexander von Humboldt Foundation, the Wellcome Trust, and NICHD of NIH (R01-HD084233), NIAID of NIH (R01 -A1124389 and R01-AI112339), FIC of NIH (D43-TW009775), and NIA of NIH (P01AG041710). The funding agencies played no role in the implementation of the study or the interpretation of the results.	Andersen PK, 2013, DEMOGR RES, V29, P1127, DOI 10.4054/DemRes.2013.29.41; [Anonymous], STAND VERB AUT QUEST; [Anonymous], INT STUDIES DEMOGRAP; [Anonymous], 2013, MMWR MORB MORTAL WKL; [Anonymous], 2014, MPIDR WORKING PAPER; [Anonymous], INSILICO VA METHOD A; [Anonymous], INTERVA4 R PACKAGE A; [Anonymous], GEND TUB; [Anonymous], MORT GLOB HLTH EST L; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Asiki G, 2016, AIDS, V30, P487, DOI 10.1097/QAD.0000000000000930; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Fottrell E, 2010, EPIDEMIOL REV, V32, P38, DOI 10.1093/epirev/mxq003; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Glynn JR, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23621; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; IRWIN JO, 1949, J HYG-CAMBRIDGE, V47, P188, DOI 10.1017/S0022172400014443; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Larmarange J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123345; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; McCormick TH, 2016, J AM STAT ASSOC, V111, P1036, DOI 10.1080/01621459.2016.1152191; Mossong J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25496; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; NATHANSON CA, 1984, ANNU REV SOCIOL, V10, P191, DOI 10.1146/annurev.so.10.080184.001203; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Reniers G, 2017, LANCET HIV, V4, pE113, DOI 10.1016/S2352-3018(16)30225-9; Reniers G, 2015, DEMOGR RES, V33, P425, DOI 10.4054/DemRes.2015.33.15; Reniers G, 2014, AIDS, V28, pS533, DOI 10.1097/QAD.0000000000000496; Seale C, 2000, SOC SCI MED, V51, P917, DOI 10.1016/S0277-9536(00)00071-X; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Staveteig S., 2013, DEMOGRAPHIC PATTERNS; Tadesse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073463; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Van den Hof S, 2010, REPORT PREPARED TUBE; WALDRON I, 1983, SOC SCI MED, V17, P321, DOI 10.1016/0277-9536(83)90234-4; WALDRON I, 1976, SOC SCI MED, V10, P349, DOI 10.1016/0037-7856(76)90090-1; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; World Health Organization, 2008, The global burden of disease: 2004 update	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185692	10.1371/journal.pone.0185692	http://dx.doi.org/10.1371/journal.pone.0185692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3JE	29016619	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000412627400027
J	Wang, L; Baser, O; Wells, P; Peacock, WF; Coleman, CI; Fermann, GJ; Schein, J; Crivera, C				Wang, Li; Baser, Onur; Wells, Phil; Peacock, W. Frank; Coleman, Craig I.; Fermann, Gregory J.; Schein, Jeff; Crivera, Concetta			Benefit of early discharge among patients with low-risk pulmonary embolism	PLOS ONE			English	Article							HOSPITAL STAY; OUTPATIENT TREATMENT; SEVERITY INDEX; STRATIFICATION; METAANALYSIS; LENGTH; MORTALITY; COMPLICATIONS; THROMBOSIS; STROKE	Clinical guidelines recommend early discharge of patients with low-risk pulmonary embolism (LRPE). This study measured the overall impact of early discharge of LRPE patients on clinical outcomes and costs in the Veterans Health Administration population. Adult patients with >= 1 inpatient diagnosis for pulmonary embolism (PE) (index date) between 10/2011-06/2015, continuous enrollment for >= 12 months pre-and 3 months post-index date were included. PE risk stratification was performed using the simplified Pulmonary Embolism Stratification Index. Propensity score matching (PSM) was used to compare 90-day adverse PE events (APEs) [recurrent venous thromboembolism, major bleed and death], hospital-acquired complications (HACs), healthcare utilization, and costs among short (<= 2 days) versus long length of stay (LOS). Net clinical benefit was defined as 1 minus the combined rate of APE and HAC. Among 6,746 PE patients, 95.4% were men, 22.0% were African American, and 1,918 had LRPE. Among LRPE patients, only 688 had a short LOS. After 1:1 PSM, there were no differences in APE, but short LOS had fewer HAC (1.5% vs 13.3%, 95% CI: 3.77-19.94) and bacterial pneumonias (5.9% vs 11.7%, 95% CI: 1.24-3.23), resulting in better net clinical benefit (86.9% vs 78.3%, 95% CI: 0.84-0.96). Among long LOS patients, HACs (52) exceeded APEs (14 recurrent DVT, 5 bleeds). Short LOS incurred lower inpatient ($2,164 vs $5,100, 95% CI: $646.8-$5225.0) and total costs ($9,056 vs $12,544, 95% CI: $636.6-$6337.7). LRPE patients with short LOS had better net clinical outcomes at lower costs than matched LRPE patients with long LOS.	[Wang, Li; Baser, Onur] STATinMED Res, Plano, TX 75093 USA; [Baser, Onur] Columbia Univ, Ctr Innovat & Outcomes Res, Dept Surg, New York, NY USA; [Baser, Onur] STATinMED Res, New York, NY USA; [Baser, Onur] MEF Univ, Dept Econ, Istanbul, Turkey; [Wells, Phil] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Phil] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Peacock, W. Frank] Baylor Coll Med, Emergency Med, Houston, TX 77030 USA; [Coleman, Craig I.] Univ Connecticut, Sch Pharm, Hartford, CT 06112 USA; [Fermann, Gregory J.; Schein, Jeff] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH USA; [Crivera, Concetta] LLC, Janssen Sci Affairs, Titusville, NJ USA	Columbia University; MEF Universitesi; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Baylor College of Medicine; University of Connecticut; University System of Ohio; University of Cincinnati; Johnson & Johnson; Janssen Pharmaceuticals	Wang, L (corresponding author), STATinMED Res, Plano, TX 75093 USA.	lwang@statinmed.com	Library, MEF/O-1457-2019	Coleman, Craig/0000-0003-4868-7158	Janssen Scientific Affairs, LLC	Janssen Scientific Affairs, LLC	This study was funded by Janssen Scientific Affairs, LLC.	Aujesky D, 2008, ARCH INTERN MED, V168, P706, DOI 10.1001/archinte.168.7.706; Aujesky D, 2009, SWISS MED WKLY, V139, P685, DOI smw-12661; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; BefElohlavekJ Dytrych V, 2013, EXP CLIN CARDIOL, V18, P129; Berghaus TM, 2010, ADV THER, V27, P648, DOI 10.1007/s12325-010-0058-x; Coleman CI, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009251; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Dentali F, 2013, J THROMB HAEMOST, V11, P2103, DOI 10.1111/jth.12420; Donadini MP, 2017, THROMB RES, V156, P155, DOI 10.1016/j.thromres.2017.06.009; Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w ostrej zatorowosci plucnej, 2014, Kardiol Pol, V72, P997, DOI 10.5603/KP.2014.0211; Hellenkamp K, 2015, INT J CARDIOL, V197, P162, DOI 10.1016/j.ijcard.2015.06.065; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Jimenez D, 2016, INTERN EMERG MED, V11, P11, DOI 10.1007/s11739-015-1388-0; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kang DK, 2011, AM J CARDIOL, V108, P133, DOI 10.1016/j.amjcard.2011.03.009; Kearon C, 2003, CAN MED ASSOC J, V168, P183; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; LaMori JC, 2015, CLIN THER, V37, P62, DOI 10.1016/j.clinthera.2014.10.024; Masotti L, 2009, VASC HEALTH RISK MAN, V5, P567; Maynard C, 2004, DIABETES CARE, V27, pB22, DOI 10.2337/diacare.27.suppl_2.B22; Miniati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030891; Ozsu S, 2014, THROMB RES, V133, P1006, DOI 10.1016/j.thromres.2014.02.032; Piran S, 2013, THROMB RES, V132, P515, DOI 10.1016/j.thromres.2013.08.012; Rali P, 2016, CRIT CARE NURS Q, V39, P131, DOI 10.1097/CNQ.0000000000000106; Research user Guide: Fiscal Year, 2009, VHA MED SAS INPATIEN; Sorbello D, 2009, CEREBROVASC DIS, V28, P378, DOI 10.1159/000230712; Squizzato A, 2012, J THROMB HAEMOST, V10, P1276, DOI 10.1111/j.1538-7836.2012.04739.x; Stamm JA, 2014, SOUTH MED J, V107, P72, DOI 10.1097/SMJ.0000000000000053; Tarbox Abigail K, 2013, Int J Crit Illn Inj Sci, V3, P69, DOI 10.4103/2229-5151.109427; Tirschwell D L, 1999, J Stroke Cerebrovasc Dis, V8, P336, DOI 10.1016/S1052-3057(99)80008-1; VA Information Resource Center, 2009, VIREC RES US GUID VH; VA Information Resource Center, VIREC RES GUID VA DA; Veterans Health Administration, VET HLTH ADM; Zondag W, 2013, EUR RESPIR J, V42, P134, DOI 10.1183/09031936.00093712	34	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185022	10.1371/journal.pone.0185022	http://dx.doi.org/10.1371/journal.pone.0185022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016692	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400012
J	Liu, Y; Stojadinovic, S; Hrycushko, B; Wardak, Z; Lau, S; Lu, WG; Yan, YL; Jiang, SB; Zhen, X; Timmerman, R; Nedzi, L; Gu, XJ				Liu, Yan; Stojadinovic, Strahinja; Hrycushko, Brian; Wardak, Zabi; Lau, Steven; Lu, Weiguo; Yan, Yulong; Jiang, Steve B.; Zhen, Xin; Timmerman, Robert; Nedzi, Lucien; Gu, Xuejun			A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery	PLOS ONE			English	Article							SUPPORT-VECTOR-MACHINES; TUMOR SEGMENTATION; IMAGES; MRI; CLASSIFICATION; IDENTIFICATION; LESIONS	Accurate and automatic brain metastases target delineation is a key step for efficient and effective stereotactic radiosurgery (SRS) treatment planning. In this work, we developed a deep learning convolutional neural network (CNN) algorithm for segmenting brain metastases on contrast-enhanced T1-weighted magnetic resonance imaging (MRI) datasets. We integrated the CNN-based algorithm into an automatic brain metastases segmentation workflow and validated on both Multimodal Brain Tumor Image Segmentation challenge (BRATS) data and clinical patients' data. Validation on BRATS data yielded average DICE coefficients (DCs) of 0.75 +/- 0.07 in the tumor core and 0.81 +/- 0.04 in the enhancing tumor, which outperformed most techniques in the 2015 BRATS challenge. Segmentation results of patient cases showed an average of DCs 0.67 +/- 0.03 and achieved an area under the receiver operating characteristic curve of 0.98 +/- 0.01. The developed automatic segmentation strategy surpasses current benchmark levels and offers a promising tool for SRS treatment planning for multiple brain metastases.	[Liu, Yan] Sichuan Univ, Sch Elect Engn & Informat, Chengdu, Sichuan, Peoples R China; [Liu, Yan; Stojadinovic, Strahinja; Hrycushko, Brian; Wardak, Zabi; Lau, Steven; Lu, Weiguo; Yan, Yulong; Jiang, Steve B.; Zhen, Xin; Timmerman, Robert; Nedzi, Lucien; Gu, Xuejun] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Zhen, Xin] Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China	Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Medical University - China	Gu, XJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	xuejun.gu@utsouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Jiang, Steve/GRO-3951-2022; Lu, Wei/AAE-2921-2022	Stojadinovic, Strahinja/0000-0002-6840-5747; Lu, Wei/0000-0002-4150-8674; Lau, Steven/0000-0002-6433-8735	China Scholarship Council [201406245043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by China Scholarship Council, Grant No.201406245043. http://en.csc.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agn Mikael, 2015, P MULT BRAIN TUM IM, P1; Assaf Hoogi AL, 2015, MICCAI BRATS 2015, P34; Bakas S., 2015, P MULT BRAIN TUM IM, P5; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Bergner N, 2013, ANALYST, V138, P3983, DOI 10.1039/c3an00326d; Bleau A, 2000, COMPUT VIS IMAGE UND, V77, P317, DOI 10.1006/cviu.2000.0822; Christ P.F., 2017, ARXIV E PRINTS; Dera D, 2016, B MATH BIOL, V78, P1450, DOI 10.1007/s11538-016-0190-0; Dusch E, 2016, P 7 INT S OPTR DEF S; Glotsos D, 2005, INT J NEURAL SYST, V15, P1, DOI 10.1142/S0129065705000013; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Gurney K., 2018, INTRO NEURAL NETWORK; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Ilunga-Mbuyamba E, 2016, EXPERT SYST APPL, V56, P59, DOI 10.1016/j.eswa.2016.02.048; Kamnitsas K, 2016, ARXIV E PRINTS; LaMontagne P, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou264.48; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Liu Y, 2016, PHYS MED BIOL, V61, P8440, DOI 10.1088/0031-9155/61/24/8440; Malmi E., 2015, P MICCAI BRAIN TUM S, P42; Meier R., 2015, P MULT BRAIN TUM IM, P48; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; OZKAN M, 1993, IEEE T MED IMAGING, V12, P534, DOI 10.1109/42.241881; Pereira S., 2015, P MICCAI WORKSH MULT, P52; Sachdeva J, 2016, APPL SOFT COMPUT, V47, P151, DOI 10.1016/j.asoc.2016.05.020; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Subudhi BN, 2016, MAGN RESON IMAGING, V34, P1292, DOI 10.1016/j.mri.2016.07.002; Tsao MN, 2012, PRACT RADIAT ONCOL, V2, P210, DOI 10.1016/j.prro.2011.12.004; Vaidhya K., 2015, P MULT BRAIN TUM IM, P60; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298; Wardak Z, 2016, J NEURO-ONCOL, V128, P251, DOI 10.1007/s11060-016-2103-3; Zhang N, 2011, COMPUT VIS IMAGE UND, V115, P256, DOI 10.1016/j.cviu.2010.09.007	34	81	87	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185844	10.1371/journal.pone.0185844	http://dx.doi.org/10.1371/journal.pone.0185844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985229	Green Published, gold			2022-12-27	WOS:000412493000011
J	Sabra, S; Malmqvist, E; Saborit, A; Gratacos, E; Roig, MDG				Sabra, Sally; Malmqvist, Ebba; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores			Heavy metals exposure levels and their correlation with different clinical forms of fetal growth restriction	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BIRTH-WEIGHT; ARSENIC EXPOSURE; GESTATIONAL-AGE; LEAD-EXPOSURE; ENVIRONMENTAL EXPOSURE; PLACENTAL-TRANSFER; DNA METHYLATION; PREGNANT-WOMEN; TRACE-ELEMENTS	Background Prenatal heavy metals exposure has shown a negative impact on birth weight. However, their influence on different clinical forms of fetal smallness was never assessed. Objectives To investigate whether there is a differential association between heavy metals exposure and fetal smallness subclassification into intrauterine growth restriction (IUGR) and small-for-gestational age (SGA). Method In this prospective case-control study, we included 178 mother-infant pairs; 96 of appropriate for gestational age (AGA) and 82 of small fetuses diagnosed in third trimester. The small ones were further subclassified into IUGR, n = 49 and SGA, n = 33. Cadmium (Cd), mercury (Hg), lead (Pb), arsenic (As) and zinc (Zn) levels were measured in the maternal and cord serum, and in the placentas of the three groups. Results Maternal serum level of Cd (p < 0.001) was higher in the small fetuses compared to AGA. Fetal serum level of Cd (p < 0.001) was increased in the small fetuses compared to AGA. Fetal serum level of Hg (p < 0.05) showed an increase in SGA compared to both IUGR and AGA. Fetal serum level of Zn was increased in the AGA (p < 0.001) compared to each of the small fetuses groups. Only differences in the levels between the small fetuses' subgroups were detected in the fetal serum levels of Cd and Hg. Fetal birth weight was negatively correlated with the fetal serum level of Cd (p < 0.001). No differences in the placental heavy metal levels were observed among the groups. Conclusion Fetal serum levels of Cd showed differential correlation between small fetuses' clinical subclassification, which together with the increased Cd levels in both maternal and fetal serum of the small fetuses reinforce the negative influence of heavy metals on birth weight. These findings provide more opportunities to verify the role of heavy metals exposure in relation to small fetuses' subclassification.	[Sabra, Sally; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores] Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med, Hosp St Joan Deu, BCNatal, Barcelona, Spain; [Sabra, Sally; Saborit, Alicia; Gratacos, Eduard; Gomez Roig, Maria Dolores] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Malmqvist, Ebba] Lund Univ, Occupat & Environm Med, Lund, Sweden; [Gratacos, Eduard] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Gratacos, Eduard] Ctr Biomed Res Rare Dis, Barcelona, Spain; [Gomez Roig, Maria Dolores] Spanish Minist Econ & Competitiveness, Hlth Res Inst Carlos III, Spanish Maternal & Child Hlth & Dev Network Ret R, Madrid, Spain; [Gomez Roig, Maria Dolores] Inst Recerca St Joan Deu, Santa Rosa 39-57, Esplugas de Llobregat, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Lund University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Spanish Ministry of Economy & Competitiveness	Roig, MDG (corresponding author), Univ Barcelona, Barcelona Ctr Maternal Fetal & Neonatal Med, Hosp St Joan Deu, BCNatal, Barcelona, Spain.; Roig, MDG (corresponding author), Univ Barcelona, Hosp Clin, Barcelona, Spain.; Roig, MDG (corresponding author), Spanish Minist Econ & Competitiveness, Hlth Res Inst Carlos III, Spanish Maternal & Child Hlth & Dev Network Ret R, Madrid, Spain.; Roig, MDG (corresponding author), Inst Recerca St Joan Deu, Santa Rosa 39-57, Esplugas de Llobregat, Spain.	lgomezroig@sjdhospitalbarcelona.org	Gratacos, Eduard/AAR-4939-2020; Roig, Maria Dolores Gómez/F-4345-2016	Gratacos, Eduard/0000-0002-7405-7224; Roig, Maria Dolores Gómez/0000-0003-2329-1851; Malmqvist, Ebba/0000-0002-5043-9789	Erasmus Programme of the European Union [2013-0040]	Erasmus Programme of the European Union	This work has been funded with support of the Erasmus Programme of the European Union (frame work agreement number: 2013-0040).	Al-Saleh I, 2014, INT J HYG ENVIR HEAL, V217, P205, DOI 10.1016/j.ijheh.2013.04.009; Al-Saleh I, 2011, INT J HYG ENVIR HEAL, V214, P79, DOI 10.1016/j.ijheh.2010.10.001; Angeli JK, 2013, FREE RADICAL BIO MED, V65, P838, DOI 10.1016/j.freeradbiomed.2013.08.167; Bamfo JEAK, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/640715; BARKER DJP, 1989, LANCET, V2, P577; Bernstein IM, 2000, AM J OBSTET GYNECOL, V182, P198, DOI 10.1016/S0002-9378(00)70513-8; Bjerregaard P, 2000, SCI TOTAL ENVIRON, V245, P195, DOI 10.1016/S0048-9697(99)00444-1; Bjerregaard P, 1996, Arctic Med Res, V55, P156; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Broberg K, 2014, J DEV ORIG HLTH DIS, V5, P288, DOI 10.1017/S2040174414000221; Brodsky Dara, 2004, J Intensive Care Med, V19, P307, DOI 10.1177/0885066604269663; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Caserta D, 2013, EUR REV MED PHARMACO, V17, P2198; CASEY CE, 1978, BRIT J NUTR, V39, P639, DOI 10.1079/BJN19780079; Chen Z, 2014, J EXPO SCI ENV EPID, V24, P537, DOI 10.1038/jes.2014.26; CLARKSON TW, 1985, SCAND J WORK ENV HEA, V11, P145, DOI 10.5271/sjweh.2239; Cornelis R, 1996, J TRACE ELEM MED BIO, V10, P103, DOI 10.1016/S0946-672X(96)80018-6; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Fiala J, 1998, Cent Eur J Public Health, V6, P241; Figueras F, 2008, EUR J OBSTET GYN R B, V136, P20, DOI 10.1016/j.ejogrb.2006.12.015; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; FRERY N, 1993, TOXICOLOGY, V79, P109, DOI 10.1016/0300-483X(93)90124-B; Grandjean P, 2001, INT J EPIDEMIOL, V30, P1272, DOI 10.1093/ije/30.6.1272; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Gundacker C, 2012, WIEN MED WOCHENSCHR, V162, P201, DOI 10.1007/s10354-012-0074-3; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Hanna CW, 2012, HUM REPROD, V27, P1401, DOI 10.1093/humrep/des038; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Harville EW, 2005, OCCUP ENVIRON MED, V62, P263, DOI 10.1136/oem.2003.012492; He WJ, 2007, TOXICOL SCI, V99, P244, DOI 10.1093/toxsci/kfm162; Hong Young-Seoub, 2014, J Prev Med Public Health, V47, P245, DOI 10.3961/jpmph.14.035; Hunt CE, 2007, ARCH DIS CHILD-FETAL, V92, P428, DOI 10.1136/adc.2006.112243; Hur J, 2013, J NUTR, V143, P67, DOI 10.3945/jn.112.161638; Ismail H, 2012, J MED ULTRASOUND, V20, P191, DOI 10.1016/j.jmu.2012.10.005; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Jiang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109984; Jin YP, 2006, ENVIRON RES, V101, P349, DOI 10.1016/j.envres.2005.11.006; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Kim BM, 2009, EUR J EPIDEMIOL, V24, P573, DOI 10.1007/s10654-009-9370-7; Kim YM, 2015, INT J ENV RES PUB HE, V12, P13482, DOI 10.3390/ijerph121013482; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; KOPP SJ, 1982, SCIENCE, V217, P837, DOI 10.1126/science.6213041; Kuhnert PM, 1982, AM J OBSTET GYNECOL, P142; Lafuente A, 2000, FOOD CHEM TOXICOL, V38, P913, DOI 10.1016/S0278-6915(00)00077-6; Lagerkvist BJ, 1996, ARCH ENVIRON HEALTH, V51, P389, DOI 10.1080/00039896.1996.9934427; Latkoczy C, 2002, J ANAL ATOM SPECTROM, V17, P1264, DOI 10.1039/b204532j; Lederman SA, 2008, ENVIRON HEALTH PERSP, V116, P1085, DOI 10.1289/ehp.10831; Lee BE, 2010, ENVIRON HEALTH PERSP, V118, P437, DOI 10.1289/ehp.0900731; Lin CM, 2011, OCCUP ENVIRON MED, V68, P641, DOI 10.1136/oem.2010.059758; Llanos MN, 2009, REPROD TOXICOL, V27, P88, DOI 10.1016/j.reprotox.2008.11.057; Longo S, 2013, J MATERN-FETAL NEO M, V26, P222, DOI 10.3109/14767058.2012.715006; Lucas M, 2004, LIPIDS, V39, P617, DOI 10.1007/s11745-004-1274-7; Markel TA, 2014, J CLIN NEONATOL, V3, P1, DOI 10.4103/2249-4847.128717; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Osman K, 2000, CLIN BIOCHEM, V33, P131, DOI 10.1016/S0009-9120(00)00052-7; PEEREBOOMSTEGEMAN JHJC, 1983, ECOTOX ENVIRON SAFE, V7, P79; Piasek M, 2001, REPROD TOXICOL, V15, P673, DOI 10.1016/S0890-6238(01)00174-5; Rahbar MH, 2015, INT J ENV RES PUB HE, V12, P4481, DOI 10.3390/ijerph120504481; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rauh Virginia A, 2010, Neoreviews, V11, P363; Rentschler G, 2014, METALLOMICS, V6, P885, DOI 10.1039/c3mt00365e; Renzetti S, 2017, ENVIRON RES, V152, P226, DOI 10.1016/j.envres.2016.10.014; Rice Kevin M, 2014, J Prev Med Public Health, V47, P74, DOI 10.3961/jpmph.2014.47.2.74; ROELS H, 1978, ENVIRON RES, V16, P236, DOI 10.1016/0013-9351(78)90159-7; SALTMAN P, 1983, ANN INTERN MED, V98, P823, DOI 10.7326/0003-4819-98-5-823; Sanders Talia, 2009, Reviews on Environmental Health, V24, P15; SCHROEDER HA, 1965, J CHRON DIS, V18, P647, DOI 10.1016/0021-9681(65)90066-4; Singh R, 2011, INDIAN J PHARMACOL, V43, P246, DOI 10.4103/0253-7613.81505; Taylor Caroline M, 2016, BMC Res Notes, V9, P291, DOI 10.1186/s13104-016-2092-5; Tchounwou P. B., 1999, Reviews on Environmental Health, V14, P211; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Tekin D, 2012, INT ARCH OCC ENV HEA, V85, P631, DOI 10.1007/s00420-011-0711-y; Thomas S, 2015, ENVIRON RES, V140, P430, DOI 10.1016/j.envres.2015.04.018; TRUSKA P, 1989, Journal of Hygiene Epidemiology Microbiology and Immunology (Prague), V33, P141; Uriu-Adams JY, 2010, BIRTH DEFECTS RES B, V89, P313, DOI 10.1002/bdrb.20264; Vejrup K, 2014, PUBLIC HEALTH NUTR, V17, P2071, DOI 10.1017/S1368980013002619; Walker JB, 2006, ENVIRON RES, V100, P295, DOI 10.1016/j.envres.2005.05.006; WIER PJ, 1990, TOXICOL APPL PHARM, V105, P156, DOI 10.1016/0041-008X(90)90367-4; Wuana Raymond A, ISRN ECOLOGY, V2011; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Zhang YL, 2004, J ENVIRON SCI HEAL A, V39, P2507, DOI [10.1081/ESE-200026331, 10.1081/lesa-200026331]	84	47	49	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185645	10.1371/journal.pone.0185645	http://dx.doi.org/10.1371/journal.pone.0185645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985223	gold, Green Published, Green Submitted			2022-12-27	WOS:000412493000007
J	Brothers, TD; Kirkland, S; Theou, O; Zona, S; Malagoli, A; Wallace, LMK; Stentarelli, C; Mussini, C; Falutz, J; Guaraldi, G; Rockwood, K				Brothers, Thomas D.; Kirkland, Susan; Theou, Olga; Zona, Stefano; Malagoli, Andrea; Wallace, Lindsay M. K.; Stentarelli, Chiara; Mussini, Cristina; Falutz, Julian; Guaraldi, Giovanni; Rockwood, Kenneth			Predictors of transitions in frailty severity and mortality among people aging with HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM MORTALITY; INJECTION-DRUG USE; DEFICIT ACCUMULATION; OLDER-ADULTS; INFECTED PERSONS; CLINICAL FRAILTY; ELDERLY SUBJECTS; AGE; DISEASE	Background People aging with HIV show variable health trajectories. Our objective was to identify longitudinal predictors of frailty severity and mortality among a group aging with HIV. Methods Exploratory analyses employing a multistate transition model, with data from the prospective Modena HIV Metabolic Clinic Cohort Study, based in Northern Italy, begun in 2004. Participants were followed over four years from their first available visit. We included all 963 participants (mean age 46.8 +/- 7.1; 29% female; 89% undetectable HIV viral load; median current CD4 count 549, IQR 405-720; nadir CD4 count 180, 81-280) with four-year data. Frailty was quantified using a 31-item frailty index. Outcomes were frailty index score or mortality at four-year follow-up. Candidate predictor variables were baseline frailty index score, demographic (age, sex), HIV-disease related (undetectable HIV viral load, current CD4+ T-cell count, nadir CD4 count, duration of HIV infection, and duration of antiretroviral therapy [ ARV] exposure), and behavioral factors (smoking, injection drug use (IDU), and hepatitis C virus co-infection). Results Four-year mortality was 3.0% (n = 29). In multivariable analyses, independent predictors of frailty index at follow-up were baseline frailty index (RR 1.06, 95% CI 1.05-1.07), female sex (RR 0.93, 95% CI 0.87-0.98), nadir CD4 cell count (RR 0.96, 95% CI 0.93-0.99), duration of HIV infection (RR 1.06, 95% CI 1.01-1.12), duration of ARV exposure (RR 1.08, 95% CI 1.02-1.14), and smoking pack-years (1.03, 1.01-1.05). Independent predictors of mortality were baseline frailty index (OR 1.19, 1.02-1.38), current CD4 count (0.34, 0.20-0.60), and IDU (2.89, 1.30-6.42). Conclusions Demographic, HIV-disease related, and social and behavioral factors appear to confer risk for changes in frailty severity and mortality among people aging with HIV.	[Brothers, Thomas D.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Kirkland, Susan] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Theou, Olga; Wallace, Lindsay M. K.; Rockwood, Kenneth] Dalhousie Univ, Dept Med, Div Geriatr Med, Halifax, NS, Canada; [Zona, Stefano; Malagoli, Andrea; Stentarelli, Chiara; Mussini, Cristina; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Adults & Children, Clin Infect Dis, Modena, Emilia Romagna, Italy; [Falutz, Julian] McGill Univ, Hosp Ctr, Montreal, PQ, Canada; [Rockwood, Kenneth] Nova Scotia Hlth Author, Ctr Hlth Care Elderly, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Universita di Modena e Reggio Emilia; McGill University	Rockwood, K (corresponding author), Dalhousie Univ, Dept Med, Div Geriatr Med, Halifax, NS, Canada.; Rockwood, K (corresponding author), Nova Scotia Hlth Author, Ctr Hlth Care Elderly, Halifax, NS, Canada.	kenneth.rockwood@dal.ca	Rockwood, Kenneth/AAD-8951-2019; Mussini, Cristina/K-8672-2016; Theou, Olga/AAS-9923-2020; Brothers, Thomas/ABH-5700-2020; Guaraldi, Giovanni/J-9467-2018; Malagoli, Andrea/I-7744-2015	Mussini, Cristina/0000-0002-6615-4198; Theou, Olga/0000-0001-6460-782X; Brothers, Thomas/0000-0002-5570-5556; Zona, Stefano/0000-0003-3451-2744; Malagoli, Andrea/0000-0001-7857-4133; Kirkland, Susan/0000-0002-8182-2369	Canadian Institutes of Health Research; Dalhousie University Internal Medicine Research Foundation; Co-morbidity in relation to AIDS [305522]; European Union; Dalhousie Medical Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dalhousie University Internal Medicine Research Foundation; Co-morbidity in relation to AIDS; European Union(European Commission); Dalhousie Medical Research Foundation	TDB was supported by a Canadian Institutes of Health Research Summer Research Studentship and an award from the Dalhousie University Internal Medicine Research Foundation. GG was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. KR is supported by the Dalhousie Medical Research Foundation through the Kathryn Allen Weldon Chain in Alzheimer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TDB was supported by a Canadian Institutes of Health Research Summer Research Studentship and an award from the Dalhousie University Internal Medicine Research Foundation. GG was partially supported by 'Co-morbidity in relation to AIDS' grant agreement (305522), European Union Seventh Framework. KR is supported by the Dalhousie Medical Research Foundation through the Kathryn Allen Weldon Chair in Alzheimer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2014, J GERONTOL A-BIOL, V69, P189, DOI 10.1093/gerona/glt148; Brothers TD, 2014, J INFECT DIS, V210, P1170, DOI 10.1093/infdis/jiu258; Brothers TD, 2014, CURR OPIN HIV AIDS, V9, P412, DOI 10.1097/COH.0000000000000070; Cacciatore F, 2013, ACTA DIABETOL, V50, P251, DOI 10.1007/s00592-012-0413-2; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Desquilbet L, 2011, J GERONTOL A-BIOL, V66, P1030, DOI 10.1093/gerona/glr097; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Erlandson KM, 2014, CURR HIV-AIDS REP, V11, P279, DOI 10.1007/s11904-014-0215-y; Escota GV, 2015, AIDS RES HUM RETROV, V31, P313, DOI [10.1089/aid.2014.0225, 10.1089/AID.2014.0225]; Galizia G, 2011, AGING CLIN EXP RES, V23, P118, DOI 10.1007/BF03351076; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Guaraldi G., 2017, HIV MED; Guaraldi G, 2006, HIV CLIN TRIALS, V7, P97, DOI 10.1310/EYWJ-8B5K-X7VQ-9CPE; Guaraldi G, 2015, AIDS, V29, P1633, DOI 10.1097/QAD.0000000000000753; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hessol NA, 2017, AIDS BEHAV, P1; Levett T, 2017, SEX TRANSM INFECT; Levett TJ, 2016, J AM GERIATR SOC, V64, P1006, DOI 10.1111/jgs.14101; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazzella F, 2010, ARCH GERONTOL GERIAT, V51, P323, DOI 10.1016/j.archger.2010.01.011; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski AB, 2017, BIOGERONTOLOGY, V2, P1; Mitnitski A, 2017, J GERONTOL A-BIOL, V72, P877, DOI 10.1093/gerona/glw089; Mitnitski A, 2015, INTERD T GERONT GERI, V40, P85, DOI 10.1159/000364933; Mitnitski A, 2014, J GERONTOL A-BIOL, V69, P295, DOI 10.1093/gerona/glt137; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Mitnitski AB, 2014, STAT METHODS MED RES, V23, P244, DOI 10.1177/0962280211406470; Molsberry SA, 2015, AIDS, V29, P713, DOI 10.1097/QAD.0000000000000561; Pajewski NM, 2016, J GERONTOL A-BIOL, V71, P649, DOI 10.1093/gerona/glv228; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Piggott DA, 2017, J GERONTOL A-BIOL, V72, P389, DOI 10.1093/gerona/glw142; Piggott DA, 2016, CURR HIV-AIDS REP, V13, P340, DOI 10.1007/s11904-016-0334-8; Piggott DA, 2015, J GERONTOL A-BIOL, V70, P1542, DOI 10.1093/gerona/glv107; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Richert L, 2014, AIDS, V28, P1441, DOI 10.1097/QAD.0000000000000246; Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271; Rockwood K, 2011, CLIN GERIATR MED, V27, P17, DOI 10.1016/j.cger.2010.08.008; Rodriguez-Manas L, 2015, LANCET, V385, pE7, DOI 10.1016/S0140-6736(14)61595-6; Sangarlangkarn A, 2016, J AM GERIATR SOC, V64, P2322, DOI 10.1111/jgs.14584; Saum KU, 2014, EUR J EPIDEMIOL, V29, P171, DOI 10.1007/s10654-014-9891-6; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Smit E, 2015, J FRALITY AGING, V4, P191, DOI 10.14283/jfa.2015.50; Steinsaltz D, 2012, EXP GERONTOL, V47, P792, DOI 10.1016/j.exger.2012.06.007; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Theou O, 2014, J AM GERIATR SOC, V62, P901, DOI 10.1111/jgs.12773; Theou O, 2013, J AM GERIATR SOC, V61, P1537, DOI 10.1111/jgs.12420; Wallace LMK, 2017, AIDS RES HUM RETROV, V33, P157, DOI [10.1089/aid.2016.0189, 10.1089/AID.2016.0189]; Wang CX, 2014, J AM GERIATR SOC, V62, P821, DOI 10.1111/jgs.12792; Zhang W, 2015, J GERONTOL A-BIOL	53	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185352	10.1371/journal.pone.0185352	http://dx.doi.org/10.1371/journal.pone.0185352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981535	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300035
J	Coccia, E; Calleja-Yague, I; Planells-Ferrer, L; Sanuy, B; Sanz, B; Lopez-Soriano, J; Moubarak, RS; Munell, F; Barneda-Zahonero, B; Comella, JX; Perez-Garcia, MJ				Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Munell, Francina; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.			Identification and characterization of new isoforms of human fas apoptotic inhibitory molecule (FAIM)	PLOS ONE			English	Article							OPEN READING FRAMES; NERVOUS-SYSTEM; CELL-DEATH; LONG FORM; EXPRESSION; PROTEIN; NEUROGENESIS; PREDICTION; MECHANISM; DISEASE	Fas Apoptosis Inhibitory Molecule (FAIM) is an evolutionarily highly conserved death receptor antagonist, widely expressed and known to participate in physiological and pathological processes. Two FAIM transcript variants have been characterized to date, namely FAIM short (FAIM-S) and FAIM long (FAIM-L). FAIM-S is ubiquitously expressed and serves as an anti-apoptotic protein in the immune system. Furthermore, in neurons, this isoform promotes NGF-induced neurite outgrowth through NF-kappa B and ERK signaling. In contrast FAIM-L is found only in neurons, where it exerts anti-apoptotic activity against several stimuli. In addition to these two variants, in silico studies point to the existence of two additional isoforms, neither of which have been characterized to date. In this regard, here we confirm the presence of these two additional FAIM isoforms in human fetal brain, fetal and adult testes, and placenta tissues. We named them FAIM-S_2a and FAIM-L_2a since they have the same sequence as FAIM-S and FAIM-L, but include exon 2a. PCR and western blot revealed that FAIM-S_2a shows ubiquitous expression in all the tissues and cellular models tested, while FAIM-L_2a is expressed exclusively in tissues of the nervous system. In addition, we found that, when overexpressed in non-neuronal cells, the splicing factor nSR100 induces the expression of the neuronal isoforms, thus identifying it as responsible for the generation of FAIM-L and FAIM-L_2a. Functionally, FAIM-S_2a and FAIM-L_2a increased neurite outgrowth in response to NGF stimulation in a neuronal model. This observation thus, supports the notion that these two isoforms are involved in neuronal differentiation. Furthermore, subcellular fractionation experiments revealed that, in contrast to FAIM-S and FAIM-L, FAIM-S_2a and FAIM-L_2a are able to localize to the nucleus, where they may have additional functions. In summary, here we report on two novel FAIM isoforms that may have relevant roles in the physiology and pathology of the nervous system.	[Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] VHIR, Cell Signaling & Apoptosis Grp, Barcelona, Spain; [Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] ISCIII, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Coccia, Elena; Calleja-Yague, Isabel; Planells-Ferrer, Laura; Sanuy, Blanca; Sanz, Belen; Lopez-Soriano, Joaquin; Moubarak, Rana S.; Barneda-Zahonero, Bruna; Comella, Joan X.; Jose Perez-Garcia, M.] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurosci, Bellaterra, Spain; [Munell, Francina] VHIR, Pediat Neurol Grp, Barcelona, Spain; [Sanz, Belen] Spanish Natl Canc Res Ctr CNIO, Cell Div, Madrid, Spain; [Sanz, Belen] Spanish Natl Canc Res Ctr CNIO, Canc Grp, Madrid, Spain; [Moubarak, Rana S.] NYU, Langone Med Ctr, Dept Pathol, New York, NY USA	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBERNED; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); New York University; NYU Langone Medical Center	Comella, JX; Perez-Garcia, MJ (corresponding author), VHIR, Cell Signaling & Apoptosis Grp, Barcelona, Spain.; Comella, JX; Perez-Garcia, MJ (corresponding author), ISCIII, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.; Comella, JX; Perez-Garcia, MJ (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, Inst Neurosci, Bellaterra, Spain.	joan.comella@vhir.org; maria.perez@vhir.org	Lopez-Soriano, Joaquin/AAB-7459-2019; Comella, Joan X/D-7333-2012; Comella, Joan/GQA-4279-2022	Comella, Joan X/0000-0002-6218-0786; Coccia, Elena/0000-0002-9849-2423; Barneda Zahonero, Bruna/0000-0002-6557-5222; Lopez-Soriano, Joaquin/0000-0002-5374-2222; Munell Casadesus, Francina/0000-0001-8580-2819; Moubarak, Rana/0000-0003-2096-1258	Spanish Government "Ministerio de Economia y Competitividad" [SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104, PIE13/00027]; Generalitat de Catalunya [2014SGR1609]; Fundacio La Marato de TV3 [201414-30]; Spanish "Ministerio de Economia y Competitividad" [SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104, PIE13/00027];  [BES-2014-069550]	Spanish Government "Ministerio de Economia y Competitividad"(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio La Marato de TV3; Spanish "Ministerio de Economia y Competitividad"(Spanish Government); 	This work was funded by the Spanish Government "Ministerio de Economia y Competitividad" (SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104 and PIE13/00027), Generalitat de Catalunya (2014SGR1609), and Fundacio La Marato de TV3 (201414-30) to JXC. Fellowship BES-2014-069550 to IC-Y.; This work was funded by grants awarded to JXC from the Spanish "Ministerio de Economia y Competitividad" (SAF2013-47989-R, SAF2016-80236-R, CIBERNED CB06/05/1104 and PIE13/00027), the "Generalitat de Catalunya" (2014SGR1609), and the "Fundacio La Marato de TV3" (201414-30). IC-Y is a recipient of fellowship BES-2014-069550	Anko ML, 2014, SEMIN CELL DEV BIOL, V32, P11, DOI 10.1016/j.semcdb.2014.03.011; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carriba P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.6; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Evin G, 2016, BIODRUGS, V30, P173, DOI 10.1007/s40259-016-0168-3; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Guigo R, 2006, MOL CELL, V23, P150, DOI 10.1016/j.molcel.2006.07.003; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Huo J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.12; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobs SBR, 2007, CELL DEATH DIFFER, V14, P1374, DOI 10.1038/sj.cdd.4402128; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim WR, 2011, DEV GROWTH DIFFER, V53, P225, DOI 10.1111/j.1440-169X.2010.01226.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Li Q, 2014, ELIFE, V3, DOI 10.7554/eLife.01201; Martinez-Marmol R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35775; Moubarak RS, 2013, J NEUROSCI, V33, P19262, DOI 10.1523/JNEUROSCI.2479-13.2013; Planells-Ferrer L, 2016, J NEUROCHEM, V139, P11, DOI 10.1111/jnc.13729; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Raj B, 2014, MOL CELL, V56, P90, DOI 10.1016/j.molcel.2014.08.011; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Schneider TJ, 1999, J EXP MED, V189, P949, DOI 10.1084/jem.189.6.949; Segura MF, 2007, J NEUROSCI, V27, P11228, DOI 10.1523/JNEUROSCI.3462-07.2007; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Somers J, 2013, INT J BIOCHEM CELL B, V45, P1690, DOI 10.1016/j.biocel.2013.04.020; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Urresti J, 2016, J BIOL CHEM, V291, P1221, DOI 10.1074/jbc.M115.677682; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wethmar K, 2014, WIRES RNA, V5, P765, DOI 10.1002/wrna.1245; Wethmar K, 2014, NUCLEIC ACIDS RES, V42, pD60, DOI 10.1093/nar/gkt952; Zhong XM, 2001, MOL IMMUNOL, V38, P65, DOI 10.1016/S0161-5890(01)00035-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185327	10.1371/journal.pone.0185327	http://dx.doi.org/10.1371/journal.pone.0185327			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981531	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300033
J	Li, H; Chen, LP; Wang, T; Wang, SG; Liu, JH				Li, Hao; Chen, Liping; Wang, Tao; Wang, Shaogang; Liu, Jihong			The effect of cavernous nerve traction on erectile function in rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MAJOR PELVIC GANGLION; RADICAL PROSTATECTOMY; CORPUS CAVERNOSUM; GROWTH-FACTOR; NEUROTROPHIC FACTOR; DIABETIC-RATS; SMOOTH-MUSCLE; STEM-CELLS; DYSFUNCTION	We performed this study to evaluate the effect of cavernous nerve (CN) traction on erectile function in rats. Thirty-two 8-week-old Sprague-Dawley rats were divided into four groups: control, 1-minute CN traction, 2-minute CN traction, and 2-minute CN crush. CN traction was performed using a glass hook with a tensile force of 0.2 Newton. One month later, the mean arterial pressure (MAP) and intracavernosal pressure (ICP) in response to CN stimulation were measured to assess erectile function. The penis and major pelvic ganglion (MPG) were harvested to explore the expression of neuronal nitric oxide synthase (nNOS) and neurofilament, fibrosis and apoptosis. The ICP/MAP ratio was reduced in the 2-minute CN traction group compared with the control group (P < 0.05). The ICP/MAP ratio in the CN crush group was lower than in the other three groups (P < 0.05, for each). Expression of nNOS in both MPG and dorsal penile nerve was lower in the CN traction group than in the control group, but was higher than in the CN crush group (P < 0.05). Nerve fiber number in the dorsal penile nerve was reduced by 2-minute CN traction (P < 0.05). The ratios of collagen to smooth muscle content and the apoptosis were both increased the in 2-minute CN traction group compared with the control group (P < 0.05). The findings indicate that CN traction is an effective CN injury model and the injury it caused is relatively mild compared with the CN crush model.	[Li, Hao; Wang, Tao; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Li, Hao; Wang, Tao; Wang, Shaogang; Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan, Hubei, Peoples R China; [Chen, Liping] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China.; Liu, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Urol, Wuhan, Hubei, Peoples R China.	jhliu@tjh.tjmu.edu.cn	Wang, Shaogang/AGO-4944-2022	Wang, Shaogang/0000-0002-3206-1495	National Natural Science Foundation of China [81471451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grant number:81471451,URL:http://www.nsfc.gov.cn/) to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan D, 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/970363; Burnett AL, 2007, J UROLOGY, V178, P597, DOI 10.1016/j.juro.2007.03.140; Canguven O, 2008, J SEX MED, V5, P1776, DOI 10.1111/j.1743-6109.2008.00955.x; Chen Y, 2012, ASIAN J ANDROL, V14, P616, DOI 10.1038/aja.2012.22; Cho MC, 2015, J UROLOGY, V193, P1716, DOI 10.1016/j.juro.2014.10.099; DING YQ, 1993, NEUROSCI LETT, V164, P187, DOI 10.1016/0304-3940(93)90888-R; El-Sakka AI, 1998, J UROLOGY, V160, P2245, DOI 10.1016/S0022-5347(01)62304-8; Ferrini MG, 2006, UROLOGY, V68, P429, DOI 10.1016/j.urology.2006.05.011; GIULIANO FA, 1995, UROL CLIN N AM, V22, P747; Gokce A, 2015, J SEX MED, V12, P1533, DOI 10.1111/jsm.12916; Gonzalez-Cadavid NF, 2000, BIOL REPROD, V63, P704, DOI 10.1095/biolreprod63.3.704; Haglind E, 2015, EUR UROL, V68, P216, DOI 10.1016/j.eururo.2015.02.029; Hannan JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29416; Hisasue SI, 2008, INT J UROL, V15, P82, DOI 10.1111/j.1442-2042.2007.01917.x; Hsieh PS, 2003, BJU INT, V92, P470, DOI 10.1046/j.1464-410X.2003.04373.x; Hu WL, 2004, BJU INT, V94, P424, DOI 10.1111/j.1464-410X.2004.04969.x; Hu WL, 2004, ASIAN J ANDROL, V6, P111; Jin HR, 2010, J SEX MED, V7, P3351, DOI 10.1111/j.1743-6109.2010.01942.x; Jung GW, 1999, INT J IMPOT RES, V11, P227, DOI 10.1038/sj.ijir.3900426; Katz EG, 2016, UROLOGY, V89, P76, DOI 10.1016/j.urology.2015.12.021; Leungwattanakij S, 2003, J ANDROL, V24, P239; Li HX, 2016, J SEX MED, V13, P22, DOI 10.1016/j.jsxm.2015.11.008; Liao CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33040; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Moran PS, 2013, INT J UROL, V20, P312, DOI 10.1111/iju.12070; Mullerad M, 2006, J SEX MED, V3, P77, DOI 10.1111/j.1743-6109.2005.00158.x; REDDY KB, 1993, J CELL PHYSIOL, V156, P48, DOI 10.1002/jcp.1041560108; Ruan YJ, 2016, J SEX MED, V13, P778, DOI 10.1016/j.jsxm.2016.02.164; Shimizu T, 2005, INT J UROL, V12, P552, DOI 10.1111/j.1442-2042.2005.01088.x; User HM, 2003, J UROLOGY, V169, P1175, DOI 10.1097/01.ju.0000048974.47461.50; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; Wang T, 2013, J UROLOGY, V190, P790, DOI 10.1016/j.juro.2013.03.043; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Yamashita S, 2009, INT J UROL, V16, P905, DOI 10.1111/j.1442-2042.2009.02382.x; You D, 2013, PROSTATE, V73, P278, DOI 10.1002/pros.22567; Zhang X H, 1999, Asian J Androl, V1, P135; Zhang Y, 2016, ONCOTARGET, V7, P39302, DOI 10.18632/oncotarget.9909	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186077	10.1371/journal.pone.0186077	http://dx.doi.org/10.1371/journal.pone.0186077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982169	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300118
J	Mekonnen, E; Bekele, E				Mekonnen, Ephrem; Bekele, Endashaw			An ancestral human genetic variant linked to an ancient disease: A novel association of FMO2 polymorphisms with tuberculosis (TB) in Ethiopian populations provides new insight into the differential ethno-geographic distribution of FMO2*1	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MYCOBACTERIUM-TUBERCULOSIS; OXYGENATION; ETHIONAMIDE; FREQUENCY; EVOLUTION; PATTERN; MOUSE	The human FMO2 (flavin-containing monooxygenase 2) gene has been shown to be involved in innate immunity against microbial infections, including tuberculosis (TB), via the modulation of oxidative stress levels. It has also been found to possess a curious loss-of-function mutation (FMO2*1/FMO2*2) that demonstrates a distinctive differentiation in expression, function and ethno-geographic distribution. However, despite evidences of ethnic-specific genetic associations in the inflammatory profile of TB, no studies were done to investigate whether these patterns of variations correlate with evidences for the involvement of FMO2 in antimicrobial immune responses and ethnic differences in the distribution of FMO2 polymorphisms except for some pharmacogenetic data that suggest a potentially deleterious role for the functional variant (FMO2* 1). This genetic epidemiological study was designed to investigate whether there is an association between FMO2 polymorphisms and TB, an ancient malady that remains a modern global health concern, in a sub-Saharan Africa setting where there is not only a relatively high co-prevalence of the disease and the ancestral FMO2* 1 variant but also where both Mycobcaterium and Homo sapiens are considered to have originated and co-evolved. Blood samples and TB related clinical data were collected from ascertained TB cases and unrelated household controls (n = 292) from 3 different ethnic groups in Ethiopia. Latent Mtb infection was determined using Quantiferon to develop reliable TB progression phenotypes. We sequenced exonic regions of FMO2. We identified for the first time an association between FMO2 and TB both at the SNP and haplotype level. Two novel SNPs achieved a study-wide significance [chr1:171181877(A), p = 3.15E-07, OR = 4.644 and chr1:171165749(T), p = 3.32E-06, OR = 6.825] while multiple SNPs (22) showed nominal signals. The pattern of association suggested a protective effect of FMO2 against both active and latent TB with distinct genetic variants underlying the TB-progression pathway. The results were robust for population stratification. Haplotype-based tests confirmed the SNP-based results with a single haplotype bearing the ancestral-and-functional FMO2*1 ("c") under bar allele ("AGCTCTACAATCCCCTCGTTGCGC") explaining the overall association (haplotype-specific-p = 0.000103). Strikingly, not only was FMO2*1 nominally associated with reduced risk to "Active TB" (p = 0.0118, OR = 0.496) but it also does not co-segregate with the 5'-3' flanking top high-TB-risk alleles. The study provides an evidence for the existence of an evolutionary adaptation to an ancient disease based on an ancestral genetic variant acting in a haplotypic framework in Ethiopian populations.	[Mekonnen, Ephrem; Bekele, Endashaw] Addis Ababa Univ, Dept Microbial Cellular Mol Biol, Addis Ababa, Ethiopia; [Mekonnen, Ephrem] Addis Ababa Univ, Inst Biotechnol, Dept Hlth Biotechnol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Mekonnen, E (corresponding author), Addis Ababa Univ, Dept Microbial Cellular Mol Biol, Addis Ababa, Ethiopia.; Mekonnen, E (corresponding author), Addis Ababa Univ, Inst Biotechnol, Dept Hlth Biotechnol, Addis Ababa, Ethiopia.	ephrememuti@gmail.com		Mekonnen, Ephrem/0000-0003-0416-649X	C.S. (National Institutes of Health) [R01HL096811]	C.S. (National Institutes of Health)	This study was in part funded by C.S. (grant # R01HL096811, National Institutes of Health).	Abate D, 2014, INT J TUBERC LUNG D, V18, P946, DOI 10.5588/ijtld.13.0926; Agonafir M, 2010, INT J TUBERC LUNG D, V14, P1259; Akiibinu M. O., 2011, European Journal of General Medicine, V8, P213; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Comas I, 2015, CURR BIOL, V25, P3260, DOI 10.1016/j.cub.2015.10.061; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; Delgado JC, 2002, J INFECT DIS, P186; Dolphin CT, 1998, J BIOL CHEM, V273, P30599, DOI 10.1074/jbc.273.46.30599; Francois AA, 2009, DRUG METAB DISPOS, V37, P178, DOI 10.1124/dmd.108.024158; Gagneux S., 2012, PHIL T R SOC B, P367; Gebretsadik G, 2015, J TUBERCULOSIS RES, V3, P63, DOI DOI 10.4236/JTR.2015.33010; Hao D, 2009, GENETICA, V137, P173, DOI 10.1007/s10709-009-9382-y; Hao DC, 2011, CHINESE SCI BULL, V56, P1246, DOI 10.1007/s11434-011-4380-8; Henderson MC, 2008, TOXICOL APPL PHARM, V233, P420, DOI 10.1016/j.taap.2008.09.017; Henderson MC, 2004, CHEM RES TOXICOL, V17, P633, DOI 10.1021/tx034253s; Hernandez D, 2004, PHARMACOGENETICS, V14, P117, DOI 10.1097/00008571-200402000-00006; I Verma, 2014, STUDIES RESP DISORDE, P101, DOI [10.1007/978-1-4939-0497-6_6., DOI 10.1007/978-1-4939-0497-6_6]; Kreuger SK, 2005, PHARMACOL THERAPEUT, V106, P3; Krueger Sharon K, 2005, Pharmacogenet Genomics, V15, P245, DOI 10.1097/01213011-200504000-00008; Krueger SK, 2004, DRUG METAB DISPOS, V32, P1337, DOI 10.1124/dmd.104.001099; Liu N, 2008, ADV GENETICS, V60; Moses A. O., 2008, European Journal of General Medicine, V5, P208; Oyedeji SO, 2013, GREENER J MED SCI, V3, P228; Palmer AL, 2012, PHARMACEUTICALS, V5, P1147, DOI 10.3390/ph5111147; Pawar BD, 2011, BIOMED RES-INDIA, V22, P455; Purcell S, 2005, DOCUMENTATION TOOLSE; Ramachandran G, 2012, PHARMACOGN PERS MED, V5, P89, DOI 10.2147/PGPM.S15454; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Siddens LK, 2014, BIOCHEM PHARMACOL, V89, P141, DOI 10.1016/j.bcp.2014.02.006; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Veeramah KR, 2008, PHARMACOGENET GENOM, V18, P877, DOI 10.1097/FPC.0b013e3283097311; Whetstine JR, 2000, TOXICOL APPL PHARM, V168, P216, DOI 10.1006/taap.2000.9050; Zhang J, 2006, DRUG METAB DISPOS, V34, P19, DOI 10.1124/dmd.105.006171	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184931	10.1371/journal.pone.0184931	http://dx.doi.org/10.1371/journal.pone.0184931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981537	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300024
J	Merchant, M; Moffat, J; Schaefer, G; Chan, J; Wang, X; Orr, C; Cheng, J; Hunsaker, T; Shao, L; Wang, SJ; Wagle, MC; Lin, E; Haverty, PM; Shahidi-Latham, S; Ngu, H; Solon, M; Eastham-Anderson, J; Koeppen, H; Huang, SMA; Schwarz, J; Belvin, M; Kirouac, D; Junttila, MR				Merchant, Mark; Moffat, John; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Wang, Stephanie J.; Wagle, Marie-Claire; Lin, Eva; Haverty, Peter M.; Shahidi-Latham, Sheerin; Ngu, Hai; Solon, Margaret; Eastham-Anderson, Jeffrey; Koeppen, Hartmut; Huang, Shih-Min A.; Schwarz, Jacob; Belvin, Marcia; Kirouac, Daniel; Junttila, Melissa R.			Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors	PLOS ONE			English	Article							NEGATIVE-FEEDBACK; PHOSPHORYLATION SITES; KINASE CASCADE; MAPK PATHWAY; RESISTANCE; BRAF; CANCER; KRAS; ACTIVATION; IDENTIFICATION	Mitogen-activated protein kinase (MAPK) pathway dysregulation is implicated in >30% of all cancers, rationalizing the development of RAF, MEK and ERK inhibitors. While BRAF and MEK inhibitors improve BRAF mutant melanoma patient outcomes, these inhibitors had limited success in other MAPK dysregulated tumors, with insufficient pathway suppression and likely pathway reactivation. In this study we show that inhibition of either MEK or ERK alone only transiently inhibits the MAPK pathway due to feedback reactivation. Simultaneous targeting of both MEK and ERK nodes results in deeper and more durable suppression of MAPK signaling that is not achievable with any dose of single agent, in tumors where feedback reactivation occurs. Strikingly, combined MEK and ERK inhibition is synergistic in RAS mutant models but only additive in BRAF mutant models where the RAF complex is dissociated from RAS and thus feedback productivity is disabled. We discovered that pathway reactivation in RAS mutant models occurs at the level of CRAF with combination treatment resulting in a markedly more active pool of CRAF. However, distinct from single node targeting, combining MEK and ERK inhibitor treatment effectively blocks the downstream signaling as assessed by transcriptional signatures and phospho-p90RSK. Importantly, these data reveal that MAPK pathway inhibitors whose activity is attenuated due to feedback reactivation can be rescued with sufficient inhibition by using a combination of MEK and ERK inhibitors. The MEK and ERK combination significantly suppresses MAPK pathway output and tumor growth in vivo to a greater extent than the maximum tolerated doses of single agents, and results in improved anti-tumor activity in multiple xenografts as well as in two Kras mutant genetically engineered mouse (GEM) models. Collectively, these data demonstrate that combined MEK and ERK inhibition is functionally unique, yielding greater than additive anti-tumor effects and elucidates a highly effective combination strategy in MAPK-dependent cancer, such as KRAS mutant tumors.	[Merchant, Mark; Schaefer, Gabriele; Chan, Jocelyn; Wang, Xi; Orr, Christine; Cheng, Jason; Hunsaker, Thomas; Shao, Lily; Junttila, Melissa R.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Moffat, John] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Wang, Stephanie J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Wagle, Marie-Claire; Huang, Shih-Min A.] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Lin, Eva] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Haverty, Peter M.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Shahidi-Latham, Sheerin] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Ngu, Hai; Eastham-Anderson, Jeffrey; Koeppen, Hartmut] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Solon, Margaret; Schwarz, Jacob] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Belvin, Marcia] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA; [Kirouac, Daniel] Genentech Inc, Dept Preclin & Translat Pharmacokinet, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Junttila, MR (corresponding author), Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA.	junttila.melissa@gene.com		wagle, Marie-Claire/0000-0002-8657-1538; /0000-0002-7789-2049; Schaefer, Gabriele/0000-0001-9727-3555	Genentech	Genentech(Roche HoldingGenentech)	Genentech provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andersson CR, HIGH THROUGHPUT SCRE, P37; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Blake JF, 2016, J MED CHEM, V59, P5650, DOI 10.1021/acs.jmedchem.6b00389; Blake JF, PREPARATION AMINOPYR; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Chan GKY, 2016, JALA-J LAB AUTOM, V21, P125, DOI 10.1177/2211068215593759; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Friday BB, 2008, CLIN CANCER RES, V14, P342, DOI 10.1158/1078-0432.CCR-07-4790; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Junttila MR, 2015, MOL CANCER THER, V14, P40, DOI 10.1158/1535-7163.MCT-14-0030; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; LANGLOIS WJ, 1995, J BIOL CHEM, V270, P25320, DOI 10.1074/jbc.270.43.25320; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rebecca VW, 2014, PIGM CELL MELANOMA R, V27, P1154, DOI 10.1111/pcmr.12303; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sever R, 2015, COLD SPRING HARB PER, V5, P5; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Weekes CD, AACR ANN M 2017 WASH; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	49	51	51	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185862	10.1371/journal.pone.0185862	http://dx.doi.org/10.1371/journal.pone.0185862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982154	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300076
J	Na, KI; Jeoung, JW; Lee, WJ; Kim, YK; Kim, CY; Park, KH				Na, Kyeong Ik; Jeoung, Jin Wook; Lee, Won June; Kim, Young Kook; Kim, Chan Yun; Park, Ki Ho		Korean Ophthalmologic Soc	Prevalence of retinal nerve fiber layer defects: The Korea National Health and Nutrition Examination Survey 2008-2012	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; OPTIC DISC HEMORRHAGE; VISUAL-FIELD DEFECTS; RISK-FACTORS; DIABETIC-RETINOPATHY; PANRETINAL PHOTOCOAGULATION; COHERENCE TOMOGRAPHY; INSULIN-RESISTANCE; VEIN OCCLUSION	Purpose To investigate the prevalence and associated factors of retinal nerve fiber layer defects (RNFLDs) in a Korean population. Methods The Korea National Health and Nutrition Examination Survey (KNHANES) is a population-based study using a complex, stratified, multistage, probability-cluster survey. We performed a review of 2008-2012 data from the KNHANES. Two masked ophthalmologists evaluated fundus photography to detect RNFLDs. All participants underwent ocular and systemic evaluations. Results A total of 28,637 subjects aged >= 19 years with at least one evaluable fundus photograph were enrolled. The estimated prevalence of RNFLDs in this Korean population was 4.8% (95% confidence interval, 4.4%-5.3%). The estimated percentages of glaucomatous RNFLD and non-glaucomatous RNFLD subjects were 34.4% and 65.6%, respectively. In a multivariate analysis, the prevalence of RNFLDs was significantly associated with older age (P < 0.001), male gender (P = 0.047), glycosylated hemoglobin (P = 0.048), disc hemorrhage (P = 0.016), ISNT rule (P < 0.001), and vertical cup to disc ratio (P < 0.001). Conclusions The prevalence of RNFLDs in a large Korean population-based sample with a minimum age of 19 years was 4.8%. RNFLD prevalence was associated with old age, male gender, glycosylated hemoglobin, disc hemorrhage, and glaucomatous optic disc.	[Na, Kyeong Ik] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Ophthalmol, Seoul, South Korea; [Jeoung, Jin Wook; Lee, Won June; Kim, Young Kook; Park, Ki Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Kim, Chan Yun] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System	Jeoung, JW; Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	neuroprotect@gmail.com; kihopark@snu.ac.kr	Lee, Won June/Y-8207-2018	Lee, Won June/0000-0002-3506-7139; Kim, Young Kook/0000-0002-6037-8449; Na, Kyeong Ik/0000-0002-0951-9162				AIRAKSINEN PJ, 1981, ACTA OPHTHALMOL, V59, P627, DOI 10.1111/j.1755-3768.1981.tb08728.x; Alencar Luciana M, 2007, Semin Ophthalmol, V22, P103, DOI 10.1080/08820530701420058; Chaum E, 2001, J NEURO-OPHTHALMOL, V21, P276, DOI 10.1097/00041327-200112000-00010; CHIHARA E, 1991, GRAEF ARCH CLIN EXP, V229, P13, DOI 10.1007/BF00172255; CHIHARA E, 1993, OPHTHALMOLOGY, V100, P1147; Cho HK, 2012, AM J OPHTHALMOL, V154, P958, DOI 10.1016/j.ajo.2012.05.025; Demir MN, 2009, EUR J OPHTHALMOL, V19, P1034, DOI 10.1177/112067210901900621; GUPTA P, 2016, INVEST OPHTH VIS SCI, V57, P2577; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; HOYT WF, 1972, BRIT J OPHTHALMOL, V56, P577, DOI 10.1136/bjo.56.8.577; Hu XX, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0322-1; Hwang JM, 2006, J GLAUCOMA, V15, P223, DOI 10.1097/01.ijg.0000212218.96932.f7; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeon SJ, 2016, INVEST OPHTH VIS SCI, V57, P4008, DOI 10.1167/iovs.16-19525; Jiang XJ, 2012, OPHTHALMOLOGY, V119, P2245, DOI 10.1016/j.ophtha.2012.05.030; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P285, DOI 10.1136/bjo.78.4.285; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Katz BJ, 2006, AM J OPHTHALMOL, V141, P248, DOI 10.1016/j.ajo.2005.09.029; Kim J, 2012, RETINA-J RET VIT DIS, V32, P2052, DOI 10.1097/IAE.0b013e3182562000; Kim KE, 2016, OPHTHALMOLOGY, V123, P532, DOI 10.1016/j.ophtha.2015.11.004; Kim M, 2011, INVEST OPHTH VIS SCI, V52, P6882, DOI 10.1167/iovs.11-7276; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; Lee SB, 2013, RETINA-J RET VIT DIS, V33, P188, DOI 10.1097/IAE.0b013e318261a710; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; LOCKWOOD A, 1992, LANCET, V340, P1100, DOI 10.1016/0140-6736(92)93123-5; Lucy M, 2002, OPHTHALMOLOGY, V109, P2232, DOI 10.1016/S0161-6420(02)01248-4; Ma Jin, 2013, Zhonghua Yan Ke Za Zhi, V49, P514; de Alencar LPM, 2007, CLINICS, V62, P197, DOI 10.1590/S1807-59322007000200016; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; Oray M, 2015, AM J OPHTHALMOL, V159, P475, DOI 10.1016/j.ajo.2014.11.029; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; QUIGLEY HA, 1993, OPHTHALMOLOGY, V100, P1800; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Stewart RMK, 2008, AM J OPHTHALMOL, V145, P394, DOI 10.1016/j.ajo.2007.11.005; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Suh MH, 2011, CLIN EXP OPHTHALMOL, V39, P513, DOI 10.1111/j.1442-9071.2010.02482.x; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Takis A, 2014, CLIN OPHTHALMOL, V8, P455, DOI 10.2147/OPTH.S47762; Vijaya L, 2008, OPHTHALMOLOGY, V115, P648, DOI 10.1016/j.ophtha.2007.04.062; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Ye C, 2011, OPHTHALMOLOGY, V118, P2196, DOI 10.1016/j.ophtha.2011.03.035; Zhang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062022; Zhao L, 2013, ABSTR APPL ANAL, V2013, P8, DOI [DOI 10.1371/J0URNAL.P0NE.0063928, DOI 10.1155/2013/812143]; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186032	10.1371/journal.pone.0186032	http://dx.doi.org/10.1371/journal.pone.0186032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982124	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300113
J	Paul-Victor, C; Vacche, SD; Sordo, F; Fink, S; Speck, T; Michaud, V; Speck, O				Paul-Victor, Cloe; Vacche, Sara Dalle; Sordo, Federica; Fink, Siegfried; Speck, Thomas; Michaud, Veronique; Speck, Olga			Effect of mechanical damage and wound healing on the viscoelastic properties of stems of flax cultivars (Linum usitatissimum L. cv. Eden and cv. Drakkar)	PLOS ONE			English	Article							WALL-ASSOCIATED PEROXIDASES; FIBERS; HISTOCHEMISTRY; DEPOSITION; BEHAVIOR; LIGNIN; GROWTH	As plant fibres are increasingly used in technical textiles and their composites, underlying principles of wound healing in living plant fibres are relevant to product quality, and provide inspiration for biomimetic healing in synthetic materials. In this work, two Linum usitatissimum cultivars differing in their stem mechanical properties, cv. Eden (stems resistant to lodging) and cv. Drakkar (with more flexible stems), were grown without wound or with stems previously wounded with a cut parallel or transversal to the stem. To investigate wound healing efficiency, growth traits, stem biomechanics with Dynamic Mechanical Analysis and anatomy were analysed after 25-day recovery. Longitudinal incisions formed open wounds while transversal incisions generated stem growth restoring the whole cross-section but not the original stem organisation. In the case of transversal wound healing, all the bast fibre bundles in the perturbed area became lignified and pulled apart by parenchyma cells growth. Both Linum cultivars showed a healing efficiency from 79% to 95% with higher scores for transversal healing. Morphological and anatomical modifications of Linum were related to mechanical properties and healing ability. Alongside with an increased understanding of wound healing in plants, our results highlight their possible impact on textile quality and fibre yield.	[Paul-Victor, Cloe; Speck, Thomas; Speck, Olga] Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany; [Paul-Victor, Cloe; Speck, Thomas; Speck, Olga] Freiburg Mat Res Ctr FMF, Freiburg, Germany; [Vacche, Sara Dalle; Sordo, Federica; Michaud, Veronique] Ecole Polytech Fed Lausanne, Inst Mat, LPAC, Lausanne, Switzerland; [Fink, Siegfried] Univ Freiburg, Inst Forest Bot, Freiburg, Germany; [Speck, Thomas; Speck, Olga] Competence Network Biomimet, Freiburg, Germany	University of Freiburg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Freiburg	Speck, O (corresponding author), Univ Freiburg, Plant Biomech Grp & Bot Garden, Freiburg, Germany.; Speck, O (corresponding author), Freiburg Mat Res Ctr FMF, Freiburg, Germany.; Speck, O (corresponding author), Competence Network Biomimet, Freiburg, Germany.	olga.speck@biologie.uni-freiburg.de	Dalle Vacche, Sara/M-3330-2017; Dalle Vacche, Sara/AAB-9820-2020; Michaud, Veronique/A-6390-2009	Dalle Vacche, Sara/0000-0001-5459-5714; Dalle Vacche, Sara/0000-0001-5459-5714; Michaud, Veronique/0000-0001-5699-740X; Paul-Victor, Cloe/0000-0001-5413-8046	European Union [290308]; German Research Foundation (DFG); University of Freiburg	European Union(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement no. 290308 (Marie Curie ITN SHeMat 'Self-Healing Materials: from Concepts to Market') is gratefully acknowledged. We thank "Terre de Lin" for providing Linum usitatissimum seeds. We thank Heidi Petarus and her team of the Botanic Garden of the University of Freiburg (Germany) for assistance in plant growing. We thank Sabine Diener, Susanne Roske and Nardo Streit (Institute for Forest Botany, University of Freiburg, Germany) for technical assistance in the anatomical sample preparation. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Alix S, 2008, COMPOS PART A-APPL S, V39, P1793, DOI 10.1016/j.compositesa.2008.08.008; [Anonymous], 2014, R LANG ENV STAT COMP; Bates D.M., 2010, LME4 MIXED EFFECTS M; Bauer G, 2012, ANN BOT-LONDON, V109, P807, DOI 10.1093/aob/mcr307; BIGGS AR, 1985, PHYTOPATHOLOGY, V75, P1191, DOI 10.1094/Phyto-75-1191; Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532; Busch S, 2010, P ROY SOC B-BIOL SCI, V277, P2113, DOI 10.1098/rspb.2010.0075; Charlet K, 2007, COMPOS PART A-APPL S, V38, P1912, DOI 10.1016/j.compositesa.2007.03.006; Charlet K, 2009, PROCEDIA ENGINEER, V1, P233, DOI 10.1016/j.proeng.2009.06.055; Duc F., 2014, THESIS; Duc F, 2014, J REINF PLAST COMP, V33, P1625, DOI 10.1177/0731684414539779; Esau K, 1943, AM J BOT, V30, P579, DOI 10.2307/2437468; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Faraway JJ., 2006, TEXTS STAT SCI, DOI [DOI 10.1111/J.1541-0420.2006.00596, 10.1111/11541-0420.2006.00596_I2.x]; Fink S, 1999, PATHOLOGICAL REGENER; Gorshkova TA, 2000, ANN BOT-LONDON, V85, P477, DOI 10.1006/anbo.1999.1091; Harrington MJ, 2016, ADV POLYM SCI, V273, P307, DOI 10.1007/12_2015_334; Hawkins S, 1996, PROTOPLASMA, V191, P96, DOI 10.1007/BF01280829; Hughes M, 2012, J MATER SCI, V47, P599, DOI 10.1007/s10853-011-6025-3; Ibrahim L, 2001, ANN BOT-LONDON, V88, P313, DOI 10.1006/anbo.2001.1461; Kalia S, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/837875; Konrad W, 2013, J THEOR BIOL, V336, P96, DOI 10.1016/j.jtbi.2013.07.013; Lamb RJ, 2008, CAN ENTOMOL, V140, P600, DOI 10.4039/N08-014; MCDOUGALL GJ, 1993, J PLANT PHYSIOL, V142, P651, DOI 10.1016/S0176-1617(11)80897-7; MCDOUGALL GJ, 1993, J SCI FOOD AGR, V62, P1, DOI 10.1002/jsfa.2740620102; MCDOUGALL GJ, 1991, J PLANT PHYSIOL, V139, P182, DOI 10.1016/S0176-1617(11)80605-X; Morvan C, 2003, PLANT PHYSIOL BIOCH, V41, P935, DOI 10.1016/j.plaphy.2003.07.001; Romhany G, 2003, J APPL POLYM SCI, V90, P3638, DOI 10.1002/app.13110; Satyanarayana KG, 2009, PROG POLYM SCI, V34, P982, DOI 10.1016/j.progpolymsci.2008.12.002; Schreiber L, 2005, PLANTA, V220, P520, DOI 10.1007/s00425-004-1364-9; Speck T, 2013, RSC SMART MATER, P359, DOI 10.1039/9781849737555-00359; Speck T, 2013, SELF-HEALING POLYMERS: FROM PRINCIPLES TO APPLICATIONS, P61; Stamboulis A, 2001, COMPOS PART A-APPL S, V32, P1105, DOI 10.1016/S1359-835X(01)00032-X; Stobbe H, 2002, ANN BOT-LONDON, V89, P773, DOI 10.1093/aob/mcf137; Trask RS, 2007, BIOINSPIR BIOMIM, V2, pP1, DOI 10.1088/1748-3182/2/1/P01; Trask RS, 2010, J R SOC INTERFACE, V7, P921, DOI 10.1098/rsif.2009.0420; Vallet C, 1996, ANN BOT-LONDON, V78, P625, DOI 10.1006/anbo.1996.0170; van der Zwaag S, 2014, MATER SCI TECH-LOND, V30, P1633, DOI 10.1179/1743284714Y.0000000624; Quirien Elfrida van Oirschot QEA, 2006, POSTHARVEST BIOL TEC, V42, P65, DOI 10.1016/j.postharvbio.2006.05.013; Williams HR, 2007, SMART MATER STRUCT, V16, P1198, DOI 10.1088/0964-1726/16/4/031; Wrobel-Kwiatkowska M, 2007, J BIOTECHNOL, V128, P919, DOI 10.1016/j.jbiotec.2006.12.030; Zhu JC, 2013, MATERIALS, V6, P5171, DOI 10.3390/ma6115171	42	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185958	10.1371/journal.pone.0185958	http://dx.doi.org/10.1371/journal.pone.0185958			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982196	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300098
J	Geary, B; Longest, SM; Ottewell, K; Lantz, SM; Walter, ST; Karubian, J; Leberg, PL				Geary, Brock; Longest, Susan M.; Ottewell, Kym; Lantz, Samantha M.; Walter, Scott T.; Karubian, Jordan; Leberg, Paul L.			Genetic structure of brown pelicans (Pelecanus occidentalis) in the northern Gulf of Mexico in the context of human management and disturbance	PLOS ONE			English	Article							DEEP-WATER-HORIZON; EFFECTIVE POPULATION-SIZE; SALMON SALMO-SALAR; OIL-SPILL; MICROSATELLITE LOCI; MOVEMENT PATTERNS; COMPUTER-PROGRAM; TEMPORAL-CHANGES; HIGHLY MOBILE; F-STATISTICS	Environmental disturbances, both natural and anthropogenic, have the capacity to substantially impact animal behavior and abundance, which can in turn influence patterns of genetic diversity and gene flow. However, little empirical information is available on the nature and degree of such changes due to the relative rarity of longitudinal genetic sampling of wild populations at appropriate intervals. Addressing this knowledge gap is therefore of interest to evolutionary biologists, policy makers, and managers. In the past half century, populations of the brown pelican (Pelecanus occidentalis) in the southeastern United States have been exposed to regional extirpations, translocations, colony losses, and oil spills, but potential impacts on genetic diversity and population structure remain unknown. To investigate the cumulative impacts of recent disturbances and management actions, we analyzed seven microsatellite loci using genetic samples collected from 540 nestlings across twelve pelican colonies from two time periods, corresponding to before (n = 305) and after (n = 235) the 2010 Deepwater Horizon oil spill. Pre-2010 populations in Texas were significantly differentiated from Louisiana, Alabama, and Florida populations to the east, with reintroduced populations in southeastern Louisiana having less genetic diversity than sites in Texas, consistent with a recent bottleneck. In contrast, there was no evidence of a geographic component to genetic structure among colonies sampled after the spill, consistent with increased dispersal among sites following the event. This pattern may be associated with reduced philopatry in response to colony abandonment in the areas most heavily impacted by the Deepwater Horizon event, though other factors (e.g., rehabilitation and translocation of oiled birds or colony loss due to erosion and tropical storms) were likely also involved. Future monitoring is necessary to determine if bottlenecks and loss of genetic variation are associated with the oil spill over time, and is recommended for other systems in which disturbance effects may be inferred via repeated genetic sampling.	[Geary, Brock; Longest, Susan M.; Ottewell, Kym; Lantz, Samantha M.; Walter, Scott T.; Karubian, Jordan] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Leberg, Paul L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Longest, Susan M.] Colorado Mesa Univ, Biol Sci Dept, Grand Junction, CO USA; [Ottewell, Kym] Dept Pk & Wildlife, Sci & Conservat Div, Perth, WA, Australia; [Walter, Scott T.] Texas State Univ, Dept Biol, San Marcos, TX USA	Tulane University; University of Louisiana Lafayette; Texas State University System; Texas State University San Marcos	Geary, B (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	brock.j.geary@gmail.com	Kym, Ottewell/I-9875-2019	Kym, Ottewell/0000-0002-4273-3224; Geary, Brock/0000-0002-6032-0052	National Science Foundation [1139962]; Louisiana Department of Wildlife and Fisheries; NSF [1139962]; LDWF	National Science Foundation(National Science Foundation (NSF)); Louisiana Department of Wildlife and Fisheries; NSF(National Science Foundation (NSF)); LDWF	This work was supported by National Science Foundation #1139962 to JK and PLL: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1139962& and Louisiana Department of Wildlife and Fisheries to PLL: http:/www.gcjv.org/working.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the US Fish and Wildlife Service, Florida Fish and Wildlife Commission, Texas Parks & Wildlife and Louisiana Department of Wildlife & Fisheries (LDWF) for permits and sampling site access. We thank Iliana Pena, Jim Rodgers, John Himes, John Dindo, Chester Smith, Winnie Burkett, Richard Zane, the Dauphin Island Sea Lab for field assistance and/or access to sampling sites, and the Karubian lab for comments and discussions to improve this manuscript. This project was funded by an NSF award #1139962 to JK and PLL, and an LDWF contract to PLL.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; Almeda R, 2013, PLOS ONE, V8, P20; [Anonymous], 2021, LANG ENV STAT COMP; Apodaca JJ, 2013, AM NAT, V181, P254, DOI 10.1086/668831; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Athrey G, 2012, EVOL APPL, V5, P540, DOI 10.1111/j.1752-4571.2011.00233.x; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; Bartlett M, 2016, CONSERV GENET, V17, P703, DOI 10.1007/s10592-016-0816-7; Becker PH, 2008, OIKOS, V117, P60, DOI 10.1111/j.2007.0030-1299.16287.x; Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cornwall W, 2015, SCIENCE, V348, P22, DOI 10.1126/science.348.6230.22; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Drabeck DH, 2014, J HERPETOL, V48, P125, DOI 10.1670/12-186; DURAND E, 2009, TESS VERSION 2 3 REF; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echols BS, 2016, CHEMOSPHERE, V144, P1893, DOI 10.1016/j.chemosphere.2015.10.082; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher CR, 2016, OCEANOGRAPHY, V29, P182, DOI 10.5670/oceanog.2016.82; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Genovart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070711; Goodbody-Gringley G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045574; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Haney JC, 2014, MAR ECOL PROG SER, V513, P239, DOI 10.3354/meps10839; HARRIS MP, 1973, IBIS, V115, P484; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hickman CR, 2008, MOL ECOL RESOUR, V8, P1439, DOI 10.1111/j.1755-0998.2008.02191.x; Holm GO, 2003, WILSON BULL, V115, P431, DOI 10.1676/03-019; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Kekkonen J, 2016, PROBLEMATIC WILDLIFE, P269; Kekkonen J, 2011, BIOL CONSERV, V144, P2931, DOI 10.1016/j.biocon.2011.08.012; King DT, 2013, WATERBIRDS, V36, P494, DOI 10.1675/063.036.0406; Klomp N. I., 1992, Ringing and Migration, V13, P73; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lane SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1944; Latch EK, 2005, CONSERV GENET, V6, P981, DOI 10.1007/s10592-005-9089-2; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Machado MD, 2009, CONSERV GENET, V10, P1033, DOI 10.1007/s10592-008-9681-3; MANTEL N, 1967, CANCER RES, V27, P209; McNease L., 1984, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V38, P165; McNease Larry, 1992, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V46, P223; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; Moum T, 2001, MOL ECOL, V10, P2463, DOI 10.1046/j.0962-1083.2001.01375.x; NEI M, 1981, GENETICS, V98, P625; NESBITT SA, 1978, WILSON BULL, V90, P443; Nielsen EE, 1997, MOL ECOL, V6, P487, DOI 10.1046/j.1365-294X.1997.00204.x; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Owen TM, 2013, WATERBIRDS, V36, P342, DOI 10.1675/063.036.0311; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Rizzo E, 2015, MAR POLLUT BULL, V94, P241, DOI 10.1016/j.marpolbul.2015.02.002; Rabalais NN, 2016, OCEANOGRAPHY, V29, P150, DOI 10.5670/oceanog.2016.79; Raynor EJ, 2013, WATERBIRDS, V36, P88, DOI 10.1675/063.036.0113; Raynor EJ, 2012, AUK, V129, P763, DOI 10.1525/auk.2012.11181; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Selman W, 2016, WATERBIRDS, V39, P45, DOI 10.1675/063.039.0106; Selman W, 2012, SOUTHEAST NAT, V11, pG1, DOI 10.1656/058.011.0117; Shields M, 2014, PELECANUS OCCIDENTAL; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Smith TB, 2008, MOL ECOL, V17, P1, DOI 10.1111/j.1365-294X.2007.03607.x; Snyder MR, 2017, MOL ECOL, V26, P1075, DOI 10.1111/mec.13997; SOULE ME, 1991, J AM PLANN ASSOC, V57, P313, DOI 10.1080/01944369108975502; Spear SF, 2012, ECOL APPL, V22, P856, DOI 10.1890/11-0627.1; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Sullivan TJ, 2014, J GREAT LAKES RES, V40, P101, DOI 10.1016/j.jglr.2012.12.004; SWENNEN C, 1991, J ORNITHOL, V132, P427, DOI 10.1007/BF01640382; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Taylor SS, 2008, MOL ECOL, V17, P545, DOI 10.1111/j.1365-294X.2007.03591.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Tracy LN, 2011, CONSERV GENET, V12, P517, DOI 10.1007/s10592-010-0158-9; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vandewoestijne S, 1999, MOL ECOL, V8, P1539, DOI 10.1046/j.1365-294x.1999.00725.x; Venables WN., 2002, MODERN APPL STAT S 4; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Walter ST, 2014, CAN J ZOOL, V92, P885, DOI 10.1139/cjz-2014-0051; Walter ST, 2014, J FIELD ORNITHOL, V85, P421, DOI 10.1111/jofo.12081; Walter ST, 2013, CONDOR, V115, P788, DOI 10.1525/cond.2013.110195; Walter ST, 2013, J COASTAL RES, V29, P187, DOI 10.2112/JCOASTRES-D-13-00018.1; Walter ST, 2013, WATERBIRDS, V36, P53, DOI 10.1675/063.036.0109; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAPLES RS, 1989, GENETICS, V121, P379; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Welch AJ, 2012, HEREDITY, V109, P19, DOI 10.1038/hdy.2012.7; WILKINSON PM, 1994, WILDLIFE SOC B, V22, P420; Wilson AS, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-8; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Zengel S, 2016, ENVIRON SCI TECHNOL, V50, P643, DOI 10.1021/acs.est.5b04371	105	1	1	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185309	10.1371/journal.pone.0185309	http://dx.doi.org/10.1371/journal.pone.0185309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977003	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100020
J	Yokoi, A; Mihara, T; Ka, K; Goto, T				Yokoi, Ayako; Mihara, Takahiro; Ka, Koui; Goto, Takahisa			Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis	PLOS ONE			English	Review							PROPHYLACTIC ANTIEMETIC EFFICACY; PATIENT-CONTROLLED ANALGESIA; HIGHLY SUSCEPTIBLE PATIENTS; RECEPTOR-ANTAGONIST; HIGH-RISK; SURGERY; ANESTHESIA; CONSENSUS; STRENGTH; QUALITY	Background Postoperative nausea and vomiting is a distressing complication of surgery, and 5-HT3 receptor antagonists are often prescribed to prevent it. Ondansetron is the agent typically administered to prevent postoperative nausea and vomiting. Although ramosetron has a longer duration of action than ondansetron, it remains unclear whether ramosetron is the more effective medication. We performed an updated meta-analysis on the comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting. Methods We searched six databases for all trials that randomly assigned patients to ramosetron or ondansetron groups. The primary outcome was postoperative nausea or vomiting in the early, late, and next-day periods. The secondary outcomes were side effects of the medications. We used the random-effects model to combine the results. Trial sequential analyses were performed to correct for repetitive testing in the updated meta-analysis. Results Twenty-seven randomized controlled trials with 3,811 patients were included in the meta-analysis. The combined results of ramosetron vs. ondansetron efficacy in preventing postoperative nausea and vomiting were as follows: Risk ratio [95% confidence interval] = 0.82 [0.69-0.98] for early postoperative nausea, 0.76 [0.65-0.89] for late postoperative nausea, 0.69 [0.57-0.84] for next-day postoperative nausea, 0.78 [0.63-0.98] for early postoperative vomiting, 0.57 [0.45-0.72] for late postoperative vomiting, and 0.61 [0.43-0.86] for next-day postoperative vomiting. Dizziness was significantly lower in ramosetron groups than in ondansetron groups (risk ratio [95% confidence interval] = 0.81 [0.66-0.98]). Trial sequential analysis revealed that the results for late postoperative nausea, late postoperative vomiting, and next-day postoperative nausea were conclusive. Conclusions Ramosetron is more effective in preventing late postoperative nausea, late postoperative vomiting, and next-day postoperative nausea than ondansetron. The incidence of dizziness may be lower in patients receiving ramosetron than in patients receiving ondansetron.	[Yokoi, Ayako; Mihara, Takahiro; Ka, Koui] Kanagawa Childrens Med Ctr, Dept Anesthesiol, Minami Ku, Yokohama, Kanagawa, Japan; [Mihara, Takahiro; Goto, Takahisa] Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Kanazawa Ku, Yokohama, Kanagawa, Japan	Yokohama City University	Mihara, T (corresponding author), Kanagawa Childrens Med Ctr, Dept Anesthesiol, Minami Ku, Yokohama, Kanagawa, Japan.; Mihara, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Anesthesiol & Crit Care Med, Kanazawa Ku, Yokohama, Kanagawa, Japan.	miharaxxxtotoro@yahoo.co.jp	Mihara, Takahiro/AAH-8487-2020	Mihara, Takahiro/0000-0003-0613-511X				Agarkar S, 2015, INDIAN J ANAESTH, V59, P222, DOI 10.4103/0019-5049.154999; [Anonymous], UPD INF 32 MG INTR O; Ansari Maulana M, 2010, Indian J Med Sci, V64, P272; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Choi DK, 2010, ACTA ANAESTH SCAND, V54, P962, DOI 10.1111/j.1399-6576.2010.02275.x; 허인영, 2006, Korean Journal of Anesthesiology, V51, P70; Choi YS, 2008, SPINE, V33, pE602, DOI 10.1097/BRS.0b013e31817c6bde; Choi YS, 2012, KOREAN J ANESTHESIOL, V62, P543, DOI 10.4097/kjae.2012.62.6.543; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gan TJ, 2005, CNS DRUGS, V19, P225, DOI 10.2165/00023210-200519030-00004; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Gao CJ, 2015, DRUG DES DEV THER, V9, P2343, DOI 10.2147/DDDT.S80407; Gupta K, 2014, INDIAN J BASIC APPL, V3, P701; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ha SH, 2015, KOREAN J ANESTHESIOL, V68, P386, DOI 10.4097/kjae.2015.68.4.386; Hahm TS, 2010, ANAESTHESIA, V65, P500, DOI 10.1111/j.1365-2044.2010.06310.x; Jamwal A, 2016, JK SCI, V18, P111; Joo J, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0210-5; Kaja S, 2014, SAUDI J ANAESTH, V8, P59, DOI 10.4103/1658-354X.125938; Kim SI, 2009, BRIT J ANAESTH, V103, P549, DOI 10.1093/bja/aep209; Kim SH, 2013, KOREAN J ANESTHESIOL, V64, P517, DOI 10.4097/kjae.2013.64.6.517; Lee H-J, 2008, KOREAN J ANESTHESIOL, V54, P63, DOI DOI 10.4097/KJAE.2008.54.1.63; Lee JW, 2011, KOREAN J ANESTHESIOL, V61, P488, DOI 10.4097/kjae.2011.61.6.488; Lee YH, 2016, BRIT J CLIN PHARMACO, V82, P762, DOI 10.1111/bcp.13010; Liberati A, 2009, PLOS MED, V6; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mihara T, 2013, ANESTH ANALG, V117, P329, DOI 10.1213/ANE.0b013e31829847a1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mujoo Samiullah, 2017, Anesth Essays Res, V11, P78, DOI 10.4103/0259-1162.200244; Nuesch E, 2009, INT J EPIDEMIOL, V38, P298, DOI 10.1093/ije/dyn265; Park YH, 2013, PEDIATR ANESTH, V23, P360, DOI 10.1111/pan.12103; Pinsornsak P, 2017, J ARTHROPLASTY, V32, P1040, DOI 10.1016/j.arth.2016.09.013; Rabasseda X, 2002, DRUGS TODAY, V38, P75, DOI 10.1358/dot.2002.38.2.820104; Ryu JH, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-63; Ryu J, 2010, SURG ENDOSC, V24, P812, DOI 10.1007/s00464-009-0670-5; Shetty A, 2015, INT RES J PHARM, V6, P435, DOI DOI 10.7897/2230-8407.06790; Shin HJ, 2015, REGION ANESTH PAIN M, V40, P583, DOI 10.1097/AAP.0000000000000300; Suman RB, 2017, J EVOL MED DENT SCI-, V6, P575, DOI 10.14260/jemds/2017/123; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; White PF, 2008, ANESTH ANALG, V107, P459, DOI 10.1213/ane.0b013e31817aa6e4; Yoon Do Geun, 2009, Korean J Anesthesiol, V56, P408, DOI 10.4097/kjae.2009.56.4.408; 도상환, 2007, Korean Journal of Anesthesiology, V52, P561	46	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0186006	10.1371/journal.pone.0186006	http://dx.doi.org/10.1371/journal.pone.0186006			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977021	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100055
J	Caduff, M; Bauer, A; Jagannathan, V; Leeb, T				Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso			OCA2 splice site variant in German Spitz dogs with oculocutaneous albinism	PLOS ONE			English	Article							PINK-EYED-DILUTION; COAT-COLOR MUTANTS; GENE; MELANINS; GENOME	We investigated a German Spitz family where the mating of a black male to a white female had yielded three puppies with an unexpected light brown coat color, lightly pigmented lips and noses, and blue eyes. Combined linkage and homozygosity analysis based on a fully penetrant monogenic autosomal recessive mode of inheritance identified a critical interval of 15 Mb on chromosome 3. We obtained whole genome sequence data from one affected dog, three wolves, and 188 control dogs. Filtering for private variants revealed a single variant with predicted high impact in the critical interval in LOC100855460 (XM_005618224.1: c.377+2T>GLT844587.1:c.-45+2T>G). The variant perfectly co-segregated with the phenotype in the family. We genotyped 181 control dogs with normal pigmentation from diverse breeds including 22 unrelated German Spitz dogs, which were all homozygous wildtype. Comparative sequence analyses revealed that LOC100855460 actually represents the 5'-end of the canine OCA2 gene. The CanFam 3.1 reference genome assembly is incorrect and separates the first two exons from the remaining exons of the OCA2 gene. We amplified a canine OCA2 cDNA fragment by RT-PCR and determined the correct full-length mRNA sequence (LT844587.1). Variants in the OCA2 gene cause oculocutaneous albinism type 2 (OCA2) in humans, pink-eyed dilution in mice, and similar phenotypes in corn snakes, medaka and Mexican cave tetra fish. We therefore conclude that the observed oculocutaneous albinism in German Spitz is most likely caused by the identified variant in the 5'-splice site of the first intron of the canine OCA2 gene.	[Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Caduff, Madleina; Bauer, Anina; Jagannathan, Vidhya; Leeb, Tosso] Univ Bern, DermFocus, Bern, Switzerland	University of Bern; University of Bern	Leeb, T (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.; Leeb, T (corresponding author), Univ Bern, DermFocus, Bern, Switzerland.	Tosso.Leeb@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Bauer, Anina/0000-0002-6765-4012	Swiss National Science Foundation [CRSII3_160738]; Albert-Heim Foundation [105]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Albert-Heim Foundation	This study was supported by grants from the Swiss National Science Foundation (CRSII3_160738; http://www.snf.ch) and the Albert-Heim Foundation (no. 105; http://www.albert-heim-stiftung.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bauer A, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006651; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Burset M, 2001, NUCLEIC ACIDS RES, V29, P255, DOI 10.1093/nar/29.1.255; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; KING RA, 1980, CLIN GENET, V17, P259; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; Manga Prashiela, 1999, Journal of Dermatology (Tokyo), V26, P738; Martinez-Garcia M, 2013, J DERMATOL, V40, P319, DOI 10.1111/1346-8138.12170; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; PROTA G, 1995, PIGM CELL RES, V8, P153, DOI 10.1111/j.1600-0749.1995.tb00657.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; RUSSELL ES, 1949, GENETICS, V34, P146; Saenko SV, 2015, SCI REP-UK, V5, DOI 10.1038/srep17118	21	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185944	10.1371/journal.pone.0185944	http://dx.doi.org/10.1371/journal.pone.0185944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973042	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900068
J	Jahandideh, F; Chakrabarti, S; Davidge, ST; Wu, JP				Jahandideh, Forough; Chakrabarti, Subhadeep; Davidge, Sandra T.; Wu, Jianping			Egg white hydrolysate shows insulin mimetic and sensitizing effects in 3T3-F442A pre-adipocytes	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; RENIN-ANGIOTENSIN SYSTEM; ACTIVATED RECEPTOR PPAR; METABOLIC SYNDROME; ADIPOSE-TISSUE; BLOOD-PRESSURE; COX-2 EXPRESSION; TNF-ALPHA; ARTERIAL-HYPERTENSION; BIOACTIVE PEPTIDES	Insulin resistance and inflammation in adipose tissue is a key mechanism underlying metabolic syndrome, a growing health problem characterized by diabetes, obesity and hypertension. Previous work from our research group has demonstrated the potential of egg white ovotransferrin derived bioactive peptides against hypertension, oxidative stress and inflammation in vitro and in vivo. Egg white hydrolysate (EWH) has also shown anti-hypertensive effects in spontaneously hypertensive rats. Given the interplay among hypertension, inflammation, oxidative stress and metabolic syndrome, the objective of the study was to test the EWH on differentiation, insulin signaling and inflammatory responses in 3T3-F442A pre-adipocytes. Our study suggested that EWH could promote adipocyte differentiation as shown by increased lipid accumulation, increased release of adiponectin and upregulation of peroxisome proliferator associated receptor gamma (PPAR.) and CCAAT/enhancer binding protein alpha (C/EBP-a). In addition to enhanced insulin effects on the upregulation of protein kinase B/Akt phosphorylation, EWH treatment increased extracellular signal regulated kinase 1/2 (ERK1/2) phosphorylation to a level similar to that of insulin, indicating insulin sensitizing and mimetic properties of the EWH. EWH further attenuated cytokine induced inflammatory marker; cyclooxygenase -2 (COX-2) by 48.78%, possibly through the AP-1 pathway by down regulating c-Jun phosphorylation in adipocytes. Given the critical role of adipose in the pathogenesis of insulin resistance and metabolic syndrome, EWH may have potential applications in the prevention and management of metabolic syndrome and its complications.	[Jahandideh, Forough; Chakrabarti, Subhadeep; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Jahandideh, Forough; Chakrabarti, Subhadeep; Davidge, Sandra T.; Wu, Jianping] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.; Wu, JP (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada.	jwu3@ualberta.ca	Jahandideh, Forough/M-4648-2019; Wu, Jian/AAU-5221-2020; Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020	Jahandideh, Forough/0000-0001-9731-0854; Wu, Jian/0000-0001-9933-7364; Davidge, Sandra/0000-0002-5559-4905; Wu, Jian/0000-0002-3394-1507	Alberta Livestock and Meat Agency (ALMA); Egg Farmers of Canada; Natural Sciences and Engineering Research Council (NSERC)	Alberta Livestock and Meat Agency (ALMA); Egg Farmers of Canada; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from Alberta Livestock and Meat Agency (ALMA), Egg Farmers of Canada, Egg Farmers of Alberta, and the Natural Sciences and Engineering Research Council (NSERC) to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beh JE, 2013, J ETHNOPHARMACOL, V150, P339, DOI 10.1016/j.jep.2013.09.001; Bell D S, 2000, Endocr Pract, V6, P272; Bou M, 2014, GEN COMP ENDOCR, V205, P218, DOI 10.1016/j.ygcen.2014.05.005; Braga MFB, 2009, AM J CARDIOL, V104, P835, DOI 10.1016/j.amjcard.2009.05.015; Chakrabarti S, 2009, J STEROID BIOCH MOL; Chakrabarti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117492; Chakrabarti S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/608979; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Christensen KB, 2009, PHYTOTHER RES, V23, P1316, DOI 10.1002/ptr.2782; Coppack S, 2005, CARDIOVASCULAR DISEASE: DIET, NUTRITION AND EMERGING RISK FACTORS, P22; de Kloet AD, 2009, ENDOCRINOLOGY, V150, P4114, DOI 10.1210/en.2009-0065; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Doyen A, 2014, FOOD CHEM, V145, P66, DOI 10.1016/j.foodchem.2013.07.108; Eduardsen K, 2011, CELL PHYSIOL BIOCHEM, V28, P1231, DOI 10.1159/000335855; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Guo W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040958; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Harwood HJ, 2012, NEUROPHARMACOLOGY, V63, P57, DOI 10.1016/j.neuropharm.2011.12.010; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hsu CK, 2015, J CELL PHYSIOL, V230, P702, DOI 10.1002/jcp.24795; Huang WY, 2012, FOOD CHEM, V135, P1600, DOI 10.1016/j.foodchem.2012.05.093; Huang WY, 2010, J AGR FOOD CHEM, V58, P10840, DOI 10.1021/jf102120c; Jahandideh F, 2016, J FUNCT FOODS; Jahandideh F, 2016, J FUNCT FOODS, V27, P667, DOI 10.1016/j.jff.2016.10.019; Jahandideh F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115006; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kadowaki T, 2002, J DIABETES COMPLICAT, V16, P41, DOI 10.1016/S1056-8727(01)00206-9; Khan HMS, 2012, AFR J PHARM PHARMACO, V6, P1805, DOI 10.5897/AJPP12.684; Kleiman E, 2009, BIOCHEM BIOPH RES CO, V388, P554, DOI 10.1016/j.bbrc.2009.08.063; Laviola Luigi, 2006, Archives of Physiology and Biochemistry, V112, P82, DOI 10.1080/13813450600736174; Lee MH, 2008, KIDNEY INT, V74, P890, DOI 10.1038/ki.2008.313; Lu HL, 2006, WORLD J GASTROENTERO, V12, P1747, DOI 10.3748/wjg.v12.i11.1747; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2015, J FUNCT FOODS, V13, P50, DOI 10.1016/j.jff.2014.12.028; Majumder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082829; Majumder K, 2013, J FUNCT FOODS, V5, P187, DOI 10.1016/j.jff.2012.10.004; Mathai ML, 2008, INT J OBESITY, V32, P1576, DOI 10.1038/ijo.2008.126; Medvedev IN, 2007, RUSS J CARDIOL, P97; Moon SH, 2013, POULTRY SCI, V92, P424, DOI 10.3382/ps.2012-02680; Muller-Wieland D, 1998, BASIC RES CARDIOL, V93, P131; Murasaki KM, 2006, CIRCULATION, V114, P71; Park SA, 2007, ANN NY ACAD SCI, V1095, P545, DOI 10.1196/annals.1397.059; Pershadsingh HA, 2004, DIABETES CARE, V27, P1015, DOI 10.2337/diacare.27.4.1015; Potenza MV, 2009, NUTR CLIN PRACT, V24, P560, DOI 10.1177/0884533609342436; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rekovets O, 2010, J HYPERTENS, V28, pE569, DOI 10.1097/01.hjh.0000379936.92800.4d; Renna NF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/513251; Rikimaru K, 2012, BIOORGAN MED CHEM, V20, P714, DOI 10.1016/j.bmc.2011.12.008; Rodrigues CEM, 2012, CLIN EXP RHEUMATOL, V30, P871; Roncal CA, 2009, AM J NEPHROL, V30, P399, DOI 10.1159/000235731; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Salazar MR, 2013, J INTERN MED, V273, P595, DOI 10.1111/joim.12036; Salazard B, 2004, CELL BIOL TOXICOL, V20, P375, DOI 10.1007/s10565-004-1471-1; Sawada Y, 2015, MOL NUTR FOOD RES, V59, P2502, DOI 10.1002/mnfr.201500324; Shahidi F, 2008, J AOAC INT, V91, P914; Smorlesi A, 2012, OBES REV, V13, P83, DOI 10.1111/j.1467-789X.2012.01039.x; Sonnenberg GE, 2004, OBES RES, V12, P180, DOI 10.1038/oby.2004.24; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Sumner DA, 2011, POULTRY SCI, V90, P241, DOI 10.3382/ps.2010-00822; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Udenigwe CC, 2012, FOOD CHEM, V132, P468, DOI 10.1016/j.foodchem.2011.11.024; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Velloso LA, 1995, FEBS LETT, V377, P353, DOI 10.1016/0014-5793(95)01370-9; Weisinger RS, 2009, PHYSIOL BEHAV, V98, P192, DOI 10.1016/j.physbeh.2009.05.009; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Wong ND, 2007, AM J CARDIOVASC DRUG, V7, P259, DOI 10.2165/00129784-200707040-00004; Yusuf S, 2001, JAMA-J AM MED ASSOC, V286, P1882, DOI 10.1001/jama.286.15.1882; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391; Zarich Stuart W, 2005, Rev Cardiovasc Med, V6, P194; Zhang DY, 2008, MOL CANCER RES, V6, P165, DOI 10.1158/1541-7786.MCR-07-0181; Zhang J, 2013, J BIOL CHEM, V288, P20692, DOI 10.1074/jbc.M113.485730; Zolotnik IA, 2012, LIFE SCI, V91, P816, DOI 10.1016/j.lfs.2012.08.038	80	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185653	10.1371/journal.pone.0185653	http://dx.doi.org/10.1371/journal.pone.0185653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972997	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900035
J	Paskevicius, S; Starkevic, U; Misiunas, A; Vitkauskiene, A; Gleba, Y; Razanskiene, A				Paskevicius, Sarunas; Starkevic, Urte; Misiunas, Audrius; Vitkauskiene, Astra; Gleba, Yuri; Razanskiene, Ausra			Plant-expressed pyocins for control of Pseudomonas aeruginosa	PLOS ONE			English	Article							TRANSPOSON MUTANT LIBRARY; HIGH-YIELD PRODUCTION; COLICIN M; PROTEIN ANTIBIOTICS; VIRAL VECTORS; BACTERIOCINS; EFFICACY; DISEASE	The emergence, persistence and spread of antibiotic-resistant human pathogenic bacteria heralds a growing global health crisis. Drug-resistant strains of gram-negative bacteria, such as Pseudomonas aeruginosa, are especially dangerous and the medical and economic burden they impose underscore the critical need for finding new antimicrobials. Recent studies have demonstrated that plant-expressed bacteriocins of the colicins family can be efficient antibacterials against all major enteropathogenic strains of E. coli. We extended our studies of colicin-like bacteriocins to pyocins, which are produced by strains of P. aeruginosa for ecological advantage against other strains of the same species. Using a plant-based transient expression system, we expressed six different pyocins, namely S5, PaeM, L1, L2, L3 and one new pyocin, PaeM4, and purified them to homogeneity. Among these pyocins, PaeM4 demonstrated the broadest spectrum of activity by controlling 53 of 100 tested clinical isolates of P. aeruginosa. The activity of plant-made pyocins was confirmed in the agar drop, liquid culture susceptibility and biofilm assays, and in the Galleria mellonella animal infection model.	[Paskevicius, Sarunas; Starkevic, Urte; Misiunas, Audrius; Razanskiene, Ausra] Nomads UAB, Gelezinio Vilko 29A, Vilnius, Lithuania; [Paskevicius, Sarunas; Starkevic, Urte] Vilnius Univ, Inst Biotechnol, Sauletekio Al 7, Vilnius, Lithuania; [Vitkauskiene, Astra] Lithuanian Univ Hlth Sci, A Mickeviciaus G 9, Kaunas, Lithuania; [Gleba, Yuri] Nomad Biosci GmbH, Biozentrum Halle, Weinbergweg 22, Halle, Saale, Germany	Vilnius University; Lithuanian University of Health Sciences	Razanskiene, A (corresponding author), Nomads UAB, Gelezinio Vilko 29A, Vilnius, Lithuania.	ausra@nomadsbio.lt	Paškevičius, Šarūnas/GPK-7815-2022	Gleba, Yuri/0000-0003-4675-7474; Paskevicius, Sarunas/0000-0001-6421-5842; Razanskiene, Ausra/0000-0002-0839-1224	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency) [J05-LVPA-K-01-0035]	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency)	LVPA (Lietuvos verslo paramos agentura, a Lithuanian Business Support Agency) provided funding for the study (grant J05-LVPA-K-01-0035, http://lvpa.lt/). Nomads UAB and its parent company Nomad Bioscience GmbH provided support in the form of salaries for authors SP, US, AM, YG, and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Barreteau H, 2012, J BIOL CHEM, V287, P37395, DOI 10.1074/jbc.M112.406439; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bassetti M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-22; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Brown CL, 2012, BIOCHEM SOC T, V40, P1549, DOI 10.1042/BST20120241; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DIAZ E, 1994, MOL MICROBIOL, V13, P855, DOI 10.1111/j.1365-2958.1994.tb00477.x; Elfarash A, 2014, MICROBIOL-SGM, V160, P261, DOI 10.1099/mic.0.070672-0; Ghequire MGK, 2017, MBIO, V8, DOI 10.1128/mBio.01961-16; Ghequire MGK, 2015, SCI REP-UK, V5, DOI 10.1038/srep17368; Ghequire MGK, 2014, FEMS MICROBIOL REV, V38, P523, DOI 10.1111/1574-6976.12079; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba YY, 2014, CURR TOP MICROBIOL, V375, P155, DOI 10.1007/82_2013_352; Grinter R, 2013, FEMS MICROBIOL LETT, V338, P1, DOI 10.1111/1574-6968.12011; Grinter R, 2012, J BIOL CHEM, V287, P38876, DOI 10.1074/jbc.M112.400150; Hahn S, 2015, PLANT BIOTECHNOL J, V13, P708, DOI 10.1111/pbi.12299; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Mah TF, 2003, LETT NAT, V426, P1, DOI DOI 10.1038/; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; McCaughey LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30201; Medina C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023055; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Moskowitz SM, 2004, J CLIN MICROBIOL, V42, P1915, DOI 10.1128/JCM.42.5.1915-1922.2004; Oey M, 2009, P NATL ACAD SCI USA, V106, P6579, DOI 10.1073/pnas.0813146106; Oey M, 2009, PLANT J, V57, P436, DOI 10.1111/j.1365-313X.2008.03702.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Scholl D, 2008, ANTIMICROB AGENTS CH, V52, P1647, DOI 10.1128/AAC.01479-07; Schulz S, 2015, P NATL ACAD SCI USA, V112, pE5454, DOI 10.1073/pnas.1513311112; Smith K, 2012, ANTIMICROB AGENTS CH, V56, P1599, DOI 10.1128/AAC.05714-11; Starkevic U, 2015, J BIOTECHNOL, V200, P10, DOI 10.1016/j.jbiotec.2015.02.028; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Tuse D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/648143; Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13	38	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185782	10.1371/journal.pone.0185782	http://dx.doi.org/10.1371/journal.pone.0185782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973027	gold, Green Submitted, Green Published			2022-12-27	WOS:000412131900049
J	Bourgeois, D; David, A; Inquimbert, C; Tramini, P; Molinari, N; Carroue, F				Bourgeois, Denis; David, Alexandra; Inquimbert, Camille; Tramini, Paul; Molinari, Nicolas; Carrouel, Florence			Quantification of carious pathogens in the interdental microbiota of young caries-free adults	PLOS ONE			English	Article							REAL-TIME PCR; STREPTOCOCCUS-MUTANS; CANDIDA-ALBICANS; DENTAL-CARIES; PROBIOTIC LACTOBACILLI; ENTEROCOCCUS-FAECALIS; PRESCHOOL-CHILDREN; BIOFILM FORMATION; BACTERIAL DIVERSITY; FUNGAL-INFECTIONS	Background The majority of caries lesions in adults occur on the proximal tooth surfaces of the posterior teeth. A comprehensive study of the composition of the oral microbiota is fundamental for a better understanding of the etiology of interdental caries. Methods Twenty-five caries-free subjects (20-35 years old) were enrolled in the study. The interdental biofilm of four interdental sites were collected. The real-time polymerase chain reaction (PCR) methodology were used to quantify (i) the following bacteria: Streptococcus spp., Streptococcus mutans, Lactobacillus spp., Enterococcus spp., and Enterococcus faecalis; (ii) the fungus Candida albicans; and (iii) total bacteria. Results Streptococcus spp. was the most abundant species, followed by Lactobacillus spp. and Enterococcus spp. Streptococcus spp. and Lactobacillus spp. were detected at all tested sites and Enterococcus spp. at 99% of sites. S. mutans was detected at only 28% of the tested sites and C. albicans was detected at 11% of sites. E. faecalis was never detected. In 54.5% of the biofilm inhabited by C. albicans, S. mutans was present. Moreover, 28% of the ID sites co-expressed S. mutans and Lactobacillus spp. The studied pathogens were organized into two correlated groups of species. Strikingly, the fungus C. albicans and the bacteria Enterococcus spp. cluster together, whereas Streptococcus spp., S. mutans and Lactobacillus spp. form one distinct cluster. Conclusion The interdental biofilm of young caries-free adults is comprised of pathogens that are able to induce interproximal caries. That several of these pathogens are implicated in heart disease or other systemic diseases is an argument for the disruption of interdental biofilms using daily oral hygiene.	[Bourgeois, Denis; David, Alexandra; Inquimbert, Camille; Carrouel, Florence] Univ Lyon 1, Lab System Hlth Care EA4129, Lyon, France; [Bourgeois, Denis] Univ Lyon 1, Fac Dent, Dept Prevent & Publ Hlth, Lyon, France; [Tramini, Paul] Univ Montpellier, Dept Dent Publ Hlth, Montpellier, France; [Molinari, Nicolas] Univ Montpellier, CHU Montpellier, Serv DIM, UMR IMAG 5149, Montpellier, France; [Carrouel, Florence] Univ Lyon 1, Fac Dent, Dept Basic & Clin Biol Sci, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Bourgeois, D (corresponding author), Univ Lyon 1, Lab System Hlth Care EA4129, Lyon, France.; Bourgeois, D (corresponding author), Univ Lyon 1, Fac Dent, Dept Prevent & Publ Hlth, Lyon, France.	denis.bourgeois@univ-lyon1.fr	Carrouel, F/X-4952-2019; molinari, nicolas/Y-9681-2019; Bourgeois, Denis/ABI-3060-2020; Bourgeois, Denis/AAH-9280-2020	Carrouel, F/0000-0002-6823-1636; Bourgeois, Denis/0000-0003-4754-2512; 	Institut Clinident SAS (Aix en Provence, France)	Institut Clinident SAS (Aix en Provence, France)	We acknowledge the support of our work by Institut Clinident SAS (Aix en Provence, France).	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Anderson AC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01534; Arino M, 2006, SCI REP, V6, P29190; Badet C, 2008, Open Microbiol J, V2, P38, DOI 10.2174/1874285800802010038; Barbosa JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150457; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bourgeois D, 2015, OPEN DENT J, V9, P431, DOI 10.2174/1874210601509010431; Bourgeois D, 2016, EUR J ORAL SCI, V124, P566, DOI 10.1111/eos.12302; Burley KM, 2012, J ENDODONT, V38, P1511, DOI 10.1016/j.joen.2012.07.004; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Carrouel F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00840; Caufield PW, 2015, J DENT RES, V94, p110S, DOI 10.1177/0022034515576052; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; Dani S, 2016, CONTEMP CLIN DENT, V7, P529, DOI 10.4103/0976-237X.194114; De-la-Torre J, 2016, MYCOSES, V59, P234, DOI 10.1111/myc.12453; Demirci Mustafa, 2010, Eur J Dent, V4, P270; Dhotre SV, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.41067; Dorri M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010431.pub2; Ekstrand KR, 2006, TANDLAEGEBLADET, V110, P788; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Farah CS, 2010, AUST DENT J, V55, P48, DOI 10.1111/j.1834-7819.2010.01198.x; Faran Ali Syed Muhammad, 2012, J Oral Biol Craniofac Res, V2, P181, DOI 10.1016/j.jobcr.2012.07.001; Fejerskov O, 2015, DENT CARIES DIS ITS, P19; Fouad AF, 2002, J CLIN MICROBIOL, V40, P3223, DOI 10.1128/JCM.40.9.3223-3231.2002; Gao XL, 2014, PEDIATR DENT, V36, P348; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Henne K, 2016, CARIES RES, V50, P480, DOI 10.1159/000448485; Heymann HO, 2012, STURDEVANTS ART SCI, P25; Kanaguchi N, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-36; Keiser-Nielsen S, 1971, Dent Pract (Ewell), V3, ppassim; Keller MK, 2011, ACTA ODONTOL SCAND, V69, P263, DOI 10.3109/00016357.2011.554863; Khalaf H, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0810-8; Kidd E.A.M., 2016, ESSENTIALS DENT CARI; Klinke T, 2011, CARIES RES, V45, P100, DOI 10.1159/000324809; Komiyama EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163001; Kouidhi B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-155; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kreth J, 2009, DNA CELL BIOL, V28, P397, DOI 10.1089/dna.2009.0868; Krzysciak W, 2014, EUR J CLIN MICROBIOL, V33, P499, DOI 10.1007/s10096-013-1993-7; Lin X, 2015, ORAL DIS, V21, pE128, DOI 10.1111/odi.12257; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Moraga CPL, 2017, ACTA ODONTOL SCAND, V75, P30, DOI 10.1080/00016357.2016.1244560; Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168; Marsh PD, 2009, ORAL MICROBIOL IMMUN, P8; Mejare I., 2002, CONS C CAR PRIM DENT, P57; Meng H., 2008, THE PERIODONTOLOGY; Metwalli KH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003616; Moalic E, 2001, CARIES RES, V35, P149, DOI 10.1159/000047447; Monteiro-da-Silva F, 2014, MED MYCOL, V52, P496, DOI 10.1093/mmy/myu027; Motisuki C, 2005, ARCH ORAL BIOL, V50, P341, DOI 10.1016/j.archoralbio.2004.08.007; Nakano K, 2008, JPN DENT SCI REV, V44, P29, DOI 10.1016/j.jdsr.2007.09.001; Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004; Ozbek SM, 2009, J APPL ORAL SCI, V17, P370, DOI 10.1590/S1678-77572009000500004; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Ramesh Krishnan, 2013, J Pharm Bioallied Sci, V5, pS63, DOI 10.4103/0975-7406.113299; Rams TE, 2013, J PERIODONTOL, V84, P1026, DOI 10.1902/jop.2012.120050; Ran SJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00795; Rehman K, 2009, PAKISTAN ORAL DENT J, V29, P119; Ribeiro AA, 2015, CARIES RES, V49, P99, DOI 10.1159/000368562; Richards Derek, 2013, Evid Based Dent, V14, P35, DOI 10.1038/sj.ebd.6400925; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Russell RRB, 2008, CARIES RES, V42, P319, DOI 10.1159/000151326; Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17; Sedgley C, 2006, J ENDODONT, V32, P104, DOI 10.1016/j.joen.2005.10.022; Sheth CC, 2016, LETT APPL MICROBIOL, V63, P254, DOI 10.1111/lam.12620; Simon-Soro A, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25443; Sindhu N, 2013, J PHARMACEUT BIOMED, V31, P1192; Soderling EM, 2011, CURR MICROBIOL, V62, P618, DOI 10.1007/s00284-010-9752-9; Souto R, 2008, ARCH ORAL BIOL, V53, P155, DOI 10.1016/j.archoralbio.2007.08.004; Stecksen-Blicks C, 2009, CARIES RES, V43, P374, DOI 10.1159/000235581; Tanzer J M, 2001, J Dent Educ, V65, P1028; Thenisch NL, 2006, CARIES RES, V40, P366, DOI 10.1159/000094280; Thomas A, 2016, J CLIN DIAGN RES, V10, pZC109, DOI 10.7860/JCDR/2016/19387.8357; Vanderas AP, 2004, PEDIATR DENT, V26, P362; Walter J, 2008, MICROBIOL-SGM, V154, P72, DOI 10.1099/mic.0.2007/010637-0; Willems HM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw039; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Xie ZJ, 2007, ORAL SURG ORAL MED O, V103, pE44, DOI 10.1016/j.tripleo.2006.12.028; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Yoshida A, 2003, J CLIN MICROBIOL, V41, P4438, DOI 10.1128/JCM.41.9.4438-4441.2003; Zaremba M L, 2006, Adv Med Sci, V51 Suppl 1, P233; Zheng JS, 2015, ENVIRON MICROBIOL, V17, P2133, DOI 10.1111/1462-2920.12662	90	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185804	10.1371/journal.pone.0185804	http://dx.doi.org/10.1371/journal.pone.0185804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016613	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400030
J	Liu, Z; Pericak-Vance, MA; Goldschmidt-Clermont, P; Seo, D; Wang, LY; Rundek, T; Beecham, GW				Liu, Zhi; Pericak-Vance, Margaret A.; Goldschmidt-Clermont, Pascal; Seo, David; Wang, Liyong; Rundek, Tatjana; Beecham, Gary W.			Coronary collateralization shows sex and racial-ethnic differences in obstructive artery disease patients	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; DIABETES-MELLITUS; VESSEL DEVELOPMENT; GENETIC-VARIATION; CIRCULATION; ASSOCIATION; HEART; DETERMINANTS; MORTALITY; GENOMES	Background Coronary collateral circulation protects cardiac tissues from myocardial infarction damage and decreases sudden cardiac death. So far, it is unclear how coronary collateralization varies by race-ethnicity groups and by sex. Methods We assessed 868 patients with obstructive CAD. Patients were assessed for collateral grades based on Rentrop grading system, as well as other covariates. DNA samples were genotyped using the Affymetrix 6.0 genotyping array. To evaluate genetic contributions to collaterals, we performed admixture mapping using logistic regression with estimated local and global ancestry. Results Overall, 53% of participants had collaterals. We found difference between sex and racialethnic groups. Men had higher rates of collaterals than women (P-value = 0.000175). White Hispanics/Latinos showed overall higher rates of collaterals than African Americans and non-Hispanic Whites (59%, 50% and 48%, respectively, P-value = 0.017), and especially higher rates in grade 1 and grade 3 collateralization than the other two populations (P-value = 0.0257). Admixture mapping showed Native American ancestry was associated with the presence of collaterals at a region on chromosome 17 (chr17: 35,243,14241,251,931, beta = 0.55, P-value = 0.000127). African ancestry also showed association with collaterals at a different region on chromosome 17 (chr17: 32,266,966-34,463,323, beta = 0.38, P-value = 0.00072). Conclusions In our study, collateralization showed sex and racial-ethnic differences in obstructive CAD patients. We identified two regions on chromosome 17 that were likely to harbor genetic variations that influenced collateralization.	[Liu, Zhi; Pericak-Vance, Margaret A.; Wang, Liyong; Beecham, Gary W.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Goldschmidt-Clermont, Pascal; Seo, David] Univ Miami, Miller Sch Med, Div Cardiol, Miami, FL 33136 USA; [Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Beecham, GW (corresponding author), Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	gbeecham@med.miami.edu			National Institutes of Health/National Heart, Lung and Blood Institute [5R01HL102487-04]	National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the grant from the National Institutes of Health/National Heart, Lung and Blood Institute (https://www.nhibi.nih.gov/) 5R01HL102487-04 (GWB/DMS).	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Benjamin EJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S11; Bhatt H, 2015, ANGIOLOGY, V66, P588, DOI 10.1177/0003319714545342; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; de Marchi SF, 2011, CARDIOLOGY, V118, P198, DOI 10.1159/000328648; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Gloekler S, 2014, HEART, V100, P160, DOI 10.1136/heartjnl-2013-304880; Grobbee DE, 1995, PROGRESSION REGRESSI, P478; Hirtle-Lewis M, 2013, CLIN CARDIOL, V36, P628, DOI 10.1002/clc.22193; Hoffman GS, 2012, INFLAMMATORY DIS BLO, V2nd; Jacobs AK, 2009, CIRC-CARDIOVASC INTE, V2, P69, DOI 10.1161/CIRCINTERVENTIONS.108.847954; Kinnaird T, 2008, CARDIOVASC RES, V78, P257, DOI 10.1093/cvr/cvm116; Koerselman J, 2003, CIRCULATION, V107, P2507, DOI 10.1161/01.CIR.0000065118.99409.5F; Koerselman J, 2007, ATHEROSCLEROSIS, V191, P191, DOI 10.1016/j.atherosclerosis.2006.03.021; Kornowski R, 2003, CORONARY ARTERY DIS, V14, P61, DOI 10.1097/00019501-200302000-00007; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee CW, 2004, J AM COLL CARDIOL, V43, P474, DOI 10.1016/j.jacc.2003.09.033; Lewis SL, 2014, NURSING MANAGEMENT C; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lumley T., 2009, PACKAGE LEAPS; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Meier P, 2012, EUR HEART J, V33, P614, DOI 10.1093/eurheartj/ehr308; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pittman DL, 1998, GENOMICS, V49, P103, DOI 10.1006/geno.1998.5226; Pohl T, 2001, J AM COLL CARDIOL, V38, P1872, DOI 10.1016/S0735-1097(01)01675-8; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Schaper W, 2012, EUR HEART J, V33, P564, DOI 10.1093/eurheartj/ehr385; Seiler C, 2003, HEART, V89, P1352, DOI 10.1136/heart.89.11.1352; Seiler C, 2013, EUR HEART J, V34, P2674, DOI 10.1093/eurheartj/eht195; Tatli Ersan, 2007, Exp Clin Cardiol, V12, P97; Teunissen PFA, 2012, J MOL CELL CARDIOL, V52, P897, DOI 10.1016/j.yjmcc.2011.09.010; Waldecker B, 2002, Z KARDIOL, V91, P243, DOI 10.1007/s003920200018; Wang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031910; Zbinden R, 2005, HEART, V91, P1289, DOI 10.1136/hrt.2004.041236; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	41	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0183836	10.1371/journal.pone.0183836	http://dx.doi.org/10.1371/journal.pone.0183836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016599	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400004
J	Schmidt, MH; Swang, TW; Hamilton, IM; Best, JA				Schmidt, Markus H.; Swang, Theodore W.; Hamilton, Ian M.; Best, Janet A.			State-dependent metabolic partitioning and energy conservation: A theoretical framework for understanding the function of sleep	PLOS ONE			English	Article							DAILY TORPOR; MAMMALIAN SLEEP; TEMPORAL ORGANIZATION; CIRCADIAN RHYTHMICITY; MEMORY CONSOLIDATION; HIBERNATION; HOMEOSTASIS; INTEGRATION; WAKEFULNESS; PLASTICITY	Metabolic rate reduction has been considered the mechanism by which sleep conserves energy, similar to torpor or hibernation. This mechanism of energy savings is in conflict with the known upregulation (compared to wake) of diverse functions during sleep and neglects a potential role in energy conservation for partitioning of biological operations by behavioral state. Indeed, energy savings as derived from state-dependent resource allocations have yet to be examined. A mathematical model is presented based on relative rates of energy deployment for biological processes upregulated during either wake or sleep. Using this model, energy savings from sleep-wake cycling over constant wakefulness is computed by comparing stable limit cycles for systems of differential equations. A primary objective is to compare potential energy savings derived from state-dependent metabolic partitioning versus metabolic rate reduction. Additionally, energy conservation from sleep quota and the circadian system are also quantified in relation to a continuous wake condition. As a function of metabolic partitioning, our calculations show that coupling of metabolic operations with behavioral state may provide comparatively greater energy savings than the measured decrease in metabolic rate, suggesting that actual energy savings derived from sleep may be more than 4-fold greater than previous estimates. A combination of state-dependent metabolic partitioning and modest metabolic rate reduction during sleep may enhance energy savings beyond what is achievable through metabolic partitioning alone; however, the relative contribution from metabolic partitioning diminishes as metabolic rate is decreased during the rest phase. Sleep quota and the circadian system further augment energy savings in the model. Finally, we propose that state-dependent resource allocation underpins both sleep homeostasis and the optimization of daily energy conservation across species. This new paradigm identifies an evolutionary selective advantage for the upregulation of central and peripheral biological processes during sleep, presenting a unifying construct to understand sleep function.	[Schmidt, Markus H.] Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Schmidt, Markus H.] Ohio Sleep Med & Neurosci Inst, Dublin, OH 43017 USA; [Swang, Theodore W.; Hamilton, Ian M.; Best, Janet A.] Ohio State Univ, Dept Math, Columbus, OH 43210 USA; [Hamilton, Ian M.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University of Bern; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schmidt, MH (corresponding author), Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland.; Schmidt, MH (corresponding author), Ohio Sleep Med & Neurosci Inst, Dublin, OH 43017 USA.	mschmidt@sleepmedicine.com	Hamilton, Ian Michael/A-4949-2012	Hamilton, Ian Michael/0000-0002-1198-3431; Schmidt, Markus/0000-0002-3299-1318	NSF CAREER Award [DMS-0956057]; Mathematical Biosciences Institute through NSF [DMS-0931642]; Inselspital; Ohio Sleep Medicine and Neuroscience Institute	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Mathematical Biosciences Institute through NSF; Inselspital; Ohio Sleep Medicine and Neuroscience Institute	Research was supported by NSF CAREER Award DMS-0956057 to Janet A. Best, by the Mathematical Biosciences Institute through NSF grant DMS-0931642, by Inselspital, and by the Ohio Sleep Medicine and Neuroscience Institute. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Carol Everson, Mark Blumberg, and Howard Roffwarg for reviewing and commenting on the manuscript. Research supported by NSF CAREER Award DMS-0956057, by the Mathematical Biosciences Institute through NSF under grant DMS-0931642, by Inselspital, and by the Ohio Sleep Medicine and Neuroscience Institute.	ALLISON T, 1970, Natural History, V79, P56; Arnardottir ES, 2014, SLEEP, V37, P1589, DOI 10.5665/sleep.4064; Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Aulsebrook AE, 2016, TRENDS ECOL EVOL, V31, P590, DOI 10.1016/j.tree.2016.05.004; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BERGER RJ, 1995, BEHAV BRAIN RES, V69, P65, DOI 10.1016/0166-4328(95)00002-B; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Everson CA, 2014, SLEEP, V37, P1929, DOI 10.5665/sleep.4244; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Gallopin T, 2005, NEUROSCIENCE, V134, P1377, DOI 10.1016/j.neuroscience.2005.05.045; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Home J. A., 1988, WHY WE SLEEP FUNCTIO; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jung CM, 2011, J PHYSIOL-LONDON, V589, P235, DOI 10.1113/jphysiol.2010.197517; Kortner G, 2000, CHRONOBIOL INT, V17, P103, DOI 10.1081/CBI-100101036; Krueger JM, 2016, SLEEP MED REV, V28, P46, DOI 10.1016/j.smrv.2015.08.005; Krueger JM, 1999, SLEEP MED REV, V3, P119, DOI 10.1016/S1087-0792(99)90019-9; Lesku JA, 2008, SLEEP MED REV, V12, P229, DOI 10.1016/j.smrv.2007.10.003; Lesku JA, 2006, AM NAT, V168, P441, DOI 10.1086/506973; Mackiewicz M, 2009, TRENDS MOL MED, V15, P79, DOI 10.1016/j.molmed.2008.12.002; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; McCauley P, 2009, J THEOR BIOL, V256, P227, DOI 10.1016/j.jtbi.2008.09.012; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Nijhout HF, 2014, MATH BIOSCI, V257, P104, DOI 10.1016/j.mbs.2014.08.015; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Ruf T, 2015, BIOL REV, V90, P891, DOI 10.1111/brv.12137; Schmidt MH, 2014, NEUROSCI BIOBEHAV R, V47, P122, DOI 10.1016/j.neubiorev.2014.08.001; Schubert KA, 2010, BIOL LETTERS, V6, P132, DOI 10.1098/rsbl.2009.0569; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; WHITE DP, 1985, J APPL PHYSIOL, V59, P384, DOI 10.1152/jappl.1985.59.2.384; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zepelin, 1989, MAMMALIAN SLEEP; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330	42	27	27	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185746	10.1371/journal.pone.0185746	http://dx.doi.org/10.1371/journal.pone.0185746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016625	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400028
J	DaSilva, JK; Husain, E; Lei, YL; Mann, GL; Morrison, AR; Tejani-Butt, S				DaSilva, Jamie K.; Husain, Eram; Lei, Yanlin; Mann, Graziella L.; Morrison, Adrian R.; Tejani-Butt, Shanaz			Social partnering alters sleep in fear-conditioned Wistar rats	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SHORT-TERM HOMEOSTASIS; REM-SLEEP; DEPRIVATION; ENVIRONMENT; SUPPORT; BRAIN; IMMOBILIZATION; DISTURBANCES; ARCHITECTURE	Social support, when provided following a traumatic experience, is associated with a lower incidence of stress-related psychiatric disorders. Our hypothesis was that providing a social interaction period with a naive conspecific would improve sleep architecture in response to cued fear conditioning in Wistar rats. Rats were randomly assigned to either the socially isolated or socially partnered groups. Rats assigned to the socially isolated group were individually housed following electrode implantation and fear conditioning. Rats assigned to the socially partnered group were initially paired-housed, and then one rat from each pair was randomly chosen for sleep electrode implantation and fear conditioning. Rats from both groups were habituated to a recording chamber, and baseline sleep was recorded over 22 hours. One day later (Training Day), they were fear-conditioned to 10 presentations of a tone (800 Hz, 90 dB, 5 sec) co-terminating with a mild electric foot shock (1.0 mA, 0.5 sec), at 30-sec intervals. While rats in the socially isolated group were left undisturbed in their home cage for 30-min, socially partnered rats interacted for 30 minutes with their non-stressed rat partner immediately after fear conditioning and while the auditory tones were presented on Days 1 and 14. The results indicated that social interaction increased sleep efficiency in partnered rats compared to isolated rats following the fear conditioning procedure. This was due to an increase in the amount of rapid eye movement sleep (REMS) during the light phase. Evaluation of REMS microarchitecture revealed that the increase in REMS was due to an increase in the number of single REMS episodes (siREMS), which represented a more consolidated REMS pattern. A surprising finding was that partnered rats had a greater number of sequential REMS episodes (seqREMS) at Baseline, on the Training Day and on Day 1 when compared to isolated rats. The greater number of seqREMS episodes in partnered rats may be due to the partnering procedure and not fear conditioning, as the effect was also seen at Baseline. Thus it appears that while the partnering procedure may have given rise to a fragmented REMS pattern, social partnering promoted a greater consolidation of REMS in response to the fear conditioning procedure.	[DaSilva, Jamie K.; Husain, Eram; Lei, Yanlin; Tejani-Butt, Shanaz] Univ Sci, Dept Pharmaceut Sci, Philadelphia, PA 19104 USA; [Mann, Graziella L.; Morrison, Adrian R.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [DaSilva, Jamie K.] Pfizer Inc, Drug Safety Res & Dev, Groton, CT USA; [Husain, Eram] Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk, Saudi Arabia	University of Pennsylvania; Pfizer; University of Tabuk	Tejani-Butt, S (corresponding author), Univ Sci, Dept Pharmaceut Sci, Philadelphia, PA 19104 USA.	s.tejani@usciences.edu		DaSilva, Jamie/0000-0003-2820-5377	United States Public Health Service [MH072897, MH090541]	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was funded by United States Public Health Service grants MH072897 to Adrian R. Morrison and MH090541 to Shanaz Tejani-Butt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1992, PHYSIOL BEHAV, V51, P345, DOI 10.1016/0031-9384(92)90151-Q; Adolphs R, 2002, NAT NEUROSCI, V5, P192, DOI 10.1038/nn0302-192; AMICI R, 1994, J SLEEP RES, V3, P250, DOI 10.1111/j.1365-2869.1994.tb00139.x; ARMARIO A, 1983, BEHAV NEURAL BIOL, V37, P332, DOI 10.1016/S0163-1047(83)91425-5; ARMARIO A, 1983, EXPERIENTIA, V39, P1316, DOI 10.1007/BF01990391; Beattie L, 2015, SLEEP MED REV, V24, P83, DOI 10.1016/j.smrv.2014.12.005; BROWNELL A, 1984, J SOC ISSUES, V40, P1, DOI 10.1111/j.1540-4560.1984.tb01104.x; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; CESPUGLIO R, 1995, ADV NEUROIMMUNOL, V5, P145, DOI 10.1016/0960-5428(95)00005-M; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Dasilva JK, 2011, NEUROSCIENCE, V199, P193, DOI 10.1016/j.neuroscience.2011.09.066; DaSilva JK, 2011, PROG NEURO-PSYCHOPH, V35, P67, DOI 10.1016/j.pnpbp.2010.08.023; Descamps A, 2010, BRAIN RES, V1335, P14, DOI 10.1016/j.brainres.2010.03.087; DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780; Fanselow M.S., 1988, P185; Febinger HY, 2014, J AM ASSOC LAB ANIM, V53, P29; Friedman EM, 2005, P NATL ACAD SCI USA, V102, P18757, DOI 10.1073/pnas.0509281102; HATCH AM, 1965, TOXICOL APPL PHARM, V7, P737, DOI 10.1016/0041-008X(65)90132-8; Iversen AC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-68; Jha SK, 2005, EUR J NEUROSCI, V21, P1077, DOI 10.1111/j.1460-9568.2005.03920.x; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim-Cohen J, 2004, CHILD DEV, V75, P651, DOI 10.1111/j.1467-8624.2004.00699.x; Kiyokawa Y, 2007, EUR J NEUROSCI, V26, P3606, DOI 10.1111/j.1460-9568.2007.05969.x; Lincoln KD, 2000, SOC SERV REV, V74, P231, DOI 10.1086/514478; Madan V, 2008, SLEEP, V31, P497, DOI 10.1093/sleep/31.4.497; Marinesco S, 1999, NEUROSCIENCE, V92, P921, DOI 10.1016/S0306-4522(99)00045-7; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Ocampo-Garces A, 2002, J SLEEP RES, V11, P81, DOI 10.1046/j.1365-2869.2002.00281.x; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; Pietrzak RH, 2010, J PSYCHOSOM RES, V69, P441, DOI 10.1016/j.jpsychores.2010.07.002; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P745, DOI 10.1002/da.20558; Platt J, 2013, COMP PSYCH, V54, pe33; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; RAMPIN C, 1991, NEUROSCI LETT, V126, P113, DOI 10.1016/0304-3940(91)90532-X; Rosen JB, 2006, BEHAV NEUROSCI, V120, P290, DOI 10.1037/0735-7044.120.2.290; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Seeman TE, 1996, PSYCHOSOM MED, V58, P459, DOI 10.1097/00006842-199609000-00008; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Suchecki D., 2009, SLEEP, V2, P151; VIVALDI EA, 1994, J NEUROPHYSIOL, V72, P1745; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Wellman LL, 2008, SLEEP, V31, P1035	50	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186017	10.1371/journal.pone.0186017	http://dx.doi.org/10.1371/journal.pone.0186017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982125	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300109
J	Martins, MT; Sardenberg, F; Bendo, CB; Abreu, MH; Vale, MP; Paiva, SM; Pordeus, IA				Martins, Milene T.; Sardenberg, Fernanda; Bendo, Cristiane B.; Abreu, Mauro Henrique; Vale, Miriam P.; Paiva, Saul M.; Pordeus, Isabela A.			Dental caries remains as the main oral condition with the greatest impact on children's quality of life	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; SOUTHERN BRAZIL; ADOLESCENTS; INEQUALITIES; MALOCCLUSION	Purpose The objective of this study was to assess the negative impact of dental caries on the OHRQoL of 8- to 10-year-old Brazilian children. Methods This population-based case-control study involved 546 children (8-10 years old), 182 cases with a high negative impact on OHRQoL and 364 controls with a low negative impact on OHRQoL. Children's OHRQOL was measured using the Child Perceptions Questionnaire (CPQ8-10). Cases and controls (1x2 ratio) were individually matched by school and gender. Dental caries experience, malocclusion, and traumatic dental injuries were used as independent variables. Dental examinations were carried out at school during daytime hours by two calibrated examiners (Kappa = 0.93-interexaminer and 0.95-intraexaminer). The data were analyzed by descriptive statistics, conditional bivariate and multiple logistic regression, with the significance level set at 5%. Results There was no significant difference in traumatic dental injuries and malocclusion between the case and control groups (p>0.05). Children with DMFT/dmft >= 3 had a 2.06-fold (95% CI = 1.28-3.31, p = 0.003) greater chance of experiencing a high negative impact on OHRQoL than those with DMFT/dmft = 0 Conclusion Children with high dental caries experience are more likely to present a high negative impact on OHRQoL than those with no dental caries experience.	[Martins, Milene T.; Sardenberg, Fernanda; Bendo, Cristiane B.; Vale, Miriam P.; Paiva, Saul M.; Pordeus, Isabela A.] Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Martins, Milene T.] Estadual Univ Montes Claros, Sch Dent, Dept Pediat Dent, Montes Claros, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Fac Dent, Dept Social & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Martins, MT (corresponding author), Univ Fed Minas Gerais, Sch Dent, Dept Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.; Martins, MT (corresponding author), Estadual Univ Montes Claros, Sch Dent, Dept Pediat Dent, Montes Claros, Brazil.	mileneelaura@yahoo.com.br	Paiva, Saul Martins/H-5757-2012; Bendo, Cristiane Baccin/H-5835-2012; Abreu, Mauro Henrique/G-6502-2012; PORDEUS, ISABELA A/B-1570-2013	Paiva, Saul Martins/0000-0002-3968-1638; Bendo, Cristiane Baccin/0000-0003-4849-8779; Abreu, Mauro Henrique/0000-0001-8794-5725; PORDEUS, ISABELA A/0000-0002-5902-7481	National Council for Scientific and Technological Development (CNPq); Ministry of Science and Technology, Brazil [161325/2015-7]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Technology, Brazil	This study was supported by the National Council for Scientific and Technological Development (CNPq), by the Ministry of Science and Technology, Brazil (161325/2015-7). MTM received a scholarship for 17 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen JO, 2007, TXB COLOR ATLAS TRAU, V4th; Barbosa TD, 2016, ORAL HLTH PREV DENT, V14, P137, DOI 10.3290/j.ohpd.a35301; Barbosa TD, 2013, ARCH ORAL BIOL, V58, P1070, DOI 10.1016/j.archoralbio.2013.01.012; Barretto EDR, 2004, PEDIATR DENT, V26, P485; Bendo CB, 2014, INT J PAEDIATR DENT, V24, P387, DOI 10.1111/ipd.12083; Bendo CB, 2014, COMMUNITY DENT ORAL, V42, P216, DOI 10.1111/cdoe.12078; Bonanato K, 2010, ORAL HLTH PREV DENT, V8, P125; Cons NC., 1986, DAI THE DENT AESTHET; Costa SD, 2013, CIENC SAUDE COLETIVA, V18, P461, DOI 10.1590/S1413-81232013000200017; Peres SHDS, 2008, CIENC SAUDE COLETIVA, V13, P2155, DOI 10.1590/S1413-81232008000900020; Edelstein BL, 2006, BMC ORAL HLTH, V15; Firmino RT, 2016, INT J PAEDIATR DENT, V26, P242, DOI 10.1111/ipd.12182; Freire-Maia FB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135369; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kramer PF, 2015, INT J PAEDIATR DENT, V25, P383, DOI 10.1111/ipd.12140; Leal SC, 2012, CARIES RES, V46, P102, DOI 10.1159/000336387; Levin Kate Ann, 2006, Evid Based Dent, V7, P83, DOI 10.1038/sj.ebd.6400436; Marques LS, 2006, AM J ORTHOD DENTOFAC, V129, P424, DOI 10.1016/j.ajodo.2005.11.003; Martins MT, 2009, EUR J PAEDIATR DENT, V10, P135; Martins MT, 2014, COMMUNITY DENT ORAL, V42, P289, DOI 10.1111/cdoe.12087; Martins MT, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0133; Martins-Junior P A, 2012, Pediatr Dent, V34, P49; Moura-Leite FR, 2011, EUR ARCH PAEDIATR DE, V12, P293, DOI 10.1007/BF03262826; Narvai PC, 2006, REV PANAM SALUD PUBL, V19, P385, DOI 10.1590/S1020-49892006000600004; Norusis MJ, 2008, SPSS STAT 17 0 ADV S; Oliveira DC, 2015, ORAL HLTH PREV DENT, V13, P417, DOI 10.3290/j.ohpd.a33922; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Roncalli AG, 2015, COMMUNITY DENT ORAL, V43, P317, DOI 10.1111/cdoe.12156; Melo RR, 2013, EUR J PAEDIATR DENT, V14, P8; Sardenberg F, 2013, ANGLE ORTHOD, V83, P83, DOI 10.2319/010912-20.1; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	32	28	28	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185365	10.1371/journal.pone.0185365	http://dx.doi.org/10.1371/journal.pone.0185365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981545	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300036
J	Robles-Fernandez, I; Martinez-Gonzalez, LJ; Pascual-Geler, M; Cozar, JM; Puche-Sanz, I; Serrano, MJ; Lorente, JA; Alvarez-Cubero, MJ				Robles-Fernandez, Inmaculada; Javier Martinez-Gonzalez, Luis; Pascual-Geler, Manrique; Manuel Cozar, Jose; Puche-Sanz, Ignacio; Jose Serrano, Maria; Antonio Lorente, Jose; Jesus Alvarez-Cubero, Maria			Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; GENETIC POLYMORPHISMS; CELL-PROLIFERATION; RISK; CYP17A1; PATHWAY; SINGLE	Novel biomarkers for prostate cancer (PCa) diagnosis and prognosis are necessary to improve the accuracy of current ones employed in clinic. We performed a retrospective study between the association of several polymorphisms in the main genes involved in the synthesis and metabolism of sex hormones and PCa risk and aggressiveness. A total of 311 Caucasian men (155 controls and 156 patients) were genotyped for 9 SNPs in AR, CYP17A1, LHCGR, ESR1 and ESR2 genes. Diagnostic PSA serum levels, Gleason score, tumor stage, D A Amico risk and data of clinical progression were obtained for patients at the moment of the diagnosis and after 54 months of follow-up. Chi-squared test were used for comparisons between clinical variables groups, logistic regression for clinical variables associations between SNPs; and Kaplan-Meier for the association between SNPs and time to biochemical progression. We found 5 variants (CYP17A1) rs743572, rs6162, rs6163; (LHCGR) rs2293275 and (ESR2) rs1256049 that were statistically significant according to clinical variables (PSA, D A Amico risk and T stage) on a case-case analysis. Moreover, the presence of A and G alleles in rs743572 and rs6162 respectively, increase the risk of higher PSA levels (>10 ng/mu l). With respect to D A Amico risk rs743572 (AG-GG), rs6162 (AG-AA) and rs6163 (AC-AA) were associated with an increased risk; and last, AC and AA genotypes for rs6163 were associated with a shorter biochemical recurrence free survival (BRFS) in patients with radical prostatectomy. In multigene analysis, several variants in SNPs rs2293275, rs6152, rs1062577, rs6162, rs6163, rs1256049 and rs1004467 were described to be associated with a more aggressiveness in patients. However, none of the selected SNPs show significant values between patients and controls. In conclusion, this study identified inherited variants in genes CYP17A1, LHCGR and ESR2 related to more aggressiveness and/or a poor progression of the disease. According to this study, new promise PCa biomarkers for clinical management could be included in these previous SNPs.	[Robles-Fernandez, Inmaculada; Javier Martinez-Gonzalez, Luis; Jose Serrano, Maria; Antonio Lorente, Jose; Jesus Alvarez-Cubero, Maria] Univ Granada, Andalusian Reg Govt, Pfizer, GENYO,Ctr Genom & Oncol Res, Granada, Spain; [Javier Martinez-Gonzalez, Luis; Pascual-Geler, Manrique; Manuel Cozar, Jose; Puche-Sanz, Ignacio] Univ Hosp Virgen de las Nieves, Urol Dept, Granada, Spain; [Jose Serrano, Maria] Clin Univ Hospital, Integral Oncol Div, Granada, Spain; [Antonio Lorente, Jose] Univ Granada, Fac Med, Dept Legal Med, Lab Genet Identificat, Granada, Spain; [Jesus Alvarez-Cubero, Maria] Univ Granada, Fac Sci, Cell Biol Dept, Granada, Spain	Pfizer; University of Granada; Hospital Universitario Virgen de las Nieves; University of Granada; University of Granada	Alvarez-Cubero, MJ (corresponding author), Univ Granada, Andalusian Reg Govt, Pfizer, GENYO,Ctr Genom & Oncol Res, Granada, Spain.; Alvarez-Cubero, MJ (corresponding author), Univ Granada, Fac Sci, Cell Biol Dept, Granada, Spain.	mjesusac@ugr.es	Cubero, Maria Jesus Alvarez/M-2892-2015; Robles-Fernandez, Inmaculada/L-3531-2017; Martinez-Gonzalez, Luis Javier/L-6136-2014; LORENTE, JOSE A./B-8372-2008; Puche-Sanz, Ignacio/J-3086-2013	Cubero, Maria Jesus Alvarez/0000-0002-5492-9355; Robles-Fernandez, Inmaculada/0000-0002-3107-9474; Martinez-Gonzalez, Luis Javier/0000-0003-2202-0662; LORENTE, JOSE A./0000-0002-9892-7386; Puche-Sanz, Ignacio/0000-0003-4121-0162				Alukal JP, 2016, UROL CLIN N AM, V43, P203, DOI 10.1016/j.ucl.2016.01.013; [Anonymous], INF NCFB; Audet-Walsh E, 2012, EUR UROL, V62, P88, DOI 10.1016/j.eururo.2011.12.021; Audet-Walsh E, 2011, EUR UROL, V60, P1226, DOI 10.1016/j.eururo.2011.06.020; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Brureau L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153609; Colicchia M, 2017, EXPERT REV MOL DIAGN, V17, P367, DOI 10.1080/14737159.2017.1302332; Dai ZJ, 2014, INT J CLIN EXP MED, V7, P5031; Disciglio V, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0115-1; El Ezzi Asmahan A, 2017, Asian Pac J Cancer Prev, V18, P93; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu CY, 2014, TUMOR BIOL, V35, P8319, DOI 10.1007/s13277-014-2086-7; Fujimoto N, 2017, CLIN GENITOURIN CANC, V15, P337, DOI 10.1016/j.clgc.2017.01.006; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Hart SN, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010332; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Helfand BT, 2015, CURR OPIN UROL, V25, P53, DOI 10.1097/MOU.0000000000000130; Hua X, 2016, AM J CANCER RES, V6, P1650; Ingles SA, 2013, INT J MOL EPIDEMIOL, V4, P228; Irshad S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006408; Alvarez-Cubero MJ, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.05.018; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Lau KM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091434; Levesque E, 2013, CLIN CANCER RES, V19, P699, DOI 10.1158/1078-0432.CCR-12-2812; Maia S, 2016, FAM CANCER, V15, P111, DOI 10.1007/s10689-015-9832-x; Narita S, 2015, INT J UROL, V22, P1029, DOI 10.1111/iju.12898; Oh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104146; Poniah P, 2015, INT J CLIN EXP MED, V8, P19232; Ramos-Montoya A, 2014, EMBO MOL MED, V6, P651, DOI 10.1002/emmm.201303581; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Stelloo S, 2015, EMBO MOL MED, V7, P1450, DOI 10.15252/emmm.201505424; Tao S, 2016, AM J TRANSL RES, V8, P1659; Udhane SS, 2016, BIOCHEM BIOPH RES CO, V477, P1005, DOI 10.1016/j.bbrc.2016.07.019; Van den Broeck T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627510; Wang Y, QUANTITATIVE ASSESSM; Weng H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40554; Wright JL, 2010, PROSTATE, V70, P1094, DOI 10.1002/pros.21143; Xu J, 2017, METHODS COMPOSITIONS; Xu JF, 2010, P NATL ACAD SCI USA, V107, P2136, DOI 10.1073/pnas.0914061107; Yamada T, 2013, INT J CLIN ONCOL, V18, P711, DOI 10.1007/s10147-012-0430-8	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185447	10.1371/journal.pone.0185447	http://dx.doi.org/10.1371/journal.pone.0185447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981526	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300039
J	Simak, M; Yeang, CH; Lu, HHS				Simak, Maria; Yeang, Chen-Hsiang; Lu, Henry Horng-Shing			Exploring candidate biological functions by Boolean Function Networks for Saccharomyces cerevisiae	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; MARKOV BLANKET INDUCTION; TIME-SERIES DATA; EXPRESSION PROGRAMS; FEATURE-SELECTION; CAUSAL DISCOVERY; STEADY-STATE; LOCAL CAUSAL; RECONSTRUCTION; MODEL	The great amount of gene expression data has brought a big challenge for the discovery of Gene Regulatory Network (GRN). For network reconstruction and the investigation of regulatory relations, it is desirable to ensure directness of links between genes on a map, infer their directionality and explore candidate biological functions from high-throughput transcriptomic data. To address these problems, we introduce a Boolean Function Network (BFN) model based on techniques of hidden Markov model (HMM), likelihood ratio test and Boolean logic functions. BFN consists of two consecutive tests to establish links between pairs of genes and check their directness. We evaluate the performance of BFN through the application to S. cerevisiae time course data. BFN produces regulatory relations which show consistency with succession of cell cycle phases. Furthermore, it also improves sensitivity and specificity when compared with alternative methods of genetic network reverse engineering. Moreover, we demonstrate that BFN can provide proper resolution for GO enrichment of gene sets. Finally, the Boolean functions discovered by BFN can provide useful insights for the identification of control mechanisms of regulatory processes, which is the special advantage of the proposed approach. In combination with low computational complexity, BFN can serve as an efficient screening tool to reconstruct genes relations on the whole genome level. In addition, the BFN approach is also feasible to a wide range of time course datasets.	[Simak, Maria] Acad Sinica, Inst Informat Sci, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Simak, Maria; Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan; [Yeang, Chen-Hsiang] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Lu, Henry Horng-Shing] Natl Chiao Tung Univ, Big Data Res Ctr, Hsinchu, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Lu, HHS (corresponding author), Natl Chiao Tung Univ, Inst Stat, Hsinchu, Taiwan.; Lu, HHS (corresponding author), Natl Chiao Tung Univ, Big Data Res Ctr, Hsinchu, Taiwan.	hslu@stat.nctu.edu.tw	Yeang, Chen-Hsiang/AAP-2962-2021		Ministry of Science and Technology [105-2118-M-009-003-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study is supported by the research grant from Ministry of Science and Technology, No. 105-2118-M-009-003-MY2 to Henry Horng-Shing Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2016, MOL BIOL CELL, V27, P1383, DOI 10.1091/mbc.E14-05-1013; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Butte A J, 2000, Pac Symp Biocomput, P418; De Caluwe J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00074; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gene Expression Omnibus [GEO], GENE EXPRESSION OMNI; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kauffman S.A., 1993, ORIGINS ORDER; KEGG, KYOTO ENCY GENES GEN; Lahdesmaki H, 2003, MACH LEARN, V52, P147, DOI 10.1023/A:1023905711304; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lebre S., 2013, G1DBN PACKAGE PERFOR; Liang S, 1998, Pac Symp Biocomput, P18; Ma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106479; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Narendra V, 2011, GENOMICS, V97, P7, DOI 10.1016/j.ygeno.2010.10.003; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; RNA, RNA SEQ ATLAS REFERE; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Vijesh N, 2013, J BIOMED SCI ENG, V6, P223, DOI DOI 10.4236/JBISE.2013.62A027; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Xiao YF, 2009, CURR GENOMICS, V10, P511, DOI 10.2174/138920209789208237; Yeung KY, 2011, P NATL ACAD SCI USA, V108, P19436, DOI 10.1073/pnas.1116442108	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185475	10.1371/journal.pone.0185475	http://dx.doi.org/10.1371/journal.pone.0185475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981547	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300041
J	Wu, MS; Rawal, S				Wu, Margaret Siyu; Rawal, Shail			"It's the difference between life and death": The views of professional medical interpreters on their role in the delivery of safe care to patients with limited English proficiency	PLOS ONE			English	Article							LENGTH-OF-STAY; HEALTH-CARE; LANGUAGE BARRIERS; PHYSICIANS; EMERGENCY; OUTCOMES; EVENTS; ERRORS; IMPACT; RATES	Background Patients with limited English proficiency (LEP) experience poorer quality care and more adverse events in hospital. Consequently, there is interest in understanding the role of professional medical interpreters in efforts to improve patient safety. Objective To describe the views of professional medical interpreters on their role in the delivery of safe patient care. Design Qualitative analysis of in-depth semi-structured interviews. Participants 15 professional medical interpreters affiliated with the Healthcare Interpretation Network in Toronto, Canada. Approach Participants' views on their role in patient safety were analyzed and organized into themes. Key results Professional medical interpreters described being uniquely situated to identify and prevent adverse events involving patients with LEP by: 1) facilitating communication and enhancing patients' comprehension, 2) giving voice to patients, and 3) speaking up about safety concerns. Participants described a tension between 'speaking up' and interpreters' ethical imperative to remain impartial. Interpreters also highlighted several challenges, including 4) medical hierarchy and healthcare providers' limited knowledge of the role of interpreters. These challenges introduced safety issues if providers asked interpreters to act outside of their scope of practice. Conclusions Our study found that professional medical interpreters view their work as integral to the delivery of safe care to patients with LEP. In order to effectively engage in patient safety efforts together, interpreters and providers require a mutual understanding of their roles. Team hierarchy and limited provider knowledge of the role of interpreters can introduce safety concerns. In addition, interpreters describe a tension between "speaking up" about patient safety and the need for interpreters to remain impartial when facilitating communication. Healthcare institutions, providers, and interpreters must engage in discussion on how to best to "speak up" and integrate interpreters into safety efforts. Importantly, the benefits of partnering with interpreters can only be realized when providers consistently use their services.	[Wu, Margaret Siyu] Univ Toronto, Fac Med, Toronto, ON, Canada; [Rawal, Shail] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada; [Rawal, Shail] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Health Network Toronto; University of Toronto	Rawal, S (corresponding author), Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada.; Rawal, S (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	shail.rawal@uhn.ca			HoPingKong Centre for Excellence in Education and Practice at the University of Toronto	HoPingKong Centre for Excellence in Education and Practice at the University of Toronto	SR held a Fellowship with the HoPingKong Centre for Excellence in Education and Practice at the University of Toronto at the time of this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FOC GEOGR SER 2011 C; Betancourt JR, 2012, IMPROVING PATIENT SA; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Carbone E, 2003, LEG REV COMMENT  MAY; Cohen AL, 2005, PEDIATRICS, V116, P575, DOI 10.1542/peds.2005-0521; Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7; Divi C, 2007, INT J QUAL HEALTH C, V19, P60, DOI 10.1093/intqhc/mzl069; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Flores G, 2003, PEDIATRICS, V111, P6, DOI 10.1542/peds.111.1.6; Hampers LC, 1999, PEDIATRICS, V103, P1253, DOI 10.1542/peds.103.6.1253; Hsieh E, 2006, SOC SCI MED, V62, P721, DOI 10.1016/j.socscimed.2005.06.029; Hsieh E, 2008, QUAL HEALTH RES, V18, P1367, DOI 10.1177/1049732308323840; Jiang HJ, 2005, AM J PUBLIC HEALTH, V95, P1561, DOI 10.2105/AJPH.2004.044222; John-Baptiste A, 2004, J GEN INTERN MED, V19, P221, DOI 10.1111/j.1525-1497.2004.21205.x; Karliner LS, 2007, HEALTH SERV RES, V42, P727, DOI 10.1111/j.1475-6773.2006.00629.x; Karliner LS, 2010, J HOSP MED, V5, P276, DOI 10.1002/jhm.658; Lindholm M, 2012, J GEN INTERN MED, V27, P1294, DOI 10.1007/s11606-012-2041-5; Lopez L, 2015, J GEN INTERN MED, V30, P783, DOI 10.1007/s11606-015-3213-x; Messias DKH, 2009, ADV NURS SCI, V32, P128, DOI 10.1097/ANS.0b013e3181a3af97; Patients With Limited English Proficiency, 2012, PAT LIM ENGL PROF; Price-Wise G., 2008, HEALTHAFFAIRS BLOG; Ryan C., 2013, LANGUAGE USE US 2011, P22; Strauss A., 1990, BASICS QUALITATIVE R; Wasserman M, 2014, J HEALTHC QUAL, V36, P5, DOI 10.1111/jhq.12065; Waxman MA, 2000, ANN EMERG MED, V36, P456, DOI 10.1067/mem.2000.108315; Wilson E, 2005, J GEN INTERN MED, V20, P800, DOI 10.1111/j.1525-1497.2005.0174.x	26	10	10	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185659	10.1371/journal.pone.0185659	http://dx.doi.org/10.1371/journal.pone.0185659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28982158	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300054
J	Alisic, E; Groot, A; Snetselaar, H; Stroeken, T; van de Putte, E				Alisic, Eva; Groot, Arend; Snetselaar, Hanneke; Stroeken, Tielke; van de Putte, Elise			Children bereaved by fatal intimate partner violence: A population-based study into demographics, family characteristics and homicide exposure	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DOMESTIC VIOLENCE; GLOBAL PREVALENCE; RISK; FEMICIDE; METAANALYSIS; WITNESS; SYSTEMS; MURDER; HEALTH	Background In the context of violence against women, intimate partner homicide increasingly receives research and policy attention. Although the impact of losing a parent due to intimate partner homicide is intuitively obvious, little is known about the children involved. We aimed to identify all children bereaved by parental intimate partner homicide in the Netherlands in the period 2003-2012, describe their demographics and family circumstances, and assess their exposure to prior violence at home and to the homicide itself. Methods and findings We cross-examined 8 national data sources and extracted data about children's demographics and circumstances prior to, and during the homicide. Our primary outcomes were prior violence at home (child maltreatment, neglect or domestic violence) and homicide witness status (ranging from being at a different location altogether to being present at the scene). During the decade under study, 256 children lost a biological parent due to 137 cases of intimate partner homicide. On average, the children were 7.4 years old at the time of the homicide (51.1% were boys; 95% CI 47.3-54.7) and most lost their mother (87.1%; full population data). Immigrant children were overrepresented (59.4%; 95% CI 52.8-66.0). Of the children for whom information about previous violence at home was gathered, 67.7% (95% CI 59.7-73.7) were certainly exposed and 16.7% (95% CI 11.3-22.2) probably. Of the children who had certainly been exposed, 43.1% (95% CI 41.1-60.9) had not received social services or mental health care. The majority of the children (58.7%; 95% CI 52.1-65.3) were present at the location of the homicide when the killing took place, with varying levels of exposure. Homicide weapons mostly involved cutting weapons and firearms, leading to graphic crime scenes. Conclusions Care providers need capacity not only to help children cope with the sudden loss of a parent but also with unaddressed histories of domestic violence and exposure to graphic homicide scenes, in a culture-sensitive way. Future directions include longitudinal monitoring of children's mental health outcomes and replication in other countries.	[Alisic, Eva] Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia; [Alisic, Eva; Groot, Arend; Snetselaar, Hanneke; Stroeken, Tielke] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Psychotrauma Ctr, Utrecht, Netherlands; [van de Putte, Elise] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands	Monash University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Alisic, E (corresponding author), Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia.; Alisic, E (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Psychotrauma Ctr, Utrecht, Netherlands.	eva.alisic@monash.edu		Alisic, Eva/0000-0002-7225-606X	Dutch Research and Documentation Centre (Ministry of Security and Justice) [2382]; Australian National Health and Medical Research Council [1090229]	Dutch Research and Documentation Centre (Ministry of Security and Justice); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Dutch Research and Documentation Centre (Ministry of Security and Justice, #2382: www.wodc.nl; PI: EA), the Prof. H.A. Weijers Stichting (no website, PI: EA) and the Australian National Health and Medical Research Council (#1090229; https://www.nhmrc.gov.au/to EA). The Dutch Research and Documentation Centre required and facilitated a study advisory board which provided feedback throughout the phases of design, data collection, and analysis of the preliminary results, but not during the preparation, review, or approval of the current manuscript. The other funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abrahams N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001412; Alisic E, 2015, CLIN CHILD FAM PSYCH, V18, P328, DOI 10.1007/s10567-015-0193-7; Alisic E, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0565-z; [Anonymous], 2016, POP KEY FIG; Armour M. P., 2011, INT PERSPECT VICT, V5, DOI [https://doi.org/10.5364/ipiv.5.2.22, DOI 10.5364/IPIV.5.2.22]; Ben-David V, 2015, CHILD ABUSE NEGLECT, V46, P132, DOI 10.1016/j.chiabu.2015.01.013; BLACK D, 1992, PSYCHOTHER PSYCHOSOM, V57, P152, DOI 10.1159/000288592; Campbell JC, 2007, TRAUMA VIOLENCE ABUS, V8, P246, DOI 10.1177/1524838007303505; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Carroll AE, 2015, JAMA-J AM MED ASSOC, V314, P1105, DOI 10.1001/jama.2015.11233; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Echeburua E, 2009, J INTERPERS VIOLENCE, V24, P925, DOI 10.1177/0886260508319370; ETH S, 1994, PSYCHIATRY, V57, P287; Frye V, 2008, AM J PUBLIC HEALTH, V98, P1473, DOI 10.2105/AJPH.2007.112813; GAENSBAUER T, 1995, J AM ACAD CHILD PSY, V34, P520, DOI 10.1097/00004583-199504000-00019; Hardesty JL, 2008, J FAM ISSUES, V29, P100, DOI 10.1177/0192513X07307845; Harris-Hendriks J, 2002, FATHER KILLS MOTHER; Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1; Holt S, 2008, CHILD ABUSE NEGLECT, V32, P797, DOI 10.1016/j.chiabu.2008.02.004; Jewkes R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001761; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Knox J., 2001, CLIN CHILD PSYCHOL P, V6, P9, DOI DOI 10.1177/1359104501006001003; Ko SJ, 2008, PROF PSYCHOL-RES PR, V39, P396, DOI 10.1037/0735-7028.39.4.396; Lewandowski LA, 2004, J FAM VIOLENCE, V19, P211, DOI 10.1023/B:JOFV.0000032631.36582.23; Lovrin M, 1999, J Child Adolesc Psychiatr Nurs, V12, P110, DOI 10.1111/j.1744-6171.1999.tb00056.x; Machisa MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150986; MALMQUIST CP, 1986, J AM ACAD CHILD PSY, V25, P320, DOI 10.1016/S0002-7138(09)60253-3; Milaniak I, 2015, PSYCHOL VIOLENCE, V5, P246, DOI 10.1037/a0037956; Morina N, 2016, CLIN PSYCHOL REV, V47, P41, DOI 10.1016/j.cpr.2016.05.006; Nieuwbeerta P, 2003, MOORD DOODSLAG NEDER; Nieuwbeerta P., 2007, DODELIJK GEWELD MOOR; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Rodenburg R, 2009, CLIN PSYCHOL REV, V29, P599, DOI 10.1016/j.cpr.2009.06.008; Salmon K, 2002, CLIN PSYCHOL REV, V22, P163, DOI 10.1016/S0272-7358(01)00086-1; Saxe GN, 2012, CHILD ADOL MENT H-UK, V17, P58, DOI 10.1111/j.1475-3588.2011.00626.x; Slaughter Virginia, 2007, Clin Child Psychol Psychiatry, V12, P525; Steeves RH, 2007, J INTERPERS VIOLENCE, V22, P1270, DOI 10.1177/0886260507305153; Steeves Richard H, 2011, J Am Psychiatr Nurses Assoc, V17, P115, DOI 10.1177/1078390311401025; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; United Nations, 2018, SUST DEV KNOWL PLATF; Vives-Cases C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148364; Wilson M, 1993, Violence Vict, V8, P3; Wolfe DA, 2003, CLIN CHILD FAM PSYCH, V6, P171, DOI 10.1023/A:1024910416164	44	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e018346	10.1371/journal.pone.0183466	http://dx.doi.org/10.1371/journal.pone.0183466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28976977	Green Published, gold			2022-12-27	WOS:000412163100003
J	Bhogal, M; Lwin, CN; Seah, XY; Murugan, E; Adnan, K; Lin, SJ; Peh, G; Mehta, JS				Bhogal, Maninder; Lwin, Chan N.; Seah, Xin-Yi; Murugan, Elavazhagan; Adnan, Khadijah; Lin, Shu-Jun; Peh, Gary; Mehta, Jodhbir S.			Real-time assessment of corneal endothelial cell damage following graft preparation and donor insertion for DMEK	PLOS ONE			English	Article							IN-VITRO; KERATOPLASTY; TISSUE; TRANSPLANTATION; LAMELLAR; MODEL; EYE; NEURODEGENERATION; VIABILITY; APOPTOSIS	Purpose To establish a method for assessing graft viability, in-vivo, following corneal transplantation. Methods Optimization of calcein AM fluorescence and toxicity assessment was performed in cultured human corneal endothelial cells and ex-vivo corneal tissue. Descemet membrane endothelial keratoplasty grafts were incubated with calcein AM and imaged pre and post preparation, and in-situ after insertion and unfolding in a pig eye model. Global, macroscopic images of the entire graft and individual cell resolution could be attained by altering the magnification of a clinical confocal scanning laser microscope. Patterns of cell loss observed in situ were compared to those seen using standard ex-vivo techniques. Results Calcein AM showed a positive dose-fluorescence relationship. A dose of 2.67 mu mol was sufficient to allow clear discrimination between viable and non-viable areas (sensitivity of 96.6% with a specificity of 96.1%) and was not toxic to cultured endothelial cells or ex-vivo corneal tissue. Patterns of cell loss seen in-situ closely matched those seen on ex-vivo assessment with fluorescence viability imaging, trypan blue/alizarin red staining or scanning electron microscopy. Iatrogenic graft damage from preparation and insertion varied between 7-35% and incarceration of the graft tissue within surgical wounds was identified as a significant cause of endothelial damage. Conclusions In-situ graft viability assessment using clinical imaging devices provides comparable information to ex-vivo methods. This method shows high sensitivity and specificity, is non-toxic and can be used to evaluate immediate cell viability in new grafting techniques in-vivo.	[Bhogal, Maninder; Lwin, Chan N.; Seah, Xin-Yi; Murugan, Elavazhagan; Adnan, Khadijah; Lin, Shu-Jun; Peh, Gary; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Bhogal, Maninder; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Bhogal, Maninder] UCL, Inst Ophthalmol, London, England; [Peh, Gary; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; University of London; University College London; National University of Singapore	Bhogal, M; Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Bhogal, M; Mehta, JS (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Bhogal, M (corresponding author), UCL, Inst Ophthalmol, London, England.; Mehta, JS (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	manibhogal@aol.com; jodmehta@gmail.com	Peh, Gary/A-8327-2010	Peh, Gary/0000-0002-5387-4209	National Research Foundation Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]	National Research Foundation Translational and Clinical Research (TCR) Programme	We gratefully acknowledge funding support by a program grant from the National Research Foundation Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013). The funding bodies had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Albon J, 2000, INVEST OPHTH VIS SCI, V41, P2887; Amann J, 2003, AM J OPHTHALMOL, V135, P584, DOI 10.1016/S0002-9394(02)02237-7; [Anonymous], 2015 EYE BANK STAT R; Bhogal M, 2016, BR J OPHTHALMOL, V56; Bhogal M, 2015, J CATARACT REFR SURG, V41, P2022, DOI 10.1016/j.jcrs.2015.08.005; BOURNE WM, 1976, ARCH OPHTHALMOL-CHIC, V94, P1730; Bourne WM, 1997, INVEST OPHTH VIS SCI, V38, P779; Bourne WM, 2001, CORNEA, V20, P560, DOI 10.1097/00003226-200108000-00002; Cordeiro MF, 2004, P NATL ACAD SCI USA, V101, P13352, DOI 10.1073/pnas.0405479101; Coster DJ, 2014, OPHTHALMOLOGY, V121, P979, DOI 10.1016/j.ophtha.2013.12.017; Dapena I, 2011, ARCH OPHTHALMOL-CHIC, V129, P88, DOI 10.1001/archophthalmol.2010.334; Dirisamer M, 2011, ARCH OPHTHALMOL-CHIC, V129, P1435, DOI 10.1001/archophthalmol.2011.195; Doughman D J, 1980, Trans Am Ophthalmol Soc, V78, P567; Droutsas K, 2014, ACTA OPHTHALMOL, V92, pE362, DOI 10.1111/aos.12371; Fuest M, 2016, REGEN MED, V11, P601, DOI 10.2217/rme-2016-0054; Gain P, 2002, BRIT J OPHTHALMOL, V86, P306, DOI 10.1136/bjo.86.3.306; Gauthier AS, 2016, BR J OPHTHALMOL; Genicio N, 2015, INVEST OPHTH VIS SCI, V56, P3051, DOI 10.1167/iovs.14-15973; George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Ide T, 2008, CORNEA, V27, P754, DOI 10.1097/ICO.0b013e31816a6266; Ide T, 2007, CORNEA, V26, P1079, DOI 10.1097/ICO.0b013e318142bdde; Koizumi N, 2012, EXP EYE RES, V95, P60, DOI 10.1016/j.exer.2011.10.014; Kuo AN, 2008, AM J OPHTHALMOL, V145, P91, DOI 10.1016/j.ajo.2007.08.036; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; MADDEN PW, 1987, CURR EYE RES, V6, P1441, DOI 10.3109/02713688709044508; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Mehta JS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1383, DOI 10.1001/archopht.126.10.1383; MollerPedersen T, 1997, CORNEA, V16, P333; Normando EM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0346-z; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Pipparelli A, 2011, INVEST OPHTH VIS SCI, V52, P6018, DOI 10.1167/iovs.10-6641; Price MO, 2008, OPHTHALMOLOGY, V115, P857, DOI 10.1016/j.ophtha.2007.06.033; Rose L, 2008, OPHTHALMOLOGY, V115, P279, DOI 10.1016/j.ophtha.2007.04.020; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; SCHIMMELPFENNIG BH, 1984, INVEST OPHTH VIS SCI, V25, P223; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Terry MA, 2009, CORNEA, V28, P1149, DOI 10.1097/ICO.0b013e3181a87a28; Terry MA, 2009, CORNEA, V28, P24, DOI 10.1097/ICO.0b013e318182a4d3	39	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184824	10.1371/journal.pone.0184824	http://dx.doi.org/10.1371/journal.pone.0184824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977017	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100012
J	Diaz, MH; Desai, HP; Morrison, SS; Benitez, AJ; Wolff, BJ; Caravas, J; Read, TD; Dean, D; Winchell, JM				Diaz, Maureen H.; Desai, Heta P.; Morrison, Shatavia S.; Benitez, Alvaro J.; Wolff, Bernard J.; Caravas, Jason; Read, Timothy D.; Dean, Deborah; Winchell, Jonas M.			Comprehensive bioinformatics analysis of Mycoplasma pneumoniae genomes to investigate underlying population structure and type-specific determinants (vol 12, e0174701, 2017)	PLOS ONE			English	Correction													Diaz, Maureen/AAM-4587-2020	Morrison, Shatavia S/0000-0002-4658-5951; Read, Timothy/0000-0001-8966-9680				DAIZ MH, 2017, PLOS ONE, V12, DOI DOI 10.1371/J0URNAL.P0NE.0174701; Diaz MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174701	2	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0186030	10.1371/journal.pone.0186030	http://dx.doi.org/10.1371/journal.pone.0186030			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977025	Green Published, gold			2022-12-27	WOS:000412163100056
J	Howe, GA; Kazda, K; Addison, CL				Howe, Grant A.; Kazda, Kayla; Addison, Christina L.			MicroRNA-30b controls endothelial cell capillary morphogenesis through regulation of transforming growth factor beta 2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; UP-REGULATION; MESENCHYMAL TRANSITION; TUMOR ANGIOGENESIS; SIGNALING PATHWAY; FACTOR EXPRESSION; TARGETING VEGFA; IN-VITRO; CANCER; ATF-2	The importance of microRNA (miRNA) to vascular biology is becoming increasingly evident; however, the function of a significant number of miRNA remains to be determined. In particular, the effect of growth factor regulation of miRNAs on endothelial cell morphogenesis is incomplete. Thus, we aimed to identify miRNAs regulated by pro-angiogenic vascular endothelial growth factor (VEGF) and determine the effects of VEGF-regulated miRNAs and their targets on processes important for angiogenesis. Human umbilical vein endothelial cells (HUVECs) were thus stimulated with VEGF and miRNA levels assessed using microarrays. We found that VEGF altered expression of many miRNA, and for this study focused on one of the most significantly down-regulated miRNA in HUVECs following VEGF treatment, miR-30b. Using specific miRNA mimics, we found that overexpression of miR-30b inhibited capillary morphogenesis in vitro, while depletion of endogenous miR-30b resulted in increased capillary morphogenesis indicating the potential significance of down-regulation of miR-30b as a pro-angiogenic response to VEGF stimulation. MiR-30b overexpression in HUVEC regulated transforming growth factor beta 2 (TGF beta 2) production, which led to increased phosphorylation of Smad2, indicating activation of an autocrine TGF beta signaling pathway. Up-regulation of TGF beta 2 by miR-30b overexpression was found to be dependent on ATF2 activation, a transcription factor known to regulate TGF beta 2 expression, as miR-30b overexpressing cells exhibited increased levels of phosphorylated ATF2 and depletion of ATF2 inhibited miR-30b-induced TGF beta 2 expression. However, miR-30b effects on ATF2 were indirect and found to be via targeting of the known ATF2 repressor protein JDP2 whose mRNA levels were indirectly correlated with miR-30b levels. Increased secretion of TGF beta 2 from HUVEC was shown to mediate the inhibitory effects of miR-30b on capillary morphogenesis as treatment with a neutralizing antibody to TGF beta 2 restored capillary morphogenesis to normal levels in miR-30b overexpressing cells. These results support that the regulation of miR-30b by VEGF in HUVEC is important for capillary morphogenesis, as increased miR-30b expression inhibits capillary morphogenesis through enhanced expression of TGF beta 2.	[Howe, Grant A.; Kazda, Kayla; Addison, Christina L.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Howe, Grant A.; Addison, Christina L.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Addison, Christina L.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Addison, CL (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Addison, CL (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.	caddison@ohri.ca			Canadian Institute of Health Research [MOP83383]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institute of Health Research (MOP83383) awarded to CLA.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiti MA, 2012, J CELL MOL MED, V16, P2413, DOI 10.1111/j.1582-4934.2012.01557.x; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; DiMaio TA, 2014, J VIROL, V88, P14301, DOI 10.1128/JVI.01696-14; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Doerr M, 2016, MICROVASC RES, V108, P48, DOI 10.1016/j.mvr.2016.08.001; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Fang S, 2016, STEM CELL TRANSL MED, V5, P1425, DOI 10.5966/sctm.2015-0367; Filkova M, 2012, BIODRUGS, V26, P131, DOI 10.2165/11631480-000000000-00000; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gong M, 2017, ONCOTARGET, V8, P45200, DOI 10.18632/oncotarget.16778; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hassel D, 2012, CIRC RES, V111, P1421, DOI 10.1161/CIRCRESAHA.112.279711; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Honeywell DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070515; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jiang Q, 2013, HYPERTENSION, V62, P592, DOI 10.1161/HYPERTENSIONAHA.113.01767; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Leng RB, 2014, FEBS LETT, V588, P2078, DOI 10.1016/j.febslet.2014.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Liu LX, 2000, BLOOD, V96, P1772, DOI 10.1182/blood.V96.5.1772.h8001772_1772_1781; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Maroni D, 2011, J CELL SCI, V124, P2501, DOI 10.1242/jcs.084558; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mechtcheriakova D, 1999, BLOOD, V93, P3811, DOI 10.1182/blood.V93.11.3811.411k40_3811_3823; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Medici D, 2011, BIOCHEM J, V437, P515, DOI 10.1042/BJ20101500; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Nikitina E. G., 2012, Experimental Oncology, V34, P2; Ocak S, 2012, CANCER-AM CANCER SOC, V118, P1293, DOI 10.1002/cncr.26382; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; PEPPER MS, 1991, J CELL PHYSIOL, V146, P170, DOI 10.1002/jcp.1041460122; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Pin AL, 2012, ANGIOGENESIS, V15, P593, DOI 10.1007/s10456-012-9283-z; Plummer PN, 2013, CANCER RES, V73, P341, DOI 10.1158/0008-5472.CAN-12-0271; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Roitbak T, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-25; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Sodhi A, 2000, CANCER RES, V60, P4873; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang R, 2014, FEBS LETT, V588, P4438, DOI 10.1016/j.febslet.2014.09.045; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Zhu T, 2000, J BIOL CHEM, V275, P2103, DOI 10.1074/jbc.275.3.2103; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	66	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185619	10.1371/journal.pone.0185619	http://dx.doi.org/10.1371/journal.pone.0185619			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977001	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100033
J	Liu, DY; Hu, Y; Guo, Y; Zhu, Z; Lu, BZ; Wang, XL; Huang, YJ				Liu, Danyang; Hu, Yang; Guo, Ying; Zhu, Zhu; Lu, Bingzheng; Wang, Xuelan; Huang, Yijun			Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2	PLOS ONE			English	Article							GASTRIC-CANCER; MEMBRANE GLYCOPROTEIN; HYORHINIS INFECTION; LIPOPROTEIN P37; GUT MICROBIOTA; INVASIVENESS; TRANSPORT; TUMORIGENESIS; PNEUMONIAE; GENITALIUM	Mycoplasma infection has been reported to be associated with cancer migration, invasion, epithelial-mesenchymal transition as well as the resistance to nucleoside analogues chemotherapeutic drugs. In this study, we found that the sensitivity of hepatocarcinoma cells to Cisplatin, Gemcitabine and Mitoxantrone was increased by mycoplasma elimination. Similar to the effect of anti-mycoplasma agent, interrupting the interaction between Mycoplasma hyorhinis membrane protein P37 and Annexin A2 of host cells using the N-terminal of ANXA2 polypeptide enhanced the sensitivity of HCC97L cells to Gemcitabine and Mitoxantrone. Meanwhile, we did not observe any changes in expression or distribution of multidrug resistance associated transporters, ATP-Binding Cassette protein B1, C1 and G2, on the removal of mycoplasma. These results suggest that mycoplasma induces a resistance to multiple drugs in hepatocarcinoma cells which required the interaction of P37 and Annexin A2. The pathway downstream this interaction needs to be explored.	[Liu, Danyang; Hu, Yang; Zhu, Zhu; Lu, Bingzheng; Wang, Xuelan; Huang, Yijun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Guo, Ying] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Wang, XL; Huang, YJ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	mdswxl@mail.sysu.edu.cn; huangyj@mail.sysu.edu.cn						Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Bronckaers A, 2008, BIOCHEM PHARMACOL, V76, P188, DOI 10.1016/j.bcp.2008.04.019; Chaudhry R, 2016, INDIAN J MED MICROBI, V34, P7, DOI 10.4103/0255-0857.174112; Chen CY, 2015, ONCOTARGET, V6, P26946, DOI 10.18632/oncotarget.4521; Choi HS, 2014, BIOCHEM BIOPH RES CO, V446, P620, DOI 10.1016/j.bbrc.2014.03.024; Dean M, 2001, J LIPID RES, V42, P1007; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Duan HY, 2014, CANCER RES, V74, P5782, DOI 10.1158/0008-5472.CAN-14-0650; Duan HY, 2014, CANCER LETT, V354, P447, DOI 10.1016/j.canlet.2014.08.018; DUDLER R, 1988, EMBO J, V7, P3963, DOI 10.1002/j.1460-2075.1988.tb03283.x; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Joyce H, 2015, EXPERT OPIN DRUG MET, V11, P795, DOI 10.1517/17425255.2015.1028356; Ketcham CM, 2005, MOL CANCER THER, V4, P1031, DOI 10.1158/1535-7163.MCT-05-0040; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Liekens S, 2009, LANCET ONCOL, V10, P628, DOI 10.1016/S1470-2045(09)70037-3; Manhart LE, 2015, CLIN INFECT DIS, V61, pS802, DOI 10.1093/cid/civ785; Manhart LE, 2013, INFECT DIS CLIN N AM, V27, P779, DOI 10.1016/j.idc.2013.08.003; Medjo B, 2014, ITAL J PEDIATR, V40, DOI 10.1186/s13052-014-0104-4; MURPHY WH, 1967, ANN NY ACAD SCI, V143, P544, DOI 10.1111/j.1749-6632.1967.tb27701.x; Raherison S, 2005, ANTIMICROB AGENTS CH, V49, P421, DOI 10.1128/AAC.49.1.421-424.2005; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rosenbaum M, 2015, TRENDS ENDOCRIN MET, V26, P493, DOI 10.1016/j.tem.2015.07.002; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sippel KH, 2009, J BACTERIOL, V191, P2585, DOI 10.1128/JB.01680-08; Sodani K, 2014, BIOCHEM PHARMACOL, V89, P52, DOI 10.1016/j.bcp.2014.02.012; STEINEMANN C, 1984, INT J CANCER, V34, P407, DOI 10.1002/ijc.2910340319; STEINEMANN C, 1984, P NATL ACAD SCI-BIOL, V81, P3747, DOI 10.1073/pnas.81.12.3747; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vande Voorde J, 2014, NUCLEOS NUCLEOT NUCL, V33, P394, DOI 10.1080/15257770.2013.851394; Vande Voorde J, 2014, J BIOL CHEM, V289, P13054, DOI 10.1074/jbc.M114.558924; Vande Voorde J, 2013, MOL PHARMACOL, V84, P865, DOI 10.1124/mol.113.088625; Voorde JV, 2015, FEBS OPEN BIO, V5, P634, DOI 10.1016/j.fob.2015.07.007; Voorde JV, 2014, EXCLI J, V13, P300; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Wang CY, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/231736; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wu J, 2016, MICROBIOL RES, V192, P253, DOI 10.1016/j.micres.2016.08.003; Yuan S, 2016, PLOS ONE, V11; Zhang ZD, 2014, NEOPLASMA, V61, P627, DOI 10.4149/neo_2014_078	45	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184578	10.1371/journal.pone.0184578	http://dx.doi.org/10.1371/journal.pone.0184578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976984	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100007
J	Muldoon, KM; Armstrong-Heimsoth, A; Thomas, J				Muldoon, Kathleen M.; Armstrong-Heimsoth, Amy; Thomas, Jodi			Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States	PLOS ONE			English	Article							CEREBRAL-PALSY; DAY-CARE; NEUROTROPIC VIRUSES; MECHANICAL TURK; INFECTION; CHILDREN; PREVENTION; TRANSMISSION; RISK; PREVALENCE	Congenital cytomegalovirus (cCMV) infections cause more children to have permanent disabilities than Down Syndrome, Fetal Alcohol Syndrome, Spina Bifida, and pediatric HIV/AIDS combined. The risk of infection during pregnancy can be significantly decreased using universal precautions, such as thorough handwashing and cleansing of surfaces and objects that have come into contact with infected body fluids. Children under 3 years of age are commonly asymptomatic excretors of CMV, with the highest viral loads present in saliva. Pediatric therapists have regular close contact with young children, and are thus likely at elevated occupational risk of acquiring CMV. Our objective was to evaluate therapist knowledge of cCMV and its transmission. We recruited American Occupational Therapy Association (AOTA) and American Physical Therapy Association (APTA) members via electronic newsletters and printed flyers from April to September 2015. Participants completed an online, anonymous 24-question survey using Survey Monkey. We compared responses between groups and previously published CMV awareness data using binomial tests of difference of proportions and multiple logistic regression. Our study identified both a low level of therapist awareness and poor demonstrated understanding of cCMV. Self-reported cCMV awareness amongst therapists was greater than awareness in the general population, and equivalent to awareness amongst health care professionals. Whereas 52% of participants self-reported awareness of cCMV, only 18% demonstrated understanding of the behavioral modes of CMV transmission. Fewer therapists reported awareness of cCMV than other, less prevalent conditions. Higher levels of health risk knowledge were associated with greater contact with children. Most participants reported learning about cCMV from the workplace. The knowledge gaps between self-reported awareness of cCMV and demonstrated understanding of modes of transmission described by our results emphasize the need for additional training of therapists. cCMV is preventable, and accurate knowledge of modes of transmission is crucial for the health of practitioners and clients.	[Muldoon, Kathleen M.] Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA; [Armstrong-Heimsoth, Amy] No Arizona Univ, Dept Occupat Therapy, Phoenix, AZ USA; [Thomas, Jodi] Midwestern Univ, Dept Phys Therapy, Glendale, AZ USA	Midwestern University; Northern Arizona University; Midwestern University	Muldoon, KM (corresponding author), Midwestern Univ, Dept Anat, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA.	kmuldo@midwestern.edu		Thomas, Jodi/0000-0002-6602-9442	Midwestern University	Midwestern University	Funding was provided by Midwestern University to KMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accreditation Council for Occupational Therapy, 2017, ACCR MAN; ADLER SP, 1989, NEW ENGL J MED, V321, P1290, DOI 10.1056/NEJM198911093211903; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; Alberman E, 2006, BMJ-BRIT MED J, V332, P63, DOI 10.1136/bmj.332.7533.63; American Academy of Pediatrics, 2015, RED BOOK 2015 REP CO; American Occupational Therapy Association, 2015, SAL WORKF SURV EX SU; [Anonymous], 2013, SPSS STAT WIND VERS; [Anonymous], 2013, PHYS THER MEMB DEM P; Atkinson NL, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1035; Baer HR, 2014, J CLIN VIROL, V60, P222, DOI 10.1016/j.jcv.2014.03.023; Bale JF, 1999, ARCH PEDIAT ADOL MED, V153, P75; BALFOUR CL, 1986, JAMA-J AM MED ASSOC, V256, P1909, DOI 10.1001/jama.256.14.1909; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Binda S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1861-z; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cannon MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0569-1; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Cannon MJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-70; Celikel E, 2015, EUR J PEDIATR, V174, P1101, DOI 10.1007/s00431-015-2513-9; Centers for Disease Control and Prevention, 2007, MMWR-MORBID MORTAL W, V57, P65; Centers for Disease Control and Prevention, 2013, CONG CMV INF TRENDS; Chandler J, 2014, AMONG AMAZON MECH TU; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Chin TL, 2014, J HOSP INFECT, V87, P11, DOI 10.1016/j.jhin.2013.12.011; Commission on Accreditation in Physical Therapy Education, 2016, STAND REQ EL ACCR PH; Cordier AG, 2012, J CLIN VIROL, V55, P158, DOI 10.1016/j.jcv.2012.06.022; Cordier AG, 2012, J CLIN VIROL, V53, P332, DOI 10.1016/j.jcv.2011.12.031; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dakovic I, 2014, EUR J PAEDIATR NEURO, V18, P618, DOI 10.1016/j.ejpn.2014.04.007; De Kegel A, 2016, RES DEV DISABIL, V48, P253, DOI 10.1016/j.ridd.2015.11.014; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Doutre SM, 2016, J EARLY HEAR DETECT, V1, P39, DOI DOI 10.15142/T32G62; Duval M, 2014, CURR OPIN OTOLARYNGO, V22, P495, DOI 10.1097/MOO.0000000000000104; DWORSKY ME, 1983, NEW ENGL J MED, V309, P950, DOI 10.1056/NEJM198310203091604; Flacker J., 1995, THESIS; FordJones EL, 1996, PEDIATR INFECT DIS J, V15, P507, DOI 10.1097/00006454-199606000-00007; Fowler KB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2128; Gantt S, 2016, JAMA PEDIATR, V170, P1173, DOI 10.1001/jamapediatrics.2016.2016; Ghekiere S, 2012, J PEDIAT OPHTH STRAB, V49, P274, DOI 10.3928/01913913-20120710-03; Gibson CS, 2006, BRIT MED J, V332, P76, DOI 10.1136/bmj.38668.616806.3A; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Harrison GJ, 2015, PEDIATR ANN, V44, pE115, DOI 10.3928/00904481-20150512-11; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Jeon J, 2006, INFECT DIS OBSTET GY, V2006, DOI [10.1155/IDOG/2006/80383, DOI 10.1155/IDOG/2006/80383]; Jones Cheryl A, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P70, DOI 10.1016/S1538-5442(03)90007-1; Joseph Serene A, 2006, Paediatr Child Health, V11, P401; Kiss P, 2002, INT J OCCUP ENV HEAL, V8, P79; Korver AMH, 2009, J CLIN VIROL, V46, pS11, DOI 10.1016/j.jcv.2009.09.006; Lepage N, 2011, EUR J CLIN MICROBIOL, V30, P65, DOI 10.1007/s10096-010-1054-4; Lynch L, 2015, CURR OPIN INFECT DIS, V28, P362, DOI 10.1097/QCO.0000000000000180; Majima Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00378; MARCIL WM, 1993, AM J OCCUP THER, V47, P523, DOI 10.5014/ajot.47.6.523; Marshall BC, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.037; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; Mechling J., 2006, ESOMAR WORLD RES C P; Mestas E, 2016, ADV NEONAT CARE, V16, P60, DOI 10.1097/ANC.0000000000000242; MURPH JR, 1991, JAMA-J AM MED ASSOC, V265, P603, DOI 10.1001/jama.265.5.603; MURPH JR, 1988, AM J DIS CHILD, V142, P843, DOI 10.1001/archpedi.1988.02150080049020; Myrhaug HT, 2014, BMC PEDIATR, V14, DOI 10.1186/s12887-014-0292-5; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; PASS RF, 1990, PEDIATR INFECT DIS J, V9, P465, DOI 10.1097/00006454-199007000-00003; Pereboom MTR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-98; Remington JS, 2001, INFECT DIS FETUS NEW, P389; Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003; Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724; Ross DS, 2008, J WOMENS HEALTH, V17, P849, DOI 10.1089/jwh.2007.0523; Schleiss MR, 2006, CURR OPIN PEDIATR, V18, P48; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Smithers-Sheedy H, 2015, J PAEDIATR CHILD H, V51, P901, DOI 10.1111/jpc.12896; Smithers-Sheedy H, 2014, DEV MED CHILD NEUROL, V56, P846, DOI 10.1111/dmcn.12467; Sobaszek A, 2000, J OCCUP ENVIRON MED, V42, P1109, DOI 10.1097/00043764-200011000-00015; Stowell JD, 2014, APPL ENVIRON MICROB, V80, P455, DOI 10.1128/AEM.03262-13; Stowell JD, 2012, J INFECT DIS, V205, P211, DOI 10.1093/infdis/jir722; Sumartojo E, 2000, AIDS, V14, pS3, DOI 10.1097/00002030-200006001-00002; Swanson EC, 2013, PEDIATR CLIN N AM, V60, P335, DOI 10.1016/j.pcl.2012.12.008; Thackeray R, CHILD CARE PROVIDER, V45, P301; Thackeray R, 2014, MATERN CHILD HLTH J, V18, P584, DOI 10.1007/s10995-013-1275-0; Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003; World Confederation for Physical Therapy, 2011, WORLD CONF PHYS THER, V5; Ziviani J, 2010, AUST OCCUP THER J, V57, P210, DOI 10.1111/j.1440-1630.2010.00850.x	87	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185635	10.1371/journal.pone.0185635	http://dx.doi.org/10.1371/journal.pone.0185635			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28976995	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100035
J	Piovani, D; Molinero, C; Wilson, A				Piovani, Duccio; Molinero, Carlos; Wilson, Alan			Urban retail location: Insights from percolation theory and spatial interaction modeling	PLOS ONE			English	Article							STREET CENTRALITY; POPULATION; TRANSITION; NETWORK; GROWTH; LAWS	Characterising road networks has been the focus of a large body of research due to it being the main driver of activities in an urban ecosystem and the structuring factor in the dynamics of the city. One of these activities, and one with the largest economical impact in a city, is retail dynamics and its evolution. Therefore, the mathematical modeling of the location of retail activities and of the emergence of clustering in retail centers has as well generated a large number of works. Despite these two interwoven components strongly depending on one another and their fundamental importance in understanding cities, little work has been done in order to compare their local and global properties. Here we compare the road network's hierarchical structure, unveiled through a percolation analysis of the network, with the retail location distribution defined by exploiting a gravity-based retail model. We interpret the great agreement in the city's organizations as it emerges from both methodologies as new evidence of the interdependence of these two crucial dimensions of a city's life.	[Piovani, Duccio; Molinero, Carlos; Wilson, Alan] UCL, Ctr Adv Spatial Anal, 90 Tottenham Court Rd, London W1T 4TJ, England; [Wilson, Alan] British Lib, Alan Turing Inst, 96 Euston Rd, London NW1 2DB, England	University of London; University College London	Piovani, D (corresponding author), UCL, Ctr Adv Spatial Anal, 90 Tottenham Court Rd, London W1T 4TJ, England.	el.piovani@ucl.ac.uk			Engineering and Physical Sciences Research Council [EP/M023583/1]; EPSRC [EP/M023583/1]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council grant: EP/M023583/1 (https://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Elsa Arcaute and Michael Batty for insights and comments, and Stanislao Gualdi for precious suggestions on the presentation of the results. The authors wish to acknowledge the support of the EPSRC grant: EP/M023583/1.	Arcaute E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150691; Barthelemy M, 2011, PHYS REP, V499, P1; Barthelemy M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02153; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; BROWN S, 1987, AREA, V19, P131; Cardillo A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066107; Christaller W., 1933, CENTRAL PLACES SO GE; CHRISTENSEN K, 1993, PHYS REV LETT, V71, P2737, DOI 10.1103/PhysRevLett.71.2737; CLERC JP, 1990, ADV PHYS, V39, P191, DOI 10.1080/00018739000101501; CONIGLIO A, 1979, PHYS REV LETT, V42, P518, DOI 10.1103/PhysRevLett.42.518; Dearden J, 2011, GEOGR ANAL, V43, P172, DOI 10.1111/j.1538-4632.2011.00812.x; Fiasconaro A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151681; HUFF DL, 1966, LAND ECON, V42, P293, DOI 10.2307/3145346; Jensen I, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020101; Jensen P, 2005, PHYSICA A, V351, P551, DOI 10.1016/j.physa.2005.01.002; King PR, 1999, PHYSICA A, V266, P107, DOI 10.1016/S0378-4371(98)00583-4; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Louf R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0924; Louf R, 2013, P NATL ACAD SCI USA, V110, P8824, DOI 10.1073/pnas.1222441110; MAKSE HA, 1995, NATURE, V377, P608, DOI 10.1038/377608a0; McFadden D, 2001, AM ECON REV, V91, P351, DOI 10.1257/aer.91.3.351; MCFADDEN D, 1980, J BUS, V53, pS13, DOI 10.1086/296093; Murcio R., 2015, MULTIFRACTAL MONOFRA, P1; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Porta S, 2006, PHYSICA A, V369, P853, DOI 10.1016/j.physa.2005.12.063; Porta S, 2012, URBAN STUD, V49, P1471, DOI 10.1177/0042098011422570; Porta S, 2009, ENVIRON PLANN B, V36, P450, DOI 10.1068/b34098; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Rozenfeld Hernan D, 2009, TECHNICAL REPORT; STAUFFER D, 1994, INTRO PERCOLATION TH; Strano E, 2012, SCI REP-UK, V2, DOI 10.1038/srep00296; Um J, 2009, P NATL ACAD SCI USA, V106, P14236, DOI 10.1073/pnas.0901898106; Wilson A. G., 2011, ENTROPY URBAN REGION; WILSON AG, 1969, J TRANSP ECON POLICY, V3, P108; WILSON AG, 1967, TRANSPORT RES, V1, P253, DOI 10.1016/0041-1647(67)90035-4; WILSON AG, 1983, ENVIRON PLANN A, V15, P265, DOI 10.1068/a150265; Wilson A, 2008, J R SOC INTERFACE, V5, P865, DOI 10.1098/rsif.2007.1288; Wilson A, 2011, J GEOGR SYST, V13, P1, DOI 10.1007/s10109-010-0134-4	38	12	12	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185787	10.1371/journal.pone.0185787	http://dx.doi.org/10.1371/journal.pone.0185787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI7FU	28977032	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100045
J	Song, G; Li, XR; Hui, R				Song, Guang; Li, Xinrong; Hui, Rong			Effect of biological soil crusts on seed germination and growth of an exotic and two native plant species in an arid ecosystem	PLOS ONE			English	Article							ALTERS NITROGEN DYNAMICS; BROMUS-TECTORUM INVASION; TENGGER-DESERT; NORTHERN CHINA; SAND DUNES; ECOLOGICAL RESTORATION; MICROBIOTIC CRUSTS; REVEGETATED AREA; VASCULAR PLANTS; COMMUNITIES	Biological soil crusts (BSCs) can improve the stability and health of native plant communities in arid ecosystems. However, it is unknown whether BSCs can also inhibit invasions of exotic vascular plants on stabilized reclaimed sand dunes. To answer this question, we conducted a greenhouse experiment to test the effects of cyanobacteria-dominated BSCs on 1) seed germination and biomass of an exotic grass (Stipa glareosa P. Smirn.), and 2) individual biomass of the exotic S. glareosa growing with two native plants, Eragrostis poaeoides Beauv. and Artemisia capillaris Thunb. Our experiment included three BSC treatments (intact crust, disturbed crust, and bare soil) and five species trials (native E. poaeoides alone, E. poaeoides mixed with exotic S. glareosa, native A. capillaris alone, A. capillaris mixed with exotic S. glareosa, and S. glareosa alone). The results showed that cyanobacteria-dominated crusts can significantly reduce the cumulative percent germination of the exotic grass (P < 0.001) and native plants (P < 0.001). Maximum cumulative percent germinations of the exotic grass and two native plants were found in bare soil, and minimum in intact crusts. The interaction of crust treatment x species trials on shoot biomass of the two native plants was significant (P < 0.05). These results indicate that the presence of BSCs on stabilized sand dunes may reduce the germination of the exotic and two native plants. The effect of reducing exotic and native plant seeds germination would maintain more diverse plant communities and contribute to the formation of clumped vegetation patterns. We conclude that BSCs act as a natural regulator for vegetation patterns and thus promote ecosystem stability and sustainability.	[Song, Guang; Li, Xinrong] Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China; [Song, Guang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XR (corresponding author), Chinese Acad Sci, Shapotou Desert Res & Expt Stn, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China.	Lxinrong@lzb.ac.cn	Li, Xinrong/GNW-6025-2022		National Natural Science Foundation of China [41621001, 41530746, 41701104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, 41621001 (prof Xinrong Li); National Natural Science Foundation of China, 41530746 (prof Xinrong Li); and National Natural Science Foundation of China, 41701104 (prof Rong Hui).	Adeel Z, 2008, Future of Drylands, P677; Alba C, 2015, J VEG SCI, V26, P102, DOI 10.1111/jvs.12212; ANDERSON DC, 1982, J RANGE MANAGE, V35, P180, DOI 10.2307/3898386; Assouline S, 2015, J GEOPHYS RES-BIOGEO, V120, P2108, DOI 10.1002/2015JG003185; Balch JK, 2013, GLOBAL CHANGE BIOL, V19, P173, DOI 10.1111/gcb.12046; Bashkin M, 2003, APPL SOIL ECOL, V22, P67, DOI 10.1016/S0929-1393(02)00108-7; Belnap J, 2006, APPL SOIL ECOL, V32, P63, DOI 10.1016/j.apsoil.2004.12.010; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; BELNAP J, 2001, BIOL SOIL CRUSTS STR, V150, P281; Belnap J., 2003, BIOL SOIL CRUSTS STR, DOI 10.1007/978-3-642-56475-8_21; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Benvenuti S, 2007, SEED SCI RES, V17, P211, DOI 10.1017/S0960258507782752; BEYMER RJ, 1991, ARID SOIL RES REHAB, V5, P187, DOI 10.1080/15324989109381279; Bowker MA, 2008, CONSERV BIOL, V22, P1533, DOI 10.1111/j.1523-1739.2008.01036.x; Briggs AL, 2011, PLANT ECOL, V212, P91, DOI 10.1007/s11258-010-9806-x; Brooks ML, 2011, RANGELAND ECOL MANAG, V64, P431, DOI 10.2111/REM-D-09-00165.1; Chacon N, 2009, BIOL FERT SOILS, V45, P321, DOI 10.1007/s00374-008-0342-y; Chambers JC, 2016, SPRINGER SER ENV MAN, P275, DOI 10.1007/978-3-319-24930-8_10; Corbin JD, 2010, PLANT ECOL, V209, P71, DOI 10.1007/s11258-010-9722-0; Crisp MD, 1975, RANGELAND J, V1, P78; DeCorte A., 2011, THESIS; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Eldridge DJ, 2000, CATENA, V40, P323, DOI 10.1016/S0341-8162(00)00082-5; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; Flory SL, 2010, OECOLOGIA, V164, P1029, DOI 10.1007/s00442-010-1697-y; Flory SL, 2010, BIOL INVASIONS, V12, P1285, DOI 10.1007/s10530-009-9546-9; Funk JL, 2007, NATURE, V446, P1079, DOI 10.1038/nature05719; Ghermandi L, 1995, ACTA OECOL, V16, P719; Godinez-Alvarez H, 2012, PLANT BIOLOGY, V14, P157, DOI 10.1111/j.1438-8677.2011.00495.x; Hawkes CV, 2004, PLANT ECOL, V170, P121, DOI 10.1023/B:VEGE.0000019035.56245.91; Hernandez RR, 2011, PLANT ECOL, V212, P1709, DOI 10.1007/s11258-011-9943-x; Jimenez MA, 2011, ECOL LETT, V14, P1227, DOI 10.1111/j.1461-0248.2011.01693.x; Knochel DG, 2010, BIOL INVASIONS, V12, P3771, DOI 10.1007/s10530-010-9769-9; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Larsen K. D., 1995, THESIS; Li XJ, 2008, GEOMORPHOLOGY, V96, P221, DOI 10.1016/j.geomorph.2007.08.006; Li XR, 2012, CATENA, V97, P119, DOI 10.1016/j.catena.2012.05.009; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2010, EARTH SURF PROC LAND, V35, P932, DOI 10.1002/esp.1963; Li XR, 2014, SCI CHINA LIFE SCI, V57, P539, DOI 10.1007/s11427-014-4633-2; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Li XR, 2002, BIOL FERT SOILS, V35, P147, DOI 10.1007/s00374-002-0453-9; Li XR, 2004, RESTOR ECOL, V12, P376, DOI 10.1111/j.1061-2971.2004.00313.x; Li XR, 2004, J ARID ENVIRON, V57, P1, DOI 10.1016/S0140-1963(03)00089-2; Liu HL, 2013, CONSERV BIOL, V27, P1011, DOI 10.1111/cobi.12084; Liu LC, 2006, J HYDROL, V328, P331, DOI 10.1016/j.jhydrol.2005.12.004; Liu LC, 2007, AUST J SOIL RES, V45, P422, DOI 10.1071/SR06175; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Luzuriaga AL, 2015, J VEG SCI, V26, P866, DOI 10.1111/jvs.12285; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maier S, 2014, BIODIVERS CONSERV, V23, P1735, DOI 10.1007/s10531-014-0719-1; Marshall VM, 2012, J ARID ENVIRON, V78, P1, DOI 10.1016/j.jaridenv.2011.11.005; McLean R.J.C., 1990, MICROBIAL MINERAL RE, P231; Mendoza-Aguilar DO, 2014, PLANT SOIL, V375, P267, DOI 10.1007/s11104-013-1958-8; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Milton SJ, 2010, BIOL INVASIONS, V12, P3935, DOI 10.1007/s10530-010-9820-x; Orrock JL, 2015, ECOLOGY, V96, P1052, DOI 10.1890/14-0732.1; Pan YX, 2010, J HYDROL, V387, P265, DOI 10.1016/j.jhydrol.2010.04.016; Patrick E, 2002, PROG PHYS GEOG, V26, P442, DOI 10.1191/0309133302pp338pr; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pointing SB, 2012, NAT REV MICROBIOL, V10, P551, DOI 10.1038/nrmicro2831; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Rieder JP, 2010, BIOL INVASIONS, V12, P2429, DOI 10.1007/s10530-009-9653-7; Ronnenberg K, 2007, J ARID ENVIRON, V71, P404, DOI 10.1016/j.jaridenv.2007.04.012; Ronnenberg K, 2008, PLANT ECOL, V196, P269, DOI 10.1007/s11258-007-9351-4; Schaeffer SM, 2012, BIOGEOCHEMISTRY, V111, P427, DOI 10.1007/s10533-011-9668-x; Schoning C, 2004, J ARID ENVIRON, V56, P43, DOI 10.1016/S0140-1963(03)00024-7; Sedia EG, 2003, OIKOS, V100, P447, DOI 10.1034/j.1600-0706.2003.12058.x; Serpe MD, 2006, PLANT ECOL, V185, P163, DOI 10.1007/s11258-005-9092-1; Shapotou Desert Research and Experiment Station Chinese Academy of Sciences, 1991, STUD SHITT SAND CONT; Shinneman DJ, 2008, J ARID ENVIRON, V72, P207, DOI 10.1016/j.jaridenv.2007.06.002; Soltani A, 2002, SEED SCI TECHNOL, V30, P51; Sperry LJ, 2006, ECOLOGY, V87, P603, DOI 10.1890/05-0836; Stohlgren Thomas J., 2001, Biological Invasions, V3, P37, DOI 10.1023/A:1011451417418; Su JQ, 2013, ECOL RES, V28, P21, DOI 10.1007/s11284-012-0994-9; Thiet RK, 2014, PLANT SOIL, V377, P235, DOI 10.1007/s11104-013-2002-8; Tsoar H, 2005, PHYSICA A, V357, P50, DOI 10.1016/j.physa.2005.05.067; Walker L.R., 1997, ASSESSMENT MANAGEMEN, P69, DOI [10.1007/978-1-4612-1926-2_7, DOI 10.1007/978-1-4612-1926-2_7]; Warren SD, 2003, BIOL SOIL CRUSTS STR, P401, DOI DOI 10.1007/978-3-642-56475-8_29; West N. E., 1990, Advances in Ecological Research, V20, P179, DOI 10.1016/S0065-2504(08)60055-0; WILLIAMS JD, 1993, P 46 ANN M SOC RANG; Wu JS, 2013, J MT SCI-ENGL, V10, P1097, DOI 10.1007/s11629-013-2435-9; Zhang Y., 2016, BIOL SOIL CRUSTS ORG, V226, DOI [10.1007/978-3-319-30214-0_19, DOI 10.1007/978-3-319-30214-0_19]; Zhang Yuan-Ming, 2011, Chinese Journal of Plant Ecology, V35, P380, DOI 10.3724/SP.J.1258.2011.00380; Zhang YM, 2015, ECOL RES, V30, P1037, DOI 10.1007/s11284-015-1305-z; Zhang YM, 2010, J ARID LAND, V2, P180, DOI 10.3724/SP.J.1227.2010.00180; Zhang ZS, 2008, J ARID ENVIRON, V72, P964, DOI 10.1016/j.jaridenv.2007.11.010	90	20	26	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185839	10.1371/journal.pone.0185839	http://dx.doi.org/10.1371/journal.pone.0185839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977018	Green Published, Green Submitted, gold			2022-12-27	WOS:000412163100049
J	Mittal, N; Minasyan, A; Romaneschi, N; Hakimian, JK; Gonzalez-Fernandez, G; Albert, R; Desai, N; Mendez, IA; Schallert, T; Ostlund, SB; Welwyn, W				Mittal, Nitish; Minasyan, Ani; Romaneschi, Nicole; Hakimian, Joshua K.; Gonzalez-Fernandez, Gabriel; Albert, Ralph; Desai, Nina; Mendez, Ian A.; Schallert, Timothy; Ostlund, Sean B.; Welwyn, Wendy			Beta-arrestin 1 regulation of rewardmotivated behaviors and glutamatergic function	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; PROTEASE-ACTIVATED RECEPTOR-2; MEDIATED ACTIN DYNAMICS; LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; AMPA RECEPTOR; IN-VIVO; COCAINE; COFILIN; MICE	The two highly homologous non-visual arrestins, beta-arrestin 1 and 2, are ubiquitously expressed in the central nervous system, yet knowledge of their disparate roles is limited. While beta-arrestin 2 (beta arr2) has been implicated in several aspects of reward-related learning and behavior, very little is known about the behavioral function of beta-arrestin 1 (beta arr1). Using mice lacking beta arr1, we focused on the role of this scaffolding and signal transduction protein in reward-motivated behaviors and in striatal glutamatergic function. We found that beta arr1 KO mice were both slower in acquiring cocaine self-administration and in extinguishing this behavior. They also showed deficits in learning tasks supported by a natural food reward, suggesting a general alteration in reward processing. We then examined glutamatergic synaptic strength in WT and KO medium spiny neurons (MSNs) of the Nucleus Accumbens (NAc) shell in naive animals, and from those that underwent cocaine selfadministration. An increase in the AMPA/NMDA (A/N) ratio and a relative lack of GluN2Benriched NMDARs was found in naive KO vs WT MSNs. Applying Lim Domain Kinase (LIMK1), the kinase that phosphorylates and inactivates cofilin, to these cells, showed that both beta arr1 and LIMK regulate the A/N ratio and GluN2B-NMDARs. Cocaine self-administration increased the A/N ratio and GluN2B-NMDARs in WT MSNs and, although the A/N ratio also increased in KO MSNs, this was accompanied by fewer GluN2B-NMDARs and an appearance of calcium-permeable AMPARs. Finally, to examine the consequences of reduced basal GluN2B-NMDARs in reward-processing seen in KO mice, we chronically infused ifenprodil, a GluN2B antagonist, into the NAc shell of WT mice. This intervention substantially reduced food-motivated behavior. Together these findings identify a previously unknown role of beta arr1 in regulating specific reward-motivated behaviors and glutamatergic function.	[Mittal, Nitish; Minasyan, Ani; Romaneschi, Nicole; Hakimian, Joshua K.; Gonzalez-Fernandez, Gabriel; Albert, Ralph; Desai, Nina; Mendez, Ian A.; Welwyn, Wendy] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90095 USA; [Mittal, Nitish; Schallert, Timothy] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Ostlund, Sean B.] Univ Calif Irvine, Sch Biol Sci, Dept Anesthesiol & Perioperat Care, Sch Med,UCI Ctr Addict Neurosci, Irvine, CA 92717 USA; [Welwyn, Wendy] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Austin; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Welwyn, W (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90095 USA.; Welwyn, W (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	wwalwyn@g.ucla.edu	Mendez, Ian/L-9592-2019	Walwyn, Wendy/0000-0001-8101-2844; Mittal, Nitish/0000-0002-4934-3157; Mendez, Ian/0000-0001-8381-4592; Hakimian, Joshua/0000-0003-2712-6204	National Institutes of Health [AG045380, DK098709, DA029035]; Sean B Ostlund; National Institute of Neurological Disorders and Stroke [5R01NS081063-04]; Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sean B Ostlund; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study is supported by the National Institutes of Health (AG045380, DK098709 and DA029035), which funded Sean B Ostlund; National Institute of Neurological Disorders and Stroke (5R01NS081063-04), which funded Timothy Schallert; Bill and Melinda Gates Foundation, a GMSP Fellowship, which funded Nitish Mittal; Shirley and Stefan Hatos Foundation, which funded NM, AM, NR, JH, GGF, RA, ND, IAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertran-Gonzalez J, 2013, J NEUROSCI, V33, P16060, DOI 10.1523/JNEUROSCI.1927-13.2013; Bjork K, 2013, PSYCHOPHARMACOLOGY, V230, P439, DOI 10.1007/s00213-013-3166-x; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Briand LA, 2014, NEUROPSYCHOPHARMACOL, V39, P759, DOI 10.1038/npp.2013.265; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Conner DA, 1997, CIRC RES, V81, P1021; Cooper S, 2017, NEUROTHERAPEUTICS; Corbit LH, 2001, J NEUROSCI, V21, P3251, DOI 10.1523/JNEUROSCI.21-09-03251.2001; Dalton GL, 2012, NEUROPHARMACOLOGY, V62, P797, DOI 10.1016/j.neuropharm.2011.09.001; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Green JA, 2016, MOL CELL BIOL, V36, P223, DOI 10.1128/MCB.00765-15; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Hanley JG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00381; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; Ibanez I, 2016, NEUROPHARMACOLOGY, V107, P376, DOI 10.1016/j.neuropharm.2016.03.042; James AS, 2013, BEHAV BRAIN RES, P1; Jedynak J, 2016, NEUROPSYCHOPHARMACOL, V41, P464, DOI 10.1038/npp.2015.168; Johnson AW, 2007, BEHAV NEUROSCI, V121, P1192, DOI 10.1037/0735-7044.121.6.1192; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kelley AE, 1997, P NATL ACAD SCI USA, V94, P12174, DOI 10.1073/pnas.94.22.12174; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kermath BA, 2013, J NEUROENDOCRINOL, V25, P887, DOI 10.1111/jne.12087; Kiraly DD, 2013, MOL PHARMACOL, V84, P582, DOI 10.1124/mol.113.087106; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Laurent V, 2014, J NEUROSCI, V34, P1358, DOI 10.1523/JNEUROSCI.4592-13.2014; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McGovern Kathryn W, 2014, Handb Exp Pharmacol, V219, P341, DOI 10.1007/978-3-642-41199-1_17; Min JA, 2011, MOL PHARMACOL, V80, P760, DOI 10.1124/mol.111.072470; Mittal N, 2013, CELL REP, V5, P1010, DOI 10.1016/j.celrep.2013.10.015; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Ortinski PI, 2012, NEUROPSYCHOPHARMACOL, V37, P1671, DOI 10.1038/npp.2012.12; Ostlund SB, 2007, J NEUROSCI, V27, P4819, DOI 10.1523/JNEUROSCI.5443-06.2007; Ostlund SB, 2017, EUR J NEUROSCI, V45, P358, DOI 10.1111/ejn.13462; Ostlund SB, 2012, NEUROPSYCHOPHARMACOL, V37, P508, DOI 10.1038/npp.2011.217; Peterson SM, 2015, P NATL ACAD SCI USA, V112; Pierce RC, 2013, COLD SPRING HARB PER, V3, P1; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Porter-Stransky KA, 2017, J PHARMACOL EXP THER, V361, P341, DOI 10.1124/jpet.117.240622; Rodd-Henricks ZA, 2002, J PHARMACOL EXP THER, V303, P1216, DOI 10.1124/jpet.102.038950; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Shieh BH, 2014, J BIOL CHEM, V289, P18526, DOI 10.1074/jbc.M114.571224; Standley S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039585; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Takei Y, 2015, J NEUROSCI, V35, P15539, DOI 10.1523/JNEUROSCI.2671-15.2015; Wang Y, 2013, J NEUROSCI, V33, P6423, DOI 10.1523/JNEUROSCI.5107-12.2013; Wolf ME, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00072; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yin HH, 2006, NEUROBIOL LEARN MEM, V85, P283, DOI 10.1016/j.nlm.2005.12.001; Yin XL, 2012, J NEUROSCI, V32, P5486, DOI 10.1523/JNEUROSCI.0718-12.2012; Yin Xu-Ming, 2013, Shengli Xuebao, V65, P178; Yuen EY, 2010, J PHYSIOL-LONDON, V588, P2361, DOI 10.1113/jphysiol.2009.186353; Zoudilova M, 2007, J BIOL CHEM, V282, P20634, DOI 10.1074/jbc.M701391200; Zoudilova M, 2010, J BIOL CHEM, V285, P14318, DOI 10.1074/jbc.M109.055806	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185796	10.1371/journal.pone.0185796	http://dx.doi.org/10.1371/journal.pone.0185796			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973019	gold, Green Published			2022-12-27	WOS:000412131900053
J	Rudebusch, J; Benkner, A; Poesch, A; Dorr, M; Volker, U; Grube, K; Hammer, E; Felix, SB				Ruedebusch, Julia; Benkner, Alexander; Poesch, Axel; Doerr, Marcus; Voelker, Uwe; Grube, Karina; Hammer, Elke; Felix, Stephan B.			Dynamic adaptation of myocardial proteome during heart failure development	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; ASSOCIATION; METABOLISM; PROTEINS; MATRIX; HSPB7; LOCI	Heart failure (HF) development is characterized by huge structural changes that are crucial for disease progression. Analysis of time dependent global proteomic adaptations during HF progression offers the potential to gain deeper insights in the disease development and identify new biomarker candidates. Therefore, hearts of TAC (transverse aortic constriction) and sham mice were examined by cardiac MRI on either day 4, 14, 21, 28, 42, and 56 after surgery (n = 6 per group/time point). At each time point, proteomes of the left (LV) and right ventricles (RV) of TAC and sham mice were analyzed by mass spectrometry (MS). In TAC mice, systolic LV heart function worsened from day 4 to day 14, remained on a stable level from day 14 to day 42, and showed a further pronounced decline at day 56. MS analysis identified in the LV 330 and in RV 246 proteins with altered abundance over time (TAC vs. sham, fc >=+/- 2). Functional categorization of proteins disclosed the time-dependent alteration of different pathways. Heat shock protein beta-7 (HSPB7) displayed differences in abundance in tissue and serum at an early stage of HF. This study not only provides an overview of the time dependent molecular alterations during transition to HF, but also identified HSPB7 as a novel blood biomarker candidate for the onset of cardiac remodeling.	[Ruedebusch, Julia; Benkner, Alexander; Poesch, Axel; Doerr, Marcus; Grube, Karina; Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Ruedebusch, Julia; Benkner, Alexander; Doerr, Marcus; Voelker, Uwe; Grube, Karina; Hammer, Elke; Felix, Stephan B.] German Ctr Cardiovasc Res, DZHK, Partner Site Greifswald, Greifswald, Germany; [Benkner, Alexander; Voelker, Uwe; Hammer, Elke] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School	Felix, SB (corresponding author), Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany.; Hammer, E; Felix, SB (corresponding author), German Ctr Cardiovasc Res, DZHK, Partner Site Greifswald, Greifswald, Germany.; Hammer, E (corresponding author), Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.	hammer@uni-greifswald.de; felix@uni-greifswald.de	Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X; Volker, Uwe/0000-0002-5689-3448; Benkner, Alexander/0000-0002-3415-0512; Rudebusch, Julia/0000-0002-8556-6665; Hammer, Elke/0000-0002-1507-0402	Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania [03IS2061A]	Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania	This study was partly supported by the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium was funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg, West Pomerania (03IS2061A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Cappola TP, 2010, CIRC-CARDIOVASC GENE, V3, P147, DOI 10.1161/CIRCGENETICS.109.898395; Chen YW, 2011, AM J PHYSIOL-HEART C, V300, pH2251, DOI 10.1152/ajpheart.01104.2010; Chiu TF, 2012, CIRC J, V76, P2226, DOI 10.1253/circj.CJ-12-0238; Dadson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121049; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Garnier S, 2015, INT J CARDIOL, V189, P105, DOI 10.1016/j.ijcard.2015.04.003; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Hammer E, 2010, PROTEOMICS, V10, P1802, DOI 10.1002/pmic.200900734; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Ke L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020395; Krief S, 1999, J BIOL CHEM, V274, P36592, DOI 10.1074/jbc.274.51.36592; Lam L, 2010, J MOL CELL CARDIOL, V48, P1014, DOI 10.1016/j.yjmcc.2009.08.015; Lau E, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.15; Li C, 2014, MOL BIOSYST, V10, P505, DOI 10.1039/c3mb70422j; Mohamed BA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0898-5; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nagoshi T, 2011, CURR PHARM DESIGN, V17, P3846, DOI 10.2174/138161211798357773; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; RUZICKA M, 1994, CIRCULATION, V90, P1989, DOI 10.1161/01.CIR.90.4.1989; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Tanonaka K, 2001, BIOCHEM BIOPH RES CO, V283, P520, DOI 10.1006/bbrc.2001.4801; Turer AT, 2010, CURR OPIN CLIN NUTR, V13, P458, DOI 10.1097/MCO.0b013e32833a55a5; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105	27	13	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185915	10.1371/journal.pone.0185915	http://dx.doi.org/10.1371/journal.pone.0185915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973020	Green Submitted, gold, Green Published			2022-12-27	WOS:000412131900066
J	Scholz, M; Reske, T; Bohmer, F; Hornung, A; Grabow, N; Lang, H				Scholz, Malte; Reske, Thomas; Boehmer, Femke; Hornung, Anne; Grabow, Niels; Lang, Hermann			In vitro chlorhexidine release from alginate based microbeads for periodontal therapy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DRUG-DELIVERY-SYSTEM; VIVO; MICROSPHERES; BEADS; ACID	Periodontitis is one of the most common infectious diseases globally that, if untreated, leads to destruction of the tooth supporting tissues and finally results in tooth loss. Evidence shows that standard procedures as mechanical root cleaning could be supported by further treatment options such as locally applied substances. Due to gingival crevicular fluid flow, substances are commonly washed out off the periodontal pockets. The evaluation of administration techniques and the development of local drug releasing devices is thus an important aspect in periodontal research. This study describes the development and examination of a new alginate based, biodegradable and easily applicable drug delivery system for chlorhexidine (CHX). Different micro beads were produced and loaded with CHX and the release profiles were investigated by high performance liquid chromatography (HPLC). The in vitrodemonstrated release of CHX from alginate based beads shows comparable releasing characteristics as clinically approved systems. Yet many characteristics of this new delivery system show to be favourable for periodontal therapy. Easy application by injection, low production costs and multifunctional adaptions to patient related specifics may improve the usage in routine care.	[Scholz, Malte; Lang, Hermann] Rostock Univ, Med Ctr, Dept Operat Dent & Periodontol, Rostock, Germany; [Reske, Thomas; Grabow, Niels] Univ Rostock, Inst Biomed Engn, Rostock, Germany; [Boehmer, Femke] Rostock Univ, Med Ctr, Inst Gen Practice, Rostock, Germany; [Hornung, Anne] Rostock Univ, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Scholz, M (corresponding author), Rostock Univ, Med Ctr, Dept Operat Dent & Periodontol, Rostock, Germany.	malte.scholz@uni-rostock.de						Abruzzo A, 2013, CARBOHYD POLYM, V91, P651, DOI 10.1016/j.carbpol.2012.08.074; Ampawong S, 2017, J BIOMATER SCI POLYM, P1; Bazban-Shotorbani S, 2016, LANGMUIR, V32, P4996, DOI 10.1021/acs.langmuir.5b04645; Bidoret A, 2017, METHODS MOL BIOL, V1479, P43, DOI 10.1007/978-1-4939-6364-5_3; Chen FM, 2012, BIOMATERIALS, V33, P6320, DOI 10.1016/j.biomaterials.2012.05.048; Chitsazi Mohammad Taghi, 2013, J Dent Res Dent Clin Dent Prospects, V7, P95, DOI 10.5681/joddd.2013.017; Da Rocha Huberth Alexandre Junior, 2015, J Int Acad Periodontol, V17, P82; Eickholz P., 2006, GLOSSAR GRUNDBEGRIFF, V17, P271; Eke PI, 2015, J PERIODONTOL, P1; Gadad AP, 2009, J APPL POLYM SCI, V114, P1921, DOI 10.1002/app.30617; Garner S, 2015, ORAL DIS, V21, P641, DOI 10.1111/odi.12328; Gonzalez-Fernandez T, 2016, TISSUE ENG PT A, V22, P776, DOI [10.1089/ten.tea.2015.0576, 10.1089/ten.TEA.2015.0576]; Goodson JM, 2003, PERIODONTOL 2000, V31, P43, DOI 10.1034/j.1600-0757.2003.03104.x; Greenstein G, 2000, J Periodontol, V71, P125; Griffiths GS, 2003, PERIODONTOL, V31, P32; He QY, 2015, NAT BIOTECHNOL, V33, P395, DOI 10.1038/nbt.3121; Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005; Jones CG, 1997, PERIODONTOL 2000, V15, P55, DOI 10.1111/j.1600-0757.1997.tb00105.x; Jordan R. A., 2016, F NFTE DTSCH MUNDGES; Kalsi Rupali, 2011, J Indian Soc Periodontol, V15, P304, DOI 10.4103/0972-124X.92559; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+; Madhumathi K, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035002; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mandal S, 2017, METHODS MOL BIOL, V1479, P273, DOI 10.1007/978-1-4939-6364-5_22; Mandlik VB, 2007, ELSEVIER, V63, P368; Matricardi P, 2008, RECENT ADV PERSPECTI, P417; Merchant AT, 2016, J DENT RES, V95, P408, DOI 10.1177/0022034515622197; Murphy Kevin G, 2003, Ann Periodontol, V8, P266, DOI 10.1902/annals.2003.8.1.266; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Poncelet D, 2001, ANN NY ACAD SCI, V944, P74; Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; SCHIOTT C R, 1970, Journal of Periodontal Research, V5, P84; Scholz M, 2013, CED IADR ABSTR B, V1, P40; Silva MD, 2017, MAT SCI ENG C-MATER, V71, P498, DOI 10.1016/j.msec.2016.10.032; Smiley CJ, 2015, J AM DENT ASSOC, V146, P508, DOI 10.1016/j.adaj.2015.01.028; Soriano-Souza CA, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5505-4; Soskolne WA, 1998, J CLIN PERIODONTOL, V25, P1017, DOI 10.1111/j.1600-051X.1998.tb02407.x; Soskolne WA, 2003, J PERIODONTOL, V74, P420, DOI 10.1902/jop.2003.74.4.420; STANLEY A, 1989, J CLIN PERIODONTOL, V16, P259, DOI 10.1111/j.1600-051X.1989.tb01651.x; Sundararaj SC, 2013, BIOMATERIALS, V34, P8835, DOI 10.1016/j.biomaterials.2013.07.093; Taylor JJ, 2016, PERIODONTOL 2000, V70, P7, DOI 10.1111/prd.12118; Tripodo G, 2015, EUR J PHARM BIOPHARM, V97, P400, DOI 10.1016/j.ejpb.2015.03.032; Wasiak J., 2015, BMJ CLIN EVID; Zhou XD, 2015, ARCH ORAL BIOL, V60, P667, DOI 10.1016/j.archoralbio.2014.11.008	47	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185562	10.1371/journal.pone.0185562	http://dx.doi.org/10.1371/journal.pone.0185562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973028	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900026
J	Valianatos, G; Valcikova, B; Growkova, K; Verlande, A; Mlcochova, J; Radova, L; Stetkova, M; Vyhnakova, M; Slaby, O; Uldrijan, S				Valianatos, Georgios; Valcikova, Barbora; Growkova, Katerina; Verlande, Amandine; Mlcochova, Jitka; Radova, Lenka; Stetkova, Monika; Vyhnakova, Michaela; Slaby, Ondrej; Uldrijan, Stjepan			A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein	PLOS ONE			English	Article							THERAPEUTIC TARGET; MICRORNAS; MELANOMA; EXPRESSION; CIPROFLOXACIN; PREDICTION; INHIBITOR; BIOMARKER; SURVIVAL; MUTATION	MdmX overexpression contributes to the development of cancer by inhibiting tumor suppressor p53. A switch in the alternative splicing of MdmX transcript, leading to the inclusion of exon 6, has been identified as the primary mechanism responsible for increased MdmX protein levels in human cancers, including melanoma. However, there are no approved drugs, which could translate these new findings into clinical applications. We analyzed the anti-melanoma activity of enoxacin, a fluoroquinolone antibiotic inhibiting the growth of some human cancers in vitro and in vivo by promoting miRNA maturation. We found that enoxacin inhibited the growth and viability of human melanoma cell lines much stronger than a structurally related fluoroquinolone ofloxacin, which only weakly modulates miRNA processing. A microarray analysis identified a set of miRNAs significantly dysregulated in enoxacin-treated A375 melanoma cells. They had the potential to target multiple signaling pathways required for cancer cell growth, among them the RNA splicing. Recent studies showed that interfering with cellular splicing machinery can result in MdmX downregulation in cancer cells. We, therefore, hypothesized that enoxacin could, by modulating miRNAs targeting splicing machinery, activate p53 in melanoma cells overexpressing MdmX. We found that enoxacin and ciprofloxacin, a related fluoroquinolone capable of promoting microRNA processing, but not ofloxacin, strongly activated wild type p53-dependent transcription in A375 melanoma without causing significant DNA damage. On the molecular level, the drugs promoted MdmX exon 6 skipping, leading to a dose-dependent downregulation of MdmX. Not only in melanoma, but also in MCF7 breast carcinoma and A2780 ovarian carcinoma cells overexpressing MdmX. Together, our results suggest that some clinically approved fluoroquinolones could potentially be repurposed as activators of p53 tumor suppressor in cancers overexpressing MdmX oncoprotein and that p53 activation might contribute to the previously reported activity of enoxacin towards human cancer cells.	[Valianatos, Georgios; Valcikova, Barbora; Growkova, Katerina; Verlande, Amandine; Stetkova, Monika; Vyhnakova, Michaela; Uldrijan, Stjepan] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Valianatos, Georgios; Verlande, Amandine; Uldrijan, Stjepan] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Mlcochova, Jitka; Radova, Lenka; Slaby, Ondrej] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno	Uldrijan, S (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.; Uldrijan, S (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	uldrijan@med.muni.cz	Uldrijan, Stjepan/N-1664-2016; Vallianatos, George/AAF-2973-2019	Uldrijan, Stjepan/0000-0001-8316-2539; Radova, Lenka/0000-0001-8103-148X; Valcikova, Barbora/0000-0002-1830-8084	Czech Science Foundation (GACR) [GA14-12166S]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/30.0009]; Specific University Research Grant [MUNI/A/0810/2016]; National Program of Sustainability II project [LQ1605]; Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge) [316345]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Specific University Research Grant; National Program of Sustainability II project; Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge)	This work was supported by the Czech Science Foundation (GACR; Grant No. GA14-12166S), the Ministry of Education, Youth and Sports of the Czech Republic (Project POSTDOC I, grant No. CZ.1.07/2.3.00/30.0009, Specific University Research Grant No. MUNI/A/0810/2016, and the National Program of Sustainability II project No. LQ1605), and the Seventh Framework Programme of the European Union (ICRC-ERA-Human Bridge, Grant No. 316345).	Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Allende-Vega N, 2013, ONCOGENE, V32, P1, DOI 10.1038/onc.2012.38; Almalki ZS, 2016, PHARMACOEPIDEM DR S, V25, P1042, DOI 10.1002/pds.4021; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Blandino G, 2014, FEBS LETT, V588, P2639, DOI 10.1016/j.febslet.2014.03.033; Bourgeois T, 2016, REGUL TOXICOL PHARM, V74, P161, DOI 10.1016/j.yrtph.2015.11.002; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Carr MI, 2016, TRANSL CANCER RES, V5, P707, DOI 10.21037/tcr.2016.11.75; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Dal Bo M, 2010, BRIT J HAEMATOL, V150, P237, DOI 10.1111/j.1365-2141.2010.08185.x; Dewaele M, 2016, J CLIN INVEST, V126, P68, DOI 10.1172/JCI82534; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; Enright AJ, 2004, GENOME BIOL, V5; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Grawenda AM, 2015, CANCER RES, V75, P698, DOI 10.1158/0008-5472.CAN-14-2637; Hammerova J, 2011, J DERMATOL SCI, V62, P22, DOI 10.1016/j.jdermsci.2011.01.006; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Herbold BA, 2001, MUTAT RES-GEN TOX EN, V498, P193, DOI 10.1016/S1383-5718(01)00275-3; Hoffman Y, 2014, J MOL CELL BIOL, V6, P192, DOI 10.1093/jmcb/mju020; Itoh T, 2006, MUTAT RES-GEN TOX EN, V603, P135, DOI 10.1016/j.mrgentox.2005.11.003; Jacob AG, 2014, PLOS ONE, V9; Kotala V, 2001, CELL MOL LIFE SCI, V58, P1333, DOI 10.1007/PL00000944; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lenos K, 2012, CANCER RES, V72, P4074, DOI 10.1158/0008-5472.CAN-12-0215; Liu L, 2012, CANCER SCI, V103, P2056, DOI 10.1111/cas.12008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maragkakis M, 2011, NUCLEIC ACIDS RES, V39, pW145, DOI 10.1093/nar/gkr294; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Pajak M, 2015, R PACKAGE; Patel K, 2016, J CLIN PHARMACOL, V56, P1060, DOI 10.1002/jcph.715; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Smalheiser NR, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00006; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sousa EJ, 2013, EPIGENETICS-US, V8, P548, DOI 10.4161/epi.24519; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Voller D, 2013, BRIT J CANCER, V109, P3116, DOI 10.1038/bjc.2013.646; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yu Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-71	50	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185801	10.1371/journal.pone.0185801	http://dx.doi.org/10.1371/journal.pone.0185801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973015	Green Submitted, gold, Green Published			2022-12-27	WOS:000412131900055
J	Li, YY; Chen, W; Wang, YS; Luo, K; Li, Y; Bai, LY; Luo, F				Li, Yingying; Chen, Wu; Wang, Yunsheng; Luo, Kun; Li, Yue; Bai, Lianyang; Luo, Feng			Identifying and sequencing a Mycobacterium sp. strain F4 as a potential bioremediation agent for quinclorac	PLOS ONE			English	Article							HERBICIDE QUINCLORAC; SOIL; IDENTIFICATION; DEGRADATION; SYSTEMS; ESTER	Quinclorac is a widely used herbicide in rice filed. Unfortunately, quinclorac residues are phytotoxic to many crops/vegetables. The degradation of quinclorac in nature is very slow. On the other hand, degradation of quinclorac using bacteria can be an effective and efficient method to reduce its contamination. In this study, we isolated a quinclorac bioremediation bacterium strain F4 from quinclorac contaminated soils. Based on morphological characteristics and 16S rRNA gene sequence analysis, we identified strain F4 as Mycobacterium sp. We investigated the effects of temperature, pH, inoculation size and initial quinclorac concentration on growth and degrading efficiency of F4 and determined the optimal quinclorac degrading condition of F4. Under optimal degrading conditions, F4 degraded 97.38% of quinclorac from an initial concentration of 50 mg/L in seven days. Our indoor pot experiment demonstrated that the degradation products were non-phytotoxic to tobacco. After analyzing the quinclorac degradation products of F4, we proposed that F4 could employ two pathways to degrade quinclorac: one is through methylation, the other is through dechlorination. Furthermore, we reconstructed the whole genome of F4 through single molecular sequencing and de novo assembly. We identified 77 methyltransferases and eight dehalogenases in the F4 genome to support our hypothesized degradation path.	[Li, Yingying; Chen, Wu; Wang, Yunsheng; Luo, Kun; Li, Yue; Luo, Feng] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Wang, Yunsheng; Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA; [Bai, Lianyang] Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China	Hunan Agricultural University; Clemson University; Hunan Academy of Agricultural Sciences	Luo, F (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.; Luo, F (corresponding author), Clemson Univ, Sch Comp, Clemson, SC USA.; Bai, LY (corresponding author), Hunan Acad Agr Sci, Changsha, Hunan, Peoples R China.	bailianyang2005@aliyun.com; luofeng@clemson.edu			National Natural Science Foundation of China [31471789]; fund from Hunan Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund from Hunan Agricultural University	This work was supported by the National Natural Science Foundation of China No. 31471789 and fund from Hunan Agricultural University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China No. 31471789 and funds from Hunan Agricultural University.	Chalut C, 2016, TUBERCULOSIS, V100, P32, DOI 10.1016/j.tube.2016.06.004; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Delcher AL, 2003, CURRENT PROTOCOLS BI, DOI DOI 10.13.11-10.13.18; Fan J, 2013, CHINESE J PESTIC SCI, V15, P316; Fan Jun, 2013, Chinese Journal of Biological Control, V29, P431; GROSSMANN K, 1995, PLANT GROWTH REGUL, V16, P183, DOI 10.1007/BF00029539; Grossmann K, 1998, WEED SCI, V46, P707, DOI 10.1017/S004317450008975X; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Hill BD, 1998, CAN J PLANT SCI, V78, P697, DOI 10.4141/P97-119; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108012; Lu ZM, 2006, J ENVIRON SCI HEAL B, V41, P821, DOI 10.1080/03601230600805873; Lu ZM, 2003, J ENVIRON SCI HEAL B, V38, P771, DOI 10.1081/PFC-120025560; Lu ZM, 2008, PEDOSPHERE, V18, P554, DOI 10.1016/S1002-0160(08)60049-1; Pan HY, 2009, J ENVIRON SCI, V21, P307, DOI 10.1016/S1001-0742(08)62269-X; Pareja L, 2012, CHEMOSPHERE, V87, P838, DOI 10.1016/j.chemosphere.2012.01.016; Pinna MV, 2012, CHEMOSPHERE, V86, P655, DOI 10.1016/j.chemosphere.2011.11.016; Rusness DG, 1998, PESTIC BIOCHEM PHYS, V61, P115, DOI 10.1006/pest.1998.2357; Singh DK, 2008, INDIAN J MICROBIOL, V48, P35, DOI 10.1007/s12088-008-0004-7; Tatusova T., 2016, NUCLEIC ACIDS RES; Tittlemier SA, 2016, FOOD ADDIT CONTAM A, V33, P1003, DOI 10.1080/19440049.2016.1179133; Viljoen A, 2017, MOL MICROBIOLOGY; XU S-x, 2012, J SAFETY ENV, V2	23	5	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185721	10.1371/journal.pone.0185721	http://dx.doi.org/10.1371/journal.pone.0185721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968436	gold, Green Submitted, Green Published			2022-12-27	WOS:000412029600039
J	Giezen, H; Stevens, M; van den Akker-Scheek, I; Reininga, IHF				Giezen, Hilde; Stevens, Martin; van den Akker-Scheek, Inge; Reininga, Inge H. F.			Validity and reliability of the Dutch version of the Copenhagen Hip And Groin Outcome Score (HAGOS-NL) in patients with hip pathology	PLOS ONE			English	Article							QUALITY-OF-LIFE; INTERNATIONAL HIP; HEALTH SURVEY; VALIDATION; DISABILITY; RESPONSIVENESS; COSMIN; SF-36; AGREEMENT; DISEASE	Background and objectives The Copenhagen Hip And Groin Outcome Score (HAGOS) was developed to assess disease- specific consequences in young to middle-aged, physically active hip and/or groin patients. The study aimed to determine validity and reliability of the Dutch version of the HAGOS (HAGOS-NL) for middle-aged patients with hip complaints. Design and methods To assess validity, 117 participants completed five questionnaires: HAGOS-NL, international Hip Outcome Tool (iHOT-12NL), Hip disability and Osteoarthritis Outcome Score (HOOS), RAND-36 Health Survey and Tegner activity scale. Structural validity was determined by conducting confirmatory factor analysis. Construct validity was analyzed by formulating predefined hypotheses regarding relationships between the HAGOS-NL and subscales of the iHOT-12NL, HOOS, RAND-36 and Tegner activity scale. The HAGOS-NL was filled out again by 67 patients to explore test-retest reliability. Reliability was assessed in terms of Cronbach's alpha, Intraclass Correlation Coefficient (ICC), Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC). The Bland and Altman method was used to explore absolute agreement. Results Factor analysis confirmed that the HAGOS-NL consists of six subscales. All hypotheses were confirmed, indicating good construct validity. Internal consistency was good, with Cronbach's alpha values ranging from 0.89 to 0.98. Test-retest reliability was considered good, with ICC values of 0.80 and higher. The SEM ranged from 6.6 to 12.3, and MDC at individual level from 18.3 to 34.1 and at group level from 2.3 to 4.4. Bland and Altman analyses showed no bias. Conclusion The HAGOS-NL is a reliable and valid instrument for measuring pain, physical functioning and quality of life in middle-aged patients with hip complaints.	[Giezen, Hilde; Stevens, Martin; van den Akker-Scheek, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Reininga, Inge H. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Trauma Surg, Groningen, Netherlands; [Reininga, Inge H. F.] Martini Hosp Groningen, Dept Orthoped, Groningen, Netherlands	University of Groningen; University of Groningen; Martini Hospital	Stevens, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.	m.stevens@umcg.nl	Reininga, Inge H.F./H-4250-2013; Stevens, Martin/A-5196-2013	Reininga, Inge H.F./0000-0003-1341-845X; Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Anokye NK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-624; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brans E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148119; de Groot IB, 2007, OSTEOARTHR CARTILAGE, V15, P104, DOI 10.1016/j.joca.2006.06.014; de Vet HCW, 2001, INT J TECHNOL ASSESS, V17, P479, DOI 10.1017/S0266462301107038; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Domholdt E., 2000, PHYS THERAPY RES PRI, V2nd ed.; Griffin DR, 2012, ARTHROSCOPY, V28, P611, DOI 10.1016/j.arthro.2012.02.027; Huch K, 2005, ANN RHEUM DIS, V64, P1715, DOI 10.1136/ard.2004.033266; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mohtadi NGH, 2012, ARTHROSCOPY, V28, P595, DOI 10.1016/j.arthro.2012.03.013; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Picavet HSJ, 2004, ANN RHEUM DIS, V63, P723, DOI 10.1136/ard.2003.010769; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; PICAVET HSJ, 2000, KLACHTEN BEWEGINGSAP; Slagers AJ, 2017, J SPORT SCI, V35, P393, DOI 10.1080/02640414.2016.1167230; Stevens M, 2015, J ORTHOP SPORT PHYS, V45, P1026, DOI 10.2519/jospt.2015.6178; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; Terwee CB, 2012, QUAL LIFE RES, V21, P651, DOI 10.1007/s11136-011-9960-1; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Thomee R, 2014, KNEE SURG SPORT TR A, V22, P835, DOI 10.1007/s00167-013-2721-7; Thorborg K, 2011, BRIT J SPORT MED, V45, P478, DOI 10.1136/bjsm.2010.080937; Thorborg K, 2010, BRIT J SPORT MED, V44, P1186, DOI 10.1136/bjsm.2009.060889; Thorborg K, 2015, BR J SPORTS MED; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186064	10.1371/journal.pone.0186064	http://dx.doi.org/10.1371/journal.pone.0186064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020040	gold, Green Published, Green Submitted			2022-12-27	WOS:000412754400062
J	Schlachetzki, JCM; Barth, J; Marxreiter, F; Gossler, J; Kohl, Z; Reinfelder, S; Gassner, H; Aminian, K; Eskofier, BM; Winkler, J; Klucken, J				Schlachetzki, Johannes C. M.; Barth, Jens; Marxreiter, Franz; Gossler, Julia; Kohl, Zacharias; Reinfelder, Samuel; Gassner, Heiko; Aminian, Kamiar; Eskofier, Bjoern M.; Winkler, Juergen; Klucken, Jochen			Wearable sensors objectively measure gait parameters in Parkinson's disease	PLOS ONE			English	Article							CLINICAL VIEW; VARIABILITY; SCALE; TECHNOLOGIES; RHYTHMICITY; RELIABILITY; DISABILITY; STABILITY; DYNAMICS; MOBILITY	Distinct gait characteristics like short steps and shuffling gait are prototypical signs commonly observed in Parkinson's disease. Routinely assessed by observation through clinicians, gait is rated as part of categorical clinical scores. There is an increasing need to provide quantitative measurements of gait, e.g. to provide detailed information about disease progression. Recently, we developed a wearable sensor-based gait analysis system as diagnostic tool that objectively assesses gait parameter in Parkinson's disease without the need of having a specialized gait laboratory. This system consists of inertial sensor units attached laterally to both shoes. The computed target of measures are spatiotemporal gait parameters including stride length and time, stance phase time, heel-strike and toe-off angle, toe clearance, and inter-stride variation from gait sequences. To translate this prototype into medical care, we conducted a cross-sectional study including 190 Parkinson's disease patients and 101 age-matched controls and measured gait characteristics during a 4x10 meter walk at the subjects' preferred speed. To determine intraindividual changes in gait, we monitored the gait characteristics of 63 patients longitudinally. Cross-sectional analysis revealed distinct spatiotemporal gait parameter differences reflecting typical Parkinson's disease gait characteristics including short steps, shuffling gait, and postural instability specific for different disease stages and levels of motor impairment. The longitudinal analysis revealed that gait parameters were sensitive to changes by mirroring the progressive nature of Parkinson's disease and corresponded to physician ratings. Taken together, we successfully show that wearable sensor-based gait analysis reaches clinical applicability providing a high biomechanical resolution for gait impairment in Parkinson's disease. These data demonstrate the feasibility and applicability of objective wearable sensor-based gait measurement in Parkinson's disease reaching high technological readiness levels for both, large scale clinical studies and individual patient care.	[Schlachetzki, Johannes C. M.; Barth, Jens; Marxreiter, Franz; Gossler, Julia; Kohl, Zacharias; Gassner, Heiko; Winkler, Juergen; Klucken, Jochen] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany; [Barth, Jens; Reinfelder, Samuel; Eskofier, Bjoern M.] FAU Erlangen Nurnberg, Dept Comp Sci, Pattern Recognit Lab, Digital Sports Grp, Erlangen, Germany; [Barth, Jens] ASTRUM IT GmbH, Wolfsmantel 2, Erlangen, Germany; [Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measurement, Stn 11, Lausanne, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Klucken, J (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Dept Mol Neurol, Erlangen, Germany.	jochen.klucken@uk-erlangen.de	Marxreiter, Franz/ABB-6982-2020; Eskofier, Bjoern/ABF-1284-2021	Marxreiter, Franz/0000-0002-5187-4344; Eskofier, Bjoern/0000-0002-0417-0336; Klucken, Jochen/0000-0001-6645-9437; Gassner, Heiko/0000-0003-2037-9460; Schlachetzki, Johannes/0000-0002-7801-9743; Winkler, Jurgen/0000-0003-0630-9204	Bavarian Research Foundation [AZ-974-11]; Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg; ASTRUM IT GmbH	Bavarian Research Foundation; Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg; ASTRUM IT GmbH	This research study was funded by the Bavarian Research Foundation (AZ-974-11) and the Emerging Fields Initiative (EFI Moves), Friedrich-Alexander University (FAU) Erlangen-Nurnberg. ASTRUM IT GmbH provided support in the form of salary for the thesis project of author J. B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bjoern M Eskofier reports grants outside the submitted work from Bosch GmbH and Adidas Sport GmbH. Zacharias Kohl reports personal fees outside the submitted work from UCB Pharma GmbH, Actelion Pharmaceuticals, Desitin Arzneimittel GmbH, Ipsen Pharma. Jurgen Winkler reports personal fees outside of the submitted work from Abbvie GmbH & Co. KG. Jochen Klucken reports personal fees outside the submitted work from Teva GmbH, Licher MT GmbH, UCB Pharma GmbH, Ever Pharma GmbH, Desitin Arzneimittel GmbH, Abbvie GmbH & Co. KG, Biogen GmbH, GlaxoSmithKline GmbH & Co. KG. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, HORIZON 2020 WORK PR; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Barth J, 2015, SENSORS-BASEL, V15, P6419, DOI 10.3390/s150306419; Barth J, 2013, IEEE ENG MED BIO, P6744, DOI 10.1109/EMBC.2013.6611104; BLIN O, 1990, J NEUROL SCI, V98, P91, DOI 10.1016/0022-510X(90)90184-O; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Del Din S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0154-5; Dewey DC, 2014, J NEUROL SCI, V345, P131, DOI 10.1016/j.jns.2014.07.026; Ebersbach G, 1999, MOVEMENT DISORD, V14, P619, DOI 10.1002/1531-8257(199907)14:4<619::AID-MDS1011>3.0.CO;2-X; Ellis T, 2011, PARKINSONISM RELAT D, V17, P693, DOI 10.1016/j.parkreldis.2011.07.004; Espay AJ, 2016, MOVEMENT DISORD, V31, P1272, DOI 10.1002/mds.26642; Galna B, 2015, MOVEMENT DISORD, V30, P359, DOI 10.1002/mds.26110; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Grieve D.W., 1968, BIOMED ENG, V3, P119; Hass CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042337; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Heldman DA, 2011, MOVEMENT DISORD, V26, P1859, DOI 10.1002/mds.23740; Henderson EJ, 2016, LANCET NEUROL, V15, P249, DOI 10.1016/S1474-4422(15)00389-0; Hobert MA, 2014, ACTA NEUROL SCAND, V130, P139, DOI 10.1111/ane.12248; HOF AL, 1996, GAIT POSTURE, V4, P222; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Kanzler CM, 2016, IEEE ENG MED BIO, P4979, DOI 10.1109/EMBC.2016.7591845; Kanzler CM, 2015, IEEE ENG MED BIO, P5424, DOI 10.1109/EMBC.2015.7319618; Klucken J, 2015, IEEE J BIOMED HEALTH, V19, P1775, DOI 10.1109/JBHI.2015.2488158; Klucken J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056956; KLUGE F, 2017, SENSORS BASEL, V17, P57587, DOI DOI 10.3390/S17071522; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Maetzler W, 2016, MOVEMENT DISORD, V31, P1263, DOI 10.1002/mds.26673; Maetzler W, 2013, MOVEMENT DISORD, V28, P1628, DOI 10.1002/mds.25628; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; Mariani B, 2013, IEEE T BIO-MED ENG, V60, P155, DOI 10.1109/TBME.2012.2227317; Mariani B, 2012, IEEE T BIO-MED ENG, V59, P3162, DOI 10.1109/TBME.2012.2216263; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Mirelman A, 2015, JAMA-J AM MED ASSOC, V314, P873, DOI 10.1001/jama.2015.8530; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Najafi B, 2011, IEEE ENG MED BIO, P6507, DOI 10.1109/IEMBS.2011.6091605; Pasluosta CF, 2015, IEEE J BIOMED HEALTH, V19, P1873, DOI 10.1109/JBHI.2015.2461555; Rampp A, 2014, IEEE T BIOMEDICAL EN; Rampp A, 2015, IEEE T BIO-MED ENG, V62, P1089, DOI 10.1109/TBME.2014.2368211; RICHARDS M, 1994, MOVEMENT DISORD, V9, P89, DOI 10.1002/mds.870090114; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Rodriguez-Martin D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040827; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Sanchez-Ferro A, 2016, MOVEMENT DISORD, V31, P1283, DOI 10.1002/mds.26723; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schulein S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0228-z; Skog I, 2010, IEEE T BIO-MED ENG, V57, P2657, DOI 10.1109/TBME.2010.2060723; Trojaniello D, 2015, GAIT POSTURE, V42, P310, DOI 10.1016/j.gaitpost.2015.06.008; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Vieregge P, 1997, J NEURAL TRANSM, V104, P237, DOI 10.1007/BF01273184; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	58	163	169	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0183989	10.1371/journal.pone.0183989	http://dx.doi.org/10.1371/journal.pone.0183989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020012	Green Submitted, Green Published, gold			2022-12-27	WOS:000412754400009
J	Smith, SG; Harris, SA; Satti, I; Bryan, D; Walker, KB; Dockrell, HM; McShane, H; Ho, MM				Smith, Steven G.; Harris, Stephanie A.; Satti, Iman; Bryan, Donna; Walker, K. Barry; Dockrell, Hazel M.; McShane, Helen; Ho, Mei Mei			Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials	PLOS ONE			English	Article							CYTOKINE STAINING ASSAY; T-CELL RESPONSES; TUBERCULOSIS VACCINE; BCG VACCINATION; ELISPOT ASSAY; IFN-GAMMA; MALAWI; QUALIFICATION; ADULTS; PANEL	Cellular immunological assays are important tools for the monitoring of responses to T-cell-inducing vaccine candidates. As these bioassays are often technically complex and require considerable experience, careful technology transfer between laboratories is critical if high quality, reproducible data that allows comparison between sites, is to be generated. The aim of this study, funded by the European Union Framework Program 7-funded TRANSVAC project, was to optimise Standard Operating Procedures and the technology transfer process to maximise the reproducibility of three bioassays for interferon-gamma responses: enzyme-linked immunosorbent assay (ELISA), ex-vivo enzyme-linked immunospot and intracellular cytokine staining. We found that the initial variability in results generated across three different laboratories reduced following a combination of Standard Operating Procedure harmonisation and the undertaking of side-by-side training sessions in which assay operators performed each assay in the presence of an assay 'lead' operator. Mean inter-site coefficients of variance reduced following this training session when compared with the pre-training values, most notably for the ELISA assay. There was a trend for increased inter-site variability at lower response magnitudes for the ELISA and intracellular cytokine staining assays. In conclusion, we recommend that on-site operator training is an essential component of the assay technology transfer process and combined with harmonised Standard Operating Procedures will improve the quality, reproducibility and comparability of data produced across different laboratories. These data may be helpful in ongoing discussions of the potential risk/benefit of centralised immunological assay strategies for large clinical trials versus decentralised units.	[Smith, Steven G.; Dockrell, Hazel M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England; [Harris, Stephanie A.; Satti, Iman; McShane, Helen] Jenner Inst, Oxford, England; [Bryan, Donna; Walker, K. Barry; Ho, Mei Mei] Natl Inst Biol Stand & Controls, Med & Healthcare Prod Regulatory Agcy, Bacteriol Div, Potters Bar, Herts, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Jenner Institute; National Institute for Biological Standards & Control; The Medicines & Healthcare Products Regulatory Agency	Smith, SG (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London, England.	steven.smith@lshtm.ac.uk		McShane, Helen/0000-0002-2126-5142; Smith, Steven/0000-0001-5623-7806; Satti, Iman/0000-0003-4760-4664	EC [FP7-INFRASTRUCTURES-2008-228403, FP7-INFRASTRUCTURES-2012-312661]	EC(European CommissionEuropean Commission Joint Research Centre)	SGS, SAH, IS, DB, KBW, HMD, HM and MH were funded by the EC FP7 TRANSVAC project (FP7-INFRASTRUCTURES-2008-228403). SGS, IS, HMD, HM and MH were also funded by the EC FP7 EURIPRED project (FP7-INFRASTRUCTURES-2012-312661). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Britten CM, 2008, CANCER IMMUNOL IMMUN, V57, P289, DOI 10.1007/s00262-007-0378-0; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Geels MJ, 2015, VACCINE, V33, P5481, DOI 10.1016/j.vaccine.2015.01.079; Gomez CE, 2013, J VIROL, V87, P7282, DOI 10.1128/JVI.03246-12; Howles S, 2010, VACCINE, V28, P7306, DOI 10.1016/j.vaccine.2010.08.077; Kagina BM, 2015, J IMMUNOL METHODS, V417, P22, DOI 10.1016/j.jim.2014.12.003; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; McNeil LK, 2013, CYTOM PART A, V83A, P728, DOI [10.1002/cyto.22319, 10.1002/cyto.a.22319]; Mensah VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167951; Patton K, 2014, CLIN VACCINE IMMUNOL, V21, P628, DOI 10.1128/CVI.00736-13; Shaftr-Weaver K, 2006, J IMMUNOTHER, V29, P328, DOI 10.1097/01.cji.0000203079.35612.c8; Smith SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138042; Smith SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007972; Sow SO, 2009, AM J TROP MED HYG, V80, P1033, DOI 10.4269/ajtmh.2009.80.1033; Spertini F, 2015, LANCET RESP MED, V3, P953, DOI 10.1016/S2213-2600(15)00435-X; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Welters MJP, 2012, CANCER IMMUNOL IMMUN, V61, P967, DOI 10.1007/s00262-012-1282-9	22	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0184391	10.1371/journal.pone.0184391	http://dx.doi.org/10.1371/journal.pone.0184391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020010	Green Published, Green Accepted, gold			2022-12-27	WOS:000412754400011
J	Lamb, JJ; Hohmann-Marriott, MF				Lamb, Jacob J.; Hohmann-Marriott, Martin F.			Manganese acquisition is facilitated by PilA in the cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							SP STRAIN PCC-6803; EQUATORIAL PACIFIC-OCEAN; IRON TRANSPORT; NANOWIRES; MOTILITY; BINDING; MICROORGANISMS; TRANSFORMATION; ACCUMULATION; CHLOROPHYLL	Manganese is an essential element required by cyanobacteria, as it is an essential part of the oxygen-evolving center of photosystem II. In the presence of atmospheric oxygen, manganese is present as manganese oxides, which have low solubility and consequently provide low bioavailability. It is unknown if cyanobacteria are able to utilize these manganese sources, and what mechanisms may be employed to do so. Recent evidence suggests that type IV pili in non-photosynthetic bacteria facilitate electron donation to extracellular electron acceptors, thereby enabling metal acquisition. Our present study investigates whether PilA1 (major pilin protein of type IV pili) enables the cyanobacterium Synechocystis PCC 6808 to access to Mn from manganese oxides. We present physiological and spectroscopic data, which indicate that the presence of PilA1 enhances the ability of cyanobacteria to grow on manganese oxides. These observations suggest a role of PilA1-containing pili in cyanobacterial manganese acquisition.	[Lamb, Jacob J.; Hohmann-Marriott, Martin F.] NTNU, Dept Biotechnol, Trondheim, Norway; [Lamb, Jacob J.; Hohmann-Marriott, Martin F.] NTNU, PhotoSynLab, Trondheim, Norway; [Lamb, Jacob J.] NTNU, Dept Elect Syst, Trondheim, Norway; [Lamb, Jacob J.] NTNU, ENERSENSE, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Hohmann-Marriott, MF (corresponding author), NTNU, Dept Biotechnol, Trondheim, Norway.; Hohmann-Marriott, MF (corresponding author), NTNU, PhotoSynLab, Trondheim, Norway.	martin.hohmann-marriott@ntnu.no	Lamb, Jacob J./AAQ-4270-2020	Lamb, Jacob J./0000-0002-1019-6655; Hohmann-Marriott, Martin/0000-0002-2957-7052	Norwegian Research Council (Norges Forskningsrad (NO)) [240741]; NTNU; Norwegian Research Council	Norwegian Research Council (Norges Forskningsrad (NO)); NTNU; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We would like to acknowledge NTNU for the PhD fellowship that funded this project, as well as funding from the Norwegian Research Council (Norges Forskningsrad (NO)) grant 240741 to Martin F. Hohmann-Marriott for research into cyanobacterial nanowires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Thor Bernt Melo for his help and for using his optical laboratory. We would also like to acknowledge NTNU for the PhD fellowship that funded this project, as well as funding from the Norwegian Research Council for research into cyanobacterial nanowires.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Badarau A, 2008, J BIOL CHEM, V283, P12520, DOI 10.1074/jbc.M709907200; BARTSEVICH VV, 1995, EMBO J, V14, P1845, DOI 10.1002/j.1460-2075.1995.tb07176.x; Bartsevich VV, 1996, J BIOL CHEM, V271, P26057, DOI 10.1074/jbc.271.42.26057; Bhaya D, 2000, MOL MICROBIOL, V37, P941, DOI 10.1046/j.1365-2958.2000.02068.x; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Blankenship RE, 2010, PLANT PHYSIOL, V154, P434, DOI 10.1104/pp.110.161687; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Dupont CL, 2006, P NATL ACAD SCI USA, V103, P17822, DOI 10.1073/pnas.0605798103; Eaton-Rye JJ, 2004, METH MOL B, V274, P309; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; HANTKE K, 1987, FEMS MICROBIOL LETT, V44, P53, DOI 10.1111/j.1574-6968.1987.tb02241.x; He QF, 1999, PLANT MOL BIOL, V39, P1175, DOI 10.1023/A:1006177103225; Kamei A, 2001, J BACTERIOL, V183, P1505, DOI 10.1128/JB.183.5.1505-1510.2001; Katoh H, 2001, PLANT CELL PHYSIOL, V42, P823, DOI 10.1093/pcp/pce106; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Keren N, 2002, BIOCHEMISTRY-US, V41, P15085, DOI 10.1021/bi026892s; Kranzler C, 2014, ISME J, V8, P409, DOI 10.1038/ismej.2013.161; Kranzler C, 2011, ENVIRON MICROBIOL, V13, P2990, DOI 10.1111/j.1462-2920.2011.02572.x; Kufryk GI, 2002, FEMS MICROBIOL LETT, V206, P215; Lamb J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132258; Lamb JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105761; Lamb JJ, 2013, CURR MICROBIOL, V67, P123, DOI 10.1007/s00284-013-0340-7; Lamb JJ, 2012, PHOTOSYNTH RES, V114, P59, DOI 10.1007/s11120-012-9777-y; Lee JW, 2007, BIOMETALS, V20, P485, DOI 10.1007/s10534-006-9070-7; Linhartova M, 2014, MOL MICROBIOL, V93, P1207, DOI 10.1111/mmi.12730; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Morris JN, 2014, NEW ZEAL J BOT, V52, P36, DOI 10.1080/0028825X.2013.846267; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Salomon E, 2011, PLANT PHYSIOL, V155, P571, DOI 10.1104/pp.110.164269; Sure S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01134; Yoshihara S, 2001, PLANT CELL PHYSIOL, V42, P63, DOI 10.1093/pcp/pce007	34	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184685	10.1371/journal.pone.0184685	http://dx.doi.org/10.1371/journal.pone.0184685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016622	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400010
J	Carlini, DB; Fong, DW				Carlini, David B.; Fong, Daniel W.			The transcriptomes of cave and surface populations of Gammarus minus (Crustacea: Amphipoda) provide evidence for positive selection on cave downregulated transcripts	PLOS ONE			English	Article							GENE-EXPRESSION; EVOLUTION; GENERATION; DROSOPHILA; HEDGEHOG; TOOLKIT	Gammarus minus, a freshwater amphipod living in the cave and surface streams in the eastern USA, is an excellent model for investigating evolutionary adaptation to the subterranean environment. RNA-Seq was conducted on one pair of morphologically distinct sister populations inhabiting surface and cave habitats to identify genes that were differentially expressed in the two populations, as well as to compare levels and patterns of genetic variation within and between populations. Of the 104,630 transcripts identified in the transcriptome assembly, 57% had higher average levels of expression in the cave population. After Benjamini-Hochberg correction for multiple tests, 1517 and 551 transcripts were significantly upregulated or downregulated, respectively, in the cave population, indicating an almost three-fold enrichment of cave-upregulated genes. The average level of nucleotide diversity across all transcripts was significantly lower in the cave population. Within the cave population, where the average nucleotide diversity of cave-downregulated transcripts was 75% that of the cave-upregulated transcripts, a highly significant difference, whereas within the spring population the nucleotide diversities of cave-downregulated and cave-upregulated transcripts was virtually identical. Three lines of evidence suggest that the reduced variation in cave downregulated transcripts is due to positive selection in the cave population: 1) the average neutrality index of cave-downregulated genes was < 1, consistent with positive selection, and significantly less than that of cave-upregulated genes; 2) Tajima's D was positively correlated with the cave: surface expression ratio, and 3) cave-downregulated transcripts were significantly more likely to be highly diverged from their surface homologs than cave-upregulated transcripts. Five transcripts had fixed premature termination codons in the cave population. The expression patterns and sequence variation in one such transcript, encoding the DNA repair protein photolyase, were examined in more detail and provide the first evidence for the relaxation of functional constraint in this light-dependent protein in a subterranean population.	[Carlini, David B.; Fong, Daniel W.] American Univ, Dept Biol, Washington, DC 20016 USA	American University	Carlini, DB (corresponding author), American Univ, Dept Biol, Washington, DC 20016 USA.	carlini@american.edu			Cave Conservancy of the Virginias [36870]	Cave Conservancy of the Virginias	This work was funded by a grant from the Cave Conservancy of the Virginias (award# 36870) awarded to DBC. There was no additional external funding received for this study.; The authors would like to thank Kianna Billman for assistance with qRT-PCR validation of photolyase expression. This work was funded in part by a grant from the Cave Conservancy of the Virginias (award #36870) awarded to DBC. There was no additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1995, ADAPTATION NATURAL S, DOI DOI 10.4159/HARVARD.9780674419070; Aspiras AC, 2012, J EVOLUTION BIOL, V25, P995, DOI 10.1111/j.1420-9101.2012.02481.x; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Carlini DB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-89; Carlini DB, 2009, MOL ECOL, V18, P1932, DOI 10.1111/j.1365-294X.2009.04161.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Fong D.W., 2012, ENCY CAVES, P341, DOI DOI 10.1016/B978-0-12-383832-2.00047-5; FONG DW, 1995, ANNU REV ECOL SYST, V26, P249, DOI 10.1146/annurev.es.26.110195.001341; FONG DW, 1989, AM MIDL NAT, V121, P361, DOI 10.2307/2426041; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; GLAZIER DS, 1992, FRESHWATER BIOL, V28, P149, DOI 10.1111/j.1365-2427.1992.tb00572.x; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Holsinger JR, 1970, POSTILLA, V146, P1; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; KANE TC, 1992, EVOLUTION, V46, P272, DOI 10.1111/j.1558-5646.1992.tb02002.x; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; KOSTALOS MS, 1979, CRUSTACEANA, V37, P113, DOI 10.1163/156854079X00942; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucas-Lledo JI, 2009, MOL BIOL EVOL, V26, P1143, DOI 10.1093/molbev/msp029; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng FW, 2013, MOL BIOL EVOL, V30, P1527, DOI 10.1093/molbev/mst079; POULSON TL, 1969, SCIENCE, V165, P971; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; ROBBINS JH, 1988, JAMA-J AM MED ASSOC, V260, P384; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero A., 2009, CAVE BIOL; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; TAJIMA F, 1989, GENETICS, V123, P585; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tierney SM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140386; Tobler M, 2008, ENVIRON BIOL FISH, V82, P101, DOI 10.1007/s10641-007-9258-x; VAWTER AT, 1987, STYGOLOGIA, V3, P83	46	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0186173	10.1371/journal.pone.0186173	http://dx.doi.org/10.1371/journal.pone.0186173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016667	gold, Green Published, Green Submitted			2022-12-27	WOS:000412601800043
J	Marquez-Rodas, I; Pollan, M; Escudero, MJ; Ruiz, A; Martin, M; Santaballa, A; del Prado, PM; Batista, N; Andres, R; Anton, A; Llombart, A; Aramburu, AF; Adrover, E; Gonzalez, S; Segui, MA; Calvo, L; Lizon, J; Lescure, AR; Cajal, TRY; Llort, G; Jara, C; Carrasco, E; Lopez-Tarruella, S				Marquez-Rodas, Ivan; Pollan, Marina; Jose Escudero, Maria; Ruiz, Amparo; Martin, Miguel; Santaballa, Ana; Martinez del Prado, Purificacion; Batista, Norberto; Andres, Raquel; Anton, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnacion; Gonzalez, Sonia; Angel Segui, Miguel; Calvo, Lourdes; Lizon, Jose; Rodriguez Lescure, Alvaro; Ramon y Cajal, Teresa; Llort, Gemma; Jara, Carlos; Carrasco, Eva; Lopez-Tarruella, Sara			Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "ElA Alamo III" retrospective study	PLOS ONE			English	Article							FAMILY-HISTORY; GERMLINE MUTATIONS; MORTALITY; PATTERNS; GUIDELINES; METAANALYSIS; ASSOCIATION; MAMMOGRAPHY; CONSORTIUM; SUBTYPES	Purpose To determine the frequency of breast cancer (BC) patients with hereditary risk features in a wide retrospective cohort of patients in Spain. Methods a retrospective analysis was conducted from 10,638 BC patients diagnosed between 1998 and 2001 in the GEICAM registry "ElA A lamo III", dividing them into four groups according to modified ESMO and SEOM hereditary cancer risk criteria: Sporadic breast cancer group (R0); Individual risk group (IR); Familial risk group (FR); Individual and familial risk group (IFR) with both individual and familial risk criteria. Results 7,641 patients were evaluable. Of them, 2,252 patients (29.5%) had at least one hereditary risk criteria, being subclassified in: FR 1.105 (14.5%), IR 970 (12.7%), IFR 177 (2.3%). There was a higher frequency of newly diagnosed metastatic patients in the IR group (5.1% vs 3.2%, p = 0.02). In contrast, in RO were lower proportion of big tumors (> T2) (43.8% vs 47.4%, p = 0.023), nodal involvement (43.4% vs 48.1%, p = 0.004) and lower histological grades (20.9% G3 for the R0 vs 29.8%) when compared to patients with any risk criteria. Conclusions Almost three out of ten BC patients have at least one hereditary risk cancer feature that would warrant further genetic counseling. Patients with hereditary cancer risk seems to be diagnosed with worse prognosis factors.	[Marquez-Rodas, Ivan; Martin, Miguel; Lopez-Tarruella, Sara] Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain; [Marquez-Rodas, Ivan; Pollan, Marina; Jose Escudero, Maria; Ruiz, Amparo; Martin, Miguel; Santaballa, Ana; Martinez del Prado, Purificacion; Batista, Norberto; Andres, Raquel; Anton, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnacion; Gonzalez, Sonia; Angel Segui, Miguel; Calvo, Lourdes; Lizon, Jose; Rodriguez Lescure, Alvaro; Ramon y Cajal, Teresa; Llort, Gemma; Jara, Carlos; Carrasco, Eva; Lopez-Tarruella, Sara] Spanish Breast Canc Res Grp GEICAM, San Sebastian Reyes, Spain; [Pollan, Marina] Inst Salud Carlos III, Madrid, Spain; [Ruiz, Amparo] Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain; [Santaballa, Ana] Hosp Univ & Politecn La Fe, Serv Oncol Med, Valencia, Spain; [Martinez del Prado, Purificacion] Hosp Basurto Osakidetza, Serv Oncol Med, Bilbao, Spain; [Batista, Norberto] Hosp Univ Canarias, Serv Oncol Med, Santa Cruz De Tenerife, Spain; [Andres, Raquel] Hosp Lozano Blesa, Serv Oncol Med, Zaragoza, Spain; [Anton, Antonio] Hosp Univ Miguel Servet, Serv Oncol Med, Zaragoza, Spain; [Llombart, Antonio] Hosp Arnau Vilanova, Serv Oncol Med, Valencia, Spain; [Fernandez Aramburu, Antonio; Adrover, Encarnacion] Complejo Univ Albacete, Secc Oncol Med, Albacete, Spain; [Gonzalez, Sonia] Hosp Mutua Terrassa, Serv Oncol Med, Barcelona, Spain; [Angel Segui, Miguel] Hosp Sabadell Consorcio Sanitario Parc Taul Sabad, Serv Oncol Med, Barcelona, Spain; [Calvo, Lourdes] Complejo Hosp Univ A Coruna, Serv Oncol Med, La Coruna, Spain; [Lizon, Jose] Hosp Univ St Joan, Serv Oncol Med, Alicante, Spain; [Rodriguez Lescure, Alvaro] Hosp Gen Univ Elche, Serv Oncol Med, Elche, Spain; [Ramon y Cajal, Teresa] Hosp Santa Creu & Sant Pau, Serv Oncol Med, Barcelona, Spain; [Llort, Gemma] Inst Oncol Valles, Unitat Consell Genet, Terrassa, Spain; [Jara, Carlos] Hosp Univ Fdn Alcorco, Unidad Oncol, Madrid, Spain	General University Gregorio Maranon Hospital; GEICAM; Instituto de Salud Carlos III; Instituto Valenciano De Oncologia; Hospital Universitari i Politecnic La Fe; Basurto Hospital; Universidad de la Laguna; Lozano Blesa University Clinical Hospital; Miguel Servet University Hospital; Hospital Universitario Mutua Terrassa; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital of Santa Creu i Sant Pau; Alcorcon Foundation University Hospital	Marquez-Rodas, I (corresponding author), Hosp Gen Univ Gregorio Maranon, Serv Oncol Med, Madrid, Spain.; Marquez-Rodas, I (corresponding author), Spanish Breast Canc Res Grp GEICAM, San Sebastian Reyes, Spain.	ivanpantic@hotmail.com	Anton, Antonio/AAP-6563-2020; Marquez-Rodas, Ivan/ABD-5532-2021; CALVO, LOURDES/F-2329-2015; Martin, Miguel/AAJ-9242-2020; Pollan, Marina/M-3259-2014	Marquez-Rodas, Ivan/0000-0002-2476-668X; CALVO, LOURDES/0000-0001-8314-0241; Martin, Miguel/0000-0001-9237-3231; Pollan, Marina/0000-0002-4328-1565; Santaballa, Ana/0000-0001-7763-320X; Llombart Cussac, Antonio/0000-0003-4515-8293; Lopez-Tarruella, Sara/0000-0002-2606-9538; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Fernandez Aramburo, Antonio/0000-0003-3897-2262				Andres R, 2014, CLIN TRANSL ONCOL, V16, P280, DOI 10.1007/s12094-013-1070-9; Baretta Z, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004975; Bethea TN, 2016, CANCER EPIDEM BIOMAR, V25, P366, DOI 10.1158/1055-9965.EPI-15-1068; Castellvi-Bel S, 2012, MUTAGENESIS, V27, P153, DOI 10.1093/mutage/ger047; de Sanjose S, 2003, INT J CANCER, V106, P588, DOI 10.1002/ijc.11271; Depypere H, 2014, MATURITAS, V79, P481, DOI 10.1016/j.maturitas.2014.09.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gonzalez-Rivera M, 2016, BREAST CANCER RES TR, V156, P507, DOI 10.1007/s10549-016-3792-1; Jara-Sanchez C., 2006, J CLIN ONCOL S, V28; Lee EH, 2010, BREAST CANCER RES TR, V122, P11, DOI 10.1007/s10549-010-0859-2; Llort G, 2015, CLIN TRANSL ONCOL, V17, P956, DOI 10.1007/s12094-015-1435-3; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; Lopez-Abente G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-535; Marquez-Rodas I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124239; Martin M, 2006, Clin Transl Oncol, V8, P508, DOI 10.1007/s12094-006-0051-7; Melvin JC, 2016, CANCER MED-US, V5, P942, DOI 10.1002/cam4.648; Mocci E, 2015, EUR J CANC OXF ENGL, V51, P1911; Paluch-Shimon S, 2016, ANN ONCOL, V27, pv103, DOI 10.1093/annonc/mdw327; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Shao J, 2015, J HUAZHONG U SCI-MED, V35, P629, DOI 10.1007/s11596-015-1481-7; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Stuckey A, 2016, AM J CLIN ONCOL-CANC, V39, P363, DOI 10.1097/COC.0000000000000073; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Zhou WB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-248; Zugazagoitia J, 2014, BREAST CANCER RES TR, V148, P415, DOI 10.1007/s10549-014-3167-4	26	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0184181	10.1371/journal.pone.0184181	http://dx.doi.org/10.1371/journal.pone.0184181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985233	Green Published, gold, Green Submitted			2022-12-27	WOS:000412493000001
J	Rehker, J; Rodhe, J; Nesbitt, RR; Boyle, EA; Martin, BK; Lord, J; Karaca, I; Naj, A; Jessen, F; Helisalmi, S; Soininen, H; Hiltunen, M; Ramirez, A; Scherer, M; Farrer, LA; Haines, JL; Pericak-Vance, MA; Raskind, WH; Cruchaga, C; Schellenberg, GD; Joseph, B; Brkanac, Z				Rehker, Jan; Rodhe, Johanna; Nesbitt, Ryan R.; Boyle, Evan A.; Martin, Beth K.; Lord, Jenny; Karaca, Ilker; Naj, Adam; Jessen, Frank; Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko; Ramirez, Alfredo; Scherer, Martin; Farrer, Lindsay A.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Raskind, Wendy H.; Cruchaga, Carlos; Schellenberg, Gerard D.; Joseph, Bertrand; Brkanac, Zoran			Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NON-APOPTOTIC ROLES; CELL-DEATH; NEURONAL APOPTOSIS; MISSENSE MUTATIONS; TREM2 DEFICIENCY; CODING VARIANTS; MOUSE MODELS; BETA; GENE	The accumulation of amyloid beta (A beta) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of Alzheimer's disease (AD). In order to identify additional AD risk genes, we performed targeted sequencing and rare variant burden association study for nine candidate genes involved in the amyloid metabolism in 1886 AD cases and 1700 controls. We identified a significant variant burden association for the gene encoding caspase-8, CASP8 (p = 8.6x10(-5)). For two CASP8 variants, p.K148R and p.I298V, the association remained significant in a combined sample of 10,820 cases and 8,881 controls. For both variants we performed bioinformatics structural, expression and enzymatic activity studies and obtained evidence for loss of function effects. In addition to their role in amyloid processing, caspase-8 and its downstream effector caspase-3 are involved in synaptic plasticity, learning, memory and control of microglia pro-inflammatory activation and associated neurotoxicity, indicating additional mechanisms that might contribute to AD. As caspase inhibition has been proposed as a mechanism for AD treatment, our finding that AD-associated CASP8 variants reduce caspase function calls for caution and is an impetus for further studies on the role of caspases in AD and other neurodegenerative diseases.	[Rehker, Jan; Nesbitt, Ryan R.; Raskind, Wendy H.; Brkanac, Zoran] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rodhe, Johanna; Joseph, Bertrand] Karolinska Inst, Canc Centrum Karolinska, Dept Oncol Pathol, Stockholm, Sweden; [Boyle, Evan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martin, Beth K.] Univ Washington, Dept Genome Sci, Seattle, WA USA; [Lord, Jenny; Cruchaga, Carlos] Washington Univ, Dept Psychiat, St Louis, MO USA; [Karaca, Ilker; Jessen, Frank; Ramirez, Alfredo] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Naj, Adam] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Jessen, Frank; Ramirez, Alfredo] Univ Cologne, Dept Psychiat & Psychotherapy, Cologne, Germany; [Jessen, Frank] German Ctr Neurodegenerat Dis, Bonn, Germany; [Helisalmi, Seppo; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland; [Hiltunen, Mikko] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Ramirez, Alfredo] Univ Bonn, Inst Human Genet, Bonn, Germany; [Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [Farrer, Lindsay A.] Boston Univ, Dept Med Biomed Genet, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Neurol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Ophthalmol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Epidemiol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Dept Biostat, Boston, MA USA; [Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Inst Computat Biol, Cleveland, OH 44106 USA; [Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Gen, Miami, FL USA; [Pericak-Vance, Margaret A.] Univ Miami, Dept Human Genet, John T Macdonald Fdn, Miami, FL USA; [Raskind, Wendy H.] Univ Washington, Dept Med, Seattle, WA USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA	University of Washington; University of Washington Seattle; Karolinska Institutet; Stanford University; University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Bonn; University of Pennsylvania; Pennsylvania Medicine; University of Cologne; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; Boston University; Boston University; Boston University; Boston University; Case Western Reserve University; Case Western Reserve University; University of Miami; University of Miami; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine	Brkanac, Z (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.	zbrkanac@uw.edu	Lord, Jenny/AAR-5643-2021; Cruchaga, Carlos/ABF-4065-2020; Florica, Camelia F./C-8929-2014; Jessen, Frank/AAK-6170-2020; Haines, Jonathan/C-3374-2012; Ramirez, Alfredo/S-5126-2019; Lord, Jenny/GYJ-1039-2022; Farrer, Lindsay/AAS-1035-2020; Enculescu, Monica/C-2091-2011	Lord, Jenny/0000-0002-0539-9343; Cruchaga, Carlos/0000-0002-0276-2899; Florica, Camelia F./0000-0003-0666-6543; Haines, Jonathan/0000-0002-4351-4728; Ramirez, Alfredo/0000-0003-4991-763X; Enculescu, Monica/0000-0002-4476-5545; Joseph, Bertrand/0000-0001-5655-9979; Farrer, Lindsay/0000-0001-5533-4225	National Institute on Aging [1R01AG039700]; Swedish Research Council; Swedish Brain Foundation; Parkinson Foundation in Sweden; Karolinska Institutet Foundations; NATIONAL INSTITUTE ON AGING [P01AG003991, U01AG016976, P50AG005681, U01AG032984, U24AG021886] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Parkinson Foundation in Sweden; Karolinska Institutet Foundations(Karolinska Institutet); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by National Institute on Aging grant 1R01AG039700 to ZB and the Swedish Research Council, the Swedish Brain Foundation, the Parkinson Foundation in Sweden, and the Karolinska Institutet Foundations for BJ.	Aplin AE, 1996, J NEUROCHEM, V67, P699; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bird T.D, 1993, ALZHEIMER DIS OVERVI; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Campion D, 1999, AM J HUM GENET, V65, P664, DOI 10.1086/302553; Caron N.S., 1993, GENEREVIEWS; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Ivins KJ, 1999, NEUROBIOL DIS, V6, P440, DOI 10.1006/nbdi.1999.0268; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kudryashova I V, 2009, Neurosci Behav Physiol, V39, P13, DOI 10.1007/s11055-008-9089-z; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee Jung-Eun, 2013, Exp Neurobiol, V22, P84, DOI 10.5607/en.2013.22.2.84; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu YJ, 2015, NEUROL SCI, V36, P1881, DOI 10.1007/s10072-015-2274-2; Ma C, 2013, GENET EPIDEMIOL, V37, P539, DOI 10.1002/gepi.21742; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Montgomery SL, 2012, J NEUROIMMUNE PHARM, V7, P42, DOI 10.1007/s11481-011-9287-2; Mukherjee A, 2017, CELL DEATH DIFFER, V24, P1411, DOI 10.1038/cdd.2017.64; Nicotera P, 2000, IUBMB LIFE, V49, P421, DOI 10.1080/152165400410272; Nicotera P, 2000, BRAIN PATHOL, V10, P276, DOI 10.1111/j.1750-3639.2000.tb00261.x; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Reitz C, 2012, INT J ALZHEIMERS DIS; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Rohn TT, 2001, NEUROBIOL DIS, V8, P1006, DOI 10.1006/nbdi.2001.0449; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; Sassi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150079; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Southam KA, 2016, J ALZHEIMERS DIS, V51, P657, DOI 10.3233/JAD-151075; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Su JH, 2001, BRAIN RES, V898, P350, DOI 10.1016/S0006-8993(01)02018-2; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Troy CM, 2015, NEUROTHERAPEUTICS, V12, P42, DOI 10.1007/s13311-014-0307-9; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Weuve J, 2015, EPIDEMIOLOGY, V26, pE4, DOI 10.1097/EDE.0000000000000199; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003	69	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0185777	10.1371/journal.pone.0185777	http://dx.doi.org/10.1371/journal.pone.0185777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985224	gold, Green Published, Green Submitted			2022-12-27	WOS:000412493000010
J	Dymarska, M; Grzeszczuk, J; Urbaniak, M; Janeczko, T; Plaskowska, E; Stepien, L; Kostrzewa-Suslow, E				Dymarska, Monika; Grzeszczuk, Jakub; Urbaniak, Monika; Janeczko, Tomasz; Plaskowska, Elzbieta; Stepien, Lukasz; Kostrzewa-Suslow, Edyta			Glycosylation of 6-methylflavone by the strain Isaria fumosorosea KCH J2	PLOS ONE			English	Article							MICROBIAL TRANSFORMATIONS; ASPERGILLUS-NIGER; DIAPHORINA-CITRI; PROMISCUITY; FUNGUS; BRAIN	Entomopathogenic fungi are known for their ability to carry out glycosylation of flavonoids, which usually results in the improvement of their stability and bioavailability. In this study we used a newly isolated strain of the entomopathogenic filamentous fungus Isaria fumosorosea KCH J2 as a biocatalyst. Our aim was to evaluate its ability to carry out the biotransformation of flavonoids and to obtain new flavonoid derivatives. The fungus was isolated from a spider's carcass and molecularly identified using analysis of the ITS1-ITS2 rDNA sequence. As a result of biotransformation of 6-methylflavone two new products were obtained: 6-methylflavone 8-O-beta-D-(4"-O-methyl)-glucopyranoside and 6-methylflavone 4'-O-beta-D-(4"-O-methyl)-glucopyranoside. Chemical structures of the products were determined based on spectroscopic methods (H-1 NMR, C-13 NMR, COSY, HMBC, HSQC). Our research allowed us to discover a new species of filamentous fungus capable of carrying out glycosylation reactions and proved that I. fumosorosea KCH J2 is an effective biocatalyst for glycosylation of flavonoid compounds. For the first time we describe biotransformations of 6-methylflavone and the attachment of the sugar unit to the flavonoid substrate having no hydroxyl group. The possibility of using flavonoid aglycones is often limited by their low bioavailability due to poor solubility in water. The incorporation of a sugar unit improves the physical properties of tested compounds and thus increases the chance of using them as pharmaceuticals.	[Dymarska, Monika; Janeczko, Tomasz; Kostrzewa-Suslow, Edyta] Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland; [Grzeszczuk, Jakub; Plaskowska, Elzbieta] Wroclaw Univ Environm & Life Sci, Fac Life Sci & Technol, Dept Plant Protect, Plant Pathol & Mycol Div, Wroclaw, Poland; [Urbaniak, Monika; Stepien, Lukasz] Polish Acad Sci, Inst Plant Genet, Dept Pathogen Genet & Plant Resistance, Plant Microorganism Interact Team, Poznan, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences	Dymarska, M (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland.	monika.dymarska@gmail.com	Urbaniak, Monika/J-8174-2017; Plaskowska, Elzbieta/ABA-8210-2020; Dymarska, Monika/A-6125-2017; Janeczko, Tomasz/AAL-3121-2020; Stepien, Lukasz/G-2322-2012; Grzeszczuk, Jakub/O-4659-2014	Urbaniak, Monika/0000-0002-1735-4556; Plaskowska, Elzbieta/0000-0002-8643-9318; Dymarska, Monika/0000-0002-2688-8883; Janeczko, Tomasz/0000-0002-9757-6684; Stepien, Lukasz/0000-0001-9740-9520; Grzeszczuk, Jakub/0000-0002-8083-6363; Kostrzewa-Suslow, Edyta/0000-0002-9259-0161	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program	Publication is supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, http://know.wroc.pl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Publication supported by Wroclaw Centre of Biotechnology, The Leading National Research Centre (KNOW) program for the years 2014-2018.	Ai JL, 1997, DRUG DEVELOP RES, V41, P99, DOI 10.1002/(SICI)1098-2299(199706)41:2<99::AID-DDR7>3.3.CO;2-9; Bartmanska A, 2012, BIOORG MED CHEM LETT, V22, P6451, DOI 10.1016/j.bmcl.2012.08.060; Bravo L, 2008, FUNCT FOOD NUTRA SER, P147; Gallou A, 2016, FUNGAL BIOL-UK, V120, P414, DOI 10.1016/j.funbio.2015.11.009; Gurung RB, 2013, MOL CELLS, V36, P355, DOI 10.1007/s10059-013-0164-0; Hall BJ, 2004, EUR J PHARMACOL, V491, P1, DOI 10.1016/j.ejphar.2004.03.014; Hussein HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152399; Ko JH, 2006, FEMS MICROBIOL LETT, V258, P263, DOI 10.1111/j.1574-6968.2006.00226.x; Kostrzewa-Suslow E, 2006, J MOL CATAL B-ENZYM, V39, P18, DOI 10.1016/j.molcatb.2006.01.020; Kostrzewa-suslow E, 2015, SCI WORLD J, V2012, P1; Kostrzewa-Suslow E, 2014, J MOL CATAL B-ENZYM, V102, P59, DOI 10.1016/j.molcatb.2014.01.013; Kostrzewa-Suslow E, 2014, POL J MICROBIOL, V63, P111; Kostrzewa-Suslow E, 2012, Z NATURFORSCH C, V67, P411; Kren V, 1997, CHEM SOC REV, V26, P463, DOI 10.1039/cs9972600463; Liu LX, 2015, FUNGAL GENET BIOL, V81, P191, DOI 10.1016/j.fgb.2015.03.009; Markham KR, FLAVONOIDS, DOI 10.1016/0022-2860(71)87109-0; Matias I, 2016, NEUROCHEM INT, V95, P85, DOI 10.1016/j.neuint.2016.01.009; Pandey RP, 2014, CARBOHYD RES, V393, P26, DOI 10.1016/j.carres.2014.03.011; Patt JM, 2015, BIOL CONTROL, V88, P37, DOI 10.1016/j.biocontrol.2015.04.014; Schocken MJ, 1997, J AGR FOOD CHEM, V45, P3647, DOI 10.1021/jf970298l; Sordon S, 2016, POL J MICROBIOL, V65, P137, DOI 10.5604/17331331.1204473; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Stepien L, 2013, WORLD MYCOTOXIN J, V6, P399, DOI 10.3920/WMJ2012.1464; Tronina T, 2013, BIOORG MED CHEM LETT, V23, P1957, DOI 10.1016/j.bmcl.2013.02.031; Vavrikova E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060899; Vogiatzoglou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128132; Wang L, 2013, CARBOHYD RES, V368, P73, DOI 10.1016/j.carres.2012.12.012; Wang XQ, 2009, FEBS LETT, V583, P3303, DOI 10.1016/j.febslet.2009.09.042; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiao JB, 2014, BIOTECHNOL ADV, V32, P1145, DOI 10.1016/j.biotechadv.2014.04.006; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Yuan W, 2010, BIOCATAL BIOTRANSFOR, V28, P117, DOI 10.3109/10242420903497354	32	25	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184885	10.1371/journal.pone.0184885	http://dx.doi.org/10.1371/journal.pone.0184885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981527	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300023
J	Gonzales-Gustavson, E; Timoneda, N; Fernandez-Cassi, X; Caballero, A; Abril, JF; Buti, M; Rodriguez-Frias, F; Girones, R				Gonzales-Gustavson, Eloy; Timoneda, N.; Fernandez-Cassi, X.; Caballero, A.; Abril, J. F.; Buti, M.; Rodriguez-Frias, F.; Girones, R.			Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology	PLOS ONE			English	Article							ACUTE VIRAL-HEPATITIS; E VIRUS; TT VIRUS; MLB-CLADE; METAGENOMICS; PREVALENCE; INFECTION; SEQUENCES; GENOTYPE; HISTORY	Hepatitis is a general term meaning inflammation of the liver, which can be caused by a variety of viruses. However, a substantial number of cases remain with unknown aetiology. We analysed the serum of patients with clinical signs of hepatitis using a metagenomics approach to characterize their viral species composition. Four pools of patients with hepatitis without identified aetiological agents were evaluated. Additionally, one pool of patients with hepatitis E (HEV) and pools of healthy volunteers were included as controls. A high diversity of anelloviruses, including novel sequences, was found in pools from patients with hepatitis of unknown aetiology. Moreover, viruses recently associated with gastroenteritis as sapovirus GV.2 and astrovirus VA3 were also detected only in those pools. Besides, most of the HEV genome was recovered from the HEV pool. Finally, GB virus C and human endogenous retrovirus were found in the HEV and healthy pools. Our study provides an overview of the virome in serum from hepatitis patients suggesting a potential role of these viruses not previously described in cases of hepatitis. However, further epidemiologic studies are necessary to confirm their contribution to the development of hepatitis.	[Gonzales-Gustavson, Eloy; Timoneda, N.; Fernandez-Cassi, X.; Girones, R.] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Lab Virus Contaminants Water & Food, Barcelona, Catalonia, Spain; [Timoneda, N.; Abril, J. F.] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Computat Genom Lab, Barcelona, Catalonia, Spain; [Timoneda, N.; Abril, J. F.] Univ Barcelona, Inst Biomed, Barcelona, Catalonia, Spain; [Caballero, A.; Buti, M.; Rodriguez-Frias, F.] Hosp Univ Vall dHebron, Barcelona, Catalonia, Spain; [Caballero, A.; Buti, M.; Rodriguez-Frias, F.] Inst Carlos III, CIBEREHD, Barcelona, Catalonia, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Girones, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Lab Virus Contaminants Water & Food, Barcelona, Catalonia, Spain.	rgirones@ub.edu	Ferrando, Josep F Abril/B-3877-2014; Girones, Rosina/B-2975-2009; Rodriguez-Frias, Francisco/AAC-3507-2020; Fernandez Cassi, Xavier/B-9088-2019; Timoneda, Natalia/I-7831-2014	Ferrando, Josep F Abril/0000-0001-7793-589X; Girones, Rosina/0000-0002-1097-6395; Fernandez Cassi, Xavier/0000-0003-2314-9126; CABALLERO, ANDREA/0000-0003-2891-6347; rodriguez-frias, francisco/0000-0002-9128-7013; Timoneda, Natalia/0000-0001-9955-0712; Gonzales-Gustavson, Eloy/0000-0001-7328-2983; Buti Ferret, Maria/0000-0002-0732-3078	Programa RecerCaixa [ACUP-00300]; Spanish MINECO [AGL2011-30461-C02-01/ALI, AGL2014-55081-R]; Catalan Government [2014SRG914]; JPI Water project METAWATER [4193-00001B]; Institut de Recerca de l'Aigua (IdRA)	Programa RecerCaixa; Spanish MINECO(Spanish Government); Catalan Government; JPI Water project METAWATER; Institut de Recerca de l'Aigua (IdRA)	The study reported here was partially funded by the Programa RecerCaixa 2012 (ACUP-00300), AGL2011-30461-C02-01/ALI and AGL2014-55081-R from Spanish MINECO. This study was partially funded by a grant from the Catalan Government to Consolidated Research Group VirBaP (2014SRG914), the JPI Water project METAWATER (4193-00001B) and with the collaboration of the Institut de Recerca de l'Aigua (IdRA). During the development of this study, Eloy Gonzales-Gustayson is a fellow of the Peruvian Government; Natalia Timoneda is a fellow of the Spanish Ministry of Science and Xavier FernandezCassi was a fellow of the Catalan Government "AGAUR" (FI-DGR).	Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banks M, 2004, EMERG INFECT DIS, V10, P953, DOI 10.3201/eid1005.030908; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biagini P, 2012, VIRUS TAXONOMY, P331; Bihari Chhagan, 2013, Hepat Res Treat, V2013, P472027, DOI 10.1155/2013/472027; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bostan N., 2013, J VACCINES VACCIN, P1; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Cacopardo B, 2000, Eur Rev Med Pharmacol Sci, V4, P117; Canuti M, 2015, PSYCHIAT RES, V229, P678, DOI 10.1016/j.psychres.2015.08.025; Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086; Chu C, 2011, MOL MED, V17, P1; Chu C-M, 2001, J MED VIROL J MED VI, V65; Chu CM, 1999, J MED VIROL, V58, P154, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;154::AID-JMV9&gt;3.0.CO;2-E; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; CLC Bio, 2008, CLC GEN WORKB; Colson P, 2013, J CLIN VIROL, V57, P191, DOI 10.1016/j.jcv.2013.03.018; Conrad ME, 2014, JAMA-J AM MED ASSOC, V312, P654, DOI 10.1001/jama.2013.279664; Delic D, 2010, VOJNOSANIT PREGL, V67, P903, DOI 10.2298/VSP1011903D; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Mateos ME, 2012, J PEDIAT HEMATOL ONC, V34, pE298, DOI 10.1097/MPH.0b013e318266ba72; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Hannon G.J., 2015, FASTX TOOLKIT; Hansman GS, 2007, EMERG INFECT DIS, V13, P133, DOI 10.3201/eid1301.061047; Hofer U, 2014, NAT REV MICROBIOL, V12, DOI 10.1038/nrmicro3192; Hsiao KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149901; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Kakkola L, 2008, VIROLOGY, V382, P182, DOI 10.1016/j.virol.2008.09.012; Kaufman B, 1997, CLIN INFECT DIS, V24, P334, DOI 10.1093/clinids/24.3.334; Kawashima Nozomu, 2015, J Infect Chemother, V21, P857, DOI 10.1016/j.jiac.2015.08.018; Leary TP, 2004, VIRAL HEPATITIS DIAG, P223; Legrand-Abravanel F, 2009, EMERG INFECT DIS, V15, P110, DOI 10.3201/eid1501.080296; Li LL, 2013, J VIROL, V87, P10912, DOI 10.1128/JVI.01839-13; Liu N, 2014, VET MICROBIOL, V170, P39, DOI 10.1016/j.vetmic.2014.01.026; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo KX, 2002, J MED VIROL, V67, P118, DOI 10.1002/jmv.2200; Manka P, 2016, VISC MED, V32, P80, DOI 10.1159/000444915; Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Meyer CT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0299-z; Mi Zhiqiang, 2014, Virologica Sinica, V29, P112, DOI 10.1007/s12250-014-3424-z; NCBI, 2016, ASS GEN; Ninomiya M, 2007, ARCH VIROL, V152, P1961, DOI 10.1007/s00705-007-1046-6; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Ohbayashi H, 2001, J GASTROEN HEPATOL, V16, P424, DOI 10.1046/j.1440-1746.2001.02460.x; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Okamoto H, 2004, PERSP MED V, V10, P241; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Olarte-Castillo XA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163548; Previsani N, 2004, PERSP MED V, V10, P1; Riveiro-Barciela M, 2015, J CLIN GASTROENTEROL, V49, P165, DOI 10.1097/MCG.0000000000000113; Rivero-Juarez A, 2017, ZOONOSES PUBLIC HLTH, V64, pe60, DOI 10.1111/zph.12347; Rosseel T, 2015, J VIROL METHODS, V222, P72, DOI 10.1016/j.jviromet.2015.05.010; Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10; Shibata S, 2015, GENOME ANNOUNCEMENTS, V3, P2, DOI DOI 10.1128/GEN0MEA.01553-14; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393; Somasekar S, 2017, CLIN INFECT DIS; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Tassopoulos NC, 2008, J GASTROEN HEPATOL, V23, P1208, DOI 10.1111/j.1440-1746.2008.05454.x; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-6; Van Thiel D H, 1994, J Okla State Med Assoc, V87, P364; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Xiao JP, 2011, ARCH VIROL, V156, P1415, DOI 10.1007/s00705-011-1011-2; Yeh CT, 2006, J INFECT DIS, V193, P1089, DOI 10.1086/501474; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; ZHANG Y, 2016, SCI REP-UK, V6, DOI DOI 10.1038/SREP26	74	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185911	10.1371/journal.pone.0185911	http://dx.doi.org/10.1371/journal.pone.0185911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982120	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300085
J	Joshi, R; van de Mortel, H; Feijs, L; Andriessen, P; van Pul, C				Joshi, Rohan; van de Mortel, Heidi; Feijs, Loe; Andriessen, Peter; van Pul, Carola			The heuristics of nurse responsiveness to critical patient monitor and ventilator alarms in a private room neonatal intensive care unit	PLOS ONE			English	Article							FALSE ALARMS; INFANTS	Aim Alarm fatigue is a well-recognized patient safety concern in intensive care settings. Decreased nurse responsiveness and slow response times to alarms are the potentially dangerous consequences of alarm fatigue. The aim of this study was to determine the factors that modulate nurse responsiveness to critical patient monitor and ventilator alarms in the context of a private room neonatal intensive care setting. Methods The study design comprised of both a questionnaire and video monitoring of nurse-responsiveness to critical alarms. The Likert scale questionnaire, comprising of 50 questions across thematic clusters (critical alarms, yellow alarms, perception, design, nursing action, and context) was administered to 56 nurses (90% response rate). Nearly 6000 critical alarms were recorded from 10 infants in approximately 2400 hours of video monitoring. Logistic regression was used to identify patient and alarm-level factors that modulate nurse-responsiveness to critical alarms, with a response being defined as a nurse entering the patient's room within the 90s of the alarm being generated. Results Based on the questionnaire, the majority of nurses found critical alarms to be clinically relevant even though the alarms did not always mandate clinical action. Based on video observations, for a median of 34% (IQR, 20-52) of critical alarms, the nurse was already present in the room. For the remaining alarms, the response rate within 90s was 26%. The median response time was 55s (IQR, 37-70s). Desaturation alarms were the most prevalent and accounted for more than 50% of all alarms. The odds of responding to bradycardia alarms, compared to desaturation alarms, were 1.47 (95% CI = 1.21-1.78; <0.001) while that of responding to a ventilator alarm was lower at 0.35 (95% CI = 0.27-0.46; p <0.001). For every 20s increase in the duration of an alarm, the odds of responding to the alarm (within 90s) increased to 1.15 (95% CI = 1.1-1.2; p <0.001). The random effect per infant improved the fit of the model to the data with the response times being slower for infants suffering from chronic illnesses while being faster for infants who were clinically unstable. Discussion Even though nurses respond to only a fraction of all critical alarms, they consider the vast majority of critical and yellow alarms as useful and relevant. When notified of a critical alarm, they seek waveform information and employ heuristics in determining whether or not to respond to the alarm. Conclusion Amongst other factors, the category and duration of critical alarms along with the clinical status of the patient determine nurse-responsiveness to alarms.	[Joshi, Rohan; Feijs, Loe] Eindhoven Univ Technol, Dept Ind Design, Eindhoven, Netherlands; [Joshi, Rohan; van Pul, Carola] Maxima Med Ctr, Dept Clin Phys, Veldhoven, Netherlands; [van de Mortel, Heidi; Andriessen, Peter] Maxima Med Ctr, Dept Neonatol, Veldhoven, Netherlands; [Andriessen, Peter] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci,Dept Pediat, Maastricht, Netherlands; [van Pul, Carola] Eindhoven Univ Technol, Dept Appl Phys, Eindhoven, Netherlands	Eindhoven University of Technology; Maxima Medical Center; Maxima Medical Center; Maastricht University; Eindhoven University of Technology	Joshi, R (corresponding author), Eindhoven Univ Technol, Dept Ind Design, Eindhoven, Netherlands.; Joshi, R (corresponding author), Maxima Med Ctr, Dept Clin Phys, Veldhoven, Netherlands.	r.joshi@tue.nl		Andriessen, Peter/0000-0002-5159-6874; van Pul, Carola/0000-0001-7342-9623	IMPULS Perinatology	IMPULS Perinatology	This work was supported by IMPULS Perinatology.	Ahlborn V, 2000, ACTA PAEDIATR, V89, P571, DOI 10.1080/080352500750027880; Bitan Y., 2004, COGN TECHNOL WORK, V6, P239, DOI DOI 10.1007/s10111-004-0162-2; Blum JM, 2010, CRIT CARE MED, V38, P702, DOI 10.1097/CCM.0b013e3181bfe97f; Bonafide Christopher P, 2014, Biomed Instrum Technol, V48, P220, DOI 10.2345/0899-8205-48.3.220; Bonafide CP, 2017, JAMA PEDIAT, V1910, P1; Bonafide CP, 2016, ASS EXPOSURE NONACTI, V10, P345; Brockmann PE, 2013, ARCH DIS CHILD-FETAL, V98, pF524, DOI 10.1136/archdischild-2012-303369; Chambrin MC, 2001, CRIT CARE, V5, P184, DOI 10.1186/cc1021; Doede M, 2017, HERD HEAL ENV RES DE; Funk M, 2014, AM J CRIT CARE, V23, pE9, DOI 10.4037/ajcc2014315; Gazarian PK, 2015, J CLIN NURS, V24, P151, DOI 10.1111/jocn.12625; Gorges M, 2009, ANESTH ANALG, V108, P1546, DOI 10.1213/ane.0b013e31819bdfbb; Joshi R, 2016, PHYSIOL MEAS, V37, P564, DOI 10.1088/0967-3334/37/4/564; MacMurchy Matt, 2017, Biomed Instrum Technol, V51, P25, DOI 10.2345/0899-8205-51.1.25; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P2315, DOI 10.1001/jama.2013.6032; Poets CF, 2015, JAMA-J AM MED ASSOC, V314, P595, DOI 10.1001/jama.2015.8841; Rayo MF, 2015, BMJ QUAL SAF, V24, P282, DOI 10.1136/bmjqs-2014-003373; Siebig S, 2010, INTENSIVE CARE UNIT, V38; Siebig S, 2010, J CRIT CARE, V25, P128, DOI 10.1016/j.jcrc.2008.09.001; Torabizadeh C, 2016, J CLIN MONIT COMPUT, P1; van Pul C, 2015, ACTA PAEDIATR, V104, pE247, DOI 10.1111/apa.12907; van Pul C, 2015, AMB INTELL SMART ENV, V20, P119, DOI 10.3233/978-1-61499-597-5-119	22	14	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184567	10.1371/journal.pone.0184567	http://dx.doi.org/10.1371/journal.pone.0184567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981515	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300014
J	Mejia, CR; Valladares-Garrido, MJ; Minan-Tapia, A; Serrano, FT; Tobler-Gomez, LE; Pereda-Castro, W; Mendoza-Flores, CR; Mundaca-Manay, MY; Valladares-Garrido, D				Mejia, Christian R.; Valladares-Garrido, Mario J.; Minan-Tapia, Armando; Serrano, Felipe T.; Tobler-Gomez, Liz E.; Pereda-Castro, William; Mendoza-Flores, Cynthia R.; Mundaca-Manay, Maria Y.; Valladares-Garrido, Danai			Use, knowledge, and perception of the scientific contribution of Sci-Hub in medical students: Study in six countries in Latin America	PLOS ONE			English	Article							AUTHORSHIP	Introduction Sci-Hub is a useful web portal for people working in science as it provides access to millions of free scientific articles. Satisfaction and usage should be explored in the Latino student population. The objective of this study was to evaluate the use, knowledge, and perception of the scientific contribution of Sci-Hub in medical students from Latin America. Methodology A multicenter, observational, analytical study was conducted in 6632 medical students from 6 countries in Latin America. We surveyed from a previously validated instrument, delving into knowledge, monthly average usage, satisfaction level, and perception of the scientific contributions provided by Sci-Hub. Frequencies and percentages are described, and generalized linear models were used to establish statistical associations. Results Only 19.2% of study participants knew of Sci-Hub and its function, while the median use was twice a month. 29.9% of Sci-Hub-aware participants claimed they always find the desired scientific information in their Sci-Hub search; 62.5% of participants affirmed that Sci-Hub contributes to scientific investigation; only 2.2% reported that Sci-Hub does not contribute to science. Conclusion The majority of Latino students are not aware of Sci-Hub.	[Mejia, Christian R.] Univ Continental, Escuela Med Humana, Huancayo, Peru; [Mejia, Christian R.] Univ Privada Antenor Orrego, Escuela Postgrad, Trujillo, Peru; [Valladares-Garrido, Mario J.; Valladares-Garrido, Danai] Univ Peruana Cayetano Heredia, Unidad Invest Enfermedades Emergentes & Cambio Cl, Lima, Peru; [Minan-Tapia, Armando] Univ Privada Tacna, Tacna, Peru; [Serrano, Felipe T.] UPTC, Grp Invest ACEMED UPTC, Tunja, Colombia; [Tobler-Gomez, Liz E.] Univ Nacl Amazonia Peruana, SOCIEMAP, Loreto, Peru; [Pereda-Castro, William] Univ Nacl Trujillo, SOCEMUNT, Trujillo, Peru; [Mendoza-Flores, Cynthia R.] Univ Andina Nestor Caceres Velasquez, ASOCEM UANCV, Juliaca, Peru; [Mundaca-Manay, Maria Y.] Univ Nacl Pedro Ruiz Gallo, Fac Med Humana, Lambayeque, Peru	Universidad Continental; Universidad Privada Antenor Orrego; Universidad Peruana Cayetano Heredia; Universidad Privada De Tacna; Universidad Pedagogica y Tecnologica de Colombia (UPTC); Universidad Nacional de la Amazonia Peruana; Universidad Nacional de Trujillo; Universidad Nacional Pedro Ruiz Gallo	Mejia, CR (corresponding author), Univ Continental, Escuela Med Humana, Huancayo, Peru.; Mejia, CR (corresponding author), Univ Privada Antenor Orrego, Escuela Postgrad, Trujillo, Peru.	christian.mejia.md@gmail.com	Valladares-Garrido, Mario J./GPI-7974-2022; Torres, Felipe Serrano/E-7396-2019	Valladares-Garrido, Mario J./0000-0003-0839-2419; Torres, Felipe Serrano/0000-0003-3224-3448; Minan-Tapia, Armando/0000-0002-0104-780X; Pereda-Castro, William/0000-0002-3936-427X	FOGARTY INTERNATIONAL CENTER [D43TW007393] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW007393] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		[Anonymous], 2016, SCIENCE; Bazan-Ruiz S, 2013, CIMEL, V18, P23; Bendezu-Quispe G, 2016, LANCET GLOB HEALTH, V4, pE608, DOI 10.1016/S2214-109X(16)30188-7; Bohannon J, 2016, SCIENCE, V352, P511, DOI 10.1126/science.352.6285.511; Faust JS, 2016, ANN EMERG MED, V68, p15A, DOI 10.1016/j.annemergmed.2016.05.010; Filardo G, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i847; Fuchs C, 2013, TRIPLEC-COMMUN CAPIT, V11, P428, DOI 10.31269/vol11iss2pp428-443; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; McNutt M, 2016, SCIENCE, V352, P497, DOI 10.1126/science.aaf9419; Okoshi K, 2014, TOHOKU J EXP MED, V234, P221, DOI 10.1620/tjem.234.221; Ospina EG, 2005, REV PANAM SALUD PUBL, V17, P230; Ramakrishnan A, 2014, J WOMENS HEALTH, V23, P927, DOI 10.1089/jwh.2014.4736; Resnick B., 2016, WHY ONE WOMAN STOLE; Russell C, 2016, COLL RES LIB NEWS, V77, P122, DOI [DOI 10.5860/CRLN.77.3.9457, 10.5860/crln.77.3.9457]; Sidhu R, 2009, J ROY SOC MED, V102, P337, DOI 10.1258/jrsm.2009.080378; Taype-Ronda A, 2011, CIMEL, V16, P90	16	12	12	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185673	10.1371/journal.pone.0185673	http://dx.doi.org/10.1371/journal.pone.0185673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982181	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300057
J	Thakuria, D; Shahi, N; Singh, AK; Khangembam, VC; Singh, AK; Kumar, S				Thakuria, Dimpal; Shahi, Neetu; Singh, Atul Kumar; Khangembam, Victoria Chanu; Singh, Arvind Kumar; Kumar, Satish			Conformational analysis of a synthetic fish kisspeptin 1 peptide in membrane mimicking environments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CIRCULAR-DICHROISM; HORMONE NEURONS; GPR54 AGONISTS; IN-VIVO; GONADOTROPIN; ACTIVATION; METASTIN; PUBERTY; ANALOGS	Kisspeptin 1 is a neuropeptide hormone of the RFamide family, which act as an upstream regulator of brain-pituitary-gonad (BPG) axis in most vertebrates including teleosts. In the present study, a 16 amino acid long putative mature bioactive peptide (kiss 1) from preprokis-speptin 1 of golden mahseer, Tor putitora (Hamilton, 1822), was synthesized and characterized using an integrated (experimental and in silico) approach. The far-UV circular dichroism (CD) spectrum of this peptide was evaluated both in aqueous and membrane mimicking solvents (TFE, HFIP and Dioxane). The results indicate that kiss 1 peptide adopted helical, turn and beta conformations in membrane like environments. The near-UV CD spectroscopy was also carried out to examine the tertiary packing around aromatic residues of kiss 1 peptide and the peptide-membrane complex. The kiss 1 peptide exhibited little signal in water, but a prominent negative band was observed at around 275 nm when membrane mimetic solution was added. The observed ordered conformations of kiss 1 peptide in the different solvents indicated its potential biological activity which could enhance the secretion of gonadotrop-inreleasing hormone (GnRH) at BPG axis. The conformational information generated from the present study reinforces the application prospects of bioactive synthetic peptide analogs of kisspeptin 1 in improving the reproductive performances of important cultivable fish species.	[Thakuria, Dimpal; Shahi, Neetu; Singh, Atul Kumar; Khangembam, Victoria Chanu] ICAR Directorate Coldwater Fisheries Res, Naini Tal, Uttarakhand, India; [Singh, Arvind Kumar; Kumar, Satish] Indian Vet Res Inst, ICAR, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Coldwater Fisheries Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Thakuria, D (corresponding author), ICAR Directorate Coldwater Fisheries Res, Naini Tal, Uttarakhand, India.	drdimpal@gmail.com		Khangembam, Victoria Chanu/0000-0003-1153-4182; Singh, Arvind Kumar/0000-0001-8711-9191; Thakuria, Dimpal/0000-0002-4434-0483	ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India	ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India	The project was funded by institutional research fund of ICAR-Directorate of Coldwater Fisheries Research, Bhimtal, Uttarakhand, India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2013, J MED CHEM, V56, P8298, DOI 10.1021/jm401056w; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; Curtis AE, 2010, AM J PHYSIOL-ENDOC M, V298, pE296, DOI 10.1152/ajpendo.00426.2009; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Ebenhan T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/867381; Elizur A, 2009, PEPTIDES, V30, P164, DOI 10.1016/j.peptides.2008.08.018; Fadhil I, 2004, J BIOL CHEM, V279, P21069, DOI 10.1074/jbc.M311468200; Felip A, 2015, REPRODUCTION, V150, P227, DOI 10.1530/REP-15-0204; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gutierrez-Pascual E, 2009, MOL PHARMACOL, V76, P58, DOI 10.1124/mol.108.053751; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Le Marec O, 2011, J MED CHEM, V54, P4806, DOI 10.1021/jm200418c; Lee JY, 2009, ARCH BIOCHEM BIOPHYS, V485, P109, DOI 10.1016/j.abb.2009.03.002; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Matsui H, 2014, EUR J PHARMACOL, V735, P77, DOI 10.1016/j.ejphar.2014.03.058; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Niida A, 2006, BIOORG MED CHEM LETT, V16, P134, DOI 10.1016/j.bmcl.2005.09.054; Nocillado JN, 2013, GEN COMP ENDOCR, V191, P168, DOI 10.1016/j.ygcen.2013.06.005; Ohga H, 2013, GEN COMP ENDOCR, V193, P130, DOI 10.1016/j.ygcen.2013.07.016; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Orsini MJ, 2007, J MED CHEM, V50, P462, DOI 10.1021/jm0609824; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Prabhu VV, 2013, ASIAN PAC J CANCER P, V14, P6215, DOI 10.7314/APJCP.2013.14.11.6215; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Saxena VK, 2015, INDIAN J EXP BIOL, V53, P676; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Siano A, 2014, J NAT PROD, V77, P831, DOI 10.1021/np4009317; Tena-Sempere M, 2012, GEN COMP ENDOCR, V175, P234, DOI 10.1016/j.ygcen.2011.11.015; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Thundimadathil J, 2006, BIOPOLYMERS, V84, P317, DOI 10.1002/bip.20470; Tomita K, 2008, BIOPOLYMERS, V90, P503, DOI 10.1002/bip.20968; Tomita K, 2007, BIOPOLYMERS, V88, P272, DOI 10.1002/bip.20676; Tomita K, 2007, J MED CHEM, V50, P3222, DOI 10.1021/jm070064l; Tomita K, 2006, BIOORGAN MED CHEM, V14, P7595, DOI 10.1016/j.bmc.2006.07.009; WALTER B, 1977, BIOPOLYMERS, V16, P17, DOI 10.1002/bip.1977.360160103; Zhao YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104330; Zmora N, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097667; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185892	10.1371/journal.pone.0185892	http://dx.doi.org/10.1371/journal.pone.0185892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977030	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100051
J	Calabro, RS; Naro, A; Russo, M; Milardi, D; Leo, A; Filoni, S; Trinchera, A; Bramanti, P				Calabro, Rocco Salvatore; Naro, Antonino; Russo, Margherita; Milardi, Demetrio; Leo, Antonino; Filoni, Serena; Trinchera, Antonia; Bramanti, Placido			Is two better than one? Muscle vibration plus robotic rehabilitation to improve upper limb spasticity and function: A pilot randomized controlled trial	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DEPRESSION RATING-SCALE; MOTOR RECOVERY; CHRONIC STROKE; INTRACORTICAL FACILITATION; POSTSTROKE DEPRESSION; ASHWORTH SCALE; EXCITABILITY; INHIBITION; MOVEMENT	Even though robotic rehabilitation is very useful to improve motor function, there is no conclusive evidence on its role in reducing post-stroke spasticity. Focal muscle vibration (MV) is instead very useful to reduce segmental spasticity, with a consequent positive effect on motor function. Therefore, it could be possible to strengthen the effects of robotic rehabilitation by coupling MV. To this end, we designed a pilot randomized controlled trial (Clinical Trial NCT03110718) that included twenty patients suffering from unilateral post-stroke upper limb spasticity. Patients underwent 40 daily sessions of Armeo-Power training (1 hour/session, 5 sessions/week, for 8 weeks) with or without spastic antagonist MV. They were randomized into two groups of 10 individuals, which received (group-A) or not (groupB) MV. The intensity of MV, represented by the peak acceleration (a-peak), was calculated by the formula (2 pi f) 2A, where f is the frequency of MV and A is the amplitude. Modified Ash-worth Scale (MAS), short intracortical inhibition (SICI), and H-max/M-max ratio (HMR) were the primary outcomes measured before and after (immediately and 4 weeks later) the end of the treatment. In all patients of group-A, we observed a greater reduction of MAS (p = 0.007, d = 0.6) and HMR (p<0.001, d = 0.7), and a more evident increase of SICI (p<0.001, d = 0.7) up to 4 weeks after the end of the treatment, as compared to group-B. Likewise, group-A showed a greater function outcome of upper limb (Functional Independence Measure p = 0.1, d = 0.7; Fugl-Meyer Assessment of the Upper Extremity p = 0.007, d = 0.4) up to 4 weeks after the end of the treatment. A significant correlation was found between the degree of MAS reduction and SICI increase in the agonist spastic muscles (p = 0.004). Our data show that this combined rehabilitative approach could be a promising option in improving upper limb spasticity and motor function. We could hypothesize that the greater rehabilitative outcome improvement may depend on a reshape of corticospinal plasticity induced by a sort of associative plasticity between Armeo-Power and MV.	[Calabro, Rocco Salvatore; Naro, Antonino; Russo, Margherita; Milardi, Demetrio; Leo, Antonino; Trinchera, Antonia; Bramanti, Placido] IRCCS Ctr Neurolesi Bonino Pulejo Messina, Messina, Italy; [Milardi, Demetrio] Univ Messina, Dept Biomed Dent Sci & Morphol & Funct Images, Messina, Italy; [Filoni, Serena] Fdn Ctr Riabilitaz Padre Pio Onlus, San Giovanni Rotondo, Italy	IRCCS Bonino Pulejo; University of Messina	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo Messina, Messina, Italy.	salbro77@tiscali.it	Leo, Antonino/ABI-7198-2020; calabro, rocco salvatore/L-9570-2019; Calabrò, Rocco S/K-7520-2016; Bramanti, Placido/K-5117-2016; MILARDI, DEMETRIO/AAD-7793-2019; Milardi, Demetrio/J-6587-2016; Leo, Antonino/K-7529-2016	Leo, Antonino/0000-0003-4163-5830; calabro, rocco salvatore/0000-0002-8566-3166; MILARDI, DEMETRIO/0000-0001-7311-2757; Milardi, Demetrio/0000-0001-7311-2757; Leo, Antonino/0000-0003-4163-5830; Filoni, Serena/0000-0002-6375-2360				Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; ANGEL RW, 1963, ARCH NEUROL-CHICAGO, V8, P591, DOI 10.1001/archneur.1963.00460060021002; [Anonymous], 2017, ACTA CLIN CROAT, V53, P294; Arpinar-Avsar P, 2013, EXP BRAIN RES, V229, P103, DOI 10.1007/s00221-013-3597-y; Arwert HJ, 1997, J SHOULDER ELB SURG, V6, P360, DOI 10.1016/S1058-2746(97)90004-5; Avanzino L, 2014, CEREB CORTEX, V24, P2807, DOI 10.1093/cercor/bht139; Bakheit AMO, 2003, J NEUROL NEUROSUR PS, V74, P646, DOI 10.1136/jnnp.74.5.646; Bartoli F, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/862978; Bilge C, 2008, EUR J PHYS REHAB MED, V44, P13; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bragoni M, 2013, AM J PHYS MED REHABI, V92, P16; Brown SHM, 2010, MUSCLE NERVE, V41, P234, DOI 10.1002/mus.21470; Calabro RS, 2016, PM&R, pS1934; Caliandro P, 2012, ARCH PHYS MED REHAB, V93, P1656, DOI 10.1016/j.apmr.2012.04.002; Casale R, EUR J PHYS REHABIL M; Chang WH, 2013, J STROKE, V15, P174, DOI 10.5853/jos.2013.15.3.174; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colomer C, 2013, NEUROLOGIA, V28, P261, DOI 10.1016/j.nrl.2012.04.017; Conrad MO, 2011, NEUROREHAB NEURAL RE, V25, P61, DOI 10.1177/1545968310378507; Cordo P, 2013, J NEUROL PHYS THER, V37, P194, DOI 10.1097/NPT.0000000000000023; Di Pino G, 2014, NAT REV NEUROL, V10, P597, DOI 10.1038/nrneurol.2014.162; Dietz V, 2007, LANCET NEUROL, V6, P725, DOI 10.1016/S1474-4422(07)70193-X; Dimitriou M, 2010, CURR BIOL, V20, P1763, DOI 10.1016/j.cub.2010.08.049; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; Donnellan C, 2010, INT J GERIATR PSYCH, V25, P1288, DOI 10.1002/gps.2482; Douven E, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0588-1; Fazekas G, 2007, J REHABIL MED, V39, P580, DOI 10.2340/16501977-0087; Frisoli A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-36; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Fukuda T.Y., 2010, J APPL RES CLIN EXP, V10, P32; Gijbels D, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-5; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Gregson JM, 2000, AGE AGEING, V29, P223, DOI 10.1093/ageing/29.3.223; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hara Yukihiro, 2015, J Nippon Med Sch, V82, P4, DOI 10.1272/jnms.82.4; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Hu XL, 2009, NEUROREHAB NEURAL RE, V23, P837, DOI 10.1177/1545968309338191; Jarrasse N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00947; Karaahmet OZ, 2017, INT J REHABIL RES, V40, P71, DOI 10.1097/MRR.0000000000000210; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Krabben T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-44; Krebs HI, 2008, NEUROREHABILITATION, V23, P81; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kumru H, 2012, CLIN NEUROPHYSIOL, V123, P45, DOI 10.1016/j.clinph.2011.06.036; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lewis GN, 2001, BRAIN RES, V900, P282, DOI 10.1016/S0006-8993(01)02369-1; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Liepert J, 2010, RESTOR NEUROL NEUROS, V28, P729, DOI 10.3233/RNN-2010-0541; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P441, DOI 10.1177/1545968308328719; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P429, DOI 10.1177/1545968308331144; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P160, DOI 10.1177/1545968308320642; Lundgren-Nilsson A, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-55; Marconi B, 2011, NEUROREHAB NEURAL RE, V25, P48, DOI 10.1177/1545968310376757; Matsuzaki S, 2015, J AFFECT DISORDERS, V176, P56, DOI 10.1016/j.jad.2015.01.020; Mazzoleni S, 2014, IEEE T HAPTICS, V7, P175, DOI 10.1109/TOH.2013.73; McNickle E, 2015, J PHYSIOL-LONDON, V593, P1649, DOI 10.1113/jphysiol.2014.280453; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS; Mehrholz Jan, 2012, Cochrane Database Syst Rev, pCD006876, DOI 10.1002/14651858.CD006876.pub3; Merlo A, 2013, NEUROREHABILITATION, V33, P523, DOI 10.3233/NRE-130998; Michaelsen SM, 2001, STROKE, V32, P1875, DOI 10.1161/01.STR.32.8.1875; Murillo N, 2014, EUR J PHYS REHAB MED, V50, P231; Nakamura H, 1997, J PHYSIOL-LONDON, V498, P817, DOI 10.1113/jphysiol.1997.sp021905; Nielsen JE, 2001, EUR J NEUROL, V8, P335, DOI 10.1046/j.1468-1331.2001.00249.x; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Noma T, 2012, J REHABIL MED, V44, P325, DOI 10.2340/16501977-0946; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Orsnes G, 2000, CLIN NEUROPHYSIOL, V111, P1372, DOI 10.1016/S1388-2457(00)00352-7; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Paoloni M, 2014, NEUROREHABILITATION, V35, P405, DOI 10.3233/NRE-141131; Posteraro F, 2010, J REHABIL MED, V42, P279, DOI 10.2340/16501977-0500; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; Reaz MBI, 2006, BIOL PROCED ONLINE, V8, P11, DOI [10.1251/bpo115, 10.1251/bpo124]; Jimenez SR, 2015, EUR J APPL PHYSIOL, V115, P1305, DOI 10.1007/s00421-015-3108-x; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Seo HG, 2016, PM&R, V8, P1083, DOI 10.1016/j.pmrj.2016.03.004; Shaw L, 2000, HEALTH TECHNOL ASSES, V14, P1; Sloan R L, 1992, Int J Rehabil Res, V15, P158, DOI 10.1097/00004356-199206000-00009; Sohn YH, 2003, J NEUROPHYSIOL, V90, P2303, DOI 10.1152/jn.00206.2003; Stoykov ME, 2009, NEUROREHAB NEURAL RE, V23, P945, DOI 10.1177/1545968309338190; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; Taub E, 2006, Eura Medicophys, V42, P241; Tavernese E, 2013, NEUROREHABILITATION, V32, P591, DOI 10.3233/NRE-130881; Toris GT, 2012, INT MED J EXP CLIN R, V17, pRA53; Trompetto C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/354906; Tropea P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-103; Tseng CH, 2012, J PROBABILITY STAT, V2012, P1; van Kordelaar J, 2012, EXP BRAIN RES, V221, P251, DOI 10.1007/s00221-012-3169-6; Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x; Wessel MJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00265; Witte JS, 2000, STAT MED, V19, P369, DOI 10.1002/(SICI)1097-0258(20000215)19:3<369::AID-SIM335>3.0.CO;2-N; Yuan HW, 2014, NEUROL SCI, V35, P171, DOI 10.1007/s10072-013-1464-z; Zariffa J, 2011, IEEE INT C REH ROB, V2011; ZARZECKI P, 1978, EXP BRAIN RES, V33, P269; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 1996, EXP BRAIN RES, V109, P127	99	37	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185936	10.1371/journal.pone.0185936	http://dx.doi.org/10.1371/journal.pone.0185936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI6UJ	28973024	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900067
J	Moran, JL; Santamaria, J				Moran, John L.; Santamaria, John			Reconsidering lactate as a sepsis risk biomarker	PLOS ONE			English	Article							NET RECLASSIFICATION IMPROVEMENT; GOAL-DIRECTED RESUSCITATION; PREDICTION MODELS; CLINICAL-CRITERIA; INCREMENTAL VALUE; IDENTIFY PATIENTS; SEPTIC SHOCK; GRAPHICAL ASSESSMENT; HOSPITAL MORTALITY; COULD LACTATE	Objectives There has been renewed interest in lactate as a risk biomarker in sepsis and septic shock. However, the ability of the odds ratio (OR) and change in the area under the receiver operator characteristic curve (AUC-ROC) to assess biomarker added-value has been questioned. Design, setting and participants A sepsis cohort was identified from the ICU database of an Australian tertiary referral hospital using APACHE III diagnostic codes. Demographic information, APACHE III scores, 24-hour post-admission patient lactate levels, and hospital mortality were accessed. Measurements and main results Hospital mortality was modelled using a base predictive logistic regression model and sequential addition of admission lactate, lactate clearance ([lactate(admission)-lactate(final)]/lactate(admission)), and area under the lactate-time curve (LTC). Added-value was assessed using lactate index OR; AUC-ROC difference (base-model versus lactate index addition); net (mortality) reclassification index (NRI; range -2 to +2); and net benefit (NB), the number of true positives per patient adjusted for the number of false positives. The data set comprised 717 patients with mean(SD) age and APACHE III score 61.1(16.5) years and 68.3 (28.2) respectively; 59.2% were male. Admission lactate was 2.3(2.5) mmol/l; with lactate of >= 4 mmol/L (37% hospital mortality) in 17% and patients with lactate <4 mmol/L having 18% hospital mortality. The admission base-model had an AUC-ROC = 0.81 with admission lactate OR = 1.127 (95% CI: 1.038, 1.224), AUC-ROC difference of 0.0032 (-0.0037, 0.01615; P = 0.61), and NRI 0.240(0.030, 0.464). The over-time model had an AUC-ROC = 0.86 with (i) clearance OR = 0.771, 95% CI: 0.578, 1.030; P = 0.08; AUC-ROC difference 0.001 (-0.003, 0.014; P = 0.78), and NRI 0.109(-0.193, 0.425) and (ii) LTC OR = 0.997, 95% CI: 0.989, 1.005, P = 0.49; AUC-ROC difference 0.004 (-0.002, 0.004; P = 0.34), and NRI 0.111(-0.222, 0.403). NB was not incremented by any lactate index. Conclusions Lactate added-value assessment is dependent upon the performance of the underlying predictive model and should incorporate risk reclassification and net benefit measures.	[Moran, John L.] Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA, Australia; [Santamaria, John] St Vincents Hosp Melbourne, Dept Crit Care Med, Fitzroy, Vic, Australia	St Vincent's Hospital Melbourne	Moran, JL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care Med, Woodville, SA, Australia.	John.moran@adelaide.edu.au	Santamaria, John/M-9581-2019					ANZICS-CORE, 2017, APD DATA DICTIONARY; Austin PC, 2013, STAT MED, V32, P661, DOI 10.1002/sim.5598; Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bartlett JW, 2015, AM J EPIDEMIOL, V182, P730, DOI 10.1093/aje/kwv114; Bilger M., 2015, STAT SOFT COMP; Bilger M, 2015, HEALTH ECON, V24, P75, DOI 10.1002/hec.3003; Casserly B, 2016, CRIT CARE MED, V44, pE178, DOI [10.1097/CCM.0000000000001533, 10.1097/CCM.0000000000001455]; Casserly B, 2015, CRIT CARE MED, V43, P567, DOI 10.1097/CCM.0000000000000742; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Gerdin M, 2016, JAMA-J AM MED ASSOC, V316, P453, DOI 10.1001/jama.2016.6410; Harrell FE, 2016, SHOULD CHANGE BE MEA; Harrell FE, 2015, SPRINGER SER STAT, P63, DOI 10.1007/978-3-319-19425-7_4; Hilden J, 2014, STAT MED, V33, P3405, DOI 10.1002/sim.5804; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Houwink API, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1243-3; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaki T, 2011, PHARM STAT, V10, P284, DOI 10.1002/pst.449; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Junhasavasdikul D, 2016, J CRIT CARE, V33, P71, DOI 10.1016/j.jcrc.2016.01.019; KAISER L, 1989, STAT MED, V8, P1183, DOI 10.1002/sim.4780081002; Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654; Kerr KF, 2011, AM J EPIDEMIOL, V174, P364, DOI 10.1093/aje/kwr086; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lee SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145181; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Liu ZJ, 2016, CRIT CARE MED, V44, pE178, DOI 10.1097/CCM.0000000000001455; Longton G, 2011, INCRISK INCREMENTAL; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; Makam AN, 2016, JAMA-J AM MED ASSOC, V316, P453, DOI 10.1001/jama.2016.6407; Martens FK, 2016, J CLIN EPIDEMIOL, V79, P159, DOI 10.1016/j.jclinepi.2016.07.002; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Moons KGM, 2012, CLIN CHEM, V58, P1408, DOI 10.1373/clinchem.2012.182550; Moran J L, 2002, Crit Care Resusc, V4, P93; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Muhlenbruch K, 2013, EUR J EPIDEMIOL, V28, P25, DOI 10.1007/s10654-012-9744-0; Nattino G, 2016, STAT MED, V35, P709, DOI 10.1002/sim.6744; Nattino G, 2014, STAT MED, V33, P2696, DOI 10.1002/sim.6126; Nguyen HB, 2013, CHEST, V143, P1521, DOI 10.1378/chest.13-0006; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Nichol A, 2011, CRIT CARE, V15, DOI 10.1186/cc10497; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pencina KM, 2014, STAT MED, V33, P4975, DOI 10.1002/sim.6286; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pepe MS, 2015, STAT BIOSCI, V7, P282, DOI 10.1007/s12561-014-9118-0; Pepe MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju041; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Puskarich MA, 2013, CHEST, V143, P1548, DOI 10.1378/chest.12-0878; Reineck LA, 2014, CRIT CARE MED, V42, P1055, DOI 10.1097/CCM.0000000000000132; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Royston P, 2016, STATA J, V16, P72, DOI 10.1177/1536867X1601600109; Seymour CW, 2016, JAMA-J AM MED ASSOC, V316, P454, DOI 10.1001/jama.2016.6413; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shlipak MG, 2013, NAT REV NEPHROL, V9, P478, DOI 10.1038/nrneph.2013.108; STACPOOLE PW, 1992, NEW ENGL J MED, V327, P1564, DOI 10.1056/NEJM199211263272204; Steichen TJ, 1999, STATA TECHNICAL B RE, V8, P137; Steyerberg EW, 2015, BIOMETRICAL J, V57, P556, DOI 10.1002/bimj.201300260; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Tang Y, 2015, QJM-INT J MED, V108, P279, DOI 10.1093/qjmed/hcu186; Thomas-Rueddel DO, 2015, J CRIT CARE, V30, P439, DOI 10.1016/j.jcrc.2014.10.027; Trzeciak S, 2004, CRIT CARE MED, V32, P1785, DOI 10.1097/01.CCM.0000134837.18530.14; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Van Calster B, 2013, MED DECIS MAKING, V33, P490, DOI 10.1177/0272989X12470757; Vasilevskis EE, 2009, MED CARE, V47, P803, DOI 10.1097/MLR.0b013e3181a39454; Vickers AJ, 2014, DECISION CURVE ANAL; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Vickers AJ, 2010, SEMIN ONCOL, V37, P31, DOI 10.1053/j.seminoncol.2009.12.004; Vincent JL, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1403-5; Wacharasint P, 2012, SHOCK, V38, P4, DOI 10.1097/SHK.0b013e318254d41a; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405	84	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185320	10.1371/journal.pone.0185320	http://dx.doi.org/10.1371/journal.pone.0185320			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972976	gold, Green Submitted, Green Published			2022-12-27	WOS:000412131900015
J	Narayan, N; Mandhair, H; Smyth, E; Dakin, SG; Kiriakidis, S; Wells, L; Owen, D; Sabokbar, A; Taylor, P				Narayan, Nehal; Mandhair, Harpreet; Smyth, Erica; Dakin, Stephanie Georgina; Kiriakidis, Serafim; Wells, Lisa; Owen, David; Sabokbar, Afsie; Taylor, Peter			The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERIPHERAL BENZODIAZEPINE-RECEPTOR; COUNTER-FLOW ELUTRIATION; RHEUMATOID-ARTHRITIS; CENTRIFUGAL ELUTRIATION; MULTIPLE-SCLEROSIS; CHOLESTEROL EFFLUX; HUMAN MONOCYTE; ACTIVATION; PET	The translocator protein (TSPO) is a mitochondrial membrane protein, of as yet uncertain function. Its purported high expression on activated macrophages, has lent utility to TSPO targeted molecular imaging in the form of positron emission tomography (PET), as a means to detect and quantify inflammation in vivo. However, existing literature regarding TSPO expression on human activated macrophages is lacking, mostly deriving from brain tissue studies, including studies of brain malignancy, and inflammatory diseases such as multiple sclerosis. Here, we utilized three human sources of monocyte derived macrophages (MDM), from THP-1 monocytes, healthy peripheral blood monocytes and synovial fluid monocytes from patients with rheumatoid arthritis, to undertake a detailed investigation of TSPO expression in activated macrophages. In this work, we demonstrate a consistent down-regulation of TSPO mRNA and protein in macrophages activated to a pro-inflammatory, or 'M1' phenotype. Conversely, stimulation of macrophages to an M2 phenotype with IL-4, dexamethasone or TGF-beta 1 did not alter TSPO expression, regardless of MDM source. The reasons for this are uncertain, but our study findings add some supporting evidence for recent investigations concluding that TSPO may be involved in negative regulation of inflammatory responses in macrophages.	[Narayan, Nehal; Mandhair, Harpreet; Dakin, Stephanie Georgina; Kiriakidis, Serafim; Sabokbar, Afsie; Taylor, Peter] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England; [Smyth, Erica; Wells, Lisa] Imanova Ctr Imaging Sci, London, England; [Owen, David] Imperial Coll, Div Brain Sci, London, England	University of Oxford; Imperial College London	Narayan, N (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England.	nehal.narayan@ndorms.ox.ac.uk		Owen, David/0000-0002-1198-7563; Smyth, Erica/0000-0002-8715-674X; Dakin, Stephanie Georgina/0000-0003-2470-1031	NIHR BRC at the University of Oxford through an unrestricted [OXF141232]; Medical Research Council [MR/N008219/1] Funding Source: researchfish; MRC [MR/N008219/1] Funding Source: UKRI	NIHR BRC at the University of Oxford through an unrestricted; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	NN was supported by the NIHR BRC at the University of Oxford through an unrestricted grant (OXF141232).	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allen AM, 2013, CLIN SCI, V124, P509, DOI 10.1042/CS20120358; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Banfalvi G, 2008, NAT PROTOC, V3, P663, DOI 10.1038/nprot.2008.34; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Berger TG, 2005, J IMMUNOL METHODS, V298, P61, DOI 10.1016/j.jim.2005.01.005; Bernards N, 2015, MOL IMAGING BIOL, V17, P67, DOI 10.1007/s11307-014-0765-9; Bonsack F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0619-2; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Ching ASC, 2012, INSIGHTS IMAGING, V3, P111, DOI 10.1007/s13244-011-0128-x; Chowdhury SM, 2015, MOL CELL PROTEOMICS, V14, P1859, DOI 10.1074/mcp.M114.045179; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Gent YYJ, 2014, J RHEUMATOL, V41, P2145, DOI 10.3899/jrheum.140059; Gent YYJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4509; Gent YYJ, 2012, ARTHRITIS RHEUM-US, V64, P62, DOI 10.1002/art.30655; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Hume DA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00370; Kennedy A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00052; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lamare F, 2011, J NUCL MED, V52, P33, DOI 10.2967/jnumed.110.079038; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO., 2012, CURR PROTOC IMMUNOL, V28, P1; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Morin D, 2016, BIOCHEM PHARMACOL, V105, P1, DOI 10.1016/j.bcp.2015.12.003; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nair A, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0226-3; Navegantes KC, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1141-8; Niyonzima N, 2015, J IMMUNOL, V195, P257, DOI 10.4049/jimmunol.1403044; Oh U, 2011, J NEUROIMMUNE PHARM, V6, P354, DOI 10.1007/s11481-010-9243-6; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Owen DR, 2010, J CEREBR BLOOD F MET, V30, P1608, DOI 10.1038/jcbfm.2010.63; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Park E, 2015, EUR J NUCL MED MOL I, V42, P1081, DOI 10.1007/s00259-015-3043-4; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Scarf AM, 2011, J NUCL MED, V52, P667, DOI 10.2967/jnumed.110.086629; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Schwanke U, 2006, J CLIN APHERESIS, V21, P153, DOI 10.1002/jca.20077; Schweitzer PJ, 2010, DRUG DISCOV TODAY, V15, P933, DOI 10.1016/j.drudis.2010.08.012; Shao X, 2013, NUCL MED BIOL, V40, P906, DOI 10.1016/j.nucmedbio.2013.06.008; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stroncek DF, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0241-y; Taylor JMW, 2014, CLIN SCI, V127, P603, DOI 10.1042/CS20140047; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; van der Laken CJ, 2008, ARTHRITIS RHEUM, V58, P3350, DOI 10.1002/art.23955; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; YASAKA T, 1981, J IMMUNOL, V127, P1515	67	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185767	10.1371/journal.pone.0185767	http://dx.doi.org/10.1371/journal.pone.0185767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968465	Green Published, gold, Green Submitted			2022-12-27	WOS:000412029600046
J	Otoshi, T; Kataoka, Y; Ikegaki, S; Saito, E; Matsumoto, H; Kaku, S; Shimada, M; Hirabayashi, M				Otoshi, Takehiro; Kataoka, Yuki; Ikegaki, Shunkichi; Saito, Emiko; Matsumoto, Hirotaka; Kaku, Sawako; Shimada, Masatoshi; Hirabayashi, Masataka			Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center	PLOS ONE			English	Article							SOLUBLE MESOTHELIN; HYALURONIC-ACID; MARKER; FLUID; SERUM; PEPTIDE; RATIO; TOOL	In this study, we aimed to examine the clinical value of the pleural effusion (PE) biomarkers, soluble mesothelin-related peptide (SMRP), cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA), and the utility of combining chest computed tomography (CT) findings with these biomarkers, in diagnosing malignant pleural mesothelioma (MPM). We conducted a retrospective cohort study in a single center. Consecutive patients with undiagnosed pleural effusions who underwent PE analysis between September 2014 and August 2016 were reviewed. This study included 240 patients (32 with MPM and 208 non-MPM). SMRP and the CYFRA 21-1/CEA ratio had a sensitivity and specificity for diagnosing MPM of 56.3% and 86.5%, and 87.5% and 74.0%, respectively. Using receiver operating characteristics (ROC) curve analysis of the ability of these markers to distinguish MPM from all other PE causes, the area under the ROC curve (AUC) for SMRP and the CYFRA 21-1/CEA ratio was 0.804 and 0.874, respectively. The sensitivity and specificity of SMRP combined with the CYFRA 21-1/CEA ratio were 93.8% and 64.9%, respectively. The sensitivity of the combination of SMRP, the CYFRA 21-1/CEA ratio, and the presence of Leung's criteria (a chest CT finding that is suggestive of malignant pleural disease) was 93.8%. In conclusion, the combined PE biomarkers had a high sensitivity for diagnosing MPM, although the addition of chest CT findings did not improve the sensitivity of SMRP combined with the CYFRA 21-1/CEA ratio. Combination of these biomarkers helped to rule out MPM effectively among patients at high risk of suffering MPM and would be valuable especially for old frail patients who have difficulty in undergoing invasive procedures such as thoracoscopy.	[Otoshi, Takehiro; Kataoka, Yuki; Ikegaki, Shunkichi; Saito, Emiko; Matsumoto, Hirotaka; Kaku, Sawako; Shimada, Masatoshi; Hirabayashi, Masataka] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan		Otoshi, T (corresponding author), Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Resp Med, Amagasaki, Hyogo, Japan.	takehiro-otoshi19850902@gmail.com		Kataoka, Yuki/0000-0001-7982-5213				Aleman C, 2009, MED CLIN-BARCELONA, V133, P449, DOI 10.1016/j.medcli.2008.11.047; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; Canessa PA, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0649-x; Canessa PA, 2013, CANCER INVEST, V31, P48, DOI 10.3109/07357907.2012.749265; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Creaney J, 2007, THORAX, V62, P569, DOI 10.1136/thx.2006.068114; Creaney J, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/413946; Damhuis RA, 2015, LUNG CANCER, V89, P212, DOI 10.1016/j.lungcan.2015.05.014; Davies HE, 2009, AM J RESP CRIT CARE, V180, P437, DOI 10.1164/rccm.200811-1729OC; Ferro P, 2013, ANTICANCER RES, V33, P2707; Filiberti R, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0543-6; Franceschini MC, 2014, ANTICANCER RES, V34, P7425; Fujimoto N, 2013, RESPIR INVESTIG, V51, P92, DOI 10.1016/j.resinv.2013.02.002; Fujimoto N, 2010, EXP THER MED, V1, P313, DOI 10.3892/etm_00000048; Fujimoto N, 2010, J CANCER RES CLIN, V136, P1755, DOI 10.1007/s00432-010-0834-7; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Hooper CE, 2013, EUR RESPIR J, V41, P18, DOI 10.1183/09031936.00148211; Kurumatani N, 2008, AM J RESP CRIT CARE, V178, P624, DOI 10.1164/rccm.200801-063OC; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Metintas M, 2002, EUR J RADIOL, V41, P1, DOI 10.1016/S0720-048X(01)00426-0; Nakamachi M, 2011, IGAKU TO YAKUGAKU, V65, P261; Paganuzzi M, 2001, CHEST, V119, P1138, DOI 10.1378/chest.119.4.1138; Parodi S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S3; Pass HI, 2008, ANN THORAC SURG, V85, P265, DOI 10.1016/j.athoracsur.2007.07.042; PETTERSSON T, 1988, CHEST, V94, P1037, DOI 10.1378/chest.94.5.1037; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Suzuki H, 2010, ANTICANCER RES, V30, P4343; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yamada S, 2011, CLIN CHEM LAB MED, V49, P1721, DOI 10.1515/CCLM.2011.242; Yilmaz U M, 1998, Respirology, V3, P33, DOI 10.1046/j.1440-1843.1998.00069.x	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185850	10.1371/journal.pone.0185850	http://dx.doi.org/10.1371/journal.pone.0185850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968445	Green Submitted, Green Published, gold			2022-12-27	WOS:000412029600060
J	Bista, D; Shrestha, S; Sherpa, P; Thapa, GJ; Kokh, M; Lama, ST; Khanal, K; Thapa, A; Jnawali, SR				Bista, Damber; Shrestha, Saroj; Sherpa, Peema; Thapa, Gokarna Jung; Kokh, Manish; Lama, Sonam Tashi; Khanal, Kapil; Thapa, Arjun; Jnawali, Shant Raj			Distribution and habitat use of red panda in the Chitwan-Annapurna Landscape of Nepal	PLOS ONE			English	Article							AILURUS-FULGENS; NATIONAL-PARK; CONSERVATION; ECOLOGY; MODELS	In Nepal, the red panda (Ailurus fulgens) has been sparsely studied, although its range covers a wide area. The present study was carried out in the previously untapped Chitwan Annapurna Landscape (CHAL) situated in central Nepal with an aim to explore current distributional status and identify key habitat use. Extensive field surveys conducted in 10 red panda range districts were used to estimate species distribution by presence-absence occupancy modeling and to predict distribution by presence-only modeling. The presence of red pandas was recorded in five districts: Rasuwa, Nuwakot, Myagdi, Baglung and Dhading. The predictive distribution model indicated that 1,904.44 km(2) of potential red panda habitat is available in CHAL with the protected area covering nearly 41% of the total habitat. The habitat suitability analysis based on the probability of occurrence showed only 16.58% (A = 315.81 km(2)) of the total potential habitat is highly suitable. Red Panda occupancy was estimated to be around 0.0667, indicating nearly 7% (218 km(2)) of the total habitat is occupied with an average detection probability of 0.4482 +/- 0.377. Based on the habitat use analysis, altogether eight variables including elevation, slope, aspect, proximity to water sources, bamboo abundance, height, cover, and seasonal precipitation were observed to have significant roles in the distribution of red pandas. In addition, 25 tree species were documented from red panda sign plots out of 165 species recorded in the survey area. Most common was Betula utilis followed by Rhododendron spp. and Abies spectabilis. The extirpation of red pandas in previously reported areas indicates a need for immediate action for the long-term conservation of this species in CHAL.	[Bista, Damber; Shrestha, Saroj; Sherpa, Peema; Lama, Sonam Tashi] Red Panda Network, Kathmandu, Nepal; [Thapa, Gokarna Jung; Khanal, Kapil; Jnawali, Shant Raj] WWF Nepal, Kathmandu, Nepal; [Thapa, Arjun] Small Mammals Conservat & Res Fdn, Kathmandu, Nepal	World Wildlife Fund	Bista, D (corresponding author), Red Panda Network, Kathmandu, Nepal.	damber.bista@redpandanetwork.org	Lama, Sonam Tashi/Z-4025-2019; Lama, Sonam Tashi T/P-3852-2018; Bista, Damber/Y-5758-2018; Bista, Damber/K-1215-2019	Lama, Sonam Tashi/0000-0002-3390-6496; Lama, Sonam Tashi T/0000-0002-3390-6496; Bista, Damber/0000-0003-2699-1642; Bista, Damber/0000-0003-2699-1642; Khanal, Kapil/0000-0001-6468-6353; Sherpa, Ang Phuri/0000-0002-3569-8280	WWF/USAID/Hariyo Ban Program [WU82]; Red Panda Network [13/2014]; Idea Wild; Department of National Parks and Wildlife Conservation; Department of Forest; Red Panda Network; Himali Conservation Forum	WWF/USAID/Hariyo Ban Program(United States Agency for International Development (USAID)); Red Panda Network; Idea Wild; Department of National Parks and Wildlife Conservation; Department of Forest; Red Panda Network; Himali Conservation Forum	We are thankful to the WWF/USAID/Hariyo Ban Program (WU82), Red Panda Network (Ref-13/2014) and Idea Wild (30July, 2015) for financially supporting this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the support from the Department of National Parks and Wildlife Conservation; Department of Forest, Red Panda Network and Himali Conservation Forum. We are very thankful to Mr. Ang Phuri Sherpa, Country Director of Red Panda Network whose support remained highly critical in concluding this work. Our sincere thanks also goes to Dr. Angela Glatston, Robert Shepherd, Brian Williams, Terrance Fleming, Shishir Shakya and all the field biologists and local people involved in this work.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Bhatta Manoj, 2014, Open Journal of Ecology, V4, P989; BISTA D, 2014, INITIATION, V5, P171, DOI DOI 10.3126/INIT.V5I0.10268; Chalise MK, 2013, BIODIVERS CONSERV, P11; Curtis JT, 1959, VEGETATION WISCONSIN; Dongol B, 2014, HABITAT DISTRI UNPUB; Dorji S, 2012, ORYX, V46, P536, DOI 10.1017/S0030605311000780; Dorji S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026483; Fox J, 1996, CONSERV BIOL, V10, P562, DOI 10.1046/j.1523-1739.1996.10020562.x; Ghose D, 2010, RED PANDA BIOL  1125, V357; Glatston A.R, 1994, STATUS SURVEY CONSER; HU JC, 1991, J SICH NORM COLL, V12, P1; Jnawali S., 2012, RED PANDA AILURUS FU; Kandel K, 2015, BIOL CONSERV, V181, P150, DOI 10.1016/j.biocon.2014.10.007; Lama Sonam Tashi, 2015, Journal of Threatened Taxa, V7, P7460, DOI 10.11609/JoTT.o4208.7460-4; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Mahato NK, 1825, DISTRIBUTION RED PAN; Ministry of Forests and Soil Conservation, 2015, RED PAND FIELD SURV; Nowak R, 1999, WALKERS MAMMALS WORL, V2, P695; Panthi S, 2012, ZOOLOGICAL STUDIES, V51; Paudel K, 2009, STATUS DISTRIBUTION; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; ROBERTS M S, 1984, Mammalian Species, P1, DOI 10.2307/3503840; Schaller G. B., 1994, THE LAST PANDA; Sharma HP, 2014, HYSTRIX, V25, P47, DOI 10.4404/hystrix-25.1-9033; Sherpa A, 2015, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2015-4.RLTS.T714A45195924.EN; Stapleton CM, 1994, EDINBURGH J BOT, V51; Steffens E, 2004, RED PANDAS CONSERVAT; Thapa A, 2015, INT J CONSERVATION S, V6; Thapa A, 2014, INITIATION, V5, P43, DOI DOI 10.3126/init.v5i0.10252; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Williams B, 2010, PROJECT PUNDE KUNDO, P393; Williams BH., 2003, CONSERV BIOL ASIA, V16, P236; Williams BH, THESIS; YONZON P, 1991, AMBIO, V20, P285; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; YONZON PB, 1991, CONSERV BIOL, V5, P196, DOI 10.1111/j.1523-1739.1991.tb00124.x; Yonzon PB, THESIS; Yonzon PB, 1989, RED PANDA BIOL, V1; Zhang JS, 2008, ECOHEALTH, V5, P6, DOI 10.1007/s10393-007-0139-8	43	29	36	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0178797	10.1371/journal.pone.0178797	http://dx.doi.org/10.1371/journal.pone.0178797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020020	Green Published, gold, Green Submitted			2022-12-27	WOS:000412754400002
J	Ramirez, J; Orini, M; Minchole, A; Monasterio, V; Cygankiewicz, I; de Luna, AB; Martinez, JP; Laguna, P; Pueyo, E				Ramirez, Julia; Orini, Michele; Minchole, Ana; Monasterio, Violeta; Cygankiewicz, Iwona; de Luna, Antonio Bayeas; Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther			Sudden cardiac death and pump failure death prediction in chronic heart failure by combining ECG and clinical markers in an integrated risk model	PLOS ONE			English	Article							T-WAVE ALTERNANS; RATE TURBULENCE; POSTINFARCTION PATIENTS; MORTALITY; REPOLARIZATION; EPIDEMIOLOGY; RESTITUTION; DISPERSION; THERAPY; STRATIFICATION	Background Sudden cardiac death (SCD) and pump failure death (PFD) are common endpoints in chronic heart failure (CHF) patients, but prevention strategies are different. Currently used tools to specifically predict these endpoints are limited. We developed risk models to specifically assess SCD and PFD risk in CHF by combining ECG markers and clinical variables. Methods The relation of clinical and ECG markers with SCD and PFD risk was assessed in 597 patients enrolled in the MUSIC (MUerte Subita en Insuficiencia Cardiaca) study. ECG indices included: turbulence slope (TS), reflecting autonomic dysfunction; T-wave alternans (TWA), reflecting ventricular repolarization instability; and T-peak-to-end restitution (Delta alpha(Tpe)) and T-wave morphology restitution (TMR), both reflecting changes in dispersion of repolarization due to heart rate changes. Standard clinical indices were also included. Results The indices with the greatest SCD prognostic impact were gender, New York Heart Association (NYHA) class, left ventricular ejection fraction, TWA, Delta alpha(Tpe) and TMR. For PFD, the indices were diabetes, NYHA class, Delta alpha(Tpe) and TS. Using a model with only clinical variables, the hazard ratios (HRs) for SCD and PFD for patients in the high-risk group (fifth quintile of risk score) with respect to patients in the low-risk group (first and second quintiles of risk score) were both greater than 4. HRs for SCD and PFD increased to 9 and 11 when using a model including only ECG markers, and to 14 and 13, when combining clinical and ECG markers. Conclusion The inclusion of ECG markers capturing complementary pro-arrhythmic and pump failure mechanisms into risk models based only on standard clinical variables substantially improves prediction of SCD and PFD in CHF patients.	[Ramirez, Julia] Queen Mary Univ London, William Harvey Res Inst, John Vane Sci Ctr, Dept Clin Pharmacol, Charterhouse Sq, London, England; [Orini, Michele] UCL, Inst Cardiovasc Sci, London, England; [Orini, Michele] St Bartholomeus Hosp, Barts Heart Ctr, London, England; [Minchole, Ana] Univ Oxford, Dept Comp Sci, Oxford, England; [Monasterio, Violeta] Univ San Jorge, Campus Univ, Villanueva De Gallego, Spain; [Cygankiewicz, Iwona] Med Univ Lodz, Dept Electrocardiol, Sterling Reg Ctr Heart Dis, Lodz, Poland; [de Luna, Antonio Bayeas] Santa Creu & St Pau Hosp, Catalan Inst Cardiovasc Sci, Barcelona, Spain; [Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, Biomed Signal Interpretat & Computat Simulat BSIC, Zaragoza, Spain; [Martinez, Juan Pablo; Laguna, Pablo; Pueyo, Esther] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain	University of London; Queen Mary University London; University of London; University College London; University of Oxford; Universidad San Jorge; Medical University Lodz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Ramirez, J (corresponding author), Queen Mary Univ London, William Harvey Res Inst, John Vane Sci Ctr, Dept Clin Pharmacol, Charterhouse Sq, London, England.	j.ramirez@qmul.ac.uk	Monasterio, Violeta/A-4183-2012; Ramírez, Julia/AAB-8153-2019; Pueyo, Esther/C-6945-2009; Martinez, Juan/GXM-4393-2022; Martínez, Juan Pablo/A-2759-2009; Orini, Michele/ABF-6272-2020	Monasterio, Violeta/0000-0001-5343-5671; Ramírez, Julia/0000-0003-4130-5866; Pueyo, Esther/0000-0002-1960-407X; Martínez, Juan Pablo/0000-0002-7503-3339; Orini, Michele/0000-0001-5773-0344; Cygankiewicz, Iwona/0000-0003-3006-311X	Spanish Ministry of Economy and Competitiveness (MINEGO), Spain [TIN2013-41998-R, DPI2016-75458-R]; MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain; European Social Fund (EU); Aragon Government through BSICoS group [T96]; European Research Council (ERC) [ERC-2014-StG 638284]	Spanish Ministry of Economy and Competitiveness (MINEGO), Spain; MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain; European Social Fund (EU)(European Social Fund (ESF)European Commission); Aragon Government through BSICoS group; European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by projects TIN2013-41998-R to EP, PL, and JR, and DPI2016-75458-R to JPM, EP, and PL from the Spanish Ministry of Economy and Competitiveness (MINEGO), Spain, the MULTITOOLS2HEART from GIBER-BBN through Institute de Salud Carlos III, Spain to JPM, EP, and PL, the European Social Fund (EU) and Aragon Government through BSICoS group (T96) to JPM, EP, and PL, and by the European Research Council (ERC) through project ERC-2014-StG 638284 to EP.	Bauer A, 2009, J ELECTROCARDIOL, V42, P597, DOI 10.1016/j.jelectrocard.2009.07.013; Bauer A, 2009, EUR HEART J, V30, P576, DOI 10.1093/eurheartj/ehn540; Buxton AE, 2005, CIRCULATION, V111, P2537, DOI 10.1161/01.CIR.0000165057.88551.2C; Carey EC, 2008, J AM GERIATR SOC, V56, P68, DOI 10.1111/j.1532-5415.2007.01496.x; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45; Cygankiewicz I, 2008, HEART RHYTHM, V5, P1095, DOI 10.1016/j.hrthm.2008.04.017; DAHLBERG ST, 1990, CARDIOLOGY, V77, P31, DOI 10.1159/000174652; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Dunlay SM, 2017, NAT REV CAR IN PRESS; Figueroa MS, 2006, RESPIR CARE, V51, P403; Fisher JP, 2009, AUTON NEUROSCI-BASIC, V148, P5, DOI 10.1016/j.autneu.2009.02.003; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Ikeda T, 2006, J AM COLL CARDIOL, V48, P2268, DOI 10.1016/j.jacc.2006.06.075; Klapholz M, 2009, MAYO CLIN PROC, V84, P718, DOI 10.4065/84.8.718; Ky B, 2012, CIRC-HEART FAIL, V5, P183, DOI 10.1161/CIRCHEARTFAILURE.111.965020; La Rovere MT, 2011, CLIN SCI, V121, P279, DOI 10.1042/CS20110063; Lane RE, 2005, HEART, V91, P674, DOI 10.1136/hrt.2003.025254; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Marynissen T, 2014, EUROPACE, V16, P1069, DOI 10.1093/europace/eut303; Monasterio V, 2012, HEART RHYTHM, V9, P383, DOI 10.1016/j.hrthm.2011.10.027; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Mozaffarian D, 2007, CIRCULATION, V116, P392, DOI 10.1161/CIRCULATIONAHA.106.687103; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Neragi-Miandoab S, 2014, MINERVA CARDIOANGIOL, V62, P481; Ogletree-Hughes ML, 2001, CIRCULATION, V104, P881, DOI 10.1161/hc3301.094911; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Qin M, 2013, J CARDIOL, V61, P162, DOI 10.1016/j.jjcc.2012.08.016; Ramirez J, 2016, IEEE T BIOM IN PRESS; Ramirez J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005310; Ramirez J, 2015, J ELECTROCARDIOL, V48, P551, DOI 10.1016/j.jelectrocard.2015.04.002; Ramirez J, 2014, J ELECTROCARDIOL, V47, P842, DOI 10.1016/j.jelectrocard.2014.08.013; Rang H.P, 2003, PHARMACOLOGY; Selvaraj RJ, 2009, EUROPACE, V11, P1529, DOI 10.1093/europace/eup295; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Verrier RL, 2009, HEART RHYTHM, V6, P416, DOI 10.1016/j.hrthm.2008.11.019; Viles-Gonzalez JF, 2017, HEART RHYTHM, V14, P79, DOI 10.1016/j.hrthm.2016.11.007; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Zannad F, 2013, EUR J HEART FAIL, V15, P1082, DOI 10.1093/eurjhf/hft095; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	42	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2017	12	10							e0186152	10.1371/journal.pone.0186152	http://dx.doi.org/10.1371/journal.pone.0186152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ4ZX	29020031	Green Published, Green Submitted, gold			2022-12-27	WOS:000412754400074
J	Kolhe, NV; Fluck, RJ; Taal, MW				Kolhe, Nitin V.; Fluck, Richard J.; Taal, Maarten W.			Effect of weekend admission on mortality associated with severe acute kidney injury in England: A propensity score matched, population-based study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HOSPITAL EPISODE STATISTICS; REPLACEMENT; CARE	Background Increased in-hospital mortality associated with weekend admission has been reported for many acute conditions, but no study has investigated "weekend effect" for acute kidney injury requiring dialysis (AKI-D). Methods In this large, propensity score matched cohort of AKI-D, we examined the impact of weekend admission and in-centre nephrology services in 53,170 AKI-D admissions between 1st April 2003 and 31st March 2015 using a hospital episode statistic dataset. Propensity score matching (PSM) was performed to match 4284 weekend admissions with AKI-D with 14,788 admissions on weekdays. Results Of the 53,170 admissions with AKI-D in the whole dataset, 12,357 (23%) were at weekends. The unadjusted mortality for weekend admissions was significantly higher compared to admissions on weekdays (40.6% versus 39.6%, p 0.046). However, in multivariable analysis of the PSM cohort, the odds of death for weekend admissions with AKI-D was 1.01 (95% CI 0.93, 1.09). Mortality was higher for weekend admissions in West Midlands (odds ratio (OR) 1.32, 95% confidence interval (CI) 1.05, 1.66) and lower in East of England (OR 0.77, 95% CI 0.59, 1.00) but was not different to weekday admissions in all other regions. In 2003-04, weekend admissions had lower odds of death (OR 0.45, 95% CI 0.21, 0.96) and in 2010-11 higher odds of death (OR 1.28, 95% CI 1.00, 1.63) but in the other ten years observed, there was no significant difference in mortality between weekday and weekend admissions. Provision of in-centre nephrology services was associated with lower odds of death at 0.57 (95% CI 0.54, 0.62). Conclusions Weekend admissions in patients with AKI-D had no effect on mortality. Further research is warranted to elucidate the reasons for the lower mortality in hospitals with in-centre nephrology services.	[Kolhe, Nitin V.; Fluck, Richard J.; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [Kolhe, Nitin V.; Taal, Maarten W.] Univ Nottingham, Div Med Sci & Grad Entry Med, Derby, England	University of Nottingham; University of Nottingham	Kolhe, NV (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.; Kolhe, NV (corresponding author), Univ Nottingham, Div Med Sci & Grad Entry Med, Derby, England.	nitin.kolhe@nhs.net		Taal, Maarten/0000-0002-9065-212X; Kolhe, Nitin/0000-0003-2528-4436				Aldridge C, 2016, LANCET, V388, P178, DOI 10.1016/S0140-6736(16)30442-1; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Bray BD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001705; Crooks CJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001437; Dayer MJ, 2014, LANCET; Fotheringham J, 2014, NEPHROL DIAL TRANSPL, V29, P422, DOI 10.1093/ndt/gft363; Freemantle N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4596; James MT, 2010, J AM SOC NEPHROL, V21, P845, DOI 10.1681/ASN.2009070682; Jen MH, 2008, J HOSP INFECT, V70, P321, DOI 10.1016/j.jhin.2008.08.005; Jen MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007103; Kolhe NV, 2016, INT J CLIN PRACT, V70, P330, DOI 10.1111/ijcp.12774; Kolhe NV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162856; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Kostis WJ, 2007, NEW ENGL J MED, V350; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Roberts SE, 2015, LANCET, V385, P1829, DOI 10.1016/S0140-6736(15)60580-3; Sibanda N, 2008, PLOS MED, V5, P1398, DOI 10.1371/journal.pmed.0050179; Stewart JAD, 2009, BRIT J HOSP MED, V70, P372, DOI 10.12968/hmed.2009.70.7.43116; Tomlinson LA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-58; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; Wilson FP, 2013, CLIN J AM SOC NEPHRO, V8, P1863, DOI 10.2215/CJN.03540413; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhou YF, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003102	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186048	10.1371/journal.pone.0186048	http://dx.doi.org/10.1371/journal.pone.0186048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016687	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400051
J	Bai, YY; Sun, XR; Jin, Y; Wang, YL; Li, J				Bai, Yuanyuan; Sun, Xiaorong; Jin, Yan; Wang, Yueling; Li, Juan			Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis	PLOS ONE			English	Article							BD MAX CDIFF; ILLUMIGENE C. DIFFICILE; STOOL SPECIMENS; TESTING ALGORITHMS; TOXIGENIC CULTURE; ABBOTT M2000; STRAIN TYPE; IMPACT; TOXIN; AMPLIFICATION	Background There is an urgent need for rapid and accurate microbiological diagnostic assay for detection of Clostridium difficile infection (CDI). We assessed the diagnostic accuracy of the Xpert Clostridium difficile assay (Xpert CD) for the diagnosis of CDI. Methods We searched PubMed, EMBASE, and Cochrane Library databases to identify studies according to predetermined criteria. STATA 13.0 software was used to analyze the tests for sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the summary receiver operating characteristic curves (AUC). QUADAS- 2 was used to assess the quality of included studies with RevMan 5.2. Heterogeneity in accuracy measures was tested with Spearman correlation coefficient and Chi-square. Results A total of 22 studies were included in the meta-analysis. The pooled sensitivity (95% confidence intervals [CI]) was 0.97 (0.95-0.99) and specificity was 0.95 (0.94-0.96). The AUC was 0.99 (0.97-0.99). Significant heterogeneity was observed when we pooled most of the accuracy measures of selected studies. Conclusions The Xpert CD assay is a useful diagnostic tool with high sensitivity and specificity in diagnosing toxigenic CDI, and this method has excellent usability due to its rapidity and simplicity.	[Bai, Yuanyuan; Jin, Yan; Wang, Yueling] Shandong Univ, Dept Clin Lab, Shandong Prov Hosp, Jinan, Shandong, Peoples R China; [Sun, Xiaorong; Li, Juan] Jinan Women & Childrens Hlth Hosp, Dept Pathol, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, J (corresponding author), Jinan Women & Childrens Hlth Hosp, Dept Pathol, Jinan, Shandong, Peoples R China.	slyybyy@163.com			Natural Science Foundation of Shandong Province [ZR2016HB44]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by Natural Science Foundation of Shandong Province (grant number ZR2016HB44) (http://www.sdnsf.gov.cn/ portal/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Microbiology, 2010, PRACT GUID DOC LAB D; ARONSSON B, 1985, J INFECT DIS, V151, P476, DOI 10.1093/infdis/151.3.476; Babady NE, 2010, J CLIN MICROBIOL, V48, P4519, DOI 10.1128/JCM.01648-10; Bai YY, GENOTYPE MTBDR PLUS; Barbut F, 2014, CLIN MICROBIOL INFEC, V20, P136, DOI 10.1111/1469-0691.12221; BARTLETT JG, 1992, CLIN INFECT DIS, V15, P573, DOI 10.1093/clind/15.4.573; Buchan BW, 2012, J CLIN MICROBIOL, V50, P3932, DOI 10.1128/JCM.02083-12; Burnham CAD, 2013, CLIN MICROBIOL REV, V26, P604, DOI 10.1128/CMR.00016-13; Chapin K, 2012, EXPERT REV MOL DIAGN, V12, P223, DOI [10.1586/erm.12.13, 10.1586/ERM.12.13]; Culbreath K, 2012, J CLIN MICROBIOL, V50, P3073, DOI 10.1128/JCM.00992-12; Dalpke AH, 2013, J CLIN MICROBIOL, V51, P1906, DOI 10.1128/JCM.00344-13; Dubberke ER, 2011, J CLIN MICROBIOL, V49, P2887, DOI 10.1128/JCM.00891-11; Eckert C, 2013, MED MALADIES INFECT, V43, P67, DOI 10.1016/j.medmal.2013.01.004; Eigner U, 2014, CLIN LAB, V60, P1343, DOI 10.7754/Clin.Lab.2013.130735; Gilbreath JJ, 2014, DIAGN MICR INFEC DIS, V80, P13, DOI 10.1016/j.diagmicrobio.2014.06.001; Goldenberg SD, 2010, DIAGN MICR INFEC DIS, V67, P304, DOI 10.1016/j.diagmicrobio.2010.02.019; Huang HH, 2009, J CLIN MICROBIOL, V47, P3729, DOI 10.1128/JCM.01280-09; Jazmati N, 2015, J CLIN MICROBIOL, V53, P1942, DOI 10.1128/JCM.00613-15; Jensen MBF, 2015, EUR J CLIN MICROBIOL, V34, P727, DOI 10.1007/s10096-014-2284-7; Jones AM, 2013, J INFECTION, V66, P115, DOI 10.1016/j.jinf.2012.10.019; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Le Guern R, 2013, EXPERT REV MOL DIAGN, V13, P681, DOI 10.1586/14737159.2013.829705; Lloyd A, 2015, DIAGN MICR INFEC DIS, V82, P4, DOI 10.1016/j.diagmicrobio.2015.02.007; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McMillen T, 2016, J CLIN MICROBIOL, V54, P775, DOI 10.1128/JCM.03075-15; Moon HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161139; Moon HW, 2016, CLIN BIOCH, V22, P30205; Novak-Weekley SM, 2010, J CLIN MICROBIOL, V48, P889, DOI 10.1128/JCM.01801-09; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; Rajabally N, 2016, J MED MICROBIOL, V65, P320, DOI 10.1099/jmm.0.000231; Rupnik M, 2008, FEMS MICROBIOL REV, V32, P541, DOI 10.1111/j.1574-6976.2008.00110.x; Shin BM, 2016, ANN LAB MED, V36, P131, DOI 10.3343/alm.2016.36.2.131; Shin S, 2012, ANN LAB MED, V32, P355, DOI 10.3343/alm.2012.32.5.355; Swindells J, 2010, J CLIN MICROBIOL, V48, P606, DOI 10.1128/JCM.01579-09; Tenover FC, 2010, J CLIN MICROBIOL, V48, P3719, DOI 10.1128/JCM.00427-10; Viala C, 2012, J MICROBIOL METH, V90, P83, DOI 10.1016/j.mimet.2012.04.017; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yoo J, 2015, DIAGN MICR INFEC DIS, V83, P7, DOI 10.1016/j.diagmicrobio.2015.05.005; Zidaric V, 2011, J MED MICROBIOL, V60, P1131, DOI 10.1099/jmm.0.030163-0; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	41	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185891	10.1371/journal.pone.0185891	http://dx.doi.org/10.1371/journal.pone.0185891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	29016644	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800025
J	Echtermeyer, S; Metelmann, PH; Hemprich, A; Dannhauer, KH; Krey, KF				Echtermeyer, Sandra; Metelmann, Philine H.; Hemprich, Alexander; Dannhauer, Karl-Heinz; Krey, Karl-Friedrich			Three-dimensional morphology of first molars in relation to ethnicity and the occurrence of cleft lip and palate	PLOS ONE			English	Article							MORPHOMETRIC-ANALYSIS; TOOTH-SIZE; DIZYGOTIC TWINS; SHAPE-ANALYSIS; ASYMMETRY; DENTITION; CROWNS; TEETH	Objectives This study aims to describe morphological peculiarities of maxillary and mandibular first molars in Europeans, Asians and Europeans with cleft lip and palate. Material and methods Reflex microscopy was used to obtain three-dimensional morphometric landmarks from 40 models (11 Europeans and 13 Asians without cleft lip and palate, 16 Europeans with unilateral cleft lip and palate). The cases were examined using traditional morphometry and geometric morphometry, and visualized using thin-plate splines. Results Classic morphometry showed no right/left differences in the study groups and no significant differences with regard to the cleft side in patients with cleft lip and palate. In Asians, a significantly greater mesiodistal width was found. Geometric morphometry showed an enlarged centroid size in Asians (maxilla and mandible). In cleft patients, the cleft site did not appear to impact the morphology of first molars. Conclusion Unilateral clefting did not affect the size and shape of molars; however, characteristic ethnicity-based differences were in fact identified. The results are relevant for orthodontic treatment with preadjusted appliances, and prosthetic CAD/CAM restorations.	[Echtermeyer, Sandra] Echtermeyer Dent Practice, Leipzig, Germany; [Metelmann, Philine H.; Krey, Karl-Friedrich] Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany; [Hemprich, Alexander] Univ Med Leipzig, Dept Maxillofacial Surg & Plast Surg, Leipzig, Germany; [Dannhauer, Karl-Heinz] Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany	Greifswald Medical School; Leipzig University; Greifswald Medical School	Krey, KF (corresponding author), Univ Med Greifswald, Ctr Dent Oral & Craniomandibular Sci, Dept Orthodont, Greifswald, Germany.	kreyk@un-greifswald.de	Doberschütz, Philine/AAR-7118-2021	Doberschütz, Philine/0000-0002-1120-8398				Akcam MO, 2008, AM J ORTHOD DENTOFAC, V134, P85, DOI 10.1016/j.ajodo.2006.05.048; ANDREWS LF, 1972, AMER J ORTHODONTICS, V62, P296, DOI 10.1016/S0002-9416(72)90268-0; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Ballard M.L., 1944, ANGLE ORTHOD, V14, P67; Bernal V, 2007, HOMO, V58, P279, DOI 10.1016/j.jchb.2006.11.003; BIGGERSTAFF RH, 1970, ARCH ORAL BIOL, V15, P721, DOI 10.1016/0003-9969(70)90036-1; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Bornert Heike, 2002, J Orofac Orthop, V63, P51, DOI 10.1007/s00056-002-0055-z; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Durwald J, 2007, J OROFAC ORTHOP, V68, P183, DOI 10.1007/s00056-007-0648-7; Edgar HJH, 2005, J FORENSIC SCI, V50, P269; Endo T, 2007, ODONTOLOGY, V95, P57, DOI 10.1007/s10266-007-0066-8; ERDBRINK D. P., 1967, Z MORPHOL ANTHROPOL, V59, P40; Ferrario V F, 1999, Int J Adult Orthodon Orthognath Surg, V14, P153; Ferrario VF, 1999, AM J PHYS ANTHROPOL, V108, P281; GARN SM, 1967, J DENT RES, V46, P963, DOI 10.1177/00220345670460055801; Gomez-Robles A, 2011, EVOLUTION, V65, P1772, DOI 10.1111/j.1558-5646.2011.01244.x; Harper DAT, 2001, PALAEONTOLOGIA ELECT; HARTMAN SE, 1988, J HUM EVOL, V17, P489, DOI 10.1016/0047-2484(88)90038-3; HASEGAWA Y, 2007, DENT ANTHR, V20, P1; HELLMAN MILO, 1928, PROC AMER PHIL SOC, V67, P157; Kirchberg A, 2014, CLEFT PALATE-CRAN J, V51, P308, DOI 10.1597/12-106; Kook YA, 2004, AM J ORTHOD DENTOFAC, V126, P680, DOI 10.1016/j.ajodo.2003.10.038; KRAUS BS, 1966, J DENT RES, V45, P1736, DOI 10.1177/00220345660450062601; Krey K, 2012, VJO, V9; Krey KF, 2015, J OROFAC ORTHOP, V76, P213, DOI 10.1007/s00056-015-0290-8; Krey KF, 2009, J OROFAC ORTHOP, V70, P237, DOI 10.1007/s00056-009-8814-8; Krey KF, 2008, J OROFAC ORTHOP, V69, P424, DOI 10.1007/s00056-008-8803-3; LUNDSTROM A, 1963, AM J HUM GENET, V15, P34; Milosevic A, 1994, Community Dent Health, V11, P83; Muhlberg G, 1969, Dtsch Stomatol, V19, P689; NOSS JF, 1983, AM J PHYS ANTHROPOL, V61, P437, DOI 10.1002/ajpa.1330610406; Peretz B, 1998, ARCH ORAL BIOL, V43, P525, DOI 10.1016/S0003-9969(98)00034-X; Polychronis G, 2013, AM J PHYS ANTHROPOL, V152, P186, DOI 10.1002/ajpa.22340; Pretty IA, 2001, BRIT DENT J, V190, P359, DOI 10.1038/sj.bdj.4800972a; Reich U, 1996, GERMANY J OROFAC ORT, V57, P246; SCOTT GR, 1977, HUM BIOL, V49, P453; Singleton M, 2011, ANAT REC, V294, P322, DOI 10.1002/ar.21315; SOFAER JA, 1979, ARCH ORAL BIOL, V24, P141, DOI 10.1016/0003-9969(79)90062-1; SPECULAND B, 1988, BRIT J ORAL MAX SURG, V26, P276, DOI 10.1016/0266-4356(88)90044-7; Stancheva N, 2015, J OROFAC ORTHOP, V76, P391, DOI 10.1007/s00056-015-0299-z; Teaford MF, 1991, P SOC PHOTO-OPT INS, P33; Ungar Peter, 2000, Palaeontologia Electronica, V3, P1; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; WERNER SP, 1989, CLEFT PALATE J, V26, P36; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	46	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185472	10.1371/journal.pone.0185472	http://dx.doi.org/10.1371/journal.pone.0185472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	29016629	Green Submitted, Green Published, gold			2022-12-27	WOS:000412601800018
J	Zabek, A; Paslawski, R; Paslawska, U; Wojtowicz, W; Drozdz, K; Polakof, S; Podhorska, M; Dziegiel, P; Mlynarz, P; Szuba, A				Zabek, Adam; Paslawski, Robert; Paslawska, Urszula; Wojtowicz, Wojciech; Drozdz, Katarzyna; Polakof, Sergio; Podhorska, Marzena; Dziegiel, Piotr; Mlynarz, Piotr; Szuba, Andrzej			The influence of different diets on metabolism and atherosclerosis processes-A porcine model: Blood serum, urine and tissues H-1 NMR metabolomics targeted analysis	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; BRANCHED-CHAIN; INOSINE MONOPHOSPHATE; INSULIN-RESISTANCE; MUSCLE; OBESE; PIGS; SPECTROSCOPY; HOMOCYSTEINE; DISEASE	The global epidemic of cardiovascular diseases leads to increased morbidity and mortality caused mainly by myocardial infarction and stroke. Atherosclerosis is the major pathological process behind this epidemic. We designed a novel model of atherosclerosis in swine. Briefly, the first group (11 pigs) received normal pig feed (balanced diet group D BDG) for 12 months, the second group (9 pigs) was fed a Western high-calorie diet (unbalanced diet group D UDG) for 12 months, the third group (8 pigs) received a Western type high-calorie diet for 9 months later replaced by a normal diet for 3 months (regression group D RG). Clinical measurements included zoometric data, arterial blood pressure, heart rate and ultrasonographic evaluation of femoral arteries. Then, the animals were sacrificed and the blood serum, urine and skeletal muscle tissue were collected and 1 H NMR based metabolomics studies with the application of fingerprinting PLS-DA and univariate analysis were done. Our results have shown that the molecular disturbances might overlap with other diseases such as onset of diabetes, sleep apnea and other obesity accompanied diseases. Moreover, we revealed that once initiated, molecular changes did not return to homeostatic equilibrium, at least for the duration of this experiment.	[Zabek, Adam; Wojtowicz, Wojciech; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Chem, Bioorgan Chem Grp, Wroclaw, Poland; [Paslawski, Robert; Paslawska, Urszula; Drozdz, Katarzyna; Szuba, Andrzej] WROVASC Reg Specialist Hosp Wroclaw, Res & Dev Ctr, Wroclaw, Poland; [Paslawski, Robert] Wroclaw Med Univ, Dept & Clin Internal & Occupat Dis & Hypertens, Wroclaw, Poland; [Paslawska, Urszula] Wroclaw Univ Environm & Life Sci, Dept Internal Dis Clin Horses Dogs & Cats, Fac Vet Med, Wroclaw, Poland; [Drozdz, Katarzyna; Szuba, Andrzej] Wroclaw Med Univ, Div Angiol, Wroclaw, Poland; [Drozdz, Katarzyna; Szuba, Andrzej] 4th Mil Hosp Wroclaw, Wroclaw, Poland; [Polakof, Sergio] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, BP 10448, Clermont Ferrand, France; [Polakof, Sergio] CRNH Auvergne, UNH, UMR 1019, INRA, Clermont Ferrand, France; [Podhorska, Marzena; Dziegiel, Piotr] Wroclaw Med Univ, Dept Histol & Embriol, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Wroclaw Medical University; Universite Clermont Auvergne (UCA); INRAE; Wroclaw Medical University	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Chem, Bioorgan Chem Grp, Wroclaw, Poland.	piotr.mlynarz@pwr.wroc.pl	Polakof, Sergio/V-1132-2017; Szuba, Andrzej/AAY-1162-2020; Paslawski, Robert/S-7743-2016	Polakof, Sergio/0000-0002-0976-8732; Podhorska-Okolow, Marzenna/0000-0003-2215-5997; Dziegiel, Piotr/0000-0002-8292-1385; Paslawski, Robert/0000-0002-9607-2919; Drozdz, Katarzyna/0000-0002-9484-7418; Mlynarz, Piotr/0000-0002-8502-4022; Szuba, Andrzej/0000-0002-7555-6201; Wojtowicz, Wojciech/0000-0001-6906-3120	KNOW project; European Regional Development Fund as part of Innovative Economy Operational Program; Wroclaw University of Science and Technology [S0401/0247/16]; WCB KNOW	KNOW project; European Regional Development Fund as part of Innovative Economy Operational Program; Wroclaw University of Science and Technology; WCB KNOW	This work was supported by KNOW project 2014-2018.; This publication is part of the project "WROVASC D Integrated Cardiovascular Centre" co-financed by the European Regional Development Fund as part of Innovative Economy Operational Program 2007-2013 implemented in the Regional Specialist Hospital, Research and Development Centre in Wroclaw. Additionally this study was partly financed by an internal project of the Wroclaw University of Science and Technology S0401/0247/16 and WCB KNOW 2014-2018.	Arriaran S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119572; Badoud F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134613; Bentzon JF, 2016, J PATHOL, V238, P257; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; de Almeida AM, 2012, J PROTEOMICS, V75, P4296, DOI 10.1016/j.jprot.2012.04.010; Djekic D, 2015, IJC METAB ENDOCR, V8, P26, DOI 10.1016/j.ijcme.2014.11.004; Doi M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1683, DOI 10.1152/ajpendo.00609.2006; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; FELIG P, 1974, J CLIN INVEST, V53, P582, DOI 10.1172/JCI107593; Fenning RS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001477; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Guo W, 2016, J PROTEOME RES, V15, P3500, DOI 10.1021/acs.jproteome.6b00179; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; Holecek M, 2001, NUTRITION, V17, P70, DOI 10.1016/S0899-9007(00)00483-4; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Hruby A, 2014, PHARMACOECONOMICS, P1, DOI DOI 10.1007/S40273-013-0118-6; James EL, 2015, CURR OPIN CLIN NUTR, V18, P478, DOI 10.1097/MCO.0000000000000200; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Koopmans SJ, 2015, EUR J PHARMACOL, V759, P231, DOI 10.1016/j.ejphar.2015.03.044; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; McConell GK, 2005, MED SCI SPORT EXER, V37, P2054, DOI 10.1249/01.mss.0000179096.03129.a4; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; Mesangeau D, 2000, CARDIOVASC RES, V45, P889, DOI 10.1016/S0008-6363(99)00406-X; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Nakamura H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.32; Newgard CB, 2009, CELL METABOLISM, V9; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Pasoawski R, 2011, ADV CLIN EXP MED, V20, P211; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Rauschert S, 2014, ANN NUTR METAB, V64, P314, DOI 10.1159/000365040; Reichard GA, 1979, J CLIN INIVEST, P63619; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P199, DOI 10.1111/j.1748-1716.1989.tb08653.x; Shockcor JP, 1996, ANAL CHEM, V68, P4431, DOI 10.1021/ac9606463; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Teerlink T, 2005, VASC MED, V10, pS73, DOI 10.1191/1358863x05vm597oa; Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Xu X, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0141-z; YOUNG VR, 1973, METABOLISM, V22, P1429, DOI 10.1016/0026-0495(73)90257-6; ZHANG AQ, 1993, BIOCHEM PHARMACOL, V45, P2185, DOI 10.1016/0006-2952(93)90187-2	50	12	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184798	10.1371/journal.pone.0184798	http://dx.doi.org/10.1371/journal.pone.0184798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991897	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800009
J	Kim, JS; Yang, HK; Hwang, JM				Kim, Jin-Soo; Yang, Hee Kyung; Hwang, Jeong-Min			Long-term outcomes of augmented unilateral recess-resect procedure in children with intermittent exotropia	PLOS ONE			English	Article							LATERAL RECTUS RECESSION; SURGICAL OUTCOMES; SURVIVAL ANALYSIS; SURGERY	Background Initial overcorrection after exotropia surgery has been considered as a desirable result. Recently, there had been several studies that reported better surgical results of augmented bilateral lateral rectus muscle recession procedure over the conventional procedure. Objectives To compare the long-term results of augmented unilateral lateral rectus recession-medial rectus resection procedure (RR) with the original surgery in exotropic children. Data extraction A retrospective cohort study was performed on a total of 121 children with exotropia who underwent RR from February 2005 to December 2012 and were followed-up for at least 24 months. In 64 patients, RR was performed based on the original surgical table (original RR group). In 57 patients, the amount of medial rectus muscle resection was increased by 1 mm (augmented RR group). Results In the original RR group, 47 of 64 patients (73.4%) had a successful outcome, 13 patients (20.3%) had recurrence, and 4 patients (6.3%) had overcorrection at 2 years after surgery. In the augmented RR group, 45 of 57 patients (79.0%) were successful, 4 patients (7.0%) had recurrence and 8 patients (14.0%) had overcorrection at 2 years after surgery. The recurrence rate was significantly lower in the augmented RR group than the original RR group, whereas the overcorrection rate was not significantly different between two groups at 2 years after surgery (P = 0.036 and P = 0.153, respectively). The cumulative probability of recurrence was lower in the augmented group at 36 months after surgery (P = 0.046, log rank test). Conclusions The long-term success rate of augmented RR in exotropic children was 79.0% and the recurrence rate was significantly lower than original RR with comparable overcorrection rates. Augmented RR can be considered as an alternative procedure in children with basic and convergence insufficiency type exotropia.	[Kim, Jin-Soo; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	hjm@snu.ac.kr	Kim, Jin-Soo/AAF-3359-2019	Kim, Jin-Soo/0000-0003-2393-5346				Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; Chia A, 2006, J AAPOS, V10, P206, DOI 10.1016/j.jaapos.2005.11.015; Choi J, 2012, AM J OPHTHALMOL, V153, P343, DOI 10.1016/j.ajo.2011.06.024; Choi J, 2011, J AAPOS, V15, P224, DOI 10.1016/j.jaapos.2010.12.019; Edelman PM, 1988, AM ORTHOPT J, V38, P111, DOI [10.1080/0065955X.1988.11981779, DOI 10.1080/0065955X.1988.11981779]; Heo H, 2013, JPN J OPHTHALMOL, V57, P475, DOI 10.1007/s10384-013-0260-x; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Kim C, 2005, EYE, V19, P637, DOI 10.1038/sj.eye.6701604; Kim H, 2016, AM J OPHTHALMOL, V163, P11, DOI 10.1016/j.ajo.2015.12.003; Kushner BJ, 1998, ARCH OPHTHALMOL-CHIC, V116, P324, DOI 10.1001/archopht.116.3.324; Lee EK, 2013, OPHTHALMOLOGY, V120, P504, DOI 10.1016/j.ophtha.2012.08.026; Lee JY, 2014, INT J OPHTHALMOL-CHI, V7, P528, DOI 10.3980/j.issn.2222-3959.2014.03.26; Lee SY, 2007, J AAPOS, V11, P266, DOI 10.1016/j.jaapos.2007.02.014; Leow PL, 2010, J PEDIAT OPHTH STRAB, V47, P12, DOI 10.3928/01913913-20100106-04; Lim SH, 2011, EYE, V25, P449, DOI 10.1038/eye.2011.12; Maruo T, 2001, Binocul Vis Strabismus Q, V16, P265; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; RICHARD JM, 1983, OPHTHALMOLOGY, V90, P1172; Suh SY, 2015, J AAPOS, V19, P507, DOI 10.1016/j.jaapos.2015.08.011; Wang B, 2014, BRIT J OPHTHALMOL, V98, P1409, DOI 10.1136/bjophthalmol-2013-304442; Wright K, 2014, COLOR ATLAS STRABISM, V2000, P3959; Yang HK, 2011, OPHTHALMOLOGY, V118, P1512, DOI 10.1016/j.ophtha.2011.01.004; Yang M, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002590; Yang X, 2014, INT J OPHTHALMOL-CHI, V7, P1043, DOI 10.3980/j.issn.2222-3959.2014.06.25	24	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2017	12	10							e0184863	10.1371/journal.pone.0184863	http://dx.doi.org/10.1371/journal.pone.0184863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ1QR	28985221	gold, Green Submitted, Green Published			2022-12-27	WOS:000412493000002
J	Ferreira, TB; Hoffer, KJ; Ribeiro, F; Ribeiro, P; O'Neill, JG				Ferreira, Tiago B.; Hoffer, Kenneth J.; Ribeiro, Filomena; Ribeiro, Paulo; O'Neill, Joao G.			Ocular biometric measurements in cataract surgery candidates in Portugal	PLOS ONE			English	Article							AXIAL LENGTH; REFRACTIVE ERROR; POPULATION; PARAMETERS; SINGAPORE; AGE; ASTIGMATISM; COMPONENTS	Objective Describe the ocular biometric parameters and their associations in a population of cataract surgery candidates. Methods A cross-sectional study of 13,012 eyes of 6,506 patients was performed. Biometric parameters of the eyes were measured by optical low-coherence reflectometry. The axial length (AL), mean keratometry (K) and astigmatism, anterior chamber depth (ACD) (epithelium to lens), lens thickness (LT), and Corneal Diameter (CD) were evaluated. Results The mean age was 69 +/- 10 years (44-99 years). Mean AL, Km, and ACD were 23.87 +/- 1.55 mm (19.8-31.92 mm), 43.91 +/- 1.71 D (40.61-51.14 D), and 3.25 +/- 0.44 mm (2.04-5.28 mm), respectively. The mean LT was 4.32 +/- 0.49 mm (2.73-5.77 mm) and the mean CD was 12.02 +/- 0.46 mm (10.50-14.15 mm). The mean corneal astigmatism was 1.08 +/- 0.84 D (0.00-7.58 D) and 43.5% of eyes had astigmatism >= 1.00 D. Male patients had longer AL and ACDs (p <.001) and flatter corneas (p <.001). In regression models considering age, gender, Km, ACD, LT, and CD, a longer AL was associated with being male and having higher ACD, LT and CD. Conclusions These data represent normative biometric values for the Portuguese population. The greatest predictor of ocular biometrics was gender. There was no significant correlation between age and AL, ACD, or Km. These results may be relevant in the evaluation of refractive error and in the calculation of intraocular lens power.	[Ferreira, Tiago B.; Ribeiro, Filomena] Hosp Luz, Dept Refract Surg, Lisbon, Portugal; [Ferreira, Tiago B.; O'Neill, Joao G.] NOVA Med Sch, Lisbon, Portugal; [Hoffer, Kenneth J.] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA USA; [Hoffer, Kenneth J.] St Marys Eye Ctr, Santa Monica, CA USA; [Ribeiro, Paulo] Fac Ciencias & Tecnol, Lisbon, Portugal	University of California System; University of California Los Angeles	Ferreira, TB (corresponding author), Hosp Luz, Dept Refract Surg, Lisbon, Portugal.; Ferreira, TB (corresponding author), NOVA Med Sch, Lisbon, Portugal.	tiagoferreira@netcabo.pt	Hoffer, Kenneth J/P-6431-2019; Ribeiro, Paulo/GYA-1014-2022; Ribeiro, Paulo/G-8563-2013	Ferreira, Tiago/0000-0001-9962-2579; Ribeiro, Filomena/0000-0002-6790-443X; Ribeiro, Paulo/0000-0001-9665-7610	Portuguese research Grant through FCT-MEC [PEst-OE/FIS/UI0068/2011, UID/FIS/00068/2013]; Fundacao para a Ciencia e Tecnologia, Portugal; Sociedade Portuguesa de Oftalmologia PhD Grant; Fundacao para a Ciencia e a Tecnologia [PEst-OE/FIS/UI0068/2011, UID/FIS/00068/2013]; Sociedade Portuguesa de Oftalmologia	Portuguese research Grant through FCT-MEC; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Oftalmologia PhD Grant; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Sociedade Portuguesa de Oftalmologia	This work was supported by Portuguese research Grant numbers PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 through the FCT-MEC, the "Plurianual" financial contribution of "Fundacao para a Ciencia e Tecnologia", Portugal and Sociedade Portuguesa de Oftalmologia PhD Grant.; Fundacao para a Ciencia e a Tecnologia-PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 - Prof Paulo Ribeiro.; Sociedade Portuguesa de Oftalmologia-N/A-Dr Tiago Ferreira.; Portuguese research Grant numbers PEst-OE/FIS/UI0068/2011 and UID/FIS/00068/2013 through the FCT-MEC, the "Plurianual" financial contribution of "Fundacao para a Ciencia e Tecnologia", Portugal and Sociedade Portuguesa de Oftalmologia PhD Grant.	ANSTICE J, 1971, AMER J OPT ARCH AM A, V48, P1001; Cao XG, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/171564; Cartwright NEK, 2010, EYE, V24, P894, DOI 10.1038/eye.2009.196; Ferrer-Blasco T, 2009, J CATARACT REFR SURG, V35, P70, DOI 10.1016/j.jcrs.2008.09.027; Fotedar R, 2010, OPHTHALMOLOGY, V117, P417, DOI 10.1016/j.ophtha.2009.07.028; GROSVENOR T, 1987, AM J OPTOM PHYS OPT, V64, P657; Hoffer KJ, 2010, J CATARACT REFR SURG, V36, P644, DOI 10.1016/j.jcrs.2009.11.007; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; HOFFER KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P914, DOI 10.1001/archopht.1993.01090070032014; Ip JM, 2007, INVEST OPHTH VIS SCI, V48, P4846, DOI 10.1167/iovs.07-0101; Jivrajka R, 2008, J CATARACT REFR SURG, V34, P289, DOI 10.1016/j.jcrs.2007.10.015; Laursen JVN, 2016, INT OPHTHALMOL, V36, P17, DOI 10.1007/s10792-015-0069-3; Lee KE, 2009, ARCH OPHTHALMOL-CHIC, V127, P88, DOI 10.1001/archophthalmol.2008.521; Lege BAM, 2004, GRAEF ARCH CLIN EXP, V242, P8, DOI 10.1007/s00417-003-0672-2; Lim LS, 2010, INVEST OPHTH VIS SCI, V51, P103, DOI 10.1167/iovs.09-3553; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P84, DOI 10.1111/j.1600-0420.2006.00774.x; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P361, DOI 10.1111/j.1600-0420.2006.00847.x; Ribeiro F, 2013, J REFRACT SURG, V29, P206, DOI 10.3928/1081597X-20130129-07; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Shufelt C, 2005, INVEST OPHTH VIS SCI, V46, P4450, DOI 10.1167/iovs.05-0435; Siahmed K, 2001, J FR OPHTALMOL, V24, P922; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P73	23	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184837	10.1371/journal.pone.0184837	http://dx.doi.org/10.1371/journal.pone.0184837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982150	Green Submitted, gold, Green Published			2022-12-27	WOS:000412360300020
J	Hernandez-Orts, JS; Brandao, M; Georgieva, S; Raga, JA; Crespo, EA; Luque, JL; Aznar, FJ				Hernandez-Orts, Jesus Servando; Brandao, Martha; Georgieva, Simona; Antonio Raga, Juan; Alberto Crespo, Enrique; Luque, Jose Luis; Javier Aznar, Francisco			From mammals back to birds: Host-switch of the acanthocephalan Corynosoma australe from pinnipeds to the Magellanic penguin Spheniscus magellanicus	PLOS ONE			English	Article							MITOCHONDRIAL GENE-SEQUENCES; PARASITE COMMUNITY STRUCTURE; AMERICAN SEA LION; PHYLOGENETIC-RELATIONSHIPS; ARCTOCEPHALUS-AUSTRALIS; POLYMORPHIDAE ACANTHOCEPHALA; ECOLOGICAL SPECIALIZATION; EVOLUTIONARY ECOLOGY; SYSTEMATIC POSITION; HELMINTH-PARASITES	Trophically-transmitted parasites are regularly exposed to potential new hosts through food web interactions. Successful colonization, or switching, to novel hosts, occur readily when 'donor' and 'target' hosts are phylogenetically related, whereas switching between distantly related hosts is rare and may result from stochastic factors (i.e. rare favourable mutations). This study investigates a host-switching event between a marine acanthocephalan specific to pinnipeds that is apparently able to reproduce in Magellanic penguins Spheniscus magellanicus from Brazil. Detailed analysis of morphological and morphometrical data from acanthocephalans from penguins indicates that they belong to Corynosoma australe Johnston, 1937. Partial fragments of the 28S rRNA and mitochondrial cox1 genes were amplified from isolates from penguins and two pinniped species (i.e. South American sea lion Otaria flavescens and South American fur seal Arctocephalus australis) to confirm this identification. Infection parameters clearly differ between penguins and the two pinniped species, which were significantly lower in S. magellanicus. The sex ratio of C. australe also differed between penguins and pinnipeds; in S. magellanicus was strongly biased against males, while in pinnipeds it was close to 1:1. Females of C. australe from O. flavescens were smaller than those from S. magellanicus and A. australis. However, fecundity (i.e. the proportion of fully developed eggs) was lower and more variable in females collected from S. magellanicus. At first glance, the occurrence of reproductive individuals of C. australe in Magellanic penguins could be interpreted as an adaptive colonization of a novel avian host through favourable mutations. However, it could also be considered, perhaps more likely, as an example of ecological fitting through the use of a plesimorphic (host) resource, since the ancestors of Corynosoma infected aquatic birds.	[Hernandez-Orts, Jesus Servando] Univ Nacl Comahue, Ctr Invest Aplicada & Transferencia Tecnol Recurs, CONICET, CIMAS,CCT,CENPAT, San Antonio Oeste, Rio Negro, Argentina; [Hernandez-Orts, Jesus Servando] Univ Nacl Comahue, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina; [Brandao, Martha; Luque, Jose Luis] Univ Fed Rural Rio de Janeiro, Dept Parasitol Anim, Seropedica, RJ, Brazil; [Georgieva, Simona] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Antonio Raga, Juan; Javier Aznar, Francisco] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Parque Cient, Valencia, Spain; [Alberto Crespo, Enrique] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Estudio Sistemas Marinos CESIMAR, Puerto Madryn, Chubut, Argentina; [Alberto Crespo, Enrique] Univ Nacl Patagonia San Juan Bosco UNPSJB, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional del Comahue; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Valencia; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de la Patagonia San Juan Bosco	Hernandez-Orts, JS (corresponding author), Univ Nacl Comahue, Ctr Invest Aplicada & Transferencia Tecnol Recurs, CONICET, CIMAS,CCT,CENPAT, San Antonio Oeste, Rio Negro, Argentina.; Hernandez-Orts, JS (corresponding author), Univ Nacl Comahue, Escuela Super Ciencias Marinas ESCiMar, San Antonio Oeste, Rio Negro, Argentina.	jesus.hernandez.orts@gmail.com	Hernandez Orts, Jesus Servando/GRF-4394-2022; Georgieva, Simona/I-3852-2018; Luque, Jose L/C-9767-2014; Georgieva, Simona/N-5193-2015; Aznar, Francisco Javier/S-3427-2018; Raga, Juan Antonio/L-7669-2014	Hernandez Orts, Jesus Servando/0000-0002-8177-7959; Georgieva, Simona/0000-0003-1721-5035; Georgieva, Simona/0000-0001-8887-472X; Aznar, Francisco Javier/0000-0002-1316-1175; Raga, Juan Antonio/0000-0003-2687-2539; Luque, Jose/0000-0003-3515-1127	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil; Ministry of Economy and Competitiveness of Spain [CGL2012-39545]; Generalitat Valenciana [PROMETEO/2011/040]; Czech Academy of Sciences	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Economy and Competitiveness of Spain(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Czech Academy of Sciences(Czech Academy of Sciences)	This study was partially supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://cnpq.br/) of Brazil to MB and JLL, the Ministry of Economy and Competitiveness (http://www.mineco.gob.es/portal/site/mineco/) of Spain through the project CGL2012-39545 to FJA, the Generalitat Valenciana (http//www.ceice.gva.es/web/ciencia) thought the project PROMETEO/2011/040 to JAR, and by Czech Academy of Sciences (http://www.avcr.cz/en/) postdoctoral fellowship to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Alonso MK, 2000, FISH B-NOAA, V98, P250; Amin OM, 2013, FOLIA PARASIT, V60, P273, DOI 10.14411/fp.2013.031; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Aznar FJ, 2012, J HELMINTHOL, V86, P156, DOI 10.1017/S0022149X11000149; Aznar FJ, 2006, J PARASITOL, V92, P548, DOI 10.1645/GE-715R.1; Aznar FJ, 2004, CAN J ZOOL, V82, P726, DOI [10.1139/z04-044, 10.1139/Z04-044]; Aznar FJ, 2001, J PARASITOL, V87, P536, DOI 10.1645/0022-3395(2001)087[0536:CCITSO]2.0.CO;2; BOERO J J, 1972, Analecta Veterinaria, V4, P17; Brandao Martha L., 2014, Check List, V10, P562; Bray RA, 2009, ACTA PARASITOL, V54, P310, DOI 10.2478/s11686-009-0045-z; Brooks Daniel R., 2008, Evolution Education and Outreach, V1, P2; Brooks DR, 2006, ECOLOGY, V87, pS76, DOI 10.1890/0012-9658(2006)87[76:EFAADO]2.0.CO;2; Brooks Daniel R., 2013, P215; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carballo MC, 2012, J FISH BIOL, V80, P15, DOI 10.1111/j.1095-8649.2011.03125.x; COMBES C, 1991, AM NAT, V138, P866, DOI 10.1086/285257; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Crompton D.W.T., 1985, P213; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz JI, 2010, COMP PARASITOL, V77, P172, DOI 10.1654/4441.1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraija-Fernandez N, 2015, INT J PARASITOL, V45, P167, DOI 10.1016/j.ijpara.2014.10.004; Frere E., 1996, Ornitologia Neotropical, V7, P35; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Garcia-Varela M, 2005, J PARASITOL, V91, P1401, DOI 10.1645/GE-523R.1; Garcia-Varela M, 2008, J PARASITOL, V94, P212, DOI 10.1645/GE-1257.1; Garcia-Varela M, 2006, MOL PHYLOGENET EVOL, V40, P61, DOI 10.1016/j.ympev.2006.02.010; Garcia-Varela M, 2013, MOL PHYLOGENET EVOL, V68, P176, DOI 10.1016/j.ympev.2013.03.029; Garcia-Varela M, 2009, J PARASITOL, V95, P178, DOI 10.1645/GE-1538.1; Gemmill AW, 2000, PARASITOLOGY, V120, P429, DOI 10.1017/S0031182099005478; Georgieva S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-64; Gonzalez AF, 2003, FISH RES, V60, P177, DOI 10.1016/S0165-7836(02)00059-0; Gregori M, 2012, DIS AQUAT ORGAN, V99, P37, DOI 10.3354/dao02457; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HELLE E, 1980, CAN J ZOOL, V58, P298, DOI 10.1139/z80-035; Hernandez-Orts JS, 2013, J HELMINTHOL, V87, P336, DOI 10.1017/S0022149X12000454; Hernandez-Orts J. S, 2013, THESIS; Hernandez-Orts JS, 2017, PARASITOL INT, V66, P905, DOI 10.1016/j.parint.2016.10.007; Hernandez-Orts JS, 2012, PARASITOLOGY, V139, P945, DOI 10.1017/S0031182012000078; Hoberg E.P., 2000, Bulletin of the Scandinavian Society for Parasitology, V10, P19; HOBERG EP, 1986, ANN PARASIT HUM COMP, V61, P199; HOBERG EP, 1992, J PARASITOL, V78, P601, DOI 10.2307/3283535; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Janz N, 1998, EVOLUTION, V52, P486, DOI [10.2307/2411084, 10.1111/j.1558-5646.1998.tb01648.x]; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Johnston T. H., 1937, Proceedings of the Linnean Society of New South Wales, V62, P9; JOHNSTON T. H., 1941, Records of the South Australian Museum, V6, P429; JOHNSTON T. HARVEY, 1953, REC DOMINION MUS, V2, P55; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Knoff M, 2001, MEM I OSWALDO CRUZ, V96, P1095, DOI 10.1590/S0074-02762001000800012; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laskowski Zdzislaw, 2005, Polish Polar Research, V26, P315; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luque JL, 2004, ACTA PARASITOL, V49, P353; MACHADO D A, 1970, Revista Brasileira de Biologia, V30, P377; Margolis L, 1997, J HELMINTHOL SOC W, V64, P161; Mateu P, 2011, J HELMINTHOL, V85, P12, DOI 10.1017/S0022149X10000180; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; McQuaid CF, 2013, B MATH BIOL, V75, P2196, DOI 10.1007/s11538-013-9887-5; Miller M.A., 2010, P GAT COMP ENV WORKS; Morini EG, 1959, ACTA TRAB C SUDAM ZO, P229; Nadler SA, 2000, PARASITOLOGY, V121, P455, DOI 10.1017/S0031182099006423; Nadler SA, 2006, SYST PARASITOL, V63, P161, DOI 10.1007/s11230-005-9009-3; Naya DE, 2002, MAR MAMMAL SCI, V18, P734, DOI 10.1111/j.1748-7692.2002.tb01070.x; Nickol BB, 2002, J PARASITOL, V88, P1222, DOI 10.1645/0022-3395(2002)088[1222:CMIGSF]2.0.CO;2; Noronha D., 1988, Arquivos Fluminenses de Medicina Veterinaria, V3, P119; Petrochenko VI, 1958, ACANTHOCEPHALA DOMES; Putz K, 2007, MAR BIOL, V152, P1227, DOI 10.1007/s00227-007-0770-5; Raga JA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P821; Rambaut A, 2009, TRACER; Rambaut A, 2012, FIGTREE V 1 4 MOL EV; Reiczigel J, 2003, STAT MED, V22, P611, DOI 10.1002/sim.1320; Reiczigel J, 2013, QUANTITATIVE PARASIT; Richardson DJ, 1997, J PARASITOL, V83, P540, DOI 10.2307/3284428; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sardella NH, 2005, SYST PARASITOL, V61, P143, DOI 10.1007/s11230-005-3131-0; Schiavini Adrián, 2005, Hornero, V20, P5; SCHMIDT GD, 1971, J PARASITOL, V57, P582, DOI 10.2307/3277920; Scolaro J.A., 1986, Cormorant, V13, P91; Scolaro JA, 1999, WATERBIRDS, V22, P104, DOI 10.2307/1521999; Silva Renato Z., 2014, Journal of Parasitic Diseases, V38, P410, DOI 10.1007/s12639-013-0250-4; Silva RZ, 2013, ESTUD BIOL, V35, P121, DOI DOI 10.7213/estud.biol.35.085.AO03; SMALES LR, 1986, SYST PARASITOL, V8, P91, DOI 10.1007/BF00009865; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stryukov A. A., 2004, Vestnik Zoologii, V38, P23; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Timi JT, 2003, INT J PARASITOL, V33, P1353, DOI 10.1016/S0020-7519(03)00203-0; Tkach V, 1999, ACTA PARASITOL, V44, P170; VALTONEN E T, 1983, Aquilo Ser Zoologica, V22, P1; VALTONEN ET, 1982, PARASITOLOGY, V85, P9, DOI 10.1017/S0031182000054093; VANCLEAVE HJ, 1953, J PARASITOL, V39, P1, DOI 10.2307/3274052; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; Ward SA, 1998, J ANIM ECOL, V67, P763, DOI 10.1046/j.1365-2656.1998.00238.x; Yamaguti S, 1963, SYSTEMA HELMINTHUM, VV; ZDZITOWIECKI K, 1986, Polish Polar Research, V7, P79; Zdzitowiecki K, 1984, ACTA PARASITOL POL, V29, P359; Zdzitowiecki Krzysztof, 2001, Polish Polar Research, V22, P205	103	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183809	10.1371/journal.pone.0183809	http://dx.doi.org/10.1371/journal.pone.0183809			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981550	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300005
J	Lu, P; Li, HH; Li, N; Singh, RN; Bishop, CE; Chen, XX; Lu, BS				Lu, Pin; Li, Huanhuan; Li, Ning; Singh, Ravi N.; Bishop, Colin E.; Chen, Xiangxian; Lu, Baisong			MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MUTATION REDUCES ADIPOSITY; I MESSENGER-RNA; COATED VESICLES; BINDING; ENDOSOMES; UBIQUITIN; TRAFFICKING; BIOGENESIS; TRANSPORT	Some RNA species, especially microRNAs, are non-randomly sorted into exosomes, but how selectivity of RNA exosomal sorting is achieved is unknown. We found that all three variants of RNA-binding ubiquitin E3 ligase (MEX3C)-MEX3C-1, MEX3C-2, and MEX3C-3-interact with adaptor-related protein complex 2 (AP-2), a cargo adaptor in clathrin-mediated endocytosis. MEX3C's C-terminal RING finger domain and the hnRNP K homology (KH) domain shared by the three MEX3C variants are both necessary for MEX3C/AP-2 interaction. MEX3C associates with the endolysosomal compartment through an endocytosis-like process. siRNA-mediated inhibition of the MEX3C or AP-2 complex substantially decreased exosomal but not cellular microRNA miR-451a expression. Exosomal sorting is ceramide-dependent but not ESCRT-dependent in microRNA miR-451a. That RNA-binding protein associates with membrane trafficking machinery, and that its involvement in exosomal microRNA expression, suggest the existence of a mechanism for specific recruiting of RNA molecules to endosomes for subsequent exosomal sorting.	[Lu, Pin; Chen, Xiangxian] Anhui Normal Univ, Wuhu, Peoples R China; [Lu, Pin; Li, Huanhuan; Li, Ning; Bishop, Colin E.; Chen, Xiangxian; Lu, Baisong] Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC 27157 USA; [Singh, Ravi N.] Wake Forest Univ Hlth Sci, Dept Canc Biol, Winston Salem, NC USA	Anhui Normal University; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Chen, XX (corresponding author), Anhui Normal Univ, Wuhu, Peoples R China.; Chen, XX; Lu, BS (corresponding author), Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC 27157 USA.	Jhchxxlu@mail.ahnu.edu.cn; blu@wakehealth.edu	Lu, Baisong/B-5837-2013; Singh, Ravi N/A-5740-2011	Lu, Baisong/0000-0001-9240-558X; Singh, Ravi N/0000-0003-0750-1804; lyu, pin/0000-0001-6841-1373				Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Batagov AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S18; Baumann S, 2014, EMBO REP, V15, P94, DOI 10.1002/embr.201338037; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831; Bolukbasi MF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.2; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9670; Cano F, 2012, EMBO J, V31, P3596, DOI 10.1038/emboj.2012.218; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dollar G, 2002, DEVELOPMENT, V129, P517; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Han CJ, 2014, J ENDOCRINOL, V221, P457, DOI 10.1530/JOE-14-0071; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Jiao Y, 2012, MOL CELL BIOL, V32, P4350, DOI 10.1128/MCB.00452-12; Jiao Y, 2012, MOL BIOL CELL, V23, P1404, DOI 10.1091/mbc.E11-11-0960; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; Konig J, 2009, EMBO J, V28, P1855, DOI 10.1038/emboj.2009.145; Konopacki FA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150218; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136630; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; SEAMAN MNJ, 1993, J CELL BIOL, V123, P1093, DOI 10.1083/jcb.123.5.1093; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Smith VL, 2015, J IMMUNOL, V195, P2722, DOI 10.4049/jimmunol.1403186; Sorkina T, 1999, J CELL SCI, V112, P317; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107	54	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185992	10.1371/journal.pone.0185992	http://dx.doi.org/10.1371/journal.pone.0185992			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982131	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300103
J	Min, YW; Song, BG; Kim, HS; Kim, K; Lee, H; Min, BH; Lee, JH; Son, HJ; Rhee, PL; Kim, JJ				Min, Yang Won; Song, Byeong Geun; Kim, Hye Seung; Kim, Kyunga; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Son, Hee Jung; Rhee, Poong-Lyul; Kim, Jae J.			Associations between reflux esophagitis and the progression of coronary artery calcification: A cohort study	PLOS ONE			English	Article							METABOLIC SYNDROME; GASTROESOPHAGEAL-REFLUX; HEART-DISEASE; EROSIVE ESOPHAGITIS; COMPUTED-TOMOGRAPHY; RISK-FACTORS; OBESITY; CALCIUM; MORTALITY; ATHEROSCLEROSIS	Background Reflux esophagitis (RE) and coronary heart disease (CHD) have common risk factors, including obesity and metabolic syndrome. This study aimed to evaluate the associations between RE and the future CHD risk. Methods This retrospective cohort study included 8,221 participants who were >= 20 years old, and who underwent esophagogastroduodenoscopy and coronary computed tomography (CT) scans during the same visit and subsequent CT scans between 2003 and 2013. RE was defined as the presence of at least Los Angeles classification grade A mucosal break. CT scan was used to determine the coronary artery calcium (CAC) scores. CAC progression was defined as an increase in the CAC score on a subsequent CT scan. Results RE was present in 984 (12.0%) participants. RE at baseline was associated with CAC progression (odds ratio [OR], 1.253; 95% confidence interval [CI], 1.088-1.444; P = 0.002), and this association persisted after adjusting the model for age, sex, smoking status, and alcohol consumption (OR, 1.175; 95% CI, 1.001-1.378; P = 0.048). This association disappeared when the model was further adjusted for body mass index, diastolic blood pressure, the presence of hypertension, glycated hemoglobin, low-density lipoprotein cholesterol, and triglycerides (OR, 1.088; 95% CI, 0.924-1.281; P = 0.311) which were selected using a step-wise selection procedure from several metabolic variables. Conclusions Our results suggest that the presence of RE is closely associated with CHD, even though RE is not a direct risk factor for CHD. Metabolic factors may play roles in CAC progression in individuals with RE.	[Min, Yang Won; Song, Byeong Geun; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Son, Hee Jung; Rhee, Poong-Lyul; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Hye Seung; Kim, Kyunga] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Son, Hee Jung] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	plrhee@skku.edu		Rhee, Poong-Lyul/0000-0003-0495-5296				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Chen CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004089; Chua CS, 2009, J GASTROEN HEPATOL, V24, P1375, DOI 10.1111/j.1440-1746.2009.05858.x; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Derakhshan MH, 2012, GUT, V61, P337, DOI 10.1136/gutjnl-2011-300633; Dunbar KB, 2016, JAMA-J AM MED ASSOC, V315, P2104, DOI 10.1001/jama.2016.5657; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Fisher BL, 1999, DIGEST DIS SCI, V44, P2290, DOI 10.1023/A:1026617106755; Flint AJ, 2010, OBES RES CLIN PRACT, V4, pE171, DOI 10.1016/j.orcp.2010.01.001; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; Friedenberg FK, 2008, AM J GASTROENTEROL, V103, P2111, DOI 10.1111/j.1572-0241.2008.01946.x; Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636; Katzmarzyk PT, 2005, DIABETES CARE, V28, P391, DOI 10.2337/diacare.28.2.391; Kim LK, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0404-7; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Lanas F, 2016, J CLIN EPIDEMIOL; Loke SS, 2013, WORLD J GASTROENTERO, V19, P5883, DOI 10.3748/wjg.v19.i35.5883; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Osawa K, 2016, GLOB HEART, V11, P287, DOI 10.1016/j.gheart.2016.08.001; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ryu J, 2013, INT J CARDIOVAS IMAG, V29, P101, DOI 10.1007/s10554-013-0319-2; Shah NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124653; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1399, DOI 10.1016/j.cgh.2013.05.009; St-Pierre AC, 2005, CAN MED ASSOC J, V172, P1301, DOI 10.1503/cmaj.1040834; Watanabe S, 2007, J GASTROENTEROL, V42, P267, DOI 10.1007/s00535-007-2033-0; Wong RKM, 2009, J GASTROEN HEPATOL, V24, P103, DOI 10.1111/j.1440-1746.2008.05680.x	32	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184996	10.1371/journal.pone.0184996	http://dx.doi.org/10.1371/journal.pone.0184996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981523	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300025
J	Rocha, LS; Rocha, FSA; Souza, TTP				Rocha, Leno S.; Rocha, Frederico S. A.; Souza, Tharsis T. P.			Is the public sector of your country a diffusion borrower? Empirical evidence from Brazil	PLOS ONE			English	Article							DEBT	We propose a diffusion process to describe the global dynamic evolution of credit operations at a national level given observed operations at a subnational level in a sovereign country. Empirical analysis with a unique dataset from Brazilian federate constituents supports the conclusions. Despite the heterogeneity observed in credit operations at a subnational level, the aggregated dynamics at a national level were accurately described by the proposed model. Results may guide management of public finances, particularly debt manager authorities in charge of reaching surplus targets.	[Rocha, Leno S.] Brazilian Treasury Secretariat, Minist Finance, Brasilia, DF, Brazil; [Rocha, Frederico S. A.] Univ Utah, Dept Comp Sci, Salt Lake City, UT 84112 USA; [Souza, Tharsis T. P.] UCL, Dept Comp Sci, London, England	Utah System of Higher Education; University of Utah; University of London; University College London	Rocha, LS (corresponding author), Brazilian Treasury Secretariat, Minist Finance, Brasilia, DF, Brazil.	leno.rocha@tesouro.gov.br		Rocha, Leno/0000-0003-1036-8063	CAPES; University of Utah; CNPq - The Brazilian National Council for Scientific and Technological Development	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Utah; CNPq - The Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	F.S.A.R. is grateful to CAPES (Coordination for Enhancement of Higher Education Personnel) and to the University of Utah for the financial support. T.T.P.S. acknowledges financial support from CNPq - The Brazilian National Council for Scientific and Technological Development.	Alesina A, 1991, MACROECONOMIC POLICY, P3830; [Anonymous], 2014, IMF GUIDELINES PUBLI; Bua G, 2014, REV DEV FINANC, V4, P1, DOI 10.1016/j.rdf.2014.02.002; Buiatti C, 2014, J POLICY MODEL, V36, P43, DOI 10.1016/j.jpolmod.2013.10.016; Carranza L, 2014, J ECON STUD, V41, P29, DOI 10.1108/JES-03-2012-0036; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026, https://doi.org/10.1098/rstl.1825.0026]; Jenkner E., 2014, WP1420 IMF; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Matesanz D, 2015, PHYSICA A, V436, P756, DOI 10.1016/j.physa.2015.05.052; Mitze T, 2015, J POLICY MODEL, V37, P208, DOI 10.1016/j.jpolmod.2015.02.003; Panizza U, 2014, J MACROECON, V41, P21, DOI 10.1016/j.jmacro.2014.03.009; SADIPEM, 2015, BRAZ NAT TREAS SECR; Sakurai SN, 2011, PUBLIC CHOICE, V148, P233, DOI 10.1007/s11127-010-9654-1; Shone R., 2002, EC DYNAMICS PHASE DI, VSecond Edition; Spilioti S., 2015, J EC ASYMMETRIES, V12, P34, DOI [10.1016/j.jeca.2014.10.001, DOI 10.1016/J.JECA.2014.10.001]; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185257	10.1371/journal.pone.0185257	http://dx.doi.org/10.1371/journal.pone.0185257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI9WM	28981532	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300031
J	Bastin, F; Savarit, F; Lafon, G; Sandoz, JC				Bastin, Florian; Savarit, Fabrice; Lafon, Gregory; Sandoz, Jean-Christophe			Age-specific olfactory attraction between Western honey bee drones (Apis mellifera) and its chemical basis	PLOS ONE			English	Article							CONGREGATION AREAS; PHEROMONE COMMUNICATION; QUEEN PHEROMONE; HYMENOPTERA; EVOLUTION; WORKERS; RADAR; ODOR; PERCEPTION; COMPONENTS	During the mating season, drones (males) of the Western honey bee (Apis mellifera) form congregations numbering thousands high in the air. Virgin queens arrive at these congregations after they have formed and mate on the fly with 15-20 drones. To explain the formation of drone congregations, a drone-produced aggregation pheromone has been proposed many years ago but due to the low accessibility of natural mating sites in bees, its study has progressed slowly. Recently, we used a walking simulator in controlled laboratory conditions to show that drones are indeed attracted by groups of other drones. Since these previous experiments were carried out with drones captured when flying out of the hive, it is currently unclear if this olfactory attraction behaviour is related to the drones' sexual maturity (usually reached between 9 and 12 days) and may thus be indicative of a possible role in congregation formation, or if it is observed at any age and may represent in-hive aggregation. We thus assessed here the dependency of drone olfactory attraction on their age. First, we performed behavioural experiments in the walking simulator to measure olfactory preferences of drones in three age groups from 2-3 to 12-15 days. Then, we performed chemical analyses in the same age groups to evaluate whether chemical substances produced by the drones may explain age differences in olfactory attraction. We show that honey bee drones are attracted by conspecifics of the same age when they are sexually mature (12-15 days old) but not when they are younger (2-3 and 7-8 days old). In parallel, our data show that drones' chemical profile changes with age, including its most volatile fraction. These results are discussed in the context of drone mutual attraction both within the hive and at drone congregations.	[Bastin, Florian; Lafon, Gregory; Sandoz, Jean-Christophe] Univ Paris Saclay, Evolut Genomes Behav & Ecol, CNRS, UMR 9191,Univ Paris Sud,IRD, Gif Sur Yvette, France; [Savarit, Fabrice] Univ Paris 13, Lab Ethol Expt & Comparee, Sorbonne Paris Cite, Villetaneuse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Universite Paris 13	Sandoz, JC (corresponding author), Univ Paris Saclay, Evolut Genomes Behav & Ecol, CNRS, UMR 9191,Univ Paris Sud,IRD, Gif Sur Yvette, France.	sandoz@egce.cnrs-gif.fr	; SANDOZ, Jean-Christophe/A-6085-2012	Lafon, Gregory/0000-0002-1825-5269; SANDOZ, Jean-Christophe/0000-0002-5423-9645; Bastin, Florian/0000-0002-2883-7860	Agence Nationale de la Recherche (FR), Paris, France [Project EVOLBEE] [2010-BLAN-1712-01]; Agence Nationale de la Recherche (FR), Paris, France [Project Bee-o-CHOC]; Agence Nationale de la Recherche (ANR), Paris, France [Project EVOLBEE] [2010-BLAN-1712-01]; Agence Nationale de la Recherche (ANR), Paris, France [Project Bee-o-CHOC]	Agence Nationale de la Recherche (FR), Paris, France [Project EVOLBEE](French National Research Agency (ANR)); Agence Nationale de la Recherche (FR), Paris, France [Project Bee-o-CHOC](French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR), Paris, France [Project EVOLBEE](French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR), Paris, France [Project Bee-o-CHOC](French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (FR) (http://www.agence-nationale-recherche.fr/), Paris, France [Projects EVOLBEE, 2010-BLAN-1712-01 and Bee-o-CHOC, 2017 to J.C.S]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Lionel Garnery and Damien Delalande for beekeeping support. We thank Andreas Brandstaetter for the development of the walking simulator. This work was supported by the Agence Nationale de la Recherche (ANR), Paris, France [Projects EVOLBEE, 2010-BLAN-1712-01 and Bee-o-CHOC, 2017 to J.C.S]. G. L thanks the ENS Cachan and Universite A Paris-Saclay.	ALLAN SA, 1987, J INSECT PHYSIOL, V33, P917, DOI 10.1016/0022-1910(87)90003-5; [Anonymous], 1974, SOCIAL BEHAV BEES; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Bastin F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06241-9; Baudry E, 1998, P ROY SOC B-BIOL SCI, V265, P2009, DOI 10.1098/rspb.1998.0533; Boucher M, 2009, ANIM BEHAV, V78, P247, DOI 10.1016/j.anbehav.2009.04.019; Brandstaetter AS, 2014, J EXP BIOL, V217, P1278, DOI 10.1242/jeb.094292; Brockmann A, 1998, NATURWISSENSCHAFTEN, V85, P283, DOI 10.1007/s001140050500; Brockmann A, 2001, NATURWISSENSCHAFTEN, V88, P78, DOI 10.1007/s001140000199; Brockmann A, 2006, J CHEM ECOL, V32, P657, DOI 10.1007/s10886-005-9027-2; Buter C. G., 1964, Journal of Apicultural Research London, V3, P65; Butler C., 1609, FEMININE MONARCHIE O; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; DRESCHER W, 1969, Z BIENENFORSCH, V9, P390; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; Farine JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040396; Free J. B., 1957, British Journal of Animal Behaviour, V5, P7, DOI 10.1016/S0950-5601(57)80038-0; Free J. B., 1987, PHEROMONES SOCIAL BE; FREE JB, 1975, ANIM BEHAV, V23, P650, DOI 10.1016/0003-3472(75)90143-8; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; GERIG L, 1972, Zeitschrift fuer Angewandte Entomologie, V70, P286; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; HARRISON JM, 1987, J EXP BIOL, V129, P53; HOWELL D. E., 1933, ANN ENT SOC AMERICA, V26, P239; Jarriault D, 2012, APIDOLOGIE, V43, P292, DOI 10.1007/s13592-011-0117-6; JAYCOX ELBERT R., 1961, ANN ENT SOC AMER, V54, P519; Jean-Prost P., 1957, ACAD SCI, V245, P2107; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; KAISSLIN.KE, 1968, Z VERGL PHYSIOL, V59, P357, DOI 10.1007/BF00365967; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Klein Alexandra-Maria, 2009, P195; KOENIGER G, 1990, APIDOLOGIE, V21, P185, DOI 10.1051/apido:19900303; KOENIGER G, 1979, BEE WORLD, V60, P53, DOI 10.1080/0005772X.1979.11097736; Koeniger G., 2014, PAARUNGSBIOLOGIE PAA; Koeniger N., 2004, Tropical Agricultural Research and Extension, V7, P13; Koeniger N, 2005, APIDOLOGIE, V36, P211, DOI 10.1051/apido:2005011; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; Kurennoi NM, 1954, PCHELOVODSTO, V30, P28; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; LENSKY Y, 1985, J INSECT PHYSIOL, V31, P265, DOI 10.1016/0022-1910(85)90002-2; LOPER GM, 1987, APIDOLOGIE, V18, P163, DOI 10.1051/apido:19870206; LOPER GM, 1992, J KANSAS ENTOMOL SOC, V65, P223; LOPER GM, 1993, J CHEM ECOL, V19, P1929, DOI 10.1007/BF00983797; MASSON C, 1984, J INSECT PHYSIOL, V30, P7, DOI 10.1016/0022-1910(84)90104-5; MASSON C, 1993, APIDOLOGIE, V24, P169, DOI 10.1051/apido:19930302; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Morse R. A., 1967, J ECON ENTOMOL, V60, P1192; Nishino H, 2009, J COMP NEUROL, V515, P161, DOI 10.1002/cne.22064; OERTEL E., 1956, ANN ENT SOC AMER, V49, P497; OHTANI T, 1974, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V19, P706; OMHOLT SW, 1988, J THEOR BIOL, V134, P309, DOI 10.1016/S0022-5193(88)80061-4; PAIN J, 1963, CR HEBD ACAD SCI, V256, P512; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; Ruttner, 1966, Z BIENENFORSCH, V8, P332; RUTTNER F, 1985, FORTS ZOOL, V31, P225; Ruttner F., 1968, Annales de l'Abeille, V11, P243, DOI 10.1051/apido:19680402; RUTTNER F, 1957, Z VERGL PHYSIOL, V39, P577, DOI 10.1007/BF00348457; RUTTNER F, 1965, Z BIENENFORSCHUNG, V8, P1; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; RUTTNER H, 1972, Apidologie, V3, P203, DOI 10.1051/apido:19720301; Sandoz JC, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00098; Sandoz JC, 2006, J EXP BIOL, V209, P3587, DOI 10.1242/jeb.02423; Sandoz JC, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08.005.2007; Schluns H, 2005, ANIM BEHAV, V70, P125, DOI 10.1016/j.anbehav.2004.11.005; Seeley T., 1995, WISDOM HIVE SOCIAL P; Skirkevicius, 1994, PHEROMONES, V4, P83; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; SLESSOR KN, 1988, NATURE, V332, P354, DOI 10.1038/332354a0; Sokal RR, 1995, BIOMETRY; Stout TL, 2011, ETHOLOGY, V117, P459, DOI 10.1111/j.1439-0310.2011.01895.x; Tofilski Adam, 1996, Pszczelnicze Zeszyty Naukowe, V40, P55; Vareschi E., 1971, J COMP PHYSIOL A, V75, P143; Vetter RS, 1997, J CHEM ECOL, V23, P1867, DOI 10.1023/B:JOEC.0000006456.90528.94; Villar G, 2015, J COMP PHYSIOL A, V201, P731, DOI 10.1007/s00359-015-1006-7; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wakonigg G, 2000, J APICULT RES, V39, P137, DOI 10.1080/00218839.2000.11101033; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; WATANABE ME, 1994, SCIENCE, V265, P1170, DOI 10.1126/science.265.5176.1170; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532; Winston M.L., 1991, BIOL HONEY BEE; WOYKE J, 1978, APIDOLOGIE, V9, P203, DOI 10.1051/apido:19780304	88	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185949	10.1371/journal.pone.0185949	http://dx.doi.org/10.1371/journal.pone.0185949			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977020	gold, Green Submitted, Green Published			2022-12-27	WOS:000412163100054
J	Nasir, NH; Mohamed, M; Lum, LCS; Ng, CJ				Nasir, Nazrila Hairin; Mohamed, Mohazmi; Lum, Lucy Chai See; Ng, Chirk Jenn			Effectiveness of a fluid chart in outpatient management of suspected dengue fever: A pilot study	PLOS ONE			English	Article							CLASSIFICATION; COUNTRIES; ILLNESS	Introduction Dengue infection is the fastest spreading mosquito-borne viral disease in the world. One of the complications of dengue is dehydration which, if not carefully monitored and treated, may lead to shock, particularly in those with dengue haemorrhagic fever. WHO has recommended oral fluid intake of five glasses or more for adults who are suspected to have dengue fever. However, there have been no published studies looking at self-care intervention measures to improve oral fluid intake among patients suspected of dengue fever. Objective To assess the feasibility and effectiveness of using a fluid chart to improve oral fluid intake in patients with suspected dengue fever in a primary care setting. Methods This feasibility study used a randomized controlled study design. The data was collected over two months at a primary care clinic in a teaching hospital. The inclusion criteria were: age > 12 years, patients who were suspected to have dengue fever based on the assessment by the primary healthcare clinician, fever for > three days, and thrombocytopenia (platelets < 150 x 10(9)/L). Both groups received a dengue home care card. The intervention group received the fluid chart and a cup (200ml). Baseline clinical and laboratory data, 24-hour fluid recall (control group), and fluid chart were collected. The main outcomes were: hospitalization rates, intravenous fluid requirement and total oral fluid intake. Findings Among the 138 participants who were included in the final analysis, there were fewer hospital admissions in the intervention group (n = 7, 10.0%) than the control group (n = 12, 17.6%) (p = 0.192). Similarly, fewer patients (n = 9, 12.9%) in the intervention group required intravenous fluid compared to the control group (n = 15, 22.1%), (p = 0.154). There was an increase in the amount of daily oral fluid intake in the intervention group (about 3,000 ml) compared to the control group (about 2,500 ml, p = 0.521). However, these differences did not reach statistical significance. Conclusion This is a feasible and acceptable study to perform in a primary care setting. The fluid chart is a simple, inexpensive tool that may reduce hospitalization and intravenous fluid requirement in suspected dengue patients. A randomized controlled trial with larger sample size is needed to determine this conclusively.	[Nasir, Nazrila Hairin; Mohamed, Mohazmi; Ng, Chirk Jenn] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Lum, Lucy Chai See] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Nasir, Nazrila Hairin] Klin Kesihatan Putrajaya Presint 18, Pejabat Kesihatan Putrajaya, Putrajaya, Malaysia	Universiti Malaya; Universiti Malaya	Ng, CJ (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.	ngcj@um.edu.my	NG, CHIRK JENN/C-1344-2010; MOHAMED, MOHAZMI/B-9062-2010; Lum, Lucy/Q-9871-2017	MOHAMED, MOHAZMI/0000-0002-2840-9815; Lum, Lucy/0000-0002-7452-4208; Ng, Chirk Jenn/0000-0002-8320-1603	University of Malaya Research Grant [P0117-2010B]	University of Malaya Research Grant	This study was funded by aid from the University of Malaya Research Grant P0117-2010B.	Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; [Anonymous], 2004, WORLD HLTH REP; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; CHIN CK, 1993, J TROP MED HYG, V96, P259; Emer Breen, 2012, Dengue Bulletin, V36, P105; Harris E, 2003, EMERG INFECT DIS, V9, P1003; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Lee IK, 2010, T ROY SOC TROP MED H, V104, P541, DOI 10.1016/j.trstmh.2010.05.003; Lum LCS, 2008, AM J TROP MED HYG, V78, P862, DOI 10.4269/ajtmh.2008.78.862; Nasir NH, 2013, THESIS; Phuong HL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-275; Potts JA, 2008, TROP MED INT HEALTH, V13, P1328, DOI 10.1111/j.1365-3156.2008.02151.x; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; WHO, 1997, DENG HAEM FEV DIAGN; Wilder-Smith A, 2004, CLIN INFECT DIS, V39, P1818, DOI 10.1086/426029; World Health Organization, 2009, DENGUE GUIDELINES DI	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0183544	10.1371/journal.pone.0183544	http://dx.doi.org/10.1371/journal.pone.0183544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977019	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100004
J	Boireau, C; Dufour, B; Praud, A				Boireau, Clemence; Dufour, Barbara; Praud, Anne			The importance of communication in promoting voluntary participation in an experimental trial: A qualitative study based on the assessment of the gamma-interferon test for the diagnosis of bovine tuberculosis in France	PLOS ONE			English	Article							FARMERS PERCEPTIONS; VETERINARY SERVICES; PIG FARMERS; CATTLE; INTERVIEWS; RESISTANCE; KNOWLEDGE; ATTITUDES; HEALTH	Understanding the factors leading each stakeholder to participate in an experimental trial is a key element for improving trial set-up and for identifying selection bias in statistical analyses. An experimental protocol, validated by the European Commission, was developed in France to assess the ability of the gamma-interferon test in terms of accuracy to replace the second intradermal skin test in cases of suspected bovine tuberculosis. Implemented between 2013 and 2015, this experimental trial was based on voluntary participation. To determine and understand the motivation or reluctance of farmers to take part in this trial, we carried out a sociological survey in France. Our study was based on semi-structured interviews with the farmers and other stakeholders involved. The analysis of findings demonstrated that shortening the lock-up period during tuberculosis suspicion, following the use of a gamma-interferon test, was an important aim and a genuine challenge for the animal health stakeholders. However, some farmers did not wish to continue the trial because it could potentially have drastic consequences for them. Moreover, misunderstandings and confusion concerning the objectives and consequences of the trial led stakeholders to reject it forcefully. Based on our results, we offer some recommendations: clear and appropriate communication tools should be prepared to explain the protocol and its aims. In addition, these types of animal health trials should be designed with the stakeholders' interests in mind. This study provides a better understanding of farmer motivations and stakeholder influences on trial participation and outcomes. The findings can be used to help design trials so that they promote participation by farmers and by all animal health stakeholders in general.	[Boireau, Clemence] VetagroSup, Ecole Natl Serv Vet, Marcy Letoile, France; [Boireau, Clemence] Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lab Lyon, Unite Epidemiol, Lyon, France; [Dufour, Barbara; Praud, Anne] Paris Est Univ, Ecole Natl Vet Alfort, Epidemiol Anim Infect Dis Unit, French Agcy Food Environm & Occupat Hlth & Safety, Maisons Alfort, France	VetAgro Sup; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Lyon; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Boireau, C (corresponding author), VetagroSup, Ecole Natl Serv Vet, Marcy Letoile, France.; Boireau, C (corresponding author), Univ Lyon, French Agcy Food Environm & Occupat Hlth & Safety, Lab Lyon, Unite Epidemiol, Lyon, France.	clemence.boireau@gmail.com			French Ministry of Agriculture	French Ministry of Agriculture	This work was partly supported by the French Ministry of Agriculture (http://agriculture.gouv.fr). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11; Alarcon P, 2014, PREV VET MED, V116, P223, DOI 10.1016/j.prevetmed.2013.08.004; Alders RG, 2007, WORLD POULTRY SCI J, V63, P139, DOI 10.1017/S0043933907001365; [Anonymous], 2014, DGAUSDSPAN2014864; [Anonymous], 2013, DGAUSDSPAN20138162; Autissier D, 2013, METHODE CONDUITE CHA; Azhar M, 2010, AVIAN DIS, V54, P749, DOI 10.1637/8713-031809-Reg.1; Bardin L., 2013, LANALYSE CONTENU; Beaud S., 2003, GUIDE ENQUETE TERRAI; Becker H.S., 2002, COMMENT CONDUIRE SA; Bernoux P, 2002, RELAT IND-IND RELAT, V57, P77, DOI 10.7202/006711ar; Bernoux P, 2010, POINTS; Blanchet Alain, 2010, ENTRETIEN ENQUETE SE; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Catley A, 2001, PREV VET MED, V49, P95, DOI 10.1016/S0167-5877(01)00171-4; Catley A, 2012, VET J, V191, P151, DOI 10.1016/j.tvjl.2011.03.010; Christley RM, 2010, EQUINE VET J, V42, P285, DOI 10.1111/j.2042-3306.2010.00074.x; Coch L, 1948, HUM RELAT, V1, P512, DOI 10.1177/001872674800100408; Collingridge DS, 2008, AM J MED QUAL, V23, P389, DOI 10.1177/1062860608320646; Crozier M, 2014, POINTS; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de Olivier Sardan J-PO, 2008, RIGUEUR QUALITATIF L; Dean W. R., 2011, International Journal of Sociology of Agriculture and Food, V18, P104; Decaudin J-M, 2013, COMMUNICATION INTERN; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Domingo M, 2014, RES VET SCI, V97, pS20, DOI 10.1016/j.rvsc.2014.03.017; Dorn ML, 2005, WILDLIFE SOC B, V33, P539, DOI 10.2193/0091-7648(2005)33[539:BTIMSA]2.0.CO;2; Enticott G, 2012, T I BRIT GEOGR, V37, P75, DOI 10.1111/j.1475-5661.2011.00452.x; Ferreol G., 2011, DICT SOCIOLOGIE; Garforth C, 2015, ZOONOSES PUBLIC HLTH, V62, P29, DOI 10.1111/zph.12189; Ghiglione R, 1998, ENQUETES SOCIOLOGIQU; Given L, 2006, LIBR HI TECH, V24, P376, DOI 10.1108/07378830610692145; Goldberg, 1999, J APPL BEHAV SCI, V35, P25, DOI [DOI 10.1177/0021886399351003, 10.1177/0021886399351003]; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104383; Henning J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-726; Humblet MF, 2011, RES VET SCI, V91, P199, DOI 10.1016/j.rvsc.2010.12.004; Jones B, 2002, PARTICIP LEARN ACTIO, V45, P5; Kaufmann Jean-Claude, 2011, ENTRETIEN COMPREHENS; KOTTER JP, 1995, HARVARD BUS REV, V73, P59; Lam TJGM, 2011, NEW ZEAL VET J, V59, P8, DOI 10.1080/00480169.2011.547163; LAWRENCE PR, 1969, HARVARD BUS REV, V47, P4; LoBue PA, 2010, INT J TUBERC LUNG D, V14, P1075; Lucand C., 2015, PINARD POILUS HIST V; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mathevet P, 2005, GTV RECUEIL JOURNEES, P73; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Meskell P, 2013, VET REC, V173, DOI 10.1136/vr.101676; More SJ, 2006, VET MICROBIOL, V112, P239, DOI 10.1016/j.vetmic.2005.11.022; Mucchielli R., 2006, ANAL CONTENU DOCUMEN; Mukamurera J., 2006, RECHERCHES QUALITATI, V26, P110, DOI [10.7202/1085400ar, DOI 10.7202/1085400AR]; Nantima N, 2016, TROP ANIM HEALTH PRO, V48, P727, DOI 10.1007/s11250-016-1015-8; O'Rourke D, 2014, VET REC, V174, DOI 10.1136/vr.g2231; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Paine P, 2003, LAHARMATTAN; Palmer Mitchell V, 2011, Vet Med Int, V2011, P816345, DOI 10.4061/2011/816345; Praud A, 2016, Vet Rec, V179, P174, DOI 10.1136/vr.103803; Praud A, 2014, EPIDEMIOL INFECT, P1; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Richens IF, 2015, VET REC, V177, P465, DOI 10.1136/vr.103415; Ryan TJ, 2000, RES VET SCI, V69, P57, DOI 10.1053/rvsc.2000.0386; Sungirai M, 2016, TICKS TICK-BORNE DIS, V7, P1, DOI 10.1016/j.ttbdis.2015.07.015; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Van Campenhoudt L., 2011, MANUEL RECHERCHE SCI; van Dijk L, 2016, PARTICIPATORY POLICY	68	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185799	10.1371/journal.pone.0185799	http://dx.doi.org/10.1371/journal.pone.0185799			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FI6UJ	28973018	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900054
J	Bean, DM; Stringer, C; Beeknoo, N; Teo, J; Dobson, RJB				Bean, Daniel M.; Stringer, Clive; Beeknoo, Neeraj; Teo, James; Dobson, Richard J. B.			Network analysis of patient flow in two UK acute care hospitals identifies key subnetworks for A&E performance	PLOS ONE			English	Article								The topology of the patient flow network in a hospital is complex, comprising hundreds of overlapping patient journeys, and is a determinant of operational efficiency. To understand the network architecture of patient flow, we performed a data-driven network analysis of patient flow through two acute hospital sites of King's College Hospital NHS Foundation Trust. Administration databases were queried for all intra-hospital patient transfers in an 18-month period and modelled as a dynamic weighted directed graph. A 'core' subnetwork containing only 13-17% of all edges channelled 83-90% of the patient flow, while an 'ephemeral' network constituted the remainder. Unsupervised cluster analysis and differential network analysis identified sub-networks where traffic is most associated with A&E performance. Increased flow to clinical decision units was associated with the best A&E performance in both sites. The component analysis also detected a weekend effect on patient transfers which was not associated with performance. We have performed the first data-driven hypothesis-free analysis of patient flow which can enhance understanding of whole healthcare systems. Such analysis can drive transformation in healthcare as it has in industries such as manufacturing.	[Bean, Daniel M.; Dobson, Richard J. B.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England; [Stringer, Clive; Beeknoo, Neeraj; Teo, James] Kings Coll Hosp NHS Fdn Trust, London, England; [Dobson, Richard J. B.] UCL, Farr Inst Hlth Informat Res, UCL Inst Hlth Informat, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; University College London	Bean, DM; Dobson, RJB (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England.; Dobson, RJB (corresponding author), UCL, Farr Inst Hlth Informat Res, UCL Inst Hlth Informat, London, England.	daniel.bean@kcl.ac.uk; richard.j.dobson@kcl.ac.uk	Teo, James/D-9696-2011; Teo, James T/ABA-1819-2020; Bean, Daniel/AFQ-4601-2022; dobson, richard/C-9269-2011	Teo, James/0000-0002-6899-8319; Teo, James T/0000-0002-6899-8319; Bean, Daniel/0000-0002-8594-7804; dobson, richard/0000-0003-4224-9245	National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and Kings College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]; King's College Hospital ICT department and Electronic Health Record team	National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust and Kings College London; National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome Trust); King's College Hospital ICT department and Electronic Health Record team	This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This research was supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and by awards establishing the Farr Institute of Health Informatics Research at UCL Partners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jack Barker for his insightful comments on the analysis, and to express thanks to the King's College Hospital ICT department and Electronic Health Record team for their support in this project.	[Anonymous], 2016, MONITOR AE DELAYS WH; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Beeknoo N., 2016, BRIT J MED MED RES, V18, P1, DOI [10.9734/bjmmr/2016/29518, DOI 10.9734/BJMMR/2016/29518]; Bray BD, 2016, LANCET, V388, P170, DOI 10.1016/S0140-6736(16)30443-3; Care Quality Commission, 2015, 2015 AD INP SURV STA; Chazard Emmanuel, 2007, AMIA Annu Symp Proc, P110; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Leong KS, 2015, J ROY COLL PHYS EDIN, V45, P260, DOI 10.4997/JRCPE.2015.402; Meacock R, 2016, J HLTH SERV RES POLI; National Audit Office, 2013, EM ADM HOSP MAN DEM; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NHS Digital, 2015, 7 DAY SERV; NHS England, 2014, 5 YEAR FORW VIEW; R Core Team, 2016, R LANG ENV STAT COMP; The Health Foundation, 2013, IMPR PAT FLOW	15	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2017	12	10							e0185912	10.1371/journal.pone.0185912	http://dx.doi.org/10.1371/journal.pone.0185912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI5MY	28968472	Green Published, Green Submitted, gold			2022-12-27	WOS:000412029600063
J	Boone, DR; Leek, JM; Falduto, MT; Torres, KEO; Sell, SL; Parsley, MA; Cowart, JC; Uchida, T; Micci, MA; DeWitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah R.; Leek, Jeanna M.; Falduto, Michael T.; Torres, Karen E. O.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Effects of AAV-mediated knockdown of nNOS and GPx-1 gene expression in rat hippocampus after traumatic brain injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RNA INTERFERENCE; WORKING-MEMORY; CLINICAL-TRIALS; ISCHEMIC-INJURY; DOWN-REGULATION; NEURODEGENERATION; INHIBITION; WAKEFULNESS; CHALLENGES	Virally mediated RNA interference (RNAi) to knock down injury-induced genes could improve functional outcome after traumatic brain injury (TBI); however, little is known about the consequences of gene knockdown on downstream cell signaling pathways and how RNAi influences neurodegeneration and behavior. Here, we assessed the effects of adeno-associated virus (AAV) siRNA vectors that target two genes with opposing roles in TBI pathogenesis: the allegedly detrimental neuronal nitric oxide synthase (nNOS) and the potentially protective glutathione peroxidase 1 (GPx-1). In rat hippocampal progenitor cells, three siRNAs that target different regions of each gene (nNOS, GPx-1) effectively knocked down gene expression. However, in vivo, in our rat model of fluid percussion brain injury, the consequences of AAV-siRNA were variable. One nNOS siRNA vector significantly reduced the number of degenerating hippocampal neurons and showed a tendency to improve working memory. GPx-1 siRNA treatment did not alter TBI-induced neurodegeneration or working memory deficits. Nevertheless, microarray analysis of laser captured, virus-infected neurons showed that knockdown of nNOS or GPx-1 was specific and had broad effects on downstream genes. Since nNOS knockdown only modestly ameliorated TBI-induced working memory deficits, despite widespread genomic changes, manipulating expression levels of single genes may not be sufficient to alter functional outcome	[Boone, Deborah R.; Leek, Jeanna M.; Sell, Stacy L.; Parsley, Margaret A.; Cowart, Jeremy C.; Uchida, Tatsuo; Micci, Maria-Adelaide; DeWitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.; Torres, Karen E. O.] GenUs Biosyst, Northbrook, IL USA	University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	Department of Anesthesiology, University of Texas Medical Branch; GenUs Biosystems;  [R01 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052532] Funding Source: NIH RePORTER	Department of Anesthesiology, University of Texas Medical Branch; GenUs Biosystems; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This work was supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The funder, GenUs Biosystems provided support in the form of salaries for authors [MTF and KEOT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Supported by R01 NS052532 (HLH) and in part by the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, METHODS MOL BIOL, V623, P313, DOI 10.1007/978-1-60761-588-0_20; [Anonymous], 2004, SAS STATO 9 1 US GUI; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Barthet G, 2013, NEUROBIOL AGING, V34, P499, DOI 10.1016/j.neurobiolaging.2012.02.024; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boudreau RL, 2011, HUM MOL GENET, V20, pR21, DOI 10.1093/hmg/ddr137; Cabrera GT, 2016, METHODS MOL BIOL, V1382, P67, DOI 10.1007/978-1-4939-3271-9_5; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Cavas M, 2006, PROG NEURO-PSYCHOPH, V30, P56, DOI 10.1016/j.pnpbp.2005.06.013; Chabrier PE, 1999, CELL MOL LIFE SCI, V55, P1029, DOI 10.1007/s000180050353; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Cheng MY, 2012, P NATL ACAD SCI USA, V109, P5475, DOI 10.1073/pnas.1113363109; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Christophel TB, 2017, TRENDS COGN SCI, V21, P111, DOI 10.1016/j.tics.2016.12.007; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Davidson BL, 2004, LANCET NEUROL, V3, P145, DOI 10.1016/S1474-4422(04)00678-7; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fei F, 2014, NEUROSCIENCE, V267, P187, DOI 10.1016/j.neuroscience.2014.02.037; Geib BR, 2017, HUM BRAIN MAPP, V38, P2242, DOI 10.1002/hbm.23518; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Greco R, 2017, EUR J PHARMACOL, V16, P30075; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hallock HL, 2016, J NEUROSCI, V36, P8372, DOI 10.1523/JNEUROSCI.0991-16.2016; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hortobagyi T, 2003, NEUROSCIENCE, V121, P983, DOI 10.1016/S0306-4522(03)00482-2; Hu Q, 2011, BRAIN RES, V1367, P347, DOI 10.1016/j.brainres.2010.10.002; Joshi CR, 2017, J NEUROIMMUNE PHARM, V12, P51, DOI 10.1007/s11481-016-9724-3; Kaelin WG, 2012, SCIENCE, V337, P421, DOI 10.1126/science.1225787; Klemm V, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120119; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Landegger LD, 2017, NAT BIOTECHNOL, V35, P280, DOI 10.1038/nbt.3781; Ledford H, 2017, CRISPR STUDIES MUDDY; LeVaillant CJ, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.78; Liu M, 2012, MOL BIOL REP, V39, P593, DOI 10.1007/s11033-011-0775-5; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Lu PY, 2005, ADV GENET, V54, P117, DOI 10.1016/S0065-2660(05)54006-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mahairaki V, 2009, J NEUROSCI METH, V179, P292, DOI 10.1016/j.jneumeth.2009.02.006; Mandel RJ, 2004, CURR OPIN MOL THER, V6, P482; Masat E, 2013, DISCOV MED, V15, P379; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Miyawaki T, 2009, NAT NEUROSCI, V12, P618, DOI 10.1038/nn.2299; Munkacsy G, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.66; Munoz MF, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00059; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Park SM, 2016, NEURAL REGEN RES, V11, P1081, DOI 10.4103/1673-5374.187039; Park SY, 2016, MOL NEU ROBIOL; Paulson H., 2005, NEUROLOGY; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Scammell TE, 2017, NEURON, V93, P747, DOI 10.1016/j.neuron.2017.01.014; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sell SL, 2016, J NEUROTRAUMA; Shabestari RM, 2017, BIOMED PHARMACOTHER, V87, P274, DOI 10.1016/j.biopha.2016.12.070; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Torres-Ruiz R, 2017, BRIEF FUNCT GENOMICS, V16, P4, DOI 10.1093/bfgp/elw025; Towne C, 2011, MOL THER, V19, P274, DOI 10.1038/mt.2010.260; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.151, 10.1038/nplants.2016.151]; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Zhang Y, 2003, J GENE MED, V5, P1039, DOI 10.1002/jgm.449; Zhang Z, 2015, NEUROSCIENCE, V300, P219, DOI 10.1016/j.neuroscience.2015.05.025; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zhou L, 2010, NAT MED; Zoubovsky SP, 2011, BIOCHEM BIOPH RES CO, V408, P707, DOI 10.1016/j.bbrc.2011.04.097	78	7	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185943	10.1371/journal.pone.0185943	http://dx.doi.org/10.1371/journal.pone.0185943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016640	Green Submitted, gold, Green Published			2022-12-27	WOS:000412627400040
J	Gramsch, C; Reuter, I; Kraff, O; Quick, HH; Tanislav, C; Roessler, F; Deuschi, C; Forsting, M; Schlamann, M				Gramsch, Carolin; Reuter, Iris; Kraff, Oliver; Quick, Harald H.; Tanislav, Christian; Roessler, Florian; Deuschi, Cornelius; Forsting, Michael; Schlamann, Marc			Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; DEEP GRAY-MATTER; DORSOLATERAL NIGRAL HYPERINTENSITY; MULTIPLE SYSTEM ATROPHY; SUBSTANTIA-NIGRA; HUMAN BRAIN; IRON DEPOSITION; IN-VIVO; HEALTHY-ADULTS; TESLA MRI	Background Visualisation of nigrosome 1, a substructure of the healthy substantia nigra, was restricted in susceptibility weighted MR imaging in almost all patients with Parkinson's disease studied so far. The purpose of this study was to determine the degree of visibility of this substructure in subjects without Parkinson's disease and to examine the potential link between increasing brain iron accumulation with age and its detectability. Methods In 46 subjects ( 21 women, 25 men; 19 to 75 y; mean age: 44.5; SD: 15.6) examined with susceptibility weighted MR imaging at 7T visibility of nigrosome 1 was rated and classified. We assessed differences related to age and to signal intensities in the substantia nigra, red nucleus and putamen as correlates of the individual iron concentration. Results In 93% nigrosome 1was at least unilaterally clearly present. In 24% at least one-sided limited visibility was observed. Using predefined classification criteria the specificity of the visibility across all age groups reached approximately 94%. We found no correlation with increasing iron concentrations with age. Conclusion Aging with a related increase in iron concentration probably does not affect the visibility of nigrosome 1 at 7T SWI MRI. Our results support the role of this feature as a future differential diagnostic tool but further large-scale prospective studies are needed to better define the extent of a "limited visibility" to which an individual can be considered healthy.	[Gramsch, Carolin; Schlamann, Marc] Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany; [Gramsch, Carolin; Deuschi, Cornelius; Forsting, Michael; Schlamann, Marc] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Reuter, Iris; Tanislav, Christian; Roessler, Florian] Univ Hosp Giessen, Dept Neurol, Giessen, Germany; [Kraff, Oliver; Quick, Harald H.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Quick, Harald H.] Univ Hosp Essen, High Field & Hybrid MR Imaging, Essen, Germany	University Hospital of Giessen & Marburg; University of Duisburg Essen; University Hospital of Giessen & Marburg; University of Duisburg Essen; University of Duisburg Essen	Gramsch, C (corresponding author), Univ Hosp Giessen, Dept Neuroradiol, Giessen, Germany.; Gramsch, C (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Carolin.Gramsch@radiol.med.uni.giessen.de	Kraff, Oliver/AAE-2238-2020	Kraff, Oliver/0000-0002-6006-8934				Aquino D, 2009, RADIOLOGY, V252, P165, DOI 10.1148/radiol.2522081399; Bae YJ, 2016, MOVEMENT DISORD, V31, P684, DOI 10.1002/mds.26584; Bartzokis G, 1997, MAGN RESON IMAGING, V15, P29, DOI 10.1016/S0730-725X(96)00234-2; Bilgic B, 2012, NEUROIMAGE, V59, P2625, DOI 10.1016/j.neuroimage.2011.08.077; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Brass Steven D, 2006, Top Magn Reson Imaging, V17, P31, DOI 10.1097/01.rmr.0000245459.82782.e4; Cherubini A, 2009, NEUROIMAGE, V48, P29, DOI 10.1016/j.neuroimage.2009.06.035; Cho ZH, 2011, MOVEMENT DISORD, V26, P713, DOI 10.1002/mds.23465; Cosottini M, 2014, RADIOLOGY, V271, P831, DOI 10.1148/radiol.14131448; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Daugherty A, 2013, NEUROIMAGE, V70, P113, DOI 10.1016/j.neuroimage.2012.12.040; Daugherty AM, 2015, NEUROPSYCHOL REV, V25, P272, DOI 10.1007/s11065-015-9292-y; De Marzi R, 2016, ANN NEUROL, V79, P1026, DOI 10.1002/ana.24646; Dickson DW, 2007, BRAIN PATHOL, V17, P74, DOI 10.1111/j.1750-3639.2007.00054.x; DUGUID JR, 1986, ANN NEUROL, V20, P744, DOI 10.1002/ana.410200618; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gao P, 2015, EUR REV MED PHARMACO, V19, P4603; Gong NJ, 2015, NMR BIOMED, V28, P1267, DOI 10.1002/nbm.3366; Gramsch C, 2013, EUR RADIOL, V23, P2622, DOI 10.1007/s00330-013-2857-3; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hagemeier J, 2013, AM J NEURORADIOL, V34, P2144, DOI 10.3174/ajnr.A3569; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Iranzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089741; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; Kim JM, 2016, PARKINSONISM RELAT D, V26, P47, DOI 10.1016/j.parkreldis.2016.01.023; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lehericy S, 2014, MOVEMENT DISORD, V29, P1574, DOI 10.1002/mds.26043; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Mahlknecht P, 2017, MOV DISORD; Mahlknecht P, 2010, NEURODEGENER DIS, V7, P300, DOI 10.1159/000314495; Noh Y, 2015, AM J NEURORADIOL, V36, P2010, DOI 10.3174/ajnr.A4412; Oh SW, 2016, AM J ROENTGENOL, V207, P1089, DOI 10.2214/AJR.16.16092; Persson N, 2015, NEUROIMAGE, V122, P385, DOI 10.1016/j.neuroimage.2015.07.050; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Pirpamer L, 2016, NEUROBIOL AGING, V43, P149, DOI 10.1016/j.neurobiolaging.2016.04.002; Ramos P, 2014, J TRACE ELEM MED BIO, V28, P13, DOI 10.1016/j.jtemb.2013.08.001; Reiter E, 2015, MOVEMENT DISORD, V30, P1068, DOI 10.1002/mds.26171; Rodrigue KM, 2011, NEUROIMAGE, V54, P750, DOI 10.1016/j.neuroimage.2010.09.068; Schelhorn J, 2015, ACTA RADIOL, V56, P1501, DOI 10.1177/0284185114559958; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Seppi K, 2005, J NEUROL, V252, P91, DOI 10.1007/s00415-005-0617-2; Sung YH, 2016, RADIOLOGY, V279, P849, DOI 10.1148/radiol.2015151466; THOMAS LO, 1993, AM J NEURORADIOL, V14, P1043; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang N, 2017, EUR RADIO; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017	53	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185489	10.1371/journal.pone.0185489	http://dx.doi.org/10.1371/journal.pone.0185489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016618	Green Submitted, Green Published, gold			2022-12-27	WOS:000412627400020
J	Kubo, Y; Imaizumi, T; Ando, M; Nakatochi, M; Yasuda, Y; Honda, H; Kuwatsuka, Y; Kato, S; Kikuchi, K; Kondo, T; Iwata, M; Nakashima, T; Yasui, H; Takamatsu, H; Okajima, H; Yoshida, Y; Maruyama, S				Kubo, Yoko; Imaizumi, Takahiro; Ando, Masahiko; Nakatochi, Masahiro; Yasuda, Yoshinari; Honda, Hiroyuki; Kuwatsuka, Yachiyo; Kato, Sawako; Kikuchi, Kyoko; Kondo, Takaaki; Iwata, Masamitsu; Nakashima, Toru; Yasui, Hiroshi; Takamatsu, Hideki; Okajima, Hiroshi; Yoshida, Yasuko; Maruyama, Shoichi			Association between kidney function and genetic polymorphisms in atherosclerotic and chronic kidney diseases: A cross-sectional study in Japanese male workers	PLOS ONE			English	Article							LIFE-STYLE FACTORS; METABOLIC SYNDROME; FOLLOW-UP; RISK; POPULATION; METAANALYSIS; NEPHROPATHY; OUTCOMES; STROKE; CX3CR1	Background Several single nucleotide polymorphisms (SNPs) have been implicated in the predisposition to chronic kidney disease (CKD). Atherosclerotic disease is deeply involved in the incidence of CKD; however, whether SNPs related to arteriosclerosis are involved in CKD remains unclear. This study aimed to identify SNPs associated with CKD and to examine whether risk allele accumulation is associated with CKD. Methods We conducted a cross-sectional study using data of 4814 male workers to examine the association between estimated glomerular filtration rate (eGFR) and 59 candidate polymorphisms (17 CKD, 42 atherosclerotic diseases). We defined the genetic risk score (GRS) as the total number of risk alleles that showed a significant association in this analysis and examined the relationship with CKD (eGFR < 60 ml/min/1.73m(2)). Multivariate logistic regression, discrimination by area under the receiver operating characteristic curve, integrated discrimination improvement (IDI), and category-free net reclassification improvement (cNRI) were evaluated. Results In total, 432 participants were categorized as having CKD. We found eight candidate SNPs with P value < 0.05 (CX3CR1 rs3732379, SHROOM3 rs17319721, MTP rs1800591, PIP5K1B rs4744712, APOA5 rs662799, BRAP rs3782886, SPATA5L1 rs2467853, and MCP1 rs1024611) in the multivariate linear regression adjusted for age, body mass index, systolic blood pressure, and fasting blood glucose. Among these eight SNPs, BRAP rs3782886 and SPATA5L1 rs2467853 were significantly associated with eGFR (false discovery rate < 0.05). GRS was significantly associated with CKD (odds ratio, 1.17; 95% confidence interval, 1.09-1.26). C-statisics improved from 0.775 to 0.780 but showed no statistical significance. However, adding GRS significantly improved IDI and cNRI (0.0057, P = 0.0028, and 0.212, P < 0.001, respectively). Conclusions After adjustment for clinical factors, kidney function was associated with BRAP rs3782886 and SPATA5L1 rs2467853 and the GRS for CKD that we developed was associated CKD.	[Kubo, Yoko; Ando, Masahiko; Nakatochi, Masahiro; Kuwatsuka, Yachiyo] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Imaizumi, Takahiro; Kato, Sawako; Kikuchi, Kyoko; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Yasuda, Yoshinari] Nagoya Univ, Grad Sch Med, Dept CKD Initiat, Nagoya, Aichi, Japan; [Honda, Hiroyuki] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi, Japan; [Kondo, Takaaki] Nagoya Univ, Grad Sch Med, Program Radiol & Med Lab Sci, Nagoya, Aichi, Japan; [Iwata, Masamitsu; Nakashima, Toru; Yasui, Hiroshi] Toyota Motor Co Ltd, Safety & Hlth Promot Div, Toyota, Japan; [Takamatsu, Hideki; Okajima, Hiroshi] Toyota Motor Co Ltd, R & D Management Div, Toyota, Japan; [Yoshida, Yasuko] Nagoya Univ, Innovat Res Ctr Preventat Med Engn, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University; Toyota Motor Corporation; Toyota Motor Corporation; Nagoya University	Ando, M (corresponding author), Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.	mando@med.nagoya-u.ac.jp	Nakatochi, Masahiro/Q-1247-2015; Kato, Sawako/T-2422-2019	Nakatochi, Masahiro/0000-0002-1838-4837; Kato, Sawako/0000-0001-7210-1888	Nagoya University Institute of Innovation for Future Society; government-led Comprehensive Special Zones for Local Revitalization project,; Toyota Motor Corporation Limited	Nagoya University Institute of Innovation for Future Society; government-led Comprehensive Special Zones for Local Revitalization project,; Toyota Motor Corporation Limited	Support for this work was provided by the Center of Innovation Stream Program at the Nagoya University Institute of Innovation for Future Society, government-led Comprehensive Special Zones for Local Revitalization project, and Toyota Motor Corporation Limited. Five authors (Masamitsu Iwata, Toru Nakashima, Hiroshi Yasui, Hideki Takamatsu, and Hiroshi Okajima) have an affiliation to the commercial funders of this research study: Toyota Motor Corporation Limited. We carefully reviewed the contribution of these authors and confirmed that although the funder provided support in the form of salaries for the five authors, it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Brenner D, 2006, STROKE, V37, P1691, DOI 10.1161/01.STR.0000226565.76113.6c; Bruce MA, 2015, ADV CHRONIC KIDNEY D, V22, P46, DOI 10.1053/j.ackd.2014.06.008; Cai GJ, 2015, MOL BIOL REP, V42, P997, DOI 10.1007/s11033-014-3836-8; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Dabrowska-Zamojcin E, 2015, TRANSPL IMMUNOL, V32, P172, DOI 10.1016/j.trim.2015.04.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Rios-Gonzalez BE, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/150358; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Hashimoto Y, 2015, CLIN J AM SOC NEPHRO, V10, P578, DOI 10.2215/CJN.08980914; Hishida A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-162; Hishida A, 2012, ENDOCR J, V59, P589, DOI 10.1507/endocrj.EJ11-0310; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Imaizumi T, 2016, OBES RES CLIN PRACT; Imaizumi T, 2016, CLIN EXP NEPHROL; Iseki Kunitoshi, 2005, Clin Exp Nephrol, V9, P46, DOI 10.1007/s10157-004-0332-9; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mao S, 2014, RENAL FAILURE, V36, P139, DOI 10.3109/0886022X.2013.832690; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Nakatochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117591; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pham MHT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049498; Su N, 2015, J RECEPT SIG TRANSD, V35, P94, DOI 10.3109/10799893.2014.936458; Tanaka H, 2006, KIDNEY INT, V69, P369, DOI 10.1038/sj.ki.5000050; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Wakasugi M, 2013, HYPERTENS RES, V36, P328, DOI 10.1038/hr.2012.186; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yoshida T, 2009, CLIN J AM SOC NEPHRO, V4, P883, DOI 10.2215/CJN.04350808	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0185476	10.1371/journal.pone.0185476	http://dx.doi.org/10.1371/journal.pone.0185476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016630	Green Submitted, gold, Green Published			2022-12-27	WOS:000412627400019
J	Magistro, G; Magistro, C; Stief, CG; Schubert, S				Magistro, Giuseppe; Magistro, Christiane; Stief, Christian G.; Schubert, Soeren			The high-pathogenicity island (HPI) promotes flagellum-mediated motility in extraintestinal pathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT COLONIZATION; YERSINIA-ENTEROCOLITICA; GENE-EXPRESSION; IRON UPTAKE; TRANSCRIPTIONAL REGULATION; SIDEROPHORE PRODUCTION; EPITHELIAL-CELLS; UROTHELIAL CELLS; VIRULENCE; INFECTION	The key of success of extraintestinal pathogenic Escherichia coli (ExPEC) to colonize niches outside the intestinal tract and to establish infection is the coordinated action of numerous virulence and fitness factors. The so-called high-pathogenicity island (HPI), responsible for synthesis, secretion and uptake of the siderophore yersiniabactin, proved to be an important virulence determinant. In this study we investigated the interaction of the flagellum-mediated motility and the HPI. The impairment of yersiniabactin production by deletion of irp2 or ybtA affected significantly motility. The gain of yersiniabactin production improved motility in both pathogenic and non-pathogenic E. coli strains. The loss of flagella expression had no adverse effect on the HPI. Strikingly, external iron abundance was not able to suppress activation of the HPI during motility. The HPI activity of swarming bacteria was comparable to iron deplete conditions, and could even be maximized by supplementing excessive iron. This fact is the first description of a regulatory mechanism, which does not follow the known hierarchical regulation of siderophore systems. Transcriptional reporter fusions of the ybtA promoter demonstrated that the entire promoter region with all YbtA binding sites is necessary for complete induction in both HPI-positive and HPI-negative strains. Altogether, these results suggest that the HPI is part of a complex regulatory network, which orchestrates various virulence mechanisms to optimize the overall fitness of ExPEC.	[Magistro, Giuseppe; Stief, Christian G.] Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany; [Magistro, Christiane; Schubert, Soeren] Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich; University of Munich	Magistro, G (corresponding author), Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany.	Giuseppe.Magistro@med.uni-muenchen.de						Alteri CJ, 2007, INFECT IMMUN, V75, P2679, DOI 10.1128/IAI.00076-06; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anisimov R, 2005, FEMS MICROBIOL LETT, V250, P27, DOI 10.1016/j.femsle.2005.06.040; Anisimov R, 2005, INT J MED MICROBIOL, V295, P19, DOI 10.1016/j.ijmm.2004.11.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Feldmann F, 2007, INFECT IMMUN, V75, P3183, DOI 10.1128/IAI.00656-06; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao QQ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-143; Garcia EC, 2011, INFECT IMMUN, V79, P1225, DOI 10.1128/IAI.01222-10; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P17104, DOI 10.1021/bi9850524; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; HULTGREN SJ, 1986, INFECT IMMUN, V54, P613, DOI 10.1128/IAI.54.3.613-620.1986; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kurabayashi K, 2016, INFECT IMMUN, V84, P3220, DOI 10.1128/IAI.00369-16; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Lv HT, 2011, J PROTEOME RES, V10, P5547, DOI 10.1021/pr200756n; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; MCCARTER L, 1989, J BACTERIOL, V171, P731, DOI 10.1128/jb.171.2.731-736.1989; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Pelludat C, 2002, INFECT IMMUN, V70, P1832, DOI 10.1128/IAI.70.4.1832-1841.2002; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Sambrook J., 2001, MOL CLONING LAB MANU; Schubert S, 2004, INT J MED MICROBIOL, V294, P83, DOI 10.1016/j.ijmm.2004.06.026; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 2000, ADV EXP MED BIOL, V485, P69; Sivick KE, 2009, TRENDS MICROBIOL, V17, P431, DOI 10.1016/j.tim.2009.07.003; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Wang QF, 2004, MOL MICROBIOL, V52, P169, DOI 10.1111/j.1365-2958.2003.03977.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wieser A, 2012, INT J MED MICROBIOL, V302, P10, DOI 10.1016/j.ijmm.2011.09.012; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0183950	10.1371/journal.pone.0183950	http://dx.doi.org/10.1371/journal.pone.0183950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016611	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400005
J	Tiam, A; Gill, MM; Hoffman, HJ; Isavwa, A; Mokone, M; Foso, M; Safrit, JT; Mofenson, LM; Tylleskar, T; Guay, L				Tiam, Appolinaire; Gill, Michelle M.; Hoffman, Heather J.; Isavwa, Anthony; Mokone, Mafusi; Foso, Matokelo; Safrit, Jeffrey T.; Mofenson, Lynne M.; Tylleskar, Thorkild; Guay, Laura			Conventional early infant diagnosis in Lesotho from specimen collection to results usage to manage patients: Where are the bottlenecks?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; TRANSMISSION; MORTALITY	Introduction Early infant diagnosis is an important step in identifying children infected with HIV during the perinatal period or in utero. Multiple factors contribute to delayed antiretroviral treatment initiation for HIV-infected children, including delays in the early infant HIV diagnosis cascade. Methods We conducted a retrospective study to evaluate early infant diagnosis turnaround times in Lesotho. Trained staff reviewed records of HIV-exposed infants (aged-6-8 weeks) who received an HIV test during 2011. Study sites were drawn from Highlands, Foothills and Lowlands regions of Lesotho. Central laboratory database data were linked to facility and laboratory register information. Turnaround time geometric means (with 95% CI) were calculated and compared by region using linear mixed models. Results 1,187 individual infant records from 25 facilities were reviewed. Overall, early infant diagnosis turnaround time was 61.7 days (95% CI: 55.3-68.7). Mean time from specimen collection to district laboratory was 14 days (95% CI: 12.1-16.1); from district to central laboratory, 2 days (95% CI 0.8-5.2); results from central laboratory to district hospital, 23.3 days (95% CI: 18.7-29.0); from district hospital to health facility, 3.2 days (95% CI 1.9-5.5); and from health facility to caregiver, 10.4 days (95% CI, 7.9-13.5). Mean times from specimen transfer to the central laboratory and for result transfer from central laboratory to district hospital were significantly shorter in the Lowlands Region (0.9 and 16.2 days, respectively), compared to Highlands Region (6.0 [P = 0.030] and 34.3 days [P = 0.0099]. Turnaround time from blood draw to receipt of results was significantly shorter for HIV infected infants compared to HIV uninfected infants [p = 0.0036] at an average of 47.1 days (95% CI: 38.9-56.9) and 62 days (95% CI: 55.9-68.7) respectively. Of 47 HIV-infected infants, 36 were initiated on antiretroviral therapy at an average of 1.3 days (95% CI: 0.3, 5.7) after caregiver received the result. Conclusion HIV-infected infants received results earlier and were rapidly initiated on antiretroviral therapy once the result was delivered to caregiver. However, average early infant diagnosis turnaround time was two months; the longest period of delay was transfer of results from central laboratory to district hospital. Turnaround time of results based on geographical regions or between hospitals and health centres varied but did not reach statistical significance.	[Tiam, Appolinaire; Tylleskar, Thorkild] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Tiam, Appolinaire; Isavwa, Anthony; Mokone, Mafusi; Foso, Matokelo] Elizabeth Glaser Pediat AIDS Fdn, Med & Sci Affairs, Maseru, Lesotho; [Gill, Michelle M.; Mofenson, Lynne M.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Res, Washington, DC USA; [Hoffman, Heather J.; Guay, Laura] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Safrit, Jeffrey T.] Int AIDS Vaccine Initiat, Res Alliances, New York, NY USA	University of Bergen; George Washington University; International AIDS Vaccine Initiative	Tiam, A (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.; Tiam, A (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Med & Sci Affairs, Maseru, Lesotho.	atiam@peciaids.org	Tylleskär, Thorkild/S-5529-2017; Mofenson, Lynne/P-9631-2019; Hoffman, Heather/AAF-6429-2020	Tylleskär, Thorkild/0000-0003-4801-4324; Mofenson, Lynne/0000-0002-2818-9808; Tiam, Appolinaire/0000-0002-8045-7590	Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA; EGPAF	Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA; EGPAF	This study was funded by grant from the Pediatric AIDS Coalition Dance Marathon at University of California, Los Angeles, USA.; The authors thank the staff from twenty-five EGPAF-supported sites from Butha Buthe, Qacha's Nek, Thaba Tseka, Mokhotlong, Maseru, and Quthing districts that made the study possible. They specifically thank Makhohlisa Matela, Masuoane Mamello.	[Anonymous], 2014, DEM HLTH SURV; [Anonymous], 2016, AIDS FREE WORLD CHIL; Buzdugan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134571; du Plessis E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S10; Ekouevi DK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-519; Government of Lesotho Ministry of Health, 2013, NAT GUID PREV MOTH C; Government of Lesotho Ministry of Health, 2016, NAT GUID HIV AIDS CA; Kikuchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041998; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Mugambi ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078891; Mugasha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115171; Naiwatanakul T, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20511; Namukwaya Z, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1213-5; Pegurri E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124041; PEPFAR, LES COUNTR OP PLAN C; Sloan DJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-490; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; UNAIDS, LES GAP REP 2015; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wagner A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0325-8; Woldesenbet SA, 2015, JAIDS-J ACQ IMM DEF, V68, pe26, DOI 10.1097/QAI.0000000000000460; World Health Organization, 2013, CONGUID UANT DRU	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184769	10.1371/journal.pone.0184769	http://dx.doi.org/10.1371/journal.pone.0184769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016634	Green Published, Green Submitted, gold			2022-12-27	WOS:000412627400011
J	Yan, YW; Zou, B; Zhu, T; Hozzein, WN; Quan, ZX				Yan, Yong-Wei; Zou, Bin; Zhu, Ting; Hozzein, Wael N.; Quan, Zhe-Xue			Modified RNA-seq method for microbial community and diversity analysis using rRNA in different types of environmental samples	PLOS ONE			English	Article							COMPLETE NITRIFICATION; BACTERIAL COMMUNITIES; MOLECULAR ANALYSIS; BULK WATER; AMPLIFICATION; PHYLLOSPHERE; GENES; CYANOBACTERIA; SEQUENCES; GRADIENT	RNA-seq-based SSU (small subunit) rRNA (ribosomal RNA) analysis has provided a better understanding of potentially active microbial community within environments. However, for RNA-seq library construction, high quantities of purified RNA are typically required. We propose a modified RNA-seq method for SSU rRNA-based microbial community analysis that depends on the direct ligation of a 5' adaptor to RNA before reverse-transcription. The method requires only a low-input quantity of RNA (10-100 ng) and does not require a DNA removal step. The method was initially tested on three mock communities synthesized with enriched SSU rRNA of archaeal, bacterial and fungal isolates at different ratios, and was subsequently used for environmental samples of high or low biomass. For high-biomass salt-marsh sediments, enriched SSU rRNA and total nucleic acid-derived RNA-seq datasets revealed highly consistent community compositions for all of the SSU rRNA sequences, and as much as 46.4%-59.5% of 16S rRNA sequences were suitable for OTU (operational taxonomic unit)-based community and diversity analyses with complete coverage of V1-V2 regions. OTU-based community structures for the two datasets were also highly consistent with those determined by all of the 16S rRNA reads. For low-biomass samples, total nucleic acid-derived RNA-seq datasets were analyzed, and highly active bacterial taxa were also identified by the OTU-based method, notably including members of the previously underestimated genus Nitrospira and phylum Acidobacteria in tap water, members of the phylum Actinobacteria on a shower curtain, and members of the phylum Cyanobacteria on leaf surfaces. More than half of the bacterial 16S rRNA sequences covered the complete region of primer 8F, and non-coverage rates as high as 38.7% were obtained for phylum-unclassified sequences, providing many opportunities to identify novel bacterial taxa. This modified RNA-seq method will provide a better snapshot of diverse microbial communities, most notably by OTU-based analysis, even communities with low-biomass samples.	[Yan, Yong-Wei; Zou, Bin; Zhu, Ting; Quan, Zhe-Xue] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China; [Hozzein, Wael N.] King Saud Univ, Coll Sci, Zool Dept, Bioprod Res Chair, Riyadh, Saudi Arabia; [Hozzein, Wael N.] Beni Suef Univ, Fac Sci, Bot & Microbiol Dept, Bani Suwayf, Egypt	Fudan University; King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef University	Quan, ZX (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai, Peoples R China.	quanzx@fudan.edu.cn	Quan, Zhexue/B-8046-2013; Zhu, Ting/F-3292-2019	Quan, Zhexue/0000-0002-7561-8572; Zhu, Ting/0000-0001-6266-7511	National Natural Science Foundation of China [31170114]; Deanship of Scientific Research at King Saud University [PRG-1436-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deanship of Scientific Research at King Saud University(King Saud University)	This work was supported by the National Natural Science Foundation of China (31170114). The authors extend their sincere appreciations to the Deanship of Scientific Research at King Saud University for funding the research group no. PRG-1436-27. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078866, 10.1371/journal.pone.0067861]; [Anonymous], 2011, SICKLE SLIDING WINDO; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Botero LM, 2005, APPL ENVIRON MICROB, V71, P1267, DOI 10.1128/AEM.71.3.1267-1275.2005; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; Dastager S.G., 2014, PROKARYOTES, P455, DOI DOI 10.1007/978-3-642-30138-4_168; Dojani S, 2007, FLORA, V202, P521, DOI 10.1016/j.flora.2006.12.001; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Goodfellow M., 2014, FAMILY NOCARDIACEAE, P595; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hafner M, 2011, RNA, V17, P1697, DOI 10.1261/rna.2799511; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Henne K, 2012, APPL ENVIRON MICROB, V78, P3530, DOI 10.1128/AEM.06373-11; Holinger EP, 2014, WATER RES, V49, P225, DOI 10.1016/j.watres.2013.11.027; Kelley ST, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-202; Kelley ST, 2004, APPL ENVIRON MICROB, V70, P4187, DOI 10.1128/AEM.70.7.4187-4192.2004; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Li XR, 2014, APPL MICROBIOL BIOT, V98, P3777, DOI 10.1007/s00253-014-5583-0; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Ludemann H, 2000, APPL ENVIRON MICROB, V66, P754, DOI 10.1128/AEM.66.2.754-762.2000; Mannan MAU, 2009, ANAL BIOCHEM, V389, P77, DOI 10.1016/j.ab.2009.03.014; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Martiny AC, 2005, APPL ENVIRON MICROB, V71, P8611, DOI 10.1128/AEM.71.12.8611-8617.2005; McDonald JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157046; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pinto AJ, 2014, MBIO, V5, DOI 10.1128/mBio.01135-14; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Rigonato J, 2016, CAN J MICROBIOL, P1, DOI DOI 10.1139/CJM2016-0229; Rigonato J, 2012, FEMS MICROBIOL ECOL, V80, P312, DOI 10.1111/j.1574-6941.2012.01299.x; Rosselli R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32165; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stackebrandt E, 2014, PROKARYOTES, P397; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tomitani A, 2006, P NATL ACAD SCI USA, V103, P5442, DOI 10.1073/pnas.0600999103; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; Tveit AT, 2014, APPL ENVIRON MICROB, V80, P5761, DOI 10.1128/AEM.01030-14; Tveit AT, 2015, P NATL ACAD SCI USA, V112, pE2507, DOI 10.1073/pnas.1420797112; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van Dijk EL, 2014, EXP CELL RES, V322, P12, DOI 10.1016/j.yexcr.2014.01.008; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; Venkatachalam S, 2016, PLANT BIOLOGY, V18, P627, DOI 10.1111/plb.12441; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WELLER R, 1989, APPL ENVIRON MICROB, V55, P1818, DOI 10.1128/AEM.55.7.1818-1822.1989; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Youssef N, 2012, APPL ENVIRON MICROB, V78, P2677, DOI 10.1128/AEM.00002-12; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Youssef NH, 2015, J ADV RES, V6, P269, DOI 10.1016/j.jare.2014.10.005; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zeleke J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00243; Zhang Y, 2009, CRIT REV ENV SCI TEC, V39, P153, DOI 10.1080/10643380701631739; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026	73	8	9	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0186161	10.1371/journal.pone.0186161	http://dx.doi.org/10.1371/journal.pone.0186161			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016661	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400057
J	Yang, EH; Rode, J; Howlader, A; Eckermann, M; Santos, JT; Armada, DH; Zheng, RX; Zou, CX; Cairo, CW				Yang, Esther H.; Rode, Julia; Howlader, Amran; Eckermann, Marina; Santos, Jobette T.; Armada, Daniel Hernandez; Zheng, Ruixiang; Zou, Chunxia; Cairo, Christopher W.			Galectin-3 alters the lateral mobility and clustering of beta 1-integrin receptors	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; BREAST-CARCINOMA CELLS; HUMAN COLON-CANCER; N-GLYCANS; AFFINITY-CHROMATOGRAPHY; MASS-SPECTROMETRY; TUMOR PROGRESSION; BINDING-PROTEIN; ADHESION; SURFACE	Glycoprotein receptors are influenced by myriad intermolecular interactions at the cell surface. Specific glycan structures may interact with endogenous lectins that enforce or disrupt receptor-receptor interactions. Glycoproteins bound by multivalent lectins may form extended oligomers or lattices, altering the lateral mobility of the receptor and influencing its function through endocytosis or changes in activation. In this study, we have examined the interaction of Galectin-3 (Gal-3), a human lectin, with adhesion receptors. We measured the effect of recombinant Gal-3 added exogenously on the lateral mobility of the alpha 5 beta 1 integrin on HeLa cells. Using single-particle tracking (SPT) we detected increased lateral mobility of the integrin in the presence of Gal-3, while its truncated C-terminal domain (Gal-3C) showed only minor reductions in lateral mobility. Treatment of cells with Gal-3 increased beta 1-integrin mediated migration with no apparent changes in viability. In contrast, Gal-3C decreased both cell migration and viability. Fluorescence microscopy allowed us to confirm that exogenous Gal-3 resulted in reorganization of the integrin into larger clusters. We used a proteomics analysis to confirm that cells expressed endogenous Gal-3, and found that addition of competitive oligosaccharide ligands for the lectin altered the lateral mobility of the integrin. Together, our results are consistent with a Gal-3-integrin lattice model of binding and confirm that the lateral mobility of integrins is natively regulated, in part, by galectins.	[Yang, Esther H.; Rode, Julia; Howlader, Amran; Eckermann, Marina; Santos, Jobette T.; Armada, Daniel Hernandez; Zheng, Ruixiang; Zou, Chunxia; Cairo, Christopher W.] Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada; [Rode, Julia] Orebro Univ, Orebro, Sweden; [Eckermann, Marina] Ludwig Maximilians Univ Munchen, Munich, Germany; [Santos, Jobette T.] Univ Toronto, Toronto, ON, Canada	University of Alberta; Orebro University; University of Munich; University of Toronto	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Alberta Glyc Ctr, Edmonton, AB, Canada.	ccairo@ualberta.ca	Rode, Julia/GPF-4088-2022; Cairo, Christopher W/B-5355-2009	Rode, Julia/0000-0001-9402-4756; Cairo, Christopher W/0000-0003-3363-8708	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC CGS-D scholarship; University of Alberta Research Experience (UARE) program	Alberta Glycomics Centre; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-D scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta Research Experience (UARE) program	This work was supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada (NSERC). MAH acknowledges support from an NSERC CGS-D scholarship. JR and ME were supported by the University of Alberta Research Experience (UARE) program.; The authors would like to thank Caishun Li (UofA) for helpful discussions. This work was supported by the Alberta Glycomics Centre and the Natural Sciences and Engineering Research Council of Canada (NSERC). MAH acknowledges support from an NSERC CGS-D scholarship. JR and ME were supported by the University of Alberta Research Experience (UARE) program.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Armada DH, 2015, CARBOHYD RES, V417, P109, DOI 10.1016/j.carres.2015.09.005; Bachhawat-Sikder K, 2001, FEBS LETT, V500, P75, DOI 10.1016/S0014-5793(01)02586-8; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s; Berbis MA, 2014, BIOCHEM BIOPH RES CO, V443, P126, DOI 10.1016/j.bbrc.2013.11.063; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Cairo CW, 2008, BIOPOLYMERS, V89, P409, DOI 10.1002/bip.20898; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chiasson-MacKenzie C, 2015, J CELL BIOL, V211, P391, DOI 10.1083/jcb.201503081; Das R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000556; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Fukumori T, 2003, CANCER RES, V63, P8302; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Gao X, 2014, GALECTIN 3 INDUCES C; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Han L, 2016, ANAL CHEM; Hernandez JD, 2002, GLYCOBIOLOGY, V12, p127R, DOI 10.1093/glycob/cwf081; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HO MK, 1982, J IMMUNOL, V128, P1221; Hughes RC, 2001, BIOCHIMIE, V83, P667; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jia F, 2016, BBA-MOL CELL BIOL L, V1861, P1170, DOI 10.1016/j.bbalip.2016.06.013; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; KUBOTA K, 2009, 2 DIM EL PROT, V519, P483, DOI DOI 10.1007/978-1-59745-281-6_32; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; MacKinnon AC, 2013, GLYCOBIOLOGY; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Mirandola L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021811; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Priglinger CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070011; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Rotshenker S, 2009, J MOL NEUROSCI, V39, P99, DOI 10.1007/s12031-009-9186-7; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saraboji K, 2012, BIOCHEMISTRY-US, V51, P296, DOI 10.1021/bi201459p; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; Shams-Ud-Doha K, 2017, ANAL CHEM, V89, P4914, DOI 10.1021/acs.analchem.6b05169; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shirure VS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044529; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Suzuki O, 2006, INT J ONCOL, V28, P155; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Vyakarnam A, 1998, EXP CELL RES, V242, P419, DOI 10.1006/excr.1998.4111; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	89	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2017	12	10							e0184378	10.1371/journal.pone.0184378	http://dx.doi.org/10.1371/journal.pone.0184378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3JE	29016609	Green Published, gold, Green Submitted			2022-12-27	WOS:000412627400008
J	Huillet, E; Bridoux, L; Wanapaisan, P; Rejasse, A; Peng, Q; Panbangred, W; Lereclus, D				Huillet, Eugenie; Bridoux, Ludovic; Wanapaisan, Pagakrong; Rejasse, Agnes; Peng, Qi; Panbangred, Watanalai; Lereclus, Didier			The CodY-dependent clhAB2 operon is involved in cell shape, chaining and autolysis in Bacillus cereus ATCC 14579	PLOS ONE			English	Article							PEPTIDOGLYCAN HYDROLASES; STATIONARY-PHASE; GLOBAL REGULATOR; ANTHRACIS; SUBTILIS; VIRULENCE; DEATH; EXPRESSION; PROTEIN; CIDR	The Gram-positive pathogen Bacillus cereus is able to grow in chains of rod-shaped cells, but the regulation of chaining remains largely unknown. Here, we observe that glucose-grown cells of B. cereus ATCC 14579 form longer chains than those grown in the absence of glucose during the late exponential and transition growth phases, and identify that the clhAB(2) operon is required for this chain lengthening phenotype. The clhAB(2) operon is specific to the B. cereus group (i.e., B. thuringiensis, B. anthracis and B. cereus) and encodes two membrane proteins of unknown function, which are homologous to the Staphylococcus aureus CidA and CidB proteins involved in cell death control within glucose-grown cells. A deletion mutant (Delta clhAB(2)) was constructed and our quantitative image analyses show that Delta clhAB(2) cells formed abnormal short chains regardless of the presence of glucose. We also found that glucose-grown cells of Delta clhAB(2) were significantly wider than wild-type cells (1.47 mu m +/- CI95% 0.04 vs 1.19 mu m +/- CI95% 0.03, respectively), suggesting an alteration of the bacterial cell wall. Remarkably, Delta clhAB(2) cells showed accelerated autolysis under autolysis- inducing conditions, compared to wild-type cells. Overall, our data suggest that the B. cereus clhAB2 operon modulates peptidoglycan hydrolase activity, which is required for proper cell shape and chain length during cell growth, and down-regulates autolysin activity. Lastly, we studied the transcription of clhAB(2) using a lacZ transcriptional reporter in wildtype, ccpA and codY deletion-mutant strains. We found that the global transcriptional regulatory protein CodY is required for the basal level of clhAB(2) expression under all conditions tested, including the transition growth phase while CcpA, the major global carbon regulator, is needed for the high-level expression of clhAB(2) in glucose-grown cells.	[Huillet, Eugenie; Bridoux, Ludovic; Wanapaisan, Pagakrong; Rejasse, Agnes; Peng, Qi; Lereclus, Didier] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [Wanapaisan, Pagakrong; Panbangred, Watanalai] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Wanapaisan, Pagakrong] Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok, Thailand; [Peng, Qi] CAAS, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Mahidol University; Mahidol University; Chinese Academy of Agricultural Sciences	Huillet, E (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France.	eugenie.huillet@inra.fr	Lereclus, Didier/AAD-8293-2019	Wanapaisan, Pagakrong/0000-0002-7682-5936; Lereclus, Didier/0000-0001-9047-9104	Thailand Research Fund	Thailand Research Fund(Thailand Research Fund (TRF))	Pagakrong Wanapaisan was a recipient of the Royal Golden Jubilee program of the Thailand Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Olivier David member of the MIAJ unit (INRA, Jouy-en-Josas) for statistical Anova and Binomial analyses and for many helpful discussions and suggestions. We thank the MIMA2 imaging facility (INRA, Jouy-en-Josas) (ntip://www6.jouy.in.inra.fr.mima2) for the MET images and thank Alexis Canette for excellent technical support. Pagakrong Wanapaisan was a recipient of the Royal Golden Jubilee program of the Thailand Research Fund. We warmly thank Arnaud Chastanet, Marie-Pierre Chapot-Chartier, Romain Briandet, Alexandra Gruss, Isabelle Poquet and Christina Nielsen-Leroux for fruitful discussions. We thank Lindsay Higgins for English correction.	Ababneh QO, 2015, J BACTERIOL, V197, P128, DOI 10.1128/JB.02063-14; Ahn JS, 2006, MOL MICROBIOL, V62, P1158, DOI 10.1111/j.1365-2958.2006.05433.x; Anderson VJ, 2011, MOL MICROBIOL, V81, P192, DOI 10.1111/j.1365-2958.2011.07688.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Chandramohan L, 2009, J BACTERIOL, V191, P4103, DOI 10.1128/JB.00314-09; Chateau A, 2013, J BACTERIOL, V195, P1204, DOI 10.1128/JB.02041-12; Chateau A, 2011, FASEB J, V25, P4445, DOI 10.1096/fj.11-188912; Chaudhari SS, 2016, MOL MICROBIOL, V101, P942, DOI 10.1111/mmi.13433; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dubois T, 2013, MOL MICROBIOL, V88, P48, DOI 10.1111/mmi.12168; Frenzel E, 2012, MOL MICROBIOL, V85, P67, DOI 10.1111/j.1365-2958.2012.08090.x; Frirdich E, 2013, CURR OPIN MICROBIOL, V16, P767, DOI 10.1016/j.mib.2013.09.005; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Hall BG, 2014, MOL BIOL EVOL, V31, P232, DOI 10.1093/molbev/mst187; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Huillet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051047; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Lindback T, 2012, ENVIRON MICROBIOL, V14, P2233, DOI 10.1111/j.1462-2920.2012.02766.x; Ludwig H, 2002, J BACTERIOL, V184, P5174, DOI 10.1128/JB.184.18.5174-5178.2002; Majed R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01054; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Raddadi N, 2005, J APPL MICROBIOL, V99, P1070, DOI 10.1111/j.1365-2672.2005.02713.x; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Richardson AR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0004-2014; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; Nguyen-Mau SM, 2012, J BACTERIOL, V194, P3841, DOI 10.1128/JB.00384-12; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Shivers RP, 2005, MOL MICROBIOL, V56, P1549, DOI 10.1111/j.1365-2958.2005.04634.x; Shivers RP, 2004, MOL MICROBIOL, V53, P599, DOI 10.1111/j.1365-2958.2004.04135.x; Slamti L, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01501; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Sonenshein AL, 2005, CURR OPIN MICROBIOL, V8, P203, DOI 10.1016/j.mib.2005.01.001; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Thomas VC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004205; Uehara T, 2011, CURR OPIN MICROBIOL, V14, P698, DOI 10.1016/j.mib.2011.10.003; van den Esker MH, 2017, ENVIRON MICROBIOL, V19, P83, DOI 10.1111/1462-2920.13454; van der Voort M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-62; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Verplaetse E, 2015, MBIO, V6, DOI 10.1128/mBio.00138-15; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05; Vilas-Boas GT, 2007, CAN J MICROBIOL, V53, P673, DOI 10.1139/W07-029; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Yang SJ, 2006, MOL MICROBIOL, V60, P458, DOI 10.1111/j.1365-2958.2006.05105.x	53	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0184975	10.1371/journal.pone.0184975	http://dx.doi.org/10.1371/journal.pone.0184975			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991912	Green Published, Green Submitted, gold			2022-12-27	WOS:000412601800011
J	Pernica, JM; Steenhoff, AP; Mokomane, M; Moorad, B; Lechiile, K; Smieja, M; Mazhani, L; Cheng, J; Kelly, MS; Loeb, M; Stordal, K; Goldfarb, DM				Pernica, Jeffrey M.; Steenhoff, Andrew P.; Mokomane, Margaret; Moorad, Banno; Lechiile, Kwana; Smieja, Marek; Mazhani, Loeto; Cheng, Ji; Kelly, Matthew S.; Loeb, Mark; Stordal, Ketil; Goldfarb, David M.			Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial	PLOS ONE			English	Article							DSM 17938; CHILDREN; GROWTH; NUTRITION; GASTROENTERITIS; INFLAMMATION; INFECTIONS; MANAGEMENT; HEALTH	Introduction Diarrhoeal disease is the second-leading cause of death in young children. Current guidelines recommend treating children with acute non-bloody diarrhea with oral rehydration solutions and zinc, but not antimicrobials. However, in many resource-limited settings, infections with treatable enteric bacterial and protozoan pathogens are common. Probiotics have shown promise as an adjunct treatment for diarrhoea but have not been studied in sub-Saharan Africa. Methods We conducted a pilot, factorial, randomized, placebo-controlled trial of children aged 2-60 months hospitalized in Botswana for acute non-bloody diarrhoea. A rapid test-and-treat intervention, consisting of multiplex PCR testing of rectal swabs taken at enrolment, accompanied by targeted antimicrobial therapy if treatable pathogens were detected, was compared to the reference standard of no stool testing. Additionally, Lactobacillus reuteri DSM 17938 x 60 days was compared to placebo treatment. The main objective of this pilot study was to assess feasibility. The primary clinical outcome was the increase in age-standardized height (HAZ) at 60 days adjusted for baseline HAZ. Results Seventy-six patients were enrolled over a seven-month study period. We judged that the recruitment rate, lab processing times, communication protocols, provision of specific antimicrobials, and follow-up rates were acceptable. Compared to the reference arm (no stool testing and placebo treatment), the combination of the rapid test-and-treat strategy plus L. reuteri DSM 17938 was associated with an increase of 0.61 HAZ (95% CI 0.09-1.13) and 93% lower odds of recurrent diarrhoea (OR 0.07, 95% CI 0.01-0.61) at 60 days. Discussion We demonstrated that it was feasible to evaluate the study interventions in Botswana. Despite the small sample size, we observed a statistically significant increase in HAZ at 60 days and significantly lower odds of recurrent diarrhoea in children receiving both rapid test-and-treat and L. reuteri. There is sufficient evidence to warrant proceeding with a larger follow-up trial in a similar setting.	[Pernica, Jeffrey M.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Ctr Global Hlth, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.; Moorad, Banno; Lechiile, Kwana] Botswana UPenn Partnership, Gaborone, Botswana; [Mokomane, Margaret] Natl Hlth Lab, Botswana Minist Hlth, Gaborone, Botswana; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mazhani, Loeto] Univ Botswana, Dept Paediat & Adolescent Hlth, Gaborone, Botswana; [Cheng, Ji] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Kelly, Matthew S.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Stordal, Ketil] Norwegian Inst Publ Hlth, Oslo, Norway; [Goldfarb, David M.] Univ British Columbia, Dept Lab Med, Vancouver, BC, Canada	McMaster University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; University of Botswana; McMaster University; Duke University; Norwegian Institute of Public Health (NIPH); University of British Columbia	Pernica, JM (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	pernica@mcmaster.ca	Pernica, Jeffrey/AAU-6379-2021; Goldfarb, David/ABD-4623-2021	Pernica, Jeffrey/0000-0002-4380-5402; Goldfarb, David/0000-0003-0835-9504	Stars in Global Health program of Grand Challenges Canada - Government of Canada [S4-0192]; Penn Center for AIDS Research (CFAR); Hamilton Health Sciences Foundation; Hamilton Health Sciences	Stars in Global Health program of Grand Challenges Canada - Government of Canada; Penn Center for AIDS Research (CFAR); Hamilton Health Sciences Foundation; Hamilton Health Sciences	This study (S4-0192) was funded by the Stars in Global Health program of Grand Challenges Canada (htlp://www.grandchallenges.ca), funded by the Government of Canada. The study would not have been possible without support from the Penn Center for AIDS Research (CFAR). Dr. Pernica is also supported by a Hamilton Health Sciences Foundation Early Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Copan Italia S.A. provided flocked swabs and transport medium. BioGaia provided L. reuteri probiotic and placebo in matching bottles. This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR). Dr. Pernica is supported by a Hamilton Health Sciences Early Career Award. We thank Jocalyn Clark for her comments on an earlier draft of this manuscript.	Agustina R, 2013, J NUTR, V143, P1184, DOI 10.3945/jn.112.166397; Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Applegate JA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S16; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; (CATMAT) CtAoTMaT, 2015, STAT TRAV DIARRH; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Fischer Walker Christa L, 2012, PLoS One, V7, pe47908, DOI 10.1371/journal.pone.0047908; Freedman SB, 2015, CLIN PEDIATR, V54, P1158, DOI 10.1177/0009922815569200; Freedman SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128754; Freedman SB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-170; Freedman Stephen B, 2013, Evid Based Child Health, V8, P1123, DOI 10.1002/ebch.1932; Goldfarb DM, 2014, J CLIN MICROBIOL; Gough EK, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2267; Guerrant RL, 2012, CLIN INFECT DIS, V54, P1674, DOI 10.1093/cid/cis241; Gutierrez-Castrellon P, 2014, PEDIATRICS, V133, pE904, DOI 10.1542/peds.2013-0652; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones SE, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-35; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; MATA LJ, 1972, AM J CLIN NUTR, V25, P1267; Mokomane M, 2016, DIAGN MICR INFEC DIS, V86, P141, DOI 10.1016/j.diagmicrobio.2016.07.007; Oria RB, 2016, NUTR REV, V74, P374, DOI 10.1093/nutrit/nuw008; Pavlinac PB, 2015, J PEDIAT INFECT DIS; Pernica JM, 2016, J PEDIAT INF DIS SOC, V5, P312, DOI 10.1093/jpids/piv028; Pernica JM, 2015, J PEDIAT INFECT DIS; Platts-Mills JA, 2014, AM J TROP MED HYG, V90, P133, DOI 10.4269/ajtmh.13-0439; Roos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056710; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Salam RA, 2015, J NUTR, V145, p1116S, DOI 10.3945/jn.114.194720; Schnadower D, 2015, CURR OPIN GASTROEN, V31, P1, DOI 10.1097/MOG.0000000000000132; Scrimshaw NS, 2003, J NUTR, V133, p316S, DOI 10.1093/jn/133.1.316S; Taniuchi M, 2013, J INFECT DIS, V208, P1794, DOI 10.1093/infdis/jit507; Traa BS, 2010, INT J EPIDEMIOL, V39, P70, DOI 10.1093/ije/dyq024; Urbanska M, 2016, ALIMENT PHARM THER, V43, P1025, DOI 10.1111/apt.13590; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2005, TREATM DIARRH MAN PH	38	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185177	10.1371/journal.pone.0185177	http://dx.doi.org/10.1371/journal.pone.0185177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FJ3AF	28991918	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000412601800012
J	Blagoev, KB; Wilkerson, J; Burotto, M; Kim, C; Espinal-Dominguez, E; Garcia-Alfonso, P; Alimchandani, M; Miettinen, M; Blanco-Codesido, M; Fojo, T				Blagoev, Krastan B.; Wilkerson, Julia; Burotto, Mauricio; Kim, Chul; Espinal-Dominguez, Edward; Garcia-Alfonso, Pilar; Alimchandani, Meghna; Miettinen, Markku; Blanco-Codesido, Montserrat; Fojo, Tito			Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; WILD-TYPE KRAS; ACQUIRED-RESISTANCE; CLINICAL RESISTANCE; POTENTIAL MECHANISM; RAS MUTATIONS; LUNG-CANCER; CETUXIMAB; SURVIVAL; CHEMOTHERAPY	Emergence of tumor resistance to an anti-cancer therapy directed against a putative target raises several questions including: (1) do mutations in the target/pathway confer resistance? (2) Are these mutations pre-existing? (3) What is the relative fitness of cells with/without the mutation? We addressed these questions in patients with metastatic colorectal cancer (mCRC). We conducted an exhaustive review of published data to establish a median doubling time for CRCs and stained a cohort of CRCs to document mitotic indices. We analyzed published data and our own data to calculate rates of growth (g) and regression (d, decay) of tumors in patients with CRC correlating these results with the detection of circulating MT-KRAS DNA. Additionally we estimated mathematically the caloric burden of such tumors using data on mitotic and apoptotic indices. We conclude outgrowth of cells harboring intrinsic or acquired MT-KRAS cannot explain resistance to anti-EGFR (epidermal growth factor receptor) antibodies. Rates of tumor growth with panitumumab are unaffected by presence/absence of MT-KRAS. While MT-KRAS cells may be resistant to anti-EGFR antibodies, WT-KRAS cells also rapidly bypass this blockade suggesting inherent resistance mechanisms are responsible and a neutral evolution model is most appropriate. Using the above clinical data on tumor doubling times and mitotic and apoptotic indices we estimated the caloric intake required to support tumor growth and suggest it may explain in part cancer-associated cachexia.	[Blagoev, Krastan B.] Natl Sci Fdn, Phys Living Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA; [Blagoev, Krastan B.] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA; [Wilkerson, Julia] NCI, Med Oncol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Burotto, Mauricio] Clin Alemana Santiago, Dept Oncol, Santiago, Chile; [Espinal-Dominguez, Edward; Garcia-Alfonso, Pilar; Blanco-Codesido, Montserrat] Gregorio Maranon Univ Hosp, Dept Oncol Med, Madrid, Spain; [Alimchandani, Meghna] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Miettinen, Markku] NCI, Lab Pathol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fojo, Tito] Columbia Univ, New York & James J Peters VA Med Ctr, Dept Med, Div Hematol & Oncol, Bronx, NY USA	National Science Foundation (NSF); Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clinica Alemana; General University Gregorio Maranon Hospital; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Columbia University	Blagoev, KB (corresponding author), Natl Sci Fdn, Phys Living Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.; Blagoev, KB (corresponding author), Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21218 USA.	krastanb@gmail.com			National Science Foundation; National Cancer Institute; National Institutes of Health; Gregorio Maranon University Hospital	National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gregorio Maranon University Hospital	The National Science Foundation supported the work of K. B. Blagoev. Mauricio Burotto, Julia Wilkerson, Chul Kim, Meghna Alimchandani, Markku Miettinen, and Tito Fojo all were supported by the intramural programs of the National Cancer Institute and the National Institutes of Health. Edward Espinal-Dominguez, Pilar Garcia-Alfonso and Montserrat Blanco-Codesido received support from Gregorio Maranon University Hospital.; K. B. Blagoev would like to thank Herbert Levine for valuable discussions. The National Science Foundation supported the work of K. B. Blagoev. Mauricio Burotto, Julia Wilkerson, Chul Kim, Meghna Alimchandani, Markku Miettinen, and Tito Fojo all were supported by the intramural programs of the National Cancer Institute and the National Institutes of Health. Edward Espinal-Dominguez, Pilar Garcia-Alfonso and Montserrat Blanco-Codesido received support from Gregorio Maranon University Hospital. The National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here are not those of the National Science Foundation and represent solely the views of the authors.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; [Anonymous], 2014, ATLAS CLIN NUCL MED; [Anonymous], 2014, MOL BIOL CELL; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Bosaeus I, 2002, J NUTR, V132, p3465S, DOI 10.1093/jn/132.11.3465S; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Cao DX, 2010, CLIN NUTR, V29, P72, DOI 10.1016/j.clnu.2009.07.001; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; EVANS WK, 1985, CANCER RES, V45, P3347; FALCONER JS, 1994, ANN SURG, V219, P325, DOI 10.1097/00000658-199404000-00001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FREDRIX EWHM, 1991, CANCER, V68, P1616, DOI 10.1002/1097-0142(19911001)68:7<1616::AID-CNCR2820680725>3.0.CO;2-3; Fredrix EWHM, 1997, CANCER, V79, P717, DOI 10.1002/(SICI)1097-0142(19970215)79:4<717::AID-CNCR8>3.0.CO;2-A; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Ignac Fogelman, 2014, ATLAS CLIN NUCL MED; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lieffers JR, 2009, AM J CLIN NUTR, V89, P1173, DOI 10.3945/ajcn.2008.27273; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Liu J, 2016, ADV CANCER RES, V130, P1, DOI 10.1016/bs.acr.2016.01.005; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Sinicrope FA, 1999, CLIN CANCER RES, V5, P1793; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Stein WD, 2008, ONCOLOGIST, V13, P1046, DOI 10.1634/theoncologist.2008-0075; Stein WD, 2008, ONCOLOGIST, V13, P1055, DOI 10.1634/theoncologist.2008-0016; Stein WD, 2012, CLIN CANCER RES, V18, P2374, DOI 10.1158/1078-0432.CCR-11-2275; Stein WD, 2011, CLIN CANCER RES, V17, P907, DOI 10.1158/1078-0432.CCR-10-1762; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Valverde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131363; VANDENBREKEL AJS, 1995, J CLIN ONCOL, V13, P2600, DOI 10.1200/JCO.1995.13.10.2600; von Bubnoff N, 2002, LANCET, V359, P487, DOI 10.1016/S0140-6736(02)07679-1; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0175484	10.1371/journal.pone.0175484	http://dx.doi.org/10.1371/journal.pone.0175484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981524	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300001
J	Gluge, J; Steinlin, C; Schalles, S; Wegmann, L; Tremp, J; Breivik, K; Hungerbuhler, K; Bogdal, C				Gluge, Juliane; Steinlin, Christine; Schalles, Simone; Wegmann, Lukas; Tremp, Josef; Breivik, Knut; Hungerbuhler, Konrad; Bogdal, Christian			Import, use, and emissions of PCBs in Switzerland from 1930 to 2100	PLOS ONE			English	Article							POLYCHLORINATED-BIPHENYLS PCBS; TOXIC EQUIVALENCY FACTORS; JOINT SEALANTS; MODEL; INVENTORY; AIR; UNCERTAINTY; PROPAGATION; VARIABILITY; ENVIRONMENT	Polychlorinated biphenyls (PCBs) are persistent organic compounds that are ubiquitously found in the environment. Their use and manufacture were restricted or banned in many countries in the 1970-1980s, however, they still persist in the antroposphere, the environment and in biota worldwide today. Conventions like the Convention on Long-range Transboundary Air Pollution encourage or bind the member parties to annually submit emission inventories of regulated air pollutants. Unfortunately, several member states have not yet reported PCB emissions. The identification and quantification of stocks and emissions sources is, however, an important precondition to handle and remove the remaining reservoirs of PCBs and, thus, to be able to reduce emissions and subsequently environmental exposure. Here, we estimate past, present, and future emissions of PCBs to air in Switzerland and provide emission factors for all relevant emission categories. Switzerland hereby represents a typical developed industrial country, and most of the assumptions and parameters presented here can be used to calculate PCB emission also for other countries. PCB emissions to air are calculated using a dynamic mass flow and emissions model for Switzerland, which is run for the years 1930-2100. The results point out the importance of the use of PCBs in open applications, which have largely been previously overlooked. Additionally, we show that PCBs will persist in applications during the coming decades with ongoing emissions. Especially the use of PCBs in open applications will cause Swiss emissions to remain above 100 kg PCB per year, even after the year 2030. Our developed model is available in Excel/VBA and can be downloaded with this article.	[Gluge, Juliane; Steinlin, Christine; Schalles, Simone; Hungerbuhler, Konrad; Bogdal, Christian] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland; [Wegmann, Lukas] Off Environm Protect & Energy Canton Basel Countr, Liestal, Switzerland; [Tremp, Josef] Fed Off Environm, Ind Chem Sect, Bern, Switzerland; [Breivik, Knut] NILU Norwegian Inst Air Res, Kjeller, Norway; [Breivik, Knut] Univ Oslo, Dept Chem, Oslo, Norway; [Steinlin, Christine] EBP Schweiz AG, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Norwegian Institute for Air Research; University of Oslo	Gluge, J; Bogdal, C (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Chem & Bioengn, Zurich, Switzerland.	juliane.gluege@chem.ethz.ch; christian.bogdal@chem.ethz.ch	Breivik, Knut/D-2311-2011	Breivik, Knut/0000-0003-1112-1900	Research Council of Norway [244298]; Carbotech AG;  [00.0009.PZ / P121-2329]	Research Council of Norway(Research Council of Norway); Carbotech AG; 	The BAFU is acknowledged for the project funding (Grant 00.0009.PZ / P121-2329). KB was supported by the Research Council of Norway (244298).; We thank Sabine Schenker, Andre Hauser, Andreas M. Buser, Christiane Wermeille (BAFU), Roland Weber (POPs Environmental Consulting), and Carbotech AG for supporting this work with helpful comments. We also thank Justin M. Boucher (ETH Zurich) for proof-reading the manuscript, Markus Zennegg (Empa Dubendorf) for providing the sewage sludge data, and Pascal S. Diefenbacher (previously ETH Zurich, currently Arcadis Switzerland) for the initial support of this project.	Abbasi G, 2015, ENVIRON SCI TECHNOL, V49, P1521, DOI 10.1021/es504007v; [Anonymous], 1988, SCHRIFT UMW; Arnet R, 2011, KONDENSATOREN VERZEI; Barghoorn M, 1988, ABSCHLUSSBERICHT FOR; Bogdal C, 2017, ENVIRON POLLUT, V220, P891, DOI 10.1016/j.envpol.2016.10.073; Bogdal C, 2014, ENVIRON SCI TECHNOL, V48, P482, DOI 10.1021/es4044352; Bogdal C, 2010, ENVIRON SCI TECHNOL, V44, P4063, DOI 10.1021/es903007h; Breivik K, 2002, SCI TOTAL ENVIRON, V290, P199, DOI 10.1016/S0048-9697(01)01076-2; BREIVIK K, 2002, EMISSIONS SCI TOTAL, V290, P296, DOI DOI 10.1016/S0048-9697(01)01075-0; Breivik K, 2007, SCI TOTAL ENVIRON, V377, P296, DOI 10.1016/j.scitotenv.2007.02.026; BUWAL, 1994, DIFF QUELL PCB SCHWE; BUWAL, 1984, SCHRIFT UMW; BUWAL, 2003, RICHTL PCB HALT FUG; BUWAL, 2000, PRAX PCB EM BEIM KOR; Cui S, 2015, SCI TOTAL ENVIRON, V533, P247, DOI 10.1016/j.scitotenv.2015.06.144; Davis J, 2007, RESOUR CONSERV RECY, V51, P118, DOI 10.1016/j.resconrec.2006.08.007; de Voogt P., 1989, PRODUCTION PROPERTIE; Diefenbacher PS, 2016, ENVIRON SCI TECHNOL, V50, P232, DOI 10.1021/acs.est.5b04626; Diefenbacher PS, 2015, ENVIRON SCI TECHNOL, V49, P2199, DOI 10.1021/es505242d; EEA, 2016, EMEP EEA AIR POLL EM, P19; Erickson MD, 2011, ENVIRON SCI POLLUT R, V18, P135, DOI 10.1007/s11356-010-0392-1; Flisak M, 2005, J ENV SCI HEAL A, V40, P43; FOEN, 2016, PAINTS VARN; FOEN, 2015, SWITZ INF INV REP 20; Frame GM, 1996, HRC-J HIGH RES CHROM, V19, P657; Gluge J, 2016, SCI TOTAL ENVIRON, V550, P1152, DOI 10.1016/j.scitotenv.2016.01.097; Grontmij, 2013, SURV PCB MAT IND AIR; Halse AK, 2011, ATMOS CHEM PHYS, V11, P1549, DOI 10.5194/acp-11-1549-2011; HARRAD SJ, 1994, ENVIRON POLLUT, V85, P131, DOI 10.1016/0269-7491(94)90079-5; Hauser A., 2014, THESENPAPIER ENTSORG; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Hu DF, 2010, ENVIRON SCI TECHNOL, V44, P2822, DOI 10.1021/es902413k; Ifeu, 1998, 98115 UBAFB IFEU; Jepson PD, 2016, SCIENCE, V352, P1388, DOI 10.1126/science.aaf9075; Jepson PD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18573; Kohler M, 2005, ENVIRON SCI TECHNOL, V39, P1967, DOI 10.1021/es048632z; Kuhn E, 1998, PCB VORSCHALTGERATEN; Li YF, 2010, ENVIRON SCI TECHNOL, V44, P2784, DOI 10.1021/es901871e; LRTAP, 1979, CONV LONG RANG TRANS; Mackay D., 2006, HDB PHYS PROP ENV FA; Macleod M, 2005, ENVIRON SCI TECHNOL, V39, P6749, DOI 10.1021/es048426r; MacLeod M, 2002, ENVIRON TOXICOL CHEM, V21, P700, DOI 10.1002/etc.5620210403; SRF, 2013, LETZT COR; Steinlin C, 2015, ENVIRON SCI TECHNOL, V49, P14092, DOI 10.1021/acs.est.5b03304; Steinlin C, 2014, ENVIRON SCI TECHNOL, V48, P7849, DOI 10.1021/es501793h; Takasuga T., 1996, ORGANOHALOGEN COMPOU, V27, P391; Tremp J, 2001, ARBEITSEXEMPLAR SCHR; Ubl S, 2012, ATMOS ENVIRON, V62, P391, DOI 10.1016/j.atmosenv.2012.07.061; UNECE, 2009, 1998 PROT PERS ORG P; UNECE, 2009, ECEEBAIR97 UNECE; UNECE, 2015, REP EM PROJ DAT CONV; UNECE, 1998, PROT 1979 CONV LONG; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Wermeille C., 2016, COMMUNICATION, V2016; Wohrnschimmel H, 2016, ENVIRON POLLUT, V217, P149, DOI 10.1016/j.envpol.2016.01.090	56	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0183768	10.1371/journal.pone.0183768	http://dx.doi.org/10.1371/journal.pone.0183768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981534	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300004
J	Oueslati, A; Salhi-Hannachi, A; Luro, F; Vignes, H; Mournet, P; Ollitrault, P				Oueslati, Amel; Salhi-Hannachi, Amel; Luro, Francois; Vignes, Helene; Mournet, Pierre; Ollitrault, Patrick			Genotyping by sequencing reveals the interspecific C. maxima / C. reticulata admixture along the genomes of modern citrus varieties of mandarins, tangors, tangelos, orangelos and grapefruits	PLOS ONE			English	Article							CHEMICAL VARIABILITY; CULTIVATED CITRUS; GENETIC DIVERSITY; ORIGIN; NUCLEAR; DENSITY; HISTORY; DOMESTICATION; TOLERANCE; DISCOVERY	The mandarin horticultural group is an important component of world citrus production for the fresh fruit market. This group formerly classified as C. reticulata is highly polymorphic and recent molecular studies have suggested that numerous cultivated mandarins were introgressed by C. maxima (the pummelos). C. maxima and C. reticulata are also the ancestors of sweet and sour oranges, grapefruit, and therefore of all the "small citrus" modern varieties (mandarins, tangors, tangelos) derived from sexual hybridization between these horticultural groups. Recently, NGS technologies have greatly modified how plant evolution and genomic structure are analyzed, moving from phylogenetics to phylogenomics. The objective of this work was to develop a workflow for phylogenomic inference from Genotyping By Sequencing (GBS) data and to analyze the interspecific admixture along the nine citrus chromosomes for horticultural groups and recent varieties resulting from the combination of the C. reticulata and C. maxima gene pools. A GBS library was established from 55 citrus varieties, using the ApekI restriction enzyme and selective PCR to improve the read depth. Diagnostic polymorphisms (DPs) of C. reticulata/C. maxima differentiation were identified and used to decipher the phylogenomic structure of the 55 varieties. The GBS approach was powerful and revealed 30,289 SNPs and 8,794 Indels with 12.6% of missing data. 11,133 DPs were selected covering the nine chromosomes with a higher density in genic regions. GBS combined with the detection of DPs was powerful for deciphering the "phylogenomic karyotypes" of cultivars derived from admixture of the two ancestral species after a limited number of interspecific recombinations. All the mandarins, mandarin hybrids, tangelos and tangors analyzed displayed introgression of C. maxima in different parts of the genome. C. reticulata/C. maxima admixture should be a major component of the high phenotypic variability of this germplasm opening up the way for association studies based on phylogenomics.	[Oueslati, Amel; Salhi-Hannachi, Amel] Univ Tunis El Manar, FST, Lab Genet Mol Immunol & Biotechnol, Tunis, Tunisia; [Oueslati, Amel; Ollitrault, Patrick] Ctr Cooperat Int Rech Agronom Dev Petit Bourg, AGAP Res Unit, Petit Bourg, Guadeloupe, France; [Luro, Francois] Inst Natl Rech Agronom, AGAPRes Unit, San Giuliano, France; [Vignes, Helene; Mournet, Pierre] Ctr Cooperat Int Rech Agronom Dev, AGAP Res Unit, Montpellier, France	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); INRAE; CIRAD	Ollitrault, P (corresponding author), Ctr Cooperat Int Rech Agronom Dev Petit Bourg, AGAP Res Unit, Petit Bourg, Guadeloupe, France.	patrick.ollitrault@cirad.fr		Mournet, Pierre/0000-0001-8011-8647; SALHI HANNACHI, Amel/0000-0003-1874-4713; Ollitrault, Patrick/0000-0002-9456-5517	CIRAD; Tunisian Ministry for Higher Education and Scientific Research; ED STVST of El Manar University in Tunis, Tunisia	CIRAD; Tunisian Ministry for Higher Education and Scientific Research; ED STVST of El Manar University in Tunis, Tunisia	This work was supported by CIRAD and a grant from the Tunisian Ministry for Higher Education and Scientific Research and ED STVST of El Manar University in Tunis, Tunisia atributed to Dr AO for an international visit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Wu G, 2017, W146 P PLANT AN GEN, P1; Aleza P, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0464-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Barrett H. C., 1976, Systematic Botany, V1, P105, DOI 10.2307/2418763; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Ben Yahmed J, 2015, SCI HORTIC-AMSTERDAM, V191, P90, DOI 10.1016/j.scienta.2015.05.005; Bernet GP, 2010, MOL BREEDING, V25, P659, DOI 10.1007/s11032-009-9363-y; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Curk F., 2014, THESIS; Curk F, 2016, ANN BOT-LONDON, V117, P565, DOI 10.1093/aob/mcw005; Curk F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125628; Curk F, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0152-1; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Davey JW, 2011, BRIEF FUNCT GENOMICS, V10, P108, DOI 10.1093/bfgp/elr007; de Moraes AP, 2007, CHROMOSOME RES, V15, P115, DOI 10.1007/s10577-006-1101-2; Dugrand-Judek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142757; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fanciullino AL, 2006, FLAVOUR FRAG J, V21, P359, DOI 10.1002/ffj.1658; Fanciullino AL, 2006, J AGR FOOD CHEM, V54, P4397, DOI 10.1021/jf0526644; Fujii H, 2016, BREEDING SCI, V66, P683, DOI 10.1270/jsbbs.16060; Fujii H, 2013, TREE GENET GENOMES, V9, P145, DOI 10.1007/s11295-012-0542-3; Garcia-Lor A, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0951-1; Garcia-Lor A, 2013, ANN BOT-LONDON, V111, P1, DOI 10.1093/aob/mcs227; Garcia-Lor A, 2012, MOL GENET GENOMICS, V287, P77, DOI 10.1007/s00438-011-0658-4; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Ipek A, 2016, BIOCHEM GENET, V54, P313, DOI 10.1007/s10528-016-9721-5; Koehler-Santos P, 2003, PESQUI AGROPECU BRAS, V38, P797, DOI 10.1590/S0100-204X2003000700003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lota ML, 2000, BIOCHEM SYST ECOL, V28, P61, DOI 10.1016/S0305-1978(99)00036-8; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Mabberley D. J., 1997, Telopea, V7, P167; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Montero-Pau J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3439-y; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Ollitrault P, 2016, INT CITR C 2016 SEP, P126; Ollitrault Patrick, 2003, P193; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-593; Ollitrault P, 2012, HANDB PLANT BREED, V8, P623, DOI 10.1007/978-1-4419-0763-9_16; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Perrier X., 2006, DARWIN SOFTWARE; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Petr D, 2011, BIOINFORMATICS; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ramadugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068410; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schilling MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095292; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Shimizu T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166969; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Stover E, 2015, ACTA HORTIC, V1065, P899; Swingle W T, 1967, CITRUS IND, P190; Tanaka T, 1954, SPECIES PROBLEM CITR, P152; Terol J., 2012, 12 INT CITR C VAL SP, V61; Wang JP, 2016, G3-GENES GENOM GENET, V6, P1417, DOI 10.1534/g3.116.026971; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Webber H.J., 1967, CITRUS IND, V1, P1; Webber HJ, 1943, CITRUS IND, V1, P475; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamamoto M, 2003, EUPHYTICA, V129, P267, DOI 10.1023/A:1022284908424	66	32	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185618	10.1371/journal.pone.0185618	http://dx.doi.org/10.1371/journal.pone.0185618			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982157	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300048
J	Revuz, S; Decullier, E; Ginon, I; Lamblin, N; Hatron, PY; Kaminsky, P; Carette, MF; Lacombe, P; Simon, AC; Riviere, S; Harle, JR; Fraisse, A; Lavigne, C; Leguy-Seguin, V; Chaouat, A; Khouatra, C; Dupuis-Girod, S; Hachulla, E				Revuz, Sabine; Decullier, Evelyne; Ginon, Isabelle; Lamblin, Nicolas; Hatron, Pierre-Yves; Kaminsky, Pierre; Carette, Marie-France; Lacombe, Pascal; Simon, Anne-Claire; Riviere, Sophie; Harle, Jean-Robert; Fraisse, Alain; Lavigne, Christian; Leguy-Seguin, Vanessa; Chaouat, Ari; Khouatra, Chahera; Dupuis-Girod, Sophie; Hachulla, Eric			Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability	PLOS ONE			English	Article							HEPATIC VASCULAR MALFORMATIONS; SICKLE-CELL-DISEASE; ARTERIAL-HYPERTENSION; SYSTOLIC PRESSURE; MUTATIONS; PATIENT; MANIFESTATIONS; PREVALENCE; ENDOGLIN; THERAPY	Background Different pulmonary hypertension (PH) mechanisms are associated with hereditary haemorrhagic telangiectasia (HHT). Methods and results We conducted a retrospective study of all suspected cases of PH (echocardiographically estimated systolic pulmonary artery pressure [sPAP] >= 40 mmHg) in patients with definite HHT recorded in the French National Reference Centre for HHT database. When right heart catheterization (RHC) was performed, PH cases were confirmed and classified among the PH groups according to the European guidelines. Among 2,598 patients in the database, 110 (4.2%) had suspected PH. Forty-seven of these 110 patients had RHC: 38/47 (81%) had a confirmed diagnosis of PH. The majority of these had isolated post-capillary PH (n = 20). We identified for the first time other haemodynamic profiles: pre-capillary pulmonary arterial hypertension (PAH) cases (n = 3) with slightly raised pulmonary vascular resistances (PVR), and combined post- and pre-capillary PH cases (n = 4). Compared to controls, survival probability was lower in patients with PAH. Conclusion This study revealed the diversity of PH mechanisms in HHT. The description of combined post- and pre-capillary PH with/or without high cardiac output (CO) suggests either a continuum between the pre- and post-capillary haemodynamic profiles or a different course in response to high CO.	[Revuz, Sabine; Hatron, Pierre-Yves] CHU Brabois, Dept Med Interne, Vandoeuvre Les Nancy, France; [Revuz, Sabine; Hatron, Pierre-Yves] CHU Brabois, Immunol Clin, Vandoeuvre Les Nancy, France; [Decullier, Evelyne] Hosp Civils Lyon, Pole IMER, Lyon, France; [Ginon, Isabelle] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Explorat Cardiol, Lyon, France; [Lamblin, Nicolas] Univ Lille, CHRU Lille, Serv Cardiol, Lille, France; [Hatron, Pierre-Yves; Hachulla, Eric] Univ Lille, CHRU Lille, Serv Med Interne, Lille, France; [Carette, Marie-France] Hop Tenon, AP HP, Serv Radiol, Paris, France; [Lacombe, Pascal] Hop Ambroise Pare, AP HP, Serv Imagerie Diagnost & Intervent, Boulogne, France; [Simon, Anne-Claire] CHU Poitiers, Serv Pneumol, Poitiers, France; [Riviere, Sophie] CHU Montpellier, Serv Med interne, Montpellier, France; [Harle, Jean-Robert] CHU Marseille, Hop Concept, Serv Med Interne, Marseille, France; [Fraisse, Alain] Royal Brompton & Harefield Hosp Trust, Paediat Cardiol Serv, London, England; [Lavigne, Christian] CHU Angers, Serv Med Interne & Malad Vasc, Angers, France; [Leguy-Seguin, Vanessa] CHU Dijon, Serv Med Interne, Dijon, France; [Leguy-Seguin, Vanessa] CHU Dijon, Immunol Clin, Dijon, France; [Chaouat, Ari] CHU Brabois, Dept Pneumol, Vandoeuvre Les Nancy, France; [Khouatra, Chahera] Hosp Civils Lyon, Hop Louis Pradel, Serv Pneumol, Bron, France; [Dupuis-Girod, Sophie] Hosp Civils Lyon, Hop Louis Pradel, Serv Genet, Bron, France; [Dupuis-Girod, Sophie] Hosp Civils Lyon, Hop Louis Pradel, Ctr Reference Maladie Rendu Osler, Bron, France	CHU de Nancy; CHU de Nancy; CHU Lyon; CHU Lyon; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU Poitiers; Universite de Poitiers; Universite de Montpellier; CHU de Montpellier; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU de Nancy; CHU Lyon; CHU Lyon; CHU Lyon	Revuz, S (corresponding author), CHU Brabois, Dept Med Interne, Vandoeuvre Les Nancy, France.; Revuz, S (corresponding author), CHU Brabois, Immunol Clin, Vandoeuvre Les Nancy, France.	s.revuz@chru-nancy.fr	Chaouat, Ari/AAP-9249-2021; Chaouat, Ari/AAP-6784-2021; Dupuis-Girod, Sophie/D-6268-2014; HACHULLA, ERIC/R-8488-2018; decullier, evelyne/AAL-5861-2021	Chaouat, Ari/0000-0001-6056-202X; HACHULLA, ERIC/0000-0001-7432-847X; LAMBLIN, NICOLAS/0000-0003-3754-1241; Revuz, Sabine/0000-0001-8421-912X				Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Armstrong DWJ, 2010, CAN J CARDIOL, V26, pE35, DOI 10.1016/S0828-282X(10)70004-0; Ayala E, 2012, CHEST, V141, P1598, DOI 10.1378/chest.11-1402; Bayrak-Toydemir P, 2006, AM J MED GENET A, V140A, P463, DOI 10.1002/ajmg.a.31101; Bhuachalla CFN, 2010, RESP MED, V104, P1218, DOI 10.1016/j.rmed.2010.03.003; Bonderman D, 2006, EUR J CLIN INVEST, V36, P71, DOI 10.1111/j.1365-2362.2006.01683.x; Buscarini E, 2004, ULTRASCHALL MED, V25, P348, DOI 10.1055/s-2004-813549; Chakinala M, 2010, PATHLIGHT        WIN, P20; Chang SA, 2011, HEART VESSELS, V26, P231, DOI 10.1007/s00380-010-0079-z; Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890; Chen YJ, 2013, EUR J CLIN INVEST, V43, P1016, DOI 10.1111/eci.12138; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Cottin V, 2007, RESPIRATION, V74, P361, DOI 10.1159/000103205; Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Dupuis-Girod S, 2010, LIVER TRANSPLANT, V16, P340, DOI 10.1002/lt.21990; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Faughnan ME, 2009, EUR RESPIR J, V33, P1186, DOI 10.1183/09031936.00061308; Garcia-Tsao G, 2000, NEW ENGL J MED, V343, P931, DOI 10.1056/NEJM200009283431305; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gincul R, 2008, HEPATOLOGY, V48, P1570, DOI 10.1002/hep.22514; Ginon I, 2013, EUR J INTERN MED, V24, pE35, DOI 10.1016/j.ejim.2012.12.013; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Harrison RE, 2005, CIRCULATION, V111, P435, DOI 10.1161/01.CIR.0000153798.78540.87; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hayes Margaret M, 2014, Ann Am Thorac Soc, V11, P1488, DOI 10.1513/AnnalsATS.201408-405CME; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Humbert N, 2015, EUR RESPIR J; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Lyle MA, 2016, CHEST, V149, P362, DOI 10.1378/chest.15-0535; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Olivieri C, 2006, GENET MED, V8, P183, DOI 10.1097/01.gim.0000204463.77319.1c; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; Pousada G, 2015, MED CLIN-BARCELONA, V144, P261, DOI 10.1016/j.medcli.2014.09.024; Rozenberg D, 2015, RESP MED, V109, P768, DOI 10.1016/j.rmed.2015.04.003; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2014, AM J RESP CRIT CARE, V190, P1217, DOI 10.1164/rccm.201407-1254CI; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Sopena B, 2013, EUR J INTERN MED, V24, pE30, DOI 10.1016/j.ejim.2012.11.012; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Vorselaars VMM, 2015, WORLD J CARDIOL, V7, P230, DOI 10.4330/wjc.v7.i5.230	44	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0184227	10.1371/journal.pone.0184227	http://dx.doi.org/10.1371/journal.pone.0184227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28981519	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300010
J	Teimoury, E; Jabbarzadeh, A; Babaei, M				Teimoury, Ebrahim; Jabbarzadeh, Armin; Babaei, Mohammadhosein			Integrating strategic and tactical decisions in livestock supply chain using bi-level programming, case study: Iran poultry supply chain	PLOS ONE			English	Article							PERISHABLE PRODUCTS; INVENTORY; OPTIONS; MODELS	Inventory management has frequently been targeted by researchers as one of the most pivotal problems in supply chain management. With the expansion of research studies on inventory management in supply chains, perishable inventory has been introduced and its fundamental differences from non-perishable inventory have been emphasized. This article presents livestock as a type of inventory that has been less studied in the literature. Differences between different inventory types, affect various levels of strategic, tactical and operational decision-making. In most articles, different levels of decision-making are discussed independently and sequentially. In this paper, not only is the livestock inventory introduced, but also a model has been developed to integrate decisions across different levels of decision-making using bi-level programming. Computational results indicate that the proposed bi-level approach is more efficient than the sequential decision-making approach.	[Teimoury, Ebrahim; Jabbarzadeh, Armin; Babaei, Mohammadhosein] Univ Sci & Technol, Dept Ind Engn, Tehran, Iran		Teimoury, E (corresponding author), Univ Sci & Technol, Dept Ind Engn, Tehran, Iran.	teimoury@iust.ac.ir	jabbarzadeh, armin/S-8809-2018; Teimoury, Ebrahim/S-8806-2018	Teimoury, Ebrahim/0000-0003-3083-1609				Baky IA, 2010, APPL MATH MODEL, V34, P2377, DOI 10.1016/j.apm.2009.11.004; Barge P, 2013, CANADIAN J ANIMAL SC, V93; Blackburn J, 2009, PROD OPER MANAG, V18, P129, DOI 10.1111/j.1937-5956.2009.01016.x; Cho G-S, 2013, INT J IND ENG, V20; Colson B., 2005, 4OR-Q J OPER RES, V3, P87, DOI DOI 10.1007/S10288-005-0071-0; Dreyer HC, 2016, PRODUCTION PLANNING, P1; Goliomytis M, 2003, POULTRY SCI, V82, P1061, DOI 10.1093/ps/82.7.1061; Heft-Neal S., 2008, SUPPLY CHAIN AUDITIN; Ifft J., 2008, POULTRY SUPPLY CHAIN; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Lapar ML, 2003, FOOD POLICY, V28, P187, DOI 10.1016/S0306-9192(03)00017-4; Liang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139558; Manning L., 2004, British Food Journal, V106, P819, DOI 10.1108/00070700410561414; Meindl S.C., 2013, SUPPLY CHAIN MANAGEM; Mohamed Z, 2013, INT C SOC RES; Mohan Usha, 2009, International Journal of Logistics Systems and Management, V5, P89, DOI 10.1504/IJLSM.2009.021646; Napel Jt, 2011, LIVEST SCI, V139, P150; Pan FB, 2016, J INTERDISCIP MATH, V19, P111, DOI 10.1080/09720502.2015.1113676; Rabbani M., 2016, UNCERTAIN SUPPLY CHA, V4, P171, DOI [10.5267/j.uscm.2016.3.001, DOI 10.5267/J.USCM.2016.3.001]; Rebolledo B, 2013, ATMOS ENVIRON, V64, P125, DOI 10.1016/j.atmosenv.2012.10.005; Roghanian E, 2007, APPL MATH COMPUT, V188, P786, DOI 10.1016/j.amc.2006.10.032; Sana SS, 2012, ECON MODEL, V29, P1024, DOI 10.1016/j.econmod.2012.03.010; Sarker BR, 2000, COMPUT OPER RES, V27, P59, DOI 10.1016/S0305-0548(99)00008-8; Sauian MS, 2012, INT C STAT SCI BUS E; Shamsuddoha M., 2009, INTEGRATING FORWARD; Shamsuddoha M., 2013, ECOFORUM J, V2, P7; Shoushtari KD, 2011, 55 ANN M ISSS; Song BD, 2016, J FOOD ENG, V169, P61, DOI 10.1016/j.jfoodeng.2015.08.027; Soysal M, 2014, INT J PROD ECON, V152, P57, DOI 10.1016/j.ijpe.2013.12.012; Stehfest E, 2013, AGR SYST, V114, P38, DOI 10.1016/j.agsy.2012.07.002; Tsao Y-C, 2016, INT J PROD RES, P1	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185743	10.1371/journal.pone.0185743	http://dx.doi.org/10.1371/journal.pone.0185743			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982180	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300064
J	Wang, JY; Kollarik, M; Ru, F; Sun, H; McNeil, B; Dong, XZ; Stephens, G; Korolevich, S; Brohawn, P; Kolbeck, R; Undem, B				Wang, Jingya; Kollarik, Marian; Ru, Fei; Sun, Hui; McNeil, Benjamin; Dong, Xinzhong; Stephens, Geoffrey; Korolevich, Susana; Brohawn, Philip; Kolbeck, Roland; Undem, Bradley			Distinct and common expression of receptors for inflammatory mediators in vagal nodose versus jugular capsaicin-sensitive/TRPV1-positive neurons detected by low input RNA sequencing	PLOS ONE			English	Article							BRONCHOPULMONARY C-FIBERS; SENSORY NEURONS; AFFERENT INNERVATION; NEURAL CREST; VAGUS NERVE; BRAIN-STEM; GANGLIA; SUBTYPES; LUNG; MODULATION	Capsaicin-sensitive sensory C-fibers derived from vagal ganglia innervate the visceral organs, and respond to inflammatory mediators and noxious stimuli. These neurons play an important role in maintenance of visceral homeostasis, and contribute to the symptoms of visceral inflammatory diseases. Vagal sensory neurons are located in two ganglia, the jugular ganglia (derived from the neural crest), and the nodose ganglia (from the epibranchial placodes). The functional difference, especially in response to immune mediators, between jugular and nodose neurons is not fully understood. In this study, we microscopically isolated murine nodose and jugular capsaicin-sensitive/Trpv1-expressing C-fiber neurons and performed transcriptome profiling using ultra-low input RNA sequencing. RNAseq detected genes with significantly differential expression in jugular and nodose neurons, which were mostly involved in neural functions. Transcriptional regulators, including Cited1, Hoxb5 and Prdm12 showed distinct expression patterns in the two C-fiber neuronal populations. Common and specific expression of immune receptor proteins was characterized in each neuronal type. The expression of immune receptors that have received little or no attention from vagal sensory biologists is highlighted including receptors for certain chemokines (CXCLs), interleukins (IL-4) and interferons (IFN alpha, IFN gamma). Stimulation of immune receptors with their cognate ligands led to activation of the C-fibers in isolated functional assays.	[Wang, Jingya; Stephens, Geoffrey; Kolbeck, Roland] MedImmune LLC, Dept Resp Inflammatory & Autoimmun, Gaithersburg, MD USA; [Kollarik, Marian; Ru, Fei; Sun, Hui; Undem, Bradley] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA; [Kollarik, Marian] Comenius Univ, Jessenius Fac Med, Biomed Ctr Martin, Dept Pathophysiol, Martin, Slovakia; [McNeil, Benjamin; Dong, Xinzhong] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Korolevich, Susana; Brohawn, Philip] MedImmune LLC, Dept Translat Med, Gaithersburg, MD USA	AstraZeneca; Medimmune; Johns Hopkins University; Comenius University Bratislava; Johns Hopkins University; Johns Hopkins Medicine; AstraZeneca; Medimmune	Undem, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA.	bundem@jhmi.edu			Johns Hopkins University [90057138]; NIH [HL137807, HL122228]; VEGA [1/0226/15];  [APVV-15-0163]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	Johns Hopkins University(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the following: 1. BU received funding from Johns Hopkins University-Medimmune CollaborativeAgreement, # 90057138, (http://releases.jhu.edu/2013/12/11/medimmune/); 2. BU received funding from NIH HL137807 and HL122228, (www.nih.gov); 3. MK was partially supported by APVV-15-0163 and VEGA 1/0226/15 (Department of Education, Slovakia) (http://www apvv.sk/?lang=en, https://www.minedu.sk/vedecka-grantova-agentura-msvvas-sr-asav-vega/); 4. JW, SK, PB and RK are full time employees and shareholders of Medlmmune, LLC (https://www.medimmune.com/). GS has been a full time employee and shareholder of Medlmmune until recently. His current affiliation is Cellcion, LLC (http://cellcion.com/). Funding bodies did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the "author contributions" section.	ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoyama M, 2005, CANCER RES, V65, P4587, DOI 10.1158/0008-5472.CAN-04-4630; Baker CVH, 2005, EMBRYOLOGY VAGAL SEN; BROWN L, 1992, P NATL ACAD SCI USA, V89, P8492, DOI 10.1073/pnas.89.18.8492; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Chen YC, 2015, NAT GENET, V47, P803, DOI 10.1038/ng.3308; Chou YL, 2008, AM J PHYSIOL-REG I, V295, pR1572, DOI 10.1152/ajpregu.90382.2008; Christianson JA, 2009, BRAIN RES REV, V60, P171, DOI 10.1016/j.brainresrev.2008.12.004; Chuaychoo B, 2005, PULM PHARMACOL THER, V18, P269, DOI 10.1016/j.pupt.2004.12.010; Czaja K, 2008, NEUROSCIENCE, V154, P621, DOI 10.1016/j.neuroscience.2008.03.055; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Driessen AK, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00378; Esmailpour T, 2012, STEM CELLS, V30, P2152, DOI 10.1002/stem.1187; Foreman RD, 1999, ANNU REV PHYSIOL, V61, P143, DOI 10.1146/annurev.physiol.61.1.143; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; Gudmundsson G, 1999, EXP LUNG RES, V25, P217; HAMILTON RB, 1987, J AUTONOM NERV SYST, V19, P153, DOI 10.1016/0165-1838(87)90008-7; Harrison TA, 1996, PEDIATR RES, V39, P90, DOI 10.1203/00006450-199601000-00013; Hayakawa T, 2011, J CHEM NEUROANAT, V41, P55, DOI 10.1016/j.jchemneu.2010.11.003; Isogai E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019297; Joshi S K, 2000, Curr Rev Pain, V4, P499; KHURANA RK, 1991, AM J ANAT, V192, P293, DOI 10.1002/aja.1001920309; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YS, 2014, NEURON, V81, P873, DOI 10.1016/j.neuron.2013.12.011; Kollarik M, 2003, J PHYSIOL-LONDON, V551, P869, DOI 10.1113/jphysiol.2003.042028; Kollarik M, 2010, AUTON NEUROSCI-BASIC, V153, P12, DOI 10.1016/j.autneu.2009.08.001; KUMMER W, 1992, NEUROSCIENCE, V49, P715, DOI 10.1016/0306-4522(92)90239-X; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; Kwong K, 2010, J PHYSIOL-LONDON, V588, P1171, DOI 10.1113/jphysiol.2009.181669; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee LY, 2014, COMPR PHYSIOL, V4, P287, DOI 10.1002/cphy.c130020; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUCIER GE, 1986, BRAIN RES BULL, V16, P713, DOI 10.1016/0361-9230(86)90143-7; Maher SA, 2015, EUR RESPIR J, V45, P1108, DOI 10.1183/09031936.00061614; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; McGovern AE, 2015, J NEUROSCI, V35, P7041, DOI 10.1523/JNEUROSCI.5128-14.2015; Miyazaki JJ, 1999, OTOLARYNG HEAD NECK, V120, P905, DOI 10.1016/S0194-5998(99)70335-9; Nassenstein C, 2010, J PHYSIOL-LONDON, V588, P4769, DOI 10.1113/jphysiol.2010.195339; Neumann H, 1997, J EXP MED, V186, P2023, DOI 10.1084/jem.186.12.2023; Peeters PJ, 2006, PHYSIOL GENOMICS, V24, P252, DOI 10.1152/physiolgenomics.00169.2005; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; RANDICH A, 1992, BRAIN RES REV, V17, P77, DOI 10.1016/0165-0173(92)90009-B; ROBERTS AM, 1985, J APPL PHYSIOL, V58, P1823, DOI 10.1152/jappl.1985.58.6.1823; Ru F, 2011, AM J PHYSIOL-GASTR L, V300, pG485, DOI 10.1152/ajpgi.00361.2010; SATODA T, 1995, NEUROSCI RES, V22, P381, DOI 10.1016/0168-0102(95)00918-J; Sherrington, 1906, INTEGRATIVE ACTION N; SPRINGALL DR, 1987, J AUTONOM NERV SYST, V20, P155, DOI 10.1016/0165-1838(87)90113-5; Surdenikova L, 2012, NEUROGASTROENT MOTIL, V24, pe517, DOI 10.1111/nmo.12002; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Trankner D, 2014, P NATL ACAD SCI USA, V111, P11515, DOI 10.1073/pnas.1411032111; Undem BJ, 2004, J PHYSIOL-LONDON, V556, P905, DOI 10.1113/jphysiol.2003.060079; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P17, DOI 10.1016/0165-1838(93)90375-5; Wank M, 2001, J COMP NEUROL, V435, P41, DOI 10.1002/cne.1192; WEINREICH D, 1995, J PHYSIOL-LONDON, V483, P735, DOI 10.1113/jphysiol.1995.sp020618; Yang CM, 2013, CELL STRUCT FUNCT, V38, P195, DOI 10.1247/csf.13010; Yu SY, 2005, J PHYSIOL-LONDON, V563, P831, DOI 10.1113/jphysiol.2004.079574	61	36	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185985	10.1371/journal.pone.0185985	http://dx.doi.org/10.1371/journal.pone.0185985			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982197	Green Published, Green Submitted, gold			2022-12-27	WOS:000412360300102
J	de Farias-Martins, F; Sperber, CF; Albeny-Simoes, D; Breaux, JA; Fianco, M; Szinwelski, N				de Farias-Martins, Fernando; Sperber, Carlos Frankl; Albeny-Simoes, Daniel; Breaux, Jennifer Ann; Fianco, Marcos; Szinwelski, Neucir			Forest litter crickets prefer higher substrate moisture for oviposition: Evidence from field and lab experiments	PLOS ONE			English	Article							BODY-SIZE; PHENOTYPIC PLASTICITY; SOIL-MOISTURE; ACHETA-DOMESTICUS; BOTTOM-UP; EGG-SHELL; TRADE-OFF; TOP-DOWN; ORTHOPTERA; BEHAVIOR	For insects, choosing a favorable oviposition site is a type of parental care, as far as it increases the fitness of its offspring. Niche theory predicts that crickets should show a bellshaped oviposition response to substrate moisture. However, lab experiments with mole crickets showed a linear oviposition response to substrate moisture. Studies with the house cricket Acheta domesticus also showed a linear juvenile body growth response to water availability, thus adult ovipositing females should respond positively to substrate moisture. We used a field experiment to evaluate the relationship between oviposition preference and substrate moisture in forest litter-dwelling cricket species. We also evaluated oviposition responses to substrate moisture level in Ubiquepuella telytokous, the most abundant litter cricket species in our study area, using a laboratory study. We offered cotton substrate for oviposition which varied in substrate moisture level from zero (i.e., dry) to maximum water absorption capacity. We used two complementary metrics to evaluate oviposition preference: (i) presence or absence of eggs in each sampling unit as binary response variable, and (ii) number of eggs oviposited per sampling unit as count response variable. To test for non-linear responses, we adjusted generalized additive models (GAMM) with mixed effects. We found that both cricket oviposition probability and effort (i. e., number of eggs laid) increased linearly with substrate moisture in the field experiment, and for U. telytokous in the lab experiment. We discarded any non-linear responses. Our results demonstrate the importance of substrate moisture as an ecological niche dimension for litter crickets. This work bolsters knowledge of litter cricket life history association with moisture, and suggests that litter crickets may be particularly threatened by changes in climate that favor habitat drying.	[de Farias-Martins, Fernando; Szinwelski, Neucir] Univ Estadual Oeste Parana, Lab Orthoptera, Cascavel, Parana, Brazil; [de Farias-Martins, Fernando] Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil; [Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Albeny-Simoes, Daniel; Breaux, Jennifer Ann] Univ Comunitaria Regiao Chapeco, Programa Posgrad Ciencias Ambientais, Chapeco, SC, Brazil; [Fianco, Marcos] Univ Fed Integracao Latinoamer, Inst Latinoamer Ciencias Vida & Nat, Foz Do Iguacu, Parana, Brazil	Universidade Estadual do Oeste do Parana; Universidade Estadual do Oeste do Parana; Universidade Federal de Vicosa; Universidade Comunitaria Regional de Chapeco; Universidade Federal da Integracao Latino-Americana	de Farias-Martins, F (corresponding author), Univ Estadual Oeste Parana, Lab Orthoptera, Cascavel, Parana, Brazil.; de Farias-Martins, F (corresponding author), Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil.	fernandof_martins@hotmal.com	Sperber, Carlos Frankl/AAH-4443-2021; Sperber, Carlos Frankl/F-9298-2012; Breaux, Jennifer/ABG-6997-2020; Simoes, Daniel A/E-5086-2016; Szinwelski, Neucir/I-2523-2012; Fianco, Marcos/AAV-5338-2021	Sperber, Carlos Frankl/0000-0002-0334-7216; Szinwelski, Neucir/0000-0003-4049-3121; Fianco, Marcos/0000-0001-6662-6311	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CRA-APQ-01478-11, BPD-00196-12]; CCBS UNIOESTE [11/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ) [5653360/2010-0]; Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG) [CRA-APQ-0003-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) [310032/2015-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [Portaria 367/VICE-EPE/2014]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CCBS UNIOESTE; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the following grants: Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (CRA-APQ-01478-11; received by Dr Carlos Frankl Sperber); CCBS UNIOESTE (11/2017; received by Dr Neucir Szinwelski); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR) (received by Fernando de Farias-Martins); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR, CNPQ) (5653360/2010-0); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-BR-FAPEMIG) (CRA-APQ-0003-11); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR) (310032/2015-6; received by Dr Carlos Frankl Sperber); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BPD-00196-12; received by Dr Neucir Szinwelski); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Portaria 367/VICE-EPE/2014; received by Dr Jennifer Ann Breaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2016, ANIM BEHAV, V121, P53, DOI 10.1016/j.anbehav.2016.08.012; ADAMO SA, 1995, J INSECT PHYSIOL, V41, P269, DOI 10.1016/0022-1910(94)00095-X; AE A, 2003, CAD SAUDE PUBLICA, V19, P1107; ALEXANDE.RD, 1968, Q REV BIOL, V43, P1, DOI 10.1086/405628; Alexander RD, 1957, OHIO J SCI, V57, P101; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Bahia State, 2006, AN AC BRAS CIENC, V78, P59; Bang HS, 2011, J ASIA-PAC ENTOMOL, V14, P373, DOI 10.1016/j.aspen.2011.04.007; BELL PD, 1980, CAN J ZOOL, V58, P1861, DOI 10.1139/z80-254; Biron DG, 2005, P ROY SOC B-BIOL SCI, V272, P2117, DOI 10.1098/rspb.2005.3213; BLANK RH, 1988, NEW ZEAL J AGR RES, V31, P211; Boychuk EC, 2015, J INSECT PHYSIOL, V81, P157, DOI 10.1016/j.jinsphys.2015.07.015; BRADFORD MJ, 1993, OECOLOGIA, V93, P263, DOI 10.1007/BF00317680; Branson David H., 2008, Journal of Orthoptera Research, V17, P259, DOI 10.1665/1082-6467-17.2.259; Brouwers NC, 2009, J INSECT CONSERV, V13, P529, DOI 10.1007/s10841-008-9199-5; Bruggisser OT, 2012, BASIC APPL ECOL, V13, P706, DOI 10.1016/j.baae.2012.10.001; Caglar SS, 2014, INSECT SCI, V21, P213, DOI 10.1111/1744-7917.12027; Chown SL, 2011, J INSECT PHYSIOL, V57, P1070, DOI 10.1016/j.jinsphys.2011.05.004; Crawley MJ, 2013, R BOOK, P557; DESTEPHANO DB, 1982, ANN ENTOMOL SOC AM, V75, P111, DOI 10.1093/aesa/75.2.111; Desutter-Grandcolas L., 1992, BIOL ECOLOGIE ANIMAL, V14, P93; Donoughe S, 2016, DEV BIOL, V411, P140, DOI 10.1016/j.ydbio.2015.04.009; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; Fernandes ML, 2015, ZOOTAXA, V4032, P407, DOI 10.11646/zootaxa.4032.4.5; Filin Ido, 2008, Journal of Orthoptera Research, V17, P283, DOI 10.1665/1082-6467-17.2.283; FORREST TG, 1991, BEHAV ECOL, V2, P327, DOI 10.1093/beheco/2.4.327; FURNEAUX PJ, 1969, J CELL SCI, V5, P227; Fusco G, 2010, PHILOS T R SOC B, V365, P547, DOI 10.1098/rstb.2009.0267; Gehrken U, 1996, J INSECT PHYSIOL, V42, P483, DOI 10.1016/0022-1910(95)00128-X; Gelman A., 2007, DATA ANAL USING REGR; GHOURI A. S. K., 1958, CANADIAN ENT, V90, P158; Girard C, 2015, GLOBAL ENVIRON CHANG, V34, P132, DOI 10.1016/j.gloenvcha.2015.07.002; Gray DA, 2001, FLA ENTOMOL, V84, P314, DOI 10.2307/3496190; Green K, 2009, ANIM BEHAV, V77, P887, DOI 10.1016/j.anbehav.2008.12.017; Griffiths AJ, 2000, INTRO GENETIC ANAL, V7th; Groll M, 2016, ECOL INDIC, V61, P219, DOI 10.1016/j.ecolind.2015.09.019; Guarneri AA, 2002, PHYSIOL ENTOMOL, V27, P142, DOI 10.1046/j.1365-3032.2002.00279.x; Gwynne DT, 2001, KATYDID BUSH CRICKET; Hertl PT, 2001, ENVIRON ENTOMOL, V30, P466, DOI 10.1603/0046-225X-30.3.466; Hilker M, 2011, PHYTOCHEMISTRY, V72, P1612, DOI 10.1016/j.phytochem.2011.02.018; Hinton HE, 1981, BIOL INSECT EGGS; Hodek I, 2003, EUR J ENTOMOL, V100, P223, DOI 10.14411/eje.2003.037; Hopper KR, 1999, ANNU REV ENTOMOL, V44, P535, DOI 10.1146/annurev.ento.44.1.535; Huber F., 1989, CRICKET BEHAV NEUROB; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ingrisch S, 1996, TROP ZOOL, V9, P431, DOI 10.1080/03946975.1996.10539321; Karagkouni M, 2016, J ZOOL SYST EVOL RES, V54, P182, DOI 10.1111/jzs.12125; Key KHL, 1979, INSECTS AUSTR, P321; Martin CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014395; McCluney KE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3201; MCFARLAN.JE, 1970, COMP BIOCHEM PHYSIOL, V37, P133, DOI 10.1016/0010-406X(70)90540-2; Miyoshi AR, 2007, IHERINGIA SER ZOOL, V97, P461, DOI 10.1590/S0073-47212007000400016; Moriyama M, 2006, J INSECT PHYSIOL, V52, P1219, DOI 10.1016/j.jinsphys.2006.09.005; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Neto EMC, 2006, ANAIS ACAD BRASILEIR; Neto SS, MANUAL ECOLOGIA INSE; Norhisham AR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-9; Ogawa H, 2011, J INSECT PHYSIOL, V57, P326, DOI 10.1016/j.jinsphys.2010.11.021; Olalla-Tarraga MA, 2009, ECOGRAPHY, V32, P581, DOI 10.1111/j.1600-0587.2008.05632.x; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; PLATT SA, 1988, J COMP PSYCHOL, V102, P254, DOI 10.1037/0735-7036.102.3.254; POTTER DA, 1983, ENVIRON ENTOMOL, V12, P1223, DOI 10.1093/ee/12.4.1223; Prakrash M., 2008, INSECT ECOLOGY; Qi XL, 2007, PHYSIOL ENTOMOL, V32, P219, DOI 10.1111/j.1365-3032.2007.00564.x; Randall D, 2011, ECKERT FISIOLOGIA AN, P531; Reale D, 2002, ANIM BEHAV, V64, P397, DOI 10.1006/anbe.2002.3084; Refsnider JM, 2010, ANNU REV ECOL EVOL S, V41, P39, DOI 10.1146/annurev-ecolsys-102209-144712; Reitz M, 2015, ANAL CHIM ACTA, V854, P47, DOI 10.1016/j.aca.2014.10.056; Ribas CR, 2005, ACTA OECOL, V27, P31, DOI 10.1016/j.actao.2004.08.008; Ross CL, 2006, OIKOS, V115, P53, DOI 10.1111/j.2006.0030-1299.15054.x; Seger J., 1987, Oxford Surveys in Evolutionary Biology, V4, P182; Srygley RB, 2014, J INSECT PHYSIOL, V65, P57, DOI 10.1016/j.jinsphys.2014.05.005; Stahlschmidt ZR, 2015, FUNCT ECOL, V29, P88, DOI 10.1111/1365-2435.12287; Stahlschmidt ZR, 2013, ANIM BEHAV, V86, P553, DOI 10.1016/j.anbehav.2013.06.009; Stahlschmidt ZR, 2013, FUNCT ECOL, V27, P800, DOI 10.1111/1365-2435.12071; Subramanian KA, 2005, CURR SCI INDIA, V89, P976; Sugano Yoshikazu C., 2008, Journal of Orthoptera Research, V17, P243, DOI 10.1665/1082-6467-17.2.243; Szinwelski N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139669; Szinwelski Neucir, 2012, International Journal of Zoology, P1; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; TALLAMY DW, 1984, BIOSCIENCE, V34, P20, DOI 10.2307/1309421; Tauber MJ, 1998, ENVIRON ENTOMOL, V27, P523, DOI 10.1093/ee/27.3.523; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Zefa E, 2008, IHERINGIA SER ZOOL, V98, P325, DOI 10.1590/S0073-47212008000300006; Zuur AF, 2012, BEGINNERS GUIDE GENE; Zuur Alain F., 2009, P1	91	0	0	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185800	10.1371/journal.pone.0185800	http://dx.doi.org/10.1371/journal.pone.0185800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977023	gold, Green Published, Green Submitted			2022-12-27	WOS:000412163100046
J	McElroy, T; McReynolds, CN; Gulledge, A; Knight, KR; Smith, WE; Albrecht, EA				McElroy, Thomas; McReynolds, C. Neal; Gulledge, Alyssa; Knight, Kelci R.; Smith, Whitney E.; Albrecht, Eric A.			Differential toxicity and venom gland gene expression in Centruroides vittatus	PLOS ONE			English	Article							INTRAGUILD PREDATION; SCORPION; PEPTIDES; DIET; TIME; VARIABILITY; TOXINS; PREY; COMPONENTS; EVOLUTION	Variation in venom toxicity and composition exists in many species. In this study, venom potency and venom gland gene expression was evaluated in Centruroides vittatus, size class I-II (immature) and size class IV (adults/penultimate instars) size classes. Venom toxicity was evaluated by probit analysis and returned ED50 values of 50.1 mu g/g for class IV compared to 134.2 mu g/g for class I-II 24 hours post injection, suggesting size class IV was 2.7 fold more potent. Next generation sequencing (NGS and qPCR were used to characterize venom gland gene expression. NGS data was assembled into 36,795 contigs, and annotated using BLASTx with UNIPROT. EdgeR analysis of the sequences showed statistically significant differential expression in transcripts associated with sodium and potassium channel modulation. Sodium channel modulator expression generally favored size class IV; in contrast, potassium channel modulators were favored in size class I-II expression. Real-time quantitative PCR of 14 venom toxin transcripts detected relative expression ratios that paralleled NGS data and identified potential family members or splice variants for several sodium channel modulators. Our data suggests ontogenetic differences in venom potency and venom related genes expression exist between size classes I-II and IV.	[McElroy, Thomas; Gulledge, Alyssa] Kennesaw State Univ, Dept Ecol Evolut & Organismal Biol, Kennesaw, GA USA; [McReynolds, C. Neal] Texas A&M Int Univ, Dept Biol & Chem, Laredo, TX USA; [Knight, Kelci R.; Smith, Whitney E.; Albrecht, Eric A.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University; Texas A&M University System; Texas A&M International University; University System of Georgia; Kennesaw State University	Albrecht, EA (corresponding author), Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA 30144 USA.	ealbrec1@kennesaw.edu		Albrecht, Eric/0000-0001-8949-2758	Kennesaw State University College Mentor Protege [432081]; Kennesaw State University Creative Activities and Research Experiences for Teams	Kennesaw State University College Mentor Protege; Kennesaw State University Creative Activities and Research Experiences for Teams	This work was supported by Kennesaw State University College Mentor Protege, grant# 432081, http://csm.kennesaw.edu/research/mentor-protege.php, EAA; and Kennesaw State University Creative Activities and Research Experiences for Teams, http://research.kennesaw.edu/our/funding/faculty.php, EAA and TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman M., 2014, VENOM GENOMICS PROTE, P1; Abdel-Rahman MA, 2009, TOXICON, V53, P349, DOI 10.1016/j.toxicon.2008.12.007; Almaaytah A, 2014, PEPTIDES, V51, P35, DOI 10.1016/j.peptides.2013.10.021; Baelde HJ, 2001, J CLIN PATHOL, V54, P778, DOI 10.1136/jcp.54.10.778; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; BOEVE JL, 1995, TOXICON, V33, P1347, DOI 10.1016/0041-0101(95)00066-U; Casewell NR, 2014, P NATL ACAD SCI USA, V111, P9205, DOI 10.1073/pnas.1405484111; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Chang D, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0592-5; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de Oliveira UC, 2015, TOXICON, V95, P52, DOI 10.1016/j.toxicon.2014.12.013; Durban J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-234; Dyason K, 2002, RAPID COMMUN MASS SP, V16, P768, DOI 10.1002/rcm.637; Edmunds MC, 2010, J ARACHNOL, V38, P123, DOI 10.1636/Hi09-38.1; El Hafny B, 2002, TOXICON, V40, P1609, DOI 10.1016/S0041-0101(02)00178-2; Finney D.J., 1952, PROBIT ANAL; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haney RA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-366; Jackman J.A., 1998, INSECTS; Kalapothakis E, 1997, TOXICON, V35, P1523, DOI 10.1016/S0041-0101(97)00017-2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lima L, 2017, ALGORITHM MOL BIOL, V12, DOI 10.1186/s13015-017-0091-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna-Ramirez K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127883; MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCormick S.J., 1990, P294; McReynolds C. Neal, 2012, Euscorpius, V144, P1; McReynolds C. Neal, 2004, Euscorpius, V12-17, P35; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; Nisani Z, 2012, TOXICON, V60, P315, DOI 10.1016/j.toxicon.2012.04.343; Olamendi-Portugal T, 2016, TOXICON, V115, P1, DOI 10.1016/j.toxicon.2016.02.017; Ozkan O, 2010, J VENOM ANIM TOXINS, V16, P505, DOI 10.1590/S1678-91992010000300017; PAPPONE PA, 1988, J GEN PHYSIOL, V91, P817, DOI 10.1085/jgp.91.6.817; Phuong MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2755-6; Pimenta AMC, 2003, RAPID COMMUN MASS SP, V17, P413, DOI 10.1002/rcm.934; Polis G., 2001, SCORPION BIOL RES; POLIS GA, 1987, ECOLOGY, V68, P332, DOI 10.2307/1939264; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polis GA, 1990, BIOL SCORPIONS; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Pucca MB, 2014, TOXICON, V90, P326, DOI 10.1016/j.toxicon.2014.08.064; Quintero-Hernandez V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117188; Richards DP, 2012, TOXICON, V59, P110, DOI 10.1016/j.toxicon.2011.10.015; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Sanchez-Pinero F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161747; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Starkov VG, 2007, TOXICON, V49, P995, DOI 10.1016/j.toxicon.2007.01.010; Sunagar K, 2016, J PROTEOMICS, V135, P62, DOI 10.1016/j.jprot.2015.09.015; Swartz KJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00873; Valdez-Cruz NA, 2004, BIOCHIMIE, V86, P387, DOI 10.1016/j.biochi.2004.05.005; YAHELNIV A, 1979, TOXICON, V17, P435, DOI 10.1016/0041-0101(79)90277-0; Zeng XC, 2005, IUBMB LIFE, V57, P13, DOI 10.1080/15216540500058899; Zhang L, 2015, J PROTEOMICS, V128, P231, DOI 10.1016/j.jprot.2015.07.030; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	59	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0184695	10.1371/journal.pone.0184695	http://dx.doi.org/10.1371/journal.pone.0184695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28976980	Green Published, gold, Green Submitted			2022-12-27	WOS:000412163100009
J	Giannini, JP; York, AG; Shroff, H				Giannini, John P.; York, Andrew G.; Shroff, Hari			Anticipating, measuring, and minimizing MEMS mirror scan error to improve laser scanning microscopy's speed and accuracy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY	We describe a method to speed up microelectromechanical system (MEMS) mirror scanning by > 20x, while also improving scan accuracy. We use Landweber deconvolution to determine an input voltage which would produce a desired output, based on the measured MEMS impulse response. Since the MEMS is weakly nonlinear, the observed behavior deviates from expectations, and we iteratively improve our input to minimize this deviation. This allows customizable MEMS angle vs. time with < 1% deviation from the desired scan pattern. We demonstrate our technique by optimizing a point scanning microscope's raster patterns to image mammal submandibular gland and pollen at similar to 10 frames/s.	[Giannini, John P.] Natl Inst Biomed Imaging & Bioengn, Sect High Resolut Opt Imaging, NIH, Bethesda, MD 20892 USA; [Giannini, John P.] Univ Maryland, Biophys Program, College Pk, MD 20742 USA; [York, Andrew G.] Calico Life Sci LLC, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); University System of Maryland; University of Maryland College Park	Giannini, JP (corresponding author), Natl Inst Biomed Imaging & Bioengn, Sect High Resolut Opt Imaging, NIH, Bethesda, MD 20892 USA.; Giannini, JP (corresponding author), Univ Maryland, Biophys Program, College Pk, MD 20742 USA.	john.p.giannini.jr@gmail.com		Giannini, John/0000-0001-7626-6540	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health; HS. Calico Life Sciences LLC.; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000074] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); HS. Calico Life Sciences LLC.; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering (https://www.nibib.nih.gov/) at the National Institutes of Health. Funding was obtained by HS. Calico Life Sciences LLC. provided support in the form of salary for author A.G.Y. during preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart E, 2012, OPT EXPRESS, V20, P21805, DOI 10.1364/OE.20.021805; De Luca GMR, 2013, BIOMED OPT EXPRESS, V4, P2644, DOI 10.1364/BOE.4.002644; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Fu L, 2006, NONLINEAR OPTICAL EN; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Kasturi A, 2017, SPIE C LAS RAD TECHN; Kim KH, 2007, OPT EXPRESS, V15, P18130, DOI 10.1364/OE.15.018130; Kumar A, 2014, NAT PROTOC, V9, P2555, DOI 10.1038/nprot.2014.172; Landweber L., 1951, AM J MATH, V73, P615, DOI DOI 10.2307/2372313; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Om KJ, 2001, CONTROL ENG PRACT, V9, P1163; Pan YT, 2001, OPT LETT, V26, P1966, DOI 10.1364/OL.26.001966; Piyawattanametha W, 2006, OPT LETT, V31, P2018, DOI 10.1364/OL.31.002018; Saggau P, 2006, CURR OPIN NEUROBIOL, V16, P543, DOI 10.1016/j.conb.2006.08.011; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019	18	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185849	10.1371/journal.pone.0185849	http://dx.doi.org/10.1371/journal.pone.0185849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973013	Green Published, gold, Green Submitted			2022-12-27	WOS:000412131900061
J	Mohammed, RH; Anderton, H; Brameld, JM; Sweetman, D				Mohammed, Rabeea Hazim; Anderton, Helen; Brameld, John Michael; Sweetman, Dylan			Effects of insulin like growth factors on early embryonic chick limb myogenesis	PLOS ONE			English	Article							MUSCLE PROGENITOR CELLS; SKELETAL-MUSCLE; SONIC HEDGEHOG; RETINOIC ACID; SOMITE; DIFFERENTIATION; EXPRESSION; SF/HGF; ORIGIN; CXCR4	Limb muscles derive from pax3 expressing precursor cells that migrate from the hypaxial somite into the developing limb bud. Once there they begin to differentiate and express muscle determination genes such as MyoD. This process is regulated by a combination of inductive or inhibitory signals including Fgf18, retinoic acid, HGF, Notch and IGFs. IGFs are well known to affect late stages of muscle development and to promote both proliferation and differentiation. We examined their roles in early stage limb bud myogenesis using chicken embryos as an experimental model. Grafting beads soaked in purified recombinant IGF-I, IGF-II or small molecule inhibitors of specific signaling pathways into developing chick embryo limbs showed that both IGF-I and IGF-II induce expression of the early stage myogenic markers pax3 and MyoD as well as myogenin. Their effects on pax3 and MyoD expression were blocked by inhibitors of both the IGF type I receptor (picropodophyllotoxin, PPP) and MEK (U0126). The PI3K inhibitor LY294002 blocked IGF-II, but not IGF-I, induction of pax3 mRNA as well as the IGF-I, but not IGF-II, induction of MyoD mRNA. In addition SU5402, an FGFR/.VEGFR inhibitor, blocked the induction of MyoD by both IGFs but had no effect on pax3 induction, suggesting a role for FGF or VEGF signaling in their induction of MyoD. This was confirmed by in situ hybridization showing that FGF18, a known regulator of MyoD in limb myoblasts, was induced by IGF-I. In addition to their well-known effects on later stages of myogenesis via their induction of myogenin expression, both IGF-I and IGF-II induced pax3 and MyoD expression in developing chick embryos, indicating that they also regulate early stages of myogenesis. The data suggests that the IGFs may have slightly different effects on IGF1R signal transduction via PI3K and that their stimulatory effects on MyoD expression may be indirect, possibly via induction of FGF18 expression.	[Mohammed, Rabeea Hazim; Anderton, Helen; Brameld, John Michael; Sweetman, Dylan] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Mohammed, Rabeea Hazim] Univ Mosul, Coll Educ, Dept Biol, Mosul, Iraq; [Sweetman, Dylan] Livestock Wellness & Performance, Zoetis VMRD GTR, Kalamazoo, MI USA	University of Nottingham; University of Mosul; Zoetis	Brameld, JM (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	john.brameld@nottingham.ac.uk	Mohammed, Rabeea Hazim/GYJ-3387-2022; Brameld, John/AAB-1745-2021	Brameld, John/0000-0003-4942-080X; Mohammed, Dr.Rabeea/0000-0002-7757-8068	Higher Committee for Education Development (HCED), Iraq and HA - a BBSRC Doctoral Training Programme PhD studentship	Higher Committee for Education Development (HCED), Iraq and HA - a BBSRC Doctoral Training Programme PhD studentship	RHM was funded by a PhD studentship from the Higher Committee for Education Development (HCED), Iraq and HA was funded by a BBSRC Doctoral Training Programme PhD studentship. The funders had no role in the design, collection of samples, data analysis, interpretation of data or writing of this manuscript.	Abu-Elmagd M, 2010, DEV BIOL, V337, P211, DOI 10.1016/j.ydbio.2009.10.023; Agrogiannis GD, 2014, MOL MED REP, V10, P579, DOI 10.3892/mmr.2014.2258; Allan GJ, 2003, ANAT EMBRYOL, V207, P73, DOI 10.1007/s00429-003-0321-x; Amthor H, 1998, CURR BIOL, V8, P642, DOI 10.1016/S0960-9822(98)70251-9; Berti F, 2015, J ANAT, V227, P361, DOI 10.1111/joa.12353; BrandSaberi B, 1996, DEV BIOL, V179, P303, DOI 10.1006/dbio.1996.0260; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; CHEVALLIER A, 1977, J EMBRYOL EXP MORPH, V41, P245; Christ B, 2002, INT J DEV BIOL, V46, P905; Davey MG, 2007, CYTOGENET GENOME RES, V117, P231, DOI 10.1159/000103184; Dietrich S, 1999, DEVELOPMENT, V126, P1621; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; Duprez D, 1998, DEVELOPMENT, V125, P495; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Kocamis H, 1998, POULTRY SCI, V77, P1913, DOI 10.1093/ps/77.12.1913; LANCEJONES C, 1988, DEV BIOL, V126, P394, DOI 10.1016/0012-1606(88)90149-2; Maki RG, 2010, J CLIN ONCOL, V28, P4985, DOI 10.1200/JCO.2009.27.5040; Marics I, 2002, DEVELOPMENT, V129, P4559; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; McQueeney K, 2001, GROWTH HORM IGF RES, V11, P346, DOI 10.1054/ghir.2001.0250; Mitchell PJ, 2002, DEV DYNAM, V223, P12, DOI 10.1002/dvdy.1227; Mohammed RH, 2016, JOVE-J VIS EXP, DOI 10.3791/53342; Mok GF, 2015, J ANAT, V227, P352, DOI 10.1111/joa.12340; Mok GF, 2014, DEV BIOL, V396, P214, DOI 10.1016/j.ydbio.2014.10.004; Mok GF, 2011, REPRODUCTION, V141, P301, DOI 10.1530/REP-10-0394; Moumne S., 2016, CAN J SCH PSYCHOL, V1, P1; Murphy M, 2011, CURR TOP DEV BIOL, V96, P1, DOI 10.1016/B978-0-12-385940-2.00001-2; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Philippou A., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P208; Reijntjes S, 2010, INT J DEV BIOL, V54, P125, DOI 10.1387/ijdb.082783sr; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scaal M, 1999, DEVELOPMENT, V126, P4885; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; Vasyutina E, 2005, GENE DEV, V19, P2187, DOI 10.1101/gad.346205; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Yusuf F, 2006, DEV DYNAM, V235, P3007, DOI 10.1002/dvdy.20951	41	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185775	10.1371/journal.pone.0185775	http://dx.doi.org/10.1371/journal.pone.0185775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28972999	Green Submitted, Green Published, gold			2022-12-27	WOS:000412131900047
J	Anders, S; Schroeter, C				Anders, Sven; Schroeter, Christiane			The impact of nutritional supplement intake on diet behavior and obesity outcomes	PLOS ONE			English	Article							HEALTH PRODUCTION FUNCTION; PROPENSITY-SCORE; LIFE-STYLE; US ADULTS; LABEL USE; VITAMIN; USERS; INFORMATION; PROGRAM; QUALITY	After decades-old efforts to nudge consumers towards healthier lifestyles through dietary guidelines, diet-related diseases are on the rise. In addition, a growing share of U.S. consumers proactively chooses nutritional supplements as an alternative preventative way of maintaining good health, a $25.5 billion industry in the United States. This paper investigates possible linkages between the economics of consumer supplement choices and the relationship to important dietary and health outcomes. We use National Health and Nutrition Examination Survey (NHANES) data to estimate the impact of nutritional supplements intake on respondent's body weight outcomes, controlling for diet quality.: The focus of this article is to determine whether nutritional supplements takers differ from non-takers with regard to their health outcomes when controlling for differences in diet quality, based on individual Healthy Eating Index (HEI-2010) score. The analysis applies treatment effects estimators that account for the selection bias and endogeneity of self-reported behavior and diet-health outcomes. The analysis demonstrates a negative association between supplement intake and BMI but no significant effect on an individual's diet quality. Our findings suggest that individuals proactively invest into their health by taking nutritional supplements instead of improving diet quality through more nutritious food choices. Our results provide important contributions to the literature on a key food policy issue. Knowledge of the determinants of supplement demand in the context of strong diet-health trends should also be helpful to stakeholders in the U.S. produce sector in their competition over consumer market share.	[Anders, Sven] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada; [Schroeter, Christiane] Calif Polytech State Univ San Luis Obispo, Agribusiness Dept, San Luis Obispo, CA 93407 USA	University of Alberta; California State University System; California Polytechnic State University San Luis Obispo	Anders, S (corresponding author), Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada.	sven.anders@ualberta.ca		Anders, Sven/0000-0001-8261-6973				Abebaw D, 2010, FOOD POLICY, V35, P286, DOI 10.1016/j.foodpol.2010.01.002; Agudo A, 2005, MEASURING INTAKE FRU; Archer SL, 2005, J AM DIET ASSOC, V105, P1106, DOI 10.1016/j.jada.2005.04.010; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Becker GS, 1999, KYKLOS, V45, P327; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; Bhatt R, 2014, SOUTH ECON J, V80, P656, DOI 10.4284/0038-4038-2012.102; Black DA, 2004, J ECONOMETRICS, V121, P99, DOI 10.1016/j.jeconom.2003.10.006; Brownie S, 2005, AUSTRALAS J AGEING, V24, P77, DOI 10.1111/j.1741-6612.2005.00088.x; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell BL, 2011, AM J AGR ECON, V93, P1099, DOI 10.1093/ajae/aar031; CDC, 2010, FDN HLTH MEAS GEN HL; CNPP, 2021, VEILL REGL CNPP FR C; Crown WH, 2014, APPL HEALTH ECON HEA, V12, P7, DOI 10.1007/s40258-013-0075-4; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; DeVol R, 2007, UNHEALTHY AM EC BURD; Dickinson A, 2006, MULTIVITAMINS OTHER; Dickinson A, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-14; DiPrete TA, 2004, DISCUSSION PAPERS; Drichoutis AC, 2005, EUR REV AGRIC ECON, V32, P93, DOI 10.1093/erae/jbi003; Drichoutis AC, 2009, KYKLOS, V62, P500, DOI 10.1111/j.1467-6435.2009.00448.x; Ervin RB, 1988, PREVALENCE LEADING T; Ervin RB, 1999, VITAL HLTH STAT SERI, V11; Fayissa B, 2005, APPL ECON, V37, P155, DOI 10.1080/00036840412331313521; Fennell D, 2004, PREV MED, V39, P932, DOI 10.1016/j.ypmed.2004.03.031; Foote JA, 2003, AM J EPIDEMIOL, V157, P888, DOI 10.1093/aje/kwg072; Gahche J, 1988, NCHS DATA BRIEF, V2011, P1; Gleason PM, 2003, AM J AGR ECON, V85, P1047, DOI 10.1111/1467-8276.00507; GOULD BW, 1994, J AGR RESOUR ECON, V19, P349; Grilli L, 2011, PROPENSITY SCORES ES; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Grossman M., 1999, HDB HLTH EC, P347; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Harrison RA, 2004, BRIT J NUTR, V91, P617, DOI 10.1079/BJN20031076; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Institute of Medicine and National Research Council, 2005, DIET SUPPL FRAM EV S; Irz X, 2015, J HEALTH ECON, V39, P188, DOI 10.1016/j.jhealeco.2014.09.002; Ishihara J, 2003, INT J EPIDEMIOL, V32, P546, DOI 10.1093/ije/dyg091; Kahle L, 2013, CALCULATION MEAN HLT; Kantor ED, 2016, JAMA-J AM MED ASSOC, V316, P1464, DOI 10.1001/jama.2016.14403; KEEN CL, 1994, AM J CLIN NUTR, V59, p532S, DOI 10.1093/ajcn/59.2.532S; KENKEL DS, 1995, HEALTH ECON, V4, P15, DOI 10.1002/hec.4730040103; Kennedy E, 2004, NUTR REV, V62, pS78, DOI 10.1111/j.1753-4887.2004.tb00093.x; Kim SY, 2001, J CONSUM AFF, V35, P346, DOI 10.1111/j.1745-6606.2001.tb00118.x; Kimmons Joel E, 2006, MedGenMed, V8, P3; Klatsky AL, 2010, PHYSIOL BEHAV, V100, P76, DOI 10.1016/j.physbeh.2009.12.019; Lechner M, 1999, J BUS ECON STAT, V17, P74, DOI 10.2307/1392240; Leuven E, 2015, STATA MODULE PERFORM; Li KR, 2010, BRIT J NUTR, V104, P1058, DOI 10.1017/S0007114510001728; Lyle BJ, 1998, J NUTR, V128, P2355, DOI 10.1093/jn/128.12.2355; Mancino L, 2009, FOOD POLICY, V34, P557, DOI 10.1016/j.foodpol.2009.09.003; Mandal B, 2014, ECON HUM BIOL, V14, P50, DOI 10.1016/j.ehb.2014.04.001; Mintel, 2015, MINT AC REP; Mursu J, 2011, ARCH INTERN MED, V171, P1625, DOI 10.1001/archinternmed.2011.445; Nayga R., 1999, FAMILY EC NUTR REV, V12, P43; Park J, 2001, AM J AGR ECON, V83, P840, DOI 10.1111/0002-9092.00213; Perez Claudio E, 2002, Health Rep, V13, P23; Petrovici DA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-222; Plurphanswat Nantaporn, 2014, BMC Obes, V1, P18, DOI 10.1186/s40608-014-0018-0; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Reinert A, 2007, EUR J NUTR, V46, P165, DOI 10.1007/s00394-007-0650-2; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; RUBIN DB, 1991, BIOMETRICS, V47, P1213, DOI 10.2307/2532381; Satia-Abouta J, 2003, AM J EPIDEMIOL, V157, P944, DOI 10.1093/aje/kwg039; Schroeter C, 2013, APPL ECON PERSPECT P, V35, P125, DOI 10.1093/aepp/pps040; Scrinis G., 2013, NUTR SCI POLITICS DI, P352; Stewart H, 2008, REV AGR ECON, V30, P43, DOI 10.1111/j.1467-9353.2007.00391.x; Thornton J, 2002, APPL ECON, V34, P59, DOI 10.1080/00036840010025650; U. S. Department of Agriculture/ U. S. Department of Health and Human Services (USDA/ HHS), 2015, DIET GUID AM 2015; United States Department of Agriculture and United States Department of Health and Human Services, 2010, DIET GUID AM 2010; United States Department of Agriculture-Food and Nutrition Service (USDA-FNS), 2010, DET PROD EL PURCH SN; Van Duyn MS, 2000, J AM DIET ASSOC, V100, P1511, DOI 10.1016/S0002-8223(00)00420-X; Variyam JN, 1999, APPL ECON, V31, P217, DOI 10.1080/000368499324444	76	7	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2017	12	10							e0185258	10.1371/journal.pone.0185258	http://dx.doi.org/10.1371/journal.pone.0185258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FJ3AF	28991921	gold, Green Submitted, Green Published			2022-12-27	WOS:000412601800013
J	de Beaufort, HWL; Coda, M; Conti, M; van Bakel, TMJ; Nauta, FJH; Lanzarone, E; Moll, FL; van Herwaarden, JA; Auricchio, F; Trimarchi, S				de Beaufort, Hector W. L.; Coda, Margherita; Conti, Michele; van Bakel, Theodorus M. J.; Nauta, Foeke J. H.; Lanzarone, Ettore; Moll, Frans L.; van Herwaarden, Joost A.; Auricchio, Ferdinando; Trimarchi, Santi			Changes in aortic pulse wave velocity of four thoracic aortic stent grafts in an ex vivo porcine model	PLOS ONE			English	Article							ASCENDING AORTA; ARTERIAL STIFFNESS; WALL; DISSECTION; ENDOGRAFTS; MECHANICS; ANEURYSMS; TISSUES; DEVICE; VALVES	Objectives Thoracic endovascular aortic repair (TEVAR) has been shown to lead to increased aortic stiffness. The aim of this study was to investigate the effect of stent graft type and stent graft length on aortic stiffness in a controlled, experimental setting. Methods Twenty porcine thoracic aortas were connected to a pulsatile mock loop system. Intraluminal pressure was recorded at two sites in order to measure pulse wave velocity (PWV) for each aorta: before stent graft deployment (t(1)); after deployment of a 100-mm long stent graft (t(2)); and after distal extension through deployment of a second 100-mm long stent graft (t(3)). Four different types of stent grafts (Conformable Gore (R) TAG (R) Device, Bolton Relay (R) Device, Cook Zenith Alpha (TM), and Medtronic Valiant (R)) were evaluated. Results For the total cohort of 20 aortas, PWV increased by a mean 0.6 m/s or 8.9% of baseline PWV after deployment of a 100-mm proximal stent graft (P<0.001), and by a mean 1.4 m/s or 23.0% of baseline PWV after distal extension of the stent graft (P<0.001). Univariable regression analysis showed a significant correlation between aortic PWV and extent of stent graft coverage, (P<0.001), but no significant effect of baseline aortic length, baseline aortic PWV, or stent graft type on the percentual increase in PWV at t(2) or at t(3). Conclusions In this experimental set-up, aortic stiffness increased significantly after stent graft deployment with each of the four types of stent graft, with the increase in aortic stiffness depending on the extent of stent graft coverage.	[de Beaufort, Hector W. L.; van Bakel, Theodorus M. J.; Nauta, Foeke J. H.; Trimarchi, Santi] Univ Milan, Policlin San Donato IRCCS, Thorac Aort Res Ctr, San Donato Milanese, Italy; [Coda, Margherita; Conti, Michele; Auricchio, Ferdinando] Univ Pavia, Dept Civil Engn & Architecture, Pavia, Italy; [Lanzarone, Ettore] Natl Res Council Italy CNR, IMATI, Milan, Italy; [Moll, Frans L.; van Herwaarden, Joost A.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands	IRCCS Policlinico San Donato; University of Milan; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Matematica Applicata e Tecnologie Informatiche "Enrico Magenes" (IMATI-CNR); Utrecht University; Utrecht University Medical Center	Trimarchi, S (corresponding author), Univ Milan, Policlin San Donato IRCCS, Thorac Aort Res Ctr, San Donato Milanese, Italy.	santi.trimarchi@grupposandonato.it	Stefanadis, Christodoulos/ABH-2232-2020; Conti, Michele/J-3580-2014; van Bakel, Theodorus/K-4994-2019; Auricchio, Ferdinando/B-9405-2009; Lanzarone, Ettore/G-1560-2011	Stefanadis, Christodoulos/0000-0001-5974-6454; Conti, Michele/0000-0003-1275-0653; van Bakel, Theodorus/0000-0001-5317-3026; Auricchio, Ferdinando/0000-0002-3735-2400; van Herwaarden, Joost/0000-0003-1165-5179; Lanzarone, Ettore/0000-0001-8816-9086	ERC [259229]; Ministero dell'Istruzione, dell'Universita e della Ricerca [2010BFXRHS]; iCardioCloud project by Cariplo Foundation [2013-1779]; Lombardy Region [42938382, 46554874]; European Society of Vascular Surgery	ERC(European Research Council (ERC)European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); iCardioCloud project by Cariplo Foundation; Lombardy Region(Regione Lombardia); European Society of Vascular Surgery	This work was supported by: ERC Starting Grant through the Project ISOBIO: Isogeometric Methods for Biomechanics [No. 259229]; Ministero dell'Istruzione, dell'Universita e della Ricerca [Project no. 2010BFXRHS], iCardioCloud project by Cariplo Foundation [no. 2013-1779] and Lombardy Region [No. 42938382; No. 46554874]. Material support was provided by Medtronic Inc, W.L. Gore & Associates, Bolton Medical, and Cook Medical. W.L. Gore & Associates have had insight into the manuscript before submitting it for publication, and have asked for correct mentioning of the name of their product in the final version of the manuscript. Hector de Beaufort gratefully acknowledges support from the European Society of Vascular Surgery by way of an Educational Travel Grant. But not W.L. Gore nor any of the other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Beaufort HWL, 2017, ANN VASC SURG; Deplano V, 2016, J BIOMECH, V49, P2031, DOI 10.1016/j.jbiomech.2016.05.005; Eggebrecht H, 2009, CIRCULATION, V120, pS276, DOI 10.1161/CIRCULATIONAHA.108.835926; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Juraszek A, 2014, EUR J CARDIO-THORAC, V46, P349, DOI 10.1093/ejcts/ezu055; Kleinstreuer C, 2008, J BIOMECH, V41, P2370, DOI 10.1016/j.jbiomech.2008.05.032; Lanzarone E, 2009, ARTIF ORGANS, V33, P1048, DOI 10.1111/j.1525-1594.2009.00812.x; Li WC, 2008, XENOTRANSPLANTATION, V15, P384, DOI 10.1111/j.1399-3089.2008.00498.x; Liu X, 2011, J BIOMECH, V44, P1123, DOI 10.1016/j.jbiomech.2011.01.024; Liu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3290, DOI 10.1152/ajpheart.00666.2007; Martin C, 2011, EUR J CARDIO-THORAC, V40, P28, DOI 10.1016/j.ejcts.2010.08.056; Morris L, 2016, EUR J VASC ENDOVASC, V51, P44, DOI 10.1016/j.ejvs.2015.07.041; Moulakakis KG, 2016, ANN VASC SURG, V1327; Nauta FJ, 2016, EUR J CARDIOTHORAC S; Nauta FJH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012270; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Polzer S, 2015, ACTA BIOMATER, V14, P133, DOI 10.1016/j.actbio.2014.11.043; Qing KX, 2012, EUR J VASC ENDOVASC, V44, P399, DOI 10.1016/j.ejvs.2012.06.004; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Sugita S., 2011, CARDIOVASCULAR ENG T, V3, DOI [10.1007/s13239-011-0067-1, DOI 10.1007/S13239-011-0067-1]; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Tzilalis VD, 2012, ANN VASC SURG, V26, P462, DOI 10.1016/j.avsg.2011.06.021; van Herwaarden JA, 2006, J ENDOVASC THER, V13, P406, DOI 10.1583/06-1848.1; van Prehn J, 2009, ANN VASC SURG, V23, P291, DOI 10.1016/j.avsg.2008.08.007; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061	26	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186080	10.1371/journal.pone.0186080	http://dx.doi.org/10.1371/journal.pone.0186080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982135	gold, Green Published, Green Submitted			2022-12-27	WOS:000412360300120
J	de la Pena, P; Wadley, L				de la Pena, Paloma; Wadley, Lyn			Technological variability at Sibudu Cave: The end of Howiesons Poort and reduced mobility strategies after 62,000 years ago	PLOS ONE			English	Article							MIDDLE-STONE-AGE; DIEPKLOOF ROCK SHELTER; SOUTH-AFRICA; KLIPDRIFT SHELTER; BONE TECHNOLOGY; WESTERN-CAPE; OCHRE; PATTERNS; CONTINUITY; ADHESIVES	We evaluate the cultural variation between the youngest Howiesons Poort layer (GR) and the oldest post-Howiesons Poort layers (RB-YA) of Sibudu Cave (KwaZulu-Natal, South Africa). We first conducted a technological analysis, secondly we performed a cladistic study with all the technological traits and, finally, we compare the technological variability with other data from Sibudu (ochre, micromorphology, fauna and plant remains). The synapomorphies of the cladistical analysis show numerous lithic technological changes between the youngest Howiesons Poort and the oldest post-Howiesons Poort layers as previously concluded. However, some technological strategies that are present, yet uncommon, in the Howiesons Poort become abundant in the overlying layers, whereas others that were fundamental to the Howiesons Poort continue, but are poorly represented in the overlying layers. We further show that lithic technological strategies appear and disappear as pulses in the post-Howiesons Poort layers studied. Among the most notable changes in the post-Howiesons Poort layers is the importance of flake production from discoidal knapping methods, the unstandardized retouched pieces and their infrequent representation, and the higher than usual frequency of grindstones. We evaluate various hypotheses to explain the transformation of a Howiesons Poort formal industry to a more 'expedient' assemblage. Since no marked environmental changes are contemporary with the technological transformation, a change in residential mobility patterns seems a plausible explanation. This hypothesis is supported by the changes observed in stratigraphy, lithic technology, site management, ochre and firewood collection.	[de la Pena, Paloma; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [de la Pena, Paloma] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand	de la Pena, P (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.; de la Pena, P (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	paloma.delapenya@gmail.com	Wadley, Lyn/AAC-6577-2022; de la Peña, Paloma/ABB-3086-2021; de la Peña, Paloma/AAA-6605-2021	de la Peña, Paloma/0000-0001-9731-7001; 	DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal); DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences	DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal); DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences	Fernando Abdala, Karim Sadr, Julien Benoit, Jerome Reynard and Aurore Val generously read the manuscript and helped us with the cladistics and discussion. The support of the DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences (CoE-Pal) towards this research is hereby acknowledged. The opinions expressed in this paper are not necessarily held by the funding body.; PP has a Post-doctoral grant from DST-National Research Foundation of South Africa Centre of Excellence in Paleosciences.	Allott L.F., 2006, S AFR HUMANIT, V18, P173; Ambrose SH, EMERGENCE MODERN HUM, P3; ARCHER F M, 1990, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V23, P959; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; Beaumont P.B., 1978, BORDER CAVE; Bentsen S. E., 2014, THESIS; Bruch AA, 2012, QUATERNARY SCI REV, V45, P7, DOI 10.1016/j.quascirev.2012.04.005; Clark JL, 2017, J HUM EVOL, V107, P49, DOI 10.1016/j.jhevol.2017.03.002; Clark JL, 2010, J ARCHAEOL SCI, V37, P2650, DOI 10.1016/j.jas.2010.06.001; Clark JL, 2008, J HUMAN EVOLUTION, V54; Clarke B.M., 2007, GEOLOGY VERULAM AREA; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Cochrane G.W.G., 2008, S AFRICAN ARCHAEOLOG, V10, P157; Conard NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130001; Conard NJ, 2012, S AFR ARCHAEOL BULL, V67, P180; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; de la Pena P, 2015, CURR ANTHROPOL, V56, P911, DOI 10.1086/684071; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Dusseldorp GL, 2014, AZANIA, V49, P317, DOI 10.1080/0067270X.2014.937080; Glenny W., 2006, SOUTH AFR HUMANIT, V18, P279; Goldberg P, 2006, PRACTICAL THEORETICA; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOULD RA, 1971, AM ANTIQUITY, V36, P149, DOI 10.2307/278668; Haidle MN, 2006, THESIS; Harper PTH, 1997, THESIS; Harper PTN, 1997, S AFR J SCI, V93, P470; HAYDEN B, 1979, PALEOLITHIC REFLECTI; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Herries, 2006, SOUTH AFR HUMANIT, V18, P131; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Hodgskiss T, 2012, SOUTH AFR HUMANIT, V24, P99; Igreja M, 2013, J ARCHAEOLOGICAL SCI, V40; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Lennox S, 2016, THESIS; Lombard M, 2012, S AFRICAN ARCHAEOLOG, V67; Lombard M., 2007, THESIS; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lourandos Harry, 1985, ARCHAEOL OCEAN, V20, P37; Lycett SJ, 2011, J EVOLUTIONARY PSYCH, V9, P143, DOI [DOI 10.1016/J.JAA.2007.07.003, DOI 10.1556/JEP.9.2011.23.1]; Lycett SJ, 2015, J ARCHAEOL SCI, V56, P21, DOI 10.1016/j.jas.2015.01.004; MacCalman NR, 1965, CIMBEBASIA, V13, P1; Mackay A, 2014, J HUMAN EVOLUTION, V72; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Marean CW, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P164; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; MILLER TO, 1979, LITHIC USE WEAR ANAL, P401; Mitchell P., 2008, S AFRICAN ARCHAEOLOG, V10, P52; Oswalt W. H, 1976, ANTHR ANAL FOOD GETT; Parry WJ., 1987, ORG CORE TECHNOLOGY, P285; Perreault C, 2013, CURR ANTHROPOL, V54, pS397, DOI 10.1086/673264; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Rautenbach I. L., 1982, MAMMALS TRANSVAAL; Renaut R., 2006, SOUTH AFR HUMANIT, V18, P235; Reynard JP, 2016, PALAEOGEOGR PALAEOCL, V449, P349, DOI 10.1016/j.palaeo.2016.02.035; Roberts P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157408; Schiegl S, 2004, S AFR J SCI, V100, P185; Schiegl S., 2006, SOUTH AFR HUMANIT, V18, P149; Sievers C., 2006, SOUTH AFR HUMANIT, V18, P203; Singer R., 1982, MIDDLE STONE AGE KLA; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; STERN N, 1994, J HUM EVOL, V27, P89, DOI 10.1006/jhev.1994.1037; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; THACKERAY AI, 1992, J WORLD PREHIST, V6, P385, DOI 10.1007/BF00975633; Torrence R., 1989, TIME ENERGY STONE TO; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Val A, 2016, QUATERN INT, V421, P173, DOI 10.1016/j.quaint.2014.11.068; van der Ryst M, 2013, AZANIA, V48, P403, DOI 10.1080/0067270X.2013.785238; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Volman T.P., 1984, P169; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L, QUARTZ KNAPPING STRA; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wallace IJ, 2006, J ARCHAEOL SCI, V33, P1293, DOI 10.1016/j.jas.2006.01.005; Wilkins J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174051; Will M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098359; Williams MJ, 2016, AREA, V48, P513, DOI 10.1111/area.12278; Williamson BS, 2000, THESIS; Wurz S., 2000, MIDDLE STONE AGE KLA; Wurz S., 2013, CURRENT ANTHR, V54	95	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185845	10.1371/journal.pone.0185845	http://dx.doi.org/10.1371/journal.pone.0185845			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FI9WM	28982148	Green Submitted, Green Published, gold			2022-12-27	WOS:000412360300075
J	Mendy, AL; Agbla, SC; Odutola, AA; Antonio, M; Greenwood, BM; Sutherland, JS; Ota, MOC				Mendy, Awa L.; Agbla, Schadrac C.; Odutola, Aderonke A.; Antonio, Martin; Greenwood, Brian M.; Sutherland, Jayne S.; Ota, Martin O. C.			Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; COLONIZATION; IMMUNOGENICITY; IMMUNIZATION; RESPONSES; ANTIGENS; DENSITY; MEASLES; SERUM	Introduction The currently used Streptococcus pneumoniae vaccines have had a significant impact on the pneumococcal diseases caused by the serotypes they cover. Their limitations have stimulated a search for alternate vaccines that will cover all serotypes, be affordable and effective in young children. Pneumococcal protein antigens are potential vaccine candidates that may meet some of the shortfalls of the current vaccines. Thus, this study aimed to determine the relationship between antibodies against pneumococcal protein antigens and nasopharyngeal carriage in infants. Methods One hundred and twenty mother-infant pairs were enrolled into the study. They had nasopharyngeal swabs(NPS) taken at birth and every two weeks for the first eight weeks after delivery, and blood samples were obtained at birth and every four weeks for the first eight weeks after delivery. Nasopharyngeal carriage of S. pneumoniae was determined from the NPS and antibodies against the pneumococcal proteins CbpA, PspA and rPly were measured in the blood samples. Results The S. pneumoniae carriage rate in infants increased to that of mothers by eight weeks of age. The odds of carriage in infants was 6.2 times (95% CI: 2.0-18.9) higher when their mothers were also carriers. Bacterial density in infants was lower at birth compared to their mothers (p = 0.004), but increased with age and became higher than that of their mothers at weeks 4 (p = 0.009), 6 (p = 0.002) and 8 (p<0.0001). At birth, the infants' antibodies against CbpA, and rPly pneumococcal protein antigens were similar, but that of PspA was lower (p<0.0001), compared to their mothers. Higher antibody concentrations to CbpA [OR (95% CI): 0.49 (0.26-0.92, p = 0.03)], but not PspA and rPly, were associated with protection against carriage in the infants. Conclusion Naturally induced antibodies against the three pneumococcal protein antigens were transferred from mother to child. The proportion of infants with nasopharyngeal carriage and the bacterial density of S. pneumoniae increased with age within the first eight weeks of life. Higher concentrations of antibodies against CbpA, but not PspA and rPly, were associated with reduced risk of nasopharyngeal carriage of S. pneumoniae in infants.	[Mendy, Awa L.; Agbla, Schadrac C.; Odutola, Aderonke A.; Antonio, Martin; Sutherland, Jayne S.; Ota, Martin O. C.] MRC Unit, Vaccines & Immun Theme, Fajara, Gambia; [Agbla, Schadrac C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Antonio, Martin; Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Antonio, Martin] Univ Warwick, Warwick Med Sch, Div Microbiol & Immun, Coventry, W Midlands, England; [Ota, Martin O. C.] WHO Reg Off Africa, Hlth Informat & Knowledge Management, Hlth Syst & Serv Cluster, Brazzaville, Rep Congo	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; World Health Organization	Ota, MOC (corresponding author), MRC Unit, Vaccines & Immun Theme, Fajara, Gambia.; Ota, MOC (corresponding author), WHO Reg Off Africa, Hlth Informat & Knowledge Management, Hlth Syst & Serv Cluster, Brazzaville, Rep Congo.	otama@who.int		Agbla, Schadrac/0000-0002-0648-3336; Sutherland, Jayne/0000-0002-7083-4997	Pfizer Prize; MRC UK; Royal Society of London; Pfizer	Pfizer Prize(Pfizer); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society of London(Royal Society of London); Pfizer(Pfizer)	Primary funding was from Pfizer Prize awarded to MOCO. The MRC UK supported funding ALM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Archibald Worwui for managing the database, all field workers and nurses involved in this study, and the staff and management of Fajikunda and Brikama Health Centres. They also thank Joseph Okeibunor (WHO AFRO) and Brenda Kwambana Adams (MRC) for helpful discussions, and James Paton (Australia) for his kind gift of the pneumococcal protein antigens. Special thanks to the Royal Society of London for selecting MOCO for the Pfizer Exceptional Merit Award, and to Pfizer for funding this study. The authors declare no competing interest both to the Royal Society of London and Pfizer.	ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; Azarian T, 2017, J INFECT DIS, V215, P713, DOI 10.1093/infdis/jiw628; Baggett HC, 2017, CLIN INFECT DIS, V64, pS317, DOI 10.1093/cid/cix100; Berglund J, 2014, CLIN VACCINE IMMUNOL, V21, P56, DOI 10.1128/CVI.00430-13; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; BOOY R, 1992, LANCET, V339, P507, DOI 10.1016/0140-6736(92)90336-2; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Egere U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049143; Francis JP, 2009, CLIN VACCINE IMMUNOL, V16, P1633, DOI 10.1128/CVI.00247-09; Friedel V, 2014, EPIDEMIOL INFECT, V142, P2186, DOI 10.1017/S0950268813003178; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; Garcia P, 1999, MOL MICROBIOL, V33, P128, DOI 10.1046/j.1365-2958.1999.01455.x; Garcia-Suarez MD, 2004, INFECT IMMUN, V72, P4534, DOI 10.1128/IAI.72.8.4534-4540.2004; Givon-Lavi N, 2010, PEDIATR INFECT DIS J, V29, P756, DOI 10.1097/INF.0b013e3181d99345; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gupta A, 2014, VACCINE, V32, P1466, DOI 10.1016/j.vaccine.2014.01.033; Hermand P, 2017, HUM VACC IMMUNOTHER, V13, P220, DOI 10.1080/21645515.2016.1234553; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Khan MN, 2014, HUM VACC IMMUNOTHER, V10, P3688, DOI 10.4161/21645515.2014.979631; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; Mina MJ, 2013, J INFECT DIS, V208, P1281, DOI 10.1093/infdis/jit317; Moral-Benito, 2016, XTDPDML LINEAR DYNAM; Mureithi MW, 2009, J INFECT DIS, V200, P783, DOI 10.1086/605023; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Odutola A, 2015, HUM VACCIN IMMUNOTHE; Odutola A, 2017, VACCINE, Vi; Odutola A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075558; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Pichichero ME, 2016, HUM VACC IMMUNOTHER, V12, P194, DOI 10.1080/21645515.2015.1052198; Richards L, 2010, IMMUNOBIOLOGY, V215, P251, DOI 10.1016/j.imbio.2009.12.004; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2015, VACCINE, V33, P7144, DOI 10.1016/j.vaccine.2015.11.012; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10; SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2; Skrondal A, 2014, J R STAT SOC C-APPL, V63, P211, DOI 10.1111/rssc.12023; Spellerberg B, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P412; Turner P, 2013, CLIN MICROBIOL INFEC, V19, pE551, DOI [10.1111/1469-0691.12286, 10.1111/1469-0691.12431]; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0185824	10.1371/journal.pone.0185824	http://dx.doi.org/10.1371/journal.pone.0185824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982123	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000412360300071
J	Minchom, A; Thavasu, P; Ahmad, Z; Stewart, A; Georgiou, A; O'Brien, MER; Popat, S; Bhosle, J; Yap, TA; de Bono, J; Banerji, U				Minchom, Anna; Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; O'Brien, Mary E. R.; Popat, Sanjay; Bhosle, Jaishree; Yap, Timothy A.; de Bono, Johann; Banerji, Udai			A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments	PLOS ONE			English	Article							EGFR MUTATIONS; IMMUNE ESCAPE; UP-REGULATION; GEFITINIB; CHEMOTHERAPY; ASSOCIATION; DOWNSTREAM; ACTIVATION; DOCETAXEL; PATHWAYS	We investigated PD-L1 changes in response to MEK and AKT inhibitors in KRAS mutant lung adenocarcinoma (adeno-NSCLC). PD-L1 expression was quantified using immunofluorescence and co-culture with a jurkat cell-line transfected with NFAT-luciferase was used to study if changes in PD-L1 expression in cancer cell lines were functionally relevant. Five KRAS mutant cell lines with high PD-L1 expression (H441, H2291, H23, H2030 and A549) were exposed to GI(50) inhibitor concentrations of a MEK inhibitor (trametinib) and an AKT inhibitor (AZD5363) for 3 weeks. Only 3/5 (H23, H2030 and A549) and 2/5 cell lines (H441 and H23) showed functionally significant increases in PD-L1 expression when exposed to trametinib or AZD5363 respectively. PD-L1 overexpression is not consistent and is unlikely to be an early mechanism of resistance to KRAS mutant adeno-NSCLC treated with MEK or AKT inhibitors.	[Minchom, Anna; O'Brien, Mary E. R.; Bhosle, Jaishree] Royal Marsden, Dept Med, Lung Unit, Sutton, Surrey, England; [Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; Yap, Timothy A.; de Bono, Johann; Banerji, Udai] Inst Canc Res, Drug Dev Unit, London, England; [Thavasu, Parames; Ahmad, Zai; Stewart, Adam; Georgiou, Alexandros; Yap, Timothy A.; de Bono, Johann; Banerji, Udai] Royal Marsden, London, England; [Popat, Sanjay] Royal Marsden, Lung Unit, London, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Banerji, U (corresponding author), Inst Canc Res, Drug Dev Unit, London, England.; Banerji, U (corresponding author), Royal Marsden, London, England.	udai.banerji@icr.ac.uk	Yap, Timothy/AAV-3573-2020; Popat, Sanjay/AAO-1634-2021	Popat, Sanjay/0000-0003-2087-4963; de Bono, Johann S/0000-0002-2034-595X; Minchom, Anna/0000-0002-9339-7101; Banerji, Udai/0000-0003-1503-3123	National Institute for Health Research Biomedical Research Centre; CRUK (Cancer Research UK); ECMC (Experimental Cancer Medicine Centre initiative); Cancer Research UK [11566] Funding Source: researchfish	National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); CRUK (Cancer Research UK)(Cancer Research UK); ECMC (Experimental Cancer Medicine Centre initiative); Cancer Research UK(Cancer Research UK)	Funding was received from National Institute for Health Research Biomedical Research Centre, CRUK (Cancer Research UK) and ECMC (Experimental Cancer Medicine Centre initiative).	Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Chen N, 2017, CANCER IMMUNOL IMMUN, V66, P1175, DOI 10.1007/s00262-017-2005-z; Chen N, 2015, J THORAC ONCOL, V10, P910, DOI 10.1097/JTO.0000000000000500; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Horn L, 2014, J CLIN ONCOL, V32; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Janne PA, 2016, EUR SOC MED ONC ANN; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park K, 2016, LANCET ONCOL, V17, P577, DOI 10.1016/S1470-2045(16)30033-X; Puglisi M, 2016, ONCOLOGY-BASEL, V90, P280, DOI 10.1159/000444928; Reck M, 2016, NEW ENG J MED; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Tolcher AW, 2015, CLIN CANCER RES, V21, P739, DOI 10.1158/1078-0432.CCR-14-1901; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Zhu ZH, 2014, PHARMACOGENOMICS, V15, P1507, DOI [10.2217/PGS.14.108, 10.2217/pgs.14.108]	26	13	15	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2017	12	10							e0186106	10.1371/journal.pone.0186106	http://dx.doi.org/10.1371/journal.pone.0186106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI9WM	28982179	Green Published, gold, Green Submitted			2022-12-27	WOS:000412360300124
J	Parajuli, N; Shrum, S; Tobacyk, J; Herb, A; Arthur, JM; MacMillan-Crow, LA				Parajuli, Nirmala; Shrum, Stephen; Tobacyk, Julia; Herb, Alex; Arthur, John M.; MacMillan-Crow, Lee Ann			Renal cold storage followed by transplantation impairs expression of key mitochondrial fission and fusion proteins	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; POLYETHYLENE-GLYCOL; UNITED-STATES; OMA1; ISCHEMIA; CELLS; YME1L; FRAGMENTATION; ACTIVATION; APOPTOSIS	Background The majority of transplanted kidneys are procured from deceased donors which all require exposure to cold storage (CS) for successful transplantation. Unfortunately, this CS leads to renal and mitochondrial damage but, specific mitochondrial targets affected by CS remain largely unknown. The goal of this study is to determine whether pathways involved with mitochondrial fusion or fission, are disrupted during renal CS. Methods Male Lewis rat kidneys were exposed to cold storage (CS) alone or cold storage combined with transplantation (CS/Tx). To compare effects induced by CS, kidney transplantation without CS exposure (autotransplantation; ATx) was also used. Mitochondrial function was assessed using high resolution respirometry. Expression of mitochondrial fusion and fission proteins were monitored using Western blot analysis. Results CS alone (no Tx) reduced respiratory complex I and II activities along with reduced expression of the primary mitochondrial fission protein, dynamin related protein (DRP1), induced loss of the long form of Optic Atrophy Protein (OPA1), and altered the mitochondrial protease, OMA1, which regulates OPA1 processing. CS followed by Tx (CS/Tx) reduced complex I, II, and III activities, and induced a profound loss of the long and short forms of OPA1, mitofusin 1 (MFN1), and mitofusin 2 (MFN2) which all control mitochondrial fusion. In addition, expression of DRP1, along with its primary receptor protein, mitochondrial fission factor (MFF), were also reduced after CS/Tx. Interestingly, CS/Tx lead to aberrant higher molecular weight OMA1 aggregate expression. Conclusions Our results suggest that CS appears to involve activation of the OMA1, which could be a key player in proteolysis of the fusion and fission protein machinery following transplantation. These findings raise the possibility that impaired mitochondrial fission and fusion may be unrecognized contributors to CS induced mitochondrial injury and compromised renal graft function after transplantation.	[Parajuli, Nirmala; Shrum, Stephen; Tobacyk, Julia; Herb, Alex; MacMillan-Crow, Lee Ann] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Arthur, John M.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	MacMillan-Crow, LA (corresponding author), Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA.	lmcrow@uams.edu	Parajuli, Nirmala/V-9901-2019	Arthur, John/0000-0003-4342-4762; Parajuli, Nirmala/0000-0003-3994-5338	American Heart Association [16SDG276000026, 16PRE30830010]; National Institutes of Health-General Medicine [T32GM106999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM106999] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health-General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association 16SDG276000026 (NP) and 16PRE30830010 (SS) and the National Institutes of Health-General Medicine T32GM106999 (SS and JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Bohovych I, 2014, J BIOL CHEM, V289, P13259, DOI 10.1074/jbc.M113.542910; Cecka J M, 1993, Clin Transpl, P1; Debout A, 2015, KIDNEY INT, V87, P343, DOI 10.1038/ki.2014.304; Doucet C, 2004, BBA-GEN SUBJECTS, V1673, P105, DOI 10.1016/j.bbagen.2004.03.018; Dutheil D, 2006, AM J TRANSPLANT, V6, P1529, DOI 10.1111/j.1600-6143.2006.01343.x; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Faure JP, 2002, J PHARMACOL EXP THER, V302, P861, DOI 10.1124/jpet.102.033688; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hauet T, 2001, J PHARMACOL EXP THER, V297, P946; Healy DA, 2006, J AM SOC NEPHROL, V17, P805, DOI 10.1681/ASN.2005090980; Jani A, 2004, AM J TRANSPLANT, V4, P1246, DOI 10.1111/j.1600-6143.2004.00498.x; Jendrach M, 2008, MITOCHONDRION, V8, P293, DOI 10.1016/j.mito.2008.06.001; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Leonard AP, 2015, BBA-MOL CELL RES, V1853, P348, DOI 10.1016/j.bbamcr.2014.11.002; Mitchell T, 2011, J PHARMACOL EXP THER, V336, P682, DOI 10.1124/jpet.110.176743; Mitchell T, 2010, FREE RADICAL BIO MED, V49, P1273, DOI 10.1016/j.freeradbiomed.2010.07.012; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Parajuli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048590; Patil NK, 2014, AM J PHYSIOL-RENAL, V306, pF734, DOI 10.1152/ajprenal.00643.2013; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Port FK, 2005, AM J TRANSPLANT, V5, P843, DOI 10.1111/j.1600-6135.2005.00831.x; Rainbolt TK, 2016, CELL REP, V14, P2041, DOI 10.1016/j.celrep.2016.02.011; Rainbolt TK, 2015, EMBO REP, V16, P97, DOI 10.15252/embr.201438976; Saba H, 2008, RENAL FAILURE, V30, P125, DOI 10.1080/08860220701813327; Saita S, 2016, GENES CELLS, V21, P408, DOI 10.1111/gtc.12351; Salahudeen AK, 2004, AM J PHYSIOL-RENAL, V287, pF181, DOI 10.1152/ajprenal.00098.2004; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2001, TRANSPLANTATION, V72, P798, DOI 10.1097/00007890-200109150-00010; Salahudeen AK, 2000, TRANSPLANTATION, V70, P1424, DOI 10.1097/00007890-200011270-00005; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Shrum S., 2016, AM J KIDNEY DIS, V2, P114; SOUTHARD JH, 1983, CRYOBIOLOGY, V20, P395, DOI 10.1016/0011-2240(83)90029-9; SOUTHARD JH, 1980, CRYOBIOLOGY, V17, P148, DOI 10.1016/0011-2240(80)90019-X; SOUTHARD JH, 1984, CRYOBIOLOGY, V21, P13, DOI 10.1016/0011-2240(84)90017-8; Stiburek L, 2012, MOL BIOL CELL, V23, P1010, DOI 10.1091/mbc.E11-08-0674; Watanabe T, 2014, EXP CELL RES, V323, P314, DOI 10.1016/j.yexcr.2014.02.027; Xiao X., 2014, J CHEM, V2014, P1; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yin M, 2002, RENAL FAILURE, V24, P147, DOI 10.1081/JDI-120004092; Zhang K, 2014, EMBO REP, V15, P576, DOI 10.1002/embr.201338240; Zolezzi JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064019	45	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2017	12	10							e0185542	10.1371/journal.pone.0185542	http://dx.doi.org/10.1371/journal.pone.0185542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI7FU	28977005	Green Submitted, Green Published, gold			2022-12-27	WOS:000412163100027
J	Leder, K; Grobusch, MP; Gautret, P; Chen, LH; Kuhn, S; Lim, PL; Yates, J; McCarthy, AE; Rothe, C; Kato, Y; Bottieau, E; Huber, K; Schwartz, E; Stauffer, W; Malvy, D; Shaw, MTM; Rapp, C; Blumberg, L; Jensenius, M; van Genderen, PJJ; Hamer, DH				Leder, Karin; Grobusch, Martin P.; Gautret, Philippe; Chen, Lin H.; Kuhn, Susan; Lim, Poh Lian; Yates, Johnnie; McCarthy, Anne E.; Rothe, Camilla; Kato, Yasuyuki; Bottieau, Emmanuel; Huber, Kristina; Schwartz, Eli; Stauffer, William; Malvy, Denis; Shaw, Marc T. M.; Rapp, Christophe; Blumberg, Lucille; Jensenius, Mogens; van Genderen, Perry J. J.; Hamer, Davidson H.		GeoSentinel Surveillance Network	Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis, 2012 to 2016	PLOS ONE			English	Article							SEXUAL TRANSMISSION; UNITED-STATES; DISEASE; SPECIFICITY; INFECTION; INDONESIA; PACIFIC	Background Zika virus (ZIKV) was first isolated in Africa; decades later, caused large outbreaks in the Pacific, and is considered endemic in Asia. We aim to describe ZIKV disease epidemiology outside the Americas, the importance of travelers as sentinels of disease transmission, and discrepancies in travel advisories from major international health organizations. Methods and findings This descriptive analysis using GeoSentinel Surveillance Network records involves sixty-four travel and tropical medicine clinics in 29 countries. Ill returned travelers with a confirmed or probable diagnosis of ZIKV disease acquired in Africa, Asia and the Pacific seen between 1 January 2012 and 31 December 2016 are included, and the frequencies of demographic, trip, and diagnostic characteristics described. ZIKV was acquired in Asia (18), the Pacific (10) and Africa (1). For five countries (Indonesia, Philippines, Thailand, Vietnam, Cameroon), GeoSentinel patients were sentinel markers of recent Zika activity. Additionally, the first confirmed ZIKV infection acquired in Kiribati was reported to GeoSentinel (2015), and a probable case was reported from Timor Leste (April 2016), representing the only case known to date. Review of Zika situation updates from major international health authorities for country risk classifications shows heterogeneity in ZIKV country travel advisories. Conclusions Travelers are integral to the global spread of ZIKV, serving as sentinel markers of disease activity. Although GeoSentinel data are collected by specialized clinics and do not capture all imported cases, we show that surveillance of imported infections by returned travelers augments local surveillance system data regarding ZIKV epidemiology and can assist with risk categorization by international authorities. However, travel advisories are variable due to risk uncertainties.	[Leder, Karin] Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Leder, Karin] Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Grobusch, Martin P.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med,Acad Med Ctr, Amsterdam, Netherlands; [Gautret, Philippe] Aix Marseille Univ, CNRS 7278, IRD 198, UM63,INSERM 1095,IHU Mediterranee Infect, Marseillle, France; [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MA USA; [Chen, Lin H.] Harvard Med Sch, Boston, MA USA; [Kuhn, Susan] Univ Calgary, Calgary, AB, Canada; [Lim, Poh Lian] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Lim, Poh Lian] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yates, Johnnie] Hawaii Permenente Med Grp, Honolulu, HI USA; [McCarthy, Anne E.] Ottawa Hosp, Dept Med, Ottawa, ON, Canada; [McCarthy, Anne E.] Univ Ottawa, Ottawa, ON, Canada; [Rothe, Camilla] Univ Hamburg, Div Trop Med & Infect Dis, Hamburg, Germany; [Kato, Yasuyuki] Natl Ctr Global Hlth & Med, Div Preparedness & Emerging Infect, Dis Control & Prevent Ctr, Tokyo, Japan; [Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Huber, Kristina] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med & Trop Dis, Tel Hashomer, Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Stauffer, William] Univ Minnesota, Dept Med & Pediat Infect Dis & Internal Med, Minneapolis, MN USA; [Malvy, Denis] Univ Bordeaux, Univ Hosp Ctr, Bordeaux, France; [Malvy, Denis] Univ Bordeaux, Inserm 1219, Bordeaux, France; [Shaw, Marc T. M.] James Cook Univ, Townsville, Qld, Australia; [Rapp, Christophe] Begin Mil Hosp, Dept Infect & Trop Dis, CMETE Travel Clin Paris, St Mande, France; [Blumberg, Lucille] Natl Inst Communicable Dis, Johannesburg, South Africa; [Jensenius, Mogens] Oslo Univ Hosp, Dept Infect Dis, Oslo, Norway; [van Genderen, Perry J. J.] Harbour Hosp, Inst Trop Dis, Rotterdam, Netherlands; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Hamer, Davidson H.] Boston Univ, Sch Med, Sect Infect Dis, Dept Med, Boston, MA USA	Monash University; Royal Melbourne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; University of Calgary; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Hamburg; National Center for Global Health & Medicine - Japan; Institute of Tropical Medicine (ITM); University of Munich; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Minnesota System; University of Minnesota Twin Cities; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; James Cook University; National Institute for Communicable Diseases (NICD); University of Oslo; Boston University; Boston University; Boston University	Leder, K (corresponding author), Monash Univ, Sch Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Leder, K (corresponding author), Royal Melbourne Hosp, Doherty Inst Infect & Immun, Victorian Infect Dis Serv, Melbourne, Vic, Australia.	karin.leder@monash.edu	Gautret, Philippe/AAY-5126-2021; MALVY, Denis/T-7930-2019; Chen, Lin/ADS-6751-2022; Hamer, Davidson Howes/J-2020-2019; Leder, Karin/AAD-2388-2019	Gautret, Philippe/0000-0002-1664-958X; Hamer, Davidson Howes/0000-0002-4700-1495; Leder, Karin/0000-0003-1368-1039; Chen, Lin/0000-0002-5684-8436	Centers for Disease Control and Prevention [U50CK00189]; ISTM; Public Health Agency of Canada; CENTERS FOR DISEASE CONTROL AND PREVENTION [U50CK000189] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ISTM; Public Health Agency of Canada; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was supported by a cooperative agreement (U50CK00189) between the Centers for Disease Control and Prevention (https://www.cdc.gov/ncezid/dgmq/) to the International Society of Travel Medicine (ISTM) and funding from the ISTM (http://www.istm.org/) and the Public Health Agency of Canada (http://www.phac-aspc.gc.ca/index-engphp). The funding agencies supported the collection of GeoSentinel data, but had no role in the writing or content of this manuscript, or in the decision to submit the paper for publication.	Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617; Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/msphere.00292-17, 10.1128/mSphere.00292-17]; Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6; Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5; Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2; Center for Disease Control, ZIK TRAV INF; Centers for Diseases Control and Prevention (CDC), ZIK VIR SE AS; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; ECDC, ZIK VIR SIT REP; ECDC, PLAC INF IMP CAS EU; ECDC, 2017, ZIK VIR DIS EP; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Goorhuis A, 2016, LANCET INFECT DIS, V16, P1204, DOI 10.1016/S1473-3099(16)30316-4; Hamer DH, 2016, ANN INTERNAL MED; HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323; Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029; Lobigs M, 2009, J VIROL, V83, P2436, DOI 10.1128/JVI.02273-08; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480; NaTHNaC, ZIK VIR COUNTR SPEC; Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011; SMITHBURN KC, 1954, J IMMUNOL, V72, P248; SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237; Veasna D, 2016, INT J INFECT DIS IJI; Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302; WHO, ZIK VIR COUNTR CLASS; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; World Health Organization, 2016, ZIK VIR DIS INT CAS; World Health Organization, ZIK VIR SIT REP; World Health Organization Fifth Meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH	46	31	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2017	12	10							e0185689	10.1371/journal.pone.0185689	http://dx.doi.org/10.1371/journal.pone.0185689			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI6UJ	28973011	Green Published, Green Accepted, gold			2022-12-27	WOS:000412131900036
